PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fargali, S; Garcia, AL; Sadahiro, M; Jiang, C; Janssen, WG; Lin, WJ; Cogliani, V; Elste, A; Mortillo, S; Cero, C; Veitenheimer, B; Graiani, G; Pasinetti, GM; Mahata, SK; Osborn, JW; Huntley, GW; Phillips, GR; Benson, DL; Bartolomucci, A; Salton, SR				Fargali, Samira; Garcia, Angelo L.; Sadahiro, Masato; Jiang, Cheng; Janssen, William G.; Lin, Wei-Jye; Cogliani, Valeria; Elste, Alice; Mortillo, Steven; Cero, Cheryl; Veitenheimer, Britta; Graiani, Gallia; Pasinetti, Giulio M.; Mahata, Sushil K.; Osborn, John W.; Huntley, George W.; Phillips, Greg R.; Benson, Deanna L.; Bartolomucci, Alessandro; Salton, Stephen R.			The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure	FASEB JOURNAL			English	Article						adrenal; chromaffin granule; CG; large dense core vesicle; LDCV; norepinephrine	GRANULE-LIKE STRUCTURES; DENSE-CORE GRANULES; NERVE GROWTH-FACTOR; CHROMOGRANIN-A; TARGETED ABLATION; NEUROPEPTIDE-Y; MESSENGER-RNA; NEUROENDOCRINE; PEPTIDE; EXPRESSION	Secretion of proteins and neurotransmitters from large dense core vesicles (LDCVs) is a highly regulated process. Adrenal LDCV formation involves the granin proteins chromogranin A (CgA) and chromogranin B (CgB); CgA- and CgB-derived peptides regulate catecholamine levels and blood pressure. We investigated function of the granin VGF (nonacronymic) in LDCV formation and the regulation of catecholamine levels and blood pressure. Expression of exogenous VGF in nonendocrine NIH 3T3 fibroblasts resulted in the formation of LDCV-like structures and depolarization-induced VGF secretion. Analysis of germline VGF-knockout mouse adrenal medulla revealed decreased LDCV size in noradrenergic chromaffin cells, increased adrenal norepinephrine and epinephrine content and circulating plasma epinephrine, and decreased adrenal CgB. These neurochemical changes in VGF-knockout mice were associated with hypertension. Germline knock-in of human VGF(1-615) into the mouse Vgf locus rescued the hypertensive knockout phenotype, while knock-in of a truncated human VGF(1-524) that lacks several C-terminal peptides, including TLQP-21, resulted in a small but significant increase in systolic blood pressure compared to hVGF(1-615) mice. Finally, acute and chronic administration of the VGF-derived peptide TLQP-21 to rodents decreased blood pressure. Our studies establish a role for VGF in adrenal LDCV formation and the regulation of catecholamine levels and blood pressure.Fargali, S., Garcia, A. L., Sadahiro, M., Jiang, C., Janssen, W. G., Lin, W.-J., Cogliani, V., Elste, A., Mortillo, S., Cero, C., Veitenheimer, B., Graiani, G., Pasinetti, G. M., Mahata, S. K., Osborn, J. W., Huntley, G. W., Phillips, G. R., Benson, D. L., Bartolomucci, A., Salton, S. R. The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure.	[Fargali, Samira; Garcia, Angelo L.; Sadahiro, Masato; Jiang, Cheng; Janssen, William G.; Lin, Wei-Jye; Cogliani, Valeria; Elste, Alice; Mortillo, Steven; Pasinetti, Giulio M.; Huntley, George W.; Phillips, Greg R.; Benson, Deanna L.; Salton, Stephen R.] Ichan Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Salton, Stephen R.] Ichan Sch Med Mt Sinai, Dept Geriatr, New York, NY 10029 USA; [Pasinetti, Giulio M.] Ichan Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Garcia, Angelo L.; Sadahiro, Masato; Jiang, Cheng] Ichan Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Pasinetti, Giulio M.; Huntley, George W.; Phillips, Greg R.; Benson, Deanna L.; Salton, Stephen R.] Ichan Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Cero, Cheryl; Veitenheimer, Britta; Osborn, John W.; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Graiani, Gallia] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy; [Mahata, Sushil K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; University of Parma; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Salton, SR (corresponding author), Ichan Sch Med Mt Sinai, Dept Neurosci, Box 1065,1 Gustave L Levy Pl, New York, NY 10029 USA.	stephen.salton@mssm.edu	Jiang, Cheng/O-6217-2017; Mahata, Sushil/AAF-8781-2021; Lin, Wei-Jye/AGW-1054-2022	Jiang, Cheng/0000-0003-4583-3295; Huntley, George W./0000-0003-3645-6192; Lin, Wei-Jye/0000-0002-6057-7325; Graiani, Gallia/0000-0003-1926-7568; Cero, Cheryl/0000-0003-0513-8669; Benson, Deanna/0000-0001-7037-1147; Salton, Stephen/0000-0003-4087-8427; Pasinetti, Giulio/0000-0002-1524-5196	American Psychological Association Diversity Program in Neuroscience predoctoral fellowship; U.S. National Institutes of Health (NIH) Endocrine Training grant [5T32DK07645]; NIH grant [RO1 DK071308, RO1 MH086499, R21/R33 MH083496, R01 HL076312]; Diabetes Action Research and Education Foundation; Minnesota Partnership for Biotechnology and Medical Genomics, Decade of Discovery in Diabetes grant; U.S. Department of Veterans Affairs Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116476, R01HL076312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071308, T32DK007645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096678, R33MH083496, R01MH086499, R21MH083496] Funding Source: NIH RePORTER	American Psychological Association Diversity Program in Neuroscience predoctoral fellowship; U.S. National Institutes of Health (NIH) Endocrine Training grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Action Research and Education Foundation; Minnesota Partnership for Biotechnology and Medical Genomics, Decade of Discovery in Diabetes grant; U.S. Department of Veterans Affairs Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank director Kevin Kelley and staff of the Mouse Genetics Core Facility (Icahn School of Medicine at Mount Sinai) for their assistance with Vgf gene targeting in ES cells and the generation of humanized VGF-knock-in mouse lines. This work was supported by an American Psychological Association Diversity Program in Neuroscience predoctoral fellowship (A. L. G.), U.S. National Institutes of Health (NIH) Endocrine Training grant 5T32DK07645 (S. F.), NIH grant RO1 DK071308 (S. R. S.), NIH grant RO1 MH086499 (S. R. S.), NIH grant R21/R33 MH083496 (S. R. S.), the Diabetes Action Research and Education Foundation (S. R. S.), a Minnesota Partnership for Biotechnology and Medical Genomics, Decade of Discovery in Diabetes grant (A. B.), NIH grant R01 HL076312 (J.W.O.), and a U.S. Department of Veterans Affairs Research Career Scientist Award (S. K. M.).	Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Canu N, 1997, GENOMICS, V45, P443, DOI 10.1006/geno.1997.4945; Chakraborty TR, 2006, BRAIN RES, V1089, P21, DOI 10.1016/j.brainres.2006.02.124; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; Courel M, 2010, J BIOL CHEM, V285, P10030, DOI 10.1074/jbc.M109.064196; Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; D'Amato F, 2008, J ENDOCRINOL, V197, P359, DOI 10.1677/JOE-07-0346; Diaz-Vera J, 2012, FASEB J, V26, P430, DOI 10.1096/fj.11-181941; Diaz-Vera J, 2010, J NEUROSCI, V30, P950, DOI 10.1523/JNEUROSCI.2894-09.2010; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Fargali S, 2012, J ENDOCRINOL, V215, P313, DOI 10.1530/JOE-12-0172; Fujihara H, 2012, ENDOCRINOLOGY, V153, P1377, DOI 10.1210/en.2011-1539; Garcia AL, 2005, J BIOL CHEM, V280, P41595, DOI 10.1074/jbc.M509122200; Gentile F, 2004, EXP CELL RES, V295, P269, DOI 10.1016/j.yexcr.2004.01.010; Grabner CP, 2005, J NEUROPHYSIOL, V94, P2093, DOI 10.1152/jn.00316.2005; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hahm S, 2002, J NEUROSCI, V22, P6929; Hanson HH, 2010, MICROSC MICROANAL, V16, P747, DOI 10.1017/S1431927610094092; Helle KB, 2004, BIOL REV, V79, P769, DOI 10.1017/S146479310400644X; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Hotta K, 2009, J ENDOCRINOL, V202, P111, DOI 10.1677/JOE-08-0531; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; Inomoto C, 2007, J HISTOCHEM CYTOCHEM, V55, P487, DOI 10.1369/jhc.6A7110.2007; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Loh YP, 2012, J MOL NEUROSCI, V48, P347, DOI 10.1007/s12031-012-9728-2; Loh YP, 2004, J MOL NEUROSCI, V22, P63, DOI 10.1385/JMN:22:1-2:63; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Natori S, 1996, P NATL ACAD SCI USA, V93, P4431, DOI 10.1073/pnas.93.9.4431; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Possenti R, 1999, ENDOCRINOLOGY, V140, P3727, DOI 10.1210/en.140.8.3727; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; SALTON SRJ, 1991, MOL CELL BIOL, V11, P2335, DOI 10.1128/MCB.11.5.2335; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Snyder SE, 2003, J ENDOCRINOL, V179, P227, DOI 10.1677/joe.0.1790227; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Stettler H, 2009, BIOCHEM J, V418, P81, DOI 10.1042/BJ20071382; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Toshinai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE394, DOI 10.1152/ajpendo.00768.2009; Trani E, 2002, J NEUROCHEM, V81, P565, DOI 10.1046/j.1471-4159.2002.00842.x; TRANI E, 1995, J NEUROCHEM, V65, P2441; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Veitenheimer B, 2011, AM J PHYSIOL-REG I, V300, pR460, DOI 10.1152/ajpregu.00371.2010; Watson E, 2005, ENDOCRINOLOGY, V146, P5151, DOI 10.1210/en.2005-0588; Watson Elizabeth, 2009, BMC Physiology, V9, P19, DOI 10.1186/1472-6793-9-19; Yamaguchi H, 2007, J BIOL CHEM, V282, P26354, DOI 10.1074/jbc.M701665200; Zhang KX, 2014, J NEUROCHEM, V129, P48, DOI 10.1111/jnc.12527; Zhang KX, 2011, CURR HYPERTENS REP, V13, P36, DOI 10.1007/s11906-010-0170-y; Zhang KX, 2009, CIRC-CARDIOVASC GENE, V2, P46, DOI 10.1161/CIRCGENETICS.108.785659	63	33	33	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2120	2133		10.1096/fj.13-239509	http://dx.doi.org/10.1096/fj.13-239509			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24497580	Green Published			2022-12-25	WOS:000335336000016
J	Ma, J; Tang, XY; Wong, PK; Jacobs, B; Borden, EC; Bedogni, B				Ma, Jun; Tang, Xiaoying; Wong, Poki; Jacobs, Barbara; Borden, Ernest C.; Bedogni, Barbara			Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Matrix Metalloproteinase (MMP); Melanoma; Notch Receptor; Protein-Protein Interactions	TUMOR-CELLS; DROSOPHILA; PROGRESSION; MIGRATION; CLEAVES; GROWTH; DIFFERENTIATION; MELANOCYTES; INHIBITION; EXPRESSION	Background: Notch1 is highly activated in melanoma where it plays protumorigenic functions, yet no Notch1-activating mutations have been identified in melanoma. Results: MT1-MMP operates as a novel protease that promotes Notch1 activation in melanoma cells. Conclusion: An MT1-MMP/Notch1 signaling pathway supports melanoma cell growth. Significance: Notch1 emerges as a new MT1-MMP substrate that plays important biological roles in melanoma. Notch1 is an evolutionarily conserved signaling molecule required for stem cell maintenance that is inappropriately reactivated in several cancers. We have previously shown that melanomas reactivate Notch1 and require its function for growth and survival. However, no Notch1-activating mutations have been observed in melanoma, suggesting the involvement of other activating mechanisms. Notch1 activation requires two cleavage steps: first by a protease and then by -secretase, which releases the active intracellular domain (Notch1(NIC)). Interestingly, although ADAM10 and -17 are generally accepted as the proteases responsible of Notch1 cleavage, here we show that MT1-MMP, a membrane-tethered matrix metalloproteinase involved in the pathogenesis of a number of tumors, is a novel protease required for the cleavage of Notch1 in melanoma cells. We find that active Notch1 and MT1-MMP expression correlate significantly in over 70% of melanoma tumors and 80% of melanoma cell lines, whereas such correlation does not exist between Notch1(NIC) and ADAM10 or -17. Modulation of MT1-MMP expression in melanoma cells affects Notch1 cleavage, whereas MT1-MMP expression in ADAM10/17 double knock-out fibroblasts restores the processing of Notch1, indicating that MT1-MMP is sufficient to promote Notch1 activation independently of the canonical proteases. Importantly, we find that MT1-MMP interacts with Notch1 at the cell membrane, supporting a potential direct cleavage mechanism of MT1-MMP on Notch1, and that MT1-MMP-dependent activation of Notch1 sustains melanoma cell growth. Together, the data highlight a novel mechanism of activation of Notch1 in melanoma cells and identify Notch1 as a new MT1-MMP substrate that plays important biological roles in melanoma.	[Ma, Jun; Tang, Xiaoying; Wong, Poki; Bedogni, Barbara] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Jacobs, Barbara; Borden, Ernest C.] Cleveland Clin Fdn, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation	Bedogni, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Wood Bldg,Rm RT400-8,10900 Euclid Ave, Cleveland, OH 44106 USA.	barbara.bedogni@case.edu			Harry Lloyd Charitable Trust	Harry Lloyd Charitable Trust	This work was supported by funding from the Harry Lloyd Charitable Trust.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Harrison M, 2004, DEV DYNAM, V231, P214, DOI 10.1002/dvdy.20113; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Herzog C, 2007, NIH PUBLICATION, V06-5767, P53; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hofmann UB, 2000, J PATHOL, V191, P245; Howlader N, 2011, SEER CANC STAT REV 1; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Koshikawa N, 2010, CANCER RES, V70, P6093, DOI 10.1158/0008-5472.CAN-10-0346; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Osawa M, 2008, J INVEST DERMATOL, V128, P2571, DOI 10.1038/jid.2008.289; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Postovit LM, 2007, J CELL BIOCHEM, V101, P908, DOI 10.1002/jcb.21227; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Razorenova O V, 2005, Mol Biol (Mosk), V39, P286; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Strizzi L, 2009, CANCER RES, V69, P7131, DOI 10.1158/0008-5472.CAN-09-1199; Sulis ML, 2011, LEUKEMIA, V25, P1564, DOI 10.1038/leu.2011.130; Tomlinson ML, 2009, CHEM BIOL, V16, P93, DOI 10.1016/j.chembiol.2008.12.005; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wen CH, 1997, DEVELOPMENT, V124, P4759; Zhang K, 2012, ONCOGENE, V31, P4609, DOI 10.1038/onc.2011.606	43	26	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8442	8449		10.1074/jbc.M113.516039	http://dx.doi.org/10.1074/jbc.M113.516039			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492617	Green Published, hybrid			2022-12-25	WOS:000333157500036
J	Tanimizu, N; Nishikawa, Y; Ichinohe, N; Akiyama, H; Mitaka, T				Tanimizu, Naoki; Nishikawa, Yuji; Ichinohe, Norihisa; Akiyama, Haruhiko; Mitaka, Toshihiro			Sry HMG Box Protein 9-positive (Sox9(+)) Epithelial Cell Adhesion Molecule-negative (EpCAM(-)) Biphenotypic Cells Derived from Hepatocytes Are Involved in Mouse Liver Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cell Polarity; Hepatocyte; Liver; Regeneration; Biphenotypic Cells; Ductular Reaction; Liver Stem; Progenitor Cells	PROGENITOR CELLS; STEM-CELLS; BILIARY TREE; MORPHOGENESIS; HEPATOBLASTS; EXPRESSION; DEVELOP; FATE	Background: Biphenotypic hepatocytes expressing Sox9 emerge upon liver injuries associated with ductular reaction. Results: Sox9(+) biphenotypic hepatocytes are derived from mature hepatocytes (MHs). Some of them are incorporated into ductular structures, whereas they efficiently differentiate to functional hepatocytes. Conclusion: Biphenotypic hepatocytes not only terminally convert to cholangiocytes but also differentiate back to MHs. Significance: Mature epithelial cells can show plasticity upon severe injuries and contribute to regeneration. It has been shown that mature hepatocytes compensate tissue damages not only by proliferation and/or hypertrophy but also by conversion into cholangiocyte-like cells. We found that Sry HMG box protein 9-positive (Sox9(+)) epithelial cell adhesion molecule-negative (EpCAM(-)) hepatocyte nuclear factor 4-positive (HNF4(+)) biphenotypic cells showing hepatocytic morphology appeared near EpCAM(+) ductular structures in the livers of mice fed 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-containing diet. When Mx1-Cre:ROSA mice, which were injected with poly(I:C) to label mature hepatocytes, were fed with the DDC diet, we found LacZ(+)Sox9(+) cells near ductular structures. Although Sox9(+)EpCAM(-) cells adjacent to expanding ducts likely further converted into ductular cells, the incidence was rare. To know the cellular characteristics of Sox9(+)EpCAM(-) cells, we isolated them as GFP(+)EpCAM(-) cells from DDC-injured livers of Sox9-EGFP mice. Sox9(+)EpCAM(-) cells proliferated and could differentiate to functional hepatocytes in vitro. In addition, Sox9(+)EpCAM(-) cells formed cysts with a small central lumen in collagen gels containing Matrigel (R) without expressing EpCAM. These results suggest that Sox9(+)EpCAM(-) cells maintaining biphenotypic status can establish cholangiocyte-type polarity. Interestingly, we found that some of the Sox9(+) cells surrounded luminal spaces in DDC-injured liver while they expressed HNF4. Taken together, we consider that in addition to converting to cholangiocyte-like cells, Sox9(+)EpCAM(-) cells provide luminal space near expanded ductular structures to prevent deterioration of the injuries and potentially supply new hepatocytes to repair damaged tissues.	[Tanimizu, Naoki; Ichinohe, Norihisa; Mitaka, Toshihiro] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Develop & Regenerat, Sapporo, Hokkaido 0608556, Japan; [Nishikawa, Yuji] Asahikawa Med Univ, Dept Pathol, Div Tumor Pathol, Asahikawa, Hokkaido 0788510, Japan; [Akiyama, Haruhiko] Kyoto Univ, Sch Med, Dept Orthoped Surg, Kyoto 6068501, Japan	Sapporo Medical University; Asahikawa Medical College; Kyoto University	Tanimizu, N (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Develop & Regenerat,Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tanimizu@sapmed.ac.jp	Mitaka, Toshihiro/K-9424-2013	Mitaka, Toshihiro/0000-0001-9467-4871; Ichinohe, Norihisa/0000-0003-3723-7418	Ministry of Education, Culture, Sports, Science and Technology, Japan [22790386, 25460271, 21390365, 24390304]; Grants-in-Aid for Scientific Research [25282135, 25293289] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Young Scientists (B) and for Scientific Research (C) 22790386 and 25460271 (to N. T.) and Grants-in-Aid for Scientific Research (B) 21390365 and 24390304 (to T. M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Cardinale V, 2012, NAT REV GASTRO HEPAT, V9, P231, DOI 10.1038/nrgastro.2012.23; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jeliazkova P, 2013, HEPATOLOGY, V57, P2469, DOI 10.1002/hep.26254; Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Nejak-Bowen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059836; Nel-Themaat L, 2009, DEV DYNAM, V238, P1100, DOI 10.1002/dvdy.21954; Nishikawa Y, 2005, AM J PATHOL, V166, P1077, DOI 10.1016/S0002-9440(10)62328-0; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112; Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Thompson MD, 2010, AM J PATHOL, V177, P1812, DOI 10.2353/ajpath.2010.100173; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	35	67	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7589	7598		10.1074/jbc.M113.517243	http://dx.doi.org/10.1074/jbc.M113.517243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482234	hybrid, Green Published			2022-12-25	WOS:000332761500029
J	Wu, D; Asiedu, M; Matsumura, F; Wei, QZ				Wu, Di; Asiedu, Michael; Matsumura, Fumio; Wei, Qize			Phosphorylation of Myosin II-interacting Guanine Nucleotide Exchange Factor (MyoGEF) at Threonine 544 by Aurora B Kinase Promotes the Binding of Polo-like Kinase 1 to MyoGEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokinesis; Guanine Nucleotide Exchange Factor (GEF); Mitosis; Phosphorylation; Rho GTPases; MyoGEF; Aurora B Kinase; Central Spindle; Plk1	REGULATORY LIGHT-CHAIN; CENTRAL SPINDLE; CELL-DIVISION; CITRON KINASE; MITOTIC KINASES; CULTURED-CELLS; PLK1 DOCKING; BOX DOMAIN; CYTOKINESIS; RHO	Background: Aurora B kinase (aurora B) and polo-like kinase 1 (Plk1) are critical regulators of cytokinesis. Results: Phosphorylation of MyoGEF at Thr-544 by aurora B promotes the binding of Plk1 to MyoGEF. Conclusion: Phosphorylation of MyoGEF by aurora B creates a docking site for Plk1. Significance: Coordinated regulation of MyoGEF localization and activation by aurora B and Plk1 contributes to the regulation of cytokinesis. We previously reported that phosphorylation of myosin II-interacting guanine nucleotide exchange factor (MyoGEF) by polo-like kinase 1 (Plk1) promotes the localization of MyoGEF to the central spindle and increases MyoGEF activity toward RhoA during mitosis. In this study we report that aurora B-mediated phosphorylation of MyoGEF at Thr-544 creates a docking site for Plk1, leading to the localization and activation of MyoGEF at the central spindle. In vitro kinase assays show that aurora B can phosphorylate MyoGEF. T544A mutation drastically decreases aurora B-mediated phosphorylation of MyoGEF in vitro and in transfected HeLa cells. Coimmunoprecipitation and in vitro pulldown assays reveal that phosphorylation of MyoGEF at Thr-544 enhances the binding of Plk1 to MyoGEF. Immunofluorescence analysis shows that aurora B colocalizes with MyoGEF at the central spindle and midbody during cytokinesis. Suppression of aurora B activity by an aurora B inhibitor disrupts the localization of MyoGEF to the central spindle. In addition, T544A mutation interferes with the localization of MyoGEF to the cleavage furrow and decreases MyoGEF activity toward RhoA during mitosis. Taken together, our results suggest that aurora B coordinates with Plk1 to regulate MyoGEF activation and localization, thus contributing to the regulation of cytokinesis.	[Wu, Di; Wei, Qize] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Asiedu, Michael] Mayo Clin Rochester, Coll Med, Dept Surg, Rochester, MN 55902 USA; [Matsumura, Fumio] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Fordham University; Mayo Clinic; Rutgers State University New Brunswick	Wei, QZ (corresponding author), Fordham Univ, Dept Biol Sci, 441 E Fordham Rd,Larkin Hall,Rm 160, Bronx, NY 10458 USA.	qwei3@fordham.edu		Matsumura, Fumio/0000-0002-8204-153X	National Institutes of Health [R15GM097702]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM097702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15GM097702 (to Q. W.).	Asiedu M, 2008, J BIOL CHEM, V283, P28392, DOI 10.1074/jbc.M801801200; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cook Danielle R, 2011, Genes Cancer, V2, P932, DOI 10.1177/1947601912437035; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Di Cunto F, 2002, J CELL SCI, V115, P4819, DOI 10.1242/jcs.00163; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Lee YH, 2011, GENE DEV, V25, P176, DOI 10.1101/gad.1975811; Litvak V, 2004, MOL CELL, V14, P319, DOI 10.1016/S1097-2765(04)00214-X; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; Madaule P, 2000, MICROSC RES TECHNIQ, V49, P123, DOI 10.1002/(SICI)1097-0029(20000415)49:2<123::AID-JEMT3>3.0.CO;2-R; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Martz MK, 2013, MOL BIOL CELL, V24, P2785, DOI 10.1091/mbc.E12-07-0533; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Pal D, 2010, CELL CYCLE, V9, P4117, DOI 10.4161/cc.9.20.13387; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Uyeda TQP, 2004, INT REV CYTOL, V240, P377, DOI 10.1016/S0074-7696(04)40004-7; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2	60	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7142	7150		10.1074/jbc.M113.510388	http://dx.doi.org/10.1074/jbc.M113.510388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24482237	Green Published, hybrid			2022-12-25	WOS:000332389400073
J	Mourabit, S; Moles, MW; Smith, E; van Aerle, R; Kudoh, T				Mourabit, Sulayman; Moles, Michael W.; Smith, Emma; van Aerle, Ronny; Kudoh, Tetsuhiro			Bmp Suppression in Mangrove Killifish Embryos Causes a Split in the Body Axis	PLOS ONE			English	Article							DORSOVENTRAL PATTERN-FORMATION; ZEBRAFISH; GRADIENT; POPULATION; GENETICS; ECTODERM; GENES; CELLS; FIN	Bone morphogenetic proteins (Bmp) are major players in the formation of the vertebrate body plan due to their crucial role in patterning of the dorsal-ventral (DV) axis. Despite the highly conserved nature of Bmp signalling in vertebrates, the consequences of changing this pathway can be species-specific. Here, we report that Bmp plays an important role in epiboly, yolk syncytial layer (YSL) movements, and anterior-posterior (AP) axis formation in embryos of the self-fertilizing mangrove killifish, Kryptolebias marmoratus. Stage and dose specific exposures of embryos to the Bmp inhibitor dorsomorphin (DM) produced three distinctive morphologies, with the most extreme condition creating the splitbody phenotype, characterised by an extremely short AP axis where the neural tube, somites, and notochord were bilaterally split. In addition, parts of caudal neural tissues were separated from the main body and formed cell islands in the posterior region of the embryo. This splitbody phenotype, which has not been reported in other animals, shows that modification of Bmp may lead to significantly different consequences during development in other vertebrate species.	[Mourabit, Sulayman; Moles, Michael W.; Smith, Emma; van Aerle, Ronny; Kudoh, Tetsuhiro] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Kudoh, T (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	t.kudoh@exeter.ac.uk		van Aerle, Ronny/0000-0002-2605-6518	Natural and Environmental Research Council (NERC) in the UK	Natural and Environmental Research Council (NERC) in the UK	SM was funded by a PhD studentship from the Natural and Environmental Research Council (NERC) in the UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2001, DEV GROWTH DIFFER, V43, P591; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; BETCHAKU T, 1978, J EXP ZOOL, V206, P381, DOI 10.1002/jez.1402060310; Connors SA, 1999, DEVELOPMENT, V126, P3119; Dick A, 2000, DEVELOPMENT, V127, P343; Hild M, 1999, DEVELOPMENT, V126, P2149; Kane DA, 1996, DEVELOPMENT, V123, P47; Kelley JL, 2012, INTEGR COMP BIOL, V52, P737, DOI 10.1093/icb/ics094; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kudoh T, 2004, DEVELOPMENT, V131, P3581, DOI 10.1242/dev.01227; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Moore GL, 2012, INTEGR COMP BIOL, V52, P781, DOI 10.1093/icb/ics052; Mourabit S, 2012, INTEGR COMP BIOL, V52, P761, DOI 10.1093/icb/ics076; Mourabit S, 2011, DEV DYNAM, V240, P1694, DOI 10.1002/dvdy.22668; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Neave B, 1997, MECH DEVELOP, V62, P183, DOI 10.1016/S0925-4773(97)00659-X; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmid B, 2000, DEVELOPMENT, V127, P957; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Tatarenkov A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012863; Tatarenkov A, 2009, P NATL ACAD SCI USA, V106, P14456, DOI 10.1073/pnas.0907852106; TRINKAUS JP, 1951, J EXP ZOOL, V118, P269, DOI 10.1002/jez.1401180204; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Turner BJ, 2006, EVOL ECOL RES, V8, P1475; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	31	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e84786	10.1371/journal.pone.0084786	http://dx.doi.org/10.1371/journal.pone.0084786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497921	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100005
J	Pamminger, T; Foitzik, S; Kaufmann, KC; Schutzler, N; Menzel, F				Pamminger, Tobias; Foitzik, Susanne; Kaufmann, Katharina C.; Schuetzler, Natalie; Menzel, Florian			Worker Personality and Its Association with Spatially Structured Division of Labor	PLOS ONE			English	Article							INSECT CUTICULAR HYDROCARBONS; SOCIAL INSECTS; PHYSICAL-PROPERTIES; ANTS; ORGANIZATION; AGGRESSION; BUMBLEBEES; EXPERIENCE; HORMONES; ROLES	Division of labor is a defining characteristic of social insects and fundamental to their ecological success. Many of the numerous tasks essential for the survival of the colony must be performed at a specific location. Consequently, spatial organization is an integral aspect of division of labor. The mechanisms organizing the spatial distribution of workers, separating inside and outside workers without central control, is an essential, but so far neglected aspect of division of labor. In this study, we investigate the behavioral mechanisms governing the spatial distribution of individual workers and its physiological underpinning in the ant Myrmica rubra. By investigating worker personalities we uncover position-associated behavioral syndromes. This context-independent and temporally stable set of correlated behaviors (positive association between movements and attraction towards light) could promote the basic separation between inside (brood tenders) and outside workers (foragers). These position-associated behavior syndromes are coupled with a high probability to perform tasks, located at the defined position, and a characteristic cuticular hydrocarbon profile. We discuss the potentially physiological causes for the observed behavioral syndromes and highlight how the study of animal personalities can provide new insights for the study of division of labor and self-organized processes in general.	[Pamminger, Tobias; Foitzik, Susanne; Kaufmann, Katharina C.; Schuetzler, Natalie; Menzel, Florian] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Evolutionary Biol, Mainz, Germany	Johannes Gutenberg University of Mainz	Pamminger, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Evolutionary Biol, Saarstr 21, Mainz, Germany.	pamminge@uni-mainz.de	Menzel, Florian/H-2436-2017; Foitzik, Susanne/A-6504-2019	Menzel, Florian/0000-0002-9673-3668; Foitzik, Susanne/0000-0001-8161-6306; Pamminger, Tobias/0000-0003-1257-3829	DFG [Fo 298/11]	DFG(German Research Foundation (DFG))	This research was funded by the DFG grant Fo 298/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchinson J., 1986, STAT ANAL COMPOSITIO; Anderson M.J., 2008, PERMANOVA PRIMER GUI; BEATTY DD, 1969, VISION RES, V9, P855, DOI 10.1016/0042-6989(69)90093-5; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Ehrhardt S., 1931, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V20, P755, DOI 10.1007/BF00407687; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Gibbs A, 1995, COMP BIOCHEM PHYS B, V112, P667, DOI 10.1016/0305-0491(95)00119-0; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hughes WOH, 2003, P NATL ACAD SCI USA, V100, P9394, DOI 10.1073/pnas.1633701100; Jandt JM, 2013, BIOL REV, DOI [101111/brv12042, DOI 10.1111/BRV.12042.ACCESSED:2013]; Johnson BR, 2008, NATURWISSENSCHAFTEN, V95, P523, DOI 10.1007/s00114-008-0354-3; Johnson BR, 2010, BEHAV ECOL, V21, P1373, DOI 10.1093/beheco/arq138; Johnson BR, 2009, AM NAT, V174, P537, DOI 10.1086/605373; Kapustjanskij A, 2007, FUNCT ECOL, V21, P1130, DOI 10.1111/j.1365-2435.2007.01329.x; Kather R, 2011, J CHEM ECOL, V37, P205, DOI 10.1007/s10886-011-9909-4; Lengyel F, 2007, J CHEM ECOL, V33, P167, DOI 10.1007/s10886-006-9185-x; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Development Core Team, 2008, R LANG ENV STAT COMP; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; Richardson TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018416; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; Seppa P, 1996, BEHAV ECOL SOCIOBIOL, V38, P207, DOI 10.1007/s002650050234; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Smith A, 1863, INQUIRY NATURE CAUSE; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Tripet F, 2004, ETHOLOGY, V110, P863, DOI 10.1111/j.1439-0310.2004.01023.x; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Wicher D, 2006, J NEUROPHYSIOL, V95, P2314, DOI 10.1152/jn.01007.2005; Wilson E.O., 1971, INSECT SOC; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391	40	48	49	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e79616	10.1371/journal.pone.0079616	http://dx.doi.org/10.1371/journal.pone.0079616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497911	gold, Green Published, Green Submitted			2022-12-25	WOS:000330617100001
J	Rolin, O; Smallridge, W; Henry, M; Goodfield, L; Place, D; Harvill, ET				Rolin, Olivier; Smallridge, Will; Henry, Michael; Goodfield, Laura; Place, David; Harvill, Eric T.			Toll-Like Receptor 4 Limits Transmission of Bordetella bronchiseptica	PLOS ONE			English	Article							INNATE HOST-DEFENSE; III SECRETION SYSTEM; T-CELLS; QUANTITATIVE HISTOCHEMISTRY; EPITHELIAL MUCOSUBSTANCES; UNIVERSITY-STUDENTS; IMMUNE-RESPONSES; INFECTION; PERTUSSIS; MICE	Transmission of pathogens has been notoriously difficult to study under laboratory conditions leaving knowledge gaps regarding how bacterial factors and host immune components affect the spread of infections between hosts. We describe the development of a mouse model of transmission of a natural pathogen, Bordetella bronchiseptica, and its use to assess the impact of host immune functions. Although B. bronchiseptica transmits poorly between wild-type mice and mice lacking other immune components, it transmits efficiently between mice deficient in Toll-Like Receptor 4 (TLR4). TLR4-mutant mice were more susceptible to initial colonization, and poorly controlled pathogen growth and shedding. Heavy neutrophil infiltration distinguished TLR4-deficient responses, and neutrophil depletion did not affect respiratory CFU load, but decreased bacterial shedding. The effect of TLR4 response on transmission may explain the extensive variation in TLR4 agonist potency observed among closely related subspecies of Bordetella. This transmission model will enable mechanistic studies of how pathogens spread from one host to another, the defining feature of infectious disease.	[Rolin, Olivier; Smallridge, Will; Henry, Michael; Goodfield, Laura; Place, David; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Rolin, Olivier; Smallridge, Will; Goodfield, Laura; Place, David] Penn State Univ, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Harvill, ET (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	harvill@psu.edu	Place, David/ABD-6703-2021	Place, David/0000-0002-1904-4164; Harvill, Eric/0000-0001-8893-2133; Henry, Michael/0000-0002-0608-9339	National Institutes of Health [GM083113]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113681, R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM083113 (to E. T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An CL, 2003, INFECT IMMUN, V71, P2065, DOI 10.1128/IAI.71.4.2065-2070.2003; Andrews R, 1997, Commun Dis Intell, V21, P145; Antunes MB, 2009, IMMUNOL ALLERGY CLIN, V29, P631, DOI 10.1016/j.iac.2009.07.004; Bemis DA, 2003, COMPARATIVE MED, V53, P11; Bjornstad ON, 2005, TRENDS MICROBIOL, V13, P355, DOI 10.1016/j.tim.2005.06.007; Bloemendaal ALA, 2011, J MED MICROBIOL, V60, P812, DOI 10.1099/jmm.0.027532-0; Brockmeier SL, 2002, VET MICROBIOL, V89, P267, DOI 10.1016/S0378-1135(02)00204-3; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; CZUPRYNSKI CJ, 1994, INFECT IMMUN, V62, P5161, DOI 10.1128/IAI.62.11.5161-5163.1994; Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408; Gorska M. M., 2004, Journal of Allergy and Clinical Immunology, V113, pS182, DOI 10.1016/j.jaci.2004.01.094; Gzyl A, 2004, INT J EPIDEMIOL, V33, P358, DOI 10.1093/ije/dyh012; HARKEMA JR, 1988, AM J PATHOL, V130, P605; HARKEMA JR, 1991, EXP LUNG RES, V17, P743, DOI 10.3109/01902149109062876; Harvill ET, 1999, INFECT IMMUN, V67, P6109, DOI 10.1128/IAI.67.11.6109-6118.1999; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Hellriegel B, 2001, TRENDS PARASITOL, V17, P102, DOI 10.1016/S1471-4922(00)01767-0; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jackson LA, 2000, CLIN INFECT DIS, V31, P3, DOI 10.1086/313911; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; KHELEF N, 1994, INFECT IMMUN, V62, P2893, DOI 10.1128/IAI.62.7.2893-2900.1994; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mann PB, 2004, INFECT IMMUN, V72, P6650, DOI 10.1128/IAI.72.11.6650-6658.2004; Mann PB, 2004, J INFECT DIS, V189, P833, DOI 10.1086/381898; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nicholson TL, 2012, INFECT IMMUN, V80, P1025, DOI 10.1128/IAI.06016-11; Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38; Pathak AK, 2010, BMC MICROBIOL, V10, DOI [10.1186/1471-2180-10-226, 10.1186/1471-2431-10-100]; Pilione MR, 2006, INFECT IMMUN, V74, P1043, DOI 10.1128/IAI.74.2.1043-1049.2006; Polyzou A, 2004, J CLIN LAB ANAL, V18, P211, DOI 10.1002/jcla.20025; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Strutt TM, 2011, ADV EXP MED BIOL, V780, P57, DOI 10.1007/978-1-4419-5632-3_6; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Thakar J, 2009, J R SOC INTERFACE, V6, P599, DOI 10.1098/rsif.2008.0363; Wagner JG, 2001, TOXICOL SCI, V60, P338, DOI 10.1093/toxsci/60.2.338; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; Wolfe DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004280; Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x; Zhang XQ, 2011, INFECT IMMUN, V79, P527, DOI 10.1128/IAI.00590-10; Zola TA, 2008, J IMMUNOL, V181, P7909, DOI 10.4049/jimmunol.181.11.7909	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85229	10.1371/journal.pone.0085229	http://dx.doi.org/10.1371/journal.pone.0085229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497924	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100007
J	Tipirisetti, NR; Govatati, S; Pullari, P; Malempati, S; Thupurani, MK; Perugu, S; Guruvaiah, P; Rao, KL; Digumarti, RR; Nallanchakravarthula, V; Bhanoori, M; Satti, V				Tipirisetti, Nageswara Rao; Govatati, Suresh; Pullari, Priyanka; Malempati, Sravanthi; Thupurani, Murali Krishna; Perugu, Shyam; Guruvaiah, Praveen; Rao, Lakshmi K.; Digumarti, Raghunadha Rao; Nallanchakravarthula, Varadacharyulu; Bhanoori, Manjula; Satti, Vishnupriya			Mitochondrial Control Region Alterations and Breast Cancer Risk: A Study in South Indian Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; D-LOOP; DNA; WOMEN; ENDOMETRIOSIS; ASSOCIATION; SEQUENCE; REPLICATION; CELLS; TRANSCRIPTION	Background: Mitochondrial displacement loop (D-loop) is the hot spot for mitochondrial DNA (mtDNA) alterations which influence the generation of cellular reactive oxygen species (ROS). Association of D-loop alterations with breast cancer has been reported in few ethnic groups; however none of the reports were documented from Indian subcontinent. Methodology: We screened the entire mitochondrial D-loop region (1124 bp) of breast cancer patients (n = 213) and controls (n = 207) of south Indian origin by PCR-sequencing analysis. Haplotype frequencies for significant loci, the standardized disequilibrium coefficient (D') for pair-wise linkage disequilibrium (LD) were assessed by Haploview Software. Principal Findings: We identified 7 novel mutations and 170 reported polymorphisms in the D-loop region of patients and/or controls. Polymorphisms were predominantly located in hypervariable region I (60%) than in II (30%) of D-loop region. The frequencies of 310'C' insertion (P = 0.018), T16189C (P = 0.0019) variants and 310'C'ins/16189C (P = 0.00019) haplotype were significantly higher in cases than in controls. Furthermore, strong LD was observed between nucleotide position 310 and 16189 in controls (D' = 0.49) as compared to patients (D' = 0.14). Conclusions: Mitochondrial D-loop alterations may constitute inherent risk factors for breast cancer development. The analysis of genetic alterations in the D-loop region might help to identify patients at high risk for bad progression, thereby helping to refine therapeutic decisions in breast cancer.	[Tipirisetti, Nageswara Rao; Satti, Vishnupriya] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Govatati, Suresh; Perugu, Shyam; Guruvaiah, Praveen; Bhanoori, Manjula] Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India; [Pullari, Priyanka] Periyar Univ, Dept Biotechnol, Salem, Tamil Nadu, India; [Malempati, Sravanthi] Krishna Univ, DrMRAR PG Ctr, Dept Biochem, Nuzvid, India; [Thupurani, Murali Krishna] Chaitanya Postgrad Coll, Dept Biotechnol, Hanamkonda, India; [Rao, Lakshmi K.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Digumarti, Raghunadha Rao] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Nallanchakravarthula, Varadacharyulu] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India	Osmania University; Osmania University; Periyar University; Krishna University Machilipatnam; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences; Sri Krishnadevaraya University	Satti, V (corresponding author), Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India.	sattivishnupriya@gmail.com	Digumarti, Raghunadharao/H-4075-2019; govatati, suresh/M-9418-2019; Bhanoori, Manjula/ACH-9333-2022	Digumarti, Raghunadharao/0000-0003-2876-3475; govatati, suresh/0000-0001-8587-4388; 	Council of Scientific and Industrial Research (CSIR), India; DBT-ISLARE (OU)	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT-ISLARE (OU)	We would like to thank Council of Scientific and Industrial Research (CSIR), India and DBT-ISLARE (OU) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhomidi MA, 2013, TUMOR BIOL, V34, P2427, DOI 10.1007/s13277-013-0793-0; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berger C, 2011, FORENSIC SCI INT-GEN, V5, P142, DOI 10.1016/j.fsigen.2010.10.002; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Chopra R, 2001, J CLIN ONCOL, V19, p106S; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Govatati S, 2013, MITOCHONDRION, V13, P782, DOI 10.1016/j.mito.2013.05.003; Govatati S, 2013, FERTIL STERIL, V99, P1980, DOI 10.1016/j.fertnstert.2013.02.021; Govatati S, 2012, GENET TEST MOL BIOMA, V16, P865, DOI 10.1089/gtmb.2011.0295; Govatati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040668; Govatati S, 2012, MOL HUM REPROD, V18, P280, DOI 10.1093/molehr/gar079; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Loueslati BY, 2010, GENET MOL RES, V9, P1690, DOI 10.4238/vol9-3gmr778; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Michikawa Y, 1992, SCIENCE, V86, P774; Mueller EE, 2011, PLOS ONE, V6; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Ray G, 2000, BREAST CANCER RES TR, V59, P163, DOI 10.1023/A:1006357330486; Schwartz GF, 2008, CANCER, V113, P2627, DOI 10.1002/cncr.23903; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Surekha D, 2011, ASIAN PAC J CANCER P, V12, P1893; Surekha D, 2009, J GENET, V88, P261, DOI 10.1007/s12041-009-0038-6; Tas F, 2005, MED ONCOL, V22, P11, DOI 10.1385/MO:22:1:011; Tipirisetti NR, 2013, MITOCHONDRION, V13, P372, DOI 10.1016/j.mito.2013.04.010; Tipirisetti NR, 2013, GENET TEST MOL BIOMA, V17, P494, DOI 10.1089/gtmb.2012.0485; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Wang Y, 2005, ANN NY ACAD SCI, V1042, P123, DOI 10.1196/annals.1338.012; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Ye CZ, 2008, CANCER EPIDEM BIOMAR, V17, P2117, DOI 10.1158/1055-9965.EPI-07-2798; Ye CZ, 2010, BREAST CANCER RES TR, V119, P431, DOI 10.1007/s10549-009-0397-y; Young CD, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2417	44	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85363	10.1371/journal.pone.0085363	http://dx.doi.org/10.1371/journal.pone.0085363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497926	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100009
J	Isakova, IA; Lanclos, C; Bruhn, J; Kuroda, MJ; Baker, KC; Krishnappa, V; Phinney, DG				Isakova, Iryna A.; Lanclos, Calvin; Bruhn, Julie; Kuroda, Marcelo J.; Baker, Kate C.; Krishnappa, Veena; Phinney, Donald G.			Allo-Reactivity of Mesenchymal Stem Cells in Rhesus Macaques Is Dose and Haplotype Dependent and Limits Durable Cell Engraftment In Vivo	PLOS ONE			English	Article							MARROW STROMAL CELLS; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE; IMMUNE-RESPONSE; DENDRITIC CELL; PERIPHERAL-BLOOD; LYMPHOCYTE; NEUTROPHIL; INHIBIT; TRANSPLANTATION	The emerging paradigm that MSCs are immune privileged has fostered the use of "off-the-shelf" allogeneic MSC-based therapies in human clinical trials. However, this approach ignores studies in experimental animals wherein transplantation of MSCs across MHC boundaries elicits measurable allo-immune responses. To determine if MSCs are hypo-immunogeneic, we characterized the immune response in rhesus macaques following intracranial administration of allogeneic vs. autologous MSCs. This analysis revealed unambiguous evidence of productive allo-recognition based on expansion of NK, B and T cell subsets in peripheral blood and detection of allo-specific antibodies in animals administered allogeneic but not autologous MSCs. Moreover, the degree of MHC class I and II mismatch between the MSC donor and recipient significantly influenced the magnitude and nature of the allo-immune response. Consistent with these findings, real-time PCR analysis of brain tissue from female recipients administered varying doses of male, allogeneic MSCs revealed a significant inverse correlation between MSC engraftment levels and cell dose. Changes in post-transplant neutrophil and lymphocyte counts also correlated with dose and were predictive of overall MSC engraftment levels. However, secondary antigen challenge failed to elicit a measurable immune response in allogeneic recipients. Finally, extensive behavior testing of animals revealed no main effect of cell dose on motor skills, social development, or temperament. Collectively, these data indicate that allogeneic MSCs are weakly immunogenic when transplanted across MHC boundaries in rhesus macaques and this negatively impacts durable engraftment levels. Therefore the use of unrelated donor MSCs should be carefully evaluated in human patients.	[Isakova, Iryna A.] Tulane Univ, Hlth Sci Ctr, Ctr Bioenvironm Res, New Orleans, LA 70118 USA; [Lanclos, Calvin; Bruhn, Julie; Kuroda, Marcelo J.] Tulane Natl Primate Res Ctr, Dept Immunol, Covington, LA USA; [Baker, Kate C.] Tulane Natl Primate Res Ctr, Dept Vet Med, Covington, LA USA; [Krishnappa, Veena] Scripps Res Inst, Kellogg Sch Sci & Technol, Jupiter, FL USA; [Krishnappa, Veena; Phinney, Donald G.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Tulane University; Tulane University; Tulane University; Scripps Research Institute; Scripps Research Institute	Phinney, DG (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	dphinney@scripps.edu	Phinney, Donald G/D-2155-2014	Phinney, Donald/0000-0002-8688-2619	National Institute of Health [R01-NS39033- 01A2]; New England National Primate Research Center [P51RR00168-43]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039033, R01NS052301] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institute of Health to DGP (R01-NS39033- 01A2) and the New England National Primate Research Center (P51RR00168-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Becher B, 2000, GLIA, V29, P293; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Boyiadzis M, 2008, BIOL BLOOD MARROW TR, V14, P290, DOI 10.1016/j.bbmt.2007.12.490; Brandau S, 2010, J LEUKOCYTE BIOL, V88, P1005, DOI 10.1189/jlb.0410207; Brazelton TB., 1973, NEONATAL BEHAV ASSES, V1st; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17; Carbone E, 1997, J EXP MED, V185, P2053, DOI 10.1084/jem.185.12.2053; Chiesa S, 2011, P NATL ACAD SCI USA, V108, P17384, DOI 10.1073/pnas.1103650108; El-Sawy T, 2005, CIRCULATION, V112, P320, DOI 10.1161/CIRCULATIONAHA.104.516708; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Engelhardt B, 2008, CURR PHARM DESIGN, V14, P1555, DOI 10.2174/138161208784705432; Gabriel C, 2009, HUM IMMUNOL, V70, P960, DOI 10.1016/j.humimm.2009.08.009; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Giuliani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019988; Grabie N, 2003, AM J PATHOL, V163, P2413, DOI 10.1016/S0002-9440(10)63596-1; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Hirayama S, 2006, MOL MED, V12, P208, DOI 10.2119/2006-00036.Hirayama; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Ibata M, 2011, MICROBIOL IMMUNOL, V55, P726, DOI 10.1111/j.1348-0421.2011.00369.x; Isakova IA, 2007, STEM CELLS, V25, P3261, DOI 10.1634/stemcells.2007-0543; Isakova IA, 2010, EXP HEMATOL, V38, P957, DOI 10.1016/j.exphem.2010.06.011; Isakova LA, 2006, MOL THER, V13, P1173, DOI 10.1016/j.ymthe.2005.12.014; Kirsner RS, 2012, LANCET, V380, P977, DOI 10.1016/S0140-6736(12)60644-8; Kreisel D, 2011, BLOOD, V118, P6172, DOI 10.1182/blood-2011-04-347823; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Liang J, 2012, CLIN RHEUMATOL, V31, P157, DOI 10.1007/s10067-011-1816-0; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; NOLAN CR, 1995, AM J KIDNEY DIS, V26, P634, DOI 10.1016/0272-6386(95)90601-0; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Renner P, 2009, TRANSPL P, V41, P2607, DOI 10.1016/j.transproceed.2009.06.119; Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Seifert M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00202; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Steinbrink K, 2009, HUM IMMUNOL, V70, P289, DOI 10.1016/j.humimm.2009.02.003; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; ZEHR KJ, 1993, J HEART LUNG TRANSPL, V12, P837	54	73	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87238	10.1371/journal.pone.0087238	http://dx.doi.org/10.1371/journal.pone.0087238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489878	Green Submitted, gold, Green Published			2022-12-25	WOS:000330570000123
J	Kembel, SW; Meadow, JF; O'Connor, TK; Mhuireach, G; Northcutt, D; Kline, J; Moriyama, M; Brown, GZ; Bohannan, BJM; Green, JL				Kembel, Steven W.; Meadow, James F.; O'Connor, Timothy K.; Mhuireach, Gwynne; Northcutt, Dale; Kline, Jeff; Moriyama, Maxwell; Brown, G. Z.; Bohannan, Brendan J. M.; Green, Jessica L.			Architectural Design Drives the Biogeography of Indoor Bacterial Communities	PLOS ONE			English	Article							RELATIVE-HUMIDITY; HEALTH; MICROBIOTA; DIVERSITY; EXPOSURE; MICROORGANISMS; PATTERN; ALLERGY; FUNGI; AIR	Background: Architectural design has the potential to influence the microbiology of the built environment, with implications for human health and well-being, but the impact of design on the microbial biogeography of buildings remains poorly understood. In this study we combined microbiological data with information on the function, form, and organization of spaces from a classroom and office building to understand how design choices influence the biogeography of the built environment microbiome. Results: Sequencing of the bacterial 16S gene from dust samples revealed that indoor bacterial communities were extremely diverse, containing more than 32,750 OTUs (operational taxonomic units, 97% sequence similarity cutoff), but most communities were dominated by Proteobacteria, Firmicutes, and Deinococci. Architectural design characteristics related to space type, building arrangement, human use and movement, and ventilation source had a large influence on the structure of bacterial communities. Restrooms contained bacterial communities that were highly distinct from all other rooms, and spaces with high human occupant diversity and a high degree of connectedness to other spaces via ventilation or human movement contained a distinct set of bacterial taxa when compared to spaces with low occupant diversity and low connectedness. Within offices, the source of ventilation air had the greatest effect on bacterial community structure. Conclusions: Our study indicates that humans have a guiding impact on the microbial biodiversity in buildings, both indirectly through the effects of architectural design on microbial community structure, and more directly through the effects of human occupancy and use patterns on the microbes found in different spaces and space types. The impact of design decisions in structuring the indoor microbiome offers the possibility to use ecological knowledge to shape our buildings in a way that will select for an indoor microbiome that promotes our health and well-being.	[Kembel, Steven W.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Kembel, Steven W.; Meadow, James F.; O'Connor, Timothy K.; Mhuireach, Gwynne; Northcutt, Dale; Kline, Jeff; Moriyama, Maxwell; Brown, G. Z.; Bohannan, Brendan J. M.; Green, Jessica L.] Univ Oregon, Biol & Built Environm Ctr, Eugene, OR 97403 USA; [Kembel, Steven W.; Meadow, James F.; O'Connor, Timothy K.; Bohannan, Brendan J. M.; Green, Jessica L.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [O'Connor, Timothy K.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Mhuireach, Gwynne; Northcutt, Dale; Kline, Jeff; Moriyama, Maxwell; Brown, G. Z.] Univ Oregon, Energy Studies Bldg Lab, Eugene, OR 97403 USA; [Brown, G. Z.] Univ Oregon, Dept Architecture, Eugene, OR 97403 USA; [Green, Jessica L.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Quebec; University of Quebec Montreal; University of Oregon; University of Oregon; University of Arizona; University of Oregon; University of Oregon; The Santa Fe Institute	Meadow, JF (corresponding author), Univ Oregon, Biol & Built Environm Ctr, Eugene, OR 97403 USA.	jfmeadow@gmail.com	Bohannan, Brendan J. M./R-1582-2017	Bohannan, Brendan J. M./0000-0003-2907-1016; Kembel, Steven/0000-0001-5224-0952; Meadow, James/0000-0002-5568-1283	Alfred P. Sloan Foundation Microbiology for the Built Environment Program	Alfred P. Sloan Foundation Microbiology for the Built Environment Program	This research was funded by a grant to the Biology and the Built Environment Center from the Alfred P. Sloan Foundation Microbiology for the Built Environment Program (http://www.sloan.org/major-program-areas/basic-research/microbiology-of-the-built-environment/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2000, OR U SYST PHYS FAC I; ARUNDEL AV, 1986, ENVIRON HEALTH PERSP, V65, P351, DOI 10.2307/3430203; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2012, ISME J, P1; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Corsi RL, 2012, INDOOR AIR, V22, P171, DOI 10.1111/j.1600-0668.2012.00782.x; Csardi N., 2006, INT J COMP SYST, V1695, P1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Frankel M, 2012, APPL ENVIRON MICROB, V78, P8289, DOI 10.1128/AEM.02069-12; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Kembel S. W., 2012, ISME J, V2012, P1; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lee T, 2006, INDOOR AIR, V16, P37, DOI 10.1111/j.1600-0668.2005.00396.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Low SY, 2011, FUNGAL BIOL-UK, V115, P625, DOI 10.1016/j.funbio.2011.03.006; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Meadow JF, 2013, PEERJ, V1, DOI 10.7717/peerj.53; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rintala H, 2012, ADV APPL MICROBIOL, V78, P75, DOI 10.1016/B978-0-12-394805-2.00004-X; Roberts DW., 2012, LABDSV ORDINATION MU; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Shade A, 2013, MBIO, V4, DOI 10.1128/mBio.00602-12; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shendell DG, 2012, J ASTHMA, V49, P502, DOI 10.3109/02770903.2012.682633; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sternberg E.M., 2009, HEALING SPACES; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Ulrich RS, 2008, HERD-HEALTH ENV RES, V1, P61, DOI 10.1177/193758670800100306; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373	51	137	139	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87093	10.1371/journal.pone.0087093	http://dx.doi.org/10.1371/journal.pone.0087093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489843	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000100
J	Luevano, M; Domogala, A; Blundell, M; Jackson, N; Pedroza-Pacheco, I; Derniame, S; Escobedo-Cousin, M; Querol, S; Thrasher, A; Madrigal, A; Saudemont, A				Luevano, Martha; Domogala, Anna; Blundell, Michael; Jackson, Nicola; Pedroza-Pacheco, Isabela; Derniame, Sophie; Escobedo-Cousin, Michelle; Querol, Sergio; Thrasher, Adrian; Madrigal, Alejandro; Saudemont, Aurore			Frozen Cord Blood Hematopoietic Stem Cells Differentiate into Higher Numbers of Functional Natural Killer Cells In Vitro than Mobilized Hematopoietic Stem Cells or Freshly Isolated Cord Blood Hematopoietic Stem Cells	PLOS ONE			English	Article							NK-CELLS; PROGENITOR CELLS; ANTITUMOR-ACTIVITY; CULTURE-SYSTEM; T-CELLS; GENERATION; EXPRESSION; MATURATION; EXPANSION; RECEPTOR	Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells that are cytotoxic but not exhausted. NK cell differentiation from hematopoietic stem cells (HSC) has become an alluring option for NK cell therapy, with umbilical cord blood (UCB) and mobilized peripheral blood (PBCD34(+)) being the most accessible HSC sources as collection procedures are less invasive. In this study we compared the capacity of frozen or freshly isolated UCB hematopoietic stem cells (CBCD34(+)) and frozen PBCD34(+) to generate NK cells in vitro. By modifying a previously published protocol, we showed that frozen CBCD34(+) cultures generated higher NK cell numbers without loss of function compared to fresh CBCD34(+) cultures. NK cells generated from CBCD34(+) and PBCD34(+) expressed low levels of killer-cell immunoglobulin-like receptors but high levels of activating receptors and of the myeloid marker CD33. However, blocking studies showed that CD33 expression did not impact on the functions of the generated cells. CBCD34(+)-NK cells exhibited increased capacity to secrete IFN-gamma and kill K562 in vitro and in vivo as compared to PBCD34(+)-NK cells. Moreover, K562 killing by the generated NK cells could be further enhanced by IL-12 stimulation. Our data indicate that the use of frozen CBCD34(+) for the production of NK cells in vitro results in higher cell numbers than PBCD34(+), without jeopardizing their functionality, rendering them suitable for NK cell immunotherapy. The results presented here provide an optimal strategy to generate NK cells in vitro for immunotherapy that exhibit enhanced effector function when compared to alternate sources of HSC.	[Luevano, Martha; Domogala, Anna; Jackson, Nicola; Pedroza-Pacheco, Isabela; Derniame, Sophie; Escobedo-Cousin, Michelle; Madrigal, Alejandro; Saudemont, Aurore] UCL, Inst Canc, London, England; [Luevano, Martha; Domogala, Anna; Pedroza-Pacheco, Isabela; Derniame, Sophie; Escobedo-Cousin, Michelle; Madrigal, Alejandro; Saudemont, Aurore] Anthony Nolan Res Inst, London, England; [Blundell, Michael; Thrasher, Adrian] UCL Inst Child Hlth, Ctr Immunodeficiency, Mol Immunol Unit, London, England; [Querol, Sergio] Programa Concordia Banc Sang & Teixits, Barcelona, Spain	University of London; University College London; University of London; University College London	Saudemont, A (corresponding author), UCL, Inst Canc, London, England.	aurore.saudemont@anthonynolan.org	Blundell, Michael P/M-1276-2015	Madrigal, Alejandro/0000-0001-8359-9917; Saudemont, Aurore/0000-0002-9376-8339; Blundell, Michael/0000-0002-9179-6870	Anthony Nolan	Anthony Nolan	Anthony Nolan funded this work. No current external funding sources were received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Boissel L, 2008, BIOL BLOOD MARROW TR, V14, P1031, DOI 10.1016/j.bbmt.2008.06.016; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Clausen J, 2007, CLIN EXP IMMUNOL, V148, P520, DOI 10.1111/j.1365-2249.2007.03360.x; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Condiotti R, 1998, EXP HEMATOL, V26, P571; Dezell SA, 2012, BIOL BLOOD MARROW TR, V18, P536, DOI 10.1016/j.bbmt.2011.11.023; El Beshlawy A, 2009, EXP CLIN TRANSPLANT, V7, P50; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Frias AM, 2008, EXP HEMATOL, V36, P61, DOI 10.1016/j.exphem.2007.08.031; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Giuliani M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002241; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grzywacz B, 2006, BLOOD, V108, P3824, DOI 10.1182/blood-2006-04-020198; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; HANDGRETINGER R, 1993, IMMUNOL LETT, V37, P223, DOI 10.1016/0165-2478(93)90034-Y; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Kim DH, 2005, EUR J HAEMATOL, V75, P299, DOI 10.1111/j.1600-0609.2005.00514.x; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Lee SM, 1996, BLOOD, V88, P945; Lehmann D, 2012, STEM CELLS DEV; Leung W, 1999, Biol Blood Marrow Transplant, V5, P69, DOI 10.1053/bbmt.1999.v5.pm10371358; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Luevano M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00319; Luevano M, 2012, HUM IMMUNOL, V73, P248, DOI 10.1016/j.humimm.2011.12.015; Martin-Fontecha A, 2011, CELL MOL LIFE SCI, V68, P3495, DOI 10.1007/s00018-011-0800-9; Mayani H, 2011, ARCH MED RES, V42, P645, DOI 10.1016/j.arcmed.2011.11.010; MILLER JS, 1994, BLOOD, V83, P2594; Miller JS, 2001, BLOOD, V98, P705, DOI 10.1182/blood.V98.3.705; Moezzi L, 2005, TRANSPL P, V37, P4500, DOI 10.1016/j.transproceed.2005.10.107; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; NAUME B, 1992, J IMMUNOL, V148, P2429; Paul SP, 2000, BLOOD, V96, P483; Perez SA, 2003, BLOOD, V101, P3444, DOI 10.1182/blood-2002-05-1501; Pinho MJ, 2012, J RECEPTOR SIGNAL TR; RABINOWICH H, 1993, CELL IMMUNOL, V152, P481, DOI 10.1006/cimm.1993.1306; Rappold I, 1997, BLOOD, V90, P111; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Taki S, 2005, J IMMUNOL, V174, P6005, DOI 10.4049/jimmunol.174.10.6005; Tanaka M, 2012, LEUKEMIA RES, V36, P699, DOI 10.1016/j.leukres.2011.11.009; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van der Velden VHJ, 2001, BLOOD, V97, P3197, DOI 10.1182/blood.V97.10.3197; White DW, 2010, BLOOD, V115, P4377, DOI 10.1182/blood-2009-09-245464; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Woll PS, 2005, J IMMUNOL, V175, P5095, DOI 10.4049/jimmunol.175.8.5095; Yoon SR, 2010, BONE MARROW TRANSPL, V45, P1038, DOI 10.1038/bmt.2009.304; Zamai L, 2012, CYTOM PART A, V81A, P294, DOI 10.1002/cyto.a.22025	54	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87086	10.1371/journal.pone.0087086	http://dx.doi.org/10.1371/journal.pone.0087086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489840	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000098
J	Maucort, G; Kasula, R; Papadopulos, A; Nieminen, TA; Rubinsztein-Dunlop, H; Meunier, FA				Maucort, Guillaume; Kasula, Ravikiran; Papadopulos, Andreas; Nieminen, Timo A.; Rubinsztein-Dunlop, Halina; Meunier, Frederic A.			Mapping Organelle Motion Reveals a Vesicular Conveyor Belt Spatially Replenishing Secretory Vesicles in Stimulated Chromaffin Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE; ACTIN; EXOCYTOSIS; GRANULES; ENDOCYTOSIS; COMPONENTS; TRANSPORT	How neurosecretory cells spatially adjust their secretory vesicle pools to replenish those that have fused and released their hormonal content is currently unknown. Here we designed a novel set of image analyses to map the probability of tracked organelles undergoing a specific type of movement (free, caged or directed). We then applied our analysis to time-lapse z-stack confocal imaging of secretory vesicles from bovine Chromaffin cells to map the global changes in vesicle motion and directionality occurring upon secretagogue stimulation. We report a defined region abutting the cortical actin network that actively transports secretory vesicles and is dissipated by actin and microtubule depolymerizing drugs. The directionality of this "conveyor belt" towards the cell surface is activated by stimulation. Actin and microtubule networks therefore cooperatively probe the microenvironment to transport secretory vesicles to the periphery, providing a mechanism whereby cells globally adjust their vesicle pools in response to secretagogue stimulation.	[Maucort, Guillaume; Kasula, Ravikiran; Papadopulos, Andreas; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia; [Maucort, Guillaume; Nieminen, Timo A.; Rubinsztein-Dunlop, Halina] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.	f.meunier@uq.edu.au	Nieminen, Timo K./GXN-2675-2022; Kasula, Ravi Kiran/ABC-3437-2021; Meunier, Frederic A/C-8161-2009; Rubinsztein-Dunlop, Halina/D-2387-2014	Nieminen, Timo K./0000-0001-6599-1835; Meunier, Frederic A/0000-0001-6400-1107; Rubinsztein-Dunlop, Halina/0000-0002-8332-2309; Papadopulos, Andreas/0000-0002-3376-1979; Nieminen, Timo/0000-0003-3055-7275	Australian Research Council [DP120104057]	Australian Research Council(Australian Research Council)	This work was supported by funding from a Australian Research Council grant (DP120104057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AA, 2013, ANNU REV PHYSIOL, V75, P393, DOI 10.1146/annurev-physiol-020911-153305; Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x; Chen F, 2001, J IMMUNOL, V166, P1771, DOI 10.4049/jimmunol.166.3.1771; Gil A, 2000, NEUROSCIENCE, V98, P605, DOI 10.1016/S0306-4522(00)00132-9; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; LELKES PI, 1986, FEBS LETT, V208, P357, DOI 10.1016/0014-5793(86)81049-3; Meunier FA, 2002, EMBO J, V21, P6733, DOI 10.1093/emboj/cdf677; Neco P, 2003, EUR J NEUROSCI, V18, P733, DOI 10.1046/j.1460-9568.2003.02801.x; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Papadopulos Andreas, 2013, Front Endocrinol (Lausanne), V4, P153, DOI 10.3389/fendo.2013.00153; Papadopulos A, 2013, J NEUROSCI, V33, P19143, DOI 10.1523/JNEUROSCI.2634-13.2013; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Tomatis VM, 2013, J CELL BIOL, V200, P301, DOI 10.1083/jcb.201204092; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Wen PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1500; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595	21	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87242	10.1371/journal.pone.0087242	http://dx.doi.org/10.1371/journal.pone.0087242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489879	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000124
J	Prieto, VM; Matos, S; Alvarez, M; Cacheda, F; Oliveira, JL				Prieto, Victor M.; Matos, Sergio; Alvarez, Manuel; Cacheda, Fidel; Oliveira, Jose Luis			Twitter: A Good Place to Detect Health Conditions	PLOS ONE			English	Article								With the proliferation of social networks and blogs, the Internet is increasingly being used to disseminate personal health information rather than just as a source of information. In this paper we exploit the wealth of user-generated data, available through the micro-blogging service Twitter, to estimate and track the incidence of health conditions in society. The method is based on two stages: we start by extracting possibly relevant tweets using a set of specially crafted regular expressions, and then classify these initial messages using machine learning methods. Furthermore, we selected relevant features to improve the results and the execution times. To test the method, we considered four health states or conditions, namely flu, depression, pregnancy and eating disorders, and two locations, Portugal and Spain. We present the results obtained and demonstrate that the detection results and the performance of the method are improved after feature selection. The results are promising, with areas under the receiver operating characteristic curve between 0.7 and 0.9, and f-measure values around 0.8 and 0.9. This fact indicates that such approach provides a feasible solution for measuring and tracking the evolution of health states within the society.	[Prieto, Victor M.; Alvarez, Manuel; Cacheda, Fidel] Dept Informat & Commun Technol, Coruna, Spain; [Matos, Sergio; Oliveira, Jose Luis] Univ Aveiro, DETI IEETA, P-3800 Aveiro, Portugal	Universidade da Coruna; Universidade de Aveiro	Prieto, VM (corresponding author), Dept Informat & Commun Technol, Campus Elvina S-N, Coruna, Spain.	victor.prieto@udc.es	Cacheda, Fidel/L-8913-2014; Matos, Sérgio/G-4941-2010; Alvarez, Manuel/L-9574-2014; Oliveira, José Luis/A-2223-2012	Cacheda, Fidel/0000-0002-6438-1661; Matos, Sérgio/0000-0003-1941-3983; Alvarez, Manuel/0000-0001-7204-2689; Oliveira, José Luis/0000-0002-6672-6176	Xunta de Galicia [CN2012/211]; Ministry of Education and Science of Spain; FEDER funds of the European Union [TIN2009-14203]; FEDER through the COMPETE programme; Portuguese national funds through FCT - "Fundacao Para a Ciencia e a Tecnologia" [PTDC/EIA-CCO/100541/2008 (FCOMP-01-0124-FEDER-010029)]; QREN Mais Centro program through the Cloud Thinking project [CENTRO-07-ST24-FEDER-002031]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Ministry of Education and Science of Spain(Spanish Government); FEDER funds of the European Union(European Commission); FEDER through the COMPETE programme; Portuguese national funds through FCT - "Fundacao Para a Ciencia e a Tecnologia"; QREN Mais Centro program through the Cloud Thinking project	The work of VMP, MA and FC was supported by Xunta de Galicia CN2012/211, the Ministry of Education and Science of Spain and FEDER funds of the European Union (Project TIN2009-14203). SM and JLO were funded by FEDER through the COMPETE programme and by Portuguese national funds through FCT - "Fundacao Para a Ciencia e a Tecnologia" under project number PTDC/EIA-CCO/100541/2008 (FCOMP-01-0124-FEDER-010029), and by the QREN Mais Centro program through the Cloud Thinking project (CENTRO-07-ST24-FEDER-002031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, PATTERN RECOGN LETT, V26, P43, DOI 10.1016/j.patrec.2004.08.015; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Bosley JC, 2012, RESUSCITATION; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Culotta A., 2010, ARXIV10074748CSIR; Culotta Aron, 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hall M., 1998, THESIS U WAIKATO HAM; Heaivilin N, 2011, J DENT RES, V90, P1047, DOI 10.1177/0022034511415273; KIRA K, 1992, MACHINE LEARNING /, P249; Lampos V., 2010, 2010 2nd International Workshop on Cognitive Information Processing (CIP 2010), P411, DOI 10.1109/CIP.2010.5604088; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Liu H, 1998, FEATURE EXTRACTION C, DOI 10. 1007/978-1-4615-5725-8; Lyon A, 2012, TRANSBOUND EMERG DIS, V59, P223, DOI 10.1111/j.1865-1682.2011.01258.x; Paul M.J., 2011, 5 INT AAAI C WEBL SO; Porter M. F., 2001, SNOWBALL LANGUAGE ST; Robnik-Sikonja M, 2004, LECT NOTES COMPUT SC, V3201, P359; Santos JC, 2013, P IWBBIO 2013; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Shuyo N, 2012, LANGUAGE DETECTION L; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Twitter, 2012, TWITT SEARCH AP	27	76	76	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86191	10.1371/journal.pone.0086191	http://dx.doi.org/10.1371/journal.pone.0086191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489699	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000028
J	Etherington, SJ; Johnstone, VPA; Everett, AW				Etherington, Sarah J.; Johnstone, Victoria P. A.; Everett, Alan W.			Modulation of Synaptic Vesicle Exocytosis in Muscle-Dependent Long-Term Depression at the Amphibian Neuromuscular Junction	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; SCHAFFER COLLATERAL-CA1 SYNAPSES; NITRIC-OXIDE; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; PRESYNAPTIC INHIBITION; VESICULAR RELEASE; FM DYES; PLASTICITY; POOLS	We have labeled recycling synaptic vesicles at the somatic Bufo marinus neuromuscular junction with the styryl dye FM2-10 and provide direct evidence for refractoriness of exocytosis associated with a muscle activity-dependent form of long-term depression (LTD) at this synapse. FM2-10 dye unloading experiments demonstrated that the rate of vesicle exocytosis from the release ready pool (RRP) of vesicles was more than halved in the LTD (induced by 20 min of low frequency stimulation). Recovery from LTD, observed as a partial recovery of nerve-evoked muscle twitch amplitude, was accompanied by partial recovery of the refractoriness of RRP exocytosis. Unexpectedly, paired pulse plasticity, another routinely used indicator of presynaptic forms of synaptic plasticity, was unchanged in the LTD. We conclude that the LTD induces refractoriness of the neuromuscular vesicle release machinery downstream of presynaptic calcium entry.	[Etherington, Sarah J.; Johnstone, Victoria P. A.; Everett, Alan W.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Etherington, Sarah J.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Johnstone, Victoria P. A.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	University of Western Australia; Murdoch University; Monash University	Etherington, SJ (corresponding author), Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia.	s.etherington@murdoch.edu.au	Johnstone, Victoria/B-5083-2015; Etherington, Sarah/HGC-7458-2022	Johnstone, Victoria/0000-0001-9885-3607; 	University of Western Australia (Perth, Australia)	University of Western Australia (Perth, Australia)	This work was supported by The University of Western Australia (Perth, Australia, http://www.uwa.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergquist S, 2010, NEURON, V66, P220, DOI 10.1016/j.neuron.2010.03.023; BETZ WJ, 1995, CURR BIOL, V5, P1098, DOI 10.1016/S0960-9822(95)00220-X; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; de Jong APH, 2009, CURR OPIN NEUROBIOL, V19, P245, DOI 10.1016/j.conb.2009.06.005; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Etherington SJ, 2008, SYNAPSE, V62, P291, DOI 10.1002/syn.20493; Etherington SJ, 2004, J PHYSIOL-LONDON, V559, P507, DOI 10.1113/jphysiol.2004.066498; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Frank C.A., 2013, NEUROPHARMACOLOGY; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Gaffield MA, 2011, J NEUROPHYSIOL, V106, P599, DOI 10.1152/jn.00123.2011; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Giniatullin RA, 1998, BRIT J PHARMACOL, V124, P839, DOI 10.1038/sj.bjp.0701881; Graves AR, 2004, J PHYSIOL-LONDON, V559, P423, DOI 10.1113/jphysiol.2004.064469; Hallermann S, 2013, TRENDS NEUROSCI, V36, P185, DOI 10.1016/j.tins.2012.10.001; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Kuromi H, 2005, NEUROSCIENTIST, V11, P138, DOI 10.1177/1073858404271679; Lindgren CA, 2013, J PHYSIOL-LONDON, V591, P4749, DOI 10.1113/jphysiol.2013.256727; Marques G, 2006, INT REV NEUROBIOL, V75, P267, DOI 10.1016/S0074-7742(06)75012-7; Muller M, 2012, J NEUROSCI, V32, P16574, DOI 10.1523/JNEUROSCI.0981-12.2012; Newman Z, 2007, EUR J NEUROSCI, V25, P1619, DOI 10.1111/j.1460-9568.2007.05422.x; Noronha-Matos JB, 2011, J NEUROCHEM, V117, P797, DOI 10.1111/j.1471-4159.2011.07216.x; Pinard A, 2008, EUR J NEUROSCI, V28, P577, DOI 10.1111/j.1460-9568.2008.06355.x; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Ratnayaka A, 2012, J PHYSIOL-LONDON, V590, P1585, DOI 10.1113/jphysiol.2011.226688; REDMAN RS, 1993, MOL PHARMACOL, V44, P835; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2003, J NEUROCYTOL, V32, P539, DOI 10.1023/B:NEUR.0000020609.19873.e8; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sanchez-Pastor E, 2007, J PHARMACOL EXP THER, V321, P439, DOI 10.1124/jpet.106.116319; Santos DA, 2003, NEUROSCI LETT, V338, P225, DOI 10.1016/S0304-3940(02)01419-2; Santschi LA, 2006, J NEUROBIOL, V66, P205, DOI 10.1002/neu.20213; Silinsky EM, 1999, PROG BRAIN RES, V120, P145; Stanton PK, 2003, J NEUROSCI, V23, P5936; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Thomas S, 2001, J NEUROSCI, V21, P1087; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Upreti C, 2013, NEUROPHARMACOLOGY, V66, P31, DOI 10.1016/j.neuropharm.2012.05.004; Vitureira N, 2012, CURR OPIN NEUROBIOL, V22, P516, DOI 10.1016/j.conb.2011.09.006; Wang XY, 2005, J NEUROSCI, V25, P343, DOI 10.1523/JNEUROSCI.3252-04.2005; Weyhersmuller A, 2011, J NEUROSCI, V31, P6041, DOI 10.1523/JNEUROSCI.6698-10.2011; Yakovleva OV, 2013, NEUROCHEM J+, V7, P103, DOI 10.1134/S1819712413020104; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87174	10.1371/journal.pone.0087174	http://dx.doi.org/10.1371/journal.pone.0087174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489862	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000114
J	Minami, H; Isomoto, H; Nakayama, T; Hayashi, T; Yamaguchi, N; Matsushima, K; Akazawa, Y; Ohnita, K; Takeshima, F; Inoue, H; Nakao, K				Minami, Hitomi; Isomoto, Hajime; Nakayama, Toshiyuki; Hayashi, Tomayoshi; Yamaguchi, Naoyuki; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Inoue, Haruhiro; Nakao, Kazuhiko			Background Coloration of Squamous Epithelium in Esophago-Pharyngeal Squamous Cell Carcinoma: What Causes the Color Change?	PLOS ONE			English	Article							MICROVASCULAR ARCHITECTURE; NEOPLASIA; HEMOGLOBIN; EXPRESSION; FEATURES; HEAD	Objectives: This study aims to clarify the cause of background coloration in the epithelia between each dilated intra papillary capillary loop in esophago-pharyngeal squamous cell carcinoma. Design: This is a single center retrospective study including 124 patients with 160 lesions who underwent esophagogastroduodenoscopy in Nagasaki University Hospital from September 2007 to March 2012; a detailed comparison between endoscopic images and pathology was performed. Immunohistological assessment using anti-human hemoglobin antibody (anti-Hb Ab) was performed to verify the presence of hemoglobin (Hb) component in the cancer cells. Real-time polymerase chain reaction (RT-PCR) and in situ hybridization (ISH) on Hb-beta mRNA were performed to assess the production of Hb component within the cancer cells. Results: A strong positivity for anti-Hb Ab was observed in the squamous cell carcinoma area, whereas non-cancerous mucosa showed no immunopositivity for Hb. The concordance rate between anti-Hb Ab immunoreactivity and the presence of BC was as high as 80.9%. The amount of Hb-beta mRNA expression was three times higher in cancer tissues compared with the surrounding non-cancerous mucosa. ISH images showed that the expression exclusively occurred in cancer cells, indicating that Hb is probably produced within cancer cells. Conclusions: The background coloration observed is partly due to an extravascular component of Hb. RT-PCR and ISH analyses indicate that Hb is produced within cancer cells.	[Minami, Hitomi; Isomoto, Hajime; Yamaguchi, Naoyuki; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan; [Nakayama, Toshiyuki; Hayashi, Tomayoshi] Nagasaki Univ Hosp, Dept Pathol, Nagasaki, Japan; [Inoue, Haruhiro] Showa Univ Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa, Japan	Nagasaki University; Nagasaki University	Isomoto, H (corresponding author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan.	hajimei2002@yahoo.co.jp		Nakayama, Toshiyuki/0000-0002-3865-7169				Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Inoue H, 2007, MAGNIFYING ENDOSCOPI, P49; Ishihara R, 2010, J GASTROEN HEPATOL, V25, P1410, DOI 10.1111/j.1440-1746.2010.06378.x; Kaga M, 2011, ONCOL REP, V26, P1063, DOI 10.3892/or.2011.1398; Kanzaki H, 2013, J GASTROEN HEPATOL, V28, P274, DOI 10.1111/jgh.12059; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Minami H, 2012, J GASTROENT IN PRESS; Minami H, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/529782; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ogane N, 2010, ANN DIAGN PATHOL, V14, P23, DOI 10.1016/j.anndiagpath.2009.10.003; OHMORI T, 2001, GASTROENTEROLOGICA S, V43, pS1613; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Shimizu Y, 2008, J GASTROEN HEPATOL, V23, P546, DOI 10.1111/j.1440-1746.2007.04990.x	18	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85553	10.1371/journal.pone.0085553	http://dx.doi.org/10.1371/journal.pone.0085553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489662	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000014
J	Okamoto, R; Gery, S; Gombart, AF; Wang, XP; Castellani, LW; Akagi, T; Chen, S; Arditi, M; Ho, Q; Lusis, AJ; Li, QL; Koeffler, HP				Okamoto, Ryoko; Gery, Sigal; Gombart, Adrian F.; Wang, Xuping; Castellani, Lawrence W.; Akagi, Tadayuki; Chen, Shuang; Arditi, Moshe; Quoc Ho; Lusis, Aldons J.; Li, Quanlin; Koeffler, H. Phillip			Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR-/- Mice	PLOS ONE			English	Article							C/EBP-EPSILON; APOLIPOPROTEIN-E; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NEUTROPHIL; LOCUS; AP2; PATHOGENESIS; CYTOKINE; ENHANCER	The CCAAT/enhancer binding proteins (C/EBPs) are transcription factors involved in hematopoietic cell development and induction of several inflammatory mediators. C/EBP epsilon is expressed only in myeloid cells including monocytes/macrophages. Atherosclerosis is an inflammatory disorder of the vascular wall and circulating immune cells such as monocytes/ macrophages. Mice deficient in the low density lipoprotein (LDL) receptor (Ldlr(-/-)) fed on a high cholesterol diet (HCD) show elevated blood cholesterol levels and are widely used as models to study human atherosclerosis. In this study, we generated Ldlr and Cebpe double-knockout (llee) mice and compared their atherogenic phenotypes to Ldlr single deficient (llEE) mice after HCD. Macrophages from llee mice have reduced lipid uptake by foam cells and impaired phagokinetic motility in vitro compared to macrophages from llEE mice. Also, compared to llEE mice, llee mice have alterations of lipid metabolism, and reduced atheroma and obesity, particularly the males. Peritoneal macrophages of llee male mice have reduced mRNA expression of FABP4, a fatty acid binding protein implicated in atherosclerosis. Overall, our study suggests that the myeloid specific factor C/EBP epsilon is involved in systemic lipid metabolism and that silencing of C/EBP epsilon could decrease the development of atherosclerosis.	[Okamoto, Ryoko; Gery, Sigal; Gombart, Adrian F.; Akagi, Tadayuki; Quoc Ho; Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA; [Gombart, Adrian F.] Oregon State Univ, Dept Biochem & Biophys, Linus Pauling Inst, Corvallis, OR 97331 USA; [Wang, Xuping; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Dept Med, Los Angeles, CA 90095 USA; [Wang, Xuping; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Castellani, Lawrence W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Li, Quanlin] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Koeffler, H. Phillip] Natl Univ Singapore, Natl Canc Inst, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; National University of Singapore; National University of Singapore	Gery, S (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA.	gerys@cshs.org	Akagi, Tadayuki/E-1078-2011; Li, Quanlin/H-2358-2015; Gombart, Adrian/AAV-4738-2020	Akagi, Tadayuki/0000-0002-1733-9452; Li, Quanlin/0000-0002-3876-0617; Gombart, Adrian/0000-0001-7830-0693	National Institutes of Health (NIH) [2R01 CA026038-32, 5R01AI65604-6]; SWLF; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; East Meets West Cedars-Sinai Fund; A*STAR of Singapore; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065604] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SWLF; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; East Meets West Cedars-Sinai Fund; A*STAR of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants (2R01 CA026038-32, 5R01AI65604-6), SWLF, the Tom Collier Memorial Regatta Foundation, Parker Hughes Fund, East Meets West Cedars-Sinai Fund, as well as, A*STAR of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; CHENEVAL D, 1991, P NATL ACAD SCI USA, V88, P8465, DOI 10.1073/pnas.88.19.8465; Chumakov AM, 1997, MOL CELL BIOL, V17, P1375, DOI 10.1128/MCB.17.3.1375; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Engelbertsen D, 2012, EXP DIABETES RES, V17, P61; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gombart AF, 2005, J LEUKOCYTE BIOL, V78, P1153, DOI 10.1189/jlb.0504286; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Scott WN, 2000, ANAL BIOCHEM, V287, P343, DOI 10.1006/abio.2000.4866; Smith DD, 2010, J PHYSIOL PHARMACOL, V61, P309; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Surra JC, 2010, J ATHEROSCLER THROMB, V17, P712; Tavor S, 2002, BLOOD, V99, P1794, DOI 10.1182/blood.V99.5.1794; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Volger OL, 2007, AM J PATHOL, V171, P326, DOI 10.2353/ajpath.2007.061196; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Williams SC, 1998, J BIOL CHEM, V273, P13493, DOI 10.1074/jbc.273.22.13493; Wolfrum S, 2010, ARTERIOSCL THROM VAS, V30, P1583, DOI 10.1161/ATVBAHA.110.205757; Zhang YQ, 2006, ARTERIOSCL THROM VAS, V26, P2316, DOI 10.1161/01.ATV.0000235697.35431.05	37	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85341	10.1371/journal.pone.0085341	http://dx.doi.org/10.1371/journal.pone.0085341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489659	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000012
J	Wester-Rosenlof, L; Casslen, V; Axelsson, J; Edstrom-Hagerwall, A; Gram, M; Holmqvist, M; Johansson, ME; Larsson, I; Ley, D; Marsal, K; Morgelin, M; Rippe, B; Rutardottir, S; Shohani, B; Akerstrom, B; Hansson, SR				Wester-Rosenlof, Lena; Casslen, Vera; Axelsson, Josefin; Edstrom-Hagerwall, Anneli; Gram, Magnus; Holmqvist, Madlene; Johansson, Martin E.; Larsson, Irene; Ley, David; Marsal, Karel; Morgelin, Matthias; Rippe, Bengt; Rutardottir, Sigurbjorg; Shohani, Behnaz; Akerstrom, Bo; Hansson, Stefan R.			A1M/alpha(1)-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia	PLOS ONE			English	Article							CELL-FREE HEMOGLOBIN; LIPOCALIN ALPHA(1)-MICROGLOBULIN; SCAVENGER ALPHA(1)-MICROGLOBULIN; INDUCED HYPERTENSION; OXIDATIVE-STRESS; ALPHA-1-MICROGLOBULIN; LIMITS; BLOOD	Preeclampsia (PE) is a serious pregnancy complication that manifests as hypertension and proteinuria after the 20th gestation week. Previously, fetal hemoglobin (HbF) has been identified as a plausible causative factor. Cell-free Hb and its degradation products are known to cause oxidative stress and tissue damage, typical of the PE placenta. A1M (alpha(1)-microglobulin) is an endogenous scavenger of radicals and heme. Here, the usefulness of A1M as a treatment for PE is investigated in the pregnant ewe PE model, in which starvation induces PE symptoms via hemolysis. Eleven ewes, in late pregnancy, were starved for 36 hours and then treated with A1M (n = 5) or placebo (n = 6) injections. After injections, the ewes were re-fed and observed for additional 72 hours. They were monitored for blood pressure, proteinuria, blood cell distribution and clinical and inflammation markers in plasma. Before termination, the utero-placental circulation was analyzed with Doppler velocimetry and the kidney glomerular function was analyzed by Ficoll sieving. At termination, blood, kidney and placenta samples were collected and analyzed for changes in gene expression and tissue structure. The starvation resulted in increased amounts of the hemolysis marker bilirubin in the blood, structural damages to the placenta and kidneys and an increased glomerular sieving coefficient indicating a defect filtration barrier. Treatment with A1M ameliorated these changes without signs of side-effects. In conclusion, A1M displayed positive therapeutic effects in the ewe starvation PE model, and was well tolerated. Therefore, we suggest A1M as a plausible treatment for PE in humans.	[Wester-Rosenlof, Lena; Edstrom-Hagerwall, Anneli; Gram, Magnus; Morgelin, Matthias; Rutardottir, Sigurbjorg; Akerstrom, Bo] Lund Univ, Dept Infect Med, Lund, Sweden; [Casslen, Vera; Holmqvist, Madlene; Larsson, Irene; Marsal, Karel; Shohani, Behnaz; Hansson, Stefan R.] Lund Univ, Dept Obstet & Gynecol, Lund, Sweden; [Axelsson, Josefin; Rippe, Bengt] Lund Univ, Dept Nephrol, Lund, Sweden; [Johansson, Martin E.] Lund Univ, Dept Lab Med, Malmo, Sweden; [Ley, David] Lund Univ, Dept Pediat, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Lund University	Akerstrom, B (corresponding author), Lund Univ, Dept Infect Med, Lund, Sweden.	bo.akerstrom@med.lu.se; stefan.hansson@med.lu.se	Gram, Magnus/AAM-4825-2021	Gram, Magnus/0000-0002-5880-2925	Swedish Research Council; Marianne & Marcus Wallenberg foundation; Torsten Soderbergs foundation; Maggie Stephens foundation; A1M Pharma AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne & Marcus Wallenberg foundation; Torsten Soderbergs foundation; Maggie Stephens foundation; A1M Pharma AB	The project was founded by the Swedish Research Council; the Marianne & Marcus Wallenberg foundation; the Torsten Soderbergs foundation, the Maggie Stephens foundation and A1M Pharma AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1985, J BIOL CHEM, V260, P4839; AKERSTROM B, 1985, EUR J BIOCHEM, V146, P353; Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Akerstrom Bo, 2006, P1; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; Anderson UD, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.058; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Axelsson J, 2013, AM J PHYSIOL-RENAL, V305, pF237, DOI 10.1152/ajprenal.00154.2013; Axelsson J, 2012, AM J PHYSIOL-RENAL, V303, pF790, DOI 10.1152/ajprenal.00153.2012; Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Berggard T, 1998, J HISTOCHEM CYTOCHEM, V46, P887, DOI 10.1177/002215549804600803; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Centlow M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/472354; Centlow M, 2008, FERTIL STERIL, V90, P1834, DOI 10.1016/j.fertnstert.2007.09.030; Enders AC, 2006, PLACENTA, V27, pS11, DOI 10.1016/j.placenta.2005.10.013; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Karumanchi SA, 2006, METH MOLEC MED, V122, P393; Kwasek A, 2007, PROTEIN EXPRES PURIF, V53, P145, DOI 10.1016/j.pep.2006.10.023; Larsson J, 2001, J LAB CLIN MED, V137, P165, DOI 10.1067/mlc.2001.112957; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Lipstein H, 2003, AM J EMERG MED, V21, P223, DOI 10.1016/S0735-6757(02)42241-3; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Malyala P, 2008, J PHARM SCI-US, V97, P2041, DOI 10.1002/jps.21152; Masuda T, 2005, AM J HEMATOL, V78, P159, DOI 10.1002/ajh.20172; May K, 2011, PLACENTA, V32, P323, DOI 10.1016/j.placenta.2011.01.017; McWaters P, 2000, VET IMMUNOL IMMUNOP, V73, P155, DOI 10.1016/S0165-2427(99)00158-0; MOTTERLINI R, 1995, AM J PHYSIOL-HEART C, V269, pH648, DOI 10.1152/ajpheart.1995.269.2.H648; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Olsson MG, 2007, FREE RADICAL BIO MED, V42, P842, DOI 10.1016/j.freeradbiomed.2006.12.017; Olsson MG, 2012, ANTIOXID REDOX SIGN, V17, P813, DOI 10.1089/ars.2011.4282; Olsson MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027505; Olsson MG, 2010, RADIAT RES, V174, P590, DOI 10.1667/RR2213.1; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Pourcelot L, 1974, APPL CLIN EXAMEN DOP; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; Shennan AH, 2001, LANCET, V357, P1534, DOI 10.1016/S0140-6736(00)04694-8; Talosi G, 1997, BIOCHEM MOL MED, V62, P58, DOI 10.1006/bmme.1997.2602; Talosi G, 2001, EUR J OBSTET GYN R B, V99, P25, DOI 10.1016/S0301-2115(01)00351-7; THATCHER CD, 1986, AM J OBSTET GYNECOL, V155, P201, DOI 10.1016/0002-9378(86)90111-0; Wicher KB, 2010, ANTIOXID REDOX SIGN, V12, P249, DOI 10.1089/ars.2009.2760	48	45	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86353	10.1371/journal.pone.0086353	http://dx.doi.org/10.1371/journal.pone.0086353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489717	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000047
J	Tuttle, TR; Hugo, ER; Tong, WS; Ben-Jonathan, N				Tuttle, Traci R.; Hugo, Eric R.; Tong, Wilson S.; Ben-Jonathan, Nira			Placental Lactogen Is Expressed but Is Not Translated into Protein in Breast Cancer	PLOS ONE			English	Article							HUMAN GROWTH-HORMONE; MESSENGER-RNA; GENE-EXPRESSION; CHORIONIC-GONADOTROPIN; ECTOPIC PRODUCTION; MAMMALIAN-CELLS; QUANTIFICATION; PREGNANCY; LOCUS; CHORIOCARCINOMA	Introduction: Several studies reported that the pregnancy-specific hormone placental lactogen (hPL) is expressed at both mRNA and protein levels in breast cancer. The overall objective was to establish hPL, the product of the CSH1 and CSH2 genes, as a biomarker for breast cancer. Methods: CSH expression was determined at the mRNA level in breast cancer cell lines (BCC) and primary carcinomas by real-time and conventional PCR and the products verified as CSH1 by sequencing. Expression of hPL protein was examined by western blots and immuno-histochemistry, using commercial and custom-made polyclonal and monoclonal antibodies. Results: Variable levels of CSH mRNA were detected in several BCC, and in some primary tumors. We detected a protein, slightly larger than recombinant hPL by western blotting using several antibodies, leading us to postulate that it represents an hPL variant ('hPL'). Furthermore, some monoclonal antibodies detected 'hPL' by immunohistochemistry in breast carcinomas but not in normal breast. However, further examination revealed that these antibodies were non-specific, as efficient suppression of CSH mRNA by shRNA did not abolish the 'hPL' band. Custom-made monoclonal antibodies against recombinant hPL detected hPL of the correct size in placental lysate and hPL-overexpressing BCC, but not in unmodified cells or primary carcinomas. hPL protein was detected only when mRNA was increased several thousand fold. Conclusions: We call into question previous reports of hPL expression in breast cancer which relied on mRNA levels as surrogates for protein and/or used improperly validated antibodies to measure hPL protein levels. Our data suggests that an inhibitory mechanism(s) prevents translation of CSH mRNA in breast cancer when not highly expressed. The mechanism by which translation of CSH mRNA is inhibited is intriguing and should be further investigated.	[Tuttle, Traci R.; Hugo, Eric R.; Tong, Wilson S.; Ben-Jonathan, Nira] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Ben-Jonathan, N (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA.	Nira.Ben-Jonathan@uc.edu	Hugo, Eric/ADA-3523-2022	Hugo, Eric/0000-0002-2990-6362	NIH [ES02909, CA096613, DOD BC05725, AR110050]; CCTST(Center for Clinical and Translational Science and Training); Ride Cincinnati Pilot Grants; NRSA(National Research Service Award) predoctoral fellowship [T32 ES007250]; NATIONAL CANCER INSTITUTE [R01CA096613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCTST(Center for Clinical and Translational Science and Training); Ride Cincinnati Pilot Grants; NRSA(National Research Service Award) predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants ES02909, CA096613, DOD BC05725, and AR110050; CCTST(Center for Clinical and Translational Science and Training); Ride Cincinnati Pilot Grants (to N.B.J); and an NRSA(National Research Service Award) predoctoral fellowship T32 ES007250 (to T.R.T). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; BARSH GS, 1983, NUCLEIC ACIDS RES, V11, P3939, DOI 10.1093/nar/11.12.3939; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; FUKUNAGA M, 1993, HUM PATHOL, V24, P1098, DOI 10.1016/0046-8177(93)90190-R; Galsgaard ED, 2009, J ENDOCRINOL, V201, P115, DOI 10.1677/JOE-08-0479; HORNE CHW, 1976, LANCET, V2, P279; Latham C, 2001, CANCER GENET CYTOGEN, V127, P16, DOI 10.1016/S0165-4608(00)00427-1; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; LIEBLICH JM, 1976, J NATL CANCER I, V56, P911, DOI 10.1093/jnci/56.5.911; LYTRAS A, 1994, ENDOCRINOLOGY, V134, P2461, DOI 10.1210/en.134.6.2461; Madersbacher S, 1998, EXP CLIN ENDOCR DIAB, V106, P61, DOI 10.1055/s-0029-1211952; MONTEIRO JCMP, 1983, EUR J CANCER CLIN ON, V19, P173, DOI 10.1016/0277-5379(83)90414-5; MONTEIRO JCMP, 1982, BRIT J CANCER, V46, P279, DOI 10.1038/bjc.1982.193; NACHTIGAL MW, 1993, J BIOL CHEM, V268, P8473; NICKEL BE, 1993, MOL CELL ENDOCRINOL, V91, P159, DOI 10.1016/0303-7207(93)90268-O; PATTILLO RA, 1971, ANN NY ACAD SCI, V172, P288, DOI 10.1111/j.1749-6632.1971.tb34942.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAMAAN N, 1966, J CLIN ENDOCR METAB, V26, P1303, DOI 10.1210/jcem-26-12-1303; Sarro SM, 2010, LEUKEMIA RES, V34, P1670, DOI 10.1016/j.leukres.2010.06.031; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SELVANAYAGAM CS, 1984, J BIOL CHEM, V259, P4642; Sesterhenn Isabell A, 2004, Cancer Control, V11, P374; SHETH NA, 1977, CANCER, V39, P1693, DOI 10.1002/1097-0142(197704)39:4<1693::AID-CNCR2820390445>3.0.CO;2-Z; Stark AM, 2006, NEUROL RES, V28, P787, DOI 10.1179/016164106X110364; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; WALKER WH, 1990, J BIOL CHEM, V265, P12940; Walsh STR, 2006, J MOL BIOL, V358, P773, DOI 10.1016/j.jmb.2006.02.038; Wu ZS, 2011, J CLIN ENDOCR METAB, V96, pE1619, DOI 10.1210/jc.2011-1245	33	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87325	10.1371/journal.pone.0087325	http://dx.doi.org/10.1371/journal.pone.0087325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475273	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800095
J	dela Paz, NG; Melchior, B; Shayo, FY; Frangos, JA				dela Paz, Nathaniel G.; Melchior, Benoit; Shayo, Francisca Y.; Frangos, John A.			Heparan Sulfates Mediate the Interaction between Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) and the G alpha(q/11) Subunits of Heterotrimeric G Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Endothelial Cell; G Protein-coupled Receptors (GPCR); Heparan Sulfate; Heterotrimeric G Proteins; Proteoglycan; Shear Stress; PECAM-1	FLUID SHEAR-STRESS; HEMOPHILIC BINDING; TEMPORAL GRADIENT; EPITHELIAL-CELLS; RECEPTOR; FLOW; GLYCOCALYX; GLYCOSAMINOGLYCANS; PROTEOGLYCAN; SYNDECAN-1	Background: The mechanisms by which the PECAM-1G(q/11) mechanosensitive complex mediates endothelial flow responses remain unclear. Results: The PECAM-1G(q/11) complex contains heparan sulfate proteoglycans (HSPGs) and is disrupted by inhibition of HS. Conclusion: The interaction between PECAM-1 and G(q/11) may be mediated by the HS of the HSPG syndecan-1. Significance: Targeting specific HSPGs may be an effective strategy for the therapeutic treatment of vascular diseases. The endothelial cell-cell junction has emerged as a major cell signaling structure that responds to shear stress by eliciting the activation of signaling pathways. Platelet endothelial cell adhesion molecule-1 (PECAM-1) and heterotrimeric G protein subunits G(q) and 11 (G(q/11)) are junctional proteins that have been independently proposed as mechanosensors. Our previous findings suggest that they form a mechanosensitive junctional complex that discriminates between different flow profiles. The nature of the PECAM-1G(q/11) interaction is still unclear although it is likely an indirect association. Here, we investigated the role of heparan sulfates (HS) in mediating this interaction and in regulating downstream signaling in response to flow. Co-immunoprecipitation studies show that PECAM-1G(q/11) binding is dramatically decreased by competitive inhibition with heparin, pharmacological inhibition with the HS antagonist surfen, and enzymatic removal of HS chains with heparinase III treatment as well as by site-directed mutagenesis of basic residues within the extracellular domain of PECAM-1. Using an in situ proximity ligation assay, we show that endogenous PECAM-1G(q/11) interactions in endothelial cells are disrupted by both competitive inhibition and HS degradation. Furthermore, we identified the heparan sulfate proteoglycan syndecan-1 in complexes with PECAM-1 that are rapidly decreased in response to flow. Finally, we demonstrate that flow-induced Akt activation is attenuated in endothelial cells in which PECAM-1 was knocked down and reconstituted with a binding mutant. Taken together, our results indicate that the PECAM-1G(q/11) mechanosensitive complex contains an endogenous heparan sulfate proteoglycan with HS chains that is critical for junctional complex assembly and regulating the flow response.	[dela Paz, Nathaniel G.; Melchior, Benoit; Shayo, Francisca Y.; Frangos, John A.] La Jolla Bioengn Inst, San Diego, CA 92121 USA	La Jolla Bioengineering Institute	dela Paz, NG (corresponding author), La Jolla Bioengn Inst, 3535 Gen Atom Ct,Suite 210, San Diego, CA 92121 USA.	ndelapaz@ljbi.org		Melchior, Ben/0000-0002-6972-1653	National Institutes of Health MERIT Award [5R37HL040696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL040696] Funding Source: NIH RePORTER	National Institutes of Health MERIT Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health MERIT Award 5R37HL040696.	ADAMSON RH, 1992, J PHYSIOL-LONDON, V445, P473, DOI 10.1113/jphysiol.1992.sp018934; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bao XP, 1999, ARTERIOSCL THROM VAS, V19, P996, DOI 10.1161/01.ATV.19.4.996; Bao XP, 2000, AM J PHYSIOL-HEART C, V278, pH1598, DOI 10.1152/ajpheart.2000.278.5.H1598; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Coombe DR, 2008, BIOCHEMISTRY-US, V47, P4863, DOI 10.1021/bi7024595; DELISSER HM, 1993, J BIOL CHEM, V268, P16037; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; FUNG YC, 1993, J BIOMECH ENG-T ASME, V115, P1, DOI 10.1115/1.2895465; Gandhi NS, 2008, BIOCHEMISTRY-US, V47, P4851, DOI 10.1021/bi702455e; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Gudi SRP, 1996, CIRC RES, V79, P834, DOI 10.1161/01.RES.79.4.834; Hamon M, 2004, GLYCOBIOLOGY, V14, P311, DOI 10.1093/glycob/cwh038; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Knox S, 2005, FEBS LETT, V579, P5019, DOI 10.1016/j.febslet.2005.07.090; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Melchior B, 2014, J CELL BIOCHEM, V115, P121, DOI 10.1002/jcb.24639; Melchior B, 2012, AM J PHYSIOL-CELL PH, V303, pC467, DOI 10.1152/ajpcell.00117.2012; Melchior B, 2010, AM J PHYSIOL-CELL PH, V299, pC621, DOI 10.1152/ajpcell.00156.2010; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Noel J, 2013, AM J PHYSIOL-LUNG C, V305, pL805, DOI 10.1152/ajplung.00123.2013; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Otte LA, 2009, J PHYSIOL-LONDON, V587, P2365, DOI 10.1113/jphysiol.2009.172643; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rosenberg RD, 1997, J CLIN INVEST, V100, pS67; Sarrazin S, 2011, COLD SPRING HARB PER, P3; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Slimani H, 2003, BBA-BIOMEMBRANES, V1617, P80, DOI 10.1016/j.bbamem.2003.09.006; Slimani H, 2003, GLYCOBIOLOGY, V13, P623, DOI 10.1093/glycob/cwg083; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Wang DZ, 2003, BIOCHEMISTRY-US, V42, P1071, DOI 10.1021/bi026425a; WATT SM, 1993, BLOOD, V82, P2649; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yates TJ, 2013, CANCER-AM CANCER SOC, V119, P61, DOI 10.1002/cncr.27661; Yeh JC, 2008, BIOCHEMISTRY-US, V47, P9029, DOI 10.1021/bi8003846; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200; Zeng Y, 2013, AM J PHYSIOL-HEART C, V305, pH811, DOI 10.1152/ajpheart.00764.2012	53	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7413	7424		10.1074/jbc.M113.542514	http://dx.doi.org/10.1074/jbc.M113.542514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497640	Green Published, hybrid			2022-12-25	WOS:000332761500013
J	Boersma, PD; Rebstock, GA				Boersma, P. Dee; Rebstock, Ginger A.			Climate Change Increases Reproductive Failure in Magellanic Penguins	PLOS ONE			English	Article							POPULATION-DYNAMICS; NEST-SITE; ATMOSPHERIC CIRCULATION; SPHENISCUS-HUMBOLDTI; TEMPERATURE EXTREMES; SURVIVAL ANALYSIS; JACKASS PENGUIN; OBSERVED TRENDS; HEAT-STRESS; EL-NINO	Climate change is causing more frequent and intense storms, and climate models predict this trend will continue, potentially affecting wildlife populations. Since 1960 the number of days with >20 mm of rain increased near Punta Tombo, Argentina. Between 1983 and 2010 we followed 3496 known-age Magellanic penguin (Spheniscus magellanicus) chicks at Punta Tombo to determine how weather impacted their survival. In two years, rain was the most common cause of death killing 50% and 43% of chicks. In 26 years starvation killed the most chicks. Starvation and predation were present in all years. Chicks died in storms in 13 of 28 years and in 16 of 233 storms. Storm mortality was additive; there was no relationship between the number of chicks killed in storms and the numbers that starved (P = 0.75) or that were eaten (P = 0.39). However, when more chicks died in storms, fewer chicks fledged (P = 0.05, R-2 = 0.14). More chicks died when rainfall was higher and air temperature lower. Most chicks died from storms when they were 9-23 days old; the oldest chick killed in a storm was 41 days old. Storms with heavier rainfall killed older chicks as well as more chicks. Chicks up to 70 days old were killed by heat. Burrow nests mitigated storm mortality (N = 1063). The age span of chicks in the colony at any given time increased because the synchrony of egg laying decreased since 1983, lengthening the time when chicks are vulnerable to storms. Climate change that increases the frequency and intensity of storms results in more reproductive failure of Magellanic penguins, a pattern likely to apply to many species breeding in the region. Climate variability has already lowered reproductive success of Magellanic penguins and is likely undermining the resilience of many other species.	[Boersma, P. Dee; Rebstock, Ginger A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Boersma, P. Dee; Rebstock, Ginger A.] Wildlife Conservat Soc, Bronx, NY USA	University of Washington; University of Washington Seattle; Wildlife Conservation Society	Boersma, PD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	boersma@u.washington.edu		Chiaradia, Andre/0000-0002-6178-4211	WCS; Exxonmobil Foundation; Pew Fellows Program in Marine Conservation; Disney Worldwide Conservation Fund; National Geographic Society; Chase Foundation; Cunningham Foundation; MKCG Foundation; Offield Foundation; Peach Foundation; Thorne Foundation; Tortuga Foundation; Kellogg Foundation; Wadsworth Endowed Chair in Conservation Science	WCS; Exxonmobil Foundation(Exxon Mobil Corporation); Pew Fellows Program in Marine Conservation; Disney Worldwide Conservation Fund; National Geographic Society(National Geographic Society); Chase Foundation; Cunningham Foundation; MKCG Foundation; Offield Foundation; Peach Foundation; Thorne Foundation; Tortuga Foundation; Kellogg Foundation; Wadsworth Endowed Chair in Conservation Science	The Penguin Project has been funded by: WCS, Exxonmobil Foundation, The Pew Fellows Program in Marine Conservation, The Disney Worldwide Conservation Fund, The National Geographic Society, The Chase Foundation, The Cunningham Foundation, The MKCG Foundation, The Offield Foundation, The Peach Foundation, The Thorne Foundation, The Tortuga Foundation, The Kellogg Foundation, The Wadsworth Endowed Chair in Conservation Science, and Friends of the Penguins. Trimble provided six rugged tablets. Canon provided two pairs of binoculars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta EA, 2008, J CLIMATE, V21, P4365, DOI 10.1175/2008JCLI2137.1; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; BIRKHEAD TR, 1976, BRIT BIRDS, V69, P490; Boersma D., 1975, P101; Boersma P.D., 1990, P15; Boersma P.D., 1992, P INT ORNITHOLOGICAL, P961; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 2009, AUK, V126, P335, DOI 10.1525/auk.2009.08144; Boersma PD, 2009, MAR ECOL PROG SER, V375, P263, DOI 10.3354/meps07753; Boersma PD, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P3; BOERSMA PD, 1986, PHYSIOL ZOOL, V59, P10, DOI 10.1086/physzool.59.1.30156084; Boersma PD, 2004, AUK, V121, P148, DOI 10.1642/0004-8038(2004)121[0148:WPEAT]2.0.CO;2; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Boulanger JP, 2006, CLIM DYNAM, V27, P233, DOI 10.1007/s00382-006-0134-8; Burton NHK, 2007, CONDOR, V109, P441, DOI 10.1650/0010-5422(2007)109[441:ILVINO]2.0.CO;2; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Chapman EW, 2011, MAR ECOL PROG SER, V436, P273, DOI 10.3354/meps09242; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; de Bary Pereda S, 1990, INFLUENCE NEST SITE; Boersma PD, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P233; Demongin L, 2010, ORNITOL NEOTROP, V21, P439; Drummond BA, 2010, AVIAN CONSERV ECOL, V5; Duchamp C, 2002, COMP BIOCHEM PHYS A, V131, P765, DOI 10.1016/S1095-6433(02)00014-4; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2013, GLOBAL CHANGE BIOL, V19, P364, DOI 10.1111/gcb.12072; Frere Esteban, 1992, Marine Ornithology, V20, P1; FROST PGH, 1976, J ZOOL, V179, P165, DOI 10.1111/j.1469-7998.1976.tb02289.x; GANDINI P, 1994, AUK, V111, P20, DOI 10.2307/4088501; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P321; Garcia-Borboroglu P, 2006, MAR POLLUT BULL, V52, P193, DOI 10.1016/j.marpolbul.2005.11.004; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Grimm AM, 2000, J CLIMATE, V13, P35, DOI 10.1175/1520-0442(2000)013<0035:CVISSA>2.0.CO;2; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; HARRISON P., 1983, SEABIRDS IDENTIFICAT; Hass T, 2012, MAR ECOL PROG SER, V454, P251, DOI 10.3354/meps09723; Haylock MR, 2006, J CLIMATE, V19, P1490, DOI 10.1175/JCLI3695.1; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jamroz D, 2004, J ANIM PHYSIOL AN N, V88, P239, DOI 10.1111/j.1439-0396.2004.00481.x; Jenouvrier S, 2009, OIKOS, V118, P1292, DOI 10.1111/j.1600-0706.2009.17498.x; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Levine JM, 2011, ECOLOGY, V92, P2236, DOI 10.1890/11-0471.1; Li J, 2013, NAT CLIM CHANGE; Lombard CD, 2010, CONDOR, V112, P56, DOI 10.1525/cond.2010.090042; Long JS., 2006, REGRESSION MODELS CA; Mallory ML, 2009, ARCTIC, V62, P333; Mallory ML, 2009, POLAR BIOL, V32, P529, DOI 10.1007/s00300-008-0547-4; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Menendez CG, 2010, CLIMATIC CHANGE, V98, P359, DOI 10.1007/s10584-009-9735-7; Moller AP, 2011, HDB BIRDS WORLD, P13; Moreno J, 2011, CURR ZOOL, V57, P375, DOI 10.1093/czoolo/57.3.375; Noy Y, 1999, J APPL POULTRY RES, V8, P16, DOI 10.1093/japr/8.1.16; Nunez MN, 2009, CLIM DYNAM, V32, P1081, DOI 10.1007/s00382-008-0449-8; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; Onley D., 2007, ALBATROSSES PETRELS; Oswald SA, 2012, INTEGR ZOOL, V7, P121, DOI 10.1111/j.1749-4877.2012.00287.x; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Paredes R, 2001, BIOL CONSERV, V100, P199, DOI 10.1016/S0006-3207(01)00023-4; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; POTTS GR, 1980, J ANIM ECOL, V49, P465, DOI 10.2307/4258; Rebstock GA, 2011, CONDOR, V113, P316, DOI 10.1525/cond.2011.100162; Renner M, 2001, IBIS, V143, P369, DOI 10.1111/j.1474-919X.2001.tb04938.x; Russo S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016260; Rusticucci M, 2004, J CLIMATE, V17, P4099, DOI 10.1175/1520-0442(2004)017<4099:OTACIT>2.0.CO;2; SAGAR P M, 1989, Notornis, V36, P171; SALZMAN AG, 1982, ECOLOGY, V63, P742, DOI 10.2307/1936795; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Schiavini Adrián, 2005, Hornero, V20, P5; Schreiber E.A., 2002, P179; SEDDON PJ, 1991, AUK, V108, P548, DOI 10.2307/4088094; Sherley RB, 2012, EMU, V112, P97, DOI 10.1071/MU11055; Sherley RB, 2012, J ORNITHOL, V153, P441, DOI 10.1007/s10336-011-0760-8; Simeone A, 2004, J ORNITHOL, V145, P35, DOI 10.1007/s10336-003-0005-6; Simeone A, 2002, MAR ECOL PROG SER, V227, P43, DOI 10.3354/meps227043; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stevenson S, 2012, J CLIMATE, V25, P2129, DOI 10.1175/JCLI-D-11-00252.1; Stokes DL, 1998, AUK, V115, P34, DOI 10.2307/4089109; STOKES DL, 1991, AUK, V108, P923; Suryan RM, 2006, PROG OCEANOGR, V68, P303, DOI 10.1016/j.pocean.2006.02.006; Suryan RM, 2001, AUK, V118, P636, DOI 10.1642/0004-8038(2001)118[0636:CAPDOB]2.0.CO;2; TAYLOR JRE, 1985, J COMP PHYSIOL B, V155, P615, DOI 10.1007/BF00694453; THOMPSON KR, 1991, J ZOOL, V225, P427, DOI 10.1111/j.1469-7998.1991.tb03826.x; Tulp I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038041; Turner J, 2005, ANN GLACIOL-SER, V41, P85, DOI 10.3189/172756405781813177; Vincent LA, 2005, J CLIMATE, V18, P5011, DOI 10.1175/JCLI3589.1; Visser G. Henk, 2002, P439; Wingfield JC, 1997, ARDEA, V85, P155; Woods RW, 1997, ATLAS BREEDING BIRDS; Yang HM, 2009, ITAL J ANIM SCI, V8, P585, DOI 10.4081/ijas.2009.585; Yorio P, 1998, ATLES DISTRIBUCION R	95	70	71	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85602	10.1371/journal.pone.0085602	http://dx.doi.org/10.1371/journal.pone.0085602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489663	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000012
J	Bowles, D; Carson, A; Isaac, P				Bowles, Dianna; Carson, Amanda; Isaac, Peter			Genetic Distinctiveness of the Herdwick Sheep Breed and Two Other Locally Adapted Hill Breeds of the UK	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; POPULATION-STRUCTURE; PROLACTIN RECEPTOR; DIVERSITY; HISTORY	There is considerable interest in locally adapted breeds of livestock as reservoirs of genetic diversity that may provide important fitness traits for future use in agriculture. In marginal areas, these animals contribute to food security and extract value from land unsuitable for other systems of farming. In England, close to 50% of the national sheep flock is farmed on grassland designated as disadvantaged areas for agricultural production. Many of these areas are in the uplands, where some native breeds of sheep continue to be commercially farmed only in highly localised geographical regions to which they are adapted. This study focuses on three of these breeds, selected for their adaptation to near identical environments and their geographical concentration in regions close to one another. Our objective has been to use retrotyping, microsatellites and single nucleotide polymorphisms to explore the origins of the breeds and whether, despite their similar adaptations and proximity, they are genetically distinctive. We find the three breeds each have a surprisingly different pattern of retrovirus insertions into their genomes compared with one another and with other UK breeds. Uniquely, there is a high incidence of the R0 retrotype in the Herdwick population, characteristic of a primitive genome found previously in very few breeds worldwide and none in the UK mainland. The Herdwick and Rough Fells carry two rare retroviral insertion events, common only in Texels, suggesting sheep populations in the northern uplands have a historical association with the original pin-tail sheep of Texel Island. Microsatellite data and analyses of SNPs associated with RXFP2 (horn traits) and PRLR (reproductive performance traits) also distinguished the three breeds. Significantly, an SNP linked to TMEM154, a locus controlling susceptibility to infection by Maedi-Visna, indicated that all three native hill breeds have a lower than average risk of infection to the lentivirus.	[Bowles, Dianna] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Bowles, Dianna; Carson, Amanda] Univ York, Sheep Trust, Registered Char 1094514, York YO10 5DD, N Yorkshire, England; [Isaac, Peter] IDna Genet Ltd, Norwich, Norfolk, England	University of York - UK; University of York - UK	Bowles, D (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	dianna.bowles@york.ac.uk			University of York; Sheep Trust Charity	University of York(European Commission); Sheep Trust Charity	The funding for this research was in part provided by the University of York to DB and in part by The Sheep Trust Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2005, J ANIM SCI, V83, P737; Alvarez I, 2004, J ANIM SCI, V82, P2246; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Brown G, 2009, HERDWICKS HERDWICK S; Carson A, 2009, LIVEST SCI, V123, P288, DOI 10.1016/j.livsci.2008.11.026; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Chu MX, 2007, ANIM BIOTECHNOL, V18, P65, DOI 10.1080/10495390601090950; Defra, 2012, UK COUNTR REP FARM A; FAO, 2009, 167 FAO; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Heaton MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055490; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Hoffmann I, 2013, ANIMAL, V7, P346, DOI 10.1017/S1751731113000815; Johnston SE, 2010, HEREDITY, V104, P196, DOI 10.1038/hdy.2009.109; Johnston SE, 2013, NATURE, V502, P93, DOI 10.1038/nature12489; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Lenstra JA, 2012, ANIM GENET, V43, P483, DOI 10.1111/j.1365-2052.2011.02309.x; Pariset L, 2006, ANIM GENET, V37, P290, DOI 10.1111/j.1365-2052.2006.01441.x; Pariset L, 2006, J HERED, V97, P531, DOI 10.1093/jhered/esl020; Patel JR, 2012, VACCINE, V30, P1767, DOI 10.1016/j.vaccine.2012.01.014; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Peterhans E, 2004, VET RES, V35, P257, DOI 10.1051/vetres:2004014; Pritchard JK, 2000, GENETICS, V155, P945; Sider LH, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-64; Tapio I, 2005, HEREDITY, V94, P448, DOI 10.1038/sj.hdy.6800640; Tapio M, 2005, MOL ECOL, V14, P3951, DOI 10.1111/j.1365-294X.2005.02727.x; Tapio M, 2007, AGR FOOD SCI, V16, P157, DOI 10.2137/145960607782219346; Thormar H, 2005, AIDS REV, V7, P233; Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WRIGHT S., 1969, Evolution and the genetics of populations. Vol. 2. The theory of gene frequencies., V2	38	26	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87823	10.1371/journal.pone.0087823	http://dx.doi.org/10.1371/journal.pone.0087823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489968	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000183
J	Doyon, G; Sobolewski, MD; Huber, K; McMahon, D; Mellors, JW; Sluis-Cremer, N				Doyon, Genevieve; Sobolewski, Michele D.; Huber, Kelly; McMahon, Deborah; Mellors, John W.; Sluis-Cremer, Nicolas			Discovery of a Small Molecule Agonist of Phosphatidylinositol 3-Kinase p110 alpha That Reactivates Latent HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL CLONE; PERIPHERAL-BLOOD; DEACETYLASE INHIBITORS; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; EXPRESSION; LYMPHOCYTES; TYPE-1; COMBINATION	Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent viral reservoir in resting memory CD4(+) T cells is impervious to cART and represents a major barrier to curing HIV-1 infection. Reactivation of latent HIV-1 represents a possible strategy for elimination of this reservoir. In this study we describe the discovery of 1,2,9,10-tetramethoxy-7H-dibenzo[de,g]quinolin-7-one (57704) which reactivates latent HIV-1 in several cell-line models of latency (J89GFP, U1 and ACH-2). 57704 also increased HIV-1 expression in 3 of 4 CD8(+)-depleted blood mononuclear cell preparations isolated from HIV-1-infected individuals on suppressive cART. In contrast, vorinostat increased HIV-1 expression in only 1 of the 4 donors tested. Importantly, 57704 does not induce global T cell activation. Mechanistic studies revealed that 57704 reactivates latent HIV-1 via the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. 57704 was found to be an agonist of PI3K with specificity to the p110 alpha isoform, but not the p110 beta, delta or gamma isoforms. Taken together, our work suggests that 57704 could serve as a scaffold for the development of more potent activators of latent HIV-1. Furthermore, it highlights the involvement of the PI3K/Akt pathway in the maintenance of HIV-1 latency.	[Doyon, Genevieve; Sobolewski, Michele D.; Huber, Kelly; McMahon, Deborah; Mellors, John W.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sluis-Cremer, N (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA.	nps2@pitt.edu	Huber, Kelly/AAE-3449-2020		University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This study was funded by funds from the University of Pittsburgh to NSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Havlir DV, 2005, J INFECT DIS, V191, P1164, DOI 10.1086/428588; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Morgan RJ, 2012, INVEST NEW DRUG, V30, P723, DOI 10.1007/s10637-010-9557-5; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; PSALLIDOPOULOS MC, 1989, J VIROL, V63, P4626, DOI 10.1128/JVI.63.11.4626-4631.1989; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10	26	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e84964	10.1371/journal.pone.0084964	http://dx.doi.org/10.1371/journal.pone.0084964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489654	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330570000008
J	Ebeling, W; Hemmi, JM				Ebeling, Wiebke; Hemmi, Jan M.			Dichromatic Colour Vision in Wallabies as Characterised by Three Behavioural Paradigms	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; TAMMAR WALLABY; AUSTRALIAN MARSUPIALS; SPECTRAL SENSITIVITY; MACROPUS-EUGENII; PHOTORECEPTORS; TRICHROMACY; EVOLUTION; SEQUENCE; RETINA	Despite lacking genetic evidence of a third cone opsin in the retina of any Australian marsupial, most species tested so far appear to be trichromatic. In the light of this, we have re-examined colour vision of the tammar wallaby which had previously been identified as a dichromat. Three different psychophysical tests, based on an operant conditioning paradigm, were used to confirm that colour perception in the wallaby can be predicted and conclusively explained by the existence of only two cone types. Firstly, colour-mixing experiments revealed a Confusion Point between the three primary colours of a LCD monitor that can be predicted by the cone excitation ratio of the short-and middle-wavelength sensitive cones. Secondly, the wavelength discrimination ability in the wallaby, when tested with monochromatic stimuli, was found to be limited to a narrow range between 440 nm and 500 nm. Lastly, an experiment designed to test the wallaby's ability to discriminate monochromatic lights from a white light provided clear evidence for a Neutral Point around 485 nm where discrimination consistently failed. Relative colour discrimination seemed clearly preferred but it was possible to train a wallaby to perform absolute colour discriminations. The results confirm the tammar wallaby as a dichromat, and so far the only behaviourally confirmed dichromat among the Australian marsupials.	[Ebeling, Wiebke] Curtin Univ, Curtin Inst Radio Astron, Bentley, WA, Australia; [Hemmi, Jan M.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Hemmi, Jan M.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia	Curtin University; University of Western Australia; University of Western Australia	Ebeling, W (corresponding author), Curtin Univ, Curtin Inst Radio Astron, Bentley, WA, Australia.	wiebke.ebeling@curtin.edu.au	Hemmi, Jan M/B-6458-2008	Hemmi, Jan M/0000-0003-4629-9362	Australian Research Council through the ARC Centre of Excellence in Vision Science [CE0561903]; Australian Department of Education, Employment and Workplace Relations (DEEWR); Australian National University; Centre for Visual Sciences at the Australian National University; Australian Research Council	Australian Research Council through the ARC Centre of Excellence in Vision Science(Australian Research Council); Australian Department of Education, Employment and Workplace Relations (DEEWR)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian National University(Australian National University); Centre for Visual Sciences at the Australian National University(Australian National University); Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council through the ARC Centre of Excellence in Vision Science (CE0561903) and by the Australian Department of Education, Employment and Workplace Relations (DEEWR) and the Australian National University through postgraduate research scholarships to WE. Additional funding was provided by the Centre for Visual Sciences at the Australian National University. JMH is grateful for his current Future Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1995, VISUAL NEUROSCI, V12, P793, DOI 10.1017/S0952523800009366; Arrese CA, 2006, CURR BIOL, V16, pR193, DOI 10.1016/j.cub.2006.02.036; Arrese CA, 2005, P ROY SOC B-BIOL SCI, V272, P791, DOI 10.1098/rspb.2004.3009; Arrese CA, 2003, VISUAL NEUROSCI, V20, P307, DOI 10.1017/S0952523803203096; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; BLAKESLEE B, 1988, J COMP PHYSIOL A, V162, P773, DOI 10.1007/BF00610966; Carroll J, 2001, J VISION, V1, P80, DOI 10.1167/1.2.2; Cowing JA, 2008, P ROY SOC B-BIOL SCI, V275, P1491, DOI 10.1098/rspb.2008.0248; Deeb SS, 2003, MOL BIOL EVOL, V20, P1642, DOI 10.1093/molbev/msg181; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Friedman H, 1967, NATURE, V25, P835; Geisbauer G, 2004, CAN J ZOOL, V82, P660, DOI [10.1139/z04-026, 10.1139/Z04-026]; Hemmi JM, 1999, J COMP PHYSIOL A, V185, P509, DOI 10.1007/s003590050411; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; Hemmi JM, 2000, VISION RES, V40, P591, DOI 10.1016/S0042-6989(99)00210-2; Hunt DM, 2009, GENE, V433, P50, DOI 10.1016/j.gene.2008.12.006; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1994, BEHAV NEUROSCI, V108, P993, DOI 10.1037/0735-7044.108.5.993; Jacobs GH, 1981, COMP COLOR VISION; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Roth LSV, 2007, J EXP BIOL, V210, P2795, DOI 10.1242/jeb.007377; Strachan J, 2004, VISUAL NEUROSCI, V21, P223, DOI 10.1017/S0952523804213281; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	25	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86531	10.1371/journal.pone.0086531	http://dx.doi.org/10.1371/journal.pone.0086531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489742	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000047
J	Hanson, J; Lee, SJ; Mohanty, S; Faiz, MA; Anstey, NM; Price, RN; Charunwatthana, P; Bin Yunus, E; Mishra, SK; Tjitra, E; Rahman, R; Nosten, F; Htut, Y; Maude, RJ; Chau, TTH; Phu, NH; Hien, TT; White, NJ; Day, NPJ; Dondorp, AM				Hanson, Josh; Lee, Sue J.; Mohanty, Sanjib; Faiz, M. Abul; Anstey, Nicholas M.; Price, Ric N.; Charunwatthana, Prakaykaew; Bin Yunus, Emran; Mishra, Saroj K.; Tjitra, Emiliana; Rahman, Ridwanur; Nosten, Francois; Htut, Ye; Maude, Richard J.; Tran Thi Hong Chau; Nguyen Hoan Phu; Tran Tinh Hien; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.			Rapid Clinical Assessment to Facilitate the Triage of Adults with Falciparum Malaria, a Retrospective Analysis	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; PLASMODIUM-FALCIPARUM; HOSPITAL MORTALITY; FEBRILE TEMPERATURES; AFRICAN CHILDREN; HYPERGLYCEMIA; PREDICTION; SCORE; RISK; DYSFUNCTION	Background: Most adults dying from falciparum malaria will die within 48 hours of their hospitalisation. An essential component of early supportive care is the rapid identification of patients at greatest risk. In resource-poor settings, where most patients with falciparum malaria are managed, decisions regarding patient care must frequently be made using clinical evaluation alone. Methods: We retrospectively analysed 4 studies of 1801 adults with severe falciparum malaria to determine whether the presence of simple clinical findings might assist patient triage. Results: If present on admission, shock, oligo-anuria, hypo-or hyperglycaemia, an increased respiratory rate, a decreased Glasgow Coma Score and an absence of fever were independently predictive of death. The variables were used to construct a simple clinical algorithm. When applied to the 1801 patients, this algorithm's positive predictive value for survival to 48 hours was 99.4 (95% confidence interval (CI) 97.8-99.9) and for survival to discharge 96.9% (95% CI 94.3-98.5). In the 712 patients receiving artesunate, the algorithm's positive predictive value for survival to 48 hours was 100% (95% CI 97.3-100) and to discharge was 98.5% (95% CI 94.8-99.8). Conclusions: Simple clinical findings are closely linked to the pathophysiology of severe falciparum malaria in adults. A basic algorithm employing these indices can facilitate the triage of patients in settings where intensive care services are limited. Patients classified as low-risk by this algorithm can be safely managed initially on a general ward whilst awaiting senior clinical review and laboratory data.	[Hanson, Josh; Lee, Sue J.; Faiz, M. Abul; Charunwatthana, Prakaykaew; Nosten, Francois; Maude, Richard J.; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Hanson, Josh; Anstey, Nicholas M.; Price, Ric N.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Lee, Sue J.; Price, Ric N.; Nosten, Francois; Maude, Richard J.; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Mohanty, Sanjib; Mishra, Saroj K.] Ispat Hosp, Dept Med, Rourkela, Orissa, India; [Faiz, M. Abul] Dev Care Fdn, Dhaka, Bangladesh; [Bin Yunus, Emran] Chittagong Med Coll, Chittagong, Bangladesh; [Tjitra, Emiliana] Natl Inst Hlth Res & Dev, Minist Hlth, Jakarta, Indonesia; [Rahman, Ridwanur] Shaheed Sharwardhy Med Coll, Dhaka, Bangladesh; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Htut, Ye] Minist Hlth, Dept Med Res, Yangon, Myanmar; [Tran Thi Hong Chau; Nguyen Hoan Phu; Tran Tinh Hien] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Charles Darwin University; Menzies School of Health Research; University of Oxford; Chittagong Medical College; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Mahidol University	Hanson, J (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	drjoshhanson@gmail.com	Maude, Richard James/AAV-3567-2020; Hanson, Josh/ABD-9328-2020; White, Nick/AAC-6527-2019; Rahman, Ridwanur/K-2637-2019; Nosten, Francois/AAC-5509-2019	Maude, Richard James/0000-0002-5355-0562; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Hanson, Josh/0000-0002-1423-3839; Price, Richard/0000-0003-2000-2874	Wellcome Trust of Great Britain; National Health and medical Research Council of Australia	Wellcome Trust of Great Britain(Wellcome Trust); National Health and medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this work was received from the Wellcome Trust of Great Britain (http://www.wellcome.ac.uk/) and the National Health and medical Research Council of Australia (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2004, J LEUKOCYTE BIOL, V75, P413, DOI 10.1189/jlb.0503195; [Anonymous], 2012, MAN SEV MAL PRACT HD; Brandts CH, 1997, LANCET, V350, P704, DOI 10.1016/S0140-6736(97)02255-1; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Cretikos M, 2007, RESUSCITATION, V73, P62, DOI 10.1016/j.resuscitation.2006.08.020; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Faiz MA, 2005, LANCET, V366, P717; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Freire AX, 2005, CHEST, V128, P3109, DOI 10.1378/chest.128.5.3109; Hanson J, 2012, J INFECT DIS, V206, P571, DOI 10.1093/infdis/jis400; Hanson J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-217; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Koh GCKW, 2012, EUR J CLIN MICROBIOL, V31, P379, DOI 10.1007/s10096-011-1337-4; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kruyt ND, 2010, NAT REV NEUROL, V6, P145, DOI 10.1038/nrneurol.2009.231; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; Long HY, 2001, PARASITOL RES, V87, P553, DOI 10.1007/s004360100374; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Mishra SK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-24; Mohapatra M K, 2009, J Assoc Physicians India, V57, P119; Moon A, 2011, RESUSCITATION, V82, P150, DOI 10.1016/j.resuscitation.2010.09.480; Newton PN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-229; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655; TRANG TTM, 1992, CLIN INFECT DIS, V15, P874, DOI 10.1093/clind/15.5.874; Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; von Seidlein L, 2012, CLIN INFECT DIS, V54, P1080, DOI 10.1093/cid/cis034; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; YOUNG PJ, 2012, INTENSIVE CARE MED; [No title captured]; [No title captured]	41	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87020	10.1371/journal.pone.0087020	http://dx.doi.org/10.1371/journal.pone.0087020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489828	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000092
J	Luo, T; Wischgoll, T; Koo, BK; Huo, YL; Kassab, GS				Luo, Tong; Wischgoll, Thomas; Koo, Bon Kwon; Huo, Yunlong; Kassab, Ghassan S.			IVUS Validation of Patient Coronary Artery Lumen Area Obtained from CT Images	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND; THINNING ALGORITHM; SHEAR-STRESS; FLOW; SEGMENTATION; ANGIOGRAPHY; PROGRESSION; ATHEROSCLEROSIS; RECONSTRUCTION; CALCIFICATION	Aims: Accurate computed tomography (CT)-based reconstruction of coronary morphometry (diameters, length, bifurcation angles) is important for construction of patient-specific models to aid diagnosis and therapy. The objective of this study is to validate the accuracy of patient coronary artery lumen area obtained from CT images based on intravascular ultrasound (IVUS). Methods and Results: Morphometric data of 5 patient CT scans with 11 arteries from IVUS were reconstructed including the lumen cross sectional area (CSA), diameter and length. The volumetric data from CT images were analyzed at sub-pixel accuracy to obtain accurate vessel center lines and CSA. A new center line extraction approach was used where an initial estimated skeleton in discrete value was obtained using a traditional thinning algorithm. The CSA was determined directly without any circular shape assumptions to provide accurate reconstruction of stenosis. The root-mean-square error (RMSE) for CSA and diameter were 16.2% and 9.5% respectively. Conclusions: The image segmentation and CSA extraction algorithm for reconstruction of coronary arteries proved to be accurate for determination of vessel lumen area. This approach provides fundamental morphometric data for patient-specific models to diagnose and treat coronary artery disease.	[Luo, Tong; Huo, Yunlong; Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Wischgoll, Thomas] Wright State Univ, Dept Comp Sci & Engn, Fairborn, OH USA; [Koo, Bon Kwon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; Wright State University Dayton; Seoul National University (SNU); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu	Huo, Yunlong/N-8155-2013	Huo, Yunlong/0000-0003-4121-3224	National Heart and Lung Institute [HL-092048]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092048] Funding Source: NIH RePORTER	National Heart and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded in part by National Heart and Lung Institute grant HL-092048.IVUS Validation of Patient Coronary Artery Lumen Area Obtained from CT Images. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; BERTRAND G, 1995, P SOC PHOTO-OPT INS, V2356, P113, DOI 10.1117/12.198601; Brunner D, 2004, P COMPUTER GRAPHICS, V2004, P48; Calvo B, 2007, INT J NUMER METH ENG, V69, P2036, DOI 10.1002/nme.1825; Cebral JR, 2001, ASME, V50, P619; Cornea ND, 2007, IEEE T VIS COMPUT GR, V13, P530, DOI 10.1109/TVCG.2007.1002; Do S, 2011, PHYS MED BIOL, V56, P7109, DOI 10.1088/0031-9155/56/22/008; Florin C, 2005, LECT NOTES COMPUT SC, V3749, P246; Gong W., 1990, Proceedings. 10th International Conference on Pattern Recognition (Cat. No.90CH2898-5), P188, DOI 10.1109/ICPR.1990.118087; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Hoffmann KR, 2002, MED PHYS, V29, P1622, DOI 10.1118/1.1488603; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Jung JW, 2006, J BIOMECH, V39, P2064, DOI 10.1016/j.jbiomech.2005.06.023; Koo BK, 2011, JACC-CARDIOVASC INTE, V4, P803, DOI 10.1016/j.jcin.2011.03.013; Krams R, 1997, ARTERIOSCL THROM VAS, V17, P2061, DOI 10.1161/01.ATV.17.10.2061; Laban M, 1995, COMPUT CARDIOL, P325, DOI 10.1109/CIC.1995.482638; Lacoste C, 2006, I S BIOMED IMAGING, P157; Ladak HM, 2000, J BIOMECH ENG-T ASME, V122, P96, DOI 10.1115/1.429646; LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004; Lohou C, 2004, DISCRETE APPL MATH, V139, P171, DOI 10.1016/j.dam.2002.11.002; Lorensen WE., 1987, ACM SIGGRAPH COMPUTE, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Moore JA, 1999, J BIOMECH ENG-T ASME, V121, P265, DOI 10.1115/1.2798319; Nissen SE, 2001, CIRCULATION, V103, P604, DOI 10.1161/01.CIR.103.4.604; Palagyi K, 1999, GRAPH MODEL IM PROC, V61, P199, DOI 10.1006/gmip.1999.0498; Palagyi K, 1999, LECT NOTES COMPUT SC, V1568, P325; Rollano-Hijarrubia E, 2005, P SOC PHOTO-OPT INS, V5745, P67, DOI 10.1117/12.595491; Rollano-Hijarrubia E, 2009, IEEE T MED IMAGING, V28, P446, DOI 10.1109/TMI.2008.2006529; SALZAR RS, 1995, J BIOMECH, V28, P1333, DOI 10.1016/0021-9290(95)00005-3; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Smith N, 2006, AM J PHYSL HEART CIR, V291; STEIN PD, 1994, AM J CARDIOL, V73, P431, DOI 10.1016/0002-9149(94)90671-8; Taylor C A, 1999, Comput Aided Surg, V4, P231, DOI 10.3109/10929089909148176; THUBRIKAR MJ, 1988, ARTERIOSCLEROSIS, V8, P410, DOI 10.1161/01.ATV.8.4.410; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; TSAO YF, 1981, COMPUT VISION GRAPH, V17, P315, DOI 10.1016/0146-664X(81)90011-3; Voros S, 2011, JACC-CARDIOVASC INTE, V4, P198, DOI 10.1016/j.jcin.2010.10.008; Wang KC, 1999, IEEE ENG MED BIOL, V18, P33, DOI 10.1109/51.805142; Wischgoll T, 2008, ANN BIOMED ENG, V36, P356, DOI 10.1007/s10439-008-9443-x; Zhang L, 2005, INVEST RADIOL, V40, P661, DOI 10.1097/01.rli.0000178433.32526.e0; Zheng Y, 2011, P SPIE MED IMAGING	42	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86949	10.1371/journal.pone.0086949	http://dx.doi.org/10.1371/journal.pone.0086949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489811	Green Published, gold			2022-12-25	WOS:000330570000083
J	McAssey, MP; Bijma, F; Tarigan, B; van Pelt, J; van Ooyen, A; de Gunst, M				McAssey, Michael P.; Bijma, Fetsje; Tarigan, Bernadetta; van Pelt, Jaap; van Ooyen, Arjen; de Gunst, Mathisca			A Morpho-Density Approach to Estimating Neural Connectivity	PLOS ONE			English	Article							SMALL-WORLD; ORGANIZATION	Neuronal signal integration and information processing in cortical neuronal networks critically depend on the organization of synaptic connectivity. Because of the challenges involved in measuring a large number of neurons, synaptic connectivity is difficult to determine experimentally. Current computational methods for estimating connectivity typically rely on the juxtaposition of experimentally available neurons and applying mathematical techniques to compute estimates of neural connectivity. However, since the number of available neurons is very limited, these connectivity estimates may be subject to large uncertainties. We use a morpho-density field approach applied to a vast ensemble of model-generated neurons. A morpho-density field (MDF) describes the distribution of neural mass in the space around the neural soma. The estimated axonal and dendritic MDFs are derived from 100,000 model neurons that are generated by a stochastic phenomenological model of neurite outgrowth. These MDFs are then used to estimate the connectivity between pairs of neurons as a function of their inter-soma displacement. Compared with other density-field methods, our approach to estimating synaptic connectivity uses fewer restricting assumptions and produces connectivity estimates with a lower standard deviation. An important requirement is that the model-generated neurons reflect accurately the morphology and variation in morphology of the experimental neurons used for optimizing the model parameters. As such, the method remains subject to the uncertainties caused by the limited number of neurons in the experimental data set and by the quality of the model and the assumptions used in creating the MDFs and in calculating estimating connectivity. In summary, MDFs are a powerful tool for visualizing the spatial distribution of axonal and dendritic densities, for estimating the number of potential synapses between neurons with low standard deviation, and for obtaining a greater understanding of the relationship between neural morphology and network connectivity.	[McAssey, Michael P.; Bijma, Fetsje; Tarigan, Bernadetta; de Gunst, Mathisca] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [van Pelt, Jaap; van Ooyen, Arjen] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	McAssey, MP (corresponding author), Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands.	m.p.mcassey@auc.nl	Tarigan, Bernadetta/AAD-1843-2019		Nederlandse Organizatie voor Wetenschappelijk Onderzoek (Netherlands Organization of Scientific Research); NWO-CLS grant [635.100.017]; Neuroscience Campus Amsterdam	Nederlandse Organizatie voor Wetenschappelijk Onderzoek (Netherlands Organization of Scientific Research); NWO-CLS grant; Neuroscience Campus Amsterdam	This work was supported by Nederlandse Organizatie voor Wetenschappelijk Onderzoek (Netherlands Organization of Scientific Research, www.nwo.nl), NWO-CLS grant 635.100.017, and Neuroscience Campus Amsterdam (http://www.neurosciencecampus-amsterdam.nl/en/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amirikian B, 2005, PLOS COMPUT BIOL, V1, P74, DOI 10.1371/journal.pcbi.0010011; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Uttley A, 1956, P R SOC LOND, V142, P229	18	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86526	10.1371/journal.pone.0086526	http://dx.doi.org/10.1371/journal.pone.0086526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489738	Green Published, gold			2022-12-25	WOS:000330570000045
J	Musharraf, A; Kruspe, D; Tomasch, J; Besenbeck, B; Englert, C; Landgraf, K				Musharraf, Amna; Kruspe, Dagmar; Tomasch, Juergen; Besenbeck, Birgit; Englert, Christoph; Landgraf, Kathrin			BOR-Syndrome-Associated Eya1 Mutations Lead to Enhanced Proteasomal Degradation of Eya1 Protein	PLOS ONE			English	Article							BRANCHIOOTORENAL SYNDROME; EYES-ABSENT; PHOSPHATASE-ACTIVITY; TYROSINE-PHOSPHATASE; DROSOPHILA; GENES; KIDNEY; THYMUS; NEPHROGENESIS; ACTIVATION	Mutations in the human EYA1 gene have been associated with several human diseases including branchio-oto (BO) and branchio-oto-renal (BOR) syndrome, as well as congenital cataracts and ocular anterior segment anomalies. BOR patients suffer from severe malformations of the ears, branchial arches and kidneys. The phenotype of Eya1-heterozygous mice resembles the symptoms of human patients suffering from BOR syndrome. The Eya1 gene encodes a multifunctional protein that acts as a protein tyrosine phosphatase and a transcriptional coactivator. It has been shown that Eya1 interacts with Six transcription factors, which are also required for nuclear translocation of the Eya1 protein. We investigated the effects of seven disease-causing Eya1 missense mutations on Eya1 protein function, in particular cellular localization, ability to interact with Six proteins, and protein stability. We show here that the BOR-associated Eya1 missense mutations S454P, L472R, and L550P lead to enhanced proteasomal degradation of the Eya1 protein in mammalian cells. Moreover, Six proteins lead to a significant stabilization of Eya1, which is caused by Six-mediated protection from proteasomal degradation. In case of the mutant L550P, loss of interaction with Six proteins leads to rapid protein degradation. Our observations suggest that protein destabilization constitutes a novel disease causing mechanism for Eya1.	[Musharraf, Amna; Kruspe, Dagmar; Tomasch, Juergen; Besenbeck, Birgit; Englert, Christoph; Landgraf, Kathrin] Fritz Lipmann Inst eV FLI, Leibniz Inst Age Res, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Landgraf, K (corresponding author), Univ Leipzig, Hosp Children & Adolescents, Ctr Pediat Res Leipzig CPL, D-04109 Leipzig, Germany.	Kathrin.Landgraf@medizin.uni-leipzig.de	Landgraf, Kathrin/J-4937-2016	Landgraf, Kathrin/0000-0002-6878-6033; Englert, Christoph/0000-0002-5931-3189; Tomasch, Jurgen/0000-0002-3914-2781	Deutsche Forschungsgemeinschaft [SFB604]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft [SFB604, project C7 to C.E.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Christensen KL, 2007, ONCOGENE, V26, P3406, DOI 10.1038/sj.onc.1210122; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; Fan XM, 2000, J BIOL CHEM, V275, P32129, DOI 10.1074/jbc.M004577200; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kumar S, 1997, GENET TEST, V1, P243, DOI 10.1089/gte.1997.1.243; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Musharraf A, 2008, CHEMBIOCHEM, V9, P2285, DOI 10.1002/cbic.200800224; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Ozaki H, 2002, J HUM GENET, V47, P107, DOI 10.1007/s100380200011; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Patrick AN, 2009, J BIOL CHEM, V284, P20781, DOI 10.1074/jbc.M109.016832; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sun JB, 2013, MOL CELL BIOL, V33, P927, DOI 10.1128/MCB.01516-12; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Valerius M. Todd, 2002, Mechanisms of Development, V112, P219, DOI 10.1016/S0925-4773(02)00008-4; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; WEIH F, 1994, ONCOGENE, V9, P3289; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 2002, DEVELOPMENT, V129, P3033	37	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87407	10.1371/journal.pone.0087407	http://dx.doi.org/10.1371/journal.pone.0087407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489909	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000141
J	Mutasa-Apollo, T; Shiraishi, RW; Takarinda, KC; Dzangare, J; Mugurungi, O; Murungu, J; Abdul-Quader, A; Woodfill, CJI				Mutasa-Apollo, Tsitsi; Shiraishi, Ray W.; Takarinda, Kudakwashe C.; Dzangare, Janet; Mugurungi, Owen; Murungu, Joseph; Abdul-Quader, Abu; Woodfill, Celia J. I.			Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRAL LOAD SUPPRESSION; MULTIPLE IMPUTATION; MISSING VALUES; ADULT PATIENTS; SCALING-UP; LOW-INCOME; CARE; MORTALITY; DECENTRALIZATION	Background: Since establishment of Zimbabwe's National Antiretroviral Therapy (ART) Programme in 2004, ART provision has expanded from,5,000 to 369,431 adults by 2011. However, patient outcomes are unexplored. Objective: To determine improvement in health status, retention and factors associated with attrition among HIV-infected patients on ART. Methods: A retrospective review of abstracted patient records of adults >= 15 years who initiated ART from 2007 to 2009 was done. Frequencies and medians were calculated for rates of retention in care and changes in key health status outcomes at 6, 12, 24 and 36 months respectively. Cox proportional hazards models were used to determine factors associated with attrition. Results: Of the 3,919 patients, 64% were female, 86% were either WHO clinical stage III or IV. Rates of patient retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. After ART initiation, median weight gains at 6, 12, and 24 months were 3, 4.5, and 5.0 kgs whilst median CD4+ cell count gains at 6, 12 and 24 months were 122, 157 and 279 cells/mu L respectively. Factors associated with an increased risk of attrition included male gender (AHR 1.2; 95% CI, 1.1-1.4), baseline WHO stage IV (AHR 1.7; 95% CI, 1.1-2.6), lower baseline body weight (AHR 2.0; 95% CI, 1.4-2. 8) and accessing care from higher level healthcare facilities (AHR 3.5; 95% 1.1-11.2). Conclusions: Our findings with regard to retention as well as clinical and immunological improvements following uptake of ART, are similar to what has been found in other settings. Factors influencing attrition also mirror those found in other parts of sub-Saharan Africa. These findings suggest the need to strengthen earlier diagnosis and treatment to further improve treatment outcomes. Whilst decentralisation improves ART coverage it should be coupled with strategies aimed at improving patient retention.	[Mutasa-Apollo, Tsitsi; Takarinda, Kudakwashe C.; Dzangare, Janet; Mugurungi, Owen; Murungu, Joseph] Zimbabwe Minist Hlth & Child Care, AIDS & TB Dept, Harare, Zimbabwe; [Woodfill, Celia J. I.] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Accra, Ghana; [Shiraishi, Ray W.; Abdul-Quader, Abu] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Mutasa-Apollo, T (corresponding author), Zimbabwe Minist Hlth & Child Care, AIDS & TB Dept, Harare, Zimbabwe.	tsitsiapollo1@gmail.com		Shiraishi, Ray/0000-0001-7640-0666	U.S. Centers for Disease Control; Expanded Support Program for HIV/AIDS (ESP)	U.S. Centers for Disease Control; Expanded Support Program for HIV/AIDS (ESP)	The survey was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and also the Expanded Support Program for HIV/AIDS (ESP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GLOB UPD HIV TREATM, P7; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brennan AT, 2013, TROP MED INT HEALTH, V18, P619, DOI 10.1111/tmi.12079; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Elston JWT, 2009, INT J STD AIDS, V20, P221, DOI 10.1258/ijsa.2008.008449; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Fehd RJ, 1998, COMPARWS COMP SUMMAR; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Gilks C, 2006, ANTIRETROVIRAL THERA, P13; Hanke SH, 2012, ZIMBABWE HYPERINFLAT; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP, P253; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, REP GLOB HIV AIDS EP, P272; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Koethe JR, 2009, CLIN INFECT DIS, V49, P787, DOI 10.1086/605285; Kuwane B, 2009, LANCET, V374, P1329, DOI 10.1016/S0140-6736(09)61823-7; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Meldrum A, 2008, LANCET, V371, P1059, DOI 10.1016/S0140-6736(08)60468-7; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Ministry of Health and Child Welfare and WHO Zimbabwe Country office, 2012, EXP SUPP PROGR HIV A; Ministry of Health and Child Welfare (MOHCW), 2013, ZIMB HIV EST 2012, P17; Ministry of Health and Child Welfare (MOHCW), 2009, ZIMB ART ANN REP 200, P15; Ministry of Health and Child Welfare (MOHCW), 2011, ZIMB GUID DEC OI ART, P12; Ministry of Health and Child Welfare (MOHCW), 2008, ZIMB ART ANN REP 200, P17; Ministry of Health and Child Welfare (MOHCW), 2006, ZIMB ART ANN REP 200, P49; Ministry of Health and Child Welfare (MOHCW), 2012, REP NAT HIV DRUG RES, P41; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Muchedzi A, 2012, 19 INT AIDS C; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204; Perriens J, 2010, ADULT ANTIRETROVIRAL; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Staveteig S, 2013, DHS COMP REPORTS, P39; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Takarinda KC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-124; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; United Nations General Assembly, 2011, 2011 POL DECL HIV AI, P8; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO UNAIDS UNICEF, 2011, GLOB PROGR EL LYMPH, P93; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization (WHO) Dept. of HIV/AIDS WHO Integrated Management of Adolescent and Adult Illness Project WHO Integrated Management of Childhood Project, 2007, CHRON HIV CAR ART PR, P61; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2, P220	72	64	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86305	10.1371/journal.pone.0086305	http://dx.doi.org/10.1371/journal.pone.0086305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489714	Green Published, gold			2022-12-25	WOS:000330570000032
J	Seitz, K; Dursch, V; Harnos, J; Bryja, V; Gentzel, M; Schambony, A				Seitz, Katharina; Duersch, Verena; Harnos, Jakub; Bryja, Vitezslav; Gentzel, Marc; Schambony, Alexandra			beta-Arrestin Interacts with the Beta/Gamma Subunits of Trimeric G-Proteins and Dishevelled in the Wnt/Ca2+ Pathway in Xenopus Gastrulation	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; WNT SIGNALING PATHWAYS; WNT/BETA-CATENIN; VERTEBRATE GASTRULATION; PARAXIAL PROTOCADHERIN; TISSUE SEPARATION; ACTIVATION; FRIZZLED-7; LAEVIS; KINASE	beta-Catenin independent, non-canonical Wnt signaling pathways play a major role in the regulation of morphogenetic movements in vertebrates. The term non-canonical Wnt signaling comprises multiple, intracellularly divergent, Wnt-activated and beta-Catenin independent signaling cascades including the Wnt/Planar Cell Polarity and the Wnt/Ca2+ cascades. Wnt/Planar Cell Polarity and Wnt/Ca2+ pathways share common effector proteins, including the Wnt ligand, Frizzled receptors and Dishevelled, with each other and with additional branches of Wnt signaling. Along with the aforementioned proteins, beta-Arrestin has been identified as an essential effector protein in the Wnt/beta-Catenin and the Wnt/Planar Cell Polarity pathway. Our results demonstrate that beta-Arrestin is required in the Wnt/Ca2+ signaling cascade upstream of Protein Kinase C (PKC) and Ca2+/Calmodulin-dependent Protein Kinase II (CamKII). We have further characterized the role of beta-Arrestin in this branch of non-canonical Wnt signaling by knock-down and rescue experiments in Xenopus embryo explants and analyzed protein-protein interactions in 293T cells. Functional interaction of beta-Arrestin, the beta subunit of trimeric G-proteins and Dishevelled is required to induce PKC activation and membrane translocation. In Xenopus gastrulation, beta-Arrestin function in Wnt/Ca2+ signaling is essential for convergent extension movements. We further show that beta-Arrestin physically interacts with the beta subunit of trimeric G-proteins and Dishevelled, and that the interaction between beta-Arrestin and Dishevelled is promoted by the beta/gamma subunits of trimeric G-proteins, indicating the formation of a multiprotein signaling complex.	[Seitz, Katharina; Duersch, Verena; Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany; [Harnos, Jakub; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, CS-61265 Brno, Czech Republic; [Gentzel, Marc] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Erlangen Nuremberg; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Max Planck Society	Schambony, A (corresponding author), Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany.	alexandra.schambony@fau.de	Bryja, Vít?zslav/H-1925-2014; Harnos, Jakub/AAE-7855-2021; Bryja, Vítězslav/P-4217-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Rauschenberger, Verena/0000-0002-3311-7489; Harnos, Jakub/0000-0002-0752-9260; Schambony, Alexandra/0000-0001-8771-5487; Gentzel, Marc/0000-0002-4482-6010	Deutsche Forschungsgemeinschaft [SCHA965/6-1]; Max-Planck-Society; Czech Science Foundation [204/09/0498, 204/09/J030]; EMBO Installation Grant; Ministry of Education Youth and Sport of the Czech Republic [MSM0021622430]; Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Society(Max Planck Society); Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Installation Grant; Ministry of Education Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Friedrich-Alexander-Universitat Erlangen-Nurnberg	This work was supported by Deutsche Forschungsgemeinschaft (SCHA965/6-1 to A. S., www.dfg.de), the Max-Planck-Society (to M. G., www.mpg.de) and by Czech Science Foundation (204/09/0498, 204/09/J030 to V. B., www.gacr.cz) and EMBO Installation Grant, the Ministry of Education Youth and Sport of the Czech Republic (MSM0021622430 to V. B., www.embo.org). In addition, the authors acknowledge support by Deutsche Forschungsgemeinschaft (www.dfg.de) and Friedrich-Alexander-Universitat Erlangen-Nurnberg (www.fau.de) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim GH, 2007, EMBO J, V26, P2513, DOI 10.1038/sj.emboj.7601688; Kim GH, 2013, BIOCHEM BIOPH RES CO, V435, P182, DOI 10.1016/j.bbrc.2013.04.088; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Nichols AS, 2013, CELL SIGNAL, V25, P1468, DOI 10.1016/j.cellsig.2013.03.009; Nieuwkoop PD, 1975, NORMAL TABLES XENOPU, P162; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Penzo-Mendez A, 2003, DEV BIOL, V257, P302, DOI 10.1016/S0012-1606(03)00067-8; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; SHIH J, 1992, DEVELOPMENT, V116, P901; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	36	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87132	10.1371/journal.pone.0087132	http://dx.doi.org/10.1371/journal.pone.0087132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489854	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000107
J	Zhao, LP; Wu, F; Jin, LG; Lu, TT; Yang, LH; Pan, XB; Shao, CF; Li, XK; Lin, ZF				Zhao, Leping; Wu, Fan; Jin, Leigang; Lu, Tingting; Yang, Lihui; Pan, Xuebo; Shao, Chuanfeng; Li, Xiaokun; Lin, Zhuofeng			Serum CXCL16 as a Novel Marker of Renal Injury in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SCAVENGER RECEPTOR; CHEMOKINE LIGAND-16; DENSITY-LIPOPROTEIN; CELL-ADHESION; ATHEROSCLEROSIS; NEPHROPATHY; CXCL16/SR-PSOX; PODOCYTES	Background: Soluble C-X-C chemokine ligand 16 (CXCL16), a scavenger receptor for oxidized low density lipoprotein, has been shown to promote atherogenic effects in vivo and to predict long-term mortality in acute coronary syndrome. The aim of this study was to explore the association of circulating CXCL16 levels with diabetic subjects with and without renal disease. Methodology/Principal Findings: One hundred twenty Chinese subjects, which included patients with type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN), and CKD, as well as healthy controls, were enrolled in this study. Serum CXCL16 levels were examined by immunoassay and other clinical biochemical parameters were tested based on standard methods. Our results indicated that, HDL and LDL cholesterol levels are significantly different in DN but not in T2D patients in comparison with healthy subjects. On the other hand, Serum CXCL16 levels were significantly increased in DN subjects compared with age and gender matched healthy and T2DM subjects (p<0.05 respectively). However, no significant changes in serum CXCL16 levels were found between T2DM and healthy subjects. Furthermore, serum CXCL16 concentration negatively correlated with estimated glomerular filtrate rate, creatinine clearance rate and blood albumin, and positively with 24 h proteinuria, blood urea nitrogen (BUN), creatinine, and uric acid after adjusting for age, gender and BMI in subjects with DN. Multiple stepwise regression analyses indicated that serum CXCL16 levels were independently associated with serum 24 h proteinuria, and BUN (p<0.05 respectively). Conclusion: Serum CXCL16 may be an indicator of renal injury in subjects with T2DM. Understanding the exact mechanism of elevated CXCL16 in subjects with DN requires further study.	[Zhao, Leping; Yang, Lihui; Shao, Chuanfeng] Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China; [Wu, Fan; Lin, Zhuofeng] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China; [Jin, Leigang; Lu, Tingting; Pan, Xuebo; Li, Xiaokun; Lin, Zhuofeng] Wenzhou Med Univ, Sch Pharm, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Jilin Agricultural University; Wenzhou Medical University	Lin, ZF (corresponding author), Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China.	zhuofenglin@wzmc.edu.cn		Leigang, Jin/0000-0002-6916-4009	Scientific Technological Projects of Wenzhou [H20100026, H2009]; Natural Science Project of Zhejiang Province [Y2110339, LY12H07002]	Scientific Technological Projects of Wenzhou; Natural Science Project of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from "Scientific Technological Projects of Wenzhou'', H20100026 (Z. Lin), H2009 (X. Pan), and Natural Science Project of Zhejiang Province, Y2110339 (Z. Lin) and LY12H07002 (L.Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2005, AM J RESP CRIT CARE, V172, P1290, DOI 10.1164/rccm.200501-142OC; Aslanian AM, 2006, CIRCULATION, V114, P583, DOI 10.1161/CIRCULATIONAHA.105.540583; Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276; Barlic J, 2009, J IMMUNOL, V182, P7928, DOI 10.4049/jimmunol.0804112; BERKMAN J, 1973, METABOLISM, V21, P715, DOI 10.1016/0026-0495(73)90243-6; Chandrasekar B, 2004, J BIOL CHEM, V279, P3188, DOI 10.1074/jbc.M311660200; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gong Q, 2012, CLIN BIOCHEM, V45, P1368, DOI 10.1016/j.clinbiochem.2012.05.014; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Gutwein P, 2009, J CELL MOL MED, V13, P3809, DOI 10.1111/j.1582-4934.2009.00761.x; Gutwein P, 2009, AM J PATHOL, V174, P2061, DOI 10.2353/ajpath.2009.080960; Jansson AM, 2009, CIRCULATION, V119, P3181, DOI 10.1161/CIRCULATIONAHA.108.806877; Kouroumichakis I, 2012, EUR J INTERN MED, V23, P309, DOI 10.1016/j.ejim.2011.12.007; Lin ZF, 2011, EUR J CLIN INVEST, V41, P836, DOI 10.1111/j.1365-2362.2011.02473.x; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Lin ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015534; Mathiesen ER, 2012, CLIN J AM SOC NEPHRO, V7, P2081, DOI 10.2215/CJN.00920112; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Okamura DM, 2007, AM J PHYSIOL-RENAL, V293, pF575, DOI 10.1152/ajprenal.00063.2007; Schramme A, 2008, KIDNEY INT, V74, P328, DOI 10.1038/ki.2008.181; Sheikine Y, 2008, ATHEROSCLEROSIS, V197, P487, DOI 10.1016/j.atherosclerosis.2007.11.034; Shimaoka T, 2003, J IMMUNOL, V171, P1647, DOI 10.4049/jimmunol.171.4.1647; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Wu TF, 2007, J IMMUNOL, V179, P7166, DOI 10.4049/jimmunol.179.10.7166; Wuttge DM, 2004, ARTERIOSCL THROM VAS, V24, P750, DOI 10.1161/01.ATV.0000124102.11472.36	26	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87786	10.1371/journal.pone.0087786	http://dx.doi.org/10.1371/journal.pone.0087786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489966	gold, Green Submitted, Green Published			2022-12-25	WOS:000330570000182
J	Chen, P; Zhang, XL; Zhao, TJ; Li, Y; Gai, JY				Chen, Pei; Zhang, Xiaolian; Zhao, Tuanjie; Li, Yan; Gai, Junyi			Genome-Wide Identification and Characterization of RBR Ubiquitin Ligase Genes in Soybean	PLOS ONE			English	Article							FAMILY; RING; ARABIDOPSIS; SYSTEM; PARKIN; DOMAIN; PALEOPOLYPLOIDY; FINGER; MODEL	RBR (RING1-IBR-RING2) proteins play an important role in protein ubiquitination and are involved in many cellular processes. Recent studies showed plant RBR genes were induced by abiotic and biotic stresses. However, detailed studies on RBR genes in the important oil crop, soybean (Glycine max (L.) Merr.), is still lacking. Here we performed a genome-wide search and identified 24 RBR domain-containing genes from the soybean genome sequence and cloned 11 of them. Most soybean RBR proteins contain a highly conserved RBR supra-domain. Phylogenetic analyses indicated all 24 soybean RBR proteins are most related to the RBR proteins from Phaseolus vulgaris, and could be classified into seven groups including Ariadne A, Ariadne B, ARA54, Plant IIA, Plant IIB, Plant IIC, and Helicase. Tandem duplication and block duplication were found among the Ariadne B and Plant IIC group of soybean RBR genes. Despite the conserved RBR supra-domain, there are extensive variations in the additional protein motifs and exon-intron structures between different groups, which indicate they might have diverse functions. Most soybean RBR proteins are predicted to localize in nucleus, and four of them were experimentally confirmed by GFP fusion proteins. Soybean RBR genes are broadly expressed in many tissue types with a little more abundant in the roots and flowers than leaves, stems, and seeds. The expression of GmRTRTP3 (Plant IIB) and GmRTRTP5 (Plant IIC) are induced by NaCl treatment, which suggests these RBR genes might be involved in soybean response to abiotic stresses.	[Chen, Pei; Zhang, Xiaolian; Zhao, Tuanjie; Li, Yan; Gai, Junyi] Nanjing Agr Univ, Soybean Res Inst, Natl Ctr Soybean Improvement,Natl Key Lab Crop Ge, MOA Key Lab Biol & Genet Improvement Soybean Gen, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, Y (corresponding author), Nanjing Agr Univ, Soybean Res Inst, Natl Ctr Soybean Improvement,Natl Key Lab Crop Ge, MOA Key Lab Biol & Genet Improvement Soybean Gen, Nanjing, Jiangsu, Peoples R China.	yanli1@njau.edu.cn; sri@njau.edu.cn			National Key Basic Research Program of China [2011CB1093, 2010CB1259]; National Hightech R & D Program of China [2011AA10A105, 2012AA101106]; Natural Science Foundation of China [31071442]; Program for New Century Excellent Talents in University [NCET-12-0891]; MOE 111 Project [B08025]; MOA Public Profit Program [200803060]; Jiangsu Higher Education PAPD Program	National Key Basic Research Program of China(National Basic Research Program of China); National Hightech R & D Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); MOE 111 Project(Ministry of Education, China - 111 Project); MOA Public Profit Program; Jiangsu Higher Education PAPD Program	This work was supported by the National Key Basic Research Program of China (2011CB1093, 2010CB1259), the National Hightech R & D Program of China (2011AA10A105, 2012AA101106), the Natural Science Foundation of China (31071442), the Program for New Century Excellent Talents in University (NCET-12-0891), the MOE 111 Project (B08025), the MOA Public Profit Program (200803060), and the Jiangsu Higher Education PAPD Program. The funders had no role in study design, data collection and analysis, decision or preparation of the manuscript.	Aguilera M, 2000, GENETICS, V155, P1231; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Duda DM, 2013, STRUCTURE; Ehrlund A, 2009, MOL CELL BIOL, V29, P2230, DOI 10.1128/MCB.00743-08; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Lang-Mladek C, 2012, PHYSIOL PLANTARUM, V145, P527, DOI 10.1111/j.1399-3054.2011.01561.x; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011579; Marin I, 2009, J MOL EVOL, V69, P54, DOI 10.1007/s00239-009-9252-3; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Qiu XH, 2006, DEV BIOL, V291, P239, DOI 10.1016/j.ydbio.2005.11.045; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Schallau A, 2010, PLANT J, V62, P773, DOI 10.1111/j.1365-313X.2010.04188.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Steggerda SM, 2002, INT REV CYTOL, V217, P41; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wauer T, 2013, EMBO J; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038	47	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87282	10.1371/journal.pone.0087282	http://dx.doi.org/10.1371/journal.pone.0087282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489889	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000124
J	Marley, CL; Fychan, R; Davies, JW; Scollan, ND; Richardson, RI; Theobald, VJ; Genever, E; Forbes, AB; Sanderson, R				Marley, Christina L.; Fychan, Rhun; Davies, John W.; Scollan, Nigel D.; Richardson, R. Ian; Theobald, Vince J.; Genever, Elizabeth; Forbes, Andy B.; Sanderson, Ruth			Effects of Chicory/Perennial Ryegrass Swards Compared with Perennial Ryegrass Swards on the Performance and Carcass Quality of Grazing Beef Steers	PLOS ONE			English	Article							CHICORY CICHORIUM-INTYBUS; TREFOIL LOTUS-CORNICULATUS; GASTROINTESTINAL NEMATODES; MINERAL-COMPOSITION; LOLIUM-PERENNE; FORAGE; PEPSINOGEN; HERBAGE; GROWTH; CATTLE	An experiment investigated whether the inclusion of chicory (Cichorium intybus) in swards grazed by beef steers altered their performance, carcass characteristics or parasitism when compared to steers grazing perennial ryegrass (Lolium perenne). Triplicate 2-ha plots were established with a chicory/ryegrass mix or ryegrass control. Forty-eight Belgian Bluecross steers were used in the first grazing season and a core group (n = 36) were retained for finishing in the second grazing season. The experiment comprised of a standardisation and measurement period. During standardisation, steers grazed a ryegrass/white clover pasture as one group. Animals were allocated to treatment on the basis of liveweight, body condition and faecal egg counts (FEC) determined 7 days prior to the measurement period. The measurement period ran from 25 May until 28 September 2010 and 12 April until 11 October 2011 in the first and second grazing year. Steers were weighed every 14 days at pasture or 28 days during housing. In the first grazing year, faecal samples were collected for FEC and parasite cultures. At the end of the first grazing year, individual blood samples were taken to determine O. ostertagi antibody and plasma pepsinogen levels. During winter, animals were housed as one group and fed silage. In the second grazing year, steers were slaughtered when deemed to reach fat class 3. Data on steer performance showed no differences in daily liveweight gain which averaged 1.04 kg/day. The conformation, fat grade and killing out proportion of beef steers grazing chicory/ryegrass or ryegrass were not found to differ. No differences in FEC, O. ostertagi antibody or plasma pepsinogen levels of beef steers grazing either chicory/ryegrass or ryegrass were observed. Overall, there were no detrimental effects of including chicory in swards grazed by beef cattle on their performance, carcass characteristics or helminth parasitism, when compared with steers grazing ryegrass.	[Marley, Christina L.; Fychan, Rhun; Davies, John W.; Scollan, Nigel D.; Theobald, Vince J.; Sanderson, Ruth] Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Gogerddan, Ceredigion, Wales; [Richardson, R. Ian] Univ Bristol, Div Farm Anim Sci DFAS, Food Sci & Food Safety Grp, Bristol, Avon, England; [Genever, Elizabeth] Agr & Hort Dev Board, EBLEX, Warwick, England; [Forbes, Andy B.] Merial Anim Hlth, Lyon, France	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Bristol; Agriculture & Horticulture Development Board (AHDB); Merial SASU	Marley, CL (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Gogerddan, Ceredigion, Wales.	cvm@aber.ac.uk		Sanderson, Ruth/0000-0001-5569-5493; Richardson, Ian/0000-0002-3514-7040; Forbes, Andrew/0000-0003-4269-914X	EBLEX	EBLEX	This work was funded by EBLEX (www.eblex.org.uk), with parasitology support and advice from Merial SAS, France (http://www.merial.com). Seed for the swards was donated by Germinal Holdings Ltd, UK. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Barry TN, 1998, J AGR SCI, V131, P251, DOI 10.1017/S002185969800584X; Barthram GT, 1986, EXPT TECHNIQUES HFRO, V1884-1985, P29; Belesky DP, 2001, AGRON J, V93, P468, DOI 10.2134/agronj2001.932468x; BERGHEN P, 1993, VET PARASITOL, V46, P175, DOI 10.1016/0304-4017(93)90057-T; BERGHEN P, 1987, AM J VET RES, V48, P664; Charlier J, 2005, PREV VET MED, V68, P277, DOI 10.1016/j.prevetmed.2005.01.011; CLARK DA, 1990, NEW ZEAL J AGR RES, V33, P219, DOI 10.1080/00288233.1990.10428413; Cockayne AH, 1915, NZ J AGR, VII, P468; Cosgrove G. P., 2003, Proceedings of the New Zealand Grassland Association, V65, P21; CUSHNAHAN A, 1994, ANIM PROD, V59, P415, DOI 10.1017/S0003356100007935; DAVIES DA, 1989, GRASS FORAGE SCI, V44, P213, DOI 10.1111/j.1365-2494.1989.tb01929.x; Dorny P, 1998, RES VET SCI, V65, P259, DOI 10.1016/S0034-5288(98)90153-9; Dorny P, 2000, VET PARASITOL, V89, P277, DOI 10.1016/S0304-4017(00)00220-X; Elliot RH, 1942, CLIFTON PARK SYSTEM; Epe C, 1999, VET REC, V144, P380, DOI 10.1136/vr.144.14.380; Eysker M, 2000, PARASITOLOGY, V120, pS109, DOI 10.1017/S0031182099005752; Fraser T. J., 1988, Proceedings of the New Zealand Grassland Association, V49, P193; Fychan R, 2011, P BRIT GRASSL SOC 10, P51; Hare M. D., 1987, Proceedings, Annual Conference, Agronomy Society of New Zealand, V17, P45; Harrington K. C., 2006, New Zealand Plant Protection, V59, P261; HILDERSON H, 1989, VET REC, V125, P376, DOI 10.1136/vr.125.14.376; Hogh-Jensen H, 2006, EUR J AGRON, V24, P247, DOI 10.1016/j.eja.2005.10.007; Holmes W., 1989, GRASS ITS PRODUCTION; Hoskin S, 2005, P DEER COURS VET DEE, V22, P85; HOSKIN SO, 1995, J AGR SCI-CAMBRIDGE, V124, P289, DOI 10.1017/S0021859600072956; Houdijk JGM, 2011, P BSAS ANN C APR 4 5, P139; Jackson FS, 1996, J SCI FOOD AGR, V72, P483, DOI 10.1002/(SICI)1097-0010(199612)72:4&lt;483::AID-JSFA684&gt;3.0.CO;2-G; JONES DIH, 1975, J SCI FOOD AGR, V26, P711, DOI 10.1002/jsfa.2740260518; KEMPSTER AJ, 1986, MEAT SCI, V17, P107, DOI [10.1016/0309-1740(86)90059-8, 10.1016/0309-1740(86)90058-6]; Komolong M., 1992, Proceedings of the New Zealand Society of Animal Production, V52, P85; Lancashire JA, 1983, P NZ GRASSLAND ASS, V44, P61; Larsson A, 2006, VET PARASITOL, V142, P197, DOI 10.1016/j.vetpar.2006.07.017; Li GD, 2005, ADV AGRON, V88, P187, DOI 10.1016/S0065-2113(05)88005-8; Lloyd-Davies H, 1962, P AUST SOC ANIM PROD, V4, P167; MAFF, 1997, MAFF TECHN B, V18; Marley CL, 2007, GRASS FORAGE SCI, V62, P1, DOI 10.1111/j.1365-2494.2007.00556.x; Marley CL, 2006, VET PARASITOL, V138, P280, DOI 10.1016/j.vetpar.2006.01.029; Marley CL, 2003, VET PARASITOL, V112, P147, DOI 10.1016/S0304-4017(02)00412-0; Marley CL, 2003, VET PARASITOL, V118, P93, DOI 10.1016/j.vetpar.2003.10.004; Marley CL, 2013, P 17 S EGF AK IC 23, P252; Marley CL, 2011, P BGS 10 RES C 20 21, P53; Marley CL, 2013, P 17 S EGF AK IC 23, P249; Matthews PNP, 1990, P AGRONOMY SOC NZ, V20, P41; McCoy JE, 1997, CROP SCI, V37, P239, DOI 10.2135/cropsci1997.0011183X003700010042x; Min BR, 1997, NEW ZEAL J AGR RES, V40, P335, DOI 10.1080/00288233.1997.9513253; MOSS RA, 1993, NEW ZEAL J AGR RES, V36, P371; Niezen J. H., 1994, Proceedings of the New Zealand Society of Animal Production, V54, P15; NIEZEN JH, 1993, J AGR SCI-CAMBRIDGE, V121, P255, DOI 10.1017/S0021859600077133; ORIORDAN EG, 2000, BRIT GRASSLAND SOC O, V35, P43; Parish J. A., 2012, Professional Animal Scientist, V28, P579; Payne RW, 2011, GENSTAT WINDOWS, P150; PEACOCK JM, 1975, J APPL ECOL, V12, P685, DOI 10.2307/2402182; Rossanigo CE, 1995, J HELMINTHOL, V69, P357, DOI 10.1017/S0022149X00014954; Rumball W, 2003, NEW ZEAL J AGR RES, V46, P53, DOI 10.1080/00288233.2003.9513529; RUMBALL W, 1986, NEW ZEAL J EXP AGR, V14, P105, DOI 10.1080/03015521.1986.10426133; SCALES GH, 1994, NZ J AGR RES, V38, P237; Schmidt JR, 2013, J ANIM SCI, V91, P4451, DOI 10.2527/jas.2012-5405; Speijers MHM, 2004, J AGR SCI, V142, P483, DOI 10.1017/S0021859604004496; STEAR MJ, 1995, INT J PARASITOL, V25, P375, DOI 10.1016/0020-7519(94)00136-C; Theil H., 1950, RANK INVARIANT METHO, V53, P386, DOI DOI 10.1007/978-94-011-2546-8_20; THOMAS TA, 1977, J SCI FOOD AGR, V28, P639, DOI 10.1002/jsfa.2740280711; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2	62	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86259	10.1371/journal.pone.0086259	http://dx.doi.org/10.1371/journal.pone.0086259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489708	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000041
J	Nucci, M; Carlesse, F; Cappellano, P; Varon, AG; Seber, A; Garnica, M; Nouer, SA; Colombo, AL				Nucci, Marcio; Carlesse, Fabianne; Cappellano, Paola; Varon, Andrea G.; Seber, Adriana; Garnica, Marcia; Nouer, Simone A.; Colombo, Arnaldo L.			Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing	PLOS ONE			English	Article							CROSS-REACTIVITY; LABORATORY DIAGNOSIS; ANTIFUNGAL TREATMENT; BIOLOGICAL MARKERS; ANTIGENEMIA; INFECTIONS; RECIPIENTS; DISEASES; PROPOSAL; PREDICT	Cross-reactivity of Fusarium species with serum galactomannan antigen (GMI) test has been observed. We sought to evaluate if GMI could help to early diagnose invasive fusariosis and to monitor treatment response. We reviewed the records of all patients with invasive fusariosis between 2008 and 2012 in three Brazilian hospitals. We selected patients who had at least 1 GMI test within 2 days before or after the date of the first clinical manifestation of fusariosis, and analyzed the temporal relationship between the first positive GMI test and the date of the diagnosis of invasive fusariosis, and the kinetics of GMI in relation to patients' response to treatment. We also selected 18 controls to determine the sensitivity and specificity of the test. Among 18 patients, 15 (83%) had at least one positive GMI (median 4, range 1-15). The sensitivity and specificity of was 83% and 67%, respectively. GMI was positive before the diagnosis of invasive fusariosis in 11 of the 15 cases (73%), at a median of 10 days (range 3-39), and after the diagnosis in 4 cases. GMI became negative in 8 of the 15 patients; 3 of these 8 patients (37.5%) were alive 90 days after the diagnosis of fusariosis compared with 2 of 7 (29%) who did not normalize GMI (p = 1.0). GMI is frequently positive in invasive fusariosis, and becomes positive before diagnosis in most patients. These findings may have important implications for the choice of antifungal therapy in settings with high prevalence of invasive fusariosis.	[Nucci, Marcio; Varon, Andrea G.; Garnica, Marcia; Nouer, Simone A.] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil; [Carlesse, Fabianne; Seber, Adriana] Univ Fed Sao Paulo UNIFESP, Inst Pediat Oncol GRAACC, Sao Paulo, Brazil; [Cappellano, Paola; Colombo, Arnaldo L.] Univ Fed Sao Paulo UNIFESP, Univ Hosp, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Nucci, M (corresponding author), Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil.	mnucci@hucff.ufrj.br	Colombo, Arnaldo Lopes/V-4417-2019; Seber, Adriana/AAG-7978-2020; Garnica, Marcia/D-5854-2013; Colombo, Arnaldo Lopes/H-4397-2012; Nucci, Marcio/G-4515-2012	Colombo, Arnaldo Lopes/0000-0003-0793-8491; Seber, Adriana/0000-0003-4578-9423; Garnica, Marcia/0000-0003-1067-6680; Nucci, Marcio/0000-0003-4867-0014; Cappellano, Paola/0000-0001-5984-2120				Bergeron A, 2012, J CLIN MICROBIOL, V50, P823, DOI 10.1128/JCM.00750-11; Chai LYA, 2012, J CLIN MICROBIOL, V50, P2330, DOI 10.1128/JCM.06513-11; Cummings JR, 2007, DIAGN MICR INFEC DIS, V59, P113, DOI 10.1016/j.diagmicrobio.2007.04.022; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Fekkar A, 2009, CLIN INFECT DIS, V49, P1457, DOI 10.1086/644499; Giacchino M, 2006, J CLIN MICROBIOL, V44, P3432, DOI 10.1128/JCM.00856-06; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Koo S, 2010, J CLIN MICROBIOL, V48, P1255, DOI 10.1128/JCM.02281-09; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Maertens J, 2009, CANCER, V115, P355, DOI 10.1002/cncr.24022; Maertens JA, 2012, HAEMATOL-HEMATOL J, V97, P325, DOI 10.3324/haematol.2012.061952; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; McCulloch E, 2012, J CLIN PATHOL, V65, P83, DOI 10.1136/jcp.2011.090464; Mikulska M, 2013, CLIN INFECT DIS, V57, P1786, DOI 10.1093/cid/cit565; Mikulska M, 2012, DIAGN MICR INFEC DIS, V72, P367, DOI 10.1016/j.diagmicrobio.2011.12.009; NOTERMANS S, 1988, J MED VET MYCOL, V26, P41; Nouer SA, 2011, CLIN INFECT DIS, V53, P671, DOI 10.1093/cid/cir441; Nouer SA, 2012, CLIN INFECT DIS, V54, pE173, DOI 10.1093/cid/cis298; Nucci M, 2013, CLIN MICROBIOL INFEC, V19, P745, DOI 10.1111/1469-0691.12002; Nucci M, 2003, CANCER, V98, P315, DOI 10.1002/cncr.11510; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Nucci M, 2006, INFECT DIS CLIN N AM, V20, P563, DOI 10.1016/j.idc.2006.06.002; Nucci M, 2010, CLIN INFECT DIS, V51, P1273, DOI 10.1086/657065; Park SH, 2011, MYCOSES, V54, P523, DOI 10.1111/j.1439-0507.2010.02009.x; Reinwald M, 2012, J ANTIMICROB CHEMOTH, V67, P2260, DOI 10.1093/jac/dks208; Tanriover MD, 2010, MYCOSES, V53, P16, DOI 10.1111/j.1439-0507.2008.01652.x; Tortorano AM, 2012, J CLIN MICROBIOL, V50, P1051, DOI 10.1128/JCM.05946-11; Van der Veer J, 2012, MED MYCOL, V50, P396, DOI 10.3109/13693786.2011.608172	29	63	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87784	10.1371/journal.pone.0087784	http://dx.doi.org/10.1371/journal.pone.0087784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489964	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000149
J	van Velden, FHP; Nissen, IA; Hayes, W; Velasquez, LM; Hoekstra, OS; Boellaard, R				van Velden, Floris H. P.; Nissen, Ida A.; Hayes, Wendy; Velasquez, Linda M.; Hoekstra, Otto S.; Boellaard, Ronald			Effects of Reusing Baseline Volumes of Interest by Applying (Non-)Rigid Image Registration on Positron Emission Tomography Response Assessments	PLOS ONE			English	Article							WHOLE-BODY PET; FDG UPTAKE; LUNG-CANCER; HISTOGRAM; CT; HETEROGENEITY; F-18-FDG; AREA	Objectives: Reusing baseline volumes of interest (VOI) by applying non-rigid and to some extent (local) rigid image registration showed good test-retest variability similar to delineating VOI on both scans individually. The aim of the present study was to compare response assessments and classifications based on various types of image registration with those based on (semi)-automatic tumour delineation. Methods: Baseline (n = 13), early (n = 12) and late (n = 9) response (after one and three cycles of treatment, respectively) whole body [F-18]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (PET/CT) scans were acquired in subjects with advanced gastrointestinal malignancies. Lesions were identified for early and late response scans. VOI were drawn independently on all scans using an adaptive 50% threshold method (A50). In addition, various types of (non-) rigid image registration were applied to PET and/or CT images, after which baseline VOI were projected onto response scans. Response was classified using PET Response Criteria in Solid Tumors for maximum standardized uptake value (SUVmax), average SUV (SUVmean), peak SUV (SUVpeak), metabolically active tumour volume (MATV), total lesion glycolysis (TLG) and the area under a cumulative SUV-volume histogram curve (AUC). Results: Non-rigid PET-based registration and non-rigid CT-based registration followed by non-rigid PET-based registration (CTPET) did not show differences in response classifications compared to A50 for SUVmax and SUVpeak,, however, differences were observed for MATV, SUVmean, TLG and AUC. For the latter, these registrations demonstrated a poorer performance for small lung lesions (<2.8 ml), whereas A50 showed a poorer performance when another area with high uptake was close to the target lesion. All methods were affected by lesions with very heterogeneous tracer uptake. Conclusions: Non-rigid PET-and CTPET-based image registrations may be used to classify response based on SUVmax and SUVpeak. For other quantitative measures future studies should assess which method is valid for response evaluations by correlating with survival data.	[van Velden, Floris H. P.; Nissen, Ida A.; Hoekstra, Otto S.; Boellaard, Ronald] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Noord Holland, Netherlands; [Hayes, Wendy; Velasquez, Linda M.] Bristol Myers Squibb Co, Exploratory Clin & Translat Res, Princeton, NJ USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Bristol-Myers Squibb	van Velden, FHP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Noord Holland, Netherlands.	f.vvelden@vumc.nl	van+Velden, Floris/AAR-8414-2020	van Velden, Floris/0000-0003-2859-2119; Hoekstra, Otto S/0000-0003-0767-2734; Nissen, Ida A./0000-0001-6910-1967; Boellaard, Ronald/0000-0002-0313-5686	Center for Translational Molecular Medicine (CTMM), AIRFORCE project [03O-103]	Center for Translational Molecular Medicine (CTMM), AIRFORCE project	The study was financially supported by Center for Translational Molecular Medicine (CTMM), AIRFORCE project (grant 03O-103, http://www.ctmm.nl). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was evaluated by the CTMM publication manager and the consortium partners. CTMM did not request any changes to the manuscript prior to publication.	Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Brooks FJ, 2013, J NUCL MED IN PRESS; Brooks FJ, 2013, EUR J NUCL MED MOL I, V40, P967, DOI 10.1007/s00259-013-2381-3; Bussink J, 2011, NAT REV CLIN ONCOL, V8, P233, DOI 10.1038/nrclinonc.2010.218; Cheebsumon P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-56; Cheebsumon P, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-35; Cheebsumon P, 2011, EUR J NUCL MED MOL I, V38, P2136, DOI 10.1007/s00259-011-1899-5; Cheebsumon P, 2011, J NUCL MED, V52, P1550, DOI 10.2967/jnumed.111.088914; Cheng G, 2013, MOL IMAGING BIOL, V15, P345, DOI 10.1007/s11307-012-0600-0; De Moor K, 2006, IEEE NUCL SCI CONF R, P3502; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Garrett CR, 2011, BRIT J CANCER, V105, P44, DOI 10.1038/bjc.2011.182; Grgic A, 2009, J NUCL MED, V50, P1921, DOI 10.2967/jnumed.109.065649; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1191, DOI 10.1007/s00259-011-1755-7; Hutton BF, 2002, EUR J NUCL MED MOL I, V29, P559, DOI 10.1007/s00259-001-0700-6; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Li X, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-62; Shekhar R, 2005, J NUCL MED, V46, P1488; Sugawara Y, 1999, RADIOLOGY, V213, P521, DOI 10.1148/radiology.213.2.r99nv37521; van Elmpt W, 2011, EUR J NUCL MED MOL I, V38, P843, DOI 10.1007/s00259-010-1716-6; van Herk M, 1997, Comput Aided Surg, V2, P346, DOI 10.1002/(SICI)1097-0150(1997)2:6<346::AID-IGS5>3.0.CO;2-#; van Velden FHP, 2013, MOL IMAGING IN PRESS; van Velden FHP, 2013, EUR J NUCL MED MOL I, V40, P1469, DOI 10.1007/s00259-013-2474-z; van Velden FHP, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-10; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Velasquez LM, 2009, J NUCL MED, V50, P1646, DOI 10.2967/jnumed.109.063347; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Watabe T, 2012, ANN NUCL MED, V26, P222, DOI 10.1007/s12149-011-0562-3	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87167	10.1371/journal.pone.0087167	http://dx.doi.org/10.1371/journal.pone.0087167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489860	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000112
J	Wang, ZY; Burwinkel, M; Chai, WD; Lange, E; Blohm, U; Breithaupt, A; Hoffmann, B; Twardziok, S; Rieger, J; Janczyk, P; Pieper, R; Osterrieder, N				Wang, Zhenya; Burwinkel, Michael; Chai, Weidong; Lange, Elke; Blohm, Ulrike; Breithaupt, Angele; Hoffmann, Bernd; Twardziok, Sven; Rieger, Juliane; Janczyk, Pawel; Pieper, Robert; Osterrieder, Nikolaus			Dietary Enterococcus faecium NCIMB 10415 and Zinc Oxide Stimulate Immune Reactions to Trivalent Influenza Vaccination in Pigs but Do Not Affect Virological Response upon Challenge Infection	PLOS ONE			English	Article							SWINE INFLUENZA; H3N2 VIRUSES; PERFORMANCE; PIGLETS; PROBIOTICS; DIARRHEA; PORCINE; HEALTH; REPLICATION; VACCINES	Swine influenza viruses (SIV) regularly cause significant disease in pigs worldwide. Since there is no causative treatment of SIV, we tested if probiotic Enterococcus (E.) faecium NCIMB 10415 or zinc (Zn) oxide as feed supplements provide beneficial effects upon SIV infection in piglets. Seventy-two weaned piglets were fed three different diets containing either E. faecium or different levels of Zn (2500 ppm, Zn-high; 50 ppm, Zn-low). Half of the piglets were vaccinated intramuscularly (VAC) twice with an inactivated trivalent SIV vaccine, while all piglets were then infected intranasally with H3N2 SIV. Significantly higher weekly weight gains were observed in the E. faecium group before virus infection, and piglets in Zn-high and E. faecium groups gained weight after infection while those in the control group (Zn-low) lost weight. Using ELISA, we found significantly higher H3N2-specific antibody levels in the E. faecium+VAC group 2 days before and at the day of challenge infection as well as at 4 and 6 days after challenge infection. Higher hemagglutination inhibition (HI) titers were also observed in the Zn-high+VAC and E. faecium+VAC groups at 0, 1 and 4 days after infection. However, there were no significant differences in virus shedding and lung lesions between the dietary groups. Using flow cytometry analysis significantly higher activated T helper cells and cytotoxic T lymphocyte percentages in the PBMCs were detected in the Zn-high and E. faecium groups at single time points after infection compared to the Zn-low control group, but no prolonged effect was found. In the BAL cells no influence of dietary supplementation on immune cell percentages could be detected. Our results suggest that feeding high doses of zinc oxide and particularly E. faecium could beneficially influence humoral immune responses after vaccination and recovery from SIV infection, but not affect virus shedding and lung pathology.	[Wang, Zhenya; Burwinkel, Michael; Chai, Weidong; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [Lange, Elke; Breithaupt, Angele] Friedrich Loeffler Inst, Abt Expt Tierhaltung & Biosicherheit, Greifswald, Germany; [Blohm, Ulrike] Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany; [Breithaupt, Angele] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany; [Hoffmann, Bernd] Friedrich Loeffler Inst, Inst Virusdiagnost, Greifswald, Germany; [Twardziok, Sven] Charite, D-13353 Berlin, Germany; [Rieger, Juliane] Free Univ Berlin, Inst Vet Anat, Berlin, Germany; [Janczyk, Pawel] Fachgrp Mol Diagnost & Genet, Bundesinst Risikobewertung, Abt Biol Sicherheit, Berlin, Germany; [Pieper, Robert] Free Univ Berlin, Inst Tierernahrung, Berlin, Germany	Free University of Berlin; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Free University of Berlin; Friedrich Loeffler Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Federal Institute for Risk Assessment; Free University of Berlin	Burwinkel, M (corresponding author), Free Univ Berlin, Inst Virol, Berlin, Germany.	michael.burwinkel@fu-berlin.de	Rieger, Juliane/G-8878-2015; Breithaupt, Angele/GON-7227-2022; Blohm, Ulrike/AAW-1851-2020; Breithaupt, Angele/B-6155-2013	Rieger, Juliane/0000-0003-1659-9460; Breithaupt, Angele/0000-0002-6373-5923; Blohm, Ulrike/0000-0003-4597-248X; Pieper, Robert/0000-0002-0292-1482; Twardziok, Sven/0000-0002-0326-5704; Osterrieder, Nikolaus/0000-0002-5313-2176; Burwinkel, Michael/0000-0003-4811-7323	Deutsche Forschungsgemeinschaft (DFG) research consortium [SFB 852]	Deutsche Forschungsgemeinschaft (DFG) research consortium	This study was supported by Deutsche Forschungsgemeinschaft (DFG) research consortium (SFB 852, subproject A5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C, 2004, J ANIM PHYSIOL AN N, V88, P381, DOI 10.1111/j.1439-0396.2004.00492.x; Broom LJ, 2006, RES VET SCI, V80, P45, DOI 10.1016/j.rvsc.2005.04.004; Buff CE, 2005, J ANIM SCI, V83, P2380; Chai WD, 2013, ARCH VIROL, V158, P799, DOI 10.1007/s00705-012-1543-0; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Heinen PP, 2001, VET IMMUNOL IMMUNOP, V82, P39, DOI 10.1016/S0165-2427(01)00342-7; Hill GM, 2001, J ANIM SCI, V79, P934; Hoffmann B, 2010, BERL MUNCH TIERARZTL, V123, P286, DOI 10.2376/0005-9366-123-286; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; KAWAOKA Y, 1987, ARCH VIROL, V93, P303, DOI 10.1007/BF01310984; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Kothalawala H, 2006, VET QUART, V28, P45, DOI 10.1080/01652176.2006.9695207; Kreuzer S, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-58; Kritas SK, 2007, VET MICROBIOL, V119, P248, DOI 10.1016/j.vetmic.2006.09.012; Kyriakis CS, 2010, VET MICROBIOL, V144, P67, DOI 10.1016/j.vetmic.2009.12.039; Lefevre EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032400; MacDonald TT, 2010, P NUTR SOC, V69, P442, DOI 10.1017/S0029665110001758; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Melin L, 2002, ACTA VET SCAND, V43, P231, DOI 10.1186/1751-0147-43-231; Molist F, 2011, BRIT J NUTR, V105, P1592, DOI 10.1017/S0007114510004575; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Paton AW, 2005, GASTROENTEROLOGY, V128, P1219, DOI 10.1053/j.gastro.2005.01.050; Porea TJ, 2000, J PEDIATR-US, V136, P688, DOI 10.1067/mpd.2000.103355; Rad AH, 2013, NUTRITION, V29, P805, DOI 10.1016/j.nut.2012.10.009; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; Roohani N, 2013, J RES MED SCI, V18, P144; Saenz RA, 2006, VECTOR-BORNE ZOONOT, V6, P338, DOI 10.1089/vbz.2006.6.338; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Schierack P, 2007, VET IMMUNOL IMMUNOP, V118, P1, DOI 10.1016/j.vetimm.2007.03.006; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Shu Q, 2001, J PEDIATR GASTR NUTR, V33, P171, DOI 10.1097/00005176-200108000-00014; TEVELTHUIS AJW, 2010, PLOS PATHOG, V0006; Uchide N, 2002, ANTIVIR RES, V56, P207, DOI 10.1016/S0166-3542(02)00109-2; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053043	39	7	9	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87007	10.1371/journal.pone.0087007	http://dx.doi.org/10.1371/journal.pone.0087007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489827	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000099
J	Maekawa, K; Baba, T; Otomo, S; Morishita, S; Tamura, N				Maekawa, Kengo; Baba, Tomoko; Otomo, Sumi; Morishita, Shoji; Tamura, Nobushige			Low Pre-Existing Gray Matter Volume in the Medial Temporal Lobe and White Matter Lesions Are Associated with Postoperative Cognitive Dysfunction after Cardiac Surgery	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; BYPASS; IMPAIRMENT; DEMENTIA; EDUCATION; OUTCOMES; BRAIN	Postoperative cognitive dysfunction (POCD) is recognized as a complication in the elderly after cardiac surgery. Imaging of the brain provides evidence of neurodegeneration in elderly patients; however, abnormalities in brain structure and their relation to POCD are uncertain. This pilot study investigated whether loss of gray matter in the bilateral medial temporal lobe (MTL), seen in preoperative MRI, was associated with POCD. Methods: Data were collected prospectively on 28 elderly patients scheduled for elective cardiac surgery. MRI of the brains of all patients were assessed for prior cerebral infarctions, and carotid and intracranial arterial stenosis. Patients also completed six neuropsychological tests of memory, attention and executive function before and after surgery. POCD was defined as an individual decrease in more than two tests of at least 1 standard deviation from the group baseline mean for that test. The degree of gray matter loss in the MTL of each patient was calculated using voxel-based morphometry with three-dimensional, T1-weighted MRI. This represented the degree of gray matter change as a Z score. Results: Postoperative cognitive dysfunction was identified in 8 of the 28 patients (29%). Patients with POCD had significantly more white matter lesions on MRI, and greater loss of gray matter in the bilateral MTL (average Z score 2.0 +/- 0.9) than patients without POCD. An analysis by stepwise logistic regression identified gray matter loss in the MTL and cerebral infarctions on MRI as independent predictors of POCD. Conclusions: These preliminary findings suggested that reduced gray matter in the bilateral MTL and white matter lesions existed in brains of elderly cardiac surgery patients who experienced POCD. Additional studies with larger sample sizes are needed to confirm these findings.	[Maekawa, Kengo] Kumamoto Univ, Grad Sch Med Sci, Dept Anesthesiol, Kumamoto, Japan; [Maekawa, Kengo; Baba, Tomoko; Otomo, Sumi] Kumamoto City Hosp, Dept Anesthesiol, Kumamoto, Japan; [Morishita, Shoji] Kumamoto City Hosp, Dept Radiol, Kumamoto, Japan; [Tamura, Nobushige] Kumamoto City Hosp, Dept Cardiovasc Surg, Kumamoto, Japan	Kumamoto University	Maekawa, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Anesthesiol, Kumamoto, Japan.	kenchom@par.odn.ne.jp						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; ATLAS SW, 1994, RADIOLOGY, V193, P1; Barber R, 2000, NEUROLOGY, V54, P1304, DOI 10.1212/WNL.54.6.1304; Bekker A, 2010, AM J SURG, V199, P782, DOI 10.1016/j.amjsurg.2009.07.042; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Evered LA, 2011, ANESTHESIOLOGY, V114, P1297, DOI 10.1097/ALN.0b013e31821b1aab; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Floyd TF, 2006, ANN THORAC SURG, V81, P2160, DOI 10.1016/j.athoracsur.2006.01.080; Goto T, 2003, ANN THORAC SURG, V75, P1912, DOI 10.1016/S0003-4975(03)00029-8; Goto T, 2001, ANN THORAC SURG, V72, P137, DOI 10.1016/S0003-4975(01)02676-5; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Hogue CW, 2006, ANESTH ANALG, V102, P1602, DOI 10.1213/01.ANE.0000219591.10826.17; Hudetz JA, 2012, EUR J ANAESTH, V29, P320, DOI 10.1097/EJA.0b013e328354223d; Keizer AMA, 2005, ACTA ANAESTH SCAND, V49, P1232, DOI 10.1111/j.1399-6576.2005.00835.x; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; Lewis MS, 2006, ACTA ANAESTH SCAND, V50, P50, DOI 10.1111/j.1399-6576.2006.00893.x; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scott DA, 2002, J CARDIOTHOR VASC AN, V16, P715, DOI 10.1053/jcan.2002.128413; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; Silbert BS, 2007, ANESTH ANALG, V104, P1023, DOI 10.1213/01.ane.0000263285.03361.3a; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P431, DOI 10.1097/00000542-200703000-00006; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Testa C, 2004, J MAGN RESON IMAGING, V19, P274, DOI 10.1002/jmri.20001; Trzepacz PT, 1999, PSYCHOSOMATICS, V40, P193, DOI 10.1016/S0033-3182(99)71235-1; van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901; van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x	37	23	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87375	10.1371/journal.pone.0087375	http://dx.doi.org/10.1371/journal.pone.0087375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475280	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300175
J	Felisbino-Mendes, MS; Villamor, E; Velasquez-Melendez, G				Felisbino-Mendes, Mariana Santos; Villamor, Eduardo; Velasquez-Melendez, Gustavo			Association of Maternal and Child Nutritional Status in Brazil: A Population Based Cross-Sectional Study	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; OBESITY; UNDERNUTRITION; MORTALITY; INFANT; HEIGHT; HEALTH	Background: Although child undernutrition and stunting has been decreasing worldwide while obesity rates increase, these extreme conditions might coexist in families from low-and middle-income countries. We examined the association between maternal and child anthropometric indicators using a population representative sample. Methods: 4,258 non-pregnant women and their children <60 months who participated in the 2006 Brazilian Demographic Health Survey. We compared the distributions of two nutritional indexes of children, height-for-age (HAZ) and body mass index-for age (BAZ) z-scores, by categories of maternal height, body mass index (BMI), and waist circumference (WC). Adjusted mean differences and 95% confidence intervals (95% CI) were estimated from linear regression, taking into account the complex survey design. We also examined the associations of maternal anthropometry with the prevalence of child stunting (HAZ<-22) and overweight/obesity (BAZ>2). Results: HAZ was positively associated with maternal height and WC in a linear fashion. After adjustment, for sociodemographic characteristics, children whose mothers' height was <145 cm had 1.2 lower HAZ than children whose mothers were >= 160 cm tall (p-trend<0.0001). After further adjustment for maternal height and maternal BMI, children of mothers with a waist circumference >= 88 cm had 0.3 higher HAZ than those of mothers with WC<80 cm (p-trend<0.01). Adjusted prevalence ratios and 95% CI for stunting by the categories of maternal height (<145, 145-149, 150-154, 155-159 and >= 160 cm) were, respectively, 2.95 (1.51; 5.77), 2.29 (1.33; 3.93), 1.09 (0.63; 1.87), and 0.89 (0.45; 1.77), (p-trend = 0.001). BAZ was positively associated with maternal BMI and WC. Conclusion: We observed a strong, positive association of maternal and child nutritional status. Mothers of low stature had children with lower stature, mothers with central obesity had taller children, and mothers with overall or abdominal obesity had children with higher BAZ.	[Felisbino-Mendes, Mariana Santos; Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Escola Enfermagem, Belo Horizonte, MG, Brazil; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Universidade Federal de Minas Gerais; University of Michigan System; University of Michigan	Velasquez-Melendez, G (corresponding author), Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Escola Enfermagem, Belo Horizonte, MG, Brazil.	guveme@ufmg.br	Felisbino-Mendes, Mariana Santos/F-9910-2014	S Felisbino-Mendes, Mariana/0000-0001-5321-5708	FAPEMIG; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Brazil	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MSFM received a PhD scholarship from FAPEMIG and would also like to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Brazil, for a scholarship that supported a fellowship at the University of Michigan, USA. GVM is a research fellow from the Brazilian National Council for Scientific and Technological Development (CNPq) and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brazilian Ministry of Health, 2008, DEM HLTH SURV REP; Brazilian Ministry of Health, 2009, PESQ NAC DEM SAUD CR; Cnattingius S, 2012, INT J OBESITY, V36, P1320, DOI 10.1038/ijo.2011.248; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deierlein AL, 2011, J PEDIATR-US, V158, P221, DOI 10.1016/j.jpeds.2010.08.008; Ferreira HS, 2009, BRIT J NUTR, V101, P1239, DOI 10.1017/S0007114508059357; Hambidge KM, 2012, J PEDIATR GASTR NUTR, V54, P117, DOI 10.1097/MPG.0b013e3182331748; HART N, 1993, POP STUD-J DEMOG, V47, P27, DOI 10.1080/0032472031000146716; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; LARSSON G, 1986, DIABETES CARE, V9, P359, DOI 10.2337/diacare.9.4.359; Leibowitz KL, 2012, WORLD J PEDIATR, V8, P76, DOI 10.1007/s12519-011-0292-6; Lourenco BH, 2015, MATERN CHILD NUTR, V11, P240, DOI 10.1111/mcn.12005; MARTORELL R, 1989, HUM ORGAN, V48, P15, DOI 10.17730/humo.48.1.x20u5450x51h5211; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Perez-Escamilla R, 2004, J NUTR, V134, P1923, DOI 10.1093/jn/134.8.1923; Perez-Escamilla R, 2008, REV NUTR, V21, P15; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; Symonds ME, 2013, ANN NUTR METAB, V62, P137, DOI 10.1159/000345598; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; World Health Organization, 2000, TRS894 WHO; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2006, CHILD GROWTH STAND T; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z	32	34	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87486	10.1371/journal.pone.0087486	http://dx.doi.org/10.1371/journal.pone.0087486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475297	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800096
J	Jadiya, P; Nazir, A				Jadiya, Pooja; Nazir, Aamir			A Pre- and Co-Knockdown of RNAseT Enzyme, Eri-1, Enhances the Efficiency of RNAi Induced Gene Silencing in Caenorhabditis elegans	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; FUNCTIONAL-ANALYSIS; AXON GUIDANCE; RAC GTPASE; INTERFERENCE; POTENT; CELL	Background: The approach of RNAi mediated gene knockdown, employing exogenous dsRNA, is being beneficially exploited in various fields of functional genomics. The immense utility of the approach came to fore from studies with model system C. elegans, but quickly became applicable with varied research models ranging from in vitro to various in vivo systems. Previously, there have been reports on the refractoriness of the neuronal cells to RNAi mediated gene silencing following which several modulators like eri-1 and lin-15 were described in C. elegans which, when present, would negatively impact the gene knockdown. Methodology/Principal Findings: Taking a clue from these findings, we went on to screen hypothesis-driven-methodologies towards exploring the efficiency in the process of RNAi under various experimental conditions, wherein these genes would be knocked down preceding to, or concurrently with, the knocking down of a gene of interest. For determining the efficiency of gene knockdown, we chose to study visually stark phenotypes of uncoordinated movement, dumpy body morphology and blistered cuticle obtained by knocking down of genes unc-73, dpy-9 and bli-3 respectively, employing the RNAi-by-feeding protocol in model system C. elegans. Conclusions/Significance: Our studies led to a very interesting outcome as the results reveal that amongst various methods tested, pre-incubation with eri-1 dsRNA synthesizing bacteria followed by co-incubation with eri-1 and gene-of-interest dsRNA synthesizing bacteria leads to the most efficient gene silencing as observed by the analysis of marker phenotypes. This provides an approach for effectively employing RNAi induced gene silencing while working with different genetic backgrounds including transgenic and mutant strains.	[Jadiya, Pooja; Nazir, Aamir] Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi, India; [Jadiya, Pooja; Nazir, Aamir] CSIR Cent Drug Res Inst, Lab Funct Genom & Mol Toxicol, Div Toxicol, Lucknow, Uttar Pradesh, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nazir, A (corresponding author), Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi, India.	anazir@cdri.res.in		Jadiya, Pooja/0000-0003-4807-9304; Nazir, Aamir/0000-0002-2503-1335	NIH National Center for Research Resources (NCRR); CSIR network project EpiHeD [BSC0118]; CSIR [113558/2K11/1]	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CSIR network project EpiHeD; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Nematode strains used in this work were provided by the C. elegans Genetics Center (CGC) University of Minnesota, MN, USA, which is funded by the NIH National Center for Research Resources (NCRR). AN acknowledges the funding support from CSIR network project EpiHeD (BSC0118). PJ is thankful to CSIR for Senior Research Fellowship (Ref: 113558/2K11/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BRENNER S, 1974, GENETICS, V77, P71; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hong J, 2005, BIOCHEM J, V390, P675, DOI 10.1042/BJ20050647; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P976; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P306, DOI 10.1016/j.bbrc.2011.08.092; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kubiseski TJ, 2003, MOL CELL BIOL, V23, P6823, DOI 10.1128/MCB.23.19.6823-6835.2003; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; LEVY AD, 1993, MOL BIOL CELL, V4, P803, DOI 10.1091/mbc.4.8.803; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Stiernagle Theresa, 2006, WormBook, P1; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	29	3	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87635	10.1371/journal.pone.0087635	http://dx.doi.org/10.1371/journal.pone.0087635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475317	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800098
J	Alves, IT; Hartjes, T; McClellan, E; Hiltemann, S; Bottcher, R; Dits, N; Temanni, MR; Janssen, B; van Workum, W; van der Spek, P; Stubbs, A; de Klein, A; Eussen, B; Trapman, J; Jenster, G				Alves, I. Teles; Hartjes, T.; McClellan, E.; Hiltemann, S.; Bottcher, R.; Dits, N.; Temanni, M. R.; Janssen, B.; van Workum, W.; van der Spek, P.; Stubbs, A.; de Klein, A.; Eussen, B.; Trapman, J.; Jenster, G.			Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer	ONCOGENE			English	Article						FAM71D; gene fusions; next-generation sequencing; prostate cancer; MPP5	ANDROGEN RECEPTOR; GENE FUSIONS; EXOME; GENOME; POLARITY; CELL; VARIANTS; RNAS	Gene fusions, mainly between TMPRSS2 and ERG, are frequent early genomic rearrangements in prostate cancer (PCa). In order to discover novel genomic fusion events, we applied whole-genome paired-end sequencing to identify structural alterations present in a primary PCa patient (G089) and in a PCa cell line (PC346C). Overall, we identified over 3800 genomic rearrangements in each of the two samples as compared with the reference genome. Correcting these structural variations for polymorphisms using whole-genome sequences of 46 normal samples, the numbers of cancer-related rearrangements were 674 and 387 for G089 and PC346C, respectively. From these, 192 in G089 and 106 in PC346C affected gene structures. Exclusion of small intronic deletions left 33 intergenic breaks in G089 and 14 in PC346C. Out of these, 12 and 9 reassembled genes with the same orientation, capable of generating a feasible fusion transcript. Using PCR we validated all the reliable predicted gene fusions. Two gene fusions were in-frame: MPP5-FAM71D in PC346C and ARHGEF3-C8ORF38 in G089. Downregulation of FAM71D and MPP5-FAM71D transcripts in PC346C cells decreased proliferation; however, no effect was observed in the RWPE-1-immortalized normal prostate epithelial cells. Together, our data showed that gene rearrangements frequently occur in PCa genomes but result in a limited number of fusion transcripts. Most of these fusion transcripts do not encode in-frame fusion proteins. The unique in-frame MPP5-FAM71D fusion product is important for proliferation of PC346C cells.	[Alves, I. Teles] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Urol & Pathol, NL-3000 CA Rotterdam, Netherlands; [Hartjes, T.; Hiltemann, S.; Bottcher, R.; Dits, N.; Jenster, G.] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Urol, NL-3000 CA Rotterdam, Netherlands; [McClellan, E.; van der Spek, P.; Stubbs, A.] Erasmus Univ, Med Ctr, Dept Bioinformat, NL-3000 CA Rotterdam, Netherlands; [McClellan, E.] Metropolitan State Univ Denver, Dept Math & Comp Sci, Denver, CO 80204 USA; [Temanni, M. R.] Univ Maryland, CMNS Inst Adv Comp Studies, College Pk, MD 20742 USA; [Janssen, B.; van Workum, W.] ServiceXS BV, Leiden, Netherlands; [de Klein, A.; Eussen, B.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Trapman, J.] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Pathol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Metropolitan State University of Denver; University System of Maryland; University of Maryland College Park; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Jenster, G (corresponding author), Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Urol, Be 362a,POB 2040, NL-3000 CA Rotterdam, Netherlands.	g.jenster@erasmusmc.nl	TEMANNI, Mohamed Ramzi/AAQ-6936-2020; Hiltemann, Saskia/AAY-9458-2020; Böttcher, René/A-5514-2015	TEMANNI, Mohamed Ramzi/0000-0001-9125-1136; Hiltemann, Saskia/0000-0003-3803-468X; Böttcher, René/0000-0001-8581-3876	CTMM; project PCMM [03O-203]; FP7 Marie Curie Initial Training Network PRO-NEST [238278]; Foundation for Scientific Urological Research (SUWO)	CTMM; project PCMM; FP7 Marie Curie Initial Training Network PRO-NEST; Foundation for Scientific Urological Research (SUWO)	We would like to thank Andre Uitterlinden from the Department of Internal Medicine, Erasmus MC for microarray assistance, Arno van Leenders from the Department of Pathology, Erasmus MC for patient sample selection, Wytske van Weerden from the Department of Urology, Erasmus MC for the expertise in PC346C cell line model systems, Complete Genomics Inc. for assistance with the NGS data and the patients whose material was used for this study. This research was made possible by financial contributions from CTMM, project PCMM (project number 03O-203), the FP7 Marie Curie Initial Training Network PRO-NEST (grant number 238278) and the Foundation for Scientific Urological Research (SUWO).	Asan, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046211; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Cheng I, 2012, GENE CHROMOSOME CANC, V51, P66, DOI 10.1002/gcc.20932; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Haimovich Adrian D., 2011, Yale Journal of Biology and Medicine, V84, P439; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hermans KG, 2009, CLIN CANCER RES, V15, P6398, DOI 10.1158/1078-0432.CCR-09-1176; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Jin GF, 2011, CARCINOGENESIS, V32, P1057, DOI 10.1093/carcin/bgr082; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kim J, 2012, BBA-REV CANCER, V1825, P186, DOI 10.1016/j.bbcan.2011.12.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Marques RB, 2005, INT J CANCER, V117, P221, DOI 10.1002/ijc.21201; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Parkinson NJ, 2012, GENOME RES, V22, P125, DOI 10.1101/gr.124016.111; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Rippe V, 2003, ONCOGENE, V22, P6111, DOI 10.1038/sj.onc.1206867; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singleton AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X; Sneddon TP, 2012, METHODS MOL BIOL, V838, P273, DOI 10.1007/978-1-61779-507-7_13; Spans L, 2012, PROSTATE, V72, P1317, DOI 10.1002/pros.22480; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vainio P, 2012, PROSTATE, V72, P789, DOI 10.1002/pros.21487; Wang Q, 2007, MOL BIOL CELL, V18, P874, DOI 10.1091/mbc.E06-07-0651; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Yao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046152; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Yeager M, 2009, HUM GENET, V126, P743, DOI 10.1007/s00439-009-0723-9	52	12	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					568	577		10.1038/onc.2013.591	http://dx.doi.org/10.1038/onc.2013.591			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24488012				2022-12-25	WOS:000348853500004
J	Kuo, NW; Gao, YG; Schill, MS; Isern, N; Dupureur, CM; LiWang, PJ				Kuo, Nai-Wei; Gao, Yong-Guang; Schill, Megan S.; Isern, Nancy; Dupureur, Cynthia M.; LiWang, Patricia J.			Structural Insights into the Interaction between a Potent Anti-inflammatory Protein, Viral CC Chemokine Inhibitor (vCCI), and the Human CC Chemokine, Eotaxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Chemokines; Molecular Docking; NMR; Protein-Protein Interactions; Anti-inflammatory Protein; Chemokine-binding Protein; Eotaxin; Fluorescence Anisotropy; vCCI	TRIPLE-RESONANCE EXPERIMENTS; BINDING-PROTEIN; VACCINIA VIRUS; DECOY RECEPTOR; CRYSTAL-STRUCTURE; WEB SERVER; INFLAMMATION; RECOGNITION; BLOCKADE; DETERMINANTS	Background: The mechanism used by viral protein vCCI to tightly bind to many CC chemokines is not known. Results: Specific positively charged residues in the chemokine eotaxin-1 mediate binding to vCCI. Conclusion: Basic residues in the chemokine each provide incremental affinity for vCCI. Significance: This work shows how vCCI can bind a variety of CC chemokines. Chemokines play important roles in the immune system, not only recruiting leukocytes to the site of infection and inflammation but also guiding cell homing and cell development. The soluble poxvirus-encoded protein viral CC chemokine inhibitor (vCCI), a CC chemokine inhibitor, can bind to human CC chemokines tightly to impair the host immune defense. This protein has no known homologs in eukaryotes and may represent a potent method to stop inflammation. Previously, our structure of the vCCIMIP-1 (macrophage inflammatory protein-1) complex indicated that vCCI uses negatively charged residues in -sheet II to interact with positively charged residues in the MIP-1 N terminus, 20s region and 40s loop. However, the interactions between vCCI and other CC chemokines have not yet been fully explored. Here, we used NMR and fluorescence anisotropy to study the interaction between vCCI and eotaxin-1 (CCL11), a CC chemokine that is an important factor in the asthma response. NMR results reveal that the binding pattern is very similar to the vCCIMIP-1 complex and suggest that electrostatic interactions provide a major contribution to binding. Fluorescence anisotropy results on variants of eotaxin-1 further confirm the critical roles of the charged residues in eotaxin-1. In addition, the binding affinity between vCCI and other wild type CC chemokines, MCP-1 (monocyte chemoattractant protein-1), MIP-1, and RANTES (regulated on activation normal T cell expressed and secreted), were determined as 1.1, 1.2, and 0.22 nm, respectively. To our knowledge, this is the first work quantitatively measuring the binding affinity between vCCI and multiple CC chemokines.	[Kuo, Nai-Wei; Schill, Megan S.; LiWang, Patricia J.] Univ Calif, Merced, CA 95343 USA; [Gao, Yong-Guang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Isern, Nancy] William R Wiley Environm Mol Sci Lab, High Field NMR Facil, Richland, WA 99352 USA; [Dupureur, Cynthia M.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA	University of California System; University of California Merced; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Missouri System; University of Missouri Saint Louis	LiWang, PJ (corresponding author), Univ Calif, Dept Mol Cell Biol, 5200 N Lake Rd, Merced, CA 95343 USA.	pliwang@ucmerced.edu	Gao, Yongguang/B-8546-2012	Gao, Yongguang/0000-0002-9359-4252	Department of Energy's Office of Biological and Environmental Research	Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank Dr. Yong-Gang Chang and Dr. Li Zhang. A portion of the research was performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory.	Alcami A, 1998, J IMMUNOL, V160, P624; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Antonets Denis V, 2010, BMC Res Notes, V3, P271, DOI 10.1186/1756-0500-3-271; Arnold PL, 2006, J VIROL, V80, P7439, DOI 10.1128/JVI.00576-06; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Bisset LR, 2005, CURR OPIN PULM MED, V11, P35, DOI 10.1097/01.mcp.0000144502.50149.e0; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Burns JM, 2002, J BIOL CHEM, V277, P2785, DOI 10.1074/jbc.M109884200; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Conlan LH, 2002, BIOCHEMISTRY-US, V41, P1335, DOI 10.1021/bi015843x; Crump MP, 1998, J BIOL CHEM, V273, P22471, DOI 10.1074/jbc.273.35.22471; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delaglio L. K., 2004, DYNAMO STRUCTURE CAL; DeRider ML, 2006, J BIOMOL NMR, V36, P22, DOI [10.1007/s10858-005-6276-x, 10.1007/s10858-006-9021-1]; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gabriel P, 2012, VIRAL IMMUNOL, V25, P411, DOI 10.1089/vim.2011.0090; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Goddard T.D., SPARKY 3; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hogan SP, 2007, INT ARCH ALLERGY IMM, V143, P3, DOI 10.1159/000101398; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Koopmann W, 1999, J IMMUNOL, V163, P2120; KUHN DE, 1995, BIOCHEM BIOPH RES CO, V211, P325, DOI 10.1006/bbrc.1995.1814; Kunkel SL, 1996, J LEUKOCYTE BIOL, V59, P6, DOI 10.1002/jlb.59.1.6; Lalani AS, 1999, CYTOKINE GROWTH F R, V10, P219, DOI 10.1016/S1359-6101(99)00018-0; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Loria JP, 1999, J MAGN RESON, V141, P180, DOI 10.1006/jmre.1999.1891; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; McCornack MA, 2003, J BIOL CHEM, V278, P1946, DOI 10.1074/jbc.M207440200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nardese V, 2001, NAT STRUCT BIOL, V8, P611, DOI 10.1038/89653; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Seet BT, 2002, J LEUKOCYTE BIOL, V72, P24; Seet BT, 2001, P NATL ACAD SCI USA, V98, P9008, DOI 10.1073/pnas.171069398; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Terkeltaub R, 1998, CURR OPIN LIPIDOL, V9, P397, DOI 10.1097/00041433-199810000-00003; Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n; vanAcker FAA, 1996, MEDIAT INFLAMM, V5, P393, DOI 10.1155/S0962935196000567; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Webb LMC, 2004, FASEB J, V18, P571, DOI 10.1096/fj.03-0485fje; Weber KSC, 2001, EUR J IMMUNOL, V31, P2458, DOI 10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; White GE, 2011, MOL PHARMACOL, V80, P328, DOI 10.1124/mol.111.071985; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xue J., 2013, BIOCH PHYSL, DOI [10.4172/2168-9652.S2-005, DOI 10.4172/2168-9652.S2-005]; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	70	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6592	6603		10.1074/jbc.M113.538991	http://dx.doi.org/10.1074/jbc.M113.538991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24482230	Green Published, hybrid			2022-12-25	WOS:000332389400024
J	Baxter, IR; Ziegler, G; Lahner, B; Mickelbart, MV; Foley, R; Danku, J; Armstrong, P; Salt, DE; Hoekenga, OA				Baxter, Ivan R.; Ziegler, Gregory; Lahner, Brett; Mickelbart, Michael V.; Foley, Rachel; Danku, John; Armstrong, Paul; Salt, David E.; Hoekenga, Owen A.			Single-Kernel Ionomic Profiles Are Highly Heritable Indicators of Genetic and Environmental Influences on Elemental Accumulation in Maize Grain (Zea mays)	PLOS ONE			English	Article							PHOSPHORUS ACQUISITION; ASSOCIATION; ADAPTATIONS; PLANTS	The ionome, or elemental profile, of a maize kernel can be viewed in at least two distinct ways. First, the collection of elements within the kernel are food and feed for people and animals. Second, the ionome of the kernel represents a developmental end point that can summarize the life history of a plant, combining genetic programs and environmental interactions. We assert that single-kernel-based phenotyping of the ionome is an effective method of analysis, as it represents a reasonable compromise between precision, efficiency, and power. Here, we evaluate potential pitfalls of this sampling strategy using several field-grown maize sample sets. We demonstrate that there is enough genetically determined diversity in accumulation of many of the elements assayed to overcome potential artifacts. Further, we demonstrate that environmental signals are detectable through their influence on the kernel ionome. We conclude that using single kernels as the sampling unit is a valid approach for understanding genetic and environmental effects on the maize kernel ionome.	[Baxter, Ivan R.; Ziegler, Gregory] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63166 USA; [Lahner, Brett; Mickelbart, Michael V.; Foley, Rachel] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Danku, John; Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Armstrong, Paul] ARS, USDA, Engn & Wind Eros Res Unit, Manhattan, KS USA; [Hoekenga, Owen A.] ARS, USDA, RW Holley Ctr Agr & Hlth, Ithaca, NY USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Aberdeen; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Baxter, IR (corresponding author), ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63166 USA.	Ivan.Baxter@ars.usda.gov; Owen.Hoekenga@ars.usda.gov	Baxter, Ivan R/A-1052-2009; Danku, John/C-3477-2014	Baxter, Ivan R/0000-0001-6680-1722; Danku, John/0000-0002-5103-3852; Hoekenga, Owen/0000-0003-4427-2000	U.S. National Science Foundation, Plant Genome Research Program [IOS 0701119, IOS 1126950]; Division Of Integrative Organismal Systems [1126950] Funding Source: National Science Foundation	U.S. National Science Foundation, Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by the U.S. National Science Foundation, Plant Genome Research Program (grant # IOS 0701119 awarded to David Salt and grant # IOS 1126950 awarded to Ivan Baxter and Owen Hoekenga) and United States Department of Agriculture-Agricultural Research Service Intramural funds to Ivan Baxter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Basten C, 2000, CARTOGRAPHER VERSION; Baxter I, 2012, SCIENCE, V336, P1661, DOI 10.1126/science.1219992; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Bray E, 2000, BIOCH MOL BIOL PLANT, P1160; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; CHURCHILL GA, 1994, GENETICS, V138, P963; Food and Agriculture Organization, 2008, FAOSTAT DAT; GOLDMAN IL, 1994, HORTSCIENCE, V29, P209, DOI 10.21273/HORTSCI.29.3.209; Graham RD, 2008, MICRONUTRIENT DEFICI, P2; Haugen JE, 2000, ANAL CHIM ACTA, V407, P23, DOI 10.1016/S0003-2670(99)00784-9; JANSEN RC, 1994, GENETICS, V136, P1447; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Lombi E, 2009, NEW PHYTOL, V184, P193, DOI 10.1111/j.1469-8137.2009.02912.x; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; Pongrac P, 2013, FOOD RES INT, V54, P125, DOI 10.1016/j.foodres.2013.06.020; Pongrac P, 2011, J AGR FOOD CHEM, V59, P1275, DOI 10.1021/jf103150d; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Tracy W.F., 1997, PLANT BREEDING REV, V14, P189, DOI [10.1002/9780470650073.ch7, DOI 10.1002/9780470650073.CH7]; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Wickham H, 2007, J STAT SOFTW, V21, P1; Wood S, 2000, SOIL RES COND, P45; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; ZENG ZB, 1994, GENETICS, V136, P1457; Ziegler G, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.07.0012	28	43	45	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87628	10.1371/journal.pone.0087628	http://dx.doi.org/10.1371/journal.pone.0087628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489944	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000164
J	Sandoval-Usme, MC; Umana-Perez, A; Guerra, B; Hernandez-Perera, O; Garcia-Castellano, JM; Fernandez-Perez, L; Sanchez-Gomez, M				Claudia Sandoval-Usme, Maria; Umana-Perez, Adriana; Guerra, Borja; Hernandez-Perera, Orlando; Manuel Garcia-Castellano, Jose; Fernandez-Perez, Leandro; Sanchez-Gomez, Myriam			Simvastatin Impairs Growth Hormone-Activated Signal Transducer and Activator of Transcription (STAT) Signaling Pathway in UMR-106 Osteosarcoma Cells	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; COLORECTAL-CANCER; MELANOMA-CELLS; GH; PHOSPHORYLATION; INHIBITORS; EXPRESSION; METASTASIS; MECHANISMS; LOVASTATIN	Recent studies have demonstrated that statins reduce cell viability and induce apoptosis in various types of cancer cells. The molecular mechanisms underlying these effects are poorly understood. The JAK/STAT pathway plays an important role in the regulation of proliferation and apoptosis in many tissues, and its deregulation is believed to be involved in tumorigenesis and cancer. The physiological activation of STAT proteins by GH is rapid but transient in nature and its inactivation is regulated mainly by the expression of SOCS proteins. UMR-106 osteosarcoma cells express a GH-responsive JAK2/STAT5 signaling pathway, providing an experimental model to study the influence of statins on this system. In this study we investigated the actions of simvastatin on cell proliferation, migration, and invasion on UMR-106 cells and examined whether alterations in GH-stimulated JAK/STAT/SOCS signaling may be observed. Results showed that treatment of osteosarcoma cells with simvastatin at 3 to 10 mu M doses decreases cell proliferation, migration, and invasion in a time-and dose-dependent manner. At the molecular level, although the mechanisms used by simvastatin are not entirely clear, the effect of the statin on the reduction of JAK2 and STAT5 phosphorylation levels may partially explain the decrease in the GH-stimulated STAT5 transcriptional activity. This effect correlated with a time-and dose-dependent increase of SOCS-3 expression levels in cells treated with simvastatin, a regulatory role that has not been previously described. Furthermore, the finding that simvastatin is capable of inducing SOCS-3 and CIS genes expression shows the potential of the JAK/STAT pathway as a therapeutic target, reinforcing the efficacy of simvastatin as chemotherapeutic drug for the treatment of osteosarcoma.	[Claudia Sandoval-Usme, Maria; Umana-Perez, Adriana; Sanchez-Gomez, Myriam] Univ Nacl Colombia, Hormone Lab, Dept Chem, Bogota, Colombia; [Guerra, Borja; Fernandez-Perez, Leandro] Univ Las Palmas Gran Canaria, Dept Clin Sci, Mol & Translat Endocrinol Grp, Canc Res Inst Canary Isl ICIC, Las Palmas Gran Canaria, Spain; [Guerra, Borja; Fernandez-Perez, Leandro] CSIC, Associated Biomed Unit, ULPGC IIBM Alberto Sols, Las Palmas Gran Canaria, Spain; [Hernandez-Perera, Orlando; Manuel Garcia-Castellano, Jose] CHUIMI, Mol Oncol Lab, Res Unit, Las Palmas Gran Canaria, Spain	Universidad Nacional de Colombia; Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Sandoval-Usme, MC (corresponding author), Univ Nacl Colombia, Hormone Lab, Dept Chem, Bogota, Colombia.	mysanchezd@unal.edu.co	Guerra, Borja/ABE-1138-2021; Fernandez-Perez, Leandro/H-1493-2015; Guerra, Borja/G-9739-2015	Guerra, Borja/0000-0003-4355-5682; Fernandez-Perez, Leandro/0000-0001-7802-465X; Guerra, Borja/0000-0003-4355-5682; Sanchez-Gomez, Myriam/0000-0002-9481-7534; Umana-Perez, Adriana/0000-0001-9262-2699	Spanish Ministry of Science and Innovation; European Regional Development Fund-European Social Fund [SAF2003-02117, SAF2006-07824]; National University of Colombia Research Council (DIB) [10879, 12243, 14233, 16056]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund-European Social Fund; National University of Colombia Research Council (DIB)	This work was supported by grants-in-aid to LF-P from the Spanish Ministry of Science and Innovation with the funding of European Regional Development Fund-European Social Fund (SAF2003-02117 and SAF2006-07824) and grants to M.S.-G. from the National University of Colombia Research Council (DIB Grants 10879, 12243, 14233 and 16056). The excellent technical assistance of C. Mateos-Diaz is greatly appreciated. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; BARNARD R, 1991, ENDOCRINOLOGY, V128, P1459, DOI 10.1210/endo-128-3-1459; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Cabrera-Benitez NE, 2008, PAPEL INHIBIDORES 3; CARMICHAEL J, 1987, CANCER RES, V47, P936; Collisson EA, 2003, MOL CANCER THER, V2, P941; Cooper JC, 2010, INT J ONCOL, V36, P1201, DOI 10.3892/ijo_00000603; Deng JY, 2010, WORLD J GASTROENTERO, V16, P5380, DOI 10.3748/wjg.v16.i42.5380; Fernandez L, 1998, ENDOCRINOLOGY, V139, P1815, DOI 10.1210/en.139.4.1815; Fromigue O, 2008, J PHARMACOL EXP THER, V325, P595, DOI 10.1124/jpet.108.136127; Gallagher EJ, 2011, CELL METAB, V13, P355, DOI 10.1016/j.cmet.2011.03.003; Gbelcova H, 2008, INT J CANCER, V122, P1214, DOI 10.1002/ijc.23242; Glynn SA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-9; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Huang KC, 2003, FEBS LETT, V555, P385, DOI 10.1016/S0014-5793(03)01297-3; Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kodach LL, 2007, GASTROENTEROLOGY, V133, P1272, DOI 10.1053/j.gastro.2007.08.021; Koyuturk M, 2007, CANCER LETT, V250, P220, DOI 10.1016/j.canlet.2006.10.009; Lima GAB, 2006, J ENDOCRINOL INVEST, V29, P1006, DOI 10.1007/BF03349215; Liu J, 2008, LIFE SCI, V82, P991, DOI 10.1016/j.lfs.2008.02.012; Mantha AJ, 2003, J CANCER RES CLIN, V129, P631, DOI 10.1007/s00432-003-0490-2; Mitra A, 2012, J BIOL CHEM, V287, P16596, DOI 10.1074/jbc.M111.319756; Morales O, 2000, J BONE MINER RES, V15, P2284, DOI 10.1359/jbmr.2000.15.11.2284; Morales O, 2002, J BIOL CHEM, V277, P34879, DOI 10.1074/jbc.M204819200; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Oliveira KAP, 2008, J BIOENERG BIOMEMBR, V40, P307, DOI 10.1007/s10863-008-9155-9; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Robles-Valero J, 2010, BLOOD, V115, P4174, DOI 10.1182/blood-2009-12-256222; Sandoval-Usme María Claudia, 2011, Rev. acad. colomb. cienc. exact. fis. nat., V35, P287; Smirnova OV, 2007, WORLD J GASTROENTERO, V13, P6478, DOI 10.3748/wjg.13.6478; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Spano JP, 2006, EUR J CANCER, V42, P2668, DOI 10.1016/j.ejca.2006.07.006; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Zhang X, 2008, J IMMUNOL, V180, P6988, DOI 10.4049/jimmunol.180.10.6988	44	17	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87769	10.1371/journal.pone.0087769	http://dx.doi.org/10.1371/journal.pone.0087769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489959	Green Published, gold			2022-12-25	WOS:000330570000176
J	Epstein, M; Barenco, M; Klein, N; Hubank, M; Callard, RE				Epstein, Michael; Barenco, Martino; Klein, Nigel; Hubank, Michael; Callard, Robin E.			Revealing Individual Signatures of Human T Cell CDR3 Sequence Repertoires with Kidera Factors	PLOS ONE			English	Article							PHYSICAL-PROPERTIES	The recent development of High Throughput Sequencing technologies has enabled an individual's TCR repertoire to be efficiently analysed at the nucleotide level. However, with unique clonotypes ranging in the tens of millions per individual, this approach gives a surfeit of information that is difficult to analyse and interpret in a biological context and gives little information about TCR structural diversity. Using publicly available TCR CDR3 sequence data, we analysed TCR repertoires by converting the encoded CDR3 amino acid sequences into Kidera Factors, a set of orthogonal physico-chemical properties that reflect protein structure. This approach enabled the TCR repertoire from different individuals to be distinguished and demonstrated the close similarity of the repertoire in different samples from the same individual.	[Epstein, Michael] UCL, Dept Stat Sci, London, England; [Epstein, Michael; Barenco, Martino; Hubank, Michael; Callard, Robin E.] UCL, CoMPLEX, London, England; [Barenco, Martino; Klein, Nigel; Hubank, Michael; Callard, Robin E.] UCL, Inst Child Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Callard, RE (corresponding author), UCL, CoMPLEX, London, England.	r.callard@ucl.ac.uk	Hubank, Michael JF/C-1837-2008	Hubank, Michael JF/0000-0002-2901-0742; Klein, Nigel/0000-0003-3925-9258	EPSRC; MRC [G0902107] Funding Source: UKRI; Medical Research Council [G0902107] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by an EPSRC doctoral training centre awarded to UCL CoMPLEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; GORSKI J, 1994, J IMMUNOL, V152, P5109; KIDERA A, 1985, J PROTEIN CHEM, V4, P23, DOI 10.1007/BF01025492; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Lefranc MP, 2001, T CELL RECEPTOR FACT; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Matsumoto Y, 2003, J IMMUNOL, V170, P4846, DOI 10.4049/jimmunol.170.9.4846; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Rackovsky S, 2009, P NATL ACAD SCI USA, V106, P14345, DOI 10.1073/pnas.0903433106; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Warren RL, 2009, BIOINFORMATICS, V25, P458, DOI 10.1093/bioinformatics/btp010	20	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86986	10.1371/journal.pone.0086986	http://dx.doi.org/10.1371/journal.pone.0086986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489822	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000088
J	Gregoriano, C; Ceschi, A; Rauber-Luthy, C; Kupferschmidt, H; Banner, NR; Krahenbuhl, S; Taegtmeyer, AB				Gregoriano, Claudia; Ceschi, Alessandro; Rauber-Luethy, Christine; Kupferschmidt, Hugo; Banner, Nicholas R.; Kraehenbuhl, Stephan; Taegtmeyer, Anne B.			Acute Thiopurine Overdose: Analysis of Reports to a National Poison Centre 1995-2013	PLOS ONE			English	Article							6-MERCAPTOPURINE; AZATHIOPRINE	Literature regarding acute human toxicity of thiopurines is limited to a handful of case reports. Our objectives were to describe all cases of overdose with thiopurines reported to the Swiss Toxicological Information Centre between 1995-2013. A retrospective analysis was performed to determine circumstances, magnitude, management and outcome of overdose with these substances. A total of 40 cases (14 paediatric) were reported (azathioprine, n = 35; 6-mercaptopurine, n = 5). Of these, 25 were with suicidal intent, 12 were accidental and 3 were iatrogenic errors. The magnitude of overdose ranged from 1.5 to 43 (median 8) times the usual dose in adults. Twelve cases (30%) had attributable symptoms. The majority of these were minor and included gastrointestinal complaints and liver function test and blood count abnormalities. Symptoms were experienced by patients who took at least 1.5-times their usual daily thiopurine dose. Overdoses over two or more consecutive days, even if of modest size, were less well tolerated. One case of azathioprine and allopurinol co-ingestion over consecutive days led to agranulocytosis. Decontamination measures were undertaken in 11 cases (10 activated charcoal, 1 gastric lavage) and these developed fewer symptoms than untreated patients. This study shows that acute overdoses with thiopurines have a favourable outcome in the majority of cases and provides preliminary evidence that gastrointestinal decontamination with activated charcoal may reduce symptom development after overdose of these substances if patients present to medical services soon after ingestion.	[Gregoriano, Claudia; Kraehenbuhl, Stephan; Taegtmeyer, Anne B.] Univ Basel, Dept Clin Pharmacol & Toxicol, Basel, Switzerland; [Gregoriano, Claudia; Kraehenbuhl, Stephan; Taegtmeyer, Anne B.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Gregoriano, Claudia] Kantonspital Baselland Liestal, Univ Clin Internal Med, Liestal, Switzerland; [Ceschi, Alessandro; Rauber-Luethy, Christine; Kupferschmidt, Hugo] Univ Zurich, Associated Inst, Swiss Toxicol Informat Ctr, Zurich, Switzerland; [Ceschi, Alessandro] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Banner, Nicholas R.] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Harefield, Middx, England; [Banner, Nicholas R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Banner, Nicholas R.] Univ London Imperial Coll Sci Technol & Med, Inst Cardiovasc Med & Res, London, England	University of Basel; University of Basel; Kantonsspital Baselland; University of Zurich; University of Zurich; University Zurich Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; Imperial College London	Taegtmeyer, AB (corresponding author), Univ Basel, Dept Clin Pharmacol & Toxicol, Basel, Switzerland.		Krähenbühl, Stephan/Z-4744-2019	Ceschi, Alessandro/0000-0002-4308-0405	University Hospital Basel; Swiss Toxicological Information Centre; Swiss National Science Foundation [SNF31003A-132992]	University Hospital Basel; Swiss Toxicological Information Centre; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided through internal funds of the University and University Hospital Basel and the Swiss Toxicological Information Centre. Stephan Krahenbuhl is supported by a grant from the Swiss National Science Foundation (SNF31003A-132992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MICR HEALTHC SER DRU; Benson BE, 2013, CLIN TOXICOL, V51, P140, DOI 10.3109/15563650.2013.770154; Blum M, 2005, THYROID, V15, P1315, DOI 10.1089/thy.2005.15.1315; CARNEY DM, 1974, AM J MED, V56, P133, DOI 10.1016/0002-9343(74)90759-1; Ceschi A, 2013, AM J TRANSPLANT, V13, P786, DOI 10.1111/j.1600-6143.2012.04347.x; Chow LML, 2004, J PEDIATR-US, V144, P669, DOI 10.1016/j.jpeds.2003.12.043; ELION GB, 1961, CANCER CHEMOTH REP, P93; Gupta N, 2009, AM J EMERG MED, V27, P513; Hendrick D, 1984, LANCET, V323, P277; Hoffinan RS, 2007, CLIN TOXICOL, V45, P943, DOI 10.1080/15563650701233370; Howland MA, 2010, GOLDFRANKS TOXICOLOG, P108; Kruger C, 1998, KLIN PADIATR, V210, P136, DOI 10.1055/s-2008-1043866; MAURO LS, 1994, ANN PHARMACOTHER, V28, P915, DOI 10.1177/106002809402800717; Persson HE, 1998, J TOXICOL-CLIN TOXIC, V36, P205, DOI 10.3109/15563659809028940; Pro Concepta Zug AG Zug Switzerland, 2012, PROD INF IM; Pro Concepta Zug AG Zug Switzerland, 2012, PROD INF PUR NETH; Uppsala Monitoring Centre, 2013, US WHO UMC SYST STAN	17	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86390	10.1371/journal.pone.0086390	http://dx.doi.org/10.1371/journal.pone.0086390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489721	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330570000036
J	Mueller, KP; Neuhauss, SCF				Mueller, Kaspar P.; Neuhauss, Stephan C. F.			Sunscreen for Fish: Co-Option of UV Light Protection for Camouflage	PLOS ONE			English	Article							ORGANELLE TRANSPORT; PIGMENT DISPERSION; ZEBRAFISH; MELANOPHORES; ULTRAVIOLET; VISION; CELLS; EYES	Many animals change their body pigmentation according to illumination of their environment. In aquatic vertebrates, this reaction is mediated through aggregation or dispersion of melanin-filled vesicles (melanosomes) in dermal pigment cells (melanophores). The adaptive value of this behavior is usually seen in camouflage by allowing the animal to visually blend into the background. When exposed to visible light from below, however, dark-adapted zebrafish embryos at the age of 2 days post fertilization (dpf) surprisingly display dispersal instead of aggregation of melanosomes, i.e. their body coloration becomes dark on a bright background. Melanosomes of older embryos and early larvae (3-5 dpf) on the other hand aggregate as expected under these conditions. Here we provide an explanation to this puzzling finding: Melanosome dispersion in larvae 3 dpf and older is efficiently triggered by ultraviolet (UV) light, irrespective of the visual background, suggesting that the extent of pigmentation is a trade-off between threats from predation and UV irradiation. The UV light-induced dispersion of melanosomes thereby is dependent on input from retinal short wavelength-sensitive (SWS) cone photoreceptors. In young embryos still lacking a functional retina, protection from UV light predominates, and light triggers a dispersal of melanosomes via photoreceptors intrinsic to the melanophores, regardless of the actual UV content. In older embryos and early larvae with functional retinal photoreceptors in contrast, this light-induced dispersion is counteracted by a delayed aggregation in the absence of UV light. These data suggest that the primary function of melanosome dispersal has evolved as a protective adaption to prevent UV damage, which was only later co-opted for camouflage.	[Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Neurosci Ctr Zurich, Zurich, Switzerland; Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Neuhauss, SCF (corresponding author), Univ Zurich, Inst Mol Life Sci, Neurosci Ctr Zurich, Zurich, Switzerland.	stephan.neuhauss@imls.uzh.ch	Neuhauss, Stephan/AAX-9915-2020	Neuhauss, Stephan/0000-0002-9615-480X	Swiss National Science Foundation [3100A_135598]; Canton of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Zurich	This study was partially funded by the Swiss National Science Foundation (www.snf.ch; 3100A_135598) and the Canton of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Bagnara JT, 1973, CHROMATOPHORES COLOR; COOHILL TP, 1970, PHYSIOL ZOOL, V43, P232, DOI 10.1086/physzool.43.3.30155532; Easter SS, 1996, DEV BIOL, V180, P646; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; HADLEY ME, 1969, AM ZOOL, V9, P489; HAFEEZ MA, 1970, Z VERGL PHYSIOL, V68, P403, DOI 10.1007/BF00297738; Laurens H, 1914, J EXP ZOOL, V16, P195, DOI 10.1002/jez.1400160203; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; McClure M, 1999, J MORPHOL, V241, P83; Miner BG, 2000, J EXP MAR BIOL ECOL, V249, P235, DOI 10.1016/S0022-0981(00)00201-X; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Parker GH, 1935, P AM ACAD ARTS SCI, V69, P439, DOI 10.2307/20023069; Parker GH, 1934, BIOL BULL-US, V66, P30, DOI 10.2307/1537459; PARKER GH, 1948, ANIMAL COLOUR CHANGE; Reilein AR, 2003, BIOCHEM BIOPH RES CO, V309, P652, DOI 10.1016/j.bbrc.2003.08.047; Rodionov VI, 1998, CURR BIOL, V8, P165, DOI 10.1016/S0960-9822(98)70064-8; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; Schmitt EA, 1999, VISUAL NEUROSCI, V16, P601, DOI 10.1017/S0952523899163181; Shiraki T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1498, DOI 10.1039/c0pp00199f; Stoppani AOM, 1942, ENDOCRINOLOGY, V30, P782, DOI 10.1210/endo-30-5-782; Tuma MC, 1999, PIGM CELL RES, V12, P283, DOI 10.1111/j.1600-0749.1999.tb00762.x; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; von Frisch K, 1911, PFLUG ARCH GES PHYS, V138, P319; YOSHIDA M, 1956, J EXP BIOL, V33, P119	29	29	34	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87372	10.1371/journal.pone.0087372	http://dx.doi.org/10.1371/journal.pone.0087372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489905	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000330570000138
J	Sun, ZQ; Zheng, LQ; Zhang, XG; Li, J; Hu, DY; Sun, YX				Sun, Zhaoqing; Zheng, Liqiang; Zhang, Xingang; Li, Jue; Hu, Dayi; Sun, Yingxian			Ethnic Differences in the Incidence of Hypertension among Rural Chinese Adults: Results from Liaoning Province	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; PREHYPERTENSION; PROGRESSION; PREVALENCE; PREDICTORS; WOMEN; RISK; MEN	Background: This study was conducted to examine the differences in the incidence of hypertension and associated risk factors between Mongolian and Han populations in northeast China. Methods: A population-based sample of 4753 Mongolian subjects and 20,247 Han subjects aged >= 35 years and free from hypertension at baseline were followed from 2004-2006 to 2010. Incident hypertension was defined as systolic blood pressure >= 140 mmHg, diastolic blood pressure >= 90 mmHg, or current use of antihypertensive medication. Results: During mean 4.3 years follow-up, a total of 8779 individuals developed hypertension. The age-adjusted incidence of hypertension for Mongolian subjects was 12.64 per 100 person-years, for Han subjects was 9.77 per 100 person-years (P < 0.05). The incidence of hypertension was positively correlated with age, physical activity, drinking, body mass index (BMI), family of hypertension and prehypertension in the Han population. In the Mongolian population, hypertension was positively correlated with age, physical activity, education level, drinking, BMI, prehypertension and family history of hypertension. The rates of awareness, treatment and control of hypertension for newly developed cases among both Han and Mongolian populations were low. (36.5% vs. 42.3%, 13.1% vs. 18.2%, 0.7% vs. 1.3%, P < 0.05, respectively). Conclusions: The incidence rate of hypertension is higher in the Mongolian populations than that in the Han populations, and hypertension in both ethnic populations was associated with similar risk factors. Our results suggest that most newly-diagnosed cases of hypertension are not adequately treated. Improvements in hypertension prevention and control programs in rural China are urgently needed.	[Sun, Zhaoqing; Zheng, Liqiang; Zhang, Xingang; Sun, Yingxian] China Med Univ, Shengjing Hosp, Div Cardiol, Shenyang, Peoples R China; [Li, Jue; Hu, Dayi] Tongji Univ, Heart Lung & Blood Vessel Ctr, Shanghai 200092, Peoples R China	China Medical University; Tongji University	Sun, YX (corresponding author), China Med Univ, Shengjing Hosp, Div Cardiol, Shenyang, Peoples R China.	sunyingxian@medmail.com.cn			key technology Research and Development program of Liaoning Province [2003225003]	key technology Research and Development program of Liaoning Province	This research was supported by grants from the key technology Research and Development program of Liaoning Province (2003225003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ALCOHOL RES HEALTH, V24, P5; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Gelber RP, 2007, AM J HYPERTENS, V20, P370, DOI 10.1016/j.amjhyper.2006.10.011; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2007, J HYPERTENS, V25, P517, DOI 10.1097/HJH.0b013e328013e7f4; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; 김영묵, 2008, Korean Circulation Journal, V38, P43; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Kim J, 2006, J HYPERTENS, V24, P2177, DOI 10.1097/01.hjh.0000249694.81241.7c; Lee JH, 2011, J KOREAN MED SCI, V26, P1286, DOI 10.3346/jkms.2011.26.10.1286; Li N, 2008, BR J NUTR, V19, P1; Natali A, 2009, J HYPERTENS, V27, P2394, DOI 10.1097/HJH.0b013e3283316c31; Sathish T, 2012, PUBLIC HEALTH, V126, P25, DOI 10.1016/j.puhe.2011.11.002; Sugimoto K, 2004, HYPERTENS RES, V27, P551, DOI 10.1291/hypres.27.551; Sun ZQ, 2008, AM J HYPERTENS, V21, P784, DOI 10.1038/ajh.2008.170; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Wu XG, 1996, J HYPERTENS, V14, P1267, DOI 10.1097/00004872-199611000-00003; Zheng LQ, 2010, EUR J CARDIOV PREV R, V17, P217, DOI 10.1097/HJR.0b013e328334f417	20	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86867	10.1371/journal.pone.0086867	http://dx.doi.org/10.1371/journal.pone.0086867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489797	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000076
J	Bettembourg, C; Diot, C; Dameron, O				Bettembourg, Charles; Diot, Christian; Dameron, Olivier			Semantic Particularity Measure for Functional Characterization of Gene Sets Using Gene Ontology	PLOS ONE			English	Article							ENRICHMENT ANALYSIS; SIMILARITY MEASURE; KNOWLEDGE; DATABASE; OVERREPRESENTATION; ANNOTATIONS; NETWORKS	Background: Genetic and genomic data analyses are outputting large sets of genes. Functional comparison of these gene sets is a key part of the analysis, as it identifies their shared functions, and the functions that distinguish each set. The Gene Ontology (GO) initiative provides a unified reference for analyzing the genes molecular functions, biological processes and cellular components. Numerous semantic similarity measures have been developed to systematically quantify the weight of the GO terms shared by two genes. We studied how gene set comparisons can be improved by considering gene set particularity in addition to gene set similarity. Results: We propose a new approach to compute gene set particularities based on the information conveyed by GO terms. A GO term informativeness can be computed using either its information content based on the term frequency in a corpus, or a function of the term's distance to the root. We defined the semantic particularity of a set of GO terms Sg1 compared to another set of GO terms Sg2. We combined our particularity measure with a similarity measure to compare gene sets. We demonstrated that the combination of semantic similarity and semantic particularity measures was able to identify genes with particular functions from among similar genes. This differentiation was not recognized using only a semantic similarity measure. Conclusion: Semantic particularity should be used in conjunction with semantic similarity to perform functional analysis of GO-annotated gene sets. The principle is generalizable to other ontologies.	[Bettembourg, Charles; Dameron, Olivier] Univ Rennes 1, Rennes, France; [Bettembourg, Charles; Diot, Christian] INRA, PEGASE, UMR1348, St Gilles, France; [Bettembourg, Charles; Diot, Christian] Agrocampus OUEST, PEGASE, UMR1348, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] IRISA, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] INRIA, Rennes, France	Universite de Rennes; INRAE; Institut Agro; Agrocampus Ouest; Inria	Bettembourg, C (corresponding author), Univ Rennes 1, Rennes, France.	charles.bettembourg@univ-rennes1.fr	Diot, Christian/AAE-2514-2020	Diot, Christian/0000-0001-9525-6401; Dameron, Olivier/0000-0001-8959-7189	French ministry of research	French ministry of research(Ministry of Research, FranceEuropean Commission)	CB was supported by a fellowship from the French ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MA, 2011, J BIOINF COMPUT BIOL, V9, P681, DOI 10.1142/S0219720011005641; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker EJ, 2012, NUCLEIC ACIDS RES, V40, pD1067, DOI 10.1093/nar/gkr968; Barriot R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-332; Benabderrahmane S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-588; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolshakova N, 2005, BIOINFORMATICS, V21, P2546, DOI 10.1093/bioinformatics/bti317; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cannata N, 2005, PLOS COMPUT BIOL, V1, P531, DOI 10.1371/journal.pcbi.0010076; Chang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055635; Chen Gang, 2013, Int J Bioinform Res Appl, V9, P173, DOI 10.1504/IJBRA.2013.052448; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Clark WT, 2013, BIOINFORMATICS, V29, P53, DOI 10.1093/bioinformatics/btt228; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Diaz-Diaz N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-360; Gillis J, 2013, BIOINFORMATICS, V29, P476, DOI 10.1093/bioinformatics/bts727; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hawkins T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-265; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Jiang J.J., 1997, P INT C RES COMP LIN; Jin B, 2010, BIOINFORMATICS, V26, P2445, DOI 10.1093/bioinformatics/btq449; Klie S, 2012, MOL BIOSYST, V8, P2233, DOI 10.1039/c2mb25089f; Kustra R, 2006, COMP MED SY, P555, DOI 10.1109/CBMS.2006.100; LORD P, 2003, PAC S BIOCOMPUT, V8, P601; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mazandu Gaston K., 2012, Advances in Bioinformatics, V2012, P975783, DOI 10.1155/2012/975783; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Ochs Michael F, 2007, Methods Mol Biol, V377, P243; Ovaska K, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-11; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Primmer CR, 2013, MOL ECOL, V22, P3216, DOI 10.1111/mec.12309; RADA R, 1989, IEEE T SYST MAN CYB, V19, P17, DOI 10.1109/21.24528; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Shannon C.E., 1948, BELL SYSTEM TECHNICA, V27; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Staab S, 2002, COLING; Stobbe M.D., 2012, BRIEF BIOINFORM; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teng ZX, 2013, BIOINFORMATICS, V29, P1424, DOI 10.1093/bioinformatics/btt160; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; WU ZB, 1994, 32ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P133; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; [No title captured]	51	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86525	10.1371/journal.pone.0086525	http://dx.doi.org/10.1371/journal.pone.0086525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489737	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000056
J	Corbett, EA; Kording, KP; Perreault, EJ				Corbett, Elaine A.; Koerding, Konrad P.; Perreault, Eric J.			Dealing with Target Uncertainty in a Reaching Control Interface	PLOS ONE			English	Article							MOTOR; MODELS	Prosthetic devices need to be controlled by their users, typically using physiological signals. People tend to look at objects before reaching for them and we have shown that combining eye movements with other continuous physiological signal sources enhances control. This approach suffers when subjects also look at non-targets, a problem we addressed with a probabilistic mixture over targets where subject gaze information is used to identify target candidates. However, this approach would be ineffective if a user wanted to move towards targets that have not been foveated. Here we evaluated how the accuracy of prior target information influenced decoding accuracy, as the availability of neural control signals was varied. We also considered a mixture model where we assumed that the target may be foveated or, alternatively, that the target may not be foveated. We tested the accuracy of the models at decoding natural reaching data, and also in a closed-loop robot-assisted reaching task. The mixture model worked well in the face of high target uncertainty. Furthermore, errors due to inaccurate target information were reduced by including a generic model that relied on neural signals only.	[Corbett, Elaine A.; Koerding, Konrad P.; Perreault, Eric J.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Corbett, Elaine A.; Koerding, Konrad P.; Perreault, Eric J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Koerding, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Perreault, Eric J.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Northwestern University	Corbett, EA (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	ecorbett@u.northwestern.edu	Perreault, Eric/B-7632-2009; Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Corbett, Elaine/0000-0001-7009-5867; Perreault, Eric/0000-0002-9860-6427	National Science Foundation [0939963]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. 0939963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WW, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046016; Batista AP, 2008, IEEE T NEUR SYS REH, V16, P24, DOI 10.1109/TNSRE.2007.906958; Corbett EA, 2013, IEEE T NEUR SYS REH, V21, P674, DOI 10.1109/TNSRE.2013.2251664; Corbett EA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036002; Corbett EA, 2011, IEEE ENG MED BIO, P5428, DOI 10.1109/IEMBS.2011.6091342; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Jacob RJK, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P573, DOI 10.1016/B978-044451020-4/50031-1; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kemere C, 2008, J NEUROPHYSIOL, V100, P2441, DOI 10.1152/jn.00924.2007; Lawhern V, 2012, NEUROCOMPUTING, V82, P117, DOI 10.1016/j.neucom.2011.10.030; Leeb R, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025011; Ljung L., 1987, SYSTEM IDENTIFICATIO; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Sachs NA, 2011, IEEE ENG MED BIO, P5432, DOI 10.1109/IEMBS.2011.6091343; Shanechi MM, 2013, IEEE T NEUR SYS REH, V21, P129, DOI 10.1109/TNSRE.2012.2221743; Srinivasan L, 2006, NEURAL COMPUT, V18, P2465, DOI 10.1162/neco.2006.18.10.2465; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	20	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86811	10.1371/journal.pone.0086811	http://dx.doi.org/10.1371/journal.pone.0086811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489788	Green Published, gold			2022-12-25	WOS:000330510000081
J	Lin, QQ; London, E				Lin, Qingqing; London, Erwin			Preparation of Artificial Plasma Membrane Mimicking Vesicles with Lipid Asymmetry	PLOS ONE			English	Article							BIOLOGICAL-MEMBRANES; CELL-MEMBRANES; PHOSPHATIDYLSERINE; CYCLODEXTRINS; CHOLESTEROL; PROTEINS; DOMAINS; ORIGIN	Lipid asymmetry, the difference in lipid distribution across the lipid bilayer, is one of the most important features of eukaryotic cellular membranes. However, commonly used model membrane vesicles cannot provide control of lipid distribution between inner and outer leaflets. We recently developed methods to prepare asymmetric model membrane vesicles, but facile incorporation of a highly controlled level of cholesterol was not possible. In this study, using hydroxypropyl-alpha-cyclodextrin based lipid exchange, a simple method was devised to prepare large unilamellar model membrane vesicles that closely resemble mammalian plasma membranes in terms of their lipid composition and asymmetry (sphingomyelin (SM) and/or phosphatidylcholine (PC) outside/phosphatidylethanolamine (PE) and phosphatidylserine (PS) inside), and in which cholesterol content can be readily varied between 0 and 50 mol%. We call these model membranes "artificial plasma membrane mimicking'' ("PMm'') vesicles. Asymmetry was confirmed by both chemical labeling and measurement of the amount of externally-exposed anionic lipid. These vesicles should be superior and more realistic model membranes for studies of lipid-lipid and lipid-protein interaction in a lipid environment that resembles that of mammalian plasma membranes.	[Lin, Qingqing; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Science Foundation grant DMR [1104367]	National Science Foundation grant DMR	This work was supported by National Science Foundation grant DMR 1104367 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cheng HT, 2011, BIOPHYS J, V100, P2671, DOI 10.1016/j.bpj.2011.04.048; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Chiantia S, 2012, BIOPHYS J, V103, P2311, DOI 10.1016/j.bpj.2012.10.033; Chiantia S, 2011, BIOPHYS J, V100, pLO1, DOI 10.1016/j.bpj.2010.11.051; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Huang Z, 2013, LANGMUIR, V29, P14631, DOI 10.1021/la4031427; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Lin Q, 2014, J BIOL CHEM IN PRESS; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; MARINETTI GV, 1976, CHEM PHYS LIPIDS, V16, P239, DOI 10.1016/0009-3084(76)90019-0; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; PAGANO RE, 1981, BIOCHEMISTRY-US, V20, P4920, DOI 10.1021/bi00520a018; SCHICK PK, 1976, J CLIN INVEST, V57, P1221, DOI 10.1172/JCI108390; Shahidullah K, 2008, J MOL BIOL, V379, P704, DOI 10.1016/j.jmb.2008.04.026; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Son M, 2013, J LIPID RES, V54, P223, DOI 10.1194/jlr.M032722; Tsamaloukas A, 2005, BIOPHYS J, V89, P1109, DOI 10.1529/biophysj.105.061846; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	25	58	60	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87903	10.1371/journal.pone.0087903	http://dx.doi.org/10.1371/journal.pone.0087903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489974	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000155
J	Pagetta, A; Tramentozzi, E; Tibaldi, E; Cendron, L; Zanotti, G; Brunati, AM; Vitadello, M; Gorza, L; Finotti, P				Pagetta, Andrea; Tramentozzi, Elisa; Tibaldi, Elena; Cendron, Laura; Zanotti, Giuseppe; Brunati, Anna Maria; Vitadello, Maurizio; Gorza, Luisa; Finotti, Paola			Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RETICULUM CHAPERONE GRP94; TYPE-1 DIABETIC SUBJECTS; REJECTION ANTIGEN GP96; ENDOPLASMIC-RETICULUM; PEPTIDE-BINDING; HSP90; CELLS; NUCLEOTIDE; PLASMA	While the mechanism by which Grp94 displays its chaperone function with client peptides in the cell has been elucidated extensively, much less is known about the nature and properties of how Grp94 can engage binding to proteins once it is exposed on the cell surface or liberated in the extra-cellular milieu, as occurs in pathological conditions. In this work, we wanted to investigate the molecular aspects and structural characteristics of complexes that Grp94 forms with human IgG, posing the attention on the influence that glycosylation of Grp94 might have on the binding capacity to IgG, and on the identification of sites involved in the binding. To this aim, we employed both native, fully glycosylated and partially glycosylated Grp94, and recombinant, non-glycosylated Grp94, as well as IgG subunits, in different experimental conditions, including the physiological setting of human plasma. Regardless of the species and type, Grp94 engages a similar, highly specific and stable binding with IgG that involves sites located in the N-terminal domain of Grp94 and the hinge region of whole IgG. Grp94 does not form stable complex with Fab, F(ab)(2) or Fc. Glycosylation turns out to be an obstacle to the Grp94 binding to IgG, although this negative effect can be counteracted by ATP and spontaneously also disappears in time in a physiological setting of incubation. ATP does not affect at all the binding capacity of non-glycosylated Grp94. However, complexes that native, partially glycosylated Grp94 forms with IgG in the presence of ATP show strikingly different characteristics with respect to those formed in absence of ATP. Results have relevance for the mechanism regulating the formation of stable Grp94-IgG complexes in vivo, in the pathological conditions associated with the extra-cellular location of Grp94.	[Pagetta, Andrea; Tramentozzi, Elisa; Finotti, Paola] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Tibaldi, Elena; Brunati, Anna Maria] Univ Padua, Dept Mol Med, Padua, Italy; [Cendron, Laura; Zanotti, Giuseppe; Gorza, Luisa] Univ Padua, Dept Biomed Sci, Padua, Italy; [Vitadello, Maurizio] Ctr Nazl Ric, CNR Inst Neurosci, Padova Sect, Padua, Italy	University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Finotti, P (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	paola.finotti@unipd.it	Brunati, Anna Maria/I-8136-2018	Brunati, Anna Maria/0000-0002-3481-9503; Cendron, Laura/0000-0002-0125-0461; Zanotti, Giuseppe/0000-0002-0945-6501; GORZA, LUISA/0000-0003-4897-400X	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; Italian Space Agency [OSMA-WP1B51-2]	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	The work was supported by Ministero dell'Universita e della Ricerca Scientifica e Tecnologica grants "ex-60%" and Italian Space Agency (grant OSMA-WP1B51-2 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; Biswas C, 2006, INT IMMUNOL, V18, P1147, DOI 10.1093/intimm/dxl049; BOEHM J, 1994, EUR J CLIN INVEST, V24, P248, DOI 10.1111/j.1365-2362.1994.tb01082.x; Cala SE, 2000, BBA-MOL CELL RES, V1496, P296, DOI 10.1016/S0167-4889(00)00028-8; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; FELDWEG AM, 1995, INT J CANCER, V63, P310, DOI 10.1002/ijc.2910630227; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Linderoth NA, 2001, BIOCHEMISTRY-US, V40, P1483, DOI 10.1021/bi0016218; Linderoth NA, 2000, J BIOL CHEM, V275, P5472, DOI 10.1074/jbc.275.8.5472; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Nicchitta CV, 2004, CELL STRESS CHAPERON, V9, P325, DOI 10.1379/CSC-62.1; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Pagetta A, 2003, DIABETOLOGIA, V46, P996, DOI 10.1007/s00125-003-1133-5; Pagetta A, 2007, MOL IMMUNOL, V44, P2870, DOI 10.1016/j.molimm.2007.01.012; QU DF, 1994, DNA CELL BIOL, V13, P117, DOI 10.1089/dna.1994.13.117; Reed RC, 2002, J BIOL CHEM, V277, P25082, DOI 10.1074/jbc.M203195200; Richter K, 2007, MOL CELL, V28, P177, DOI 10.1016/j.molcel.2007.10.007; Rosser MFN, 2004, BIOCHEMISTRY-US, V43, P8835, DOI 10.1021/bi049539q; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Srivastava PK, 2006, CURR OPIN IMMUNOL, V18, P201, DOI 10.1016/j.coi.2006.01.009; SRIVASTAVA PK, 1994, BIOCHEM J, V301, P919, DOI 10.1042/bj3010919; Thorne ME, 2004, BIOCHEM BIOPH RES CO, V323, P1163, DOI 10.1016/j.bbrc.2004.08.215; Tramentozzi E, 2008, MOL IMMUNOL, V45, P3639, DOI 10.1016/j.molimm.2008.04.020; Tramentozzi E, 2009, J CELL MOL MED, V13, P1336, DOI 10.1111/j.1582-4934.2008.00354.x; Vitadello M, 1998, BIOCHEM J, V332, P351, DOI 10.1042/bj3320351; Vogen S, 2002, J BIOL CHEM, V277, P40742, DOI 10.1074/jbc.M205323200; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Weber CK, 2010, RHEUMATOLOGY, V49, P2255, DOI 10.1093/rheumatology/keq272; Wieten L, 2007, FEBS LETT, V581, P3716, DOI 10.1016/j.febslet.2007.04.082; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	43	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86198	10.1371/journal.pone.0086198	http://dx.doi.org/10.1371/journal.pone.0086198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489700	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000035
J	Reis, M; Pascoa, I; Rocha, H; Aguiar, B; Vieira, CP; Vieira, J				Reis, Micael; Pascoa, Ines; Rocha, Helder; Aguiar, Bruno; Vieira, Cristina P.; Vieira, Jorge			Genes Belonging to the Insulin and Ecdysone Signaling Pathways Can Contribute to Developmental Time, Lifespan and Abdominal Size Variation in Drosophila americana	PLOS ONE			English	Article							CORRELATED RESPONSES; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; LARVAL DEVELOPMENT; MELANOGASTER; SELECTION; GROWTH; LONGEVITY; PROTEIN; TRAITS	Even within a single genus, such as Drosophila, cases of lineage-specific adaptive evolution have been found. Therefore, the molecular basis of phenotypic variation must be addressed in more than one species group, in order to infer general patterns. In this work, we used D. americana, a species distantly-related to D. melanogaster, to perform an F2 association study for developmental time (DT), chill-coma recovery time (CRT), abdominal size (AS) and lifespan (LS) involving the two strains (H5 and W11) whose genomes have been previously sequenced. Significant associations were found between the 43 large indel markers developed here and DT, AS and LS but not with CRT. Significant correlations are also found between DT and LS, and between AS and LS, that might be explained by variation at genes belonging to the insulin and ecdysone signaling pathways. Since, in this F2 association study a single marker, located close to the Ecdysone receptor (EcR) gene, explained as much as 32.6% of the total variation in DT, we performed a second F2 association study, to determine whether large differences in DT are always due to variation in this genome region. No overlapping signal was observed between the two F2 association studies. Overall, these results illustrate that, in D. americana, pleiotropic genes involved in the highly-conserved insulin and ecdysone signaling pathways are likely responsible for variation observed in ecologically relevant phenotypic traits, although other genes are also involved.	[Reis, Micael; Pascoa, Ines; Rocha, Helder; Aguiar, Bruno; Vieira, Cristina P.; Vieira, Jorge] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal	Universidade do Porto	Vieira, J (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Vieira, Jorge/J-7477-2013; Vieira, Cristina/K-1775-2013	Vieira, Jorge/0000-0001-7032-5220; Pascoa, Ines/0000-0003-2297-7480; Vieira, Cristina/0000-0002-7139-2107; Rocha, Helder/0000-0003-1062-2498; Reis, Micael/0000-0002-2601-0886	FEDER Funds through the Operational Competitiveness Programme - COMPETE; national funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-037277 (PEst-C/SAU/LA0002/2013), FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008)]; FCT [SFRH/BD/61142/2009, SFRH/BD/69207/2010]	FEDER Funds through the Operational Competitiveness Programme - COMPETE; national funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER Funds through the Operational Competitiveness Programme - COMPETE and by national funds through FCT - Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-037277 (PEst-C/SAU/LA0002/2013) and FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008). Micael Reis and Bruno Aguiar are funded by PhD grants attributed by FCT with the references SFRH/BD/61142/2009 and SFRH/BD/69207/2010, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Bachtrog D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-334; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Bono JM, 2008, MOL ECOL, V17, P3211, DOI 10.1111/j.1365-294X.2008.03823.x; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Chippindale AK, 1997, EVOLUTION, V51, P1536, DOI [10.2307/2411206, 10.1111/j.1558-5646.1997.tb01477.x]; Chippindale AK, 2004, METHUSELAH FLIES CAS, P413; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; D'Avino PP, 2000, DEV BIOL, V220, P211, DOI 10.1006/dbio.2000.9650; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; Folguera G, 2008, BIOL J LINN SOC, V95, P233, DOI 10.1111/j.1095-8312.2008.01053.x; Fonseca NA, 2013, GENOME BIOL EVOL, V5, P661, DOI 10.1093/gbe/evt037; Fry SN, 2008, J NEUROSCI METH, V171, P110, DOI 10.1016/j.jneumeth.2008.02.016; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hsu T. C., 1952, University of Texas Publications, Vno. 5204, P35; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; JAMES AC, 1995, J EVOLUTION BIOL, V8, P315, DOI 10.1046/j.1420-9101.1995.8030315.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Llopart A, 2008, GENETICS, V179, P1009, DOI 10.1534/genetics.107.086231; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Matzkin LM, 2008, GENETICS, V178, P1073, DOI 10.1534/genetics.107.083287; Mensch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011229; Mensch J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-78; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB455, DOI 10.1093/gerona/55.9.B455; Morales-Hojas R, 2009, HEREDITY, V102, P573, DOI 10.1038/hdy.2009.11; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; Morales-Hojas R, 2011, MOL PHYLOGENET EVOL, V60, P249, DOI 10.1016/j.ympev.2011.04.022; Nunney L, 1996, EVOLUTION, V50, P1193, DOI 10.2307/2410660; Oldham S, 2000, PHILOS T R SOC B, V355, P945, DOI 10.1098/rstb.2000.0630; Paaby AB, 2009, FLY, V3, P29, DOI 10.4161/fly.3.1.7771; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Prasad NG, 2001, EVOLUTION, V55, P1363, DOI 10.1111/j.0014-3820.2001.tb00658.x; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Reis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025520; Sambucetti P, 2006, HEREDITAS, V143, P77, DOI 10.1111/j.2006.0018-0661.01934.x; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; van't Land J, 1999, J EVOLUTION BIOL, V12, P222, DOI 10.1046/j.1420-9101.1999.00029.x; Walker JA, 2006, GENE DEV, V20, P3311, DOI 10.1101/gad.1466806; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; ZWAAN B, 1995, EVOLUTION, V49, P635, DOI 10.2307/2410317	43	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86690	10.1371/journal.pone.0086690	http://dx.doi.org/10.1371/journal.pone.0086690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489769	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000072
J	Druart, C; Neyrinck, AM; Vlaeminck, B; Fievez, V; Cani, PD; Delzenne, NM				Druart, Celine; Neyrinck, Audrey M.; Vlaeminck, Bruno; Fievez, Veerle; Cani, Patrice D.; Delzenne, Nathalie M.			Role of the Lower and Upper Intestine in the Production and Absorption of Gut Microbiota-Derived PUFA Metabolites	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; FATTY-ACIDS; HUMAN HEALTH; DIETARY-FAT; MILK-FAT; ISOMERS; BIOSYNTHESIS; BACTERIA; OBESITY; CLA	In vitro studies have suggested that isolated gut bacteria are able to metabolize PUFA into CLA (conjugated linoleic acids) and CLnA (conjugated linolenic acids). However, the bioavailability of fatty acid metabolites produced in vivo by the gut microbes remains to be studied. Therefore, we measured intestinal concentration and plasma accumulation of bacterial metabolites produced from dietary PUFA in mice, first injected with a lipoprotein lipase inhibitor, then force-fed with either sunflower oil (200 mu l) rich in n-6 PUFA or linseed oil (200 mu l) rich in n-3 PUFA. The greatest production of bacterial metabolites was observed in the caecum and colon, and at a much lesser extent in the jejunum and ileum. In the caecal content, CLA proportions were higher in sunflower oil force-fed mice whereas CLnA proportions were higher in linseed oil force-fed mice. The accumulation of the main metabolites (CLA cis-9, trans-11-18: 2 and CLnA cis-9, trans-11, cis-15-18:3) in the caecal tissue was not associated with their increase in the plasma, therefore suggesting that, if endogenously produced CLA and CLnA have any biological role in host metabolism regulation, their effect would be confined at the intestinal level, where the microbiota is abundant.	[Druart, Celine; Neyrinck, Audrey M.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Vlaeminck, Bruno; Fievez, Veerle] Univ Ghent, Fac Biosci Engn, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; Ghent University; Universite Catholique Louvain; WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Fievez, Veerle/E-2333-2016; Neyrinck, Audrey/AAE-7929-2019; Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016	Fievez, Veerle/0000-0001-5042-6200; Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Druart, Celine/0000-0002-7786-9172	Danone Institute grant; Scientific Research-Flanders (Belgium); ERC Starting grant	Danone Institute grant(Danone Nutricia); Scientific Research-Flanders (Belgium)(FWO); ERC Starting grant(European Research Council (ERC))	CD benefits from a Danone Institute grant. BV is a Postdoctoral Fellow of the Fund for Scientific Research-Flanders (Belgium). PDC is a research associate from the FRS-FNRS (Fonds de la Recherche Scientifique, Belgium). PDC and NMD are recipients of FSR and FRSM subsidies (Fonds speciaux de recherches, UCL, Belgium; Fonds de la recherche scientifique medicale, Belgium). PDC is a recipient of ERC Starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031238; BORENSZTAJN J, 1976, BIOCHEM J, V156, P539, DOI 10.1042/bj1560539; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Chilliard Y, 2007, EUR J LIPID SCI TECH, V109, P828, DOI 10.1002/ejlt.200700080; Churruca I, 2009, BIOFACTORS, V35, P105, DOI 10.1002/biof.13; Coakley M, 2003, J APPL MICROBIOL, V94, P138, DOI 10.1046/j.1365-2672.2003.01814.x; Coakley M, 2009, LIPIDS, V44, P249, DOI 10.1007/s11745-008-3269-z; Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67; de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011; Destaillats F, 2007, J CHROMATOGR A, V1145, P222, DOI 10.1016/j.chroma.2007.01.062; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Druart C, 2013, BR J NUTR, V18, P1, DOI DOI 10.1017/S000711451300278X; Dubois V, 2007, EUR J LIPID SCI TECH, V109, P710, DOI 10.1002/ejlt.200700040; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Evans ME, 2002, J NUTR BIOCHEM, V13, P508, DOI 10.1016/S0955-2863(02)00211-5; Field CJ, 2009, APPL PHYSIOL NUTR ME, V34, P979, DOI 10.1139/H09-079; Gorissen L, 2010, APPL MICROBIOL BIOT, V87, P2257, DOI 10.1007/s00253-010-2713-1; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Huang EY, 2013, JPEN-PARENTER ENTER, V37, P746, DOI 10.1177/0148607113486931; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kramer JKG, 2008, LIPIDS, V43, P259, DOI 10.1007/s11745-007-3143-4; Lerch S, 2012, J DAIRY SCI, V95, P7269, DOI 10.3168/jds.2012-5654; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Miranda J, 2011, LIPIDS, V46, P1005, DOI 10.1007/s11745-011-3615-4; Mujico JR, 2013, BR J NUTR, P1; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; O'Shea EF, 2012, INT J FOOD MICROBIOL, V152, P189, DOI 10.1016/j.ijfoodmicro.2011.05.025; Or-Rashid MM, 2011, APPL MICROBIOL BIOT, V89, P387, DOI 10.1007/s00253-010-2865-z; Park Y, 2005, BBA-MOL CELL BIOL L, V1687, P120, DOI 10.1016/j.bbalip.2004.11.010; Precht D, 2001, LIPIDS, V36, P213, DOI 10.1007/s11745-001-0710-z; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schmidt J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C110.200477; Stefanov I, 2010, J AGR FOOD CHEM; SZENTKUTI L, 1995, HISTOCHEM J, V27, P466; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tricon S, 2006, CURR OPIN CLIN NUTR, V9, P105, DOI 10.1097/01.mco.0000214567.44568.fb; Tricon S, 2005, P NUTR SOC, V64, P171, DOI 10.1079/PNS2005418; Vinolo MAR, 2012, CURR OPIN CLIN NUTR, V15, P112, DOI 10.1097/MCO.0b013e32834f4598; Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	48	53	56	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87560	10.1371/journal.pone.0087560	http://dx.doi.org/10.1371/journal.pone.0087560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475308	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300201
J	Wang, JY; Jiang, JC; Wang, HF; Kang, HM; Zhang, Q; Liu, JF				Wang, Jiying; Jiang, Jicai; Wang, Haifei; Kang, Huimin; Zhang, Qin; Liu, Jian-Feng			Enhancing Genome-Wide Copy Number Variation Identification by High Density Array CGH Using Diverse Resources of Pig Breeds	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; POLYMORPHISM; SELECTION; VARIANTS; TRAITS	Copy number variations (CNVs) are important forms of genomic variation, and have attracted extensive attentions in humans as well as domestic animals. In the study, using a custom-designed 2.1 M array comparative genomic hybridization (aCGH), genome-wide CNVs were identified among 12 individuals from diverse pig breeds, including one Asian wild population, six Chinese indigenous breeds and two modern commercial breeds (Yorkshire and Landrace), with one individual of the other modern commercial breed, Duroc, as the reference. A total of 1,344 CNV regions (CNVRs) were identified, covering 47.79 Mb (similar to 1.70%) of the pig genome. The length of these CNVRs ranged from 3.37 Kb to 1,319.0 Kb with a mean of 35.56 Kb and a median of 11.11 Kb. Compared with similar studies reported, most of the CNVRs (74.18%) were firstly identified in present study. In order to confirm these CNVRs, 21 CNVRs were randomly chosen to be validated by quantitative real time PCR (qPCR) and a high rate (85.71%) of confirmation was obtained. Functional annotation of CNVRs suggested that the identified CNVRs have important function, and may play an important role in phenotypic and production traits difference among various breeds. Our results are essential complementary to the CNV map in the pig genome, which will provide abundant genetic markers to investigate association studies between various phenotypes and CNVs in pigs.	[Wang, Jiying; Jiang, Jicai; Wang, Haifei; Kang, Huimin; Zhang, Qin; Liu, Jian-Feng] China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Coll Anim Sci & Technol,Minist Agr, Beijing 100094, Peoples R China; [Wang, Jiying] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Prov Key Lab Anim Dis Control & Breeding, Jinan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences	Liu, JF (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Coll Anim Sci & Technol,Minist Agr, Beijing 100094, Peoples R China.	liujf@cau.edu.cn		Jiang, Jicai/0000-0001-6890-7539; Liu, Jian-Feng/0000-0002-5766-7864	Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; National High Technology Research and Development Program of China (863 Program) [2011AA100302, 2013AA102503]; National Natural Science Foundations of China [31272419]; New-Century Training Program Foundation for the Talents by the State Education Commission of China [NETC-10-0783]	Program for Changjiang Scholar and Innovation Research Team in University; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); New-Century Training Program Foundation for the Talents by the State Education Commission of China	This work was financially supported by the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191), the National High Technology Research and Development Program of China (863 Program 2011AA100302, 2013AA102503), the National Natural Science Foundations of China (31272419) and the New-Century Training Program Foundation for the Talents by the State Education Commission of China (NETC-10-0783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; de Smith AJ, 2008, CYTOGENET GENOME RES, V123, P17, DOI 10.1159/000184688; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Jiang YZ, 2012, GENET MOL RES, V11, P4447, DOI 10.4238/2012.September.19.6; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2012, FUNCT INTEGR GENOMIC, V12, P609, DOI 10.1007/s10142-012-0289-9; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lu P, 2008, FOOD CHEM, V107, P1529, DOI 10.1016/j.foodchem.2007.10.010; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiner G, 2002, VET PARASITOL, V106, P99, DOI 10.1016/S0304-4017(02)00041-9; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Wang Jiying, 2013, PLoS One, V8, pe68683, DOI 10.1371/journal.pone.0068683; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zhang CY, 2011, CURR GENOMICS, V12, P138, DOI 10.2174/138920211795564386; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang ZG, 1986, PIG BREEDS CHINA, P17	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87571	10.1371/journal.pone.0087571	http://dx.doi.org/10.1371/journal.pone.0087571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475311	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300204
J	Wu, WP; Lai, MN; Lin, CH; Li, YF; Lin, CY; Wu, MJ				Wu, Wen-Pyng; Lai, Ming-Nan; Lin, Ching-Heng; Li, Yu-Fen; Lin, Ching-Yuang; Wu, Ming-Ju			Addition of Immunosuppressive Treatment to Hemoperfusion Is Associated with Improved Survival after Paraquat Poisoning: A Nationwide Study	PLOS ONE			English	Article							INTRAVENOUS CYCLOPHOSPHAMIDE; PULSE THERAPY; CANCER-RISK; LUNG INJURY; METHYLPREDNISOLONE; DEXAMETHASONE; PROTECTS; EFFICACY; MODERATE; SINGLE	Paraquat poisoning associates very high mortality rate. Early treatment with hemoperfusion is strongly suggested by animal and human studies. Although the survival benefit of additional immunosuppressive treatment (IST) in combination with hemoperfusion is also reported since 1971, the large-scale randomized control trials to confirm the effects of IST is difficult to be executed. Therefore, we designed this nationwide large-scale population-based retrospective cohort study to investigate the outcome of paraquat poisoning with hemoperfusion and the additional effects of IST combined with hemoperfusion. This nationwide retrospective cohort study utilized data retrieved from the National Health Insurance Research Database (NHIRD) of Taiwan. A total of 1811 hospitalized patients with a diagnosis of paraquat poisoning who received hemoperfusion between 1997 and 2009 were enrolled. The mean age of all 1811 study subjects was 47.3 years. 70% was male. The overall survival rate was only 26.4%. Respiratory failure and renal failure were diagnosed in 56.2% and 36% patients. The average frequency of hemoperfusion was twice. IST was added in 42.2% patients. IST significantly increases survival rate (from 24.3% to 29.3%, P<0.001). The combined IST with methylprednisolone, cyclophosphamide and dexamethasone associates with the highest survival rate (48%, P<0.001). Moreover, patients younger than 45 years of age in the IST group had the best survival (41.0% vs. 33.7%, p<0.001). Our results support the use of IST with hemoperfusion for paraquat-poisoned patients. The best survival effect of IST is the combination of methylprednisolone, cyclophosphamide and daily dexamethasone, especially in patients with younger age.	[Wu, Wen-Pyng; Lin, Ching-Yuang; Wu, Ming-Ju] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wu, Wen-Pyng] Chang Bing Show Chwan Mem Hosp, Div Nephrol, Changhua, Taiwan; [Lai, Ming-Nan] Feng Chia Univ, Dept Stat, Taichung 40724, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Li, Yu-Fen] China Med Univ, Inst Biostat, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan; [Wu, Ming-Ju] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Ming-Ju] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Ju] Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan; [Wu, Ming-Ju] Taichung Vet Gen Hosp, Div Nephrol, Dept Med, Taichung, Taiwan	China Medical University Taiwan; Chang Bing Show Chwan Memorial Hospital; Feng Chia University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Chung Shan Medical University; National Chung Hsing University; Taichung Veterans General Hospital	Lin, CY (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	cylin@mail.cmuh.org.tw; wmj530@gmail.com	LI, YU-FEN/F-4770-2010	LI, YU-FEN/0000-0002-3960-6101				ADDO E, 1986, LANCET, V1, P1117, DOI 10.1016/S0140-6736(86)91836-2; Afzali S, 2008, ARCH IRAN MED, V11, P387, DOI 08114/AIM.009; Agarwal R., 2006, SMJ Singapore Medical Journal, V47, P1033; BATEMAN DN, 1987, HUM TOXICOL, V6, P57, DOI 10.1177/096032718700600109; BISMUTH C, 1987, HUM TOXICOL, V6, P63, DOI 10.1177/096032718700600110; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; Day BJ, 1996, TOXICOL APPL PHARM, V140, P94, DOI 10.1006/taap.1996.0201; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2006, TOXICOLOGY, V227, P73, DOI 10.1016/j.tox.2006.07.025; Dinis-Oliveira RJ, 2006, PEDIATR EMERG CARE, V22, P537, DOI 10.1097/01.pec.0000223179.07633.8a; Eddleston M, 2003, QJM-INT J MED, V96, P809, DOI 10.1093/qjmed/hcg137; GADEK JE, 1984, ENVIRON HEALTH PERSP, V55, P297, DOI 10.2307/3429709; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; HAMPSON ECGM, 1990, J PHARMACOL EXP THER, V254, P732; HOFFMAN GS, 1990, AM J MED, V89, P403, DOI 10.1016/0002-9343(90)90367-M; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048397; Ito T., 2008, J RURAL MED, V3, P5; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Lang JD, 2002, CHEST, V122, p314S, DOI 10.1378/chest.122.6_suppl.314S; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Li LR, 2012, COCHRANE DB SYST REV, V7; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Malone J D, 1971, J Ir Med Assoc, V64, P59; MCCUNE WJ, 1988, NEW ENGL J MED, V318, P1423, DOI 10.1056/NEJM198806023182203; MEREDITH TJ, 1987, HUM TOXICOL, V6, P49, DOI 10.1177/096032718700600108; PERRIENS JH, 1992, HUM EXP TOXICOL, V11, P129, DOI 10.1177/096032719201100212; POND SM, 1993, J TOXICOL-CLIN TOXIC, V31, P229, DOI 10.3109/15563659309000391; Sittipunt Chanchai, 2005, Respir Care, V50, P383; Sun CY, 2006, ACTA NEPHROLOGICA, V20, P98; Suntres Z. E., 1995, Biomedical and Environmental Sciences, V8, P289; SUZUKI K, 1993, HUM EXP TOXICOL, V12, P323, DOI 10.1177/096032719301200411; TABEI K, 1982, ARTIF ORGANS, V6, P37, DOI 10.1111/j.1525-1594.1982.tb04055.x; TALBOT AR, 1988, HUM TOXICOL, V7, P325, DOI 10.1177/096032718800700405; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Yamashita M, 2000, HUM EXP TOXICOL, V19, P99, DOI 10.1191/096032700678815729	40	31	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87568	10.1371/journal.pone.0087568	http://dx.doi.org/10.1371/journal.pone.0087568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475310	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300203
J	Zawada, DG; Mazel, CH				Zawada, David G.; Mazel, Charles H.			Fluorescence-Based Classification of Caribbean Coral Reef Organisms and Substrates	PLOS ONE			English	Article							CENSUS TECHNIQUES; PROTEIN; DISCRIMINATION; PIGMENTATION; EMISSION; SPECTRA; HOST	A diverse group of coral reef organisms, representing several phyla, possess fluorescent pigments. We investigated the potential of using the characteristic fluorescence emission spectra of these pigments to enable unsupervised, optical classification of coral reef habitats. We compiled a library of characteristic fluorescence spectra through in situ and laboratory measurements from a variety of specimens throughout the Caribbean. Because fluorescent pigments are not species-specific, the spectral library is organized in terms of 15 functional groups. We investigated the spectral separability of the functional groups in terms of the number of wavebands required to distinguish between them, using the similarity measures Spectral Angle Mapper (SAM), Spectral Information Divergence (SID), SID-SAM mixed measure, and Mahalanobis distance. This set of measures represents geometric, stochastic, joint geometric-stochastic, and statistical approaches to classifying spectra. Our hyperspectral fluorescence data were used to generate sets of 4-, 6-, and 8-waveband spectra, including random variations in relative signal amplitude, spectral peak shifts, and water-column attenuation. Each set consisted of 2 different band definitions: 'optimally-picked' and 'evenly-spaced.' The optimally-picked wavebands were chosen to coincide with as many peaks as possible in the functional group spectra. Reference libraries were formed from half of the spectra in each set and used for training purposes. Average classification accuracies ranged from 76.3% for SAM with 4 evenly-spaced wavebands to 93.8% for Mahalanobis distance with 8 evenly-spaced wavebands. The Mahalanobis distance consistently outperformed the other measures. In a second test, empirically-measured spectra were classified using the same reference libraries and the Mahalanobis distance for just the 8 evenly-spaced waveband case. Average classification accuracies were 84% and 87%, corresponding to the extremes in modeled water-column attenuation. The classification results from both tests indicate that a high degree of separability among the 15 fluorescent-spectra functional groups is possible using only a modest number of spectral bands.	[Zawada, David G.] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA; [Mazel, Charles H.] Phys Sci Inc, Andover, MA 01810 USA	United States Department of the Interior; United States Geological Survey; Physical Sciences Inc.	Zawada, DG (corresponding author), US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA.	dzawada@usgs.gov		Zawada, David/0000-0003-4547-4878	Environmental Optics Program of the Office of Naval Research; U.S. Geological Survey Coastal Marine and Geology Program	Environmental Optics Program of the Office of Naval Research(Office of Naval Research); U.S. Geological Survey Coastal Marine and Geology Program(United States Geological Survey)	This research was supported by funding from the Environmental Optics Program of the Office of Naval Research (CHM and DGZ, when previously employed by Physical Sciences Incorporated) and the U.S. Geological Survey Coastal Marine and Geology Program (DGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; CATALASTUCKI R, 1959, NATURE, V183, P949, DOI 10.1038/183949a0; Chang CI, 2000, IEEE T INFORM THEORY, V46, P1927, DOI 10.1109/18.857802; D'Angelo C, 2012, CORAL REEFS, V31, P1045, DOI 10.1007/s00338-012-0926-8; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Du YZ, 2004, OPT ENG, V43, P1777, DOI 10.1117/1.1766301; Duckworth J., 1998, APPL SPECTROSCOPY CO, P165, DOI [10.1016/B978-012764070-9/50007-X, DOI 10.1016/B978-012764070-9/50007-X]; Gnanadesikan R, 1997, METHODS STAT DATA AN, P81; Hedley JD, 2002, ADV MAR BIOL, V43, P277, DOI 10.1016/S0065-2881(02)43006-4; Jaramillo S, 2011, CORAL REEFS, V30, P11, DOI 10.1007/s00338-011-0731-9; Kawaguti S., 1944, Palao Tropical Biological Station Studies Tokyo, V2, P617; KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LIMBAUGH C, 1956, NATURE, V178, P497, DOI 10.1038/178497b0; Matz MV, 2006, METHOD BIOCHEM ANAL, V47, P139; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; Matz MV, 2002, BIOESSAYS, V24, P953, DOI 10.1002/bies.10154; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P522, DOI 10.4319/lo.2003.48.1_part_2.0522; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Mazel CH, 1997, OPT ENG, V36, P2612, DOI 10.1117/1.601486; Mazel CH, 1997, P SOC PHOTO-OPT INS, V2963, P240, DOI 10.1117/12.266450; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Phillips CES, 1927, NATURE, V119, P747, DOI 10.1038/119747c0; Piniak GA, 2005, CORAL REEFS, V24, P496, DOI 10.1007/s00338-005-0495-1; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Torres, 2004, SUBSURFACE SENSING T, V5, P25, DOI DOI 10.1023/B:SSTA.0000018445.25977.F3; Treiber M, 2010, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84996-235-3; WARD WW, 2002, BIOLUMINESCENCE CHEM, P123; Zawada DG, 2008, REV BIOL TROP, V56, P51; Zawada DG, 2003, LIMNOL OCEANOGR, V48, P412, DOI 10.4319/lo.2003.48.1_part_2.0412	34	19	19	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84570	10.1371/journal.pone.0084570	http://dx.doi.org/10.1371/journal.pone.0084570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24482676	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100025
J	Xiao, WD; Feng, YJ; Holst, JJ; Hartmann, B; Yang, H; Teitelbaum, DH				Xiao, Weidong; Feng, Yongjia; Holst, Jens J.; Hartmann, Bolette; Yang, Hua; Teitelbaum, Daniel H.			Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition	FASEB JOURNAL			English	Article						proliferation; epithelial barrier function; taste receptor; metabotropic glutamate receptor	BITTER TASTE RECEPTORS; RAT SMALL-INTESTINE; GASTROINTESTINAL-TRACT; BARRIER FUNCTION; EPITHELIAL-CELLS; GROWTH-FACTOR; UMAMI TASTE; MONOSODIUM GLUTAMATE; POTENTIAL MECHANISM; MULTIPLE RECEPTORS	Small intestine luminal nutrient sensing may be crucial for modulating physiological functions. However, its mechanism of action is incompletely understood. We used a model of enteral nutrient deprivation, or total parenteral nutrition (TPN), resulting in intestinal mucosal atrophy and decreased epithelial barrier function (EBF). We examined how a single amino acid, glutamate (GLM), modulates intestinal epithelial cell (IEC) growth and EBF. Controls were chow-fed mice, T1 receptor-3 (T1R3)-knockout (KO) mice, and treatment with the metabotropic glutamate receptor (mGluR)-5 antagonist MTEP. TPN significantly changed the amount of T1Rs, GLM receptors, and transporters, and GLM prevented these changes. GLM significantly prevented TPN-associated intestinal atrophy (2.5-fold increase in IEC proliferation) and was dependent on up-regulation of the protein kinase pAkt, but independent of T1R3 and mGluR5 signaling. GLM led to a loss of EBF with TPN (60% increase in FITC-dextran permeability, 40% decline in transepithelial resistance); via T1R3, it protected EBF, whereas mGluR5 was associated with EBF loss. GLM led to a decline in circulating glucagon-like peptide 2 (GLP-2) during TPN. The decline was regulated by T1R3 and mGluR5, suggesting a novel negative regulator pathway for IEC proliferation not previously described. Loss of luminal nutrients with TPN administration may widely affect intestinal taste sensing. GLM has previously unrecognized actions on IEC growth and EBF. Restoring luminal sensing via GLM could be a strategy for patients on TPN.Xiao, W., Feng, Y., Holst, J. J., Hartmann, B., Yang, H., Teitelbaum, D. H. Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition.	[Xiao, Weidong; Feng, Yongjia; Teitelbaum, Daniel H.] Univ Michigan, Pediat Surg Sect, Dept Surg, Sch Med, Ann Arbor, MI 48109 USA; [Xiao, Weidong; Feng, Yongjia; Teitelbaum, Daniel H.] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Xiao, Weidong; Yang, Hua] Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Holst, Jens J.; Hartmann, Bolette] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Army Medical University; University of Copenhagen	Teitelbaum, DH (corresponding author), Univ Michigan, Pediat Surg Sect, Mott Childrens Hosp F3970, Ann Arbor, MI 48109 USA.	dttlbm@umich.edu	Holst, Jens/AAA-8022-2022	Holst, Jens Juul/0000-0001-6853-3805; Hartmann, Bolette/0000-0001-8509-2036	Ajinomoto Co. Inc. (Tokyo, Japan); U.S. National Institutes of Health [2R01AI-44076-14]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044076] Funding Source: NIH RePORTER	Ajinomoto Co. Inc. (Tokyo, Japan); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank P. J. Browner and Drs. R. Sueyoshi, M. W. Ralls, and R. S. Herman for assistance with mouse care, sample collection, and the Ussing chamber experiment, and H. K. Yoon for technical assistance. This work was supported by Ajinomoto Co. Inc. (Tokyo, Japan) and U.S. National Institutes of Health grant 2R01AI-44076-14. The authors declare no conflicts of interest.	Agency for Healthcare Research and Quality, 2010, DAT PN EN US; Akiba Y, 2011, ACTA PHYSIOL, V201, P77, DOI 10.1111/j.1748-1716.2010.02149.x; Akiba Y, 2011, DIGESTION, V83, P25, DOI 10.1159/000323401; Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; Akiba Y, 2009, AM J CLIN NUTR, V90, p826S, DOI 10.3945/ajcn.2009.27462U; Amagase K, 2012, J PHARMACOL SCI, V118, P131, DOI 10.1254/jphs.11R03FM; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Chance WT, 2006, PEPTIDES, V27, P883, DOI 10.1016/j.peptides.2005.09.012; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; Delay ER, 2006, CHEM SENSES, V31, P351, DOI 10.1093/chemse/bjj039; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Feng YJ, 2010, AM J PHYSIOL-GASTR L, V298, pG833, DOI 10.1152/ajpgi.00030.2010; Feng YJ, 2009, J PHYSIOL-LONDON, V587, P641, DOI 10.1113/jphysiol.2008.162719; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Grossmann J, 1998, AM J PATHOL, V153, P53, DOI 10.1016/S0002-9440(10)65545-9; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Kinnamon SC, 2009, AM J CLIN NUTR, V90, p753S, DOI 10.3945/ajcn.2009.27462K; Kondoh T, 2009, AM J CLIN NUTR, V90, p832S, DOI 10.3945/ajcn.2009.27462V; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Kubera C, 2012, NEUROSCIENCE, V219, P271, DOI 10.1016/j.neuroscience.2012.05.064; Li XD, 2009, AM J CLIN NUTR, V90, p733S, DOI 10.3945/ajcn.2009.27462G; Liu XW, 2006, AM J CLIN NUTR, V84, P1142, DOI 10.1093/ajcn/84.5.1142; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Negri R, 2011, J PEDIATR GASTR NUTR, V53, P601, DOI 10.1097/MPG.0b013e3182309641; Nelson DW, 2008, AM J PHYSIOL-REG I, V294, pR1175, DOI 10.1152/ajpregu.00238.2007; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Nguyen CA, 2012, CURR MED CHEM, V19, P28; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Nochi R, 2012, EUR J NEUROSCI, V36, P2273, DOI 10.1111/j.1460-9568.2012.08128.x; Nose K, 2010, J INTERF CYTOK RES, V30, P67, DOI 10.1089/jir.2009.0046; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Schunemann DP, 2010, PATHOL ONCOL RES, V16, P285, DOI 10.1007/s12253-009-9223-4; Sharp CD, 2003, AM J PHYSIOL-HEART C, V285, pH2592, DOI 10.1152/ajpheart.00520.2003; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Shin YJ, 2010, NEUROCHEM RES, V35, P1628, DOI 10.1007/s11064-010-0223-2; Sternini C, 2007, AM J PHYSIOL-GASTR L, V292, pG457, DOI 10.1152/ajpgi.00411.2006; Sun XY, 2008, AM J PHYSIOL-GASTR L, V294, pG139, DOI 10.1152/ajpgi.00386.2007; Sun XY, 2006, JPEN-PARENTER ENTER, V30, P474, DOI 10.1177/0148607106030006474; Swartz TD, 2012, BRIT J NUTR, V107, P621, DOI 10.1017/S0007114511003412; Vermeulen MAR, 2011, WORLD J GASTROENTERO, V17, P1569, DOI 10.3748/wjg.v17.i12.1569; Wang JH, 2011, J PHARMACOL EXP THER, V339, P464, DOI 10.1124/jpet.111.184788; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wildhaber BE, 2005, J SURG RES, V123, P8, DOI 10.1016/j.jss.2004.06.015; Wildhaber BE, 2002, PEDIATR SURG INT, V18, P570, DOI 10.1007/s00383-002-0869-1; Wildhaber BE, 2003, J SURG RES, V112, P144, DOI 10.1016/S0022-4804(03)00160-4; Yang H, 2003, AM J PHYSIOL-GASTR L, V284, pG629, DOI 10.1152/ajpgi.00290.2002; Yang H, 2008, ANN SURG, V248, P849, DOI 10.1097/SLA.0b013e31818a1522; Yang H, 2009, ANN NY ACAD SCI, V1165, P338, DOI 10.1111/j.1749-6632.2009.04026.x; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Yasumatsu K, 2009, AM J CLIN NUTR, V90, p747S, DOI 10.3945/ajcn.2009.27462J; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932; Zhang CJ, 2009, J NUTR, V139, P1315, DOI 10.3945/jn.108.096669; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao L, 2011, NEUROSCIENCE, V192, P185, DOI 10.1016/j.neuroscience.2011.06.044; Znalesniak EB, 2010, CELL PHYSIOL BIOCHEM, V25, P533, DOI 10.1159/000303057	61	31	35	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2073	2087		10.1096/fj.13-238311	http://dx.doi.org/10.1096/fj.13-238311			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24497581	Green Published, Green Submitted			2022-12-25	WOS:000335336000012
J	Jung, M; Philpott, M; Muller, S; Schulze, J; Badock, V; Eberspacher, U; Moosmayer, D; Bader, B; Schmees, N; Fernandez-Montalvan, A; Haendler, B				Jung, Marie; Philpott, Martin; Mueller, Susanne; Schulze, Jessica; Badock, Volker; Eberspaecher, Uwe; Moosmayer, Dieter; Bader, Benjamin; Schmees, Norbert; Fernandez-Montalvan, Amaury; Haendler, Bernard			Affinity Map of Bromodomain Protein 4 ( BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cancer Therapy; Chromatin; Histones; Mutant; Acetylation; BET Family; BRD4; Bromodomain	ACUTE MYELOID-LEUKEMIA; BET BROMODOMAINS; STRUCTURAL BASIS; SELECTIVE-INHIBITION; AGGRESSIVE CARCINOMA; ACETYLATED CHROMATIN; BINDING; RECOGNITION; TRANSCRIPTION; CANCER	Background: BRD4 is a reader of acetylated histones. Results: Mutational analysis of BRD4 BD1 allowed the identification of three groups with different binding profiles. Conclusion: Pro-82, Leu-94, Asp-145, and Ile-146 have a differentiated role in acetyl-lysine and inhibitor interaction. Significance: Identification of residues essential for BRD4 function will guide the design of novel inhibitors. Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain (BET) protein family. It binds to acetylated histone tails via its tandem bromodomains BD1 and BD2 and forms a complex with the positive transcription elongation factor b, which controls phosphorylation of RNA polymerase II, ultimately leading to stimulation of transcription elongation. An essential role of BRD4 in cell proliferation and cancer growth has been reported in several recent studies. We analyzed the binding of BRD4 BD1 and BD2 to different partners and showed that the strongest interactions took place with di- and tetra-acetylated peptides derived from the histone 4 N-terminal tail. We also found that several histone 4 residues neighboring the acetylated lysines significantly influenced binding. We generated 10 different BRD4 BD1 mutants and analyzed their affinities to acetylated histone tails and to the BET inhibitor JQ1 using several complementary biochemical and biophysical methods. The impact of these mutations was confirmed in a cellular environment. Altogether, the results show that Trp-81, Tyr-97, Asn-140, and Met-149 play similarly important roles in the recognition of acetylated histones and JQ1. Pro-82, Leu-94, Asp-145, and Ile-146 have a more differentiated role, suggesting that different kinds of interactions take place and that resistance mutations compatible with BRD4 function are possible. Our study extends the knowledge on the contribution of individual BRD4 amino acids to histone and JQ1 binding and may help in the design of new BET antagonists with improved pharmacological properties.	[Jung, Marie; Schulze, Jessica; Badock, Volker; Eberspaecher, Uwe; Moosmayer, Dieter; Bader, Benjamin; Schmees, Norbert; Fernandez-Montalvan, Amaury; Haendler, Bernard] Bayer HealthCare, Global Drug Discovery, D-13353 Berlin, Germany; [Jung, Marie] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Philpott, Martin; Mueller, Susanne] Univ Oxford, Struct Genom Consortium, Nuffield Dept Clin Med, Oxford OX3 7DQ, England; [Philpott, Martin; Mueller, Susanne] Univ Oxford, Target Discovery Inst, Nuffield Dept Clin Med, Oxford OX3 7DQ, England	Bayer AG; Bayer Healthcare Pharmaceuticals; Free University of Berlin; University of Oxford; University of Oxford	Haendler, B (corresponding author), Bayer HealthCare, Dept Chromatin Modulat & OncoGen, Therapeut Res Grp Oncol Gynecol Therapies, Global Drug Discovery, Mullerstr 178, D-13353 Berlin, Germany.	bernard.haendler@bayer.com		Fernandez-Montalvan, Amaury/0000-0001-9156-0000; Bader, Benjamin/0000-0002-5299-396X; Muller-Knapp, Susanne/0000-0003-2402-4157; Philpott, Martin/0000-0003-3632-0084	SGC [1097737]; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	SGC; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the SGC, a registered charity (1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z).	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; Chung CW, 2011, J BIOMOL SCREEN, V16, P1170, DOI 10.1177/1087057111421372; Da Costa D, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.24; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; French CA, 2013, HEAD NECK PATHOL, V7, P11, DOI 10.1007/s12105-013-0428-1; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gamsjaeger R, 2011, MOL CELL BIOL, V31, P2632, DOI 10.1128/MCB.05413-11; Herrmann H, 2012, ONCOTARGET, V3, P1588, DOI 10.18632/oncotarget.733; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ito T, 2011, CHEM BIOL, V18, P495, DOI 10.1016/j.chembiol.2011.02.009; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oliver SS, 2011, ANGEW CHEM INT EDIT, V50, P5801, DOI 10.1002/anie.201101414; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Steiner S, 2013, FEBS LETT, V587, P2158, DOI 10.1016/j.febslet.2013.05.032; Sun HB, 2007, BIOCHEM BIOPH RES CO, V358, P435, DOI 10.1016/j.bbrc.2007.04.139; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Weidner-Glunde M, 2010, FRONT BIOSCI-LANDMRK, V15, P537, DOI 10.2741/3632; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zou Z., 2013, ONCOGENE, DOI 10.1038/onc.2013.179; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	67	97	117	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9304	9319		10.1074/jbc.M113.523019	http://dx.doi.org/10.1074/jbc.M113.523019			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24497639	hybrid, Green Published			2022-12-25	WOS:000333472100047
J	Abeykoon, A; Wang, GH; Chao, CC; Chock, PB; Gucek, M; Ching, WM; Yang, DCH				Abeykoon, Amila; Wang, Guanghui; Chao, Chien-Chung; Chock, P. Boon; Gucek, Marjan; Ching, Wei-Mei; Yang, David C. H.			Multimethylation of Rickettsia OmpB Catalyzed by Lysine Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cell Surface Protein; Enzyme Catalysis; Mass Spectrometry (MS); Protein Methylation	OUTER-MEMBRANE-PROTEIN; PROTEOMIC ANALYSIS; METHYLATION; PROWAZEKII; INFECTION; TYPHI; TRIMETHYLLYSINE; RECOGNITION; ANTIGENS; INVASION	Background: Methylation of OmpB has been implicated in rickettsial virulence. Results: Native OmpBs purified from Rickettsia contain mono- and trimethyllysine at specific locations that coincide with those catalyzed by methyltransferases in vitro. Conclusion: The number of trimethyllysine clusters in OmpBs correlates with degree of virulence. Significance: This study provides new insight into methylation of OmpB and its correlation with virulence. Methylation of rickettsial OmpB (outer membrane protein B) has been implicated in bacterial virulence. Rickettsial methyltransferases RP789 and RP027-028 are the first biochemically characterized methyltransferases to catalyze methylation of outer membrane protein (OMP). Methylation in OMP remains poorly understood. Using semiquantitative integrated liquid chromatography-tandem mass spectroscopy, we characterize methylation of (i) recombinantly expressed fragments of Rickettsia typhi OmpB exposed in vitro to trimethyltransferases of Rickettsia prowazekii RP027-028 and of R. typhi RT0101 and to monomethyltransferases of R. prowazekii RP789 and of R. typhi RT0776, and (ii) native OmpBs purified from R. typhi and R. prowazekii strains Breinl, RP22, and Madrid E. We found that in vitro trimethylation occurs at relatively specific locations in OmpB with consensus motifs, KX(G/A/V/I)N and KT(I/L/F), whereas monomethylation is pervasive throughout OmpB. Native OmpB from virulent R. typhi contains mono- and trimethyllysines at locations well correlated with methylation in recombinant OmpB catalyzed by methyltransferases in vitro. Native OmpBs from highly virulent R. prowazekii strains Breinl and RP22 contain multiple clusters of trimethyllysine in contrast to a single cluster in OmpB from mildly virulent R. typhi. Furthermore, OmpB from the avirulent strain Madrid E contains mostly monomethyllysine and no trimethyllysine. The native OmpB from Madrid E was minimally trimethylated by RT0101 or RP027-028, consistent with a processive mechanism of trimethylation. This study provides the first in-depth characterization of methylation of an OMP at the molecular level and may lead to uncovering the link between OmpB methylation and rickettsial virulence.	[Abeykoon, Amila; Yang, David C. H.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Wang, Guanghui; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA; [Chao, Chien-Chung; Ching, Wei-Mei] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA; [Chock, P. Boon] NHLBI, Biochem Lab, Bethesda, MD 20892 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yang, DCH (corresponding author), Georgetown Univ, Dept Chem, Washington, DC 20057 USA.	yangdc@georgetown.edu	Yang, David/A-7294-2009		Naval Medical Logistic Command Award [N62645];  [6000.RAD1.J.A0310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000202, ZICHL005903] Funding Source: NIH RePORTER	Naval Medical Logistic Command Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by Naval Medical Logistic Command Award N62645 (to Georgetown University) and Work Unit 6000.RAD1.J.A0310 (to the Naval Medical Research Center).	Abeykoon AH, 2012, J BACTERIOL, V194, P6410, DOI 10.1128/JB.01379-12; Anacker RL., 1981, RICKETTSIAE RICKETTS, P71; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Botelho-Nevers E, 2011, EUR J CLIN MICROBIOL, V30, P1139, DOI 10.1007/s10096-011-1208-z; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07; Chao CC, 2007, BBA-PROTEINS PROTEOM, V1774, P373, DOI 10.1016/j.bbapap.2007.01.001; Ching W.M., 1993, TECHNIQUES PROTEIN C, P307; Chou M. F., 2011, CURR PROTOC BIOINFOR, V2011, P15; DASCH GA, 1981, J CLIN MICROBIOL, V14, P333, DOI 10.1128/JCM.14.3.333-341.1981; DASCH GA, 1981, INFECT IMMUN, V31, P276, DOI 10.1128/IAI.31.1.276-288.1981; Daze KD, 2013, ACCOUNTS CHEM RES, V46, P937, DOI 10.1021/ar300072g; Daze KD, 2012, CHEM SCI, V3, P2695, DOI 10.1039/c2sc20583a; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Georgiades K., 2011, PLOS ONE, V6; GILMORE RD, 1991, MOL MICROBIOL, V5, P2361, DOI 10.1111/j.1365-2958.1991.tb02082.x; GRANADOS EN, 1980, BIOCHEMISTRY-US, V19, P3227, DOI 10.1021/bi00555a020; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Kinter M., 2000, PROTEIN SEQUENCING I, P154; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Lu ZY, 2009, J AM CHEM SOC, V131, P14928, DOI 10.1021/ja904951t; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; ROBERTS DM, 1986, J BIOL CHEM, V261, P1491; RODIONOV AV, 1990, BIOORG KHIM+, V16, P1687; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	44	18	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7691	7701		10.1074/jbc.M113.535567	http://dx.doi.org/10.1074/jbc.M113.535567			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497633	hybrid, Green Published			2022-12-25	WOS:000332761500037
J	Hassan, I; Gaines, KS; Hottel, WJ; Wishy, RM; Miller, SE; Powers, LS; Rutkowski, DT; Monick, MM				Hassan, Ihab; Gaines, Kayla S.; Hottel, Wesley J.; Wishy, Ryan M.; Miller, Sara E.; Powers, Linda S.; Rutkowski, D. Thomas; Monick, Martha M.			Inositol-requiring Enzyme 1 Inhibits Respiratory Syncytial Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Signaling; ER Stress; Negative-strand RNA Viruses; Viral Replication; IRE1	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEPATITIS-C VIRUS; ER STRESS; EPITHELIAL-CELLS; AIRWAY EPITHELIA; MESSENGER-RNA; INFECTION; ACTIVATION; INDUCTION	Background: The endoplasmic reticulum (ER) stress response is increasingly implicated in the pathogenesis of viral infections. Results: Respiratory syncytial virus (RSV) infection induces the inositol-requiring enzyme 1 (IRE1) stress pathway. IRE1 activity inhibits RSV replication. Conclusion: ER stress may be a novel cellular anti-RSV defense mechanism. Significance: Identification of a novel regulator of RSV replication may have therapeutic implications. Despite being a major health problem, respiratory syncytial virus (RSV) infections remain without specific therapy. Identification of novel host cellular responses that play a role in the pathogenesis of RSV infection is needed for therapeutic development. The endoplasmic reticulum (ER) stress response is an evolutionarily conserved cellular signaling cascade that has been implicated in multiple biological phenomena, including the pathogenesis of some viral infections. In this study, we investigate the role of the ER stress response in RSV infection using an in vitro A549 cell culture model. We found that RSV infection induces a non-canonical ER stress response with preferential activation of the inositol-requiring enzyme 1 (IRE1) and activated transcription factor 6 (ATF6) pathways with no concomitant significant activation of the protein kinase R-like ER kinase (PERK) pathway. Furthermore, we discovered that IRE1 has an inhibitory effect on RSV replication. Our data characterize, for the first time, the nature of the ER stress response in the setting of RSV infection and identify the IRE1 stress pathway as a novel cellular anti-RSV defense mechanism.	[Hassan, Ihab; Gaines, Kayla S.; Hottel, Wesley J.; Wishy, Ryan M.; Miller, Sara E.; Powers, Linda S.; Monick, Martha M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Rutkowski, D. Thomas] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Hassan, I (corresponding author), Univ Iowa, Div Pulm Crit Care & Occupat Med, Rm 100 EMRB, Iowa City, IA 52242 USA.	ihab-hassan@uiowa.edu		Rutkowski, Thomas/0000-0001-6586-4449	National Institutes of Health [R01 HL079901, R01 HL096625, R21 HL109589, R01 DK084058]; NIEHS, National Institutes of Health [P30 ES005605]; National Center for Research Resources (NCRR), National Institutes of Health [UL1RR024979]; American Thoracic Society Foundation Research Grant [2012-04]; National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096625, R01HL079901, R21HL109589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources (NCRR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Thoracic Society Foundation Research Grant; National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901, R01 HL096625, and R21 HL109589 (to M. M. M.); R01 DK084058 (to D. T. R.); NIEHS, National Institutes of Health Grant P30 ES005605; and National Center for Research Resources (NCRR), National Institutes of Health Grant UL1RR024979. This work was also supported by American Thoracic Society Foundation Research Grant 2012-04 (to I. H.) and by the National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; Arensdorf AM, 2013, J CELL SCI, V126, P4026, DOI 10.1242/jcs.130757; Bechill J, 2008, J VIROL, V82, P4492, DOI 10.1128/JVI.00017-08; Beeler JA, 2013, MICROB PATHOGENESIS, V55, P9, DOI 10.1016/j.micpath.2012.11.013; Dickey DD, 2012, J GENE MED, V14, P366, DOI 10.1002/jgm.2632; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Gupta S., 2010, INT J CELL BIOL, V2010; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUNTER JA, 1985, P NATL ACAD SCI USA, V82, P4633, DOI 10.1073/pnas.82.14.4633; Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kim HT, 2004, LAB INVEST, V84, P816, DOI 10.1038/labinvest.3700104; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; LOOK DC, 1992, AM J PHYSIOL, V263, pL79, DOI 10.1152/ajplung.1992.263.1.L79; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Onn A, 2010, NAT STRUCT MOL BIOL, V17, P924, DOI 10.1038/nsmb0810-924; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Stewart MJ, 2006, J INTERF CYTOK RES, V26, P521, DOI 10.1089/jir.2006.26.521; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Volkmann K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199737; Walsh EE, 1999, AM J RESP CRIT CARE, V160, P791, DOI 10.1164/ajrccm.160.3.9901004; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye ZD, 2008, BBA-GEN SUBJECTS, V1780, P1383, DOI 10.1016/j.bbagen.2008.07.009; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	55	28	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7537	7546		10.1074/jbc.M113.510594	http://dx.doi.org/10.1074/jbc.M113.510594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497642	Green Published, hybrid			2022-12-25	WOS:000332761500024
J	Serrano-Villar, S; Perez-Elias, MJ; Dronda, F; Casado, JL; Moreno, A; Royuela, A; Perez-Molina, JA; Sainz, T; Navas, E; Hermida, JM; Quereda, C; Moreno, S				Serrano-Villar, Sergio; Jesus Perez-Elias, Maria; Dronda, Fernando; Luis Casado, Jose; Moreno, Ana; Royuela, Ana; Antonio Perez-Molina, Jose; Sainz, Talia; Navas, Enrique; Manuel Hermida, Jose; Quereda, Carmen; Moreno, Santiago			Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio	PLOS ONE			English	Article							T-CELL-ACTIVATION; GENERAL-POPULATION; IMMUNE ACTIVATION; OLD POPULATION; KIDNEY-DISEASE; SWEDISH PEOPLE; SURVIVAL; COHORT; ATHEROSCLEROSIS; CD8	Background: A low CD4/CD8 ratio has been identified in the general population as a hallmark of inmmunosenescence and a surrogate of all-cause mortality. We aimed to investigate in treated HIV-infected individuals the relationship between the CD4/CD8 ratio and serious non-AIDS events. Methods: Case-control study within a prospective hospital-based cohort of HIV-infected subjects during at least one year of ART-mediated viral suppression. Cases were patients with serious non-AIDS events (non-AIDS malignancies, cardiovascular disease, and end-stage kidney disease), and controls individuals who did not developed non-AIDS events during follow-up. Data were analyzed using ROC analysis and multivariate logistic regression. Conditional logistic regression was performed in 200 cases/controls matched by age, sex, nadir CD4 and proximal CD4 counts. Results: We analyzed 407 subjects (109 cases, 298 controls). The CD4/CD8 ratio was lower in cases (0.44 vs. 0.70, P<0.0001), with higher discriminatory ability for the detection of non-AIDS events than the CD4 count, CD8 count and nadir CD4. Multivariate analyses (adjusted for age, sex, nadir CD4, proximal CD4 count, year of ART initiation and ART duration) confirmed the independent association of a low CD4/CD8 ratio with the risk of non-AIDS morbidity (per CD4/CD8 ratio quartile decrease, OR, 2.9; 95% CI, 1.3-6.2) and non-AIDS mortality (OR, 2.8; 95% CI, 1.5-5.3). Conclusions: The CD4/CD8 ratio provides additional information to the CD4 counts and nadir CD4 in treated HIV-infected individuals, since it is independently associated with the risk of non-AIDS-related morbidity and mortality. This association is robust and maintained within different subgroups of patients.	[Serrano-Villar, Sergio; Jesus Perez-Elias, Maria; Dronda, Fernando; Luis Casado, Jose; Moreno, Ana; Antonio Perez-Molina, Jose; Navas, Enrique; Manuel Hermida, Jose; Quereda, Carmen; Moreno, Santiago] Univ Hosp Ramon y Cajal, Inst Hlth Res IRICYS, Dept Infect Dis, Madrid, Spain; [Royuela, Ana] Univ Hosp Ramon y Cajal, CIBER, Clin Biostat Unit, IRYCIS, Madrid, Spain; [Sainz, Talia] Univ Hosp Gregorio Maranon, Lab Mol Immune Biol, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; Hospital Universitario Ramon y Cajal; General University Gregorio Maranon Hospital	Serrano-Villar, S (corresponding author), Univ Hosp Ramon y Cajal, Inst Hlth Res IRICYS, Dept Infect Dis, Madrid, Spain.	serranovillar@gmail.com	Elias, Maria Jesus Perez/AAD-8652-2020; Padilla, Sergio/U-7682-2017; Vicente, Ana Royuela/AAC-4284-2021	Vicente, Ana Royuela/0000-0003-1665-081X; Casado, Jose Luis/0000-0002-7639-8591; Serrano-Villar, Sergio/0000-0002-5447-3554; Perez Elias/0000-0001-5700-5257; Perez-Molina, Jose Antonio/0000-0001-8735-4124	Instituto de Salud Carlos III [RD06/0006]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	CORIS is integrated in the Spanish AIDS Research Network Red Tematica Cooperativa de Investigacion en SIDA (RD06/0006), supported by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Devitt E, 2013, 20 C RETR OPP INF MA; Dock JN, 2011, AGING DIS, V2, P382; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Li TS, 2011, CLIN INFECT DIS, V53, P944, DOI 10.1093/cid/cir552; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Odden MC, 2007, ARCH INTERN MED, V167, P2213, DOI 10.1001/archinte.167.20.2213; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Powles T, 2009, J CLIN ONCOL, V27, P884, DOI 10.1200/JCO.2008.19.6626; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Stephan C, 2012, JAIDS-J ACQ IMM DEF, V61, pE73, DOI 10.1097/QAI.0b013e3182737254; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1	38	136	143	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85798	10.1371/journal.pone.0085798	http://dx.doi.org/10.1371/journal.pone.0085798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497929	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100010
J	Chandrananda, D; Thorne, NP; Ganesamoorthy, D; Bruno, DL; Benjamini, Y; Speed, TP; Slater, HR; Bahlo, M				Chandrananda, Dineika; Thorne, Natalie P.; Ganesamoorthy, Devika; Bruno, Damien L.; Benjamini, Yuval; Speed, Terence P.; Slater, Howard R.; Bahlo, Melanie			Investigating and Correcting Plasma DNA Sequencing Coverage Bias to Enhance Aneuploidy Discovery	PLOS ONE			English	Article							CELL-FREE DNA; FREE FETAL DNA; MATERNAL PLASMA; CIRCULATING DNA; PRENATAL-DIAGNOSIS; ORIGIN; GENOME; SERUM	Pregnant women carry a mixture of cell-free DNA fragments from self and fetus (non-self) in their circulation. In recent years multiple independent studies have demonstrated the ability to detect fetal trisomies such as trisomy 21, the cause of Down syndrome, by Next-Generation Sequencing of maternal plasma. The current clinical tests based on this approach show very high sensitivity and specificity, although as yet they have not become the standard diagnostic test. Here we describe improvements to the analysis of the sequencing data by reducing GC bias and better handling of the genomic repeats. We show substantial improvements in the sensitivity of the standard trisomy 21 statistical tests, which we measure by artificially reducing read coverage. We also explore the bias stemming from the natural cleavage of plasma DNA by examining DNA motifs and position specific base distributions. We propose a model to correct this fragmentation bias and observe that incorporating this bias does not lead to any further improvements in the detection of fetal trisomy. The improved bias corrections that we demonstrate in this work can be readily adopted into existing fetal trisomy detection protocols and should also lead to improvements in sub-chromosomal copy number variation detection.	[Chandrananda, Dineika; Thorne, Natalie P.; Speed, Terence P.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Chandrananda, Dineika; Thorne, Natalie P.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Ganesamoorthy, Devika; Bruno, Damien L.; Slater, Howard R.] Murdoch Childrens Res Inst, Victorian Clin Genet Serv Cytogenet Lab, Melbourne, Vic, Australia; [Ganesamoorthy, Devika; Slater, Howard R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Benjamini, Yuval; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of California System; University of California Berkeley; University of Melbourne	Chandrananda, D (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia.	chandrananda@wehi.edu.au	Ganesamoorthy, Devika/J-8359-2014; Bruno, Damien L/C-3665-2013	Ganesamoorthy, Devika/0000-0001-8149-6703; Bahlo, Melanie/0000-0001-5132-0774; Chandrananda, Dineika/0000-0002-8834-9500	Victorian State Government; Australian Government NHMRC IRIISS; Australian Postgraduate Awards; John and Patricia Farrant Scholarship; National Science Foundation VIGRE Graduate Fellowship; National Health and Medical Research Council Australia Fellowship [575503]; National Institutes of Health [5R01 GM083084-03]; Australian Research Council Future Fellowship [FT100100764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER	Victorian State Government; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards(Australian Government); John and Patricia Farrant Scholarship; National Science Foundation VIGRE Graduate Fellowship(National Science Foundation (NSF)); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Future Fellowship(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. Additional support provided by Australian Postgraduate Awards (to DC and DG); The John and Patricia Farrant Scholarship (to DC); National Science Foundation VIGRE Graduate Fellowship (to YB); National Health and Medical Research Council Australia Fellowship (grant number 575503 to TPS); National Institutes of Health (grant number 5R01 GM083084-03 to TPS.) and an Australian Research Council Future Fellowship (grant number FT100100764 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, OBSTET GYNECOL, V110, P1459; Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Ashoor G, 2012, FETAL DIAGN THER, V31, P237, DOI 10.1159/000337373; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bettecken T, 2012, J BIOMOL STRUCT DYN, V30, P211, DOI 10.1080/07391102.2012.677772; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Boon EMJ, 2013, PRENATAL DIAG, V33, P563, DOI 10.1002/pd.4111; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chitty LS, 2013, PRENATAL DIAG, V33, P511, DOI 10.1002/pd.4136; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Ferguson-Smith MA, 2010, PRENATAL DIAG, V30, P601, DOI 10.1002/pd.2574; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Jahr S, 2001, CANCER RES, V61, P1659; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lui YNYN, 2002, CLIN CHEM, V48, P421; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Mandel P., 1948, CR SOC BIOL, V142, P241; Morris JK, 2009, BMJ, V339; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peters DL, 2011, CLIN CHIM ACTA, V412, P806, DOI 10.1016/j.cca.2011.01.026; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Smit A, 1996, REPEATMASKER OPEN 30; Stroun M, 2005, CELL MOL BIOL, V51, P767, DOI 10.1170/T685; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Suzuki N, 2008, CLIN CHIM ACTA, V387, P55, DOI 10.1016/j.cca.2007.09.001; Szerlong HJ, 2011, BIOCHEM CELL BIOL, V89, P24, DOI 10.1139/O10-139; van der Vaart M, 2007, CLIN CHEM, V53, P2215, DOI 10.1373/clinchem.2007.092734; Wataganara T, 2005, AM J OBSTET GYNECOL, V193, P496, DOI 10.1016/j.ajog.2004.12.015; Wellesley D, 2012, EUROPEAN J HUMAN GEN; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993; [No title captured]	47	18	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86993	10.1371/journal.pone.0086993	http://dx.doi.org/10.1371/journal.pone.0086993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489824	Green Published, gold			2022-12-25	WOS:000330570000089
J	Huang, CC; Chung, CM; Leu, HB; Lin, LY; Chiu, CC; Hsu, CY; Chiang, CH; Huang, PH; Chen, TJ; Lin, SJ; Chen, JW; Chan, WL				Huang, Chin-Chou; Chung, Chia-Min; Leu, Hsin-Bang; Lin, Liang-Yu; Chiu, Chun-Chih; Hsu, Chien-Yi; Chiang, Chia-Hung; Huang, Po-Hsun; Chen, Tzeng-Ji; Lin, Shing-Jong; Chen, Jaw-Wen; Chan, Wan-Leong			Diabetes Mellitus and the Risk of Alzheimer's Disease: A Nationwide Population-Based Study	PLOS ONE			English	Article							DEMENTIA; INSULIN; STATE	Objectives: Possible association between diabetes mellitus (DM) and Alzheimer's disease (AD) has been controversial. This study used a nationwide population-based dataset to investigate the relationship between DM and subsequent AD incidence. Methods: Data were collected from Taiwan's National Health Insurance Research Database, which released a cohort dataset of 1,000,000 randomly sampled people and confirmed it to be representative of the Taiwanese population. We identified 71,433 patients newly diagnosed with diabetes (age 58.74 +/- 14.02 years) since January 1997. Using propensity score, we matched them with 71,311 non-diabetic subjects by time of enrollment, age, gender, hypertension, hyperlipidemia, and previous stroke history. All the patients were followed up to December 31, 2007. The endpoint of the study was occurrence of AD. Results: Over a maximum 11 years of follow-up, diabetic patients experienced a higher incidence of AD than non-diabetic subjects (0.48% vs. 0.37%, p<0.001). After Cox proportional hazard regression model analysis, DM (hazard ratio [HR], 1.76; 95% confidence interval [CI], 1.50-2.07, p<0.001), age (HR, 1.11; 95% CI, 1.10-1.12, p<0.001), female gender (HR, 1.24; 95% CI, 1.06-1.46, p=0.008), hypertension (HR, 1.30; 95% CI, 1.07-1.59, p=0.01), previous stroke history (HR, 1.79; 95% CI, 1.28-2.50, p<0.001), and urbanization status (metropolis, HR, 1.32; 95% CI, 1.07-1.63, p=0.009) were independently associated with the increased risk of AD. Neither monotherapy nor combination therapy with oral antidiabetic medications were associated with the risk of AD after adjusting for underlying risk factors and the duration of DM since diagnosis. However, combination therapy with insulin was found to be associated with greater risk of AD (HR, 2.17; 95% CI, 1.04-4.52, p=0.039). Conclusion: Newly diagnosed DM was associated with increased risk of AD. Use of hypoglycemic agents did not ameliorate the risk.	[Huang, Chin-Chou; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Chin-Chou; Leu, Hsin-Bang; Chiu, Chun-Chih; Hsu, Chien-Yi; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Chan, Wan-Leong] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Leu, Hsin-Bang; Chan, Wan-Leong] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Lin, Liang-Yu] Taipei Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Huang, Chin-Chou; Leu, Hsin-Bang; Chiu, Chun-Chih; Hsu, Chien-Yi; Chiang, Chia-Hung; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Lin, Liang-Yu; Chiu, Chun-Chih; Hsu, Chien-Yi; Chiang, Chia-Hung; Huang, Po-Hsun; Chan, Wan-Leong] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Huang, Chin-Chou; Lin, Liang-Yu; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Leu, Hsin-Bang; Chiang, Chia-Hung; Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chiang, Chia-Hung] Zhudong Vet Hosp, Dept Med, Div Cardiol, Hsinchu, Taiwan; [Chung, Chia-Min] China Med Univ Hosp, Environm Omics Dis Res Ctr, Taichung, Taiwan; [Chung, Chia-Min] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, JW (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	jwchen@vghtpe.gov.tw; DRWLChan2012@gmail.com	Chen, TJ/AAH-8430-2021; Lin, Liang-Yu/R-8480-2017	Lin, Liang-Yu/0000-0003-0334-790X; Hsu, Chien-Yi/0000-0002-9493-7325	Taipei Veterans General Hospital, Taipei, Taiwan [V99B1-011, V99C1-125, V100B-004, V100B-013, V102B-024]; Yen Tjing Ling Medical Foundation, Taipei, Taiwan [CI-97-13, CI-98-16]; National Science Council [NSC 100-2314-B-075-055, NSC 102-2314-B-075-022-MY3]; UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-99-2911-I-009-101-A2]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yen Tjing Ling Medical Foundation, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council	The present study was partly supported by research grants V99B1-011, V99C1-125, V100B-004, V100B-013, and V102B-024 from Taipei Veterans General Hospital, Taipei, Taiwan; CI-97-13 and CI-98-16 from the Yen Tjing Ling Medical Foundation, Taipei, Taiwan; NSC 100-2314-B-075-055, NSC 102-2314-B-075-022-MY3, and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101-A2 from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BACHMAN DL, 1992, NEUROLOGY, V42, P115, DOI 10.1212/WNL.42.1.115; Banks WA, 1997, PEPTIDES, V18, P1257, DOI 10.1016/S0196-9781(97)00198-8; Beeri MS, 2008, NEUROLOGY, V71, P750, DOI 10.1212/01.wnl.0000324925.95210.6d; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; *BUR NAT HLTH INS, 2002, NAT HLTH INS ANN STA; Chen HF, 2008, DIABETES CARE, V31, P75, DOI 10.2337/dc07-1072; Chiang CW, 2007, PHARMACOEPIDEM DR S, V16, P412, DOI 10.1002/pds.1322; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Euser SM, 2010, DIABETES, V59, P1601, DOI 10.2337/db09-0568; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Guideline Subcommittee of the Taiwan Dementia Society, 2011, Acta Neurol Taiwan, V20, P85; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Hsu CY, 2013, CIRC J, V77, P405, DOI 10.1253/circj.CJ-12-0658; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; MacKnight C, 2002, DEMENT GERIATR COGN, V14, P77, DOI 10.1159/000064928; Maiorini AF, 2002, J CLIN PHARM THER, V27, P169, DOI 10.1046/j.1365-2710.2002.00415.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Roberts JS, 2010, FUTUR NEUROL, V5, P501, DOI 10.2217/FNL.10.31; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Sohn MW, 2009, DIABETES CARE, V32, P816, DOI 10.2337/dc08-1695; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; WHO Collaborating Center for Drugs Statistics Methodology, 2003, ATC IND DDDS 2003; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Wu JH, 2003, ANN EPIDEMIOL, V13, P369, DOI 10.1016/S1047-2797(02)00464-7; Xu WL, 2004, NEUROLOGY, V63, P1181, DOI 10.1212/01.WNL.0000140291.86406.D1; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	37	154	156	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87095	10.1371/journal.pone.0087095	http://dx.doi.org/10.1371/journal.pone.0087095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489845	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000101
J	Jiang, YZ; Xia, C; Peng, WT; Yu, KD; Zhuang, ZG; Shao, ZM				Jiang, Yi-Zhou; Xia, Chen; Peng, Wen-Ting; Yu, Ke-Da; Zhuang, Zhi-Gang; Shao, Zhi-Ming			Preoperative Measurement of Breast Cancer Overestimates Tumor Size Compared to Pathological Measurement	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM; MASTECTOMY; CARCINOMA; SURVIVORS; SUBTYPES; THERAPY; RISK	Background: Tumor size is one of the most important factors in making clinical and pathological assessment of breast cancer. In the present study, we aimed to determine whether the preoperative measurement of tumor size, by imaging modalities, deviate from the postoperative pathological measurement in breast cancer. Patients and Methods: 1296 patients diagnosed with invasive ductal breast carcinoma (IDC) during 2007 and 2009 were involved. Pre- and postoperative measurements of tumor size were compared using paired t-test and Chi-square test. Results: The mean maximum diameters of tumors by imaging modalities and pathology were 27.9 mm and 22.4 mm, respectively. There was a statistically significant difference of 5.5 mm (95% CI: 4.7-6.2, p < 0.001) between them. The discordance between pre- and post-surgical measurements of tumor size had significant effect on choosing surgery type, causing less application of breast conserving therapy (p < 0.0001). Conclusion: Compared to pathological size, preoperative measurement by imaging modalities tends to overestimate tumor size. These differences could have implications in the treatment of patients with breast cancer.	[Jiang, Yi-Zhou; Peng, Wen-Ting; Yu, Ke-Da; Zhuang, Zhi-Gang; Shao, Zhi-Ming] Fudan Univ, Ctr Canc, Shanghai Med Coll, Dept Breast Surg, Shanghai 200433, Peoples R China; [Jiang, Yi-Zhou; Peng, Wen-Ting; Yu, Ke-Da; Zhuang, Zhi-Gang; Shao, Zhi-Ming] Fudan Univ, Inst Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xia, Chen; Zhuang, Zhi-Gang] Tongji Univ, Dept Breast Surg, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Tongji University	Zhuang, ZG (corresponding author), Fudan Univ, Ctr Canc, Shanghai Med Coll, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhigangzhuangFMIH@gmail.com; zhiminqshao@yahoo.com			National Natural Science Foundation of China [81001169]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Shanghai Key Laboratory of Breast Cancer [12DZ2260100]; Zhuo-Xue Project of Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai United Developing Technology Project of Municipal Hospitals; Shanghai Key Laboratory of Breast Cancer; Zhuo-Xue Project of Fudan University	This research was supported by grants from the National Natural Science Foundation of China (81001169), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Shanghai Key Laboratory of Breast Cancer (12DZ2260100), and the Zhuo-Xue Project of Fudan University (For Y.K.D.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2008, J CANCER RES CLIN, V134, P1311, DOI 10.1007/s00432-008-0418-y; Blair S, 2006, J SURG ONCOL, V94, P220, DOI 10.1002/jso.20561; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Downes KJ, 2005, CANCER-AM CANCER SOC, V103, P906, DOI 10.1002/cncr.20851; Egner JR, 2010, JAMA-J AM MED ASSOC, V304, P1726, DOI DOI 10.1001/JAMA.2010.1525; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Grimsby GM, 2009, AM J SURG, V198, P500, DOI 10.1016/j.amjsurg.2009.07.012; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Lampen-Sachar K, 2012, LUNG CANCER, V75, P332, DOI 10.1016/j.lungcan.2011.08.001; Ohsumi S, 2009, JPN J CLIN ONCOL, V39, P491, DOI 10.1093/jjco/hyp060; Onesti JK, 2008, AM J SURG, V196, P844, DOI 10.1016/j.amjsurg.2008.07.028; Sahdev A, 2007, INT J GYNECOL CANCER, V17, P629, DOI 10.1111/j.1525-1438.2007.00829.x; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284	13	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86676	10.1371/journal.pone.0086676	http://dx.doi.org/10.1371/journal.pone.0086676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489766	Green Submitted, gold, Green Published			2022-12-25	WOS:000330570000058
J	Li, LG; Li, DQ; You, HL; Dodson, P				Li, Li-Guo; Li, Da-Qing; You, Hai-Lu; Dodson, Peter			A New Titanosaurian Sauropod from the Hekou Group (Lower Cretaceous) of the Lanzhou-Minhe Basin, Gansu Province, China	PLOS ONE			English	Article							MORRISON FORMATION; DINOSAURIA; OSTEOLOGY; REDESCRIPTION; REEVALUATION; PATAGONIA; GENUS	Increased excavation of dinosaurs from China over the last two decades has enriched the record of Asian titanosauriform sauropods. However, the relationships of these sauropods remain contentious, and hinges on a few well-preserved taxa, such as Euhelopus zdanskyi. Here we describe a new sauropod, Yongjinglong datangi gen. nov. et sp. nov., from the Lower Cretaceous Hekou Group in the Lanzhou Basin of Gansu Province, northwestern China. Yongjinglong datangi is characterized by the following unique combination of characters, including seven autapomorphies: long-crowned, spoon-shaped premaxillary tooth; axially elongate parapophyses on the cervical vertebra; very deep lateral pneumatic foramina on the lateral surfaces of the cervical and cranial dorsal vertebral centra; low, unbifurcated neural spine fused with the postzygapophyses to form a cranially-pointing, triangular plate in a middle dorsal vertebra; an "XI"-shaped configuration of the laminae on the arches of the middle dorsal vertebrae; a very long scapular blade with straight cranial and caudal edges; and a tall, deep groove on the lateral surface of the distal shaft of the radius. The new specimen shares several features with other sauropods: a pronounced M. triceps longus tubercle on the scapula and ventrolaterally elongated parapophyses in its cervical vertebra as in Euhelopodidae. Based on phylogenetic analyses Yongjinglong datangi is highly derived within Titanosauria, which suggests either a remarkable convergence with more basal titanosauriform sauropods in the Early Cretaceous or a retention of plesiomorphic features that were lost in other titanosaurians. The morphology and remarkable length of the scapulocoracoid reveal an unusual relationship between the shoulder and the middle trunk: the scapulocoracoid spans over half of the length of the trunk. The medial, notch-shaped coracoid foramen and the partially fused scapulocoracoid synostosis suggest that the specimen is a subadult individual. This specimen sheds new light on the diversity of Early Cretaceous Titanosauriformes in China.	[Li, Li-Guo] China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China; [Li, Li-Guo; Dodson, Peter] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Li, Da-Qing] Gansu Geol Museum, Lanzhou, Peoples R China; [You, Hai-Lu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China	China University of Geosciences; University of Pennsylvania; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Li, LG (corresponding author), China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China.	dinoliguo@gmail.com		You, Hai-Lu/0000-0003-2203-6461	National Natural Science Foundation of China; Hundred Talents Project of the Chinese Academy of Sciences; Gansu Bureau of Geology and Mineral Resources; NSF EAR [1024671]; Division Of Earth Sciences [1024671] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); Gansu Bureau of Geology and Mineral Resources; NSF EAR(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the National Natural Science Foundation of China and the Hundred Talents Project of the Chinese Academy of Sciences to YHL, and by the Gansu Bureau of Geology and Mineral Resources to Li DQ. The authors acknowledge the support of NSF EAR 1024671 to PD (YHL and LDQ co-PIs) for research in the Early Cretaceous of Gansu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco JL, 2005, PALEONTOLOGIA NATURA, V15, P1; Barrett Paul M., 2007, Palaeoworld, V16, P265, DOI 10.1016/j.palwor.2007.07.001; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Curtice Brian D., 1996, Museum of Northern Arizona Bulletin, V60, P87; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2012, J VERTEBR PALEONTOL, V32, P883, DOI 10.1080/02724634.2012.671204; Dong ZM, 1997, GIGANTIC SAUROPOD HU, P102; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Gilmore C. W., 1925, Memoirs of the Carnegie Museum, V10, P347; Gilmore CW., 1946, US DEP INTERGEOL SUR, V210-C, P29, DOI DOI 10.3133/PP210C; Goloboff P., 2013, TNT TREE ANAL USING; Hallett M, 1987, DINOSAURS PRESENT, V1, P97; Harris JD, 2006, PALAEONTOLOGY, V49, P1091, DOI 10.1111/j.1475-4983.2006.00577.x; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; He XL, 1988, MIDDLE JURASSIC DINO, VIV, P143; He XL, 1984, VERTEBRATE FOSSILS S, P168; Hirasawa T, 2013, J ANAT, P1, DOI [10.1111/joa.12037, DOI 10.1111/J0A.12037]; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; JENSEN JA, 1985, GREAT BASIN NAT, V45, P697; Ksepka DT, 2010, AM MUS NOVIT, P1, DOI 10.1206/3700.2; Lovelace David M., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P527; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; MARTIN V, 1994, CR ACAD SCI II, V319, P1085; McIntosh J.S., 1990, P345; McIntosh JS, 2005, LIFE O PAST, P38; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; Osborn H. F., 1921, MEMOIRS AM MUSEUM NA, V3, P249; Ouyang H, 2002, 1 MAMENCHISAURIAN SK, P111; Parrish J. M, 2002, J VERTEBR PALEONTO S, V22, p95A; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Romer A.S, 1956, OSTEOLOGY REPTILES; Romer AS, 1962, VERTEBRATE BODY, P592; Schwarz D, 2007, ANAT REC, V290, P32, DOI 10.1002/ar.20405; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; Wilhite R, 2003, THESIS LOUISIANA STA, P225; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 1998, SOC VERTEBRATE PALEO, V5, P168; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; Wilson Jeffrey A., 2012, Contributions from the Museum of Paleontology University of Michigan, V32, P1; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; You HL, 2009, P ROY SOC B-BIOL SCI, V276, P4077, DOI 10.1098/rspb.2009.1278; You Hailu, 2006, Geological Review (Beijing), V52, P668; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P424; You HL., 2008, GANSU GEOLOGY, V17, P1; Young C. C., 1939, Bulletin of the Geological Society of China, V19, P279; YOUNG C. C., 1935, BULL GEOL SOC CHINA, V14, P519; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1; Young C.-C., 1954, SCI SINICA, V3, P491; YOUNG CHUNG-CHIEN, 1958, VERTEBR PALASIAT [CHINA], V2, P1; Zhang Y, 1984, J CHENGDU COLL GEOLO, V2, P1; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; Zhang YH, 1988, MIDDLE JURASSIC DINO, VII, P89	62	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85979	10.1371/journal.pone.0085979	http://dx.doi.org/10.1371/journal.pone.0085979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489684	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000021
J	Maesani, A; Fernando, PR; Floreano, D				Maesani, Andrea; Fernando, Pradeep Ruben; Floreano, Dario			Artificial Evolution by Viability Rather than Competition	PLOS ONE			English	Article							COVARIANCE-MATRIX ADAPTATION; GENETIC ALGORITHM; MULTIOBJECTIVE OPTIMIZATION; DIVERSITY; POPULATIONS; DESIGN	Evolutionary algorithms are widespread heuristic methods inspired by natural evolution to solve difficult problems for which analytical approaches are not suitable. In many domains experimenters are not only interested in discovering optimal solutions, but also in finding the largest number of different solutions satisfying minimal requirements. However, the formulation of an effective performance measure describing these requirements, also known as fitness function, represents a major challenge. The difficulty of combining and weighting multiple problem objectives and constraints of possibly varying nature and scale into a single fitness function often leads to unsatisfactory solutions. Furthermore, selective reproduction of the fittest solutions, which is inspired by competition-based selection in nature, leads to loss of diversity within the evolving population and premature convergence of the algorithm, hindering the discovery of many different solutions. Here we present an alternative abstraction of artificial evolution, which does not require the formulation of a composite fitness function. Inspired from viability theory in dynamical systems, natural evolution and ethology, the proposed method puts emphasis on the elimination of individuals that do not meet a set of changing criteria, which are defined on the problem objectives and constraints. Experimental results show that the proposed method maintains higher diversity in the evolving population and generates more unique solutions when compared to classical competition-based evolutionary algorithms. Our findings suggest that incorporating viability principles into evolutionary algorithms can significantly improve the applicability and effectiveness of evolutionary methods to numerous complex problems of science and engineering, ranging from protein structure prediction to aircraft wing design.	[Maesani, Andrea; Fernando, Pradeep Ruben; Floreano, Dario] Ecole Polytech Fed Lausanne, LIS, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Floreano, D (corresponding author), Ecole Polytech Fed Lausanne, LIS, Lausanne, Switzerland.	dario.floreano@epfl.ch			Swiss National Science Foundation [200021_127143]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research has been supported by the Swiss National Science Foundation, grant number 200021_127143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2006, NAT REV GENET, V7, P109, DOI 10.1038/nrg1771; Adra SF, 2011, IEEE T EVOLUT COMPUT, V15, P183, DOI 10.1109/TEVC.2010.2058117; Arnold DV, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P297, DOI 10.1145/2330163.2330207; Ashby W. R., 1956, INTRO CYBERNETICS; Ashby W. R., 1960, DESIGN BRAIN; ATMAR W, 1994, IEEE T NEURAL NETWOR, V5, P130, DOI 10.1109/72.265967; Aubin J. P., 1991, VIABILITY THEORY; Back T., 1996, EVOLUTIONARY ALGORIT; Baum EB, 2001, EVOL COMPUT, V9, P93, DOI 10.1162/10636560151075130; Beer RD, 1997, ROBOT AUTON SYST, V20, P257, DOI 10.1016/S0921-8890(96)00063-2; Bongard J, 2011, P NATL ACAD SCI USA, V108, P1234, DOI 10.1073/pnas.1015390108; Cannon W.B., 1932, WISDOM BODY; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Coello CAC, 2002, COMPUT METHOD APPL M, V191, P1245, DOI 10.1016/S0045-7825(01)00323-1; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Darwin C., 1859, ORIGIN SPECIES MEANS; DEB K, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P42; Deb K, 2002, IEEE C EVOL COMPUTAT, P825, DOI 10.1109/CEC.2002.1007032; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Degiacomi MT, 2013, STRUCTURE, V21, P1097, DOI 10.1016/j.str.2013.05.014; Eiben A. E., 1997, HDB EVOLUTIONARY COM; Eiben AE, 2002, INFORM PROCESS LETT, V82, P1, DOI 10.1016/S0020-0190(02)00204-1; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Eiben AE, 1997, EVOL COMPUT, V5, P347, DOI 10.1162/evco.1997.5.3.347; Floreano D., 2008, BIOINSPIRED ARTIFICI; Fogel D. B., 1995, EVOLUTIONARY COMPUTA; FOGEL DB, 1994, IEEE T NEURAL NETWOR, V5, P3, DOI 10.1109/72.265956; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; GEIGER RL, 1985, IEEE CIRCUITS DEVICE, V1, P20, DOI 10.1109/MCD.1985.6311946; Goldberg D.E., 1987, P 2 INT C GEN ALG GE; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Gomes J, 2012, LECT NOTES ARTIF INT, V7637, P281, DOI 10.1007/978-3-642-34654-5_29; Hansen N, 2003, EVOL COMPUT, V11, P1, DOI 10.1162/106365603321828970; Igel C, 2007, EVOL COMPUT, V15, P1, DOI 10.1162/evco.2007.15.1.1; Jin Y, 2005, IEEE T EVOLUT COMPUT, V9, P303, DOI 10.1109/TEVC.2005.846356; Juric M., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P619, DOI 10.1109/ICEC.1994.349988; Kallel L, 2001, NAT COMPUT SER, P175; Konak A, 2006, RELIAB ENG SYST SAFE, V91, P992, DOI 10.1016/j.ress.2005.11.018; KUMAR V, 1992, AI MAG, V13, P32; Lassig J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046702; Lassig J, 2008, P 2008 GECCO C COMP, P2181, DOI [10.1145/1388969.1389044, DOI 10.1145/1388969.1389044]; Lehman J., 2011, P GEN EV COMP C GECC; Lehman J, 2010, P GEN EV COMP C GECC; LEHMAN J, 2008, ARTIF LIFE, V11, P329; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Li JP, 2002, EVOL COMPUT, V10, P207, DOI 10.1162/106365602760234081; Marin J, 1999, IEEE T EVOLUT COMPUT, V3, P272, DOI 10.1109/4235.797970; Mattiussi C, 2004, EVOL COMPUT, V12, P495, DOI 10.1162/1063656043138923; Mattiussi C, 2003, TECHNICAL REPORT; Mc Ginley B, 2011, IEEE T EVOLUT COMPUT, V15, P692, DOI 10.1109/TEVC.2010.2046173; Mezura-Montes E, 2011, SWARM EVOL COMPUT, V1, P173, DOI 10.1016/j.swevo.2011.10.001; Muhlenbein H, 1993, EVOL COMPUT, V1, P335, DOI 10.1162/evco.1993.1.4.335; Ofria C, 2004, ARTIF LIFE, V10, P191, DOI 10.1162/106454604773563612; Park T, 2010, IEEE T EVOLUT COMPUT, V14, P865, DOI 10.1109/TEVC.2010.2043362; Petrowski A, 1996, P 1996 IEEE INT C EV; Ray TS, 1991, SCI EXCELLENCE SUPER, P489; Ronikkonen J, 2008, LECT NOTES COMPUT SC, V5361, P239; Shir OF, 2006, LECT NOTES COMPUT SC, V4193, P142; Singh G, 2006, GECCO 2006: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1305; Storn R, 1999, IEEE T EVOLUT COMPUT, V3, P22, DOI 10.1109/4235.752918; Toffolo A, 2003, EVOL COMPUT, V11, P151, DOI 10.1162/106365603766646816; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P116; Wineberg M, 2003, LECT NOTES COMPUT SC, V2724, P1493; Wischmann S, 2012, P NATL ACAD SCI USA, V109, P864, DOI 10.1073/pnas.1104267109; Woldesenbet YG, 2009, IEEE T EVOLUT COMPUT, V13, P514, DOI 10.1109/TEVC.2008.2009032	67	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86831	10.1371/journal.pone.0086831	http://dx.doi.org/10.1371/journal.pone.0086831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489790	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000072
J	Mensen, A; Poryazova, R; Schwartz, S; Khatami, R				Mensen, Armand; Poryazova, Rositsa; Schwartz, Sophie; Khatami, Ramin			Humor as a Reward Mechanism: Event-Related Potentials in the Healthy and Diseased Brain	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; FACIAL EMOTION RECOGNITION; PARKINSONS-DISEASE; DOPAMINERGIC MODULATION; COGNITIVE FUNCTION; HUMAN NARCOLEPSY; DECISION-MAKING; FUNCTIONAL MRI; AMYGDALA; CATAPLEXY	Humor processing involves distinct processing stages including incongruity detection, emotional response, and engagement of mesolimbic reward regions. Dysfunctional reward processing and clinical symptoms in response to humor have been previously described in both hypocretin deficient narcolepsy-cataplexy (NC) and in idiopathic Parkinson disease (PD). For NC patients, humor is the strongest trigger for cataplexy, a transient loss of muscle tone, whereas dopamine-deficient PD-patients show blunted emotional responses to humor. To better understand the role of reward system and the various contributions of hypocretinergic and dopaminergic mechanisms to different stages of humor processing we examined the electrophysiological response to humorous and neutral pictures when given as reward feedback in PD, NC and healthy controls. Humor compared to neutral feedback demonstrated modulation of early ERP amplitudes likely corresponding to visual processing stages, with no group differences. At 270 ms post-feedback, conditions showed topographical and amplitudinal differences for frontal and left posterior electrodes, in that humor feedback was absent in PD patients but increased in NC patients. We suggest that this effect relates to a relatively early affective response, reminiscent of increased amygdala response reported in NC patients. Later ERP differences, corresponding to the late positive potential, revealed a lack of sustained activation in PD, likely due to altered dopamine regulation in reward structures in these patients. This research provides new insights into the temporal dynamics and underlying mechanisms of humor detection and appreciation in health and disease.	[Mensen, Armand; Khatami, Ramin] Clin Barmelweid, Dept Sleep Med, Barmelweid, Switzerland; [Poryazova, Rositsa] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland	University of Zurich; University Zurich Hospital; University of Geneva	Khatami, R (corresponding author), Clin Barmelweid, Dept Sleep Med, Barmelweid, Switzerland.	Ramin.Khatami@Barmelweid.ch		Schwartz, Sophie/0000-0001-7718-4053	Swiss National Science Foundation [32003B-124763]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by Swiss National Science Foundation Grant-No: 32003B-124763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Bassetti C, 1997, SLEEP, V20, P630, DOI 10.1093/sleep/20.8.630; Bekinschtein TA, 2011, J NEUROSCI, V31, P9665, DOI 10.1523/JNEUROSCI.5058-10.2011; Benke T, 1998, BRAIN COGNITION, V38, P36, DOI 10.1006/brcg.1998.1013; Calipari ES, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00054; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Coulson S, 2005, J COGNITIVE NEUROSCI, V17, P494, DOI 10.1162/0898929053279568; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; de la Fuente-Fernandez R, 2004, BIOL PSYCHIAT, V56, P67, DOI 10.1016/j.biopsych.2003.11.019; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; Euteneuer F, 2009, NEUROPSYCHOLOGIA, V47, P2882, DOI 10.1016/j.neuropsychologia.2009.06.014; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; GOTHAM AM, 1986, LANCET, V2, P970; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kobayakawa M, 2008, MOVEMENT DISORD, V23, P547, DOI 10.1002/mds.21865; Korb S, 2012, SOC NEUROSCI-UK, V7, P510, DOI 10.1080/17470919.2012.667573; Korotkova TM, 2003, J NEUROSCI, V23, P7; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Marinkovic K, 2011, COGN AFFECT BEHAV NE, V11, P113, DOI 10.3758/s13415-010-0017-7; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mensen A, 2013, NEUROIMAGE, V67, P111, DOI 10.1016/j.neuroimage.2012.10.027; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Nakashima T, 2008, NEUROSCI RES, V62, P225, DOI 10.1016/j.neures.2008.08.009; Overeem S, 2004, J SLEEP RES, V13, P257, DOI 10.1111/j.1365-2869.2004.00411.x; Overeem S, 2004, PSYCHOPHYSIOLOGY, V41, P254, DOI 10.1111/j.1469-8986.2003.00145.x; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Ponz A, 2010, ANN NEUROL, V67, P394, DOI 10.1002/ana.21881; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Raggi A, 2011, NEUROSCI BIOBEHAV R, V35, P1144, DOI 10.1016/j.neubiorev.2010.12.001; Ramachandran VS, 1998, MED HYPOTHESES, V51, P351, DOI 10.1016/S0306-9877(98)90061-5; Sabatinelli D, 2013, BIOL PSYCHOL, V92, P513, DOI 10.1016/j.biopsycho.2012.04.005; Saletu M, 2008, CLIN NEUROPHYSIOL, V119, P1782, DOI 10.1016/j.clinph.2008.04.297; Samson AC, 2008, SOC NEUROSCI-UK, V3, P125, DOI 10.1080/17470910701745858; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Schwartz S, 2008, BRAIN, V131, P514, DOI 10.1093/brain/awm292; Sinha N, 2013, J NEUROPSYCHOL, V7, P255, DOI 10.1111/jnp.12013; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tobimatsu Shozo, 2012, Brain and Nerve (Tokyo), V64, P717; Tucci V, 2003, SLEEP, V26, P558, DOI 10.1093/sleep/26.5.558; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; van Wouwe NC, 2012, NEUROPSYCHOLOGIA, V50, P583, DOI 10.1016/j.neuropsychologia.2011.12.012; Watson KK, 2007, CEREB CORTEX, V17, P314, DOI 10.1093/cercor/bhj149; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Yoshimura N, 2005, NEUROSCIENCE, V131, P523, DOI 10.1016/j.neuroscience.2004.09.054; Young JW, 2010, BIOL PSYCHIAT, V67, P784, DOI 10.1016/j.biopsych.2009.12.015; Zinbarg RE, 2010, J ABNORM PSYCHOL, V119, P307, DOI 10.1037/a0017552	65	18	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85978	10.1371/journal.pone.0085978	http://dx.doi.org/10.1371/journal.pone.0085978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489683	Green Accepted, gold, Green Published			2022-12-25	WOS:000330570000020
J	Tsuruta, JK; Klauber-DeMore, N; Streeter, J; Samples, J; Patterson, C; Mumper, RJ; Ketelsen, D; Dayton, P				Tsuruta, James K.; Klauber-DeMore, Nancy; Streeter, Jason; Samples, Jennifer; Patterson, Cam; Mumper, Russell J.; Ketelsen, David; Dayton, Paul			Ultrasound Molecular Imaging of Secreted Frizzled Related Protein-2 Expression in Murine Angiosarcoma	PLOS ONE			English	Article							BREAST-CANCER; TUMOR; ANGIOGENESIS; SFRP2; CELLS; HYPERMETHYLATION; APOPTOSIS; GROWTH; GENES	Angiosarcoma is a biologically aggressive vascular malignancy with a high metastatic potential. In the era of targeted medicine, knowledge of specific molecular tumor characteristics has become more important. Molecular imaging using targeted ultrasound contrast agents can monitor tumor progression non-invasively. Secreted frizzled related protein 2 (SFRP2) is a tumor endothelial marker expressed in angiosarcoma. We hypothesize that SFRP2-directed imaging could be a novel approach to imaging the tumor vasculature. To develop an SFRP2 contrast agent, SFRP2 polyclonal antibody was biotinylated and incubated with streptavidin-coated microbubbles. SVR angiosarcoma cells were injected into nude mice, and when tumors were established the mice were injected intravenously with the SFRP2 -targeted contrast agent, or a control streptavidin-coated contrast agent. SFRP2 -targeted contrast agent detected tumor vasculature with significantly more signal intensity than control contrast agent: the normalized fold-change was 1.6+/-0.27 (n = 13, p = 0.0032). The kidney was largely devoid of echogenicity with no significant difference between the control contrast agent and the SFRP2-targeted contrast agent demonstrating that the SFRP2-targeted contrast agent was specific to tumor vessels. Plotting average pixel intensity obtained from SFRP2-targeted contrast agent against tumor volume showed that the average pixel intensity increased as tumor volume increased. In conclusion, molecularly-targeted imaging of SFRP2 visualizes angiosarcoma vessels, but not normal vessels, and intensity increases with tumor size. Molecular imaging of SFRP2 expression may provide a rapid, non-invasive method to monitor tumor regression during therapy for angiosarcoma and other SFRP2 expressing cancers, and contribute to our understanding of the biology of SFRP2 during tumor development and progression.	[Tsuruta, James K.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Klauber-DeMore, Nancy; Samples, Jennifer; Ketelsen, David] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Klauber-DeMore, Nancy; Patterson, Cam] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC USA; [Tsuruta, James K.; Streeter, Jason; Mumper, Russell J.; Dayton, Paul] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA; [Tsuruta, James K.; Streeter, Jason; Mumper, Russell J.; Dayton, Paul] N Carolina State Univ, Raleigh, NC 27695 USA; [Mumper, Russell J.; Dayton, Paul] UNC Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Klauber-DeMore, N (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA.	nancy_demore@med.unc.edu	Streeter, Jason/ABA-4809-2020; , Animal Studies Core/AAF-4432-2022; , Animal Studies Core/ADK-4234-2022		National Institute of Health [1R01CA142657-01A1, R01 HL61656, R01 EB009066]; University Cancer Research Fund; Nancy DeMore Research Foundation; NATIONAL CANCER INSTITUTE [R01CA142657] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009066] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; Nancy DeMore Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institute of Health 1R01CA142657-01A1 to NK-D, R01 HL61656 to CP, and R01 EB009066 to PD; University Cancer Research Fund to CP, Nancy DeMore Research Foundation to NK-D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2009, CURR MOL MED, V9, P929, DOI 10.2174/156652409789712828; Banerjee P, 2013, CANCER LETT, V338, P292, DOI 10.1016/j.canlet.2013.05.036; Bensch F, 2013, EUR J PHARMACOL, V717, P2, DOI 10.1016/j.ejphar.2013.01.079; Bhati R, 2008, AM J PATHOL, V172, P1381, DOI 10.2353/ajpath.2008.070988; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Deshpande N, 2010, ANGIOGENESIS, V13, P175, DOI 10.1007/s10456-010-9175-z; Espat N J, 2000, Sarcoma, V4, P173, DOI 10.1080/13577140020025896; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; Fontenot E, 2013, MOL CANCER THER, V12, P685, DOI 10.1158/1535-7163.MCT-12-1066; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Gehmert S, 2008, BIOCHEM BIOPH RES CO, V371, P752, DOI 10.1016/j.bbrc.2008.04.151; Gessner R, 2010, MOL IMAGING, V9, P117, DOI 10.2310/7290.2010.00022; Kinoshita T, 2011, HEPATO-GASTROENTEROL, V58, P1051; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Martin KH, 2013, WIRES NANOMED NANOBI, V5, P329, DOI 10.1002/wnan.1219; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Munson J, 2013, CELL CYCLE, V12, P2200, DOI 10.4161/cc.25334; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Siamakpour-Reihani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020412; Streeter JE, 2011, MOL IMAGING, V10, P460, DOI 10.2310/7290.2011.00015; Streeter JE, 2010, MOL IMAGING, V9, P87, DOI 10.2310/7290.2010.00005; Tanaka J, 2008, HEPATO-GASTROENTEROL, V55, P1265; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Yamamura S, 2010, MOL CANCER THER, V9, P1680, DOI 10.1158/1535-7163.MCT-10-0012	28	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86642	10.1371/journal.pone.0086642	http://dx.doi.org/10.1371/journal.pone.0086642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489757	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000053
J	Zhang, Y; Hu, LQ; Cui, Y; Qi, ZG; Huang, XP; Cai, LY; Zhang, T; Yin, YX; Lu, ZY; Xiang, JY				Zhang, Yan; Hu, Lingqing; Cui, Yan; Qi, Zhigang; Huang, Xiaoping; Cai, Liyi; Zhang, Ting; Yin, Yongxiang; Lu, Zhiyi; Xiang, Jingying			Roles of PPAR gamma/NF-kappa B Signaling Pathway in the Pathogenesis of Intrahepatic Cholestasis of Pregnancy	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; HUMAN GESTATIONAL TISSUES; PROINFLAMMATORY CYTOKINES; LIPID-METABOLISM; BILE-ACIDS; INFLAMMATION; ALPHA; INTERLEUKIN-6; INHIBITION; EXPRESSION	Background: Intrahepatic cholestasis of pregnancy (ICP) is the most prevalent pregnancy specific liver disease. However, the pathogenesis and etiology of ICP is poorly understood. Aim: To assess the expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) and nuclear factor kappa B (NF-kappa B) in placenta and HTR-8/SVneo cell, and evaluate the serum levels of cytokines, bile acids, hepatic function and lipids in control and ICP patients and the fetal outcome, in order to explore the role of PPAR gamma/NF-kappa B signaling pathway in the possible mechanism of ICP. Methods: Clinical data of the pregnant women were collected and serum levels of cytokines, bile acids, hepatic function and lipids were measured. Expressions of PPAR gamma and NF-kappa B in placenta and HTR-8/SVneo cell were determined. The newborn information was collected to demonstrate the relationship between PPAR gamma/NF-kappa B signaling pathway and ICP. Results: The serum levels of bile acids, hepatic function, triglycerides (TG), total cholesterol (TC), IL-6, IL-12 and TNF-alpha in ICP group were significantly increased (P < 0.01), and serum level of IL-4 was significantly decreased (P, 0.01). PPAR gamma and NF-kappa B staining were found in the membrane and cytoplasm of placental trophoblast cell. The expression of PPAR gamma and NF-kappa B were significantly higher in ICP group and taurocholate acid (TCA) treated HTR-8/SVneo cell (P<0.01). The new-born information in severe ICP group were significantly different as compared to that in control group (P<0.05), and part of information in mild ICP group were also difference to that in control group (P<0.05). Conclusions: The higher expressions of PPAR gamma and NF-kappa B in ICP placenta and TCA treated HTR-8/SVneo cell, together with the abnormal serum levels of cytokines, might induced by the imbalance of inflammatory and immune reaction, and then disturb placental bile acid and serum lipids transportation, finally result in fatal cholestasis which probably be one of the mechanism of ICP.	[Zhang, Yan; Hu, Lingqing; Huang, Xiaoping; Cai, Liyi; Zhang, Ting; Yin, Yongxiang; Xiang, Jingying] Nanjing Med Univ, Affiliated Hosp, Wuxi Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Wuxi, Jiangsu, Peoples R China; [Zhang, Yan; Cui, Yan] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Qi, Zhigang] Wuxi Peoples Hosp, Dept Pharmaceut, Wuxi, Jiangsu, Peoples R China; [Lu, Zhiyi] Wuxi Hosp Tradit Chinese Med, Dept Obstet & Gynecol, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; Jiangnan University	Zhang, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp, Wuxi Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Wuxi, Jiangsu, Peoples R China.	2004zhangshanshi@163.com; wxxjy89@163.com	hu, ling/GWC-1104-2022		joint research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City [YGZX1204]	joint research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City	This work was supported by the joint research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City (No. YGZX1204). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hayyeh S, 2013, HEPATOLOGY, V57, P716, DOI 10.1002/hep.26055; Ai Ying, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P322; Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Borel V., 2008, PPAR RES, V2008, P1; Calleja-Agius J, 2012, HUM REPROD, V27, P349, DOI 10.1093/humrep/der402; Carpentier PA, 2011, AM J PATHOL, V178, P2802, DOI 10.1016/j.ajpath.2011.02.042; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chaouat G, 2004, IMMUNOL LETT, V92, P207, DOI 10.1016/j.imlet.2004.01.011; Chen JB, 2013, INT J GYNECOL OBSTET, V122, P5, DOI 10.1016/j.ijgo.2013.02.015; Dann AT, 2006, OBSTET GYNECOL, V107, P106, DOI 10.1097/01.AOG.0000189096.94874.9c; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Diken Z, 2013, AM J PERINATOL; Du Q, 2013, HEPATOL RES; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Fitzgerald K.A., 2001, CYTOKINE FACTSBOOK, P515; Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009; Fournier T, 2011, J REPROD IMMUNOL, V90, P41, DOI 10.1016/j.jri.2011.05.003; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Genolet Raphael, 2004, Current Drug Targets - Inflammation and Allergy, V3, P361, DOI 10.2174/1568010042634578; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Greig PC, 1997, OBSTET GYNECOL, V90, P465, DOI 10.1016/S0029-7844(97)00294-9; Hadfield KA, 2011, J REPROD IMMUNOL, V89, P1, DOI 10.1016/j.jri.2010.11.008; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Hu Y, 2010, AM J REPROD IMMUNOL, V63, P267, DOI 10.1111/j.1600-0897.2009.00798.x; Hutter S, 2013, PPAR RES, V2013, DOI 10.1155/2013/970276; Joshi D, 2010, LANCET, V375, P594, DOI 10.1016/S0140-6736(09)61495-1; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kenyon AP, 2011, OBSTETRICSCHOLESTASI; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; Lappas M, 2002, J CLIN ENDOCR METAB, V87, P4667, DOI 10.1210/jc.2002-020613; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Ling B, 2007, CELL MOL IMMUNOL, V4, P71; Liu Xing-hui, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P321; Liu ZJ, 2008, ZHONGHUA FU CHAN KE, V43, P292; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Mandard S, 2013, PPAR RES, V2013, DOI 10.1155/2013/613864; Marie C, 1996, MEDIAT INFLAMM, V5, P334, DOI 10.1155/S0962935196000488; Martinez N, 2008, REPRODUCTION, V136, P95, DOI 10.1530/REP-08-0028; McCracken SA, 2004, J IMMUNOL, V172, P4583, DOI 10.4049/jimmunol.172.7.4583; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Murthi P, 2013, PLACENTA, V34, P299, DOI 10.1016/j.placenta.2013.01.005; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Painter JN, 2005, EUR J HUM GENET, V13, P435, DOI 10.1038/sj.ejhg.5201355; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004; Reyes H, 2008, HEPATOLOGY, V47, P376, DOI 10.1002/hep.22139; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rieger L, 2002, MOL HUM REPROD, V8, P255, DOI 10.1093/molehr/8.3.255; Rook M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028343; Rusterholz C, 2007, SEMIN IMMUNOPATHOL, V29, P151, DOI 10.1007/s00281-007-0071-6; Savander M, 2003, GUT, V52, P1025, DOI 10.1136/gut.52.7.1025; Schaiff WT, 2006, MOL CELL ENDOCRINOL, V249, P10, DOI 10.1016/j.mce.2006.02.009; Shalom-Barak T, 2012, DEV BIOL, V372, P143, DOI 10.1016/j.ydbio.2012.08.021; Shemer EW, 2012, PLACENTA, V33, P914, DOI 10.1016/j.placenta.2012.08.005; Shi Q, 1998, ZHONGHUA FU CHAN KE, V33, P292; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416739; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Waite LL, 2000, J CLIN ENDOCR METAB, V85, P3808, DOI 10.1210/jc.85.10.3808; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; WEGMANN TG, 1992, DEV COMP IMMUNOL, V16, P425, DOI 10.1016/0145-305X(92)90026-9; Wei J, 2010, ARCH GYNECOL OBSTET, V281, P801, DOI 10.1007/s00404-009-1156-3; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065; Zeng C, 2011, MOLECULES, V16, P8552, DOI 10.3390/molecules16108552; Zhou F, 2013, PLACENTA, V34, P401, DOI 10.1016/j.placenta.2013.02.006	77	15	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87343	10.1371/journal.pone.0087343	http://dx.doi.org/10.1371/journal.pone.0087343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489901	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000135
J	Zhou, W; Lv, R; Qi, WL; Wu, D; Xu, YY; Liu, W; Mou, YP; Wang, LW				Zhou, Wei; Lv, Ran; Qi, Weilin; Wu, Di; Xu, Yunyun; Liu, Wei; Mou, Yiping; Wang, Liewei			Snail Contributes to the Maintenance of Stem Cell-Like Phenotype Cells in Human Pancreatic Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC-SIGNIFICANCE; METASTASIS; NANOG; TWIST; OVEREXPRESSION; IDENTIFICATION; COEXPRESSION; EXPRESSION; SLUG	Snail, a potent repressor of E-cadherin expression, plays a key role in epithelial-to-mesenchymal transition (EMT) in epithelial cancer. Recently, EMT and stemness programs are found linked together. In the current study, the expression of Snail and its contribution to cancer stem cell (CSC) marker expression, invasiveness, self-renewal, clonogenicity, and tumorigenicity of pancreatic cancer cells were studied. Our results showed that Snail was highly expressed in CSChigh cell line Panc-1. Stable, short hairpin RNA (shRNA)-mediated Snail knockdown decreased invasion in Panc-1 cells, in line with increased E-cadherin expression and its translocation from the nucleus to the membrane. Snail silencing in Panc-1 also inhibited CSC marker ALDH expression, together with decreased sphere and colony forming capacity, which was highly consistent with the expression of stem cell associated transcription factors like Sox2 and Oct4. In mouse xenograft models, knockdown of Snail led to a reduced number of tumor-bearing mice and a reduced average size of tumors, which had a stronger membrane staining of E-cadherin and lighter staining of Oct4. Collectively, these findings implicate Snail is required for the maintenance of stem cell-like phenotype in pancreatic cancer, and inhibition of Snail could be an efficient strategy to treat pancreatic cancer by targeting CSCs.	[Zhou, Wei; Qi, Weilin; Wu, Di; Xu, Yunyun; Liu, Wei; Mou, Yiping] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Lv, Ran] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Zhejiang University; Zhejiang University; Mayo Clinic	Zhou, W (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China.	nuzwlvran@aliyun.com			National Natural Science Foundation of China [81001095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [81001095]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jones RJ, 2004, JNCI-J NATL CANCER I, V96, P583, DOI 10.1093/jnci/djh095; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Kuo KT, 2012, ANN SURG ONCOL, V19, pS549, DOI 10.1245/s10434-011-2043-2; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Luo WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056324; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishioka R, 2010, EXP MOL PATHOL, V89, P149, DOI 10.1016/j.yexmp.2010.05.008; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; van Nes JGH, 2012, BREAST CANCER RES TR, V133, P49, DOI 10.1007/s10549-011-1684-y; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhu JH, 2012, J PROTEOME RES, V11, P2272, DOI 10.1021/pr201059g	40	62	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87409	10.1371/journal.pone.0087409	http://dx.doi.org/10.1371/journal.pone.0087409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489910	Green Submitted, gold, Green Published			2022-12-25	WOS:000330570000142
J	Dalio, RJD; Fleischmann, F; Humez, M; Osswald, W				Dalio, Ronaldo J. D.; Fleischmann, Frank; Humez, Martina; Osswald, Wolfgang			Phosphite Protects Fagus sylvatica Seedlings towards Phytophthora plurivora via Local Toxicity, Priming and Facilitation of Pathogen Recognition	PLOS ONE			English	Article							EUCALYPTUS-MARGINATA; DEFENSE RESPONSES; CINNAMOMI; PHOTOSYNTHESIS; SENSITIVITY; PHOSPHORUS; CITRICOLA; FUNGICIDE; OAK	Phytophthora plurivora causes severe damage on Fagus sylvatica and is responsible for the extensive decline of European Beech throughout Europe. Unfortunately, no effective treatment against this disease is available. Phosphite (Phi) is known to protect plants against Phytophthora species; however, its mode of action towards P. plurivora is still unknown. To discover the effect of Phi on root infection, leaves were sprayed with Phi and roots were subsequently inoculated with P. plurivora zoospores. Seedling physiology, defense responses, colonization of root tissue by the pathogen and mortality were monitored. Additionally the Phi concentration in roots was quantified. Finally, the effect of Phi on mycelial growth and zoospore formation was recorded. Phi treatment was remarkably efficient in protecting beech against P. plurivora; all Phi treated plants survived infection. Phi treated and infected seedlings showed a strong up-regulation of several defense genes in jasmonate, salicylic acid and ethylene pathways. Moreover, all physiological parameters measured were comparable to control plants. The local Phi concentration detected in roots was high enough to inhibit pathogen growth. Phi treatment alone did not harm seedling physiology or induce defense responses. The up-regulation of defense genes could be explained either by priming or by facilitation of pathogen recognition of the host.	[Dalio, Ronaldo J. D.; Fleischmann, Frank; Humez, Martina; Osswald, Wolfgang] Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany	Technical University of Munich	Osswald, W (corresponding author), Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany.	osswald@tum.de	Dalio, Ronaldo J. D./E-8151-2015	Dalio, Ronaldo J. D./0000-0002-1457-4828	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, has granted Dr. Ronaldo J.D. Dalio a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm J, 1999, J PHYTOPATHOL, V147, P409, DOI 10.1111/j.1439-0434.1999.tb03842.x; COFFEY MD, 1985, PHYTOPATHOLOGY, V75, P1042, DOI 10.1094/Phyto-75-1042; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Daniel R, 2006, PHYTOPATHOLOGY, V96, pS28; Dobrowolski MP, 2008, PLANT PATHOL, V57, P928, DOI 10.1111/j.1365-3059.2008.01883.x; Ellsworth DS, 2004, GLOBAL CHANGE BIOL, V10, P2121, DOI 10.1111/j.1365-2486.2004.00867.x; Eshraghi L, 2011, PLANT PATHOL, V60, P1086, DOI 10.1111/j.1365-3059.2011.02471.x; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fleischmann F, 2005, PLANT BIOLOGY, V7, P650, DOI 10.1055/s-2005-872891; Machinandiarena MF, 2012, J PLANT PHYSIOL, V169, P1417, DOI 10.1016/j.jplph.2012.05.005; Garbelotto M., 2007, Arboriculture & Urban Forestry, V33, P309; GUEST D, 1991, BIOL REV, V66, P159, DOI 10.1111/j.1469-185X.1991.tb01139.x; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Hardy GES, 2001, AUSTRALAS PLANT PATH, V30, P133, DOI 10.1071/AP01012; Jackson TJ, 2000, PLANT PATHOL, V49, P147, DOI 10.1046/j.1365-3059.2000.00422.x; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; King M, 2010, MOL GENET GENOMICS, V284, P425, DOI 10.1007/s00438-010-0579-7; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; Massoud K, 2012, PLANT PHYSIOL, V159, P286, DOI 10.1104/pp.112.194647; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Osswald W, 2012, ECOL STUD-ANAL SYNTH, V220, P53, DOI 10.1007/978-3-642-30645-7_3; OUIMETTE D, 1985, PHYTOPATHOLOGY, V75, P1330; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pilbeam RA, 2011, TREES-STRUCT FUNCT, V25, P1121, DOI 10.1007/s00468-011-0587-1; Portz RL, 2011, FOREST PATHOL, V41, P202, DOI 10.1111/j.1439-0329.2010.00667.x; Roos GHP, 1999, COMMUN SOIL SCI PLAN, V30, P2323, DOI 10.1080/00103629909370376; RYDER DS, 1986, J CHROMATOGR, V354, P438, DOI 10.1016/S0021-9673(01)87045-X; Schlink K, 2010, FUNCT INTEGR GENOMIC, V10, P253, DOI 10.1007/s10142-009-0143-x; Shearer BL, 2006, FOREST PATHOL, V36, P119, DOI 10.1111/j.1439-0329.2006.00440.x; Van Wees Saskia C M, 2013, Methods Mol Biol, V1011, P35, DOI 10.1007/978-1-62703-414-2_4; Werres S, 1995, EUR J FOREST PATHOL, V25, P381; Wilkinson CJ, 2001, PLANT PATHOL, V50, P587, DOI 10.1046/j.1365-3059.2001.00605.x; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037	37	53	58	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87860	10.1371/journal.pone.0087860	http://dx.doi.org/10.1371/journal.pone.0087860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489973	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000154
J	Lombardo, FL; Maggini, M; De Bellis, A; Seghieri, G; Anichini, R				Lombardo, Flavia L.; Maggini, Marina; De Bellis, Alessandra; Seghieri, Giuseppe; Anichini, Roberto			Lower Extremity Amputations in Persons with and without Diabetes in Italy: 2001-2010	PLOS ONE			English	Article							CRITICAL LIMB ISCHEMIA; FOOT CARE; DECREASING INCIDENCE; MAJOR AMPUTATIONS; POPULATION; PEOPLE; INDIVIDUALS; REDUCTION; ENGLAND; DISEASE	Objective: To analyze hospitalization for lower extremity amputations (LEAs) and amputee rates in persons with and without diabetes in Italy. Research Design and Methods: All patients with LEAs in the period 2001-2010 were identified analyzing the National Hospital Discharge Record database. For each year, amputee and hospitalization rates for LEAs were calculated either for persons with diabetes or without. Time trend for major and minor amputations were analysed. Results: From 2001 to 2010 a mean annual number of 11,639 individuals underwent a lower extremity amputation: 58.6% had diabetes accounting for 60.7% of total hospitalizations. In 2010, the crude amputee rate for LEAs was 20.4 per 100,000 inhabitants: 247.2 for 100.000 persons with diabetes, and 8.6 for those without diabetes. Having diabetes was associated to an increased risk of amputation (Poisson estimated RR 10.9, 95% CI 9.4-12.8). Over the whole period, a progressive reduction of amputee rates was observed for major amputations either among persons with diabetes (-30.7%) or without diabetes (-12.5%), while the rates of minor amputations increased progressively (+22.4%) among people without diabetes and were nearly stable in people with diabetes (-4.6%). A greater number of minor amputations were performed among persons with than without diabetes: in 2010, the minor-to-major ratio among persons with diabetes (2.5) was more than twice than in those without diabetes (1.0). Conclusions: The nationwide analyses confirm a progressive reduction of hospitalization and amputee rates for major LEAs, suggesting an earlier and more diffuse approach aimed at limb salvage.	[Lombardo, Flavia L.; Maggini, Marina] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [De Bellis, Alessandra; Seghieri, Giuseppe; Anichini, Roberto] Gen Hosp Pistoia, Dept Internal Med, Diabet Unit, Pistoia, Italy; [De Bellis, Alessandra; Seghieri, Giuseppe; Anichini, Roberto] Gen Hosp Pistoia, Dept Internal Med, Diabet Foot Unit, Pistoia, Italy	Istituto Superiore di Sanita (ISS)	Anichini, R (corresponding author), Gen Hosp Pistoia, Dept Internal Med, Diabet Unit, Pistoia, Italy.	r.anichini@usl3.toscana.it	anichini, roberto/U-4181-2017; SEGHIERI, GIUSEPPE/AAF-1161-2019; Lombardo, Flavia/AAA-9723-2021	anichini, roberto/0000-0002-8227-9388; SEGHIERI, GIUSEPPE/0000-0002-7599-4455; Lombardo, Flavia Lucia/0000-0001-6183-0735				Anichini R, 2007, DIABETES RES CLIN PR, V75, P153, DOI 10.1016/j.diabres.2006.05.014; [Anonymous], 1990, Diabet Med, V7, P360; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Buckley CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041492; Faglia E, 2002, J INTERN MED, V252, P225, DOI 10.1046/j.1365-2796.2002.01015.x; Faglia E, 2009, DIABETES CARE, V32, P822, DOI 10.2337/dc08-1223; Fosse S, 2009, DIABETIC MED, V26, P391, DOI 10.1111/j.1464-5491.2009.02698.x; Graziani L, 2010, CATHETER CARDIO INTE, V75, P433, DOI 10.1002/ccd.22287; Holstein P, 2000, DIABETOLOGIA, V43, P844, DOI 10.1007/s001250051459; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Ikonen TS, 2010, DIABETES CARE, V33, P2598, DOI 10.2337/dc10-0462; Jeffcoate WJ, 2005, ACTA CHIR BELG, V105, P140, DOI 10.1080/00015458.2005.11679687; Jeffcoate WJ, 2004, DIABETOLOGIA, V47, P2051, DOI 10.1007/s00125-004-1584-3; Krishnan S, 2008, DIABETES CARE, V31, P99, DOI 10.2337/dc07-1178; LARSSON J, 1995, DIABETIC MED, V12, P770, DOI 10.1111/j.1464-5491.1995.tb02078.x; Layden J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4947; Li YF, 2012, DIABETES CARE, V35, P273, DOI 10.2337/dc11-1360; Lopez-de-Andres A, 2011, DIABETES CARE, V34, P1570, DOI 10.2337/dc11-0077; Lupattelli T, 2010, J ENDOVASC THER, V17, P366, DOI 10.1583/09-2960.1; Manzi M, 2012, J ENDOVASC THER, V19, P461, DOI 10.1583/12-3854L12-3867L12-3867L.461; Margolis DJ, 2011, DATA POINTS PUBLICAT; Moxey PW, 2011, DIABETIC MED, V28, P1144, DOI 10.1111/j.1464-5491.2011.03279.x; Moxey PW, 2010, BRIT J SURG, V97, P1348, DOI 10.1002/bjs.7092; Rayman G, 2004, DIABETES CARE, V27, P1892, DOI 10.2337/diacare.27.8.1892; Romagnoli F, 2003, DIABETES NUTR METAB, V16, P155; Schofield CJ, 2009, DIABETIC MED, V26, P773, DOI 10.1111/j.1464-5491.2009.02770.x; Trautner C, 2007, DIABETES CARE, V30, P2633, DOI 10.2337/dc07-0876; Vaccaro O, 2002, NUTR METAB CARDIOVAS, V12, P331; Vamos EP, 2010, DIABETES CARE, V33, P2592, DOI 10.2337/dc10-0989; van Battum P, 2011, DIABETIC MED, V28, P199, DOI 10.1111/j.1464-5491.2010.03192.x; van Houtum WH, 2004, DIABETES CARE, V27, P1042, DOI 10.2337/diacare.27.5.1042; Werneck CCF, 2009, ANN VASC SURG, V23, P554, DOI 10.1016/j.avsg.2009.05.007	32	85	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86405	10.1371/journal.pone.0086405	http://dx.doi.org/10.1371/journal.pone.0086405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489723	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000049
J	Tsai, JC; Lin, YW; Huang, CY; Lin, CY; Tsai, YT; Shih, CM; Lee, CY; Chen, YH; Li, CY; Chang, NC; Lin, FY; Tsai, CS				Tsai, Jui-Chi; Lin, Yi-Wen; Huang, Chun-Yao; Lin, Chih-Yuan; Tsai, Yi-Ting; Shih, Chun-Min; Lee, Chung-Yi; Chen, Yung-Hsiang; Li, Chi-Yuan; Chang, Nen-Chung; Lin, Feng-Yen; Tsai, Chien-Sung			The Role of Calpain-Myosin 9-Rab7b Pathway in Mediating the Expression of Toll-Like Receptor 4 in Platelets: A Novel Mechanism Involved in alpha-Granules Trafficking	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; THROMBIN RECEPTOR; ACTIVATED PLATELETS; LIPOPOLYSACCHARIDE; TLR4; AGGREGATION; KINASE; PHOSPHORYLATION; THROMBOCYTOPENIA; LOCALIZATION	Toll-like receptors (TLRs) plays a critical role in innate immunity. In 2004, Aslam R. and Shiraki R. first determined that murine and human platelets express functional TLRs. Additionally, Andonegui G. demonstrated that platelets express TLR4, which contributes to thrombocytopenia. However, the underlying mechanisms of TLR4 expression by platelets have been rarely explored until now. The aim of this study was to identify the mechanism of TLR4 expression underlying thrombin treatment. The human washed platelets were used in this study. According to flowcytometry and western blot analysis, the surface levels of TLR4 were significantly enhanced in thrombin-activated human platelets and decreased by TMB-8, calpeptin, and U73122, but not Y27632 (a Rho-associated protein kinase ROCK inhibitor) indicating that thrombin-mediated TLR4 expression was modulated by PAR/PLC pathway, calcium and calpain. Co-immunoprecipitation (co-IP) assay demonstrated that the interaction between TLR4 and myosin-9 (a substrate of calpain) was regulated by calpain; cleavage of myosin-9 enhanced TLR4 expression in thrombin treated platelets. Transmission electron microscope data indicated that human platelets used alpha-granules to control TLR4 expression; the co-IP experiment suggested that myosin-9 did not coordinate with Rab7b to negatively regulate TLR4 trafficking in thrombin treated platelets. In summary, phospholipase C gamma-calpain-myosin 9-Rab7b axis was responsible for the mechanism underlying the regulation of TLR4 containing alpha-granules trafficking in thrombin-stimulated platelets, which was involved in coagulation.	[Tsai, Jui-Chi] Triserv Gen Hosp, Grad Inst Med Sci, Natl Def Med Ctr, Taipei, Taiwan; [Lin, Yi-Wen; Lin, Chih-Yuan; Tsai, Yi-Ting; Lee, Chung-Yi; Tsai, Chien-Sung] Triserv Gen Hosp, Div Cardiovasc Surg, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Jui-Chi; Huang, Chun-Yao; Shih, Chun-Min; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ, Dept Internal Med, Taipei, Taiwan; [Huang, Chun-Yao; Shih, Chun-Min; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ Hosp, Div Cardiol, Taipei, Taiwan; [Huang, Chun-Yao; Shih, Chun-Min; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, FY (corresponding author), Taipei Med Univ, Dept Internal Med, Taipei, Taiwan.	g870905@tmu.edu.tw; sung1500@mail.ndmctsgh.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Li, Chi-Yuan/0000-0003-3390-7568	National Science Council [NSC 97-2314-B-038-035-MY2, NSC 101-2314-B-038-041-MY3, NSC 101-2314-B-016-007-MY2]; National Defense Medical Center, Taiwan [TSGH-C98-25]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Taiwan	This work was supported by the National Science Council (NSC 97-2314-B-038-035-MY2, NSC 101-2314-B-038-041-MY3 and NSC 101-2314-B-016-007-MY2) and partial by the National Defense Medical Center (TSGH-C98-25), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Althaus K, 2009, SEMIN THROMB HEMOST, V35, P189, DOI 10.1055/s-0029-1220327; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Aslam R, 2004, PLATELETS, V15, P267; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; BRASS LF, 1992, J BIOL CHEM, V267, P13795; Bucci Cecilia, 2010, Commun Integr Biol, V3, P401, DOI 10.4161/cib.3.5.12341; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cognasse F, 2008, BRIT J HAEMATOL, V141, P84, DOI 10.1111/j.1365-2141.2008.06999.x; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Fitzgerald ML, 1999, BIOCHEM J, V342, P353, DOI 10.1042/0264-6021:3420353; Freedman JE, 1996, CIRCULATION, V94, P2434, DOI 10.1161/01.CIR.94.10.2434; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; HUNG DT, 1992, J BIOL CHEM, V267, P20831; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; ISHII H, 1991, DIABETOLOGIA, V34, P332, DOI 10.1007/BF00405005; Jayachandran M, 2007, J APPL PHYSIOL, V102, P429, DOI 10.1152/japplphysiol.01576.2005; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kato H, 2008, ARCH BIOCHEM BIOPHYS, V475, P80, DOI 10.1016/j.abb.2008.04.023; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Lin YW, 2011, INT J ANDROL, V34, pE368, DOI 10.1111/j.1365-2605.2010.01130.x; Ma AC, 2008, J THROMB HAEMOST, V6, P415, DOI 10.1111/j.1538-7836.2007.02865.x; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Nurden P, 2011, BLOOD, V118, P5928, DOI 10.1182/blood-2011-07-365601; ODA M, 1985, J LIPID RES, V26, P1294; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Randriamboavonjy V, 2010, ADV PHARMACOL, V59, P235, DOI 10.1016/S1054-3589(10)59008-2; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Semple JW, 2007, BLOOD, V109, P4803, DOI 10.1182/blood-2006-12-062695; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023; Solum NO, 1999, ARTERIOSCL THROM VAS, V19, P2841, DOI 10.1161/01.ATV.19.12.2841; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613; Tavener SA, 2004, CIRC RES, V95, P700, DOI 10.1161/01.RES.0000144175.70140.8c; Tokuda H, 2012, INT J MOL MED, V30, P1387, DOI 10.3892/ijmm.2012.1146; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Ward JR, 2005, THROMB HAEMOSTASIS, V94, P831, DOI 10.1160/TH05-01-0009; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249; Youssefian T, 2002, BLOOD, V99, P4021, DOI 10.1182/blood-2001-12-0191; Yuan YP, 1997, J BIOL CHEM, V272, P21847, DOI 10.1074/jbc.272.35.21847; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884	55	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85833	10.1371/journal.pone.0085833	http://dx.doi.org/10.1371/journal.pone.0085833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489676	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000021
J	de Souza, RD; Batista, MT; Luiz, WB; Cavalcante, RCM; Amorim, JH; Bizerra, RSP; Martins, EG; Ferreira, LCD				de Souza, Renata Damasio; Batista, Milene Tavares; Luiz, Wilson Barros; Marques Cavalcante, Rafael Ciro; Amorim, Jaime Henrique; Pereira Bizerra, Raiza Sales; Martins, Eduardo Gimenes; de Souza Ferreira, Luis Carlos			Bacillus subtilis Spores as Vaccine Adjuvants: Further Insights into the Mechanisms of Action	PLOS ONE			English	Article							IMMUNE-RESPONSE; ENDOSPORES; DELIVERY	Bacillus subtilis spores have received growing attention regarding potential biotechnological applications, including the use as probiotics and in vaccine formulations. B. subtilis spores have also been shown to behave as particulate vaccine adjuvants, promoting the increase of antibody responses after co-administration with antigens either admixed or adsorbed on the spore surface. In this study, we further evaluated the immune modulatory properties of B. subtilis spores using a recombinant HIV gag p24 protein as a model antigen. The adjuvant effects of B. subtilis spores were not affected by the genetic background of the mouse lineage and did not induce significant inflammatory or deleterious effects after parenteral administration. Our results demonstrated that co-administration, but not adsorption to the spore surface, enhanced the immunogenicity of that target antigen after subcutaneous administration to BALB/c and C57BL/6 mice. Spores promoted activation of antigen presenting cells as demonstrated by the upregulation of MHC and CD40 molecules and enhanced secretion of pro-inflammatory cytokines by murine dendritic cells. In addition, in vivo studies indicated a direct role of the innate immunity on the immunomodulatory properties of B. subtilis spores, as demonstrated by the lack of adjuvant effects on MyD88 and TLR2 knockout mouse strains.	[de Souza, Renata Damasio; Batista, Milene Tavares; Luiz, Wilson Barros; Amorim, Jaime Henrique; Pereira Bizerra, Raiza Sales; Martins, Eduardo Gimenes; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Vaccine Dev Lab, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Marques Cavalcante, Rafael Ciro] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ferreira, LCD (corresponding author), Univ Sao Paulo, Vaccine Dev Lab, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.	lcsf@usp.br	Luiz, Wilson/L-7575-2015; Luiz, Wilson/H-2073-2012; Amorim, Jaime Henrique/O-9222-2017; Ferreira, Luis/M-3954-2014	Luiz, Wilson/0000-0003-3265-8547; Luiz, Wilson/0000-0001-5219-6699; Amorim, Jaime Henrique/0000-0002-0623-2879; Ferreira, Luis/0000-0002-4883-1693	Foundation of the State of SApoundo Paulo(FAPESP); National Counsel of Technological and Scientific Development (CNPq)	Foundation of the State of SApoundo Paulo(FAPESP); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Foundation of the State of SA o pound Paulo(FAPESP) and the National Counsel of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034; Amuguni H, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.20694; Barnes AGC, 2007, EUR J IMMUNOL, V37, P1538, DOI 10.1002/eji.200636875; Bozzacco L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041897; Breyhan H, 2009, ACTA NEUROPATHOL, V117, P677, DOI 10.1007/s00401-009-0539-7; Christmas P., 2010, NAT ED, V3, P85; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; DEUERLING E, 1995, J BACTERIOL, V177, P4105, DOI 10.1128/jb.177.14.4105-4112.1995; Fierens K, 2012, CURR PHARM DESIGN, V18, P2305, DOI 10.2174/138161212800166004; Heegaard PMH, 2011, ARCH VIROL, V156, P183, DOI 10.1007/s00705-010-0863-1; Huang JM, 2008, FEMS IMMUNOL MED MIC, V53, P195, DOI 10.1111/j.1574-695X.2008.00415.x; Huang JM, 2010, VACCINE, V28, P1021, DOI 10.1016/j.vaccine.2009.10.127; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Li XM, 2012, CLIN VACCINE IMMUNOL, V19, P723, DOI 10.1128/CVI.05700-11; Liard C, 2011, VACCINE, V29, P6379, DOI 10.1016/j.vaccine.2011.04.080; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Miyaji EN, 2011, BRAZ J MED BIOL RES, V44, P500, DOI 10.1590/S0100-879X2011007500064; Montomoli E, 2011, EXPERT REV VACCINES, V10, P1053, DOI [10.1586/erv.11.48, 10.1586/ERV.11.48]; Negri A, 2013, J MED MICROBIOL, V62, P1379, DOI 10.1099/jmm.0.057372-0; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Paccez JD, 2007, VACCINE, V25, P4671, DOI 10.1016/j.vaccine.2007.04.021; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rodrigues JF, 2011, J BIOL CHEM, V286, P5222, DOI 10.1074/jbc.M110.173682; Song M, 2012, VACCINE, V30, P3266, DOI 10.1016/j.vaccine.2012.03.016; Tagliamonte M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043318; Tavares MB, 2013, CURR MICROBIOL, V66, P279, DOI 10.1007/s00284-012-0269-2; Tavares MB, 2010, FEMS IMMUNOL MED MIC, V59, P131, DOI 10.1111/j.1574-695X.2010.00669.x; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	33	32	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87454	10.1371/journal.pone.0087454	http://dx.doi.org/10.1371/journal.pone.0087454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475289	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300184
J	Lo, CY; Tjong, YW; Ho, JCY; Siu, CW; Cheung, SY; Tang, NL; Yu, S; Tse, HF; Yao, XQ				Lo, Chun-Yin; Tjong, Yung-Wui; Ho, Jenny Chung-Yee; Siu, Chung-Wah; Cheung, Sin-Ying; Tang, Nelson L.; Yu, Shan; Tse, Hung-Fat; Yao, Xiaoqiang			An Upregulation in the Expression of Vanilloid Transient Potential Channels 2 Enhances Hypotonicity-Induced Cytosolic Ca2+ Rise in Human Induced Pluripotent Stem Cell Model of Hutchinson Gillford Progeria	PLOS ONE			English	Article							CALCIUM; LAMIN; GENERATION; TRPV2; INHIBITION; MUTATIONS; MECHANISM; INFLUX; ION	Hutchinson-Gillford Progeria Syndrome (HGPS) is a fatal genetic disorder characterized by premature aging in multiple organs including the skin, musculoskeletal and cardiovascular systems. It is believed that an increased mechanosensitivity of HGPS cells is a causative factor for vascular cell death and vascular diseases in HGPS patients. However, the exact mechanism is unknown. Transient receptor potential (TRP) channels are cationic channels that can act as cellular sensors for mechanical stimuli. The aim of this present study was to examine the expression and functional role of TRP channels in human induced pluripotent stem cell-derived endothelial cells (IPSC-ECs) from the patients with HGPS. The mRNA and protein expression of TRP channels in HGPS and control (IMR90) iPSC-ECs were examined by semi-quantitative RT-PCRs and immunoblots, respectively. Hypotonicity-induced cytosolic Ca2+ ([Ca2+](i)) rise in iPSC-ECs was measured by confocal microscopy. RT-PCRs and immunoblots showed higher expressional levels of TRPV2 in iPSC-ECs from HGPS patients than those from normal individuals. In functional studies, hypotonicity induced a transient [Ca2+](i) rise in iPSC-ECs from normal individuals but a sustained [Ca2+](i) elevation in iPSC-ECs from HGPS patients. A nonselective TRPV inhibitor, ruthenium red (RuR, 20 mu M), and a specific TRPV2 channel inhibitor, tranilast (100 mu M), abolished the sustained phase of hypotonicity-induced [Ca2+](i) rise in iPSC-ECs from HGPS patients, and also markedly attenuated the transient phase of the [Ca2+](i) rise in these cells. Importantly, a short 10 min hypotonicity treatment caused a substantial increase in caspase 8 activity in iPSC-ECs from HGPS patients but not in cells from normal individuals. Tranilast could also inhibit the hypotonicity-induced increase in caspase 8 activity. Taken together, our data suggest that an up-regulation in TRPV2 expression causes a sustained [Ca2+](i) elevation in HGPS-iPSC-ECs under hypotonicity, consequently resulting in apoptotic cell death. This mechanism may contribute to the pathogenesis of vascular diseases in HGPS patients.	[Lo, Chun-Yin; Tjong, Yung-Wui; Cheung, Sin-Ying; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Ho, Jenny Chung-Yee; Siu, Chung-Wah; Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L.] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Yu, Shan] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University	Tse, HF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	hftse@hku.hk; yao2068@cuhk.edu.hk	Siu, Chung Wah/C-6947-2011; Yao, Xiaoqiang/I-5413-2016; Tang, Nelson L/P-5018-2017; Tse, Hung-Fat/C-4426-2009	Yao, Xiaoqiang/0000-0002-0687-8186; Tang, Nelson L/0000-0002-3607-5819; Tse, Hung-Fat/0000-0002-9578-7808; Lo, Chun-Yin/0000-0001-7554-6014; Tse, Hung Fat/0000-0003-4665-7887	Hong Kong Research Grant Council [HKU8/CRF/09, T13-706/11, CUHK2/CRF/11G, CUHK478710]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was supported by HKU8/CRF/09, T13-706/11, CUHK2/CRF/11G and CUHK478710 from the Hong Kong Research Grant Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLAM TJ, 1986, FEBS LETT, V207, P95, DOI 10.1016/0014-5793(86)80019-9; Ho JCY, 2012, DIABETES-METAB RES, V28, P462, DOI 10.1002/dmrr.2304; Ho JCY, 2011, AGING-US, V3, P380, DOI 10.18632/aging.100277; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Jin M, 2011, TRP CHANNELS, P353; Kalinowski A, 2013, BIOPHYS J, V104, P2246, DOI 10.1016/j.bpj.2013.04.016; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Lai WH, 2010, CELL REPROGRAM, V12, P641, DOI 10.1089/cell.2010.0051; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; McHugh J, 2010, HYPERTENSION, V55, P1438, DOI 10.1161/HYPERTENSIONAHA.110.151860; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, P1; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pollex RL, 2004, CLIN GENET, V66, P375, DOI 10.1111/j.1399-0004.2004.00315.x; Reddy S, 2012, EXP CELL RES, V318, P1, DOI 10.1016/j.yexcr.2011.08.009; Sato M, 2013, J ENDODONT, V39, P779, DOI 10.1016/j.joen.2013.01.012; Silvera VM, 2013, AM J NEURORADIOL, V34, P1091, DOI 10.3174/ajnr.A3341; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043186; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	33	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87273	10.1371/journal.pone.0087273	http://dx.doi.org/10.1371/journal.pone.0087273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475260	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300159
J	Yu, XF; Li, YY; Wang, XY				Yu, Xuefei; Li, Yanyan; Wang, Xiaoyuan			The Role of ACT-Like Subdomain in Bacterial Threonine Dehydratases	PLOS ONE			English	Article							L-ISOLEUCINE PRODUCTION; DEAMINASE; EVOLUTION; DOMAIN	In bacteria, threonine dehydratases could convert L-threonine to 2-ketobutyrate. Some threonine dehydratases contain only a catalytic domain, while others contain an N-terminal catalytic domain and a C-terminal regulatory domain composed of one or two ACT-like subdomains. However, the role of the ACT-like subdomain in threonine dehydratases is not clear. Here, nine different bacterial threonine dehydratases were studied. Three of the nine contain no ACT-like subdomain, four of them contain a single ACT-like subdomain, and two of them contain two ACT-like subdomains. The nine genes encoding these threonine dehydratases were individually overexpressed in E. coli BL21(DE3), and the enzymes were purified to homogeneity. Activities of the purified enzymes were analyzed after incubation at different temperatures and different pHs. The results showed that threonine dehydratases with a single ACT-like subdomain are more stable at higher temperatures and a broad range of pH than those without ACT-like subdomain or with two ACT-like subdomains. Furthermore, the specific activity of threonine dehydratases increases with the increase of the number of ACT-like subdomains they contain. The results suggest that the ACT-like subdomain plays an important role in bacterial threonine dehydratases.	[Yu, Xuefei; Wang, Xiaoyuan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Yu, Xuefei; Li, Yanyan] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China; [Wang, Xiaoyuan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wang, XY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	xiaoyuanwang@hotmail.com			National Key Basic Research Program of China [2012CB725202]	National Key Basic Research Program of China(National Basic Research Program of China)	This project was financially supported by grants from National Key Basic Research Program of China (2012CB725202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershtein S, 2008, MOL BIOL EVOL, V25, P2311, DOI 10.1093/molbev/msn174; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen L, 2013, APPL MICROBIOL BIOT, V97, P2939, DOI 10.1007/s00253-012-4176-z; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fondi M, 2009, RES MICROBIOL, V160, P502, DOI 10.1016/j.resmic.2009.05.001; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Guillouet S, 1999, APPL ENVIRON MICROB, V65, P3100; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hashiguchi K, 1997, BIOSCI BIOTECH BIOCH, V61, P105, DOI 10.1271/bbb.61.105; PETERSEN JGL, 1988, GENETICS, V119, P527; Shulman A, 2008, BIOCHEMISTRY-US, V47, P11783, DOI 10.1021/bi800901n; Simanshu DK, 2007, J BIOSCIENCES, V32, P1195, DOI 10.1007/s12038-007-0121-1; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; SZAMOSI I, 1993, PLANT PHYSIOL, V101, P999, DOI 10.1104/pp.101.3.999; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Yin LH, 2012, METAB ENG, V14, P542, DOI 10.1016/j.ymben.2012.06.002	21	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87550	10.1371/journal.pone.0087550	http://dx.doi.org/10.1371/journal.pone.0087550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475306	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800097
J	Wang, N; Robaye, B; Gossiel, F; Boeynaems, JM; Gartland, A				Wang, Ning; Robaye, Bernard; Gossiel, Fatima; Boeynaems, Jean-Marie; Gartland, Alison			The P2Y(13) receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development	FASEB JOURNAL			English	Article						knockout; bone phenotype; purinergic; ADP	HUMAN ARTICULAR CHONDROCYTES; NORADRENALINE RELEASE; MINERAL METABOLISM; DIETARY PHOSPHATE; P2Y13 RECEPTOR; ADP RECEPTOR; P2 RECEPTORS; GROWTH; EXPRESSION; ATP	Purinergic signaling mediates many cellular processes, including embryonic development and regulation of endocrine signaling. The ADP P2Y(13) receptor is known to regulate bone and stem cells activities, although relatively little is known about its role in bone development. In this study we demonstrate, using contemporary techniques, that deletion of the P2Y(13) receptor results in an age-dependent skeletal phenotype that is governed by changes in phosphate metabolism and hormone levels. Neonatal and postnatal (2 wk) P2Y(13) receptor-knockout (KO) mice were indistinguishable from their wild-type (WT) littermate controls. A clear bone phenotype was observed in young (4-wk-old) KO mice compared WT controls, with 14% more trabecular bone, 35% more osteoblasts, 73% fewer osteoclasts, and a 17% thicker growth plate. Mature (>10 wk of age) KO mice showed the opposite bone phenotype, with 14% less trabecular bone, 22% fewer osteoblasts, and 10% thinner growth plate. This age-dependent phenotype correlated with serum fibroblast growth factor-23 (FGF-23) and phosphorus levels that were 65 and 16% higher, respectively, in young KO mice but remained unchanged in mature mice. These findings provide novel insights for the role of the P2Y(13) receptor in skeletal development via coordination with hormonal regulators of phosphate homeostasis.Wang, N., Robaye, B., Gossiel, F., Boeynaems, J.-M., Gartland, A. The P2Y(13) receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development.	[Wang, Ning; Gossiel, Fatima; Gartland, Alison] Univ Sheffield, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield S10 2RX, S Yorkshire, England; [Robaye, Bernard; Boeynaems, Jean-Marie] Univ Libre Bruxelles, Inst Interdisciplinary Res, IRIBHM, Gosselies, Belgium; [Boeynaems, Jean-Marie] Free Univ Brussels, Erasme Hosp, Dept Med Chem, B-1050 Brussels, Belgium	University of Sheffield; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Gartland, A (corresponding author), Univ Sheffield, Mellanby Ctr Bone Res, Dept Human Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	a.gartland@sheffield.ac.uk	Gartland, Alison/A-2152-2012	Gartland, Alison/0000-0002-3712-2437; WANG, NING/0000-0002-2663-7515	European Commission [202231]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding Source: European Commission under the 7th Framework Programme (proposal 202231) performed as a collaborative project among the members of the ATPBone Consortium (Copenhagen University, Copenhagen, Denmark; University College London, London, UK; University of Maastricht, Maastricht, The Netherlands; University of Ferrara, Ferrara, Italy; University of Liverpool, Liverpool, UK; University of Sheffield, Sheffield, UK; and Universite Libre de Bruxelles, Brussels, Belgium), and is a substudy under the main study, "Fighting osteoporosis by blocking nucleotides: purinergic signaling in bone formation and homeostasis." The authors declare no conflicts of interest.	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Bacic D, 2003, PFLUG ARCH EUR J PHY, V446, P52, DOI 10.1007/s00424-002-0969-8; Bailey MA, 2009, PURINERG SIGNAL, V5, P473, DOI 10.1007/s11302-009-9149-z; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8; Biver G, 2013, STEM CELLS, V31, P2747, DOI 10.1002/stem.1411; Boyan BD, 2002, CRIT REV ORAL BIOL M, V13, P143, DOI 10.1177/154411130201300205; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Burnstock G, 2011, CELL MOL LIFE SCI, V68, P1369, DOI 10.1007/s00018-010-0614-1; CASWELL AM, 1991, BIOCHIM BIOPHYS ACTA, V1074, P151, DOI 10.1016/0304-4165(91)90054-K; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Csolle C, 2008, J NEUROCHEM, V106, P347, DOI 10.1111/j.1471-4159.2008.05391.x; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; Farrow EG, 2010, J ENDOCRINOL, V207, P67, DOI 10.1677/JOE-10-0181; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Grimm I, 2009, J CELL SCI, V122, P2524, DOI 10.1242/jcs.044891; HATORI M, 1995, J CELL PHYSIOL, V165, P468, DOI 10.1002/jcp.1041650304; Heinrich A, 2008, NEUROPHARMACOLOGY, V54, P375, DOI 10.1016/j.neuropharm.2007.10.013; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hung CT, 1997, AM J PHYSIOL-CELL PH, V272, pC1611, DOI 10.1152/ajpcell.1997.272.5.C1611; Inscho EW, 2009, AM J PHYSIOL-RENAL, V297, pF1166, DOI 10.1152/ajprenal.00506.2009; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Kaplan AD, 1996, ENDOCRINOLOGY, V137, P4757, DOI 10.1210/en.137.11.4757; Knight MM, 2009, J ANAT, V214, P275, DOI 10.1111/j.1469-7580.2008.01021.x; Koolpe M, 1999, ARTHRITIS RHEUM, V42, P258, DOI 10.1002/1529-0131(199902)42:2<258::AID-ANR7>3.0.CO;2-O; Krajisnik T, 2007, J ENDOCRINOL, V195, P125, DOI 10.1677/JOE-07-0267; Lanske B, 2007, CURR OPIN NEPHROL HY, V16, P311, DOI 10.1097/MNH.0b013e3281c55eca; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Pinter O., 2007, END ABSTR, V14, P617; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Queiroz G, 2003, J PHARMACOL EXP THER, V307, P809, DOI 10.1124/jpet.103.054809; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Rhees BK, 2000, J EXP ZOOL, V288, P151, DOI 10.1002/1097-010X(20000815)288:2&lt;151::AID-JEZ6&gt;3.0.CO;2-6; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sondergaard M, 2003, AM J PHYSIOL-ENDOC M, V285, pE427, DOI 10.1152/ajpendo.00573.2002; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Wang N, 2013, J BONE MINER RES, V28, P1446, DOI 10.1002/jbmr.1877; Wang N, 2012, MOL ENDOCRINOL, V26, P142, DOI 10.1210/me.2011-1083; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Zhang FL, 2002, J PHARMACOL EXP THER, V301, P705, DOI 10.1124/jpet.301.2.705	59	23	24	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2249	2259		10.1096/fj.13-243626	http://dx.doi.org/10.1096/fj.13-243626			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24487286	Green Published			2022-12-25	WOS:000335336000027
J	Stark, R; Guebre-Egziabher, F; Zhao, XJ; Feriod, C; Dong, JY; Alves, TC; Ioja, S; Pongratz, RL; Bhanot, S; Roden, M; Cline, GW; Shulman, GI; Kibbey, RG				Stark, Romana; Guebre-Egziabher, Fitsum; Zhao, Xiaojian; Feriod, Colleen; Dong, Jianying; Alves, Tiago C.; Ioja, Simona; Pongratz, Rebecca L.; Bhanot, Sanjay; Roden, Michael; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.			A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Gluconeogenesis; Glyceroneogenesis; GTPase; Intermediary Metabolism; Metabolic Regulation; Metabolic Tracers; Metabolism; Mitochondrial Metabolism; Phosphoenolpyruvate Carboxykinase	GUINEA-PIG LIVER; INTRACELLULAR-DISTRIBUTION; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; MOUSE-LIVER; RAT-LIVER; EXPRESSION; PYRUVATE; HYPERGLYCEMIA	Background: PEPCK-M is generally considered irrelevant for glucose production, although gluconeogenesis has never been characterized in its absence. Results: PEPCK-M loss impaired gluconeogenesis from lactate, lowered plasma glucose, insulin, and triglycerides, reduced hepatic glycogen, and increased glycerol turnover. Conclusion: Approximately a third of gluconeogenesis comes from PEPCK-M. Significance: The nutrient-sensitive PEPCK-M has been overlooked and is potentially important for metabolic diseases such as diabetes. Synthesis of phosphoenolpyruvate (PEP) from oxaloacetate is an absolute requirement for gluconeogenesis from mitochondrial substrates. Generally, this reaction has solely been attributed to the cytosolic isoform of PEPCK (PEPCK-C), although loss of the mitochondrial isoform (PEPCK-M) has never been assessed. Despite catalyzing the same reaction, to date the only significant role reported in mammals for the mitochondrial isoform is as a glucose sensor necessary for insulin secretion. We hypothesized that this nutrient-sensing mitochondrial GTP-dependent pathway contributes importantly to gluconeogenesis. PEPCK-M was acutely silenced in gluconeogenic tissues of rats using antisense oligonucleotides both in vivo and in isolated hepatocytes. Silencing PEPCK-M lowers plasma glucose, insulin, and triglycerides, reduces white adipose, and depletes hepatic glycogen, but raises lactate. There is a switch of gluconeogenic substrate preference to glycerol that quantitatively accounts for a third of glucose production. In contrast to the severe mitochondrial deficiency characteristic of PEPCK-C knock-out livers, hepatocytes from PEPCK-M-deficient livers maintained normal oxidative function. Consistent with its predicted role, gluconeogenesis rates from hepatocytes lacking PEPCK-M are severely reduced for lactate, alanine, and glutamine, but not for pyruvate and glycerol. Thus, PEPCK-M has a direct role in fasted and fed glucose homeostasis, and this mitochondrial GTP-dependent pathway should be reconsidered for its involvement in both normal and diabetic metabolism.	[Stark, Romana; Guebre-Egziabher, Fitsum; Zhao, Xiaojian; Dong, Jianying; Alves, Tiago C.; Ioja, Simona; Pongratz, Rebecca L.; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Feriod, Colleen; Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Dong, Jianying; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92010 USA; [Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Isis Pharmaceuticals Inc; Deutsches Diabetes-Zentrum (DDZ)	Kibbey, RG (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	richard.kibbey@yale.edu	Carmen, Team1/Y-7382-2019; Shulman, Gerald I./P-7176-2019; Carmen, Team3/Y-7384-2019; Roden, Michael/AAD-3843-2019	Carmen, Team1/0000-0003-4234-1746; Shulman, Gerald I./0000-0003-1529-5668; Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Stark, Romana/0000-0002-4264-0060	National Institutes of Health [R01 DK092606, K08 DK080142, R01 DK-40936, R24 DK-085638, U24 DK-059635, P30 DK79310-01, P30 DK34989, P30 DK45735]; American Diabetes Association [7-12-BS-092]; Societe Francophone de Nephrologie, Hospices Civils de Lyon; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, P30DK079310, R01DK040936, K08DK080142, P30DK034989, U24DK059635, R24DK085638, R01DK092606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Societe Francophone de Nephrologie, Hospices Civils de Lyon; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK092606 (to R. G. K.), K08 DK080142 (to R. G. K.), R01 DK-40936 (to G. I. S.), R24 DK-085638 (to G. I. S.), U24 DK-059635, P30 DK79310-01, P30 DK34989, and P30 DK45735. This work was also supported by the American Diabetes Association (Grant 7-12-BS-092) (to R. G. K.), and Societe Francophone de Nephrologie, Hospices Civils de Lyon (to F. G. E.). S. B. is employed by and holds stocks in ISIS Pharmaceuticals.	BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Caton PW, 2009, LIFE SCI, V84, P738, DOI 10.1016/j.lfs.2009.02.024; CORNELL NW, 1986, J NUTR, V116, P1101, DOI 10.1093/jn/116.6.1101; DIESTERHAFT M, 1971, BIOCHEM MED METAB B, V5, P297, DOI 10.1016/0006-2944(71)90032-9; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; GARBER AJ, 1969, J BIOL CHEM, V244, P4696; Gastaldelli A, 2004, J CLIN ENDOCR METAB, V89, P3914, DOI 10.1210/jc.2003-031941; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hanson RW, 2009, J BIOL CHEM, V284, P27021, DOI 10.1074/jbc.R109.040519; HEITZMAN RJ, 1972, FEBS LETT, V20, P19, DOI 10.1016/0014-5793(72)80006-1; Horn DB, 1997, METABOLISM, V46, P414, DOI 10.1016/S0026-0495(97)90058-5; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jamison RA, 2011, AM J PHYSIOL-ENDOC M, V301, pE1174, DOI 10.1152/ajpendo.00175.2011; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; MACDONALD MJ, 1978, J BIOL CHEM, V253, P116; Maggs DG, 1998, ANN INTERN MED, V128, P176, DOI 10.7326/0003-4819-128-3-199802010-00002; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mendez-Lucas A, 2013, J HEPATOL, V59, P105, DOI 10.1016/j.jhep.2013.02.020; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; NORDLIE RC, 1963, J BIOL CHEM, V238, P2259; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; SAGGERSON ED, 1975, BIOCHEM J, V146, P329, DOI 10.1042/bj1460329; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SOLING HD, 1970, EUR J BIOCHEM, V16, P289, DOI 10.1111/j.1432-1033.1970.tb01084.x; SOLING HD, 1973, EUR J BIOCHEM, V37, P233, DOI 10.1111/j.1432-1033.1973.tb02980.x; Stark R., 2013, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbagen.2013.10.033; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; USATENKO MS, 1970, BIOCHEM MED METAB B, V3, P298, DOI 10.1016/0006-2944(70)90030-X; UTTER MF, 1954, J BIOL CHEM, V207, P787; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; WIESE TJ, 1991, COMP BIOCHEM PHYS B, V100, P297, DOI 10.1016/0305-0491(91)90378-Q; WOLFE RR, 1988, AM J PHYSIOL, V254, pE532, DOI 10.1152/ajpendo.1988.254.4.E532; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yu RZ, 2007, DRUG METAB DISPOS, V35, P460, DOI 10.1124/dmd.106.012401	41	64	66	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7257	7263		10.1074/jbc.C113.544759	http://dx.doi.org/10.1074/jbc.C113.544759			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497630	Green Published, hybrid			2022-12-25	WOS:000332761500001
J	Cunha, HA; Medeiros, BV; Barbosa, LA; Cremer, MJ; Marigo, J; Lailson-Brito, J; Azevedo, AF; Sole-Cava, AM				Cunha, Haydee A.; Medeiros, Bruna V.; Barbosa, Lupercio A.; Cremer, Marta J.; Marigo, Juliana; Lailson-Brito, Jose; Azevedo, Alexandre F.; Sole-Cava, Antonio M.			Population Structure of the Endangered Franciscana Dolphin (Pontoporia blainvillei): Reassessing Management Units	PLOS ONE			English	Article							INCIDENTALLY CAUGHT; GENETIC-STRUCTURE; SOUTHERN BRAZIL; CONSERVATION; CETACEA; EVOLUTION; ABUNDANCE; SOFTWARE; ECOLOGY	Franciscanas are the most endangered dolphins in the Southwestern Atlantic. Due to their coastal and estuarine habits, franciscanas suffer from extensive fisheries bycatch, as well as from habitat loss and degradation. Four Franciscana Management Areas (FMA), proposed based on biology, demography, morphology and genetic data, were incorporated into management planning and in the delineation of research efforts. We re-evaluated that proposal through the analysis of control region sequences from franciscanas throughout their distribution range (N = 162), including novel sequences from the northern limit of the species and two other previously unsampled localities in Brazil. A deep evolutionary break was observed between franciscanas from the northern and southern portions of the species distribution, indicating that they must be managed as two Evolutionarily Significant Units (ESU). Furthermore, additional FMAs should be recognised to accommodate the genetic differentiation found in each ESU. These results have immediate consequences for the conservation and management of this endangered species.	[Cunha, Haydee A.; Medeiros, Bruna V.; Sole-Cava, Antonio M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Biodiversidade Mol, Rio De Janeiro, Brazil; [Cunha, Haydee A.; Lailson-Brito, Jose; Azevedo, Alexandre F.] Univ Estado Rio de Janeiro, Fac Oceanografia, Lab Mamiferos Aquat & Bioindicadores, BR-20550011 Rio De Janeiro, Brazil; [Barbosa, Lupercio A.] Org Consciencia Ambiental, Vila Velha, ES, Brazil; [Cremer, Marta J.] Univ Regiao Joinville, Dept Ciencias Biol, Joinville, SC, Brazil; [Marigo, Juliana] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Patol Comparada Anim Selvagen, Sao Paulo, Brazil; [Marigo, Juliana] Projeto Biopesca, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade da Regiao de Joinville; Universidade de Sao Paulo	Cunha, HA (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Lab Biodiversidade Mol, Rio De Janeiro, Brazil.	haydeecunha@yahoo.com.br	Cunha, Haydee/O-1940-2017; Azevedo, Alexandre/B-9660-2013; Cremer, Marta/T-2653-2019; Sole-Cava, Antonio M/G-4209-2011; AZEVEDO, ALEXANDRE/HII-5648-2022; Brito, Jose Lailson/B-3572-2013	Azevedo, Alexandre/0000-0002-3754-9035; Cremer, Marta/0000-0003-3521-1409; Sole-Cava, Antonio M/0000-0003-0363-5821; Brito, Jose Lailson/0000-0001-8366-458X; Marigo, Juliana/0000-0002-3279-2909; Vieira de Medeiros, Bruna/0000-0002-8830-0053	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/Brazil; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was financially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/Brazil (www.cnpq.br) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MB, 2012, ENVIRON POLLUT, V170, P152, DOI 10.1016/j.envpol.2012.06.001; Alonso MB, 2012, ENVIRON INT, V47, P99, DOI 10.1016/j.envint.2012.06.010; Azevedo Alexandre F., 2002, Latin American Journal of Aquatic Mammals, V1, P191; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbato BHA, 2012, J MAR BIOL ASSOC UK, V92, P1645, DOI 10.1017/S0025315411000725; Barbosa, 2003, LAT AM J AQUAT MAMM, V2, P57, DOI DOI 10.5597/LAJAM00033; Bastida R, 2007, MAMIFEROS ACUATICOS; Bertozzi Carolina P., 2002, Latin American Journal of Aquatic Mammals, V1, P153; Botta S, 2010, J MAR BIOL ASSOC UK, V90, P1493, DOI 10.1017/S0025315410001141; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Costa-Urrutia P, 2012, J HERED, V103, P92, DOI 10.1093/jhered/esr103; Crespo EA, 2002, ENCY MARINE MAMMALS, P484; Crespo EA, 2010, MAR MAMMAL SCI, V26, P17, DOI 10.1111/j.1748-7692.2009.00313.x; Crespo Enrique Alberto, 1994, Reports of the International Whaling Commission Special Issue, V15, P269; Danilewicz D, 2010, J MAR BIOL ASSOC UK, V90, P1649, DOI 10.1017/S0025315409991482; Danilewicz D, 2009, J MAR BIOL ASSOC UK, V89, P943, DOI 10.1017/S002531540900054X; Di Beneditto Ana Paula Madeira, 2003, Latin American Journal of Aquatic Mammals, V2, P79; Di Beneditto APM, 1998, BRAZ ARCH BIOL TECHN, V41, P296; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gago-Ferrero P, 2013, ENVIRON SCI TECHNOL, V47, P5619, DOI 10.1021/es400675y; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; IUCN, 2012, IUCN RED LIST CATEGO, VSecond; Kajiwara N, 2004, ARCH ENVIRON CON TOX, V46, P124, DOI 10.1007/s00244-003-2239-y; KINAS PG, 2002, LATIN AM J AQUATIC M, V1, P43; Lailson-Brito J, 2007, ORGANOHALOGEN COMPOU, V69, P1741; Lailson-Brito J, 2011, CHEMOSPHERE, V84, P882, DOI 10.1016/j.chemosphere.2011.06.018; Lazaro M, 2004, MAR MAMMAL SCI, V20, P201, DOI 10.1111/j.1748-7692.2004.tb01151.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Moreno Ignacio B., 2003, Latin American Journal of Aquatic Mammals, V2, P131; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Netto Ricardo de Freitas, 2007, Boletim do Museu de Biologia Mello Leitao, V21, P35; Ott P.H., 2002, THESIS U FEDERAL RIO; Ott PH, 2008, 13 REUN TRAB ESP MAM, P81; Pinedo MC, 1991, THESIS U CALIFORNIA; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Praderi R, 1997, 2 ENC COORD PESQ MAN, P42; Ramos Renata M.A., 2002, Latin American Journal of Aquatic Mammals, V1, P129; Rocha-Campos C.C, 2010, PLANO ACAO NACL CONS; Rosas Fernando C. Weber, 2002, Latin American Journal of Aquatic Mammals, V1, P161; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Ryman N., 1987, POPULATION GENETICS; Sambrook J., 1989, MOL CLONING LAB MANU; Secchi E.R., 2006, THESIS U OTAGO DUNED; Secchi Eduardo R., 2003, Journal of Cetacean Research and Management, V5, P61; Secchi ER, 2010, WILDL PROT DESTR EXT, P301; Secchi ER, 2010, WILDL PROT DESTR EXT, P323; Secchi Eduardo R., 1997, Report of the International Whaling Commission, V47, P653; Secchi Eduardo R., 2004, Latin American Journal of Aquatic Mammals, V3, P61; Secchi ER, 1998, CAN J ZOOL, V76, P1622, DOI 10.1139/cjz-76-9-1622; Secchi ER, 2001, LAT AM J AQUAT MAMM, V1, P11; Siciliano Salvatore, 1994, Reports of the International Whaling Commission Special Issue, V15, P241; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Panebianco MV, 2012, ANIM REPROD SCI, V131, P41, DOI 10.1016/j.anireprosci.2012.02.005; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x	59	40	43	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85633	10.1371/journal.pone.0085633	http://dx.doi.org/10.1371/journal.pone.0085633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497928	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900010
J	Yoshida, S; Lee, JO; Nakamura, K; Suzuki, S; Hendon, DN; Kobayashi, M; Suzuki, F				Yoshida, Shohei; Lee, Jong O.; Nakamura, Kiwamu; Suzuki, Sumihiro; Hendon, David N.; Kobayashi, Makiko; Suzuki, Fujio			Effect of Glycyrrhizin on Pseudomonal Skin Infections in Human-Mouse Chimeras	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVE COMPONENT; LICORICE ROOTS; CHRONIC HEPATITIS; CELLS; ACID; MACROPHAGES; EXPRESSION; PHAGOCYTOSIS; REPLICATION	In our previous studies, peripheral blood lineage(-)CD34(+)CD31(+) cells (CD31(+) IMC) appearing in severely burned patients have been characterized as inhibitor cells for the production of beta-defensins (HBDs) by human epidermal keratinocytes (NHEK). In this study, the effect of glycyrrhizin on pseudomonal skin infections was studied in a chimera model of thermal injury. Two different chimera models were utilized. Patient chimeras were created in murine antimicrobial peptide-depleted NOD-SCID IL-2r gamma(null) mice that were grafted with unburned skin tissues of severely burned patients and inoculated with the same patient peripheral blood CD31(+) IMC. Patient chimera substitutes were created in the same mice that were grafted with NHEK and inoculated with experimentally induced CD31(+) IMC. In the results, both groups of chimeras treated with glycyrrhizin resisted a 20 LD50 dose of P. aeruginosa skin infection, while all chimeras in both groups treated with saline died within 3 days of the infection. Human antimicrobial peptides were detected from the grafted site tissues of both groups of chimeras treated with glycyrrhizin, while the peptides were not detected in the same area tissues of controls. HBD-1 was produced by keratinocytes in transwell-cultures performed with CD31(+) IMC and glycyrrhizin. Also, inhibitors (IL-10 and CCL2) of HBD-1 production by keratinocytes were not detected in cultures of patient CD31(+) IMC treated with glycyrrhizin. These results indicate that sepsis stemming from pseudomonal grafted site infections in a chimera model of burn injury is controllable by glycyrrhizin. Impaired antimicrobial peptide production at the infection site of severely burned patients may be restored after treatment with glycyrrhizin.	[Yoshida, Shohei; Nakamura, Kiwamu; Kobayashi, Makiko; Suzuki, Fujio] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Lee, Jong O.; Hendon, David N.; Kobayashi, Makiko; Suzuki, Fujio] Shriners Hosp Children, Galveston, TX 77550 USA; [Suzuki, Sumihiro] Univ N Texas, Hlth Sci Ctr, Dept Biostat, Ft Worth, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of North Texas System; University of North Texas Health Science Center	Suzuki, F (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	fsuzuki@utmb.edu			Shriners Hospitals for Children [85110]	Shriners Hospitals for Children	This work was supported by the Shriners Hospitals for Children Grant #85110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE N, 1982, MICROBIOL IMMUNOL, V26, P535, DOI 10.1111/j.1348-0421.1982.tb00207.x; ARMANINI D, 1983, CLIN ENDOCRINOL, V19, P609, DOI 10.1111/j.1365-2265.1983.tb00038.x; Braff MH, 2006, CURR TOP MICROBIOL, V306, P91; Cherng JM, 2006, EUR J PHARMACOL, V547, P10, DOI 10.1016/j.ejphar.2006.06.080; Cherng JM, 2004, ANTIVIR RES, V62, P27, DOI 10.1016/j.antiviral.2003.11.005; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Dai JH, 2001, IMMUNOLOGY, V103, P235, DOI 10.1046/j.1365-2567.2001.01224.x; Di Paola R, 2009, INTENS CARE MED, V35, P687, DOI 10.1007/s00134-008-1334-y; FRAZIERJESSEN MR, 1995, J IMMUNOL, V154, P1838; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Heggers JP., 2002, TOTAL BURN CARE, P120, DOI DOI 10.1038/SREP41441; Herndon DN., 2017, TOTAL BURN CARE, V5th; Honda H, 2012, J LEUKOCYTE BIOL, V91, P967, DOI 10.1189/jlb.0112038; Hunsicker LM, 2001, CLINICAL MANAGEMENT OF INFECTIONS IN IMMUNOCOMPROMISED INFANTS AND CHILDREN, P327; Iino S, 2001, HEPATOL RES, V19, P31, DOI 10.1016/S1386-6346(00)00079-6; ITO M, 1988, ANTIVIR RES, V10, P289, DOI 10.1016/0166-3542(88)90047-2; Itoh K., 1983, INT CONG SERIES EXCE, P460; Jones VC, 2010, J IMMUNOL, V184; Kobayashi M, 2008, J LEUKOCYTE BIOL, V83, P1354, DOI 10.1189/jlb.0807541; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEVEY RH, 1966, P NATL ACAD SCI USA, V56, P1130, DOI 10.1073/pnas.56.4.1130; Li M, 2011, J CLIN ENDOCR METAB, V96, P2502, DOI 10.1210/jc.2011-0055; Ma CH, 2013, J ETHNOPHARMACOL, V148, P755, DOI 10.1016/j.jep.2013.04.021; Maree AFM, 2008, J APPL PHYSIOL, V104, P157, DOI 10.1152/japplphysiol.00514.2007; Menegazzi M, 2008, PHARMACOL RES, V58, P22, DOI 10.1016/j.phrs.2008.05.012; Milner SM, 1999, BURNS, V25, P411, DOI 10.1016/S0305-4179(98)00192-2; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; MUKAIDA N, 1991, J IMMUNOL, V146, P1212; NUMAZAKI K, 1994, J LEUKOCYTE BIOL, V55, P24, DOI 10.1002/jlb.55.1.24; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Ortega MR, 2000, BURNS, V26, P724, DOI 10.1016/S0305-4179(00)00052-8; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Sato H, 1996, ANTIVIR RES, V30, P171, DOI 10.1016/0166-3542(96)00942-4; Sawamura D, 2005, GENE THER, V12, P857, DOI 10.1038/sj.gt.3302472; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; STORMER FC, 1993, FOOD CHEM TOXICOL, V31, P303, DOI 10.1016/0278-6915(93)90080-I; SUZUKI F, 1974, P SOC EXP BIOL MED, V146, P78; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Utsunomiya T, 1997, ANTIMICROB AGENTS CH, V41, P551, DOI 10.1128/AAC.41.3.551; Utsunomiya T, 1999, CLIN EXP IMMUNOL, V116, P291; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012; Yoshida S, 2013, PLOS ONE; Yoshida T, 2010, J LEUKOCYTE BIOL, V87, P35, DOI 10.1189/jlb.1208760	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e83747	10.1371/journal.pone.0083747	http://dx.doi.org/10.1371/journal.pone.0083747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497916	Green Published, Green Submitted, gold			2022-12-25	WOS:000330617100003
J	Dacheux, L; Cervantes-Gonzalez, M; Guigon, G; Thiberge, JM; Vandenbogaert, M; Maufrais, C; Caro, V; Bourhy, H				Dacheux, Laurent; Cervantes-Gonzalez, Minerva; Guigon, Ghislaine; Thiberge, Jean-Michel; Vandenbogaert, Mathias; Maufrais, Corinne; Caro, Valerie; Bourhy, Herve			A Preliminary Study of Viral Metagenomics of French Bat Species in Contact with Humans: Identification of New Mammalian Viruses	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; BORNA-DISEASE; GENETIC DIVERSITY; GENOME ANALYSIS; GENOGROUP-I; FRUIT BATS; PICOBIRNAVIRUSES; CORONAVIRUS; ORTHOREOVIRUS; ASTROVIRUSES	The prediction of viral zoonosis epidemics has become a major public health issue. A profound understanding of the viral population in key animal species acting as reservoirs represents an important step towards this goal. Bats harbor diverse viruses, some of which are of particular interest because they cause severe human diseases. However, little is known about the diversity of the global population of viruses found in bats (virome). We determined the viral diversity of five different French insectivorous bat species (nine specimens in total) in close contact with humans. Sequence-independent amplification, high-throughput sequencing with Illumina technology and a dedicated bioinformatics analysis pipeline were used on pooled tissues (brain, liver and lungs). Comparisons of the sequences of contigs and unassembled reads provided a global taxonomic distribution of virus-related sequences for each sample, highlighting differences both within and between bat species. Many viral families were present in these viromes, including viruses known to infect bacteria, plants/fungi, insects or vertebrates, the most relevant being those infecting mammals (Retroviridae, Herpesviridae, Bunyaviridae, Poxviridae, Flaviviridae, Reoviridae, Bornaviridae, Picobirnaviridae). In particular, we detected several new mammalian viruses, including rotaviruses, gammaretroviruses, bornaviruses and bunyaviruses with the identification of the first bat nairovirus. These observations demonstrate that bats naturally harbor viruses from many different families, most of which infect mammals. They may therefore constitute a major reservoir of viral diversity that should be analyzed carefully, to determine the role played by bats in the spread of zoonotic viral infections.	[Dacheux, Laurent; Cervantes-Gonzalez, Minerva; Bourhy, Herve] Inst Pasteur, Lyssavirus Dynam & Host Adaptat Unit, Natl Reference Ctr Rabies, WHO Reference Ctr Reference & Res Rabies, Paris, France; [Guigon, Ghislaine; Thiberge, Jean-Michel; Vandenbogaert, Mathias; Caro, Valerie] Inst Pasteur, Genotyping Pathogens & Publ Hlth Platform, Paris, France; [Maufrais, Corinne] Inst Pasteur, Comp Ctr Biol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dacheux, L (corresponding author), Inst Pasteur, Lyssavirus Dynam & Host Adaptat Unit, Natl Reference Ctr Rabies, WHO Reference Ctr Reference & Res Rabies, Paris, France.	laurent.dacheux@pasteur.fr	Dacheux, Laurent/AAJ-5372-2020	Vandenbogaert, Mathias/0000-0002-3073-9688; Dacheux, Laurent/0000-0002-4401-3706	Direction Generale de la Sante, France; PREDEMICS UE [278433]	Direction Generale de la Sante, France; PREDEMICS UE	This work was financed by the Direction Generale de la Sante, France, and PREDEMICS UE project No. 278433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Banyai K, 2008, J GEN VIROL, V89, P534, DOI 10.1099/vir.0.83134-0; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; BOURHY H, 1989, J CLIN MICROBIOL, V27, P519, DOI 10.1128/JCM.27.3.519-523.1989; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; BRUSSOW H, 1992, J CLIN MICROBIOL, V30, P67; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Coffin J, 1997, RETROVIRUSES; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; Cui J, 2012, J GEN VIROL, V93, P2037, DOI 10.1099/vir.0.043760-0; Cui J, 2012, J VIROL, V86, P4288, DOI 10.1128/JVI.06624-11; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Davis PL, 2006, INFECT GENET EVOL, V6, P464, DOI 10.1016/j.meegid.2006.02.007; DELATORRE JC, 1990, VIROLOGY, V179, P853, DOI 10.1016/0042-6822(90)90154-J; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Elliot R.M., 2000, VIRUS TAXONOMY, P599; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; Estes MK, 2001, NOVART FDN SYMP, V238, P82; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Fenaux M, 2006, J VIROL, V80, P5219, DOI 10.1128/JVI.02664-05; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Ganesh B, 2012, REV MED VIROL, V22, P245, DOI 10.1002/rmv.1707; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ghosh S, 2011, J GEN VIROL, V92, P2201, DOI 10.1099/vir.0.033001-0; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Giordano MO, 2011, J INFECTION, V62, P45, DOI 10.1016/j.jinf.2010.09.031; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; He B, 2013, J VIROL; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Joffret ML, 2013, J GEN VIROL; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Kim HJ, 2011, VET MICROBIOL, V152, P291, DOI 10.1016/j.vetmic.2011.05.017; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lelli D, 2013, ZOONOSES PUBLIC HLTH, V60, P84, DOI 10.1111/zph.12001; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Lipkin WI, 2007, FIELDS VIROLOGY, P1449; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Mackenzie JS, 2005, J NEUROVIROL, V11, P434, DOI 10.1080/13550280591002487; Maeda K, 2008, EMERG INFECT DIS, V14, P347, DOI 10.3201/eid1402.070932; Marriott AC, 1996, J GEN VIROL, V77, P1775, DOI 10.1099/0022-1317-77-8-1775; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2006, J VIROL, V80, P3801, DOI 10.1128/JVI.80.8.3801-3810.2006; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; NICHOL ST, 2001, FIELDS VIROLOGY, V2, P1603; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; ROTT R, 1995, CURR TOP MICROBIOL, V190, P17; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Smits SL, 2012, EMERG INFECT DIS, V18, P1539, DOI 10.3201/eid1809.120507; Smits SL, 2011, EMERG INFECT DIS, V17, P2328, DOI 10.3201/eid1712.110934; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1966, DOI 10.3201/eid1812.111237; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Walter CT, 2011, J GEN VIROL, V92, P80, DOI 10.1099/vir.0.024240-0; Watanabe S, 2010, EMERG INFECT DIS, V16, P986, DOI 10.3201/eid1606.091567; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu HC, 2009, J GEN VIROL, V90, P883, DOI 10.1099/vir.0.007732-0	86	79	79	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87194	10.1371/journal.pone.0087194	http://dx.doi.org/10.1371/journal.pone.0087194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489870	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000119
J	Djonlagic, I; Guo, MS; Matteis, P; Carusona, A; Stickgold, R; Malhotra, A				Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Carusona, Andrea; Stickgold, Robert; Malhotra, Atul			Untreated Sleep-Disordered Breathing: Links to Aging-Related Decline in Sleep-Dependent Memory Consolidation	PLOS ONE			English	Article							SLOW-WAVE SLEEP; WAKING COGNITIVE PERFORMANCE; CARDIOVASCULAR RISK-FACTORS; MIDDLE-AGED ADULTS; OLDER-ADULTS; DECLARATIVE MEMORY; MOTOR SKILL; INTERMITTENT HYPOXIA; INSOMNIA COMPLAINTS; HEART HEALTH	Background: Increasing age is associated with a decline in cognition and motor skills, while at the same time exacerbating one's risk of developing obstructive sleep apnea (OSA). OSA-related cognitive deficits are highly prevalent and can affect various memory systems including overnight memory consolidation on a motor sequence task. Thus, the aim of our study was to examine the effect of aging on sleep-dependent motor memory consolidation in patients with and without OSA. Methods: We studied 44 patients (19-68 years) who had been referred by a physician for a baseline polysomnography (PSG) evaluation. Based on their PSG, patients were assigned either to the OSA group (AHI>5/h), or control (Non-OSA) group (AHI<5/h). All subjects performed the Psychomotor Vigilance Task (PVT) and the Motor Sequence Learning Task (MST) in the evening and again in the morning after their PSG. Results: Despite similar learning in the evening, OSA subjects showed significantly less overnight improvement on the MST, both for immediate (OSA -2.7%+/- 2.8% vs. controls 12.2%+/- 3.5%; p = 0.002) and plateau improvement (OSA 4.9%+/- 2.3% vs. controls 21.1%+/- 4.0%; p = 0.001). Within the OSA group, there was a significant negative correlation between overnight MST improvement and age (r(2) = 0.3; p = 0.01), an effect that was not observed in the Non-OSA group (r(2) = 0.08; p = 0.23) Conclusions: Consistent with previous research, healthy sleepers demonstrated a higher degree of sleep-dependent overnight improvement on the MST, an effect not mitigated by increasing age. However, the presence of untreated obstructive sleep apnea is associated with an aging-related cognitive deficit, otherwise not present in individuals without OSA. As other research has linked the presence of OSA to a higher likelihood of developing dementia, future studies are necessary to examine if the inhibition of memory consolidation is tied to the onset of neurodegenerative disease.	[Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Carusona, Andrea; Malhotra, Atul] Brigham & Womens Hosp, Div Sleep Med, Sleep Disorders Res Program, Boston, MA 02115 USA; [Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Carusona, Andrea; Stickgold, Robert; Malhotra, Atul] Harvard Univ, Sch Med, Boston, MA USA; [Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Stickgold, Robert] Beth Israel Hosp, Dept Psychiat, Ctr Sleep & Cognit, Boston, MA USA; [Malhotra, Atul] Univ Calif San Diego, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Diego	Djonlagic, I (corresponding author), Brigham & Womens Hosp, Div Sleep Med, Sleep Disorders Res Program, 75 Francis St, Boston, MA 02115 USA.	idonlagic@partners.org			American Board of Sleep Medicine Junior Faculty Research Award [K23 HL10385-01, P01 HL 095491, K24 HL 093218, R01 HL090897, AHA 0840159N, R01 HL085188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL103850, R01HL090897, P01HL095491, R01HL085188, K24HL093218] Funding Source: NIH RePORTER	American Board of Sleep Medicine Junior Faculty Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by K23 HL10385-01, American Board of Sleep Medicine Junior Faculty Research Award, P01 HL 095491, K24 HL 093218, R01 HL090897, AHA 0840159N, R01 HL085188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanatis M, 2008, SLEEP BREATH, V12, P17, DOI 10.1007/s11325-007-0133-y; Ancoli-Israel S, 1989, Clin Geriatr Med, V5, P347; Ancoli-Israel S, 2008, HARVARD REV PSYCHIAT, V16, P279, DOI 10.1080/10673220802432210; ANCOLIISRAEL S, 1993, SLEEP, V16, pS25, DOI 10.1093/sleep/16.suppl_8.S25; ANCOLIISRAEL S, 1995, AM J RESP CRIT CARE, V152, P1946, DOI 10.1164/ajrccm.152.6.8520760; AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; ANCOLIISRAEL S, 1991, BIOFEEDBACK SELF-REG, V16, P349, DOI 10.1007/BF00999989; Ayalon L, 2010, AM J RESP CRIT CARE, V182, P413, DOI 10.1164/rccm.200912-1805OC; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Boehlecke B A, 2000, Curr Opin Pulm Med, V6, P471, DOI 10.1097/00063198-200011000-00002; BONNET MH, 1993, SLEEP, V16, pS65, DOI 10.1093/sleep/16.suppl_8.S65; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Crenshaw MC, 1999, PHYSIOL BEHAV, V66, P485, DOI 10.1016/S0031-9384(98)00316-3; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; Dealberto MJ, 1996, J AM GERIATR SOC, V44, P1287, DOI 10.1111/j.1532-5415.1996.tb01397.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Djonlagic I, 2009, LEARN MEMORY, V16, P751, DOI 10.1101/lm.1634509; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Edinger JD, 2000, PHYSIOL BEHAV, V70, P127, DOI 10.1016/S0031-9384(00)00238-9; Engleman HM, 2000, SLEEP, V23, pS102; Federal Interagency Forum on Aging-Related Statistics, 2010, OLD AM 2012 KEY IND; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gozal D, 2003, J NEUROCHEM, V86, P1545, DOI 10.1046/j.1471-4159.2003.01973.x; GRANAT P, 1990, J FAM PRACTICE, V30, P632; GRUNSTEIN RR, 1995, INT J OBESITY, V19, P410; HOCH CC, 1990, SLEEP, V13, P502, DOI 10.1093/sleep/13.6.502; Hornung OP, 2005, EXP GERONTOL, V40, P279, DOI 10.1016/j.exger.2005.02.001; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Iber C., 2007, AASM MANUAL SCORING; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lavie P, 2009, J SLEEP RES, V18, P397, DOI 10.1111/j.1365-2869.2009.00754.x; Malhotra A., 2006, AM J MED, V119, p72.; Manabe K, 2000, GERONTOLOGY, V46, P318, DOI 10.1159/000022184; Manoach DS, 2010, J PSYCHIATR RES, V44, P112, DOI 10.1016/j.jpsychires.2009.06.011; MANT A, 1995, SLEEP, V18, P433, DOI 10.1093/sleep/18.6.433; MCCANN UD, 1992, BIOL PSYCHIAT, V31, P1082, DOI 10.1016/0006-3223(92)90153-Q; Newman AB, 1997, J AM GERIATR SOC, V45, P1; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Rockwood K, 2001, J AM GERIATR SOC, V49, P639, DOI 10.1046/j.1532-5415.2001.49125.x; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Tucker M, 2011, J AM GERIATR SOC, V59, P603, DOI 10.1111/j.1532-5415.2011.03324.x; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yim-Yeh S, 2010, SLEEP, V33, P1177, DOI 10.1093/sleep/33.9.1177; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	64	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85918	10.1371/journal.pone.0085918	http://dx.doi.org/10.1371/journal.pone.0085918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489679	gold, Green Published			2022-12-25	WOS:000330570000019
J	Finkle, WD; Greenland, S; Ridgeway, GK; Adams, JL; Frasco, MA; Cook, MB; Fraumeni, JF; Hoover, RN				Finkle, William D.; Greenland, Sander; Ridgeway, Gregory K.; Adams, John L.; Frasco, Melissa A.; Cook, Michael B.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.			Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OLDER MEN; CARDIOVASCULAR EVENTS; HORMONE-THERAPY; METAANALYSIS; THROMBOSIS; AUTOPSY; BLOOD	Background: An association between testosterone therapy (TT) and cardiovascular disease has been reported and TT use is increasing rapidly. Methods: We conducted a cohort study of the risk of acute non-fatal myocardial infarction (MI) following an initial TT prescription (N = 55,593) in a large health-care database. We compared the incidence rate of MI in the 90 days following the initial prescription (post-prescription interval) with the rate in the one year prior to the initial prescription (pre-prescription interval) (post/pre). We also compared post/pre rates in a cohort of men prescribed phosphodiesterase type 5 inhibitors (PDE5I; sildenafil or tadalafil, N = 167,279), and compared TT prescription post/pre rates with the PDE5I post/pre rates, adjusting for potential confounders using doubly robust estimation. Results: In all subjects, the post/pre-prescription rate ratio (RR) for TT prescription was 1.36 (1.03, 1.81). In men aged 65 years and older, the RR was 2.19 (1.27, 3.77) for TT prescription and 1.15 (0.83, 1.59) for PDE5I, and the ratio of the rate ratios (RRR) for TT prescription relative to PDE5I was 1.90 (1.04, 3.49). The RR for TT prescription increased with age from 0.95 (0.54, 1.67) for men under age 55 years to 3.43 (1.54, 7.56) for those aged >= 75 years (p(trend) = 0.03), while no trend was seen for PDE5I (p(trend) = 0.18). In men under age 65 years, excess risk was confined to those with a prior history of heart disease, with RRs of 2.90 (1.49, 5.62) for TT prescription and 1.40 (0.91, 2.14) for PDE5I, and a RRR of 2.07 (1.05, 4.11). Discussion: In older men, and in younger men with pre-existing diagnosed heart disease, the risk of MI following initiation of TT prescription is substantially increased.	[Finkle, William D.; Ridgeway, Gregory K.; Adams, John L.; Frasco, Melissa A.] Consolidated Res Inc, Los Angeles, CA 90045 USA; [Greenland, Sander] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Greenland, Sander] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; [Cook, Michael B.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Finkle, WD (corresponding author), Consolidated Res Inc, Los Angeles, CA 90045 USA.	bill@consolidated-research.com; hooverr@mail.nih.gov	Cook, Michael B/A-5641-2009	Cook, Michael B/0000-0002-0533-7302; Frasco, Melissa/0000-0002-3437-1518; Ridgeway, Greg/0000-0001-6911-0804	National Cancer Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAYI AAL, 1995, CIRCULATION, V91, P2742, DOI 10.1161/01.CIR.91.11.2742; Baillargeon J, 2013, JAMA INTERN MED, P1; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Baskurt OK, 2012, SEMIN THROMB HEMOST, V38, P854, DOI 10.1055/s-0032-1325616; Bremner WJ, 2010, NEW ENGL J MED, V363, P189, DOI 10.1056/NEJMe1006197; Corona G, 2011, EUR J ENDOCRINOL, V165, P687, DOI 10.1530/EJE-11-0447; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hensen LG, 2010, HLTH RES DATA REAL W; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jackson G, 2006, UROLOGY, V68, P47, DOI 10.1016/j.urology.2006.05.047; JAMA, 1970, JAMA, V214, P1303, DOI DOI 10.1001/JAMA.1970.03180070069012; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; O'Connor A, 2013, MENS USE HORMONES RI; Oliva A, 2011, ATHEROSCLEROSIS, V218, P28, DOI 10.1016/j.atherosclerosis.2011.05.012; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Peerschke EI, 2007, AM J CLIN PATHOL, V127, P422, DOI 10.1309/B29E2AHMTQA1KAKJ; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Roger VL, 2001, AM J MED, V110, P267, DOI 10.1016/S0002-9343(00)00709-9; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Ruige JB, 2011, HEART, V97, P870, DOI 10.1136/hrt.2010.210757; Sandset PM, 2009, THROMB RES, V123, pS70, DOI 10.1016/S0049-3848(09)70015-5; Seeger JD, 2003, AM J CARDIOL, V92, P1447, DOI 10.1016/j.amjcard.2003.08.057; Spitzer M, 2013, NAT REV ENDOCRINOL, V9, DOI [10.1038/nrendo.2013.73-c2, 10.1038/nrendo.2013.73]; Swerdloff RS, 2000, J CLIN ENDOCR METAB, V85, P4500, DOI 10.1210/jc.85.12.4500; Urhausen A, 2003, J STEROID BIOCHEM, V84, P369, DOI 10.1016/S0960-0760(03)00105-5; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108	31	491	500	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85805	10.1371/journal.pone.0085805	http://dx.doi.org/10.1371/journal.pone.0085805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489673	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000017
J	Lu, HL; Liu, GF				Lu, Heli; Liu, Guifang			Recent Observations of Human-induced Asymmetric Effects on Climate in Very High-Altitude Area	PLOS ONE			English	Article							TIME-SERIES; TEMPERATURE TRENDS; VEGETATION INDEX; LAND DEGRADATION; QUALITY-CONTROL; NETWORK; IMPACT; MAXIMUM; DEFORESTATION; URBANIZATION	Like urban heat islands (UHI), human-induced land degradation (HLD) is a phenomenon attributed to human activities, but this phenomenon occurs in non-urban areas. Although a large body of work has demonstrated that land-cover change influences local climate systems, little work has been done on separating the impact of HLD from naturally-occurring fluctuations in very high-altitude areas. We developed an innovative NDVI-difference method in order to evaluate HLD effects upon the climate system in the central Tibet Plateau. The results show that the minimum temperature increased at a significantly faster pace than the maximum temperature in the growing season at HLD meteorological stations, but this was reversed at stations with natural forces only. Further analysis revealed that abrupt changes of minimum temperature occurred five years earlier and amplitudes of these changes were 1.4 times larger than at stations with natural forces only. Therefore, our results complement other evidence that points to the fact that local effects from UHI contribute to climatic asymmetry observed between minimum and maximum temperature trends. Accordingly, we stress the need for consideration of non-urban factors from anthropogenic activities, such as human-induced land degradation, in understanding these asymmetric diurnal changes.	[Lu, Heli; Liu, Guifang] Henan Univ, Inst Nat Resources & Environm Sci, Kaifeng, Peoples R China; [Lu, Heli; Liu, Guifang] Henan Univ, Coll Environm & Planning, Kaifeng, Peoples R China; [Lu, Heli] Henan Collaborat Innovat Ctr Coordinated Dev Cent, Zhengzhou, Peoples R China; [Lu, Heli] United Nations Univ Inst Adv Studies, Yokohama, Kanagawa, Japan	Henan University; Henan University; United Nations University	Lu, HL (corresponding author), Henan Univ, Inst Nat Resources & Environm Sci, Kaifeng, Peoples R China.	cluheli@gmail.com		LU, Heli/0000-0002-9443-4031	National Natural Science Foundation of China [41371525]; National Basic Research Program of China (973 Program) [2012CB955800 (2012CB955804)]; China Postdoctoral Science Foundation [2012M521390, 2013T60696]; Scientific Research Foundation for Returned Scholars [2013(693)];  [2013B065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); 	This project is funded with support from National Natural Science Foundation of China under Project 41371525, National Basic Research Program of China (973 Program) 2012CB955800 (2012CB955804), China Postdoctoral Science Foundation funded project (2012M521390 & 2013T60696), Scientific Research Foundation for Returned Scholars 2013(693) and 2013B065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E., 2003, 53 WCDMP WORLD MET O; Andersson E, 1999, Q J ROY METEOR SOC, V125, P697, DOI 10.1256/smsqj.55415; Andersson E, 2011, ANNU REV ENV RESOUR, V36, P295, DOI 10.1146/annurev-environ-033110-092827; Balling RC, 1998, CLIMATIC CHANGE, V40, P669, DOI 10.1023/A:1005370115396; BALLING RC, 1991, B AM METEOROL SOC, V72, P232; Barrow C. J., 1991, LAND DEGRADATION DEV; Beniston M, 1996, 5001035179 SWISS NAT; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Brown ME, 2005, QUANTITATIVE COMP 4; Chattopadhyay S, 2011, METEOROL APPL, V18, P70, DOI 10.1002/met.211; Cornelis WM, 2009, LAND USE LAND COVER, V3; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Dingguo Y, 1992, P CHENGD S IAHS, P471; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Fast JD, 2005, J APPL METEOROL, V44, P3, DOI 10.1175/JAM-2176.1; Feng S, 2004, INT J CLIMATOL, V24, P853, DOI 10.1002/joc.1047; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; Gallo KP, 1996, J CLIMATE, V9, P2941, DOI 10.1175/1520-0442(1996)009<2941:TIOLUC>2.0.CO;2; Gallo KP, 1999, J CLIMATE, V12, P1344, DOI 10.1175/1520-0442(1999)012<1344:TTOTUS>2.0.CO;2; Gallo KP, 2005, J CLIMATE, V18, P1629, DOI 10.1175/JCLI3358.1; Gerstengarbe FW, 1999, CLIMATE RES, V11, P97, DOI 10.3354/cr011097; Gilbert R. O., 1987, STAT METHODS ENV POL; Goossens C, 1987, NATO ASI SERIES C, V216, P31, DOI DOI 10.1007/978-94-009-3993-6_3; Hale RC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009548; Hawkins TW, 2004, J APPL METEOROL, V43, P476, DOI 10.1175/1520-0450(2004)043&lt;0476:TRORVI&gt;2.0.CO;2; Hollander M., 1973, NONPARAMETRIC STAT M; IPCC, 1996, FULL TEXT CLIM CHANG; JONES PD, 1990, NATURE, V347, P169, DOI 10.1038/347169a0; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Lin ZY., 1981, ACTA GEOGR SIN, V36, P22, DOI DOI 10.11821/XB198101003; Liu XY, 2002, ONGOING NATL PROVENC; LORENC AC, 1988, Q J ROY METEOR SOC, V114, P515, DOI 10.1002/qj.49711448012; Ma Y, 2009, HYDROL EARTH SYST SC, V13, P1103, DOI 10.5194/hess-13-1103-2009; Marland G, 2003, CLIM POLICY, V3, P149, DOI 10.1016/S1469-3062(03)00028-7; Mintenbeck K., 2022, CLIMATE CHANGE 2022; Modarres R, 2007, J ARID ENVIRON, V70, P344, DOI 10.1016/j.jaridenv.2006.12.024; Myneni RB, 1998, J GEOPHYS RES-ATMOS, V103, P6145, DOI 10.1029/97JD03603; Owen TW, 2000, J CLIMATE, V13, P4028, DOI 10.1175/1520-0442(2001)013<4028:UPMFUS>2.0.CO;2; Owen TW, 1998, INT J REMOTE SENS, V19, P3451, DOI 10.1080/014311698214127; Pinker RT, 2005, SCIENCE, V308, P850, DOI 10.1126/science.1103159; PINZON J, 2002, SCI 2002 C P JUL 14; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Spronken-Smith RA, 1998, INT J REMOTE SENS, V19, P2085, DOI 10.1080/014311698214884; Tabari H, 2011, ENVIRON MONIT ASSESS, V177, P273, DOI 10.1007/s10661-010-1633-y; Theil H., 1950, NEDERLANDSCHE AKAD W, V53, P1397; Theil H., 1950, NEDERL AKAD WETENSCH, V53, P512; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; WMO, 2005, 989 WMO; Yao TD, 2000, CHINESE SCI BULL, V45, P1236, DOI 10.1007/BF02886087; Zhou LM, 2007, P NATL ACAD SCI USA, V104, P17937, DOI 10.1073/pnas.0700290104; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	58	25	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e81535	10.1371/journal.pone.0081535	http://dx.doi.org/10.1371/journal.pone.0081535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489643	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000004
J	Mirkina, I; Hadzijusufovic, E; Krepler, C; Mikula, M; Mechtcheriakova, D; Strommer, S; Stella, A; Jensen-Jarolim, E; Holler, C; Wacheck, V; Pehamberger, H; Valent, P				Mirkina, Irina; Hadzijusufovic, Emir; Krepler, Clemens; Mikula, Mario; Mechtcheriakova, Diana; Strommer, Sabine; Stella, Alexander; Jensen-Jarolim, Erika; Hoeller, Christoph; Wacheck, Volker; Pehamberger, Hubert; Valent, Peter			Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; INITIATING CELLS; THERAPIES; SURVIVAL; KINASES; GROWTH	Malignant melanoma is a life-threatening skin cancer increasingly diagnosed in the western world. In advanced disease the prognosis is grave. Growth and metastasis formation in melanomas are regulated by a network of cytokines, cytokine-receptors, and adhesion molecules. However, little is known about surface antigens and target expression profiles in human melanomas. We examined the cell surface antigen profile of human skin melanoma cells by multicolor flow cytometry, and compared their phenotype with 4 melanoma cell lines (A375, 607B, Mel-Juso, SK-Mel28). Melanoma cells were defined as CD45-/CD31- cells co-expressing one or more melanoma-related antigens (CD63, CD146, CD166). In most patients, melanoma cells exhibited ErbB3/Her3, CD44/Pgp-1, ICAM-1/CD54 and IGF-1-R/CD221, but did not express CD20, ErbB2/Her2, KIT/CD117, AC133/CD133 or MDR-1/CD243. Melanoma cell lines were found to display a similar phenotype. In most patients, a distinct subpopulation of melanoma cells (4-40%) expressed the erythropoietin receptor (EPO-R) and ErbB4 together with PD-1 and NGF-R/CD271. Both the EPO-R+ and EPO-R2 subpopulations produced melanoma lesions in NOD/SCID IL-2Rgamma(null) (NSG) mice in first and secondary recipients. Normal skin melanocytes did not express ErbB4 or EPO-R, but expressed a functional KIT receptor (CD117) as well as NGF-R, ErbB3/Her3, IGF-1-R and CD44. In conclusion, melanoma cells display a unique composition of surface target antigens and cytokine receptors. Malignant transformation of melanomas is accompanied by loss of KIT and acquisition of EPO-R and ErbB4, both of which are co-expressed with NGF-R and PD-1 in distinct subfractions of melanoma cells. However, expression of EPO-R/ErbB4/PD-1 is not indicative of a selective melanoma-initiating potential.	[Mirkina, Irina; Hadzijusufovic, Emir; Krepler, Clemens; Mechtcheriakova, Diana; Jensen-Jarolim, Erika; Pehamberger, Hubert; Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Hadzijusufovic, Emir; Valent, Peter] Med Univ Vienna, Dept Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Hadzijusufovic, Emir] Univ Vet Med Vienna, Clin Unit Internal Med, Clin Small Anim, Dept Clin Compan Anim & Horses, Vienna, Austria; [Krepler, Clemens; Mikula, Mario; Hoeller, Christoph; Pehamberger, Hubert] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Mikula, Mario; Strommer, Sabine] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Mechtcheriakova, Diana; Jensen-Jarolim, Erika] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Stella, Alexander; Wacheck, Volker] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Vienna, Austria; [Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria	Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Valent, P (corresponding author), Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria.	peter.valent@meduniwien.ac.at	Test, PV/U-9451-2019; Valent, Peter/B-8533-2016; Hadzijusufovic, Emir/B-8109-2016; Zelle, Mast/V-2890-2019; Test, Test/Y-7921-2019; Jensen-Jarolim, Erika/C-5120-2018; Wacheck, Volker/ABD-4893-2021; Gamperl, Susi/V-2715-2019	Valent, Peter/0000-0003-0456-5095; Hadzijusufovic, Emir/0000-0001-7409-4204; Zelle, Mast/0000-0001-7409-4204; Jensen-Jarolim, Erika/0000-0003-4019-5765; Gamperl, Susi/0000-0003-0456-5095; Mechtcheriakova, Diana/0000-0002-8737-3592; Mikula, Mario/0000-0001-5782-0681	Research Grant on Tumor Stem Cells of the Medical University of Vienna	Research Grant on Tumor Stem Cells of the Medical University of Vienna	Supported by a Research Grant on Tumor Stem Cells of the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonitsis N., 2006, Experimental Oncology, V28, P187; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Djerf EA, 2009, MELANOMA RES, V19, P156, DOI 10.1097/CMR.0b013e32832c6339; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Haluska F, 2007, SEMIN ONCOL, V34, P546, DOI 10.1053/j.seminoncol.2007.09.011; Heine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028030; Kumar SM, 2012, ONCOGENE, V31, P1649, DOI 10.1038/onc.2011.366; Kumar SM, 2005, AM J PATHOL, V166, P823, DOI 10.1016/S0002-9440(10)62303-6; Kumar SM, 2006, MELANOMA RES, V16, P275, DOI 10.1097/01.cmr.0000222594.60611.c3; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lindholm C, 2004, CANCER-AM CANCER SOC, V101, P2067, DOI 10.1002/cncr.20602; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; McWilliams RR, 2008, EXPERT REV ANTICANC, V8, P743, DOI 10.1586/14737140.8.5.743; Mechtcheriakova D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025611; Mirmohammadsadegh A, 2010, J INVEST DERMATOL, V130, P201, DOI 10.1038/jid.2009.162; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Murakami T, 2004, J DERMATOL SCI, V36, P71, DOI 10.1016/j.jdermsci.2004.03.002; Natarajan N, 2011, DRUGS, V71, P1233, DOI 10.2165/11591380-000000000-00000; Nikolaou VA, 2012, J INVEST DERMATOL, V132, P854, DOI 10.1038/jid.2011.421; Passegue E, 2009, NAT MED, V15, P612, DOI [10.1038/nm0109-23, 10.1038/nm0609-612]; Pho L, 2006, CURR OPIN ONCOL, V18, P173, DOI 10.1097/01.cco.0000208791.22442.09; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Radford KJ, 1996, BIOCHEM BIOPH RES CO, V222, P13, DOI 10.1006/bbrc.1996.0690; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Selzer E, 2000, MELANOMA RES, V10, P421, DOI 10.1097/00008390-200010000-00003; Smalley KSM, 2009, INT J CANCER, V124, P1245, DOI 10.1002/ijc.24129; Swart GWM, 2005, CANCER METAST REV, V24, P223, DOI 10.1007/s10555-005-1573-0; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368	36	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e84417	10.1371/journal.pone.0084417	http://dx.doi.org/10.1371/journal.pone.0084417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489649	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000007
J	Salvadori, MR; Ando, RA; do Nascimento, CAO; Correa, B				Salvadori, Marcia R.; Ando, Romulo A.; Oller do Nascimento, Claudio A.; Correa, Benedito			Intracellular Biosynthesis and Removal of Copper Nanoparticles by Dead Biomass of Yeast Isolated from the Wastewater of a Mine in the Brazilian Amazonia	PLOS ONE			English	Article							BIOLOGICAL SYNTHESIS; AQUEOUS-SOLUTION; HEAVY-METAL; MICROBIAL SYNTHESIS; BIOSORPTION; CADMIUM; OXIDE; IONS; FABRICATION; ADSORPTION	In this study was developed a natural process using a biological system for the biosynthesis of nanoparticles (NPs) and possible removal of copper from wastewater by dead biomass of the yeast Rhodotorula mucilaginosa. Dead and live biomass of Rhodotorula mucilaginosa was used to analyze the equilibrium and kinetics of copper biosorption by the yeast in function of the initial metal concentration, contact time, pH, temperature, agitation and inoculum volume. Dead biomass exhibited the highest biosorption capacity of copper, 26.2 mg g(-1), which was achieved within 60 min of contact, at pH 5.0, temperature of 30 degrees C, and agitation speed of 150 rpm. The equilibrium data were best described by the Langmuir isotherm and Kinetic analysis indicated a pseudo-second-order model. The average size, morphology and location of NPs biosynthesized by the yeast were determined by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDS) and transmission electron microscopy (TEM). The shape of the intracellularly synthesized NPs was mainly spherical, with an average size of 10.5 nm. The X-ray photoelectron spectroscopy (XPS) analysis of the copper NPs confirmed the formation of metallic copper. The dead biomass of Rhodotorula mucilaginosa may be considered an efficiently bioprocess, being fast and low-cost to production of copper nanoparticles and also a probably nano-adsorbent of this metal ion in wastewater in bioremediation process.	[Salvadori, Marcia R.; Correa, Benedito] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed 2, Sao Paulo, Brazil; [Ando, Romulo A.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil; [Oller do Nascimento, Claudio A.] Univ Sao Paulo, Dept Engn Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Salvadori, MR (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed 2, Sao Paulo, Brazil.	mrsal@usp.br	Nascimento, Claudio A.O./G-8565-2014; Ando, Romulo Augusto/C-9665-2012	Nascimento, Claudio A.O./0000-0001-6110-0249; Ando, Romulo Augusto/0000-0002-3872-8094; Salvadori, Marcia Regina/0000-0001-6771-5447; Correa, Benedito/0000-0003-4314-0751	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri M, 2009, MATER LETT, V63, P1231, DOI 10.1016/j.matlet.2009.02.042; Ahmad Iqbal, 2006, Indian J Exp Biol, V44, P73; Aizpurua J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.057401; Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Bharde AA, 2008, LANGMUIR, V24, P5787, DOI 10.1021/la704019p; Bishnoi NR, 2005, J SCI IND RES INDIA, V64, P93; Briggs D., 1990, PRATICAL SURFACE ANA, V1; Cho DH, 2003, BIOPROC BIOSYST ENG, V25, P271, DOI 10.1007/s00449-002-0315-8; Cho DH, 2002, THEORIES APPL CHEM E, V8, P4037; DAMERON CT, 1989, NATURE, V338, P596, DOI 10.1038/338596a0; Du AX, 2009, WATER AIR SOIL POLL, V201, P99, DOI 10.1007/s11270-008-9930-6; Elmaci A, 2007, WATER ENVIRON RES, V79, P1000, DOI 10.2175/106143007X183961; Evans P, 2008, NAT NANOTECHNOL, V3, P577, DOI 10.1038/nnano.2008.286; Faryal R, 2006, PAK J BOT, V38, P817; FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; Gericke M, 2006, GOLD BULL, V39, P22, DOI 10.1007/BF03215529; Ghodselahi T, 2008, APPL SURF SCI, V255, P2730, DOI 10.1016/j.apsusc.2008.08.110; Goksungur Y, 2005, BIORESOURCE TECHNOL, V96, P103, DOI 10.1016/j.biortech.2003.04.002; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Grimm A, 2008, BIORESOURCE TECHNOL, V99, P2559, DOI 10.1016/j.biortech.2007.04.036; Guo ZH, 2007, COMPOS SCI TECHNOL, V67, P2036, DOI 10.1016/j.compscitech.2006.11.017; Hasan SS, 2008, J NANOSCI NANOTECHNO, V8, P3191, DOI 10.1166/jnn.2008.095; He SY, 2008, BIOTECHNOL PROGR, V24, P476, DOI 10.1021/bp0703174; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Honary S, 2012, DIG J NANOMATER BIOS, V7, P999; Jeong S, 2008, ADV FUNCT MATER, V18, P679, DOI 10.1002/adfm.200700902; Jha AK, 2009, BIOCHEM ENG J, V43, P303, DOI 10.1016/j.bej.2008.10.016; Kowshik M, 2003, NANOTECHNOLOGY, V14, P95, DOI 10.1088/0957-4484/14/1/321; Kowshik M, 2002, ADV MATER, V14, P815, DOI 10.1002/1521-4095(20020605)14:11<815::AID-ADMA815>3.0.CO;2-K; Kowshik M, 2002, BIOTECHNOL BIOENG, V78, P583, DOI 10.1002/bit.10233; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kumar BN, 2011, SEP SCI TECHNOL, V46, P997, DOI 10.1080/01496395.2010.537727; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Langergren S., 1898, SVEN VETENSKAPSAKAD, V24, P1, DOI DOI 10.1007/BF01501332; Li YM, 2008, MATER RES BULL, V43, P2380, DOI 10.1016/j.materresbull.2007.07.045; Li Z, 2008, BIORESOURCE TECHNOL, V99, P1339, DOI 10.1016/j.biortech.2007.02.004; Li ZJ, 2006, APPL MICROBIOL BIOT, V73, P458, DOI 10.1007/s00253-006-0473-8; Liu YG, 2006, T NONFERR METAL SOC, V16, P681, DOI 10.1016/S1003-6326(06)60121-0; Machado MD, 2010, J HAZARD MATER, V180, P347, DOI 10.1016/j.jhazmat.2010.04.037; Nakajima A, 2001, WORLD J MICROB BIOT, V17, P343, DOI 10.1023/A:1016638230043; Naumkin A. V., 2012, 20 NIST; Neter J., 1996, APPL LINEAR STAT MOD; Nguyen TH, 1998, APPL MICROBIOL BIOT, V50, P206, DOI 10.1007/s002530051278; Nimrichter L, 2005, MICROBES INFECT, V7, P789, DOI 10.1016/j.micinf.2005.03.002; PANDAY KK, 1986, WATER AIR SOIL POLL, V27, P287, DOI 10.1007/BF00649410; Rai A, 2006, LANGMUIR, V22, P736, DOI 10.1021/la052055q; Ramanathan R, 2013, NANOSCALE, V5, P2300, DOI 10.1039/c2nr32887a; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989; ROME L, 1987, APPL MICROBIOL BIOT, V26, P84, DOI DOI 10.1007/BF00282153; Sanghi R, 2009, BIORESOURCE TECHNOL, V100, P501, DOI 10.1016/j.biortech.2008.05.048; Selatnia A, 2004, BIOCHEM ENG J, V19, P127, DOI 10.1016/j.bej.2003.12.007; Singh AV, 2010, CURR NANOSCI, V6, P365; Tortora G., 1998, MICROBIOLOGY INTRO; Varshney R., 2012, NANO BIOMED ENG, V4, P99, DOI [10.5101/nbe.v4i2.p99-106, DOI 10.5101/NBE.V4I2.P99-106]; Veit MT, 2005, PROCESS BIOCHEM, V40, P3303, DOI 10.1016/j.procbio.2005.03.029; Villegas LB, 2005, J BASIC MICROB, V45, P381, DOI 10.1002/jobm.200510569; Volesky B, 2003, HYDROMETALLURGY, V71, P179, DOI 10.1016/S0304-386X(03)00155-5; Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2; Yahaya YA, 2009, J HAZARD MATER, V161, P189, DOI 10.1016/j.jhazmat.2008.03.104; Yilmazer P, 2009, J CHEM TECHNOL BIOT, V84, P604, DOI 10.1002/jctb.2088; Zhang DL, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159551	64	59	59	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87968	10.1371/journal.pone.0087968	http://dx.doi.org/10.1371/journal.pone.0087968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489975	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000185
J	Sims, RE; Dale, N				Sims, Robert Edward; Dale, Nicholas			Activity-Dependent Adenosine Release May Be Linked to Activation of Na+-K+ ATPase: An In Vitro Rat Study	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL SLICES; ISCHEMIA; NEURONS; BRAIN; INHIBITION; EXPRESSION; KINASE; DEPOLARIZATION; WAKEFULNESS	In the brain, extracellular adenosine increases as a result of neuronal activity. The mechanisms by which this occurs are only incompletely understood. Here we investigate the hypothesis that the Na+ influxes associated with neuronal signalling activate the Na+-K+ ATPase which, by consuming ATP, generates intracellular adenosine that is then released via transporters. By measuring adenosine release directly with microelectrode biosensors, we have demonstrated that AMPA-receptor evoked adenosine release in basal forebrain and cortex depends on extracellular Na+. We have simultaneously imaged intracellular Na+ and measured adenosine release. The accumulation of intracellular Na+ during AMPA receptor activation preceded adenosine release by some 90 s. By removing extracellular Ca2+, and thus preventing indiscriminate neuronal activation, we used ouabain to test the role of the Na+-K+ ATPase in the release of adenosine. Under conditions which caused a Na+ influx, brief applications of ouabain increased the accumulation of intracellular Na+ but conversely rapidly reduced extracellular adenosine levels. In addition, ouabain greatly reduced the amount of adenosine released during application of AMPA. Our data therefore suggest that activity of the Na+-K+ ATPase is directly linked to the efflux of adenosine and could provide a universal mechanism that couples adenosine release to neuronal activity. The Na+-K+ ATPase-dependent adenosine efflux is likely to provide adenosine-mediated activity-dependent negative feedback that will be important in many diverse functional contexts including the regulation of sleep.	[Sims, Robert Edward; Dale, Nicholas] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Sims, RE (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.e.sims@aston.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949; Sims, Robert/0000-0003-1373-7514	Wellcome Trust [WT087968MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust, grant WT087968MA, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Blom H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-16; Boison D, 2006, TRENDS PHARMACOL SCI, V27, P652, DOI 10.1016/j.tips.2006.10.008; Brundege JM, 1998, NEUROREPORT, V9, P3007, DOI 10.1097/00001756-199809140-00016; Brundege JM, 1996, J NEUROSCI, V16, P5603; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Dale N, 2000, J PHYSIOL-LONDON, V526, P143, DOI 10.1111/j.1469-7793.2000.00143.x; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Dunwiddie T V, 1999, Adv Neurol, V79, P1001; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; Etherington LAV, 2009, NEUROPHARMACOLOGY, V56, P429, DOI 10.1016/j.neuropharm.2008.09.016; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Frenguelli BG, 2003, J NEUROCHEM, V86, P1506, DOI 10.1046/j.1471-4159.2003.01957.x; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Gourine AV, 2008, J PHYSIOL-LONDON, V586, P3963, DOI 10.1113/jphysiol.2008.154567; Hirsh AJ, 2007, BIOCHEMISTRY-US, V46, P10373, DOI 10.1021/bi7009647; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Klyuch BP, 2011, J PHYSIOL-LONDON, V589, P283, DOI 10.1113/jphysiol.2010.198986; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Ma YF, 2011, CEREB CORTEX, V21, P2639, DOI 10.1093/cercor/bhr051; Meier C, 2002, HISTOCHEM CELL BIOL, V117, P461, DOI 10.1007/s00418-002-0417-z; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Santos SD, 2010, J PROTEOME RES, V9, P1670, DOI 10.1021/pr900766r; Schmitt LI, 2012, J NEUROSCI, V32, P4417, DOI 10.1523/JNEUROSCI.5689-11.2012; Sims RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053814; Studer FE, 2006, NEUROSCIENCE, V142, P125, DOI 10.1016/j.neuroscience.2006.06.016; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Torok TL, 2007, PROG NEUROBIOL, V82, P287, DOI 10.1016/j.pneurobio.2007.06.003; Wall MJ, 2007, J PHYSIOL-LONDON, V581, P553, DOI 10.1113/jphysiol.2006.126417; Wall MJ, 2013, J PHYSIOL-LONDON, V591, P3853, DOI 10.1113/jphysiol.2013.253450; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009; zur Nedden S, 2011, J NEUROSCI, V31, P6221, DOI 10.1523/JNEUROSCI.4039-10.2011	43	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87481	10.1371/journal.pone.0087481	http://dx.doi.org/10.1371/journal.pone.0087481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489921	Green Accepted, Green Published, gold			2022-12-25	WOS:000330570000148
J	Testini, M; Gurrado, A; Portincasa, P; Scacco, S; Marzullo, A; Piccinni, G; Lissidini, G; Greco, L; De Salvia, MA; Bonfrate, L; Debellis, L; Sardaro, N; Staffieri, F; Carratu, MR; Crovace, A				Testini, Mario; Gurrado, Angela; Portincasa, Piero; Scacco, Salvatore; Marzullo, Andrea; Piccinni, Giuseppe; Lissidini, Germana; Greco, Luigi; De Salvia, Maria Antonietta; Bonfrate, Leonilde; Debellis, Lucantonio; Sardaro, Nicola; Staffieri, Francesco; Carratu, Maria Rosaria; Crovace, Antonio			Bovine Pericardium Patch Wrapping Intestinal Anastomosis Improves Healing Process and Prevents Leakage in a Pig Model	PLOS ONE			English	Article							STAPLE-LINES; COLORECTAL SURGERY; BURST PRESSURE; IN-VITRO; REINFORCEMENT; COLON; BUTTRESS; BOWEL; RAT	Failure of intestinal anastomosis is a major complication following abdominal surgery. Biological materials have been introduced as reinforcement of abdominal wall hernia in contaminated setting. An innovative application of biological patch is its use as reinforcement of gastrointestinal anastomosis. The aim of study was to verify whether the bovine pericardium patch improves the healing of anastomosis, when in vivo wrapping the suture line of pig intestinal anastomosis, avoiding leakage in the event of deliberately incomplete suture. Forty-three pigs were randomly divided: Group 1 (control, n = 14): hand-sewn ileo-ileal and colo-colic anastomosis; Group 2 (n = 14): standard anastomosis wrapped by pericardium bovine patch; Group 3 (n = 1) and 4 (n = 14): one suture was deliberately incomplete and also wrapped by patch in the last one. Intraoperative evaluation, histological, biochemical, tensiometric and electrophysiological studies of intestinal specimens were performed at 48 h, 7 and 90 days after. In groups 2 and 4, no leak, stenosis, abscess, peritonitis, mesh displacement or shrinkage were found and adhesion rate decreased compared to control. Biochemical studies showed mitochondrial function improvement in colic wrapped anastomosis. Tensiometric evaluations suggested that the patch preserves the colic contractility similar to the controls. Electrophysiological results demonstrated that the patch also improves the mucosal function restoring almost normal transport properties. Use of pericardium bovine patch as reinforcement of intestinal anastomosis is safe and effective, significantly improving the healing process. Data of prevention of acute peritonitis and leakage in cases of iatrogenic perforation of anastomoses, covered with patch, is unpublished.	[Testini, Mario; Gurrado, Angela; Piccinni, Giuseppe; Lissidini, Germana] Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Unit Endocrine Digest & Emergency Surg, Bari, Italy; [Portincasa, Piero; Bonfrate, Leonilde] Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Unit Med A Murri, Bari, Italy; [Scacco, Salvatore; Sardaro, Nicola] Univ Med Sch A Moro, Dept Basic Med Sci, Bari, Italy; [Marzullo, Andrea] Univ Med Sch A Moro, Dept Emergency Surg & Organ Transplantat, Unit Pathol, Bari, Italy; [Greco, Luigi] Univ Med Sch A Moro, Dept Emergency Surg & Organ Transplantat, Unit Gen Surg & Liver Transplantat, Bari, Italy; [De Salvia, Maria Antonietta; Carratu, Maria Rosaria] Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Sect Pharmachol, Bari, Italy; [Debellis, Lucantonio] Univ Med Sch A Moro, Dept Biosci Biotechnol & Pharmacol Sci, Bari, Italy; [Staffieri, Francesco; Crovace, Antonio] Univ Med Sch A Moro, Dept Emergency Surg & Organ Transplantat, Div Vet Clin & Anim Prod, Bari, Italy		Testini, M (corresponding author), Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Unit Endocrine Digest & Emergency Surg, Bari, Italy.	mario.testini@uniba.it	Bonfrate, Leonilde/ABH-1835-2021; Scacco, Salvatore/AAC-7406-2022; Lissidini, Germana/AAP-7189-2020; Staffieri, Francesco/K-4230-2016; crovace, antonio/K-6375-2016	Scacco, Salvatore/0000-0003-2717-2489; Debellis, Lucantonio/0000-0002-7571-0969; De Salvia, Maria Antonietta/0000-0001-5326-792X; Staffieri, Francesco/0000-0002-2085-376X; crovace, antonio/0000-0002-1391-339X; portincasa, piero/0000-0001-5359-1471; Testini, Mario/0000-0002-9297-4894; Carratu, Maria/0000-0002-9709-6533				Arnold W, 2005, OBES SURG, V15, P164, DOI 10.1381/0960892053268309; BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P395, DOI 10.1016/0006-2944(78)90089-3; CRAWFORD FA, 1986, ANN THORAC SURG, V41, P602, DOI 10.1016/S0003-4975(10)63068-8; Debellis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005074; Dilek ON, 1996, ACTA CHIR BELG, V96, P261; DOCHERTY JG, 1995, ANN SURG, V221, P176, DOI 10.1097/00000658-199502000-00008; Downey DM, 2005, OBES SURG, V15, P1379, DOI 10.1381/096089205774859254; Enestvedt CK, 2006, MICROSURG, V26, P137, DOI 10.1002/micr.20198; Gaertner WB, 2010, J BIOMED MATER RES B, V92B, P48, DOI 10.1002/jbm.b.31488; Hagerman GF, 2007, DIS COLON RECTUM, V50, P1053, DOI 10.1007/s10350-007-0212-y; Hoeppner J, 2010, EUR SURG RES, V45, P68, DOI 10.1159/000318856; Hoeppner J, 2010, J GASTROINTEST SURG, V14, P977, DOI 10.1007/s11605-010-1191-1; Hoeppner J, 2009, INT J COLORECTAL DIS, V24, P543, DOI 10.1007/s00384-009-0637-y; HUTSON JM, 1985, ANN ROY COLL SURG, V67, P107; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Kimberger O, 2007, ANESTH ANALG, V105, P773, DOI 10.1213/01.ane.0000277490.90387.96; Kosmidis C, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-6; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006; Morell VO, 2007, ANN THORAC SURG, V84, P1312, DOI 10.1016/j.athoracsur.2007.05.036; Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769; Nocca D, 2009, J LAPAROENDOSC ADV S, V19, P79, DOI 10.1089/lap.2008.0028; Portillo G, 2010, J LAPAROENDOSC ADV S, V20, P323, DOI 10.1089/lap.2009.0201; Schreinemacher MH, 2011, INT J COLORECTAL DIS, V26, P729, DOI 10.1007/s00384-011-1158-z; Shikora SA, 2003, OBES SURG, V13, P37, DOI 10.1381/096089203321136566; Telem DA, 2010, ARCH SURG-CHICAGO, V145, P371, DOI 10.1001/archsurg.2010.40; Testini M, 1998, EUR SURG RES, V30, P1, DOI 10.1159/000008551; Testini M, 2002, WORLD J SURG, V26, P493, DOI 10.1007/s00268-001-0255-5; Testini M, 2003, ANN ITAL CHIR, V74, P247; van Tuil Cornelia, 2006, Hernia, V10, P41; Zacharakis E, 2007, J INVEST SURG, V20, P9, DOI 10.1080/08941930601126074; Zhou HY, 2011, ANN SURG, V253, P1033, DOI 10.1097/SLA.0b013e31821260f3	33	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86627	10.1371/journal.pone.0086627	http://dx.doi.org/10.1371/journal.pone.0086627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489752	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000052
J	Alaimo, A; Alberdi, A; Gomis-Perez, C; Fernandez-Orth, J; Bernardo-Seisdedos, G; Malo, C; Millet, O; Areso, P; Villarroel, A				Alaimo, Alessandro; Alberdi, Araitz; Gomis-Perez, Carolina; Fernandez-Orth, Juncal; Bernardo-Seisdedos, Ganeko; Malo, Covadonga; Millet, Oscar; Areso, Pilar; Villarroel, Alvaro			Pivoting between Calmodulin Lobes Triggered by Calcium in the Kv7.2/Calmodulin Complex	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN-PEPTIDE; APO-CALMODULIN; GATING DOMAIN; IQ MOTIF; BINDING; CHANNELS; RECOGNITION; CALCINEURIN; MODULATION	Kv7.2 (KCNQ2) is the principal molecular component of the slow voltage gated M-channel, which strongly influences neuronal excitability. Calmodulin (CaM) binds to two intracellular C-terminal segments of Kv7.2 channels, helices A and B, and it is required for exit from the endoplasmic reticulum. However, the molecular mechanisms by which CaM controls channel trafficking are currently unknown. Here we used two complementary approaches to explore the molecular events underlying the association between CaM and Kv7.2 and their regulation by Ca2+. First, we performed a fluorometric assay using dansylated calmodulin (D-CaM) to characterize the interaction of its individual lobes to the Kv7.2 CaM binding site (Q2AB). Second, we explored the association of Q2AB with CaM by NMR spectroscopy, using N-15-labeled CaM as a reporter. The combined data highlight the interdependency of the N- and C-lobes of CaM in the interaction with Q2AB, suggesting that when CaM binds Ca2+ the binding interface pivots between the N-lobe whose interactions are dominated by helix B and the C-lobe where the predominant interaction is with helix A. In addition, Ca2+ makes CaM binding to Q2AB more difficult and, reciprocally, the channel weakens the association of CaM with Ca2+.	[Alaimo, Alessandro; Alberdi, Araitz; Gomis-Perez, Carolina; Fernandez-Orth, Juncal; Bernardo-Seisdedos, Ganeko; Malo, Covadonga; Villarroel, Alvaro] Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Leioa, Spain; [Areso, Pilar] Univ Basque Country, UPV EHU, Dept Farmacol, Leioa, Spain; [Millet, Oscar] CICbioGUNE, Struct Biol Unit, Derio, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Villarroel, A (corresponding author), Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Leioa, Spain.	alvaro.villarroel@csic.es	Bernardo-Seisdedos, Ganeko/C-6923-2016; Arco, Mariangeles/C-6181-2016; Alaimo, Alessandro/C-6334-2016; Millet, Oscar/F-9696-2011; Gomis-Perez, Carolina/J-6472-2012; Villarroel, Alvaro/H-5580-2015	Bernardo-Seisdedos, Ganeko/0000-0002-1372-3844; Arco, Mariangeles/0000-0002-0993-7460; Alaimo, Alessandro/0000-0002-5888-6268; Millet, Oscar/0000-0001-8748-4105; Gomis-Perez, Carolina/0000-0002-6818-4403; 	Spanish Ministry of Education [BFU2012-39883, BFU2009-07581]; Spanish Ion Channel Initiative Consolider project [CSD2008-00005]; Basque Government [SAIOTEK SA-2006/00023, 304211ENA9]; Fundacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation [BES-2008-002314]; CSIC; European Social Funds; Basque Country Government [BFI-2011-159]	Spanish Ministry of Education(Spanish Government); Spanish Ion Channel Initiative Consolider project; Basque Government(Basque Government); Fundacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; European Social Funds(European Social Fund (ESF)); Basque Country Government(Basque Government)	This work was supported by grants from the Spanish Ministry of Education (BFU2012-39883 and BFU2009-07581), the Spanish Ion Channel Initiative Consolider project (CSD2008-00005), and the Basque Government (SAIOTEK SA-2006/00023 and 304211ENA9). A. Alaimo and C. Malo were partially funded by Fundacion Biofisica Bizkaia. J. Fernandez-Orth held a FPI fellowship from the Spanish Ministry of Science and Innovation (BES-2008-002314). A. Alberdi holds a JAE-predoctoral CSIC fellowship cofinanced with European Social Funds. G. Bernardo-Seisdedos holds a fellowship from the Basque Country Government (BFI-2011-159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2012, METHOD MOL BIOL, V998, P217; Alaimo A, 2013, J CELL SCI, V126, P244, DOI 10.1242/jcs.114082; Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Bellini G, 2010, GENEREVIEWS; Black DJ, 2010, BIOCHEMISTRY-US, V49, P78, DOI 10.1021/bi901695p; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Gomez-Posada JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025508; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jama AM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.157057; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; KINCAID RL, 1982, J BIOL CHEM, V257, P638; LINSE S, 1991, J BIOL CHEM, V266, P8050; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Mruk K, 2012, P NATL ACAD SCI USA, V109, P13579, DOI 10.1073/pnas.1207606109; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Sanabria H, 2008, BIOPHYS J, V95, P6002, DOI 10.1529/biophysj.108.138974; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Ye QL, 2006, BIOCHEMISTRY-US, V45, P738, DOI 10.1021/bi0521801; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zhang M, 2013, P NATL ACAD SCI USA, V110, P4828, DOI 10.1073/pnas.1220253110; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941	52	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86711	10.1371/journal.pone.0086711	http://dx.doi.org/10.1371/journal.pone.0086711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489773	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000074
J	He, DX; Jin, D; Baquero, C; Liu, DY				He, Dongxiao; Jin, Di; Baquero, Carlos; Liu, Dayou			Link Community Detection Using Generative Model and Nonnegative Matrix Factorization	PLOS ONE			English	Article							COMPLEX NETWORKS	Discovery of communities in complex networks is a fundamental data analysis problem with applications in various domains. While most of the existing approaches have focused on discovering communities of nodes, recent studies have shown the advantages and uses of link community discovery in networks. Generative models provide a promising class of techniques for the identification of modular structures in networks, but most generative models mainly focus on the detection of node communities rather than link communities. In this work, we propose a generative model, which is based on the importance of each node when forming links in each community, to describe the structure of link communities. We proceed to fit the model parameters by taking it as an optimization problem, and solve it using nonnegative matrix factorization. Thereafter, in order to automatically determine the number of communities, we extend the above method by introducing a strategy of iterative bipartition. This extended method not only finds the number of communities all by itself, but also obtains high efficiency, and thus it is more suitable to deal with large and unexplored real networks. We test this approach on both synthetic benchmarks and real-world networks including an application on a large biological network, and compare it with two highly related methods. Results demonstrate the superior performance of our approach over competing methods for the detection of link communities.	[He, Dongxiao; Liu, Dayou] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [He, Dongxiao; Jin, Di; Liu, Dayou] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Jin, Di] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Jin, Di] Bournemouth Univ, Sch Design Engn & Comp, Poole BH12 5BB, Dorset, England; [Baquero, Carlos] INESC TEC, HASLab, Braga, Portugal; [Baquero, Carlos] Univ Minho, Braga, Portugal	Jilin University; Jilin University; Tianjin University; Bournemouth University; INESC TEC; Universidade do Minho	Jin, D (corresponding author), Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China.	jindi@tju.edu.cn; liudy@jlu.edu.cn	Jin, Di/AAC-3716-2019; Baquero, Carlos/AAA-2371-2021	Baquero, Carlos/0000-0002-3933-6850	Major State Basic Research Development Program of China [2013CB329301]; National Natural Science Foundation of China [61303110, 61133011, 61373053, 61070089, 61373165, 61202308]; PhD Programs Foundation of Ministry of Education of China [20130032120043]; Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education [93K172013K02]; Innovation Foundation of Tianjin University [60302034]; TECHNO II project within Erasmus Mundus Programme of European Union; China Scholarship Council	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China); Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education; Innovation Foundation of Tianjin University; TECHNO II project within Erasmus Mundus Programme of European Union; China Scholarship Council(China Scholarship Council)	This work is supported by Major State Basic Research Development Program of China (2013CB329301), National Natural Science Foundation of China (61303110, 61133011, 61373053, 61070089, 61373165, 61202308), PhD Programs Foundation of Ministry of Education of China (20130032120043), Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education (93K172013K02), Innovation Foundation of Tianjin University (60302034), the TECHNO II project within Erasmus Mundus Programme of European Union, and the China Scholarship Council (award to Dongxiao He for one year's study abroad at Washington University in St Louis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Altman D.G., 1999, PRACTICAL STAT MED R; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ball B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036103; Boyd S., 2004, CONVEX OPTIMIZATION; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Evans TS, 2010, EUR PHYS J B, V77, P265, DOI 10.1140/epjb/e2010-00261-8; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grunwald P. D., 2007, MINIMUM DESCRIPTION; He DX, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/10/P10015; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kim Y, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026110; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pan L, 2011, PROC INT C TOOLS ART, P884, DOI 10.1109/ICTAI.2011.140; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Ren W, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036111; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shen HW, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056111; Tan VYF, 2013, IEEE T PATTERN ANAL, V35, P1592, DOI 10.1109/TPAMI.2012.240; Wang F, 2011, DATA MIN KNOWL DISC, V22, P493, DOI 10.1007/s10618-010-0181-y; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Zhang Y., 2012, P 18 ACM SIGKDD INT, P606, DOI [DOI 10.1145/2339530.2339629, 10.1145/2339530.2339629]; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803	31	14	16	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86899	10.1371/journal.pone.0086899	http://dx.doi.org/10.1371/journal.pone.0086899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489803	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000088
J	Leonard, SM; Perry, T; Woodman, CB; Kearns, P				Leonard, Sarah M.; Perry, Tracey; Woodman, Ciaran B.; Kearns, Pamela			Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia	PLOS ONE			English	Article							LOW-DOSE DECITABINE; DNA METHYLATION; PHASE-II; 5-AZA-2'-DEOXYCYTIDINE; MULTICENTER; COMBINATION; INHIBITORS; CELLS	The current interest in epigenetic priming is underpinned by the belief that remodelling of the epigenetic landscape will sensitise tumours to subsequent therapy. In this pre-clinical study, paediatric AML cells expanded in culture and primary AML xenografts were treated with decitabine, a DNA demethylating agent, and cytarabine, a frontline cytotoxic agent used in the treatment of AML, either alone or in combination. Sequential treatment with decitabine and cytarabine was found to be more effective in reducing tumour burden than treatment with cytarabine alone suggesting that the sequential delivery of these agents may a have real clinical advantage in the treatment of paediatric AML. However we found no evidence to suggest that this outcome was dependent on priming with a hypomethylating agent, as the benefits observed were independent of the order in which these drugs were administered.	[Leonard, Sarah M.; Perry, Tracey; Woodman, Ciaran B.] Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England; [Kearns, Pamela] Univ Birmingham, Sch Canc Sci, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England	University of Birmingham; Cancer Research UK; University of Birmingham	Woodman, CB (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England.	c.b.woodman@bham.ac.uk; p.r.kearns@bham.ac.uk	Kearns, Pamela/AAD-6011-2021	Kearns, Pamela/0000-0003-2756-5813	Leukemia and Lymphoma Research UK; Janssen Research and Development	Leukemia and Lymphoma Research UK(Leukemia and Lymphoma Society); Janssen Research and Development	This work was supported by Leukemia and Lymphoma Research UK and by Janssen Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salihi M, 2011, EPIGENETICS-US, V6, P1021, DOI 10.4161/epi.6.8.16064; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; BOEHM TLJ, 1982, CANCER RES, V42, P1537; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Claus R, 2013, LEUKEMIA RES, V37, P190, DOI 10.1016/j.leukres.2012.10.015; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; Link PA, 2008, CANCER RES, V68, P9358, DOI 10.1158/0008-5472.CAN-08-1860; Mims A, 2013, LEUKEMIA, V27, P871, DOI 10.1038/leu.2012.342; Negrotto S, 2012, LEUKEMIA, V26, P244, DOI 10.1038/leu.2011.207; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; Phillips CL, 2013, BRIT J HAEMATOL, V161, P406, DOI 10.1111/bjh.12268; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Ricart AD, 2011, CLIN CANCER RES, V17, P6417, DOI 10.1158/1078-0432.CCR-11-0486; Scandura JM, 2011, BLOOD, V118, P1472, DOI 10.1182/blood-2010-11-320093; Schuringa Jan Jacob, 2009, V538, P287, DOI 10.1007/978-1-59745-418-6_14; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956	21	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87475	10.1371/journal.pone.0087475	http://dx.doi.org/10.1371/journal.pone.0087475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489920	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000137
J	Lutay, N; Hakansson, G; Alaridah, N; Hallgren, O; Westergren-Thorsson, G; Godaly, G				Lutay, Nataliya; Hakansson, Gisela; Alaridah, Nader; Hallgren, Oskar; Westergren-Thorsson, Gunilla; Godaly, Gabriela			Mycobacteria Bypass Mucosal NF-kB Signalling to Induce an Epithelial Anti-Inflammatory IL-22 and IL-10 Response	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HEPARIN-BINDING HEMAGGLUTININ; CALMETTE-GUERIN INFECTION; COMPLETE GENOME SEQUENCE; FACTOR-KAPPA-B; INNATE IMMUNITY; TRANSCRIPTION FACTORS; HOST-DEFENSE; INTRACELLULAR PERSISTENCE; DENDRITIC CELLS	The mechanisms by which mycobacteria subvert the inflammatory defence to establish chronic infection remain an unresolved question in the pathogenesis of tuberculosis. Using primary epithelial cells, we have analysed mycobacteria induced epithelial signalling pathways from activation of TLRs to cytokine secretion. Mycobacterium bovis bacilli Calmette-Guerin induced phosphorylation of glycogen synthase kinase (GSK)3 by PI3K-Akt in the signalling pathway downstream of TLR2 and TLR4. Mycobacteria did not supress NF-kappa B by activating the peroxisome proliferator-activated receptor gamma. Instead the pro-inflammatory NF-kappa B was bypassed by mycobacteria induced GSK3 inhibition that promoted the anti-inflammatory transcription factor CREB. Mycobacterial infection did not thus induce mucosal pro-inflammatory response as measured by TNF alpha and IFN gamma secretion, but led to an anti-inflammatory IL-10 and IL-22 production. Apart from CREB, MAP3Ks p38 and ERK1/2 activated the transcription factor AP-1 leading to IL-6 production. Interestingly, blocking of TLR4 before infection decreased epithelial IL-6 secretion, but increased the CREB-activated IL-10 production. Our data indicate that mycobacteria supress epithelial pro-inflammatory production by supressing NF-kappa B activation thereby shifting the infection towards an anti-inflammatory state. This balance between the host immune response and the pathogen could determine the outcome of infection.	[Lutay, Nataliya; Hakansson, Gisela; Alaridah, Nader; Godaly, Gabriela] Lund Univ, Div Lab Med, Dept MIG, Lund, Sweden; [Hallgren, Oskar] Lund Univ, Dept Resp Med & Allergol, Div Clin Sci, Lund, Sweden; [Westergren-Thorsson, Gunilla] Lund Univ, Div Vasc & Resp Res Unit Lung Biol, Dept Expt Med Sci, Lund, Sweden	Lund University; Lund University; Lund University	Godaly, G (corresponding author), Lund Univ, Div Lab Med, Dept MIG, Lund, Sweden.	Gabriela.godaly@med.lu.se	Godaly, Gabriela/AAD-7545-2019; Godaly, Gabriela/C-8786-2014; Lutay, Nataliya/K-1733-2014	Godaly, Gabriela/0000-0002-3467-1350; Godaly, Gabriela/0000-0002-3467-1350; Lutay, Nataliya/0000-0003-1852-1288; Alaridah, Nader/0000-0003-3659-8203	Swedish Medical Research Council [2005-7364, 7364, 11550]; Crafoord Foundation; Heart and Lung Foundation; Evy and Gunnar Sandberg Foundation; Medical Faculty of Lund University, Sweden	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Evy and Gunnar Sandberg Foundation; Medical Faculty of Lund University, Sweden	This study was supported by a Research Scientist Grant from the Swedish Medical Research Council (2005-7364, 7364, 11550); the Crafoord Foundation; the Heart and Lung Foundation; Evy and Gunnar Sandberg Foundation and the Medical Faculty of Lund University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, SCAND J IMMUNOL, V62, P16, DOI 10.1111/j.1365-3083.2005.01639.x; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Andersson M, 2012, INNATE IMMUN-LONDON, V18, P531, DOI 10.1177/1753425911426591; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Caceres N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029010; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Dhiman R, 2007, BBA-GEN SUBJECTS, V1770, P649, DOI 10.1016/j.bbagen.2006.11.016; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Elkington PTG, 2005, J IMMUNOL, V175, P5333, DOI 10.4049/jimmunol.175.8.5333; Florio W, 2009, CAN J MICROBIOL, V55, P975, DOI [10.1139/W09-053, 10.1139/w09-053]; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Godaly G, 2005, CELL MICROBIOL, V7, P591, DOI 10.1111/j.1462-5822.2004.00489.x; Gopal R, 2013, MUCOSAL IMMUNOL; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Hakansson G, 2012, IMMUNOBIOLOGY; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jacobs M, 2000, IMMUNOLOGY, V100, P494, DOI 10.1046/j.1365-2567.2000.00053.x; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knight D, 2011, PULM PHARMACOL THER, V24, P193, DOI 10.1016/j.pupt.2010.10.005; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; Li Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/791392; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Matthews K, TUBERCULOSIS EDINB, V91, P587; Mazurek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042515; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Mendez-Samperio P, 2007, CELL IMMUNOL, V245, P111, DOI 10.1016/j.cellimm.2007.04.005; Menozzi FD, 2006, MICROBES INFECT, V8, P1, DOI 10.1016/j.micinf.2005.03.023; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Muhl H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00018; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Neufert C, 2001, J IMMUNOL, V167, P1542, DOI 10.4049/jimmunol.167.3.1542; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pethe K, 2001, MOL MICROBIOL, V39, P89, DOI 10.1046/j.1365-2958.2001.02206.x; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Saini D, 2012, TUBERCULOSIS, V92, P160, DOI 10.1016/j.tube.2011.11.007; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; SILVA MT, 1989, MICROB PATHOGENESIS, V6, P369, DOI 10.1016/0882-4010(89)90079-X; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Toossi Z, 1997, J IMMUNOL, V159, P4109; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2	69	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86466	10.1371/journal.pone.0086466	http://dx.doi.org/10.1371/journal.pone.0086466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489729	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000052
J	Zhao, F; Pan, SL; Gu, Y; Guo, SY; Dai, QC; Yu, YY; Zhang, W				Zhao, Feng; Pan, Shengli; Gu, Yan; Guo, Shanyu; Dai, Qiancheng; Yu, Yingyan; Zhang, Wei			Small Activating RNA Restores the Activity of the Tumor Suppressor HIC-1 on Breast Cancer	PLOS ONE			English	Article							INDUCE TRANSCRIPTIONAL ACTIVATION; MAMMALIAN-CELLS; BINDING PROTEIN; UP-REGULATION; EXPRESSION; GENE; KINASE; OVEREXPRESSION; APOPTOSIS; INVASION	HIC-1 is a gene that is hypermethylated in cancer, and commonly downregulated in human breast cancer. However, the precise mechanisms and molecular pathways regulated by HIC-1 remain unclear. We assessed HIC-1 expression on a tissue microarray containing 80 cases of breast cancer. We also analyzed its biological function by restoring HIC-1 expression using 5-aza-2' deoxycytidine (5-CdR) and small-activating RNAs for the reversal of HIC-1 tumor suppressive effects on MCF-7 and MDA-MB-231 cell lines. An Agilent Q44h global expressing microarray was probed after restoring the expression of HIC-1. Data demonstrated that HIC-1 expression was reduced significantly in breast cancer tissues. HIC-1 immunohistochemistry resulted in mean staining scores in cancer tissue and normal ductal epithelia of 3.54 and 8.2, respectively (p < 0.01). 5-CdR partially reversed HIC-1 expression, and modulated cell growth and apoptosis. dsHIC1-2998, an saRNA, showed activating efficacy in breast cancer cells. A group of differentially expressed genes were characterized by cDNA microarray. Upon saRNA treatment, genes upregulated included those involved in immune activation, cell cycle interference, the induction of apoptosis, anti-metastasis, and cell differentiation. Downregulated genes included oncogenes and those that play roles in cell invasion, cell growth, and cell division. Our findings may provide valuable resources not only for gene functional studies, but also for potential clinical applications to develop novel drug targets.	[Zhao, Feng; Gu, Yan; Guo, Shanyu; Dai, Qiancheng; Zhang, Wei] Shanghai Jiao Tong Univ, Dept Surg, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Yu, Yingyan] Shanghai Jiao Tong Univ, Dept Surg, Shanghai Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, W (corresponding author), Shanghai Jiao Tong Univ, Dept Surg, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China.	weizh1518@hotmail.com	Gu, Yan/AFQ-1163-2022		National High Tech Program [2012AA02A504, 2012AA02A203]; National Natural Science Foundation of China [81172329, 81372644]; Shanghai Science and Technology Commission [12410706400]	National High Tech Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was partly supported by the National High Tech Program (2012AA02A504, 2012AA02A203); National Natural Science Foundation of China (81172329 and 81372644), and the International Cooperative Project from Shanghai Science and Technology Commission (12410706400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann V, 2001, J PATHOL, V195, P191, DOI 10.1002/path.941; Bando Hiroko, 2007, Breast Cancer, V14, P163, DOI 10.2325/jbcs.968; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen Z, 2008, MOL CANCER THER, V7, P698, DOI 10.1158/1535-7163.MCT-07-2312; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Fujita T, 2009, CANCER SCI, V100, P238, DOI 10.1111/j.1349-7006.2008.01026.x; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Hall CL, 1995, J NEURO-ONCOL, V26, P221, DOI 10.1007/BF01052625; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hassan ZK, 2012, ASIAN PAC J CANCER P, V13, P3259, DOI 10.7314/APJCP.2012.13.7.3259; Hirata A, 2005, CANCER RES, V65, P4253, DOI 10.1158/0008-5472.CAN-04-2748; Hu J, 2012, BIOCHEM J, V447, P407, DOI 10.1042/BJ20120256; Huang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008848; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kang MR, 2012, CANCER RES, V72, P5069, DOI 10.1158/0008-5472.CAN-12-1871; Krishnan A, 2008, BIOCHEM PHARMACOL, V75, P1924, DOI 10.1016/j.bcp.2008.02.013; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Larrieu-Lahargue F, 2011, CIRC RES, V109, P770, DOI 10.1161/CIRCRESAHA.111.247239; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Lopez-Munoz E, 2012, CLIN TRANSL ONCOL, V14, P586, DOI 10.1007/s12094-012-0845-8; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; Mao QQ, 2008, BIOCHEM BIOPH RES CO, V375, P566, DOI 10.1016/j.bbrc.2008.08.059; Mao ZG, 2010, APOPTOSIS, V15, P1211, DOI 10.1007/s10495-010-0513-9; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Nicoll G, 2001, BRIT J CANCER, V85, P1878, DOI 10.1054/bjoc.2001.2163; O'Donovan N, 2007, ANTICANCER RES, V27, P1285; Oliveras-Ferraros C, 2008, INT J ONCOL, V33, P1165, DOI 10.3892/ijo_00000106; Pan SL, 2013, GENE, V527, P102, DOI 10.1016/j.gene.2013.05.034; Parrella P, 2005, CANCER LETT, V222, P75, DOI 10.1016/j.canlet.2004.08.026; Place RF, 2010, CURR PHARM BIOTECHNO, V11, P518; Portnoy V, 2011, WIRES RNA, V2, P748, DOI 10.1002/wrna.90; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Pushparaj PN, 2008, BIOINFORMATION, V2, P235, DOI 10.6026/97320630002235; Qin Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-11; Radetzki S, 2002, ONCOGENE, V21, P227, DOI 10.1038/sj/onc/1205010; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rood BR, 2013, EXPERT OPIN THER TAR, V17, P811, DOI 10.1517/14728222.2013.788152; Sankaran D, 2012, J BIOL CHEM, V287, P5483, DOI 10.1074/jbc.M111.324632; Shen DY, 2010, LIVER INT, V30, P119, DOI 10.1111/j.1478-3231.2009.02106.x; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Slotky M, 2005, BREAST CANCER RES, V7, pR737, DOI 10.1186/bcr1278; Soung YH, 2008, HUM PATHOL, V39, P895, DOI 10.1016/j.humpath.2007.10.015; Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07; Tokuda Y, 2009, BREAST CANCER-TOKYO, V16, P295, DOI 10.1007/s12282-009-0142-8; Ueda S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-384; URIA JA, 1994, CANCER RES, V54, P2091; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wall NR, 2003, LANCET, V362, P1401, DOI 10.1016/S0140-6736(03)14637-5; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang XC, 2009, BIOCHEM BIOPH RES CO, V379, P1107, DOI 10.1016/j.bbrc.2009.01.028; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Ward S, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13suppl1/01; Wei JX, 2010, CANCER SCI, V101, P1790, DOI 10.1111/j.1349-7006.2010.01594.x; Westbrook L, 2007, CANCER RES, V67, P11393, DOI 10.1158/0008-5472.CAN-06-4173; Westbrook L, 2009, INT J ONCOL, V34, P1425, DOI 10.3892/ijo_00000271; Yang SX, 2011, INT J ONCOL, V38, P1445, DOI 10.3892/ijo.2011.966; Yang SX, 2009, EXPERT REV ANTICANC, V9, P1715, DOI 10.1586/ERA.09.153; Yuan Y, 2011, DIAGN CYTOPATHOL, V39, P562, DOI 10.1002/dc.21424; Zhang W, 2011, INT J MOL SCI, V12, P5672, DOI 10.3390/ijms12095672; Zheng JH, 2013, CLIN CANCER RES, V19, P1400, DOI 10.1158/1078-0432.CCR-12-2888; Zhou RX, 2002, J NEURO-ONCOL, V59, P15, DOI 10.1023/A:1016373015569; Zou YY, 2002, CANCER RES, V62, P8	68	15	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86486	10.1371/journal.pone.0086486	http://dx.doi.org/10.1371/journal.pone.0086486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489730	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000053
J	Griffing, D; Larson, S; Hollander, J; Carpenter, T; Christiansen, J; Doss, C				Griffing, Denise; Larson, Shawn; Hollander, Joel; Carpenter, Tim; Christiansen, Jeff; Doss, Charles			Observations on Abundance of Bluntnose Sixgill Sharks, Hexanchus griseus, in an Urban Waterway in Puget Sound, 2003-2005	PLOS ONE			English	Article							NOTORYNCHUS-CEPEDIANUS; HYDROLAGUS-COLLIEI; MOVEMENTS; RATFISH; GEORGIA; STRAIT	The bluntnose sixgill shark, Hexanchus griseus, is a widely distributed but poorly understood large, apex predator. Anecdotal reports of diver-shark encounters in the late 1990's and early 2000's in the Pacific Northwest stimulated interest in the normally deep-dwelling shark and its presence in the shallow waters of Puget Sound. Analysis of underwater video documenting sharks at the Seattle Aquarium's sixgill research site in Elliott Bay and mark-resight techniques were used to answer research questions about abundance and seasonality. Seasonal changes in relative abundance in Puget Sound from 2003-2005 are reported here. At the Seattle Aquarium study site, 45 sixgills were tagged with modified Floy visual marker tags, along with an estimated 197 observations of untagged sharks plus 31 returning tagged sharks, for a total of 273 sixgill observations recorded. A mark-resight statistical model based on analysis of underwater video estimated a range of abundance from a high of 98 sharks seen in July of 2004 to a low of 32 sharks seen in March of 2004. Both analyses found sixgills significantly more abundant in the summer months at the Seattle Aquarium's research station.	[Griffing, Denise; Larson, Shawn; Hollander, Joel; Carpenter, Tim; Christiansen, Jeff] Seattle Aquarium, Life Sci, Seattle, WA 98101 USA; [Doss, Charles] Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Larson, S (corresponding author), Seattle Aquarium, Life Sci, Seattle, WA 98101 USA.	s.larson@seattleaquarium.org		Doss, Charles Raouf/0000-0003-1364-5222	Royal Caribbean Ocean Fund; Foley Frischkorn Conservation Fund; Seattle Aquarium	Royal Caribbean Ocean Fund; Foley Frischkorn Conservation Fund; Seattle Aquarium	The authors acknowledge The Seattle Aquarium, a grant from Royal Caribbean Ocean Fund, and a grant from the Foley Frischkorn Conservation Fund for financial support of this project. In kind contributions were provided by staff at The NOAA Northwest Fisheries Science Center, the Washington Department of Fish and Wildlife, Ocean Systems Inc. (Splashcam), and City Fish in Pike Place Market, Seattle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KS, 2007, CAN J ZOOL, V85, P1136, DOI 10.1139/Z07-088; Andrews KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012549; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Castro J. I., 1983, SHARKS N AM WATERS; Celona Antonio, 2005, Bollettino del Museo Civico di Storia Naturale di Venezia, V56, P137; Compagno L.J.V., 1984, FAO SPECIES CATALOGU, V4; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Dunbrack R, 2003, CAN J ZOOL, V81, P1107, DOI 10.1139/Z03-087; Dunbrack R, 2005, CAN FIELD NAT, V119, P537, DOI 10.22621/cfn.v119i4.184; Dunbrack R, 2008, CAN FIELD NAT, V122, P124, DOI 10.22621/cfn.v122i2.570; Ebert D. A., 1986, INDOPACIFIC FISH BIO, P437; Fowler SL, 2005, SHARKS RAYS CHIMAERA; Gallucci V. F., 2009, BIOL MANAGEMENT SPIN, P1; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; Kabasakal Hakan, 2006, Annales Series Historia Naturalis, V16, P29; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Klimley AP, 1985, S CAL ACAD SCI MEM, V9, P15; Klimley AP, 1982, THESIS U CALIFORNIA; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Larson S, 2011, CONSERV GENET, V12, P679, DOI 10.1007/s10592-010-0174-9; Levin PS, 2012, CURR ZOOL, V58, P103, DOI 10.1093/czoolo/58.1.103; Lucifora LO, 2005, MAR ECOL PROG SER, V289, P237, DOI 10.3354/meps289237; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; McClintock BT, 2009, ECOLOGY, V90, P313, DOI 10.1890/08-0973.1; Nakano H., 1994, B NATL RES I FAR SEA, V31, P141; QUINN TP, 1980, FISH B-NOAA, V78, P816; Reum JCP, 2008, ESTUAR COAST, V31, P790, DOI 10.1007/s12237-008-9064-5; Ruckelshaus M.H., 2007, SOUND SCI SYNTHESIZI; Springer S, 1950, TEX J SCI, V1950, P349; Strickland RM, 1983, FERTILE FJORD PLANKT; White G. C., 2012, PROGRAM MARK; Williams GD, 2012, J FISH BIOL, V80, P1380, DOI 10.1111/j.1095-8649.2011.03179.x; Williams GD, 2010, T AM FISH SOC, V139, P108, DOI 10.1577/T09-045.1; [No title captured]	34	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87081	10.1371/journal.pone.0087081	http://dx.doi.org/10.1371/journal.pone.0087081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475229	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300136
J	Leu, WJ; Chang, HS; Chan, SH; Hsu, JL; Yu, CC; Hsu, LC; Chen, IS; Guh, JH				Leu, Wohn-Jenn; Chang, Hsun-Shuo; Chan, She-Hung; Hsu, Jui-Ling; Yu, Chia-Chun; Hsu, Lih-Ching; Chen, Ih-Sheng; Guh, Jih-Hwa			Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell Cycle	PLOS ONE			English	Article							CARDIAC-GLYCOSIDES; NA+/K+-ATPASE; BETA-SUBUNIT; DNA-DAMAGE; APOPTOSIS; PROLIFERATION; NA,K-ATPASE; OLEANDRIN; ACTIVATION; PATHWAY	In the past decade, there has been a profound increase in the number of studies revealing that cardenolide glycosides display inhibitory activity on the growth of human cancer cells. The use of potential cardenolide glycosides may be a worthwhile approach in anticancer research. Reevesioside A, a cardenolide glycoside isolated from the root of Reevesia formosana, displayed potent anti-proliferative activity against human hormone-refractory prostate cancers. A good correlation (r(2) = 0.98) between the expression of Na+/K+-ATPase alpha(3) subunit and anti-proliferative activity suggested the critical role of the alpha(3) subunit. Reevesioside A induced G1 arrest of the cell cycle and subsequent apoptosis in a thymidine block-mediated synchronization model. The data were supported by the down-regulation of several related cell cycle regulators, including cyclin D1, cyclin E and CDC25A. Reevesioside A also caused a profound decrease of RB phosphorylation, leading to an increased association between RB and E2F1 and the subsequent suppression of E2F1 activity. The protein and mRNA levels of c-myc, which can activate expression of many downstream cell cycle regulators, were dramatically inhibited by reevesioside A. Transient transfection of c-myc inhibited the down-regulation of both cyclin D1 and cyclin E protein expression to reevesioside A action, suggesting that c-myc functioned as an upstream regulator. Flow cytometric analysis of JC-1 staining demonstrated that reevesioside A also induced the significant loss of mitochondrial membrane potential. In summary, the data suggest that reevesioside A inhibits c-myc expression and down-regulates the expression of CDC25A, cyclin D1 and cyclin E, leading to a profound decrease of RB phosphorylation. G1 arrest is, therefore, induced through E2F1 suppression. Consequently, reevesioside A causes mitochondrial damage and an ultimate apoptosis in human hormone-refractory prostate cancer cells.	[Leu, Wohn-Jenn; Chan, She-Hung; Hsu, Jui-Ling; Yu, Chia-Chun; Hsu, Lih-Ching; Guh, Jih-Hwa] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Chang, Hsun-Shuo; Chen, Ih-Sheng] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan	National Taiwan University; Kaohsiung Medical University	Guh, JH (corresponding author), Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan.	jhguh@ntu.edu.tw		HSU, LIH-CHING/0000-0002-7816-3825; GUH, JIH-HWA/0000-0002-6738-6054; Chang, Hsun-Shuo/0000-0003-2745-139X	National Science Council of the Republic of China [101-2320-B-002-018-MY3, 101-2811-B-002-095]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors acknowledge the support provided by the National Science Council of the Republic of China (101-2320-B-002-018-MY3 and 101-2811-B-002-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, LEUKEMIA LYMPHOMA, V52, P1544, DOI 10.3109/10428194.2011.570821; Bertero T, 2013, CELL DEATH DIFFER, V20, P800, DOI 10.1038/cdd.2013.5; Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Chang HS, 2013, PHYTOCHEMISTRY, V87, P86, DOI 10.1016/j.phytochem.2012.11.024; Chiu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064739; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Demeterco C, 2002, J CLIN ENDOCR METAB, V87, P3475, DOI 10.1210/jc.87.7.3475; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Hogstrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031366; Hsu JL, 2011, J UROLOGY, V185, P1967, DOI 10.1016/j.juro.2010.12.091; Kim SH, 2013, PROG NEURO-PSYCHOPH, V45, P73, DOI 10.1016/j.pnpbp.2013.04.018; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin WC, 2001, GENE DEV, V15, P1833; Lin Yun, 2010, J Exp Ther Oncol, V8, P271; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Lu PH, 2007, EUR J PHARMACOL, V556, P45, DOI 10.1016/j.ejphar.2006.10.061; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Ma YH, 2003, MOL CANCER THER, V2, P73; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manna SK, 2000, CANCER RES, V60, P3838; McConkey DJ, 2000, CANCER RES, V60, P3807; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Mijatovic T, 2013, PLANTA MED, V79, P189, DOI 10.1055/s-0032-1328243; Nasu K, 2005, MOL HUM REPROD, V11, P817, DOI 10.1093/molehr/gah249; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Newman RA, 2007, INTEGR CANCER THER, V6, P354, DOI 10.1177/1534735407309623; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Qiu DZ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-185; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Santander VS, 2006, MOL CELL BIOCHEM, V291, P167, DOI 10.1007/s11010-006-9212-9; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Uribesalgo I, 2012, CELL CYCLE, V11, P1757, DOI 10.4161/cc.19883; Vaklavas C, 2011, PHARMACOL THERAPEUT, V130, P177, DOI 10.1016/j.pharmthera.2011.01.009; Wang JQ, 2012, CANCER RES, V72, P4765, DOI 10.1158/0008-5472.CAN-12-0820; Watabe M, 1997, CELL GROWTH DIFFER, V8, P871; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Yang PY, 2009, MOL CANCER THER, V8, P2319, DOI 10.1158/1535-7163.MCT-08-1085	50	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87323	10.1371/journal.pone.0087323	http://dx.doi.org/10.1371/journal.pone.0087323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475272	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300168
J	Perot, G; Soubeyran, I; Ribeiro, A; Bonhomme, B; Savagner, F; Boutet-Bouzamondo, N; Hostein, I; Bonichon, F; Godbert, Y; Chibon, F				Perot, Gaelle; Soubeyran, Isabelle; Ribeiro, Agnes; Bonhomme, Benjamin; Savagner, Frederique; Boutet-Bouzamondo, Nathalie; Hostein, Isabelle; Bonichon, Francoise; Godbert, Yann; Chibon, Frederic			Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas	PLOS ONE			English	Article							LUNG-CANCER; PAPILLARY; PROTEIN; ALK; PATIENT; GENES; NPM	Thyroid carcinoma is the most common endocrine malignant tumor and accounts for 1% of all new malignant diseases. Among all types and subtypes of thyroid cancers that have been described so far, papillary thyroid carcinoma is the most frequent. The standard management treatment of these tumors consists of surgery, followed by radioiodine treatment in case of high risk of relapse. The most aggressive forms are commonly treated by chemotherapy, radiotherapy or experimental drug testing. We recently reported the case of a patient presenting an anaplastic thyroid carcinoma with lung metastases. Fluorescence in situ hybridization analysis allowed us to detect a rearrangement of the anaplastic lymphoma kinase (ALK) gene in both tumors. The patient was treated with crizotinib and presented an excellent drug response. We present here the subsequent investigations carried out to further characterize this genetic alteration and to assess the prevalence of ALK rearrangements in thyroid lesions. High resolution array-comparative genomic hybridization data complemented by RT-PCR and sequencing analyses, allowed us to demonstrate the presence of a STRN/ALK fusion. The STRN/ALK transcript consisted of the fusion between exon 3 of STRN and exon 20 of ALK. Subsequent screening of 75 various thyroid tumors by RT-PCR revealed that 2 out of 29 papillary thyroid carcinomas exhibited the same fusion transcript. None was detected in other types of malignant or benign thyroid lesions analyzed. These findings could pave the way for the development of new targeted therapeutic strategies in the treatment of papillary thyroid carcinomas and point to ALK inhibitors as promising agents that merit rapid evaluation.	[Perot, Gaelle; Soubeyran, Isabelle; Ribeiro, Agnes; Bonhomme, Benjamin; Hostein, Isabelle] Inst Bergonie, Dept Biopathol, Bordeaux, France; [Perot, Gaelle; Soubeyran, Isabelle; Chibon, Frederic] Inst Bergonie, INSERM, U916, Bordeaux, France; [Savagner, Frederique; Boutet-Bouzamondo, Nathalie] Inst Biol Sante, INSERM, U694, Angers, France; [Bonichon, Francoise; Godbert, Yann] Inst Bergonie, Dept Nucl Med, Bordeaux, France; [Chibon, Frederic] Inst Bergonie, Bordeaux, France	UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie	Chibon, F (corresponding author), Inst Bergonie, INSERM, U916, Bordeaux, France.	f.chibon@bordeaux.unicancer.fr	Pérot, Gaëlle/W-8038-2019; Pérot, Gaëlle/J-3912-2014; chibon, frederic/A-2651-2013	chibon, Frederic/0000-0002-6548-2181				Baudin E, 2007, LANCET ONCOL, V8, P148, DOI 10.1016/S1470-2045(07)70034-7; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Boonyaratanakornkit V, 2011, STEROIDS, V76, P877, DOI 10.1016/j.steroids.2011.02.017; Brose MS, 2013, ASCO M, V31, P4; Curtis CE, 2007, BRIT J HAEMATOL, V138, P77, DOI 10.1111/j.1365-2141.2007.06628.x; D'Avanzo A, 2004, CANCER-AM CANCER SOC, V100, P1123, DOI 10.1002/cncr.20081; DeLellis R, 2004, WHO CLASSIFICATION T; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Godbert Y, J CLIN ONCO IN PRESS; Hamatani K, 2012, THYROID, V22, P1153, DOI 10.1089/thy.2011.0511; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Martinez P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052261; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Perot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040015; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; Schlumberger M, 2012, EUR J ENDOCRINOL, V166, P5, DOI 10.1530/EJE-11-0631; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; SHIOTA M, 1994, ONCOGENE, V9, P1567; Smallridge RC, 2012, J CLIN ENDOCR METAB, V97, P2566, DOI 10.1210/jc.2012-1314; Terrier-Lacombe MJ, 2009, MODERN PATHOL, V22, P87, DOI 10.1038/modpathol.2008.156; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431	27	59	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87170	10.1371/journal.pone.0087170	http://dx.doi.org/10.1371/journal.pone.0087170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475247	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300149
J	Schroder, H; Ribas, L; Koebnick, C; Funtikova, A; Gomez, SF; Fito, M; Perez-Rodrigo, C; Serra-Majem, L				Schroeder, Helmut; Ribas, Lourdes; Koebnick, Corinna; Funtikova, Anna; Gomez, Santiago F.; Fito, Montserat; Perez-Rodrigo, Carmen; Serra-Majem, Lluis			Prevalence of Abdominal Obesity in Spanish Children and Adolescents. Do We Need Waist Circumference Measurements in Pediatric Practice?	PLOS ONE			English	Article							TO-HEIGHT RATIO; BODY-MASS INDEX; TRUNK FAT MASS; CARDIOMETABOLIC RISK; CENTRAL ADIPOSITY; CARDIOVASCULAR-DISEASE; SCREENING TOOL; OVERWEIGHT; TRENDS; PREDICTORS	Background: Evidence indicates that central adiposity has increased to a higher degree than general adiposity in children and adolescents in recent decades. However, waist circumference is not a routine measurement in clinical practice. Objective: This study aimed to determine the prevalence of abdominal obesity based on waist circumferences (WC) and waist to height ratio (WHtR) in Spanish children and adolescents aged 6 to 17 years. Further, the prevalence of abdominal obesity (AO) among normal and overweight individuals was analyzed. Design: Data were obtained from a study conducted from 1998 to 2000 in a representative national sample of 1521 children and adolescents aged 6 to 17 years (50.0% female) in Spain. WC and WHtR measurements were obtained in addition to BMI. AO was defined as WHtR >= 0.50 (WHtR-AO), sex and age specific WC >= 90th percentile (WC-AO1), and sex and age specific WC cut-off values associated with high trunk fat measured by by dual-energy X-ray absorptiometry (WC-AO2). Results: IOTF-based overweight and obsity prevalence was 21.5% and 6.6% in children and 17.4% and 5.2% in adolescents, respectively. Abdominal obesity (AO) was defined as WHtR >= 0.50 (WHtR-AO), sex-and age-specific WC >= 90th percentile (WC-AO1), and sex- and age-specific WC cut-off values associated with high trunk fat measured by dual-energy X-ray absorptiometry (WC-AO2). The respective prevalence of WHtR-AO, WC-AO1, and WC-AO2 was 21.3% (24.6% boys; 17.9% girls), 9.4% (9.1% boys; 9.7% girls), and 26.8% (30.6% boys; 22.9% girls) in children and 14.3% (20.0% boys; 8.7% girls), 9.6% (9.8% boys; 9.5% girls), and 21.1% (28.8% boys; 13.7% girls) in adolescents. Conclusion: The prevalence of AO in Spanish children and adolescents is of concern. The high proportion of AO observed in young patients who are normal weight or overweight indicates a need to include waist circumference measurements in routine clinical practice.	[Schroeder, Helmut; Funtikova, Anna; Gomez, Santiago F.; Fito, Montserat] Hosp del Mar Med Res Inst IMIM, REGICOR Study Grp, Cardiovasc Risk & Nutr Res, Res Programme Inflammatory & Cardiovasc Disorders, Barcelona, Spain; [Schroeder, Helmut; Funtikova, Anna] Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Ribas, Lourdes; Serra-Majem, Lluis] Nutr Res Fdn, Barcelona, Spain; [Ribas, Lourdes; Fito, Montserat; Serra-Majem, Lluis] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain; [Koebnick, Corinna] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Gomez, Santiago F.] Fdn THAO, Barcelona, Spain; [Perez-Rodrigo, Carmen] Bilbao Dept Publ Hlth, Community Nutr Unit, Bilbao, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Kaiser Permanente; Universidad de Las Palmas de Gran Canaria	Schroder, H (corresponding author), Hosp del Mar Med Res Inst IMIM, REGICOR Study Grp, Cardiovasc Risk & Nutr Res, Res Programme Inflammatory & Cardiovasc Disorders, Barcelona, Spain.	hschroeder@imim.es	Santos, Santiago Felipe Gómez/H-9478-2017; Perez-Rodrigo, Carmen/N-3251-2018; Koebnick, Corinna/P-4767-2016; Schroder, Helmut/G-2586-2015; Fito, Montserrat/C-1822-2012; Serra-Majem, Lluis/I-6708-2019	Santos, Santiago Felipe Gómez/0000-0003-3352-2510; Koebnick, Corinna/0000-0001-8274-0309; Schroder, Helmut/0000-0003-2231-5081; Fito, Montserrat/0000-0002-1817-483X; Serra-Majem, Lluis/0000-0002-9658-9061; Perez-Rodrigo, Carmen/0000-0002-4554-6184	Instituto de Salud Carlos III-FEDER [PI11/01900]; Spanish Ministry of Health, Fundacion Dieta Mediterranea, Spain; Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacion Nutricional [Miguel Servet CP03/00115]; Instituto de Salud Carlos III; Health Department of the Catalan Government (Generalitat de Catalunya)	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Health, Fundacion Dieta Mediterranea, Spain; Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacion Nutricional; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya)	This work was supported by grants from Instituto de Salud Carlos III-FEDER, (PI11/01900), the Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain; and Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria and the Fundacion para la Investigacion Nutricional and by a joint contract (Miguel Servet CP03/00115) with the Instituto de Salud Carlos III and the Health Department of the Catalan Government (Generalitat de Catalunya). The CIBERESP and the CIBEROBN and the RETIC Predimed are initiatives of the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bibiloni Mdel M, 2013, PLOS ONE, V8; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Moraes ACF, 2011, OBES REV, V12, P69, DOI 10.1111/j.1467-789X.2010.00753.x; Elizondo-Montemayor L, 2011, METAB SYNDR RELAT D, V9, P183, DOI 10.1089/met.2010.0116; Garnett SP, 2011, OBES REV, V12, P887, DOI 10.1111/j.1467-789X.2011.00899.x; Graves L, 2013, PEDIAT OBES; Guntsche Z, 2010, J PEDIATR ENDOCR MET, V23, P245; Hara Mitsuhiko, 2002, J Atheroscler Thromb, V9, P127; Hernandez M., 1988, CURVAS TABLAS CRECIM; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; KOENKER R, 1994, BIOMETRIKA, V81, P673; Koenker R, 2010, LECT NOTES STAT, V196, P23; Koenker R., QUANTREG QUANTILE RE; Kromeyer-Hauschild K, 2013, OBESITY FACTS, V6, P165, DOI 10.1159/000351066; Kruger HS, 2013, NUTRITION, V29, P502, DOI 10.1016/j.nut.2012.08.009; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2005, INT J OBESITY, V29, P157, DOI 10.1038/sj.ijo.0802849; McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624; Ministerio de Ciencia e Innovacion Espana, 2009, GUIA PRACT CLIN PREV; Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73; Okosun IS, 2006, ETHNIC DIS, V16, P338; Ortega FB, 2008, INT J PEDIATR OBES, V3, P212, DOI 10.1080/17477160802068965; Perez-Farinos N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/163687; R Core Team, 2021, R LANG ENV STAT COMP; Sanchez-Cruz JJ, 2013, REV ESP CARDIOL, V66, P371, DOI [10.1016/j.rec.2012.10.012, 10.1016/j.recesp.2012.10.016]; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Taylor RW, 2011, OBESITY, V19, P1062, DOI 10.1038/oby.2010.217; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Tzotzas T, 2011, HIPPOKRATIA, V15, P48; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	36	76	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87549	10.1371/journal.pone.0087549	http://dx.doi.org/10.1371/journal.pone.0087549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475305	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300199
J	Wang, AM; Ren, J; Wang, CP; Hascall, VC				Wang, Aimin; Ren, Juan; Wang, Christina P.; Hascall, Vincent C.			Heparin Prevents Intracellular Hyaluronan Synthesis and Autophagy Responses in Hyperglycemic Dividing Mesangial Cells and Activates Synthesis of an Extensive Extracellular Monocyte-adhesive Hyaluronan Matrix after Completing Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Diabetes; ER Stress; Glucose Metabolism; Heparin; Hyaluronate; Inflammation; Lipids; Diabetic Nephropathy; Monocyte Adhesive Hyaluronan Matrix	CARBOHYDRATE ELECTROPHORESIS FACE; EXPERIMENTAL DIABETIC-NEPHROPATHY; UDP-N-ACETYLHEXOSAMINES; SMOOTH-MUSCLE-CELLS; C-FOS INDUCTION; GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; CYCLIN D3; DOWN-REGULATION; GENE PROMOTER; SYNTHASE 2	Background: Hyperglycemic dividing mesangial cells initiate intracellular hyaluronan synthesis, autophagy, and cyclin D3-mediated hyaluronan matrix formation. Results: Heparin prevents the intracellular responses but induces synthesis of a monocyte-adhesive extracellular hyaluronan matrix after cell division. Conclusion: Heparin inhibits inflammatory responses in diabetic glomeruli. Significance: Responses of dividing cells to hyperglycemia contribute to diabetic pathologies. Growth-arrested rat mesangial cells (RMCs) at a G(0)/G(1) interphase stimulated to divide in hyperglycemic medium initiate intracellular hyaluronan synthesis that induces autophagy/cyclin D3-induced formation of a monocyte-adhesive extracellular hyaluronan matrix after completing cell division. This study shows that heparin inhibits the intracellular hyaluronan synthesis and autophagy responses, but at the end of cell division it induces synthesis of a much larger extracellular monocyte-adhesive hyaluronan matrix. Heparin bound to RMC surfaces by 1 h, internalizes into the Golgi/endoplasmic reticulum region by 2 h, and was nearly gone by 4 h. Treatment by heparin for only the first 4 h was sufficient for its function. Streptozotocin diabetic rats treated daily with heparin showed similar results. Glomeruli in sections of diabetic kidneys showed extensive accumulation of autophagic RMCs, increased hyaluronan matrix, and influx of macrophages over 6 weeks. Hyaluronan staining in the glomeruli of heparin-treated diabetic rats was very high at week 1 and decreased to near control level by 6 weeks without any RMC autophagy. However, the influx of macrophages by 6 weeks was as pronounced as in diabetic glomeruli. The results are as follows: 1) heparin blocks synthesis of hyaluronan in intracellular compartments, which prevents the autophagy and cyclin D3 responses thereby allowing RMCs to complete cell division and sustain function; 2) interaction of heparin with RMCs in early G(1) phase is sufficient to induce signaling pathway(s) for its functions; and 3) influxed macrophages effectively remove the hyaluronan matrix without inducing pro-fibrotic responses that lead to nephropathy and proteinurea in diabetic kidneys.	[Wang, Aimin; Ren, Juan; Wang, Christina P.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wang, AM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			National Institutes of Health, NHLBI [P01 HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Hyaluronan Matrices in Vascular Pathologies is funded in its entirety by National Institutes of Health P01 HL107147 from NHLBI.	Barski OA, 1999, GENOMICS, V60, P188, DOI 10.1006/geno.1999.5915; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; CASTELLOT JJ, 1986, AM J PATHOL, V125, P493; CASTELLOT JJ, 1985, AM J PATHOL, V120, P427; COFFEY AK, 1985, AM J PATHOL, V120, P248; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DIAMOND JR, 1991, AM J PHYSIOL, V260, pF779, DOI 10.1152/ajprenal.1991.260.6.F779; DIAMOND JR, 1986, RENAL PHYSIOL BIOCH, V9, P366; DOHI K, 1982, ACTA PATHOL JAPON, V32, P1047; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Dunlop ME, 1996, KIDNEY INT, V50, P40, DOI 10.1038/ki.1996.284; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; GUIJARRO C, 1995, AM J KIDNEY DIS, V26, P152, DOI 10.1016/0272-6386(95)90169-8; HANEDA M, 1990, METABOLISM, V39, P40, DOI 10.1016/0026-0495(90)90145-3; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Keane WF, 2000, KIDNEY INT, V57, pS27, DOI 10.1046/j.1523-1755.2000.07503.x; Kikkawa R, 2003, AM J KIDNEY DIS, V41, pS19, DOI 10.1053/ajkd.2003.50077; Kim YH, 2007, J CELL BIOCHEM, V101, P987, DOI 10.1002/jcb.21316; Kimmelstiel P, 1936, AM J PATHOL, V12, P83; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lane MD, 1996, INT J OBESITY, V20, pS91; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; LEE HS, 1991, CLIN NEPHROL, V36, P67; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; MARSHALL S, 1991, J BIOL CHEM, V266, P10155; Masson E, 2006, IUBMB LIFE, V58, P381, DOI 10.1080/15216540600755980; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Mene P, 2001, NEPHROL DIAL TRANSPL, V16, P913, DOI 10.1093/ndt/16.5.913; Miralem T, 1996, J BIOL CHEM, V271, P17100, DOI 10.1074/jbc.271.29.17100; NAPARSTEK Y, 1990, ARTHRITIS RHEUM, V33, P1554, DOI 10.1002/art.1780331013; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Noh H, 2007, KIDNEY INT, V72, pS49, DOI 10.1038/sj.ki.5002386; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Oda H, 1997, KIDNEY INT, V52, pS36; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sayeski PP, 1997, NUCLEIC ACIDS RES, V25, P1458, DOI 10.1093/nar/25.7.1458; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; SIMONSON MS, 1990, METHOD ENZYMOL, V187, P544; Singh LP, 2004, AM J PHYSIOL-RENAL, V286, pF409, DOI 10.1152/ajprenal.00007.2003; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; Urbonaviciute V., 2003, BIOLOGIJA, V3, P45; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; Whiteside CI, 2002, AM J PHYSIOL-RENAL, V282, pF975, DOI 10.1152/ajprenal.00014.2002; Wolf G, 1999, KIDNEY INT, V56, P1262, DOI 10.1046/j.1523-1755.1999.00695.x; Yamamoto D, 2003, CELL SIGNAL, V15, P575, DOI 10.1016/S0898-6568(02)00142-0; Yamazaki K, 2000, GENE, V261, P329, DOI 10.1016/S0378-1119(00)00497-2; Young B., 1992, Journal of the American Society of Nephrology, V3, P770; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139	69	19	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9418	9429		10.1074/jbc.M113.541441	http://dx.doi.org/10.1074/jbc.M113.541441			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24482224	Green Published, hybrid			2022-12-25	WOS:000333472100057
J	Bernsmeier, C; Meyer-Gerspach, AC; Blaser, LS; Jeker, L; Steinert, RE; Heim, MH; Beglinger, C				Bernsmeier, Christine; Meyer-Gerspach, Anne C.; Blaser, Lea S.; Jeker, Lia; Steinert, Robert E.; Heim, Markus H.; Beglinger, Christoph			Glucose-Induced Glucagon-Like Peptide 1 Secretion Is Deficient in Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; HEPATIC STEATOSIS; ENERGY-INTAKE; GLP-1 ANALOG; INCRETIN; RESPONSES; RECEPTOR; ASSOCIATION; SENSITIVITY; OVERWEIGHT	Background & Aims: The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gastrointestinal peptide hormones regulating postprandial insulin release from pancreatic beta-cells. GLP-1 agonism is a treatment strategy in Type 2 diabetes and is evaluated in Non-alcoholic fatty liver disease (NAFLD). However, the role of incretins in its pathophysiology is insufficiently understood. Studies in mice suggest improvement of hepatic steatosis by GLP-1 agonism. We determined the secretion of incretins after oral glucose administration in non-diabetic NAFLD patients. Methods: N = 52 patients (n = 16 NAFLD and n = 36 Non-alcoholic steatohepatitis (NASH) patients) and n = 50 matched healthy controls were included. Standardized oral glucose tolerance test was performed. Glucose, insulin, glucagon, GLP-1 and GIP plasma levels were measured sequentially for 120 minutes after glucose administration. Results: Glucose induced GLP-1 secretion was significantly decreased in patients compared to controls (p < 0.001). In contrast, GIP secretion was unchanged. There was no difference in GLP-1 and GIP secretion between NAFLD and NASH subgroups. All patients were insulin resistant, however HOMA2-IR was highest in the NASH subgroup. Fasting and glucose-induced insulin secretion was higher in NAFLD and NASH compared to controls, while the glucose lowering effect was diminished. Concomitantly, fasting glucagon secretion was significantly elevated in NAFLD and NASH. Conclusions: Glucose-induced GLP-1 secretion is deficient in patients with NAFLD and NASH. GIP secretion is contrarily preserved. Insulin resistance, with hyperinsulinemia and hyperglucagonemia, is present in all patients, and is more severe in NASH compared to NAFLD. These pathophysiologic findings endorse the current evaluation of GLP-1 agonism for the treatment of NAFLD.	[Bernsmeier, Christine; Heim, Markus H.; Beglinger, Christoph] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland; [Bernsmeier, Christine; Meyer-Gerspach, Anne C.; Blaser, Lea S.; Jeker, Lia; Steinert, Robert E.; Heim, Markus H.; Beglinger, Christoph] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Bernsmeier, C (corresponding author), Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland.	c.bernsmeier@unibas.ch	Meyer-Gerspach, Anne Christin/A-9865-2012; Heim, Markus/A-7526-2008	Meyer-Gerspach, Anne Christin/0000-0003-4104-8812; Heim, Markus/0000-0002-7523-4894; Bernsmeier, Christine/0000-0002-5558-0503; Steinert, Robert E/0000-0001-7884-5036	Astra-Altana research funding; Swiss National Science Foundation [320030-132960/1]; Stiftung zur Forderung der Gastroenterologischen Forschung; Hoffmann-La Roche	Astra-Altana research funding; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung zur Forderung der Gastroenterologischen Forschung; Hoffmann-La Roche(Hoffmann-La Roche)	The Basel NAFLD cohort is supported by an Astra-Altana research funding. The current work has further been supported by the Swiss National Science Foundation (Grant No. 320030-132960/1), the Stiftung zur Forderung der Gastroenterologischen Forschung, and an unrestricted grant from Hoffmann-La Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003995; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Cuthbertson DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050117; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Feinle C, 2002, PEPTIDES, V23, P1491, DOI 10.1016/S0196-9781(02)00087-6; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; MacIntosh CG, 1999, AM J CLIN NUTR, V69, P999; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Mells JE, 2012, AM J PHYSIOL-GASTR L, V302, pG225, DOI 10.1152/ajpgi.00274.2011; Miyazaki M, 2012, MOL MED REP, V5, P729, DOI 10.3892/mmr.2011.707; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rizzo M, 2009, EXPERT OPIN INV DRUG, V18, P1495, DOI 10.1517/14728220903241633; Seimon RV, 2013, AM J PHYSIOL-ENDOC M, V304, pE294, DOI 10.1152/ajpendo.00533.2012; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025269; Steinert RE, 2009, CLIN PHARMACOL THER, V86, P644, DOI 10.1038/clpt.2009.159; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Tomas E, 2011, REGUL PEPTIDES, V169, P43, DOI 10.1016/j.regpep.2011.04.006; Trahair LG, 2012, J CLIN ENDOCR METAB, V97, P844, DOI 10.1210/jc.2011-2583; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Roque MIV, 2006, GASTROENTEROLOGY, V131, P1717, DOI 10.1053/j.gastro.2006.10.025; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046; Zhang LL, 2013, LIVER INT, V33, P794, DOI 10.1111/liv.12120	42	73	79	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87488	10.1371/journal.pone.0087488	http://dx.doi.org/10.1371/journal.pone.0087488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489924	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000330570000151
J	Cowan, GJM; Bockau, U; Eleni-Muus, J; Aldag, I; Samuel, K; Creasey, AM; Hartmann, MWW; Cavanagh, DR				Cowan, Graeme J. M.; Bockau, Ulrike; Eleni-Muus, Janna; Aldag, Ingo; Samuel, Kay; Creasey, Alison M.; Hartmann, Marcus W. W.; Cavanagh, David R.			A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PARASITE PLASMODIUM-FALCIPARUM; C-TERMINAL FRAGMENT; INTRINSICALLY UNSTRUCTURED PROTEINS; BLOOD-STAGE VACCINE; GROWTH IN-VITRO; ESCHERICHIA-COLI; ERYTHROCYTE INVASION; SEQUENCE DIVERSITY; ANTIBODY EPITOPES	Development of effective malaria vaccines is hampered by the problem of producing correctly folded Plasmodium proteins for use as vaccine components. We have investigated the use of a novel ciliate expression system, Tetrahymena thermophila, as a P. falciparum vaccine antigen platform. A synthetic vaccine antigen composed of N-terminal and C-terminal regions of merozoite surface protein-1 (MSP-1) was expressed in Tetrahymena thermophila. The recombinant antigen was secreted into the culture medium and purified by monoclonal antibody (mAb) affinity chromatography. The vaccine was immunogenic in MF1 mice, eliciting high antibody titers against both N- and C-terminal components. Sera from immunized animals reacted strongly with P. falciparum parasites from three antigenically different strains by immunofluorescence assays, confirming that the antibodies produced are able to recognize parasite antigens in their native form. Epitope mapping of serum reactivity with a peptide library derived from all three MSP-1 Block 2 serotypes confirmed that the MSP-1 Block 2 hybrid component of the vaccine had effectively targeted all three serotypes of this polymorphic region of MSP-1. This study has successfully demonstrated the use of Tetrahymena thermophila as a recombinant protein expression platform for the production of malaria vaccine antigens.	[Cowan, Graeme J. M.; Creasey, Alison M.; Cavanagh, David R.] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Bockau, Ulrike; Eleni-Muus, Janna; Aldag, Ingo; Hartmann, Marcus W. W.] Cilian AG, Munster, Germany; [Samuel, Kay] Scottish Natl Blood Transfus Serv, Cell Therapy Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh	Cavanagh, DR (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.	david.cavanagh@ed.ac.uk	Cowan, Graeme/F-2842-2011; Cavanagh, David R/A-1828-2008	Cowan, Graeme/0000-0002-1949-4253; Cavanagh, David/0000-0003-4360-2637	EU [LSHP-CT-2007-037304]	EU(European Commission)	This project was funded by an EU Framework 6 STREP grant (CILMALVAC), awarded jointly to Cilian AG, Germany, The University of Edinburgh, UK and the Centre for Medical Parasitology, University of Copenhagen, Denmark (LSHP-CT-2007-037304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; Aldag I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-11; Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; Babon JJ, 2007, MOL BIOCHEM PARASIT, V153, P31, DOI 10.1016/j.molbiopara.2007.01.015; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; CassidyHanley D, 1997, GENETICS, V146, P135; Cavanagh DR, 1997, MOL BIOCHEM PARASIT, V85, P197, DOI 10.1016/S0166-6851(96)02826-5; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Cowan GJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026616; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Gaertig J, 2000, METHOD CELL BIOL, V62, P485; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Gaertig J, 1999, NAT BIOTECHNOL, V17, P462, DOI 10.1038/8638; Galamo CD, 2009, J INFECT DIS, V199, P1151, DOI 10.1086/597426; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garrity RR, 1997, J IMMUNOL, V159, P279; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Hellenbroich D, 1999, APPL MICROBIOL BIOT, V51, P447, DOI 10.1007/s002530051415; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Huckriede A, 2003, VACCINE, V21, P925, DOI 10.1016/S0264-410X(02)00542-X; Jayaram J, 2010, BIOPHARM INT S; Jiang GF, 2000, ACTA TROP, V74, P51, DOI 10.1016/S0001-706X(99)00045-5; Keitel WA, 1999, VACCINE, V18, P531, DOI 10.1016/S0264-410X(99)00221-2; Khan F, 2012, BIOTECHNOL J, V7, P133, DOI 10.1002/biot.201100331; KIY T, 1992, APPL MICROBIOL BIOT, V38, P141; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau OS, 2010, PLANT BIOTECHNOL J, V8, P994, DOI 10.1111/j.1467-7652.2010.00526.x; Mawili-Mboumba DP, 2003, J INFECT DIS, V187, P1137, DOI 10.1086/368414; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCBRIDE JS, 1985, J EXP MED, V161, P160, DOI 10.1084/jem.161.1.160; Milich DR, 2001, VACCINE, V20, P771, DOI 10.1016/S0264-410X(01)00400-5; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Morgan WD, 2004, MOL BIOCHEM PARASIT, V138, P29, DOI 10.1016/j.molbiopara.2004.06.014; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Parra M, 2000, INFECT IMMUN, V68, P2685, DOI 10.1128/IAI.68.5.2685-2691.2000; Peterson DS, 2002, MOL BIOCHEM PARASIT, V122, P119, DOI 10.1016/S0166-6851(02)00079-8; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; POLLACK Y, 1982, NUCLEIC ACIDS RES, V10, P539, DOI 10.1093/nar/10.2.539; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; QUAKYI IA, 1994, J IMMUNOL, V153, P2082; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Victor ME, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-325; Weide T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-19; Weide T, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-12; WHO, 2011, QUEST ANSW MAL VACC	72	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87198	10.1371/journal.pone.0087198	http://dx.doi.org/10.1371/journal.pone.0087198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489871	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000120
J	De Gaetano, A; Panunzi, S; Eliopoulos, D; Hardy, T; Mingrone, G				De Gaetano, Andrea; Panunzi, Simona; Eliopoulos, Dimitris; Hardy, Thomas; Mingrone, Geltrude			Mathematical Modeling of Renal Tubular Glucose Absorption after Glucose Load	PLOS ONE			English	Article							DIABETES-MELLITUS; TRANSPORT; THRESHOLD; MECHANISM; HOMEOSTASIS; GLYCOSURIA; EXCRETION; GLYCEMIA; KIDNEY; SGLT2	A partial differential Progressive Tubular Reabsorption (PTR) model, describing renal tubular glucose reabsorption and urinary glucose excretion following a glucose load perturbation, is proposed and fitted to experimental data from five subjects. For each subject the Glomerular Filtration Rate was estimated and both blood and urine glucose were sampled following an Intra-Venous glucose bolus. The PTR model was compared with a model representing the conventional Renal Threshold Hypothesis (RTH). A delay bladder compartment was introduced in both formulations. For the RTH model, the average threshold for glycosuria varied between 9.90 +/- 4.50 mmol/L and 10.63 +/- 3.64 mmol/L (mean +/- Standard Deviation) under different hypotheses; the corresponding average maximal transport rates varied between 0.48 +/- 0.45 mmol/min (86.29 +/- 81.22 mg/min) and 0.50 +/- 0.42 mmol/min (90.62 +/- 76.15 mg/min). For the PTR Model, the average maximal transports rates varied between 0.61 +/- 0.52 mmol/min (109.57 +/- 93.77 mg/min) and 0.83 +/- 0.95 mmol/min (150.13 +/- 171.85 mg/min). The time spent by glucose inside the tubules before entering the bladder compartment varied between 1.66 +/- 0.73 min and 2.45 +/- 1.01 min. The PTR model proved much better than RTH at fitting observations, by correctly reproducing the delay of variations of glycosuria with respect to the driving glycemia, and by predicting non-zero urinary glucose elimination at low glycemias. This model is useful when studying both transients and steady-state glucose elimination as well as in assessing drug-related changes in renal glucose excretion.	[De Gaetano, Andrea; Panunzi, Simona] CNR, Inst Syst Anal & Comp Sci IASI, BioMatLab, Rome, Italy; [Eliopoulos, Dimitris] Univ Athens Med Sch, Dept Internal Med 2, Hippokration, Greece; [Hardy, Thomas] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Mingrone, Geltrude] Univ Cattolica S Cuore, Dept Internal Med, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Eli Lilly; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Panunzi, S (corresponding author), CNR, Inst Syst Anal & Comp Sci IASI, BioMatLab, Rome, Italy.	simona.panunzi@biomatematica.it	Mingrone, Geltrude/AAB-9681-2019; Panunzi, Simona/AAK-9337-2020; De Gaetano, Andrea/AAC-4805-2021	De Gaetano, Andrea/0000-0001-7712-056X; Mingrone, Geltrude/0000-0003-2021-528X; Panunzi, Simona/0000-0003-0956-8578				Benedict S, 1918, J BIOL CHEM, V34, P217; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bernard C, 1877, LECONS DIABETE GLYCO; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Faber K, 1926, J CLIN INVEST, V3, P203, DOI 10.1172/JCI100075; Faber K, 1921, ACTA MED SCAND, VLIV; Faber K, 1921, ACTA MED SCAND, VLIII; Frank E, 1913, ARCH EXP PATHOL PHAR, V72, P387, DOI 10.1007/BF01863106; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; GLAUBER H, 1987, DIABETES, V36, P1187, DOI 10.2337/diabetes.36.10.1187; Hansen KM, 1923, INVESTIGATIONS BLOOD; Himsworth HP, 1931, BIOCHEM J, V25, P1128, DOI 10.1042/bj0251128; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; Jacobsen AT, 1917, BLODSUKKERINDHOLDET; JOHANSEN K, 1984, DIABETOLOGIA, V26, P180; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; KOUSHANPOUR E, 1971, J THEOR BIOL, V31, P177, DOI 10.1016/0022-5193(71)90182-2; Leibniz G.W., 1765, OEUVRES PHILOS LATIN; Ni TG, 1930, BIOCHEM J, V24, P1039, DOI 10.1042/bj0241039; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; R Core Team, 2022, R LANG ENV STAT COMP; Rave K, 2006, NEPHROL DIAL TRANSPL, V21, P2166, DOI 10.1093/ndt/gfl175; RICHARDS AN, 1929, METHODS RESULTS DIRE; Ruhnau B, 1997, DIABETES RES CLIN PR, V36, P27, DOI 10.1016/S0168-8227(97)01389-2; Triplitt Curtis L, 2012, Am J Manag Care, V18, pS4; Weinstein AM, 2007, AM J PHYSIOL-RENAL, V292, pF1164, DOI 10.1152/ajprenal.00392.2006; WEINSTEIN AM, 1994, ANNU REV PHYSIOL, V56, P691, DOI 10.1146/annurev.ph.56.030194.003355	28	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86963	10.1371/journal.pone.0086963	http://dx.doi.org/10.1371/journal.pone.0086963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489817	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000086
J	Li, ST; Meng, FY; Liao, XL; Wang, YM; Sun, ZX; Guo, FC; Li, XX; Meng, M; Li, Y; Sun, CH				Li, Songtao; Meng, Fanyu; Liao, Xilu; Wang, Yemei; Sun, Zongxiang; Guo, Fuchuan; Li, Xiaoxia; Meng, Man; Li, Ying; Sun, Changhao			Therapeutic Role of Ursolic Acid on Ameliorating Hepatic Steatosis and Improving Metabolic Disorders in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Rats	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; PPAR-ALPHA; PENTACYCLIC TRITERPENE; INSULIN-RESISTANCE; LIPID-METABOLISM; LDL RECEPTOR; STEATOHEPATITIS; INFLAMMATION; AGONIST; HYPERLIPIDEMIA	Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases around the world, and is closely associated with obesity, diabetes, and insulin resistance. Ursolic acid (UA), an ubiquitous triterpenoid with multifold biological roles, is distributed in various plants. This study was conducted to investigate the therapeutic effect and potential mechanisms of UA against hepatic steatosis in a high-fat diet (HFD)-induced obese non-alcoholic fatty liver disease (NAFLD) rat model. Methodology/Principal Findings: Obese NAFLD model was established in Sprague-Dawley rats by 8-week HFD feeding. Therapeutic role of UA was evaluated using 0.125%, 0.25%, 0.5% UA-supplemented diet for another 6 weeks. The results from both morphologic and histological detections indicated that UA significantly reversed HFD-induced hepatic steatosis and liver injury. Besides, hepatic peroxisome proliferator-activated receptor (PPAR)-alpha was markedly up-regulated at both mRNA and protein levels by UA. Knocking down PPAR-alpha significantly inhibited the anti-steatosis role of UA in vitro. HFD-induced adverse changes in the key genes, which participated in hepatic lipid metabolism, were also alleviated by UA treatment. Furthermore, UA significantly ameliorated HFD-induced metabolic disorders, including insulin resistance, inflammation and oxidative stress. Conclusions/Significance: These results demonstrated that UA effectively ameliorated HFD-induced hepatic steatosis through a PPAR-alpha involved pathway, via improving key enzymes in the controlling of lipids metabolism. The metabolic disorders were accordingly improved with the decrease of hepatic steatosis. Thereby, UA could be a promising candidate for the treatment of NAFLD.	[Li, Songtao; Meng, Fanyu; Liao, Xilu; Wang, Yemei; Sun, Zongxiang; Guo, Fuchuan; Li, Xiaoxia; Meng, Man; Li, Ying; Sun, Changhao] Harbin Med Univ, Dept Nutr & Food Hyg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Li, Y (corresponding author), Harbin Med Univ, Dept Nutr & Food Hyg, Harbin, Heilongjiang Pr, Peoples R China.	sun2002changhao@yahoo.com	SUN, CHANG/GXM-3680-2022; Li, Songtao/I-1490-2019	Li, Songtao/0000-0002-2926-673X	National High Technology Research and Development Program of China (863 program) [2010AA023002]; National 12th Five-Year Scientific and Technical Support Program of China [2012BAI02B02]; NSFC [81130049, 81102111, 81202185]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National 12th Five-Year Scientific and Technical Support Program of China; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the grant of National High Technology Research and Development Program of China (863 program, No. 2010AA023002) the National 12th Five-Year Scientific and Technical Support Program of China (2012BAI02B02) and NSFC (81130049 and 81102111 and 81202185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chen XS, 2011, EXP DIABETES RES, DOI 10.1155/2011/853501; Choudhury Jayanta, 2004, Clin Liver Dis, V8, P575, DOI 10.1016/j.cld.2004.04.006; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Erickson SK, 2009, J LIPID RES, V50, pS412, DOI 10.1194/jlr.R800089-JLR200; Ferreira DD, 2010, PARASITOL RES, V106, P985, DOI 10.1007/s00436-010-1740-2; Fiorucci S, 2005, J PHARMACOL EXP THER, V315, P58, DOI 10.1124/jpet.105.085597; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983; Hu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039664; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; James OFW, 1998, J HEPATOL, V29, P495, DOI 10.1016/S0168-8278(98)80073-1; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Jia Y, 2011, BIOORG MED CHEM LETT, V21, P5876, DOI 10.1016/j.bmcl.2011.07.095; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Laurent A, 2004, HEPATOLOGY, V39, P1277, DOI 10.1002/hep.20177; Le May C, 2005, J NUTR, V135, P2313, DOI 10.1093/jn/135.10.2313; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li ST, 2013, INT J CARDIOL, V168, P2548, DOI 10.1016/j.ijcard.2013.03.057; Li Y, 2010, MOL NUTR FOOD RES, V54, P1609, DOI 10.1002/mnfr.200900564; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005; Lu N, 2008, J AGR FOOD CHEM, V56, P11526, DOI 10.1021/jf802607x; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191; Rafiq N, 2008, SEMIN LIVER DIS, V28, P427, DOI 10.1055/s-0028-1091986; Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453; Rao VS, 2011, J MED FOOD, V14, P1375, DOI 10.1089/jmf.2010.0267; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Sun F, 2010, PHYTOMEDICINE, V17, P669, DOI 10.1016/j.phymed.2009.10.021; Sundaresan A, 2012, GEN PHYSIOL BIOPHYS, V31, P323, DOI 10.4149/gpb_2012_037; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Tailleux A, 2011, BIOCH BIOPHYS ACTA; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	51	53	60	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86724	10.1371/journal.pone.0086724	http://dx.doi.org/10.1371/journal.pone.0086724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489777	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000064
J	Root, JJ; Shriner, SA; Bentler, KT; Gidlewski, T; Mooers, NL; Ellis, JW; Spraker, TR; VanDalen, KK; Sullivan, HJ; Franklin, AB				Root, J. Jeffrey; Shriner, Susan A.; Bentler, Kevin T.; Gidlewski, Thomas; Mooers, Nicole L.; Ellis, Jeremy W.; Spraker, Terry R.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.			Extended Viral Shedding of a Low Pathogenic Avian Influenza Virus by Striped Skunks (Mephitis mephitis)	PLOS ONE			English	Article							UNITED-STATES; INFECTION	Background: Striped skunks (Mephitis mephitis) are susceptible to infection with some influenza A viruses. However, the viral shedding capability of this peri-domestic mammal and its potential role in influenza A virus ecology are largely undetermined. Methodology/Principal Findings: Striped skunks were experimentally infected with a low pathogenic (LP) H4N6 avian influenza virus (AIV) and monitored for 20 days post infection (DPI). All of the skunks exposed to H4N6 AIV shed large quantities of viral RNA, as detected by real-time RT-PCR and confirmed for live virus with virus isolation, from nasal washes and oral swabs (maximum <= 10(6.02) PCR EID50 equivalent/mL and <= 10(5.19) PCR EID50 equivalent/mL, respectively). Some evidence of potential fecal shedding was also noted. Following necropsy on 20 DPI, viral RNA was detected in the nasal turbinates of one individual. All treatment animals yielded evidence of a serological response by 20 DPI. Conclusions/Significance: These results indicate that striped skunks have the potential to shed large quantities of viral RNA through the oral and nasal routes following exposure to a LP AIV. Considering the peri-domestic nature of these animals, along with the duration of shedding observed in this species, their presence on poultry and waterfowl operations could influence influenza A virus epidemiology. For example, this species could introduce a virus to a naive poultry flock or act as a trafficking mechanism of AIV to and from an infected poultry flock to naive flocks or wild bird populations.	[Root, J. Jeffrey; Shriner, Susan A.; Bentler, Kevin T.; Mooers, Nicole L.; Ellis, Jeremy W.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.] Wildlife Serv, USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA; [Gidlewski, Thomas] Wildlife Serv, USDA, Natl Wildlife Dis Program, Ft Collins, CO USA; [Spraker, Terry R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Colorado State University	Root, JJ (corresponding author), Wildlife Serv, USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA.	Jeff.root@aphis.usda.gov		Franklin, Alan/0000-0001-9491-795X; Shriner, Susan/0000-0003-0349-7182; Ellis, Jeremy/0000-0003-4512-0906	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the findings were independently developed by the authors.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Armstrong DM, 2011, MAMMALS OF COLORADO, 2ND EDITION, P1; AVMA, 2011, 2009 H1N1 FLU OUTBR; Bailey CF, 1983, EXPT INFECT RACCOON; BEARD CW, 1970, B WORLD HEALTH ORGAN, V42, P779; Britton AP, 2010, EMERG INFECT DIS, V16, P1043, DOI 10.3201/eid1606.100352; CRABTREE RL, 1988, WILDLIFE SOC B, V16, P163; Dragoo JW, 1997, J MAMMAL, V78, P426, DOI 10.2307/1382896; FITZGERALD J, 1994, MAMMALS COLORADO; Hall JS, 2008, EMERG INFECT DIS, V14, P1842, DOI 10.3201/eid1412.071371; Halvorson D.A., 2008, AVIAN INFLUENZA, V439, P513; KAWAOKA Y, 1987, ARCH VIROL, V93, P303, DOI 10.1007/BF01310984; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; KLINGEBORN B, 1985, ARCH VIROL, V86, P347, DOI 10.1007/BF01309839; Lariviere S, 1999, AM MIDL NAT, V142, P96, DOI 10.1674/0003-0031(1999)142[0096:SBSSMM]2.0.CO;2; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; NVSL, 2008, AVPRO1510042008 NVSL; NVSL, 2003, AVPRO010005 NVSL; Pedersen K, 2010, AVIAN DIS, V54, P405, DOI 10.1637/8693-031309-Reg.1; ProMED-mail, 2006, AV INFL WORLDW 70 AS; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Root JJ, 2013, ECOLOGICAL ROUTES AV; Rosatte R., 2003, WILD MAMMALS N AM BI, P692; Schrenzel MD, 2011, EMERG INFECT DIS, V17, P747, DOI [10.3201/eid1706.101355, 10.3201/eid1704.101355]; Shriner SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039206; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Szretter K.J., 2006, CURRENT PROTOCOLS MI, V3, DOI [10.1002/0471729256.mc15g01-3, DOI 10.1002/0471729256.MC15G01-3, 10.1002/0471729256.mc15g01s3, DOI 10.1002/0471729256.MC15G01S3]; Vandalen KK, 2009, MAMMAL REV, V39, P167, DOI 10.1111/j.1365-2907.2009.00144.x; WADESMITH J, 1982, MAMMALIAN SPECIES, V173, P1, DOI DOI 10.2307/3503883; WHO, 2006, AV INFL H5N1 INF FOU; Yoon KJ, 2012, J VET DIAGN INVEST, V24, P388, DOI 10.1177/1040638711428349	32	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e70639	10.1371/journal.pone.0070639	http://dx.doi.org/10.1371/journal.pone.0070639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489638	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000001
J	Watkins, SC; Smith, JR; Hayes, PK; Watts, JEM				Watkins, Siobhan C.; Smith, James R.; Hayes, Paul K.; Watts, Joy E. M.			Characterisation of Host Growth after Infection with a Broad-Range Freshwater Cyanopodophage	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS-AERUGINOSA; GENETIC DIVERSITY; MARINE; CYANOPHAGES; PHAGE; BACTERIOPHAGE; GENOME; SEQUENCES; PROCHLOROCOCCUS; IDENTIFICATION	Freshwater cyanophages are poorly characterised in comparison to their marine counterparts, however, the level of genetic diversity that exists in freshwater cyanophage communities is likely to exceed that found in marine environments, due to the habitat heterogeneity within freshwater systems. Many cyanophages are specialists, infecting a single host species or strain; however, some are less fastidious and infect a number of different host genotypes within the same species or even hosts from different genera. Few instances of host growth characterisation after infection by broad host-range phages have been described. Here we provide an initial characterisation of interactions between a cyanophage isolated from a freshwater fishing lake in the south of England and its hosts. Designated Phi MHI42, the phage is able to infect isolates from two genera of freshwater cyanobacteria, Planktothrix and Microcystis. Transmission Electron Microscopy and Atomic Force Microscopy indicate that Phi MHI42 is a member of the Podoviridae, albeit with a larger than expected capsid. The kinetics of host growth after infection with Phi MHI42 differed across host genera, species and strains in a way that was not related to the growth rate of the uninfected host. To our knowledge, this is the first characterisation of the growth of cyanobacteria in the presence of a broad host-range freshwater cyanophage.	[Watkins, Siobhan C.; Hayes, Paul K.; Watts, Joy E. M.] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England; [Smith, James R.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England	University of Portsmouth; University of Portsmouth	Watts, JEM (corresponding author), Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England.	joy.watts@port.ac.uk	Smith, James R/D-2350-2011; Smith, James R/F-1108-2014	Smith, James R/0000-0001-8805-3788; Smith, James R/0000-0001-8805-3788; Watts, Joy/0000-0001-9595-0540	EU FP7 KBBE award [265409]	EU FP7 KBBE award	Funding provided by EU FP7 KBBE award 265409: MicroAqua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2003, APPL ENVIRON MICROB, V69, P7499, DOI 10.1128/AEM.69.12.7499-7506.2003; Acinas SG, 2009, ISME J, V3, P31, DOI 10.1038/ismej.2008.78; Ackermann Hans-W, 2012, Bacteriophage, V2, P122; Ackermann HW, 2009, BACTERIOPHAGES METHO, V1, P175; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Ankrah NYD, 2013, ISME J; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Baker AC, 2006, APPL ENVIRON MICROB, V72, P5713, DOI 10.1128/AEM.00270-06; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; BOOKER MJ, 1979, BRIT PHYCOL J, V14, P141, DOI 10.1080/00071617900650161; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Chenard C, 2008, APPL ENVIRON MICROB, V74, P5317, DOI 10.1128/AEM.02480-07; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cook A., 2003, THESIS U WARWICK UK; Delbruck M, 1940, J GEN PHYSIOL, V23, P643, DOI 10.1085/jgp.23.5.643; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Dreher TW, 2011, ENVIRON MICROBIOL, V13, P1858, DOI 10.1111/j.1462-2920.2011.02502.x; Dunbar J, 1997, APPL ENVIRON MICROB, V63, P1326, DOI 10.1128/AEM.63.4.1326-1331.1997; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; Hadas H, 1997, MICROBIOL-UK, V143, P179, DOI 10.1099/00221287-143-1-179; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Hoskisson PA, 2007, CURR OPIN MICROBIOL, V10, P396, DOI 10.1016/j.mib.2007.04.003; Huang SJ, 2012, ENVIRON MICROBIOL, V14, P540, DOI 10.1111/j.1462-2920.2011.02667.x; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Humbert JF, 2005, MICROB ECOL, V49, P308, DOI 10.1007/s00248-004-0004-z; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Jenkins CA, 2006, J MAR BIOL ASSOC UK, V86, P529, DOI 10.1017/S0025315406013439; Kimura S, 2013, APPL ENVIRON MICROB, V79, P2789, DOI 10.1128/AEM.03751-12; Kuno S, 2012, APPL ENVIRON MICROB, V78, P5353, DOI 10.1128/AEM.00626-12; Kuznetsov YG, 2012, MICRON, V43, P1336, DOI 10.1016/j.micron.2012.02.013; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Labrie SJ, 2013, ENVIRON MICROBIOL, V15, P1356, DOI 10.1111/1462-2920.12053; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Lu J, 2001, APPL ENVIRON MICROB, V67, P3285, DOI 10.1128/AEM.67.7.3285-3290.2001; Mann NH, 2003, FEMS MICROBIOL REV, V27, P17, DOI 10.1016/S0168-6445(03)00016-0; Marston MF, 2003, APPL ENVIRON MICROB, V69, P4639, DOI 10.1128/AEM.69.8.4639-4647.2003; McDaniel L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003263; Middelboe M, 2000, MICROBIAL ECOL, V40, P114; Miller R.V., 2008, BACTERIOPHAGE ECOLOG, P114, DOI DOI 10.1017/CBO9780511541483.008; Nelissen B, 1996, J MOL EVOL, V42, P194, DOI 10.1007/BF02198845; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Pepe-Ranney C, 2012, ENVIRON MICROBIOL, V14, P1182, DOI 10.1111/j.1462-2920.2012.02698.x; Petrov VM, 2006, J MOL BIOL, V361, P46, DOI 10.1016/j.jmb.2006.05.071; Ponsero AJ, 2013, GENOME ANNOUNC, V1, P3; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rohrlack T, 2008, LIMNOL OCEANOGR, V53, P1279, DOI 10.4319/lo.2008.53.4.1279; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Shan J, 2008, FEMS MICROBIOL LETT, V283, P154, DOI 10.1111/j.1574-6968.2008.01148.x; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Sikora AE, 2012, SOFT MATTER, V8, P6358, DOI 10.1039/c2sm07213k; SNYDER L, 1995, MOL MICROBIOL, V15, P415, DOI 10.1111/j.1365-2958.1995.tb02255.x; Sogge H, 2013, APPL ENVIRON MICROB, V79, P508, DOI 10.1128/AEM.02417-12; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Tanabe Y, 2009, ENV MICROBIOL REP, V1, P575, DOI 10.1111/j.1758-2229.2009.00088.x; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Yoshida T, 2008, J BACTERIOL, V190, P1762, DOI 10.1128/JB.01534-07; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zhao FQ, 2006, PHYSIOL GENOMICS, V24, P181, DOI 10.1152/physiolgenomics.00255.2005; Zhong F, 2011, WATER RES, V45, P6479, DOI 10.1016/j.watres.2011.09.044	70	19	20	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87339	10.1371/journal.pone.0087339	http://dx.doi.org/10.1371/journal.pone.0087339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489900	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000134
J	Xiao, WB; Hong, H; Awadallah, A; Zhou, L; Xin, W				Xiao, Wenbin; Hong, Hong; Awadallah, Amad; Zhou, Lan; Xin, Wei			Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis	PLOS ONE			English	Article							HOMEOBOX GENE CDX2; INTESTINAL METAPLASIA; IMMUNOHISTOCHEMICAL SURVEY; GASTRIC CARCINOMAS; TRANSGENIC MICE; CANCER; MICROARRAYS; MUCOSA; MARKER; TUMORS	CDX2, a master transcriptional regulator of intestinal cell differentiation and survival, has been used as a marker to indicate colorectal lineage in adenocarcinomas of unknown origin. Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes for adenocarcinomas of unknown origin, but CDX2 expression in pancreatic disease remains unclear. In this study, we systemically and extensively investigated the expression and role of CDX2 in PDAC. We reported that CDX2 expression is weak and heterogeneous is all normal pancreas and chronic pancreatitis. It is largely expressed in epithelial-lining cells of pancreatic ducts including main ducts, inter-lobular ducts, intra-lobular ducts, intercalated ducts and centroacinar cells, but not in acinar cells or islet cells. CDX2 expression is down regulated during the transformation process from PanIN to PDAC. Only one third of PDACs retain some degree of CDX2 expression, and this group of PDACs have reduced median survival time compared to that of CDX2 negative group (308 days vs. 586 days, p = 0.0065). Metastatic PDACs remain similar expression pattern to that of the primary sites. Our study clearly demonstrates CDX2 expression in pancreatic diseases including PDAC, which is practically important when CDX2 is used to establish the primary sites of adenocarcinomas of unknown origin. In addition, our study also provides CDX2 as a prognostic marker for PDAC and implicates an important role of CDX2 in the development of normal pancreas and PDAC.	[Xiao, Wenbin; Hong, Hong; Awadallah, Amad; Zhou, Lan; Xin, Wei] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Xiao, Wenbin; Hong, Hong; Zhou, Lan; Xin, Wei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Xin, W (corresponding author), Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA.	wei.xin@case.edu		Hong, Hong/0000-0002-1009-3621; Xiao, Wenbin/0000-0001-8586-8500	Case Western Reserve University faculty startup fund; University Hospital Case Medical Center Pathology small research grant; NATIONAL CANCER INSTITUTE [P50CA150964] Funding Source: NIH RePORTER	Case Western Reserve University faculty startup fund; University Hospital Case Medical Center Pathology small research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partially supported by Case Western Reserve University faculty startup fund, and University Hospital Case Medical Center Pathology small research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2003, J PATHOL, V199, P36, DOI 10.1002/path.1246; Chang YT, 2007, J GASTROEN HEPATOL, V22, P389, DOI 10.1111/j.1440-1746.2006.04487.x; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chu PG, 2005, AM J SURG PATHOL, V29, P359, DOI 10.1097/01.pas.0000149708.12335.6a; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Huang LP, 2012, INT J GYNECOL CANCER, V22, P1170, DOI 10.1097/IGC.0b013e318261d89c; Li QL, 2011, PATHOL ONCOL RES, V17, P561, DOI 10.1007/s12253-010-9346-7; Liu HY, 2012, ARCH PATHOL LAB MED, V136, P601, DOI 10.5858/arpa.2011-0326-OA; Logsdon CD, 2003, CANCER RES, V63, P2649; Matsumoto K, 2004, ONCOL REP, V12, P1239; Mizoshita T, 2001, Gastric Cancer, V4, P185, DOI 10.1007/PL00011741; Mizoshita T, 2003, J CANCER RES CLIN, V129, P727, DOI 10.1007/s00432-003-0499-6; Moskaluk CA, 2003, MODERN PATHOL, V16, P913, DOI 10.1097/01.MP.0000086073.92773.55; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Phillips RW, 2003, AM J SURG PATHOL, V27, P1442, DOI 10.1097/00000478-200311000-00006; Roessler K, 2005, WORLD J GASTROENTERO, V11, P3182, DOI 10.3748/wjg.v11.i21.3182; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Satoh K, 2002, HELICOBACTER, V7, P192, DOI 10.1046/j.1523-5378.2002.00080.x; Seno H, 2002, INT J ONCOL, V21, P769; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Takahashi K, 2009, PANCREAS, V38, P49, DOI 10.1097/MPA.0b013e31817fa2ba; Tamai Y, 1999, CANCER RES, V59, P2965; Thoene S, 2009, LEUKEMIA, V23, P649, DOI 10.1038/leu.2008.355; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Werling RW, 2003, AM J SURG PATHOL, V27, P303, DOI 10.1097/00000478-200303000-00003	28	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86853	10.1371/journal.pone.0086853	http://dx.doi.org/10.1371/journal.pone.0086853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489794	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000073
J	Beurel, E; Harrington, LE; Buchser, W; Lemmon, V; Jope, RS				Beurel, Eleonore; Harrington, Laurie E.; Buchser, William; Lemmon, Vance; Jope, Richard S.			Astrocytes Modulate the Polarization of CD4(+) T Cells to Th1 Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; GLUTAMATE RECEPTORS; MULTIPLE-SCLEROSIS; EMERGING EVIDENCE; DENDRITIC CELLS; IMMUNE CELLS; IFN-GAMMA; LYMPHOCYTES; ACTIVATION	T-cell characteristics are dynamic and influenced by multiple factors. To test whether cells and the environment in the central nervous system (CNS) can influence T-cells, we tested if culturing mouse CD4(+) T-cells on mouse primary astrocytes, compared with standard feeder cells, modified T-cell polarization to Th1 and Treg subtypes. Astrocytes supported the production of Th1 cells and Tregs, which was diminished by inflammatory activation of astrocytes, and glutamate accumulation that may result from impaired glutamate uptake by astrocytes strongly promoted Th1 production. These results demonstrate that astrocytes and the environment in the CNS have the capacity to regulate T-cell characteristics.	[Beurel, Eleonore; Jope, Richard S.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Beurel, Eleonore; Jope, Richard S.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Harrington, Laurie E.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Buchser, William] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Lemmon, Vance] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA	University of Miami; University of Miami; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of Miami	Beurel, E (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.	ebeurel@med.miami.edu	Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Buchser, William/0000-0002-6675-6359	NIH [MH090236, MH095380]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095380, R00MH090236, K99MH090236] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the NIH (MH090236 and MH095380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Aloisi F, 1999, EUR J IMMUNOL, V29, P2705, DOI 10.1002/(SICI)1521-4141(199909)29:09<2705::AID-IMMU2705>3.0.CO;2-1; Aloisi F, 1998, J IMMUNOL, V160, P4671; Aloisi F, 1999, ADV EXP MED BIOL, V468, P123; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Boldyrev AA, 2005, J NEUROCHEM, V95, P913, DOI 10.1111/j.1471-4159.2005.03456.x; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Buchser WJ, 2012, CANCER RES, V72, P2970, DOI 10.1158/0008-5472.CAN-11-3396; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; FRASCA D, 1985, J IMMUNOL, V134, P3907; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Kvaratskhelia E, 2009, NEUROIMMUNOMODULAT, V16, P201, DOI 10.1159/000204234; Levite M, 2001, TRENDS IMMUNOL, V22, P2, DOI 10.1016/S1471-4906(00)01799-3; Lindblad SS, 2012, NEUROSIGNALS, V20, P61, DOI 10.1159/000329551; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lombardi G, 2001, BRIT J PHARMACOL, V133, P936, DOI 10.1038/sj.bjp.0704134; Mashkina AP, 2007, NEUROCHEM INT, V51, P356, DOI 10.1016/j.neuint.2007.04.009; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miglio G, 2007, BIOCHEM BIOPH RES CO, V361, P404, DOI 10.1016/j.bbrc.2007.07.015; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nikcevich KM, 1997, J IMMUNOL, V158, P614; Ontaneda D, 2012, ANNU REV MED, V63, P389, DOI 10.1146/annurev-med-042910-135833; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; Pacheco R, 2007, J NEUROIMMUNOL, V185, P9, DOI 10.1016/j.jneuroim.2007.01.003; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Pacheco Rodrigo, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P65; Poulopoulou C, 2005, MOL PHARMACOL, V67, P856, DOI 10.1124/mol.67.3.856; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ron-Hare N, 2011, BRAIN BEHAV IMMUN, V25, P1036, DOI 10.1016/j.bbi.2010.12.011; Ron-Harel N, 2008, REJUV RES, V11, P903, DOI 10.1089/rej.2008.0755; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Stuve O, 2010, ARCH NEUROL-CHICAGO, V67, P1307, DOI 10.1001/archneurol.2010.158; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004	50	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86257	10.1371/journal.pone.0086257	http://dx.doi.org/10.1371/journal.pone.0086257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489707	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000040
J	Cooper, DL; Harirforoosh, S				Cooper, Dustin L.; Harirforoosh, Sam			Design and Optimization of PLGA-Based Diclofenac Loaded Nanoparticles	PLOS ONE			English	Article							SOLID LIPID NANOPARTICLES; CONTROLLED DRUG-DELIVERY; BEHAVIOR IN-VITRO; ORAL DELIVERY; BIODEGRADABLE NANOPARTICLES; TOPICAL APPLICATION; CONTROLLED-RELEASE; SODIUM; MICROSPHERES; FORMULATION	Drug based nanoparticle (NP) formulations have gained considerable attention over the past decade for their use in various drug formulations. NPs have been shown to increase bioavailability, decrease side effects of highly toxic drugs, and prolong drug release. Nonsteroidal anti-inflammatory drugs such as diclofenac block cyclooxygenase expression and reduce prostaglandin synthesis, which can lead to several side effects such as gastrointestinal bleeding and renal insufficiency. The aim of this study was to formulate and characterize diclofenac entrapped poly(lactide-co-glycolide) (PLGA) based nanoparticles. Nanoparticles were formulated using an emulsion-diffusion-evaporation technique with varying concentrations of poly vinyl alcohol (PVA) (0.1, 0.25, 0.5, or 1%) or didodecyldimethylammonium bromide (DMAB) (0.1, 0.25, 0.5, 0.75, or 1%) stabilizers centrifuged at 8,800 rpm or 12,000 rpm. The resultant nanoparticles were evaluated based on particle size, zeta potential, and entrapment efficacy. DMAB formulated NPs showed the lowest particle size (108 +/- 2.1 nm) and highest zeta potential (-27.71 +/- 0.6 mV) at 0.1 and 0.25% respectively, after centrifugation at 12,000 rpm. Results of the PVA based NP formulation showed the smallest particle size (92.4 +/- 7.6 nm) and highest zeta potential (-11.14 +/- 0.5 mV) at 0.25% and 1% w/v, respectively, after centrifugation at 12,000 rpm. Drug entrapment reached 77.3 +/- 3.5% and 80.2 +/- 1.2% efficiency with DMAB and PVA formulations, respectively. The results of our study indicate the use of DMAB for increased nanoparticle stability during formulation. Our study supports the effective utilization of PLGA based nanoparticle formulation for diclofenac.	[Cooper, Dustin L.; Harirforoosh, Sam] E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA	East Tennessee State University	Harirforoosh, S (corresponding author), E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA.	harirfor@etsu.edu	Harirforoosh, Sam/J-9493-2013	Harirforoosh, Sam/0000-0002-2631-3756	Research and Development Committee Major Grant, East Tennessee State University	Research and Development Committee Major Grant, East Tennessee State University	This study was funded by a Research and Development Committee Major Grant, East Tennessee State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri SM, 2009, NANOMED-NANOTECHNOL, V5, P90, DOI 10.1016/j.nano.2008.07.003; Ahuja M, 2011, J MICROENCAPSUL, V28, P37, DOI 10.3109/02652048.2010.523794; Attama AA, 2008, INT J PHARM, V355, P307, DOI 10.1016/j.ijpharm.2007.12.007; Barbucci R, 2012, ACTA BIOMATER, V8, P4244, DOI 10.1016/j.actbio.2012.09.006; Barzegar-Jalali M, 2012, POWDER TECHNOL, V219, P211, DOI 10.1016/j.powtec.2011.12.046; Caldwell FJ, 2004, AM J VET RES, V65, P271, DOI 10.2460/ajvr.2004.65.271; Cetin M, 2010, AAPS PHARMSCITECH, V11, P1250, DOI 10.1208/s12249-010-9489-6; Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013; Chawla V, 2000, DRUG DEV IND PHARM, V26, P675, DOI 10.1081/DDC-100101283; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dehar N, 2012, INT J APPL BASIC MED, V2, P25, DOI DOI 10.4103/2229-516X.96799; El-Sousi S, 2013, J PHARM PHARMACOL, V65, P193, DOI 10.1111/j.2042-7158.2012.01587.x; Feng SS, 2001, J CONTROL RELEASE, V71, P53, DOI 10.1016/S0168-3659(00)00364-3; Gavini E, 2011, J PHARM PHARMACOL, V63, P472, DOI 10.1111/j.2042-7158.2010.01220.x; Gohel MC, 1998, J CONTROL RELEASE, V51, P115, DOI 10.1016/S0168-3659(97)00102-8; Gohel MC, 1999, DRUG DEV IND PHARM, V25, P247, DOI 10.1081/DDC-100102167; Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3; Gursoy A, 2000, J MICROENCAPSUL, V17, P565; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Huanbutta K, 2013, EUR J PHARM SCI, V50, P303, DOI 10.1016/j.ejps.2013.07.010; Italia JL, 2007, J CONTROL RELEASE, V119, P197, DOI 10.1016/j.jconrel.2007.02.004; Italia JL, 2009, PHARM RES-DORDR, V26, P1324, DOI 10.1007/s11095-009-9841-2; Jain A, 2013, BIOMATTER, V3; Konan YN, 2003, EUR J PHARM BIOPHARM, V55, P115, DOI 10.1016/S0939-6411(02)00128-5; Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Levine DG, 2009, AM J VET RES, V70, P1323, DOI 10.2460/ajvr.70.11.1323; Liu D, 2013, J LIPOSOME RES; Liu DF, 2010, J MICROENCAPSUL, V27, P726, DOI 10.3109/02652048.2010.513456; Mathew A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032616; Mittal G, 2007, J CONTROL RELEASE, V119, P77, DOI 10.1016/j.jconrel.2007.01.016; Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4; National Center for Biotechnology Information, PUBCHEM COMP DAT; Park H, 2008, SMALL, V4, P192, DOI 10.1002/smll.200700807; Patricio B F de Carvalho, 2013, World J Nucl Med, V12, P24, DOI 10.4103/1450-1147.113946; RODRIGUES JM, 1994, TROP MED PARASITOL, V45, P223; Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158; Saxena V, 2004, INT J PHARMACEUT, V278, P293, DOI 10.1016/j.ijpharm.2004.03.032; Sena MM, 2004, J PHARMACEUT BIOMED, V36, P743, DOI 10.1016/j.jpba.2004.08.001; SETH BL, 1992, ARZNEIMITTEL-FORSCH, V42-1, P120; Sonaje K, 2007, PHARM RES-DORDR, V24, P899, DOI 10.1007/s11095-006-9207-y; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Wohlfart S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019121; Zacher J, 2008, CURR MED RES OPIN, V24, P925, DOI [10.1185/030079908X273066, 10.1185/030079908X273066 ]	44	57	61	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87326	10.1371/journal.pone.0087326	http://dx.doi.org/10.1371/journal.pone.0087326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489896	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000129
J	Hou, SK; Ding, H; Lv, Q; Yin, XF; Song, JQ; Landen, NX; Fan, HJ				Hou, Shike; Ding, Hui; Lv, Qi; Yin, Xiaofeng; Song, Jianqi; Landen, Ning Xu; Fan, Haojun			Therapeutic Effect of Intravenous Infusion of Perfluorocarbon Emulsion on LPS-Induced Acute Lung Injury in Rats	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; LIQUID VENTILATION; OXYGEN CARRIERS; IN-VITRO; INHIBITION; RELEASE; ARDS	Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS) are the leading causes of death in critical care. Despite extensive efforts in research and clinical medicine, mortality remains high in these diseases. Perfluorocarbon (PFC), a chemical compound known as liquid ventilation medium, is capable of dissolving large amounts of physiologically important gases (mainly oxygen and carbon dioxide). In this study we aimed to investigate the effect of intravenous infusion of PFC emulsion on lipopolysaccharide (LPS) induced ALI in rats and elucidate its mechanism of action. Forty two Wistar rats were randomly divided into three groups: 6 rats were treated with saline solution by intratracheal instillation (control group), 18 rats were treated with LPS by intratracheal instillation (LPS group) and the other 18 rats received PFC through femoral vein prior to LPS instillation (LPS+ PFC group). The rats in the control group were sacrificed 6 hours later after saline instillation. At 2, 4 and 6 hours of exposure to LPS, 6 rats in the LPS group and 6 rats in LPS+ PFC group were sacrificed at each time point. By analyzing pulmonary pathology, partial pressure of oxygen in the blood (PaO2) and lung wet-dry weight ratio (W/D) of each rat, we found that intravenous infusion of PFC significantly alleviated acute lung injury induced by LPS. Moreover, we showed that the expression of pulmonary myeloperoxidase (MPO), intercellular adhesion molecule-1 (ICAM-1) of endothelial cells and CD11b of polymorphonuclear neutrophils (PMN) induced by LPS were significantly decreased by PFC treatment in vivo. Our results indicate that intravenous infusion of PFC inhibits the infiltration of PMNs into lung tissue, which has been shown as the core pathogenesis of ALI/ARDS. Thus, our study provides a theoretical foundation for using intravenous infusion of PFC to prevent and treat ALI/ARDS in clinical practice.	[Hou, Shike; Ding, Hui; Lv, Qi; Yin, Xiaofeng; Song, Jianqi; Fan, Haojun] Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Rescue Med Res Inst, Tianjin, Peoples R China; [Landen, Ning Xu] Karolinska Univ Hosp, Mol Dermatol Res Grp, CMM, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Fan, HJ (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Rescue Med Res Inst, Tianjin, Peoples R China.	haojunfan86@163.com	Landén, Ning Xu/AFL-2883-2022	Landén, Ning Xu/0000-0003-4868-3798; Lv, Qi/0000-0001-9076-7042; Fan, Haojun/0000-0003-1111-0232	capital development fund [2009-3091]; Key program of PAPF [WJHQ2010-08]	capital development fund; Key program of PAPF	This work was supported by grants from the capital development fund (2009-3091), Key program of PAPF (WJHQ2010-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaghdadi AS, 2010, RESUSCITATION, V81, P353, DOI 10.1016/j.resuscitation.2009.11.018; Angus DC, 2006, CRIT CARE MED, V34, P2885, DOI 10.1097/01.CCM.0000248727.29055.25; ASHBAUGH DG, 1967, LANCET, V2, P319; Baba A, 2000, CRIT CARE MED, V28, P1113, DOI 10.1097/00003246-200004000-00034; Bernard GR, 1999, CHEST, V116, p260S; Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737; Brower RG, 2004, NEW ENGL J MED, V351, P327; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Chang H, 2005, INTENS CARE MED, V31, P977, DOI 10.1007/s00134-005-2652-y; Chopra M, 2009, EXP BIOL MED, V234, P361, DOI 10.3181/0811-MR-318; Dickinson S, 2011, CRIT CARE CLIN, V27, P511, DOI 10.1016/j.ccc.2011.05.010; Doerschuk CM, 1996, J IMMUNOL, V157, P4609; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Faithfull NS, 1998, VOX SANG, V74, P243, DOI 10.1111/j.1423-0410.1998.tb05426.x; Gale SC, 2007, J SURG RES, V138, P135, DOI 10.1016/j.jss.2006.08.029; Garber BG, 1996, CRIT CARE MED, V24, P687, DOI 10.1097/00003246-199604000-00023; Gardinali M, 2000, AM J RESP CRIT CARE, V161, P1022, DOI 10.1164/ajrccm.161.3.9901066; GREENSPAN JS, 1990, J PEDIATR-US, V117, P106, DOI 10.1016/S0022-3476(05)82457-6; Greenspan JS, 2000, SEMIN PERINATOL, V24, P396, DOI 10.1053/sper.2000.20092; Hadjiliadis D, 2000, SEM RESP CRIT CARE M, V21, P175, DOI 10.1055/s-2000-9852; Hale DF, 2012, J TRAUMA ACUTE CARE, V72, P1634, DOI 10.1097/TA.0b013e318247cd4f; Keipert PE, 2001, ANASTH INTENSIV NOTF, V36, pS104; KERINS DM, 1994, AM J MED SCI, V307, P218, DOI 10.1097/00000441-199403000-00009; Lu YM, 2004, INTENS CARE MED, V30, P2197, DOI 10.1007/s00134-004-2479-y; [马希刚 MA Xigang], 2006, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V26, P363; Michetti C, 2003, J SURG RES, V115, P92, DOI 10.1016/S0022-4804(03)00219-1; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824; Sharma J, 2009, J IMMUNOL METHODS, V351, P30, DOI 10.1016/j.jim.2009.09.008; Shashikant BN, 2005, CRIT CARE MED, V33, P1096, DOI 10.1097/01.CCM.0000163218.79770.29; Shen Y, 2011, EXPERT REV RESP MED, V5, P107, DOI [10.1586/ers.10.80, 10.1586/ERS.10.80]; Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Spahn DR, 1999, CRIT CARE, V3, pR93, DOI 10.1186/cc364; Spiess BD, 2009, J APPL PHYSIOL, V106, P1444, DOI 10.1152/japplphysiol.90995.2008; Taut FJH, 2008, CHEST, V134, P724, DOI 10.1378/chest.08-0362; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741; Wang X, 2013, CLIN RESPIR  J, DOI [10.1111/crj.12053, DOI 10.1111/CRJ.12053.[]; Wolfson MR, 2004, PAEDIATR ANAESTH, V14, P15, DOI 10.1046/j.1460-9592.2003.01206.x; Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716; Yoxall CW, 1997, THORAX, V52, pS3, DOI 10.1136/thx.52.2008.S3; Zhang XP, 2009, J PANCREAS, V10, P8; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051	47	29	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87826	10.1371/journal.pone.0087826	http://dx.doi.org/10.1371/journal.pone.0087826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489970	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000152
J	Tsumuraya, T; Matsushita, M				Tsumuraya, Tomoyuki; Matsushita, Masayuki			COPA and SLC4A4 are Required for Cellular Entry of Arginine-Rich Peptides	PLOS ONE			English	Article							TAT-FUSION PROTEINS; FUNCTIONAL EXPRESSION; PENETRATING PEPTIDES; IN-VIVO; TRANSDUCTION; ENDOCYTOSIS; DELIVERY; INTERNALIZATION; MECHANISM; COATOMER	Cell-penetrating peptides (CPPs) have gained attention as promising tools to enable the delivery of various molecules in a non-invasive manner. Among the CPPs, TAT and poly-arginine have been extensively utilized in numerous studies for the delivery of functional proteins, peptides, and macromolecules to analyze cellular signaling. However, the molecular mechanisms of cellular entry remain largely unknown. Here, we applied siRNA library screening to identify the regulatory genes for the cellular entry of poly-arginine peptide based on microscopic observation of the entry of fluorescent peptides in siRNA-treated cells. In this screening, we identified the cell membrane gene SLC4A4 and the trafficking regulator gene COPA, which also plays an important role in early endosome maturation. These results demonstrated that cellular entry of poly-arginine requires at least two different steps, probably binding on the cell surface and endosomal entry. The identification of genes for cellular entry of poly-arginine provides insights into its mechanisms and should further aid in the development of highly efficient cell-penetrating peptides.	[Tsumuraya, Tomoyuki; Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Okinawa, Japan	University of the Ryukyus	Matsushita, M (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Okinawa, Japan.	masayuki@med.u-ryukyu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Uehara Memorial Foundation; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). This research was also supported by the Uehara Memorial Foundation and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; Chen LM, 2011, J PHYSIOL-LONDON, V589, P877, DOI 10.1113/jphysiol.2010.198713; Choi I, 2003, AM J PHYSIOL-RENAL, V284, pF1199, DOI 10.1152/ajprenal.00131.2002; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Katayama S, 2013, BBA-BIOMEMBRANES, V1828, P2134, DOI 10.1016/j.bbamem.2013.05.016; Kondo E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1952; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Matsushita M, 2004, FEBS LETT, V572, P221, DOI 10.1016/j.febslet.2004.07.033; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Perry C, 2007, AM J PHYSIOL-RENAL, V293, pF68, DOI 10.1152/ajprenal.00454.2006; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Sudo H, 2010, GENOMICS, V95, P210, DOI 10.1016/j.ygeno.2010.02.002; Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	34	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86639	10.1371/journal.pone.0086639	http://dx.doi.org/10.1371/journal.pone.0086639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489756	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000067
J	Vandal, G; Geiling, B; Dankort, D				Vandal, Guillaume; Geiling, Benjamin; Dankort, David			Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation	PLOS ONE			English	Article							CELL-CYCLE ARREST; GROWTH-FACTOR RECEPTOR; EML4-ALK FUSION GENE; ONCOGENIC RAS; IN-VIVO; K-RAS; PROTEIN-KINASE; PROMOTER HYPERMETHYLATION; TRANSGENIC MICE; CANCER MODELS	Lung cancer is currently the most deadly malignancy in industrialized countries and accounts for 18% of all cancer-related deaths worldwide. Over 70% of patients with non-small cell lung cancer (NSCLC) are diagnosed at a late stage, with a 5-year survival below 10%. KRAS and the EGFR are frequently mutated in NSCLC and while targeted therapies for patients with EGFR mutations exist, oncogenic KRAS is thus far not druggable. KRAS activates multiple signalling pathways, including the PI3K/Akt pathway, the Raf-Mek-Erk pathway and the RalGDS/Ral pathway. Lung-specific expression of BrafV600E, the most prevalent BRAF mutation found in human tumors, results in Raf-Mek-Erk pathway activation and in the formation of benign adenomas that undergo widespread senescence in a Cre-activated Braf mouse model (Braf(CA)). However, oncogenic KRAS expression in mice induces adenocarcinomas, suggesting additional KRAS-activated pathways cooperate with sustained RAF-MEK-ERK signalling to bypass the oncogene-induced senescence proliferation arrest. To determine which KRAS effectors were responsible for tumor progression, we created four effector domain mutants (S35, G37, E38 and C40) in G12V-activated KRAS and expressed these alone or with BrafV600E in mouse lungs. The S35 and E38 mutants bind to Raf proteins but not PI3K or RalGDS; the G37 mutant binds to RalGDS and not Raf or PI3K and the C40 mutant is specific to PI3K. We designed lentiviral vectors to code for Cre recombinase along with KRAS mutants (V12, V12/S35, V12/G37, V12/E38 or V12/C40) or EGFP as a negative control.. These lentiviruses were used to infect Braf(CA) and wild-type mice. Surprisingly there was a significant decrease in tumor number and penetrance with each KRAS effector domain mutant relative to controls, suggesting that KRAS directly activates effectors with tumor suppressive functions.	[Vandal, Guillaume; Geiling, Benjamin; Dankort, David] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Dankort, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	david.dankort@mcgill.ca		Dankort, David/0000-0002-5862-6829	Canadian Institutes of Health Research [MOP-97925]; Melanoma Research Alliance; Canadian Cancer Society [2011-700876]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Melanoma Research Alliance; Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by the Canadian Institutes of Health Research [operating grant MOP-97925 to DD, Graduate scholarship to GV]; the Melanoma Research Alliance [New Investigator Award]; and the Canadian Cancer Society [CCSRI# 2011-700876]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadi C, 2012, GENE DEV, V26, P1945, DOI 10.1101/gad.193458.112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Dumur CI, 2003, GENOMICS, V81, P260, DOI 10.1016/S0888-7543(03)00020-X; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Farago AF, 2012, CELL, V149, P246, DOI 10.1016/j.cell.2012.03.015; Ferlay J, 2010, IARC CANCERBASE, V2; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Gandhi L, 2012, CLIN CANCER RES, V18, P3737, DOI 10.1158/1078-0432.CCR-11-2393; Gaughan Elizabeth M, 2011, Ther Adv Med Oncol, V3, P113, DOI 10.1177/1758834010397569; Geiling B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076279; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Irimia M, 2004, ONCOGENE, V23, P8695, DOI 10.1038/sj.onc.1207914; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jacquemart IC, 2009, INT J ONCOL, V34, P517, DOI 10.3892/ijo_00000177; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Johnson LG, 2003, HUM GENE THER, V14, P729, DOI 10.1089/104303403765255138; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Laurent-Puig P, 2009, CLIN CANCER RES, V15, P1133, DOI 10.1158/1078-0432.CCR-08-0905; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Little AG, 2005, ANN THORAC SURG, V80, P2051, DOI 10.1016/j.athoracsur.2005.06.071; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Maldonado JL, 2004, AM J PATHOL, V164, P1783, DOI 10.1016/S0002-9440(10)63736-4; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Musteanu M, 2012, NAT METHODS, V9, P897, DOI 10.1038/nmeth.2130; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rodig SJ, 2010, CURR OPIN INVEST DR, V11, P1477; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seo JS, 2012, GENOME RES; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song H, 2010, BIOCHEM BIOPH RES CO, V391, P969, DOI 10.1016/j.bbrc.2009.11.175; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tommasi S, 2005, CANCER RES, V65, P92; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Trejo CL, 2012, CANCER RES, V72, P3048, DOI 10.1158/0008-5472.CAN-11-3649; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	84	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84745	10.1371/journal.pone.0084745	http://dx.doi.org/10.1371/journal.pone.0084745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489653	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000009
J	Zughaier, SM; Kandler, JL; Shafer, WM				Zughaier, Susu M.; Kandler, Justin L.; Shafer, William M.			Neisseria gonorrhoeae Modulates Iron-Limiting Innate Immune Defenses in Macrophages	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; GONOCOCCAL-INFECTION; EPITHELIAL-CELLS; MEDIATED IRON; HEPCIDIN 20; RESISTANCE; EXPRESSION; LIPOCALIN-2; METABOLISM; EFFLUX	Neisseria gonorrhoeae is a strict human pathogen that causes the sexually transmitted infection termed gonorrhea. The gonococcus can survive extracellularly and intracellularly, but in both environments the bacteria must acquire iron from host proteins for survival. However, upon infection the host uses a defensive response by limiting the bioavailability of iron by a number of mechanisms including the enhanced expression of hepcidin, the master iron-regulating hormone, which reduces iron uptake from the gut and retains iron in macrophages. The host also secretes the antibacterial protein NGAL, which sequesters bacterial siderophores and therefore inhibits bacterial growth. To learn whether intracellular gonococci can subvert this defensive response, we examined expression of host genes that encode proteins involved in modulating levels of intracellular iron. We found that N. gonorrhoeae can survive in association (tightly adherent and intracellular) with monocytes and macrophages and upregulates a panel of its iron-responsive genes in this environment. We also found that gonococcal infection of human monocytes or murine macrophages resulted in the upregulation of hepcidin, NGAL, and NRAMP1 as well as downregulation of the expression of the gene encoding the short chain 3-hydroxybutyrate dehydrogenase (BDH2); BDH2 catalyzes the production of the mammalian siderophore 2,5-DHBA involved in chelating and detoxifying iron. Based on these findings, we propose that N. gonorrhoeae can subvert the iron-limiting innate immune defenses to facilitate iron acquisition and intracellular survival.	[Zughaier, Susu M.; Kandler, Justin L.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] Dept Vet Affairs Med Ctr, Labs Microbial Pathogenesis, Decatur, GA USA	Emory University	Zughaier, SM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	szughai@emory.edu	Zughaier, Susu/N-3185-2019; Zughaier, Susu/GLQ-9288-2022	Zughaier, Susu/0000-0001-7487-8770; 	Emory-Egleston Children's Research Center; NIH [U19 AI0131496]; Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI131496] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000112] Funding Source: NIH RePORTER	Emory-Egleston Children's Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by an Emory-Egleston Children's Research Center grant to S.M.Z., NIH grant U19 AI0131496 (P. F. Sparling, PI, University of North Carolina School of Medicine, W. M. S., Co-Investigator) and by a VA Merit Award grant to W. M. S. from the Medical Research Service of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Bahmani P, 2010, CELL STRESS CHAPERON, V15, P395, DOI 10.1007/s12192-009-0154-5; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Cabantchik ZI, 2002, ADV EXP MED BIOL, V509, P55; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; Criss AK, 2006, CELL MICROBIOL, V8, P1430, DOI 10.1111/j.1462-5822.2006.00722.x; Criss AK, 2012, NAT REV MICROBIOL, V10, P178, DOI 10.1038/nrmicro2713; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Ganz T, 2002, ISRAEL MED ASSOC J, V4, P1043; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; Hollander A, 2011, INFECT IMMUN, V79, P4764, DOI 10.1128/IAI.05806-11; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Jackson LA, 2010, J BACTERIOL, V192, P77, DOI 10.1128/JB.00741-09; Jerse AE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00107; Johnson MB, 2013, CELL MICROBIOL, V15, P1323, DOI 10.1111/cmi.12117; Johnson MB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00077; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Layoun A, 2012, INFLAMMATION, V35, P1500, DOI 10.1007/s10753-012-9463-4; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Lipinski Pawel, 2010, Postepy Biochem, V56, P305; Liu Y, 2012, MUCOSAL IMMUNOL, V5, P320, DOI 10.1038/mi.2012.12; Liu ZM, 2012, J MOL MED, V90, P1209, DOI 10.1007/s00109-012-0899-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Maisetta G, 2013, FEBS J, V280, P2842, DOI 10.1111/febs.12288; Maisetta G, 2010, PEPTIDES, V31, P1995, DOI 10.1016/j.peptides.2010.08.007; Mercante AD, 2012, ANTIMICROB AGENTS CH, V56, P1491, DOI 10.1128/AAC.06112-11; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; NIELSEN H, 1987, ACTA PATH MICRO IM C, V95, P81; Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Rodrigues PN, 2011, IMMUNOBIOLOGY, V216, P1127, DOI 10.1016/j.imbio.2011.04.004; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; SHAFER WM, 1984, J INFECT DIS, V149, P175, DOI 10.1093/infdis/149.2.175; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; World Health Organization Department of Reproductive Health and Research, 2011, WHORHR1114 DEP REPR; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	56	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87688	10.1371/journal.pone.0087688	http://dx.doi.org/10.1371/journal.pone.0087688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489950	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000145
J	Houben, R; Schmid, CP; Maier, M; Wobser, M; Motschenbacher, S; Becker, JC; Vetter-Kauczok, CS; Weyandt, G; Hesbacher, S; Haferkamp, S				Houben, Roland; Schmid, Corinna P.; Maier, Melissa; Wobser, Marion; Motschenbacher, Stephanie; Becker, Juergen C.; Vetter-Kauczok, Claudia S.; Weyandt, Gerhard; Hesbacher, Sonja; Haferkamp, Sebastian			p53 Regulation by TRP2 Is Not Pervasive in Melanoma	PLOS ONE			English	Article							HUMAN-MALIGNANT MELANOMA; CELL-LINES; DOPACHROME-TAUTOMERASE; EXPRESSION; MUTATION; GENE; AMPLIFICATION; PROGRESSION; TYROSINASE; MOLECULES	p53 is a central tumor suppressor protein and its inhibition is believed to be a prerequisite for cancer development. In approximately 50% of all malignancies this is achieved by inactivating mutations in the p53 gene. However, in several cancer entities, including melanoma, p53 mutations are rare. It has been recently proposed that tyrosinase related protein 2 (TRP2), a protein involved in melanin synthesis, may act as suppressor of the p53 pathway in melanoma. To scrutinize this notion we analyzed p53 and TRP2 expression by immunohistochemistry in 172 melanoma tissues and did not find any correlation. Furthermore, we applied three different TRP2 shRNAs to five melanoma cell lines and could not observe a target specific effect of the TRP2 knockdown on either p53 expression nor p53 reporter gene activity. Likewise, ectopic expression of TRP2 in a TRP2 negative melanoma cell line had no impact on p53 expression. In conclusion our data suggest that p53 repression critically controlled by TRP2 is not a general event in melanoma.	[Houben, Roland; Schmid, Corinna P.; Maier, Melissa; Wobser, Marion; Motschenbacher, Stephanie; Vetter-Kauczok, Claudia S.; Weyandt, Gerhard; Hesbacher, Sonja; Haferkamp, Sebastian] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany; [Becker, Juergen C.] Med Univ Graz, Dept Gen Dermatol, Graz, Austria	University of Wurzburg; Medical University of Graz	Haferkamp, S (corresponding author), Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany.	haferkamp_s@ukw.de	Haferkamp, Sebastian/ABD-7390-2021; Haferkamp, Sebastian/AAN-3649-2021	Haferkamp, Sebastian/0000-0002-3894-8345; Houben, Roland/0000-0003-4538-2324	German Cancer Aid (Melanoma Research Network); Interdisciplinary Center for Clinical Research [IZKF B-193]; University of Wurzburg; German Research Foundation (DFG)	German Cancer Aid (Melanoma Research Network)(Deutsche Krebshilfe); Interdisciplinary Center for Clinical Research; University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	This work is supported by research grants from the German Cancer Aid (Melanoma Research Network) and the Interdisciplinary Center for Clinical Research (IZKF B-193) Wurzburg. SH is a Else-Kroner-Research-Fellow. CPS and MM are supported by Medical Faculty scholarships of the University of Wurzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Bakker ABH, 1998, J IMMUNOL, V160, P5239; BECKER JC, 1991, J IMMUNOL, V147, P4398; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cregger M, 2006, ARCH PATHOL LAB MED, V130, P1026; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Eberle J, 2010, PIGM CELL MELANOMA R, V23, P296, DOI 10.1111/j.1755-148X.2010.00684.x; Essmann F, 2012, BRIT J PHARMACOL, V165, P328, DOI 10.1111/j.1476-5381.2011.01570.x; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Gembarska A, 2012, NAT MED; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; HERLYN M, 1985, J NATL CANCER I, V74, P283; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022096; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; JARA JR, 1990, BIOCHIM BIOPHYS ACTA, V1035, P276, DOI 10.1016/0304-4165(90)90089-F; Jiao ZX, 2006, DEV BIOL, V296, P396, DOI 10.1016/j.ydbio.2006.06.006; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee JT, 2012, J INVEST DERMATOL, V132, P263, DOI 10.1038/jid.2011.362; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; Matin RN, 2013, J EXP MED, V210, P581, DOI 10.1084/jem.20121439; MUNGER K, 1992, CANCER SURV, V12, P197; Muthusamy V, 2006, GENE CHROMOSOME CANC, V45, P447, DOI 10.1002/gcc.20310; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Olivares C, 2001, BIOCHEM J, V354, P131, DOI 10.1042/0264-6021:3540131; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Polsky D, 2001, CANCER RES, V61, P7642; Reid YA, 2011, METHODS MOL BIOL, V731, P35, DOI 10.1007/978-1-61779-080-5_4; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Smith SL, 2009, J VIROL METHODS, V157, P47, DOI 10.1016/j.jviromet.2008.12.002; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takeuchi H, 2003, CANCER RES, V63, P441; Tuve S, 2004, INT J CANCER, V108, P162, DOI 10.1002/ijc.11552; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; WESTERMARK B, 1986, P NATL ACAD SCI USA, V83, P7197, DOI 10.1073/pnas.83.19.7197	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87440	10.1371/journal.pone.0087440	http://dx.doi.org/10.1371/journal.pone.0087440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475287	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300182
J	Labasque, M; Hivert, B; Nogales-Gadea, G; Querol, L; Illa, I; Faivre-Sarrailh, C				Labasque, Marilyne; Hivert, Bruno; Nogales-Gadea, Gisela; Querol, Luis; Illa, Isabel; Faivre-Sarrailh, Catherine			Specific Contactin N-Glycans Are Implicated in Neurofascin Binding and Autoimmune Targeting in Peripheral Neuropathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Protein; Glycoprotein; Myelin; Neuroinflammation	MYELINATED AXONS; CELL-ADHESION; MYASTHENIA-GRAVIS; CRYSTAL-STRUCTURE; RANVIER; GLIOMEDIN; COMPLEX; NODES; DOMAINS; TAG-1	Background: The glycoproteins contactin and neurofascin-155 are implicated in axo-glial junctions insulating the node of Ranvier. Results:N-Glycosylated contactin is targeted in inflammatory neuropathy. Conclusion: Autoantibodies reveal specific N-glycans that are implicated in adhesive interaction between contactin and neurofascin-155. Significance: Autoantibodies against N-glycosylated contactin may be pathogenic via functional blocking. Cell adhesion molecules (CAMs) play a crucial role in the formation of the nodes of Ranvier and in the rapid propagation of the nerve impulses along myelinated axons. These CAMs are the targets of autoimmunity in inflammatory neuropathies. We recently showed that a subgroup of patients with aggressive chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) shows autoantibodies to contactin (1). The complex of contactinCasprneurofascin-155 (NF155) enables the formation of paranodal junctions, suggesting that antibody attack against paranodes may participate in the severity of CIDP. In the present study, we mapped the molecular determinants of contactin targeted by the autoantibodies. In three patients, immunoreactivity was directed against the Ig domains of contactin and was dependent on N-glycans. The serum of one patient was selectively directed against contactin bearing mannose-rich N-glycans. Strikingly, the oligomannose type sugars of contactin are required for association with its glial partner NF155 (2). To investigate precisely the role of contactin N-glycans, we have mutated each of the nine consensus N-glycosylation sites independently. We found that the mutation of three sites (N467Q/N473Q/N494Q) in Ig domain 5 of contactin prevented soluble NF155-Fc binding. In contrast, these mutations did not abolish cis-association with Caspr. Next, we showed that the cluster of N-glycosylation sites (Asn-467, Asn-473, and Asn-494) was required for immunoreactivity in one patient. Using cell aggregation assays, we showed that the IgGs from the four CIDP patients prevented adhesive interaction between contactinCaspr and NF155. Importantly, we showed that the anti-contactin autoantibodies induced alteration of paranodal junctions in myelinated neuronal culture. These results strongly suggest that antibodies to CAMs may be pathogenic and induce demyelination via functional blocking activity.	[Labasque, Marilyne; Hivert, Bruno; Faivre-Sarrailh, Catherine] Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR7286, F-13344 Marseille, France; [Nogales-Gadea, Gisela; Querol, Luis; Illa, Isabel] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, Barcelona 08025, Spain; [Nogales-Gadea, Gisela; Querol, Luis; Illa, Isabel] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerat CIBERNED, Madrid 28031, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBERNED; Instituto de Salud Carlos III	Faivre-Sarrailh, C (corresponding author), Fac Med Nord, CRN2M UMR7286, Ctr Rech Neurobiol & Neurophysiol Marseille, Bd Pierre Dramard, F-13344 Marseille 15, France.	catherine.sarrailh@univ-amu.fr	Faivre-Sarrailh, Catherine/M-6738-2016; ILLA, Isabel/AAD-1816-2019; Nogales-Gadea, Gisela/N-4004-2014; Querol, Luis/H-2119-2015; Labasque, Marilyne/AAE-2498-2022	Nogales-Gadea, Gisela/0000-0002-7414-212X; Querol, Luis/0000-0002-4289-8264; Labasque, Marilyne/0000-0002-1467-2866; Faivre-Sarrailh, Catherine/0000-0002-1718-0533	Association pour la Recherche sur la Sclerose en Plaques; European E-rare-2 project	Association pour la Recherche sur la Sclerose en Plaques; European E-rare-2 project	This work was supported by the Association pour la Recherche sur la Sclerose en Plaques (to C. F.-S.) and the European E-rare-2 project (to C. F.-S. and I. I.).	Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Bonnon C, 2007, MOL BIOL CELL, V18, P229, DOI 10.1091/mbc.E06-06-0570; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cervello M, 1996, J CELL SCI, V109, P699; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Devaux JJ, 2012, AM J PATHOL, V181, P1402, DOI 10.1016/j.ajpath.2012.06.034; Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Huijbers MG, 2013, P NATL ACAD SCI USA, V110, P20783, DOI 10.1073/pnas.1313944110; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Labasque M, 2010, FEBS LETT, V584, P1787, DOI 10.1016/j.febslet.2009.08.025; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Ng JKM, 2012, NEUROLOGY, V79, P2241, DOI 10.1212/WNL.0b013e31827689ad; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Pruss H, 2011, BRAIN, V134, DOI 10.1093/brain/awq372; Querol L., 2014, NEUROLOGY IN PRESS; Querol L, 2013, CURR OPIN NEUROL, V26, P459, DOI 10.1097/WCO.0b013e328364c079; Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; STANLEY P, 1995, FASEB J, V9, P1436, DOI 10.1096/fasebj.9.14.7589985; Thaxton C, 2010, J NEUROSCI, V30, P4868, DOI 10.1523/JNEUROSCI.5951-09.2010; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203; ZISCH AH, 1995, MOL CELL NEUROSCI, V6, P263, DOI 10.1006/mcne.1995.1021	38	74	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7907	7918		10.1074/jbc.M113.528489	http://dx.doi.org/10.1074/jbc.M113.528489			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497634	Green Published, hybrid			2022-12-25	WOS:000332761500055
J	Zemoura, K; Benke, D				Zemoura, Khaled; Benke, Dietmar			Proteasomal Degradation of gamma-Aminobutyric Acid(B) Receptors Is Mediated by the Interaction of the GABA(B2) C Terminus with the Proteasomal ATPase Rtp6 and Regulated by Neuronal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER-associated Degradation; GABA Receptors; Proteasome; Ubiquitin	RETICULUM-ASSOCIATED DEGRADATION; SYNAPTIC PLASTICITY; LYSOSOMAL DEGRADATION; HIPPOCAMPAL-NEURONS; PROTEIN-DEGRADATION; PROXIMITY LIGATION; 26S PROTEASOME; UBIQUITINATION; SUBUNIT; SUG1	Background: The expression level of GABA(B) receptors is controlled by proteasomal degradation. Results: Proteasomal degradation of GABA(B) receptors is mediated by interaction with Rpt6 and modulated by neuronal activity. Conclusion: The level of neuronal activity regulates via proteasomal degradation the ER pool of GABA(B) receptor competent for forward trafficking. Significance: This mechanism might contribute to homeostatic neuronal plasticity. Regulation of cell surface expression of neurotransmitter receptors is crucial for determining synaptic strength and plasticity, but the underlying mechanisms are not well understood. We previously showed that proteasomal degradation of GABA(B) receptors via the endoplasmic reticulum (ER)-associated protein degradation (ERAD) machinery determines the number of cell surface GABA(B) receptors and thereby GABA(B) receptor-mediated neuronal inhibition. Here, we show that proteasomal degradation of GABA(B) receptors requires the interaction of the GABA(B2) C terminus with the proteasomal AAA-ATPase Rpt6. A mutant of Rpt6 lacking ATPase activity prevented degradation of GABA(B) receptors but not the removal of Lys(48)-linked ubiquitin from GABA(B2). Blocking ERAD activity diminished the interaction of Rtp6 with GABA(B) receptors resulting in increased total as well as cell surface expression of GABA(B) receptors. Modulating neuronal activity affected proteasomal activity and correspondingly the interaction level of Rpt6 with GABA(B2). This resulted in altered cell surface expression of the receptors. Thus, neuronal activity-dependent proteasomal degradation of GABA(B) receptors by the ERAD machinery is a potent mechanism regulating the number of GABA(B) receptors available for signaling and is expected to contribute to homeostatic neuronal plasticity.	[Zemoura, Khaled; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Benke, Dietmar] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Benke, Dietmar] ETH, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch			Swiss National Science Foundation [31003A_121963, 31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A_121963 and 31003A_138382 (to D. B.).	Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Inoue T, 2006, BIOCHEM BIOPH RES CO, V342, P829, DOI 10.1016/j.bbrc.2006.02.025; Jakawich SK, 2010, NEUROSCIENCE, V171, P1016, DOI 10.1016/j.neuroscience.2010.09.061; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Masuyama H, 1998, J CELL BIOCHEM, V71, P429, DOI 10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P; Pagano A, 2001, J NEUROSCI, V21, P1189; Rezvani K, 2012, J NEUROCHEM, V122, P24, DOI 10.1111/j.1471-4159.2012.07752.x; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Saliba RS, 2009, J BIOL CHEM, V284, P32544, DOI 10.1074/jbc.M109.040071; Schneider S, 1997, GENE, V197, P337, DOI 10.1016/S0378-1119(97)00280-1; Sledz P, 2013, J MOL BIOL, V425, P1415, DOI 10.1016/j.jmb.2013.01.036; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang HF, 2007, J NEUROCHEM, V101, P1651, DOI 10.1111/j.1471-4159.2007.04460.x; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang YF, 2012, EMBO REP, V13, P1004, DOI 10.1038/embor.2012.144; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	41	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7738	7746		10.1074/jbc.M113.541987	http://dx.doi.org/10.1074/jbc.M113.541987			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482233	Green Published, hybrid			2022-12-25	WOS:000332761500041
J	Wei, CY; Wang, HP; Zhu, ZY; Sun, YH				Wei, Chang-Yong; Wang, Hou-Peng; Zhu, Zuo-Yan; Sun, Yong-Hua			Transcriptional Factors Smad1 and Smad9 Act Redundantly to Mediate Zebrafish Ventral Specification Downstream of Smad5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Development; Gene Regulation; SMAD Transcription Factor; Zebrafish; Dorso-ventral Patterning; Myelopoiesis	DORSOVENTRAL PATTERN-FORMATION; PROTEIN; EXPRESSION; GENES; IDENTIFICATION; SOMITABUN; TERMINUS; DEFECTS; REVEALS; SIGNALS	Background: Ventral specification is regulated by Smad1-, Smad5-, and/or Smad9-mediated bone morphogenetic protein (BMP) signaling. Results: Double knockdown instead of single knockdown of smad1 and smad9 induces dorsalization, which cannot be rescued by smad5 overexpression. Conclusion:smad1 and smad9 act redundantly and downstream of smad5 to mediate ventral specification. Significance: The regulation network and cooperative roles of BMP R-Smads in early development are clarified. Bone morphogenetic proteins (BMPs) are multifunctional growth factors that play crucial roles during embryonic development and cell fate determination. Nuclear transduction of BMP signals requires the receptor type Smad proteins, Smad1, Smad5, and Smad9. However, how these Smad proteins cooperate in vivo to regulate various developmental processes is largely unknown. In zebrafish, it was widely believed that the maternally expressed smad5 is essential for dorso-ventral (DV) patterning, and the zygotically transcribed smad1 is not required for normal DV axis establishment. In the present study, we have identified zygotically expressed smad9, which cooperates with smad1 downstream of smad5, to mediate zebrafish early DV patterning in a functional redundant manner. Although knockdown of smad1 or smad9 alone does not lead to visible dorsalization, double knockdown strongly dorsalizes zebrafish embryos, which cannot be efficiently rescued by smad5 overexpression, whereas the dorsalization induced by smad5 knockdown can be fully rescued by overexpression of smad1 or smad9. We have further revealed that the transcription initiations of smad1 and smad9 are repressed by each other, that they are direct transcriptional targets of Smad5, and that smad9, like smad1, is required for myelopoiesis. In conclusion, our study uncovers that smad1 and smad9 act redundantly to each other downstream of smad5 to mediate ventral specification and to regulate embryonic myelopoiesis.	[Wei, Chang-Yong; Wang, Hou-Peng; Zhu, Zuo-Yan; Sun, Yong-Hua] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China; [Wei, Chang-Yong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, YH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, 7 Donghu South Rd, Wuhan 430072, Peoples R China.	yhsun@ihb.ac.cn	Sun, Yonghua/B-5025-2012	Sun, Yonghua/0000-0001-9368-6969; Wei, Changyong/0000-0002-0390-4094	China 973 Project [2010CB126306, 2012CB944504]; National Natural Science Foundation of China (NSFC) [31222052]; NSFC [30771100]; FEBL Grant [2011FBZ23]	China 973 Project(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); FEBL Grant	This work was supported by China 973 Project Grants 2010CB126306 and 2012CB944504, the National Science Fund for Excellent Young Scholars of the National Natural Science Foundation of China (NSFC) Grant 31222052, NSFC Grant 30771100, and FEBL Grant 2011FBZ23 (to Y. H. S.).	Alcaraz-Perez F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-81; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen CH, 2009, DEV DYNAM, V238, P2850, DOI 10.1002/dvdy.22105; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Dee CT, 2007, INT J DEV BIOL, V51, P79, DOI 10.1387/ijdb.062204cd; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Dick A, 1999, DEV DYNAM, V216, P285, DOI 10.1002/(SICI)1097-0177(199911)216:3<285::AID-DVDY7>3.0.CO;2-L; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gilardelli CN, 2004, DEV DYNAM, V230, P494, DOI 10.1002/dvdy.20073; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Haffter P, 1996, DEVELOPMENT, V123, P1; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; Hazen VM, 2012, DEV BIOL, V367, P216, DOI 10.1016/j.ydbio.2012.05.014; He C, 2005, BIOCHEM BIOPH RES CO, V329, P324, DOI 10.1016/j.bbrc.2005.01.133; Henningfeld KA, 2002, J BIOL CHEM, V277, P2097, DOI 10.1074/jbc.M108524200; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hild M, 1999, DEVELOPMENT, V126, P2149; Jia SJ, 2012, DEV CELL, V22, P1065, DOI 10.1016/j.devcel.2012.03.001; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim RH, 2000, GENE DEV, V14, P1605; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kramer C, 2002, DEV BIOL, V250, P263, DOI 10.1006/dbio.2002.0805; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Le Dreau G, 2012, DEVELOPMENT, V139, P259, DOI 10.1242/dev.074948; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Li W, 2001, BIOCHEM BIOPH RES CO, V286, P1163, DOI 10.1006/bbrc.2001.5529; Liu YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000707; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; MAENO M, 1994, P NATL ACAD SCI USA, V91, P10260, DOI 10.1073/pnas.91.22.10260; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; Muller F, 1999, MECH DEVELOP, V88, P73, DOI 10.1016/S0925-4773(99)00173-2; Mullins MC, 1996, DEVELOPMENT, V123, P81; NORDNES S, 1994, BBA-GENE STRUCT EXPR, V1219, P529, DOI 10.1016/0167-4781(94)90081-7; Orvis GD, 2008, BIOL REPROD, V78, P994, DOI 10.1095/biolreprod.107.066605; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Poulain M, 2002, DEVELOPMENT, V129, P4901; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Suzuki A, 1997, DEV BIOL, V184, P402, DOI 10.1006/dbio.1997.8548; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whitman M, 2005, DEVELOPMENT, V132, P4205, DOI 10.1242/dev.02023; Wong YL, 2012, DEV BIOL, V363, P247, DOI 10.1016/j.ydbio.2011.12.037; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yang X, 1999, DEVELOPMENT, V126, P1571	66	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6604	6618		10.1074/jbc.M114.549758	http://dx.doi.org/10.1074/jbc.M114.549758			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24488494	hybrid, Green Published			2022-12-25	WOS:000332389400025
J	Barnett, WH; Cymbalyuk, GS				Barnett, William H.; Cymbalyuk, Gennady S.			A Codimension-2 Bifurcation Controlling Endogenous Bursting Activity and Pulse-Triggered Responses of a Neuron Model	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; INTERSEGMENTAL COORDINATION; HEART INTERNEURONS; I-H; OSCILLATORY ACTIVITY; LIMB MOVEMENTS; PHASE; LEECH; MECHANISMS; DYNAMICS	The dynamics of individual neurons are crucial for producing functional activity in neuronal networks. An open question is how temporal characteristics can be controlled in bursting activity and in transient neuronal responses to synaptic input. Bifurcation theory provides a framework to discover generic mechanisms addressing this question. We present a family of mechanisms organized around a global codimension-2 bifurcation. The cornerstone bifurcation is located at the intersection of the border between bursting and spiking and the border between bursting and silence. These borders correspond to the blue sky catastrophe bifurcation and the saddle-node bifurcation on an invariant circle (SNIC) curves, respectively. The cornerstone bifurcation satisfies the conditions for both the blue sky catastrophe and SNIC. The burst duration and interburst interval increase as the inverse of the square root of the difference between the corresponding bifurcation parameter and its bifurcation value. For a given set of burst duration and interburst interval, one can find the parameter values supporting these temporal characteristics. The cornerstone bifurcation also determines the responses of silent and spiking neurons. In a silent neuron with parameters close to the SNIC, a pulse of current triggers a single burst. In a spiking neuron with parameters close to the blue sky catastrophe, a pulse of current temporarily silences the neuron. These responses are stereotypical: the durations of the transient intervals-the duration of the burst and the duration of latency to spiking-are governed by the inverse-square-root laws. The mechanisms described here could be used to coordinate neuromuscular control in central pattern generators. As proof of principle, we construct small networks that control metachronal-wave motor pattern exhibited in locomotion. This pattern is determined by the phase relations of bursting neurons in a simple central pattern generator modeled by a chain of oscillators.	[Barnett, William H.; Cymbalyuk, Gennady S.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Cymbalyuk, GS (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	gcymbalyuk@gsu.edu	Barnett, William/GWU-7996-2022		National Science Foundation [PHY-0750456]; Division Of Physics [0750456] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by National Science Foundation grant PHY-0750456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola J, 2012, J NEUROSCI, V32, P2166, DOI 10.1523/JNEUROSCI.5297-11.2012; ANGSTADT JD, 1991, J NEUROPHYSIOL, V66, P1858, DOI 10.1152/jn.1991.66.6.1858; [Anonymous], 1998, METHODS QUALITATIVE; ARBAS EA, 1984, J COMP PHYSIOL, V155, P783, DOI 10.1007/BF00611595; BAL T, 1988, J COMP PHYSIOL A, V163, P715, DOI 10.1007/BF00604049; Berge P, 1987, ORDER CHAOS DETERMIN; Booth V, 1997, SIAM J APPL MATH, V57, P1406, DOI 10.1137/S0036139995295104; Butera RJ, 1997, BIOL CYBERN, V77, P307, DOI 10.1007/s004220050392; Cao XJ, 2011, J NEUROPHYSIOL, V106, P630, DOI 10.1152/jn.00015.2010; Channell P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.134101; COHEN AH, 1992, TRENDS NEUROSCI, V15, P434, DOI 10.1016/0166-2236(92)90006-T; Cymbalyuk G, 2005, J COMPUT NEUROSCI, V18, P255, DOI 10.1007/s10827-005-0354-7; Cymbalyuk GS, 2002, J NEUROSCI, V22, P10580; Cymbalyuk GS, 2001, NEUROCOMPUTING, V38, P159, DOI 10.1016/S0925-2312(01)00414-3; DiCaprio RA, 1997, J EXP BIOL, V200, P963; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P225, DOI 10.1162/neco.1994.6.2.225; Ermentrout B, 2004, SIAM; ERMENTROUT GB, 1994, SIAM J APPL MATH, V54, P478, DOI 10.1137/S0036139992231964; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; FENICHEL N, 1979, J DIFFER EQUATIONS, V31, P53, DOI 10.1016/0022-0396(79)90152-9; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Friesen W.O., 1993, Seminars in the Neurosciences, V5, P41, DOI 10.1016/S1044-5765(05)80023-5; Ghigliazza RM, 2004, SIAM J APPL DYN SYST, V3, P636, DOI 10.1137/030602307; Ghosh A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041930; Guckenheimer J, 1997, J COMPUT NEUROSCI, V4, P257, DOI 10.1023/A:1008871803040; Gutkin BS, 1998, NEURAL COMPUT, V10, P1047, DOI 10.1162/089976698300017331; HARRISWARRICK RM, 1987, J NEUROSCI, V7, P2113; Hill AAV, 2001, J COMPUT NEUROSCI, V10, P281, DOI 10.1023/A:1011216131638; HOOPER SL, 1987, J NEUROSCI, V7, P2097; Hooper SL, 2002, NAT NEUROSCI, V5, P552, DOI 10.1038/nn838; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P191, DOI 10.1023/A:1008822218061; Hoppensteadt FC, 1997, APPL MATH SCI, V126; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Jones SR, 2003, J NEUROSCI, V23, P3457; KHIBNIK AI, 1993, PHYSICA D, V62, P360, DOI 10.1016/0167-2789(93)90294-B; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Kloppenburg P, 1999, J NEUROPHYSIOL, V81, P29, DOI 10.1152/jn.1999.81.1.29; KOPELL N, 1988, MATH BIOSCI, V90, P87, DOI 10.1016/0025-5564(88)90059-4; Kopp-Scheinpflug C, 2011, NEURON, V71, P911, DOI 10.1016/j.neuron.2011.06.028; Kozlov A, 2009, P NATL ACAD SCI USA, V106, P20027, DOI 10.1073/pnas.0906722106; KRISTAN WB, 1974, J COMP PHYSIOL, V94, P97, DOI 10.1007/BF00617837; Laing CR, 2003, J COMPUT NEUROSCI, V14, P329, DOI 10.1023/A:1023269128622; Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Malashchenko T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041910; Malashchenko T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021782; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MATSUSHIMA T, 1992, J NEUROPHYSIOL, V67, P373, DOI 10.1152/jn.1992.67.2.373; Meng XY, 2011, J COMPUT NEUROSCI, V31, P117, DOI 10.1007/s10827-010-0297-5; Mouser C, 2008, J MATH BIOL, V57, P161, DOI 10.1007/s00285-007-0150-2; Mullins OJ, 2011, PROG NEUROBIOL, V93, P244, DOI 10.1016/j.pneurobio.2010.11.001; Nadim F, 1997, J NEUROSCI, V17, P4461; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2983, DOI 10.1152/jn.00407.2007; OPDYKE CA, 1994, J COMP PHYSIOL A, V175, P781; POMEAU Y, 1980, COMMUN MATH PHYS, V74, P189, DOI 10.1007/BF01197757; Pontryagin L. S., 1960, SOV MATH DOKL, V1, P611; Popovych OV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.228102; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Pulver S, 2012, FRONT BEH NEUR C 10; Ramirez JM, 2011, J BIOL PHYS, V37, P241, DOI 10.1007/s10867-011-9214-z; RINZEL J, 1978, FED PROC, V37, P2793; Rinzel J, 1987, LECT NOTES BIOMATH, V71; Rinzel J., 1998, METHODS NEURONAL MOD, V2, P251; Roa MAD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021911; Rodgers EW, 2011, J NEUROSCI, V31, P16387, DOI 10.1523/JNEUROSCI.3770-11.2011; Rodgers EW, 2011, J NEUROSCI, V31, P13046, DOI 10.1523/JNEUROSCI.2194-11.2011; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Shilnikov A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048101; Shilnikov L, 2001, METHODS QUALITATIVE, V2; Shilnikov L. P., 2000, METHODS QUALITATIVE, V200, P165; Simoni ME, 2004, IEEE T BIO-MED ENG, V51, P342, DOI 10.1109/TBME.2003.820390; Skinner FK, 1998, J NEUROSCI, V18, P3831; Smarandache C, 2009, J NEUROSCI, V29, P9351, DOI 10.1523/JNEUROSCI.1744-09.2009; Soofi W, 2012, J COMPUT NEUROSCI, V33, P77, DOI 10.1007/s10827-011-0375-3; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Teka W, 2011, B MATH BIOL, V73, P1292, DOI 10.1007/s11538-010-9559-7; Tobin AE, 2005, J NEUROPHYSIOL, V94, P3938, DOI 10.1152/jn.00340.2005; Varkonyi PL, 2008, J COMPUT NEUROSCI, V25, P245, DOI 10.1007/s10827-008-0076-8; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; WILLIAMS TL, 1989, J EXP BIOL, V143, P559; Yanchuk S, 2011, CHAOS, V21, DOI 10.1063/1.3665200	96	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85451	10.1371/journal.pone.0085451	http://dx.doi.org/10.1371/journal.pone.0085451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497927	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900009
J	Li, J; Gao, GZ; Xu, K; Chen, BY; Yan, GX; Li, F; Qiao, JW; Zhang, TY; Wu, XM				Li, Jun; Gao, Guizhen; Xu, Kun; Chen, Biyun; Yan, Guixin; Li, Feng; Qiao, Jiangwei; Zhang, Tianyao; Wu, Xiaoming			Genome-Wide Survey and Expression Analysis of the Putative Non-Specific Lipid Transfer Proteins in Brassica rapa L	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; INTRACELLULAR EXCHANGE; POLLEN DEVELOPMENT; BINDING PROTEINS; DROUGHT STRESS; GENE FAMILIES; C GENOMES; ARABIDOPSIS; NAPUS; IDENTIFICATION	Background: Plant non-specific lipid transfer proteins (nsLtps) are small, basic proteins encoded by multigene families and have reported functions in many physiological processes such as mediating phospholipid transfer, defense reactions against phytopathogens, the adaptation of plants to various environmental conditions, and sexual reproduction. To date, no genome-wide overview of the Brassica rapa nsLtp (BrnsLtp) gene family has been performed. Therefore, as the first step and as a helpful strategy to elucidate the functions of BrnsLtps, a genome-wide study for this gene family is necessary. Methodology/Principal Finding: In this study, a total of 63 putative BrnsLtp genes were identified through a comprehensive in silico analysis of the whole genome of B. rapa. Based on the sequence similarities, these BrnsLtps was grouped into nine types (I, II, III, IV, V, VI, VIII, IX, and XI). There is no type VII nsLtps in B. rapa, and a new type, XI nsLtps, was identified in B. rapa. Furthermore, nine type II AtLtps have no homologous genes in B. rapa. Gene duplication analysis demonstrated that the conserved collinear block of each BrnsLtp is highly identical to those in Arabidopsis and that both segmental duplications and tandem duplications seem to play equal roles in the diversification of this gene family. Expression analysis indicated that 29 out of the 63 BrnsLtps showed specific expression patterns. After careful comparison and analysis, we hypothesize that some of the type I BrnsLtps may function like Arabidopsis pathogenesis-related-14 (PR-14) proteins to protect the plant from phytopathogen attack. Eleven BrnsLtps with inflorescence-specific expression may play important roles in sexual reproduction. Additionally, BrnsLtpI.3 may have functions similar to Arabidopsis LTP1. Conclusions/Significance: The genome-wide identification, bioinformatic analysis and expression analysis of BrnsLtp genes should facilitate research of this gene family and polyploidy evolution and provide new insight towards elucidating their biological functions in plants.	[Li, Jun; Gao, Guizhen; Xu, Kun; Chen, Biyun; Yan, Guixin; Li, Feng; Qiao, Jiangwei; Zhang, Tianyao; Wu, Xiaoming] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wu, XM (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	wuxm@oilcrops.cn		Li, Jun/0000-0002-1285-6514	Chinese National Basic Research and Development Program [2011CB109302]; National Natural Science Foundation of China [31100236]; Wuhan Youth Science and Technology Chen Guang Program [201271031402]	Chinese National Basic Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Youth Science and Technology Chen Guang Program	This study was supported by the Chinese National Basic Research and Development Program (2011CB109302), the National Natural Science Foundation of China (31100236), and the Wuhan Youth Science and Technology Chen Guang Program (201271031402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2001, BIOCHEMISTRY-US, V40, P4229, DOI 10.1021/bi002537v; ARONDEL V, 1990, MOL CELL BIOCHEM, V98, P49; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Blein JP, 2002, TRENDS PLANT SCI, V7, P293, DOI 10.1016/S1360-1385(02)02284-7; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Bohuon EJR, 1996, THEOR APPL GENET, V93, P833, DOI 10.1007/BF00224083; Boutrot F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-86; Brotman Y, 2012, MICROBIOL-SGM, V158, P139, DOI 10.1099/mic.0.052621-0; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cardoza V, 2004, IN VITRO CELL DEV-PL, V40, P542, DOI 10.1079/IVP2004568; Carvalho AD, 2007, PEPTIDES, V28, P1144, DOI 10.1016/j.peptides.2007.03.004; Chae K, 2011, ANN BOT-LONDON, V108, P627, DOI 10.1093/aob/mcr015; Chae K, 2010, J EXP BOT, V61, P4277, DOI 10.1093/jxb/erq228; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Champigny MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00230; Champigny MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-125; Chen CM, 2011, PLANT SCI, V181, P439, DOI 10.1016/j.plantsci.2011.07.003; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Choi YE, 2012, PLANT J, V70, P480, DOI 10.1111/j.1365-313X.2011.04886.x; COUTOSTHEVENOT P, 1993, EUR J BIOCHEM, V217, P885, DOI 10.1111/j.1432-1033.1993.tb18317.x; Douliez JP, 2000, J CEREAL SCI, V32, P1, DOI 10.1006/jcrs.2000.0315; Dvorakova L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-412; Edstam MM, 2011, MOL PLANT, V4, P947, DOI 10.1093/mp/ssr019; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Ellerstrom M, 1996, PLANT MOL BIOL, V32, P1019, DOI 10.1007/BF00041385; EVANS DE, 1992, PLANTA, V186, P343, DOI 10.1007/BF00195314; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FOSTER GD, 1992, PLANT SCI, V84, P187, DOI 10.1016/0168-9452(92)90133-7; Giordani T, 2011, THEOR APPL GENET, V122, P1039, DOI 10.1007/s00122-010-1509-0; GUERCHE P, 1990, PLANT CELL, V2, P469, DOI 10.1105/tpc.2.5.469; Guiderdoni E, 2002, PLANT MOL BIOL, V49, P683, DOI 10.1023/A:1015595100145; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo CK, 2013, PLANT MOL BIOL, V82, P239, DOI 10.1007/s11103-013-0057-9; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Jose-Estanyol M, 2000, PLANT PHYSIOL BIOCH, V38, P97, DOI 10.1016/S0981-9428(00)00165-0; Jung HW, 2003, PLANT CELL ENVIRON, V26, P915, DOI 10.1046/j.1365-3040.2003.01024.x; KADER JC, 1984, EUR J BIOCHEM, V139, P411, DOI 10.1111/j.1432-1033.1984.tb08020.x; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; KADER JC, 1975, BIOCHIM BIOPHYS ACTA, V380, P31, DOI 10.1016/0005-2760(75)90042-9; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim TH, 2008, J PLANT PHYSIOL, V165, P345, DOI 10.1016/j.jplph.2007.06.004; Lee SB, 2009, PLANT PHYSIOL, V150, P42, DOI 10.1104/pp.109.137745; LEHMANN MS, 1989, J MOL BIOL, V210, P235, DOI 10.1016/0022-2836(89)90303-3; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Lim GAC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-40; Lin P, 2007, PEPTIDES, V28, P1514, DOI 10.1016/j.peptides.2007.06.028; Liu Wanfei, 2010, Genomics Proteomics & Bioinformatics, V8, P229, DOI 10.1016/S1672-0229(10)60024-1; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Lukens L, 2003, GENETICS, V164, P359; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Molina A, 1997, PLANT J, V12, P669, DOI 10.1046/j.1365-313X.1997.00669.x; Molina A, 1996, MOL GEN GENET, V252, P162, DOI 10.1007/BF02173216; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nieuwland J, 2005, PLANT CELL, V17, P2009, DOI 10.1105/tpc.105.032094; OSTERGAARD J, 1993, BIOCHIM BIOPHYS ACTA, V1170, P109, DOI 10.1016/0005-2760(93)90059-I; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Park SY, 2003, PLANT MOL BIOL, V51, P183, DOI 10.1023/A:1021139502947; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 2003, GENOME, V46, P291, DOI [10.1139/g03-006, 10.1139/G03-006]; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piffanelli P, 1997, PLANT J, V11, P549, DOI 10.1046/j.1365-313X.1997.11030549.x; Pii Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24836; Pii Y, 2010, PLANT SIGNAL BEHAV, V5, P594, DOI 10.4161/psb.11499; Potocka I, 2012, PLANT CELL REP, V31, P2031, DOI 10.1007/s00299-012-1314-0; Rogers HJ, 2001, PLANT MOL BIOL, V45, P577, DOI 10.1023/A:1010695226241; Sarowar S, 2009, PLANT CELL REP, V28, P419, DOI 10.1007/s00299-008-0653-3; Sawano Y, 2008, PLANT PHYSIOL, V146, P1909, DOI 10.1104/pp.107.111500; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; SHIN DH, 1995, STRUCTURE, V3, P189, DOI 10.1016/S0969-2126(01)00149-6; SLEIGHT RG, 1987, ANNU REV PHYSIOL, V49, P193; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stalberg K, 1996, PLANTA, V199, P515, DOI 10.1007/BF00195181; STERK P, 1991, PLANT CELL, V3, P907, DOI 10.1105/tpc.3.9.907; Suwabe K, 2008, GENOME, V51, P169, DOI 10.1139/G07-113; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapia G, 2013, PLANT MOL BIOL, V82, P485, DOI 10.1007/s11103-013-0080-x; Tassin S, 1998, BIOCHEMISTRY-US, V37, P3623, DOI 10.1021/bi9723515; THOMA S, 1994, PLANT PHYSIOL, V105, P35, DOI 10.1104/pp.105.1.35; Tian AM, 2009, MOL BIOL REP, V36, P307, DOI 10.1007/s11033-007-9180-5; TSUBOI S, 1992, J BIOCHEM-TOKYO, V111, P500, DOI 10.1093/oxfordjournals.jbchem.a123787; U. N., 1935, Japanese Journal of Botany, V7, P389; VANCE JE, 1991, J BIOL CHEM, V266, P8241; VERGNOLLE C, 1992, METHOD ENZYMOL, V209, P522; Wang CM, 2008, PLANT CELL REP, V27, P159, DOI 10.1007/s00299-007-0434-4; Wang HW, 2012, DNA RES, V19, P179, DOI 10.1093/dnares/dss003; Wang NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S9; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2005, FEBS LETT, V579, P1683, DOI 10.1016/j.febslet.2005.02.024; Yuan J, 2008, PLANT PHYSIOL, V146, P1637, DOI 10.1104/pp.107.110304; Zhang DS, 2010, PLANT PHYSIOL, V154, P149, DOI 10.1104/pp.110.158865; Zhou ZF, 2012, J EXP BOT, V63, P2041, DOI 10.1093/jxb/err405	102	27	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e84556	10.1371/journal.pone.0084556	http://dx.doi.org/10.1371/journal.pone.0084556			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497919	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900006
J	Cordoni, G; Norscia, I				Cordoni, Giada; Norscia, Ivan			Peace-Making in Marsupials: The First Study in the Red-Necked Wallaby (Macropus rufogriseus)	PLOS ONE			English	Article							POST-CONFLICT BEHAVIOR; SELF-DIRECTED BEHAVIOR; CHIMPANZEES PAN-TROGLODYTES; PLACENTAL MAMMAL PHYLOGENY; MACAQUES MACACA-FUSCATA; GORILLA-GORILLA-GORILLA; LONG-TAILED MACAQUES; POSTCONFLICT AFFILIATION; REPRODUCTIVE SUCCESS; RELATIONSHIP QUALITY	The issue of reconciliation has been widely investigated in many eutherian mammal species. Nevertheless, no data are available for marsupial mammals. Indeed, the majority of reports focus on group dynamics from an ecological and reproductive perspective, but no study has investigated them from a social point of view. We observed the red-necked wallaby colony (Macropus rufogriseus) hosted at the Tierparc Zoo Berlin (Germany) and collected data on aggressive and post-conflict interactions between group members. We found that the phenomenon of reconciliation is present in the study species (mean group CCT 27.40% +/-8.89% SE). Therefore, we demonstrated, for the first time, the occurrence of reconciliation in a gregarious marsupial mammal. Post-conflict reunion was not affected by the relationship quality between individuals (friendship or kinship) but it was fine-tuned according to the aggression intensity. For example, low intensity conflicts were reconciled whereas high intensity ones were not. Reconciliation reduced anxiety-related scratching in both of the former opponents and limited further attacks towards the victim during the post-conflict period. These findings suggest that the red-necked wallaby, like many eutherian species, can evaluate the costs of reconciliation and engage in peacemaking behavior in the right contexts, in order to maximize its pay-offs.	[Cordoni, Giada; Norscia, Ivan] Univ Pisa, Museo Storia Nat, Pisa, Italy	University of Pisa	Cordoni, G (corresponding author), Univ Pisa, Museo Storia Nat, Pisa, Italy.	cordoni@vademecos.eu	Cordoni, Giada/ABE-2242-2020; Norscia, Ivan/J-3321-2015	Cordoni, Giada/0000-0001-7093-0025; Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2006, HDB NEUROCHEMISTRY M; Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; Arnold K, 2007, PRIMATES PERSPECTIVE, P592; Arnold Kate, 2007, P592; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F, 2002, BEHAV BRAIN SCI, V25, P23, DOI 10.1017/S0140525X02250013; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli Filippo, 2000, P199; Barros M, 2000, BEHAV BRAIN RES, V108, P205, DOI 10.1016/S0166-4328(99)00153-9; Blumstein Daniel T., 2003, Acta Ethologica, V5, P95, DOI 10.1007/s10211-002-0070-5; Butovskaya M, 1996, PRIMATES, V37, P261, DOI 10.1007/BF02381858; Byers JA, 1999, J ZOOL, V247, P349, DOI 10.1017/S0952836999003064; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; Castles DL, 1998, ETHOLOGY, V104, P148; CHAUVET MT, 1983, GEN COMP ENDOCR, V51, P309, DOI 10.1016/0016-6480(83)90086-2; Cilia J, 1997, PHARMACOL BIOCHEM BE, V58, P85, DOI 10.1016/S0091-3057(96)00376-0; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cooper MA, 2007, ETHOLOGY, V113, P26, DOI 10.1111/j.1439-0310.2006.01287.x; Cordoni G, 2008, ETHOLOGY, V114, P298, DOI 10.1111/j.1439-0310.2008.01474.x; Cordoni G, 2007, J COMP PSYCHOL, V121, P171, DOI 10.1037/0735-7036.121.2.171; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Cords M., 2000, NATURAL CONFLICT RES, P177; Cozzi A, 2010, BEHAV PROCESS, V85, P185, DOI 10.1016/j.beproc.2010.07.007; Das M, 1998, INT J PRIMATOL, V19, P53, DOI 10.1023/A:1020354826422; de Waal F., 1996, GOOD NATURED ORIGINS; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DeWaal FBM, 1997, ANN NY ACAD SCI, V807, P317; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Fraser ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018118; FRIED RG, 1994, J AM ACAD DERMATOL, V30, P993, DOI 10.1016/S0190-9622(94)70125-3; Fujisawa KK, 2005, AGGRESSIVE BEHAV, V31, P138, DOI 10.1002/ab.20076; Gemmell RT, 2002, REPRODUCTION, V123, P301, DOI 10.1530/rep.0.1230301; Higginbottom K, 2000, WILDLIFE BIOL, V6, P129, DOI 10.2981/wlb.2000.008; Higginbottom Karen, 1999, Symposia of the Zoological Society of London, V72, P80; Isler K, 2011, BIOESSAYS, V33, P173, DOI 10.1002/bies.201000123; Jarman PJ, 2000, PRIMATE MALES, P21; JARMAN PJ, 1991, ADV STUD BEHAV, V20, P1, DOI 10.1016/S0065-3454(08)60318-6; JOHNSON CN, 1987, AUST WILDLIFE RES, V14, P125, DOI 10.1071/WR9870125; JOHNSON CN, 1989, J MAMMAL, V70, P18, DOI 10.2307/1381665; JOHNSON CN, 1986, BEHAV ECOL SOCIOBIOL, V19, P143, DOI 10.1007/BF00299949; JOHNSON CN, 1985, THESIS U NEW ENGLAND; Judge PG, 2013, ANIM BEHAV, V85, P881, DOI 10.1016/j.anbehav.2013.02.011; KAPPELER PM, 1993, ANIM BEHAV, V45, P901, DOI 10.1006/anbe.1993.1110; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Karlen SJ, 2007, PROG NEUROBIOL, V82, P122, DOI 10.1016/j.pneurobio.2007.03.003; Koo J. Y. M., 2003, PSYCHOCUTANEOUS MED, P139; Koyama NF, 2001, ETHOLOGY, V107, P975, DOI 10.1046/j.1439-0310.2001.00731.x; KRAUSE L, 1983, BRIT MED J, V287, P1199, DOI 10.1136/bmj.287.6400.1199; Kutsukake N, 2003, BEHAVIOUR, V140, P1153, DOI 10.1163/156853903322589687; Kutsukake N, 2001, ANIM COGN, V4, P59; Kutsukake N, 2009, ECOL RES, V24, P521, DOI 10.1007/s11284-008-0563-4; Leca JB, 2002, INT J PRIMATOL, V23, P979, DOI 10.1023/A:1019641830918; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Martin P., 2007, MEASURING BEHAV INTR, V3; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Morris Desmond, 1977, MANWATCHING FIELD GU; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nunn CL, 2004, BEHAV ECOL SOCIOBIOL, V57, P50, DOI 10.1007/s00265-004-0830-5; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2008, AM J PRIMATOL, V70, P949, DOI 10.1002/ajp.20587; Palagi E, 2011, STRESS, V14, P93, DOI 10.3109/10253890.2010.505272; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Parry LJ, 2000, EXP PHYSIOL, V85, p91S, DOI 10.1111/j.1469-445X.2000.tb00012.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rothman S, 1941, PHYSIOL REV, V21, P357, DOI 10.1152/physrev.1941.21.2.357; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 1998, BEHAVIOUR, V135, P343, DOI 10.1163/156853998793066302; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; SHANLEY KJ, 1988, VET CLIN N AM-SMALL, V18, P971, DOI 10.1016/S0195-5616(88)50101-8; Stangier U, 2003, BEHAV RES THER, V41, P991, DOI 10.1016/S0005-7967(02)00176-6; Tran BW, 2010, ACTA DERM-VENEREOL, V90, P354, DOI 10.2340/00015555-0890; Troisi A, 2000, J NERV MENT DIS, V188, P13, DOI 10.1097/00005053-200001000-00003; Van Hooff Jan A.R.A.M., 2001, P67; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Wahaj SA, 2001, ETHOLOGY, V107, P1057, DOI 10.1046/j.1439-0310.2001.00717.x; WATSON DM, 1993, ETHOLOGY, V94, P1; Watson DM, 1996, ETHOLOGY, V102, P336; Watson DM, 1990, THESIS U NEW S WALES; Watts DP, 2006, INT J PRIMATOL, V27, P1337, DOI 10.1007/s10764-006-9081-9; Weaver A, 2003, MAR MAMMAL SCI, V19, P836, DOI 10.1111/j.1748-7692.2003.tb01134.x; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Zar JH, 1999, BIOSTATISTICAL ANAL	91	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86859	10.1371/journal.pone.0086859	http://dx.doi.org/10.1371/journal.pone.0086859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489796	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000075
J	Li, XW; Jiang, HX; Zhang, XC; Shelton, AM; Feng, JN				Li, Xiao-Wei; Jiang, Hong-Xue; Zhang, Xiao-Chen; Shelton, Anthony M.; Feng, Ji-Nian			Post-Mating Interactions and Their Effects on Fitness of Female and Male Echinothrips americanus (Thysanoptera: Thripidae), a New Insect Pest in China	PLOS ONE			English	Article							SEXUAL-HARASSMENT; CALLOSOBRUCHUS-MACULATUS; MATE CHOICE; COSTS; LONGEVITY; FECUNDITY; BEHAVIOR; FLY; REPRODUCTION; FREQUENCY	Post-mating, sexual interactions of opposite sexes differ considerably in different organisms. Post-mating interactions such as re-mating behavior and male harassment can affect the fitness of both sexes. Echinothrips americanus is a new insect pest in Mainland China, and little is known about its post-mating interactions. In this study, we observed re-mating frequency and male harassment frequency and their effects on fitness parameters and offspring sex ratios of E. americanus females. Furthermore, we tested the impact of mating and post-mating interactions on fitness parameters of males. Our results revealed that the re-mating frequency in female adults was extremely low during a 30-day period. However, post-mating interactions between females and males, consisting mainly of male harassment and female resistance, did occur and significantly reduced female longevity and fecundity. Interestingly, increased access to males did not affect the ratio of female offspring. For males, mating dramatically reduced their longevity. However, post-mating interactions with females had no effects on the longevity of mated males. These results enrich our basic knowledge about female and male mating and post-mating behaviors in this species and provide important information about factors that may influence population regulation of this important pest species.	[Li, Xiao-Wei; Jiang, Hong-Xue; Zhang, Xiao-Chen; Feng, Ji-Nian] Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China; [Li, Xiao-Wei; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Northwest A&F University - China; Cornell University	Feng, JN (corresponding author), Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China.	jinianf@nwsuaf.edu.cn			National Science Foundation of China [3127344]; Doctoral Fund of Ministry of Education of China [20090204110003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	The project was supported by the National Science Foundation of China (3127344) and Doctoral Fund of Ministry of Education of China (20090204110003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GR, 1994, ANIM BEHAV, V48, P635, DOI 10.1006/anbe.1994.1283; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Burton-Chellew MN, 2007, EVOL ECOL RES, V9, P921; Cheng LI, 2004, J INSECT BEHAV, V17, P227, DOI 10.1023/B:JOIR.0000028572.76021.d9; CluttonBrock T, 1997, BEHAV ECOL, V8, P392, DOI 10.1093/beheco/8.4.392; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; CRESPI BJ, 1986, ECOL ENTOMOL, V11, P119, DOI 10.1111/j.1365-2311.1986.tb00286.x; CRESPI BJ, 1988, AM MIDL NAT, V119, P83, DOI 10.2307/2426056; CRESPI BJ, 1988, BEHAV ECOL SOCIOBIOL, V22, P293, DOI 10.1007/BF00299845; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; den Hollander M, 2009, ANIM BEHAV, V78, P1061, DOI 10.1016/j.anbehav.2009.06.036; EBERHARD WG, 1995, TRENDS ECOL EVOL, V10, P493, DOI 10.1016/S0169-5347(00)89205-8; Edvardsson M, 2007, ANIM BEHAV, V74, P183, DOI 10.1016/j.anbehav.2006.07.018; Gay L, 2009, PHYSIOL ENTOMOL, V34, P86, DOI 10.1111/j.1365-3032.2008.00656.x; Gilbert JDJ, 2013, BIOL J LINN SOC, V109, P802, DOI 10.1111/bij.12100; Gosden TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000580; HEADY SE, 1993, PHYSIOL ENTOMOL, V18, P263, DOI 10.1111/j.1365-3032.1993.tb00598.x; Helinski MEH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1131, DOI 10.1007/s00265-012-1365-9; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kotiaho JS, 2003, J INSECT PHYSIOL, V49, P817, DOI 10.1016/S0022-1910(03)00117-3; KRAINACKER DA, 1990, EXP APPL ACAROL, V9, P169, DOI 10.1007/BF01193426; Lachmann AD, 2000, INVERTEBR REPROD DEV, V37, P233, DOI 10.1080/07924259.2000.9652423; Li XW, 2012, ENVIRON ENTOMOL, V41, P706, DOI 10.1603/EN11325; Macke E, 2012, AM NAT, V179, pE147, DOI 10.1086/665002; Maklakov AA, 2009, ANIM BEHAV, V77, P1375, DOI 10.1016/j.anbehav.2009.03.005; McLain DK, 1999, BEHAV ECOL SOCIOBIOL, V46, P164, DOI 10.1007/s002650050606; Milne M, 1997, THESIS U QUEENSLAND; Mirab-Balou Majid, 2010, Acta Zootaxonomica Sinica, V35, P674; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Oetting Ronald D., 1993, Zoology (Journal of Pure and Applied Zoology), V4, P307; Papadopoulos NT, 2010, J INSECT PHYSIOL, V56, P283, DOI 10.1016/j.jinsphys.2009.10.014; Parker G. A., 1979, SEXUAL SELECTION REP; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Ringo J, 1996, ANNU REV ENTOMOL, V41, P473, DOI 10.1146/annurev.en.41.010196.002353; Ronn J, 2006, ANIM BEHAV, V72, P335, DOI 10.1016/j.anbehav.2005.10.024; Rossi BH, 2010, ANIM BEHAV, V79, P165, DOI 10.1016/j.anbehav.2009.10.023; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Sakurai G, 2008, ANIM BEHAV, V75, P1367, DOI 10.1016/j.anbehav.2007.09.010; Shuker DM, 2006, ANIM BEHAV, V72, P313, DOI 10.1016/j.anbehav.2005.10.020; Simmons LW, 2007, J EVOLUTION BIOL, V20, P488, DOI 10.1111/j.1420-9101.2006.01274.x; Sirot LK, 2001, ANIM BEHAV, V61, P415, DOI 10.1006/anbe.2000.1605; SMITH AF, 1990, J INSECT PHYSIOL, V36, P369, DOI 10.1016/0022-1910(90)90019-C; SPENCER JL, 1992, J INSECT BEHAV, V5, P689, DOI 10.1007/BF01047980; STONE GN, 1995, ANIM BEHAV, V50, P405, DOI 10.1006/anbe.1995.0255; Takahashi Y, 2009, ENTOMOL SCI, V12, P219, DOI 10.1111/j.1479-8298.2009.00326.x; Terry I., 1993, Zoology (Journal of Pure and Applied Zoology), V4, P339; Thornhill R., 1983, pi; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; VARADARASAN S, 1982, Proceedings of the Indian National Science Academy Part B Biological Sciences, V48, P35; Wagner WE, 2001, EVOLUTION, V55, P994, DOI 10.1554/0014-3820(2001)055[0994:FRALSB]2.0.CO;2; WALKER WF, 1980, AM NAT, V115, P780, DOI 10.1086/283600; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101	57	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87725	10.1371/journal.pone.0087725	http://dx.doi.org/10.1371/journal.pone.0087725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489956	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000174
J	Salhia, B; Kiefer, J; Ross, JTD; Metapally, R; Martinez, RA; Johnson, KN; DiPerna, DM; Paquette, KM; Jung, S; Nasser, S; Wallstrom, G; Tembe, W; Baker, A; Carpten, J; Resau, J; Ryken, T; Sibenaller, Z; Petricoin, EF; Liotta, LA; Ramanathan, RK; Berens, ME; Tran, NL				Salhia, Bodour; Kiefer, Jeff; Ross, Julianna T. D.; Metapally, Raghu; Martinez, Rae Anne; Johnson, Kyle N.; DiPerna, Danielle M.; Paquette, Kimberly M.; Jung, Sungwon; Nasser, Sara; Wallstrom, Garrick; Tembe, Waibhav; Baker, Angela; Carpten, John; Resau, Jim; Ryken, Timothy; Sibenaller, Zita; Petricoin, Emanuel F.; Liotta, Lance A.; Ramanathan, Ramesh K.; Berens, Michael E.; Tran, Nhan L.			Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOLECULAR PORTRAITS; INTRINSIC SUBTYPES; TUMOR PROGRESSION; GENE; PROGNOSIS; RELAPSE; MAP	The brain is a common site of metastatic disease in patients with breast cancer, which has few therapeutic options and dismal outcomes. The purpose of our study was to identify common and rare events that underlie breast cancer brain metastasis. We performed deep genomic profiling, which integrated gene copy number, gene expression and DNA methylation datasets on a collection of breast brain metastases. We identified frequent large chromosomal gains in 1q, 5p, 8q, 11q, and 20q and frequent broad-level deletions involving 8p, 17p, 21p and Xq. Frequently amplified and overexpressed genes included ATAD2, BRAF, DERL1, DNMTRB and NEK2A. The ATM, CRYAB and HSPB2 genes were commonly deleted and underexpressed. Knowledge mining revealed enrichment in cell cycle and G2/M transition pathways, which contained AURKA, AURKB and FOXM1. Using the PAM50 breast cancer intrinsic classifier, Luminal B, Her2+/ER negative, and basal-like tumors were identified as the most commonly represented breast cancer subtypes in our brain metastasis cohort. While overall methylation levels were increased in breast cancer brain metastasis, basal-like brain metastases were associated with significantly lower levels of methylation. Integrating DNA methylation data with gene expression revealed defects in cell migration and adhesion due to hypermethylation and downregulation of PENK, EDN3, and ITGAM. Hypomethylation and upregulation of KRT8 likely affects adhesion and permeability. Genomic and epigenomic profiling of breast brain metastasis has provided insight into the somatic events underlying this disease, which have potential in forming the basis of future therapeutic strategies.	[Salhia, Bodour; Martinez, Rae Anne; Johnson, Kyle N.; DiPerna, Danielle M.; Jung, Sungwon; Baker, Angela; Carpten, John] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA; [Kiefer, Jeff; Metapally, Raghu; Tembe, Waibhav] Translat Genom Res Inst, Collaborat Ctr Bioinformat, Phoenix, AZ USA; [Ross, Julianna T. D.; Paquette, Kimberly M.; Berens, Michael E.; Tran, Nhan L.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Nasser, Sara] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Wallstrom, Garrick] Arizona State Univ, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Resau, Jim] Van Andel Res Inst, Grand Rapids, MI USA; [Ryken, Timothy] Iowa Spine & Brain Inst, Iowa City, IA USA; [Sibenaller, Zita] Univ Iowa, Dept Radiat Biol, Iowa City, IA USA; [Petricoin, Emanuel F.; Liotta, Lance A.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Ramanathan, Ramesh K.] Scottsdale Healthcare, Virginia G Piper Canc Ctr, Scottsdale, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe; Van Andel Institute; University of Iowa; George Mason University; Scottsdale Healthcare Osborn	Salhia, B (corresponding author), Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA.	bsalhia@tgen.org; ntran@tgen.org	Jeff/ABB-2636-2021	Jeff/0000-0002-1238-3120; Martinez, Rae Anne M./0000-0003-0262-1049	National Institutes of Health [R01 CA130940]; C. A. R. E. Board of Trustees, Scottsdale, Arizona; TGen-Van Andel Integration Grant; NATIONAL CANCER INSTITUTE [R01CA130940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C. A. R. E. Board of Trustees, Scottsdale, Arizona; TGen-Van Andel Integration Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grant R01 CA130940 (NLT), a grant from the C. A. R. E. Board of Trustees, Scottsdale, Arizona (NLT, RKR), TGen-Van Andel Integration Grant (NLT, JC, BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysal BE, 2001, EUR J HUM GENET, V9, P121, DOI 10.1038/sj.ejhg.5200585; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; El Gammal AT, 2010, CLIN CANCER RES, V16, P56, DOI 10.1158/1078-0432.CCR-09-1423; Gori S, 2007, ONCOLOGIST, V12, P766, DOI 10.1634/theoncologist.12-7-766; Hamilton A, 2013, MOL CELL NEUROSCI, V53, P42, DOI 10.1016/j.mcn.2012.10.004; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Ishiwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042118; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Merico D, 2011, METHODS MOL BIOL, V781, P257, DOI 10.1007/978-1-61779-276-2_12; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Shao MM, 2011, MED MOL MORPHOL, V44, P15, DOI 10.1007/s00795-010-0495-2; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Tosoni A, 2008, CRIT REV ONCOL HEMAT, V68, P212, DOI 10.1016/j.critrevonc.2008.04.004; Wang CJ, 2009, GENE CHROMOSOME CANC, V48, P1091, DOI 10.1002/gcc.20711; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Wang SL, 2012, J CELL BIOCHEM, V113, P1904, DOI 10.1002/jcb.24059; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083	31	76	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85448	10.1371/journal.pone.0085448	http://dx.doi.org/10.1371/journal.pone.0085448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489661	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000011
J	Xu, GG; McMahan, CA; Walter, CA				Xu, Guogang; McMahan, C. Alex; Walter, Christi A.			Early-Life Exposure to Benzo[a]pyrene Increases Mutant Frequency in Spermatogenic Cells in Adulthood	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-ADDUCTS; CHILDRENS HEALTH; GERM-CELLS; SPONTANEOUS MUTATION; PHAGOCYTIC FUNCTION; GENE-EXPRESSION; SERTOLI-CELLS; TOBACCO-SMOKE; DIOL EPOXIDE	Children are vulnerable to environmental mutagens, and the developing germline could also be affected. However, little is known about whether exposure to environmental mutagens in childhood will result in increased germline mutations in subsequent adult life. In the present study, male transgenic lacI mice at different ages (7, 25 and 60 days old) were treated with a known environmental mutagen (benzo[a]pyrene, B[a]P) at different doses (0, 50, 200 or 300 mg/kg body weight). Mutant frequency was then determined in a meiotic cell type (pachytene spermatocyte), a post-meiotic cell type (round spermatid) and epididymal spermatozoa after at least one cycle of spermatogenesis. Our results show that 1) mice treated with B[a]P at 7 or 25 days old, both being pre-adult ages, had significantly increased mutant frequencies in all spermatogenic cell types tested when they were 60 days old; 2) spermatogenic cells from mice treated before puberty were more susceptible to B[a]P-associated mutagenesis compared to adult mice; and 3) unexpectedly, epididymal spermatozoa had the highest mutant frequency among the spermatogenic cell types tested. These data show that pre-adult exposure to B[a]P increases the male germline mutant frequency in young adulthood. The data demonstrate that exposure to environmental genotoxins at different life phases (e.g., pre-adult and adult) can have differential effects on reproductive health.	[Xu, Guogang; Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [McMahan, C. Alex] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Sci, San Antonio, TX 78229 USA; [Walter, Christi A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Walter, CA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	walter@uthscsa.edu			 [AG021163]; NATIONAL INSTITUTE ON AGING [R01AG021163] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by AG021163, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2000, ENVIRON HEALTH PERSP, V108, P573, DOI 10.2307/3454549; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barton HA, 2005, ENVIRON HEALTH PERSP, V113, P1125, DOI 10.1289/ehp.7667; Bartsch H, 1996, MUTAT RES-REV GENET, V340, P67, DOI 10.1016/S0165-1110(96)90040-8; BEARER CF, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432337; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Braun RE, 1998, NAT GENET, V18, P202, DOI 10.1038/ng0398-202; CHEMES H, 1986, ENDOCRINOLOGY, V119, P1673, DOI 10.1210/endo-119-4-1673; CONNEY AH, 1994, DRUG METAB REV, V26, P125, DOI 10.3109/03602539409029788; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dym M, 1970, Biology Reprod., V3, P308; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; GENEROSO WM, 1982, MUTAT RES, V94, P155, DOI 10.1016/0027-5107(82)90178-6; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Grandjean V, 1997, DEV BIOL, V184, P165, DOI 10.1006/dbio.1997.8518; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hill KA, 1999, MUTAT RES-REV MUTAT, V436, P11, DOI 10.1016/S1383-5742(98)00024-6; Hill KA, 2004, ENVIRON MOL MUTAGEN, V43, P110, DOI 10.1002/em.20004; Hill KA, 1999, MUTAT RES-FUND MOL M, V425, P47, DOI 10.1016/S0027-5107(98)00248-6; IARC, 1983, POL AR COMP 1; Jansen J, 2001, NUCLEIC ACIDS RES, V29, P1791, DOI 10.1093/nar/29.8.1791; KADLUBAR FF, 1980, CHEM-BIOL INTERACT, V31, P255, DOI 10.1016/0009-2797(80)90014-9; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; Landrigan PJ, 2011, MT SINAI J MED, V78, P1, DOI 10.1002/msj.20236; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P257, DOI 10.1289/ehp.6115; Leavitt SA, 2008, MUTAGENESIS, V23, P445, DOI 10.1093/mutage/gen033; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; MACKENZIE KM, 1981, BIOL REPROD, V24, P183, DOI 10.1095/biolreprod24.1.183; Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108; McCullagh P, 1989, GEN STAT MODELS; Mohamed ESA, 2010, HUM REPROD, V25, P2427, DOI 10.1093/humrep/deq205; Nishino H, 1996, ENVIRON MOL MUTAGEN, V28, P299; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oh SM, 2009, ENVIRON TOXICOL, V24, P225, DOI 10.1002/tox.20422; Olivo-Marston SE, 2009, CANCER EPIDEM BIOMAR, V18, P3375, DOI 10.1158/1055-9965.EPI-09-0986; Olsen AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011349; PANIAGUA R, 1984, J ANAT, V139, P535; PINEAU C, 1991, CELL TISSUE RES, V264, P589, DOI 10.1007/BF00319048; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Schober S. E., 2008, Morbidity and Mortality Weekly Report, V57, P744; Shane BS, 2000, CARCINOGENESIS, V21, P715, DOI 10.1093/carcin/21.4.715; Somers CM, 2004, SCIENCE, V304, P1008, DOI 10.1126/science.1095815; Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Verhofstad N, 2011, TOXICOL SCI, V119, P218, DOI 10.1093/toxsci/kfq325; Verhofstad N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-333; Verhofstad N, 2010, ENVIRON MOL MUTAGEN, V51, P123, DOI 10.1002/em.20516; Walter CA, 2004, DNA REPAIR, V3, P495, DOI 10.1016/j.dnarep.2004.01.005; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Wei QY, 2000, J NATL CANCER I, V92, P1764; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wijker CA, 1996, MUTAT RES-FUND MOL M, V349, P229, DOI 10.1016/0027-5107(95)00187-5; Wild CP, 2003, CANCER EPIDEM BIOMAR, V12, P1389; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Xu GG, 2008, MUTAT RES-GEN TOX EN, V654, P150, DOI 10.1016/j.mrgentox.2008.05.012; Yauk CL, 1996, P NATL ACAD SCI USA, V93, P12137, DOI 10.1073/pnas.93.22.12137; Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7	69	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87439	10.1371/journal.pone.0087439	http://dx.doi.org/10.1371/journal.pone.0087439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489914	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000145
J	Cardoso, DC; Pompolo, SD; Cristiano, MP; Tavares, MG				Cardoso, Danon Clemes; Pompolo, Silvia das Gracas; Cristiano, Maykon Passos; Tavares, Mara Garcia			The Role of Fusion in Ant Chromosome Evolution: Insights from Cytogenetic Analysis Using a Molecular Phylogenetic Approach in the Genus Mycetophylax	PLOS ONE			English	Article							KARYOTYPE EVOLUTION; HYMENOPTERA-FORMICIDAE; SPECIATION; EMERY; ORTHOPTERA; INFERENCE; PATTERNS; ORIGIN; BASES	Among insect taxa, ants exhibit one of the most variable chromosome numbers ranging from n=1 to n=60. This high karyotype diversity is suggested to be correlated to ants diversification. The karyotype evolution of ants is usually understood in terms of Robertsonian rearrangements towards an increase in chromosome numbers. The ant genus Mycetophylax is a small monogynous basal Attini ant (Formicidae: Myrmicinae), endemic to sand dunes along the Brazilian coastlines. A recent taxonomic revision validates three species, Mycetophylax morschi, M. conformis and M. simplex. In this paper, we cytogenetically characterized all species that belongs to the genus and analyzed the karyotypic evolution of Mycetophylax in the context of a molecular phylogeny and ancestral character state reconstruction. M. morschi showed a polymorphic number of chromosomes, with colonies showing 2n = 26 and 2n = 30 chromosomes. M. conformis presented a diploid chromosome number of 30 chromosomes, while M. simplex showed 36 chromosomes. The probabilistic models suggest that the ancestral haploid chromosome number of Mycetophylax was 17 (Likelihood framework) or 18 (Bayesian framework). The analysis also suggested that fusions were responsible for the evolutionary reduction in chromosome numbers of M. conformis and M. morschi karyotypes whereas fission may determines the M. simplex karyotype. These results obtained show the importance of fusions in chromosome changes towards a chromosome number reduction in Formicidae and how a phylogenetic background can be used to reconstruct hypotheses about chromosomes evolution.	[Cardoso, Danon Clemes; Pompolo, Silvia das Gracas; Cristiano, Maykon Passos; Tavares, Mara Garcia] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Cardoso, DC (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil.	danon.cardoso@ufv.br	Cristiano, Maykon Passos/H-7723-2012; Cardoso, Danon Clemes/D-2313-2009	Cristiano, Maykon Passos/0000-0001-7850-9155; Cardoso, Danon Clemes/0000-0002-2811-2536	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CRA-APQ-00540-11, CBB-22004-11]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), process numbers: CRA-APQ-00540-11 and CBB-22004-11. Financial support was also provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros LAC, 2010, SOCIOBIOLOGY, V56, P57; Cardoso DC, 2011, INSECT SOC, V58, P427, DOI 10.1007/s00040-011-0160-3; Cardoso DC, 2014, MOL PHYLOGENET EVOL, V70, P378, DOI 10.1016/j.ympev.2013.10.012; Cardoso DC, 2012, CR BIOL, V335, P619, DOI 10.1016/j.crvi.2012.09.012; Cardoso DC, 2012, MYRMECOL NEWS, V16, P57; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; de Freitas TRO, 2006, GENETICA, V126, P227, DOI 10.1007/s10709-005-1451-2; Dillenburg SR, 2009, LECT NOTES EARTH SCI, V107, P1, DOI 10.1007/978-3-540-44771-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Gokhman VE, 2009, KARYOTYPES PARASITIC, DOI 10.1007/978-1-4020-9807-9; Guerra M, 2012, PLANT BIOSYST, V146, P703, DOI 10.1080/11263504.2012.717973; Hemp C, 2013, ORG DIVERS EVOL, V13, P521, DOI 10.1007/s13127-013-0133-7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IMAI HT, 1989, CHROMOSOMA, V98, P456, DOI 10.1007/BF00292792; IMAI HT, 1994, JPN J GENET, V69, P137, DOI 10.1266/jjg.69.137; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1986, AM NAT, V128, P900, DOI 10.1086/284612; IMAI HT, 1977, CHROMOSOMA, V59, P341, DOI 10.1007/BF00327974; Imai HT, 2001, J THEOR BIOL, V210, P475, DOI 10.1006/jtbi.2001.2327; KEMPF W W, 1972, Studia Entomologica, V15, P3; King M., 1993, SPECIES EVOLUTION; Klingenberg C, 2007, STUD NEOTROP FAUNA E, V42, P121, DOI 10.1080/01650520601065509; Klingenberg C, 2009, ZOOTAXA, P1; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Livingstone K, 2004, NEW PHYTOL, V161, P107, DOI 10.1046/j.1469-8137.2003.00942.x; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Lukhtanov VA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-109; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Mehdiabadi NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1844; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; POMPOLO SG, 1990, INSECT SOC, V37, P251, DOI 10.1007/BF02224052; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Rodrigues LSRR, 2003, CARYOLOGIA, V56, P413, DOI 10.1080/00087114.2003.10589352; Santos IS, 2010, ANN ENTOMOL SOC AM, V103, P424, DOI 10.1603/AN09101; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2002, INSECT SOC, V49, P331, DOI 10.1007/PL00012657; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; Sosa-Calvo J, 2010, ANN ENTOMOL SOC AM, V103, P181, DOI 10.1603/AN09108; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Warchalowska-Sliwa E, 2013, EUR J ENTOMOL, V110, P1, DOI 10.14411/eje.2013.001; WHITE M J D, 1973, P961	44	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87473	10.1371/journal.pone.0087473	http://dx.doi.org/10.1371/journal.pone.0087473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489918	Green Published, gold			2022-12-25	WOS:000330510000135
J	Kawamura, T; Stephens, B; Qin, L; Yin, X; Dores, MR; Smith, TH; Grimsey, N; Abagyan, R; Trejo, J; Kufareva, I; Fuster, MM; Salanga, CL; Handel, TM				Kawamura, Tetsuya; Stephens, Bryan; Qin, Ling; Yin, Xin; Dores, Michael R.; Smith, Thomas H.; Grimsey, Neil; Abagyan, Ruben; Trejo, JoAnn; Kufareva, Irina; Fuster, Mark M.; Salanga, Catherina L.; Handel, Tracy M.			A General Method for Site Specific Fluorescent Labeling of Recombinant Chemokines	PLOS ONE			English	Article							ENDOTHELIAL HEPARAN-SULFATE; PHOSPHOPANTETHEINYL TRANSFERASES; LYMPHATIC ENDOTHELIUM; RECEPTOR; PROTEIN; CXCR4; CELLS; BINDING; IDENTIFICATION; BIOCHEMISTRY	Chemokines control cell migration in many contexts including development, homeostasis, immune surveillance and inflammation. They are also involved in a wide range of pathological conditions ranging from inflammatory diseases and cancer, to HIV. Chemokines function by interacting with two types of receptors: G protein-coupled receptors on the responding cells, which transduce signaling pathways associated with cell migration and activation, and glycosaminogly-cans on cell surfaces and the extracellular matrix which organize and present some chemokines on immobilized surface gradients. To probe these interactions, imaging methods and fluorescence-based assays are becoming increasingly desired. Herein, a method for site-specific fluorescence labeling of recombinant chemokines is described. It capitalizes on previously reported 11-12 amino acid tags and phosphopantetheinyl transferase enzymes to install a fluorophore of choice onto a specific serine within the tag through a coenzyme A-fluorophore conjugate. The generality of the method is suggested by our success in labeling several chemokines (CXCL12, CCL2, CCL21 and mutants thereof) and visualizing them bound to chemokine receptors and glycosaminoglycans. CXCL12 and CCL2 showed the expected co-localization on the surface of cells with their respective receptors CXCR4 and CCR2 at 4 degrees C, and co-internalization with their receptors at 37 degrees C. By contrast, CCL21 showed the presence of large discrete puncta that were dependent on the presence of both CCR7 and glycosaminoglycans as co-receptors. These data demonstrate the utility of this labeling approach for the detection of chemokine interactions with GAGs and receptors, which can vary in a chemokine-specific manner as shown here. For some applications, the small size of the fluorescent adduct may prove advantageous compared to other methods (e.g. antibody labeling, GFP fusion) by minimally perturbing native interactions. Other advantages of the method are the ease of bacterial expression, the versatility of labeling with any maleimide-fluorophore conjugate of interest, and the covalent nature of the fluorescent adduct.	[Kawamura, Tetsuya; Stephens, Bryan; Qin, Ling; Abagyan, Ruben; Kufareva, Irina; Salanga, Catherina L.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Stephens, Bryan; Smith, Thomas H.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Yin, Xin] Huaihai Inst Technol, Marine Drug Res Inst, Lianyungang, Peoples R China; [Yin, Xin; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Yin, Xin; Fuster, Mark M.] Univ Calif San Diego, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92093 USA; [Dores, Michael R.; Smith, Thomas H.; Grimsey, Neil; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Jiangsu Ocean University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Grimsey, Neil/AAB-9153-2020; Grimsey, Neil/B-1634-2015	Grimsey, Neil/0000-0002-0481-4920; Grimsey, Neil/0000-0002-0481-4920; TREJO, JOANN/0000-0003-4405-6228; Stephens, Bryan/0000-0002-5398-7406; Kufareva, Irina/0000-0001-9083-7039; Smith, Thomas/0000-0002-8798-7228	National Institute of Health (NIH) [U01 GM094612, R01 AI37113]; Cellular and Molecular Pharmacology [T32-GM007752]; San Diego IRACDA NIH [K12 GM06852]; American Heart Association Postdoctoral Fellowship; NIH [R01 GM071872, U54 GM094618, R01 GM090689]; NIH/National Heart, Lung, and Blood Institute (NHLBI) [R01-HL107652-01A1, P01 HL57345-14]; Veterans Affairs Merit Review Program (VA-Merit) [I01BX000987-01]; American Cancer Society [RSG-08-153-01-CSM]; NIH/NHLBI [T32-HL098062-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444, R01HL107652, T32HL098062, P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872, T32GM008326, K12GM068524, U01GM094612, U54GM094618, T32GM007752, R01GM090689] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Pharmacology; San Diego IRACDA NIH; American Heart Association Postdoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs Merit Review Program (VA-Merit); American Cancer Society(American Cancer Society); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of Health (NIH) grant U01 GM094612 and R01 AI37113 to TMH. BS was supported by the Cellular and Molecular Pharmacology Training Grant T32-GM007752. MRD was supported by San Diego IRACDA NIH K12 GM06852. NG was supported by an American Heart Association Postdoctoral Fellowship. RA acknowledges NIH R01 GM071872 and U54 GM094618. JT acknowledges NIH R01 GM090689. MMF acknowledges NIH/National Heart, Lung, and Blood Institute (NHLBI) R01-HL107652-01A1, P01 HL57345-14, the Veterans Affairs Merit Review Program (VA-Merit I01BX000987-01) and the American Cancer Society (RSG-08-153-01-CSM) for support. XY is supported by an NIH/NHLBI training grant T32-HL098062-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Ford Laura B, 2013, Methods Mol Biol, V1013, P203, DOI 10.1007/978-1-62703-426-5_13; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Hatse S, 2004, CYTOM PART A, V61A, P178, DOI 10.1002/cyto.a.20070; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Humpert ML, 2012, PROTEOMICS, V12, P1938, DOI 10.1002/pmic.201100581; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kramp BK, 2011, EXP CELL RES, V317, P655, DOI 10.1016/j.yexcr.2010.11.014; Lechertier T, 2004, ANTICANCER RES, V24, P4011; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Rodriguez-Frade JM, 2009, METHODS MOL BIOL, V571, P179, DOI 10.1007/978-1-60761-198-1_12; Nijmeijer S, 2010, J BIOL CHEM, V285, P29632, DOI 10.1074/jbc.M110.115618; O'Hayre M, 2009, METHOD ENZYMOL, V460, P331, DOI 10.1016/S0076-6879(09)05216-1; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Rostand KS, 1997, INFECT IMMUN, V65, P1; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Sunbul M, 2009, METHOD ENZYMOL, V458, P255, DOI 10.1016/S0076-6879(09)04810-1; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thelen M, 2010, CURR OPIN PHARMACOL, V10, P38, DOI 10.1016/j.coph.2009.09.004; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Yin X, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-316; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	35	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e81454	10.1371/journal.pone.0081454	http://dx.doi.org/10.1371/journal.pone.0081454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489642	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000002
J	Zhou, W; Stojanovic, A				Zhou, Wen; Stojanovic, Aleksandar			Comparison of Corneal Epithelial and Stromal Thickness Distributions between Eyes with Keratoconus and Healthy Eyes with Corneal Astigmatism >= 2.0 D	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FREQUENCY DIGITAL ULTRASOUND; TOPOGRAPHY-GUIDED ABLATION; 3-DIMENSIONAL DISPLAY; BOWMANS LAYER; ARTEMIS; PROFILES; DIAGNOSIS; ECTASIA; LASIK	Purpose: To identify corneal epithelial-and stromal-thickness distribution patterns in keratoconus using spectral-domain optical coherence tomography (SD-OCT). Patients and Methods: We analyzed SD-OCT findings in 20 confirmed cases of keratoconus (group 1) and in 20 healthy subjects with corneal astigmatism >= 2 D (group 2). Epithelial and stromal thicknesses were measured at 11 strategic locations along the steepest and flattest meridians, previously located by corneal topography. Vertical mirrored symmetry superimposition was used in the statistical analysis. Results: The mean maximum keratometry measurements in groups 1 and 2 were 47.9+/-2.9 D (range, 41.8-52.8) and 45.6+/-1.1 D (range, 42.3-47.5), respectively, with mean corneal cylinders of 3.3+/-2.2 D (range, 0.5-9.5) and 3.6+/-1.2 D (range, 2.0-6.4), respectively. The mean epithelial thickness along the steepest meridian in group 1 was the lowest (37.4+/-4.4 mu m) at 1.2 mm inferotemporally and the highest (59.3+/-4.4 mu m) at 1.4 mm supranasally from the corneal vertex. There was only a small deviation in thickness along the steepest meridian in group 2, as well as along the flattest meridians in both groups. The stromal thickness distribution in the two groups was similar to the epithelial, while the stromal thickness was generally lower in group 1 than in group 2. Conclusions: SD-OCT provides details about the distribution of corneal epithelial and stromal thicknesses. The epithelium and stroma in keratoconic eyes were thinner inferotemporally and thicker supranasally compared with control eyes. The distribution pattern was more distinct in epithelium than in stroma. This finding may help improve the early diagnosis of keratoconus.	[Zhou, Wen; Stojanovic, Aleksandar] SynsLaser Kirurgi AS, Tromso, Troms, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Eye Dept, Tromso, Troms, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway	Stojanovic, A (corresponding author), SynsLaser Kirurgi AS, Tromso, Troms, Norway.	aleks@online.no	Stojanovic, Aleksandar/AAG-9933-2019		SynsLaser AS; Norwegian Research Council	SynsLaser AS; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was supported by the SynsLaser AS and the Norwegian Research Council and that no additional external funding was received for this study. The funders had no role n study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XJ, 2012, J REFRACT SURG, V28, P120, DOI 10.3928/1081597X-20110926-01; Correa-Perez ME, 2012, INVEST OPHTH VIS SCI, V53, P1752, DOI 10.1167/iovs.11-9033; Du CX, 2012, CORNEA, V31, P1036, DOI 10.1097/ICO.0b013e31823f8d56; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Haque S, 2006, J REFRACT SURG, V22, P486, DOI 10.3928/1081-597X-20060501-11; Haque S, 2008, OPTOMETRY VISION SCI, V85, P963, DOI 10.1097/OPX.0b013e318188892c; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kanellopoulos AJ, 2012, CLIN OPHTHALMOL, V6, P789, DOI 10.2147/OPTH.S31524; Li HF, 1997, CURR EYE RES, V16, P214, DOI 10.1076/ceyr.16.3.214.15412; Li Y, 2012, OPHTHALMOLOGY, V119, P2425, DOI 10.1016/j.ophtha.2012.06.023; Li Y, 2008, OPHTHALMOLOGY, V115, P2159, DOI 10.1016/j.ophtha.2008.08.004; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Prakash G, 2012, INVEST OPHTH VIS SCI, V53, P2580, DOI 10.1167/iovs.11-8981; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Reinstein DZ, 2012, J REFRACT SURG, V28, P657, DOI 10.3928/1081597X-20120815-02; Reinstein DZ, 2011, J REFRACT SURG, V27, P356, DOI 10.3928/1081597X-20100930-01; Reinstein DZ, 2010, J REFRACT SURG, V26, P259, DOI 10.3928/1081597X-20100218-01; Reinstein DZ, 2009, J REFRACT SURG, V25, P604, DOI 10.3928/1081597X-20090610-06; Reinstein DZ, 2009, J REFRACT SURG, V25, P444, DOI 10.3928/1081597X-20090422-07; Rocha KM, 2013, J REFRACT SURG, V29, P173, DOI 10.3928/1081597X-20130129-08; Schlegel Z, 2008, J CATARACT REFR SURG, V34, P789, DOI 10.1016/j.jcrs.2007.12.036; Schmoll T, 2012, OPTOMETRY VISION SCI, V89, pE795, DOI 10.1097/OPX.0b013e3182504346; Sin S, 2006, OPTOMETRY VISION SCI, V83, P360, DOI 10.1097/01.opx.0000221388.26031.23	23	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85994	10.1371/journal.pone.0085994	http://dx.doi.org/10.1371/journal.pone.0085994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489687	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000029
J	Kiyoshi, M; Caaveiro, JMM; Miura, E; Nagatoishi, S; Nakakido, M; Soga, S; Shirai, H; Kawabata, S; Tsumoto, K				Kiyoshi, Masato; Caaveiro, Jose M. M.; Miura, Eri; Nagatoishi, Satoru; Nakakido, Makoto; Soga, Shinji; Shirai, Hiroki; Kawabata, Shigeki; Tsumoto, Kouhei			Affinity Improvement of a Therapeutic Antibody by Structure-Based Computational Design: Generation of Electrostatic Interactions in the Transition State Stabilizes the Antibody-Antigen Complex	PLOS ONE			English	Article							SINGLE-CHAIN; CYTOCHROME-C; BINDING; ASSOCIATION; RESIDUES; ATHEROSCLEROSIS; THERMODYNAMICS; RECOGNITION; SPECIFICITY; MATURATION	The optimization of antibodies is a desirable goal towards the development of better therapeutic strategies. The antibody 11K2 was previously developed as a therapeutic tool for inflammatory diseases, and displays very high affinity (4.6 pM) for its antigen the chemokine MCP-1 (monocyte chemo-attractant protein-1). We have employed a virtual library of mutations of 11K2 to identify antibody variants of potentially higher affinity, and to establish benchmarks in the engineering of a mature therapeutic antibody. The most promising candidates identified in the virtual screening were examined by surface plasmon resonance to validate the computational predictions, and to characterize their binding affinity and key thermodynamic properties in detail. Only mutations in the light-chain of the antibody are effective at enhancing its affinity for the antigen in vitro, suggesting that the interaction surface of the heavy-chain (dominated by the hot-spot residue Phe101) is not amenable to optimization. The single-mutation with the highest affinity is L-N31R (4.6-fold higher affinity than wild-type antibody). Importantly, all the single-mutations showing increase affinity incorporate a charged residue (Arg, Asp, or Glu). The characterization of the relevant thermodynamic parameters clarifies the energetic mechanism. Essentially, the formation of new electrostatic interactions early in the binding reaction coordinate (transition state or earlier) benefits the durability of the antibody-antigen complex. The combination of in silico calculations and thermodynamic analysis is an effective strategy to improve the affinity of a matured therapeutic antibody.	[Kiyoshi, Masato; Miura, Eri; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Caaveiro, Jose M. M.; Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Caaveiro, Jose M. M.; Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Lab Med Prote, Minato Ku, Tokyo, Japan; [Soga, Shinji; Shirai, Hiroki; Kawabata, Shigeki] Astellas Pharma Inc, Drug Discovery Res, Mol Med Res Labs, Tsukuba, Ibaraki, Japan; [Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Astellas Pharmaceuticals; University of Tokyo	Tsumoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	tsumoto@bioeng.t.u-tokyo.ac.jp	Miura-Fujiwara, Eri/A-1023-2010; Caaveiro, Jose/J-2790-2013; Satoru, NAGATOISHI/AAY-8198-2021	Miura-Fujiwara, Eri/0000-0002-7672-3534; Caaveiro, Jose/0000-0001-5568-2369; Satoru, NAGATOISHI/0000-0002-0794-3963; Kiyoshi, Masato/0000-0002-5969-8138; Nakakido, Makoto/0000-0003-0328-9914	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the program for world-leading innovative R&D on science and technology (FIRST) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acchione M, 2012, MABS-AUSTIN, V4, P362, DOI 10.4161/mabs.19449; ADAIR JR, 1992, IMMUNOL REV, V130, P5, DOI 10.1111/j.1600-065X.1992.tb01519.x; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Baron R, 2013, ANNU REV PHYS CHEM, V64, P151, DOI 10.1146/annurev-physchem-040412-110047; Beck A, 2011, MABS-AUSTIN, V3, P107, DOI 10.4161/mabs.3.2.14785; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Constantinou A, 2008, BIOCONJUGATE CHEM, V19, P643, DOI 10.1021/bc700319r; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Hagihara Yoshihisa, 2012, Methods Mol Biol, V911, P399, DOI 10.1007/978-1-61779-968-6_24; Hayashida K, 2001, ARTHRITIS RES, V3, P118, DOI 10.1186/ar149; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; Kabat EA, 1991, SEQUENCES PROTEINS I; Kawa S, 2011, MABS-AUSTIN, V3, P479, DOI 10.4161/mabs.3.5.17228; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Kusano KF, 2004, CIRC J, V68, P671, DOI 10.1253/circj.68.671; Lawson ADG, 2012, NAT REV DRUG DISCOV, V11, P519, DOI 10.1038/nrd3756; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lipschultz CA, 2002, J MOL RECOGNIT, V15, P44, DOI 10.1002/jmr.559; Lutgens E, 2005, CIRCULATION, V111, P3443, DOI 10.1161/CIRCULATIONAHA.104.510073; Marvin JS, 2003, BIOCHEMISTRY-US, V42, P7077, DOI 10.1021/bi026947q; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Muda M, 2011, PROTEIN ENG DES SEL, V24, P447, DOI 10.1093/protein/gzq123; Nagao C, 2012, PROTEINS, V80, P2426, DOI 10.1002/prot.24127; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Park H, 2011, J MOL GRAPH MODEL, V29, P643, DOI 10.1016/j.jmgm.2010.11.010; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Renaut Laurence, 2012, Methods Mol Biol, V907, P451, DOI 10.1007/978-1-61779-974-7_26; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sakamoto S, 2009, J MOL BIOL, V389, P880, DOI 10.1016/j.jmb.2009.04.050; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103	45	58	63	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87099	10.1371/journal.pone.0087099	http://dx.doi.org/10.1371/journal.pone.0087099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475232	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300139
J	Mustaev, A; Malik, M; Zhao, XL; Kurepina, N; Luan, G; Oppegard, LM; Hiasa, H; Marks, KR; Kerns, RJ; Berger, JM; Drlica, K				Mustaev, Arkady; Malik, Muhammad; Zhao, Xilin; Kurepina, Natalia; Luan, Gan; Oppegard, Lisa M.; Hiasa, Hiroshi; Marks, Kevin R.; Kerns, Robert J.; Berger, James M.; Drlica, Karl			Fluoroquinolone-Gyrase-DNA Complexes TWO MODES OF DRUG BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Action; Bacteria; DNA Topoisomerase; Enzyme Inhibitors; Escherichia coli; Mycobacterium smegmatis; Bacterium; Cleaved Complexes; Cross-linking; Resistance Mutations	TOPOISOMERASE IV-QUINOLONE; RESISTANCE-DETERMINING REGION; ESCHERICHIA-COLI; IIA TOPOISOMERASES; NALIDIXIC-ACID; IN-VITRO; STRUCTURAL BASIS; CLEAVAGE; MECHANISM; GENE	Background: X-ray crystal structures of fluoroquinolone-gyrase-DNA complexes reveal a single drug-binding mode. Results: A ciprofloxacin derivative with a chloroacetyl moiety at the C-7 end cross-linked with cysteine substitutions in both GyrA and GyrB that were 17 apart. Conclusion: Cleaved complexes containing gyrase have two fluoroquinolone-binding modes. Significance: The additional drug-binding mode provides new ways to investigate inhibitor-topoisomerase interactions. DNA gyrase and topoisomerase IV control bacterial DNA topology by breaking DNA, passing duplex DNA through the break, and then resealing the break. This process is subject to reversible corruption by fluoroquinolones, antibacterials that form drug-enzyme-DNA complexes in which the DNA is broken. The complexes, called cleaved complexes because of the presence of DNA breaks, have been crystallized and found to have the fluoroquinolone C-7 ring system facing the GyrB/ParE subunits. As expected from x-ray crystallography, a thiol-reactive, C-7-modified chloroacetyl derivative of ciprofloxacin (Cip-AcCl) formed cross-linked cleaved complexes with mutant GyrB-Cys(466) gyrase as evidenced by resistance to reversal by both EDTA and thermal treatments. Surprisingly, cross-linking was also readily seen with complexes formed by mutant GyrA-G81C gyrase, thereby revealing a novel drug-gyrase interaction not observed in crystal structures. The cross-link between fluoroquinolone and GyrA-G81C gyrase correlated with exceptional bacteriostatic activity for Cip-AcCl with a quinolone-resistant GyrA-G81C variant of Escherichia coli and its Mycobacterium smegmatis equivalent (GyrA-G89C). Cip-AcCl-mediated, irreversible inhibition of DNA replication provided further evidence for a GyrA-drug cross-link. Collectively these data establish the existence of interactions between the fluoroquinolone C-7 ring and both GyrA and GyrB. Because the GyrA-Gly(81) and GyrB-Glu(466) residues are far apart (17 ) in the crystal structure of cleaved complexes, two modes of quinolone binding must exist. The presence of two binding modes raises the possibility that multiple quinolone-enzyme-DNA complexes can form, a discovery that opens new avenues for exploring and exploiting relationships between drug structure and activity with type II DNA topoisomerases.	[Mustaev, Arkady; Malik, Muhammad; Zhao, Xilin; Kurepina, Natalia; Luan, Gan; Drlica, Karl] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Mustaev, Arkady; Malik, Muhammad; Zhao, Xilin; Kurepina, Natalia; Luan, Gan; Drlica, Karl] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Oppegard, Lisa M.; Hiasa, Hiroshi] Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA; [Marks, Kevin R.; Kerns, Robert J.] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA; [Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of California System; University of California Berkeley	Drlica, K (corresponding author), Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.	drlicaka@njms.rutgers.edu	Zhao, Xilin/Y-6795-2019	Zhao, Xilin/0000-0001-8375-8658	National Institutes of Health from the NIAID [R01AI073491, R01AI87671]; NIGMS [R01GM-30717]; NCI [R01-CA077373]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087671, R01AI073491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365, R01GM030717] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI073491 and R01AI87671 from the NIAID, R01GM-30717 from the NIGMS, and R01-CA077373 from the NCI.	Aedo S, 2012, ANTIMICROB AGENTS CH, V56, P5458, DOI 10.1128/AAC.01182-12; Aldred KJ, 2013, NUCLEIC ACIDS RES, V41, P4628, DOI 10.1093/nar/gkt124; Aldred KJ, 2012, BIOCHEMISTRY-US, V51, P370, DOI 10.1021/bi2013905; Azema J, 2009, BIOORGAN MED CHEM, V17, P5396, DOI 10.1016/j.bmc.2009.06.053; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175; Deweese JE, 2010, METALLOMICS, V2, P450, DOI 10.1039/c003759a; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Golanbar GD, 2011, J CLIN MICROBIOL, V49, P2121, DOI 10.1128/JCM.02373-10; GOSS WA, 1965, J BACTERIOL, V89, P1068, DOI 10.1128/JB.89.4.1068-1074.1965; Hiasa H, 2000, J BIOL CHEM, V275, P34780, DOI 10.1074/jbc.M001608200; HIASA H, 1994, J BIOL CHEM, V269, P2093; Hiasa H, 2002, BIOCHEMISTRY-US, V41, P11779, DOI 10.1021/bi026352v; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Kampranis SC, 1998, J BIOL CHEM, V273, P22615, DOI 10.1074/jbc.273.35.22615; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KREUZER KN, 1980, CELL, V20, P245, DOI 10.1016/0092-8674(80)90252-4; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; LIU LF, 1983, J BIOL CHEM, V258, P5365; Lu T, 1999, ANTIMICROB AGENTS CH, V43, P2969, DOI 10.1128/AAC.43.12.2969; Malik M, 2011, ANTIMICROB AGENTS CH, V55, P2335, DOI 10.1128/AAC.00033-11; Malik M, 2010, ANTIMICROB AGENTS CH, V54, P149, DOI 10.1128/AAC.01035-09; Malik M, 2009, ANTIMICROB AGENTS CH, V53, P3103, DOI 10.1128/AAC.00019-09; Miller J. H., 1972, EXPT MOL GENETICS, P433; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oppegard LM, 2009, ANTIMICROB AGENTS CH, V53, P2110, DOI 10.1128/AAC.01440-08; Pan XS, 2009, ANTIMICROB AGENTS CH, V53, P3822, DOI 10.1128/AAC.00113-09; Perlman DC, 1997, AIDS, V11, P1473, DOI 10.1097/00002030-199712000-00011; Pohlhaus JR, 2005, MOL MICROBIOL, V56, P1416, DOI 10.1111/j.1365-2958.2005.04638.x; Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665; Shea ME, 1999, J BIOL CHEM, V274, P22747, DOI 10.1074/jbc.274.32.22747; Sindelar G, 2000, ANTIMICROB AGENTS CH, V44, P3337, DOI 10.1128/AAC.44.12.3337-3343.2000; SNYDER M, 1979, J MOL BIOL, V131, P287, DOI 10.1016/0022-2836(79)90077-9; STERNGLANZ R, 1981, P NATL ACAD SCI-BIOL, V78, P2747, DOI 10.1073/pnas.78.5.2747; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; TRISLER P, 1984, J BACTERIOL, V160, P184, DOI 10.1128/JB.160.1.184-191.1984; WALL JD, 1974, VIROLOGY, V59, P532, DOI 10.1016/0042-6822(74)90463-2; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Wentzell LM, 2000, J MOL BIOL, V304, P779, DOI 10.1006/jmbi.2000.4266; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647, DOI 10.1128/AAC.35.8.1647; Zhou JF, 2000, J INFECT DIS, V182, P517, DOI 10.1086/315708	52	92	94	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12300	12312		10.1074/jbc.M113.529164	http://dx.doi.org/10.1074/jbc.M113.529164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24497635	Green Published, hybrid			2022-12-25	WOS:000335581400010
J	Zhang, Y; Park, S; Blaser, S; Sheets, MD				Zhang, Yan; Park, Sookhee; Blaser, Susanne; Sheets, Michael D.			Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Kidney; mRNA; RNA Binding Protein; RNA Silencing; Transforming Growth Factor Beta (TGFbeta); Translation Regulation; Xenopus; Maternal mRNA	MENTAL-RETARDATION PROTEIN; MESSENGER-RNAS; XENOPUS EMBRYOS; KH DOMAINS; RECOGNITION; PATHWAY	Background: Bicaudal-C RNA binding proteins are important translational repressors in many different biological contexts. Results: A minimal site for RNA binding and translation repression by Bicaudal-C was identified. Conclusion: The RNA binding site for Bicaudal-C forms a stem-loop structure important for binding and translational repression. Significance: This will facilitate the identification of Bicaudal-C binding sites in other mRNAs. Bicaudal-C (Bic-C) RNA binding proteins function as important translational repressors in multiple biological contexts within metazoans. However, their RNA binding sites are unknown. We recently demonstrated that Bic-C functions in spatially regulated translational repression of the xCR1 mRNA during Xenopus development. This repression contributes to normal development by confining the xCR1 protein, a regulator of key signaling pathways, to specific cells of the embryo. In this report, we combined biochemical approaches with in vivo mRNA reporter assays to define the minimal Bic-C target site within the xCR1 mRNA. This 32-nucleotide Bic-C target site is predicted to fold into a stem-loop secondary structure. Mutational analyses provided evidence that this stem-loop structure is important for Bic-C binding. The Bic-C target site was sufficient for Bic-C mediated repression in vivo. Thus, we describe the first RNA binding site for a Bic-C protein. This identification provides an important step toward understanding the mechanisms by which evolutionarily conserved Bic-C proteins control cellular function in metazoans.	[Zhang, Yan; Park, Sookhee; Blaser, Susanne; Sheets, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sheets, MD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA.	mdsheets@wisc.edu		Sheets, Michael/0000-0002-5786-9407	National Science Foundation [1050395]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 1050395 (to M. D. S.).	Anko ML, 2012, TRENDS BIOCHEM SCI, V37, P255, DOI 10.1016/j.tibs.2012.02.005; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; Darnell JC, 2004, MENT RETARD DEV D R, V10, P49, DOI 10.1002/mrdd.20008; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Fritz BR, 2001, DEV BIOL, V236, P230, DOI 10.1006/dbio.2001.0324; Gamberi C, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/141386; Hou ZG, 2005, P NATL ACAD SCI USA, V102, P8489, DOI 10.1073/pnas.0503525102; Hou ZG, 2009, MOL CELL BIOL, V29, P687, DOI 10.1128/MCB.00202-08; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Kraus MRC, 2012, HUM MUTAT, V33, P86, DOI 10.1002/humu.21610; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; MEADOR J, 1990, EUR J BIOCHEM, V187, P549, DOI 10.1111/j.1432-1033.1990.tb15336.x; MEADOR J, 1990, GENE, V95, P1, DOI 10.1016/0378-1119(90)90406-H; Nakel K, 2010, RNA, V16, P2058, DOI 10.1261/rna.2315010; Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Saffman EE, 1998, MOL CELL BIOL, V18, P4855, DOI 10.1128/MCB.18.8.4855; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Takahashi K, 1970, Adv Biophys, V1, P53; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Wessely O, 2000, DEVELOPMENT, V127, P2053; Zhang Y, 2013, RNA, V19, P1575, DOI 10.1261/rna.041665.113; Zhang Y, 2009, MOL CELL BIOL, V29, P3791, DOI 10.1128/MCB.01865-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7497	7504		10.1074/jbc.M113.526426	http://dx.doi.org/10.1074/jbc.M113.526426			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478311	hybrid, Green Published			2022-12-25	WOS:000332761500020
J	Simonson, MA; McQueen, MB; Keller, MC				Simonson, Matthew A.; McQueen, Matthew B.; Keller, Matthew C.			Whole-Genome Pathway Analysis on 132,497 Individuals Identifies Novel Gene-Sets Associated with Body Mass Index	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; WIDE ASSOCIATION; COMMON SNPS; ADIPOCYTE DIFFERENTIATION; CARDIOVASCULAR-DISEASE; ENRICHMENT ANALYSIS; COMPLEX TRAITS; OBESITY; RISK; SCHIZOPHRENIA	Whole genome pathway analysis is a powerful tool for the exploration of the combined effects of gene-sets within biological pathways. This study applied Interval Based Enrichment Analysis (INRICH) to perform whole-genome pathway analysis of body-mass index (BMI). We used a discovery set composed of summary statistics from a meta-analysis of 123,865 subjects performed by the GIANT Consortium, and an independent sample of 8,632 subjects to assess replication of significant pathways. We examined SNPs within nominally significant pathways using linear mixed models to estimate their contribution to overall BMI heritability. Six pathways replicated as having significant enrichment for association after correcting for multiple testing, including the previously unknown relationships between BMI and the Reactome regulation of ornithine decarboxylase pathway, the KEGG lysosome pathway, and the Reactome stabilization of P53 pathway. Two non-overlapping sets of genes emerged from the six significant pathways. The clustering of shared genes based on previously identified protein-protein interactions listed in PubMed and OMIM supported the relatively independent biological effects of these two gene-sets. We estimate that the SNPs located in examined pathways explain similar to 20% of the heritability for BMI that is tagged by common SNPs (3.35% of the 16.93% total).	[Simonson, Matthew A.] Univ Colorado, Inst Behav Genet, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [McQueen, Matthew B.] Univ Colorado, Inst Behav Genet, Dept Integrat Physiol, Boulder, CO 80309 USA; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Simonson, Matthew A.] Mayo Clin, Dept Hlth Sci, Div Biomed Stat & Informat, Rochester, MN USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Mayo Clinic	Simonson, MA (corresponding author), Univ Colorado, Inst Behav Genet, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	simonson.matthew@mayo.edu	McQueen, Matthew/X-5845-2019	KELLER, MATTHEW/0000-0002-6075-9882	National Institute of Child Health and Human Development [T32 HD 7289-28, R01HD060726]; National Institutes of Mental Health [K01MH085812, R01MH100141]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726, T32HD007289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH085812, R01MH100141] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Contributions by MAS were partially supported by two institutional training grants from the National Institute of Child Health and Human Development (T32 HD 7289-28, Michael C. Stallings, Director) and (T32 HD 7289-28, Michael C. Stallings, Director). Contributions by MCK were supported by National Institutes of Mental Health Grants K01MH085812 and R01MH100141. MBM was supported by a grant from the National Institute of Child Health and Human Development (R01HD060726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], CARDIA COR RISK DEV; Benyamin B., 2013, MOL PSYCHIAT, DOI 10.1038/mp.2012.184; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Haby MM, 2012, HEALTH PROMOT INT, V27, P250, DOI 10.1093/heapro/dar036; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jia PL, 2012, J MED GENET, V49, P96, DOI 10.1136/jmedgenet-2011-100397; Jia PL, 2011, INT J NEUROPSYCHOPH, V14, P567, DOI 10.1017/S1461145710001446; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lee PH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.95; Lee PH, 2011, INTERVAL ENRICHMENT; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu YJ, 2010, OBESITY, V18, P2339, DOI 10.1038/oby.2010.83; Liu YF, 2013, STAT INTERFACE, V6, P1; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Molchadsky A, 2013, CELL DEATH DIFFER; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Penman Alan D, 2006, Prev Chronic Dis, V3, pA74; Peterson RE, 2011, HUM GENET, V129, P221, DOI 10.1007/s00439-010-0917-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Simonson MA, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-146; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stewart SE, 2013, MOL PSYCHIAT; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; *TEAM TDC, 2008, R LANG ENV STAT COMP; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	72	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e78546	10.1371/journal.pone.0078546	http://dx.doi.org/10.1371/journal.pone.0078546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497910	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900001
J	Witham, MD; Donnan, PT; Vadiveloo, T; Sniehotta, FF; Crombie, IK; Feng, ZQ; McMurdo, MET				Witham, Miles D.; Donnan, Peter T.; Vadiveloo, Thenmalar; Sniehotta, Falko F.; Crombie, Iain K.; Feng, Zhiqiang; McMurdo, Marion E. T.			Association of Day Length and Weather Conditions with Physical Activity Levels in Older Community Dwelling People	PLOS ONE			English	Article							ADULTS; HEALTH; ACCELEROMETER; VALIDITY; GENDER; AGE	Background: Weather is a potentially important determinant of physical activity. Little work has been done examining the relationship between weather and physical activity, and potential modifiers of any relationship in older people. We therefore examined the relationship between weather and physical activity in a cohort of older community-dwelling people. Methods: We analysed prospectively collected cross-sectional activity data from community-dwelling people aged 65 and over in the Physical Activity Cohort Scotland. We correlated seven day triaxial accelerometry data with daily weather data (temperature, day length, sunshine, snow, rain), and a series of potential effect modifiers were tested in mixed models: environmental variables (urban vs rural dwelling, percentage of green space), psychological variables (anxiety, depression, perceived behavioural control), social variables (number of close contacts) and health status measured using the SF-36 questionnaire. Results: 547 participants, mean age 78.5 years, were included in this analysis. Higher minimum daily temperature and longer day length were associated with higher activity levels; these associations remained robust to adjustment for other significant associates of activity: age, perceived behavioural control, number of social contacts and physical function. Of the potential effect modifier variables, only urban vs rural dwelling and the SF-36 measure of social functioning enhanced the association between day length and activity; no variable modified the association between minimum temperature and activity. Conclusions: In older community dwelling people, minimum temperature and day length were associated with objectively measured activity. There was little evidence for moderation of these associations through potentially modifiable health, environmental, social or psychological variables.	[Witham, Miles D.; McMurdo, Marion E. T.] Univ Dundee, Dundee, Scotland; [Donnan, Peter T.; Vadiveloo, Thenmalar] Univ Dundee, Dundee Epidemiol & Biostat Unit, Dundee, Scotland; [Sniehotta, Falko F.] Newcastle Univ, Dept Hlth Psychol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Crombie, Iain K.] Univ Dundee, Dept Publ Hlth, Dundee, Scotland; [Feng, Zhiqiang] Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews, Fife, Scotland	University of Dundee; University of Dundee; Newcastle University - UK; University of Dundee; University of St Andrews	Witham, MD (corresponding author), Univ Dundee, Dundee, Scotland.	m.witham@dundee.ac.uk	Sniehotta, Falko/ABF-7131-2021; Sniehotta, Falko F/C-5481-2008	Sniehotta, Falko/0000-0003-1738-4269; Sniehotta, Falko F/0000-0003-1738-4269; Donnan, Peter/0000-0001-7828-0610; Witham, Miles/0000-0002-1967-0990; Vadiveloo, Thenmalar/0000-0001-5531-6289	Scottish Executive grant [CZH/4/518]; University of Dundee; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	Scottish Executive grant; University of Dundee; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Scottish Executive grant CZH/4/518. The sponsor was the University of Dundee. Neither funder nor sponsor had a role in the design, conduct or interpretation of the study.	Badland HM, 2011, HEALTH PLACE, V17, P1084, DOI 10.1016/j.healthplace.2011.06.003; Baker PRA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub2; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Brandon CA, 2009, APPL PHYSIOL NUTR ME, V34, P182, DOI 10.1139/H09-004; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Feinglass J, 2011, J PHYS ACT HEALTH, V8, P934, DOI 10.1123/jpah.8.7.934; Flowerdew R, 2007, COMPUT ENVIRON URBAN, V31, P76, DOI 10.1016/j.compenvurbsys.2005.07.008; Fox KR, 2011, HEALTH PLACE, V17, P633, DOI 10.1016/j.healthplace.2011.01.002; Hagger MS, 2002, BRIT J HEALTH PSYCH, V7, P283, DOI 10.1348/135910702760213689; Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058; Harper R, 2003, MEASURING SOCIAL CAP; Kochersberger G, 1996, ARCH PHYS MED REHAB, V77, P793, DOI 10.1016/S0003-9993(96)90258-0; Lyden K, 2011, EUR J APPL PHYSIOL, V111, P187, DOI 10.1007/s00421-010-1639-8; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; McMurdo MET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031878; McMurdo MET, 2010, J AM GERIATR SOC, V58, P2099, DOI 10.1111/j.1532-5415.2010.03127.x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Pivarnik JM, 2003, MED SCI SPORT EXER, V35, P1004, DOI 10.1249/01.MSS.0000069747.55950.B1; Pollard B, 2001, SOC SCI MED, V52, P921, DOI 10.1016/S0277-9536(00)00194-5; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; Scottish Government, URB RUR CLASS 2009 2; Sumukadas D, 2009, J EPIDEMIOL COMMUN H, V63, P305, DOI 10.1136/jech.2008.080838; Sumukadas D, 2008, AGING CLIN EXP RES, V20, P15; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Talbot LA, 2002, AM J CARDIOL, V89, P1187, DOI 10.1016/S0002-9149(02)02302-0; Togo F, 2005, INT J BIOMETEOROL, V50, P83, DOI 10.1007/s00484-005-0277-z; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Tudor-Locke C, 2004, ANN BEHAV MED, V28, P158, DOI 10.1207/s15324796abm2803_3; Witham MD, 2005, AM J CARDIOL, V95, P1120, DOI 10.1016/j.amjcard.2005.01.031; Yildirim M, 2013, J PHYS ACT HLTH	30	43	43	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85331	10.1371/journal.pone.0085331	http://dx.doi.org/10.1371/journal.pone.0085331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302PJ	24497925	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100008
J	Lescroel, A; Ballard, G; Gremillet, D; Authier, M; Ainley, DG				Lescroel, Amelie; Ballard, Grant; Gremillet, David; Authier, Matthieu; Ainley, David G.			Antarctic Climate Change: Extreme Events Disrupt Plastic Phenotypic Response in Adelie Penguins	PLOS ONE			English	Article							ROSS SEA; REACTION NORMS; ENVIRONMENTAL-CHANGE; PYGOSCELIS-ADELIAE; FORAGING BEHAVIOR; ICE-SHELF; SURVIVAL; VARIABILITY; ICEBERGS; ECOLOGY	In the context of predicted alteration of sea ice cover and increased frequency of extreme events, it is especially timely to investigate plasticity within Antarctic species responding to a key environmental aspect of their ecology: sea ice variability. Using 13 years of longitudinal data, we investigated the effect of sea ice concentration (SIC) on the foraging efficiency of Adelie penguins (Pygoscelis adeliae) breeding in the Ross Sea. A 'natural experiment' brought by the exceptional presence of giant icebergs during 5 consecutive years provided unprecedented habitat variation for testing the effects of extreme events on the relationship between SIC and foraging efficiency in this sea-ice dependent species. Significant levels of phenotypic plasticity were evident in response to changes in SIC in normal environmental conditions. Maximum foraging efficiency occurred at relatively low SIC, peaking at 6.1% and decreasing with higher SIC. The 'natural experiment' uncoupled efficiency levels from SIC variations. Our study suggests that lower summer SIC than currently observed would benefit the foraging performance of Adelie penguins in their southernmost breeding area. Importantly, it also provides evidence that extreme climatic events can disrupt response plasticity in a wild seabird population. This questions the predictive power of relationships built on past observations, when not only the average climatic conditions are changing but the frequency of extreme climatic anomalies is also on the rise.	[Lescroel, Amelie] Univ Rennes 1, URU 420, Rennes, France; [Lescroel, Amelie; Gremillet, David; Authier, Matthieu] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Ballard, Grant] Point Blue Conservat Sci, Petaluma, CA USA; [Gremillet, David] Univ Cape Town, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Gremillet, David] Univ Cape Town, DST NRF Excellence Ctr, ZA-7700 Rondebosch, South Africa; [Ainley, David G.] HT Harvey & Associates, Los Gatos, CA USA	Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Cape Town; University of Cape Town	Lescroel, A (corresponding author), Univ Rennes 1, URU 420, Rennes, France.	amelie.lescroel@cefe.cnrs.fr	Gremillet, David/W-1946-2018	Gremillet, David/0000-0002-7711-9398; Authier, Matthieu/0000-0001-7394-1993	NSF [OPP 9526865, 9814882, 0125608, 0440643, 0944411]; CNRS; French Polar Institut (IPEV) within the ADACLIM program [388]; Office of Polar Programs (OPP) [0944411, 0944141] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Polar Institut (IPEV) within the ADACLIM program; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by NSF grants OPP 9526865, 9814882, 0125608, 0440643 and 0944411. DG is funded by CNRS and the French Polar Institut (IPEV) within the ADACLIM program (grant 388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2012, POLAR BIOL, V35, P1, DOI 10.1007/s00300-011-1042-x; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Juarez EIAY, 2012, TRENDS ECOL EVOL, V27, P272, DOI 10.1016/j.tree.2011.11.005; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Arrigo KR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014160; Ballard G, 2001, CONDOR, V103, P481, DOI 10.1650/0010-5422(2001)103[0481:EOIAAO]2.0.CO;2; Ballard G, 2012, BIOL CONSERV, V156, P72, DOI 10.1016/j.biocon.2011.11.017; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Bates D, 2012, IME4 LINEAR MIXED EF; Canale CI, 2010, CLIM RES, V43, P135, DOI 10.3354/cr00897; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Chambert T, 2012, P ROY SOC B-BIOL SCI, V279, P4532, DOI 10.1098/rspb.2012.1733; Chapman EW, 2010, DEEP-SEA RES PT II, V57, P543, DOI 10.1016/j.dsr2.2009.10.005; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Christensen JH, 2007, CONTRIBUTION WORKING; Clarke J, 2003, MAR ECOL PROG SER, V248, P267, DOI 10.3354/meps248267; Clarke J, 2002, POLAR BIOL, V25, P21, DOI 10.1007/s003000100307; Clarke J, 1998, POLAR BIOL, V20, P248, DOI 10.1007/s003000050301; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Donnelly A, 2012, CLIM RES, V53, P245, DOI 10.3354/cr01102; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; Dunn MJ, 2011, POLAR BIOL, V34, P205, DOI 10.1007/s00300-010-0870-4; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Emmerson L, 2008, ECOLOGY, V89, P2096, DOI 10.1890/08-0011.1; Emslie SD, 2003, MAR ECOL PROG SER, V262, P19, DOI 10.3354/meps262019; Emslie SD, 2007, GEOLOGY, V35, P61, DOI 10.1130/G23011A.1; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Field C.B., 2012, MANAGING RISKS EXTRE; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gille ST, 2008, J CLIMATE, V21, P4749, DOI 10.1175/2008JCLI2131.1; Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; JACOBS SS, 1986, J GLACIOL, V32, P464, DOI 10.3189/S0022143000012181; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Kato A, 2009, POLAR BIOL, V32, P181, DOI 10.1007/s00300-008-0518-9; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; KEYS HJR, 1990, ANTARCT SCI, V2, P243; Kooyman GL, 2007, ANTARCT SCI, V19, P31, DOI 10.1017/S0954102007000065; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; LAZZARA MA, 1999, POLAR GEOGR, V23, P201, DOI DOI 10.1080/10889379909377676; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; Lindquist MA, 2012, NEUROIMAGE, V59, P490, DOI 10.1016/j.neuroimage.2011.07.077; Lynch HJ, 2012, ECOLOGY, V93, P1367; Madhusoodanan MS, 2011, OCEAN DYNAM, V61, P873, DOI 10.1007/s10236-011-0386-7; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; Martin S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006700; Mulvaney R, 2012, NATURE, V489, P141, DOI 10.1038/nature11391; Nettles M, 2010, ANNU REV EARTH PL SC, V38, P467, DOI 10.1146/annurev-earth-040809-152414; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Pinheiro J, 2012, LINEAR NONLINEAR MIX; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pitman RL, 2010, POLAR BIOL, V33, P1589, DOI 10.1007/s00300-010-0853-5; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Rockova V, 2012, STAT MED, V31, P1221, DOI 10.1002/sim.4439; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Shepherd LD, 2005, P NATL ACAD SCI USA, V102, P16717, DOI 10.1073/pnas.0502281102; Siniff DB, 2008, ANTARCT SCI, V20, P425, DOI 10.1017/S0954102008001351; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; Smith WO, 2007, PHILOS T R SOC B, V362, P95, DOI 10.1098/rstb.2006.1956; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Thompson RM, 2013, ECOL LETT, DOI DOI 10.1111/ELE.12095/FULL; Thrush SF, 2011, MAR ECOL-EVOL PERSP, V32, P289, DOI 10.1111/j.1439-0485.2011.00462.x; Ujvari B, 2011, ECOLOGY, V92, P1858, DOI 10.1890/11-0129.1; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Vonesh EF, 1996, BIOMETRICS, V52, P572, DOI 10.2307/2532896; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Westneat DF, 2011, AM NAT, V178, P652, DOI 10.1086/662173; Zuur Alain F., 2009, P1	93	39	40	3	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85291	10.1371/journal.pone.0085291	http://dx.doi.org/10.1371/journal.pone.0085291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489657	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000009
J	Little, MP; Kukush, AG; Masiuk, SV; Shklyar, S; Carroll, RJ; Lubin, JH; Kwon, D; Brenner, AV; Tronko, MD; Mabuchi, K; Bogdanova, TI; Hatch, M; Zablotska, LB; Tereshchenko, VP; Ostroumova, E; Bouville, AC; Drozdovitch, V; Chepurny, MI; Kovgan, LN; Simon, SL; Shpak, VM; Likhtarev, IA				Little, Mark P.; Kukush, Alexander G.; Masiuk, Sergii V.; Shklyar, Sergiy; Carroll, Raymond J.; Lubin, Jay H.; Kwon, Deukwoo; Brenner, Alina V.; Tronko, Mykola D.; Mabuchi, Kiyohiko; Bogdanova, Tetiana I.; Hatch, Maureen; Zablotska, Lydia B.; Tereshchenko, Valeriy P.; Ostroumova, Evgenia; Bouville, Andre C.; Drozdovitch, Vladimir; Chepurny, Mykola I.; Kovgan, Lina N.; Simon, Steven L.; Shpak, Victor M.; Likhtarev, Ilya A.			Impact of Uncertainties in Exposure Assessment on Estimates of Thyroid Cancer Risk among Ukrainian Children and Adolescents Exposed from the Chernobyl Accident	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; MEASUREMENT ERROR PROBLEMS; MORTALITY DOSE-RESPONSE; REGRESSION CALIBRATION; CERVICAL-CANCER; RADIATION; MODELS; CURVATURE; I-131; EPIDEMIOLOGY	The 1986 accident at the Chernobyl nuclear power plant remains the most serious nuclear accident in history, and excess thyroid cancers, particularly among those exposed to releases of iodine-131 remain the best-documented sequelae. Failure to take dose-measurement error into account can lead to bias in assessments of dose-response slope. Although risks in the Ukrainian-US thyroid screening study have been previously evaluated, errors in dose assessments have not been addressed hitherto. Dose-response patterns were examined in a thyroid screening prevalence cohort of 13,127 persons aged <18 at the time of the accident who were resident in the most radioactively contaminated regions of Ukraine. We extended earlier analyses in this cohort by adjusting for dose error in the recently developed TD-10 dosimetry. Three methods of statistical correction, via two types of regression calibration, and Monte Carlo maximum-likelihood, were applied to the doses that can be derived from the ratio of thyroid activity to thyroid mass. The two components that make up this ratio have different types of error, Berkson error for thyroid mass and classical error for thyroid activity. The first regression-calibration method yielded estimates of excess odds ratio of 5.78 Gy(-1) (95% CI 1.92, 27.04), about 7% higher than estimates unadjusted for dose error. The second regression-calibration method gave an excess odds ratio of 4.78 Gy(-1) (95% CI 1.64, 19.69), about 11% lower than unadjusted analysis. The Monte Carlo maximum-likelihood method produced an excess odds ratio of 4.93 Gy(-1) (95% CI 1.67, 19.90), about 8% lower than unadjusted analysis. There are borderline-significant (p=0.101-0.112) indications of downward curvature in the dose response, allowing for which nearly doubled the low-dose linear coefficient. In conclusion, dose-error adjustment has comparatively modest effects on regression parameters, a consequence of the relatively small errors, of a mixture of Berkson and classical form, associated with thyroid dose assessment.	[Little, Mark P.; Kwon, Deukwoo; Brenner, Alina V.; Mabuchi, Kiyohiko; Hatch, Maureen; Ostroumova, Evgenia; Bouville, Andre C.; Drozdovitch, Vladimir; Simon, Steven L.] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20892 USA; [Kukush, Alexander G.; Masiuk, Sergii V.; Shklyar, Sergiy; Chepurny, Mykola I.; Kovgan, Lina N.; Likhtarev, Ilya A.] Ukrainian Radiat Protect Inst, Kiev, Ukraine; [Kukush, Alexander G.; Shklyar, Sergiy] Taras Shevchenko Natl Univ Kyiv, Kiev, Ukraine; [Carroll, Raymond J.] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Lubin, Jay H.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20892 USA; [Kwon, Deukwoo] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Tronko, Mykola D.; Bogdanova, Tetiana I.; Tereshchenko, Valeriy P.; Shpak, Victor M.] Ukraine Acad Med Sci, State Inst Inst Endocrinol & Metab, Kiev, Ukraine; [Zablotska, Lydia B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Academy of Medical Sciences of Ukraine; National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; National Academy of Medical Sciences of Ukraine; V. P. Komissarenko Institute of Endocrinology & Metabolism of the National Academy of Medical Science of Ukraine; University of California System; University of California San Francisco	Little, MP (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20892 USA.	mark.little@nih.gov	Tronko, Mykola/AAQ-3327-2021; Likhtarev, Ilja/E-6414-2018; Kukush, Alexander G./I-1313-2018; Shklyar, Sergiy/O-4680-2015	Tronko, Mykola/0000-0001-7421-0981; Likhtarev, Ilja/0000-0002-6168-5758; Shklyar, Sergiy/0000-0001-8726-7936; Bogdanova, Tetiana/0000-0001-5119-0236; Masiuk, Sergii/0000-0002-5123-9674; Kukush, Alexander/0000-0002-4143-8928; Little, Mark/0000-0003-0980-7567; Shpak, Viktor/0000-0002-6983-5490; Ostroumova, Evgenia/0000-0003-4729-1733; Drozdovitch, Vladimir/0000-0002-7952-379X; Chepurny, Mykola/0000-0001-9852-0669	National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics; National Cancer Institute [R37-CA057030]; NATIONAL CANCER INSTITUTE [R01CA057030, R37CA057030] Funding Source: NIH RePORTER	National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics. Professor RJC's research was supported by a grant from the National Cancer Institute (R37-CA057030). The National Cancer Institute approved the present paper for publication. The funders (NIH) had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annex A, 2008, UNSCEAR 2006 REP, P13; Bateson TF, 2010, AM J EPIDEMIOL, V172, P344, DOI 10.1093/aje/kwq123; BAVERSTOCK K, 1992, NATURE, V359, P21, DOI 10.1038/359021b0; Bennett J, 2004, RADIAT ENVIRON BIOPH, V43, P233, DOI 10.1007/s00411-004-0258-3; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Burnham KP, 1998, MODEL SELECTION MULT, P1; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Carroll RJ, 2006, MODERN PERSPECTIVE, P1; Claeskens G., 2008, CAMBRIDGE SERIES STA, P1; CLAYTON D, 1988, STAT MED, V7, P819, DOI 10.1002/sim.4780070802; Davis S, 2004, JAMA-J AM MED ASSOC, V292, P2600, DOI 10.1001/jama.292.21.2600; Deschavanne PJ, 1996, INT J RADIAT ONCOL, V34, P251, DOI 10.1016/0360-3016(95)02029-2; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716; Fearn T, 2008, STAT MED, V27, P2159, DOI 10.1002/sim.3163; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; Kukush A, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1281; Likhtarev I, 2006, RADIAT RES, V166, P271, DOI 10.1667/RR3545.1; Likhtarev I, 2003, RADIAT PROT DOSIM, V105, P601, DOI 10.1093/oxfordjournals.rpd.a006310; LIKHTAREV IA, 1995, HEALTH PHYS, V69, P6, DOI 10.1097/00004032-199507000-00002; Likhtarov I, 2013, HEALTH PHYS, V104, P78, DOI 10.1097/HP.0b013e31826e188e; Likhtarov I, 2014, HLTH PHYS IN PRESS; Likhtarov I, 2011, DOSIMETRY OPERATIONS; Likhtarov I, 2013, MATH LIFE SCI, P231; Little MP, 2008, RADIAT RES, V169, P660, DOI 10.1667/RR1091.1; Little MP, 1998, INT J RADIAT BIOL, V74, P471, DOI 10.1080/095530098141348; Little MP, 2000, INT J RADIAT BIOL, V76, P939, DOI 10.1080/09553000050050954; Little MP, 2004, RADIAT ENVIRON BIOPH, V43, P67, DOI 10.1007/s00411-004-0244-9; Little MP, 1997, INT J RADIAT BIOL, V71, P589, DOI 10.1080/095530097143923; Little MP, 1999, RADIAT RES, V152, P280, DOI 10.2307/3580328; Little MP, 1996, INT J RADIAT BIOL, V70, P83, DOI 10.1080/095530096145364; Little MP, 2000, RADIAT ENVIRON BIOPH, V39, P241, DOI 10.1007/s004110000070; LUNDELL M, 1994, RADIAT RES, V140, P334, DOI 10.2307/3579110; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Molitor J, 2007, ENVIRON HEALTH PERSP, V115, P1147, DOI 10.1289/ehp.9849; PIERCE DA, 1991, J RADIAT RES, V32, P108, DOI 10.1269/jrr.32.SUPPLEMENT_108; PIERCE DA, 1990, RADIAT RES, V123, P275, DOI 10.2307/3577733; RICHARDSON S, 1993, STAT MED, V12, P1703, DOI 10.1002/sim.4780121806; RICHARDSON S, 1993, AM J EPIDEMIOL, V138, P430, DOI 10.1093/oxfordjournals.aje.a116875; Richardson S, 2002, J ROY STAT SOC A STA, V165, P549, DOI 10.1111/1467-985X.00252; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Sachs RK, 2005, P NATL ACAD SCI USA, V102, P13040, DOI 10.1073/pnas.0506648102; Schollnberger H, 2012, RADIAT ENVIRON BIOPH, V51, P165, DOI 10.1007/s00411-012-0410-4; SHORE RE, 1993, AM J EPIDEMIOL, V137, P1068, DOI 10.1093/oxfordjournals.aje.a116610; Sigurdson AJ, 2005, LANCET, V365, P2014, DOI 10.1016/S0140-6736(05)66695-0; Stezhko VA, 2004, RADIAT RES, V161, P481, DOI 10.1667/3148; Stram DO, 2003, RADIAT RES, V160, P408, DOI 10.1667/3046; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; THOMAS DC, 1992, BIOMETRICS, V48, P781, DOI 10.2307/2532344; Tronko MD, 2006, JNCI-J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 1993, UNSCEAR 1993 REP GEN, P1; Walsh L, 2013, RADIAT ENVIRON BIOPH, V52, P135, DOI 10.1007/s00411-012-0441-x; Walsh L, 2011, RADIAT ENVIRON BIOPH, V50, P21, DOI 10.1007/s00411-010-0337-6; Wang C, 2012, BIOMETRICS, V68, P661, DOI 10.1111/j.1541-0420.2011.01731.x; Yamashita S, 1997, P 5 CHERN SAS MED CO, P1; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967	55	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85723	10.1371/journal.pone.0085723	http://dx.doi.org/10.1371/journal.pone.0085723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489667	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000014
J	Lalanza, JF; Caimari, A; del Bas, JM; Torregrosa, D; Cigarroa, I; Pallas, M; Capdevila, L; Arola, L; Escorihuela, RM				Lalanza, Jaume F.; Caimari, Antoni; del Bas, Josep M.; Torregrosa, Daniel; Cigarroa, Igor; Pallas, Merce; Capdevila, Lluis; Arola, Lluis; Escorihuela, Rosa M.			Effects of a Post-Weaning Cafeteria Diet in Young Rats: Metabolic Syndrome, Reduced Activity and Low Anxiety-Like Behaviour	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; HIGH-FAT DIET; PALATABLE DIET; ENVIRONMENTAL ENRICHMENT; SOCIAL-INTERACTION; CHRONIC STRESS; OBESITY; CONSUMPTION; OVERWEIGHT; EXPRESSION	Among adolescents, overweight, obesity and metabolic syndrome are rapidly increasing in recent years as a consequence of unhealthy palatable diets. Animal models of diet-induced obesity have been developed, but little is known about the behavioural patterns produced by the consumption of such diets. The aim of the present study was to determine the behavioural and biochemical effects of a cafeteria diet fed to juvenile male and female rats, as well as to evaluate the possible recovery from these effects by administering standard feeding during the last week of the study. Two groups of male and female rats were fed with either a standard chow diet (ST) or a cafeteria (CAF) diet from weaning and for 8 weeks. A third group of males (CAF withdrawal) was fed with the CAF diet for 7 weeks and the ST in the 8th week. Both males and females developed metabolic syndrome as a consequence of the CAF feeding, showing overweight, higher adiposity and liver weight, increased plasma levels of glucose, insulin and triglycerides, as well as insulin resistance, in comparison with their respective controls. The CAF diet reduced motor activity in all behavioural tests, enhanced exploration, reduced anxiety-like behaviour and increased social interaction; this last effect was more pronounced in females than in males. When compared to animals only fed with a CAF diet, CAF withdrawal increased anxiety in the open field, slightly decreased body weight, and completely recovered the liver weight, insulin sensitivity and the standard levels of glucose, insulin and triglycerides in plasma. In conclusion, a CAF diet fed to young animals for 8 weeks induced obesity and metabolic syndrome, and produced robust behavioural changes in young adult rats, whereas CAF withdrawal in the last week modestly increased anxiety, reversed the metabolic alterations and partially reduced overweight.	[Lalanza, Jaume F.; Torregrosa, Daniel; Cigarroa, Igor; Escorihuela, Rosa M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain; [Lalanza, Jaume F.; Capdevila, Lluis] Univ Autonoma Barcelona, Dept Psicol Basica, Lab Psicol Esport, E-08193 Barcelona, Spain; [Caimari, Antoni; del Bas, Josep M.; Arola, Lluis] CEICS, TECNIO, CTNS, Reus, Spain; [Cigarroa, Igor] Univ Santo Tomas, Fac Salud, Santiago, Chile; [Pallas, Merce] Univ Barcelona, Fac Farm, Inst Biomed, Seccio Farmacol & Farmacognosia, E-08028 Barcelona, Spain; [Pallas, Merce] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Arola, Lluis] Univ Rovira & Virgili, Nutrigen Res Grp, Dept Bioquim & Biotecnol, E-43007 Tarragona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Universidad Santo Tomas; University of Barcelona; CIBERNED; Universitat Rovira i Virgili	Escorihuela, RM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain.	rosamaria.escorihuela@uab.cat	cigarroa, igor/AAV-3527-2020; del Bas, Josep M/K-2327-2014; Escorihuela, Rosa M/L-4524-2014; Capdevila, Lluis/I-2530-2015; F. Lalanza, Jaume/C-9186-2011; del Bas, Josep Maria/K-9310-2019; Arola, Lluís/C-6074-2011; Pallas, Merce/H-3129-2016	cigarroa, igor/0000-0003-0418-8787; del Bas, Josep M/0000-0002-0700-2004; Escorihuela, Rosa M/0000-0001-9368-5173; Capdevila, Lluis/0000-0002-7319-4745; F. Lalanza, Jaume/0000-0003-2481-2188; del Bas, Josep Maria/0000-0002-0700-2004; Arola, Lluís/0000-0003-2767-1974; Pallas, Merce/0000-0003-3095-4254; Caimari, Antoni/0000-0001-6144-0294	Spanish Ministry of Economy and Competitiveness [PSI 2011-29807-C02/PSIC]; ACC1O [TECRD11-1-0012]; European Union [244995]; Generalitat de Catalunya [FI-DGR 2011]; Universidad Santo Tomas de Chile	Spanish Ministry of Economy and Competitiveness(Spanish Government); ACC1O; European Union(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Universidad Santo Tomas de Chile	The research leading to these results has received funding from the Spanish Ministry of Economy and Competitiveness (PSI 2011-29807-C02/PSIC), ACC1O (TECRD11-1-0012) and the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement nu 244995 (BIOCLAIMS Project). JFL received a fellowship from the Generalitat de Catalunya (FI-DGR 2011) and IC received a fellowship from the Universidad Santo Tomas de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsio J, 2009, GENES BRAIN BEHAV, V8, P193, DOI 10.1111/j.1601-183X.2008.00464.x; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Bennett J, 2013, APPETITE, V60, P187, DOI 10.1016/j.appet.2012.09.023; Benton D, 2010, CLIN NUTR, V29, P288, DOI 10.1016/j.clnu.2009.12.001; Buchenauer T, 2009, PHYSIOL BEHAV, V98, P563, DOI 10.1016/j.physbeh.2009.09.003; Caimari A, 2010, INT J OBESITY, V34, P831, DOI 10.1038/ijo.2010.17; Canetti L, 2002, BEHAV PROCESS, V60, P157, DOI 10.1016/S0376-6357(02)00082-7; Cooper SJ, 2005, APPETITE, V44, P133, DOI 10.1016/j.appet.2005.01.003; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Fernandez-Teruel A, 2002, PHARMACOL BIOCHEM BE, V73, P225, DOI 10.1016/S0091-3057(02)00784-0; FILE SE, 1980, J NEUROSCI METH, V2, P219, DOI 10.1016/0165-0270(80)90012-6; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Iemolo A, 2013, NEUROPSYCHOPHARMACOL, V38, P2456, DOI 10.1038/npp.2013.147; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Krolow R, 2010, APPETITE, V55, P108, DOI 10.1016/j.appet.2010.03.013; Krolow R, 2013, METABOLISM, V62, P1268, DOI 10.1016/j.metabol.2013.04.009; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; Lukkes JL, 2009, HORM BEHAV, V55, P248, DOI 10.1016/j.yhbeh.2008.10.014; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P717, DOI 10.1016/j.psyneuen.2009.10.013; Martire SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060407; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mela V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048915; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ong ZY, 2013, APPETITE, V65, P189, DOI 10.1016/j.appet.2013.01.014; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019; Pickering C, 2009, PSYCHOPHARMACOLOGY, V204, P431, DOI 10.1007/s00213-009-1474-y; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Quesada H, 2009, INT J OBESITY, V33, P1007, DOI 10.1038/ijo.2009.136; Ribot J, 2008, OBESITY, V16, P723, DOI 10.1038/oby.2008.113; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Rodriguez AM, 2001, OBES RES, V9, P579, DOI 10.1038/oby.2001.75; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Ros-Simo C, 2012, PHARMACOL BIOCHEM BE, V102, P434, DOI 10.1016/j.pbb.2012.06.001; Sagae SC, 2012, PHYSIOL BEHAV, V105, P1104, DOI 10.1016/j.physbeh.2011.12.002; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Shafat A, 2009, APPETITE, V52, P34, DOI 10.1016/j.appet.2008.07.004; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; van Vliet M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-106; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Zeeni N, 2013, STRESS, V16, P211, DOI 10.3109/10253890.2012.708952	55	62	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85049	10.1371/journal.pone.0085049	http://dx.doi.org/10.1371/journal.pone.0085049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24482678	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100052
J	Armstrong, DA; Lesseur, C; Conradt, E; Lester, BM; Marsit, CJ				Armstrong, David A.; Lesseur, Corina; Conradt, Elisabeth; Lester, Barry M.; Marsit, Carmen J.			Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research	FASEB JOURNAL			English	Article						cord blood; epigenetic epidemiology; placenta; saliva	GLUCOCORTICOID-RECEPTOR; CORD BLOOD; IN-UTERO; EPIGENETIC REGULATION; CYTOSINE METHYLATION; TRANSCRIPTION FACTOR; EXPOSURE; BINDING; LEPTIN; EXPRESSION	An increasing number of population studies are assessing epigenetic variation in relation to early-life outcomes in tissues accessible to epidemiologic researchers. Epigenetic mechanisms are highly tissue specific, however, and it is unclear whether the variation observed in one of the tissue types is representative of other sources or whether the variation in DNA methylation is distinct, reflecting potential functional differences across tissues. To assess relations between DNA methylation in various samples from newborns and children in early infancy, we measured promoter or gene-body DNA methylation in matched term placenta, cord blood, and 3-6 mo saliva samples from 27 unrelated infants enrolled in the Rhode Island Child Health Study. We investigated 7 gene loci (KLF15, NR3C1, LEP, DEPTOR, DDIT4, HSD11B2, and CEBPB) and global methylation, using repetitive region LINE-1 and ALUYb8 sequences. We observed a great degree of interlocus, intertissue, and interindividual epigenetic variation in most of the analyzed loci. In correlation analyses, only cord blood NR3C1 promoter methylation correlated negatively with methylation in saliva. We conclude that placenta, cord blood, and saliva cannot be used as a substitute for one another to evaluate DNA methylation at these loci during infancy. Each tissue has a unique epigenetic signature that likely reflects their differential functions. Future studies should consider the uniqueness of these features, to improve epigenetic biomarker discovery and translation.Armstrong, D. A., Lesseur, C., Conradt, E., Lester, B. M., Marsit, C. J. Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research.	[Armstrong, David A.; Lesseur, Corina; Marsit, Carmen J.] Dartmouth Coll, Geisel Sch Med, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Marsit, Carmen J.] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Sect Biostat & Epidemiol, Hanover, NH 03755 USA; [Conradt, Elisabeth; Lester, Barry M.] Brown Alpert Med Sch, Brown Ctr Study Children Risk, Providence, RI USA; [Conradt, Elisabeth; Lester, Barry M.] Brown Univ, Women & Infants Hosp, Providence, RI USA	Dartmouth College; Dartmouth College; Brown University; Brown University; Women & Infants Hospital Rhode Island	Marsit, CJ (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, 7650 Remsen, Hanover, NH 03755 USA.	carmen.j.marsit@dartmouth.edu	Lesseur, Corina/W-1034-2019	Lesseur, Corina/0000-0001-6744-6750; Marsit, Carmen/0000-0003-4566-150X	National Institute of Environmental Health Sciences (NIEHS) [P01 ES022832/EPA RD83544201, R01ES022223]; National Institute of Mental Health (NIMH) [R01MH094609]; U.S. National Institutes of Health (Bethesda, MD, USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022832, R01ES022223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094609] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Joyce Lee (Department of Pediatrics, Women's and Infants Hospital) for her efforts in sample collection and Susan Simon (Media Learning Technologist, Jones Media Center, Dartmouth College Library) for assistance with figure preparation. The study was funded by grants from the National Institute of Environmental Health Sciences (NIEHS; P01 ES022832/EPA RD83544201 and R01ES022223) and the National Institute of Mental Health (NIMH; R01MH094609), U.S. National Institutes of Health (Bethesda, MD, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Appleton AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074691; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Boeke CE, 2012, EPIGENETICS-US, V7, P253, DOI 10.4161/epi.7.3.19082; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Bromer C, 2013, DEV PSYCHOBIOL, V55, P673, DOI 10.1002/dev.21061; Burris HH, 2014, J APPL TOXICOL, V34, P113, DOI 10.1002/jat.2904; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Christensen B. C., 2012, EPIGENETIC EPIDEMIOL, P197; Conradt E, 2013, EPIGENETICS-US, V8, P1321, DOI 10.4161/epi.26634; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7; De Matteis R, 2002, J ANAT, V201, P363, DOI 10.1046/j.0021-8782.2002.00106.x; Eckmann-Scholz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039014; Edelman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048597; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Groom A, 2012, DIABETES, V61, P391, DOI 10.2337/db11-1039; Haggarty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068896; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Herbstman JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072824; Hogg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062969; Hogg K, 2013, MOL CELL ENDOCRINOL, V367, P64, DOI 10.1016/j.mce.2012.12.018; Ikegame T, 2013, NEUROSCI RES, V77, P208, DOI 10.1016/j.neures.2013.08.004; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Kim JH, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-33; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koestler DC, 2013, ENVIRON HEALTH PERSP, V121, P971, DOI 10.1289/ehp.1205925; Lesseur C, 2013, MOL CELL ENDOCRINOL, V381, P160, DOI 10.1016/j.mce.2013.07.024; Marsit C, 2013, ADV EXP MED BIOL, V754, P233, DOI 10.1007/978-1-4419-9967-2_12; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Michels K. B., 2012, EPIGENETIC EPIDEMIOL, P105; Mill J, 2013, NAT REV GENET, V14, P585, DOI 10.1038/nrg3405; Mparmpakas D, 2012, CLIN SCI, V122, P349, DOI 10.1042/CS20110378; Mueller B., 1928, INT J LEGAL MED, V11, P211; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Ng J. W., 2012, GENOME BIOL, V13, P1; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Parle-McDermott A, 2011, ADV NUTR, V2, P463, DOI 10.3945/an.111.001008; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; R Core Team, 2013, LANG ENV STAT COMP; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; SALAHUDDIN SZ, 1981, BLOOD, V58, P931; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tyrka AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030148; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wilhelm-Benartzi CS, 2012, ENVIRON HEALTH PERSP, V120, P296, DOI 10.1289/ehp.1103927	72	59	60	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2088	2097		10.1096/fj.13-238402	http://dx.doi.org/10.1096/fj.13-238402			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24478308	Green Published			2022-12-25	WOS:000335336000013
J	Numata, S; Nagata, M; Mao, H; Sekimizu, K; Kaito, C				Numata, Shunsuke; Nagata, Makiko; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara			CvfA Protein and Polynucleotide Phosphorylase Act in an Opposing Manner to Regulate Staphylococcus aureus Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Genetics; Bacterial Pathogenesis; Ribonuclease; RNA Metabolism; RNA Modification; RNA Processing; Staphylococcus aureus	ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MESSENGER-RNA; GENE; DEGRADATION; EXPRESSION; AGR; ENDORIBONUCLEASE; IDENTIFICATION; BACTERIA	Background: Production of 3-phosphorylated RNA by CvfA affects S. aureus virulence gene expression. Results: Disrupting pnpA-encoding exonuclease suppressed the cvfA-deleted mutant phenotype. Purified PNPase did not degrade 3-phosphorylated RNA. Conclusion: CvfA-produced 3-phosphorylated RNA inhibits PNPase-induced RNA degradation, resulting in hemolysin production by S. aureus. Significance: Altering the nucleotide structure at the RNA 3 terminus regulates S. aureus virulence. We previously identified CvfA (SA1129) as a Staphylococcus aureus virulence factor using a silkworm infection model. S. aureus cvfA-deleted mutants exhibit decreased expression of the agr locus encoding a positive regulator of hemolysin genes and decreased hemolysin production. CvfA protein hydrolyzes a 2,3-cyclic phosphodiester bond at the RNA 3 terminus, producing RNA with a 3-phosphate (3-phosphorylated RNA, RNA with a 3-phosphate). Here, we report that the cvfA-deleted mutant phenotype (decreased agr expression and hemolysin production) was suppressed by disrupting pnpA-encoding polynucleotide phosphorylase (PNPase) with 3- to 5-exonuclease activity. The suppression was blocked by introducing a pnpA-encoding PNPase with exonuclease activity but not by a pnpA-encoding mutant PNPase without exonuclease activity. Therefore, loss of PNPase exonuclease activity suppressed the cvfA-deleted mutant phenotype. Purified PNPase efficiently degraded RNA with 2,3-cyclic phosphate at the 3 terminus (2,3-cyclic RNA), but it inefficiently degraded 3-phosphorylated RNA. These findings indicate that 3-phosphorylated RNA production from 2,3-cyclic RNA by CvfA prevents RNA degradation by PNPase and contributes to the expression of agr and hemolysin genes. We speculate that in the cvfA-deleted mutant, 2,3-cyclic RNA is not converted to the 3-phosphorylated form and is efficiently degraded by PNPase, resulting in the loss of RNA essential for expressing agr and hemolysin genes, whereas in the cvfA/pnpA double-disrupted mutant, 2,3-cyclic RNA is not degraded by PNPase, leading to hemolysin production. These findings suggest that CvfA and PNPase competitively regulate RNA degradation essential for S. aureus virulence.	[Numata, Shunsuke; Nagata, Makiko; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Mochida Memorial Foundation for Medical and Pharmaceutical Research; Genome Pharmaceuticals Institute	Mochida Memorial Foundation for Medical and Pharmaceutical Research; Genome Pharmaceuticals Institute	This work was supported by grants-in-aid for scientific research and in part by the Mochida Memorial Foundation for Medical and Pharmaceutical Research and the Genome Pharmaceuticals Institute.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Anderson Kelsi L, 2009, Int J Microbiol, V2009, P525491, DOI 10.1155/2009/525491; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Beran RK, 2001, MOL MICROBIOL, V39, P112, DOI 10.1046/j.1365-2958.2001.02216.x; Bermudez-Cruz RM, 2005, BIOCHIMIE, V87, P737, DOI 10.1016/j.biochi.2005.03.005; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DRAPER DE, 1977, P NATL ACAD SCI USA, V74, P4786, DOI 10.1073/pnas.74.11.4786; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Hardwick SW, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120028; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Jarrige AC, 2002, J MOL BIOL, V321, P397, DOI 10.1016/S0022-2836(02)00645-9; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Jeong DW, 2012, MOL MICROBIOL, V86, P331, DOI 10.1111/j.1365-2958.2012.08198.x; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Kang SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037367; Kang SO, 2010, INFECT IMMUN, V78, P2754, DOI 10.1128/IAI.01370-09; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Lehnik-Habrink M, 2012, MOL MICROBIOL, V84, P1005, DOI 10.1111/j.1365-2958.2012.08072.x; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Luttinger A, 1996, MOL MICROBIOL, V19, P343, DOI 10.1046/j.1365-2958.1996.380907.x; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; MARKHAM R, 1952, BIOCHEM J, V52, P552, DOI 10.1042/bj0520552; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Matsuo M, 2003, FEMS MICROBIOL LETT, V222, P107, DOI 10.1016/S0378-1097(03)00260-X; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Piazza F, 1996, J BACTERIOL, V178, P5513, DOI 10.1128/jb.178.18.5513-5521.1996; Polissi A, 2003, RES MICROBIOL, V154, P573, DOI 10.1016/S0923-2508(03)00167-0; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Romilly C, 2012, RNA BIOL, V9, P402, DOI 10.4161/rna.20103; Rosenzweig JA, 2005, J BIOL CHEM, V280, P156, DOI 10.1074/jbc.M405662200; Rosenzweig JA, 2007, FEMS MICROBIOL LETT, V270, P255, DOI 10.1111/j.1574-6968.2007.00689.x; Roux CM, 2011, J BACTERIOL, V193, P5520, DOI 10.1128/JB.05485-11; Sambrook J, 2001, MOL CLONING LAB MANU; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wang W, 1996, J BACTERIOL, V178, P2375, DOI 10.1128/jb.178.8.2375-2382.1996; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10; Zangrossi S, 2000, MOL MICROBIOL, V36, P1470, DOI 10.1046/j.1365-2958.2000.01971.x; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	59	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8420	8431		10.1074/jbc.M114.554329	http://dx.doi.org/10.1074/jbc.M114.554329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492613	hybrid, Green Published			2022-12-25	WOS:000333157500034
J	Melo, FR; Vita, F; Berent-Maoz, B; Levi-Schaffer, F; Zabucchi, G; Pejler, G				Melo, Fabio R.; Vita, Francesca; Berent-Maoz, Beata; Levi-Schaffer, Francesca; Zabucchi, Giuliano; Pejler, Gunnar			Proteolytic Histone Modification by Mast Cell Tryptase, a Serglycin Proteoglycan-dependent Secretory Granule Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Histone Modification; Mast Cell; Protease; Proteoglycan; Proteolytic Enzymes; mMCP-6; Secretory Granules; Serglycin; Tryptase	APOPTOSIS; IMMUNITY; DEATH; REGULATORS; TETRAMER	Background: Tryptase is a serglycin proteoglycan-dependent protease localized in mast cell granules. Results: Tryptase was found to degrade core histones, both during apoptosis and in viable cells. Conclusion: A serglycin-tryptase axis is identified as a novel mechanism for histone modification. Significance: Secretory granule compounds are implicated in the regulation of nuclear events. A hallmark feature of mast cells is their high content of cytoplasmic secretory granules filled with various preformed compounds, including proteases of tryptase-, chymase-, and carboxypeptidase A3 type that are electrostatically bound to serglycin proteoglycan. Apart from participating in extracellular processes, serglycin proteoglycan and one of its associated proteases, tryptase, are known to regulate cell death by promoting apoptosis over necrosis. Here we sought to outline the underlying mechanism and identify core histones as primary proteolytic targets for the serglycin-tryptase axis. During the cell death process, tryptase was found to relocalize from granules into the cytosol and nucleus, and it was found that the absence of tryptase was associated with a pronounced accumulation of core histones both in the cytosol and in the nucleus. Intriguingly, tryptase deficiency resulted in defective proteolytic modification of core histones even at baseline conditions, i.e. in the absence of cytotoxic agent, suggesting that tryptase has a homeostatic impact on nuclear events. Indeed, tryptase was found in the nucleus of viable cells and was shown to cleave core histones in their N-terminal tail. Moreover, it was shown that the absence of the serglycin-tryptase axis resulted in altered chromatin composition. Together, these findings implicate histone proteolysis through a secretory granule-derived serglycin-tryptase axis as a novel principle for histone modification, during both cell homeostasis and cell death.	[Melo, Fabio R.; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Vita, Francesca; Zabucchi, Giuliano] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Berent-Maoz, Beata; Levi-Schaffer, Francesca] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Dept Pharmacol, IL-91120 Jerusalem, Israel	Swedish University of Agricultural Sciences; University of Trieste; Hebrew University of Jerusalem	Melo, FR (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Box 575, S-75123 Uppsala, Sweden.	Fabio.Melo@slu.se; Gunnar.Pejler@slu.se	Melo, Fabio Rabelo/GQP-0844-2022	Levi-Schaffer, Francesca/0000-0003-0620-2810	Swedish Research Council; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by grants from The Swedish Research Council (to G. P.) and The Swedish Cancer Foundation (to G.P.).	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GRIFFITHS G, 1986, J HISTOCHEM CYTOCHEM, V34, P1389, DOI 10.1177/34.11.3534077; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Kim JA, 2012, P NATL ACAD SCI USA, V109, P5779, DOI 10.1073/pnas.1203453109; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Melo FR, 2012, J BIOL CHEM, V287, P18142, DOI 10.1074/jbc.M112.344796; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Ronnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Sommerhoff CP, 1999, P NATL ACAD SCI USA, V96, P10984, DOI 10.1073/pnas.96.20.10984; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Teoh SSY, 2010, J BIOL CHEM, V285, P10862, DOI 10.1074/jbc.M109.073171; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; ZABUCCHI G, 1992, BLOOD, V80, P2903	26	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7682	7690		10.1074/jbc.M113.546895	http://dx.doi.org/10.1074/jbc.M113.546895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478313	Green Published, hybrid			2022-12-25	WOS:000332761500036
J	Helfer, M; Koppensteiner, H; Schneider, M; Rebensburg, S; Forcisi, S; Muller, C; Schmitt-Kopplin, P; Schindler, M; Brack-Werner, R				Helfer, Markus; Koppensteiner, Herwig; Schneider, Martha; Rebensburg, Stephanie; Forcisi, Sara; Mueller, Constanze; Schmitt-Kopplin, Philippe; Schindler, Michael; Brack-Werner, Ruth			The Root Extract of the Medicinal Plant Pelargonium sidoides Is a Potent HIV-1 Attachment Inhibitor	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; (-)-EPIGALLOCATECHIN GALLATE; ANTIRETROVIRAL THERAPY; CHEMOKINE RECEPTOR; ENTRY INHIBITORS; REPLICATION; INFECTION; SAFETY; PHARMACOKINETICS; IDENTIFICATION	Global HIV-1 treatment would benefit greatly from safe herbal medicines with scientifically validated novel anti-HIV-1 activities. The root extract from the medicinal plant Pelargonium sidoides (PS) is licensed in Germany as the herbal medicine EPs (R) 7630, with numerous clinical trials supporting its safety in humans. Here we provide evidence from multiple cell culture experiments that PS extract displays potent anti-HIV-1 activity. We show that PS extract protects peripheral blood mononuclear cells and macrophages from infection with various X4 and R5 tropic HIV-1 strains, including clinical isolates. Functional studies revealed that the extract from PS has a novel mode-of-action. It interferes directly with viral infectivity and blocks the attachment of HIV-1 particles to target cells, protecting them from virus entry. Analysis of the chemical footprint of anti-HIV activity indicates that HIV-1 inhibition is mediated by multiple polyphenolic compounds with low cytotoxicity and can be separated from other extract components with higher cytotoxicity. Based on our data and its excellent safety profile, we propose that PS extract represents a lead candidate for the development of a scientifically validated herbal medicine for anti-HIV-1 therapy with a mode-of-action different from and complementary to current single-molecule drugs.	[Helfer, Markus; Koppensteiner, Herwig; Schneider, Martha; Rebensburg, Stephanie; Schindler, Michael; Brack-Werner, Ruth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany; [Forcisi, Sara; Mueller, Constanze; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Analyt BioGeoChem, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Brack-Werner, R (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany.	brack@helmholtz-muenchen.de	Brack-Werner, Ruth/M-4615-2014; Schindler, Michael/C-1647-2015; Schmitt-Kopplin, Philippe/H-6271-2011	Brack-Werner, Ruth/0000-0002-8651-9318; Schindler, Michael/0000-0001-8989-5813; Schmitt-Kopplin, Philippe/0000-0003-0824-2664	Helmholtz Zentrum Munchen	Helmholtz Zentrum Munchen(Helmholtz Association)	Financial support for this study was provided by intramural funding of the Helmholtz Zentrum Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo USDoHaHSH, 2012, HIV ITS TREATM FDA A; Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10; Brendler T, 2008, J ETHNOPHARMACOL, V119, P420, DOI 10.1016/j.jep.2008.07.037; Cordell GA, 2012, J NAT PROD, V75, P514, DOI 10.1021/np200803m; Cos P, 2008, PLANTA MED, V74, P1323, DOI 10.1055/s-2008-1081314; Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; De Clercq E, 2009, REV MED VIROL, V19, P287, DOI 10.1002/rmv.624; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Forcisi S, 2013, J CHROMATOGR A, V1292, P51, DOI 10.1016/j.chroma.2013.04.017; Francois K, 2010, MED RES REV, V32, P349; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Fuss IJ., 2009, CURRENT PROTOCOLS IM; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Gibson RM, 2012, CURR HIV RES, V10, P19, DOI 10.2174/157016212799304616; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Hawkins T, 2010, ANTIVIR RES, V85, P201, DOI 10.1016/j.antiviral.2009.10.016; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hertje M, 2010, CHEMMEDCHEM, V5, P1825, DOI 10.1002/cmdc.201000292; Huskens D, 2012, MAR DRUGS, V10, P1476, DOI 10.3390/md10071476; Jones J, 2007, BIOTECHNIQUES, V43, P589, DOI 10.2144/000112624; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kolodziej H, 2007, PHYTOMEDICINE, V14, P9, DOI 10.1016/j.phymed.2006.11.021; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Kremb S, 2010, ANTIMICROB AGENTS CH, V54, P5257, DOI 10.1128/AAC.00515-10; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; Magalhaes PJ, 2010, J CHROMATOGR A, V1217, P3258, DOI 10.1016/j.chroma.2009.10.068; Marcus KA, 2012, CURR OPIN HIV AIDS, V7, P292, DOI 10.1097/COH.0b013e328354dcac; Michaelis M, 2011, PHYTOMEDICINE, V18, P384, DOI 10.1016/j.phymed.2010.09.008; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Mukhtar M, 2008, VIRUS RES, V131, P111, DOI 10.1016/j.virusres.2007.09.008; Overy DP, 2008, NAT PROTOC, V3, P471, DOI 10.1038/nprot.2007.512; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Schnitzler P, 2008, PHYTOMEDICINE, V15, P1108, DOI 10.1016/j.phymed.2008.06.009; Singh IP, 2010, NAT PROD REP, V27, P1781, DOI 10.1039/c0np00025f; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Stadeli KM, 2012, ANTIVIRAL THERAPY; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Theisen LL, 2012, ANTIVIRAL RES; Timmer A, 2008, COCHRANE DATABASE SY, V3; Vella S, 2012, AIDS, V26, P1231, DOI 10.1097/QAD.0b013e32835521a3; Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9; Yang J, 2011, FITOTERAPIA	48	49	53	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87487	10.1371/journal.pone.0087487	http://dx.doi.org/10.1371/journal.pone.0087487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489923	gold, Green Submitted, Green Published			2022-12-25	WOS:000330570000150
J	Jani, PK; Kajdacsi, E; Megyeri, M; Dobo, J; Doleschall, Z; Futosi, K; Timar, CI; Mocsai, A; Mako, V; Gal, P; Cervenak, L				Jani, Peter K.; Kajdacsi, Erika; Megyeri, Marton; Dobo, Jozsef; Doleschall, Zoltan; Futosi, Krisztina; Timar, Csaba I.; Mocsai, Attila; Mako, Veronika; Gal, Peter; Cervenak, Laszlo			MASP-1 Induces a Unique Cytokine Pattern in Endothelial Cells: A Novel Link between Complement System and Neutrophil Granulocytes	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SERINE PROTEASE-1 MASP-1; NF-KAPPA-B; LECTIN-PATHWAY; KINASE PATHWAYS; ACTIVATION; EXPRESSION; GENE; INTERLEUKIN-8; INITIATION	Microbial infection urges prompt intervention by the immune system. The complement cascade and neutrophil granulocytes are the predominant contributors to this immediate anti-microbial action. We have previously shown that mannan-binding lectin-associated serine protease-1 (MASP-1), the most abundant enzyme of the complement lectin pathway, can induce p38-MAPK activation, NFkappaB signaling, and Ca2+-mobilization in endothelial cells. Since neutrophil chemotaxis and transmigration depends on endothelial cell activation, we aimed to explore whether recombinant MASP-1 (rMASP-1) is able to induce cytokine production and subsequent neutrophil chemotaxis in human umbilical vein endothelial cells (HUVEC). We found that HUVECs activated by rMASP-1 secreted IL-6 and IL-8, but not IL-1alpha, IL-1ra, TNFalpha and MCP-1. rMASP-1 induced dose-dependent IL-6 and IL-8 production with different kinetics. rMASP-1 triggered IL-6 and IL-8 production was regulated predominantly by the p38-MAPK pathway. Moreover, the supernatant of rMASP-1-stimulated HUVECs activated the chemotaxis of neutrophil granulocytes as an integrated effect of cytokine production. Our results implicate that besides initializing the complement lectin pathway, MASP-1 may activate neutrophils indirectly, via the endothelial cells, which link these effective antimicrobial host defense mechanisms.	[Jani, Peter K.; Kajdacsi, Erika; Mako, Veronika; Cervenak, Laszlo] Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary; [Megyeri, Marton; Dobo, Jozsef; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Doleschall, Zoltan] Natl Inst Oncol, Dept Pathogenet, Budapest, Hungary; [Futosi, Krisztina; Timar, Csaba I.; Mocsai, Attila] Semmelweis Univ, Sch Med, Dept Physiol, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; National Institute of Oncology Hungary; Semmelweis University	Jani, PK (corresponding author), Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary.	jani.peter@med.semmelweis-univ.hu	Timar, Csaba/N-9948-2017; Dobo, Jozsef/C-7331-2014; Mocsai, Attila/B-2792-2008; Cervenak, Laszlo/F-1672-2010; Gal, Peter/B-5886-2011	Kajdacsi, Erika/0000-0003-0739-2193; Cervenak, Laszlo/0000-0003-0166-8697; Futosi, Krisztina/0000-0002-1661-4635; Timar, Csaba/0000-0001-8472-0897; Mocsai, Attila/0000-0002-0512-1157; Dobo, Jozsef/0000-0001-9187-8502	'Janos Bolyai' Research Fellowship of the Hungarian Academy of Sciences [BO/00218/10]; Hungarian Scientific Research Fund (OTKA) [K100684, K75084, K81277, NK100834, NK77978]; European Research Council (Starting Independent Investigator [206283]; Wellcome Trust [087782]; 'Jedlik Anyos' [TAMOP 4.2.4.A/1-11-1-2012-0001]	'Janos Bolyai' Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Research Council (Starting Independent Investigator; Wellcome Trust(Wellcome TrustEuropean Commission); 'Jedlik Anyos'	This work was supported by 'Janos Bolyai' Research Fellowship of the Hungarian Academy of Sciences to L. C. (research fellowship number BO/00218/10, http://mta.hu/osztondijak); and grants No. K100684 (to L. C.), K75084 and K81277 (to E. L.), NK100834 and NK77978 (to P. G.) from The Hungarian Scientific Research Fund (OTKA, http://www.otka.hu/en); grant No. 206283 (to A. M.) from European Research Council (Starting Independent Investigator, http://erc.europa.eu). A. M. is also a recipient of International Senior Research Fellowships (087782) of the Wellcome Trust(http://www.wellcome.ac.uk/). K. F. is a recipient of 'Jedlik Anyos' predoctoral fellowship (TAMOP 4.2.4.A/1-11-1-2012-0001, http://www.nfu.hu/?lang= en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Cherla RP, 2006, J LEUKOCYTE BIOL, V79, P397, DOI 10.1189/jlb.0605313; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Dobo J, 2008, ACTA CRYSTALLOGR F, V64, P781, DOI 10.1107/S174430910802294X; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Futosi K, 2012, BLOOD, V119, P4981, DOI 10.1182/blood-2011-07-369041; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Hippenstiel S, 2000, BLOOD, V95, P3044; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; LUKACS NW, 1995, BLOOD, V86, P2767; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Megyeri M, 2013, J BIOL CHEM, V288, P8922, DOI 10.1074/jbc.M112.446500; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Niu QX, 2008, CLIN EXP PHARMACOL P, V35, P89, DOI 10.1111/j.1440-1681.2007.04755.x; Oie CI, 2011, J HEPATOL, V55, P1346, DOI 10.1016/j.jhep.2011.03.013; Oroszlan M, 2006, INT IMMUNOL, V18, P871, DOI 10.1093/intimm/dxl023; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; SHREENIWAS R, 1992, J CLIN INVEST, V90, P2333, DOI 10.1172/JCI116122; Storm D, 1997, J BIOL CHEM, V272, P31043, DOI 10.1074/jbc.272.49.31043; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Szabo-Fresnais N, 2008, MOL CELL ENDOCRINOL, V284, P28, DOI 10.1016/j.mce.2007.12.017; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; Yuen DYC, 2009, DIABETES, V58, P1086, DOI 10.2337/db08-0775	42	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87104	10.1371/journal.pone.0087104	http://dx.doi.org/10.1371/journal.pone.0087104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489848	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000330570000104
J	Jonas, JB; Wang, NL; Wang, YX; You, QS; Xie, XB; Yang, DY; Xu, L				Jonas, Jost B.; Wang, Ningli; Wang, Ya Xing; You, Qi Sheng; Xie, Xiaobin; Yang, Diya; Xu, Liang			Body Height, Estimated Cerebrospinal Fluid Pressure and Open-Angle Glaucoma. The Beijing Eye Study 2011	PLOS ONE			English	Article							OCULAR DIMENSIONS; ADULT-POPULATION; LAMINA-CRIBROSA; MASS INDEX; TANJONG PAGAR; PARAMETERS; STATURE; CHINA; ASSOCIATIONS; PREVALENCE	Purpose: To examine potential associations between body height, cerebrospinal fluid pressure (CSFP), trans-lamina cribrosa pressure difference (TLCPD) and prevalence of open-angle glaucoma (OAG) in a population-based setting. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6+/-9.8 years (range: 50-93 years). A detailed ophthalmic examination was performed. Based on a previous study with lumbar cerebrospinal fluid pressure (CSFP) measurements, CSFP was calculated as CSFP[mmHg] = 0.44xBody Mass Index[kg/m(2)]+0.16xDiastolic Blood Pressure[mmHg]-0.18xAge[Years]-1.91 Results: Data of IOP and CSFP were available for 3353 (96.7%) subjects. Taller body height was associated with higher CSFP (P < 0.001; standardized correlation coefficient beta: 0.13; regression coefficient B:0.29; 95% confidence interval (CI): 0.25,0.33) after adjusting for male gender, urban region of habitation, higher educational level, and pulse rate. If TLCPD instead of CSFP was added, taller body height was associated with lower TLCPD (P < 0.001; beta: -0.10; B: -0.20; 95% CI: -0.25,-0.15). Correspondingly, higher CSFP was associated with taller body height (P = 0.003; beta: 0.02;B:0.01;95%CI:0.00,0.02), after adjusting for age, gender, body mass index, pulse, systolic blood pressure, and blood concentration of cholesterol. If IOP was added to the model, higher CSFP was associated with higher IOP (P < 0.001; beta: 0.02; B: 0.02; 95% CI: 0.01,0.03). TLCPD was associated with lower body height (P = 0.003; beta: -0.04; B -0.02,95%CI:-0.04,-0.01) after adjusting for age, body mass index, systolic blood pressure, pulse, blood concentrations of triglycerides, axial length, central corneal thickness, corneal curvature radius, and anterior chamber depth. Adding the prevalence of OAG to the multivariate analysis revealed, that taller body height was associated with a lower OAG prevalence (P = 0.03; beta:-0.03;B:-1.20; 95% CI:-2.28,-0.12) after adjusting for educational level and gender. Conclusions: Taller body height was associated with higher CSFP and lower TLCPD (and vice versa), after adjusting for systemic and ocular parameters. Parallel to the associations between a higher prevalence of glaucoma with a lower CSFP or higher TLCPD, taller body height was associated with a lower prevalence of OAG.	[Jonas, Jost B.; Wang, Ya Xing; You, Qi Sheng; Xu, Liang] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany; [Wang, Ningli; Xie, Xiaobin; Yang, Diya] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Xu, L (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio@yahoo.cn	You, Qisheng/AAG-7153-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China [81770890]; Beijing NOVA Program [2011058]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Program(Beijing Municipal Science & Technology Commission); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	This work was supported by National Natural Science Foundation of China 81770890; Beijing NOVA Program 2011058 and by National Key Technology R&D Program of the Ministry of Science and Technology (No. 2012BAH05F05 and 2013BAH19F04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bourne RRA, 2008, BRIT J OPHTHALMOL, V92, P310, DOI 10.1136/bjo.2007.123349; Chang L, 2009, EYE, V23, P1775, DOI 10.1038/eye.2008.375; Eysteinsson T, 2005, ACTA OPHTHALMOL SCAN, V83, P734, DOI 10.1111/j.1600-0420.2005.00540.x; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Nangia V, 2010, GRAEF ARCH CLIN EXP, V248, P1657, DOI 10.1007/s00417-010-1448-0; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1237; Wu HM, 2007, CLIN EXP OPHTHALMOL, V35, P834, DOI 10.1111/j.1442-9071.2007.01638.x; Xie XW, 2009, GRAEF ARCH CLIN EXP, V247, P1651, DOI 10.1007/s00417-009-1161-z; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2007, ACTA OPHTHALMOL SCAN, V85, P914, DOI 10.1111/j.1600-0420.2007.00966.x; Xu L, 2011, ACTA OPHTHALMOL, V89, P442, DOI 10.1111/j.1755-3768.2009.01734.x; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470	26	36	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86678	10.1371/journal.pone.0086678	http://dx.doi.org/10.1371/journal.pone.0086678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489767	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000059
J	Lu, XL; Li, Y; Wang, WQ; Chen, SC; Liu, T; Jia, D; Quan, XP; Sun, DL; Chang, AK; Gao, B				Lu, Xiuli; Li, Yang; Wang, Weiqi; Chen, Shuchao; Liu, Ting; Jia, Dan; Quan, Xiaoping; Sun, Deliang; Chang, Alan K.; Gao, Bing			3 beta-Hydroxysteroid-Delta 24 Reductase (DHCR24) Protects Neuronal Cells from Apoptotic Cell Death Induced by Endoplasmic Reticulum (ER) Stress	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; INSULIN; MECHANISMS; SELADIN-1; IMPAIRMENT; EXPRESSION; CAVEOLAE; RECEPTOR; HOMOLOG	3 beta-Hydroxysteroid-Delta 24 reductase (DHCR24) is an endoplasmic reticulum (ER)-localized multifunctional enzyme that possesses anti-apoptotic and cholesterol-synthesizing activities. Accumulating evidence suggests that ER stress is involved in the pathogenesis of neurodegenerative disease. In this study, we investigated whether DHCR24 may function as a neuroprotective protein under ER stress. Neuroblastoma N2A cells were infected with adenovirus expressing myc-tagged DHCR24 (Ad-DHCR24) or lacZ (Ad-lacZ, serving as a control) and subjected to ER-stress, induced with Tunicamycin (TM). Cells infected with Ad-DHCR24-myc were resistant to TM-induced apoptosis, and showed weaker level of caspase-12 activity. These cells also exhibited lower levels of Bip and CHOP proteins than Ad-LacZ-infected cells. Moreover, a stronger and rapid activation of PERK, and a prolonged activation of JNK and p38 were observed in Ad-LacZ-infected cells. The generation of intracellular reactive oxygen species from ER stress was also diminished by the overexpression of DHCR24. Additionally, intracellular cholesterol level was also elevated in the Ad-DHCR24-infected cells, accompanied by a well-organized formation of caveolae (cholesterol-rich microdomain) on the plasma membrane, and improved colocalization of caveolin-1 and insulin-like growth factor 1 receptor. These results demonstrated for the first time that DHCR24 could protect neuronal cells from apoptosis induced by ER stress.	[Lu, Xiuli; Li, Yang; Wang, Weiqi; Chen, Shuchao; Liu, Ting; Jia, Dan; Quan, Xiaoping; Sun, Deliang; Chang, Alan K.] Liaoning Univ, Sch Life Sci, Shenyang 110036, Peoples R China; [Gao, Bing] Shenyang Med Coll, Sch Basic Med Sci, Shenyang, Peoples R China	Liaoning University; Shenyang Medical College	Lu, XL (corresponding author), Liaoning Univ, Sch Life Sci, Shenyang 110036, Peoples R China.	luxiulidr@gmail.com; gaobingdr@gmail.com		Lu, Xiuli/0000-0003-4267-1112	National Natural Science Foundation of China [31271494]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China to Q. C. (No. 31271494) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dandona P, 2011, J CLIN ENDOCR METAB, V96, P1783, DOI 10.1210/jc.2010-2961; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Fujita E, 2002, CELL DEATH DIFFER, V9, P1108, DOI 10.1038/sj.cdd.4401080; Gasparini L, 2003, TRENDS NEUROSCI, V26, P404, DOI 10.1016/S0166-2236(03)00163-2; Greeve I, 2000, J NEUROSCI, V20, P7345; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huo HR, 2003, J BIOL CHEM, V278, P11561, DOI 10.1074/jbc.M211785200; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Kondo T., 2013, CELL STEM CELL; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lamsa R, 2007, AM J MED GENET B, V144B, P906, DOI 10.1002/ajmg.b.30532; Lu X, 2008, EXP CELL RES, V314, P342, DOI 10.1016/j.yexcr.2007.10.013; Lu X, 2008, ENDOCRINOLOGY, V149, P3267, DOI 10.1210/en.2008-0024; Lu XL, 2006, ENDOCRINOLOGY, V147, P3123, DOI 10.1210/en.2005-1426; Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sarkar D, 2001, J CLIN ENDOCR METAB, V86, P5130, DOI 10.1210/jc.86.11.5130; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharpe LJ, 2012, J ALZHEIMERS DIS, V30, P35, DOI 10.3233/JAD-2012-111955; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Vanmierlo T, 2010, J ALZHEIMERS DIS, V19, P117, DOI 10.3233/JAD-2010-1209; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	41	24	26	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86753	10.1371/journal.pone.0086753	http://dx.doi.org/10.1371/journal.pone.0086753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489783	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000069
J	Maurya, SR; Mahalakshmi, R				Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan			Influence of Protein - Micelle Ratios and Cysteine Residues on the Kinetic Stability and Unfolding Rates of Human Mitochondrial VDAC-2	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; OUTER-MEMBRANE PROTEIN; BETA-BARREL; THERMODYNAMIC STABILITY; STRUCTURAL STABILITY; LIPID INTERACTIONS; PARALLEL PATHWAYS; APOPTOSIS; ISOFORMS; DYNAMICS	Delineating the kinetic and thermodynamic factors which contribute to the stability of transmembrane beta-barrels is critical to gain an in-depth understanding of membrane protein behavior. Human mitochondrial voltage-dependent anion channel isoform 2 (hVDAC-2), one of the key anti-apoptotic eukaryotic beta-barrel proteins, is of paramount importance, owing to its indispensable role in cell survival. We demonstrate here that the stability of hVDAC-2 bears a strong kinetic contribution that is dependent on the absolute micellar concentration used for barrel folding. The refolding efficiency and ensuing stability is sensitive to the lipid-to-protein (LPR) ratio, and displays a non-linear relationship, with both low and high micellar amounts being detrimental to hVDAC-2 structure. Unfolding and aggregation process are sequential events and show strong temperature dependence. We demonstrate that an optimal lipid-to-protein ratio of 2600:1 - 13000:1 offers the highest protection against thermal denaturation. Activation energies derived only for lower LPRs are similar to 17 kcal mol(-1) for full-length hVDAC-2 and similar to 23 kcal mol(-1) for the Cys-less mutant, suggesting that the nine cysteine residues of hVDAC-2 impart additional malleability to the barrel scaffold. Our studies reveal that cysteine residues play a key role in the kinetic stability of the protein, determine barrel rigidity and thereby give rise to strong micellar association of hVDAC-2. Non-linearity of the Arrhenius plot at high LPRs coupled with observation of protein aggregation upon thermal denaturation indicates that contributions from both kinetic and thermodynamic components stabilize the 19-stranded beta-barrel. Lipid-protein interaction and the linked kinetic contribution to free energy of the folded protein are together expected to play a key role in hVDAC-2 recycling and the functional switch at the onset of apoptosis.	[Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India.	maha@iiserb.ac.in	Mahalakshmi, Radhakrishnan/B-3143-2008; Maurya, Svetlana/H-3664-2018	Mahalakshmi, Radhakrishnan/0000-0003-1549-7550; Maurya, Svetlana/0000-0002-4700-2711	Department of Biotechnology (DBT), Govt. of India [BT/01/IYBA/2009]; Council of Scientific and Industrial Research, India; DBT, Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); DBT, Govt. of India(Department of Biotechnology (DBT) India)	This work is supported by the Department of Biotechnology (DBT), Govt. of India award number BT/01/IYBA/2009. S.R.M. is supported by a senior research fellowship from Council of Scientific and Industrial Research, India. R. M. is a recipient of the Ramalingaswami Fellowship from DBT, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y; Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Chaturvedi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079351; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 1996, Ion Channels, V4, P169; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Eddy MT, 2012, J AM CHEM SOC, V134, P6375, DOI 10.1021/ja300347v; Garbuzynskiy SO, 2013, P NATL ACAD SCI USA, V110, P147, DOI 10.1073/pnas.1210180110; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Huysmans GHM, 2012, J MOL BIOL, V416, P453, DOI 10.1016/j.jmb.2011.12.039; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jayaraman S, 2005, BIOPHYS J, V88, P2907, DOI 10.1529/biophysj.104.055921; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Palazzo G, 2010, BBA-PROTEINS PROTEOM, V1804, P137, DOI 10.1016/j.bbapap.2009.09.021; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saccone C, 2003, J MOL EVOL, V57, pS277, DOI 10.1007/s00239-003-0037-9; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f; Schlebach JP, 2012, PROTEIN SCI, V21, P97, DOI 10.1002/pro.766; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Shoshan-Barmatz V, 2013, PROG MOL BIOL TRANSL, V117, P303, DOI 10.1016/B978-0-12-386931-9.00011-8; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; Tan EHL, 1996, BIOPHYS J, V70, P2385, DOI 10.1016/S0006-3495(96)79806-5; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859	56	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87701	10.1371/journal.pone.0087701	http://dx.doi.org/10.1371/journal.pone.0087701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24494036	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000171
J	Park, S; Park, MS; Jung, KH; Song, J; Kim, YA; Cho, HJ; Min, BI; Bae, H				Park, Soojin; Park, Min-Sun; Jung, Kyung-Hwa; Song, Joohyun; Kim, You Ah; Cho, Hi Jae; Min, Byung-Il; Bae, Hyunsu			Treatment with Pyranopyran-1, 8-Dione Attenuates Airway Responses in Cockroach Allergen Sensitized Asthma in Mice	PLOS ONE			English	Article							UNRESTRAINED PLETHYSMOGRAPHY; INHALED CORTICOSTEROIDS; STRUCTURAL-CHANGES; IL-4 RECEPTOR; MODEL; INFLAMMATION; CHILDREN; DISEASE; CELLS; RESPONSIVENESS	Chronic allergic asthma is characterized by Th2-typed inflammation, and contributes to airway remodeling and the deterioration of lung function. Viticis Fructus (VF) has long been used in China and Korea as a traditional herbal remedy for treating various inflammatory diseases. Previously, we have isolated a novel phytochemical, pyranopyran-1, 8-dione (PPY), from VF. This study was conducted to evaluate the ability of PPY to prevent airway inflammation and to attenuate airway responses in a cockroach allergen-induced asthma model in mice. The mice sensitized to and challenged with cockroach allergen were treated with oral administration of PPY. The infiltration of total cells, eosinophils and lymphocytes into the BAL fluid was significantly inhibited in cockroach allergen-induced asthma mice treated with PPY (1, 2, or 10 mg/kg). Th2 cytokines and chemokine, such as IL-4, IL-5, IL-13 and eotaxin in BAL fluid were also reduced to normal levels following treatment with PPY. In addition, the levels of IgE were also markedly suppressed after PPY treatment. Histopathological examination demonstrated that PPY substantially inhibited eosinophil infiltration into the airway, goblet cell hyperplasia and smooth muscle hypertrophy. Taken together, these results demonstrate that PPY possesses a potent efficacy on controlling allergic asthma response such as airway inflammation and remodeling.	[Park, Soojin; Jung, Kyung-Hwa; Song, Joohyun; Bae, Hyunsu] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Park, Min-Sun; Min, Byung-Il] Kyung Hee Univ, Dept East West Med, Seoul, South Korea; [Kim, You Ah; Cho, Hi Jae] Korea Promot Inst Tradit Med Ind, Dept Nat Prod, Kyungbuk, South Korea	Kyung Hee University; Kyung Hee University	Bae, H (corresponding author), Kyung Hee Univ, Coll Korean Med, Seoul, South Korea.	hbae@khu.ac.kr	JUNG, KYOUNGHWA/AAL-3317-2021; Bae, Hyunsu/ABH-6248-2020	Bae, Hyunsu/0000-0002-0299-3582; Kim, You Ah/0000-0002-6744-2490	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0006220]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (No. 2011-0006220). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Michael J, 2003, Am J Respir Med, V2, P287; Adler A, 2004, J APPL PHYSIOL, V97, P286, DOI 10.1152/japplphysiol.00821.2003; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; BARNES PJ, 1993, AM REV RESPIR DIS, V148, pS1, DOI 10.1164/ajrccm/148.4_Pt_2.S1; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Bergeron C, 2006, CHEST, V129, P1068, DOI 10.1378/chest.129.4.1068; Berlin AA, 2005, AM J RESP CRIT CARE, V171, P35, DOI 10.1164/rccm.200403-385OC; Blaeser F, 2003, J EXP MED, V198, P1189, DOI 10.1084/jem.20030471; Busse PJ, 2010, ANN ALLERG ASTHMA IM, V104, P236, DOI 10.1016/j.anai.2009.12.006; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Choi MS, 2013, CYTOKINE, V61, P256, DOI 10.1016/j.cyto.2012.10.005; Ci XX, 2012, INFLAMM RES, V61, P749, DOI 10.1007/s00011-012-0470-6; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Corry DB, 2002, NAT REV DRUG DISCOV, V1, P55, DOI 10.1038/nrd702; Finn PW, 2000, J ALLERGY CLIN IMMUN, V105, P933, DOI 10.1067/mai.2000.106546; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Gorman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067823; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kariyawasam HH, 2007, CURR OPIN IMMUNOL, V19, P681, DOI 10.1016/j.coi.2007.07.021; Katherine L., 2011, PHARMACOTHERAPY; Kelly HW, 2003, J ALLERGY CLIN IMMUN, V112, P469, DOI 10.1067/mai.2003.1718; Kim DY, 2011, J ETHNOPHARMACOL, V136, P230, DOI 10.1016/j.jep.2011.04.048; Kim J, 2007, J ETHNOPHARMACOL, V114, P186, DOI 10.1016/j.jep.2007.07.038; Kim SR, 2013, J ALLERGY CLIN IMMUN; Kips JC, 2001, EUR RESPIR J, V18, p24S, DOI 10.1183/09031936.01.00229601; Korenblat PE, 2001, ANN ALLERG ASTHMA IM, V86, P31, DOI 10.1016/S1081-1206(10)62309-5; Laviolette M, 1999, AM J RESP CRIT CARE, V160, P1862, DOI 10.1164/ajrccm.160.6.9803042; Lederlin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048493; Lee HD, 2010, EXP MECH, V50, P661, DOI 10.1007/s11340-009-9245-6; Lee H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/769830; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P205, DOI 10.4168/aair.2011.3.3.205; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Lundblad LKA, 2002, J APPL PHYSIOL, V93, P1198, DOI 10.1152/japplphysiol.00080.2002; LUNDGREN JD, 1990, J ALLERGY CLIN IMMUN, V85, P399, DOI 10.1016/0091-6749(90)90147-V; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; Mcgee HS, 2009, AM J RESP CRIT CARE, V180, P211, DOI 10.1164/rccm.200809-1505OC; Nagai T, 2004, INT IMMUNOPHARMACOL, V4, P1353, DOI 10.1016/j.intimp.2004.05.021; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; Oh BG, 2009, PHYTOMEDICINE, V16, P814, DOI 10.1016/j.phymed.2009.01.009; Patterson ML, 2002, CLIN EXP ALLERGY, V32, P721, DOI 10.1046/j.1365-2222.2002.01397.x; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Pease James E., 2001, Current Opinion in Pharmacology, V1, P248, DOI 10.1016/S1471-4892(01)00044-3; RENZ H, 1995, INT ARCH ALLERGY IMM, V106, P46, DOI 10.1159/000236889; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Royce SG, 2012, ARCH IMMUNOL THER EX, V60, P295, DOI 10.1007/s00005-012-0180-3; SAETTA M, 1991, AM REV RESPIR DIS, V143, P138, DOI 10.1164/ajrccm/143.1.138; Scalabrin DMF, 1996, J ASTHMA, V33, P407, DOI 10.3109/02770909609068185; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Shin TY, 2000, J ETHNOPHARMACOL, V72, P443, DOI 10.1016/S0378-8741(00)00258-0; Tanaka H, 2000, CLIN EXP ALLERGY, V30, P874; Tsujiyama I, 2013, ORIENTAL PHARM EXP M, V13, P175, DOI 10.1007/s13596-012-0093-z; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142	70	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87558	10.1371/journal.pone.0087558	http://dx.doi.org/10.1371/journal.pone.0087558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489937	Green Submitted, gold, Green Published			2022-12-25	WOS:000330570000158
J	Sommer, B; Waege, I; Pollmann, D; Seitz, T; Thomm, M; Sterner, R; Hausner, W				Sommer, Bettina; Waege, Ingrid; Poellmann, David; Seitz, Tobias; Thomm, Michael; Sterner, Reinhard; Hausner, Winfried			Activation of a Chimeric Rpb5/RpoH Subunit Using Library Selection	PLOS ONE			English	Article							RNA-POLYMERASE-II; SITE-DIRECTED MUTAGENESIS; VIRUS X-PROTEIN; IN-VIVO; ARCHAEAL TRANSCRIPTION; COMPLEX STRUCTURE; CRYSTAL-STRUCTURE; RPB5; YEAST; ENZYME	Rpb5 is a general subunit of all eukaryotic RNA polymerases which consists of a N-terminal and a C-terminal domain. The corresponding archaeal subunit RpoH contains only the conserved C-terminal domain without any N-terminal extensions. A chimeric construct, termed rp5H, which encodes the N-terminal yeast domain and the C-terminal domain from Pyrococcus furiosus is unable to complement the lethal phenotype of a yeast rpb5 deletion strain (Delta rpb5). By applying a random mutagenesis approach we found that the amino acid exchange E197K in the C-terminal domain of the chimeric Rp5H, either alone or with additional exchanges in the N-terminal domain, leads to heterospecific complementation of the growth deficiency of Delta rpb5. Moreover, using a recently described genetic system for Pyrococcus we could demonstrate that the corresponding exchange E62K in the archaeal RpoH subunit alone without the eukaryotic N-terminal extension was stable, and growth experiments indicated no obvious impairment in vivo. In vitro transcription experiments with purified RNA polymerases showed an identical activity of the wild type and the mutant Pyrococcus RNA polymerase. A multiple alignment of RpoH sequences demonstrated that E62 is present in only a few archaeal species, whereas the great majority of sequences within archaea and eukarya contain a positively charged amino acid at this position. The crystal structures of the Sulfolobus and yeast RNA polymerases show that the positively charged arginine residues in subunits RpoH and Rpb5 most likely form salt bridges with negatively charged residues from subunit RpoK and Rpb1, respectively. A similar salt bridge might stabilize the interaction of Rp5H-E197K with a neighboring subunit of yeast RNA polymerase and thus lead to complementation of Delta rpb5.	[Sommer, Bettina; Seitz, Tobias; Sterner, Reinhard] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Waege, Ingrid; Poellmann, David; Thomm, Michael; Hausner, Winfried] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; [Waege, Ingrid; Poellmann, David; Thomm, Michael; Hausner, Winfried] Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Sterner, R (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.	Reinhard.Sterner@biologie.uni-regensburg.de; Winfried.Hausner@biologie.uni-regensburg.de	Sterner, Reinhard/ABI-6781-2020	Sterner, Reinhard/0000-0001-8177-8460	Deutsche Forschungsgemeinschaft [TH422/13-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (TH422/13-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; Goede B, 2006, J BIOL CHEM, V281, P30581, DOI 10.1074/jbc.M605209200; Grunberg S, 2010, NUCLEIC ACIDS RES, V38, P1950, DOI 10.1093/nar/gkp1190; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jun SH, 2011, CRIT REV BIOCHEM MOL, V46, P27, DOI 10.3109/10409238.2010.538662; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-38; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kreuzer M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-9; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; LANGER D, 1995, P NATL ACAD SCI USA, V92, P5768, DOI 10.1073/pnas.92.13.5768; Lin Y, 1997, J BIOL CHEM, V272, P7132, DOI 10.1074/jbc.272.11.7132; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; Miyao T, 1998, P NATL ACAD SCI USA, V95, P15281, DOI 10.1073/pnas.95.26.15281; Miyao T, 1998, MOL GEN GENET, V259, P123, DOI 10.1007/s004380050796; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; Navarro F, 2000, RNA, V6, P103, DOI 10.1017/S1355838200991714; Ochs SM, 2012, J BIOL CHEM, V287, P18863, DOI 10.1074/jbc.M112.365742; Reich C, 2009, MOL MICROBIOL, V71, P989, DOI 10.1111/j.1365-2958.2008.06577.x; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Schwab T, 2011, CHEMBIOCHEM, V12, P1581, DOI 10.1002/cbic.201000770; SHPAKOVSKI GV, 1995, MOL CELL BIOL, V15, P4702; Thiru A, 1999, J MOL BIOL, V287, P753, DOI 10.1006/jmbi.1999.2638; Thomm M, 2009, BIOCHEM SOC T, V37, P18, DOI 10.1042/BST0370018; Todone F, 2000, P NATL ACAD SCI USA, V97, P6306, DOI 10.1073/pnas.97.12.6306; Waege I, 2010, APPL ENVIRON MICROB, V76, P3308, DOI 10.1128/AEM.01951-09; Wei WX, 2001, J BIOL CHEM, V276, P12266, DOI 10.1074/jbc.M009634200; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Widlund PO, 2005, YEAST, V22, P769, DOI 10.1002/yea.1244; Wojtas MN, 2013, BIOCHEM SOC T, V41, P356, DOI 10.1042/BST20120305; Wojtas MN, 2012, NUCLEIC ACIDS RES, V40, P9941, DOI 10.1093/nar/gks692; Yee A, 2000, P NATL ACAD SCI USA, V97, P6311, DOI 10.1073/pnas.97.12.6311; Zaros C, 2007, NUCLEIC ACIDS RES, V35, P634, DOI 10.1093/nar/gkl686	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87485	10.1371/journal.pone.0087485	http://dx.doi.org/10.1371/journal.pone.0087485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489922	Green Published, gold			2022-12-25	WOS:000330570000149
J	Winer-Jones, JP; Vahidi, B; Arquilevich, N; Fang, C; Ferguson, S; Harkins, D; Hill, C; Klem, E; Pagano, PC; Peasley, C; Romero, J; Shartle, R; Vasko, RC; Strauss, WM; Dempsey, PW				Winer-Jones, Jessamine P.; Vahidi, Behrad; Arquilevich, Norma; Fang, Cong; Ferguson, Samuel; Harkins, Darren; Hill, Cory; Klem, Erich; Pagano, Paul C.; Peasley, Chrissy; Romero, Juan; Shartle, Robert; Vasko, Robert C.; Strauss, William M.; Dempsey, Paul W.			Circulating Tumor Cells: Clinically Relevant Molecular Access Based on a Novel CTC Flow Cell	PLOS ONE			English	Article							PERIPHERAL-BLOOD; EPITHELIAL-CELLS; BREAST-CANCER; HEALTHY-SUBJECTS; SURVIVAL; PROGRESSION; POPULATION; CARCINOMA	Background: Contemporary cancer diagnostics are becoming increasing reliant upon sophisticated new molecular methods for analyzing genetic information. Limiting the scope of these new technologies is the lack of adequate solid tumor tissue samples. Patients may present with tumors that are not accessible to biopsy or adequate for longitudinal monitoring. One attractive alternate source is cancer cells in the peripheral blood. These rare circulating tumor cells (CTC) require enrichment and isolation before molecular analysis can be performed. Current CTC platforms lack either the throughput or reliability to use in a clinical setting or they provide CTC samples at purities that restrict molecular access by limiting the molecular tools available. Methodology/Principal Findings: Recent advances in magetophoresis and microfluidics have been employed to produce an automated platform called LiquidBiopsyH. This platform uses high throughput sheath flow microfluidics for the positive selection of CTC populations. Furthermore the platform quantitatively isolates cells useful for molecular methods such as detection of mutations. CTC recovery was characterized and validated with an accuracy (<20% error) and a precision (CV<25%) down to at least 9 CTC/ml. Using anti-EpCAM antibodies as the capture agent, the platform recovers 78% of MCF7 cells within the linear range. Non specific recovery of background cells is independent of target cell density and averages 55 cells/mL. 10% purity can be achieved with as low as 6 CTCs/mL and better than 1% purity can be achieved with 1 CTC/mL. Conclusions/Significance: The LiquidBiopsy platform is an automated validated platform that provides high throughput molecular access to the CTC population. It can be validated and integrated into the lab flow enabling CTC enumeration as well as recovery of consistently high purity samples for molecular analysis such as quantitative PCR and Next Generation Sequencing. This tool opens the way for clinically relevant genetic profiling of CTCs.	[Winer-Jones, Jessamine P.; Arquilevich, Norma; Fang, Cong; Harkins, Darren; Hill, Cory; Klem, Erich; Pagano, Paul C.; Peasley, Chrissy; Romero, Juan; Vasko, Robert C.; Strauss, William M.; Dempsey, Paul W.] Cynvenio Biosyst, Res & Dev, Westlake Village, CA USA; [Vahidi, Behrad; Ferguson, Samuel; Shartle, Robert] Cynvenio Biosyst, Engn, Westlake Village, CA USA		Winer-Jones, JP (corresponding author), Cynvenio Biosyst, Res & Dev, Westlake Village, CA USA.	jwinerjones@cynvenio.com	Winer-Jones, Jessamine P/N-7458-2013	Winer-Jones, Jessamine P/0000-0002-6412-4139	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [HHSN261201100115C, HHSN261201100109C]; Cynvenio Biosystems	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cynvenio Biosystems	This study was funded in part with federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract Nos. HHSN261201100115C and HHSN261201100109C. Additional funding was provided by Cynvenio Biosystems. All authors are employees of Cynvenio Biosystems and Cynvenio Biosystems played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bhatia S, 2012, NAT BIOTECHNOL, V30, P604, DOI 10.1038/nbt.2294; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Giorgi V, 2010, J INVEST DERMATOL, V130, P2440, DOI 10.1038/jid.2010.141; Elshal MF, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-29; Fiegl M, 2003, CLIN CANCER RES, V9, P1224; Franken B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3333; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; HANCOCK JP, 1993, J IMMUNOL METHODS, V164, P51, DOI 10.1016/0022-1759(93)90275-C; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Irwin PL, 2010, ANAL BIOANAL CHEM, V398, P895, DOI 10.1007/s00216-010-3967-2; Marrinucci D, 2010, J ONCOL, V2010, P1, DOI DOI 10.1016/S1470-2045(07)70140-7; McCloskey KE, 2003, ANAL CHEM, V75, P6868, DOI 10.1021/ac034315j; Mikolajczyk S. D., 2011, J ONCOL, V2011, P1, DOI [DOI 10.1186/1477-7819-4-67, 10.1186/1477-7819-4-67]; Mostert B, 2012, CANCER LETT, V319, P49, DOI 10.1016/j.canlet.2011.12.031; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Rowand JL, 2007, CYTOM PART A, V71A, P105, DOI 10.1002/cyto.a.20364; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; You FL, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-2	27	55	60	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86717	10.1371/journal.pone.0086717	http://dx.doi.org/10.1371/journal.pone.0086717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489774	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000063
J	Wyszko, E; Mueller, F; Gabryelska, M; Bondzio, A; Popenda, M; Barciszewski, J; Erdmann, VA				Wyszko, Eliza; Mueller, Florian; Gabryelska, Marta; Bondzio, Angelika; Popenda, Mariusz; Barciszewski, Jan; Erdmann, Volker A.			Spiegelzymes (R) Mirror-Image Hammerhead Ribozymes and Mirror-Image DNAzymes, an Alternative to siRNAs and microRNAs to Cleave mRNAs In Vivo?	PLOS ONE			English	Article							DNA; DESIGN; OLIGONUCLEOTIDES; ANTICOAGULANT; THERAPEUTICS; APTAMER	With the discovery of small non-coding RNA (ncRNA) molecules as regulators for cellular processes, it became intriguing to develop technologies by which these regulators can be applied in molecular biology and molecular medicine. The application of ncRNAs has significantly increased our knowledge about the regulation and functions of a number of proteins in the cell. It is surprising that similar successes in applying these small ncRNAs in biotechnology and molecular medicine have so far been very limited. The reasons for these observations may lie in the high complexity in which these RNA regulators function in the cells and problems with their delivery, stability and specificity. Recently, we have described mirror-image hammerhead ribozymes and DNAzymes (Spiegelzymes (R)) which can sequence-specifically hydrolyse mirror-image nucleic acids, such as our mirror-image aptamers (Spiegelmers) discovered earlier. In this paper, we show for the first time that Spiegelzymes are capable of recognising complementary enantiomeric substrates (D-nucleic acids), and that they efficiently hydrolyse them at submillimolar magnesium concentrations and at physiologically relevant conditions. The Spiegelzymes are very stable in human sera, and do not require any protein factors for their function. They have the additional advantages of being non-toxic and non-immunogenic. The Spiegelzymes can be used for RNA silencing and also as therapeutic and diagnostic tools in medicine. We performed extensive three-dimensional molecular modelling experiments with mirror-image hammerhead ribozymes and DNAzymes interacting with D-RNA targets. We propose a model in which L/D-double helix structures can be formed by natural Watson-Crick base pairs, but where the nucleosides of one of the two strands will occur in an anticlinal conformation. Interestingly enough, the duplexes (L-RNA/D-RNA and L-DNA/D-RNA) in these models can show either right-or left-handedness. This is a very new observation, suggesting that molecular symmetry of enantiomeric nucleic acids is broken down.	[Wyszko, Eliza; Gabryelska, Marta; Popenda, Mariusz; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Mueller, Florian] Pentafolium Soft, Rosengarten, Germany; [Bondzio, Angelika] Free Univ Berlin, Inst Biochem, Berlin, Germany; [Erdmann, Volker A.] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Erdmann, Volker A.] Erdmann Technol GmbH, Berlin, Germany	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Free University of Berlin; Free University of Berlin	Erdmann, VA (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.	vae@zedat.fu-berlin.de	Barciszewski, Jan/N-9283-2019	Barciszewski, Jan/0000-0001-7766-5594; Gabryelska, Marta/0000-0002-4433-282X; Popenda, Mariusz/0000-0001-9965-0430; Wyszko, Eliza/0000-0001-9524-0960	Berlin RNA Network; Federal Ministry of Science (BMBF); Deutsches Zentrum fur Luft- und Raumfahrt (DLR); Deutsche Forschungsgemeinschaft [SFB Transregio 19]; Polish Ministry of Sciences of Higher Education; NCN; Foreign Office of the Free University of Berlin	Berlin RNA Network; Federal Ministry of Science (BMBF); Deutsches Zentrum fur Luft- und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Polish Ministry of Sciences of Higher Education; NCN; Foreign Office of the Free University of Berlin	The authors are grateful for financial support from the Berlin RNA Network, the Federal Ministry of Science (BMBF), Deutsches Zentrum fur Luft- und Raumfahrt (DLR), The Deutsche Forschungsgemeinschaft for funding of the SFB Transregio 19 (project C1), the Polish Ministry of Sciences of Higher Education, and NCN. The financial support from the Foreign Office of the Free University of Berlin is also appreciated. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley GW, 1992, J AM CHEM SOC, V114, P9721; Becker R C, 2007, Hamostaseologie, V27, P378; BLOMMERS MJJ, 1994, BIOCHEMISTRY-US, V33, P7886, DOI 10.1021/bi00191a016; Boeckel CAA, 1987, J MOL EVOL, V25, P100; Burgess DJ, 2012, NAT REV CANCER, V12, P508, DOI 10.1038/nrc3328; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Chen X, 2009, RNA, V15, P2035, DOI 10.1261/rna.1635209; DAMHA MJ, 1994, BIOCHEMISTRY-US, V33, P7877, DOI 10.1021/bi00191a015; Eulberg D, 2006, APTAMER HDB FUNCTION; FUJIMORI S, 1990, J AM CHEM SOC, V112, P7436, DOI 10.1021/ja00176a077; Gaglione M, 2010, MINI-REV MED CHEM, V10, P578, DOI 10.2174/138955710791384036; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P4159, DOI 10.1093/nar/21.18.4159; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scott WG, 2010, RNA TECHNOL, P305, DOI 10.1007/978-3-642-12168-5_14; URATA H, 1993, J AM CHEM SOC, V115, P9852, DOI 10.1021/ja00074a083; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wang J, 2009, CHEMBIOCHEM, V10, P2171, DOI 10.1002/cbic.200900408; Wyszko E, 2013, PLOS ONE, V1, pe5471	25	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86673	10.1371/journal.pone.0086673	http://dx.doi.org/10.1371/journal.pone.0086673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489764	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000057
J	Anglani, R; Creanza, TM; Liuzzi, VC; Piepoli, A; Panza, A; Andriulli, A; Ancona, N				Anglani, Roberto; Creanza, Teresa M.; Liuzzi, Vania C.; Piepoli, Ada; Panza, Anna; Andriulli, Angelo; Ancona, Nicola			Loss of Connectivity in Cancer Co-Expression Networks	PLOS ONE			English	Article							MOLECULAR-ORIGINS; TUMOR-SUPPRESSOR; MICROARRAY DATA; GENE; EXPRESSION; MUTATIONS; PATHWAYS; BREAST; SET; CELLS	Differential gene expression profiling studies have lead to the identification of several disease biomarkers. However, the oncogenic alterations in coding regions can modify the gene functions without affecting their own expression profiles. Moreover, post-translational modifications can modify the activity of the coded protein without altering the expression levels of the coding gene, but eliciting variations to the expression levels of the regulated genes. These considerations motivate the study of the rewiring of networks co-expressed genes as a consequence of the aforementioned alterations in order to complement the informative content of differential expression. We analyzed 339 mRNAomes of five distinct cancer types to find single genes that presented co-expression patterns strongly differentiated between normal and tumor phenotypes. Our analysis of differentially connected genes indicates the loss of connectivity as a common topological trait of cancer networks, and unveils novel candidate cancer genes. Moreover, our integrated approach that combines the differential expression together with the differential connectivity improves the classic enrichment pathway analysis providing novel insights on putative cancer gene biosystems not still fully investigated.	[Anglani, Roberto; Creanza, Teresa M.; Liuzzi, Vania C.; Ancona, Nicola] CNR ISSIA, Inst Intelligent Syst Automat, Natl Res Council, Bari, Italy; [Creanza, Teresa M.] Univ Turin, Ctr Complex Syst Mol Biol & Med, Turin, Italy; [Piepoli, Ada; Panza, Anna; Andriulli, Angelo] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Div & Lab Gastroenterol, San Giovanni Rotondo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Studi sui Sistemi Intelligenti per l'Automazione (ISSIA-CNR); University of Turin; IRCCS Casa Sollievo Della Sofferenza	Ancona, N (corresponding author), CNR ISSIA, Inst Intelligent Syst Automat, Natl Res Council, Bari, Italy.	ancona@ba.issia.cnr.it	Ancona, Nicola/AAD-4772-2022; Piepoli, Ada/K-9299-2016; Andriulli, Angelo/B-5027-2017; Panza, Anna/K-1989-2016; CREANZA, TERESA MARIA/AAX-6584-2020; Ancona, Nicola/E-9971-2013	Piepoli, Ada/0000-0001-7487-8754; Andriulli, Angelo/0000-0001-8862-7083; Panza, Anna/0000-0001-5840-0849; CREANZA, TERESA MARIA/0000-0003-4926-6451; Ancona, Nicola/0000-0003-0065-0321; Anglani, Roberto/0000-0002-7175-5991	Regione Puglia PO FESR Progetto BISIMANE [44]; Progetto FIRB [RBAP11B2SX]; Progetto di Ricerca Finalizzata [RF/2009-1471624]	Regione Puglia PO FESR Progetto BISIMANE; Progetto FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Progetto di Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was partially supported by grants from Regione Puglia PO FESR 2007--2013 Progetto BISIMANE (Cod. n. 44), Progetto FIRB RBAP11B2SX, Progetto di Ricerca Finalizzata 2009 RF/2009-1471624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benz CC, 1998, ENDOCR-RELAT CANCER, V5, P271, DOI 10.1677/erc.0.0050271; Califano A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.117; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen LM, 2011, J CELL BIOCHEM, V112, P933, DOI 10.1002/jcb.23009; Cheng XX, 2005, CANCER LETT, V223, P339, DOI 10.1016/j.canlet.2004.11.013; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fearon ER, 1999, CURR BIOL, V9, pR62, DOI 10.1016/S0960-9822(99)80012-8; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giaccone G, 2008, ANN ONCOL, V19, P1219, DOI 10.1093/annonc/mdn048; Good P., 2013, PERMUTATION TESTS PR; Grutzmann R, 2005, ONCOGENE, V24, P5079, DOI 10.1038/sj.onc.1208696; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hollander M., 2014, WILEY SERIES PROBABI, V3rd; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2012, LECT NOTES COMPUTER, P1; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shin SM, 2006, GASTROENTEROLOGY, V130, P2074, DOI 10.1053/j.gastro.2006.03.055; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Stern HM, 2010, CLIN CANCER RES, V16, P1587, DOI 10.1158/1078-0432.CCR-09-3108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thibodeau J, 2012, ONCOIMMUNOLOGY, V1, P908, DOI 10.4161/onci.21205; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xulvi-Brunet R, 2010, BIOINFORMATICS, V26, P205, DOI 10.1093/bioinformatics/btp632; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	54	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87075	10.1371/journal.pone.0087075	http://dx.doi.org/10.1371/journal.pone.0087075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489837	Green Published, gold			2022-12-25	WOS:000330510000104
J	Ducas, VC; Rhoades, E				Ducas, Vanessa C.; Rhoades, Elizabeth			Investigation of Intramolecular Dynamics and Conformations of alpha-, beta- and gamma-Synuclein	PLOS ONE			English	Article							SECONDARY STRUCTURE; LOOP FORMATION; AGGREGATION; MUTATION; PROTEINS; DEMENTIA; BINDING; HELIX; MODEL; LOCALIZATION	The synucleins are a family of natively unstructured proteins consisting of alpha-, beta-, and gamma-synuclein which are primarily expressed in neurons. They have been linked to a wide variety of pathologies, including neurological disorders, such as Parkinson's disease (alpha-synuclein) and dementia with Lewy bodies (alpha- and beta-synuclein), as well as various types of cancers (gamma-synuclein). Self-association is a key pathological feature of many of these disorders, with alpha-synuclein having the highest propensity to form aggregates, while beta-synuclein is the least prone. Here, we used a combination of fluorescence correlation spectroscopy and single molecule Forster resonance energy transfer to compare the intrinsic dynamics of different regions of all three synuclein proteins to investigate any correlation with putative functional or dysfunctional interactions. Despite a relatively high degree of sequence homology, we find that individual regions sample a broad range of diffusion coefficients, differing by almost a factor of four. At low pH, a condition that accelerates aggregation of alpha-synuclein, on average smaller diffusion coefficients are measured, supporting a hypothesis that slower intrachain dynamics may be correlated with self-association. Moreover, there is a surprising inverse correlation between dynamics and bulkiness of the segments. Aside from this observation, we could not discern any clear relationship between the physico-chemical properties of the constructs and their intrinsic dynamics. This work suggests that while protein dynamics may play a role in modulating self-association or interactions with other binding partners, other factors, particularly the local cellular environment, may be more important.	[Ducas, Vanessa C.; Rhoades, Elizabeth] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rhoades, Elizabeth] Yale Univ, Dept Phys, New Haven, CT USA	Yale University; Yale University	Rhoades, E (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	elizabeth.rhoades@yale.edu			National Institutes of Health [GM102815, NS079955, GM067543, GM008283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102815, T32GM067543, T32GM008283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health GM102815 and NS079955 (to ER) and predoctoral training grants GM067543 and GM008283 (to VCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bradbury J, 2003, LANCET NEUROL, V2, P715, DOI 10.1016/S1474-4422(03)00601-X; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; CHAZIN WJ, 1989, P NATL ACAD SCI USA, V86, P2195, DOI 10.1073/pnas.86.7.2195; Chen HM, 2007, P NATL ACAD SCI USA, V104, P10459, DOI 10.1073/pnas.0704073104; Das RK, 2013, P NATL ACAD SCI; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Ducas VC, 2012, J MOL BIOL, V423, P528, DOI 10.1016/j.jmb.2012.08.008; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Fujita M, 2009, J NEUROL, V256, pS286, DOI 10.1007/s00415-009-5246-8; George JM, 2002, GENOME BIOL, V3; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gregersen N, 2005, MOL BIOTECHNOL, V31, P141, DOI 10.1385/MB:31:2:141; Grupi A, 2011, J MOL BIOL, V405, P1267, DOI 10.1016/j.jmb.2010.11.011; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Lavedan C, 1998, HUM GENET, V103, P106, DOI 10.1007/s004390050792; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lee JC, 2007, J PHYS CHEM B, V111, P2107, DOI 10.1021/jp068604y; Manivel P, 2011, J MOL MODEL, V17, P251, DOI 10.1007/s00894-010-0718-4; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; O'Brien EP, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082151; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Pan ZZ, 2006, INT J ONCOL, V29, P1201; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Schweyer Paul, 1909; SEGREST JP, 1992, J LIPID RES, V33, P141; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh VK, 2007, CANCER RES, V67, P626, DOI 10.1158/0008-5472.CAN-06-1820; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Surgucheva I, 2005, CELL MOL NEUROBIOL, V25, P1009, DOI 10.1007/s10571-005-8471-4; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei J, 2007, J BIOL CHEM, V282, P28904, DOI 10.1074/jbc.M703711200; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	74	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86983	10.1371/journal.pone.0086983	http://dx.doi.org/10.1371/journal.pone.0086983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489820	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000096
J	Liu, T; Zhang, XY; He, XH; Geng, JS; Liu, Y; Kong, DJ; Shi, QY; Liu, F; Wei, W; Pang, D				Liu, Tong; Zhang, Xian-Yu; He, Xiao-Hui; Geng, Jing-Shu; Liu, Yang; Kong, De-Jia; Shi, Qing-Yu; Liu, Feng; Wei, Wei; Pang, Da			High Levels of BCOX1 Expression Are Associated with Poor Prognosis in Patients with Invasive Ductal Carcinomas of the Breast	PLOS ONE			English	Article							AFRICAN-AMERICAN; CANCER; PATTERNS; BIOLOGY; WOMEN; HER2	This study was to examine the breast cancer-overexpressed gene 1 (BCOX1) expression in invasive ductal carcinomas (IDC) of the breast and its value in the prognosis of the disease. The levels of BCOX1 expression in 491 paired IDC and surrounding non-tumor breast tissues as well as 40 paired fresh specimens were evaluated by tissue microarray, immunohistochemistry and quantitative RT-PCR. The potential associations of high BCOX1 expression with clinicopathological variables and the overall survival of these patients were analyzed. The relative levels of BCOX1 mRNA transcripts in the IDC breast tissues were significantly higher than that in the corresponding non-tumor tissues (P = 0.005). The anti-BCOX1 was predominantly stained in the cytoplasm of breast tissue cells and the levels of BCOX1 expression in the majority of breast cancer tissues were obviously higher than that in the corresponding non-tumor breast tissues. High levels of BCOX1 expression were found in 59.5% (292/491) of breast cancer tissues. The high BCOX1 expression was significantly associated with high histological grade (P = 0.037), positive expression of human epidermal growth factor receptor 2 (HER2, P = 0.031) and triple negative breast cancer (P = 0.027). The high BCOX1 expression in breast cancers was significantly associated with a shorter overall survival of these patients (P = 0.023), particularly in patients with triple negative breast cancer (P = 0.005). Therefore, the high BCOX1 expression may serve as a novel marker of poor prognosis and a potential therapeutic target for patients with IDC of the breast.	[Liu, Tong; Zhang, Xian-Yu; Liu, Yang; Kong, De-Jia; Shi, Qing-Yu; Liu, Feng; Wei, Wei; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [He, Xiao-Hui] Harbin Med Univ, Affiliated Hosp 3, Dept Med Records, Harbin, Peoples R China; [Geng, Jing-Shu] Harbin Med Univ, Affiliated Tumor Hosp, Dept Pathol, Harbin, Peoples R China; [Geng, Jing-Shu] Harbin Med Univ, Dept Med Genet, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China.	pangda@ems.hrbmu.edu.cn		LIU, TONG/0000-0001-9234-1328	Heilongjiang Provincial Finance Department [2011-14]	Heilongjiang Provincial Finance Department	This study was supported by the fund of Heilongjiang Provincial Finance Department(Da Pang, Grant no. 2011-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2007, ANN ONCOL, V18, P1904, DOI 10.1093/annonc/mdm487; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Ang KK, 2002, CANCER RES, V62, P7350; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Ma KK, 2012, ASIAN PAC J CANCER P, V13, P2109, DOI 10.7314/APJCP.2012.13.5.2109; Mishra DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057967; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Nagase T, 1995, DNA Res, V2, P51, DOI 10.1093/dnares/2.1.51; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song J, 2006, BBA-GEN SUBJECTS, V1760, P62, DOI 10.1016/j.bbagen.2005.09.017; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061640; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396	16	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86952	10.1371/journal.pone.0086952	http://dx.doi.org/10.1371/journal.pone.0086952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489812	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000092
J	Liu, XF; Yang, WT; Xu, R; Liu, JT; Zheng, PS				Liu, Xiao-Fang; Yang, Wen-Ting; Xu, Rui; Liu, Jun-Tian; Zheng, Peng-Sheng			Cervical Cancer Cells with Positive Sox2 Expression Exhibit the Properties of Cancer Stem Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; PROSPECTIVE IDENTIFICATION; PANCREATIC-CANCER; PROSTATE-CANCER; DOWN-REGULATION; METASTASIS; CARCINOMA; SUBPOPULATION; LEUKEMIA	Background: Although Sox2 expression has been found in several types of cancer, it has not yet been used to identify or isolate CSCs in somatic carcinoma. Methods: SiHa and C33A cells stably transfected with a plasmid containing human Sox2 transcriptional elements driving the enhanced green fluorescent protein (EGFP) reporter were sorted into the Sox2-positive and the Sox2-negative populations by FACS, and Sox2 expression was detected by western blot and immunohistochemistry. The differentiation, self-renewal and tumor formation abilities, as well as the expression of the stemness and the EMT related genes of the Sox2-positive and the Sox2-negative cervical cancer cells were characterized in vitro and in vivo. Results: A pSox2/EGFP system was used to separate the Sox2-positive and the Sox2-negative cells from cervical cancer cell lines, SiHa and C33A cells. Compared with the Sox2-negative cells, the Sox2-positive SiHa and C33A cells exhibited greater capacities for self-renewal, differentiation and tumor formation. Furthermore, Sox2-positive SiHa and C33A cells expressed higher levels of stemness-related genes, such as Sox2/Bmi-1/Oct4/ALDH1, and EMT-related genes, such as vimentin/snail/beta-catenin. Taken together, all these results indicated that cells expressing endogenous Sox2 are CSCs in cervical carcinomas. Conclusion: This study is the first to establish a functional link between endogenous Sox2 expression and CSCs in cervical carcinomas. Additionally, this study demonstrated that it is feasible to develop a tool to isolate CSCs from somatic tumors based on the expression of the endogenous nuclear protein Sox2 instead of cell surface markers.	[Liu, Xiao-Fang; Yang, Wen-Ting; Xu, Rui; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Sch Med, Xian 710049, Peoples R China; [Liu, Xiao-Fang; Liu, Jun-Tian] Xi An Jiao Tong Univ, Dept Pharmacol, Sch Med, Xian 710049, Peoples R China; [Yang, Wen-Ting; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Dept Biochem & Mol Biol, Sch Med, Xian 710049, Peoples R China; [Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Div Canc Stem Cell Res, Sch Med, Key Lab Environm & Genes Related Dis,Minist Educ, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Sch Med, Xian 710049, Peoples R China.	zpsheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [30571951]; special scientific Distinguished Young Scientists Fund grant [30725043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special scientific Distinguished Young Scientists Fund grant	This work was supported by a general grant from the National Natural Science Foundation of China to Prof. Peng-Sheng Zheng (No. 30571951), a special scientific Distinguished Young Scientists Fund grant (No. 30725043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bareiss PM, 2013, CANCER RES, V73, P5544, DOI 10.1158/0008-5472.CAN-12-4177; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Giakoumopoulos M, 2010, REPROD SCI, V17, P798, DOI 10.1177/1933719110371853; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Leis O, 2011, ONCOGENE; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Madka V, 2011, INDIAN J EXP BIOL, V49, P826; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sakashita Hiroyuki, 2007, Gan To Kagaku Ryoho, V34, P1721; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun SY, 2010, BIOCHEM BIOPH RES CO, V396, P843, DOI 10.1016/j.bbrc.2010.04.170; Tomuleasa C, 2011, J GASTROINTEST LIVER, V20, P443; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Xu R, 2013, HUM PATHOL, V44, P208, DOI 10.1016/j.humpath.2012.02.020; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856	35	76	79	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87092	10.1371/journal.pone.0087092	http://dx.doi.org/10.1371/journal.pone.0087092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489842	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000106
J	Lui, JLC; Chen, WP; Cheung, CSF; Baron, J				Lui, Julian C.; Chen, Weiping; Cheung, Crystal S. F.; Baron, Jeffrey			Broad Shifts in Gene Expression during Early Postnatal Life Are Associated with Shifts in Histone Methylation Patterns	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTOME ANALYSIS; CHROMATIN STATE; GENOME; DIFFERENTIATION; REVEALS; H3K4ME3; DISEASE; LISTS; CHIP	During early postnatal life, extensive changes in gene expression occur concomitantly in multiple major organs, indicating the existence of a common core developmental genetic program. This program includes hundreds of growth-promoting genes that are downregulated with age in liver, kidney, lung, and heart, and there is evidence that this component of the program drives the widespread decline in cell proliferation that occurs in juvenile life, as organs approach adult sizes. To investigate epigenetic changes that might orchestrate this program, we performed chromatin immunoprecipitation-promoter tiling array to assess temporal changes in histone H3K4 and H3K27 trimethylation (me3) at promoter regions throughout the genome in kidney and lung, comparing 1- to 4-wk-old mice. We found extensive genome-wide shifts in H3K4me3 and H3K27me3 occurring with age in both kidney and lung. The number of genes with concordant changes in the two organs was far greater than expected by chance. Temporal changes in H3K4me3 showed a strong, positive association with changes in gene expression, assessed by microarray, whereas changes in H3K27me3 showed a negative association. Gene ontology analysis indicated that shifts in specific histone methylation marks were associated with specific developmental functions. Of particular interest, genes with decreases in H3K4me3 with age in both organs were strongly implicated in cell cycle and cell proliferation functions. Taken together, the findings suggest that the common core developmental program of gene expression which occurs in multiple organs during juvenile life is associated with a common core developmental program of histone methylation. In particular, declining H3K4me3 is strongly associated with gene downregulation and occurs in the promoter regions of many growth-regulating genes, suggesting that this change in histone methylation may contribute to the component of the genetic program that drives juvenile body growth deceleration.	[Lui, Julian C.; Cheung, Crystal S. F.; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Microarray Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Lui, JLC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.	luichunk@mail.nih.gov	Chen, Wei/GZK-7348-2022; Lui, Julian/E-2253-2012	Lui, Julian/0000-0002-0611-4901	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JI, 2004, DEV BIOL, V265, P491, DOI 10.1016/j.ydbio.2003.09.041; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Herlofsen SR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-105; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Y, 2012, GENES IMMUN, V13, P311, DOI 10.1038/gene.2011.87; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yao M, 2007, ENDOCRINOLOGY, V148, P2518, DOI 10.1210/en.2006-1413; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86957	10.1371/journal.pone.0086957	http://dx.doi.org/10.1371/journal.pone.0086957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489814	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000093
J	Mott, KR; Allen, SJ; Zandian, M; Akbari, O; Hamrah, P; Maazi, H; Wechsler, SL; Sharpe, AH; Freeman, GJ; Ghiasi, H				Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Akbari, Omid; Hamrah, Pedram; Maazi, Hadi; Wechsler, Steven L.; Sharpe, Arlene H.; Freeman, Gordon J.; Ghiasi, Homayon			Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN DENDRITIC CELLS; CD8(+) T-CELLS; IN-VIVO; TYPE-1 LATENCY; COSTIMULATORY MOLECULE; STROMAL KERATITIS; MICE; EXPRESSION; REPLICATION	CD80 plays a critical role in stimulation of T cells and subsequent control of infection. To investigate the effect of CD80 on HSV-1 infection, we constructed a recombinant HSV-1 virus that expresses two copies of the CD80 gene in place of the latency associated transcript (LAT). This mutant virus (HSV-CD80) expressed high levels of CD80 and had similar virus replication kinetics as control viruses in rabbit skin cells. In contrast to parental virus, this CD80 expressing recombinant virus replicated efficiently in immature dendritic cells (DCs). Additionally, the susceptibility of immature DCs to HSV-CD80 infection was mediated by CD80 binding to PD-L1 on DCs. This interaction also contributed to a significant increase in T cell activation. Taken together, these results suggest that inclusion of CD80 as a vaccine adjuvant may promote increased vaccine efficacy by enhancing the immune response directly and also indirectly by targeting to DC.	[Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Ghiasi, Homayon] Cedars Sinai Med Ctr, Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA; [Akbari, Omid; Maazi, Hadi] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Hamrah, Pedram] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Dept Ophthalmol, Dept Microbiol & Mol Genet,Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Ctr Virus Res, Irvine, CA 92717 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Womens Hosp Med Ctr, Boston, MA USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Dept Med Oncol, Boston, MA 02115 USA	Cedars Sinai Medical Center; University of Southern California; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ghiasi, H (corresponding author), Cedars Sinai Med Ctr, Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA.	ghiasih@CSHS.org	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Maazi, Hadi/0000-0002-8979-3769; Allen, Sariah J./0000-0001-8118-2413	Public Health Service [AI093941, EY13615, EY013191, P01 AI056299, 5P01AI078897]; NATIONAL EYE INSTITUTE [K08EY020575, R01EY022695, R01EY013191, R01EY013615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093941, P01AI056299, P01AI078897] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI093941, EY13615, EY013191, P01 AI056299 and 5P01AI078897 (GJF and AHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; ALBERS I, 1989, VIROLOGY, V169, P466, DOI 10.1016/0042-6822(89)90174-8; Allen SJ, 2011, J VIROL, V85, P9945, DOI 10.1128/JVI.05208-11; Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; Allen SJ, 2010, J VIROL, V84, P12315, DOI 10.1128/JVI.01600-10; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BARRON BA, 1994, OPHTHALMOLOGY, V101, P1871; Brahmer Julie R, 2012, Clin Adv Hematol Oncol, V10, P674; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Colonna M, 2006, NAT IMMUNOL, V7, P117, DOI 10.1038/ni0206-117; COREY L, 1986, NEW ENGL J MED, V314, P686, DOI 10.1056/NEJM198603133141105; Cunningham AL, 2008, EUR J IMMUNOL, V38, P2377, DOI 10.1002/eji.200838521; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Ghiasi H, 1996, VACCINE, V14, P107, DOI 10.1016/0264-410X(95)00169-2; Ghiasi H, 2002, J VIROL, V76, P9069, DOI 10.1128/JVI.76.18.9069-9078.2002; Ghiasi H, 2002, VIROLOGY, V302, P144, DOI 10.1006/viro.2002.1609; GHIASI H, 1994, J VIROL, V68, P2118, DOI 10.1128/JVI.68.4.2118-2126.1994; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Koelle DM, 2005, CURR EYE RES, V30, P929, DOI 10.1080/02713680500313153; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; LARSEN CP, 1994, J IMMUNOL, V152, P5208; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; Maazi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059599; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, MOL VIS, V13, P1802; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2009, J VIROL, V83, P2246, DOI 10.1128/JVI.02234-08; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Osorio Y, 2005, EXP NEUROL, V193, P1, DOI 10.1016/j.expneurol.2004.12.004; Osorio Y, 2002, OCUL IMMUNOL INFLAMM, V10, P105, DOI 10.1076/ocii.10.2.105.13982; Paroli M, 2000, J NEUROIMMUNOL, V107, P201, DOI 10.1016/S0165-5728(00)00228-9; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; SARMIENTO M, 1990, J IMMUNOL, V144, P1942; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1980, J INVEST DERMATOL, V75, P14, DOI 10.1111/1523-1747.ep12521052; Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; TEUTE H, 1983, INTERVIROLOGY, V20, P32, DOI 10.1159/000149371; Tiwari V, 2012, GLYCOBIOLOGY, V22, P1402, DOI 10.1093/glycob/cws106; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van den Broeke LT, 2003, J IMMUNOL, V171, P5842, DOI 10.4049/jimmunol.171.11.5842; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wilhelmus KR, 1996, BRIT J OPHTHALMOL, V80, P969, DOI 10.1136/bjo.80.11.969; ZHOU LJ, 1995, J IMMUNOL, V154, P3821; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	68	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87617	10.1371/journal.pone.0087617	http://dx.doi.org/10.1371/journal.pone.0087617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475315	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300208
J	Howitt, J; Gysbers, AM; Ayton, S; Carew-Jones, F; Putz, U; Finkelstein, DI; Halliday, GM; Tan, SS				Howitt, Jason; Gysbers, Amanda M.; Ayton, Scott; Carew-Jones, Francine; Putz, Ulrich; Finkelstein, David I.; Halliday, Glenda M.; Tan, Seong-Seng			Increased Ndfip1 in the Substantia Nigra of Parkinsonian Brains Is Associated with Elevated Iron Levels	PLOS ONE			English	Article							METAL TRANSPORTER 1; ALPHA-SYNUCLEIN; NEURONAL SURVIVAL; DMT1 REGULATION; DISEASE; NEUROTOXICITY; HOMEOSTASIS; EXPRESSION; DIAGNOSIS; PATHWAYS	Iron misregulation is a central component in the neuropathology of Parkinson's disease. The iron transport protein DMT1 is known to be increased in Parkinson's brains linking functional transport mechanisms with iron accumulation. The regulation of DMT1 is therefore critical to the management of iron uptake in the disease setting. We previously identified post-translational control of DMT1 levels through a ubiquitin-mediated pathway led by Ndfip1, an adaptor for Nedd4 family of E3 ligases. Here we show that loss of Ndfip1 from mouse dopaminergic neurons resulted in misregulation of DMT1 levels and increased susceptibility to iron induced death. We report that in human Parkinson's brains increased iron concentrations in the substantia nigra are associated with upregulated levels of Ndfip1 in dopaminergic neurons containing a-synuclein deposits. Additionally, Ndfip1 was also found to be misexpressed in astrocytes, a cell type normally devoid of this protein. We suggest that in Parkinson's disease, increased iron levels are associated with increased Ndfip1 expression for the regulation of DMT1, including abnormal Ndfip1 activation in non-neuronal cell types such as astrocytes.	[Howitt, Jason; Ayton, Scott; Putz, Ulrich; Finkelstein, David I.; Tan, Seong-Seng] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Gysbers, Amanda M.; Carew-Jones, Francine; Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [Gysbers, Amanda M.; Carew-Jones, Francine; Halliday, Glenda M.] Univ New S Wales, Sydney, NSW, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Neuroscience Research Australia; University of New South Wales Sydney	Tan, SS (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	sst@unimelb.edu.au	Halliday, Glenda M/E-8555-2011; Carew-Jones, Francine/A-7419-2015; Ayton, Scott/J-8000-2015; Ayton, Scott/AAJ-3414-2021; Finkelstein, David/B-9617-2009	Halliday, Glenda M/0000-0003-0422-8398; Ayton, Scott/0000-0002-3479-2427; Finkelstein, David/0000-0002-8167-4917; Howitt, Jason/0000-0001-9922-7931	National Health and Medical Research Council (NHMRC); Victorian Government through the Operational Infrastructure Scheme	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government through the Operational Infrastructure Scheme	This work was supported by the National Health and Medical Research Council (NH&MRC) and the Victorian Government through the Operational Infrastructure Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding QX, 2001, J NEUROCHEM, V77, P1010, DOI 10.1046/j.1471-4159.2001.00302.x; Faucheux BA, 2003, J NEUROCHEM, V86, P1142, DOI 10.1046/j.1471-4159.2003.01923.x; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Foot NJ, 2011, BLOOD, V117, P638, DOI 10.1182/blood-2010-07-295287; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Garrick MD, 2012, BIOMETALS; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Halliday G, 2002, ACTA NEUROPATHOL, V104, P72, DOI 10.1007/s00401-002-0529-5; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; Howitt J, 2012, J CELL BIOL, V196, P29, DOI 10.1083/jcb.201105009; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Lackovic J, 2012, EXP NEUROL, V235, P326, DOI 10.1016/j.expneurol.2012.02.014; Lewy FH, 1912, HDB NEUROLOGIE; Lis A, 2005, BIOCHEM PHARMACOL, V69, P1647, DOI 10.1016/j.bcp.2005.03.023; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Michaeli S, 2007, MOVEMENT DISORD, V22, P334, DOI 10.1002/mds.21227; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Olanow CW, 1998, ANN NEUROL, V44, pS167; Paradkar PN, 2006, J NEUROCHEM, V96, P1768, DOI 10.1111/j.1471-4159.2006.03702.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Schieber C, 2011, J BIOL CHEM, V286, P8555, DOI 10.1074/jbc.M110.203448; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Song YJC, 2009, J NEUROPATH EXP NEUR, V68, P1073, DOI 10.1097/NEN.0b013e3181b66f1b; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; White AR, 2003, J NEUROSCI RES, V71, P889, DOI 10.1002/jnr.10537; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Ye FQ, 1996, MOVEMENT DISORD, V11, P243, DOI 10.1002/mds.870110305	34	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87119	10.1371/journal.pone.0087119	http://dx.doi.org/10.1371/journal.pone.0087119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475238	gold, Green Published			2022-12-25	WOS:000330339800084
J	Pahlevan, NM; Gharib, M				Pahlevan, Niema M.; Gharib, Morteza			A Bio-Inspired Approach for the Reduction of Left Ventricular Workload	PLOS ONE			English	Article							WAVE REFLECTION; INPUT IMPEDANCE; HEART-FAILURE; PRESSURE; HYPERTENSION; MAMMALS; SIZE	Previous studies have demonstrated the existence of optimization criteria in the design and development of mammalians cardiovascular systems. Similarities in mammalian arterial wave reflection suggest there are certain design criteria for the optimization of arterial wave dynamics. Inspired by these natural optimization criteria, we investigated the feasibility of optimizing the aortic waves by modifying wave reflection sites. A hydraulic model that has physical and dynamical properties similar to a human aorta and left ventricle was used for a series of in-vitro experiments. The results indicate that placing an artificial reflection site (a ring) at a specific location along the aorta may create a constructive wave dynamic that could reduce LV pulsatile workload. This simple bio-inspired approach may have important implications for the future of treatment strategies for diseased aorta.	[Pahlevan, Niema M.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Gharib, Morteza] CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Gharib, M (corresponding author), CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA.	mgharib@caltech.edu	Pahlevan, Niema/AAY-4299-2020; Pahlevan, Niema M/ABF-7268-2021	Pahlevan, Niema/0000-0001-7498-0396; Gharib, Mohammed/0000-0001-9611-1693	American Heart Association (AHA) [12PRE9610015]	American Heart Association (AHA)(American Heart Association)	Niema M. Pahlevan acknowledges support from the American Heart Association (AHA) Predoctoral fellowship (Award Id: 12PRE9610015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attinger E.O., 1964, PULSATILE BLOOD FLOW; Avrahami I, 2008, J FLUID MECH, V608, P139, DOI 10.1017/S0022112008002012; Davies JE, 2006, CIRCULATION, V113, P1768, DOI 10.1161/CIRCULATIONAHA.105.603050; ELZINGA G, 1991, CIRC RES, V68, P1495, DOI 10.1161/01.RES.68.6.1495; Hickerson AI, 2005, EXP FLUIDS, V38, P534, DOI 10.1007/s00348-005-0946-z; Ishikawa J, 2012, ARTERY RES, V6, P97, DOI 10.1016/j.artres.2012.01.002; Klingensmith ME., 2008, WASHINGTON MANUAL SU; Knight GEW, 1971, CIRCULATORY RESP MAS; LASKEY WK, 1987, CIRCULATION, V75, P711, DOI 10.1161/01.CIR.75.4.711; Li JK-J., 2018, DYNAMICS VASCULAR SY; LI JKJ, 1991, AM J PHYSIOL, V261, pR519, DOI 10.1152/ajpregu.1991.261.3.R519; LIU ZR, 1989, HYPERTENSION, V14, P129, DOI 10.1161/01.HYP.14.2.129; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Loumes L, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2856528; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; Milnor W. R., 1989, HAEMODYNAMICS; MILNOR WR, 1979, AM J PHYSIOL, V237, pR3, DOI 10.1152/ajpregu.1979.237.1.R3; Mitchell GF, 2001, HYPERTENSION, V38, P1433, DOI 10.1161/hy1201.098298; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Nichols W, 1998, MCDONALDS BLOOD FLOW; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; O'ROURKE MICHAEL F., 1967, CARDIOVASC RES, V1, P313, DOI 10.1093/cvr/1.4.313; ORourke MF, 1996, CLIN EXP PHARMACOL P, V23, pS11, DOI 10.1111/j.1440-1681.1996.tb03035.x; OROURKE MF, 1984, ANN BIOMED ENG, V12, P119, DOI 10.1007/BF02584226; Pahlevan NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023106; Quick CM, 2001, AM J PHYSIOL-HEART C, V280, pH1519, DOI 10.1152/ajpheart.2001.280.4.H1519; Safar ME, 2006, HDB HYPERTENSION, V23; WESTERHOF N, 1991, AM J PHYSIOL, V261, pR126, DOI 10.1152/ajpregu.1991.261.1.R126; WESTERHOF N, 1995, J HYPERTENS, V13, P943, DOI 10.1097/00004872-199509000-00002; Westerhof N, 2005, SNAPSHOTS HEMODYNAMI; Zamir M, 1998, P ROY SOC B-BIOL SCI, V265, P439, DOI 10.1098/rspb.1998.0314; Zamir M., 2000, PHYS PULSATILE FLOW	32	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87122	10.1371/journal.pone.0087122	http://dx.doi.org/10.1371/journal.pone.0087122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475239	gold, Green Accepted, Green Published			2022-12-25	WOS:000330339800085
J	Iqbal, MA; Siddiqui, FA; Chaman, N; Gupta, V; Kumar, B; Gopinath, P; Bamezai, RNK				Iqbal, Mohd Askandar; Siddiqui, Farid Ahmad; Chaman, Noor; Gupta, Vibhor; Kumar, Bhupender; Gopinath, Prakasam; Bamezai, Rameshwar N. K.			Missense Mutations in Pyruvate Kinase M2 Promote Cancer Metabolism, Oxidative Endurance, Anchorage Independence, and Tumor Growth in a Dominant Negative Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Tumor Promoter; Enzyme Mutation; Glycolysis; Pyruvate Kinase; Tumor Metabolism; Bloom Syndrome; Dominant Negative Mutation; PKM2	AEROBIC GLYCOLYSIS; CELL-METABOLISM; ISOFORM; PKM2; PROLIFERATION; PROTEIN; TARGET; DOMAIN	Background: We earlier reported novel mutations in PKM2 that reduce its activity. Results: These mutations promoted cancer features and tumor growth in a dominant negative manner. Conclusion: Impaired PKM2 activity due to mutations benefits cancer. Significance: This study provides the first evidence linking natural mutations in PKM2 with cancer. The present study was designed to examine the functional relevance of two heterozygous mutations (H391Y and K422R), observed earlier by us in the Bloom syndrome condition. Cells stably expressing exogenous wild-type or mutant PKM2 (K422R or H391Y) or co-expressing both wild type and mutant (PKM2-K422R or PKM2-H391Y) were assessed for cancer metabolism and tumorigenic potential. Interestingly, cells co-expressing PKM2 and mutant (K422R or H391Y) showed significantly aggressive cancer metabolism as compared with cells expressing either wild-type or mutant PKM2 independently. A similar trend was observed for oxidative endurance, tumorigenic potential, cellular proliferation, and tumor growth. These observations signify the dominant negative nature of mutations. Remarkably, PKM2-H391Y co-expressed cells showed a maximal effect on all the studied parameters. Such a dominant negative impaired function of PKM2 in tumor development is not known; this study demonstrates for the first time the possible predisposition of Bloom syndrome patients with impaired PKM2 activity to cancer and the importance of studying genetic variations in PKM2 in the future to understand their relevance in cancer in general.	[Iqbal, Mohd Askandar; Siddiqui, Farid Ahmad; Chaman, Noor; Gupta, Vibhor; Kumar, Bhupender; Gopinath, Prakasam; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Mehrauli Rd, New Delhi 110067, India.	bame0200@mail.jnu.ac.in	Kumar, Bhupender/GLR-8413-2022; prakasam, Gopinath/S-8438-2017; Siddiqui, Farid/AAI-2408-2021	Kumar, Bhupender/0000-0003-3887-5040; prakasam, Gopinath/0000-0003-1839-7969; Siddiqui, Farid/0000-0002-3292-2363; Iqbal, Mohammad Askandar/0000-0003-3485-3530	University Grants Commission (UGC), Government of India; UGC	University Grants Commission (UGC), Government of India(University Grants Commission, India); UGC(University Grants Commission, India)	Supported by a research fellowship from the University Grants Commission (UGC), Government of India.; Supported by research funds from the UGC. To whom correspondence should be addressed. Tel.: 91-11-26704518; Fax: 91-11-26742211; E-mail: bame0200@mail.jnu.ac.in or bamezai@hotmail.com.	Akhtar K, 2009, J BIOL CHEM, V284, P11971, DOI 10.1074/jbc.M808761200; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; [Anonymous], 2013, CANC DISCOV, V3, pOF14; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Fritsch A, 2009, J BIOL CHEM, V284, P30248, DOI 10.1074/jbc.M109.045294; Gajko-Galicka A, 2002, ACTA BIOCHIM POL, V49, P433; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Gutman M, 2003, INT J CANCER, V103, P268, DOI 10.1002/ijc.10803; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Iqbal MA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-72; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Lee CC, 2010, BIOCHEM J, V430, P425, DOI 10.1042/BJ20100609; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Ryu H, 2008, BRIT J PHARMACOL, V154, P1035, DOI 10.1038/bjp.2008.148; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	35	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8098	8105		10.1074/jbc.M113.515742	http://dx.doi.org/10.1074/jbc.M113.515742			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492614	hybrid, Green Published			2022-12-25	WOS:000333157500008
J	Rossa, J; Ploeger, C; Vorreiter, F; Saleh, T; Protze, J; Gunzel, D; Wolburg, H; Krause, G; Piontek, J				Rossa, Jan; Ploeger, Carolin; Vorreiter, Fraenze; Saleh, Tarek; Protze, Jonas; Guenzel, Dorothee; Wolburg, Hartwig; Krause, Gerd; Piontek, Joerg			Claudin-3 and Claudin-5 Protein Folding and Assembly into the Tight Junction Are Controlled by Non-conserved Residues in the Transmembrane 3 (TM3) and Extracellular Loop 2 (ECL2) Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Electron Microscopy (EM); Membrane Proteins; Protein Assembly; Tight Junctions; Claudin; Freeze Fracture; Mutagenesis; Protein-Protein Interaction	BLOOD-BRAIN-BARRIER; DETERMINANTS; SELECTIVITY; RESISTANCE; FRACTURE; OCCLUDIN; STRANDS; MODEL	Background: The transmembrane claudins assemble into polymeric tight junction strands. Results: Residues involved in differential folding and assembly of claudin-3 and claudin-5 were identified. Conclusion: Subtype-specific cis-dimerization contributes to the differing ultrastructure of tight junction strands. Significance: The molecular insights improve the understanding of the formation of paracellular barriers to molecules. The mechanism of tight junction (TJ) assembly and the structure of claudins (Cldn) that form the TJ strands are unclear. This limits the molecular understanding of paracellular barriers and strategies for drug delivery across tissue barriers. Cldn3 and Cldn5 are both common in the blood-brain barrier but form TJ strands with different ultrastructures. To identify the molecular determinants of folding and assembly of these classic claudins, Cldn3/Cldn5 chimeric mutants were generated and analyzed by cellular reconstitution of TJ strands, live cell confocal imaging, and freeze-fracture electron microscopy. A comprehensive screening was performed on the basis of the rescue of mutants deficient for strand formation. Cldn3/Cldn5 residues in transmembrane segment 3, TM3 (Ala-127/Cys-128, Ser-136/Cys-137, Ser-138/Phe-139), and the transition of TM3 to extracellular loop 2, ECL2 (Thr-141/Ile-142) and ECL2 (Asn-148/Asp-149, Leu-150/Thr-151, Arg-157/Tyr-158), were identified to be involved in claudin folding and/or assembly. Blue native PAGE and FRET assays revealed 1% n-dodecyl -d-maltoside-resistant cis-dimerization for Cldn5 but not for Cldn3. This homophilic interaction was found to be stabilized by residues in TM3. The resulting subtype-specific cis-dimer is suggested to be a subunit of polymeric TJ strands and contributes to the specific ultrastructure of the TJ detected by freeze-fracture electron microscopy. In particular, the Cldn5-like exoplasmic face-associated and particle-type strands were found to be related to cis-dimerization. These results provide new insight into the mechanisms of paracellular barrier formation by demonstrating that defined non-conserved residues in TM3 and ECL2 of classic claudins contribute to the formation of TJ strands with differing ultrastructures.	[Rossa, Jan; Ploeger, Carolin; Vorreiter, Fraenze; Saleh, Tarek; Protze, Jonas; Krause, Gerd; Piontek, Joerg] Leibniz Inst Mol Pharmacol, Dept Biol Struct, D-13125 Berlin, Germany; [Saleh, Tarek; Guenzel, Dorothee; Piontek, Joerg] Charite, Inst Clin Physiol, D-12203 Berlin, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, Dept Gen Pathol, D-72076 Tubingen, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Piontek, J (corresponding author), Charite, Inst Clin Physiol, Hindenburgdamm 30, D-12203 Berlin, Germany.	joerg.piontek@charite.de	Piontek, Joerg/K-6305-2013; Protze, Jonas/ABB-9737-2020	Piontek, Joerg/0000-0002-0880-8915; Protze, Jonas/0000-0002-1506-9831; Gunzel, Dorothee/0000-0002-7998-7164	Deutsche Forschungsgesellschaft (DFG) [PI 837/2-1]; DFG Research Unit [FOR 721/2 TP6, TP7]; Forschungsverbund Berlin e.V.	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); DFG Research Unit(German Research Foundation (DFG)); Forschungsverbund Berlin e.V.	This work was supported by Deutsche Forschungsgesellschaft (DFG) Grant PI 837/2-1, by DFG Research Unit Grant FOR 721/2 TP6 and TP7, and by the Forschungsverbund Berlin e.V.	Amasheh S, 2005, CELL TISSUE RES, V321, P89, DOI 10.1007/s00441-005-1101-0; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; CLAUDE P, 1978, J MEMBRANE BIOL, V39, P219, DOI 10.1007/BF01870332; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Cording J, 2013, J CELL SCI, V126, P554, DOI 10.1242/jcs.114306; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Inai T, 2010, EUR J CELL BIOL, V89, P547, DOI 10.1016/j.ejcb.2010.01.003; Inai T, 2009, HISTOCHEM CELL BIOL, V131, P681, DOI 10.1007/s00418-009-0571-7; Kaufmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031128; Koval M, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24518; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Piehl C, 2010, CELL MOL LIFE SCI, V67, P2131, DOI 10.1007/s00018-010-0332-8; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Veshnyakova A, 2012, J BIOL CHEM, V287, P1698, DOI 10.1074/jbc.M111.312165; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Wolburg Hartwig, 2003, Methods Mol Med, V89, P51; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhang JJ, 2010, P NATL ACAD SCI USA, V107, P1425, DOI 10.1073/pnas.0911996107	34	58	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7641	7653		10.1074/jbc.M113.531012	http://dx.doi.org/10.1074/jbc.M113.531012			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478310	Green Published, hybrid			2022-12-25	WOS:000332761500033
J	Agroskin, D; Klackl, J; Jonas, E				Agroskin, Dmitrij; Klackl, Johannes; Jonas, Eva			The Self-Liking Brain: A VBM Study on the Structural Substrate of Self-Esteem	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MAJOR DEPRESSIVE DISORDER; EMOTION REGULATION; MATTER VOLUME; HIPPOCAMPAL VOLUME; SOCIAL-BEHAVIOR; NEURAL BASES; STRESS; ANXIETY; GRAY	Abundant evidence suggests that self-esteem is an important personality resource for emotion regulation in response to stressful experiences. It was thus hypothesized that the relative grey matter volume of brain regions involved in responding to and coping with stress is related to individual differences in trait self-esteem. Using structural magnetic resonance imaging of 48 healthy adults in conjunction with voxel-based morphometry and diffeomorphic anatomical registration using exponentiated lie algebra (VBM-DARTEL), positive associations between self-esteem and regional grey matter volume were indeed found in the anterior cingulate cortex (ACC), right lateral prefrontal cortex (LPFC), right hippocampus, and left hypothalamus. In addition, self-esteem positively covaried with grey matter volume in the right temporo-parietal junction (TPJ), which has been implicated in pride and theory of mind. The results suggest that persons with low self-esteem have reduced grey matter volume in brain regions that contribute to emotion/stress regulation, pride, and theory of mind. The findings provide novel neuroanatomical evidence for the view that self-esteem constitutes a vital coping resource.	[Agroskin, Dmitrij; Klackl, Johannes; Jonas, Eva] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria	Salzburg University	Agroskin, D (corresponding author), Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria.	dmitrij.agroskin@sbg.ac.at	Jonas, Eva/B-1500-2017; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018	Jonas, Eva/0000-0003-1016-3076; Klackl, Johannes/0000-0003-2619-4715	Doctoral College "Imaging the Mind"; Austrian Science Fund [FWF-W1233]	Doctoral College "Imaging the Mind"; Austrian Science Fund(Austrian Science Fund (FWF))	This research was supported by the Doctoral College "Imaging the Mind," funded by the Austrian Science Fund (FWF-W1233) (http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2010, VBM TUTORIAL; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baroncini M, 2012, NEUROIMAGE, V59, P168, DOI 10.1016/j.neuroimage.2011.07.013; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bielau H, 2005, EUR ARCH PSY CLIN N, V255, P401, DOI 10.1007/s00406-005-0581-y; Blair RJR, 2010, CURR PSYCHIAT REP, V12, P76, DOI 10.1007/s11920-009-0086-x; Blairy S, 2004, J AFFECT DISORDERS, V79, P97, DOI 10.1016/S0165-0327(02)00347-6; Blascovich J., 1991, MEAS PERSONALITY SOC, VVolume 1, P115, DOI DOI 10.1002/JTS.20680; Bradley R, 2005, J TRAUMA STRESS, V18, P685, DOI 10.1002/jts.20077; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Brooks JO, 2009, PSYCHIAT RES-NEUROIM, V172, P200, DOI 10.1016/j.pscychresns.2008.06.007; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cahill KR, 2007, SOC DEV, V16, P45, DOI 10.1111/j.1467-9507.2007.00371.x; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P542; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Collani G., 2003, Z DIFFERENTIELLE DIA, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; Donnellan MB, 2005, PSYCHOL SCI, V16, P328, DOI 10.1111/j.0956-7976.2005.01535.x; Dori GA, 1999, SUICIDE LIFE-THREAT, V29, P309; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fava GA, 2001, J AFFECT DISORDERS, V65, P185, DOI 10.1016/S0165-0327(00)00267-6; Ferring D, 1996, DIAGNOSTICA, V42, P284; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Giuliani NR, 2011, BIOL PSYCHOL, V86, P379, DOI 10.1016/j.biopsycho.2010.11.010; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Herman JP, 2004, ANN NY ACAD SCI, V1018, P35, DOI 10.1196/annals.1296.004; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Klackl J, 2014, SOC COGN AFFECT NEUR, V9, P1754, DOI 10.1093/scan/nst167; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kugaya A, 2005, CNS SPECTRUMS, V10, P808, DOI 10.1017/S1092852900010403; Kuhn S, 2012, J AFFECT DISORDERS, V141, P352, DOI 10.1016/j.jad.2012.03.024; Kuster F, 2012, PERS SOC PSYCHOL B, V38, P747, DOI 10.1177/0146167212437250; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leary MR, 2003, HANDBOOK OF SELF AND IDENTITY, P401; Levesque J, 2004, NEUROSCIENCE, V129, P361, DOI 10.1016/j.neuroscience.2004.07.032; Lewis PA, 2011, NEUROIMAGE, V57, P1624, DOI 10.1016/j.neuroimage.2011.05.030; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lochhead RA, 2004, BIOL PSYCHIAT, V55, P1154, DOI 10.1016/j.biopsych.2004.02.026; Lopez-Larson MP, 2002, BIOL PSYCHIAT, V52, P93, DOI 10.1016/S0006-3223(02)01350-1; LORR M, 1988, J CLIN PSYCHOL, V44, P36, DOI 10.1002/1097-4679(198801)44:1<36::AID-JCLP2270440107>3.0.CO;2-B; Mak AKY, 2009, PROG NEURO-PSYCHOPH, V33, P1184, DOI 10.1016/j.pnpbp.2009.06.025; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marenco S, 2010, NEUROPSYCHOPHARMACOL, V35, P1708, DOI 10.1038/npp.2010.35; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Neiss MB, 2009, J PERS, V77, P327, DOI 10.1111/j.1467-6494.2008.00549.x; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OCHSNER KN, 2006, SOCIAL NEUROSCIENCE, P245; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Pruessner JC, 2010, PSYCHONEUROENDOCRINO, V35, P179, DOI 10.1016/j.psyneuen.2009.02.016; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Ridgway GR, GET TOTALS; Roberts JE, 1996, J PERS SOC PSYCHOL, V70, P310, DOI 10.1037/0022-3514.70.2.310; Romeo RD, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 3: P-Z, P304; Rosenberg M., 1979, CONCEIVING SELF; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Sapolsky R., 2007, HDB EMOTION REGULATI, P606; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R., HDB COGNITIVE NEUROS; Saxe R, 2010, RIGHT TEMPORO PARIET; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Silverstone Peter H, 2003, Ann Gen Hosp Psychiatry, V2, P2, DOI 10.1186/1475-2832-2-2; SILVERSTONE PH, 1991, BRIT J CLIN PSYCHOL, V30, P185, DOI 10.1111/j.2044-8260.1991.tb00936.x; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Taylor SE, 2003, J PERS SOC PSYCHOL, V85, P605, DOI 10.1037/0022-3514.85.4.605; Taylor SE, 2003, J PERS SOC PSYCHOL, V84, P165, DOI 10.1037//0022-3514.84.1.165; Taylor SE, 2008, J PERS SOC PSYCHOL, V95, P197, DOI 10.1037/0022-3514.95.1.197; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x	108	24	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86430	10.1371/journal.pone.0086430	http://dx.doi.org/10.1371/journal.pone.0086430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489727	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000040
J	Brenneman, KE; Willingham, C; Kilbourne, JA; Curtiss, R; Roland, KL				Brenneman, Karen E.; Willingham, Crystal; Kilbourne, Jacquelyn A.; Curtiss, Roy, III; Roland, Kenneth L.			A Low Gastric pH Mouse Model to Evaluate Live Attenuated Bacterial Vaccines	PLOS ONE			English	Article							ACID TOLERANCE RESPONSE; ORAL TYPHOID VACCINE; ENTERICA SEROVAR TYPHIMURIUM; PROBIOTIC ESCHERICHIA-COLI; CONTROLLED FIELD TRIAL; SALMONELLA-TYPHIMURIUM; ANTIMICROBIAL PEPTIDES; ANTIGEN-EXPRESSION; SHIGELLA-FLEXNERI; IMMUNE-RESPONSE	The low pH of the stomach serves as a barrier to ingested microbes and must be overcome or bypassed when delivering live bacteria for vaccine or probiotic applications. Typically, the impact of stomach acidity on bacterial survival is evaluated in vitro, as there are no small animal models to evaluate these effects in vivo. To better understand the effect of this low pH barrier to live attenuated Salmonella vaccines, which are often very sensitive to low pH, we investigated the value of the histamine mouse model for this application. A low pH gastric compartment was transiently induced in mice by the injection of histamine. This resulted in a gastric compartment of approximately pH 1.5 that was capable of distinguishing between acid-sensitive and acid-resistant microbes. Survival of enteric microbes during gastric transit in this model directly correlated with their in vitro acid resistance. Because many Salmonella enterica serotype Typhi vaccine strains are sensitive to acid, we have been investigating systems to enhance the acid resistance of these bacteria. Using the histamine mouse model, we demonstrate that the in vivo survival of S. Typhi vaccine strains increased approximately 10-fold when they carried a sugar-inducible arginine decarboxylase system. We conclude that this model will be a useful for evaluating live bacterial preparations prior to clinical trials.	[Brenneman, Karen E.; Willingham, Crystal; Kilbourne, Jacquelyn A.; Curtiss, Roy, III; Roland, Kenneth L.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Roland, KL (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	kenneth.roland@asu.edu			National Institutes of Health [AI092307, R01 AI60557-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557, R01AI093348, R21AI092307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the R21 grant AI092307 from the National Institutes of Health (http://www.nih.gov). The authors would like to acknowledge additional funding support from grant R01 AI60557-08 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini B, 2010, EUR J PHARM SCI, V40, P359, DOI 10.1016/j.ejps.2010.04.011; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Berk PA, 2005, J APPL MICROBIOL, V99, P859, DOI 10.1111/j.1365-2672.2005.02658.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bhagwat AA, 2005, INFECT IMMUN, V73, P4993, DOI 10.1128/IAI.73.8.4993-5003.2005; Bhagwat AA, 2004, FEMS MICROBIOL LETT, V234, P139, DOI [10.1111/j.1574-6968.2004.tb09525.x, 10.1016/j.femsle.2004.03.020]; BLACK JW, 1972, NATURE, V236, P385, DOI 10.1038/236385a0; BLACK R, 1982, DEV BIOLOGICALS, V53, P9; Borza AD, 2010, J MICROENCAPSUL, V27, P387, DOI 10.3109/02652040903367293; Brenneman KE, 2013, J BACTERIOL, V195, P3062, DOI 10.1128/JB.00104-13; BUTTERTON JR, 1995, INFECT IMMUN, V63, P2689, DOI 10.1128/IAI.63.7.2689-2696.1995; Casalino M, 2010, INT J MED MICROBIOL, V300, P289, DOI 10.1016/j.ijmm.2009.10.008; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG37, DOI 10.1152/ajpgi.90247.2008; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Coldewey SM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-21; CURTISS R, 1991, COLONIZATION CONTROL, P169; DiPetrillo MD, 1999, VACCINE, V18, P449, DOI 10.1016/S0264-410X(99)00246-7; Durant JA, 2000, J FOOD PROTECT, V63, P573, DOI 10.4315/0362-028X-63.5.573; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; FELIX A, 1951, J HYG-CAMBRIDGE, V49, P92, DOI 10.1017/S0022172400015394; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Foster JW, 1999, CURR OPIN MICROBIOL, V2, P170, DOI 10.1016/S1369-5274(99)80030-7; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Furutani K, 2003, J PHARMACOL EXP THER, V307, P331, DOI 10.1124/jpet.103.052019; Gahan ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006062; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GIANNELLA RA, 1972, GUT, V13, P251, DOI 10.1136/gut.13.4.251; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; HONE DM, 1994, VACCINE, V12, P895, DOI 10.1016/0264-410X(94)90031-0; HOWDEN CW, 1987, GUT, V28, P96, DOI 10.1136/gut.28.1.96; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Kirkpatrick BD, 2005, J INFECT DIS, V192, P360, DOI 10.1086/431605; KOELZ HR, 1992, SCAND J GASTROENTERO, V27, P2, DOI 10.3109/00365529209095998; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; LEE IS, 1995, MOL MICROBIOL, V17, P155; LEVINE MM, 1987, LANCET, V1, P1049; LEVINE MM, 1990, LANCET, V336, P891; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Merrell DS, 2000, J BACTERIOL, V182, P5342, DOI 10.1128/JB.182.19.5342-5350.2000; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Nguyen NV, 2004, GASTROENTEROLOGY, V127, P145, DOI 10.1053/j.gastro.2004.04.016; NWOKOLO CU, 1994, EUR J GASTROEN HEPAT, V6, P697, DOI 10.1097/00042737-199408000-00009; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Robbe-Saule V, 1999, FEMS MICROBIOL LETT, V170, P141, DOI 10.1111/j.1574-6968.1999.tb13366.x; Russell DW S. J., 2001, MOL CLONING LAB MANU; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; Tennant SM, 2008, INFECT IMMUN, V76, P639, DOI 10.1128/IAI.01138-07; Tiwari RP, 2004, J BASIC MICROB, V44, P137, DOI 10.1002/jobm.200310333; VERDU E, 1994, GUT, V35, P455, DOI 10.1136/gut.35.4.455; Viala JPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022397; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAHDAN MH, 1980, B WORLD HEALTH ORGAN, V58, P469; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Waterman SR, 1996, INFECT IMMUN, V64, P2808, DOI 10.1128/IAI.64.7.2808-2811.1996; WilmesRiesenberg MR, 1997, INFECT IMMUN, V65, P203, DOI 10.1128/IAI.65.1.203-210.1997; Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI [10.1139/O09-182, 10.1139/o09-182]; ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402	71	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87411	10.1371/journal.pone.0087411	http://dx.doi.org/10.1371/journal.pone.0087411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489912	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000143
J	Degtyarev, M; Reichelt, M; Lin, K				Degtyarev, Michael; Reichelt, Mike; Lin, Kui			Novel Quantitative Autophagy Analysis by Organelle Flow Cytometry after Cell Sonication	PLOS ONE			English	Article							SUBCELLULAR FRACTIONATION; RAT-LIVER; PROTEIN; DEGRADATION; VACUOLES; IDENTIFICATION; COMPARTMENTS; GUIDELINES; INHIBITOR; ASSAYS	Autophagy is a dynamic process of bulk degradation of cellular proteins and organelles in lysosomes. Current methods of autophagy measurement include microscopy-based counting of autophagic vacuoles (AVs) in cells. We have developed a novel method to quantitatively analyze individual AVs using flow cytometry. This method, OFACS (organelle flow after cell sonication), takes advantage of efficient cell disruption with a brief sonication, generating cell homogenates with fluorescently labeled AVs that retain their integrity as confirmed with light and electron microscopy analysis. These AVs could be detected directly in the sonicated cell homogenates on a flow cytometer as a distinct population of expected organelle size on a cytometry plot. Treatment of cells with inhibitors of autophagic flux, such as chloroquine or lysosomal protease inhibitors, increased the number of particles in this population under autophagy inducing conditions, while inhibition of autophagy induction with 3-methyladenine or knockdown of ATG proteins prevented this accumulation. This assay can be easily performed in a high-throughput format and opens up previously unexplored avenues for autophagy analysis.	[Degtyarev, Michael; Lin, Kui] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Reichelt, Mike] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Lin, K (corresponding author), Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA.	klin@gene.com			Genentech, Inc; Roche group	Genentech, Inc(Roche HoldingGenentech); Roche group	This study was funded by Genentech, Inc., a member of the Roche group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cossarizza A, 1996, EXP CELL RES, V222, P84, DOI 10.1006/excr.1996.0011; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Degtyarev M, 2009, AUTOPHAGY, V5, P415, DOI 10.4161/auto.5.3.7827; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Fialka I, 1999, J BIOL CHEM, V274, P26233, DOI 10.1074/jbc.274.37.26233; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gauthier DJ, 2008, EXPERT REV PROTEOMIC, V5, P603, DOI 10.1586/14789450.5.4.603; GLAUMANN H, 1986, EXP CELL RES, V163, P151, DOI 10.1016/0014-4827(86)90567-7; GRAY RH, 1981, EXP MOL PATHOL, V34, P72, DOI 10.1016/0014-4800(81)90037-X; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; MURPHY RF, 1985, P NATL ACAD SCI USA, V82, P8523, DOI 10.1073/pnas.82.24.8523; Paglin S, 2001, CANCER RES, V61, P439; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasquali C, 1999, J CHROMATOGR B, V722, P89, DOI 10.1016/S0378-4347(98)00314-4; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rajotte D, 2003, CYTOM PART A, V55A, P94, DOI 10.1002/cyto.a.10065; Seglen PO, 1996, ADV EXP MED BIOL, V389, P103; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Silva R, 2011, BIOMACROMOLECULES, V12, P3353, DOI 10.1021/bm200658b; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; WILSON RB, 1989, METHOD CELL BIOL, V31, P293	33	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87707	10.1371/journal.pone.0087707	http://dx.doi.org/10.1371/journal.pone.0087707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489953	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000173
J	Hagger-Johnson, G; Deary, IJ; Davies, CA; Weiss, A; Batty, GD				Hagger-Johnson, Gareth; Deary, Ian J.; Davies, Carolyn A.; Weiss, Alexander; Batty, G. David			Reaction Time and Mortality from the Major Causes of Death: The NHANES-III Study	PLOS ONE			English	Article							ALL-CAUSE-MORTALITY; CARDIOVASCULAR-DISEASE MORTALITY; LATE ADOLESCENCE/EARLY ADULTHOOD; MENTAL SURVEY 1932; RISK-FACTORS; CHILDHOOD IQ; MIDDLE-AGE; PREMATURE MORTALITY; PUBLIC-HEALTH; LIFE	Objective: Studies examining the relation of information processing speed, as measured by reaction time, with mortality are scarce. We explored these associations in a representative sample of the US population. Methods: Participants were 5,134 adults (2,342 men) aged 20-59 years from the Third National Health and Nutrition Examination Survey (NHANES III, 1988-94). Results: Adjusted for age, sex, and ethnic minority status, a 1 SD slower reaction time was associated with a raised risk of mortality from all-causes (HR = 1.25, 95% CI 1.12, 1.39) and cardiovascular disease (CVD) (HR = 1.36, 95% CI 1.17, 1.58). Having 1 SD more variable reaction time was also associated with greater risk of all-cause (HR = 1.36, 95% CI 1.19, 1.55) and CVD (HR = 1.50, 95% CI 1.33, 1.70) mortality. No associations were observed for cancer mortality. The magnitude of the relationships was comparable in size to established risk factors in this dataset, such as smoking. Interpretation: Alongside better-established risk factors, reaction time is associated with increased risk of premature death and cardiovascular disease. It is a candidate risk factor for all-cause and cause-specific mortality.	[Hagger-Johnson, Gareth; Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England; [Deary, Ian J.; Weiss, Alexander; Batty, G. David] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Carolyn A.] Univ Glasgow, MRC, CSO, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of London; University College London; University of Edinburgh; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Hagger-Johnson, G (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	g.hagger-johnson@ucl.ac.uk	Batty, GD/Y-4401-2018; Deary, Ian J/C-6297-2009	Batty, GD/0000-0003-1822-5753; Deary, Ian J/0000-0002-1733-263X	Economic and Social Research Council (ESRC) National Centre for Research Methods (NCRM); Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); Medical Research Council (MRC); MRC [G0700704] Funding Source: UKRI; Medical Research Council [MR/K026992/1, G0700704] Funding Source: researchfish	Economic and Social Research Council (ESRC) National Centre for Research Methods (NCRM)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Gareth Hagger-Johnson is supported by a grant from the Economic and Social Research Council (ESRC) National Centre for Research Methods (NCRM). The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE) is part of the cross council Lifelong Health and Wellbeing initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC) and Medical Research Council (MRC) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER EL, 1985, J OCCUP ENVIRON MED, V27, P206; Batterham PJ, 2009, INTELLIGENCE, V37, P551, DOI 10.1016/j.intell.2008.10.004; Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2008, J EPIDEMIOL COMMUN H, V62, P522, DOI 10.1136/jech.2007.064881; Batty GD, 2007, ANN ONCOL, V18, P21, DOI 10.1093/annonc/mdl473; Batty GD, 2008, EUR J CARDIOV PREV R, V15, P359, DOI 10.1097/HJR.0b013e3282f738a6; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P997, DOI 10.1136/jech.2006.054494; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P241, DOI 10.1136/jech.2006.048215; Batty GD, 2009, PSYCHO-ONCOLOGY, V18, P1122, DOI 10.1002/pon.1521; Batty GD, 2009, EUR HEART J, V30, P1903, DOI 10.1093/eurheartj/ehp254; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Batty GD, 2008, BRIT J PSYCHIAT, V193, P461, DOI 10.1192/bjp.bp.107.037424; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Corley J, 2009, INTELLIGENCE, V37, P238, DOI 10.1016/j.intell.2008.11.003; Deary I, 2012, GERONTOLOGY; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; Deary IJ, 2010, PSYCHOL AGING, V25, P219, DOI 10.1037/a0017750; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Enders C. K., 2010, APPL MISSING DATA AN; Hagger-Johnson G, 2012, J GERONTOLOGY B; Hart CL, 2005, BRIT J HEALTH PSYCH, V10, P153, DOI 10.1348/135910704X14591; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hendrickson AE, 1982, MODEL INTELLIGENCE, P151, DOI DOI 10.1007/978-3-642-68664-1_6; Johnson W, 2011, INTELLIGENCE, V39, P405, DOI 10.1016/j.intell.2011.07.003; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Lager A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5282; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; Letz R, 1990, NEUROBEHAVIORAL EVAL; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Metter EJ, 2005, J GERONTOL A-BIOL, V60, P840, DOI 10.1093/gerona/60.7.840; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pearce MS, 2006, PUBLIC HEALTH, V120, P1020, DOI 10.1016/j.puhe.2006.06.015; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Roberts BA, 2009, INTELLIGENCE, V37, P561, DOI 10.1016/j.intell.2009.02.001; Shipley BA, 2006, PSYCHOSOM MED, V68, P17, DOI 10.1097/01.psy.0000195867.66643.0f; Shipley BA, 2008, J PSYCHOSOM RES, V65, P143, DOI 10.1016/j.jpsychores.2008.02.017; SINGHMANOUX A, 2012, BMJ-BRIT MED J, V5, P344; Starr JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-307; Suzuki L, 2005, PSYCHOL PUBLIC POL L, V11, P320, DOI 10.1037/1076-8971.11.2.320; U.S. Department of Health and Human Services (DHHS), 1996, 76200 US DHHS CDCP N; *US DEP HHS, 1996, 3 NAT HLTH NUTR EX S; Walker AJ, 2009, AUST PSYCHOL, V44, P216, DOI 10.1080/00050060902833469; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	47	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e82959	10.1371/journal.pone.0082959	http://dx.doi.org/10.1371/journal.pone.0082959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489645	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000330570000005
J	Inoue, M; Kuroda, T; Honda, A; Komabayashi-Suzuki, M; Komai, T; Shinkai, Y; Mizutani, KI				Inoue, Mayuko; Kuroda, Takao; Honda, Aya; Komabayashi-Suzuki, Mariko; Komai, Tae; Shinkai, Yoichi; Mizutani, Ken-ichi			Prdm8 Regulates the Morphological Transition at Multipolar Phase during Neocortical Development	PLOS ONE			English	Article							INTERMEDIATE PROGENITOR CELLS; RADIAL NEURONAL MIGRATION; BIPOLAR TRANSITION; SUBVENTRICULAR ZONE; GUIDANCE CUES; STEM-CELLS; EXPRESSION; GLIA; NEUROGENESIS; INTEGRATION	Here, we found that the PR domain protein Prdm8 serves as a key regulator of the length of the multipolar phase by controlling the timing of morphological transition. We used a mouse line with expression of Prdm8-mVenus reporter and found that Prdm8 is predominantly expressed in the middle and upper intermediate zone during both the late and terminal multipolar phases. Prdm8 expression was almost coincident with Unc5D expression, a marker for the late multipolar phase, although the expression of Unc5D was found to be gradually down-regulated to the point at which mVenus expression was gradually up-regulated. This expression pattern suggests the possible involvement of Prdm8 in the control of the late and terminal multipolar phases, which controls the timing for morphological transition. To test this hypothesis, we performed gain-and loss-of-function analysis of neocortical development by using in utero electroporation. We found that the knockdown of Prdm8 results in premature change from multipolar to bipolar morphology, whereas the overexpression of Prdm8 maintained the multipolar morphology. Additionally, the postnatal analysis showed that the Prdm8 knockdown stimulated the number of early born neurons, and differentiated neurons located more deeply in the neocortex, however, majority of those cells could not acquire molecular features consistent with laminar location. Furthermore, we found the candidate genes that were predominantly utilized in both the late and terminal multipolar phases, and these candidate genes included those encoding for guidance molecules. In addition, we also found that the expression level of these guidance molecules was inhibited by the introduction of the Prdm8 expression vector. These results indicate that the Prdm8-mediated regulation of morphological changes that normally occur during the late and terminal multipolar phases plays an important role in neocortical development.	[Inoue, Mayuko; Kuroda, Takao; Honda, Aya; Komabayashi-Suzuki, Mariko; Mizutani, Ken-ichi] Doshisha Univ, Lab Neural Differentiat, Grad Sch Brain Sci, Kyoto 602, Japan; [Inoue, Mayuko; Komai, Tae] Kyoto Univ, Dept Mol & Cellular Biol, Grad Sch Biostudies, Kyoto, Japan; [Shinkai, Yoichi] RIKEN, Cellular Memory Lab, Saitama, Japan; [Mizutani, Ken-ichi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	Doshisha University; Kyoto University; RIKEN; Japan Science & Technology Agency (JST)	Mizutani, KI (corresponding author), Doshisha Univ, Lab Neural Differentiat, Grad Sch Brain Sci, Kyoto 602, Japan.	kmizutan@mail.doshisha.ac.jp	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	JST, PRESTO "Development and Function of Neural Networks"; MEXT of Japan	JST, PRESTO "Development and Function of Neural Networks"; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by JST, PRESTO "Development and Function of Neural Networks", and a Grant-in-Aid for Scientific Research on Innovative Areas "Neurovascular" from the MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Cameron DA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-90; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Diez-Rouz G, 2008, PLOS BIOL, V9; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Evsyukova I, 2013, ANNU REV CELL DEV BI, V29, P299, DOI 10.1146/annurev-cellbio-101512-122400; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Hirai S, 2002, DEVELOPMENT, V129, P4483; Jossin Y, 2011, NAT NEUROSCI, V79, P1123; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karaulanov E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005742; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Komai T, 2009, GENE EXPR PATTERNS, V9, P503, DOI 10.1016/j.gep.2009.07.005; Li QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065703; Liu XX, 2012, P NATL ACAD SCI USA, V109, P8280, DOI 10.1073/pnas.1205880109; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Melani M, 2010, ANNU REV CELL DEV BI, V26, P639, DOI 10.1146/annurev.cellbio.093008.093324; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oeschger FM, 2012, CEREB CORTEX, V22, P1343, DOI 10.1093/cercor/bhr197; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Ohtaka-Maruyama C, 2012, NEUROSCIENCE, V201, P67, DOI 10.1016/j.neuroscience.2011.11.006; Ohtaka-Maruyama C, 2013, CELL REP, V3, P458, DOI 10.1016/j.celrep.2013.01.012; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; Ross SE, 2012, NEURON, V73, P292, DOI 10.1016/j.neuron.2011.09.035; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Sicca F, 2003, NEUROLOGY, V61, P1042, DOI 10.1212/WNL.61.8.1042; Stanco A, 2009, P NATL ACAD SCI USA, V106, P7595, DOI 10.1073/pnas.0811343106; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Sun YM, 2010, J BIOL CHEM, V285, P39039, DOI 10.1074/jbc.M110.168351; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Takemoto M, 2011, CEREB CORTEX, V21, P1925, DOI 10.1093/cercor/bhq265; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Xie MJ, 2013, CEREB CORTEX, V23, P1410, DOI 10.1093/cercor/bhs123; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189	57	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86356	10.1371/journal.pone.0086356	http://dx.doi.org/10.1371/journal.pone.0086356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489718	Green Submitted, gold, Green Published			2022-12-25	WOS:000330570000034
J	Killick, E; Tymrakiewicz, M; Cieza-Borrella, C; Smith, P; Thompson, DJ; Pooley, KA; Easton, DF; Bancroft, E; Page, E; Leongamornlert, D; Kote-Jarai, Z; Eeles, RA				Killick, Emma; Tymrakiewicz, Malgorzata; Cieza-Borrella, Clara; Smith, Paula; Thompson, Deborah J.; Pooley, Karen A.; Easton, Doug F.; Bancroft, Elizabeth; Page, Elizabeth; Leongamornlert, Daniel; Kote-Jarai, Zsofia; Eeles, Rosalind A.		IMPACT Collaborators	Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status	PLOS ONE			English	Article							BREAST-CANCER RISK; CIGARETTE-SMOKING; CELLS; DNA; SURVIVAL; CARRIERS; DISEASE; BLOOD; WOMEN	This study aimed to determine whether telomere length (TL) is a marker of cancer risk or genetic status amongst two cohorts of BRCA1 and BRCA2 mutation carriers and controls. The first group was a prospective set of 665 male BRCA1/2 mutation carriers and controls (mean age 53 years), all healthy at time of enrolment and blood donation, 21 of whom have developed prostate cancer whilst on study. The second group consisted of 283 female BRCA1/2 mutation carriers and controls (mean age 48 years), half of whom had been diagnosed with breast cancer prior to enrolment. TL was quantified by qPCR from DNA extracted from peripheral blood lymphocytes. Weighted and unweighted Cox regressions and linear regression analyses were used to assess whether TL was associated with BRCA1/2 mutation status or cancer risk. We found no evidence for association between developing cancer or being a BRCA1 or BRCA2 mutation carrier and telomere length. It is the first study investigating TL in a cohort of genetically predisposed males and although TL and BRCA status was previously studied in females our results don't support the previous finding of association between hereditary breast cancer and shorter TL.	[Killick, Emma] Univ Hosp Southampton NHS Fdn Trust, Div Med Oncol, Southampton, Hants, England; [Killick, Emma; Tymrakiewicz, Malgorzata; Page, Elizabeth; Leongamornlert, Daniel; Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, Surrey, England; [Cieza-Borrella, Clara] Univ Salamanca, Unidad Med Mol, E-37008 Salamanca, Spain; [Smith, Paula; Thompson, Deborah J.; Pooley, Karen A.; Easton, Doug F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Cambridge, England; [Bancroft, Elizabeth] Royal Marsden Hosp NHS Trust, London, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Salamanca; University of Cambridge; Royal Marsden NHS Foundation Trust	Killick, E (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Div Med Oncol, Southampton, Hants, England.	emma.killick@uhs.nhs.uk	Valdagni, Riccardo/K-1361-2016; Thong, Meow-Keong/B-9960-2010; Foulkes, William D./AAR-9586-2021; Kiemeney, Lambertus A./D-3357-2009; Amor, David J/A-6478-2018; Nicolai, Nicola/D-1091-2017; Tischkowitz, Marc/O-4452-2018; balmaña, judith/AAH-1908-2019; Evans, D Gareth/AAB-4308-2022; Blanco, Ignacio/AAN-5426-2021; Petelin, Lara/I-3954-2015	Valdagni, Riccardo/0000-0001-5140-9728; Thong, Meow-Keong/0000-0002-7288-7910; Foulkes, William D./0000-0001-7427-4651; Kiemeney, Lambertus A./0000-0002-2368-1326; Amor, David J/0000-0001-7191-8511; Nicolai, Nicola/0000-0002-5718-2699; Tischkowitz, Marc/0000-0002-7880-0628; Evans, D Gareth/0000-0002-8482-5784; Blanco, Ignacio/0000-0002-7414-7481; Osther, Palle Jorn Sloth/0000-0001-7962-1640; Cornford, Philip/0000-0002-7146-9258; Leongamornlert, Daniel/0000-0002-3486-3168; Cieza-Borrella, Clara/0000-0003-2739-1040; catto, james/0000-0003-2787-8828; Balmana, Judith/0000-0002-0762-6415; Bancroft, Elizabeth/0000-0002-5482-5660; Skytte, Anne-Bine/0000-0002-0067-9557; Gerdes, Anne-Marie/0000-0002-0328-3320; McGaughran, Julie/0000-0002-0926-7858; Petelin, Lara/0000-0003-3245-8895; Eeles, Rosalind/0000-0002-3698-6241	Annabel Evans Memorial Fund; CRUK [C5047/A13232, C5047/A15007]; NIHR; Ronald and Rita McAulay foundation; Cancer Research UK [15007, 10118, 13232, 11022, 16563] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Annabel Evans Memorial Fund; CRUK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); Ronald and Rita McAulay foundation; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge funding from the Annabel Evans Memorial Fund, CRUK (grant numbers C5047/A13232 and C5047/A15007), NIHR support to the Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust and the Ronald and Rita McAulay foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodvarsdottir SK, 2012, MUTAT RES-FUND MOL M, V729, P90, DOI 10.1016/j.mrfmmm.2011.10.002; Cabuy E, 2008, CYTOGENET GENOME RES, V122, P336, DOI 10.1159/000167820; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Diker-Cohen T, 2013, LEUK LYMPHOMA; Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896; Guinan EM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-138; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hu H, 2010, J CANCER RES CLIN, V136, P1407, DOI 10.1007/s00432-010-0795-x; Killick E, 2012, CLIN ONCOL R COLL RA; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Maeda T, 2012, INT J RAD BIOL; Martinez-Delgado B, 2012, J MED GENET, V49, P341, DOI 10.1136/jmedgenet-2012-100807; Martinez-Delgado B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002182; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Min J, 2012, J BIOL CHEM, V287, P5091, DOI 10.1074/jbc.M111.278994; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Murillo-Ortiz B, 2012, AGING MALE, V15, P54, DOI 10.3109/13685538.2011.593658; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Shen J, 2007, CANCER RES, V67, P5538, DOI 10.1158/0008-5472.CAN-06-3490; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005	32	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86659	10.1371/journal.pone.0086659	http://dx.doi.org/10.1371/journal.pone.0086659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489760	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000330570000054
J	Kinung'hi, SM; Magnussen, P; Kaatano, GM; Kishamawe, C; Vennervald, BJ				Kinung'hi, Safari M.; Magnussen, Pascal; Kaatano, Godfrey M.; Kishamawe, Coleman; Vennervald, Birgitte J.			Malaria and Helminth Co-Infections in School and Preschool Children: A Cross-Sectional Study in Magu District, North-Western Tanzania	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SCHISTOSOMA-MANSONI INFECTION; HOOKWORM INFECTION; KENYAN SCHOOLCHILDREN; URINARY SCHISTOSOMIASIS; PARASITIC INFECTIONS; PANGANI DISTRICT; PREGNANT-WOMEN; MWERA DIVISION; EAST-AFRICA	Background: Malaria, schistosomiasis and soil transmitted helminth infections (STH) are important parasitic infections in Sub-Saharan Africa where a significant proportion of people are exposed to co-infections of more than one parasite. In Tanzania, these infections are a major public health problem particularly in school and pre-school children. The current study investigated malaria and helminth co-infections and anaemia in school and pre-school children in Magu district, Tanzania. Methodology: School and pre-school children were enrolled in a cross-sectional study. Stool samples were examined for Schistosoma mansoni and STH infections using Kato Katz technique. Urine samples were examined for Schistosoma haematobium using the urine filtration method. Blood samples were examined for malaria parasites and haemoglobin concentrations using the Giemsa stain and Haemoque methods, respectively. Principal Findings: Out of 1,546 children examined, 1,079 (69.8%) were infected with one or more parasites. Malaria-helminth co-infections were observed in 276 children (60% of all children with P. falciparum infection). Malaria parasites were significantly more prevalent in hookworm infected children than in hookworm free children (p = 0.046). However, this association was non-significant on multivariate logistic regression analysis (OR = 1.320, p = 0.064). Malaria parasite density decreased with increasing infection intensity of S. mansoni and with increasing number of co-infecting helminth species. Anaemia prevalence was 34.4% and was significantly associated with malaria infection, S. haematobium infection and with multiple parasite infections. Whereas S. mansoni infection was a significant predictor of malaria parasite density, P. falciparum and S. haematobium infections were significant predictors of anaemia. Conclusions/Significance: These findings suggest that multiple parasite infections are common in school and pre-school children in Magu district. Concurrent P. falciparum, S. mansoni and S. haematobium infections increase the risk of lower Hb levels and anaemia, which in turn calls for integrated disease control interventions. The associations between malaria and helminth infections detected in this study need further investigation.	[Kinung'hi, Safari M.; Kaatano, Godfrey M.; Kishamawe, Coleman] Mwanza Ctr, NIMR, Mwanza, Tanzania; [Magnussen, Pascal; Vennervald, Birgitte J.] Univ Copenhagen, DBL Ctr Hlth Res & Dev, Dept Vet Dis Biol, Copenhagen, Denmark	National Institute of Medical Research; University of Copenhagen	Kinung'hi, SM (corresponding author), Mwanza Ctr, NIMR, Mwanza, Tanzania.	kinunghi_csm@hotmail.com		Vennervald, Birgitte/0000-0001-5721-3494; Magnussen, Pascal/0000-0001-7372-0250	Danish Development Assistance (DANIDA) through the DBL-Centre for Heath Research and Development, Faculty of Life Sciences, University of Copenhagen and Denmark	Danish Development Assistance (DANIDA) through the DBL-Centre for Heath Research and Development, Faculty of Life Sciences, University of Copenhagen and Denmark	Financial support for this study was provided by the Danish Development Assistance (DANIDA) through the DBL-Centre for Heath Research and Development, Faculty of Life Sciences, University of Copenhagen and Denmark, and formed part of PhD training for SMK. The funding agency (DANIDA) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ajanga A, 2006, T ROY SOC TROP MED H, V100, P59, DOI 10.1016/j.trstmh.2005.06.024; Archie CAC, 2006, TROP MED INT HEALTH, V4, P490; Bhargava Alok, 2003, Food and Nutrition Bulletin, V24, P332; Booth M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-13; Booth M, 2004, T ROY SOC TROP MED H, V98, P125, DOI 10.1016/S0035-9203(03)00018-X; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Brooker S, 2000, E AFR MED J, V77, P157; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brooker SJ, 2012, J INFECT DIS, V205, P841, DOI 10.1093/infdis/jir844; Bustinduy AL, 2013, AM J TROP MED HYG, P12; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Egwunyenga AO, 2001, MEM I OSWALDO CRUZ, V96, P1055, DOI 10.1590/S0074-02762001000800005; Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Helmby H, 2007, TRENDS PARASITOL, V23, P88, DOI 10.1016/j.pt.2007.01.001; Hillier SD, 2008, J INFECT DIS, V198, P920, DOI 10.1086/591183; Hopkins DR, 2008, ANN NY ACAD SCI, V1136, P45, DOI 10.1196/annals.1425.015; Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Howard SC, 2002, ACTA TROP, V83, P141, DOI 10.1016/S0001-706X(02)00093-1; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Kabatereine NB, 2004, T ROY SOC TROP MED H, V98, P711, DOI 10.1016/j.trstmh.2004.06.003; Keiser J, 2002, J PARASITOL, V88, P461, DOI 10.2307/3285432; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Lwambo NJS, 1999, T ROY SOC TROP MED H, V93, P497, DOI 10.1016/S0035-9203(99)90349-8; LWAMBO NJS, 1992, EPIDEMIOL INFECT, V108, P469, DOI 10.1017/S0950268800049980; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Magnussen P, 2002, ANN TROP MED PARASIT, V96, P843, DOI 10.1179/000349802125002329; Magnussen P, 2001, T ROY SOC TROP MED H, V95, P58, DOI 10.1016/S0035-9203(01)90333-5; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Mboera LE, 2001, AFR J HLTH SCI, V8, P14; Mboera LEG, 2004, TANZANIA HLTH RES B, V6, P11; MCCULLOUGH FS, 1972, TROP GEOGR MED, V24, P199; McDevitt Michael A, 2004, Curr Hematol Rep, V3, P97; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Mwatha JK, 2003, J INFECT DIS, V187, P1337, DOI 10.1086/368362; Nacher M, 2001, AM J TROP MED HYG, V65, P644, DOI 10.4269/ajtmh.2001.65.644; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Naus CWA, 2003, J INFECT DIS, V187, P1272, DOI 10.1086/368361; NBS (National Bureau of Statistics), 2002, POP HOUS CENS; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; Olsen A, 1998, T ROY SOC TROP MED H, V92, P643, DOI 10.1016/S0035-9203(98)90795-7; Petney Trevor N., 1998, International Journal for Parasitology, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Pierrot C, 2006, INFECT IMMUN, V74, P3347, DOI 10.1128/IAI.01724-05; Pradhan P, 2009, J VECTOR DIS, V46, P100; Rugemalila JB, 1991, HLTH DIS TANZANIA, P144; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; STEPHENSON LS, 1993, J NUTR, V123, P1036; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Tchuem Tchuente LA, 2003, TROP MED INT HEALTH, V8, P975, DOI 10.1046/j.1360-2276.2003.01120.x; Tshikuka JG, 1996, ANN TROP MED PARASIT, V90, P277, DOI 10.1080/00034983.1996.11813053; Warrell DA, 2002, ESSENTIAL MALARIOLOG, V4th, P236; WEBBE G, 1962, B WORLD HEALTH ORGAN, V27, P59; Wilson S, 2007, TROP MED INT HEALTH, V12, P1442, DOI 10.1111/j.1365-3156.2007.01950.x; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT; Yatich NJ, 2009, AM J TROP MED HYG, V80, P896, DOI 10.4269/ajtmh.2009.80.896	66	52	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86510	10.1371/journal.pone.0086510	http://dx.doi.org/10.1371/journal.pone.0086510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489732	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000042
J	Rentsch, C; Bebu, I; Guest, JL; Rimland, D; Agan, BK; Marconi, V				Rentsch, Christopher; Bebu, Ionut; Guest, Jodie L.; Rimland, David; Agan, Brian K.; Marconi, Vincent			Combining Epidemiologic and Biostatistical Tools to Enhance Variable Selection in HIV Cohort Analyses	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; AIC MODEL SELECTION; AKAIKE INFORMATION CRITERION; INFERENCE; SURVIVAL; ACCESS	Background: Variable selection is an important step in building a multivariate regression model for which several methods and statistical packages are available. A comprehensive approach for variable selection in complex multivariate regression analyses within HIV cohorts is explored by utilizing both epidemiological and biostatistical procedures. Methods: Three different methods for variable selection were illustrated in a study comparing survival time between subjects in the Department of Defense's National History Study and the Atlanta Veterans Affairs Medical Center's HIV Atlanta VA Cohort Study. The first two methods were stepwise selection procedures, based either on significance tests (Score test), or on information theory (Akaike Information Criterion), while the third method employed a Bayesian argument (Bayesian Model Averaging). Results: All three methods resulted in a similar parsimonious survival model. Three of the covariates previously used in the multivariate model were not included in the final model suggested by the three approaches. When comparing the parsimonious model to the previously published model, there was evidence of less variance in the main survival estimates. Conclusions: The variable selection approaches considered in this study allowed building a model based on significance tests, on an information criterion, and on averaging models using their posterior probabilities. A parsimonious model that balanced these three approaches was found to provide a better fit than the previously reported model.	[Rentsch, Christopher; Guest, Jodie L.; Rimland, David; Marconi, Vincent] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Guest, Jodie L.; Rimland, David; Marconi, Vincent] Emory Univ, Sch Med, Atlanta, GA USA; [Guest, Jodie L.; Marconi, Vincent] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Bebu, Ionut; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Emory University; Rollins School Public Health; Uniformed Services University of the Health Sciences - USA	Marconi, V (corresponding author), Atlanta Vet Affairs Med Ctr, Decatur, GA USA.	vcmarco@emory.edu	Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Rentsch, Christopher/0000-0002-1408-7907; Guest, Jodie/0000-0002-3650-3975; Agan, Brian/0000-0002-5114-1669	Infectious Disease Clinical Research Program (IDCRP) [IDCRP-000-24]; Department of Defense program through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; Emory University's Center for AIDS Research [CFAR P30-AI50409]; IDCRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP); Department of Defense program through the Uniformed Services University of the Health Sciences(United States Department of Defense); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory University's Center for AIDS Research; IDCRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by [IDCRP-000-24] the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement [Y1-AI-5072]. The content of this publication is the sole responsibility of the authors and does not necessarily reflect the views or policies of the NIH, Department of Health and Human Services, Department of Defense, Department of Veterans Affairs, or the departments of the Army, Navy, or Air Force. Mention of trade names, or commercial products, or organizations does not imply endorsement by the U. S. Government. This collaboration is funded by a grant from Emory University's Center for AIDS Research [CFAR P30-AI50409] and by the IDCRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Breslow NE, 1980, STAT METHODS CANC RE; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; DALES LG, 1978, INT J EPIDEMIOL, V7, P373, DOI 10.1093/ije/7.4.373; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; Guest JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062273; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Johnson BR., 1997, EDUCATION, V118, P282, DOI DOI 10.1016/J.CEDPSYCH.2016.09.005; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; KLEINBAUM DG, 1982, COMMUN STAT A-THEOR, V11, P485, DOI 10.1080/03610928208828251; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lehmann E, 2009, ELEMENTS LARGE SAMPL; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; REGAL RR, 1991, STAT MED, V10, P717, DOI 10.1002/sim.4780100506; ROBINS JM, 1986, AM J EPIDEMIOL, V123, P392, DOI 10.1093/oxfordjournals.aje.a114254; ROTHMAN KJ, 1977, CANCER, V39, P1771, DOI 10.1002/1097-0142(197704)39:4+<1771::AID-CNCR2820390803>3.0.CO;2-2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; SAS Institute Inc, 2012, SAS GUID PERS COMP; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Therneau TM, 2000, MODELING SURVIVAL DA; Volinsky CT, 1997, J R STAT SOC C-APPL, V46, P433, DOI 10.1111/1467-9876.00082; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Weintrob AC, 2009, JAIDS-J ACQ IMM DEF, V52, P574, DOI 10.1097/QAI.0b013e3181b98537	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87352	10.1371/journal.pone.0087352	http://dx.doi.org/10.1371/journal.pone.0087352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489902	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000330570000136
J	Smith, T; Quesnel, F; De Ploeg, G; De Franceschi, D; Metais, G; De Bast, E; Sole, F; Folie, A; Boura, A; Claude, J; Dupuis, C; Gagnaison, C; Iakovleva, A; Martin, J; Maubert, F; Prieur, J; Roche, E; Storme, JY; Thomas, R; Tong, H; Yans, J; Buffetaut, E				Smith, Thierry; Quesnel, Florence; De Ploeeg, Gael; De Franceschi, Dario; Metais, Gregoire; De Bast, Eric; Sole, Floreal; Folie, Annelise; Boura, Anais; Claude, Julien; Dupuis, Christian; Gagnaison, Cyril; Iakovleva, Alina; Martin, Jeremy; Maubert, Francois; Prieur, Judicael; Roche, Emile; Storme, Jean-Yves; Thomas, Romain; Tong, Haiyan; Yans, Johan; Buffetaut, Eric			First Clarkforkian Equivalent Land Mammal Age in the Latest Paleocene Basal Sparnacian Facies of Europe: Fauna, Flora, Paleoenvironment and (Bio)stratigraphy	PLOS ONE			English	Article							EARLIEST EOCENE; MIDDLE EOCENE; EARLY PALEOGENE; ORGANIC-CARBON; MORPHOLOGY; VERTEBRATES; EVOLUTION; EXCURSION; BOUNDARY; SECTION	The Paleocene-Eocene Thermal Maximum (PETM) is correlated with the first occurrences of earliest modern mammals in the Northern Hemisphere. The latest Paleocene Clarkforkian North American Land Mammal Age, that has yielded rodents and carnivorans, is the only exception to this rule. However, until now no pre-PETM localities have yielded modern mammals in Europe or Asia. We report the first Clarkforkian equivalent Land Mammal Age in the latest Paleocene deposits of the basal Sparnacian facies at Rivecourt, in the north-central part of the Paris Basin. The new terrestrial vertebrate and macroflora assemblages are analyzed through a multidisciplinary study including sedimentologic, stratigraphic, isotopic, and palynological aspects in order to reconstruct the paleoenvironment and to evaluate biochronologic and paleogeographic implications. The mammals are moderately diverse and not abundant, contrary to turtles and champsosaurs. The macroflora is exceptional in preservation and diversity with numerous angiosperms represented by flowers, fruits, seeds and wood preserved as lignite material, revealing an abundance of Arecaceae, Betulaceae, Icacinaceae, Menispermaceae, Vitaceae and probably Cornaceae. Results indicate a Late Paleocene age based on carbon isotope data, palynology and vertebrate occurrences such as the choristoderan Champsosaurus, the arctocyonid Arctocyon, and the plesiadapid Plesiadapis tricuspidens. However, several mammal species compare better with the earliest Eocene. Among these, the particular louisinid Teilhardimys musculus, also recorded from the latest Paleocene of the Spanish Pyrenees, suggests a younger age than the typical MP6 reference level. Nevertheless, the most important aspect of the Rivecourt fauna is the presence of dental remains of a rodent and a "miacid" carnivoran, attesting to the presence of two modern mammalian orders in the latest Paleocene of Europe. Interestingly, these two groups are also the only modern groups recorded from the latest Paleocene of North America, making Rivecourt the first direct equivalent to the Clarkforkian Land Mammal Age outside of North America.	[Smith, Thierry; De Bast, Eric; Sole, Floreal; Folie, Annelise] Inst Royal Sci Nat Belg, Direct Operat Terre & Hist Vie, Brussels, Belgium; [Quesnel, Florence] Univ Orleans, CNRS, BRGM, DGR GAT,Bur Rech Geol & Minieres French Geol Surv, Orleans, France; [De Ploeeg, Gael; Prieur, Judicael] Ctr Permanent Initiat Environm Pays Oise, Verberie, France; [De Franceschi, Dario; Metais, Gregoire; Boura, Anais; Thomas, Romain] CNRS MNHN UPMC, Ctr Rech Paleobiodiversite & Paleoenvironm, Museum Natl Hist Nat, Paris, France; [De Franceschi, Dario; Metais, Gregoire; Boura, Anais; Thomas, Romain] Univ Paris 06, Paris, France; [Claude, Julien] Univ Montpellier 2, Inst Sci Evolut Montpellier, F-34059 Montpellier, France; [Dupuis, Christian] Univ Mons, Geol GFA, Fac Polytech, B-7000 Mons, Belgium; [Gagnaison, Cyril] Inst Polytech LaSalle Beauvais, Beauvais, France; [Iakovleva, Alina] Russian Acad Sci, Inst Geol, Moscow V71, Russia; [Martin, Jeremy] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Maubert, Francois] Lafarge Granulats Seine Nord, Paris, France; [Roche, Emile] Univ Liege, Dept Geol, Liege, Belgium; [Storme, Jean-Yves; Yans, Johan] Univ Namur, Dept Geol, Namur, Belgium; [Tong, Haiyan] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Kantarawichai, Thailand; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75231 Paris, France	Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Mons; UniLaSalle; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences; University of Bristol; University of Liege; University of Namur; Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Smith, T (corresponding author), Inst Royal Sci Nat Belg, Direct Operat Terre & Hist Vie, Brussels, Belgium.	thierry.smith@naturalsciences.be	Claude, julien/G-7411-2016; Martin, Jeremy/L-4542-2016; Anaïs, Boura/ABB-7025-2021; QUESNEL, Florence/AAR-9253-2021; IAKOVLEVA, ALINA/ABH-9243-2020	Claude, julien/0000-0002-9267-1228; Martin, Jeremy/0000-0001-9159-645X; Anaïs, Boura/0000-0002-3144-8217; QUESNEL, Florence/0000-0002-4081-1911; IAKOVLEVA, ALINA/0000-0001-8569-1880; Folie, Annelise/0000-0002-5839-4212; Smith, Thierry/0000-0002-1795-2564	Federal Science Policy Office of Belgium [MO/36/020, BR/121/A3/PALEURAFRICA]; BRGM	Federal Science Policy Office of Belgium; BRGM	This work was supported by projects MO/36/020 and BR/121/A3/PALEURAFRICA of the Federal Science Policy Office of Belgium (to TS; http://www.belspo.be), and Research cooperation contract funded by the BRGM ("Regolithe" and "Paleosurface eocene-PETM" research projects; to FQ, TS, CD, AI, ER and JYS; http://www.brgm.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JRL, 1964, SEDIMENTOLOGY, V3, P163, DOI 10.1111/j.1365-3091.1964.tb00459.x; [Anonymous], 1997, MEMOIRES TRAVAUX EPH, V21, P769; [Anonymous], 1977, PALAEONTOGR ABT B; Aubry M.P., 2005, STRATIGRAPHY, V2, P65; Aubry MP, 2007, EPISODES, V30, P271, DOI 10.18814/epiiugs/2007/v30i4/003; BLONDEAU A., 1976, B INF GEOL BASS PARI, V13, P3; Boyer DM, 2012, AM J PHYS ANTHROPOL, V149, P329, DOI 10.1002/ajpa.22119; BRIDGE JS, 1986, SEDIMENTOLOGY, V33, P851, DOI 10.1111/j.1365-3091.1986.tb00987.x; Broin F de, 1977, NOUVELLE C, V33; Brunet M., 1987, MUNCHNER GEOWISSEN A, V10, P13, DOI DOI 10.1111/GCB.12846; Buffetaut E, 2002, GEOL SOC AM SPEC PAP, V356, P303; Cavagnetto Carla, 2000, Palaeontographica Abteilung B Palaeophytologie, V255, P147; Cavelier C, 1968, MEM BRGM, V59, P13; Chateauneuf J.J., 1968, MEMOIRE BUREAU RECHE, V59, P113; Collinson J D, 1996, SEDIMENTARY ENV FACI, P37, DOI DOI 10.2307/3514634; Collinson ME, 2007, J GEOL SOC LONDON, V164, P87, DOI 10.1144/0016-76492005-185; de Coninck J., 1981, Bulletin de la Societe Belge de Geologie, V90, P121; De Franceschi Dario, 2003, Geodiversitas, V25, P633; de Ploeg G., 1998, Strata Series 1 Communications, V9, P108; Delfino M, 2012, J VERTEBR PALEONTOL, V32, P1358, DOI 10.1080/02724634.2012.699484; Delfino M, 2009, ZOOL J LINN SOC-LOND, V156, P140, DOI 10.1111/j.1096-3642.2008.00478.x; Estes R., 1988, P119; Fensom RA, 2004, AASP CONTRIBUTION SE, V42; Feugueur L., 1963, MEMOIRE SERVIR EXPLI; Folie A, 2013, GEOL BELG, V16, P227; Folk R.L., 1957, J SEDIMENT RES, V27, P3, DOI [10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D, 10.1306/74d70646-2b21-11d7-8648000102c1865]; Gagnaison Cyril, 2009, Bulletin d'Information des Geologues du Bassin de Paris, V46, P3; Gheerbrant E, 1999, ECLOGAE GEOL HELV, V92, P517; Gingerich P.D., 1976, U MICHIGAN PAPERS PA, V15; Gingerich P. D., 1983, CONTRIB MUS PALEONTO, V26, P187; GINGERICH PD, 2001, PAPERS PALEONTOLOGY, V33, P1; Godinot M., 1980, PALAEOVERTEBRATA MEM, P167; Graves L., 1847, ESSAI TOPOGRAPHIE GE; Gruas-Cavagnetto C., 1976, Bulletin d'Information des Geologues du Bassin de Paris, V13, P11; Gruas-Cavagnetto C, 1968, MEM SOC GEOL FRANCE, V110, P1; Heilmann-Clausen C., 1985, DANMARKS GEOLOGISK A, V7, P1, DOI DOI 10.34194/SERIEA.V7.7026; Heinrich RE, 2008, J PALEONTOL, V82, P154, DOI 10.1666/05-118.1; Herre W., 1950, Zoologischer Anzeiger, V145, P286; Hooker JJ, 2012, ZOOL J LINN SOC-LOND, V164, P856, DOI 10.1111/j.1096-3642.2011.00787.x; Jacques FMB, 2005, REV PALAEOBOT PALYNO, V135, P61, DOI 10.1016/j.revpalbo.2005.02.005; Jehle Martin, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P487, DOI 10.1007/s12549-012-0100-x; Johnson H D, 1996, SEDIMENTARY ENV PROC, P232; Knox R., 2010, PETROLEUM GEOLOGICAL, P210; Krutzsch W., 1958, Z ANGEW GEOL, V11, P509; Ladeveze S, 2010, J VERTEBR PALEONTOL, V30, P1559, DOI 10.1080/02724634.2010.501440; Lopez-Martinez N, 1999, B SOC GEOL FR, V170, P681; Maas MC, 2001, J VERTEBR PALEONTOL, V21, P578, DOI 10.1671/0272-4634(2001)021[0578:ENUFTE]2.0.CO;2; Magioncalda R, 2004, GEOLOGY, V32, P553, DOI 10.1130/G20476.1; Magioncalda R, 2001, B SOC GEOL FR, V172, P349, DOI 10.2113/172.3.349; Martin Larry D., 1992, Natural History Museum of Los Angeles County Science Series, V36, P97; Martini E., 1971, P 2 PLANKT C ROM 197, V2, P739; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Metais Gregoire, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P477, DOI 10.1007/s12549-012-0095-3; Nel A, 1999, CR ACAD SCI II A, V329, P65, DOI 10.1016/S1251-8050(99)80229-8; Perez-Garcia A, 2012, J VERTEBR PALEONTOL, V32, P545, DOI 10.1080/02724634.2012.658933; Pflug H.D., 1953, PALAEONTOGR ABT B, V95, P60; PFLUG HANS, 1952, PALAEONTOL ZEITSCHR, V26, P112; PLINT AG, 1983, SEDIMENTOLOGY, V30, P625, DOI 10.1111/j.1365-3091.1983.tb00699.x; Plint AG, 1988, TERTIARY RES, V10, P107; Quesnel F, 2006, GEOLOGIE TERRITOIRE; Rage J.-C., 2001, PART 2 BOIDAE PALAEO, V30, P111, DOI DOI 10.18563/pv.36.1-4.37-73; Reineck H.E., 1980, DEPOSITIONAL SEDIMEN, P5; Roche E, 1973, MEMOIRES SERVIR EXPL, V13, P13; Roche E, 2009, GNS SCI MISCELLANEOU, V16, P122; ROSE K D, 1981, Museum of Paleontology Papers on Paleontology, P1; Rouvillois A, 1960, MEMOIRE MUSEUM HIST, VVIII; Russell D. E, 1980, PALAEOVERTEBRATA MEM; RUSSELL DONALD E., 1964, MEM MUS NAT HIST NATUR NOW SER SER C SCI TERRE, V13, P1; Sanchiz B., 1998, HDB PALAOHERPETOLOGI, V4, P275; Schumm S. A., 1977, FLUVIAL SYSTEM; SIGOGNEAU-RUSSEL D, 1979, Annales de Paleontologie Vertebres, V65, P93; Smith T, 2000, GFF, V122, P148, DOI 10.1080/11035890001221148; Smith T, 1996, B SOC BELG GEOL, V104, P119; Smith T, 2006, P NATL ACAD SCI USA, V103, P11223, DOI 10.1073/pnas.0511296103; Smith T, 2011, CR PALEVOL, V10, P11, DOI 10.1016/j.crpv.2010.11.004; Sole F, J VERTEBRATE PALEONT; Sole F, 2011, PALAEONTOL ELECTRON, V14; Steurbaut E., 2003, Geological Society of America Special Paper, V369, P291; Steurbaut Etienne, 1998, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P91; Storme JY, 2012, TERRA NOVA, V24, P114, DOI 10.1111/j.1365-3121.2011.01044.x; STOTT LD, 1996, GEOLOGICAL SOC SPECI, V0101; Sukhanov Vladimir B., 2000, P309; Tabuce R, 2006, ACTA PALAEONTOL POL, V51, P37; Teilhard de Chardin P, 1927, MEMOIRES MUSEE ROYAL, V6, P1; THIRY M., 2006, STRATIGRAPHY, V3, P119; Vitek N. S., 2012, PALAEONTOL ELECTRON, V15, P1; Wellnhofer P., 1983, HDB PALAOHERPETOLOGI, P1; Woodburne Michael O., 2009, Denver Museum of Nature & Science Annals, V1, P1; Yans J, 2006, AM J SCI, V306, P712, DOI 10.2475/09.2006.02; Yans J, 2010, PALAEOGEOGR PALAEOCL, V291, P85, DOI 10.1016/j.palaeo.2010.01.014; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	91	44	45	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86229	10.1371/journal.pone.0086229	http://dx.doi.org/10.1371/journal.pone.0086229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489703	Green Published, gold			2022-12-25	WOS:000330570000029
J	Tabone, M; Lioy, VS; Ayora, S; Machon, C; Alonso, JC				Tabone, Mariangela; Lioy, Virginia S.; Ayora, Silvia; Machon, Cristina; Alonso, Juan C.			Role of Toxin zeta and Starvation Responses in the Sensitivity to Antimicrobials	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; FUNCTIONAL-ANALYSIS; ANTIBIOTIC TOLERANCE; ADDICTION SYSTEM; (P)PPGPP; RESISTANCE; STRESS; CELLS	A fraction of otherwise antimicrobial-sensitive Bacillus subtilis cells, called persisters, are phenotypically tolerant of antimicrobial treatment. We report that, independently of B. subtilis' growth phase, transient zeta toxin expression induces a dormant state and alters cellular responses so that cells are more sensitive to antimicrobials with different modes of action. This outcome is modulated by fine tuning (p) ppGpp and GTP levels: i) in the presence of low "dysregulated" (p) ppGpp levels (as in relA(-) cells) hyper-tolerance to both toxin and antimicrobials was observed; ii) physiological or low (p) ppGpp levels (as in the wild-type, sasA(-), sasB(-) and relA(-) sasA(-) context) show a normal toxin and antimicrobial tolerance; and iii) lower levels (in relA(-) sasB(-)) or absence of (p) ppGpp (in the relA(-) sasA(-) sasB(-) context), in concert with elevated GTP levels, potentiate the efficacy of both toxin and antimicrobial action, rendering tolerance vulnerable to eradication.	[Tabone, Mariangela; Lioy, Virginia S.; Ayora, Silvia; Machon, Cristina; Alonso, Juan C.] CSIC, CNB, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CSIC, CNB, Dept Biotecnol Microbiana, Madrid, Spain.	jcalonso@cnb.csic.es	Tabone, Mariangela/ABG-3195-2020; Ayora, Silvia/D-2552-2009; Lioy, Vicky S./AAL-9782-2021; Sobrado, Cristina Machón/K-1634-2014; Alonso, Juan Carlos/D-2595-2009; Lioy, Vicky/AAE-4039-2022	Ayora, Silvia/0000-0003-3121-1786; Lioy, Vicky S./0000-0002-5366-0462; Sobrado, Cristina Machón/0000-0001-5363-2958; Alonso, Juan Carlos/0000-0002-5178-7179; Lioy, Vicky/0000-0002-5366-0462; Tabone, Mariangela/0000-0003-2688-6922	European Union [Health-F3-2009-223111]; Ministerio de Economia y Competividad (MINECO) [BFU2012-39879-C02-01]; MINECO [BFU2012-39879-C02-02]; Comunidad de Madrid [CM-BIO0260-2006]	European Union(European Commission); Ministerio de Economia y Competividad (MINECO)(Spanish Government); MINECO(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	The research was partially financed by the European Union (Grant Health-F3-2009-223111) and by the Ministerio de Economia y Competividad (MINECO) (BFU2012-39879-C02-01) to J.C.A., by the MINECO (BFU2012-39879-C02-02) and by the Comunidad de Madrid (CM-BIO0260-2006) to S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Belda E, 2013, MICROBIOL-SGM, V159, P757, DOI 10.1099/mic.0.064691-0; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; Bokinsky G, 2013, J BACTERIOL, V195, P3173, DOI 10.1128/JB.02210-12; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CASHEL M, 1996, ESCHERICHIA COLI SAL, V1, P1458; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Drlica K, 2009, CURR TOP MED CHEM; ECDC-EMEA, 2009, JOINT TECHN REP BACT; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL; Goldman Robert C., 2004, Current Drug Targets - Infectious Disorders, V4, P241, DOI 10.2174/1568005043340812; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Lioy VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030282; Lioy VS, 2010, PLASMID, V63, P31, DOI 10.1016/j.plasmid.2009.09.005; Lioy VS, 2010, SISTEMA TOXINA ANTIT; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Meinhart A, 2001, ACTA CRYSTALLOGR D, V57, P745, DOI 10.1107/S0907444901004176; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Viducic D, 2006, MICROBIOL IMMUNOL, V50, P349, DOI 10.1111/j.1348-0421.2006.tb03793.x; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; Wu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023909; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83	54	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86615	10.1371/journal.pone.0086615	http://dx.doi.org/10.1371/journal.pone.0086615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489751	Green Submitted, gold, Green Published			2022-12-25	WOS:000330570000051
J	Davies, GF; Berg, A; Postnikoff, SDL; Wilson, HL; Arnason, TG; Kusalik, A; Harkness, TAA				Davies, Gerald F.; Berg, Arnie; Postnikoff, Spike D. L.; Wilson, Heather L.; Arnason, Terra G.; Kusalik, Anthony; Harkness, Troy A. A.			TFPI1 Mediates Resistance to Doxorubicin in Breast Cancer Cells by Inducing a Hypoxic-Like Response	PLOS ONE			English	Article							TISSUE FACTOR PATHWAY; TUMOR MICROENVIRONMENT; ANTIANGIOGENIC THERAPY; HISTONE DEACETYLASES; ILLUMINA MICROARRAY; ENDOTHELIAL-CELLS; METASTATIC GROWTH; INHIBITOR; PROTEIN; PROGRESSION	Thrombin and hypoxia are important players in breast cancer progression. Breast cancers often develop drug resistance, but mechanisms linking thrombin and hypoxia to drug resistance remain unresolved. Our studies using Doxorubicin (DOX) resistant MCF7 breast cancer cells reveals a mechanism linking DOX exposure with hypoxic induction of DOX resistance. Global expression changes between parental and DOX resistant MCF7 cells were examined. Westerns, Northerns and immunocytochemistry were used to validate drug resistance and differentially expressed genes. A cluster of genes involved in the anticoagulation pathway, with Tissue Factor Pathway Inhibitor 1 (TFPI1) the top hit, was identified. Plasmids overexpressing TFPI1 were utilized, and 1% O-2 was used to test the effects of hypoxia on drug resistance. Lastly, microarray datasets from patients with drug resistant breast tumors were interrogated for TFPI1 expression levels. TFPI1 protein levels were found elevated in 3 additional DOX resistant cells lines, from humans and rats, indicating evolutionarily conservation of the effect. Elevated TFPI1 in DOX resistant cells was active, as thrombin protein levels were coincidentally low. We observed elevated HIF1 alpha protein in DOX resistant cells, and in cells with forced expression of TFPI1, suggesting TFPI1 induces HIF1 alpha. TFPI1 also induced c-MYC, c-SRC, and HDAC2 protein, as well as DOX resistance in parental cells. Growth of cells in 1% O-2 induced elevated HIF1 alpha, BCRP and MDR-1 protein, and these cells were resistant to DOX. Our in vitro results were consistent with in vivo patient datasets, as tumors harboring increased BCRP and MDR-1 expression also had increased TFPI1 expression. Our observations are clinically relevant indicating that DOX treatment induces an anticoagulation cascade, leading to inhibition of thrombin and the expression of HIF1 alpha. This in turn activates a pathway leading to drug resistance.	[Davies, Gerald F.; Postnikoff, Spike D. L.; Harkness, Troy A. A.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Arnason, Terra G.] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada; [Berg, Arnie; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada; [Wilson, Heather L.] Univ Saskatchewan, VIDO, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Harkness, TAA (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada.	troy.harkness@usask.ca		Wilson, Heather/0000-0002-1261-0901; Harkness, Troy/0000-0002-8271-7229	Canadian Breast Cancer Foundation; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants to TAH and TGA from the Canadian Breast Cancer Foundation and the Canadian Foundation for Innovation, and to AK from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2012, SEMIN THROMB HEMOST, V38, P129, DOI 10.1055/s-0032-1301410; Amirkhosravi A, 2007, SEMIN THROMB HEMOST, V33, P643, DOI 10.1055/s-2007-991531; Bharadwaj LA, 2002, PHARMACOL RES, V45, P175, DOI 10.1006/phrs.2001.0911; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Castelli R, 2010, CURR VASC PHARMACOL, V8, P482, DOI 10.2174/157016110791330799; Conley SJ, 2012, CELL CYCLE, V11, P1265, DOI 10.4161/cc.19890; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Davies GF, 2010, CANCER LETT, V288, P236, DOI 10.1016/j.canlet.2009.07.011; Davies GF, 2009, DRUG DES DEV THER, V3, P79; Davies GF, 2005, LEUKEMIA LYMPHOMA, V46, P1199, DOI 10.1080/10428190500102555; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Donati MB, 2012, THROMB RES, V129, P348, DOI 10.1016/j.thromres.2011.12.022; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gandemer V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-385; Garnier D, 2012, THROMB RES, V129, pS22, DOI 10.1016/S0049-3848(12)70012-9; Girard TJ, 2007, THROMB RES, V121, P427, DOI 10.1016/j.thromres.2007.04.015; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Henkin J, 2011, EXPERT OPIN THER TAR, V15, P1369, DOI 10.1517/14728222.2011.640319; Henriquez S, 2011, J CELL PHYSIOL, V226, P3278, DOI 10.1002/jcp.22689; Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790; Iversen N, 2002, THROMB RES, V105, P33, DOI 10.1016/S0049-3848(01)00404-2; Iversen N, 1998, BRIT J HAEMATOL, V102, P889, DOI 10.1046/j.1365-2141.1998.00875.x; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Khan DH, 2013, J BIOL CHEM, V288, P16518, DOI 10.1074/jbc.M112.440446; Kurer MA, 2007, MOL BIOL REP, V34, P221, DOI 10.1007/s11033-006-9036-4; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lin YF, 2007, APOPTOSIS, V12, P2163, DOI 10.1007/s10495-007-0136-y; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Liu Y, 2011, CANCER RES, V71, P6492, DOI 10.1158/0008-5472.CAN-11-1145; Liu YY, 1999, ARCH BIOCHEM BIOPHYS, V370, P112, DOI 10.1006/abbi.1999.1371; Lo Nigro C, 2013, J INVEST DERMATOL, V133, P1278, DOI 10.1038/jid.2012.493; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Maciejczyk A, 2013, ADV CLIN EXP MED, V22, P5; Mah LJ, 2010, EPIGENETICS-US, V5, P129, DOI 10.4161/epi.5.2.11080; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; Maroney SA, 2010, THROMB RES, V125, pS52, DOI 10.1016/j.thromres.2010.01.038; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Mast AE, 2000, J BIOL CHEM, V275, P31715, DOI 10.1074/jbc.M006595200; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; Naldini A, 2009, EUR J CANCER, V45, P454, DOI 10.1016/j.ejca.2008.10.012; Noble S, 2010, BRIT J CANCER, V102, pS2, DOI 10.1038/sj.bjc.6605599; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Piro O, 2005, J THROMB HAEMOST, V3, P2677, DOI 10.1111/j.1538-7836.2005.01636.x; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Ruf W, 2003, CANCER RES, V63, P5381; Ruf W, 2012, THROMB RES, V130, pS84, DOI 10.1016/j.thromres.2012.08.285; Schuepbach RA, 2011, BLOOD, V117, P6338, DOI 10.1182/blood-2010-10-316257; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sierko E, 2010, THROMB HAEMOSTASIS, V103, P198, DOI 10.1160/TH09-06-0416; Spek CA, 2012, THROMB RES, V129, pS80, DOI 10.1016/S0049-3848(12)70022-1; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047184; Stavik B, 2010, MOL CARCINOGEN, V49, P951, DOI 10.1002/mc.20679; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Stunkel W, 2011, J BIOMOL SCREEN, V16, P1153, DOI 10.1177/1087057111422103; Suzuki H, 2001, ONCOGENE, V20, P5779, DOI 10.1038/sj.onc.1204742; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Toffoli S, 2007, BBA-MOL CELL RES, V1773, P1558, DOI 10.1016/j.bbamcr.2007.06.002; Volpert OV, 1997, ONCOGENE, V14, P1495, DOI 10.1038/sj.onc.1200977; Waldmann T, 2013, CURR OPIN CELL BIOL, V25, P184, DOI 10.1016/j.ceb.2013.01.001; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; ZACHARSKI LR, 1981, JAMA-J AM MED ASSOC, V245, P831, DOI 10.1001/jama.245.8.831; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028	74	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84611	10.1371/journal.pone.0084611	http://dx.doi.org/10.1371/journal.pone.0084611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489651	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000007
J	Ramirez-Bajo, MJ; de Atauri, P; Ortega, F; Westerhoff, HV; Gelpi, JL; Centelles, JJ; Cascante, M				Jose Ramirez-Bajo, Maria; de Atauri, Pedro; Ortega, Fernando; Westerhoff, Hans V.; Lluis Gelpi, Josep; Centelles, Josep J.; Cascante, Marta			Effects of Cadmium and Mercury on the Upper Part of Skeletal Muscle Glycolysis in Mice	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; ENZYME-ACTIVITIES; SYSTEMS; COPPER; BIOACCUMULATION; THREONINE; TOXICITY; FLUX	The effects of pre-incubation with mercury (Hg2+) and cadmium (Cd2+) on the activities of individual glycolytic enzymes, on the flux and on internal metabolite concentrations of the upper part of glycolysis were investigated in mouse muscle extracts. In the range of metal concentrations analysed we found that only hexokinase and phosphofructokinase, the enzymes that shared the control of the flux, were inhibited by Hg2+ and Cd2+. The concentrations of the internal metabolites glucose-6-phosphate and fructose-6-phosphate did not change significantly when Hg2+ and Cd2+ were added. A mathematical model was constructed to explore the mechanisms of inhibition of Hg2+ and Cd2+ on hexokinase and phosphofructokinase. Equations derived from detailed mechanistic models for each inhibition were fitted to the experimental data. In a concentration-dependent manner these equations describe the observed inhibition of enzyme activity. Under the conditions analysed, the integral model showed that the simultaneous inhibition of hexokinase and phosphofructokinase explains the observation that the concentrations of glucose-6-phosphate and fructose-6-phosphate did not change as the heavy metals decreased the glycolytic flux.	[Jose Ramirez-Bajo, Maria; de Atauri, Pedro; Ortega, Fernando; Lluis Gelpi, Josep; Centelles, Josep J.; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Jose Ramirez-Bajo, Maria; de Atauri, Pedro; Ortega, Fernando; Lluis Gelpi, Josep; Centelles, Josep J.; Cascante, Marta] Univ Barcelona, Fac Biol, IBUB, Barcelona, Spain; [de Atauri, Pedro; Centelles, Josep J.; Cascante, Marta] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Westerhoff, Hans V.] Vrije Univ Amsterdam, Fac Biol, BioCtr Amsterdam, Dept Mol Cell Physiol, Amsterdam, Netherlands; [Westerhoff, Hans V.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester Interdisciplinary Bioctr 3 018, Manchester, Lancs, England; [Westerhoff, Hans V.] Univ Amsterdam, SILS, Amsterdam, Netherlands; [Westerhoff, Hans V.] Univ Amsterdam, NISB, Amsterdam, Netherlands	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Amsterdam; Vrije Universiteit Amsterdam; University of Manchester; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain.	martacascante@ub.edu	Centelles, Josep J./K-2972-2014; Gelpí, Josep Ll./M-6401-2013; Ortega, Fernando/G-2129-2015; de Atauri, Pedro Ramón/R-3957-2019; CASCANTE, MARTA/AFK-5991-2022; de Atauri, Pedro/AAG-2384-2020; Westerhoff, Hans V/I-5762-2012; CASCANTE, MARTA/AAG-4355-2022	Centelles, Josep J./0000-0002-6289-9678; Gelpí, Josep Ll./0000-0002-0566-7723; Ortega, Fernando/0000-0002-3172-2095; de Atauri, Pedro Ramón/0000-0002-7754-7851; CASCANTE, MARTA/0000-0002-2062-4633; Westerhoff, Hans V/0000-0002-0443-6114; CASCANTE, MARTA/0000-0002-2062-4633; ramirez-bajo, maria jose/0000-0003-0119-1331	European Commission [270086]; Spanish Government; European Union [SAF2011-25726]; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spanish Government & European Regional Development Fund (ERDF) [RD06/0020/0046]; Generalitat de Catalunya-AGAUR [2009SGR1308]; ICREA foundation-Generalitat de Catalunya; BBSRC; EPSRC [BBD0190791, BBC0082191, BBF0035281, BBF0035521, BBF0035361, BBG5302251]; EU [91206069]; BBSRC [BB/F003544/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003544/1, BB/C008219/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission); Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spanish Government & European Regional Development Fund (ERDF); Generalitat de Catalunya-AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); ICREA foundation-Generalitat de Catalunya(ICREA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Commission Seventh Framework Programme FP7 (Synergy-COPD project grant agreement no. 270086); the Spanish Government and the European Union FEDER funds (SAF2011-25726) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spanish Government & European Regional Development Fund (ERDF) "Una manera de hacer Europa'' ISCIII-RTICC (RD06/0020/0046); Generalitat de Catalunya-AGAUR, (2009SGR1308). MC acknowledges the support received through the prize "ICREA Academia'' for excellence in research, funded by ICREA foundation-Generalitat de Catalunya. The authors thank the BBSRC, EPSRC (BBD0190791, BBC0082191, BBF0035281, BBF0035521, BBF0035521, BBF0035361, BBG5302251, SySMO), EU-FP7 (BioSim, NucSys, EC-MOAN), ZON-MW (91206069), and other funders for systems biology support (http://www.systembiology.net/support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeyer HU, 1984, METHODS ENZYMATIC AN, VIII; Bergmeyer HU, 1984, METHODS ENZYMATIC AN, VII; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND IA, 1974, J BIOL CHEM, V249, P7824; Chassagnole C, 2003, CR BIOL, V326, P501, DOI 10.1016/S1631-0691(03)00098-2; Ciapaite J, 2009, FEBS J, V276, P3656, DOI 10.1111/j.1742-4658.2009.07084.x; Diaz S, 2006, ENVIRON INT, V32, P711, DOI 10.1016/j.envint.2006.03.004; Fell D., 1997, UNDERSTANDING CONTRO; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; Forstner U., 1979, METAL POLLUTION AQUA; GROEN AK, 1982, J BIOL CHEM, V257, P2754; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; HILMY AM, 1985, COMP BIOCHEM PHYS C, V81, P139, DOI 10.1016/0742-8413(85)90105-7; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jalilehvand F, 2009, INORG CHEM, V48, P5758, DOI 10.1021/ic802278r; Jannaschk D, 1999, FEBS LETT, V445, P144, DOI 10.1016/S0014-5793(99)00117-9; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; KACSER H, 1993, EUR J BIOCHEM, V216, P361, DOI 10.1111/j.1432-1033.1993.tb18153.x; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KESSELER A, 1994, EUR J BIOCHEM, V225, P897, DOI 10.1111/j.1432-1033.1994.0897b.x; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Letelier ME, 2005, CHEM-BIOL INTERACT, V151, P71, DOI 10.1016/j.cbi.2004.12.004; Liliom K, 2000, EUR J BIOCHEM, V267, P4731, DOI 10.1046/j.1432-1327.2000.01526.x; Liliom K, 1999, BIOCHEM BIOPH RES CO, V264, P605, DOI 10.1006/bbrc.1999.1547; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Mas A, 1993, METALES SISTEMAS BIO; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Ovadi J, 1997, CHANNELLING INTERMED, P237; PASSOW H, 1961, PHARMACOL REV, V13, P185; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Puigjaner J, 1997, FEBS LETT, V418, P47, DOI 10.1016/S0014-5793(97)01347-1; Quig D, 1998, Altern Med Rev, V3, P262; Rais B, 1996, BIOTHERMOKINETICS LI, P174; RAPOPORT TA, 1974, EUR J BIOCHEM, V42, P107, DOI 10.1111/j.1432-1033.1974.tb03320.x; Rodriguez-Prados JC, 2009, BIOTECHNOL BIOENG, V103, P609, DOI 10.1002/bit.22271; SMALL JR, 1993, EUR J BIOCHEM, V213, P613, DOI 10.1111/j.1432-1033.1993.tb17801.x; Strydom C, 2006, WATER SA, V32, P543; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x	39	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e80018	10.1371/journal.pone.0080018	http://dx.doi.org/10.1371/journal.pone.0080018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489641	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000001
J	Takasu, M; Tamura, T; Kaichi, Y; Tanitame, K; Akiyama, Y; Date, S; Sakai, A; Kuroda, Y; Awai, K				Takasu, Miyuki; Tamura, Takayuki; Kaichi, Yoko; Tanitame, Keizo; Akiyama, Yuji; Date, Shuji; Sakai, Akira; Kuroda, Yoshiaki; Awai, Kazuo			Magnetic Resonance Evaluation of Multiple Myeloma at 3.0 Tesla: How Do Bone Marrow Plasma Cell Percentage and Selection of Protocols Affect Lesion Conspicuity?	PLOS ONE			English	Article							WATER-FAT DECOMPOSITION; 3-POINT DIXON TECHNIQUE; WORKING GROUP; SUPPRESSION; SEPARATION; DIAGNOSIS; SPINE; IDEAL; MRI	Purpose: To compare various pulse sequences in terms of percent contrast and contrast-to-noise ratio (CNR) for detection of focal multiple myeloma lesions and to assess the dependence of lesion conspicuity on the bone marrow plasma cell percent (BMPC%). Materials and Methods: Sagittal T-1-weighted FSE, fat-suppressed T-2-weighted FSE (FS-T-2 FSE), fast STIR and iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of the lumbar spine were performed (n = 45). Bone marrow (BM)-focal myeloma lesion percent contrast and CNR were calculated. Spearman rank correlation coefficients were obtained between percent contrast, CNR and BMPC%. Percent contrasts and CNRs were compared among the three imaging sequences. Results: BM-focal lesion percent contrasts, CNRs and BMPC% showed significant negative correlations in the three fat-suppression techniques. Percent contrast and CNRs were significantly higher for FS-T2 FSE than for STIR (P < 0.01, P < 0.05, respectively), but no significant differences were found among the three fat-suppression methods in the low tumor load BM group. Conclusion: The higher BMPC% was within BM, the less conspicuous the focal lesion was on fat-suppressed MRI. The most effective protocol for detecting focal lesions was FS-T-2 FSE. In the high tumor load BM group, no significant differences in lesion conspicuity were identified among the three fat-suppression techniques.	[Takasu, Miyuki; Tamura, Takayuki; Kaichi, Yoko; Tanitame, Keizo; Akiyama, Yuji; Date, Shuji; Awai, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan; [Sakai, Akira] Fukushima Med Univ Sch Med, Dept Radiat Life Sci, Fukushima, Japan; [Kuroda, Yoshiaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan	Hiroshima University; Fukushima Medical University; Hiroshima University	Takasu, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan.	my-takasu@syd.odn.ne.jp	Takasu, Miyuki/AAG-7737-2019	Takasu, Miyuki/0000-0001-7375-6501	International Myeloma Foundation Japan's Research Grants; Grants-in-Aid for Scientific Research [23591768] Funding Source: KAKEN	International Myeloma Foundation Japan's Research Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.T. was supported by International Myeloma Foundation Japan's Research Grants 2012, which provided funding for the Japan Myeloma Study Group. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur-Melnyk A, 2005, EUR J RADIOL, V55, P56, DOI 10.1016/j.ejrad.2005.01.017; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Durie Brian G M, 2003, Hematol J, V4, P379; FLECKENSTEIN JL, 1991, RADIOLOGY, V179, P499, DOI 10.1148/radiology.179.2.2014300; Gerdes CM, 2007, AM J ROENTGENOL, V189, pW284, DOI 10.2214/AJR.07.2593; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hanrahan CJ, 2010, RADIOGRAPHICS, V30, P127, DOI 10.1148/rg.301095066; KRICUN ME, 1985, SKELETAL RADIOL, V14, P10, DOI 10.1007/BF00361188; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Ma JF, 2004, J MAGN RESON IMAGING, V20, P1025, DOI 10.1002/jmri.20201; Moulopoulos LA, 2005, ANN ONCOL, V16, P1824, DOI 10.1093/annonc/mdi362; Nakatsu M, 2000, JMRI-J MAGN RESON IM, V11, P56, DOI 10.1002/(SICI)1522-2586(200001)11:1<56::AID-JMRI8>3.0.CO;2-D; RAHMOUNI A, 1993, AM J ROENTGENOL, V160, P1049, DOI 10.2214/ajr.160.5.8470574; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reeder SB, 2004, MAGNET RESON MED, V51, P35, DOI 10.1002/mrm.10675; RICCI C, 1990, RADIOLOGY, V177, P83, DOI 10.1148/radiology.177.1.2399343; Sommer G, 2011, EUR RADIOL, V21, P857, DOI 10.1007/s00330-010-1950-0; Sormaala MJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-128; Tagliafico A, 2011, SKELETAL RADIOL, V40, P717, DOI 10.1007/s00256-010-1050-x; Takasu M, 2012, EUR RADIOL, V22, P1114, DOI 10.1007/s00330-011-2351-8; Terpos E, 2005, ANN ONCOL, V16, P1223, DOI 10.1093/annonc/mdi235; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Walker R, 2007, J CLIN ONCOL, V25, P1121, DOI 10.1200/JCO.2006.08.5803; YEUNG HN, 1986, RADIOLOGY, V159, P783, DOI 10.1148/radiology.159.3.3704157; Yu HZ, 2005, MAGN RESON MED, V54, P1032, DOI 10.1002/mrm.20654	28	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85931	10.1371/journal.pone.0085931	http://dx.doi.org/10.1371/journal.pone.0085931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489680	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000024
J	Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C				Pinter, Daniela; Sumowski, James; DeLuca, John; Fazekas, Franz; Pichler, Alexander; Khalil, Michael; Langkammer, Christian; Fuchs, Siegrid; Enzinger, Christian			Higher Education Moderates the Effect of T2 Lesion Load and Third Ventricle Width on Cognition in Multiple Sclerosis	PLOS ONE			English	Article							BRAIN ATROPHY; RESERVE; IMPAIRMENT	Background: Previous work suggested greater intellectual enrichment might moderate the negative impact of brain atrophy on cognition. This awaits confirmation in independent cohorts including investigation of the role of T2-lesion load (T2-LL), which is another important determinant of cognition in MS. We here thus aimed to test this cognitive reserve hypothesis by investigating whether educational attainment (EA) moderates the negative effects of both brain atrophy and T2-LL on cognitive function in a large sample of MS patients. Methods: 137 patients participated in the study. Cognition was assessed by the Brief Repeatable Battery of Neuropsychological Tests.''T2-LL, normalized brain volume (global volume loss) and third ventricle width (regional volume loss) served as MRI markers. Results: Both T2-LL and atrophy predicted worse cognition, with a stronger effect of T2-LL. Higher EA (as assessed by years of education) also predicted better cognition. Interactions showed that the negative effects of T2-LL and regional brain atrophy were moderated by EA. Conclusions: In a cohort with different stages of MS, higher EA attenuated the negative effects of white matter lesion burden and third ventricle width (suggestive of thalamic atrophy) on cognitive performance. Actively enhancing cognitive reserve might thus be a means to reduce or prevent cognitive problems in MS in parallel to disease modifying drugs.	[Pinter, Daniela; Fazekas, Franz; Pichler, Alexander; Khalil, Michael; Langkammer, Christian; Fuchs, Siegrid; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Sumowski, James] Kessler Fdn Res Ctr West Orange, Neuropsychol & Neurosci Lab, W Orange, NJ USA; [DeLuca, John] Kessler Fdn Res Ctr West Orange, Dept Phys Med & Rehabil & Neurol & Neurosci, W Orange, NJ USA; [Enzinger, Christian] Med Univ Graz, Div Neuroradiol, Graz, Austria	Medical University of Graz; Medical University of Graz	Enzinger, C (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	chris.enzinger@medunigraz.at	Langkammer, Christian/AAC-9044-2020	Langkammer, Christian/0000-0002-7097-9707; Khalil, Michael/0000-0002-5350-3328; Pinter, Daniela/0000-0003-3138-5225				Amato MP, 2013, NEUROLOGY, V80, P1728, DOI 10.1212/WNL.0b013e3182918c6f; Arnett PA, 2013, NEUROLOGY, V80, P1724, DOI 10.1212/WNL.0b013e3182919083; Arnett PA, 2010, NEUROLOGY, V74, P1934, DOI 10.1212/WNL.0b013e3181e4fc52; Beatty WW, 2002, CLIN NEUROPSYCHOL, V16, P472, DOI 10.1076/clin.16.4.472.13904; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Feinstein A, 2013, J NEUROL, V260, P2256, DOI 10.1007/s00415-013-6952-9; Filippi M, 2010, NEUROL SCI, V31, P231, DOI 10.1007/s10072-010-0367-5; Ghaffar O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047206; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller D, 2013, TRENDS COGN SCI, P1; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Plummer DL., 1992, REV NEU RORADIOL, V5, P489, DOI 10.1177/197140099200500413; Rao S, 1990, MANUAL BRIEF REPEATA; Scarpazza C, 2013, RESTOR NEUROL NEUROS, V31, P619, DOI 10.3233/RNN-120261; Schwartz CE, 2013, MULT SCLER J, V19, P87, DOI 10.1177/1352458512444914; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sumowski JF, 2010, NEUROLOGY, V75, P1428, DOI 10.1212/WNL.0b013e3181f881a6; Sumowski JF, 2013, NEUROLOGY, V80, P2186, DOI 10.1212/WNL.0b013e318296e98b; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912	23	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87567	10.1371/journal.pone.0087567	http://dx.doi.org/10.1371/journal.pone.0087567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475309	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300202
J	Prause, M; Christensen, DP; Billestrup, N; Mandrup-Poulsen, T				Prause, Michala; Christensen, Dan Ploug; Billestrup, Nils; Mandrup-Poulsen, Thomas			JNK1 Protects against Glucolipotoxicity-Mediated Beta-Cell Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; N-TERMINAL KINASE; ACTIVATING TRANSCRIPTION FACTOR-3; OXIDATIVE STRESS; FATTY-ACID; TYPE-2; GENE; DEATH; PALMITATE; GLUCOSE	Pancreatic beta-cell dysfunction is central to type 2 diabetes pathogenesis. Prolonged elevated levels of circulating free-fatty acids and hyperglycemia, also termed glucolipotoxicity, mediate beta-cell dysfunction and apoptosis associated with increased c-Jun N-terminal Kinase (JNK) activity. Endoplasmic reticulum (ER) and oxidative stress are elicited by palmitate and high glucose concentrations further potentiating JNK activity. Our aim was to determine the role of the JNK subtypes JNK1, JNK2 and JNK3 in palmitate and high glucose-induced beta-cell apoptosis. We established insulin-producing INS1 cell lines stably expressing JNK subtype specific shRNAs to understand the differential roles of the individual JNK isoforms. JNK activity was increased after 3 h of palmitate and high glucose exposure associated with increased expression of ER and mitochondrial stress markers. JNK1 shRNA expressing INS1 cells showed increased apoptosis and cleaved caspase 9 and 3 compared to non-sense shRNA expressing control INS1 cells when exposed to palmitate and high glucose associated with increased CHOP expression, ROS formation and Puma mRNA expression. JNK2 shRNA expressing INS1 cells did not affect palmitate and high glucose induced apoptosis or ER stress markers, but increased Puma mRNA expression compared to non-sense shRNA expressing INS1 cells. Finally, JNK3 shRNA expressing INS1 cells did not induce apoptosis compared to non-sense shRNA expressing INS1 cells when exposed to palmitate and high glucose but showed increased caspase 9 and 3 cleavage associated with increased DP5 and Puma mRNA expression. These data suggest that JNK1 protects against palmitate and high glucose-induced beta-cell apoptosis associated with reduced ER and mitochondrial stress.	[Prause, Michala; Christensen, Dan Ploug; Mandrup-Poulsen, Thomas] Univ Copenhagen, Endocrinol Res Sect, Dept Biomed Sci, Copenhagen, Denmark; [Billestrup, Nils] Univ Copenhagen, Dept Biomed Sci, Sect Cellular & Metab Res, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Copenhagen; University of Copenhagen; Karolinska Institutet	Prause, M (corresponding author), Univ Copenhagen, Endocrinol Res Sect, Dept Biomed Sci, Copenhagen, Denmark.	michalapr@sund.ku.dk		Billestrup, Nils/0000-0002-4968-8067; Prause, Michala/0000-0002-5922-0396; Mandrup-Poulsen, Thomas/0000-0002-3215-9273	Novo Nordisk foundation; PhD program of Molecular metabolism	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); PhD program of Molecular metabolism	The work was funded by the Novo Nordisk foundation (http://www.novonordiskfonden.dk/) and The PhD program of Molecular metabolism (http://metabolism-endocrinology.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2009, DIABETOLOGIA, V52, P1871, DOI 10.1007/s00125-009-1431-7; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bachar E, 2010, DIABETOLOGIA, V53, P2177, DOI 10.1007/s00125-010-1833-6; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Duprez J, 2011, BIOCHEM BIOPH RES CO, V415, P294, DOI 10.1016/j.bbrc.2011.10.048; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Haase TN, 2013, DIABETOLOGIA, V56, P763, DOI 10.1007/s00125-012-2821-9; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee SM, 2011, MOL CELL BIOCHEM, V354, P207, DOI 10.1007/s11010-011-0820-7; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lin N, 2012, ENDOCRINE, V42, P107, DOI 10.1007/s12020-012-9633-z; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Maris M, 2013, J PROTEOME RES, V12, P347, DOI 10.1021/pr300596g; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Santin I, 2011, DIABETES, V60, P3279, DOI 10.2337/db11-0758; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Varona-Santos JL, 2008, DIABETOLOGIA, V51, P2271, DOI 10.1007/s00125-008-1169-7; Wang PZ, 2010, BMB REP, V43, P738, DOI 10.5483/BMBRep.2010.43.11.738; Wang Q, 2009, MOL CELL BIOCHEM, V324, P183, DOI 10.1007/s11010-008-9997-9; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	46	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87067	10.1371/journal.pone.0087067	http://dx.doi.org/10.1371/journal.pone.0087067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475223	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800082
J	Zhang, PL; Chang, WH; Fong, B; Gao, F; Liu, CM; Al Alam, D; Bellusci, S; Lu, WG				Zhang, Peilin; Chang, Wen-Hsuan; Fong, Brendan; Gao, Fan; Liu, Chunming; Al Alam, Denise; Bellusci, Saverio; Lu, Wange			Regulation of Induced Pluripotent Stem ( iPS) Cell Induction by Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Gene Expression; Induced Pluripotent Stem (iPS) Cell; Reprogramming; Wnt Signaling; c-myc	EMBRYONIC STEM; BETA-CATENIN; SOMATIC-CELLS; SELF-RENEWAL; EXPRESSION; MYC; DIFFERENTIATION; ACTIVATION; NETWORK; TARGET	Background: Wnt signaling plays an important role in somatic cell reprogramming. Results: Through interaction with Klf4, Oct4 and Sox2, -catenin enhances expression of pluripotency circuitry genes to promote somatic cell reprogramming. However, -catenin is not required for pluripotent stem cell self-renewal. Conclusion: Wnt/-catenin signaling has different roles in pluripotent stem cell self-renewal and somatic cell reprogramming. Significance: These studies reveal novel mechanisms underlying the reprogramming process by Wnt/-catenin signaling. Wnt signaling has been implicated in promoting somatic cell reprogramming. However, its molecular mechanisms remain unknown. Here we report that Wnt/-catenin enhances iPSCs induction at the early stage of reprogramming. The augmented reprogramming induced by -catenin is not due to increased total cell population or activation of c-Myc. In addition, -catenin interacts with reprogramming factors Klf4, Oct4, and Sox2, further enhancing expression of pluripotency circuitry genes. These studies reveal novel mechanisms underlying the regulation of reprogramming somatic cells to pluripotency by Wnt/-catenin signaling.	[Zhang, Peilin; Chang, Wen-Hsuan; Fong, Brendan; Gao, Fan; Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Chang, Wen-Hsuan] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Liu, Chunming; Bellusci, Saverio] Univ Kentucky, Dept Mol & Cellular Biochem, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA; [Al Alam, Denise] Childrens Hosp Los Angeles, Dev Biol & Regenerat Med, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Kentucky; Children's Hospital Los Angeles	Zhang, PL (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	peilinzh@usc.edu; wangelu@usc.edu	Alam, Denise Al/AAG-9406-2019	Chang, Wen-Hsuan/0000-0002-6155-8644	California Institute of Regenerative Medicine [RB1-01353]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This research was supported by a grant from the California Institute of Regenerative Medicine (RB1-01353).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Evans P, 2010, TLS-TIMES LIT SUPPL, P30; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wu D., TRENDS BIOCH SCI, V35, P161; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	34	36	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9221	9232		10.1074/jbc.M113.542845	http://dx.doi.org/10.1074/jbc.M113.542845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24482235	Green Published, hybrid			2022-12-25	WOS:000333472100040
J	Abarca, N; Jahn, R; Zimmermann, J; Enke, N				Abarca, Nelida; Jahn, Regine; Zimmermann, Jonas; Enke, Neela			Does the Cosmopolitan Diatom Gomphonema parvulum (Kutzing) Kutzing Have a Biogeography?	PLOS ONE			English	Article							BACILLARIOPHYTA; TYPIFICATION; DISPERSAL; DIVERSITY; PATTERNS; PROVIDE; AFRICA; TAXA	Diatom cultures of the G. parvulum species complex were established from seven different sites in the Faroe Islands, Sweden, Germany, Mexico and Korea, and were studied in detail. Eight morphodemes were identified which corresponded to the descriptions of the cosmopolitan taxon G. parvulum (Kutzing) Kutzing sensu lato: its nominate variety (var. parvulum), G. parvulum var. exilissimum Grunow and G. parvulum f. saprophilum Lange-Bertalot & Reichardt, G. [parvulum var.] lagenula Kutzing plus four unidentifiable morphodemes. The concatenated analysis of the sequences of the markers 18SV4, rbcL, and ITS as well as morphological data resulted in a separation of four taxa based on their biogeography in Mexico, Korea, central Continental Europe and Northern Atlantic Europe. Mantel tests showed a significant correlation between molecular and geographical distances. The diagnoses of two taxa, G. parvulum sensu stricto, and G. lagenula, were emended, G. saprophilum elevated to species rank and epitypes designated. One species was newly described.	[Abarca, Nelida; Jahn, Regine; Zimmermann, Jonas; Enke, Neela] Free Univ Berlin, Bot Garten, Berlin, Germany; [Abarca, Nelida; Jahn, Regine; Zimmermann, Jonas; Enke, Neela] Free Univ Berlin, Bot Museum Berlin Dahlem, Berlin, Germany; [Zimmermann, Jonas] Univ Giessen, AG Spezielle Bot, D-35390 Giessen, Germany	Free University of Berlin; Free University of Berlin; Justus Liebig University Giessen	Abarca, N (corresponding author), Free Univ Berlin, Bot Garten, Berlin, Germany.	n.abarca@bgbm.org		Zimmermann, Jonas/0000-0002-0522-0569	Verein der Freunde des Botanischen Gartens Berlin	Verein der Freunde des Botanischen Gartens Berlin	The authors thank the Verein der Freunde des Botanischen Gartens Berlin for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algal Flora of Korea, 2011, FRESHW DIAT 4, V3; Alverson AJ, 2008, PROTIST, V159, P339, DOI 10.1016/j.protis.2008.04.001; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Bellinger BJ, 2006, HYDROBIOLOGIA, V573, P75, DOI 10.1007/s10750-006-0262-5; Besse-Lototskaya A, 2011, ECOL INDIC, V11, P456, DOI 10.1016/j.ecolind.2010.06.017; Boo SM, 2010, MOL ECOL, V19, P4328, DOI 10.1111/j.1365-294X.2010.04813.x; Carter JR, 1960, J QUEKETT MICROSCOPI, V12, P255; Cermeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010037; Chao A, 2006, OIKOS, V114, P479, DOI 10.1111/j.2006.0030-1299.14814.x; Chen GF, 2007, EUR J PHYCOL, V42, P163, DOI 10.1080/09670260601149784; Cleve PT, 1894, KONGL SVENSKA VETENS, V26; Cocquyt C, 2007, CRYPTOGAMIE ALGOL, V28, P107; Dawson PA, 1972, BRIT PHYCOL J, V7, P255, DOI DOI 10.1080/00071617200650261; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finlay BJ, 2002, PROTIST, V153, P261, DOI 10.1078/1434-4610-00103; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Frenguelli J, 1923, B ACAD NAC CIENC COR, V32, P11; GEITLER LOTHAR, 1932, ARCH PROTISTENK, V78, P1; Grunow A, 1878, ABH ZOOL BOT GES WIE, V10; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heiberg P.A.C., 1863, CONSPECTUS CRITICUS; Hofmann G, 2011, DIATOMEEN SUSSWASSER; HOHN MATTHEW H., 1959, NOTULAE NATURAE [PHILADELPHIA], V316, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hustedt F., 1930, S WASSER FLORA MITTE, V10; Hustedt F, 1985, KIESELALGEN DEUTSCHL, V7; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jahn R., 1986, P 8 INT DIATOM S, P191; Juttner I, 2013, DIATOM RES, V28, P303, DOI 10.1080/0269249X.2013.797924; Kaczmarska I, 2009, EUR J PHYCOL, V44, P461, DOI 10.1080/09670260902855873; Kermarrec L, 2013, PROTIST, V164, P686, DOI 10.1016/j.protis.2013.07.005; Klemencic AK, 2010, PERIOD BIOL, V112, P179; Kobayasi H, 2006, H KOBAYASISS ATLAS J, V1; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1991, BACILLARIOPHYCEAE 1; Krienitz L, 2012, FOTTEA, V12, P231, DOI 10.5507/fot.2012.017; Kutzing F. T., 1844, KIESELSCHALIGEN BACI; KUTZING F.T., 1849, SPECIES ALGARUM; Lange-Bertalot H., 1993, BIBLIOTHECA DIATOMOL, V27, P1; Lange-Bertalot H., 1996, ICONOGR DIATOMOL, V2; Lange-Bertalot H, 1999, ICONOGR DIATOMOL, V6; LANGEBERTALOT H, 2007, P 1 CENTR EUR DIAT M, P107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mann DG, 2004, PHYCOLOGIA, V43, P459, DOI 10.2216/i0031-8884-43-4-459.1; MANTEL N, 1967, CANCER RES, V27, P209; Mayer, 1928, DENKSCHR K BAYER BOT, VXI, P83; McBride Stacy A., 1998, Diatom Research, V13, P293; Metzeltin Ditmar, 2005, V15, P7; Michels-Estrada A, 2003, THESIS TU MUNCHEN; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moser G., 1998, BIBLIOTHECA DIATOMOL, V38, P464; Mpawenayo B, 2005, BELG J BOT, V138, P152; Muller K., 2005, PHYDE 0 995 PHYLOGEN; PADISAK J, 2009, ENCY INLAND WATERS, V1, P219, DOI DOI 10.1016/B978-012370626-3.00256-8; Patrick R., 1975, ACAD NATURAL SCI PHI, V13; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulickova A, 2010, PROTIST, V161, P353, DOI 10.1016/j.protis.2009.12.003; R Core Team, 2021, R LANG ENV STAT COMP; Rabenhorst L, 1864, FLORA EUROPACA ALGAR, V1; Rambaut A., 2008, FIGTREE V1 2 2; Reichardt E, 1999, ICONOGR DIATOMOL, V9; Romero OE, 2013, DIATOM RES, V28, P175, DOI 10.1080/0269249X.2013.770801; Ross R, 1979, NOVA HEDWIGIA S, V64, P513; Round FE, 1990, DIATOMS BIOL MORPHOL; Souffreau C, 2013, PROTIST, V164, P101, DOI 10.1016/j.protis.2012.04.001; Souffreau C, 2011, MOL PHYLOGENET EVOL, V61, P866, DOI 10.1016/j.ympev.2011.08.031; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Van Heurck H., 1896, TREATISE DIATOMACEAE; VANDAM H, 1994, NETHERLANDS J AQUATI, V28, P117, DOI DOI 10.1007/BF02334251; Vanormelingen P, 2008, BIODIVERS CONSERV, V17, P393, DOI 10.1007/s10531-007-9257-4; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; WALLACE JOHN H., 1950, BUTLER UNIV BOT STUD, V9, P227; Walley WJ, 2001, WATER RES, V35, P4285, DOI 10.1016/S0043-1354(01)00162-2; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wortley AH, 2006, SYST BIOL, V55, P677, DOI 10.1080/10635150600899798; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	84	73	80	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86885	10.1371/journal.pone.0086885	http://dx.doi.org/10.1371/journal.pone.0086885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489799	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000077
J	Hilbert, A; Baldofski, S; Zenger, M; Lowe, B; Kersting, A; Braehler, E				Hilbert, Anja; Baldofski, Sabrina; Zenger, Markus; Loewe, Bernd; Kersting, Anette; Braehler, Elmar			Weight Bias Internalization Scale: Psychometric Properties and Population Norms	PLOS ONE			English	Article							PERCEIVED DISCRIMINATION; OBESITY; HEALTH; ADULTS; OVERWEIGHT; STIGMA; ASSOCIATIONS; SAMPLE	Objective: Internalizing the pervasive weight bias commonly directed towards individuals with overweight and obesity, co-occurs with increased psychopathology and impaired quality of life. This study sought to establish population norms and psychometric properties of the most widely used self-report questionnaire, the Weight Bias Internalization Scale (WBIS), in a representative community sample. Design and Methods: In a survey of the German population, N = 1158 individuals with overweight and obesity were assessed with the WBIS and self-report measures for convergent validation. Results: Item analysis revealed favorable item-total correlation of all but one WBIS item. With this item removed, item homogeneity and internal consistency were excellent. The one-factor structure of the WBIS was confirmed using confirmatory factor analysis. Convergent validity was shown through significant associations with measures of depressive and somatoform symptoms. The WBIS contributed to the explanation of variance in depressive and somatoform symptoms over and above body mass index. Higher WBIS scores were found in women than in men, in individuals with obesity than in individuals with overweight, and in those with lower education or income than those with higher education or income. Sex-specific norms were provided. Conclusions: The results showed good psychometric properties of the WBIS after removal of one item. Future research is warranted on further indicators of reliability and validity, for example, retest reliability, sensitivity to change, and prognostic validity.	[Hilbert, Anja; Baldofski, Sabrina] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr AdiposityDis, D-04109 Leipzig, Germany; [Hilbert, Anja; Baldofski, Sabrina; Zenger, Markus; Braehler, Elmar] Univ Leipzig, Med Ctr, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Loewe, Bernd] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Kersting, Anette] Univ Leipzig, Med Ctr, Clin Psychosomat Med & Psychotherapy, D-04109 Leipzig, Germany; [Braehler, Elmar] Univ Clin Giessen Marburg, Clin Psychosomat & Psychotherapy, Giessen, Germany	Leipzig University; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; University Hospital of Giessen & Marburg	Hilbert, A (corresponding author), Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr AdiposityDis, D-04109 Leipzig, Germany.	anja.hilbert@medizin.uni-leipzig.de	Braehler, Elmar/C-6535-2009; Löwe, Bernd/AAG-4038-2020	Braehler, Elmar/0000-0002-2648-2728; Lowe, Bernd/0000-0003-4220-3378	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research [01EO1001]; German Research Foundation; Leipzig University	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Leipzig University	This research was supported by internal funds by the Department of Medical Psychology and Medical Sociology at the University of Leipzig and by grant 01EO1001 from the German Federal Ministry of Education and Research. We acknowledge support from the German Research Foundation and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Carels RA, 2010, EAT BEHAV, V11, P180, DOI 10.1016/j.eatbeh.2010.03.002; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DESTATIS (Federal Statistical Office), 2013, POP 2013; Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448; Durso LE, 2012, OBESITY FACTS, V5, P869, DOI 10.1159/000345931; Durso LE, 2012, INT J EAT DISORDER, V45, P423, DOI 10.1002/eat.20933; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Gierk B, JAMA INTERN IN PRESS; Han E, 2011, ECON HUM BIOL, V9, P381, DOI 10.1016/j.ehb.2011.07.002; Hansson LM, 2010, SCAND J PUBLIC HEALT, V38, P587, DOI 10.1177/1403494810372266; Hilbert A, 2013, OBESITY, DOI [10.1002/oby.20561, DOI 10.1002/0BY.20561.[]; Hilbert A, 2010, ESSANFAELLE ADIPOSIT; Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kurth BM, 2012, BUNDESGESUNDHEITSBLA, V55, P980, DOI 10.1007/s00103-012-1504-5; Latner JD, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-3; Li W, 2009, OBES REV, V10, P87, DOI 10.1111/j.1467-789X.2008.00528.x; Lillis J, 2010, OBESITY, V18, P971, DOI 10.1038/oby.2009.353; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Pearl RL, 2013, BODY IMAGE, DOI [10.1016/j.bodyim.2013.09.005, DOI 10.1016/J.B0DYIM.2013.09.005.[]; Puhl RM, 2007, OBESITY, V15, P19, DOI 10.1038/oby.2007.521; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Roberto CA, 2012, OBESITY, V20, P533, DOI 10.1038/oby.2011.123; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schollgen I, 2011, HEALTH PSYCHOL, V30, P326, DOI 10.1037/a0022514; Visscher TLS, 2006, OBESITY, V14, P2054, DOI 10.1038/oby.2006.240	31	85	86	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86303	10.1371/journal.pone.0086303	http://dx.doi.org/10.1371/journal.pone.0086303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489713	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000031
J	Huang, AH; Xu, SZ; Cai, XD				Huang, Anhui; Xu, Shizhong; Cai, Xiaodong			Whole-Genome Quantitative Trait Locus Mapping Reveals Major Role of Epistasis on Yield of Rice	PLOS ONE			English	Article							EMPIRICAL BAYESIAN LASSO; FUNCTIONAL GENOMICS; DRAFT SEQUENCE; GENETIC-BASIS; HYBRID; POPULATION; SELECTION; QTLS; REGRESSION; HETEROSIS	Although rice yield has been doubled in most parts of the world since 1960s, thanks to the advancements in breeding technologies, the biological mechanisms controlling yield are largely unknown. To understand the genetic basis of rice yield, a number of quantitative trait locus (QTL) mapping studies have been carried out, but whole-genome QTL mapping incorporating all interaction effects is still lacking. In this paper, we exploited whole-genome markers of an immortalized F-2 population derived from an elite rice hybrid to perform QTL mapping for rice yield characterized by yield per plant and three yield component traits. Our QTL model includes additive and dominance main effects of 1,619 markers and all pair-wise interactions, with a total of more than 5 million possible effects. The QTL mapping identified 54, 5, 28 and 4 significant effects involving 103, 9, 52 and 7 QTLs for the four traits, namely the number of panicles per plant, the number of grains per panicle, grain weight, and yield per plant. Most identified QTLs are involved in digenic interactions. An extensive literature survey of experimentally characterized genes related to crop yield shows that 19 of 54 effects, 4 of 5 effects, 12 of 28 effects and 2 of 4 effects for the four traits, respectively, involve at least one QTL that locates within 2 cM distance to at least one yield-related gene. This study not only reveals the major role of epistasis influencing rice yield, but also provides a set of candidate genetic loci for further experimental investigation.	[Huang, Anhui; Cai, Xiaodong] Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA; [Xu, Shizhong] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of Miami; University of California System; University of California Riverside	Cai, XD (corresponding author), Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA.	x.cai@miami.edu			National Science Foundation (NSF) [0746882]; Agriculture and Food Research Initiative (AFRI) of the USDA National Institute of Food and Agriculture under the Plant Genome, Genetics and Breeding Program [2007-35300-18285]; Division of Computing and Communication Foundations [0746882] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Agriculture and Food Research Initiative (AFRI) of the USDA National Institute of Food and Agriculture under the Plant Genome, Genetics and Breeding Program; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation (NSF) under NSF CAREER Award no. 0746882 to XC and by the Agriculture and Food Research Initiative (AFRI) of the USDA National Institute of Food and Agriculture under the Plant Genome, Genetics and Breeding Program 2007-35300-18285 to SX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; de Los Campos Gustavo, 2013, Methods Mol Biol, V1019, P299, DOI 10.1007/978-1-62703-447-0_12; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Heang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031325; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Huang AH, 2013, BMC GENET, V13, DOI 10.1186/1471-2156-14-5; Ikeda M, 2013, CURR OPIN PLANT BIOL, V16, P213, DOI 10.1016/j.pbi.2013.02.002; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jiang YH, 2012, BIOTECHNOL ADV, V30, P1059, DOI 10.1016/j.biotechadv.2011.08.013; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; LANDER ES, 1989, GENETICS, V121, P185; Li F, 2010, CELL RES, V20, P838, DOI 10.1038/cr.2010.69; Li JX, 2000, THEOR APPL GENET, V101, P248, DOI 10.1007/s001220051476; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; R Development Core Team, 2012, R LANG ENV STAT COMP; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Song XJ, 2008, RICE, V1, P135, DOI 10.1007/s12284-008-9018-3; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang ET, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-108; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Xu SZ, 2003, GENETICS, V163, P789; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yi NJ, 2009, GENETICS, V181, P1101, DOI 10.1534/genetics.108.099556; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZENG ZB, 1994, GENETICS, V136, P1457; Zha XJ, 2009, PLANT BIOTECHNOL J, V7, P611, DOI 10.1111/j.1467-7652.2009.00428.x; Zhang QF, 2008, MOL PLANT, V1, P715, DOI 10.1093/mp/ssn043; Zhou G, 2012, P NATL ACAD SCI USA, V109, P15847, DOI 10.1073/pnas.1214141109; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	47	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87330	10.1371/journal.pone.0087330	http://dx.doi.org/10.1371/journal.pone.0087330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489897	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000132
J	Kahn, JG; Jiwani, A; Gomez, GB; Hawkes, SJ; Chesson, HW; Broutet, N; Kamb, ML; Newman, LM				Kahn, James G.; Jiwani, Aliya; Gomez, Gabriela B.; Hawkes, Sarah J.; Chesson, Harrell W.; Broutet, Nathalie; Kamb, Mary L.; Newman, Lori M.			The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEXUALLY-TRANSMITTED INFECTIONS; ANTENATAL SYPHILIS; CONGENITAL-SYPHILIS; DIAGNOSTIC-ACCURACY; MATERNAL SYPHILIS; CARE; OUTCOMES; METAANALYSIS; PREVALENCE	Background: Syphilis in pregnancy imposes a significant global health and economic burden. More than half of cases result in serious adverse events, including infant mortality and infection. The annual global burden from mother-to-child transmission (MTCT) of syphilis is estimated at 3.6 million disability-adjusted life years (DALYs) and $309 million in medical costs. Syphilis screening and treatment is simple, effective, and affordable, yet, worldwide, most pregnant women do not receive these services. We assessed cost-effectiveness of scaling-up syphilis screening and treatment in existing antenatal care (ANC) programs in various programmatic, epidemiologic, and economic contexts. Methods and Findings: We modeled the cost, health impact, and cost-effectiveness of expanded syphilis screening and treatment in ANC, compared to current services, for 1,000,000 pregnancies per year over four years. We defined eight generic country scenarios by systematically varying three factors: current maternal syphilis testing and treatment coverage, syphilis prevalence in pregnant women, and the cost of healthcare. We calculated program and net costs, DALYs averted, and net costs per DALY averted over four years in each scenario. Program costs are estimated at $4,142,287 - $8,235,796 per million pregnant women (2010 USD). Net costs, adjusted for averted medical care and current services, range from net savings of $12,261,250 to net costs of $1,736,807. The program averts an estimated 5,754 - 93,484 DALYs, yielding net savings in four scenarios, and a cost per DALY averted of $24 - $111 in the four scenarios with net costs. Results were robust in sensitivity analyses. Conclusions: Eliminating MTCT of syphilis through expanded screening and treatment in ANC is likely to be highly cost-effective by WHO-defined thresholds in a wide range of settings. Countries with high prevalence, low current service coverage, and high healthcare cost would benefit most. Future analyses can be tailored to countries using local epidemiologic and programmatic data.	[Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Kahn, James G.] Super Models Global Hlth, Berkeley, CA USA; [Jiwani, Aliya] Super Models Global Hlth, Arlington, VA 22203 USA; [Gomez, Gabriela B.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Hawkes, Sarah J.] UCL, UCL Inst Global Hlth, London, England; [Chesson, Harrell W.; Kamb, Mary L.] Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA; [Broutet, Nathalie; Newman, Lori M.] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland	University of California System; University of California San Francisco; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Centers for Disease Control & Prevention - USA; World Health Organization	Jiwani, A (corresponding author), Super Models Global Hlth, Arlington, VA 22203 USA.	ajiwani@gmail.com	Hawkes, Sarah/AAK-7375-2020	Hawkes, Sarah/0000-0003-1062-3538	World Health Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X; [Anonymous], 2012, CHOOS INT AR COST EF; Blandford JM, 2007, SEX TRANSM DIS, V34, pS61, DOI 10.1097/01.olq.0000258314.20752.5f; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Hossain M, 2007, SEX TRANSM DIS, V34, pS22, DOI 10.1097/01.olq.0000261049.84824.40; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Jamison DT, 2006, GLOBAL BURDEN DIS RI; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lujan J, 2008, SAMJ S AFR MED J, V98, P49; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Mehta SD, 2006, JAIDS-J ACQ IMM DEF, V42, P116, DOI 10.1097/01.qai.0000200662.40215.34; Montoya PJ, 2006, B WORLD HEALTH ORGAN, V84, P97, DOI 10.2471/BLT.04.018663; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P997, DOI 10.1097/OLQ.0b013e3182260987; Peeling RW, 2006, SEX TRANSM INFECT, V82, P425, DOI 10.1136/sti.2005.017251; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; STIGMA, 2019, GUID MAN SEX TRANSM; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Tinajeros F, 2006, SEX TRANSM INFECT, V82, pV17, DOI 10.1136/sti.2006.022640; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; World Bank, 2010, GDP PER CAP CURR US; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2008, COUNTD 2015 TRACK PR; World Health Organization, 2013, WHO CHOICE COUNTR SP; World Health Organization, 2007, GLOB EL CONG SYPH RA; World Health Organization, 2008, GLOB HLTH OBS DAT RE; World Health Organization, 2012, INV CAS EL MOTH TO C; World Health Organization, 2011, CHOOSING INT AR COST	35	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87510	10.1371/journal.pone.0087510	http://dx.doi.org/10.1371/journal.pone.0087510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489931	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330570000156
J	Leitner, NR; Lassnig, C; Rom, R; Heider, S; Bago-Horvath, Z; Eferl, R; Muller, S; Kolbe, T; Kenner, L; Rulicke, T; Strobl, B; Muller, M				Leitner, Nicole R.; Lassnig, Caroline; Rom, Rita; Heider, Susanne; Bago-Horvath, Zsuzsanna; Eferl, Robert; Mueller, Simone; Kolbe, Thomas; Kenner, Lukas; Ruelicke, Thomas; Strobl, Birgit; Mueller, Mathias			Inducible, Dose-Adjustable and Time-Restricted Reconstitution of Stat1 Deficiency In Vivo	PLOS ONE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; ENCEPHALOMYOCARDITIS VIRUS; TRANSCRIPTIONAL ACTIVATION; SERINE PHOSPHORYLATION; TARGETED DISRUPTION; GENE-EXPRESSION; TRANSGENIC MICE; VIRAL DISEASE; INTERFERON; MUTATIONS	Signal transducer and activator of transcription (STAT) 1 is a key player in interferon (IFN) signaling, essential in mediating host defense against viruses and other pathogens. STAT1 levels are tightly regulated and loss-or gain-of-function mutations in mice and men lead to severe diseases. We have generated a doxycycline (dox) -inducible, FLAG-tagged Stat1 expression system in mice lacking endogenous STAT1 (i.e. Stat1(ind) mice). We show that STAT1 expression depends on the time and dose of dox treatment in primary cells and a variety of organs isolated from Stat1(ind) mice. In bone marrow-derived macrophages, a fraction of the amount of STAT1 present in WT cells is sufficient for full expression of IFN-induced genes. Dox-induced STAT1 established protection against virus infections in primary cells and mice. The availability of the Stat1(ind) mouse model will enable an examination of the consequences of variable amounts of STAT1. The model will also permit the study of STAT1 dose-dependent and reversible functions as well as of STAT1's contributions to the development, progression and resolution of disease.	[Leitner, Nicole R.; Lassnig, Caroline; Rom, Rita; Bago-Horvath, Zsuzsanna; Mueller, Simone; Strobl, Birgit; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Lassnig, Caroline; Kolbe, Thomas; Mueller, Mathias] Univ Vet Med Vienna, Univ Ctr Biomodels Austria BIAT, Vienna, Austria; [Heider, Susanne; Bago-Horvath, Zsuzsanna; Kenner, Lukas] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Heider, Susanne; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Bago-Horvath, Zsuzsanna] Univ Vet Med Vienna, Inst Pharmacol & Toxicol, Vienna, Austria; [Eferl, Robert] Med Univ Vienna, Inst Canc Res, Dept Internal Med 1, Ctr Comprehens Canc, Vienna, Austria; [Kolbe, Thomas] Univ Nat Resources & Appl Life Sci, Dept IFA Tulln, Tulln, Austria; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna	Leitner, NR (corresponding author), Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria.	nicole.leitner@vetmeduni.ac.at; mathias.mueller@vetmeduni.ac.at	Kolbe, Thomas/H-8215-2018	Kolbe, Thomas/0000-0003-2974-8066; Muller, Mathias/0000-0002-7879-3552; Eferl, Robert/0000-0002-6074-7144; Strobl, Birgit/0000-0001-5716-3212; Kenner, Lukas/0000-0003-2184-1338; LASSNIG, Caroline/0000-0001-7905-3620	Austrian Science Fund [SFB-F28]; Austrian Genome Research Programme GEN-AU II and III "Austromouse"	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Genome Research Programme GEN-AU II and III "Austromouse"	This work was supported by the Austrian Science Fund SFB-F28 "JAK-STAT" and the Austrian Genome Research Programme GEN-AU II and III "Austromouse." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders K, 2012, TRANSGENIC RES, V21, P1099, DOI 10.1007/s11248-011-9580-0; Averbuch D, 2011, PEDIATR INFECT DIS J, V30, P352, DOI 10.1097/INF.0b013e3181fdff4a; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Baran-Marszak F, 2004, BLOOD, V104, P2475, DOI 10.1182/blood-2003-10-3508; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BOCKER R, 1984, ARZNEIMITTEL-FORSCH, V34-1, P446; BOCKER R, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2116; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Carocci M, 2012, VIRULENCE, V3, P351, DOI 10.4161/viru.20573; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Chen LS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-22; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Choi J, 2013, BREAST CANCER RES TR, V137, P417, DOI 10.1007/s10549-012-2383-z; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Doi K, 2011, J COMP PATHOL, V144, P25, DOI 10.1016/j.jcpa.2010.05.001; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Gil MP, 2006, BLOOD, V107, P987, DOI 10.1182/blood-2005-07-2834; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Guleria A, 2011, J BIOSCIENCES, V36, P929, DOI 10.1007/s12038-011-9164-4; Hannesdottir L, 2012, INT J DEV BIOL, V56, P279, DOI 10.1387/ijdb.113397lh; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hori T, 2012, J CLIN IMMUNOL, V32, P1213, DOI 10.1007/s10875-012-9744-6; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Klover PJ, 2010, NEOPLASIA, V12, P899, DOI 10.1593/neo.10716; Ko JK, 2011, FASEB J, V25, P2638, DOI 10.1096/fj.11-181560; Kong XF, 2010, BLOOD, V116, P5895, DOI 10.1182/blood-2010-04-280586; Koromilas Antonis E, 2013, JAKSTAT, V2, pe23353, DOI 10.4161/jkst.23353; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Kristensen IA, 2011, J CLIN IMMUNOL, V31, P265, DOI 10.1007/s10875-010-9480-8; Lee CK, 1999, J EXP MED, V190, P1451, DOI 10.1084/jem.190.10.1451; Leitner NR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-48; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liddle FJ, 2006, BIOCHEMISTRY-US, V45, P5599, DOI 10.1021/bi0525674; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Ohtaki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00367; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Prchal-Murphy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039141; Raven JF, 2011, CELL CYCLE, V10, P794, DOI 10.4161/cc.10.5.14956; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Romberg N, 2013, J ALLERGY CLIN IMMUN, V131, P1691, DOI 10.1016/j.jaci.2013.01.004; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Schneckenleithner C, 2011, ONCOTARGET, V2, P1043; Schonig K, 2013, TRANSGENIC RES, V22, P251, DOI 10.1007/s11248-012-9660-9; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Schultz J, 2010, CLIN EXP METASTAS, V27, P133, DOI 10.1007/s10585-010-9310-7; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Takiguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054009; Teppner I, 2004, LAB ANIM-UK, V38, P406, DOI 10.1258/0023677041958882; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; VOGEL SN, 1987, J VIROL, V61, P812, DOI 10.1128/JVI.61.3.812-818.1987; Wallner B, 2012, TRANSGENIC RES, V21, P217, DOI 10.1007/s11248-011-9519-5; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114	77	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86608	10.1371/journal.pone.0086608	http://dx.doi.org/10.1371/journal.pone.0086608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489749	Green Submitted, gold, Green Published			2022-12-25	WOS:000330570000050
J	Priest, HD; Fox, SE; Rowley, ER; Murray, JR; Michael, TP; Mockler, TC				Priest, Henry D.; Fox, Samuel E.; Rowley, Erik R.; Murray, Jessica R.; Michael, Todd P.; Mockler, Todd C.			Analysis of Global Gene Expression in Brachypodium distachyon Reveals Extensive Network Plasticity in Response to Abiotic Stress	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; HIGH-SALINITY; COLD STRESS; RUBISCO ACTIVASE; PLANT-RESPONSES; GENOME SEQUENCE; DOWN-REGULATION; LOW-TEMPERATURE; ARABIDOPSIS; DROUGHT	Brachypodium distachyon is a close relative of many important cereal crops. Abiotic stress tolerance has a significant impact on productivity of agriculturally important food and feedstock crops. Analysis of the transcriptome of Brachypodium after chilling, high-salinity, drought, and heat stresses revealed diverse differential expression of many transcripts. Weighted Gene Co-Expression Network Analysis revealed 22 distinct gene modules with specific profiles of expression under each stress. Promoter analysis implicated short DNA sequences directly upstream of module members in the regulation of 21 of 22 modules. Functional analysis of module members revealed enrichment in functional terms for 10 of 22 network modules. Analysis of condition-specific correlations between differentially expressed gene pairs revealed extensive plasticity in the expression relationships of gene pairs. Photosynthesis, cell cycle, and cell wall expression modules were down-regulated by all abiotic stresses. Modules which were up-regulated by each abiotic stress fell into diverse and unique gene ontology GO categories. This study provides genomics resources and improves our understanding of abiotic stress responses of Brachypodium.	[Priest, Henry D.; Rowley, Erik R.; Murray, Jessica R.; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Priest, Henry D.; Mockler, Todd C.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Fox, Samuel E.; Rowley, Erik R.; Mockler, Todd C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Fox, Samuel E.; Rowley, Erik R.; Mockler, Todd C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Michael, Todd P.] Rutgers State Univ, Waksman Inst, New Brunswick, NJ 08903 USA; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Donald Danforth Plant Science Center; Washington University (WUSTL); Oregon State University; Oregon State University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Mockler, TC (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	tmockler@danforthcenter.org	Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; Priest, Henry/0000-0002-0998-8137	TCM from the DOE - Plant Feedstock Genomics for Bioenergy Program [DE-FG02-08ER64630]; Direct For Biological Sciences [1025965] Funding Source: National Science Foundation	TCM from the DOE - Plant Feedstock Genomics for Bioenergy Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant to TCM (DE-FG02-08ER64630) from the DOE - Plant Feedstock Genomics for Bioenergy Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Ashraf M, 2010, J MED PLANTS RES, V4, P112; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Chew YH, 2011, CURR OPIN BIOTECH, V22, P281, DOI 10.1016/j.copbio.2010.11.011; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feltus FA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-44; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fisher R.A., 1963, STAT TABLES BIOL AGR, V6th; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Haga N, 2011, PLANT PHYSIOL, V157, P706, DOI 10.1104/pp.111.180836; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janska A, 2011, FUNCT INTEGR GENOMIC, V11, P307, DOI 10.1007/s10142-011-0213-8; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim K, 2005, PLANT CELL PHYSIOL, V46, P522, DOI 10.1093/pcp/pci052; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lauria M, 2011, BBA-GENE REGUL MECH, V1809, P369, DOI 10.1016/j.bbagrm.2011.03.002; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-65; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim H, 2009, MOL CELLS, V27, P641, DOI 10.1007/s10059-009-0085-0; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; LOPUSHINSKY W, 1969, BOT GAZ, V130, P258, DOI 10.1086/336501; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Marino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2479; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Mukhopadhyay P, 2013, PLANT CELL PHYSIOL, V54, P528, DOI 10.1093/pcp/pct012; Oliveira G, 2004, PLANT ECOL, V175, P179, DOI 10.1007/s11258-005-4876-x; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parre E, 2007, PLANT PHYSIOL, V144, P503, DOI 10.1104/pp.106.095281; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Rowley ER, 2011, INTECH OPEN ACCESS J; Salvucci ME, 2001, PLANT PHYSIOL, V127, P1053, DOI 10.1104/pp.010357; Sarkar NK, 2014, PLANT MOL BIOL, V84, P125, DOI 10.1007/s11103-013-0123-3; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Turano FJ, 1998, PLANT PHYSIOL, V117, P1411, DOI 10.1104/pp.117.4.1411; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Witcombe JR, 2008, PHILOS T R SOC B, V363, P703, DOI 10.1098/rstb.2007.2179; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yazaki J, 2004, PHYSIOL GENOMICS, V17, P87, DOI 10.1152/physiolgenomics.00201.2003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhao HJ, 2005, PHOTOSYNTHETICA, V43, P473, DOI 10.1007/s11099-005-0076-0; Zhong L, 2009, AFR J BIOTECHNOL, V8, P6201; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	71	63	64	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87499	10.1371/journal.pone.0087499	http://dx.doi.org/10.1371/journal.pone.0087499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489928	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000154
J	Rojo-Arreola, L; Long, T; Asarnow, D; Suzuki, BM; Singh, R; Caffrey, CR				Rojo-Arreola, Liliana; Long, Thavy; Asarnow, Dan; Suzuki, Brian M.; Singh, Rahul; Caffrey, Conor R.			Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis	PLOS ONE			English	Article							HMG-COA REDUCTASE; MEVALONATE PATHWAY; IN-VITRO; PROTEIN PRENYLATION; ANTISCHISTOSOMAL ACTION; MOLECULAR-MECHANISMS; MANSONI; CANCER; INHIBITORS; PARASITE	The mevalonate pathway is essential in eukaryotes and responsible for a diversity of fundamental synthetic activities. 3-hydroxy- 3-methylglutaryl coenzyme A reductase (HMGR) is the rate-limiting enzyme in the pathway and is targeted by the ubiquitous statin drugs to treat hypercholesterolemia. Independent reports have indicated the cidal effects of statins against the flatworm parasite, S. mansoni, and the possibility that SmHMGR is a useful drug target to develop new statin-based anti-schistosome therapies. For six commercially available statins, we demonstrate concentration-and time-dependent killing of immature (somule) and adult S. mansoni in vitro at sub-micromolar and micromolar concentrations, respectively. Cidal activity trends with statin lipophilicity whereby simvastatin and pravastatin are the most and least active, respectively. Worm death is preventable by excess mevalonate, the product of HMGR. Statin activity against somules was quantified both manually and automatically using a new, machine learning-based automated algorithm with congruent results. In addition, to chemical targeting, RNA interference (RNAi) of HMGR also kills somules in vitro and, again, lethality is blocked by excess mevalonate. Further, RNAi of HMGR of somules in vitro subsequently limits parasite survival in a mouse model of infection by up to 80%. Parasite death, either via statins or specific RNAi of HMGR, is associated with activation of apoptotic caspase activity. Together, our genetic and chemical data confirm that S. mansoni HMGR is an essential gene and the relevant target of statin drugs. We discuss our findings in context of a potential drug development program and the desired product profile for a new schistosomiasis drug.	[Rojo-Arreola, Liliana; Long, Thavy; Suzuki, Brian M.; Singh, Rahul; Caffrey, Conor R.] Univ Calif San Francisco, Dept Pathol, Ctr Discovery & Innovat Parasit Dis, San Francisco, CA 94140 USA; [Asarnow, Dan; Singh, Rahul] San Francisco State Univ, Dept Comp Sci, San Francisco, CA 94132 USA	University of California System; University of California San Francisco; California State University System; San Francisco State University	Caffrey, CR (corresponding author), Univ Calif San Francisco, Dept Pathol, Ctr Discovery & Innovat Parasit Dis, San Francisco, CA 94140 USA.	conor.caffrey@ucsf.edu		Asarnow, Daniel/0000-0001-7870-5308; Rojo-Arreola, Liliana/0000-0002-4163-0506	UC MEXUS-CONACYT; National Institute of Allergy And Infectious Diseases of the National Institutes of Health [1R01AI089896, R21AI107390]; National Science Foundation [IIS 0644418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089896, R21AI107390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	UC MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	LR-A was supported by a UC MEXUS-CONACYT Postdoctoral Research Fellowship. The research reported was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under award numbers 1R01AI089896 (BMS, CRC, DA, and RS) and R21AI107390 (CRC), and by the National Science Foundation through grant IIS 0644418 (DA and RS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478; Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; Andersson M, 1996, J INTERF CYTOK RES, V16, P435, DOI 10.1089/jir.1996.16.435; ANDREWS P, 1985, PHARMACOL THERAPEUT, V29, P129, DOI 10.1016/0163-7258(85)90020-8; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Araújo Neusa, 2002, Rev. Soc. Bras. Med. Trop., V35, P35, DOI 10.1590/S0037-86822002000100007; Asarnow DE, 2013, IEEE T MED IMAGING, V32, P1007, DOI 10.1109/TMI.2013.2247412; Barrios-Gonzalez J, 2010, APPL MICROBIOL BIOT, V85, P869, DOI 10.1007/s00253-009-2239-6; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Berndt N, 2011, NAT PROTOC, V6, P1775, DOI 10.1038/nprot.2011.387; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Caffrey CR, 2011, CURR OPIN INFECT DIS, V24, P410, DOI 10.1097/QCO.0b013e328349156f; Chang HL, 2013, BBA-GEN SUBJECTS, V1830, P4053, DOI 10.1016/j.bbagen.2013.04.011; CHEN GZ, 1990, N-S ARCH PHARMACOL, V342, P477; CHEN GZ, 1993, MOL BIOCHEM PARASIT, V59, P287, DOI 10.1016/0166-6851(93)90226-N; CHEN GZ, 1991, EXP PARASITOL, V73, P82, DOI 10.1016/0014-4894(91)90010-T; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Corcos L, 2013, DIGEST LIVER DIS, V45, P795, DOI 10.1016/j.dld.2013.02.002; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COXON FP, 2008, IBMS BONEKEY, V5, P357; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; de Hostos E. L., 2012, PARASITIC HELMINTHS, P217, DOI [10.1002/9783527652969.ch13, DOI 10.1002/9783527652969.CH13]; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Doenhoff MJ, 2009, PARASITOLOGY, V136, P1825, DOI 10.1017/S0031182009000493; Dubois F, 2009, MOL BIOCHEM PARASIT, V168, P7, DOI 10.1016/j.molbiopara.2009.06.001; Dvorak J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000449; Eastman RT, 2006, J LIPID RES, V47, P233, DOI 10.1194/jlr.R500016-JLR200; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; ENDO A, 1985, J MED CHEM, V28, P401, DOI 10.1021/jm00382a001; ENDO A, 1992, J LIPID RES, V33, P1569; Garzoni LR, 2004, INT J ANTIMICROB AG, V23, P273, DOI 10.1016/j.ijantimicag.2003.07.020; GOLDSTEIN JL, 1984, J LIPID RES, V25, P1450; GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Henneman L, 2011, BBA-MOL CELL BIOL L, V1811, P227, DOI 10.1016/j.bbalip.2011.01.002; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jolly ER, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r65; Joshi Hemant N., 1999, Pharmacy and Pharmacology Communications, V5, P269; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Lee H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S4; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Manjunath BS, 1996, IEEE T PATTERN ANAL, V18, P837, DOI 10.1109/34.531803; Manzoni M, 2002, APPL MICROBIOL BIOT, V58, P555, DOI 10.1007/s00253-002-0932-9; MEYER F, 1970, BIOCHIM BIOPHYS ACTA, V210, P257, DOI 10.1016/0005-2760(70)90170-0; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Mo HB, 2004, EXP BIOL MED, V229, P567, DOI 10.1177/153537020422900701; Montalvetti A, 2000, BIOCHEM J, V349, P27, DOI 10.1042/0264-6021:3490027; Montalvetti A, 2001, J BIOL CHEM, V276, P33930, DOI 10.1074/jbc.M103950200; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ochocki JD, 2013, MEDCHEMCOMM, V4, P476, DOI 10.1039/c2md20299a; Olliaro P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001138; Osman A, 1999, MOL BIOCHEM PARASIT, V100, P27, DOI 10.1016/S0166-6851(99)00029-8; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; Paveley RA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001762; Platt J., 1998, SEQUENTIAL MINIMAL O; Pradines B, 2007, ANTIMICROB AGENTS CH, V51, P2654, DOI 10.1128/AAC.01330-06; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; RAJKOVIC A, 1989, P NATL ACAD SCI USA, V86, P8217, DOI 10.1073/pnas.86.21.8217; Rauthan M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-243; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Rozen S, 2000, Methods Mol Biol, V132, P365; SABAH AA, 1986, EXP PARASITOL, V61, P294, DOI 10.1016/0014-4894(86)90184-0; Sashank Singhvi R., 2009, 2009 INT C CONTR AUT, P1; Soliman MFM, 2005, ACTA TROP, V93, P1, DOI 10.1016/j.actatropica.2004.08.006; Stefanic S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000850; Tamarozzi F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-53; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; VANDEWAA EA, 1989, AM J PHYSIOL, V257, pR618, DOI 10.1152/ajpregu.1989.257.3.R618; Vermeire JJ, 2003, INT J PARASITOL, V33, P721, DOI 10.1016/S0020-7519(03)00046-8; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wasko BM, 2011, J PHARMACOL EXP THER, V337, P540, DOI 10.1124/jpet.110.175521; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	86	52	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87594	10.1371/journal.pone.0087594	http://dx.doi.org/10.1371/journal.pone.0087594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489942	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000162
J	von Borstel, UK; Glissman, C				von Borstel, Uta Koenig; Glissman, Chantal			Alternatives to Conventional Evaluation of Rideability in Horse Performance Tests: Suitability of Rein Tension and Behavioural Parameters	PLOS ONE			English	Article							BREEDING OBJECTIVES; PERSONALITY-TRAITS; TEMPERAMENT TESTS; PRACTICAL GUIDE; REPEATABILITY; EQUITATION; SITUATION; RESPONSES; HANDLER; RIDDEN	Rideability, i.e. the ease and comfort with which a horse can be ridden, is considered to be one of the most important traits in riding horses. However, at present rideability is evaluated rather subjectively in breeding horse performance tests. The aim of the present study was to evaluate the role horse behaviour as well as degree and quality of rein tension might play in judges' evaluation of horses' rideability. Mares (n = 33) and stallions (n = 13) from two different mare-and one stallion-testing station were observed twice during their performance test dressage training. During these rides, rein tension was measured continuously, and frequency of behaviour patterns such as head-tossing, tail swishing, and snorting was recorded. Rein tension parameters showed reasonable repeatabilities within horse-rider pairs (e. g. mean rein tension: r(2) = 0.61 +/- 0.11; variance of rein tension: r(2) = 0.52 +/- 0.14). Regression analysis revealed that a larger proportion of variance in rideability scores could be explained by maximum (17%), mean (16%) and variance (15%) of rein tension compared to horses' or riders' behavioural parameters (tail-swishing: 5% and rider's use of hands: 5%, respectively). According to mixed model analysis, rideability scores dropped (all P<0.05) with increasing mean, maximum and variability in rein tension (e. g. -0.37 +/- 0.14 scores per additional 10 Newton in mean tension). However, mean rein tension differed between testing stations (P<0.0001) ranging between 9.1 +/- 1.6 N in one station and 21.7 +/- 1.3 N in another station. These results indicate that quantity and consistency of rein tension is either directly or indirectly an important factor for judges to derive rideability scores. Given the importance of rein tension parameters to both rider comfort and horse welfare, potentially, measurements of rein tension along with behaviour observations assessing the quality of rein contact (e. g. distinguishing a light contact from attempts to evade contact) might be used to make the assessment of rideability more impartial.	[von Borstel, Uta Koenig; Glissman, Chantal] Univ Gottingen, Dept Anim Sci, D-37073 Gottingen, Germany	University of Gottingen	von Borstel, UK (corresponding author), Univ Gottingen, Dept Anim Sci, D-37073 Gottingen, Germany.	koenigvb@gwdg.de	von Borstel, Uta U. König/H-6747-2012	Konig von Borstel, Uta/0000-0002-7313-1197	EU via the European Funds for Regional Development; German Research Foundation; Open Access Publication Funds of the Gottingen University	EU via the European Funds for Regional Development; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by the EU via the European Funds for Regional Development, the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner M, 2010, SCHWEIZ ARCH TIERH, V152, P194; Beer N, 1993, THESIS U MUNICH GERM; BMVEL (Federal Ministry of Food Agriculture and Consumer Protection), 2003, LEITL VER HENGST DTS; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BROWN JS, 1951, J EXP PSYCHOL, V41, P317, DOI 10.1037/h0060166; Christensen JW, 2011, EQUINE VET J, V43, P223, DOI 10.1111/j.2042-3306.2010.00151.x; Clayton HM, 2003, EXP TECHNIQUES, V27, P34, DOI 10.1111/j.1747-1567.2003.tb00112.x; Egenvall A, 2012, J VET BEHAV, V7, P157, DOI 10.1016/j.jveb.2011.08.006; Falconer D. S., 1984, EINFUHRUNG QUANTITAT, P184; Glissmann C, 2012, 8 INT EQ SCI C 2012, P20; Gorecka-Bruzda A, 2011, ANTHROZOOS, V24, P379, DOI 10.2752/175303711X13159027359827; Gorecka-Bruzda A, 2011, APPL ANIM BEHAV SCI, V133, P207, DOI 10.1016/j.applanim.2011.05.011; Gorecka-Bruzda A, 2010, ANIM SCI PAP REP, V28, P27; Graf P, 2013, J VET BEHAV, V8, P316, DOI 10.1016/j.jveb.2013.05.006; Graf P, 2013, ZUCHTUNGSKUNDE, V85, P129; Hawson LA, 2010, J VET BEHAV, V5, P170, DOI 10.1016/j.jveb.2009.12.010; Heleski CR, 2009, VET J, V181, P56, DOI 10.1016/j.tvjl.2009.03.011; Janssens S, 2010, 44 INT C INT SOC APP, P207; Koenen EPC, 2004, LIVEST PROD SCI, V88, P77, DOI 10.1016/j.livprodsci.2003.10.011; Konig v. Borstel U., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138006; Konig von Borstel U, 2012, 8 INT EQ SCI C 2012, P129; Kuhnke S, 2010, COMP EXERC PHYSIOL, V7, P57, DOI 10.1017/S1755254010000243; Larose C, 2006, LATERALITY, V11, P355, DOI 10.1080/13576500600624221; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Lewczuk D, 2004, ANIM SCI PAP REP, P125; Ludewig AK, 2013, J VET BEHAV, V8, P15; McGreevy PD, 2009, J VET BEHAV, V4, P193, DOI 10.1016/j.jveb.2008.08.001; Miesner S., 2000, RICHTLINIEN REITEN F, V1; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Oki H, 2007, J ANIM BREED GENET, V124, P185, DOI 10.1111/j.1439-0388.2007.00659.x; Pasing S, 2012, 8 INT EQ SCI C 2012, P125; Pasing S, 2011, 62 ANN M EUR ASS AN, P142; Peeters M, 2012, J VET BEHAV, V7, P311, DOI 10.1016/j.jveb.2011.10.008; Randle H, 2013, 9 INT EQ SCI C 2013, P37; Roberds JH, 2006, FOREST ECOL MANAG, V228, P215, DOI 10.1016/j.foreco.2006.03.005; Rothmann J, 2010, 61 ANN M EUR ASS AN, P151; Teegen R, 2008, ZUCHTUNGSKUNDE, V80, P99; Visser EK, 2003, APPL ANIM BEHAV SCI, V82, P279, DOI 10.1016/S0168-1591(03)00083-2; von Borstel UK, 2011, PHYSIOL BEHAV, V104, P454, DOI 10.1016/j.physbeh.2011.05.010; von Borstel UK, 2013, J VET BEHAV, V8, P326, DOI 10.1016/j.jveb.2013.04.066; von Borstel UK, 2012, APPL ANIM BEHAV SCI, V139, P251, DOI 10.1016/j.applanim.2012.04.007; von Borstel UK, 2011, APPL ANIM BEHAV SCI, V135, P277, DOI 10.1016/j.applanim.2011.10.007; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; von Velsen-Zerweck A, 1998, INTEGRIERTE ZUCHTWER; Warren-Smith AK, 2007, APPL ANIM BEHAV SCI, V108, P157, DOI 10.1016/j.applanim.2006.11.017; Wejer J, 2013, J EQUINE VET SCI, V33, P483, DOI 10.1016/j.jevs.2012.07.009	46	33	33	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87285	10.1371/journal.pone.0087285	http://dx.doi.org/10.1371/journal.pone.0087285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489890	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000130
J	Zhang, J; Chen, J; Yang, J; Xu, CW; Ding, JW; Yang, J; Guo, Q; Hu, Q; Jiang, H				Zhang, Jing; Chen, Jing; Yang, Jian; Xu, Changwu; Ding, Jiawang; Yang, Jun; Guo, Qing; Hu, Qi; Jiang, Hong			Sodium Ferulate Inhibits Neointimal Hyperplasia in Rat Balloon Injury Model	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; DRUG-ELUTING STENTS; BARE-METAL STENTS; ANGIOTENSIN-CONVERTING ENZYME; OXIDATIVE STRESS; VASCULAR INJURY; NADPH OXIDASE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; DEPENDENT PATHWAY	Background/Aim: Neointimal formation after vessel injury is a complex process involving multiple cellular and molecular processes. Inhibition of intimal hyperplasia plays an important role in preventing proliferative vascular diseases, such as restenosis. In this study, we intended to identify whether sodium ferulate could inhibit neointimal formation and further explore potential mechanisms involved. Methods: Cultured vascular smooth muscle cells (VSMCs) isolated from rat thoracic aorta were pre-treated with 200 mu mol/L sodium ferulate for 1 hour and then stimulated with 1 mu mol/L angiotensin II (Ang II) for 1 hour or 10% serum for 48 hours. Male Sprague-Dawley rats subjected to balloon catheter insertion were administrated with 200 mg/kg sodium ferulate (or saline) for 7 days before sacrificed. Results: In presence of sodium ferulate, VSMCs exhibited decreased proliferation and migration, suppressed intracellular reactive oxidative species production and NADPH oxidase activity, increased SOD activation and down-regulated p38 phosphorylation compared to Ang II-stimulated alone. Meanwhile, VSMCs treated with sodium ferulate showed significantly increased protein expression of smooth muscle alpha-actin and smooth muscle myosin heavy chain protein. The components of Notch pathway, including nuclear Notch-1 protein, Jagged-1, Hey-1 and Hey-2 mRNA, as well as total beta-catenin protein and Cyclin D1 mRNA of Wnt signaling, were all significantly decreased by sodium ferulate in cells under serum stimulation. The levels of serum 8-iso-PGF2 alpha and arterial collagen formation in vessel wall were decreased, while the expression of contractile markers was increased in sodium ferulate treated rats. A decline of neointimal area, as well as lower ratio of intimal to medial area was observed in sodium ferulate group. Conclusion: Sodium ferulate attenuated neointimal hyperplasia through suppressing oxidative stress and phenotypic switching of VSMCs.	[Zhang, Jing; Chen, Jing; Xu, Changwu; Hu, Qi; Jiang, Hong] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Yang, Jian; Ding, Jiawang; Yang, Jun] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Cardiol, Yichang, Hubei, Peoples R China; [Guo, Qing] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Ophthalmol, Yichang, Hubei, Peoples R China	Wuhan University; China Three Gorges University; China Three Gorges University	Jiang, H (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China.	jianghongmed@126.com			National Natural Science Foundation of the People's Republic of China [81170195, 81200088, 81200156]; Fundamental Research Funds for the Central Universities [20103020201000203, 201130202020014, 302274023]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of the People's Republic of China (NO. 81170195, 81200088 and 81200156) and the Fundamental Research Funds for the Central Universities (20103020201000203, 201130202020014; 302274023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmar AE, 2009, INT J CARDIOL, V132, P398, DOI 10.1016/j.ijcard.2008.03.001; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Barone E, 2009, BIOGERONTOLOGY, V10, P97, DOI 10.1007/s10522-008-9160-8; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Chen GP, 2009, LIFE SCI, V84, P81, DOI 10.1016/j.lfs.2008.11.003; Chen LL, 2009, J PHARMACEUT BIOMED, V50, P127, DOI 10.1016/j.jpba.2009.03.039; Chen YL, 2013, INT J MOL MED, V31, P597, DOI 10.3892/ijmm.2013.1256; Choi R, 2011, EXP MOL MED, V43, P676, DOI 10.3858/emm.2011.43.12.078; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; De Labriolle A, 2009, ARCH CARDIOVASC DIS, V102, P209, DOI 10.1016/j.acvd.2009.01.004; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; FERNANDEZORTIZ A, 1994, J AM COLL CARDIOL, V23, P1562, DOI 10.1016/0735-1097(94)90657-2; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Frid MG, 1997, ARTERIOSCL THROM VAS, V17, P1203, DOI 10.1161/01.ATV.17.7.1203; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gao LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062489; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Hou YZ, 2004, EUR J PHARMACOL, V499, P85, DOI 10.1016/j.ejphar.2004.07.107; HUANG HC, 1992, EUR J PHARMACOL, V221, P381; Jin Y, 2005, ACTA PHARMACOL SIN, V26, P943, DOI 10.1111/j.1745-7254.2005.00158.x; Jin Y, 2007, ACTA PHARMACOL SIN, V28, P1881, DOI 10.1111/j.1745-7254.2007.00634.x; Khan W, 2012, J CONTROL RELEASE, V161, P703, DOI 10.1016/j.jconrel.2012.02.010; Kibos A, 2007, Acute Card Care, V9, P111, DOI 10.1080/17482940701263285; Kim SR, 2013, J MED FOOD, V16, P95, DOI 10.1089/jmf.2013.1602.com; Kochiadakis GE, 2010, INT J CARDIOL, V142, P33, DOI 10.1016/j.ijcard.2008.12.105; Koh PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054217; Landmesser U, 2001, CORONARY ARTERY DIS, V12, P455, DOI 10.1097/00019501-200109000-00004; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Lyon C, 2011, FRONT BIOSCI-LANDMRK, V16, P644, DOI 10.2741/3711; Ma ZC, 2010, BIOL PHARM BULL, V33, P752, DOI 10.1248/bpb.33.752; Merlet E, 2013, CARDIOVASC RES, V98, P458, DOI 10.1093/cvr/cvt045; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Nikol S, 1996, ATHEROSCLEROSIS, V123, P17, DOI 10.1016/0021-9150(96)05807-8; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Papafaklis MI, 2012, PHARMACOL THERAPEUT, V134, P43, DOI 10.1016/j.pharmthera.2011.12.006; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rhyu MR, 2005, J CARDIOVASC PHARM, V46, P99, DOI 10.1097/01.fjc.0000164092.88821.49; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Sorescu D, 2001, FREE RADICAL BIO MED, V30, P603, DOI 10.1016/S0891-5849(00)00507-4; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Wang BH, 2005, CARDIOVASC DRUG REV, V23, P161; Zargham R, 2008, CLIN SCI, V114, P257, DOI 10.1042/CS20070228; Zhang DX, 2009, J CARDIOVASC PHARM T, V14, P302, DOI 10.1177/1074248409347986; Zhu LH, 2013, MOL CELL BIOCHEM, V373, P53, DOI 10.1007/s11010-012-1474-9	58	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87561	10.1371/journal.pone.0087561	http://dx.doi.org/10.1371/journal.pone.0087561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489938	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000159
J	Boyle, PM; Park, CJ; Arevalo, HJ; Vigmond, EJ; Trayanova, NA				Boyle, Patrick M.; Park, Carolyn J.; Arevalo, Hermenegild J.; Vigmond, Edward J.; Trayanova, Natalia A.			Sodium Current Reduction Unmasks a Structure-Dependent Substrate for Arrhythmogenesis in the Normal Ventricles	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; BRUGADA-SYNDROME; CARDIAC TISSUE; IMPULSE PROPAGATION; IONIC MECHANISMS; SLOW CONDUCTION; DEATH-SYNDROME; HEART; REPOLARIZATION; RABBIT	Background: Organ-scale arrhythmogenic consequences of source-sink mismatch caused by impaired excitability remain unknown, hindering the understanding of pathophysiology in disease states like Brugada syndrome and ischemia. Objective: We sought to determine whether sodium current (I-Na) reduction in the structurally normal heart unmasks a regionally heterogeneous substrate for the induction of sustained arrhythmia by premature ventricular contractions (PVCs). Methods: We conducted simulations in rabbit ventricular computer models with 930 unique combinations of PVC location (10 sites) and coupling interval (250-400 ms), I-Na reduction (30 or 40% of normal levels), and post-PVC sinus rhythm (arrested or persistent). Geometric characteristics and source-sink mismatch were quantitatively analyzed by calculating ventricular wall thickness and a newly formulated 3D safety factor (SF), respectively. Results: Reducing I-Na to 30% of its normal level created a substrate for sustained arrhythmia induction by establishing large regions of critical source-sink mismatch (SF<1) for ectopic wavefronts propagating from thin to thick tissue. In the same simulations but with 40% of normal I-Na, PVCs did not induce reentry because the volume of tissue with SF<1 was >95% smaller. Likewise, when post-PVC sinus activations were persistent instead of arrested, no ectopic excitations initiated sustained reentry because sinus activation breakthroughs engulfed the excitable gap. Conclusion: Our new SF formulation can quantify ectopic wavefront propagation robustness in geometrically complex 3D tissue with impaired excitability. This novel methodology was applied to show that I-Na reduction precipitates source-sink mismatch, creating a potent substrate for sustained arrhythmia induction by PVCs originating near regions of ventricular wall expansion, such as the RV outflow tract.	[Boyle, Patrick M.; Park, Carolyn J.; Arevalo, Hermenegild J.; Trayanova, Natalia A.] Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA; [Vigmond, Edward J.] Univ Bordeaux 1, Inst LIRYC, Bordeaux, France	Johns Hopkins University; UDICE-French Research Universities; Universite de Bordeaux	Trayanova, NA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA.	ntrayanova@jhu.edu	Boyle, Patrick/HDN-7133-2022	Boyle, Patrick/0000-0001-9048-1239; Park, Carolyn/0000-0002-0877-2959; Trayanova, Natalia/0000-0002-8661-063X	National Science and Engineering Research Council of Canada; US National Institutes of Health [NIH-R01-HL103428, NIH-DP1-HL123271]; US National Science Foundation [NSF-CDI-1124804, NSF-OCI-108849]; French National Research Agency [ANR-10-IAHU-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL123271, R01HL103428] Funding Source: NIH RePORTER; Direct For Biological Sciences [1124804] Funding Source: National Science Foundation	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); French National Research Agency(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a postdoctoral fellowship from the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), US National Institutes of Health (http://www.nih.gov) grants NIH-R01-HL103428 and NIH-DP1-HL123271, US National Science Foundation (http://www.nsf.gov) grants NSF-CDI-1124804 and NSF-OCI-108849, and French National Research Agency (http://www.agence-nationale-recherche.fr/Intl) grant ANR-10-IAHU-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo H, 2007, CHAOS, V17, DOI 10.1063/1.2430637; Baroudi G, 2000, FEBS LETT, V467, P12, DOI 10.1016/S0014-5793(00)01099-1; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; Boukens BJ, 2013, CIRC RES, V113, P137, DOI 10.1161/CIRCRESAHA.113.301565; Boyle PM, 2010, BIOPHYS J, V98, pL57, DOI 10.1016/j.bpj.2010.03.018; Boyle PM, 2010, ANN BIOMED ENG, V38, P456, DOI 10.1007/s10439-009-9829-4; Bueno-Orovio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052234; Catalano O, 2009, EUR HEART J, V30, P2241, DOI 10.1093/eurheartj/ehp252; Ciaccio EJ, 2000, CIRCULATION, V102, P464; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; FAST VG, 1995, CARDIOVASC RES, V30, P449, DOI 10.1016/0008-6363(95)00071-2; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; Hoogendijk MG, 2011, HEART RHYTHM, V8, P111, DOI 10.1016/j.hrthm.2010.09.066; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lambiase PD, 2009, CIRCULATION, V120, P106, DOI 10.1161/CIRCULATIONAHA.108.771401; LOBO FV, 1992, CAN J CARDIOL, V8, P261; Lukas A, 1996, CARDIOVASC RES, V32, P593, DOI 10.1016/0008-6363(96)00115-0; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; MENDEZ C, 1970, CIRC RES, V26, P135, DOI 10.1161/01.RES.26.2.135; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Morita H, 2003, J CARDIOVASC ELECTR, V14, P373, DOI 10.1046/j.1540-8167.2003.02365.x; Nademanee K, 1997, CIRCULATION, V96, P2595, DOI 10.1161/01.CIR.96.8.2595; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Papavassiliu T, 2004, J CARDIOVASC ELECTR, V15, P1133, DOI 10.1046/j.1540-8167.2004.03681.x; Postema PG, 2010, J AM COLL CARDIOL, V55, P789, DOI 10.1016/j.jacc.2009.11.033; Postema PG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P379, DOI 10.1161/CIRCEP.108.790543; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; Rodriguez B, 2005, CIRC RES, V97, P168, DOI 10.1161/01.RES.0000174429.00987.17; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; Shaw RM, 1997, CIRC RES, V81, P727; Shirai N, 2002, CARDIOVASC RES, V53, P348, DOI 10.1016/S0008-6363(01)00494-1; Tada H, 1998, AM J CARDIOL, V81, P519, DOI 10.1016/S0002-9149(97)00942-9; Tan BH, 2006, AM J PHYSIOL-HEART C, V291, pH1822, DOI 10.1152/ajpheart.00101.2006; Trayanova N, 2002, CHAOS, V12, P962, DOI 10.1063/1.1483955; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Veeraraghavan R, 2008, CARDIOVASC RES, V77, P749, DOI 10.1093/cvr/cvm090; Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Volders PGA, 1999, CIRCULATION, V99, P206, DOI 10.1161/01.CIR.99.2.206; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86947	10.1371/journal.pone.0086947	http://dx.doi.org/10.1371/journal.pone.0086947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489810	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000091
J	de Moraes, FR; Neshich, IAP; Mazoni, I; Yano, IH; Pereira, JGC; Salim, JA; Jardine, JG; Neshich, G				de Moraes, Fabio R.; Neshich, Izabella A. P.; Mazoni, Ivan; Yano, Inacio H.; Pereira, Jose G. C.; Salim, Jose A.; Jardine, Jose G.; Neshich, Goran			Improving Predictions of Protein-Protein Interfaces by Combining Amino Acid-Specific Classifiers Based on Structural and Physicochemical Descriptors with Their Weighted Neighbor Averages	PLOS ONE			English	Article							WEB-BASED APPLICATION; SITE PREDICTION; BINDING-SITE; GENOMICS; SERVER; IDENTIFICATION; CONSERVATION; COMPLEXES; ALGORITHM; RESIDUES	Protein-protein interactions are involved in nearly all regulatory processes in the cell and are considered one of the most important issues in molecular biology and pharmaceutical sciences but are still not fully understood. Structural and computational biology contributed greatly to the elucidation of the mechanism of protein interactions. In this paper, we present a collection of the physicochemical and structural characteristics that distinguish interface-forming residues (IFR) from free surface residues (FSR). We formulated a linear discriminative analysis (LDA) classifier to assess whether chosen descriptors from the BlueStar STING database (http://www.cbi.cnptia.embrapa.br/SMS/) are suitable for such a task. Receiver operating characteristic (ROC) analysis indicates that the particular physicochemical and structural descriptors used for building the linear classifier perform much better than a random classifier and in fact, successfully outperform some of the previously published procedures, whose performance indicators were recently compared by other research groups. The results presented here show that the selected set of descriptors can be utilized to predict IFRs, even when homologue proteins are missing (particularly important for orphan proteins where no homologue is available for comparative analysis/indication) or, when certain conformational changes accompany interface formation. The development of amino acid type specific classifiers is shown to increase IFR classification performance. Also, we found that the addition of an amino acid conservation attribute did not improve the classification prediction. This result indicates that the increase in predictive power associated with amino acid conservation is exhausted by adequate use of an extensive list of independent physicochemical and structural parameters that, by themselves, fully describe the nano-environment at protein-protein interfaces. The IFR classifier developed in this study is now integrated into the BlueStar STING suite of programs. Consequently, the prediction of protein-protein interfaces for all proteins available in the PDB is possible through STING_interfaces module, accessible at the following website: (http://www.cbi.cnptia.embrapa.br/SMS/predictions/index.html).	[de Moraes, Fabio R.; Neshich, Izabella A. P.; Mazoni, Ivan; Pereira, Jose G. C.] Univ Estadual Campinas, Inst Biol, Sao Paulo, Brazil; [de Moraes, Fabio R.; Neshich, Izabella A. P.; Mazoni, Ivan; Yano, Inacio H.; Pereira, Jose G. C.; Jardine, Jose G.; Neshich, Goran] Natl Ctr Agr Informat, Brazilian Agr Res Corp EMBRAPA, Sao Paulo, Brazil; [Salim, Jose A.] Univ Estadual Campinas, Sch Elect & Comp Engn, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Campinas	Neshich, G (corresponding author), Natl Ctr Agr Informat, Brazilian Agr Res Corp EMBRAPA, Sao Paulo, Brazil.	Goran.Neshich@cnptia.embrapa.br	de Moraes, Fábio R/B-8331-2017; Salim, José Augusto/AAY-4366-2020; Yano, Inacio H/F-3109-2013; Pena, Izabella/P-6345-2017	de Moraes, Fábio R/0000-0002-0425-0352; Salim, José Augusto/0000-0002-8675-7068; Pena, Izabella/0000-0001-5242-3724; Yano, Inacio/0000-0003-2698-6309	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/03108-1, 2009/16376-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Grants #2009/03108-1 and #2009/16376-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Borro LC, 2006, GENET MOL RES, V5, P193; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chang DTH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S3; Chen CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037706; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen HL, 2008, BIOPHYS J, V94, P918, DOI 10.1529/biophysj.107.114280; da Silveira CH, 2009, PROTEINS, V74, P727, DOI 10.1002/prot.22187; deFreitas SM, 1997, FEBS LETT, V409, P121, DOI 10.1016/S0014-5793(97)00419-5; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandez JH, 2003, BIOCHEM BIOPH RES CO, V308, P219, DOI 10.1016/S0006-291X(03)01363-9; Hamer R, 2010, PROTEINS, V78, P2781, DOI 10.1002/prot.22792; Higa RH, 2004, BIOINFORMATICS, V20, P1983, DOI 10.1093/bioinformatics/bth185; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Johnson D., 1998, APPL MULTIVARIATE ME; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-553; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Mancini AL, 2004, BIOINFORMATICS, V20, P2145, DOI 10.1093/bioinformatics/bth203; Marcellino LH, 1996, FEBS LETT, V385, P154, DOI 10.1016/0014-5793(96)00375-4; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Melo RC, 2007, GENET MOL RES, V6, P946; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neshich G, 2006, GENET MOL RES, V5, P717; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pD269, DOI 10.1093/nar/gki111; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pW29, DOI 10.1093/nar/gki397; Neshich IAP, SURFACE HYD IN PRESS; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Ponstingl H, 2005, PROG BIOPHYS MOL BIO, V89, P9, DOI 10.1016/j.pbiomolbio.2004.07.010; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Poupon A, 2010, METHODS MOL BIOL, V609, P349, DOI 10.1007/978-1-60327-241-4_20; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Schneider M, 2009, PROTEINS, V77, P97, DOI 10.1002/prot.22421; Simoes M, 2007, MOL BIOCHEM PARASIT, V154, P134, DOI 10.1016/j.molbiopara.2007.04.003; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SRIDHARAN S, 1992, FASEB J, V6, pA174; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Terwilliger TC, 2000, NAT STRUCT BIOL, V7, P935, DOI 10.1038/80700; Tsuchiya Y, 2006, PROTEIN ENG DES SEL, V19, P421, DOI 10.1093/protein/gzl026; Tuncbag N, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035006; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013; Xenarios L, 2001, CURR OPIN BIOTECH, V12, P334, DOI 10.1016/S0958-1669(00)00224-X; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Zar J. H., 2009, BIOSTATISTICAL ANAL; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	60	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87107	10.1371/journal.pone.0087107	http://dx.doi.org/10.1371/journal.pone.0087107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489849	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000108
J	Margolis, DJ; Gartland, AJ; Singer, JH; Detwiler, PB				Margolis, David J.; Gartland, Andrew J.; Singer, Joshua H.; Detwiler, Peter B.			Network Oscillations Drive Correlated Spiking of ON and OFF Ganglion Cells in the rd1 Mouse Model of Retinal Degeneration	PLOS ONE			English	Article							VISUAL FUNCTION; RESPONSES; SIGNALS; MICE; MECHANISMS; GENERATION; CHANNELS	Following photoreceptor degeneration, ON and OFF retinal ganglion cells (RGCs) in the rd-1/rd-1 mouse receive rhythmic synaptic input that elicits bursts of action potentials at similar to 10 Hz. To characterize the properties of this activity, RGCs were targeted for paired recording and morphological classification as either ON alpha, OFF alpha or non-alpha RGCs using two-photon imaging. Identified cell types exhibited rhythmic spike activity. Cross-correlation of spike trains recorded simultaneously from pairs of RGCs revealed that activity was correlated more strongly between alpha RGCs than between alpha and non-alpha cell pairs. Bursts of action potentials in alpha RGC pairs of the same type, i.e. two ON or two OFF cells, were in phase, while bursts in dissimilar alpha cell types, i.e. an ON and an OFF RGC, were 180 degrees out of phase. This result is consistent with RGC activity being driven by an input that provides correlated excitation to ON cells and inhibition to OFF cells. A2 amacrine cells were investigated as a candidate cellular mechanism and found to display 10 Hz oscillations in membrane voltage and current that persisted in the presence of antagonists of fast synaptic transmission and were eliminated by tetrodotoxin. Results support the conclusion that the rhythmic RGC activity originates in a presynaptic network of electrically coupled cells including A2s via a Na+-channel dependent mechanism. Network activity drives out of phase oscillations in ON and OFF cone bipolar cells, entraining similar frequency fluctuations in RGC spike activity over an area of retina that migrates with changes in the spatial locus of the cellular oscillator.	[Margolis, David J.] Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA; [Gartland, Andrew J.; Detwiler, Peter B.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gartland, Andrew J.; Detwiler, Peter B.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Singer, Joshua H.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Rutgers State University New Brunswick; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland College Park	Margolis, DJ (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA.	david.margolis@rutgers.edu; detwiler@uw.edu			NIH [EY002048, EY-017836, 5 T32 GM007108]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001730, R01EY002048, R01EY017836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants: EY002048 (PBD), EY-017836 (JHS), and 5 T32 GM007108 (AJG). JHS was a Special Scholar for Retinitis Pigmentosa sponsored by Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bloomfield SA, 2004, VISION RES, V44, P3297, DOI 10.1016/j.visres.2004.07.012; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Cembrowski MS, 2012, CELL REP, V1, P155, DOI 10.1016/j.celrep.2011.12.006; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Jones Bryan W, 2005, Clin Exp Optom, V88, P282; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Margolis DJ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/507037; Margolis DJ, 2010, J NEUROSCI, V30, P7127, DOI 10.1523/JNEUROSCI.5694-09.2010; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; PEICHL L, 1987, J COMP NEUROL, V263, P25, DOI 10.1002/cne.902630103; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Tian M, 2010, J NEUROSCI, V30, P4650, DOI 10.1523/JNEUROSCI.4212-09.2010; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	31	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86253	10.1371/journal.pone.0086253	http://dx.doi.org/10.1371/journal.pone.0086253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489706	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000039
J	Pischedda, A; Shahandeh, MP; Cochrane, WG; Cochrane, VA; Turner, TL				Pischedda, Alison; Shahandeh, Michael P.; Cochrane, Wesley G.; Cochrane, Veronica A.; Turner, Thomas L.			Natural Variation in the Strength and Direction of Male Mating Preferences for Female Pheromones in Drosophila melanogaster	PLOS ONE			English	Article							MUTUAL SEXUAL SELECTION; CUTICULAR HYDROCARBONS; PREMATING ISOLATION; FORCED COPULATIONS; GENETIC-ANALYSIS; COURTSHIP; POPULATION; ATTRACTIVENESS; DESICCATION; RECOGNITION	Many animal species communicate using chemical signals. In Drosophila, cuticular hydrocarbons (CHCs) are involved in species and sexual identification, and have long been thought to act as stimulatory pheromones as well. However, a previous study reported that D. melanogaster males were more attracted to females that were lacking CHCs. This surprising result is consistent with several evolutionary hypotheses but is at odds with other work demonstrating that female CHCs are attractive to males. Here, we investigated natural variation in male preferences for female pheromones using transgenic flies that cannot produce CHCs. By perfuming females with CHCs and performing mate choice tests, we found that some male genotypes prefer females with pheromones, some have no apparent preference, and at least one male genotype prefers females without pheromones. This variation provides an excellent opportunity to further investigate the mechanistic causes and evolutionary implications of divergent pheromone preferences in D. melanogaster males.	[Pischedda, Alison; Shahandeh, Michael P.; Cochrane, Wesley G.; Cochrane, Veronica A.; Turner, Thomas L.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Cochrane, Veronica A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	University of California System; University of California Santa Barbara; Oregon Health & Science University	Pischedda, A (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	alison.pischedda@lifesci.ucsb.edu	Shahandeh, Michael/AAM-6045-2021	Cochrane, Wesley/0000-0002-3325-6921	National Institutes of Health [R01 GM098614]; MRSEC Program of the NSF [DMR 1121053]; NSF-Materials Research Facilities Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRSEC Program of the NSF(National Science Foundation (NSF)); NSF-Materials Research Facilities Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (R01 GM098614). The MRL Shared Experimental Facilities are supported by the MRSEC Program of the NSF under Award No. DMR 1121053, a member of the NSF-funded Materials Research Facilities Network (www.mrfn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Chenoweth SF, 2003, EVOLUTION, V57, P2326; Chenoweth SF, 2005, AM NAT, V165, P281, DOI 10.1086/427271; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dukas R, 2004, BEHAV ECOL, V15, P695, DOI 10.1093/beheco/arh068; Dukas R, 2012, ANIM BEHAV, V84, P1501, DOI 10.1016/j.anbehav.2012.09.023; Dukas R, 2012, ANIM BEHAV, V84, P1177, DOI 10.1016/j.anbehav.2012.08.021; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Etges WJ, 2008, J EVOLUTION BIOL, V21, P1641, DOI 10.1111/j.1420-9101.2008.01601.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Fang S, 2002, GENETICS, V162, P781; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, GENETICA, V97, P73, DOI 10.1007/BF00132583; Foley BR, 2011, HEREDITY, V106, P68, DOI 10.1038/hdy.2010.40; Friberg U, 2006, ANIM BEHAV, V72, P1259, DOI 10.1016/j.anbehav.2006.03.021; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Grillet M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00224; Havens JA, 2013, J EVOLUTION BIOL, V26, P562, DOI 10.1111/jeb.12073; HOLM S, 1979, SCAND J STAT, V6, P65; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Long TAF, 2007, P ROY SOC B-BIOL SCI, V274, P3105, DOI 10.1098/rspb.2007.1140; Lu BK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002587; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; MANNING A., 1959, ANIMAL BEHAVIOR, V7, P60, DOI 10.1016/0003-3472(59)90031-4; Marcillac F, 2004, J EXP BIOL, V207, P3927, DOI 10.1242/jeb.01236; Markow TA, 2000, AM NAT, V156, P100, DOI 10.1086/303368; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Rouault J, 2000, GENETICA, V110, P117, DOI 10.1023/A:1017987220814; Rouault JD, 2004, GENETICA, V120, P195, DOI 10.1023/B:GENE.0000017641.75820.49; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1981, J INSECT PHYSIOL, V27, P17, DOI 10.1016/0022-1910(81)90026-3; Turner TL, 2012, GENETICS, V191, P633, DOI 10.1534/genetics.112.139337; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	54	13	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87509	10.1371/journal.pone.0087509	http://dx.doi.org/10.1371/journal.pone.0087509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489930	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000139
J	Ravi, VK; Swain, T; Chandra, N; Swaminathan, R				Ravi, Vijay Kumar; Swain, Tulsi; Chandra, Nividh; Swaminathan, Rajaram			On the Characterization of Intermediates in the Isodesmic Aggregation Pathway of Hen Lysozyme at Alkaline pH	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; FLUORESCENCE ANISOTROPY; AMYLOID FIBRILS; SIMULATIONS; MODEL; TRYPTOPHAN; MECHANISM	Protein aggregation leading to formation of amyloid fibrils is a symptom of several diseases like Alzheimer's, type 2 diabetes and so on. Elucidating the poorly understood mechanism of such phenomena entails the difficult task of characterizing the species involved at each of the multiple steps in the aggregation pathway. It was previously shown by us that spontaneous aggregation of hen-eggwhite lysozyme (HEWL) at room temperature in pH 12.2 is a good model to study aggregation. Here in this paper we investigate the growth kinetics, structure, function and dynamics of multiple intermediate species populating the aggregation pathway of HEWL at pH 12.2. The different intermediates were isolated by varying the HEWL monomer concentration in the 300 nM-0.12 mM range. The intermediates were characterized using techniques like steady-state and nanosecond time-resolved fluorescence, atomic force microscopy and dynamic light scattering. Growth kinetics of non-fibrillar HEWL aggregates were fitted to the von Bertalanffy equation to yield a HEWL concentration independent rate constant (k = (6.6+/-0.6) x 10(-5) s(-1)). Our results reveal stepwise changes in size, molecular packing and enzymatic activity among growing HEWL aggregates consistent with an isodesmic aggregation model. Formation of disulphide bonds that crosslink the monomers in the aggregate appear as a unique feature of this aggregation. AFM images of multiple amyloid fibrils emanating radially from amorphous aggregates directly confirmed that on-pathway fibril formation was feasible under isodesmic polymerization. The isolated HEWL aggregates are revealed as polycationic protein nanoparticles that are robust at neutral pH with ability to take up non-polar molecules like ANS.	[Ravi, Vijay Kumar; Swain, Tulsi; Chandra, Nividh; Swaminathan, Rajaram] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Swaminathan, R (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	rsw@iitg.ernet.in	Swaminathan, Rajaram/I-2250-2019; Swaminathan, Rajaram/B-1230-2008	Swaminathan, Rajaram/0000-0003-1294-8379; Ravi, Vijay/0000-0003-3772-0573	Department of Science and Technology, New Delhi [SR/SO/BB-48/2009]; RGNF fellowship from UGC, New Delhi	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); RGNF fellowship from UGC, New Delhi	RS acknowledges funding support from Department of Science and Technology, New Delhi under project SR/SO/BB-48/2009. VKR acknowledges RGNF fellowship from UGC, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken M., 2010, MATH BIOL SCI; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; Carlsson F, 2001, J PHYS CHEM B, V105, P12189, DOI 10.1021/jp012235i; Chan HY, 2012, BIOPHYS J, V102, P1934, DOI [10.1016/j.bpj.2012.03.025, 10.1016/j.bpj.2012.03.1125]; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; DAVIES RC, 1969, BIOCHIM BIOPHYS ACTA, V178, P294, DOI 10.1016/0005-2744(69)90397-0; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Homchaudhuri L, 2006, FEBS LETT, V580, P2097, DOI 10.1016/j.febslet.2006.03.012; Homchaudhuri L, 2006, THESIS INDIAN I TECH; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kumar S, 2010, CURR SCI INDIA, V98, P639; Kumar S, 2008, BIOCHEM J, V415, P275, DOI 10.1042/BJ20071499; Kumar S, 2007, J CHEM SCI, V119, P141, DOI 10.1007/s12039-007-0021-9; Kumar S, 2009, BBA-PROTEINS PROTEOM, V1794, P913, DOI 10.1016/j.bbapap.2009.01.009; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lund M, 2003, BIOPHYS J, V85, P2940, DOI 10.1016/S0006-3495(03)74714-6; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Nishimoto E, 1998, BIOCHEMISTRY-US, V37, P5599, DOI 10.1021/bi9718651; OOI T, 1962, ARCH BIOCHEM BIOPHYS, V98, P1, DOI 10.1016/0003-9861(62)90138-8; Pellicane G, 2012, J PHYS CHEM B, V116, P2114, DOI 10.1021/jp212048j; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Price WS, 1999, J AM CHEM SOC, V121, P11503, DOI 10.1021/ja992265n; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Ravi VK, 2012, BIOPHYS J, V102, p255A, DOI 10.1016/j.bpj.2011.11.1406; Ravi VK, 2014, PLOS ONE, DOI [10.1371/journal.pone.0087012, DOI 10.1371/J0URNAL.P0NE.0087012]; Scheinost J.C., 2010, PROTEIN MISFOLDING D, P615; Sekhar A, 2011, BIOCHEMISTRY-US, V50, P805, DOI 10.1021/bi101312h; SOPHIANOPOULOS A, 1961, J BIOL CHEM, V236, pPC82; SOPHIANOPOULOS AJ, 1964, J BIOL CHEM, V239, P2516; Steiner R. F., 1991, TOPICS FLUORESCENCE, V2, P1, DOI DOI 10.1007/0-306-47058-6_; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Trexler AJ, 2007, CURR PROTEIN PEPT SC, V8, P537, DOI 10.2174/138920307783018659; Wei GH, 2007, PRION, V1, P3, DOI 10.4161/pri.1.1.3969; WETTER LR, 1951, J BIOL CHEM, V192, P237; Zhang J, 2003, J CHEM PHYS, V119, P10972, DOI 10.1063/1.1622380; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c	44	17	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87256	10.1371/journal.pone.0087256	http://dx.doi.org/10.1371/journal.pone.0087256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489883	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000121
J	Selvarajah, V; Pasea, L; Ojha, S; Wilkinson, IB; Tomlinson, LA				Selvarajah, Viknesh; Pasea, Laura; Ojha, Sanjay; Wilkinson, Ian B.; Tomlinson, Laurie A.			Pre-Dialysis Systolic Blood Pressure-Variability Is Independently Associated with All-Cause Mortality in Incident Haemodialysis Patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK; DISEASE PATIENTS	Systolic blood pressure variability is an independent risk factor for mortality and cardiovascular events. Standard measures of blood pressure predict outcome poorly in haemodialysis patients. We investigated whether systolic blood pressure variability was associated with mortality in incident haemodialysis patients. We performed a longitudinal observational study of patients commencing haemodialysis between 2005 and 2011 in East Anglia, UK, excluding patients with cardiovascular events within 6 months of starting haemodialysis. The main exposure was variability independent of the mean (VIM) of systolic blood pressure from short-gap, pre-dialysis blood pressure readings between 3 and 6 months after commencing haemodialysis, and the outcome was all-cause mortality. Of 203 patients, 37 (18.2%) patients died during a mean follow-up of 2.0 (SD 1.3) years. The age and sex-adjusted hazard ratio (HR) for mortality was 1.09 (95% confidence interval (CI) 1.02-1.17) for a one-unit increase of VIM. This was not altered by adjustment for diabetes, prior cardiovascular disease and mean systolic blood pressure (HR 1.09, 95% CI 1.02-1.16). Patients with VIM of systolic blood pressure above the median were 2.4 (95% CI 1.17-4.74) times more likely to die during follow-up than those below the median. Results were similar for all measures of blood pressure variability and further adjustment for type of dialysis access, use of antihypertensives and absolute or variability of fluid intake did not alter these findings. Diastolic blood pressure variability showed no association with all cause mortality. Our study shows that variability of systolic blood pressure is a strong and independent predictor of all-cause mortality in incident haemodialysis patients. Further research is needed to understand the mechanism as this may form a therapeutic target or focus for management.	[Selvarajah, Viknesh] Univ Cambridge, Dept Med, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Selvarajah, Viknesh; Ojha, Sanjay] Cambridge Univ Hosp NHS Fdn Trust, Dept Nephrol, Cambridge, England; [Pasea, Laura] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 2QQ, England; [Wilkinson, Ian B.; Tomlinson, Laurie A.] Univ Cambridge, Cambridge Clin Trials Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Selvarajah, V (corresponding author), Univ Cambridge, Dept Med, Clin Pharmacol Unit, Cambridge CB2 2QQ, England.	vs321@cam.ac.uk		wilkinson, ian/0000-0001-6598-9399; Tomlinson, Laurie/0000-0001-8848-9493	British Heart Foundation; Cambridge Biomedical Research Centre; British Heart Foundation [FS/12/8/29377] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cambridge Biomedical Research Centre(General Electric); British Heart Foundation(British Heart Foundation)	IBW and VS are supported by the British Heart Foundation and the Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2007, SEMIN DIALYSIS, V20, P498, DOI 10.1111/j.1525-139X.2007.00340.x; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Brunelli SM, 2008, AM J KIDNEY DIS, V52, P716, DOI 10.1053/j.ajkd.2008.04.032; Chang TI, 2014, J HUM HYPERTENS, V28, P18, DOI 10.1038/jhh.2013.49; Chang TI, 2011, CURR HYPERTENS REP, V13, P362, DOI 10.1007/s11906-011-0223-x; Di Iorio B, 2013, J NEPHROL, V26, P173, DOI 10.5301/jn.5000108; Flythe JE, 2013, AJKD, P1; Lacy P, 2006, CLIN SCI, V110, P101, DOI 10.1042/CS20050192; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mallamaci F, 2013, BLOOD PURIFICAT, V36, P58, DOI 10.1159/000351004; Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Raimann JG, 2012, KIDNEY INT, V81, P548, DOI 10.1038/ki.2011.426; Rohrscheib MR, 2008, CLIN J AM SOC NEPHRO, V3, P1407, DOI 10.2215/CJN.00110108; Rossignol P, 2012, HYPERTENSION, V60, P339, DOI 10.1161/HYPERTENSIONAHA.111.190397; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Vita G, 1999, KIDNEY INT, V56, P232, DOI 10.1046/j.1523-1755.1999.00511.x; Wang AYM, 2010, HYPERTENSION, V56, P210, DOI 10.1161/HYPERTENSIONAHA.110.151167; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8	21	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86514	10.1371/journal.pone.0086514	http://dx.doi.org/10.1371/journal.pone.0086514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489735	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000055
J	Zhang, DP; Meng, SN; Xu, P; Lu, HY; Zhuang, MH; Wu, GH; Liu, YL; Pan, XH; Yan, HJ; Chen, X; Fan, LR; Li, CM; Fu, XJ; Qi, JL; Han, L; Ma, FC; Lv, F; Sun, JP				Zhang, Dapeng; Meng, Sining; Xu, Peng; Lu, Hongyan; Zhuang, Minghua; Wu, Guohui; Liu, Yanling; Pan, Xiaohong; Yan, Hongjing; Chen, Xi; Fan, Lirui; Li, Chengmei; Fu, Xiaojing; Qi, Jinlei; Han, Lei; Ma, Fuchang; Lv, Fan; Sun, Jiangping			Experience of Offering HIV Rapid Testing to At-Risk Patients in Community Health Centers in Eight Chinese Cities	PLOS ONE			English	Article							COST-EFFECTIVENESS; CARE; PROGRAM	Objective: To explore the feasibility of offering HIV counseling and testing in community health centers (CHCs) and to provide evidence for the HIV/AIDS response in China. Methods: Forty-two CHCs were selected from the eight cities that participated in the study. Rapid testing was mainly provided to: clients seeking HIV testing and counseling (HTC); outpatients with high-risk behavior of contracting HIV; inpatients and outpatients of key departments. Aggregate administrative data were collected in CHCs and general hospitals and differences between the two categories were compared. Results: There were 23,609 patients who underwent HIV testing, accounting for 0.37% of all estimated clinic visits at the 42 sites (0.03%-4.35% by site). Overall, positive screening prevalence was 0.41% (95% confidence interval [CI] 0.33%-0.49%, range 0.00%-0.98%), which is higher than in general hospitals (0.17%). The identification efficiency was 0.22% (95% CI: 0.16%-0.27%) in pilot CHCs, 3.5 times higher than in general hospitals (0.06%) (Chi square test = 95.196, p<0.001). The percentage of those receiving confirmatory tests among those who screened positive was slightly lower in CHCs (73.7%) than in general hospitals (80.1%) (Chi-square test = 17.472, p<0.001). Composition of clients mobilized for testing was consistent with the usage of basic public health and medical services in CHCs. The rate of patients testing HIV positive was higher among patients from key CHC departments (0.68%) than among high-risk Voluntary Counseling and Testing (VCT) clients (0.56%), those participating in outreach activities (0.41%), pregnant women (0.05%), and surgical patients (0.00%). Conclusion: This project demonstrates that providing HIV testing services for patients who exhibit high risk behavior has a high HIV case detection rate and that CHCs have the capacity to integrate HTC into routine work. It provides concrete evidence supporting the involvement of CHCs in the expansion of HIV/AIDS testing and case finding.	[Zhang, Dapeng; Meng, Sining; Xu, Peng; Li, Chengmei; Fu, Xiaojing; Qi, Jinlei; Ma, Fuchang; Lv, Fan; Sun, Jiangping] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Lu, Hongyan] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhuang, Minghua] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wu, Guohui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Liu, Yanling] Harbin Ctr Dis Control & Prevent, Harbin, Peoples R China; [Pan, Xiaohong] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Yan, Hongjing] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Chen, Xi] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Fan, Lirui] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Han, Lei] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Sun, JP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	jpsun@chinaaids.cn	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022		China-Gates Foundation HIV Cooperation Program [Opp49277]	China-Gates Foundation HIV Cooperation Program	This work was supported by the China-Gates Foundation HIV Cooperation Program (grant number Opp49277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WHO RAP HIV TESTS GU; Arthur GR, 2005, JAIDS-J ACQ IMM DEF, V40, P329, DOI 10.1097/01.qai.0000166376.23846.38; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chao TT, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/841979; China Ministry of Health UNAIDS WHO, 2012, CHIN J AIDS STD, V18, P1; Chinese Center for Diseae Control and Prevention, 2009, NAT GUILD DET HIV AI; Chinese Center for Diseae Control and Prevention, 2009, NAT GUID HIV VOL TES; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Cunningham CO, 2009, AIDS PATIENT CARE ST, V23, P619, DOI 10.1089/apc.2009.0005; Doran TI, 2000, ARCH FAM MED, V9, P924, DOI 10.1001/archfami.9.9.924; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Guenter D, 2008, AIDS PATIENT CARE ST, V22, P195, DOI 10.1089/apc.2007.0137; Hesketh T, 2005, SEX TRANSM INFECT, V81, P108, DOI 10.1136/sti.2004.009704; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Lu H, 2008, CAPITAL J PUBLIC HLT, V2, P61; Martin EG, 2011, J CLIN VIROL, V52, P7; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; Myers JJ, 2009, J GEN INTERN MED, V24, P1269, DOI 10.1007/s11606-009-1070-1; Pan XL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-93; Ramesh M, 2013, HLTH GOVERNANCE HEAL; Roberts KJ, 2007, AIDS PATIENT CARE ST, V21, P621, DOI 10.1089/apc.2006.0196; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; Waheed U, 2013, J CLIN VIROL, V56, P367, DOI 10.1016/j.jcv.2012.12.012; Wang HF, 2011, HEALTH POLICY, V99, P37, DOI 10.1016/j.healthpol.2010.07.003; Wang SH, 2011, ASIA-PAC J PUBLIC HE, V23, P620, DOI 10.1177/1010539511412576; Weis KE, 2009, AIDS PATIENT CARE ST, V23, P251, DOI 10.1089/apc.2008.0167; WU Z, 2010, INT J EPIDEMIOL S2, V39, P1, DOI DOI 10.1093/IJE/DYQ220; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431; 吴尊友, 2011, [中国公共卫生, China Public Health], V27, P1505	34	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86609	10.1371/journal.pone.0086609	http://dx.doi.org/10.1371/journal.pone.0086609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489750	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000063
J	Kong, QS; Yuan, JX; Niu, PH; Xie, JJ; Jiang, W; Huang, Y; Bie, ZL				Kong, Qiusheng; Yuan, Jingxian; Niu, Penghui; Xie, Junjun; Jiang, Wei; Huang, Yuan; Bie, Zhilong			Screening Suitable Reference Genes for Normalization in Reverse Transcription Quantitative Real-Time PCR Analysis in Melon	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYSTEMATIC VALIDATION; EXPRESSION ANALYSIS; SELECTION; IDENTIFICATION; ARABIDOPSIS; SEQUENCE; CDNA; CATALASE; COLONIZATION	Melon (Cucumis melo. L) is not only an economically important cucurbitaceous crop but also an attractive model for studying many biological characteristics. Screening appropriate reference genes is essential to reverse transcription quantitative real-time PCR (RT-qPCR), which is key to many studies involving gene expression analysis. In this study, 14 candidate reference genes were selected, and the variations in their expression in roots and leaves of plants subjected to biotic stress, abiotic stress, and plant growth regulator treatment were assessed by RT-qPCR. The stability of the expression of the selected genes was determined and ranked using geNorm and NormFinder. geNorm identified the two most stable genes for each set of conditions: CmADP and CmUBlep across all samples, CmUBIep and CmRPL in roots, CmRAN and CmACT in leaves, CmADP and CmRPL under abiotic stress conditions, CmTUA and CmACT under biotic stress conditions, and CmRAN and CmACT under plant growth regulator treatments. NormFinder determined CmRPL to be the best reference gene in roots and under biotic stress conditions and CmADP under the other experimental conditions. CmUBC2 and CmPP2A were not found to be suitable under many experimental conditions. The catalase family genes CmCAT1, CmCAT2, and CmCAT3 were identified in melon genome and used as target genes to validate the reliability of identified reference genes. The catalase family genes showed the most upregulation 3 days after inoculation with Fusarium wilt in roots, after which they were downregulated. Their levels of expression were significantly overestimated when the unsuitable reference gene was used for normalization. These results not only provide guidelines for the selection of reference genes for gene expression analyses in melons but may also provide valuable information for studying the functions of catalase family genes in stress responses.	[Kong, Qiusheng; Yuan, Jingxian; Niu, Penghui; Xie, Junjun; Jiang, Wei; Huang, Yuan; Bie, Zhilong] Huazhong Agr Univ, Coll Hort & Forestry, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Bie, ZL (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	biezhilong@hotmail.com	Kong, Qiusheng/F-7710-2012	Kong, Qiusheng/0000-0003-0939-4424	earmarked fund for Modern Agro-industry Technology Research System [CARS-26-16]; National Science & Technology Pillar Program [2012BAD02B03-16]; Special Fund for Agro-scientific Research in the Public Interest [201003066-6]	earmarked fund for Modern Agro-industry Technology Research System; National Science & Technology Pillar Program; Special Fund for Agro-scientific Research in the Public Interest	This work was founded by the earmarked fund for Modern Agro-industry Technology Research System (CARS-26-16), National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAD02B03-16) and Special Fund for Agro-scientific Research in the Public Interest (201003066-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bahar O, 2009, EUR J PLANT PATHOL, V123, P71, DOI 10.1007/s10658-008-9345-7; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Cheng H, 2012, MOL BIOL REP, V39, P1903, DOI 10.1007/s11033-011-0936-6; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dai N, 2011, PLANT MOL BIOL, V76, P1, DOI 10.1007/s11103-011-9757-1; Deng YW, 2010, MOL BIOTECHNOL, V44, P51, DOI 10.1007/s12033-009-9203-7; Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fita A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035387; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; Frugoli JA, 1996, PLANT PHYSIOL, V112, P327, DOI 10.1104/pp.112.1.327; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hao H, 2012, GENE, V503, P147, DOI 10.1016/j.gene.2012.04.059; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Liu Z, 2013, PLANT CELL TISS ORG, V113, P469, DOI 10.1007/s11240-013-0288-0; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Blanca JM, 2011, PLANT GENOME-US, V4, P118, DOI 10.3835/plantgenome2011.01.0003; Min MK, 2013, PLANT PHYSIOL, V161, P676, DOI 10.1104/pp.112.209148; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Oumouloud A, 2010, EUPHYTICA, V176, P183, DOI 10.1007/s10681-010-0201-4; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051502; Portnoy V, 2011, PLANT GENOME-US, V4, P36, DOI 10.3835/plantgenome2010.11.0026; Qin XQ, 2011, PLANTA, V234, P737, DOI 10.1007/s00425-011-1442-8; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sestili S, 2013, J PLANT BIOCHEM BIOT, V3, P1; Sestili S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-122; Shan WY, 2012, SCI HORTIC-AMSTERDAM, V139, P96, DOI 10.1016/j.scienta.2012.03.010; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wei LB, 2013, PLANTA, V237, P873, DOI 10.1007/s00425-012-1805-9; Wei SW, 2013, MOL BIOL REP, V40, P2915, DOI 10.1007/s11033-012-2307-3; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zvirin T, 2010, PLANT PATHOL, V59, P576, DOI 10.1111/j.1365-3059.2009.02225.x	51	50	54	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87197	10.1371/journal.pone.0087197	http://dx.doi.org/10.1371/journal.pone.0087197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475250	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300151
J	Tsai, LL; Hu, FW; Lee, SS; Yu, CH; Yu, CC; Chang, YC				Tsai, Lo-Lin; Hu, Fang-Wei; Lee, Shiuan-Shinn; Yu, Chuan-Hang; Yu, Cheng-Chia; Chang, Yu-Chao			Oct4 Mediates Tumor Initiating Properties in Oral Squamous Cell Carcinomas through the Regulation of Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							CANCER STEM-LIKE; NECK-CANCER; GENES OCT4; EXPRESSION; NANOG; HEAD; PLURIPOTENCY; LINE; TRANSDIFFERENTIATION; IDENTIFICATION	Background: Overexpression of Oct4, an important transcription factor of embryonic stem cells (ESC), has been reported in several cancers. The aim of this study was to determine the emerging role of Oct4 in oral squamous cell carcinoma (OSCC) both in vitro and in vivo. Methodology/Principal Finding: Tumourigenic activity and molecular mechanisms of Oct4 overexpression or knockdown by lentiviral infection in OSCC was investigated in vitro and in vivo. Initially, we demonstrated that Oct4 expression was increased in OSCC cell lines as compared to a normal oral epithelial cell line SG. Overexpression of Oct4 was demonstrated to enhance cell proliferation, invasiveness, anchorage-independent growth and xenotransplantation tumourigenicity. These findings were coupled with epithelial-mesenchymal transition (EMT) transformation in OSCCs. In contrast, the silence of Oct4 significantly blocked the xenograft tumorigenesis of OSCC-derived cancer stem cells (OSCC-CSCs) and significantly improved the recipient survival. Clinically, the level of Oct4 expression was higher in recurrent and metastatic OSCC specimens but lower in primary OSCC specimens. Conclusion/Significance: Our results suggest that Oct4-mediated tumorigenecity is associated with the regulation of EMT. Oct4 might be a therapeutic target for OSCC.	[Tsai, Lo-Lin; Hu, Fang-Wei; Yu, Chuan-Hang; Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Tsai, Lo-Lin; Hu, Fang-Wei; Yu, Chuan-Hang; Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Lee, Shiuan-Shinn] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Yu, CC (corresponding author), Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.	ccyu@csmu.edu.tw; cyc@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021		Chung Shan Medical University Hospital [CSH-2013-C-015]; National Science Council in Taiwan, ROC [100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 -MY3]	Chung Shan Medical University Hospital; National Science Council in Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from Chung Shan Medical University Hospital (CSH-2013-C-015) and the National Science Council (100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 -MY3) in Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CY, 2009, J PATHOL, V219, P347, DOI 10.1002/path.2604; Chen HM, 2011, J ORAL PATHOL MED, V40, P483, DOI 10.1111/j.1600-0714.2010.00973.x; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chen YW, 2010, MOL CANCER THER, V9, P2879, DOI 10.1158/1535-7163.MCT-10-0504; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Han XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073341; Hu FW, 2012, MOL NUTR FOOD RES, V56, P1247, DOI 10.1002/mnfr.201200150; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lee SS, 2008, ORAL ONCOL, V44, P884, DOI 10.1016/j.oraloncology.2007.11.004; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lin SC, 2004, J ORAL PATHOL MED, V33, P79, DOI 10.1111/j.1600-0714.2004.00034.x; Liu DB, 2011, TUMOR BIOL, V32, P941, DOI 10.1007/s13277-011-0196-z; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Okumura K, 1996, J CANCER RES CLIN, V122, P243, DOI 10.1007/BF01209653; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Shieh TM, 2007, CLIN CANCER RES, V13, P4378, DOI 10.1158/1078-0432.CCR-06-2685; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Srisopark S S, 1975, J Dent Assoc Thai, V25, P77; Ugolkov AV, 2011, PROSTATE, V71, P18, DOI 10.1002/pros.21217; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Way TD, 2013, EUR J CANC; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wu MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-283; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Yu FS, 2011, J DENT RES, V90, P168, DOI 10.1177/0022034510384619; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	47	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87207	10.1371/journal.pone.0087207	http://dx.doi.org/10.1371/journal.pone.0087207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475251	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300152
J	Parkinson, RM; Collins, SL; Horton, MR; Powell, JD				Parkinson, Rose M.; Collins, Samuel L.; Horton, Maureen R.; Powell, Jonathan D.			Egr3 Induces a Th17 Response by Promoting the Development of gamma delta T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; INTERFERON-GAMMA; CUTTING EDGE; TGF-BETA; OPPOSING REGULATION; THYMIC SELECTION; DIFFERENTIATION; THYMOCYTES; INDUCTION; INFECTION	The transcription factor Early Growth Response 3 (Egr3) has been shown to play an important role in negatively regulating T cell activation and promoting T cell anergy in Th1 cells. However, its role in regulating other T helper subsets has yet to be described. We sought to determine the role of Egr3 in a Th17 response using transgenic mice that overexpress Egr3 in T cells (Egr3 TG). Splenocytes from Egr3 TG mice demonstrated more robust generation of Th17 cells even under non-Th17 skewing conditions. We found that while Egr3 TG T cells were not intrinsically more likely to become Th17 cells, the environment encountered by these cells was more conducive to Th17 development. Further analysis revealed a considerable increase in the number of gamma delta T cells in both the peripheral lymphoid organs and mucosal tissues of Egr3 TG mice, a cell type which normally accounts for only a small fraction of peripheral lymphocytes. Consistent with this marked increase in peripheral gamma delta T cells, thymocytes from Egr3 TG mice also appear biased toward gamma delta T cell development. Coculture of these Egr3-induced gamma delta T cells with wildtype CD4+ T cells increases Th17 differentiation, and Egr3 TG mice are more susceptible to bleomycin-induced lung inflammation. Overall our findings strengthen the role for Egr3 in promoting gamma delta T cell development and show that Egr3-induced gamma delta T cells are both functional and capable of altering the adaptive immune response in a Th17-biased manner. Our data also demonstrates that the role played by Egr3 in T cell activation and differentiation is more complex than previously thought.	[Parkinson, Rose M.; Powell, Jonathan D.] Johns Hopkins Sch Med, Sidney Kimmel Canc Res Ctr, Baltimore, MD 21218 USA; [Collins, Samuel L.; Horton, Maureen R.] Johns Hopkins Univ, Sch Med, Div Pulm Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Powell, JD (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Canc Res Ctr, Baltimore, MD 21218 USA.	poweljo@jhmi.edu			National Institutes of Health [R01 CA098109, PO1 AI072677]; NATIONAL CANCER INSTITUTE [R01CA098109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI072677, T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 CA098109 and PO1 AI072677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Collins S, 2006, J IMMUNOL, V177, P8301, DOI 10.4049/jimmunol.177.12.8301; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Do JS, 2011, J IMMUNOL, V186, P4546, DOI 10.4049/jimmunol.1004021; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Haas J, 2009, NATION, V289, P6; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Han GC, 2010, IMMUNOLOGY, V129, P197, DOI 10.1111/j.1365-2567.2009.03166.x; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huang ZF, 2007, EXPERT OPIN THER TAR, V11, P737, DOI 10.1517/14728222.11.6.737; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; MAGES HW, 1993, INT IMMUNOL, V5, P63, DOI 10.1093/intimm/5.1.63; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; O'Brien RL, 2001, CHEM IMMUNOL, V79, P1; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pociask DA, 2011, AM J PATHOL, V178, P1167, DOI 10.1016/j.ajpath.2010.11.055; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	51	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87265	10.1371/journal.pone.0087265	http://dx.doi.org/10.1371/journal.pone.0087265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475259	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800091
J	Gordillo, GM; Biswas, A; Khanna, S; Pan, X; Sinha, M; Roy, S; Sen, CK				Gordillo, Gayle M.; Biswas, Ayan; Khanna, Savita; Pan, Xueliang; Sinha, Mithun; Roy, Sashwati; Sen, Chandan K.			Dicer Knockdown Inhibits Endothelial Cell Tumor Growth via MicroRNA 21a-3p Targeting of Nox-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dicer; Endothelial Cell; MicroRNA; NADPH Oxidase; Tumor; Hemangioendothelioma; miR-21a-3p; Monocyte Chemoattractant Protein-1	DOWN-REGULATION; WOUND ANGIOGENESIS; OXIDATIVE STRESS; EXPRESSION; HEMANGIOMA; 8-OHDG; THROMBOCYTOPENIA; ASSOCIATION; ANEMIA; DROSHA	Background: Endothelial cell tumors are the most common soft tissue tumor in infants. Results: Dicer knockdown up-regulated miR-21a-3p that targeted nox-4 mRNA preventing endothelial cell tumor formation in vivo. Conclusion: Nox-4 silencing inhibits endothelial cell tumor formation. Dicer knockdown up-regulates miR 21a-3p, which targets the Nox-4 3-UTR. Significance: Novel drivers of endothelial cell tumor formation are reported. MicroRNAs (miR) are emerging as biomarkers and potential therapeutic targets in tumor management. Endothelial cell tumors are the most common soft tissue tumors in infants, yet little is known about the significance of miR in regulating their growth. A validated mouse endothelial cell (EOMA) tumor model was used to demonstrate that post-transcriptional gene silencing of dicer, the enzyme that converts pre-miR to mature miR, can prevent tumor formation in vivo. Tumors were formed in eight of eight mice injected with EOMA cells transfected with control shRNA but formed in only four of ten mice injected with EOMA cells transfected with dicer shRNA. Tumors that formed in the dicer shRNA group were significantly smaller than tumors in the control group. This response to dicer knockdown was mediated by up-regulated miR 21a-3p activity targeting the nox-4 3-UTR. EOMA cells were transfected with miR 21a-3p mimic and luciferase reporter plasmids containing either intact nox-4 3-UTR or with mutation of the proposed 3-UTR miR21a-3p binding sites. Mean luciferase activity was decreased by 85% in the intact compared with the site mutated vectors (p < 0.01). Attenuated Nox-4 activity resulted in decreased cellular hydrogen peroxide production and decreased production of oxidant-inducible monocyte chemoattractant protein-1, which we have previously shown to be critically required for endothelial cell tumor formation. These findings provide the first evidence establishing the significance of dicer and microRNA in promoting endothelial cell tumor growth in vivo.	[Gordillo, Gayle M.; Biswas, Ayan] Ohio State Univ, Wexner Med Ctr, Dept Plast Surg, Columbus, OH 43210 USA; [Khanna, Savita; Sinha, Mithun; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Wexner Med Ctr, Dept Surg, Columbus, OH 43210 USA; [Gordillo, Gayle M.; Biswas, Ayan; Khanna, Savita; Sinha, Mithun; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Pan, Xueliang] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gordillo, GM (corresponding author), 915 Olentangy River Rd Ste 2100, Columbus, OH 43212 USA.	gayle.gordillo@osumc.edu	Gordillo, Gayle M/E-3136-2011; Roy, sashwati/E-3990-2011; Sinha, Mithun/N-8172-2019	Sinha, Mithun/0000-0002-9222-1921; Pan, Xueliang/0000-0002-2342-3212	National Institutes of Health [GM095657, DK076566, GM069589, GM077185]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566, R56DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077185, R01GM095657, R01GM069589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM095657 (to G. M. G.), DK076566 (to S. R.), and GM069589 and GM077185 (to C. K. S.).	Anglesio MS, 2013, J PATHOL, V229, P400, DOI 10.1002/path.4135; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Chan YC, 2012, J BIOL CHEM, V287, P41032, DOI 10.1074/jbc.M112.413294; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chen JQ, 2013, ANAL BIOCHEM, V442, P97, DOI 10.1016/j.ab.2013.07.022; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Dudek H, 2014, MOL THER, V22, P92, DOI 10.1038/mt.2013.233; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gordillo G, 2009, ANTIOXID REDOX SIGN, V11, P47, DOI 10.1089/ars.2008.2150; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Gordillo GM, 2004, AM J PHYSIOL-CELL PH, V287, pC866, DOI 10.1152/ajpcell.00238.2003; Gordillo GM, 2002, METHOD ENZYMOL, V352, P422; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hinkal GW, 2011, BRIT J CANCER, V104, P387, DOI 10.1038/sj.bjc.6606022; HOAK JC, 1971, J LAB CLIN MED, V77, P941; JACOBS AH, 1976, PEDIATRICS, V58, P218; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Kitagawa N, 2013, CANCER SCI, V104, P543, DOI 10.1111/cas.12126; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Kuo HW, 2007, MUTAT RES-GEN TOX EN, V631, P62, DOI 10.1016/j.mrgentox.2007.04.009; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma X., 2014, UROL ONCOL, V32, P46; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mulliken JB, 1988, VASCULAR BIRTHMARKS, P41; Pache JC, 2011, NAT MED, V17, P31, DOI 10.1038/nm0111-31; Paller AS, 2000, J INVEST DERM SYMP P, V5, P83, DOI 10.1046/j.1087-0024.2000.00011.x; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Pesta M, 2010, ANTICANCER RES, V30, P3579; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Rustandi RR, 2012, ELECTROPHORESIS, V33, P2790, DOI 10.1002/elps.201200095; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; WARNER ED, 1971, ARCH PATHOL, V91, P523; Yano T, 2009, LUNG CANCER, V63, P111, DOI 10.1016/j.lungcan.2008.04.014; Yu H., 2011, PLOS ONE, V6; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	54	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9027	9038		10.1074/jbc.M113.519264	http://dx.doi.org/10.1074/jbc.M113.519264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24497637	Green Published, hybrid			2022-12-25	WOS:000333472100024
J	Alam, MS; Getz, M; Yi, S; Kurkewich, J; Safeukui, I; Haldar, K				Alam, Md. Suhail; Getz, Michelle; Yi, Sue; Kurkewich, Jeffrey; Safeukui, Innocent; Haldar, Kasturi			Plasma Signature of Neurological Disease in the Monogenetic Disorder Niemann-Pick Type C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomarkers; Genetic Diseases; Inflammation; Neurodegeneration; Neuroinflammation; Cathepsin S; Lysozyme	LYSOSOMAL STORAGE DISEASE; CHOLESTEROL ACCUMULATION; EVERY ORGAN; MOUSE MODEL; CATHEPSIN-D; CELL-DEATH; EXPRESSION; MICE; OXYSTEROLS; NEUROINFLAMMATION	Background: Neurodegenerative diseases are associated with inflammation in the brain and other organs. Results: In murine Niemann-Pick Type C, cathepsin S was elevated and a plasma marker of liver inflammation. Lysozyme was an inflammatory plasma marker derived from both liver and brain. Conclusion: Their dual analysis suggested four distinct severity states of neurodegeneration. Significance: Cerebral inflammatory disease may be detectable in plasma. Early diagnosis of neurological disorders would greatly improve their management and treatment. A major hurdle is that inflammatory products of cerebral disease are not easily detected in blood. Inflammation in multiple organs and heterogeneity in disease present additional challenges in distinguishing the extent to which a blood-based marker reflects disease in brain or other afflicted organs. Murine models of the monogenetic disorder Niemann-Pick Type C present aggressive forms of cerebral and liver inflammatory disease. Microarray analyses previously revealed age-dependent changes in innate immunity transcripts in the mouse brain. We have now validated four putative secretory inflammatory markers that are also elevated in mouse liver. We include limited, first time analysis of human Niemann-Pick Type C liver and cerebellum. Furthermore, we utilized 2-hydroxypropyl--cyclodextrin (HPCD, an emerging therapeutic) administered intraperitoneally in mice, which abrogates inflammatory pathology in the liver but has limited effect on the brain. By analyzing the corresponding effects on inflammatory plasma proteins, we identified cathepsin S as a lead indicator of liver disease. In contrast, lysozyme was a marker of both brain and liver disease. 2-Hydroxypropyl--cyclodextrin had no effect on transcripts of neuron-specific 24-hydroxylase, and its product 24(S)-hydroxycholesterol was not a useful indicator in mouse plasma. Our data suggest that dual analysis of levels of the inflammatory markers lysozyme and cathepsin S may enable detection of multiple distinct states of neurodegeneration in plasma.	Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Haldar, K (corresponding author), Univ Notre Dame, Dept Biol Sci, Ctr Rare & Neglected Dis, 103 Galvin Life Sci, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014		National Institutes of Health [P01HL078826]; Center for Rare and Neglected Diseases at the University of Notre Dame, Indiana; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Rare and Neglected Diseases at the University of Notre Dame, Indiana; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL078826 (to K. H.). This work was also supported by the Center for Rare and Neglected Diseases at the University of Notre Dame, Indiana.	Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Cappellano Giuseppe, 2013, Am J Neurodegener Dis, V2, P89; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Cologna SM, 2014, J INHERIT METAB DIS, V37, P83, DOI 10.1007/s10545-013-9610-6; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; De Windt A, 2007, DNA CELL BIOL, V26, P665, DOI 10.1089/dna.2006.0570; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Grammatikakis I, 2009, CLIN EXP OBSTET GYN, V36, P235; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hughes TM, 2013, J ALZHEIMERS DIS, V33, P891, DOI 10.3233/JAD-2012-121585; Imrie J, 2007, J INHERIT METAB DIS, V30, P51, DOI 10.1007/s10545-006-0384-7; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Leto G, 1996, EUR J CLIN CHEM CLIN, V34, P555; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Lv BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041813; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Nakanishi H, 2003, MOL NEUROBIOL, V27, P163, DOI 10.1385/MN:27:2:163; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Olsen BN, 2012, BBA-BIOMEMBRANES, V1818, P330, DOI 10.1016/j.bbamem.2011.06.014; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; PILAR A, 2013, MOL NEUROBIOL; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Ramirez CM, 2011, J LIPID RES, V52, P688, DOI 10.1194/jlr.M013789; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rimkunas VM, 2008, HEPATOLOGY, V47, P1504, DOI 10.1002/hep.22327; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Trexler AJ, 2007, CURR PROTEIN PEPT SC, V8, P537, DOI 10.2174/138920307783018659; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Yerushalmi B, 2002, J PEDIATR GASTR NUTR, V35, P44, DOI 10.1097/00005176-200207000-00011; Yu T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003462	57	24	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8051	8066		10.1074/jbc.M113.526392	http://dx.doi.org/10.1074/jbc.M113.526392			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24488491	Green Published, hybrid			2022-12-25	WOS:000333157500005
J	Romano, M; Buratti, E; Romano, G; Klima, R; Belluz, LD; Stuani, C; Baralle, F; Feiguin, F				Romano, Maurizio; Buratti, Emanuele; Romano, Giulia; Klima, Raffaella; Belluz, Lisa Del Bel; Stuani, Cristiana; Baralle, Francisco; Feiguin, Fabian			Evolutionarily Conserved Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A/B Proteins Functionally Interact with Human and Drosophila TAR DNA-binding Protein 43 (TDP-43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Neuroscience; Retinal Degeneration; RNA Splicing; RNA-binding Proteins; Hrb98DE; Hrp38; TBPH; TDP-43; hnRNP A; B	FRONTOTEMPORAL LOBAR DEGENERATION; MEDIATES NEURODEGENERATION; INTERACTION NETWORK; SPLICING REGULATION; ACID BINDING; RNA TARGETS; RICH DOMAIN; AGGREGATION; EXON-9; MUTATIONS	Background: TDP-43 and hnRNPA1/A2 factors are implicated in neurodegeneration. Results: The human and fruit fly TDP-43 and hnRNPA1/A2 orthologs show physical, genetic, and functional interplays. Conclusion: The functional cooperation between TBPH/Hrp38 and TDP-43/hnRNP A/B is conserved throughout evolution. Significance: TBPH/Hrp38 interplay can be critical for neurodegeneration, and Drosophila is a model suitable to study the impact of this interaction. Human TDP-43 represents the main component of neuronal inclusions found in patients with neurodegenerative diseases, especially frontotemporal lobar degeneration and amyotrophic lateral sclerosis. In vitro and in vivo studies have shown that the TAR DNA-binding protein 43 (TDP-43) Drosophila ortholog (TBPH) can biochemically and functionally overlap the properties of the human factor. The recent direct implication of the human heterogeneous nuclear ribonucleoproteins (hnRNPs) A2B1 and A1, known TDP-43 partners, in the pathogenesis of multisystem proteinopathy and amyotrophic lateral sclerosis supports the hypothesis that the physical and functional interplay between TDP-43 and hnRNP A/B orthologs might play a crucial role in the pathogenesis of neurodegenerative diseases. To test this hypothesis and further validate the fly system as a useful model to study this type of diseases, we have now characterized human TDP-43 and Drosophila TBPH similarity in terms of protein-protein interaction pathways. In this work we show that TDP-43 and TBPH share the ability to associate in vitro with Hrp38/Hrb98DE/CG9983, the fruit fly ortholog of the human hnRNP A1/A2 factors. Interestingly, the protein regions of TDP-43 and Hrp38 responsible for reciprocal interactions are conserved through evolution. Functionally, experiments in HeLa cells demonstrate that TDP-43 is necessary for the inhibitory activity of Hrp38 on splicing. Finally, Drosophila in vivo studies show that Hrp38 deficiency produces locomotive defects and life span shortening in TDP-43 with and without animals. These results suggest that hnRNP protein levels can play a modulatory role on TDP-43 functions.	[Romano, Maurizio; Belluz, Lisa Del Bel] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Buratti, Emanuele; Romano, Giulia; Klima, Raffaella; Stuani, Cristiana; Baralle, Francisco; Feiguin, Fabian] Int Ctr Genet Engn Biotechnol, I-34149 Trieste, Italy	University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB)	Romano, M (corresponding author), Univ Trieste, Dept Life Sci, Via A Valerio 28, I-34127 Trieste, Italy.	mromano@units.it	Romano, Giulia/U-4156-2018; Romano, Maurizio/G-9431-2012; Buratti, Emanuele/K-4691-2016; Feiguin, Fabian/ABC-2514-2020	Romano, Giulia/0000-0003-0356-4947; Romano, Maurizio/0000-0002-4820-2897; Buratti, Emanuele/0000-0002-1356-9074; 	AriSLA (TARMA); AriSLA (ALSMNDTDP-43); Thierry Latran Foundation (REHNPALS); University of Trieste-Finanziamento per Ricercatori di Ateneo	AriSLA (TARMA); AriSLA (ALSMNDTDP-43); Thierry Latran Foundation (REHNPALS); University of Trieste-Finanziamento per Ricercatori di Ateneo	This work was supported by AriSLA (TARMA; to F. B.) and (ALSMNDTDP-43; to F. F.), Thierry Latran Foundation (REHNPALS; to E. B. and F. F.), and University of Trieste-Finanziamento per Ricercatori di Ateneo.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arrisi-Mercado P, 2004, J BIOL CHEM, V279, P39331, DOI 10.1074/jbc.M405566200; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bolker J, 2012, NATURE, V491, P31, DOI 10.1038/491031a; Budini M, 2012, BRAIN RES, V1462, P139, DOI 10.1016/j.brainres.2012.02.031; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Greenberg SA, 2011, CURR OPIN RHEUMATOL, V23, P574, DOI 10.1097/BOR.0b013e32834b53cc; Hahm B, 1998, FEBS LETT, V425, P401, DOI 10.1016/S0014-5793(98)00269-5; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ji YBA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1759; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; MATUNIS EL, 1992, J CELL BIOL, V116, P257, DOI 10.1083/jcb.116.2.257; MATUNIS MJ, 1992, J CELL BIOL, V116, P245, DOI 10.1083/jcb.116.2.245; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niksic M, 1999, HUM MOL GENET, V8, P2339, DOI 10.1093/hmg/8.13.2339; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Romano M., 2012, J AMINO ACIDS, V2012; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zu K, 1996, MOL BIOL CELL, V7, P1059, DOI 10.1091/mbc.7.7.1059	61	32	33	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7121	7130		10.1074/jbc.M114.548859	http://dx.doi.org/10.1074/jbc.M114.548859			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24492607	Green Published, hybrid			2022-12-25	WOS:000332389400071
J	Carvalho, HH; Brustolini, OJB; Pimenta, MR; Mendes, GC; Gouveia, BC; Silva, PA; Silva, JCF; Mota, CS; Soares-Ramos, JRL; Fontes, EPB				Carvalho, Humberto H.; Brustolini, Otavio J. B.; Pimenta, Maiana R.; Mendes, Giselle C.; Gouveia, Bianca C.; Silva, Priscila A.; Silva, Jose Cleydson F.; Mota, Clenilso S.; Soares-Ramos, Juliana R. L.; Fontes, Elizabeth P. B.			The Molecular Chaperone Binding Protein BiP Prevents Leaf Dehydration-Induced Cellular Homeostasis Disruption	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; VACUOLAR PROCESSING ENZYME; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; MESSENGER-RNA; SIGNALING PATHWAY; DROUGHT TOLERANCE; TRANSLOCON PORE	BiP overexpression improves leaf water relations during droughts and delays drought-induced leaf senescence. However, whether BiP controls cellular homeostasis under drought conditions or simply delays dehydration-induced leaf senescence as the primary cause for water stress tolerance remains to be determined. To address this issue, we examined the drought-induced transcriptomes of BiP-overexpressing lines and wild-type (WT) lines under similar leaf water potential (psi(w)) values. In the WT leaves, a psi(w) reduction of -1.0 resulted in 1339 up-regulated and 2710 down-regulated genes; in the BiP-overexpressing line 35S::BiP-4, only 334 and 420 genes were induced and repressed, respectively, at a similar leaf psi(w) = -1.0 MPa. This level of leaf dehydration was low enough to induce a repertory of typical drought-responsive genes in WT leaves but not in 35S::BiP-4 dehydrated leaves. The responders included hormone-related genes, functional and regulatory genes involved in drought protection and senescence-associated genes. The number of differentially expressed genes in the 35S::BiP-4 line approached the wild type number at a leaf psi(w) = -1.6 MPa. However, N-rich protein (NRP)-mediated cell death signaling genes and unfolded protein response (UPR) genes were induced to a much lower extent in the 35S::BiP-4 line than in the WT even at psi(w) = -1.6 MPa. The heatmaps for UPR, ERAD (ER-associated degradation protein system), drought-responsive and cell death-associated genes revealed that the leaf transcriptome of 35S::BiP-4 at psi(w) = -1.0 MPa clustered together with the transcriptome of well-watered leaves and they diverged considerably from the drought-induced transcriptome of the WT (psi(w) = -1.0, 21.7 and 22.0 MPa) and 35S::BiP-4 leaves at psi(w) = -1.6 MPa. Taken together, our data revealed that BiP-overexpressing lines requires a much higher level of stress (psi(w) = -1.6 MPa) to respond to drought than that of WT (psi(w) = -1.0). Therefore, BiP overexpression maintains cellular homeostasis under water stress conditions and thus ameliorates endogenous osmotic stress.	[Carvalho, Humberto H.; Brustolini, Otavio J. B.; Mendes, Giselle C.; Gouveia, Bianca C.; Silva, Priscila A.; Mota, Clenilso S.; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Natl Inst Sci & Technol Plant Pest Interact, Vicosa, MG, Brazil; [Brustolini, Otavio J. B.; Gouveia, Bianca C.; Silva, Priscila A.; Soares-Ramos, Juliana R. L.; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Dept Bioquim & Biol Mol Bioagro, Vicosa, MG, Brazil; [Carvalho, Humberto H.; Pimenta, Maiana R.; Mendes, Giselle C.; Silva, Jose Cleydson F.] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Fontes, EPB (corresponding author), Univ Fed Vicosa, Natl Inst Sci & Technol Plant Pest Interact, Vicosa, MG, Brazil.	bbfontes@ufv.br	Mendes, Giselle/F-4277-2016; Silva, Cleydson/AAR-8163-2020; Mendes, Giselle/AFV-6426-2022; da Silva, Priscila Alves/C-6614-2016; Fontes, Elizabeth/K-3159-2012	Mendes, Giselle/0000-0003-4361-9359; da Silva, Priscila Alves/0000-0002-4505-2248; Fontes, Elizabeth/0000-0002-7986-1369; Silva, Jose Cleydson F/0000-0001-5435-702X	CNPq [573600/2008-2, 470287/2011-0]; FAPEMIG [CBB-APQ-00070-09]; FINEP [01.09.0625.00]; CNPq; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was funded through the following grants from Brazilian Government Agencies: CNPq grants 573600/2008-2 and 470287/2011-0 (to EPBF); FAPEMIG grant CBB-APQ-00070-09; and FINEP grant 01.09.0625.00 (to EPBF). GCM and PAAR were supported by CNPq graduate fellowships, and HHC was supported by a FAPEMIG graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirrezabal L, 2006, PLANT CELL ENVIRON, V29, P2216, DOI 10.1111/j.1365-3040.2006.01595.x; Al-Asbahi A. A., 2012, Journal of Stress Physiology & Biochemistry, V8, P179; Alves MS, 2011, J BIOL CHEM, V286, P20020, DOI 10.1074/jbc.M111.233494; Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Anderson JV, 1994, PLANT PHYSL ROCKV, V104, P1395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Buzeli RAA, 2002, PLANT MOL BIOL, V50, P757, DOI 10.1023/A:1019994721545; Carvalho HH, 2014, PLANT PHYSIOL, V164, P654, DOI 10.1104/pp.113.231928; Cascardo JCM, 2001, PLANT SCI, V160, P273, DOI 10.1016/S0168-9452(00)00384-8; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Che P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001140; Costa MDL, 2008, J BIOL CHEM, V283, P20209, DOI 10.1074/jbc.M802654200; Deng Y, 2013, INT J MOL SCI, V14, P8188, DOI 10.3390/ijms14048188; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Fanata WID, 2013, J PROTEOMICS, V93, P356, DOI 10.1016/j.jprot.2013.04.023; Faria JAQA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-129; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hayashi S, 2012, PLANT J, V69, P946, DOI 10.1111/j.1365-313X.2011.04844.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; KAISER WM, 1987, PHYSIOL PLANTARUM, V71, P142, DOI 10.1111/j.1399-3054.1987.tb04631.x; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Li J, 2001, Genome Inform, V12, P3; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Lu SJ, 2012, MOL PLANT, V5, P504, DOI 10.1093/mp/ssr115; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mendes GC, 2013, P NATL ACAD SCI USA, V110, P19627, DOI 10.1073/pnas.1311729110; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Noh SJ, 2002, BBA-GENE STRUCT EXPR, V1575, P130, DOI 10.1016/S0167-4781(02)00237-3; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Reis PAA, 2011, PLANT PHYSIOL, V157, P1853, DOI 10.1104/pp.111.179697; Reis PAB, 2012, PLANT SIGNAL BEHAV, V7, P628, DOI 10.4161/psb.20111; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Srivastava R, 2013, PLANT CELL, V25, P1416, DOI 10.1105/tpc.113.110684; Srivastava R, 2012, PLANT J, V70, P1033, DOI 10.1111/j.1365-313X.2012.04943.x; Sung DY, 2001, PHYSIOL PLANTARUM, V113, P443, DOI 10.1034/j.1399-3054.2001.1130402.x; Tajima H, 2008, BIOCHEM BIOPH RES CO, V374, P242, DOI 10.1016/j.bbrc.2008.07.021; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Urade R, 2009, BIOFACTORS, V35, P326, DOI 10.1002/biof.45; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang B, 2012, MOL BIOL REP, V39, P6319, DOI 10.1007/s11033-012-1453-y; Xu FX, 1999, PLANT J, V17, P321, DOI 10.1046/j.1365-313X.1999.00370.x; Xu W, 2000, FEBS L, V474, P11	63	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86661	10.1371/journal.pone.0086661	http://dx.doi.org/10.1371/journal.pone.0086661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489761	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000055
J	Lahti, J; Lahti, M; Pesonen, AK; Heinonen, K; Kajantie, E; Forsen, T; Wahlbeck, K; Osmond, C; Barker, DJP; Eriksson, JG; Raikkonen, K				Lahti, Jari; Lahti, Marius; Pesonen, Anu-Katriina; Heinonen, Kati; Kajantie, Eero; Forsen, Tom; Wahlbeck, Kristian; Osmond, Clive; Barker, David J. P.; Eriksson, Johan G.; Raikkonen, Katri			Prenatal and Childhood Growth, and Hospitalization for Alcohol Use Disorders in Adulthood: The Helsinki Birth Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY-LIFE; DEVELOPMENTAL ORIGINS; PERSONALITY-DISORDERS; PSYCHIATRIC-DISORDER; SUBSTANCE DEPENDENCE; BEHAVIORAL SYMPTOMS; GENERAL-POPULATION; FOLLOW-UP; WEIGHT	Background: Small birth size - an indicator of a sub-optimal prenatal environment - and variation in growth after birth have been associated with non-communicable diseases in later life. We tested whether birth size or growth in childhood associated with the risk of hospital admission for alcohol use disorders (AUDs) from early to late adulthood. Methods: The sample comprised 6544 men and 6050 women born between 1934 and 1944 in Helsinki, Finland. Data on anthropometric measures were extracted from medical records and diagnoses of AUD from the Finnish Hospital Discharge Register and Causes of Death Register covering a 40-year period from 1969 to 2008. Results: Altogether 171 women (2.8%) and 657 men (10.0%) were diagnosed at a hospital with AUD. After adjusting for major confounders, shorter length at birth, shorter height up to two years of age, and lower weight at two years associated with hospitalization for AUD in women. In men, slower growth in height, particularly from 2 to 7 years, and slower weight gain from 7 to 11 years as well as shorter height and lower weight at 7 and 11 years associated with a diagnosis of AUD in men. Conclusions: Pre-and postnatal growth associates with the risk for AUD later in life differently in women than in men: the fetal period and infancy seem to be the sensitive periods for women, whereas those for men the occur from toddlerhood onwards.	[Lahti, Jari; Lahti, Marius; Pesonen, Anu-Katriina; Heinonen, Kati; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Kajantie, Eero; Forsen, Tom; Wahlbeck, Kristian; Eriksson, Johan G.] Natl Publ Hlth Inst, Helsinki, Finland; [Osmond, Clive; Barker, David J. P.] Univ Southampton, Med Res Council Lifecourse Epidemiol Unit, Southampton SO9 5NH, Hants, England; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland	University of Helsinki; Finland National Institute for Health & Welfare; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Helsinki	Lahti, J (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	jari.lahti@helsinki.fi	Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018; Wahlbeck, Kristian/F-8394-2011; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Heinonen, Kati/0000-0002-1262-5599; Pesonen, Anu-Katriina/0000-0002-0662-6261; Osmond, Clive/0000-0002-9054-4655; Wahlbeck, Kristian/0000-0003-3754-3933; Eriksson, Johan/0000-0002-2516-2060; Lahti-Pulkkinen, Marius/0000-0002-5244-5525	Academy of Finland; Doctoral Programme of Psychology; Alfred Kordelin foundation; Ella and Georg Ehrnrooths Stiftelse; Yrjo Jahnsson Foundation; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish; MRC [MC_UP_A620_1017] Funding Source: UKRI	Academy of Finland(Academy of Finland); Doctoral Programme of Psychology; Alfred Kordelin foundation; Ella and Georg Ehrnrooths Stiftelse; Yrjo Jahnsson Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Academy of Finland, Doctoral Programme of Psychology, Alfred Kordelin foundation, Ella and Georg Ehrnrooths Stiftelse, and Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel KM, 2010, ARCH GEN PSYCHIAT, V67, P923, DOI 10.1001/archgenpsychiatry.2010.100; Alati R, 2007, AM J EPIDEMIOL, V165, P575, DOI 10.1093/aje/kwk036; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Anderson SE, 2006, ARCH PEDIAT ADOL MED, V160, P285, DOI 10.1001/archpedi.160.3.285; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Becker ES, 2001, INT J OBESITY, V25, pS5, DOI 10.1038/sj.ijo.0801688; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Bowman RE, 2004, ENDOCRINOLOGY, V145, P3778, DOI 10.1210/en.2003-1759; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Disney ER, 2008, PEDIATRICS, V122, pE1225, DOI 10.1542/peds.2008-1380; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; Evans BE, 2012, ADDICTION, V107, P312, DOI 10.1111/j.1360-0443.2011.03568.x; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Green AI, 2006, J CLIN PSYCHIAT, V67, P31; Gustafsson WM, 2009, ACTA PSYCHIAT SCAND, V119, P54, DOI 10.1111/j.1600-0447.2008.01267.x; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Hallin AL, 2011, SCAND J PSYCHOL, V52, P251, DOI 10.1111/j.1467-9450.2010.00850.x; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Kelly YJ, 2001, INT J EPIDEMIOL, V30, P88, DOI 10.1093/ije/30.1.88; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Lahti J, 2006, J CHILD PSYCHOL PSYC, V47, P1167, DOI 10.1111/j.1469-7610.2006.01661.x; Lahti J, 2010, ACTA PSYCHIAT SCAND, V121, P227, DOI 10.1111/j.1600-0447.2009.01432.x; Lahti J, 2009, BRIT J PSYCHIAT, V195, P132, DOI 10.1192/bjp.bp.108.054387; Lahti M, 2011, J PERS DISORD, V25, P620, DOI 10.1521/pedi.2011.25.5.620; Lahti M, 2010, PSYCHIAT RES, V179, P226, DOI 10.1016/j.psychres.2009.08.024; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lumeng JC, 2003, PEDIATRICS, V112, P1138, DOI 10.1542/peds.112.5.1138; Makela P, 2008, J EPIDEMIOL COMMUN H, V62, P728, DOI 10.1136/jech.2007.065672; Makikyro T, 1998, EUR PSYCHIAT, V13, P57, DOI 10.1016/S0924-9338(98)80019-9; Manjarrez G, 2005, J PEDIATR-US, V147, P592, DOI 10.1016/j.jpeds.2005.06.025; MCCORMICK CM, 1995, DEV BRAIN RES, V84, P55, DOI 10.1016/0165-3806(94)00153-Q; Mikkonen M, MOTHERS MARITA UNPUB; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Ohlmeier MD, 2008, ALCOHOL ALCOHOLISM, V43, P300, DOI 10.1093/alcalc/agn014; Osler M, 2008, ANN EPIDEMIOL, V18, P422, DOI 10.1016/j.annepidem.2007.12.008; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Perrin MA, 2007, BRIT J PSYCHIAT, V191, P512, DOI 10.1192/bjp.bp.106.034694; Pirkola SP, 2006, ALCOHOL ALCOHOLISM, V41, P315, DOI 10.1093/alcalc/agh240; POIKOLAINEN K, 1983, DRUG ALCOHOL DEPEN, V12, P315, DOI 10.1016/0376-8716(83)90002-9; Raikkonen K, 2012, BEST PRACT RES CL EN, V26, P599, DOI 10.1016/j.beem.2012.03.001; Raikkonen K, 2011, J PSYCHIATR RES, V45, P332, DOI 10.1016/j.jpsychires.2010.07.003; Raznahan A, 2012, P NATL ACAD SCI USA, V109, P11366, DOI 10.1073/pnas.1203350109; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rice F, 2007, ACTA PSYCHIAT SCAND, V115, P171, DOI 10.1111/j.1600-0447.2006.00895.x; Roza SJ, 2008, NEUROIMAGE, V39, P1491, DOI 10.1016/j.neuroimage.2007.11.004; SAMPSON PD, 1994, AM J PUBLIC HEALTH, V84, P1421, DOI 10.2105/AJPH.84.9.1421; Schlotz W, 2007, PEDIATRICS, V120, pE1237, DOI 10.1542/peds.2006-3277; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Schulte MT, 2009, CLIN PSYCHOL REV, V29, P535, DOI 10.1016/j.cpr.2009.06.003; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Slotkin TA, 2006, NEUROPSYCHOPHARMACOL, V31, P904, DOI 10.1038/sj.npp.1300892; Sood B, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e34; STEWART AL, 1983, AM J PUBLIC HEALTH, V73, P171, DOI 10.2105/AJPH.73.2.171; Strang-Karlsson S, 2008, AM J PSYCHIAT, V165, P1345, DOI 10.1176/appi.ajp.2008.08010085; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; Trull TJ, 2010, J PERS DISORD, V24, P412, DOI 10.1521/pedi.2010.24.4.412; Veijola J, 2008, SOC PSYCH PSYCH EPID, V43, P11, DOI 10.1007/s00127-007-0268-y; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Walhovd KB, 2012, P NATL ACAD SCI USA, V109, P20089, DOI 10.1073/pnas.1208180109; Weinstock M, 2011, STRESS, V14, P604, DOI 10.3109/10253890.2011.588294; Wiles NJ, 2005, BRIT J PSYCHIAT, V187, P21, DOI 10.1192/bjp.187.1.21	74	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87404	10.1371/journal.pone.0087404	http://dx.doi.org/10.1371/journal.pone.0087404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489908	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330570000140
J	Mannironi, C; Proietto, M; Bufalieri, F; Cundari, E; Alagia, A; Danovska, S; Rinaldi, T; Famiglini, V; Coluccia, A; La Regina, G; Silvestri, R; Negri, R				Mannironi, Cecilia; Proietto, Marco; Bufalieri, Francesca; Cundari, Enrico; Alagia, Angela; Danovska, Svetlana; Rinaldi, Teresa; Famiglini, Valeria; Coluccia, Antonio; La Regina, Giuseppe; Silvestri, Romano; Negri, Rodolfo			An High-Throughput In Vivo Screening System to Select H3K4-Specific Histone Demethylase Inhibitors	PLOS ONE			English	Article							JUMONJI C DOMAIN; H3K4 DEMETHYLATION; METHYLATION; CHROMATIN; CANCER; TRIMETHYLATION; IDENTIFICATION; TRANSCRIPTION; METHYLTRANSFERASE; BINDING	Background: Histone demethylases (HDMs) have a prominent role in epigenetic regulation and are emerging as potential therapeutic cancer targets. The search for small molecules able to inhibit HDMs in vivo is very active but at the present few compounds were found to be specific for defined classes of these enzymes. Methodology/Principal Findings: In order to discover inhibitors specific for H3K4 histone demethylation we set up a screening system which tests the effects of candidate small molecule inhibitors on a S. cerevisiae strain which requires Jhd2 demethylase activity to efficiently grow in the presence of rapamycin. In order to validate the system we screened a library of 45 structurally different compounds designed as competitive inhibitors of alpha -ketoglutarate (alpha-KG) cofactor of the enzyme, and found that one of them inhibited Jhd2 activity in vitro and in vivo. The same compound effectively inhibits human Jumonji AT-Rich Interactive Domain (JARID) 1B and 1D in vitro and increases H3K4 tri-methylation in HeLa cell nuclear extracts (NEs). When added in vivo to HeLa cells, the compound leads to an increase of tri-methyl-H3K4 (H3K4me3) but does not affect H3K9 tri-methylation. We describe the cytostatic and toxic effects of the compound on HeLa cells at concentrations compatible with its inhibitory activity. Conclusions/Significance: Our screening system is proved to be very useful in testing putative H3K4-specific HDM inhibitors for the capacity of acting in vivo without significantly altering the activity of other important 2-oxoglutarate oxygenases.	[Mannironi, Cecilia; Cundari, Enrico] CNR, Ist Biol & Patol Mol, Rome, Italy; [Proietto, Marco; Bufalieri, Francesca; Alagia, Angela; Danovska, Svetlana; Rinaldi, Teresa; Negri, Rodolfo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Famiglini, Valeria; Coluccia, Antonio; La Regina, Giuseppe; Silvestri, Romano] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome	Negri, R (corresponding author), Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Biol & Biotecnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	rodolfo.negri@uniroma1.it	Proietto, Marco/AAQ-2915-2020; mannironi, cecilia/D-5745-2017; La Regina, Giuseppe/I-2161-2012; Rinaldi, Teresa/AAC-9710-2020; Bufalieri, Francesca/AAT-3937-2020; Coluccia, Antonio/K-3114-2018	mannironi, cecilia/0000-0001-6934-8425; La Regina, Giuseppe/0000-0003-3252-1161; Rinaldi, Teresa/0000-0001-6291-245X; Bufalieri, Francesca/0000-0002-9571-318X; Coluccia, Antonio/0000-0002-7940-8206; Silvestri, Romano/0000-0003-2489-0178; PROIETTO, Marco/0000-0001-5681-3199	FIRB [RBIN06E9Z8]; PRIN [2010W7YRLZ]; Progetti di Ricerca di Ateneo [C26A1139XY]; Progetti di Ricerca di Universita, Sapienza Universita di Roma; Bando Futuro in Ricerca [RBFR10ZJQT]; Regione Lazio	FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Progetti di Ricerca di Ateneo; Progetti di Ricerca di Universita, Sapienza Universita di Roma; Bando Futuro in Ricerca; Regione Lazio(Regione Lazio)	This work has been supported by: FIRB 2011-2013 (grant no. RBIN06E9Z8) "Molecular Bases of Diseases"; PRIN 2009 "Role of S. cerevisiae General Regulatory Factors in chromatin organization and dynamics" and Progetti di Ricerca di Ateneo (grant no. C26A1139XY) to RN and: PRIN 2010 (grant no. 2010W7YRLZ); Progetti di Ricerca di Universita, Sapienza Universita di Roma 2012 and Bando Futuro in Ricerca 2010 (grant no. RBFR10ZJQT) to RS. VL fellowship is sponsored by Regione Lazio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz N, 2010, RNA, V15, P277; Chaturvedi CP, 2012, P NATL ACAD SCI USA, V109, P18845, DOI 10.1073/pnas.1213951109; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hamada S, 2010, J MED CHEM, V53, P5629, DOI 10.1021/jm1003655; Hou JL, 2012, AM J TRANSL RES, V4, P247; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Korb O, 2006, ANT COL OPT SWARM IN; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kristensen LH, 2012, FEBS J, V279, P1905, DOI 10.1111/j.1742-4658.2012.08567.x; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lohse B, 2011, BIOORGAN MED CHEM, V19, P3625, DOI 10.1016/j.bmc.2011.01.046; Luo XL, 2011, J AM CHEM SOC, V133, P9451, DOI 10.1021/ja201597b; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mishra BP, 2009, FEBS J, V276, P1629, DOI 10.1111/j.1742-4658.2009.06895.x; Mitra D, 2011, J BIOL CHEM, V286, P40531, DOI 10.1074/jbc.M111.304865; Nielsen AL, 2012, FEBS LETT, V586, P1190, DOI 10.1016/j.febslet.2012.03.001; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Spannhoff A, 2009, CHEMMEDCHEM, V4, P1568, DOI 10.1002/cmdc.200900301; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhou BO, 2011, J BIOL CHEM, V286, P34770, DOI 10.1074/jbc.M111.273128	51	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86002	10.1371/journal.pone.0086002	http://dx.doi.org/10.1371/journal.pone.0086002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489688	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000022
J	Misuno, K; Tran, SD; Khalili, S; Huang, JW; Liu, YN; Hu, S				Misuno, Kaori; Tran, Simon D.; Khalili, Saeed; Huang, Junwei; Liu, Younan; Hu, Shen			Quantitative Analysis of Protein and Gene Expression in Salivary Glands of Sjogren's-Like Disease NOD Mice Treated by Bone Marrow Soup	PLOS ONE			English	Article							STEM-CELLS; IDENTIFICATION; BIOMARKERS; ACTIVATION; KALLIKREIN; DIFFERENTIATION; ORGANIZATION; PATHWAYS; LYMPHOMA; SYSTEM	Background: Bone marrow cell extract (termed as BM Soup) has been demonstrated to repair irradiated salivary glands (SGs) and restore saliva secretion in our previous study. In the present study, we aim to investigate if the function of damaged SGs in non-obese diabetic (NOD) mice can be restored by BM Soup treatment and the molecular alterations associated with the treatment. Methods: Whole BM cells were lysed and soluble intracellular contents ("BM Soup") were injected I. V. into NOD mice. Tandem mass tagging with 2-D liquid chromatography-mass spectrometry was used to quantify proteins in the submandibular glands (SMGs) between untreated and BM Soup-treated mice. Quantitative PCR was used to identify genes with altered expression in the treated mice. Results BM Soup: restored salivary flow rates to normal levels and significantly reduced the focus scores of SMGs in NOD mice. More than 1800 proteins in SMG cells were quantified by the proteomic approach. Many SMG proteins involved in inflammation and apoptosis were found to be down-regulated whereas those involved in salivary gland biology and development/regeneration were up-regulated in the BM Soup-treated mice. qPCR analysis also revealed expression changes of growth factors and cytokines in the SMGs of the treated NOD mice. Conclusion: BM Soup treatment is effective to restore the function of damaged SGs in NOD mice. Through gene/protein expression analysis, we have found that BM Soup treatment might effectuate via inhibiting apoptosis, focal adhesion and inflammation whereas promoting development, regeneration and differentiation of the SG cells in NOD mice. These findings provide important insights on the potential mechanisms underlying the BM Soup treatment for functional restoration of damaged SGs in NOD mice. Additional studies are needed to further confirm the identified target genes and their related signaling pathways that are responsible for the BM Soup treatment.	[Misuno, Kaori; Huang, Junwei; Hu, Shen] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Tran, Simon D.; Khalili, Saeed; Liu, Younan] McGill Univ, Fac Dent, Craniofacial Tissue Engn & Stem Cells Lab, Montreal, PQ, Canada	University of California System; University of California Los Angeles; McGill University	Tran, SD (corresponding author), McGill Univ, Fac Dent, Craniofacial Tissue Engn & Stem Cells Lab, Montreal, PQ, Canada.	simon.tran@mcgill.ca; shenhu@ucla.edu	Hu, Steve/B-3799-2011		Canadian Institutes of Health Research (CIHR); Canada Research Chairs (CRC); Sjogren's Syndrome Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC)(Canada Research Chairs); Sjogren's Syndrome Foundation	This study was supported in part by the Canadian Institutes of Health Research (CIHR, ST) and Canada Research Chairs (CRC, ST), and partially supported by the Sjogren's Syndrome Foundation (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3523; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Beroukas D, 2002, LAB INVEST, V82, P1547, DOI 10.1097/01.LAB.0000038502.42845.9E; Berridge MJ, 1997, J EXP BIOL, V200, P315; Bhoola K, 2001, BIOL CHEM, V382, P77, DOI 10.1515/BC.2001.013; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; Castro A, 1996, CELL CALCIUM, V20, P493, DOI 10.1016/S0143-4160(96)90091-3; Colomer J, 2008, CALCIUM SIGNALLING D, P169; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; DANIELS TE, 1992, RHEUM DIS CLIN N AM, V18, P571; Faustman DL, 2010, INT J BIOCHEM CELL B, V42, P1576, DOI 10.1016/j.biocel.2010.06.012; FISHLEDER A, 1987, NEW ENGL J MED, V316, P1118, DOI 10.1056/NEJM198704303161803; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; Hjelmervik TOR, 2009, ORAL DIS, V15, P342, DOI 10.1111/j.1601-0825.2009.01531.x; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2011, PROTEOMICS, V11, P1499, DOI 10.1002/pmic.201000206; Hu S, 2010, ARTHRIT CARE RES, V62, P1633, DOI 10.1002/acr.20289; Hu S, 2009, ARTHRITIS RHEUM-US, V60, P81, DOI 10.1002/art.24150; Humphreys-Beher MG, 1999, CLIN EXP IMMUNOL, V116, P383; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; KAWANO S, 1995, J PHYSIOL-LONDON, V486, P593, DOI 10.1113/jphysiol.1995.sp020837; Khalili S, 2013, CYTOTHERAPY IN PRESS; Khalili S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038615; Khalili S, 2010, INT J BIOCHEM CELL B, V42, P1893, DOI 10.1016/j.biocel.2010.08.008; Khovidhunkit W, 2005, AM J PHYSIOL-REG I, V288, pR1306, DOI 10.1152/ajpregu.00007.2004; KOHSAKA H, 1990, J CLIN INVEST, V85, P1566, DOI 10.1172/JCI114606; Kuo J-C, 2013, J CELLULAR MOL MED; Lam K, 2005, J CELL PHYSIOL, V203, P353, DOI 10.1002/jcp.20247; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Liu XB, 2000, P SOC EXP BIOL MED, V225, P211, DOI 10.1046/j.1525-1373.2000.22527.x; Lombaert IMA, 2006, CLIN CANCER RES, V12, P1804, DOI 10.1158/1078-0432.CCR-05-2381; Lombaert IMA, 2008, CLIN CANCER RES, V14, P7741, DOI 10.1158/1078-0432.CCR-08-1449; Maria OM, 2007, ORAL DIS, V13, P11, DOI 10.1111/j.1601-0825.2006.01324.x; MARSHALL ICB, 1993, J EXP BIOL, V184, P161; Mishra J, 2002, BIOPHYS J, V83, P1298, DOI 10.1016/S0006-3495(02)73901-5; Olsson AY, 2002, BIOCHEM BIOPH RES CO, V299, P305; Peluso G, 2007, ARTHRITIS RHEUM, V56, P2216, DOI 10.1002/art.22738; Ring T, 2006, CLIN RHEUMATOL, V25, P891, DOI 10.1007/s10067-005-0086-0; Robinson CP, 1997, P NATL ACAD SCI USA, V94, P5767, DOI 10.1073/pnas.94.11.5767; ROYCE LS, 1993, DIFFERENTIATION, V52, P247, DOI 10.1111/j.1432-0436.1993.tb00637.x; Ryu OH, 2006, RHEUMATOLOGY, V45, P1077, DOI 10.1093/rheumatology/kei212; Sequeira SJ, 2012, BIOMATERIALS, V33, P3175, DOI 10.1016/j.biomaterials.2012.01.010; Sipsas NV, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3262; Sisto M, 2006, J AUTOIMMUN, V27, P38, DOI 10.1016/j.jaut.2006.05.001; Sumida T, 2010, AUTOIMMUN REV, V9, P615, DOI 10.1016/j.autrev.2010.05.008; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Takada K, 2005, J BIOL CHEM, V280, P3982, DOI 10.1074/jbc.M410157200; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; Tran SD, 2007, ANN RHEUM DIS, V66, P812, DOI 10.1136/ard.2006.064030; Tran SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061632; Tran SD, 2011, BIOL BLOOD MARROW TR, V17, P429, DOI 10.1016/j.bbmt.2010.09.021; Tran SD, 2011, INT J BIOCHEM CELL B, V43, P5, DOI 10.1016/j.biocel.2010.10.010; Ulbricht KU, 2003, AUTOIMMUN REV, V2, P109, DOI 10.1016/S1568-9972(03)00002-8; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; You S, 2012, INVEST OPHTH VIS SCI, V53, P126, DOI 10.1167/iovs.11-7893; You S, 2011, INVEST OPHTH VIS SCI, V52, P2087, DOI 10.1167/iovs.10-5686; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zheng CY, 1998, J CELL PHYSIOL, V177, P628, DOI 10.1002/(SICI)1097-4652(199812)177:4<628::AID-JCP13>3.0.CO;2-L	64	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87158	10.1371/journal.pone.0087158	http://dx.doi.org/10.1371/journal.pone.0087158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489858	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000110
J	Parker, HL; Rylott, EL; Hunt, AJ; Dodson, JR; Taylor, AF; Bruce, NC; Clark, JH				Parker, Helen L.; Rylott, Elizabeth L.; Hunt, Andrew J.; Dodson, Jennifer R.; Taylor, Andrew F.; Bruce, Neil C.; Clark, James H.			Supported Palladium Nanoparticles Synthesized by Living Plants as a Catalyst for Suzuki-Miyaura Reactions	PLOS ONE			English	Article							GOLD NANOPARTICLES; COUPLING REACTIONS; HETEROGENEOUS CATALYST; HYDROGENATION; OXIDATION; EFFICIENT; BIOMASS; COPPER; SILVER; PD	The metal accumulating ability of plants has previously been used to capture metal contaminants from the environment; however, the full potential of this process is yet to be realized. Herein, the first use of living plants to recover palladium and produce catalytically active palladium nanoparticles is reported. This process eliminates the necessity for nanoparticle extraction from the plant and reduces the number of production steps compared to traditional catalyst palladium on carbon. These heterogeneous plant catalysts have demonstrated high catalytic activity in Suzuki coupling reactions between phenylboronic acid and a range of aryl halides containing iodo-, bromo- and chloro- moieties.	[Parker, Helen L.; Hunt, Andrew J.; Dodson, Jennifer R.; Clark, James H.] Univ York, Dept Chem, Green Chem Ctr Excellence, York YO10 5DD, N Yorkshire, England; [Rylott, Elizabeth L.; Taylor, Andrew F.; Bruce, Neil C.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Bruce, NC (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	neil.bruce@york.ac.uk; james.clark@york.ac.uk	Rylott, Elizabeth L/A-6059-2012; Clark, James/C-2064-2012	Rylott, Elizabeth L/0000-0002-1609-414X; Clark, James/0000-0002-5860-2480; Taylor, Andrew/0000-0003-1689-5737; /0000-0003-3983-8313; Bruce, Neil Charles/0000-0003-0398-2997; Dodson, Jennifer/0000-0001-6233-2252	EPSRC [EP/P505178/1, EP/K022482/1]; Engineering and Physical Sciences Research Council [EP/K022482/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was received from EPSRC, grant code: EP/P505178/1. Funding was also received from "The G8 Research Councils Initiative on Multilateral Research Funding" (funds came from EPSRC) grant code: EP/K022482/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak L, 2009, J ORG CHEM, V74, P3982, DOI 10.1021/jo9003037; Anderson CWN, 2013, ACS SUSTAIN CHEM ENG, V1, P640, DOI 10.1021/sc400011s; Anderson CWN, 1998, NATURE, V395, P553, DOI 10.1038/26875; Astruc D, 2005, ANGEW CHEM INT EDIT, V44, P7852, DOI 10.1002/anie.200500766; Badone D, 1997, J ORG CHEM, V62, P7170, DOI 10.1021/jo970439i; Bennett JA, 2010, CHEM ENG SCI, V65, P282, DOI 10.1016/j.ces.2009.06.069; Brooks RR, 1998, PLANTS THAT HYPERACCUMULATE HEAVY METALS: THEIR ROLE IN PHYTOREMEDIATION, MICROBIOLOGY, ARCHAEOLOGY, MINERAL EXPLORATION AND PHYTOMINING, P1; Coker VS, 2010, ACS NANO, V4, P2577, DOI 10.1021/nn9017944; Datye AK, 2006, CATAL TODAY, V111, P59, DOI 10.1016/j.cattod.2005.10.013; De Corte S, 2012, MICROB BIOTECHNOL, V5, P5, DOI 10.1111/j.1751-7915.2011.00265.x; Dodson J, 2013, RSC GREEN CHEM SER, V22, P220, DOI 10.1039/9781849737340-00220; Foulkes JM, 2011, ACS CATAL, V1, P1589, DOI 10.1021/cs200400t; FOX B, 1982, J BIOL CHEM, V257, P2498; Harris AT, 2008, J NANOPART RES, V10, P691, DOI 10.1007/s11051-007-9288-5; Haverkamp RG, 2009, J NANOPART RES, V11, P1453, DOI 10.1007/s11051-008-9533-6; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jiang L, 2009, J ELECTROCHEM SOC, V156, pB643, DOI 10.1149/1.3098478; Joo SH, 2009, NAT MATER, V8, P126, DOI 10.1038/NMAT2329; Karami K, 2013, CATAL COMMUN, V38, P10, DOI 10.1016/j.catcom.2013.04.003; Losfeld G, 2012, CATAL TODAY, V189, P111, DOI 10.1016/j.cattod.2012.02.044; Manceau A, 2008, ENVIRON SCI TECHNOL, V42, P1766, DOI 10.1021/es072017o; Mandal S, 2004, CHEM MATER, V16, P3714, DOI 10.1021/cm0352504; Nemutandani T., 2006, Toxicological and Environmental Chemistry, V88, P175, DOI 10.1080/02772240600585842; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; SALT DE, 1995, BIO-TECHNOL, V13, P468, DOI 10.1038/nbt0595-468; Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a; Singaravelu G, 2007, COLLOID SURFACE B, V57, P97, DOI 10.1016/j.colsurfb.2007.01.010; Sobjerg LS, 2009, GREEN CHEM, V11, P2041, DOI 10.1039/b918351p; Torborg C, 2009, ADV SYNTH CATAL, V351, P3027, DOI 10.1002/adsc.200900587; Wolfe JP, 1999, J AM CHEM SOC, V121, P9550, DOI 10.1021/ja992130h; Yang CX, 2011, J MATER CHEM, V21, P187, DOI 10.1039/c0jm03145c; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2	32	67	69	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87192	10.1371/journal.pone.0087192	http://dx.doi.org/10.1371/journal.pone.0087192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489869	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000118
J	Wong, HR; Weiss, SL; Giuliano, JS; Wainwright, MS; Cvijanovich, NZ; Thomas, NJ; Allen, GL; Anas, N; Bigham, MT; Hall, M; Freishtat, RJ; Sen, A; Meyer, K; Checchia, PA; Shanley, TP; Nowak, J; Quasney, M; Chopra, A; Fitzgerald, JC; Gedeit, R; Banschbach, S; Beckman, E; Lahni, P; Hart, K; Lindsell, CJ				Wong, Hector R.; Weiss, Scott L.; Giuliano, John S., Jr.; Wainwright, Mark S.; Cvijanovich, Natalie Z.; Thomas, Neal J.; Allen, Geoffrey L.; Anas, Nick; Bigham, Michael T.; Hall, Mark; Freishtat, Robert J.; Sen, Anita; Meyer, Keith; Checchia, Paul A.; Shanley, Thomas P.; Nowak, Jeffrey; Quasney, Michael; Chopra, Arun; Fitzgerald, Julie C.; Gedeit, Rainer; Banschbach, Sharon; Beckman, Eileen; Lahni, Patrick; Hart, Kimberly; Lindsell, Christopher J.			Testing the Prognostic Accuracy of the Updated Pediatric Sepsis Biomarker Risk Model	PLOS ONE			English	Article							EXPRESSION PROFILES; IDENTIFICATION	Background: We previously derived and validated a risk model to estimate mortality probability in children with septic shock (PERSEVERE; PEdiatRic SEpsis biomarkEr Risk modEl). PERSEVERE uses five biomarkers and age to estimate mortality probability. After the initial derivation and validation of PERSEVERE, we combined the derivation and validation cohorts (n = 355) and updated PERSEVERE. An important step in the development of updated risk models is to test their accuracy using an independent test cohort. Objective: To test the prognostic accuracy of the updated version PERSEVERE in an independent test cohort. Methods: Study subjects were recruited from multiple pediatric intensive care units in the United States. Biomarkers were measured in 182 pediatric subjects with septic shock using serum samples obtained during the first 24 hours of presentation. The accuracy of PERSEVERE 28-day mortality risk estimate was tested using diagnostic test statistics, and the net reclassification improvement (NRI) was used to test whether PERSEVERE adds information to a physiology-based scoring system. Results: Mortality in the test cohort was 13.2%. Using a risk cut-off of 2.5%, the sensitivity of PERSEVERE for mortality was 83% (95% CI 62-95), specificity was 75% (68-82), positive predictive value was 34% (22-47), and negative predictive value was 97% (91-99). The area under the receiver operating characteristic curve was 0.81 (0.70-0.92). The false positive subjects had a greater degree of organ failure burden and longer intensive care unit length of stay, compared to the true negative subjects. When adding PERSEVERE to a physiology-based scoring system, the net reclassification improvement was 0.91 (0.47-1.35; p<0.001). Conclusions: The updated version of PERSEVERE estimates mortality probability reliably in a heterogeneous test cohort of children with septic shock and provides information over and above a physiology-based scoring system.	[Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Lahni, Patrick] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Lahni, Patrick] Cincinnati Childrens Res Fdn, Cincinnati, OH 45229 USA; [Wong, Hector R.] Univ Cincinnati Coll Med, Dept Pediat, Cincinnati, OH USA; [Weiss, Scott L.; Fitzgerald, Julie C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Giuliano, John S., Jr.] Yale Univ, Sch Med, Dept Pediat, Div Crit Care Med, New Haven, CT USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Cvijanovich, Natalie Z.] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Thomas, Neal J.] Penn State Hershey Childrens Hosp, Hershey, PA USA; [Allen, Geoffrey L.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Anas, Nick] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Bigham, Michael T.] Akron Childrens Hosp, Akron, OH USA; [Hall, Mark] Nationwide Childrens Hosp, Columbus, OH USA; [Freishtat, Robert J.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sen, Anita] Columbia Univ, Med Ctr, Morgan Stanley Childrens Hosp, New York, NY USA; [Meyer, Keith] Miami Childrens Hosp, Miami, FL USA; [Checchia, Paul A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Shanley, Thomas P.; Quasney, Michael] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Nowak, Jeffrey] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Chopra, Arun] St Christophers Hosp Children, Philadelphia, PA 19133 USA; [Gedeit, Rainer] Childrens Hosp Wisconsin, Milwaukee, WI USA; [Hart, Kimberly; Lindsell, Christopher J.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Ann & Robert H. Lurie Children's Hospital of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Children's Mercy Hospital; Childrens Hospital of Orange County; Akron Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's National Health System; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Baylor College of Medicine; University of Michigan System; University of Michigan; Children's Hospitals & Clinics of Minnesota; Children's Hospital of Wisconsin; University System of Ohio; University of Cincinnati	Wong, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA.	hector.wong@cchmc.org	Hall, Mark/E-3193-2011; Chopra, Arun/AAA-6983-2019	Freishtat, Robert/0000-0002-7411-2342; Gedeit, Rainer/0000-0003-2420-9493; Weiss, Scott/0000-0002-7040-3281; Thomas, Neal/0000-0002-7991-7510; Wong, Hector/0000-0001-7989-1173; Meyer, Keith/0000-0001-7354-5552; Chopra, Arun/0000-0002-1418-6470; Lindsell, Christopher/0000-0002-3297-2811; Giuliano, John/0000-0003-2753-8460; Fitzgerald, Julie/0000-0001-9936-9569; Shanley, Thomas/0000-0001-8936-377X	National Institutes of Health [RC1HL100474, RO1GM064619, RO1GM099773]; Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR [8UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008478, R01GM064619, R01GM099773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RC1HL100474, RO1GM064619, and RO1GM099773, and an Innovation Award from the Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation. This work was also supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR 8UL1 TR000077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulebda A, 2013, CRIT CARE MED; Basu RK, 2011, CRIT CARE, V15, DOI 10.1186/cc10554; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Che DS, 2011, ADV EXP MED BIOL, V696, P191, DOI 10.1007/978-1-4419-7046-6_19; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; Giuliano Jr JS, 2013, PEDIAT CRIT CARE MED; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hanna W, 2013, CRIT CARE CLIN, V29, P203, DOI 10.1016/j.ccc.2012.11.003; Kaplan JM, 2011, PEDIATR CRIT CARE ME, V12, P165, DOI 10.1097/PCC.0b013e3181e28876; Lowry R., 2013, VASSARSTATS WEBSITE; Muller R, 2008, CLIN CHIM ACTA, V394, P1, DOI 10.1016/j.cca.2008.04.007; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE210, DOI 10.1097/PCC.0b013e318238b5cd; Wong HR, 2008, AM J RESP CRIT CARE, V178, P276, DOI 10.1164/rccm.200801-131OC; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2013, PEDIATR RES, V73, P564, DOI 10.1038/pr.2013.11; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652; Wong HR, 2011, CRIT CARE MED, V39, P2511, DOI 10.1097/CCM.0b013e3182257675; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169	26	45	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86242	10.1371/journal.pone.0086242	http://dx.doi.org/10.1371/journal.pone.0086242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489704	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000030
J	Chen, P; Zhang, L; Weng, TJ; Zhang, SC; Sun, SJ; Chang, MT; Li, Y; Zhang, B; Zhang, LY				Chen, Peng; Zhang, Li; Weng, Tujun; Zhang, Shichang; Sun, Shijin; Chang, Mingtao; Li, Yang; Zhang, Bo; Zhang, Lianyang			A Ser252Trp Mutation in Fibroblast Growth Factor Receptor 2 (FGFR2) Mimicking Human Apert Syndrome Reveals an Essential Role for FGF Signaling in the Regulation of Endochondral Bone Formation	PLOS ONE			English	Article							OF-FUNCTION MUTATION; PROTEIN-KINASE-C; OSTEOBLAST DIFFERENTIATION; STEM-CELLS; MOUSE; MICE; CRANIOSYNOSTOSIS; ACTIVATION; P38; ABNORMALITIES	A S252W mutation of fibroblast growth factor receptor 2 (FGFR2), which is responsible for nearly two-thirds of Apert syndrome (AS) cases, causes retarded development of the skeleton and skull malformation resulting from premature fusion of the craniofacial sutures. We utilized a Fgfr2(+/S252W) mouse (a knock-in mouse model mimicking human AS) to demonstrate decreased bone mass due to reduced trabecular bone volume, reduced bone mineral density, and shortened growth plates in the long bones. In vitro bone mesenchymal stem cells (BMSCs) culture studies revealed that the mutant mice showed reduced BMSC proliferation, a reduction in chondrogenic differentiation, and reduced mineralization. Our results suggest that these phenomena are caused by up-regulation of p38 and Erk1/2 phosphorylation. Treatment of cultured mutant bone rudiments with SB203580 or PD98059 resulted in partial rescue of the bone growth retardation. The p38 signaling pathway especially was found to be responsible for the retarded long bone development. Our data indicate that the S252W mutation in FGFR2 directly affects endochondral ossification, resulting in growth retardation of the long bone. We also show that the p38 and Erk1/2 signaling pathways partially mediate the effects of the S252W mutation of FGFR2 on long bone development.	[Chen, Peng; Zhang, Li; Weng, Tujun; Zhang, Shichang; Sun, Shijin; Chang, Mingtao; Li, Yang; Zhang, Bo; Zhang, Lianyang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Chen, Peng] PLA 324 Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University	Zhang, B (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	zhangbo67184@163.com; dpzhangly@163.com	Zhang, Shichang/K-1715-2019	Zhang, Shichang/0000-0002-6587-2518; Li, Yang/0000-0003-2327-0444	Special Funds for Major State Basic Research Program of China (973 program) [2011CB964701]; National Natural Science Foundation of China [81000422]	Special Funds for Major State Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the Special Funds for Major State Basic Research Program of China (973 program) (No. 2011CB964701) and National Natural Science Foundation of China (No. 81000422). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Chen L, 2001, HUM MOL GENET, V10, P457, DOI 10.1093/hmg/10.5.457; Cohen M M Jr, 1988, Am J Med Genet Suppl, V4, P99; COHEN MM, 1993, AM J MED GENET, V47, P624, DOI 10.1002/ajmg.1320470509; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Hurley MM, 2006, BIOCHEM BIOPH RES CO, V341, P989, DOI 10.1016/j.bbrc.2006.01.044; Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Jin M, 2012, HUM MOL GENET, V21, P5443, DOI 10.1093/hmg/dds390; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; Lemonnier J, 2000, EXP CELL RES, V256, P158, DOI 10.1006/excr.2000.4820; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Nagata M, 2011, BONE, V48, P847, DOI 10.1016/j.bone.2010.11.014; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; PARK WJ, 1995, AM J HUM GENET, V57, P321; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Rice DPC, 2003, BONE, V33, P14, DOI 10.1016/S8756-3282(03)00163-7; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; So N, 2008, BIOCHEM BIOPH RES CO, V376, P454, DOI 10.1016/j.bbrc.2008.08.165; Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890; Su N, 2010, HUM MOL GENET, V19, P1199, DOI 10.1093/hmg/ddp590; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang YL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-22; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yin L, 2008, BONE, V42, P631, DOI 10.1016/j.bone.2007.11.019; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu K, 2001, P NATL ACAD SCI USA, V98, P3641, DOI 10.1073/pnas.081082498	46	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87311	10.1371/journal.pone.0087311	http://dx.doi.org/10.1371/journal.pone.0087311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489893	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000127
J	Evans, SE; Groenke, JR; Jones, MEH; Turner, AH; Krause, DW				Evans, Susan E.; Groenke, Joseph R.; Jones, Marc E. H.; Turner, Alan H.; Krause, David W.			New Material of Beelzebufo, a Hyperossified Frog (Amphibia: Anura) from the Late Cretaceous of Madagascar	PLOS ONE			English	Article							PALEOGENE PIPID FROG; MORPHOLOGICAL EVOLUTION; MAHAJANGA BASIN; SOUTH-AMERICA; MOLECULAR PHYLOGENY; MAEVARANO FORMATION; CO-OSSIFICATION; FOSSIL RECORD; ORIGIN; GENUS	The extant anuran fauna of Madagascar is exceptionally rich and almost completely endemic. In recent years, many new species have been described and understanding of the history and relationships of this fauna has been greatly advanced by molecular studies, but very little is known of the fossil history of frogs on the island. Beelzebufo ampinga, the first named pre-Holocene frog from Madagascar, was described in 2008 on the basis of numerous disarticulated cranial and postcranial elements from the Upper Cretaceous (Maastrichtian) Maevarano Formation of Madagascar. These specimens documented the presence of a hyperossified taxon that differed strikingly from extant Malagasy frogs in its large size and heavy coarse cranial exostosis. Here we describe and analyse new, articulated, and more complete material of the skull, vertebral column, and hind limb, as well as additional isolated elements discovered since 2008. mu CT scans allow a detailed understanding of both internal and external morphology and permit a more accurate reconstruction. The new material shows Beelzebufo to have been even more bizarre than originally interpreted, with large posterolateral skull flanges and sculptured vertebral spine tables. The apparent absence of a tympanic membrane, the strong cranial exostosis, and vertebral morphology suggest it may have burrowed during seasonally arid conditions, which have been interpreted for the Maevarano Formation from independent sedimentological and taphonomic evidence. New phylogenetic analyses, incorporating both morphological and molecular data, continue to place Beelzebufo with hyloid rather than ranoid frogs. Within Hyloidea, Beelzebufo still groups with the South American Ceratophryidae thus continuing to pose difficulties with both biogeographic interpretations and prior molecular divergence dates.	[Evans, Susan E.; Jones, Marc E. H.] UCL, Dept Cell & Dev Biol, London, England; [Groenke, Joseph R.; Turner, Alan H.; Krause, David W.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Jones, Marc E. H.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of London; University College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Adelaide	Evans, SE (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	ucgasue@ucl.ac.uk	Huw, Emyr/C-1516-2010; Evans, Susan/C-1888-2008	Huw, Emyr/0000-0002-0146-9623; Evans, Susan/0000-0002-0799-4154; Groenke, Joseph/0000-0002-9527-1887	National Science Foundation [DEB-9224396, EAR-9418816, EAR-9706302, DEB-9904045, EAR-0106477, EAR-0116517, EAR-0446488]; National Geographic Society; NSF; Directorate For Geosciences [1123642] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially funded by grants from the National Science Foundation ((DEB-9224396, EAR-9418816, EAR-9706302, DEB-9904045, EAR-0106477, EAR-0116517, EAR-0446488, EAR-0116517) and the National Geographic Society (1999, 2001, 2004, 2009) to David W. Krause. NSF (www.nsf.gov) funded fieldwork expeditions to the Mahajanga Basin (including return travel for JG,DK,AT); laboratory preparation costs, travel for SEE to visit SBU, shipment of specimens to and from U. K., computer upgrade to efficiently run Avizo software. NG (www.nationalgeographic.com) funded fieldwork expeditions to the Mahajanga Basin (including return travel for JG, DK, AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin Federico L., 2005, Studia Geologica Salmanticensia, V41, P45; Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Ali JR, 2009, J BIOGEOGR, V36, P1778, DOI 10.1111/j.1365-2699.2009.02105.x; AmphibiaWeb, 2013, INF AMPH BIOL CONS; Andreone F, 2008, PLOS BIOL, V6, P943, DOI 10.1371/journal.pbio.0060118; Asher RJ, 1998, J VERTEBR PALEONTOL, V18, P696, DOI 10.1080/02724634.1998.10011098; BAEZ A M, 1990, Ameghiniana, V27, P379; Baez A.M, 1977, Acta Geologica Lilloana, V14, P149; BAEZ A M, 1981, Ameghiniana, V18, P127; BAEZ A M, 1989, Anais da Academia Brasileira de Ciencias, V61, P447; Baez A.M., 2005, B RESUMOS MUSEU NACL, P45; Baez A.M., 1996, AMEGHINIANA, V33, P460; Baez AM, 2005, PALAEONTOLOGY, V48, P723, DOI 10.1111/j.1475-4983.2005.00477.x; Baez AM, 1998, PALAEONTOLOGY, V41, P669; Baez AM, 2003, ZOOL J LINN SOC-LOND, V139, P439, DOI 10.1046/j.1096-3642.2003.00085.x; Baez AM, 2000, J VERTEBR PALEONTOL, V20, P490, DOI 10.1671/0272-4634(2000)020[0490:TEKPFF]2.0.CO;2; Baez AM, 1998, J VERTEBR PALEONTOL, V18, P511, DOI 10.1080/02724634.1998.10011078; Baez AM, 2007, CRETACEOUS RES, V28, P1005, DOI 10.1016/j.cretres.2007.01.004; Baez AM, 2012, GONDWANA RES, V22, P1141, DOI 10.1016/j.gr.2012.02.021; Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Baez Ana Maria, 2000, Amphibian Biology, V4, P1388; Besairie H., 1972, ANN GEOL MADAGASCAR, V35, P1; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Brandley MC, 2006, SYST BIOL, V55, P138, DOI 10.1080/10635150500431155; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Carrano Matthew T., 2011, Smithsonian Contributions to Paleobiology, P1; Casamiquela R.M., 1963, AMEGHINIANA, V5, P141; Case Judd A., 2002, Journal of Vertebrate Paleontology, V22, p42A; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Clemente-Carvalho RBG, 2011, J HERPETOL, V45, P94, DOI 10.1670/09-164.1; Clemente-Carvalho RBG, 2009, J MORPHOL, V270, P1285, DOI 10.1002/jmor.10755; CODDINGTON J, 1994, CLADISTICS, V10, P415; Colbert EH, 1981, GONDWANA 5, P277; Colbert EH, 1971, IMPLICATIONS CONTINE, P395; Contreras Victor Hugo, 1998, Boletin de la Sociedad de Biologia de Concepcion, V69, P83; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Crowley BE, 2013, HOLOCENE, V23, P1066, DOI 10.1177/0959683613484675; Davies Margaret, 1993, P15; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duellman W. E., 1986, BIOL AMPHIBIANS; DUELLMAN WE, 1994, HERPETOLOGICA, V50, P51; DUNLAP DONALD G., 1960, JOUR MORPHOL, V106, P1, DOI 10.1002/jmor.1051060102; Dutta SK, 2004, CURR SCI INDIA, V86, P211; EMERSON SB, 1985, HERPETOLOGICA, V41, P177; EMERSON SB, 1976, J MORPHOL, V149, P437, DOI 10.1002/jmor.1051490402; EMERSON SB, 1979, BIOL J LINN SOC, V11, P153, DOI 10.1111/j.1095-8312.1979.tb00032.x; Evans F. G., 1939, Annals of the New York Academy of Sciences, V39, P29; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Fabrezi M, 2006, J ZOOL SYST EVOL RES, V44, P153, DOI 10.1111/j.1439-0469.2005.00349.x; Fabrezi M, 2003, J ZOOL, V260, P41, DOI 10.1017/S0952836903003479; Fabrezi M, 2011, EVOL BIOL, V38, P390, DOI 10.1007/s11692-011-9128-5; Fabrezi M, 2008, ZOOL J LINN SOC-LOND, V154, P752, DOI 10.1111/j.1096-3642.2008.00420.x; Fabrezi Marissa, 1993, Alytes (Paris), V11, P47; Feller AE, 1998, MOL PHYLOGENET EVOL, V9, P509, DOI 10.1006/mpev.1998.0500; Fernicola JC, 2001, AMEGHINIANA, V38, P385; Fischer von Waldheim G, 1813, ZOOGNOSIA TABULIS SY, V1; Flynn L.J., 1988, J VERTEBR PALEONTOL, V7, P469; Ford Linda S., 1993, Herpetological Monographs, V7, P94, DOI 10.2307/1466954; Forster CA, 1996, NATURE, V382, P532, DOI 10.1038/382532a0; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gaffney ES, 2011, AM MUS NOVIT, P1; Gaupp E., 1896, ANATOMIE FROSCHES; Gayer S.M.P., 1984, Revista Brasileira de Zoologia, V2, P113; Glaw F., 2003, P883; Glaw F., 1994, FIELD GUIDE AMPHIBIA; Glaw F, 2006, ZOOTAXA, P27, DOI 10.11646/zootaxa.1334.1.2; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Goloboff Pablo A., 2005, P148; Gomez RO, 2011, J VERTEBR PALEONTOL, V31, P50, DOI 10.1080/02724634.2011.539654; Gomez-Mestre I, 2010, J EVOLUTION BIOL, V23, P1364, DOI 10.1111/j.1420-9101.2010.02016.x; GRIFFITHS I, 1963, BIOL REV, V38, P241, DOI 10.1111/j.1469-185X.1963.tb00784.x; Hay WW, 1999, GEOL S AM S, P1; HAYES T, 1992, J EXP ZOOL, V264, P130, DOI 10.1002/jez.1402640203; Heinicke MP, 2009, ZOOTAXA, P1; Henrici AC, 2002, ANN CARNEGIE MUS, V71, P241; Hoffstetter R., 1961, Bull Mus Hist nat Paris, V33, P152; Huene F.V., 1933, MEMOIRS GEOLOGICAL S, V21, P1; Huene F. von, 1929, Anales del Museo de La Plata, V3, P1; Irisarri I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-626; JACOBS LL, 1990, NATL GEOGR RES, V6, P196; Jared C, 2005, J ZOOL, V265, P1, DOI 10.1017/S0952836904005953; Johnston P, 2011, J MORPHOL, V272, P1492, DOI 10.1002/jmor.10998; Jones MEH, 2003, ANN CARNEGIE MUS, V72, P65; Karche JP, 1967, ITINERAIRE GEOLOGIQU; Kosuch J, 2001, MOL PHYLOGENET EVOL, V21, P398, DOI 10.1006/mpev.2001.1034; Krause D, 2003, J VERTEBR PALEONTOL, V23, p69A; Krause D, 2012, J VERTEBR PALEONTOL, V32, P123; Krause DW, 2006, ANN MO BOT GARD, V93, P178, DOI 10.3417/0026-6493(2006)93[178:LCTVFM]2.0.CO;2; Krause DW, 2010, J VERTEBR PALEONTOL, V30, P4, DOI 10.1080/02724634.2010.516784; Krause DW, 2003, J VERTEBR PALEONTOL, V23, P842, DOI 10.1671/9; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1999, GSA TODAY, V9, P1; Krause DW, 2010, SOC VERTEBR PALEONTO, V10; Kurabayashi A, 2008, MOL BIOL EVOL, V25, P874, DOI 10.1093/molbev/msn031; Laduke TC, 2010, J VERTEBR PALEONTOL, V30, P109, DOI 10.1080/02724630903409188; Laloy F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074874; Lynch J. D., 1971, Misc Publs Mus nat Hist Univ Kansas, VNo. 53, P1; LYNCH JD, 1982, SYST ZOOL, V31, P166, DOI 10.2307/2413035; MACPHEE RDE, 1985, INT J PRIMATOL, V6, P463, DOI 10.1007/BF02735571; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Markwick PJ, 2004, PALAEOGEOGR PALAEOCL, V213, P37, DOI 10.1016/j.palaeo.2004.06.015; MAXSON LR, 1988, J HERPETOL, V22, P228, DOI 10.2307/1564003; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Muzzopappa P, 2010, ACTA PALAEONTOL POL, V55, P645, DOI 10.4202/app.2009.0093; Nomura F, 2009, J ETHOL, V27, P195, DOI 10.1007/s10164-008-0112-1; Noonan BP, 2006, AM NAT, V168, P730, DOI 10.1086/509052; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Papini M, 1998, J AFR EARTH SCI, V26, P229, DOI 10.1016/S0899-5362(98)00007-4; Parker HW, 1934, MONOGRAPH FROGS FAMI; Prasad Guntupalli V. R., 2004, Revue de Paleobiologie, V23, P99; Prasad GVR, 2009, B SOC GEOL FR, V180, P369, DOI 10.2113/gssgfbull.180.4.369; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Quinzio S, 2012, ANAT REC, V295, P2089, DOI 10.1002/ar.22601; Quinzio Silvia I., 2006, South American Journal of Herpetology, V1, P202, DOI 10.2994/1808-9798(2006)1[202:ROTTOC]2.0.CO;2; Radhakrishnan C, 2007, CURR SCI INDIA, V92, P213; RAGE J-C, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P1; Rakotoarison A, 2012, ZOOTAXA, P1; Rambaut A, 2014, TRACER V1 6; REIG O A, 1963, Physis (Buenos Aires), V24, P113; Reig O. A., 1963, Physis, V24, P181; Reig O.A., 1972, EVOLUTION GENUS BUFO, P14; REIG OA, 1959, ACTAS TRAB PRIMER C, V4, P133; REIG OSVALDO A., 1958, PHYSIS, V21, P109; Reilly SM, 2011, J MORPHOL, V272, P149, DOI 10.1002/jmor.10902; Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047; RITLAND RICHARD MARTIN, 1955, J MORPH, V97, P215, DOI 10.1002/jmor.1050970203; Rocek Z, 1995, J VERTEBR PALEONTOL, V15, P506; Rocek Z, 2008, CRETACEOUS RES, V29, P577, DOI 10.1016/j.cretres.2008.01.005; Rocek Zbynek, 2000, Amphibian Biology, V4, P1332; Rocek Zbynek, 2000, Amphibian Biology, V4, P1295; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers RR, 2007, J VERTEBR PALEONTOL, V27, P21, DOI 10.1671/0272-4634(2007)27[21:PAPOMC]2.0.CO;2; Rogers RR, 2007, SCI AM, V296, P42, DOI 10.1038/scientificamerican0207-42; Rogers RR, 2013, CRETACEOUS RES, V44, P12, DOI 10.1016/j.cretres.2013.03.008; Rogers RR, 2005, GEOLOGY, V33, P297, DOI 10.1130/G21036.1; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROYER JY, 1992, AM GEOPHYS UNION GEO, V70, P471; Ruane S, 2011, J EVOLUTION BIOL, V24, P274, DOI 10.1111/j.1420-9101.2010.02164.x; RUIBAL R, 1984, J HERPETOL, V18, P313, DOI 10.2307/1564085; RUIBAL R, 1988, COPEIA, P591; RUSSELL D, 1976, COMPTES RENDUS SOMMA, V5, P205; Sahni A., 2010, P91; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2007, SOC VERTEBR PALEONTO, V8; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sanchiz B., 1998, ENCY PALEOHERPETOL 4; Scotese C.R., 1998, CONTINENTAL DRIFT 0; Scott E, 2005, CLADISTICS, V21, P507, DOI 10.1111/j.1096-0031.2005.00079.x; SEIBERT EA, 1974, PHYSIOL ZOOL, V47, P261, DOI 10.1086/physzool.47.4.30152529; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sheil CA, 1999, J MORPHOL, V240, P49, DOI 10.1002/(SICI)1097-4687(199904)240:1<49::AID-JMOR5>3.0.CO;2-Z; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Spinar Z.V., 1986, Journal of Vertebrate Paleontology, V6, P113; SPINAR Z V, 1985, Amphibia-Reptilia, V6, P363, DOI 10.1163/156853885X00353; Stigall AL, 2008, PALAEONTOLOGY, V51, P1053, DOI 10.1111/j.1475-4983.2008.00799.x; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; Tomassini RL, 2011, J VERTEBR PALEONTOL, V31, P1005, DOI 10.1080/02724634.2011.596602; Trueb L, 2006, J VERTEBR PALEONTOL, V26, P44, DOI 10.1671/0272-4634(2006)26[44:ROTECC]2.0.CO;2; Trueb L, 2005, J VERTEBR PALEONTOL, V25, P533, DOI 10.1671/0272-4634(2005)025[0533:ANPAFT]2.0.CO;2; Trueb L., 1973, P65; TRUEB L, 1978, COPEIA, P498; Trueb L., 1970, U KANS PUBL MUS NAT, V18, P547; Trueb Linda, 1993, P255; Turner AH., 2006, HIST BIOL, V18, P255, DOI [10.1080/08912960500516112, DOI 10.1080/08912960500516112]; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; TURNER FREDERICK B., 1960, AMER MIDLAND NAT, V64, P327, DOI 10.2307/2422665; Tyler M., 1998, AUSTR FROGS NATURAL; U. S. Geological Survey, 2013, NON AQ SPEC DAT; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Vences M, 2003, J ZOOL SYST EVOL RES, V41, P205, DOI 10.1046/j.1439-0469.2003.00205.x; Vences M, 2004, ITAL J ZOOL, V71, P217, DOI 10.1080/11250000409356639; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vences Miguel, 2001, Spixiana, V24, P85; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; von Huene F, 1929, GEOL RUNDSCH, V20, P89; von HUENE FRIEDRICH, 1927, BOL ACRID NACION CIENC ARGENTINA, V30, P231; Wells N, 2003, NATURAL HIST MADAGAS, P16; Wever E. G., 1985, AMPHIBIAN EAR; Wiens JJ, 2011, EVOLUTION, V65, P1283, DOI 10.1111/j.1558-5646.2011.01221.x; Wild ER, 1999, J MORPHOL, V242, P229, DOI 10.1002/(SICI)1097-4687(199912)242:3<229::AID-JMOR3>3.0.CO;2-N; Wild ER, 1997, J MORPHOL, V232, P169, DOI 10.1002/(SICI)1097-4687(199705)232:2<169::AID-JMOR4>3.0.CO;2-5; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1	202	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87236	10.1371/journal.pone.0087236	http://dx.doi.org/10.1371/journal.pone.0087236			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489877	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000119
J	Mascaro, J; Asner, GP; Knapp, DE; Kennedy-Bowdoin, T; Martin, RE; Anderson, C; Higgins, M; Chadwick, KD				Mascaro, Joseph; Asner, Gregory P.; Knapp, David E.; Kennedy-Bowdoin, Ty; Martin, Roberta E.; Anderson, Christopher; Higgins, Mark; Chadwick, K. Dana			A Tale of Two "Forests": Random Forest Machine Learning Aids Tropical Forest Carbon Mapping	PLOS ONE			English	Article							BIOMASS ESTIMATION; STOCKS; PATTERNS; CLASSIFICATION; EMISSIONS; ACCURACY; DENSITY; LEVEL	Accurate and spatially-explicit maps of tropical forest carbon stocks are needed to implement carbon offset mechanisms such as REDD+ (Reduced Deforestation and Degradation Plus). The Random Forest machine learning algorithm may aid carbon mapping applications using remotely-sensed data. However, Random Forest has never been compared to traditional and potentially more reliable techniques such as regionally stratified sampling and upscaling, and it has rarely been employed with spatial data. Here, we evaluated the performance of Random Forest in upscaling airborne LiDAR (Light Detection and Ranging)-based carbon estimates compared to the stratification approach over a 16-million hectare focal area of the Western Amazon. We considered two runs of Random Forest, both with and without spatial contextual modeling by including-in the latter case-x, and y position directly in the model. In each case, we set aside 8 million hectares (i.e., half of the focal area) for validation; this rigorous test of Random Forest went above and beyond the internal validation normally compiled by the algorithm (i.e., called "out-of-bag"), which proved insufficient for this spatial application. In this heterogeneous region of Northern Peru, the model with spatial context was the best preforming run of Random Forest, and explained 59% of LiDAR-based carbon estimates within the validation area, compared to 37% for stratification or 43% by Random Forest without spatial context. With the 60% improvement in explained variation, RMSE against validation LiDAR samples improved from 33 to 26 Mg C ha(-1) when using Random Forest with spatial context. Our results suggest that spatial context should be considered when using Random Forest, and that doing so may result in substantially improved carbon stock modeling for purposes of climate change mitigation.	[Mascaro, Joseph; Asner, Gregory P.; Knapp, David E.; Kennedy-Bowdoin, Ty; Martin, Roberta E.; Anderson, Christopher; Higgins, Mark; Chadwick, K. Dana] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA	Carnegie Institution for Science	Mascaro, J (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	jmascaro@carnegiescience.edu	Asner, Gregory/G-9268-2013; Chadwick, K. Dana/AGN-9988-2022; Chadwick, K. Dana/G-4643-2013; Martin, Roberta/A-5073-2015	Asner, Gregory/0000-0001-7893-6421; Chadwick, K. Dana/0000-0002-5633-4865; Anderson, Christopher/0000-0001-7392-4368; Martin, Roberta/0000-0003-3509-8530	John D. and Catherine T. MacArthur Foundation; endowment of the Carnegie Institution for Science	John D. and Catherine T. MacArthur Foundation; endowment of the Carnegie Institution for Science	This study was supported by the John D. and Catherine T. MacArthur Foundation and the endowment of the Carnegie Institution for Science. The Carnegie Airborne Observatory is made possible by the Avatar Alliance Foundation, Gordon and Betty Moore Foundation, W. M. Keck Foundation, Margaret A. Cargill Foundation, Grantham Foundation for the Protection of the Environment, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen Arild, 2008, MOVING AHEAD REDD IS; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Asner GP, 2012, CARBON BAL MANAGE, V7, DOI [10.1186/1750-0680-1187-1182, DOI 10.1186/1750-0680-1187-1182]; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Asner Gregory P, 2013, Carbon Balance Manag, V8, P7, DOI 10.1186/1750-0680-8-7; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Asner GP, 2011, FRONT ECOL ENVIRON, V9, P434, DOI 10.1890/100179; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Asner GP, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034009; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/nclimate1354, 10.1038/NCLIMATE1354]; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Colgan MS, 2013, ECOL APPL, V23, P1170, DOI 10.1890/12-0922.1; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dahlin KM, 2013, P NATL ACAD SCI USA, V110, P6895, DOI 10.1073/pnas.1215513110; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; Drake JB, 2003, GLOBAL ECOL BIOGEOGR, V12, P147, DOI 10.1046/j.1466-822X.2003.00010.x; Ene LT, 2012, REMOTE SENS ENVIRON, V123, P579, DOI 10.1016/j.rse.2012.04.017; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Fabbri R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1322432.1322434; Fanelli G, 2011, PROC CVPR IEEE, P617, DOI 10.1109/CVPR.2011.5995458; Herold M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014002; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Higgins MA, 2012, REMOTE SENS-BASEL, V4, P2401, DOI 10.3390/rs4082401; Hudak AT, 2008, REMOTE SENS ENVIRON, V112, P2232, DOI 10.1016/j.rse.2007.10.009; Hudak AT, 2012, REMOTE SENS ENVIRON, V123, P25, DOI 10.1016/j.rse.2012.02.023; INGEMMET, 2000, GEOL PER; Jarvis A., 2008, HOLE FILLED SEAMLESS; Josse C, 2007, ECOLOGICAL SYSTEMS A; Legendre P., 1998, DEV ENV MODELLING, V20; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; R Core Team, 2021, R LANG ENV STAT COMP; Rodriguez-Galiano VF, 2011, PROCEDIA ENVIRON SCI, V3, P44, DOI 10.1016/j.proenv.2011.02.009; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Triebel R, 2013, WORKSH ACT LEARN ROB; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037	44	87	87	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85993	10.1371/journal.pone.0085993	http://dx.doi.org/10.1371/journal.pone.0085993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489686	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000028
J	Brissos, V; Goncalves, N; Melo, EP; Martins, LO				Brissos, Vania; Goncalves, Nadia; Melo, Eduardo P.; Martins, Ligia O.			Improving Kinetic or Thermodynamic Stability of an Azoreductase by Directed Evolution	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MOLECULAR-CLONING; PROTEIN; STABILIZATION; ENZYMES; LACCASE; OLIGO-1,6-GLUCOSIDASE; THERMOSTABILIZATION; DETOXIFICATION; WASTEWATERS	Protein stability arises from a combination of factors which are often difficult to rationalise. Therefore its improvement is better addressed through directed evolution than by rational design approaches. In this study, five rounds of mutagenesis/recombination followed by high-throughput screening (approximate to 10,000 clones) yielded the hit 1B6 showing a 300-fold higher half life at 50 degrees C than that exhibited by the homodimeric wild type PpAzoR azoreductase from Pseudomonas putida MET94. The characterization using fluorescence, calorimetry and light scattering shows that 1B6 has a folded state slightly less stable than the wild type (with lower melting and optimal temperatures) but in contrast is more resistant to irreversible denaturation. The superior kinetic stability of 1B6 variant was therefore related to an increased resistance of the unfolded monomers to aggregation through the introduction of mutations that disturbed hydrophobic patches and increased the surface net charge of the protein. Variants 2A1 and 2A1-Y179H with increased thermodynamic stability (10 to 20 degrees C higher melting temperature than wild type) were also examined showing the distinctive nature of mutations that lead to improved structural robustness: these occur in residues that are mostly involved in strengthening the solvent-exposed loops or the inter-dimer interactions of the folded state.	[Brissos, Vania; Goncalves, Nadia; Martins, Ligia O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Melo, Eduardo P.] Univ Algarve, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Faro, Portugal	Universidade Nova de Lisboa; Universidade do Algarve	Martins, LO (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	lmartins@itqb.unl.pt	Martins, Lígia O./C-2513-2009; Melo, Eduardo P/A-4743-2008; Brissos, Vania/M-5789-2013	Martins, Lígia O./0000-0003-0082-9591; Brissos, Vania/0000-0002-8171-0113; Pinho Melo, Eduardo/0000-0002-0974-8977; Moreira Goncalves, Nadia/0000-0002-4580-2969	European Union [BIORENEW,, FP6-2004-NMP-NI-4/026456]; Fundacao para a Ciencia e Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/QUI-BIQ/119677/2010]; FCT, Portugal [SFRH/BPD/46808/2008]	European Union(European Commission); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by European Union grant BIORENEW, FP6-2004-NMP-NI-4/026456; Fundacao para a Ciencia e Tecnologia, Portugal: PEst-OE/EQB/LA0004/ 2011 and PTDC/QUI-BIQ/119677/2010. V. B. acknowledges a Post-doc fellowship (SFRH/BPD/46808/2008) from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Baik SH, 2005, APPL ENVIRON MICROB, V71, P3285, DOI 10.1128/AEM.71.6.3285-3293.2005; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Cervantes FJ, 2011, REV ENVIRON SCI BIO, V10, P125, DOI 10.1007/s11157-011-9228-9; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Cirino Patrick C., 2003, V230, P117; Correia B, 2011, ACTA CRYSTALLOGR F, V67, P121, DOI 10.1107/S1744309110048220; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; dos Santos AB, 2007, BIORESOURCE TECHNOL, V98, P2369, DOI 10.1016/j.biortech.2006.11.013; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fernandes AT, 2009, BBA-PROTEINS PROTEOM, V1794, P75, DOI 10.1016/j.bbapap.2008.09.006; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Flores H, 2002, J MOL BIOL, V315, P325, DOI 10.1006/jmbi.2001.5223; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Goncalves AMD, 2013, FEBS J, V280, P6643, DOI 10.1111/febs.12568; Ito K, 2008, J BIOL CHEM, V283, P13889, DOI 10.1074/jbc.M710070200; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Joern John M, 2003, Methods Mol Biol, V231, P85; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lee B, 1997, CURR OPIN BIOTECH, V8, P423, DOI 10.1016/S0958-1669(97)80063-8; Leelakriangsak M, 2008, MOL MICROBIOL, V67, P1108, DOI 10.1111/j.1365-2958.2008.06110.x; Liu GF, 2009, J BACTERIOL, V191, P6394, DOI 10.1128/JB.00552-09; Liu ZJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P68, DOI 10.1016/j.abb.2007.03.003; Maier J, 2004, APPL ENVIRON MICROB, V70, P837, DOI 10.1128/AEM.70.2.837-844.2004; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Mendes S, 2011, APPL MICROBIOL BIOT, V92, P393, DOI 10.1007/s00253-011-3366-4; Mendes S, 2011, BIORESOURCE TECHNOL, V102, P9852, DOI 10.1016/j.biortech.2011.07.108; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Salazar O, 2003, CHEMBIOCHEM, V4, P891, DOI 10.1002/cbic.200300660; Salazar Oriana, 2003, V230, P85; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Shivange AV, 2012, APPL MICROBIOL BIOT, V95, P405, DOI 10.1007/s00253-011-3756-7; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sollner S, 2009, BIOCHEMISTRY-US, V48, P8636, DOI 10.1021/bi900734a; Spiller B, 1999, P NATL ACAD SCI USA, V96, P12305, DOI 10.1073/pnas.96.22.12305; Suzuki Y, 2001, J BIOL CHEM, V276, P9059, DOI 10.1074/jbc.M008083200; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; van den Burg B, 2002, CURR OPIN BIOTECH, V13, P333, DOI 10.1016/S0958-1669(02)00325-7; Vazquez-Figueroa E, 2008, PROTEIN ENG DES SEL, V21, P673, DOI 10.1093/protein/gzn048; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Volkin D.B., 1989, PROTEIN FUNCTION PRA, P1; Wang CJ, 2007, J MOL BIOL, V373, P1213, DOI 10.1016/j.jmb.2007.08.048; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Watanabe K, 1996, APPL ENVIRON MICROB, V62, P2066, DOI 10.1128/AEM.62.6.2066-2073.1996; Zhang NY, 2003, PROTEIN ENG, V16, P599, DOI 10.1093/protein/gzg074; Zhao HM, 1997, NUCLEIC ACIDS RES, V25, P1307, DOI 10.1093/nar/25.6.1307; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	57	25	25	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87209	10.1371/journal.pone.0087209	http://dx.doi.org/10.1371/journal.pone.0087209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475252	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300153
J	Jiang, PL; Pasaribu, B; Chen, CS				Jiang, Pei-Luen; Pasaribu, Buntora; Chen, Chii-Shiarng			Nitrogen-Deprivation Elevates Lipid Levels in Symbiodinium spp. by Lipid Droplet Accumulation: Morphological and Compositional Analyses	PLOS ONE			English	Article							NUTRIENT LIMITATION; OIL BODIES; ZOOXANTHELLAE; MICROALGA; PROTEINS; GROWTH; CORAL; CHLAMYDOMONAS; METABOLISM; SYMBIOSIS	Stable cnidarian-dinoflagellate (genus Symbiodinium) endosymbioses depend on the regulation of nutrient transport between Symbiodinium populations and their hosts. It has been previously shown that the host cytosol is a nitrogen-deficient environment for the intracellular Symbiodinium and may act to limit growth rates of symbionts during the symbiotic association. This study aimed to investigate the cell proliferation, as well as ultrastructural and lipid compositional changes, in free-living Symbiodinium spp. (clade B) upon nitrogen (N)-deprivation. The cell proliferation of the N-deprived cells decreased significantly. Furthermore, staining with a fluorescent probe, boron dipyrromethane 493/503 (BODIPY 493/503), indicated that lipid contents progressively accumulated in the N-deprived cells. Lipid analyses further showed that both triacylglycerol (TAG) and cholesterol ester (CE) were drastically enriched, with polyunsaturated fatty acids (PUFA; i.e., docosahexaenoic acid, heneicosapentaenoic acid, and oleic acid) became more abundant. Ultrastructural examinations showed that the increase in concentration of these lipid species was due to the accumulation of lipid droplets (LDs), a cellular feature that have previously shown to be pivotal in the maintenance of intact endosymbioses. Integrity of these stable LDs was maintained via electronegative repulsion and steric hindrance possibly provided by their surface proteins. Proteomic analyses of these LDs identified proteins putatively involved in lipid metabolism, signaling, stress response and energy metabolism. These results suggest that LDs production may be an adaptive response that enables Symbiodinium to maintain sufficient cellular energy stores for survival under the N-deprived conditions in the host cytoplasm.	[Jiang, Pei-Luen; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Jiang, Pei-Luen; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Taiwan Coral Res Ctr, Pingtung, Taiwan; [Pasaribu, Buntora] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan	National Dong Hwa University; National Museum of Marine Biology & Aquarium; National Chung Hsing University; National Sun Yat Sen University	Chen, CS (corresponding author), Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan.	cchen@nmmba.gov.tw	; Jiang, Pei-Luen/I-8706-2014	Pasaribu, Buntora/0000-0002-9639-1506; Jiang, Pei-Luen/0000-0003-1580-0484	National Science Council in Taiwan [NSC 101-2311-B-291-002-MY3, NSC 100-2313-B-291-003, NSC 102-2313-B-291-001]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This works was supported by National Science Council in Taiwan to C. S. Chen (NSC 101-2311-B-291-002-MY3) and PL Jiang (NSC 100-2313-B-291-003 and NSC 102-2313-B-291-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1998, ANAL BIOCHEM, V258, P149, DOI 10.1006/abio.1998.2580; Bartz R, 2007, MOL BIOL CELL, V18, P3015, DOI 10.1091/mbc.E06-09-0869; BELDA CA, 1993, MAR BIOL, V117, P655, DOI 10.1007/BF00349778; Bigogno C, 2002, LIPIDS, V37, P209, DOI 10.1007/s11745-002-0882-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CARROLL S, 1984, BIOL BULL, V166, P409, DOI 10.2307/1541226; Chen DH, 2012, PLANT PHYSIOL BIOCH, V60, P18024; COOK CB, 1987, SYMBIOSIS, V4, P199; CORZO A, 1991, Scientia Marina, V55, P405; Danne JC, 2011, J MOL BIOL, V408, P643, DOI 10.1016/j.jmb.2011.02.057; Davidi L, 2012, PLANTA, V236, P19, DOI 10.1007/s00425-011-1585-7; Deng XD, 2011, AFR J MICROBIOL RES, V5, P260; Ferl RJ, 2002, GENOME BIOL, V3; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Fuchs B, 2007, ANAL BIOANAL CHEM, V389, P827, DOI 10.1007/s00216-007-1488-4; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Haugland R, 1996, HDB FLUORESCENT PROB, P13; Hu HH, 2006, BIOTECHNOL LETT, V28, P987, DOI 10.1007/s10529-006-9026-6; Huang NL, 2013, PLANT PHYSIOL, V161, P1862, DOI 10.1104/pp.112.212514; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2010, NEW BIOTECHNOL, V27, P59, DOI 10.1016/j.nbt.2009.11.006; Lin IP, 2012, PLANT PHYSIOL BIOCH, V61, P80, DOI 10.1016/j.plaphy.2012.09.008; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; Minzangi K., 2011, African Journal of Food Science, V5, P219; MITCHELL SF, 1992, J PLANKTON RES, V14, P379, DOI 10.1093/plankt/14.3.379; Muller-Parker G, 1998, LIFE DEATH CORAL REE, P96; MullerParker G, 1996, J PHYCOL, V32, P987, DOI 10.1111/j.0022-3646.1996.00987.x; MUSCATINE L, 1980, CELLULAR INTERACTION, P229; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Norici A, 2011, PLANT CELL ENVIRON, V34, P1666, DOI 10.1111/j.1365-3040.2011.02362.x; Oku H, 2003, FISHERIES SCI, V69, P625, DOI 10.1046/j.1444-2906.2003.00665.x; Palmucci M, 2011, J PHYCOL, V47, P313, DOI 10.1111/j.1529-8817.2011.00963.x; Pasaribu B, 2014, BIOTECHNOL LETT, V36, P175, DOI 10.1007/s10529-013-1332-1; Peled E, 2011, LIPIDS, V46, P851, DOI 10.1007/s11745-011-3579-4; Peng SE, 2012, BIOL LETTERS, V8, P434, DOI 10.1098/rsbl.2011.0893; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Pereira H, 2012, MAR DRUGS, V10, P1920, DOI 10.3390/md10091920; PIORRECK M, 1984, PHYTOCHEMISTRY, V23, P207, DOI 10.1016/S0031-9422(00)80304-0; Praveenkumar R, 2012, BIOMASS BIOENERG, V37, P60, DOI 10.1016/j.biombioe.2011.12.035; Prescha A, 2001, J AGR FOOD CHEM, V49, P3638, DOI 10.1021/jf010258o; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; RAHAV O, 1989, PROC R SOC SER B-BIO, V236, P325, DOI 10.1098/rspb.1989.0026; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Rodriguez-Roman A, 2005, MAR BIOL, V146, P1063, DOI 10.1007/s00227-004-1529-x; ROESSLER PG, 1990, J PHYCOL, V26, P393, DOI 10.1111/j.0022-3646.1990.00393.x; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; STEEN RG, 1986, BIOL BULL, V170, P267, DOI 10.2307/1541808; STERNER RW, 1993, LIMNOL OCEANOGR, V38, P857, DOI 10.4319/lo.1993.38.4.0857; SZMANTFROELICH A, 1984, MAR BIOL, V81, P153, DOI 10.1007/BF00393114; Takagi M, 2000, APPL MICROBIOL BIOT, V54, P112, DOI 10.1007/s002530000333; Tan R, 2013, PLOS ONE, V8; TILLBERG JE, 1989, PHYSIOL PLANTARUM, V75, P315, DOI 10.1111/j.1399-3054.1989.tb04633.x; Tzen JTC, 1997, J BIOCHEM-TOKYO, V121, P762, DOI 10.1093/oxfordjournals.jbchem.a021651; Tzen JTC, 2003, CURR TOPICS BIOCH RE, V5, P133; VANDONK E, 1993, OECOLOGIA, V93, P508, DOI 10.1007/BF00328958; von Schacky C, 2008, CURR OPIN CLIN NUTR, V11, P94, DOI 10.1097/MCO.0b013e3282f44bdf; Wang JT, 1998, J EXP BIOL, V201, P2445; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yeesang C, 2011, BIORESOURCE TECHNOL, V102, P3034, DOI 10.1016/j.biortech.2010.10.013; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhu B., 2010, MAR ECO, V32, P15	70	44	45	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87416	10.1371/journal.pone.0087416	http://dx.doi.org/10.1371/journal.pone.0087416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475285	Green Submitted, Green Published			2022-12-25	WOS:000330507300180
J	Silverwood, RJ; Richards, M; Pierce, M; Hardy, R; Sattar, N; Ferro, C; Savage, C; Kuh, D; Nitsch, D				Silverwood, Richard J.; Richards, Marcus; Pierce, Mary; Hardy, Rebecca; Sattar, Naveed; Ferro, Charles; Savage, Caroline; Kuh, Diana; Nitsch, Dorothea		Teams, NS&DC	Cognitive and Kidney Function: Results from a British Birth Cohort Reaching Retirement Age	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; METABOLIC SYNDROME; SERUM CREATININE; CYSTATIN-C; DISEASE; ADULTS; IMPAIRMENT; DECLINE; RISK	Background: Previous studies have found associations between cognitive function and chronic kidney disease. We aimed to explore possible explanations for this association in the Medical Research Council National Survey of Health and Development, a prospective birth cohort representative of the general British population. Methods: Cognitive function at age 60-64 years was quantified using five measures (verbal memory, letter search speed and accuracy, simple and choice reaction times) and glomerular filtration rate (eGFR) at the same age was estimated using cystatin C. The cross-sectional association between cognitive function and eGFR was adjusted for background confounding factors (socioeconomic position, educational attainment), prior cognition, and potential explanations for any remaining association (smoking, diabetes, hypertension, inflammation, obesity). Results: Data on all the analysis variables were available for 1306-1320 study members (depending on cognitive measure). Verbal memory and simple and choice reaction times were strongly associated with eGFR. For example, the lowest quartile of verbal memory corresponded to a 4.1 (95% confidence interval 2.0, 6.2) ml/min/1.73 m(2) lower eGFR relative to the highest quartile. Some of this association was explained by confounding due to socioeconomic factors, but very little of it by prior cognition. Smoking, diabetes, hypertension, inflammation and obesity explained some but not all of the remaining association. Conclusions: These analyses support the notion of a shared pathophysiology of impaired cognitive and kidney function at older age, which precedes clinical disease. The implications of these findings for clinical care and research are important and under-recognised, though further confirmatory studies are required.	[Silverwood, Richard J.; Nitsch, Dorothea] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Richards, Marcus; Pierce, Mary; Hardy, Rebecca; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovascular Res Ctr, Glasgow, Lanark, Scotland; [Ferro, Charles] Queen Elizabeth Hosp, Dept Renal Med, Birmingham B15 2TH, W Midlands, England; [Savage, Caroline] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Glasgow; University of Birmingham; University of Birmingham	Silverwood, RJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Richard.Silverwood@lshtm.ac.uk	Silverwood, Richard/A-1249-2014; Kuh, Diana/L-6019-2014; Hardy, Rebecca/AFR-1989-2022; Ferro, Charles J./O-8912-2016; ferro, charles/L-7250-2019	Silverwood, Richard/0000-0002-2744-1194; Kuh, Diana/0000-0001-7386-2857; Ferro, Charles J./0000-0003-0577-7081; ferro, charles/0000-0003-0577-7081; Hardy, Rebecca/0000-0001-9949-0799; Richards, Marcus/0000-0001-9191-2192; Sattar, Naveed/0000-0002-1604-2593; Nitsch, Dorothea/0000-0001-5767-248X	Kidney Research UK [RP34/2009]; UK Medical Research Council [U123092720, G1001143]; MRC [G1001143, MC_UU_12019/3, MC_UU_12019/1] Funding Source: UKRI; Medical Research Council [MC_UU_12019/1, MC_UU_12019/3, G1001143] Funding Source: researchfish; National Institute for Health Research [PDF-2012-05-205] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Kidney Research UK (grant number RP34/2009) to RJS and DN, and the UK Medical Research Council to MP, RH and DK. The data collection was funded by the UK Medical Research Council (Unit Programme number U123092720), with additional analyses funded by the UK Medical Research Council (grant number G1001143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1970, CLASS OCC; Arismendi-Morillo G, 2010, ULTRASTRUCT PATHOL, V34, P214, DOI 10.3109/01913121003743690; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Clennell S, 2008, J EPIDEMIOL COMMUN H, V62, P1051, DOI 10.1136/jech.2007.068312; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; Feng L, 2012, J AM GERIATR SOC, V60, P1208, DOI 10.1111/j.1532-5415.2012.04043.x; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Kuriyama N, 2013, ARCH GERONTOL GERIAT, V56, P55, DOI 10.1016/j.archger.2011.11.009; Lande MB, 2011, CLIN J AM SOC NEPHRO, V6, P1831, DOI 10.2215/CJN.00810111; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Munang L, 2007, AGE AGEING, V36, P323, DOI 10.1093/ageing/afl178; Murray AM, 2009, NEUROLOGY, V73, P916, DOI 10.1212/WNL.0b013e3181b99a2e; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Silverwood RJ, 2013, J AM SOC NEPHROL, V24, P813, DOI 10.1681/ASN.2012070675; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; StataCorp, 2011, STAT STAT SOFTW REL; Tamura MK, 2011, AM J KIDNEY DIS, V58, P756, DOI 10.1053/j.ajkd.2011.05.027; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wills AK, 2012, EPIDEMIOLOGY, V23, P203, DOI 10.1097/EDE.0b013e3182456567; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237	28	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86743	10.1371/journal.pone.0086743	http://dx.doi.org/10.1371/journal.pone.0086743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24482683	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330283100205
J	Murdoch, CE; Shuler, M; Haeussler, DJF; Kikuchi, R; Bearelly, P; Han, JY; Watanabe, Y; Fuster, JJ; Walsh, K; Ho, YS; Bachschmid, MM; Cohen, RA; Matsui, R				Murdoch, Colin E.; Shuler, Michaela; Haeussler, Dagmar J. F.; Kikuchi, Ryosuke; Bearelly, Priyanka; Han, Jingyan; Watanabe, Yosuke; Fuster, Jose J.; Walsh, Kenneth; Ho, Ye-Shih; Bachschmid, Markus M.; Cohen, Richard A.; Matsui, Reiko			Glutaredoxin-1 Up-regulation Induces Soluble Vascular Endothelial Growth Factor Receptor 1, Attenuating Post-ischemia Limb Revascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Animal Models; Glutathionylation; Ischemia; NF-kappa B (NF-B); Redox Regulation; Vascular Endothelial Growth Factor (VEGF)	NF-KAPPA-B; S-GLUTATHIONYLATION; REDOX REGULATION; ANGIOTENSIN-II; CELL FUNCTION; MOUSE MODEL; DNA-BINDING; ANGIOGENESIS; GLUTATHIOLATION; ACTIVATION	Background: Glutaredoxin-1 (Glrx) inhibits endothelial cell migration by reversing protein-glutathione adducts. Results: Revascularization after hind limb ischemia was inhibited in Glrx transgenic mice. Glrx overexpression increased soluble VEGF receptor 1 (sFlt) in endothelial cells via NF-B-dependent Wnt5a production. Conclusion: Glrx enhances Wnt5a-induced anti-angiogenic sFlt in endothelial cells. Significance: Up-regulated Glrx inhibits VEGF signaling by increased sFlt causing impaired vascularization. Glutaredoxin-1 (Glrx) is a cytosolic enzyme that regulates diverse cellular function by removal of GSH adducts from S-glutathionylated proteins including signaling molecules and transcription factors. Glrx is up-regulated during inflammation and diabetes, and Glrx overexpression inhibits VEGF-induced EC migration. The aim was to investigate the role of up-regulated Glrx in EC angiogenic capacities and in vivo revascularization in the setting of hind limb ischemia. Glrx-overexpressing EC from Glrx transgenic (TG) mice showed impaired migration and network formation and secreted higher levels of soluble VEGF receptor 1 (sFlt), an antagonizing factor to VEGF. After hind limb ischemia surgery Glrx TG mice demonstrated impaired blood flow recovery, associated with lower capillary density and poorer limb motor function compared with wild type littermates. There were also higher levels of anti-angiogenic sFlt expression in the muscle and plasma of Glrx TG mice after surgery. Noncanonical Wnt5a is known to induce sFlt. Wnt5a was highly expressed in ischemic muscles and EC from Glrx TG mice, and exogenous Wnt5a induced sFlt expression and inhibited network formation in human microvascular EC. Adenoviral Glrx-induced sFlt in EC was inhibited by a competitive Wnt5a inhibitor. Furthermore, Glrx overexpression removed GSH adducts on p65 in ischemic muscle and EC and enhanced NF-B activity, which was responsible for Wnt5a-sFlt induction. Taken together, up-regulated Glrx induces sFlt in EC via NF-B-dependent Wnt5a, resulting in attenuated revascularization in hind limb ischemia. The Glrx-induced sFlt explains part of the mechanism of redox-regulated VEGF signaling.	[Murdoch, Colin E.; Shuler, Michaela; Haeussler, Dagmar J. F.; Bearelly, Priyanka; Han, Jingyan; Watanabe, Yosuke; Bachschmid, Markus M.; Cohen, Richard A.; Matsui, Reiko] Boston Univ, Vasc Biol Sect, Dept Med, Boston, MA 02118 USA; [Murdoch, Colin E.; Shuler, Michaela; Haeussler, Dagmar J. F.; Kikuchi, Ryosuke; Bearelly, Priyanka; Han, Jingyan; Watanabe, Yosuke; Fuster, Jose J.; Walsh, Kenneth; Bachschmid, Markus M.; Cohen, Richard A.; Matsui, Reiko] Boston Univ, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Dept Biochem & Mol Biol, Detroit, MI 48202 USA	Boston University; Boston University; Wayne State University	Matsui, R (corresponding author), Boston Univ, Vasc Biol Sect, Dept Med, 650 Albany St, Boston, MA 02118 USA.	rmatsui@bu.edu	Kikuchi, Ryosuke/AAX-4971-2021; Murdoch, Colin Edward/I-1106-2019	Murdoch, Colin Edward/0000-0002-0274-819X; Bachschmid, Markus Michael/0000-0002-0748-5528; /0000-0002-1070-6408; Fuster, Jose Javier/0000-0002-5970-629X	National Institutes of Health [PO1 HL 068758, R37 HL104017, HL081587, HL007224]; NHLBI [HHSN268201000031C]; Department of Medicine, Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R37HL104017, P01HL068758, P01HL081587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Medicine, Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 068758, R37 HL104017 (to R. A. C.), and HL081587 (to K. W.) and NHLBI Contract HHSN268201000031C (to R. A. C.). This work was also supported by Robert Dawson Evans Scholar Award from the Department of Medicine, Boston University School of Medicine (to R. A. C.).; Supported by a Cardiovascular post-doctoral Training Grant from the National Institutes of Health, HL007224.	Abdelsaid MA, 2012, J CELL SCI, V125, P4751, DOI 10.1242/jcs.103481; Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Adluri RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034790; Aesif SW, 2011, FREE RADICAL BIO MED, V51, P1249, DOI 10.1016/j.freeradbiomed.2011.06.025; Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Ahmad S, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-15; Bachschmid MM, 2010, FREE RADICAL BIO MED, V49, P1221, DOI 10.1016/j.freeradbiomed.2010.07.005; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Clavreul N, 2006, ARTERIOSCL THROM VAS, V26, P2454, DOI 10.1161/01.ATV.0000242791.28953.4c; Du Y., 2013, ACTA DIABETOL, DOI 10.1007/s00592-013-0498-2; Dulce RA, 2011, CIRC RES, V108, P531, DOI 10.1161/RES.0b013e3182147d74; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Haeussler DJ, 2013, J BIOL CHEM, V288, P15380, DOI 10.1074/jbc.M112.427765; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Khazaei M, 2011, CLINICS, V66, P1419, DOI 10.1590/S1807-59322011000800019; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Klatt P, 1999, J BIOL CHEM, V274, P15857, DOI 10.1074/jbc.274.22.15857; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Koch S., 2012, COLD SPRING HARBOR P, P2; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Lukosz M, 2010, ANTIOXID REDOX SIGN, V12, P713, DOI 10.1089/ars.2009.2609; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Nanbara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034434; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Okuda M, 2001, ARTERIOSCL THROM VAS, V21, P1483, DOI 10.1161/hq0901.095550; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Shao D., 2014, J BIOL CHEM, DOI 10.1074/jbc.M113.520403; Shelton MD, 2008, MOL CELLS, V25, P332; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Stefater JA, 2013, BLOOD, V121, P2574, DOI 10.1182/blood-2012-06-434621; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Tirziu D, 2012, CIRCULATION, V126, P2589, DOI 10.1161/CIRCULATIONAHA.112.119321; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251	60	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8633	8644		10.1074/jbc.M113.517219	http://dx.doi.org/10.1074/jbc.M113.517219			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24482236	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000333157500053
J	Otzen, C; Bardl, B; Jacobsen, ID; Nett, M; Brock, M				Otzen, Christian; Bardl, Bettina; Jacobsen, Ilse D.; Nett, Markus; Brock, Matthias			Candida albicans Utilizes a Modified beta-Oxidation Pathway for the Degradation of Toxic Propionyl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Candida albicans; Enzyme Kinetics; Fatty Acid Metabolism; Fatty Acid Oxidation; Pathogenesis; CUG clade; -Hydroxypropionate; Odd-chain Fatty Acids	METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE; FUNGUS ASPERGILLUS-FUMIGATUS; SACCHAROMYCES-CEREVISIAE; COENZYME-A; 3-HYDROXYISOBUTYRATE DEHYDROGENASE; METHYLCITRATE SYNTHASE; ESCHERICHIA-COLI; GLYOXYLATE CYCLE; PHENOTYPIC CHARACTERIZATION; TRANSCRIPTIONAL RESPONSE	Background: Propionyl-CoA is a common metabolic intermediate that requires degradation to avoid intoxication of cellular metabolism. Results: A key enzyme involved in a modified -oxidation pathway in Candida albicans has been identified. Conclusion: Although fungi generally use the methyl citrate cycle to degrade propionyl-CoA, CUG clade yeasts form an exception. Significance: The modified -oxidation pathway could provide a target for new antifungal compounds. Propionyl-CoA arises as a metabolic intermediate from the degradation of propionate, odd-chain fatty acids, and some amino acids. Thus, pathways for catabolism of this intermediate have evolved in all kingdoms of life, preventing the accumulation of toxic propionyl-CoA concentrations. Previous studies have shown that fungi generally use the methyl citrate cycle for propionyl-CoA degradation. Here, we show that this is not the case for the pathogenic fungus Candida albicans despite its ability to use propionate and valerate as carbon sources. Comparative proteome analyses suggested the presence of a modified -oxidation pathway with the key intermediate 3-hydroxypropionate. Gene deletion analyses confirmed that the enoyl-CoA hydratase/dehydrogenase Fox2p, the putative 3-hydroxypropionyl-CoA hydrolase Ehd3p, the 3-hydroxypropionate dehydrogenase Hpd1p, and the putative malonate semialdehyde dehydrogenase Ald6p essentially contribute to propionyl-CoA degradation and its conversion to acetyl-CoA. The function of Hpd1p was further supported by the detection of accumulating 3-hydroxypropionate in the hpd1 mutant on propionyl-CoA-generating nutrients. Substrate specificity of Hpd1p was determined from recombinant purified enzyme, which revealed a preference for 3-hydroxypropionate, although serine and 3-hydroxyisobutyrate could also serve as substrates. Finally, virulence studies in a murine sepsis model revealed attenuated virulence of the hpd1 mutant, which indicates generation of propionyl-CoA from host-provided nutrients during infection.	[Otzen, Christian; Bardl, Bettina; Jacobsen, Ilse D.; Nett, Markus] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Brock, Matthias] Univ Jena, Inst Microbiol, D-07745 Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Brock, M (corresponding author), Univ Jena, Beutenbergstr 11a, D-07745 Jena, Germany.	Matthias.brock@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Brock, Matthias/AAX-1430-2021	Jacobsen, Ilse/0000-0002-6033-9984; Nett, Markus/0000-0003-0847-086X; Brock, Matthias/0000-0003-2774-1856	Hans-Knoell-Institute; Jena School for Microbial Communication	Hans-Knoell-Institute; Jena School for Microbial Communication	This work was supported by funds from the Hans-Knoell-Institute and the Jena School for Microbial Communication.	Ansede JH, 1999, APPL ENVIRON MICROB, V65, P5075; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Brock M, 2005, APPL ENVIRON MICROB, V71, P5465, DOI 10.1128/AEM.71.9.5465-5475.2005; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Brock M, 2001, EUR J BIOCHEM, V268, P3577, DOI 10.1046/j.1432-1327.2001.02262.x; Brock M, 2000, MOL MICROBIOL, V35, P961, DOI 10.1046/j.1365-2958.2000.01737.x; Brock M., 2010, HDB HYDROCARBON LIPI, P3279; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Chandler RJ, 2005, MOL GENET METAB, V86, P34, DOI 10.1016/j.ymgme.2005.07.020; Chowdhury EK, 1996, BIOSCI BIOTECH BIOCH, V60, P2043, DOI 10.1271/bbb.60.2043; De Lucas JR, 1999, ARCH MICROBIOL, V171, P386, DOI 10.1007/s002030050725; De Lucas JR, 2001, FEMS MICROBIOL LETT, V201, P193, DOI 10.1016/S0378-1097(01)00261-0; Domin N, 2009, MICROBIOL-SGM, V155, P3903, DOI 10.1099/mic.0.031781-0; Fazius F, 2012, MOL MICROBIOL, V86, P1508, DOI 10.1111/mmi.12076; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Graybill ER, 2007, ARCH BIOCHEM BIOPHYS, V465, P26, DOI 10.1016/j.abb.2007.04.039; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Grimm C, 2003, J MOL BIOL, V328, P609, DOI 10.1016/S0022-2836(03)00358-9; HALARNKAR PP, 1989, COMP BIOCHEM PHYS B, V92, P227, DOI 10.1016/0305-0491(89)90270-8; HASEGAWA J, 1982, J FERMENT TECHNOL, V60, P591; HASEGAWA J, 1981, AGR BIOL CHEM TOKYO, V45, P2805, DOI 10.1080/00021369.1981.10864958; Hawes JW, 1996, J BIOL CHEM, V271, P26430, DOI 10.1074/jbc.271.42.26430; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hynes MJ, 2011, EUKARYOT CELL, V10, P547, DOI 10.1128/EC.00295-10; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; Ishigure K, 2001, CLIN CHIM ACTA, V312, P115, DOI 10.1016/S0009-8981(01)00597-6; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Lee SH, 2009, J MICROBIOL BIOTECHN, V19, P474, DOI 10.4014/jmb.0808.473; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lucas KA, 2007, J BIOL CHEM, V282, P24980, DOI 10.1074/jbc.M701028200; Luttik MAH, 2000, J BACTERIOL, V182, P7007, DOI 10.1128/JB.182.24.7007-7013.2000; Maerker C, 2005, FEBS J, V272, P3615, DOI 10.1111/j.1742-4658.2005.04784.x; MIYAKOSHI S, 1987, AGR BIOL CHEM TOKYO, V51, P2381; Moran C, 2009, PEDIATR INFECT DIS J, V28, P433, DOI 10.1097/INF.0b013e3181920ffd; Morath MA, 2008, J INHERIT METAB DIS, V31, P35, DOI 10.1007/s10545-007-0571-5; Muller S, 2011, ENVIRON MICROBIOL, V13, P1534, DOI 10.1111/j.1462-2920.2011.02458.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OOIWA T, 1995, BBA-GEN SUBJECTS, V1243, P216, DOI 10.1016/0304-4165(94)00061-2; Otzen C, 2013, FEMS YEAST RES, V13, P553, DOI 10.1111/1567-1364.12057; Piekarska K, 2008, MICROBIOL-SGM, V154, P3061, DOI 10.1099/mic.0.2008/020289-0; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; POPOV KM, 1992, BIOCHIM BIOPHYS ACTA, V1119, P69, DOI 10.1016/0167-4838(92)90236-7; PRONK JT, 1994, MICROBIOL-UK, V140, P717, DOI 10.1099/00221287-140-4-717; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Schwab MA, 2006, BIOCHEM J, V398, P107, DOI 10.1042/BJ20060221; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; STEELE MI, 1992, J BIOL CHEM, V267, P13585; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Talfournier F, 2011, J BIOL CHEM, V286, P21971, DOI 10.1074/jbc.M110.213280; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Vodisch M, 2009, PROTEOMICS, V9, P1407, DOI 10.1002/pmic.200800394; Yao TR, 2010, APPL BIOCHEM BIOTECH, V160, P694, DOI 10.1007/s12010-009-8685-x; Zhang YQ, 2004, GENETICS, V168, P785, DOI 10.1534/genetics.104.027540; Zhou H, 2008, MICROBIOL-SGM, V154, P500, DOI 10.1099/mic.0.2007/014555-0	68	24	24	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8151	8169		10.1074/jbc.M113.517672	http://dx.doi.org/10.1074/jbc.M113.517672			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497638	hybrid, Green Published			2022-12-25	WOS:000333157500012
J	Freemerman, AJ; Johnson, AR; Sacks, GN; Milner, JJ; Kirk, EL; Troester, MA; Macintyre, AN; Goraksha-Hicks, P; Rathmell, JC; Makowski, L				Freemerman, Alex J.; Johnson, Amy R.; Sacks, Gina N.; Milner, J. Justin; Kirk, Erin L.; Troester, Melissa A.; Macintyre, Andrew N.; Goraksha-Hicks, Pankuri; Rathmell, Jeffery C.; Makowski, Liza			Metabolic Reprogramming of Macrophages GLUCOSE TRANSPORTER 1 (GLUT1)-MEDIATED GLUCOSE METABOLISM DRIVES A PROINFLAMMATORY PHENOTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucose Transport; Glycolysis; Inflammation; Macrophages; Metabolomics; Mitochondrial Metabolism; Obesity; Pentose Phosphate Pathway; Crown-like Structure	ACID-BINDING PROTEIN; ADIPOSE-TISSUE; CHOLESTEROL-BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; DIETARY-CHOLESTEROL; INSULIN-RESISTANCE; CELL ACTIVATION; NADPH OXIDASE; FATTY-ACIDS; EXPRESSION	Background: GLUT1 is the main glucose transporter in certain immune cells. Results: Overexpressing GLUT1 in macrophages results in increased glucose uptake and glucose utilization. Conclusion: Driving glucose uptake and metabolism through GLUT1 induces a proinflammatory response that is dependent upon glycolysis and reactive oxygen species. Significance: Understanding how macrophage substrate metabolism impacts inflammation is crucial to develop novel therapeutics for obesity and diabetes. Glucose is a critical component in the proinflammatory response of macrophages (M phi s). However, the contribution of glucose transporters (GLUTs) and the mechanisms regulating subsequent glucose metabolism in the inflammatory response are not well understood. Because M phi s contribute to obesity-induced inflammation, it is important to understand how substrate metabolism may alter inflammatory function. We report that GLUT1 (SLC2A1) is the primary rate-limiting glucose transporter on proinflammatory-polarized M phi s. Furthermore, in high fat diet-fed rodents, M phi s in crown-like structures and inflammatory loci in adipose and liver, respectively, stain positively for GLUT1. We hypothesized that metabolic reprogramming via increased glucose availability could modulate the M phi inflammatory response. To increase glucose uptake, we stably overexpressed the GLUT1 transporter in RAW264.7 M phi s (GLUT1-OE M phi s). Cellular bioenergetics analysis, metabolomics, and radiotracer studies demonstrated that GLUT1 overexpression resulted in elevated glucose uptake and metabolism, increased pentose phosphate pathway intermediates, with a complimentary reduction in cellular oxygen consumption rates. Gene expression and proteome profiling analysis revealed that GLUT1-OE M phi s demonstrated a hyperinflammatory state characterized by elevated secretion of inflammatory mediators and that this effect could be blunted by pharmacologic inhibition of glycolysis. Finally, reactive oxygen species production and evidence of oxidative stress were significantly enhanced in GLUT1-OE M phi s; antioxidant treatment blunted the expression of inflammatory mediators such as PAI-1 (plasminogen activator inhibitor 1), suggesting that glucose-mediated oxidative stress was driving the proinflammatory response. Our results indicate that increased utilization of glucose induced a ROS-driven proinflammatory phenotype in M phi s, which may play an integral role in the promotion of obesity-associated insulin resistance.	[Freemerman, Alex J.; Johnson, Amy R.; Sacks, Gina N.; Milner, J. Justin; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Kirk, Erin L.; Troester, Melissa A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Kirk, Erin L.; Troester, Melissa A.] Univ N Carolina, Sch Med, Dept Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Makowski, Liza] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Macintyre, Andrew N.; Goraksha-Hicks, Pankuri; Rathmell, Jeffery C.] Duke Univ, Sarah W Stedman Ctr Nutr & Metab, Dept Immunol, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Makowski, L (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, CB 7461 Dept Nutr,2203 McGavran Greenberg Hall, Chapel Hill, NC 27599 USA.	liza.makowski@unc.edu		Makowski, Liza/0000-0002-5337-8037; Macintyre, Andrew/0000-0002-5297-0207	National Institutes of Health [AA017376, ES019472, P30DK034987, P30DK056350, R01HL108006]; NATIONAL CANCER INSTITUTE [P50CA058223, P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, U01ES019472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017376, K99AA017376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA017376 (UNC University Cancer Research Fund), ES019472, and P30DK034987; to L. M.), P30DK056350 (UNC Nutrition Obesity Research Consortium (to L. M. and M. T.), and R01HL108006 (J. C. R.).	Bentley J, 2003, J BIOL CHEM, V278, P39337, DOI 10.1074/jbc.M305689200; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Chang M, 2009, CELL SIGNAL, V21, P1361, DOI 10.1016/j.cellsig.2009.04.003; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Gamelli RL, 1996, J LEUKOCYTE BIOL, V59, P639, DOI 10.1002/jlb.59.5.639; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hayek T, 2007, ATHEROSCLEROSIS, V195, P277, DOI 10.1016/j.atherosclerosis.2006.12.026; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Kaplan M, 2008, J CARDIOVASC PHARM, V52, P324, DOI 10.1097/FJC.0b013e3181879d98; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Malide D, 1998, AM J PHYSIOL-ENDOC M, V274, pE516, DOI 10.1152/ajpendo.1998.274.3.E516; Mauerer R, 2009, EXP MOL MED, V41, P126, DOI 10.3858/emm.2009.41.2.015; Mauldin JP, 2008, CIRCULATION, V117, P2785, DOI 10.1161/CIRCULATIONAHA.107.741314; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; O'Rourke L, 2002, J BIOL CHEM, V277, P42557, DOI 10.1074/jbc.M202151200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Qin YY, 2014, ALCOHOL CLIN EXP RES, V38, P204, DOI 10.1111/acer.12210; Salh B, 1998, J IMMUNOL, V161, P6947; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; SPOLARICS Z, 1994, J LEUKOCYTE BIOL, V56, P453, DOI 10.1002/jlb.56.4.453; Stewart DA, 2012, MOL CANCER RES, V10, P727, DOI 10.1158/1541-7786.MCR-11-0604; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Subramanian S, 2009, CURR OPIN LIPIDOL, V20, P39, DOI 10.1097/MOL.0b013e32831bef8b; TADA H, 1994, DIABETES RES CLIN PR, V24, P33, DOI 10.1016/0168-8227(94)90083-3; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YEOP HC, 2010, DIABETES, V59, P386, DOI DOI 10.2337/DB09-0925)	48	458	472	18	112	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7884	7896		10.1074/jbc.M113.522037	http://dx.doi.org/10.1074/jbc.M113.522037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492615	Green Published, hybrid			2022-12-25	WOS:000332761500053
J	Johnell, K; Laflamme, L; Moller, J; Monarrez-Espino, J				Johnell, Kristina; Laflamme, Lucie; Moller, Jette; Monarrez-Espino, Joel			The Role of Marital Status in the Association between Benzodiazepines, Psychotropics and Injurious Road Traffic Crashes: A Register-Based Nationwide Study of Senior Drivers in Sweden	PLOS ONE			English	Article							OLDER DRIVERS; VEHICLE CRASHES; RISK; ACCIDENTS; DRUGS; HOSPITALIZATION; POLYPHARMACY; MEDICATIONS; PERFORMANCE; ADULTS	Background: Among senior drivers, benzodiazepines (BZDs) have a documented effect on the risk of road traffic crashes (RTCs). It remains unclear however if BZDs play the same role when considering marital status. Therefore, we aimed to investigate the role of marital status in the association between BZD use and injurious RTCs among senior drivers. Methods: Matched case-control study based on five national Swedish registers (n = 154 225). Cases comprised the first non-alcohol-related injurious RTC sustained by drivers aged 50-80 years from July 2005 to December 2009 and controls included registered residents with a valid license who did not crash during that period. Four controls were matched to each case by sex, age and place of residence. Conditional logistic regression analysis for injurious RTC was performed with adjustment for occupation and number of medications. The main exposure was dispensation of BZDs, alone or in combination with other psychotropic medications, 1-30 days prior to the crash date stratified by marital status. Results: BZD use, alone or in combination with other psychotropic medications, increased the risk of being involved in an RTC (BZD only: adjusted OR: 1.26, 95% CI: 1.17-1.36; BZDs and other psychotropics: adjusted OR: 1.25, 95% CI: 1.12-1.41). Compared to married drivers, those divorced (1.48, 1.43-1.53) and widowed (1.54; 1.45-1.63) had higher adjusted ORs. Marital status modified the association between BZDs and RTCs, particularly among younger male drivers. Conclusions: Both BZDs and marital status independently affect the risk for senior drivers to be involved in an RTC. However, marital status plays a role in the association between BZD use and RTCs and this may have implications for targeting risk populations for RTCs among senior drivers.	[Johnell, Kristina] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Johnell, Kristina] Stockholm Univ, S-10691 Stockholm, Sweden; [Laflamme, Lucie; Moller, Jette; Monarrez-Espino, Joel] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Johnell, K (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	Kristina.Johnell@ki.se	Laflamme, Lucie/T-2953-2019	Laflamme, Lucie/0000-0002-6443-1307; Moller, Jette/0000-0001-9513-5896	Petrus and Augusta Hedlund's Foundation; Swedish Transport Agency; Swedish Research Council [2007-5870, 2007-5681]	Petrus and Augusta Hedlund's Foundation; Swedish Transport Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by different project specific and individual grants, including the Petrus and Augusta Hedlund's Foundation, the Swedish Transport Agency and the Swedish Research Council (2007-5870 and 2007-5681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Wahlberg AE, 2007, J SAFETY RES, V38, P453, DOI 10.1016/j.jsr.2007.01.013; Akalanka EC, 2012, ASIA-PAC J PUBLIC HE, V24, P91, DOI 10.1177/1010539510376304; Barbone F, 1998, LANCET, V352, P1331, DOI 10.1016/S0140-6736(98)04087-2; Betz ME, 2010, J AM GERIATR SOC, V58, P1931, DOI 10.1111/j.1532-5415.2010.03010.x; Cheung YB, 1998, SOC SCI MED, V47, P1325, DOI 10.1016/S0277-9536(98)00210-X; Cooper L, 2011, ASIA-PAC J PUBLIC HE, V23, P443, DOI 10.1177/1010539511407661; Dassanayake T, 2011, DRUG SAFETY, V34, P125, DOI 10.2165/11539050-000000000-00000; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Eaker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018040; Engeland A, 2007, ANN EPIDEMIOL, V17, P597, DOI 10.1016/j.annepidem.2007.03.009; Farley JF, 2006, AM J MANAG CARE, V12, P110; Ferrer A, 2013, J AM GERIATR SOC, V61, P294, DOI 10.1111/jgs.12154; Fildes BN, 2008, TRAFFIC INJ PREV, V9, P387, DOI 10.1080/15389580802272435; French DD, 2005, PHARMACOEPIDEM DR S, V14, P17, DOI 10.1002/pds.967; Grube Joel W, 2004, Traffic Inj Prev, V5, P199, DOI 10.1080/15389580490465229; Haider SI, 2008, CLIN THER, V30, P419, DOI 10.1016/j.clinthera.2008.02.010; Hemmelgarn B, 1997, JAMA-J AM MED ASSOC, V278, P27, DOI 10.1001/jama.278.1.27; Johnell K, 2013, DEMENT GERIATR COGN, V35, P239, DOI 10.1159/000348408; Johnell K, 2009, INT J GERIATR PSYCH, V24, P731, DOI 10.1002/gps.2189; Lader M, 2012, BR J CLIN PHARM; Lagarde E, 2004, EPIDEMIOLOGY, V15, P762, DOI 10.1097/01.ede.0000142140.77194.ad; Madhusoodanan Subramoniam, 2004, Expert Opin Drug Saf, V3, P485, DOI 10.1517/14740338.3.5.485; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Meuleners LB, 2011, J AM GERIATR SOC, V59, P1575, DOI 10.1111/j.1532-5415.2011.03561.x; Mitchell CGB, 2013, ACCIDENT ANAL PREV, V50, P732, DOI 10.1016/j.aap.2012.06.027; Moden B, 2012, EUR J PUBLIC HEALTH, V22, P726, DOI 10.1093/eurpub/ckr110; Moller J, 2011, AGING MENT HEALTH, V15, P259, DOI 10.1080/13607863.2010.513041; Monarrez-Espino J, INJ PREV IN PRESS; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Organisation for Economic Cooperation and Development (OECD), 2001, AG TRANSP MOB NEEDS; RAY WA, 1992, AM J EPIDEMIOL, V136, P873, DOI 10.1093/aje/136.7.873; Razmpa E, 2011, INDIAN J OTOLARYNGOL, V63, P269, DOI 10.1007/s12070-011-0235-5; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sims RV, 2000, J GERONTOL A-BIOL, V55, pM22; Smink BE, 2010, CNS DRUGS, V24, P639, DOI 10.2165/11533170-000000000-00000; Stutts JC, 1998, ACCIDENT ANAL PREV, V30, P337, DOI 10.1016/S0001-4575(97)00108-5; Vanakoski J, 2000, EUR J CLIN PHARMACOL, V56, P453, DOI 10.1007/s002280000167; Vaughn MG, 2011, J PSYCHIATR RES, V45, P347, DOI 10.1016/j.jpsychires.2010.06.016; Vollmer WM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-155; Wang CC, 2004, J AM GERIATR SOC, V52, P143, DOI 10.1111/j.1532-5415.2004.52025.x; Whitlock G, 2004, INJURY PREV, V10, P33, DOI 10.1136/ip.2003.003020; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P769, DOI 10.1093/gerona/glq003	43	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86742	10.1371/journal.pone.0086742	http://dx.doi.org/10.1371/journal.pone.0086742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489781	gold, Green Published			2022-12-25	WOS:000330570000067
J	Leung, JM; Rould, MA; Konradt, C; Hunter, CA; Ward, GE				Leung, Jacqueline M.; Rould, Mark A.; Konradt, Christoph; Hunter, Christopher A.; Ward, Gary E.			Disruption of TgPHIL1 Alters Specific Parameters of Toxoplasma gondii Motility Measured in a Quantitative, Three-Dimensional Live Motility Assay	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; HOST-CELL INVASION; GLIDING MOTILITY; REVEALS; INFECTION; MIGRATION; MYOSIN; TRAJECTORIES; CYTOSKELETON; INHIBITION	T. gondii uses substrate-dependent gliding motility to invade cells of its hosts, egress from these cells at the end of its lytic cycle and disseminate through the host organism during infection. The ability of the parasite to move is therefore critical for its virulence. T. gondii engages in three distinct types of gliding motility on coated two-dimensional surfaces: twirling, circular gliding and helical gliding. We show here that motility in a three-dimensional Matrigel-based environment is strikingly different, in that all parasites move in irregular corkscrew-like trajectories. Methods developed for quantitative analysis of motility parameters along the smoothed trajectories demonstrate a complex but periodic pattern of motility with mean and maximum velocities of 0.58 +/- 0.07 mu m/s and 2.01 +/- 0.17 mu m/s, respectively. To test how a change in the parasite's crescent shape might affect trajectory parameters, we compared the motility of Delta phil1 parasites, which are shorter and wider than wild type, to the corresponding parental and complemented lines. Although comparable percentages of parasites were moving for all three lines, the Delta phil1 mutant exhibited significantly decreased trajectory lengths and mean and maximum velocities compared to the parental parasite line. These effects were either partially or fully restored upon complementation of the Delta phil1 mutant. These results show that alterations in morphology may have a significant impact on T. gondii motility in an extracellular matrix-like environment, provide a possible explanation for the decreased fitness of Delta phil1 parasites in vivo, and demonstrate the utility of the quantitative three-dimensional assay for studying parasite motility.	[Leung, Jacqueline M.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Leung, Jacqueline M.] Univ Vermont, Program Cellular Mol & Biomed Sci, Burlington, VT USA; [Rould, Mark A.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT USA; [Konradt, Christoph; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Vermont; University of Vermont; University of Vermont; University of Pennsylvania	Ward, GE (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	gary.ward@uvm.edu		Ward, Gary/0000-0003-4138-3055	US Public Health Service grant [AI054961]; German Research Foundation, DFG [KO4609/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054961, R56AI054961] Funding Source: NIH RePORTER	US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); German Research Foundation, DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US Public Health Service grant AI054961 (GEW) and research grant KO4609/1-1 from the German Research Foundation, DFG (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AM, 2012, MOL BIOCHEM PARASIT, V184, P39, DOI 10.1016/j.molbiopara.2012.03.006; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Barkhuff WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023977; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Child MA, 2013, NAT CHEM BIOL, V9, P651, DOI 10.1038/nchembio.1315; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Crenshaw HC, 2000, J EXP BIOL, V203, P961; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frixione E, 1996, CELL MOTIL CYTOSKEL, V34, P152, DOI 10.1002/(SICI)1097-0169(1996)34:2&lt;152::AID-CM6&gt;3.0.CO;2-D; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gregg B, 2013, INFECT IMMUN, V81, P1635, DOI 10.1128/IAI.01126-12; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143; KIMSEY RB, 1990, J INFECT DIS, V162, P1205, DOI 10.1093/infdis/162.5.1205; Kreyszig E., 1991, DIFFERENTIAL GEOMETR; Kudryashev M, 2012, CELL MICROBIOL, V14, P1757, DOI 10.1111/j.1462-5822.2012.01836.x; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Ma C, 2007, MOL BIOL CELL, V18, P4711, DOI 10.1091/mbc.E07-04-0379; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; Press W.H., 1996, NUMERICAL RECIPES FO; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Schrodinger L., 2020, PYMOL; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheng J, 2010, P NATL ACAD SCI USA, V107, P2082, DOI 10.1073/pnas.0912254107; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Su TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01664; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Volkmann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041409; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	54	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85763	10.1371/journal.pone.0085763	http://dx.doi.org/10.1371/journal.pone.0085763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489670	gold, Green Submitted, Green Published			2022-12-25	WOS:000330570000015
J	Luo, Z; Dong, XC; Li, YX; Zhang, Q; Kim, C; Song, Y; Kang, L; Liu, YL; Wu, KL; Wu, JG				Luo, Zhen; Dong, Xingchen; Li, Youxing; Zhang, Qi; Kim, Cholho; Song, Yu; Kang, Lei; Liu, Yingle; Wu, Kailang; Wu, Jianguo			PolyC-Binding Protein 1 Interacts with 5 '-Untranslated Region of Enterovirus 71 RNA in Membrane-Associated Complex to Facilitate Viral Replication	PLOS ONE			English	Article							POLY(RC) BINDING-PROTEIN; RIBOSOMAL ENTRY SITE; VIRUS-RNA; GENE-EXPRESSION; POLIOVIRUS RNA; ELEMENT; TRANSLATION; SEQUENCE; CLOVERLEAF; INITIATION	Enterovirus 71 (EV71) is one causative agent of hand, foot, and mouth disease (HFMD), which may lead to severe neurological disorders and mortality in children. EV71 genome is a positive single-stranded RNA containing a single open reading frame (ORF) flanked by 5'-untranslated region (5'UTR) and 3'UTR. The 5'UTR is fundamentally important for virus replication by interacting with cellular proteins. Here, we revealed that poly(C)-binding protein 1 (PCBP1) specifically binds to the 5'UTR of EV71. Detailed studies indicated that the RNA-binding K-homologous 1 (KH1) domain of PCBP1 is responsible for its binding to the stem-loop I and IV of EV71 5'UTR. Interestingly, we revealed that PCBP1 is distributed in the nucleus and cytoplasm of uninfected cells, but mainly localized in the cytoplasm of EV71-infected cells due to interaction and co-localization with the viral RNA. Furthermore, sub-cellular distribution analysis showed that PCBP1 is located in ER-derived membrane, in where virus replication occurred in the cytoplasm of EV71-infected cells, suggesting PCBP1 is recruited in a membrane-associated replication complex. In addition, we found that the binding of PCBP1 to 5'UTR resulted in enhancing EV71 viral protein expression and virus production so as to facilitate viral replication. Thus, we revealed a novel mechanism in which PCBP1 as a positive regulator involved in regulation of EV71 replication in the host specialized membrane-associated replication complex, which provides an insight into cellular factors involved in EV71 replication.	[Luo, Zhen; Dong, Xingchen; Li, Youxing; Zhang, Qi; Kim, Cholho; Song, Yu; Kang, Lei; Liu, Yingle; Wu, Kailang; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Luo, Zhen; Dong, Xingchen; Li, Youxing; Zhang, Qi; Kim, Cholho; Song, Yu; Kang, Lei; Liu, Yingle; Wu, Kailang; Wu, Jianguo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Wu, Jianguo] Wuhan Univ, Zhongnan Hosp, Chinese French Liver Dis Res Inst, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Wu, KL (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	wukailang@whu.edu.cn; jwu@whu.edu.cn		Zhen, Luo/0000-0002-1142-2845; Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program (973 Program) [2012CB518900]; National Natural Science Foundation of China [31230005, 81171525]; National Mega Project on Major Infectious Disease Prevention [2012ZX10004-207]; National Mega Project on Major Drug Development [2011ZX09401-302]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention; National Mega Project on Major Drug Development	This work was supported by research grants from Major State Basic Research Development Program (973 Program) (2012CB518900), National Natural Science Foundation of China (31230005 and 81171525), National Mega Project on Major Infectious Disease Prevention (2012ZX10004-207), National Mega Project on Major Drug Development (2011ZX09401-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bailey JM, 2007, J VIROL, V81, P650, DOI 10.1128/JVI.01327-06; Barton DJ, 2001, EMBO J, V20, P1439, DOI 10.1093/emboj/20.6.1439; Beura LK, 2011, J VIROL, V85, P12939, DOI 10.1128/JVI.05177-11; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Fernandez N, 2010, VIROLOGY; GutierrezEscolano L, 1996, ARCH MED RES, V27, P413; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Huo LR, 2010, BBA-PROTEINS PROTEOM, V1804, P1954, DOI 10.1016/j.bbapap.2010.07.002; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; LIU YT, 2010, J ACCOUNT RES, V3, P3; Lyons T, 2001, J VIROL, V75, P10696, DOI 10.1128/JVI.75.22.10696-10708.2001; Magliano D, 1998, VIROLOGY, V240, P57, DOI 10.1006/viro.1997.8906; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Maul A, 1991, ASPECTS STAT METHODE, P143; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Nishimura K, 2004, VIROLOGY, V325, P364, DOI 10.1016/j.virol.2004.04.041; Ogram SA, 2010, VIROLOGY, V397, P14, DOI 10.1016/j.virol.2009.11.006; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; Qu J, 2011, FEBS LETT, V585, P4002, DOI 10.1016/j.febslet.2011.11.008; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Sharma N, 2009, VIROLOGY, V393, P238, DOI 10.1016/j.virol.2009.07.039; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; Spear A, 2008, VIROLOGY, V374, P280, DOI 10.1016/j.virol.2007.12.039; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Vogt DA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000936; Wang Li-chun, 2010, Virologica Sinica, V25, P98, DOI 10.1007/s12250-010-3102-8; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Xia M, 2012, CELL CYCLE, V11, P2833, DOI 10.4161/cc.21169; Zhou X, 2012, CELL RES, V22, P717, DOI 10.1038/cr.2011.184	51	37	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87491	10.1371/journal.pone.0087491	http://dx.doi.org/10.1371/journal.pone.0087491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489926	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000152
J	Sasaoka, N; Sakamoto, M; Kanemori, S; Kan, M; Tsukano, C; Takemoto, Y; Kakizuka, A				Sasaoka, Norio; Sakamoto, Megumi; Kanemori, Shoko; Kan, Michiru; Tsukano, Chihiro; Takemoto, Yoshiji; Kakizuka, Akira			Long-Term Oral Administration of Hop Flower Extracts Mitigates Alzheimer Phenotypes in Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALLEVIATE MENOPAUSAL DISCOMFORTS; HUMULUS-LUPULUS L.; GAMMA-SECRETASE; BETA-PROTEIN; COGNITIVE DECLINE; ACID RECEPTOR; DOUBLE-BLIND; DISEASE; MUTATION	Coincident with the expanding population of aged people, the incidence of Alzheimer disease (AD) is rapidly increasing in most advanced countries. At present, no effective prophylactics are available. Among several pathological mechanisms proposed for AD, the "amyloid hypothesis" has been most widely accepted, in which accumulation or deposition of A beta is considered to be the initial event. Thus, prevention of A beta production would be an ideal strategy for the treatment or prevention of AD. A beta is produced via the proteolytic cleavage of its precursor protein, APP (amyloid precursor protein), by two different enzymes, beta and gamma-secretases. Indeed, inhibitors against either or both enzymes have been developed and tested for clinical efficacy. Based on the "amyloid hypothesis", we developed a luciferase-based screening method to monitor gamma-secretase activity, screened more than 1,600 plant extracts, most of which have long been used in Chinese medicine, and observed that Hop extracts significantly inhibit A beta production in cultured cells. A major component of the inhibitory activity was purified, and its chemical identity was determined by NMR to be Garcinielliptone HC. In vivo, oral administration of Hop extracts to AD model mice decreased A beta depositions in the cerebral cortex of the parietal lobe, hippocampus, and artery walls (amyloid angiopathy) in the brains. In a Morris water maze test, AD model mice that had daily consumed Hop extracts in their drinking water showed significant mitigation of memory impairment at ages of 9 and 12 months. Moreover, in the open field test oral administration of Hop extracts also prevented an emotional disturbance that appeared in the AD mice at 18 months. Despite lifelong consumption of Hop extracts, no deleterious side effects were observed at any age. These results support the "amyloid hypothesis", and indicate that Hop extract is a promising candidate for an effective prophylactic for AD.	[Sasaoka, Norio; Sakamoto, Megumi; Kanemori, Shoko; Kan, Michiru; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Sakyo Ku, Kyoto, Japan; [Tsukano, Chihiro; Takemoto, Yoshiji] Kyoto Univ, Dept Organ Chem, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Kakizuka, A (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Sakyo Ku, Kyoto, Japan.	kakizuka@lif.kyoto-u.ac.jp	Takemoto, Yoshiji/C-7099-2009; Tsukano, Chihiro/B-7697-2014	Tsukano, Chihiro/0000-0002-9361-0857	Solution-Oriented Research for Science and Technology of the Japan Science and Technology Agency; Ministry of Health, Labour, and Welfare of Japan	Solution-Oriented Research for Science and Technology of the Japan Science and Technology Agency; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by research grants from Solution-Oriented Research for Science and Technology of the Japan Science and Technology Agency and the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2012, CHEM BIODIVERS, V9, P1045, DOI 10.1002/cbdv.201100233; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Chadwick LR, 2006, PHYTOMEDICINE, V13, P119, DOI 10.1016/j.phymed.2004.07.006; Choi Y, 2008, COMB CHEM HIGH T SCR, V11, P1; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Desai A, 2012, ATHEROSCLEROSIS, V223, P130, DOI 10.1016/j.atherosclerosis.2012.05.004; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Erkkola R, 2010, PHYTOMEDICINE, V17, P389, DOI 10.1016/j.phymed.2010.01.007; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Martinez-Aguilar JF, 2009, J AGR FOOD CHEM, V57, P1933, DOI 10.1021/jf802141d; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Funato H, 1998, AM J PATHOL, V152, P1633; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Godbolt AK, 2004, ARCH NEUROL-CHICAGO, V61, P1743, DOI 10.1001/archneur.61.11.1743; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heyerick A, 2006, MATURITAS, V54, P164, DOI 10.1016/j.maturitas.2005.10.005; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kelleher RJ, 2010, SCIENCE, V330, P1055, DOI 10.1126/science.1198668; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; Kumari P, 2011, ANAL BIOCHEM, V415, P134, DOI 10.1016/j.ab.2011.04.010; Levine AJ, 2004, ARCH CLIN NEUROPSYCH, V19, P769, DOI 10.1016/j.acn.2003.09.004; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Lu YH, 2008, PHYTOCHEMISTRY, V69, P225, DOI 10.1016/j.phytochem.2007.06.026; Morelli L, 2012, INT J ALZHEIMERS DIS, V2012; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Neugroschl J, 2010, MT SINAI J MED, V77, P3, DOI 10.1002/msj.20165; Nilsson LNG, 2004, NEUROBIOL AGING, V25, P1153, DOI 10.1016/j.neurobiolaging.2003.12.011; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011; Raschetti R, 2005, EUR J CLIN PHARMACOL, V61, P361, DOI 10.1007/s00228-005-0946-1; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; SAITOU M, 1994, J BIOL CHEM, V269, P19101; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Thomas P, 2007, MUTAGENESIS, V22, P15, DOI 10.1093/mutage/gel055; Van Cleemput M, 2009, J NAT PROD, V72, P1220, DOI 10.1021/np800740m; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; von Bernhardi R, 2010, J ALZHEIMERS DIS, V19, P405, DOI 10.3233/JAD-2010-1248; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Wang Xiao-Ping, 2008, Neurosci Bull, V24, P105, DOI 10.1007/s12264-008-0105-7; Wharton W, 2011, J ALZHEIMERS DIS, V26, P495, DOI 10.3233/JAD-2011-110341; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yamamoto Y, 2001, CELL DEATH DIFFER, V8, P871, DOI 10.1038/sj.cdd.4400901	64	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87185	10.1371/journal.pone.0087185	http://dx.doi.org/10.1371/journal.pone.0087185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489866	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000116
J	Tofik, R; Ohlsson, S; Bakoush, O				Tofik, Rafid; Ohlsson, Sophie; Bakoush, Omran			Urinary Concentration of Monocyte Chemoattractant Protein-1 in Idiopathic Glomerulonephritis: A Long-Term Follow-Up Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; LUPUS NEPHRITIS; CREATININE ASSAYS; RENAL-DISEASE; MCP-1; PROGRESSION; PREDICTION; EXCRETION; ALBUMIN	Background: Monocyte chemoattractant protein-1 (MCP-1), which is up regulated in kidney diseases, is considered a marker of kidney inflammation. We examined the value of urine MCP-1 in predicting the outcome in idiopathic glomerulonephritis. Methods: Between 1993 and 2004, 165 patients (68 females) diagnosed with idiopathic proteinuric glomerulopathy and with serum creatinine >150 mu mol/L at diagnosis were selected for the study. Urine concentrations of MCP-1 were analyzed by ELISA in early morning spot urine samples collected on the day of the diagnostic kidney biopsy. The patients were followed until 2009. The progression rate to end-stage kidney disease was calculated using Kaplan-Meier survival analysis. End-stage kidney disease (ESKD) was defined as the start of kidney replacement therapy during the study follow-up time. Results: Patients with proliferative glomerulonephritis had significantly higher urinary MCP-1 excretion levels than those with non-proliferative glomerulonephritis (p<0.001). The percentage of patients whose kidney function deteriorated significantly was 39.0% in the high MCP-1 excretion group and 29.9% in the low MCP-1 excretion group. However, after adjustment for confounding variables such as glomerular filtration rate (GFR) and proteinuria, there was no significant association between urine MCP-1 concentration and progression to ESKD, (HR = 1.75, 95% CI = 0.64-4.75, p = 0.27). Conclusion: Our findings indicate that progression to end-stage kidney disease in patients with idiopathic glomerulopathies is not associated with urine MCP-1 concentrations at the time of diagnosis.	[Tofik, Rafid; Ohlsson, Sophie; Bakoush, Omran] Lund Univ, Dept Nephrol, S-22101 Lund, Sweden; [Bakoush, Omran] UAE Univ, Dept Internal Med, Al Ain, U Arab Emirates	Lund University; United Arab Emirates University	Bakoush, O (corresponding author), Lund Univ, Dept Nephrol, S-22101 Lund, Sweden.	Omran.Bakoush@uaeu.ac.ae	Bakoush, Omran/ABF-8443-2021; Ohlsson, Sophie/W-9495-2019; Bakoush, Omran/B-9395-2009	Bakoush, Omran/0000-0003-1447-9836; Ohlsson, Sophie/0000-0002-5253-1650; Bakoush, Omran/0000-0003-1447-9836	ALF grants from Lund University Research Fund	ALF grants from Lund University Research Fund	This study was supported by ALF grants from Lund University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Bakoush O, 2001, KIDNEY INT, V60, P1904, DOI 10.1046/j.1523-1755.2001.00018.x; Barbado J, 2012, CYTOKINE, V60, P583, DOI 10.1016/j.cyto.2012.07.009; Bazzi C, 2012, J NEPHROL, V25, P810, DOI 10.5301/jn.5000069; Bjork J, 2007, SCAND J CLIN LAB INV, V67, P678, DOI 10.1080/00365510701326891; Furuichi K, 2003, J AM SOC NEPHROL, V14, P1066, DOI 10.1097/01.ASN.0000059339.14780.E4; Kim MJ, 2011, CLIN CHIM ACTA, V412, P2022, DOI 10.1016/j.cca.2011.07.023; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Lepenies J, 2011, NEPHRON CLIN PRACT, V119, pC97, DOI 10.1159/000324765; Lieberthal JG, 2013, J RHEUMATOL, V40, P674, DOI 10.3899/jrheum.120879; McQuarrie EP, 2011, NEPHROL DIAL TRANSPL, V26, P1563, DOI 10.1093/ndt/gfq605; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Murea M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-148; Nam BY, 2012, APOPTOSIS, V17, P1, DOI 10.1007/s10495-011-0661-6; Nyman U, 2006, SCAND J CLIN LAB INV, V66, P451, DOI 10.1080/00365510600902362; Ohlsson S, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/584916; PRICE CP, 1983, ANN CLIN BIOCHEM, V20, P1; Rosa RF, 2012, J RHEUMATOL, V39, P1948, DOI 10.3899/jrheum.110201; Rovin BH, 1996, AM J KIDNEY DIS, V27, P640, DOI 10.1016/S0272-6386(96)90097-9; Singh RG, 2012, LUPUS, V21, P1214, DOI 10.1177/0961203312452622; SVENDSEN P, 1991, DETERMINATION HUMAN; Tencer J, 1996, SCAND J CLIN LAB INV, V56, P691, DOI 10.3109/00365519609088816; Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006; Tofik R, 2011, SCAND J CLIN LAB INV, V71, P123, DOI 10.3109/00365513.2010.542828; Wu CC, 2010, CLIN CHIM ACTA, V411, P700, DOI 10.1016/j.cca.2010.01.036; Yu C, 2007, J AM SOC NEPHROL, V18, P750, DOI 10.1681/ASN.2006070770	28	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87857	10.1371/journal.pone.0087857	http://dx.doi.org/10.1371/journal.pone.0087857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489972	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000184
J	de Santos-Sierra, D; Sendina-Nadal, I; Leyva, I; Almendral, JA; Anava, S; Ayali, A; Papo, D; Boccaletti, S				de Santos-Sierra, Daniel; Sendina-Nadal, Irene; Leyva, Inmaculada; Almendral, Juan A.; Anava, Sarit; Ayali, Amir; Papo, David; Boccaletti, Stefano			Emergence of Small-World Anatomical Networks in Self-Organizing Clustered Neuronal Cultures	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NERVOUS-SYSTEM; DYNAMICS	In vitro primary cultures of dissociated invertebrate neurons from locust ganglia are used to experimentally investigate the morphological evolution of assemblies of living neurons, as they self-organize from collections of separated cells into elaborated, clustered, networks. At all the different stages of the culture's development, identification of neurons' and neurites' location by means of a dedicated software allows to ultimately extract an adjacency matrix from each image of the culture. In turn, a systematic statistical analysis of a group of topological observables grants us the possibility of quantifying and tracking the progression of the main network's characteristics during the self-organization process of the culture. Our results point to the existence of a particular state corresponding to a small-world network configuration, in which several relevant graph's micro-and meso-scale properties emerge. Finally, we identify the main physical processes ruling the culture's morphological transformations, and embed them into a simplified growth model qualitatively reproducing the overall set of experimental observations.	[de Santos-Sierra, Daniel; Sendina-Nadal, Irene; Leyva, Inmaculada; Almendral, Juan A.; Papo, David] Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain; [Sendina-Nadal, Irene; Leyva, Inmaculada; Almendral, Juan A.] Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain; [Anava, Sarit; Ayali, Amir] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Florence, Italy; [Boccaletti, Stefano] Ist Nazl Fis Nucl, I-50125 Florence, Italy	Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Universidad Rey Juan Carlos; Tel Aviv University; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Istituto Nazionale di Fisica Nucleare (INFN)	de Santos-Sierra, D (corresponding author), Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain.	daniel.desantos@ctb.upm.es	Leyva, I./M-1820-2013; Ayali, Amir/B-1050-2008; Sendiña-Nadal, Irene/M-3083-2013; Almendral, Juan/ABC-8025-2021; Boccaletti, Stefano/U-7603-2019	Leyva, I./0000-0001-9634-5385; Ayali, Amir/0000-0001-6152-2927; Sendiña-Nadal, Irene/0000-0003-0432-235X; Almendral, Juan/0000-0003-1100-7446; Boccaletti, Stefano/0000-0002-5758-7012; Papo, David/0000-0003-1889-2791	Spanish Ministerio de Ciencia e Innovacion (Spain) [FIS2009-07072]; Comunidad de Madrid (Spain) [MODELICO-CM S2009ESP-1691]; Comunidad de Madrid through the R+D Activity Program [NEUROTEC-CM (2010/BMD-2460)]	Spanish Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid); Comunidad de Madrid through the R+D Activity Program	The authors acknowledge financial support from the Spanish Ministerio de Ciencia e Innovacion (Spain) under project FIS2009-07072, and from Comunidad de Madrid (Spain) under project MODELICO-CM S2009ESP-1691. DSS is supported by the Comunidad de Madrid through the R+D Activity Program NEUROTEC-CM (2010/BMD-2460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Anava S, 2013, INSECT MOL BIOL, V22, P457, DOI 10.1111/imb.12036; Anava S, 2009, BIOPHYS J, V96, P1661, DOI 10.1016/j.bpj.2008.10.058; Ayali A, 2004, COMPLEXITY, V9, P25, DOI 10.1002/cplx.20046; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 2001, RANDOM GRAPHS; Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Eckmann JP, 2007, PHYS REP, V449, P54, DOI 10.1016/j.physrep.2007.02.014; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Li DQ, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68004; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Rad AA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228701; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Segev R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.168101; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Shefi O, 2002, NEUROCOMPUTING, V44, P635, DOI 10.1016/S0925-2312(02)00451-4; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Woiterski L, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025029	28	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85828	10.1371/journal.pone.0085828	http://dx.doi.org/10.1371/journal.pone.0085828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489675	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330510000020
J	Herrero, A; Zamora, R				Herrero, Asier; Zamora, Regino			Plant Responses to Extreme Climatic Events: A Field Test of Resilience Capacity at the Southern Range Edge	PLOS ONE			English	Article							DROUGHT-INDUCED MORTALITY; SCOTS PINE; NORTHERN ARIZONA; TREE MORTALITY; CHANGE IMPACTS; NEEDLE GROWTH; VEGETATION; SYLVESTRIS; FORESTS; NIGRA	The expected and already observed increment in frequency of extreme climatic events may result in severe vegetation shifts. However, stabilizing mechanisms promoting community resilience can buffer the lasting impact of extreme events. The present work analyzes the resilience of a Mediterranean mountain ecosystem after an extreme drought in 2005, examining shoot-growth and needle-length resistance and resilience of dominant tree and shrub species (Pinus sylvestris vs Juniperus communis, and P. nigra vs J. oxycedrus) in two contrasting altitudinal ranges. Recorded high vegetative-resilience values indicate great tolerance to extreme droughts for the dominant species of pine-juniper woodlands. Observed tolerance could act as a stabilizing mechanism in rear range edges, such as the Mediterranean basin, where extreme events are predicted to be more detrimental and recurrent. However, resistance and resilience components vary across species, sites, and ontogenetic states: adult Pinus showed higher growth resistance than did adult Juniperus; saplings displayed higher recovery rates than did conspecific adults; and P. nigra saplings displayed higher resilience than did P. sylvestris saplings where the two species coexist. P. nigra and J. oxycedrus saplings at high and low elevations, respectively, were the most resilient at all the locations studied. Under recurrent extreme droughts, these species-specific differences in resistance and resilience could promote changes in vegetation structure and composition, even in areas with high tolerance to dry conditions.	[Herrero, Asier; Zamora, Regino] Univ Granada, Dept Ecol, Granada, Andalusia, Spain; [Herrero, Asier] Univ Alcala, Dept Life Sci, Madrid, Spain	University of Granada; Universidad de Alcala	Herrero, A (corresponding author), Univ Granada, Dept Ecol, Granada, Andalusia, Spain.	asier@ugr.es	Herrero, Asier/A-9746-2018; Zamora, Regino/B-3179-2010	Herrero, Asier/0000-0003-2932-5194; Zamora, Regino/0000-0002-5049-9968	Ministerio de Ciencia e Innovacion (Spanish Government) [CGL2008-04794, CGL2011-29910]; FPU-MEC [AP2005-1561]	Ministerio de Ciencia e Innovacion (Spanish Government)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU-MEC(Spanish Government)	This study was supported by Ministerio de Ciencia e Innovacion (Spanish Government) Projects CGL2008-04794 and CGL2011-29910 to R.Z.,and by grant FPU-MEC (AP2005-1561) to A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2004, OECOLOGIA, V140, P217, DOI 10.1007/s00442-004-1585-4; Afzal-Rafii Z, 2007, MOL ECOL, V16, P723, DOI 10.1111/j.1365-294X.2006.03183.x; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Bigler C, 2006, ECOSYSTEMS, V9, P330, DOI 10.1007/s10021-005-0126-2; Blanco E., 1997, BOSQUES IBERICOS INT; Boulant N, 2008, DIVERS DISTRIB, V14, P862, DOI 10.1111/j.1472-4642.2008.00494.x; Briffa KR, 2009, INT J CLIMATOL, V29, P1894, DOI 10.1002/joc.1836; Linares JC, 2010, TREE PHYSIOL, V30, P795, DOI 10.1093/treephys/tpq052; Castro J, 2004, RESTOR ECOL, V12, P352, DOI 10.1111/j.1061-2971.2004.0316.x; Castro J, 2004, J ECOL, V92, P266, DOI 10.1111/j.0022-0477.2004.00870.x; Day ME, 2011, TREE PHYSIOL-NETH, V4, P91, DOI 10.1007/978-94-007-1242-3_4; De Dato G, 2008, IFOREST, V1, P39, DOI 10.3832/ifor0418-0010039; Debain S, 2007, CAN J FOREST RES, V37, P705, DOI 10.1139/X06-265; DeClerck FAJ, 2006, ECOLOGY, V87, P2787, DOI 10.1890/0012-9658(2006)87[2787:SRASSI]2.0.CO;2; Della-Marta PM, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008510; Dobbertin M, 2010, TREE PHYSIOL, V30, P346, DOI 10.1093/treephys/tpp123; EDENIUS L, 1995, CAN J FOREST RES, V25, P529, DOI 10.1139/x95-060; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Floyd ML, 2009, ECOL APPL, V19, P1223, DOI 10.1890/08-1265.1; Galiano L, 2010, ECOSYSTEMS, V13, P978, DOI 10.1007/s10021-010-9368-8; Garcia D, 2003, J VEG SCI, V14, P921, DOI 10.1111/j.1654-1103.2003.tb02227.x; Garcia-Herrera R, 2007, J HYDROMETEOROL, V8, P483, DOI 10.1175/JHM578.1; GARRETT PW, 1973, ECOLOGY, V54, P1328, DOI 10.2307/1934195; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Herrero A, 2012, PLANT ECOL, V213, P459, DOI 10.1007/s11258-011-9993-0; Herrero A, 2013, OECOLOGIA, V173, P1613, DOI 10.1007/s00442-013-2707-7; Hodar JA, 2003, BIOL CONSERV, V110, P123, DOI 10.1016/S0006-3207(02)00183-0; Holling C.S., 1996, ENG ECOL CONSTRAINTS, V31, P32, DOI DOI 10.17226/4919.[; ISIK K, 1990, FOREST ECOL MANAG, V35, P261, DOI 10.1016/0378-1127(90)90007-X; Koepke DF, 2010, OECOLOGIA, V163, P1079, DOI 10.1007/s00442-010-1671-8; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lloret F, 2004, GLOBAL CHANGE BIOL, V10, P2092, DOI 10.1111/j.1365-2486.2004.00870.x; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Lloret F, 2011, OIKOS, V120, P1909, DOI 10.1111/j.1600-0706.2011.19372.x; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Mutke S, 2003, ANN FOREST SCI, V60, P527, DOI 10.1051/forest:2003046; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; PRUSGLOWACKI W, 1994, SILVAE GENET, V43, P7; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Richter S, 2012, OECOLOGIA, V169, P269, DOI 10.1007/s00442-011-2191-x; Royce EB, 2001, AM J BOT, V88, P919, DOI 10.2307/2657045; Slik JWF, 2004, OECOLOGIA, V141, P114, DOI 10.1007/s00442-004-1635-y; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thabeet A, 2009, TREES-STRUCT FUNCT, V23, P843, DOI 10.1007/s00468-009-0326-z; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Willms J, 1998, TREES-STRUCT FUNCT, V12, P215, DOI 10.1007/s004680050143; Zamora R, 2001, FOREST ECOL MANAG, V144, P33, DOI 10.1016/S0378-1127(00)00362-5; Zweifel R, 2009, J VEG SCI, V20, P442, DOI 10.1111/j.1654-1103.2009.05701.x	58	39	40	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87842	10.1371/journal.pone.0087842	http://dx.doi.org/10.1371/journal.pone.0087842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489971	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000153
J	Hojland, DH; Jensen, KMV; Kristensen, M				Hojland, Dorte H.; Jensen, Karl-Martin Vagn; Kristensen, Michael			Adaptation of Musca domestica L. Field Population to Laboratory Breeding Causes Transcriptional Alterations	PLOS ONE			English	Article							RESISTANT HOUSE-FLIES; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; CROSS-RESISTANCE; DROSOPHILA; GENES; P450; EXPRESSION; EVOLUTION; GENETICS	Background: The housefly, Musca domestica, has developed resistance to most insecticides applied for its control. Expression of genes coding for detoxification enzymes play a role in the response of the housefly when encountered by a xenobiotic. The highest level of constitutive gene expression of nine P450 genes was previously found in a newly-collected susceptible field population in comparison to three insecticide-resistant laboratory strains and a laboratory reference strain. Results: We compared gene expression of five P450s by qPCR as well as global gene expression by RNAseq in the newly-acquired field population (845b) in generation F-1, F-13 and F-29 to test how gene expression changes following laboratory adaption. Four (CYP6A1, CYP6A36, CYP6D3, CYP6G4) of five investigated P450 genes adapted to breeding by decreasing expression. CYP6D1 showed higher female expression in F-29 than in F-1. For males, about half of the genes accessed in the global gene expression were up-regulated in F-13 and F-29 in comparison with the F-1 population. In females, 60% of the genes were up-regulated in F-13 in comparison with F-1, while 33% were up-regulated in F-29. Forty potential P450 genes were identified. In most cases, P450 gene expression was decreased in F-13 flies in comparison with F-1. Gene expression then increased from F-13 to F-29 in males and decreased further in females. Conclusion: The global gene expression changes massively during adaptation to laboratory breeding. In general, global expression decreased as a result of laboratory adaption in males, while female expression was not unidirectional. Expression of P450 genes was in general down-regulated as a result of laboratory adaption. Expression of hexamerin, coding for a storage protein was increased, while gene expression of genes coding for amylases decreased. This suggests a major impact of the surrounding environment on gene response to xenobiotics and genetic composition of housefly strains.	[Hojland, Dorte H.; Jensen, Karl-Martin Vagn; Kristensen, Michael] Aarhus Univ, Dept Agroecol, Aarhus, Denmark	Aarhus University	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Aarhus, Denmark.	michael.kristensen@agrsci.dk	Kristensen, Michael/F-5536-2016; Jensen, Karl-Martin Vagn/E-9756-2016	Kristensen, Michael/0000-0001-7332-3490; Hojland, Dorte H./0000-0002-9758-5783	Danish Agency for Science Technology and Innovation	Danish Agency for Science Technology and Innovation	This work was funded by a mobility stipend to Dorte H Hojland from the Danish Agency for Science Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2001, GENETICS, V157, P667; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Capurro MD, 2000, INSECT MOL BIOL, V9, P169, DOI 10.1046/j.1365-2583.2000.00173.x; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Gao Q, 2012, PESTIC BIOCHEM PHYS, V104, P252, DOI 10.1016/j.pestbp.2012.09.006; Geng Hua, 2004, Acta Genetica Sinica, V31, P1344; Gullan P.J., 2010, INSECTS OUTLINE ENTO; Hojland DH, 2014, PEST MANAG SCI, V70, P1237, DOI 10.1002/ps.3681; KAY MA, 1987, TRENDS GENET, V3, P347, DOI 10.1016/0168-9525(87)90295-2; Keiding J, 1986, VECTOR CONTROL SERIE; Kristensen M, 2004, PEST MANAG SCI, V60, P894, DOI 10.1002/ps.883; Kristensen M, 2008, PEST MANAG SCI, V64, P126, DOI 10.1002/ps.1481; Kristensen M, 2006, PEST MANAG SCI, V62, P738, DOI 10.1002/ps.1231; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; LEE SST, 1989, PESTIC BIOCHEM PHYS, V35, P1, DOI 10.1016/0048-3575(89)90096-5; Markussen MDK, 2012, PEST MANAG SCI, V68, P75, DOI 10.1002/ps.2223; Sawicki R.M., 1987, COMBATING RESISTANCE, P105; Schaub L, 2002, PEST MANAG SCI, V58, P959, DOI 10.1002/ps.561; Scott H.G., 1962, FLIES PUBLIC HLTH IM; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; SHONO T, 1990, J ECON ENTOMOL, V83, P686, DOI 10.1093/jee/83.3.686; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; White NM, 1997, INSECT MOL BIOL, V6, P329, DOI 10.1046/j.1365-2583.1997.00187.x; Zhang ML, 1996, PESTIC BIOCHEM PHYS, V55, P150, DOI 10.1006/pest.1996.0044; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	28	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85965	10.1371/journal.pone.0085965	http://dx.doi.org/10.1371/journal.pone.0085965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489682	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000026
J	Jujo, T; Sakao, S; Tsukahara, M; Kantake, S; Maruoka, M; Tanabe, N; Masuda, M; Tatsumi, K				Jujo, Takayuki; Sakao, Seiichiro; Tsukahara, Masanori; Kantake, Seiji; Maruoka, Miki; Tanabe, Nobuhiro; Masuda, Masahisa; Tatsumi, Koichiro			The Role of Matrix Metalloproteinase in the Intimal Sarcoma-Like Cells Derived from Endarterectomized Tissues from a Chronic Thromboembolic Pulmonary Hypertension Patient	PLOS ONE			English	Article							INHIBITOR BATIMASTAT; PROGENITOR CELLS; TUMOR-GROWTH; INVASION; MT1-MMP; METASTASIS; SPREAD; ARTERY; MODEL; BB-94	Sarcoma-like cells (SCLs) were derived from endarterectomized tissue of a single chronic thromboembolic pulmonary hypertension (CTEPH) patient during incubation of those thrombi at second passage as described at our previous report. These cells had malignant potential, with an increased expression of matrix metalloproteinase-14 (MMP-14), leading to tumor emboli within pulmonary arteries in in vivo studies. The purpose of this study was to perform a more detailed evaluation of the characteristics of SCLs, and to elucidate the role of the increased expression of MMP-14 expression in the growth and death of these cells. In order to elucidate the characteristics of SCLs and to confirm the protein expression of MMP-14, three-dimentional culture, invasion assays, a Western blot analysis and immunohistochemical studies were performed. To examine the role of MMP-14 in tumorigenesis, the metalloproteinase inhibitor, batimastat, was administered to SCID mice which were subcutaneously injected with SCLs. Those mice were sacrificed on day 14 and the tumor volume was evaluated. A Western blot analysis showed the increased expression of MMP-14 in comparison to the expression in lung adenocarcinoma cells (A549). Immunohistochemistry showed that SCLs were positive for vimentin, MMP-14, MMP-2 and CD44. However, endothelial markers, such as CD31 and von Willebrand factor (vWF), were negative. The in vivo studies demonstrated that batimastat could suppress the growth of the subcutaneous tumors formed by the SCLs. This study suggested that MMPs had critical roles on the pathological activities of SCLs and that batimastat might have anti-proliferative and anti-invasive effects on these cells.	[Jujo, Takayuki; Sakao, Seiichiro; Tsukahara, Masanori; Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol B2, Inohana Chuo Ku, Chiba, Japan; [Kantake, Seiji] Kimitsu Chuo Hosp, Kisarazu City, Japan; [Maruoka, Miki] Natl Hosp Org, Chiba Med Ctr, Chuo Ku, Chiba, Japan; [Masuda, Masahisa] Natl Hosp Org, Chiba Med Ctr, Chuo Ku, Chiba, Japan	Chiba University	Jujo, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol B2, Inohana Chuo Ku, Chiba, Japan.	naikamo_resp19184@yahoo.co.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Cardiovascular Research Fund; Research Grants for the Respiratory Failure Research Group; Ministry of Health, Labour and Welfare, Japan [24-57]; Takeda Science Foundation	Cardiovascular Research Fund; Research Grants for the Respiratory Failure Research Group; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	Takayuki Jujo was supported by The Cardiovascular Research Fund. Seiichiro Sakao was supported by Research Grants for the Respiratory Failure Research Group and the Cardiovascular Diseases (24-57) from the Ministry of Health, Labour and Welfare, Japan and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN NH, 1973, JOHNS HOPKINS MED J, V133, P214; Bloomberg RD, 2003, CAN J CARDIOL, V19, P843; Botos I, 1996, P NATL ACAD SCI USA, V93, P2749, DOI 10.1073/pnas.93.7.2749; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; CHIRIVI RGS, 1994, INT J CANCER, V58, P460, DOI 10.1002/ijc.2910580326; DAVIES B, 1993, CANCER RES, V53, P2087; Doyle C, 2006, CA-CANCER J CLIN, V56, P323, DOI 10.3322/canjclin.56.6.323; Firth AL, 2010, AM J PHYSIOL-CELL PH, V298, pC1217, DOI 10.1152/ajpcell.00416.2009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jujo T, 2012, INT J ONCOL, V41, P701, DOI 10.3892/ijo.2012.1493; Kadono Y, 1998, BIOCHEM BIOPH RES CO, V251, P681, DOI 10.1006/bbrc.1998.9531; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; SLEDGE GW, 1995, J NATL CANCER I, V87, P1546, DOI 10.1093/jnci/87.20.1546; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Ueda J, 2003, ONCOGENE, V22, P8716, DOI 10.1038/sj.onc.1206962; Vasuri F, 2012, HISTOPATHOLOGY, V61, P737, DOI 10.1111/j.1365-2559.2012.04241.x; WANG X, 1994, CANCER RES, V54, P4726; WATSON SA, 1995, CANCER RES, V55, P3629; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yao WJ, 2009, AM J PHYSIOL-LUNG C, V296, pL870, DOI 10.1152/ajplung.90413.2008; Zervos EE, 1997, J SURG RES, V69, P367, DOI 10.1006/jsre.1997.5086	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87489	10.1371/journal.pone.0087489	http://dx.doi.org/10.1371/journal.pone.0087489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489925	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000138
J	Kwon, YD; LaLonde, JM; Yang, YP; Elban, MA; Sugawara, A; Courter, JR; Jones, DM; Smith, AB; Debnath, AK; Kwong, PD				Kwon, Young Do; LaLonde, Judith M.; Yang, Yongping; Elban, Mark A.; Sugawara, Akihiro; Courter, Joel R.; Jones, David M.; Smith, Amos B., III; Debnath, Asim K.; Kwong, Peter D.			Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; STRUCTURE-BASED DESIGN; CD4-MIMETIC MINIPROTEIN; ANTIVIRAL ACTIVITY; ENTRY INHIBITORS; X-RAY; RECEPTOR; CCR5; BINDING; MECHANISM	Efforts to develop therapeutic agents that inhibit HIV-1 entry have led to the identification of several small molecule leads. One of the most promising is the NBD series, which binds within a conserved gp120 cavity and possesses para-halogen substituted aromatic rings, a central oxalamide linker, and a tetramethylpiperidine moiety. In this study, we characterized structurally the interactions of four NBD analogues containing meta-fluoro substitution on the aromatic ring and various heterocyclic ring replacements of the tetramethylpiperidine group. The addition of a meta-fluorine to the aromatic ring improved surface complementarity and did not alter the position of the analogue relative to gp120. By contrast, heterocyclic ring replacements of the tetramethylpiperidine moiety exhibited diverse positioning and interactions with the vestibule of the gp120 cavity. Overall, the biological profile of NBD-congeners was modulated by ligand interactions with the gp120-cavity vestibule. Herein, six co-crystal structures of NBD-analogues with gp120 provide a structural framework for continued small molecule-entry inhibitor optimization.	[Kwon, Young Do; Yang, Yongping; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [LaLonde, Judith M.] Bryn Mawr Coll, Dept Chem, Bryn Mawr, PA 19010 USA; [Elban, Mark A.; Sugawara, Akihiro; Courter, Joel R.; Jones, David M.; Smith, Amos B., III] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Debnath, Asim K.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Mol Modeling & Drug Design, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Bryn Mawr College; University of Pennsylvania; New York Blood Center	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Sugawara, Akihiro/G-6120-2017; Do Kwon, Young/A-6957-2010	Sugawara, Akihiro/0000-0003-1266-7497; Do Kwon, Young/0000-0002-1188-7458	Intramural AIDS Targeted Antiviral Program; Intramural Research Program of the National Institutes of Health (NIH); NIH [GM 56550]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this work was provided by the Intramural AIDS Targeted Antiviral Program, by the Intramural Research Program of the National Institutes of Health (NIH), and by NIH GM 56550 to JL and ABS. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2013, STRUCTURE, V21, P1018, DOI 10.1016/j.str.2013.04.015; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Billick E, 2004, J VIROL, V78, P4134, DOI 10.1128/JVI.78.8.4134-4144.2004; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Curreli F, 2012, J MED CHEM, V55, P4764, DOI 10.1021/jm3002247; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lalezari JP, 2003, AIDS, V17, P691, DOI 10.1097/00002030-200303280-00007; LaLonde JM, 2013, ACS MED CHEM LETT, V4, P338, DOI 10.1021/ml300407y; LaLonde JM, 2012, J MED CHEM, V55, P4382, DOI 10.1021/jm300265j; LaLonde JM, 2011, BIOORGAN MED CHEM, V19, P91, DOI 10.1016/j.bmc.2010.11.049; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Morellato-Castillo L, 2013, J MED CHEM, V56, P5033, DOI 10.1021/jm4002988; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Stricher F, 2008, J MOL BIOL, V382, P510, DOI 10.1016/j.jmb.2008.06.069; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Tuzer F, 2013, PROTEINS, V81, P271, DOI 10.1002/prot.24184; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yoshimura K, 2010, J VIROL, V84, P7558, DOI 10.1128/JVI.00227-10; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008	39	37	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85940	10.1371/journal.pone.0085940	http://dx.doi.org/10.1371/journal.pone.0085940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489681	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000025
J	Diamant, E; Lachmi, BE; Keren, A; Barnea, A; Marcus, H; Cohen, S; Ben David, A; Zichel, R				Diamant, Eran; Lachmi, Bat-El; Keren, Adi; Barnea, Ada; Marcus, Hadar; Cohen, Shoshana; Ben David, Alon; Zichel, Ran			Evaluating the Synergistic Neutralizing Effect of Anti-Botulinum Oligoclonal Antibody Preparations	PLOS ONE			English	Article							MOUSE MONOCLONAL-ANTIBODIES; DOMAIN-BASED ASSAYS; NEUROTOXIN TYPE-A; IMMUNE-COMPLEXES; HIGH-AFFINITY; TOXIN; BINDING; SEQUENCE; IMMUNOASSAY; SEROTYPE	Botulinum neurotoxins (BoNT) are considered some of the most lethal known substances. There are seven botulinum serotypes, of which types A, B and E cause most human botulism cases. Anti-botulinum polyclonal antibodies (PAbs) are currently used for both detection and treatment of the disease. However, significant improvements in immunoassay specificity and treatment safety may be made using monoclonal antibodies (MAbs). In this study, we present an approach for the simultaneous generation of highly specific and neutralizing MAbs against botulinum serotypes A, B, and E in a single process. The approach relies on immunization of mice with a trivalent mixture of recombinant C-terminal fragment (Hc) of each of the three neurotoxins, followed by a parallel differential robotic hybridoma screening. This strategy enabled the cloning of seven to nine MAbs against each serotype. The majority of the MAbs possessed higher anti-botulinum ELISA titers than anti-botulinum PAbs and had up to five orders of magnitude greater specificity. When tested for their potency in mice, neutralizing MAbs were obtained for all three serotypes and protected against toxin doses of 10 MsLD50-500 MsLD50. A strong synergistic effect of up to 400-fold enhancement in the neutralizing activity was observed when serotype-specific MAbs were combined. Furthermore, the highly protective oligoclonal combinations were as potent as a horse-derived PAb pharmaceutical preparation. Interestingly, MAbs that failed to demonstrate individual neutralizing activity were observed to make a significant contribution to the synergistic effect in the oligoclonal preparation. Together, the trivalent immunization strategy and differential screening approach enabled us to generate highly specific MAbs against each of the A, B, and E BoNTs. These new MAbs may possess diagnostic and therapeutic potential.	[Diamant, Eran; Keren, Adi; Barnea, Ada; Marcus, Hadar; Cohen, Shoshana; Ben David, Alon; Zichel, Ran] Israel Inst Biol Res, Dept Biotechnol, IL-70450 Ness Ziona, Israel; [Lachmi, Bat-El] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Zichel, R (corresponding author), Israel Inst Biol Res, Dept Biotechnol, IL-70450 Ness Ziona, Israel.	ranz@iibr.gov.il			Israel Institute for Biological Research [SB/5122-89]	Israel Institute for Biological Research	This work was funded by Israel Institute for Biological Research grant SB/5122-89. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasova SG, 2011, RUSS J BIOORG CHEM+, V37, P307, DOI 10.1134/S1068162011030022; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Atassi MZ, 1999, CRIT REV IMMUNOL, V19, P219; Atassi MZ, 1996, J PROTEIN CHEM, V15, P691, DOI 10.1007/BF01886751; BINZ T, 1990, J BIOL CHEM, V265, P9153; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Brown DR, 1997, HYBRIDOMA, V16, P447, DOI 10.1089/hyb.1997.16.447; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Chiarella P, 2008, BIOTECHNOL LETT, V30, P1303, DOI 10.1007/s10529-008-9706-5; Chiarella P, 2011, BIOTECHNOL PROGR, V27, P571, DOI 10.1002/btpr.564; Chow SK, 2012, TOXINS, V4, P430, DOI 10.3390/toxins4060430; CLAYTON MA, 1995, INFECT IMMUN, V63, P2738, DOI 10.1128/IAI.63.7.2738-2742.1995; Corbett CR, 2007, J IMMUNOL METHODS, V328, P128, DOI 10.1016/j.jim.2007.08.017; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; EP, 2011, EUROPEAN PHARMACOPOE, V949; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Gessler F, 2005, APPL ENVIRON MICROB, V71, P7897, DOI 10.1128/AEM.71.12.7897-7903.2005; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Guglielmo-Viret V, 2005, J IMMUNOL METHODS, V301, P164, DOI 10.1016/j.jim.2005.04.003; Hatheway C.L., 1988, LAB DIAGNOSIS INFECT, P111; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Liu YYB, 2012, ANAL BIOCHEM, V425, P28, DOI 10.1016/j.ab.2012.02.038; Lovdal T, 2000, J CELL SCI, V113, P3255; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Mazor O, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P275, DOI 10.1007/978-90-481-9054-6_30; MELLING J, 1988, EYE, V2, P16, DOI 10.1038/eye.1988.5; Meng Q, 2012, ANAL BIOCHEM, V430, P141, DOI 10.1016/j.ab.2012.08.005; Meng Q, 2012, ANAL BIOCHEM, V421, P351, DOI 10.1016/j.ab.2011.09.030; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pless DD, 2001, INFECT IMMUN, V69, P570, DOI 10.1128/IAI.69.1.570-574.2001; Prigent J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013245; Ravichandran E, 2007, INFECT IMMUN, V75, P3043, DOI 10.1128/IAI.01893-06; SHONE C, 1985, APPL ENVIRON MICROB, V50, P63, DOI 10.1128/AEM.50.1.63-67.1985; Smith LA, 2007, CRIT REV IMMUNOL, V27, P303, DOI 10.1615/CritRevImmunol.v27.i4.20; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Sugiyama H, 1980, MICROBIOL REV, V44; Teshima G, 2011, J CHROMATOGR A, V1218, P2091, DOI 10.1016/j.chroma.2010.10.107; VOLK WA, 1984, INFECT IMMUN, V45, P604, DOI 10.1128/IAI.45.3.604-609.1984; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006; WHELAN SM, 1992, EUR J BIOCHEM, V204, P657, DOI 10.1111/j.1432-1033.1992.tb16679.x; WHELAN SM, 1992, APPL ENVIRON MICROB, V58, P2345, DOI 10.1128/AEM.58.8.2345-2354.1992; Yang GH, 2004, TOXICON, V44, P19, DOI 10.1016/j.toxicon.2004.03.016; Yu YZ, 2010, BIOCHIMIE, V92, P1315, DOI 10.1016/j.biochi.2010.06.010; Zhao HY, 2012, JPN J INFECT DIS, V65, P138; Zichel R, 2010, CLIN VACCINE IMMUNOL, V17, P784, DOI 10.1128/CVI.00496-09; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001	54	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87089	10.1371/journal.pone.0087089	http://dx.doi.org/10.1371/journal.pone.0087089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475231	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300138
J	Garcia, DE; Keasling, JD				Garcia, David E.; Keasling, Jay D.			Kinetics of Phosphomevalonate Kinase from Saccharomyces cerevisiae	PLOS ONE			English	Article							MEVALONATE PATHWAY; ISOPENTENYL DIPHOSPHATE; ADVANCED BIOFUELS; ESCHERICHIA-COLI; IDENTIFICATION; BIOSYNTHESIS; MECHANISM; RESIDUES; SYNTHASE; ENZYME	The mevalonate-based isoprenoid biosynthetic pathway is responsible for producing cholesterol in humans and is used commercially to produce drugs, chemicals, and fuels. Heterologous expression of this pathway in Escherichia coli has enabled high-level production of the antimalarial drug artemisinin and the proposed biofuel bisabolane. Understanding the kinetics of the enzymes in the biosynthetic pathway is critical to optimize the pathway for high flux. We have characterized the kinetic parameters of phosphomevalonate kinase (PMK, EC 2.7.4.2) from Saccharomyces cerevisiae, a previously unstudied enzyme. An E. coli codon-optimized version of the S. cerevisiae gene was cloned into pET-52b+, then the C-terminal 6X His-tagged protein was expressed in E. coli BL21(DE3) and purified on a Ni2+ column. The K-M of the ATP binding site was determined to be 98.3 mu M at 30 degrees C, the optimal growth temperature for S. cerevisiae, and 74.3 mu M at 37 degrees C, the optimal growth temperature for E. coli. The K-M of the mevalonate-5-phosphate binding site was determined to be 885 mu M at 30 degrees C and 880 mu M at 37 degrees C. The V-max was determined to be 4.51 mu mol/min/mg enzyme at 30 degrees C and 5.33 mu mol/min/mg enzyme at 37 degrees C. PMK is Mg2+ dependent, with maximal activity achieved at concentrations of 10 mM or greater. Maximum activity was observed at pH = 7.2. PMK was not found to be substrate inhibited, nor feedback inhibited by FPP at concentrations up to 10 mu M FPP.	[Garcia, David E.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Garcia, David E.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Garcia, David E.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	Joint BioEnergy Institute (JBEI); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	Joint BioEnergy Institute (JBEI)(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was funded by the Joint BioEnergy Institute (JBEI), which is funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, under contract number DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MS, 1989, J BIOL CHEM, V264, P19169; Andreassi JL, 2009, BIOCHEMISTRY-US, V48, P6461, DOI 10.1021/bi900537u; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Chou HH, 2011, HOST CELLS METHODS P; Doun SS, 2005, PROTEIN SCI, V14, P1134, DOI 10.1110/ps.041210405; Eyzaguirre J, 2006, ARCH BIOCHEM BIOPHYS, V454, P189, DOI 10.1016/j.abb.2006.08.002; Herdendorf TJ, 2006, BIOCHEMISTRY-US, V45, P3235, DOI 10.1021/bi052231u; Krepkiy D, 2004, ABSTR PAP AM CHEM S, V228, pU187; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Kuzuyama T, 2012, P JPN ACAD B-PHYS, V88, P41, DOI 10.2183/pjab.88.41; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Ma SM, 2011, METAB ENG, V13, P588, DOI 10.1016/j.ymben.2011.07.001; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; MIDDLETON B, 1972, BIOCHEM J, V126, P35, DOI 10.1042/bj1260035; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Singh P, 2012, PROTEOMICS, V12, P1289, DOI 10.1002/pmic.201100482; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	26	11	15	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87112	10.1371/journal.pone.0087112	http://dx.doi.org/10.1371/journal.pone.0087112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475236	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300143
J	Massilamany, C; Gangaplara, A; Jia, T; Elowsky, C; Kang, GB; Riethoven, JJ; Li, QS; Zhou, Y; Reddy, J				Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Jia, Ting; Elowsky, Christian; Kang, Guobin; Riethoven, Jean-Jack; Li, Qingsheng; Zhou, You; Reddy, Jay			Direct Staining with Major Histocompatibility Complex Class II Dextramers Permits Detection of Antigen-Specific, Autoreactive CD4 T Cells In Situ	PLOS ONE			English	Article							MYELIN PROTEOLIPID PROTEIN; HEAVY CHAIN-ALPHA; CUTTING EDGE; A/J MICE; MHC; TETRAMERS; IDENTIFICATION; MYOCARDITIS; ACTIVATION; VISUALIZATION	We report here the utility of major histocompatibility complex (MHC) class II dextramers for in situ detection of self-reactive CD4 T cells in two target organs, the brain and heart. We optimized the conditions for in situ detection of antigen-specific CD4 T cells using brain sections obtained from SJL mice immunized with myelin proteolipid protein (PLP) 139-151; the sections were costained with IA(s)/PLP 139-151 (specific) or Theiler's murine encephalomyelitis virus (TMEV) 70-86 (control) dextramers and anti-CD4. Analysis of sections by laser scanning confocal microscope revealed detection of cells positive for PLP 139-151 but not for TMEV 70-86 dextramers to be colocalized with CD4-expressing T cells, indicating that the staining was specific to PLP 139-151 dextramers. Further, we devised a method to reliably enumerate the frequencies of antigen-specific T cells by counting the number of dextramer(+) CD4(+) T cells in the 'Z' serial images acquired sequentially. We next extended these observations to detect cardiac myosin-specific T cells in autoimmune myocarditis induced in A/J mice by immunizing with cardiac myosin heavy chain-alpha (Myhc) 334-352. Heart sections prepared from immunized mice were costained with Myhc 334-352 (specific) or bovine ribonuclease 43-56 (control) dextramers together with anti-CD4; the sections showed the infiltrations of Myhc-specific CD4 T cells. The data suggest that MHC class II dextramers are useful tools for enumerating the frequencies of antigen-specific CD4 T cells in situ by direct staining without having to amplify the fluorescent signals, an approach commonly employed with conventional MHC tetramers.	[Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Jia, Ting; Reddy, Jay] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Elowsky, Christian; Riethoven, Jean-Jack; Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Kang, Guobin; Li, Qingsheng] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Kang, Guobin; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Reddy, J (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	nreddy2@unl.edu	Massilamany, Chandirasegaran/D-9305-2016; Reddy, Jay/K-7200-2014; Gangaplara, Arunakumar/K-5922-2019	Massilamany, Chandirasegaran/0000-0002-0205-282X; Reddy, Jay/0000-0003-4082-9254; Gangaplara, Arunakumar/0000-0001-6307-9391; Riethoven, Jean-Jack/0000-0002-2709-7880	American Heart Association; Children's Cardiomyopathy Foundation [SDG2462390204001]; National Institutes of Health [HL114669]; Myocarditis Foundation, NJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Children's Cardiomyopathy Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myocarditis Foundation, NJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Heart Association and the Children's Cardiomyopathy Foundation (SDG2462390204001), and the National Institutes of Health (HL114669). CM is a recipient of a postdoctoral research fellowship grant awarded by the Myocarditis Foundation, NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Batard P, 2006, J IMMUNOL METHODS, V310, P136, DOI 10.1016/j.jim.2006.01.006; Buckner JH, 2002, J ALLERGY CLIN IMMUN, V110, P199, DOI 10.1067/mai.2002.125976; Cameron TO, 2001, J IMMUNOL, V166, P741, DOI 10.4049/jimmunol.166.2.741; Carneiro Jorge, 2009, V514, P95, DOI 10.1007/978-1-60327-527-9_7; Cecconi V, 2008, CYTOM PART A, V73A, P1010, DOI 10.1002/cyto.a.20603; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; DONERMEYER DL, 1995, J EXP MED, V182, P1291, DOI 10.1084/jem.182.5.1291; Ferlin W, 2000, CURR OPIN IMMUNOL, V12, P670, DOI 10.1016/S0952-7915(00)00161-8; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; Helms T, 2000, J IMMUNOL, V164, P3723, DOI 10.4049/jimmunol.164.7.3723; Kwok WW, 2002, J IMMUNOL METHODS, V268, P71, DOI 10.1016/S0022-1759(02)00201-6; Landais E, 2009, J IMMUNOL, V183, P7949, DOI 10.4049/jimmunol.0902493; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; LIAO L, 1993, J CLIN INVEST, V92, P2877, DOI 10.1172/JCI116909; Mallone R, 2004, CLIN IMMUNOL, V110, P232, DOI 10.1016/j.clim.2003.11.004; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; Massilamany C, 2011, CELL IMMUNOL, V271, P438, DOI 10.1016/j.cellimm.2011.08.013; Massilamany C, 2011, J IMMUNOL METHODS, V372, P107, DOI 10.1016/j.jim.2011.07.004; Massilamany C, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-40; Massilamany C, 2010, J NEUROIMMUNOL, V219, P17, DOI 10.1016/j.jneuroim.2009.11.006; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Novak EJ, 2001, INT IMMUNOL, V13, P799, DOI 10.1093/intimm/13.6.799; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Reddy J, 2003, J IMMUNOL, V170, P870, DOI 10.4049/jimmunol.170.2.870; Skinner P. J., 2004, CURR PROTOC IMMUNOL; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Skinner PJ, 2002, J IMMUNOL METHODS, V268, P29, DOI 10.1016/S0022-1759(02)00197-7; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Vollers SS, 2008, IMMUNOLOGY, V123, P305, DOI 10.1111/j.1365-2567.2007.02801.x; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x	33	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87519	10.1371/journal.pone.0087519	http://dx.doi.org/10.1371/journal.pone.0087519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475302	Green Published, gold			2022-12-25	WOS:000330507300196
J	Schneider, L				Schneider, Leonid			Survival of Neural Stem Cells Undergoing DNA Damage-Induced Astrocytic Differentiation in Self-Renewal-Promoting Conditions In Vitro	PLOS ONE			English	Article								We recently reported that neural stem cells (NSCs) become senescent and commit to astrocytic differentiation upon X-ray irradiation. Surprisingly, under self-renewing culture conditions, some of these senescent cells undergo p53-independent apoptosis, which can be suppressed by caspase inhibition and BCL2 overexpression. Inhibition of apoptosis proved beneficial for astroglial differentiation efficiency; hence the toxicity of DNA damage on NSCs was specifically tested in context of the culture conditions. In this regard, self-renewal-promoting culture conditions proved incompatible with terminal astrocyte differentiation and impacted negatively on the viability of NSCs following DNA damage-induced cell cycle exit. On the contrary, a switch to differentiation-supporting conditions ablated apoptosis and conveyed tolerance to DNA damage. Thus, stem cell death has likely not originated from DNA break toxicity, while the potentially confounding effect of stem cell niche should always be taken in consideration in stem cell irradiation experiments.	[Schneider, Leonid] IFOM Fdn, Milan, Italy; [Schneider, Leonid] Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany	IFOM - FIRC Institute of Molecular Oncology; Technical University of Darmstadt	Schneider, L (corresponding author), IFOM Fdn, Milan, Italy.	leonid.schneider@gmail.com	Schneider, Leonid/H-3275-2013	Schneider, Leonid/0000-0002-6204-9470	IFOM Foundation; IFOM-IEO-Campus facilities (Milan, Italy)	IFOM Foundation; IFOM-IEO-Campus facilities (Milan, Italy)	The author thanks Dr. Fabrizio d'Adda di Fagagna and the IFOM Foundation as well as IFOM-IEO-Campus facilities (Milan, Italy) for financing, help and support associated with this project.	Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fukuda H, 2004, CELL DEATH DIFFER, V11, P1166, DOI 10.1038/sj.cdd.4401472; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129; Schneider L, 2013, STEM CELL REPORTS, V1; Spiliotopoulos D, 2009, NEUROBIOL DIS, V34, P320, DOI 10.1016/j.nbd.2009.02.007; Taga T, 2005, CLIN REV ALLERG IMMU, V28, P249, DOI 10.1385/CRIAI:28:3:249; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	15	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87228	10.1371/journal.pone.0087228	http://dx.doi.org/10.1371/journal.pone.0087228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475256	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300157
J	Subasinghe, AK; Walker, KZ; Evans, RG; Srikanth, V; Arabshahi, S; Kartik, K; Kalyanram, K; Thrift, AG				Subasinghe, Asvini K.; Walker, Karen Z.; Evans, Roger G.; Srikanth, Velandai; Arabshahi, Simin; Kartik, Kamakshi; Kalyanram, Kartik; Thrift, Amanda G.			Association between Farming and Chronic Energy Deficiency in Rural South India	PLOS ONE			English	Article							HOOKWORM INFECTION; PREGNANT-WOMEN; RISK-FACTORS; NORTH-INDIA; PREVALENCE; ANEMIA; HYPERTENSION; CHILDREN; POPULATION; FOOD	Objective: To examine factors associated with chronic energy deficiency (CED) and anaemia in disadvantaged Indian adults who are mostly involved in subsistence farming. Design: A cross-sectional study in which we collected information on socio-demographic factors, physical activity, anthropometry, blood haemoglobin concentration, and daily household food intake. These data were used to calculate body mass index (BMI), basal metabolic rate (BMR), daily energy expenditure, and energy and nutrient intake. Multivariable backward stepwise logistic regression was used to assess socioeconomic and lifestyle factors associated with CED (defined as BMI<18 kg/m(2)) and anaemia. Setting: The study was conducted in 12 villages, in the Rishi Valley, Andhra Pradesh, India. Subjects: Individuals aged 18 years and above, residing in the 12 villages, were eligible to participate. Results: Data were available for 1178 individuals (45% male, median age 36 years (inter quartile range (IQR 27-50)). The prevalence of CED (38%) and anaemia (25%) was high. Farming was associated with CED in women (2.20, 95% CI: 1.39-3.49) and men (1.71, 95% CI: (1.06-2.74). Low income was also significantly associated with CED, while not completing high school was positively associated with anaemia. Median iron intake was high: 35.7 mg/day (IQR 26-46) in women and 43.4 mg/day (IQR 34-55) in men. Conclusions: Farming is an important risk factor associated with CED in this rural Indian population and low dietary iron is not the main cause of anaemia. Better farming practice may help to reduce CED in this population.	[Subasinghe, Asvini K.; Srikanth, Velandai; Arabshahi, Simin; Thrift, Amanda G.] Monash Univ, Dept Med, Monash Med Ctr, Southern Clin Sch, Melbourne, Vic 3004, Australia; [Walker, Karen Z.] Monash Univ, Dept Nutr & Dietet, Melbourne, Vic 3004, Australia; [Evans, Roger G.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Kartik, Kamakshi; Kalyanram, Kartik] Rishi Valley Rural Hlth Ctr, Bangalore, Andhra Pradesh, India; [Thrift, Amanda G.] Florey Neurosci Inst, Melbourne, Vic, Australia	Monash University; Monash University; Monash University; Florey Institute of Neuroscience & Mental Health	Subasinghe, AK (corresponding author), Monash Univ, Dept Med, Monash Med Ctr, Southern Clin Sch, Melbourne, Vic 3004, Australia.	asvini.subasinghe@monash.edu	Evans, Roger/N-8580-2019; Thrift, Amanda/I-6251-2012; Arabshahi, Simin/I-1991-2013	Evans, Roger/0000-0002-9241-0757; Thrift, Amanda/0000-0001-8533-4170; Srikanth, Velandai/0000-0002-8442-8981; Arabshahi, Simin/0000-0001-9381-2291	NHMRC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	A.G.T. and R.G.E. were supported by fellowships from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LT, 2003, PUBLIC HEALTH NUTR, V6, P131, DOI 10.1079/PHN2002367; [Anonymous], INT J PUBLIC HLTH; [Anonymous], USDA NAT NUTR DAT ST; [Anonymous], NUTR REQ REC THEOR A; [Anonymous], MALN DAT MAPP PROV I; [Anonymous], 2002, DIET NUTR STAT RUR P; [Anonymous], FOOD COMPOSITION TRA; [Anonymous], ADDR FOOD INS PROTR; [Anonymous], 2006, DIET NUTR STAT POP P; [Anonymous], DATABASE IRON DEFICI; [Anonymous], 2008, WORLDW PREV AN 1993; Arlappa N., 2009, Journal of Nutrition for the Elderly, V28, P301, DOI 10.1080/01639360903140338; Chakraborty R, 2009, HOMO, V60, P45, DOI 10.1016/j.jchb.2008.06.007; Dongre AR, 2011, FOOD NUTR BULL, V32, P315, DOI 10.1177/156482651103200402; Fiedler JL, 2012, FOOD NUTR BULL, V33, pS170, DOI 10.1177/15648265120333S205; GRIMM RH, 1985, ARCH INTERN MED, V145, P1191, DOI 10.1001/archinte.145.7.1191; Gulati A, 2012, FOOD NUTR BULL, V33, P74, DOI 10.1177/156482651203300108; GUPTA R, 1994, J HUM HYPERTENS, V8, P823; He FJ, 2012, REV PANAM SALUD PUBL, V32, P293, DOI 10.1590/S1020-49892012001000008; Iwaoka H, 2001, J NUTR SCI VITAMINOL, V47, P222, DOI 10.3177/jnsv.47.222; Malhotra P, 1999, J HUM HYPERTENS, V13, P467, DOI 10.1038/sj.jhh.1000864; Meshram II, 2011, ANN HUM BIOL, V38, P93, DOI 10.3109/03014460.2010.498387; Misra A, 2009, J Assoc Physicians India, V57, P163; Nair KM, 2009, INDIAN J MED RES, V130, P634; NATARAJAN VS, 1993, AGE AGEING, V22, P103, DOI 10.1093/ageing/22.2.103; Panwar B, 1998, INT J FOOD SCI NUTR, V49, P243, DOI 10.3109/09637489809086418; Pasricha SR, 2012, PATHOLOGY, V44, P139, DOI 10.1097/PAT.0b013e32834e8291; Pasricha SR, 2010, J PAEDIATR CHILD H, V46, P497, DOI 10.1111/j.1440-1754.2010.01839.x; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Rao S, 2011, PUBLIC HEALTH NUTR, V14, P365, DOI 10.1017/S1368980010002776; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Singh RB, 1997, CORONARY ARTERY DIS, V8, P463, DOI 10.1097/00019501-199707000-00009; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; SRINIVASAN V, 1987, T ROY SOC TROP MED H, V81, P973, DOI 10.1016/0035-9203(87)90369-5; Thrift AG, 2011, J HYPERTENS, V29, P443, DOI 10.1097/HJH.0b013e328341888c; Vedantam A, 2010, PUBLIC HEALTH NUTR, V13, P1328, DOI 10.1017/S1368980009991674; WHO, 2001, IRON DEFICIENCY ANAE	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87423	10.1371/journal.pone.0087423	http://dx.doi.org/10.1371/journal.pone.0087423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475286	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300181
J	Yang, YZ; Tan, BC				Yang, Yan-Zhuo; Tan, Bao-Cai			A Distal ABA Responsive Element in AtNCED3 Promoter Is Required for Positive Feedback Regulation of ABA Biosynthesis in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE GENE; MOLYBDENUM COFACTOR SULFURASE; OSMOTIC-STRESS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; ALDEHYDE OXIDASE; KEY ENZYME; G-BOX; EXPRESSION	The plant hormone abscisic acid (ABA) plays a crucial role in plant development and responses to abiotic stresses. Recent studies indicate that a positive feedback regulation by ABA exists in ABA biosynthesis in plants under dehydration stress. To understand the molecular basis of this regulation, we analyzed the cis-elements of the AtNCED3 promoter in Arabidopsis. AtNCED3 encodes the first committed and highly regulated dioxygenase in the ABA biosynthetic pathway. Through delineated and mutagenesis analyses in stable-transformed Arabidopsis, we revealed that a distal ABA responsive element (ABRE: GGCACGTG, -2372 to -2364 bp) is required for ABA-induced AtNCED3 expression. By analyzing the AtNCED3 expression in ABRE binding protein ABF3 over-expression transgenic plants and knock-out mutants, we provide evidence that the ABA feedback regulation of AtNCED3 expression is not mediated by ABF3.	[Yang, Yan-Zhuo; Tan, Bao-Cai] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Inst Plant Mol Biol & Agr Biotechnol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Tan, BC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Inst Plant Mol Biol & Agr Biotechnol, Shatin, Hong Kong, Peoples R China.	bctan@cuhk.edu.hk			Research Grants Council of the Hong Kong Special Administrative Region [473512, 473611]; National Natural Science Foundation of China [31170298]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region to B.-C.T. (Project no. 473512 and 473611), and a grant from the National Natural Science Foundation of China to B.-C.T. (Project no. 31170298). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-69; Babak B, 2013, DNA RES, V20, P315, DOI 10.1093/dnares/dst012; Bang SW, 2013, PLANTA, V237, P211, DOI 10.1007/s00425-012-1764-1; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Cao XY, 2007, PLANT PHYSIOL, V143, P720, DOI 10.1104/pp.106.091454; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DONALD RGK, 1990, EMBO J, V9, P1717, DOI 10.1002/j.1460-2075.1990.tb08295.x; Endo A, 2008, PLANT PHYSIOL, V147, P1984, DOI 10.1104/pp.108.116632; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liang JH, 2009, BIOSCI BIOTECH BIOCH, V73, P2103, DOI 10.1271/bbb.90133; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; MASON HS, 1993, PLANT CELL, V5, P241, DOI 10.1105/tpc.5.3.241; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; QIN XF, 1994, PLANT CELL, V6, P863, DOI 10.1105/tpc.6.6.863; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; SHEN QX, 1995, PLANT CELL, V7, P295, DOI 10.1105/tpc.7.3.295; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang ZY, 2011, PLANT CELL, V23, P1971, DOI 10.1105/tpc.110.081943; Woo DH, 2011, J PLANT PHYSIOL, V168, P140, DOI 10.1016/j.jplph.2010.06.006; WRIGHT STC, 1969, NATURE, V224, P719, DOI 10.1038/224719a0; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	59	18	19	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87283	10.1371/journal.pone.0087283	http://dx.doi.org/10.1371/journal.pone.0087283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475264	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300162
J	Berry, R; Headey, SJ; Call, MJ; McCluskey, J; Tregaskes, CA; Kaufman, J; Koh, R; Scanlon, MJ; Call, ME; Rossjohn, J				Berry, Richard; Headey, Stephen J.; Call, Melissa J.; McCluskey, James; Tregaskes, Clive A.; Kaufman, Jim; Koh, Ruide; Scanlon, Martin J.; Call, Matthew E.; Rossjohn, Jamie			Structure of the Chicken CD3 epsilon delta/gamma Heterodimer and Its Assembly with the alpha beta T Cell Receptor*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Immunology; Protein Assembly; Protein Evolution; Protein Structure	INDUCED CONFORMATIONAL-CHANGE; ANTIGEN RECEPTOR; SURFACE EXPRESSION; CRYSTAL-STRUCTURE; TYROSINE KINASE; CD3-GAMMA CHAIN; ZETA-CHAIN; COMPLEX; TCR; CD3-EPSILON-GAMMA	Background: Chickens possess a CD3/ chain that assembles with T cell receptor to mediate immune signaling. Results: Chicken CD3E/ has an atypical heterodimer interface and surface but associates with TCR. Conclusion: Chicken CD3/ represents a hybrid chain possessing features in common with human CD3 and CD3. Significance: Understanding the ancestral TCR signaling complex provides insights into the evolution of this signaling apparatus. In mammals, the T cell receptor (TCR) signaling complex is composed of a TCR heterodimer that is noncovalently coupled to three dimeric signaling molecules, CD3E, CD3E, and CD3. The nature of the TCR signaling complex and subunit arrangement in different species remains unclear however. Here we present a structural and biochemical analysis of the more primitive ancestral form of the TCR signaling complex found in chickens. In contrast to mammals, chickens do not express separate CD3 and CD3 chains but instead encode a single hybrid chain, termed CD3/, that is capable of pairing with CD3E. The NMR structure of the chicken CD3E/ heterodimer revealed a unique dimer interface that results in a heterodimer with considerable deviation from the distinct side-by-side architecture found in human and murine CD3E and CD3E. The chicken CD3E/ heterodimer also contains a unique molecular surface, with the vast majority of surface-exposed, nonconserved residues being clustered to a single face of the heterodimer. Using an in vitro biochemical assay, we demonstrate that CD3E/ can assemble with both chicken TCR and TCR via conserved polar transmembrane sites. Moreover, analogous to the human TCR signaling complex, the presence of two copies of CD3E/ is required for assembly. These data provide insight into the evolution of this critical receptor signaling apparatus.	[Berry, Richard; Koh, Ruide; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Headey, Stephen J.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Call, Melissa J.; Call, Matthew E.] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia; [Call, Melissa J.; Call, Matthew E.] Univ Melbourne, Parkville, Vic 3010, Australia; [McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Tregaskes, Clive A.; Kaufman, Jim] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Cambridge; Cardiff University	Call, ME (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia.	mecall@wehi.edu.au; Jamie.rossjohn@monash.edu	Call, Melissa/HHZ-6671-2022; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013	Call, Melissa/0000-0001-7684-5841; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Scanlon, Martin/0000-0002-9230-7506; Call, Matthew/0000-0001-5846-6469; berry, richard/0000-0001-7043-0469; Kaufman, Jim/0000-0002-7216-8422; Headey, Stephen/0000-0001-8015-7064	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); ARC; VESKI; NHMRC Australia	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); VESKI; NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council (ARC) grant.; Supported by an National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship.; Supported by an ARC Future Fellowship.; Supported by a VESKI Innovation Fellowship and an ARC Queen Elizabeth II Fellowship (QEII) Fellowship. To whom correspondence may be addressed. Tel.: 61-3-9345-2306; Fax: 61-3-9345-2686; E-mail: mecall@wehi.edu.au.; Supported by an NHMRC Australia Fellowship. To whom correspondence may be addressed. Tel.: 61-3-9902-9236; Fax: 61-3-9905-4699; E-mail: Jamie.rossjohn@monash.edu.	AKIYAMA Y, 1974, BIKEN J, V17, P105; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BERNOT A, 1991, P NATL ACAD SCI USA, V88, P2550, DOI 10.1073/pnas.88.6.2550; Berry R, 2011, TRENDS IMMUNOL, V32, P165, DOI 10.1016/j.it.2011.01.007; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BRENNER MB, 1985, CELL, V40, P183, DOI 10.1016/0092-8674(85)90321-6; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Chen W, 2013, IMMUNOL REV, V256, P160, DOI 10.1111/imr.12122; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Dunstone MA, 2004, ACTA CRYSTALLOGR D, V60, P1425, DOI 10.1107/S0907444904012041; Eckle SBG, 2013, CURR OPIN IMMUNOL, V25, P653, DOI 10.1016/j.coi.2013.07.010; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gobel TWF, 1998, J IMMUNOL, V160, P1552; Gobel TWF, 2000, J IMMUNOL, V164, P879, DOI 10.4049/jimmunol.164.2.879; Gouaillard C, 2001, EUR J IMMUNOL, V31, P3798, DOI 10.1002/1521-4141(200112)31:12<3798::AID-IMMU3798>3.0.CO;2-Z; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hayes SM, 2006, J EXP MED, V203, P47, DOI 10.1084/jem.20051886; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Kim ST, 2010, J IMMUNOL, V185, P2951, DOI 10.4049/jimmunol.1000732; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Laird DJ, 2000, P NATL ACAD SCI USA, V97, P6924, DOI 10.1073/pnas.97.13.6924; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Siegers GM, 2007, J EXP MED, V204, P2537, DOI 10.1084/jem.20070782; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; TJOELKER LW, 1990, P NATL ACAD SCI USA, V87, P7856, DOI 10.1073/pnas.87.20.7856; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200	55	11	12	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8240	8251		10.1074/jbc.M113.544965	http://dx.doi.org/10.1074/jbc.M113.544965			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24488493	hybrid, Green Published			2022-12-25	WOS:000333157500019
J	Kach, J; Sandbo, N; La, J; Denner, D; Reed, EB; Akimova, O; Koltsova, S; Orlov, SN; Dulin, NO				Kach, Jacob; Sandbo, Nathan; La, Jennifer; Denner, Darcy; Reed, Eleanor B.; Akimova, Olga; Koltsova, Svetlana; Orlov, Sergei N.; Dulin, Nickolai O.			Antifibrotic Effects of Noscapine through Activation of Prostaglandin E-2 Receptors and Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibrosis; Microtubules; Myofibroblast; Prostaglandins; Protein Kinase A (PKA); Noscapine; SRF; Stress Fibers	IDIOPATHIC PULMONARY-FIBROSIS; SERUM RESPONSE FACTOR; GROWTH-FACTOR-BETA; MYOFIBROBLAST DIFFERENTIATION; MICROTUBULE DYNAMICS; LUNG FIBROBLASTS; GENE-EXPRESSION; CYCLOOXYGENASE-2-DEFICIENT MICE; OVARIAN-CANCER; H-3 NOSCAPINE	Background: Noscapine is a safe orally available anticough medicine also known to bind microtubules and induce cancer cell death. Results: Noscapine inhibits myofibroblast differentiation and pulmonary fibrosis through prostaglandin receptors and activation of PKA. Conclusion: Noscapine is an antifibrotic drug acting through PKA activation via EP2 prostaglandin receptors. Significance: This study describes a novel antifibrotic function and novel mechanism of action of noscapine. Myofibroblast differentiation is a key process in the pathogenesis of fibrotic disease. We have shown previously that differentiation of myofibroblasts is regulated by microtubule polymerization state. In this work, we examined the potential antifibrotic effects of the antitussive drug, noscapine, recently found to bind microtubules and affect microtubule dynamics. Noscapine inhibited TGF--induced differentiation of cultured human lung fibroblasts (HLFs). Therapeutic noscapine treatment resulted in a significant attenuation of pulmonary fibrosis in the bleomycin model of the disease. Noscapine did not affect gross microtubule content in HLFs, but inhibited TGF--induced stress fiber formation and activation of serum response factor without affecting Smad signaling. Furthermore, noscapine stimulated a rapid and profound activation of protein kinase A (PKA), which mediated the antifibrotic effect of noscapine in HLFs, as assessed with the PKA inhibitor, PKI. In contrast, noscapine did not activate PKA in human bronchial or alveolar epithelial cells. Finally, activation of PKA and the antifibrotic effect of noscapine in HLFs were blocked by the EP2 prostaglandin E-2 receptor antagonist, PF-04418948, but not by the antagonists of EP4, prostaglandin D-2, or prostacyclin receptors. Together, we demonstrate for the first time the antifibrotic effect of noscapine in vitro and in vivo, and we describe a novel mechanism of noscapine action through EP2 prostaglandin E-2 receptor-mediated activation of PKA in pulmonary fibroblasts.	[Kach, Jacob; La, Jennifer; Denner, Darcy; Reed, Eleanor B.; Dulin, Nickolai O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sandbo, Nathan] Univ Wisconsin, Dept Med, Madison, WI 53792 USA; [Akimova, Olga; Koltsova, Svetlana; Orlov, Sergei N.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia	University of Chicago; University of Wisconsin System; University of Wisconsin Madison; Lomonosov Moscow State University	Dulin, NO (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave,MC6076, Chicago, IL 60637 USA.	ndulin@medicine.bsd.uchicago.edu	Akimova, Olga/I-2669-2014		National Institutes of Health [R01 GM85058, K08 HL093367-01A1, T32HL007237]; American Heart Association [10PRE4190120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093367, T32HL007237, T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM85058 (to N. O. D), K08 HL093367-01A1 (to N. S.), and T32HL007237 (to J. K.). This work was also supported by American Heart Association Fellowship 10PRE4190120 (to J. K.).	Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004; Aneja R, 2006, BIOORGAN MED CHEM, V14, P8352, DOI 10.1016/j.bmc.2006.09.012; Aneja R, 2006, MOL PHARMACOL, V69, P1801, DOI 10.1124/mol.105.021899; Ayabe S, 2013, J PHARMACOL SCI, V121, P312, DOI 10.1254/jphs.12275FP; Barken I, 2008, ANTICANCER RES, V28, P3701; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; EMPEY DW, 1979, EUR J CLIN PHARMACOL, V16, P393, DOI 10.1007/BF00568199; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Kach J, 2013, AM J PHYSIOL-LUNG C, V304, pL757, DOI 10.1152/ajplung.00262.2012; KAMEI J, 1993, EUR J PHARMACOL, V242, P209, DOI 10.1016/0014-2999(93)90083-T; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; KARLSSON MO, 1990, EUR J CLIN PHARMACOL, V39, P275, DOI 10.1007/BF00315110; KARLSSON MO, 1988, EUR J PHARMACOL, V145, P195, DOI 10.1016/0014-2999(88)90230-0; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Landen JW, 2002, CANCER RES, V62, P4109; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MOUREY RJ, 1992, MOL PHARMACOL, V42, P619; Noble PW, 2005, AM J RESP CELL MOL, V33, P113, DOI 10.1165/rcmb.F301; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Petkova DK, 2003, HISTOPATHOLOGY, V43, P381, DOI 10.1046/j.1365-2559.2003.01718.x; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Sandbo N, 2013, J BIOL CHEM, V288, P15466, DOI 10.1074/jbc.M113.464461; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taurin S, 2007, J BIOL CHEM, V282, P19518, DOI 10.1074/jbc.M702655200; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; White ES, 2003, J PATHOL, V201, P343, DOI 10.1002/path.1446; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; Zhu YJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-34	49	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7505	7513		10.1074/jbc.M113.546812	http://dx.doi.org/10.1074/jbc.M113.546812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492608	hybrid, Green Published			2022-12-25	WOS:000332761500021
J	Park, H; Dovas, A; Hanna, S; Lastrucci, C; Cougoule, C; Guiet, R; Maridonneau-Parini, I; Cox, D				Park, Haein; Dovas, Athanassios; Hanna, Samer; Lastrucci, Claire; Cougoule, Celine; Guiet, Romain; Maridonneau-Parini, Isabelle; Cox, Dianne			Tyrosine Phosphorylation of Wiskott-Aldrich Syndrome Protein (WASP) by Hck Regulates Macrophage Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemotaxis; Extracellular Matrix; Invasion; Nonreceptor Tyrosine Kinase; Phagocytosis; Hck; Macrophage; WASP	SRC-FAMILY KINASES; RECEPTOR-MEDIATED PHAGOCYTOSIS; DIFFERENTIAL INVOLVEMENT; 3-DIMENSIONAL MIGRATION; ACTIN REORGANIZATION; PLASMA-MEMBRANE; CELL MIGRATION; PARACRINE LOOP; TUMOR-CELLS; ACTIVATION	Background: Tyrosine phosphorylation of WASP is required for macrophage functions. Results: WASP phosphorylation is dependent on the Src tyrosine kinase Hck. Conclusion: Hck is the predominant kinase that phosphorylates WASP in cells and is required for WASP-dependent functions. Significance: Although many tyrosine kinases can phosphorylate WASP, Hck appears to be the predominant kinase to phosphorylate WASP in macrophages in response to physiological ligands. We have shown previously that tyrosine phosphorylation of Wiskott-Aldrich syndrome protein (WASP) is important for diverse macrophage functions including phagocytosis, chemotaxis, podosome dynamics, and matrix degradation. However, the specific tyrosine kinase mediating WASP phosphorylation is still unclear. Here, we provide evidence that Hck, which is predominantly expressed in leukocytes, can tyrosine phosphorylate WASP and regulates WASP-mediated macrophage functions. We demonstrate that tyrosine phosphorylation of WASP in response to stimulation with CX3CL1 or via Fc receptor ligation were severely reduced in Hck(-/-) bone marrow-derived macrophages (BMMs) or in RAW/LR5 macrophages in which Hck expression was silenced using RNA-mediated interference (Hck shRNA). Consistent with reduced WASP tyrosine phosphorylation, phagocytosis, chemotaxis, and matrix degradation are reduced in Hck(-/-) BMMs or Hck shRNA cells. In particular, WASP phosphorylation was primarily mediated by the p61 isoform of Hck. Our studies also show that Hck and WASP are required for passage through a dense three-dimensional matrix and transendothelial migration, suggesting that tyrosine phosphorylation of WASP by Hck may play a role in tissue infiltration of macrophages. Consistent with a role for this pathway in invasion, WASP(-/-) BMMs do not invade into tumor spheroids with the same efficiency as WT BMMs and cells expressing phospho-deficient WASP have reduced ability to promote carcinoma cell invasion. Altogether, our results indicate that tyrosine phosphorylation of WASP by Hck is required for proper macrophage functions.	[Park, Haein; Dovas, Athanassios; Hanna, Samer; Cox, Dianne] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Lastrucci, Claire; Cougoule, Celine; Guiet, Romain; Maridonneau-Parini, Isabelle] CNRS, Inst Pharmacol & Biol Struct, Dept Mech Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Lastrucci, Claire; Cougoule, Celine; Guiet, Romain; Maridonneau-Parini, Isabelle] Univ Toulouse 3, UPS, IPBS, F-31077 Toulouse, France	Yeshiva University; Albert Einstein College of Medicine; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cox, D (corresponding author), 1300 Morris Pk Ave,MRRC306, Bronx, NY 10461 USA.	dianne.cox@einstein.yu.edu	COUGOULE, Céline/ABB-4180-2021; Maridonneau-Parini, Isabelle/F-1985-2011	Maridonneau-Parini, Isabelle/0000-0003-0189-0976; Cox, Dianne/0000-0002-0591-9767	National Institutes of Health [GM071828]; ANR [2010-01301 MigreFlame]; FRM DEQ [20110421312]; European Community [HEALTH-F4-2011-282095-TARKINAID]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); FRM DEQ; European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071828 (to D.C.) and ANR 2010-01301 MigreFlame, FRM DEQ 20110421312, and European Community's seventh framework programme (FP7-2007-2013) under Grant HEALTH-F4-2011-282095-TARKINAID.	Baruzzi A, 2008, CELL MOL LIFE SCI, V65, P2175, DOI 10.1007/s00018-008-8005-6; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Cammer M, 2009, J BIOL CHEM, V284, P23302, DOI 10.1074/jbc.M109.036384; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Carreno S, 2002, J BIOL CHEM, V277, P21007, DOI 10.1074/jbc.M201212200; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cougoule C, 2005, TRAFFIC, V6, P682, DOI 10.1111/j.1600-0854.2005.00307.x; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; Cougoule C, 2010, BLOOD, V115, P1444, DOI 10.1182/blood-2009-04-218735; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Dovas A, 2011, CELL SIGNAL, V23, P1225, DOI 10.1016/j.cellsig.2011.02.004; Dovas Athanassios, 2010, Commun Integr Biol, V3, P101; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Giagulli C, 2006, J IMMUNOL, V177, P604, DOI 10.4049/jimmunol.177.1.604; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Guiet R, 2008, EUR J CELL BIOL, V87, P527, DOI 10.1016/j.ejcb.2008.03.008; Guiet R, 2011, J IMMUNOL, V187, P3806, DOI 10.4049/jimmunol.1101245; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Ishihara D, 2013, CELL REP, V4, P429, DOI 10.1016/j.celrep.2013.07.007; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; LOCK P, 1991, MOL CELL BIOL, V11, P4363, DOI 10.1128/MCB.11.9.4363; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Park H, 2011, J BIOL CHEM, V286, P14762, DOI 10.1074/jbc.M110.185181; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Scholz G, 2000, J BIOL CHEM, V275, P14615, DOI 10.1074/jbc.275.19.14615; Shi YQ, 2009, BIOCHEM CELL BIOL, V87, P207, DOI 10.1139/O08-130; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Stabile H, 2010, BLOOD, V115, P2818, DOI 10.1182/blood-2009-07-235804; Stanley E R, 1997, Methods Mol Biol, V75, P301; Suzuki T, 2000, J IMMUNOL, V165, P473, DOI 10.4049/jimmunol.165.1.473; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verollet C, 2013, FASEB J, V27, P3608, DOI 10.1096/fj.13-232736; Verollet C, 2011, EUR J IMMUNOL, V41, P2805, DOI 10.1002/eji.201141538; Vincent C, 2007, J BIOL CHEM, V282, P19565, DOI 10.1074/jbc.M701501200; Welch H, 1997, J BIOL CHEM, V272, P102; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zhang H, 2006, IMMUNITY, V25, P285, DOI 10.1016/j.immuni.2006.06.014	50	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7897	7906		10.1074/jbc.M113.509497	http://dx.doi.org/10.1074/jbc.M113.509497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482227	Green Published, hybrid			2022-12-25	WOS:000332761500054
J	Amin, L; Azad, MAK; Gausmian, MH; Zulkifli, F				Amin, Latifah; Azad, Md Abul Kalam; Gausmian, Mohd Hanafy; Zulkifli, Faizah			Determinants of Public Attitudes to Genetically Modified Salmon	PLOS ONE			English	Article							MODIFIED FOODS; ETHICAL PERCEPTION; FIT INDEXES; RISK PERCEPTION; BIOTECHNOLOGY; CONSUMER; ACCEPTANCE; KNOWLEDGE; SCIENCE; ISSUES	The objective of this paper is to assess the attitude of Malaysian stakeholders to genetically modified (GM) salmon and to identify the factors that influence their acceptance of GM salmon using a structural equation model. A survey was carried out on 434 representatives from various stakeholder groups in the Klang Valley region of Malaysia. Public attitude towards GM salmon was measured using self-developed questionnaires with seven-point Likert scales. The findings of this study have confirmed that public attitudes towards GM salmon is a complex issue and should be seen as a multi-faceted process. The most important direct predictors for the encouragement of GM salmon are the specific application-linked perceptions about religious acceptability of GM salmon followed by perceived risks and benefits, familiarity, and general promise of modern biotechnology. Encouragement of GM salmon also involves the interplay among other factors such as general concerns of biotechnology, threatening the natural order of things, the need for labeling, the need for patenting, confidence in regulation, and societal values. The research findings can serve as a database that will be useful for understanding the social construct of public attitude towards GM foods in a developing country.	[Amin, Latifah; Azad, Md Abul Kalam; Zulkifli, Faizah] Univ Kebangsaan Malaysia, Ctr Gen Studies, Bangi 43600, Selangor, Malaysia; [Azad, Md Abul Kalam] Khamarbari, Dept Agr Extens, Dhaka, Bangladesh; [Gausmian, Mohd Hanafy] Univ Kebangsaan Malaysia, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Amin, L (corresponding author), Univ Kebangsaan Malaysia, Ctr Gen Studies, Bangi 43600, Selangor, Malaysia.	nilam@ukm.my	abdullah, mohammed azad/ABB-7670-2020	abdullah, mohammed azad/0000-0002-7488-4019	Food Safety and Quality Division, Department of Public Health, Ministry of Health, Malaysia [11JC/010/2006]; Universiti Kebangsaan Malaysia [UKM-AP-CMNB-21-2009/1]	Food Safety and Quality Division, Department of Public Health, Ministry of Health, Malaysia; Universiti Kebangsaan Malaysia	The authors would like to thank the Food Safety and Quality Division, Department of Public Health, Ministry of Health, Malaysia, for supporting this research under the 11JC/010/2006 grant. Additional thanks to the Universiti Kebangsaan Malaysia for the UKM-AP-CMNB-21-2009/1 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni P, 2004, AQUAT SCI, V66, P327, DOI 10.1007/s00027-004-0715-8; Aerni P, 1999, THESIS SWISS FEDERAL; Aiken L. R., 1994, PSYCHOL TESTING ASSE; Amin L., 2007, J PENGAJIAN UMUM, V8, P195; Amin L, 2012, SOCIAL SCI, V7, P502, DOI DOI 10.3923/SSCIENCE.2012.502.509; Amin L, 2006, J PENGAJIAN UMUM, V7, P87; Amin L, 2011, INT J SCI SOC, V2, P1; Amin L, 2011, AFR J BIOTECHNOL, V10, P12469; Amin L, 2011, AFR J BIOTECHNOL, V10, P12457; Amin L, 2011, AFR J BIOTECHNOL, V10, P12435; Amin L, 2011, PUBLIC UNDERST SCI, V20, P674, DOI 10.1177/0963662510369622; Arbuckle JL, 1999, AMOS 4 0 YSERS GUIDE; BABAS, 1999, ETH ASP AGR BIOT; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Batiste JM, 2000, MODELOS ECUACIONES E; Bauer MW, 2009, SCI TECHNOL SOC, V14, P221, DOI 10.1177/097172180901400202; Bauer MW, 2002, PUBLIC UNDERST SCI, V11, P93, DOI 10.1088/0963-6625/11/2/301; Bentler P. M., 2002, EQS 6 STRUCTURAL EQU; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bertolini P, 2003, 7 ICABR INT COS AGR; Blume Y, 2008, BIOTECHNOL BIOTEC EQ, V22, P641, DOI 10.1080/13102818.2008.10817527; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Borcherding K, 1986, NEW DIRECTIONS RES D, P245; Bredahl L, 1999, APPETITE, V33, P343, DOI 10.1006/appe.1999.0267; Bredahl L., 2001, J CONSUMER POLICY, V24, P23, DOI [10.1023/A:1010950406128, DOI 10.1023/A:1010950406128]; BREDAHL L, 1998, CONSUMER POLICY, V21, P251; Bucchi M, 2004, SCIENCE, V304, P1749, DOI 10.1126/science.1095861; Bucchi M, 2002, NATURE, V416, P261, DOI 10.1038/416261a; Bukraba-Rylska I, 2003, GENTICALLY MODIFIED; Byrne B. M., 2001, STRUCTURAL EQUATION; Chen MF, 2007, FOOD QUAL PREFER, V18, P662, DOI 10.1016/j.foodqual.2006.10.002; Chern Wen S., 2002, AgBioForum, V5, P105; Comstock G, 2000, ETHICS GENETICALLY M; Connor M, 2010, SCI COMMUN, V32, P514, DOI 10.1177/1075547009358919; Costa-Font J, 2007, FOOD QUAL PREFER, V18, P173, DOI 10.1016/j.foodqual.2005.09.013; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Cowx IG., 2010, EFSA, V7, p69E, DOI [10.2903/sp.efsa.2010.EN-69, DOI 10.2903/SP.EFSA.2010.EN-69]; Demirci A, 2008, AFR J BIOTECHNOL, V7, P4321; Earle TC, 1995, SOCIAL TRUST COSMOPO; Einsiedel EF, 2000, NAT BIOTECHNOL, V18, P943, DOI 10.1038/79419; Fischhoff B., 2004, PERCEPTION RISK RISK; FISHBEIN M, 1963, HUM RELAT, V16, P233, DOI 10.1177/001872676301600302; Fletcher G L, 1991, Genet Eng (N Y), V13, P331; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Frewer LJ, 1996, FOOD QUAL PREFER, V7, P61, DOI 10.1016/0950-3293(95)00017-8; Frewer LJ, 1998, PESTIC SCI, V52, P388, DOI 10.1002/(SICI)1096-9063(199804)52:4&lt;388::AID-PS740&gt;3.0.CO;2-F; Frewer LJ, 1997, SCI TECHNOL HUM VAL, V22, P98, DOI 10.1177/016224399702200105; Frewer LJ., 1994, BRIT FOOD J, V96, P26, DOI [10.1108/00070709410072562, DOI 10.1108/00070709410072562]; Fritz S., 2003, AgBioForum, V6, P178; Furedi F., 1997, CULTURE FEAR RISK TA; Ganiere P, 2006, J AGR RESOUR ECON, V31, P129; Gaskell G, 2000, NAT BIOTECHNOL, V18, P935, DOI 10.1038/79403; Gaskell G, 2004, RISK ANAL, V24, P185, DOI 10.1111/j.0272-4332.2004.00421.x; Gaskell G, 2003, EUROPEANS BIOTECHNOL; Gath M, 1998, POTENTIAL EFFECTS LA; Ghasemi S, 2013, SCI ENG ETHICS, V19, P1201, DOI 10.1007/s11948-012-9383-6; Glenn LM, 2004, ETHICAL ISSUES GENET; Goos H, 2001, P INT C PERSP COMP E; Gott M, 2004, ATLA-ALTERN LAB ANIM, V32, P391, DOI 10.1177/026119290403201s64; Grimsrud KM, 2002, AM AGR EC ASS ANN M; Grunert K. G., 2003, Innovative Food Science & Emerging Technologies, V4, P435, DOI 10.1016/S1466-8564(03)00035-3; Grunert K.G., 2000, 72 MAPP; Grunert K.G., 2004, INT C RES ADVERTISIN; Grunert KG, 2001, FOOD QUAL PREFER, V12, P527, DOI 10.1016/S0950-3293(01)00049-0; Gursoy D, 2004, ANN TOURISM RES, V31, P495, DOI 10.1016/j.annals.2003.08.008; Gutteling J, 2006, PUBLIC UNDERST SCI, V15, P103, DOI 10.1177/0963662506057479; Hair J.F., 2010, MULTIVARIATE DATA AN, P1; Hair J.F., 2006, MULTIVARIANT DATA AN, V6th; Hair J.F., 1998, PEARSON LOND, V5th; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Haro MN, 2012, FNI REPORT, P1; HARRIS MM, 1990, J MANAGE, V16, P337, DOI 10.1177/014920639001600206; Henseler J, 2012, J ACAD MARKET SCI, V40, P402, DOI 10.1007/s11747-011-0298-6; Herren RV, 2005, INTRO BIOTECHNOLOGY; Hew CL, 1997, CHEM IND-LONDON, P311; Hossain F., 2004, INT J CONSUM STUD, V28, P255, DOI [DOI 10.1111/j.1470-6431.2004.00352.x, 10.1111/ijc.2004.28.issue-310.1111/j.1470-6431.2004.00352.x, DOI 10.1111/IJC.2004.28.ISSUE-310.1111/J.1470-6431.2004.00352.X]; House L., 2004, AgBioForum, V7, P113; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; J/reskog K.G., 1988, LISREL 7 GUIDE PROGR; Joreskog KG., 1986, LISREL 6 ANAL LINEAR; Kaiser M, 2005, REV SCI TECH OIE, V24, P75, DOI 10.20506/rst.24.1.1552; Kamaldeen S, 2000, 17 U GUELPH DEP PLAN; Kelley J, 1995, PUBLIC PERCEPTIONS G; Kiesel K, 2005, AM J AGR ECON, V87, P378, DOI 10.1111/j.1467-8276.2005.00729.x; Kirk SFL, 2002, APPETITE, V38, P189, DOI 10.1006/appe.2001.0478; Kline R.B., 2011, PRINCIPLES PRACTICE, V4th ed., DOI [10.1177/0049124187016001004, DOI 10.1038/156278A0]; Koch K, 1998, C Q RES, V9, P761; Kuznesof S., 1996, British Food Journal, V98, P39, DOI 10.1108/00070709610119874; Lake Research Partners, 2010, ATT FDAS PLAN GEN EN; Leisinger KM, 2007, ANN REV SYNGENTA FDN; Levy J. P, 2003, ANALISIS MULTIVARIAB; Luque T, 2000, TECNICAS ANALISIS DA; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Macer D. R. J., 2000, International Journal of Biotechnology, V2, P313, DOI 10.1504/IJBT.2000.000142; MACER DRJ, 2000, INT J BIOTECHNOLOGY, V3, P116; Margulis C, 2006, ENVIRON HEALTH PERSP, V114, pA146, DOI 10.1289/ehp.114-a146; Marlier E., 1992, Biotechnology in public: a review of recent research., P52; Marlier E, 1993, EUROBAROMETER 39 1 B; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; McLeod C, 2006, SUPER SALMON IND FIS, P17; Menozzi D., 2012, AgBioForum, V15, P276; Ministry of Health Malaysia, 2006, GUID ETH REV CLIN RE; Monroe Jr JC, 1993, STAT PROBLEM SOLVING; Mora C., 2008, FOOD EC ACTA AGR S C, V5, P92, DOI [10.1080/16507540903034907, DOI 10.1080/16507540903034907]; Navin Srivastava, 2011, Biotechnology, V10, P136; Nep S, 2013, SOC NATUR RESOUR, V26, P506, DOI 10.1080/08941920.2012.716904; Nicholas B, 2000, ETHICAL ISSUES GENET; Olesen I, 2011, J AGR ENVIRON ETHIC, V24, P381, DOI 10.1007/s10806-010-9269-z; Pardo R, 2002, J BIOTECHNOL, V98, P9, DOI 10.1016/S0168-1656(02)00082-2; Persley GJ, 1999, APPL BIOTECHNOLOGY C; Pollara Research and Earnscliffe Research and Communications, 2000, PUBL OP RES BIOT ISS; Potrykus I, 2001, PLANT PHYSIOL, V125, P1157, DOI 10.1104/pp.125.3.1157; Priest SH, 2000, NAT BIOTECHNOL, V18, P939, DOI 10.1038/79412; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Qin W, 2006, SCI COMMUN, V28, P243, DOI 10.1177/1075547006294770; Ringle CM, 2012, MIS QUART, V36, pIII; Rogers W.L., 1976, QUALITY AM LIFE PERC; ROHRMANN B, 1994, AUST J PSYCHOL, V46, P150, DOI 10.1080/00049539408259490; Rohrmann B, 1999, RISK PERCEPTION RES; Rowe G, 2004, TRENDS BIOTECHNOL, V22, P107, DOI 10.1016/j.tibtech.2004.01.007; Sandman PeterM., 1987, EPA J, P21, DOI DOI 10.1177/0893318988002002006; Seralini GE, 2007, ARCH ENVIRON CON TOX, V52, P596, DOI 10.1007/s00244-006-0149-5; Sheehy H., 1998, J CONSUMER POLICY, V21, P359; Shrader-Frechette K, 2005, SCI ENG ETHICS, V11, P137, DOI 10.1007/s11948-005-0065-5; Siegrist M, 2000, RISK ANAL, V20, P195, DOI 10.1111/0272-4332.202020; Siegrist M, 1999, J APPL SOC PSYCHOL, V29, P2093, DOI 10.1111/j.1559-1816.1999.tb02297.x; Singh OV, 2006, APPL MICROBIOL BIOT, V71, P598, DOI 10.1007/s00253-006-0449-8; Singh R., 2009, MARKETING REV, V9, P199, DOI [DOI 10.1362/146934709X467767, 10.1362/146934709X467767]; Sjoberg L, 2004, EMBO REP, V5, pS47, DOI 10.1038/sj.embor.7400258; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Smith MD, 2010, SCIENCE, V330, P1052, DOI 10.1126/science.1197769; SPARKS P, 1994, RISK ANAL, V14, P799, DOI 10.1111/j.1539-6924.1994.tb00291.x; Straughan R, 2000, CURR OPIN PLANT BIOL, V3, P163, DOI 10.1016/S1369-5266(99)00056-4; Szczurowska T, 2005, POLES BIOTECHNOLOGY; Taylor SL, 2001, ALLERGY, V56, P64, DOI 10.1034/j.1398-9995.2001.00920.x; The Canadian Trade Commissioner Service, 2006, WELC KIT MAL; Traill W. B., 2006, Acta Agricultura Scandinavica. Section C, Food Economics, V3, P12, DOI 10.1080/16507540600733900; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Uzogara SG, 2000, BIOTECHNOL ADV, V18, P179, DOI 10.1016/S0734-9750(00)00033-1; Verdurme A., 2003, QUAL MARK RES INT J, V6, P95, DOI [10.1108/13522750310470109, DOI 10.1108/13522750310470109]; Wansink B, 2001, AM BEHAV SCI, V44, P1405, DOI 10.1177/00027640121956755; Weil V, 2002, SCI ENG ETHICS, V8, P223, DOI 10.1007/s11948-002-0023-4; Wynne B, 2006, COMMUNITY GENET, V9, P211, DOI 10.1159/000092659	144	32	32	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86174	10.1371/journal.pone.0086174	http://dx.doi.org/10.1371/journal.pone.0086174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489695	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000025
J	Cortes, LK; Scarcelli, JJ; Taron, CH				Cortes, Leslie K.; Scarcelli, John J.; Taron, Christopher H.			Complementation of Essential Yeast GPI Mannosyltransferase Mutations Suggests a Novel Specificity for Certain Trypanosoma and Plasmodium PigB Proteins	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; 4TH MANNOSE; BIOSYNTHESIS; CRUZI; GENES; IDENTIFICATION; GLYCOPROTEIN	The glycosylphosphatidylinositol (GPI) anchor is an essential glycolipid that tethers certain eukaryotic proteins to the cell surface. The core structure of the GPI anchor is remarkably well conserved across evolution and consists of NH2-CH2-CH2-PO4- 6Man alpha 1,2Man alpha 1,6Man alpha 1,4-GlcN alpha 1,6-myo-inositol-PO4-lipid. The glycan portion of this structure may be modified with various side-branching sugars or other compounds that are heterogeneous and differ from organism to organism. One such modification is an alpha(1,2)-linked fourth mannose (Man-IV) that is side-branched to the third mannose (Man-III) of the trimannosyl core. In fungi and mammals, addition of Man-III and Man-IV occurs by two distinct Family 22 alpha(1,2)-mannosyltransferases, Gpi10/PigB and Smp3/PigZ, respectively. However, in the five protozoan parasite genomes we examined, no genes encoding Smp3/PigZ proteins were observed, despite reports of tetramannosyl-GPI structures (Man(4)-GPIs) being produced by some parasites. In this study, we tested the hypothesis that the Gpi10/PigB proteins produced by protozoan parasites have the ability to add both Man-III and Man-IV to GPI precursors. We used yeast genetics to test the in vivo specificity of Gpi10/PigB proteins from several Plasmodium and Trypanosoma species by examining their ability to restore viability to Saccharomyces cerevisiae strains harboring lethal defects in Man-III (gpi10 Delta) or Man-IV (smp3 Delta) addition to GPI precursor lipids. We demonstrate that genes encoding PigB enzymes from T. cruzi, T. congolense and P. falciparum are each capable of separately complementing essential gpi10 Delta and smp3 Delta mutations, while PIGB genes from T. vivax and T. brucei only complement gpi10 Delta. Additionally, we show the ability of T. cruzi PIGB to robustly complement a gpi10 Delta/ smp3 Delta double mutant. Our data suggest that certain Plasmodium and Trypanosoma PigB mannosyltransferases can transfer more than one mannose to GPI precursors in vivo, and suggest a novel biosynthetic mechanism by which Man(4)-GPIs may be synthesized in these organisms.	[Cortes, Leslie K.; Scarcelli, John J.; Taron, Christopher H.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Taron, CH (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	taron@neb.com		Taron, Christopher/0000-0001-8149-4556	New England Biolabs, Inc	New England Biolabs, Inc	This research was privately funded by New England Biolabs, Inc. The funders had no role in experimental design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida IC, 2001, J LEUKOCYTE BIOL, V70, P467; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boutlis CS, 2005, CURR TOP MICROBIOL, V297, P145; BREWIS IA, 1995, J BIOL CHEM, V270, P22946, DOI 10.1074/jbc.270.39.22946; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cardoso MS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002369; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; Delorenzi M, 2002, INFECT IMMUN, V70, P4510, DOI 10.1128/IAI.70.8.4510-4522.2002; Rodriguez AE, 2010, VET PARASITOL, V167, P227, DOI 10.1016/j.vetpar.2009.09.024; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Ferguson MAJ, 2009, ESSENTIALS GLYCOBIOL, V2nd, P143; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grimme SJ, 2001, J BIOL CHEM, V276, P27731, DOI 10.1074/jbc.M101986200; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; SERRANO AA, 1995, J BIOL CHEM, V270, P27244, DOI 10.1074/jbc.270.45.27244; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sutterlin C, 1998, BIOCHEM J, V332, P153; TAGUCHI R, 1994, BIOCHEMISTRY-US, V33, P1017, DOI 10.1021/bi00170a021; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87673	10.1371/journal.pone.0087673	http://dx.doi.org/10.1371/journal.pone.0087673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489949	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000169
J	Han, K; Park, YM; Kwon, HS; Ko, SH; Lee, SH; Yim, HW; Lee, WC; Park, YG; Kim, MK; Park, YM				Han, Kyungdo; Park, Yu-Mi; Kwon, Hyuk-Sang; Ko, Seung-Hyun; Lee, Seung-Hwan; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong Gyu; Kim, Mee Kyoung; Park, Yong-Moon			Sarcopenia as a Determinant of Blood Pressure in Older Koreans: Findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; METABOLIC SYNDROME; ASSOCIATION; OBESITY; HYPERTENSION; PREVALENCE	Background: Blood pressure (BP) is directly and causally associated with body size in the general population. Whether muscle mass is an important factor that determines BP remains unclear. Objective: To investigate whether sarcopenia is associated with hypertension in older Koreans. Participants: We surveyed 2,099 males and 2,747 females aged 60 years or older. Measurements: Sarcopenia was defined as an appendicular skeletal muscle mass divided by body weight (ASM/Wt) that was <1 SD below the gender-specific mean for young adults. Obesity was defined as a body mass index (BMI) >= 25 kg/m(2). Subjects were divided into four groups based on presence or absence of obesity or sarcopenia. Hypertension was defined as a systolic BP (SBP) >= 140 mmHg, a diastolic BP (DBP) >= 90 mmHg, or a self-reported current use of antihypertensive medications. Results: The overall prevalence of hypertension in the four groups was as follows 49.7% for non-obese non-sarcopenia, 60.9% for non-obese sarcopenia, 66.2% for obese non-sarcopenia and 74.7% for obese sarcopenia. After adjustment for age, gender, regular activity, current smoking and alcohol use, the odds ratio (OR) for having hypertension was 1.5 (95% confidence interval (CI) = 1.23-1.84) in subjects in the non-obese sarcopenia group, 2.08 (95% CI = 1.68-2.57) in the obese non-sarcopenia group and 3.0 (95% CI = 2.48-3.63) in the obese sarcopenia group, compared with the non-obese non-sarcopenia group (p for trend <0.001). Controlling further for body weight and waist circumference did not change the association between hypertension and sarcopenia. The association between sarcopenia and hypertension was more robust in the subjects with diabetes mellitus. Conclusion: Body composition beyond BMI has a considerable impact on hypertension in elderly Koreans. Subjects with sarcopenic obesity appear to have a greater risk of hypertension than simply obese or sarcopenia subjects.	[Han, Kyungdo; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Dept Prevent Med, Seoul, South Korea; [Han, Kyungdo; Park, Yong Gyu] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Park, Yu-Mi] Catholic Univ Korea, Sch Med, Seoul, South Korea; [Kwon, Hyuk-Sang; Ko, Seung-Hyun; Lee, Seung-Hwan; Kim, Mee Kyoung] Catholic Univ Korea, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Kim, MK (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	makung@catholic.ac.kr; markYMpark@gmail.com	Lee, Seung-Hwan/C-7568-2018; Lee, Seung-Hwan/AAG-1361-2019; PARK, YONG-MOON ("MARK")/ABA-2765-2021	Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877; PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Park, Yong Gyu/0000-0002-8721-3230				Adams V, 1999, J AM COLL CARDIOL, V33, P959, DOI 10.1016/S0735-1097(98)00626-3; Anker SD, 1997, CIRCULATION, V96, P526; Burton LA, 2011, CLIN ENDOCRINOL, V75, P725, DOI 10.1111/j.1365-2265.2011.04148.x; Cappuccio FP, 2008, EPIDEMIOLOGY, V19, P38, DOI 10.1097/EDE.0b013e31815c4d2c; Chin SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060119; Choi KM, 2003, DIABETIC MED, V20, P99, DOI 10.1046/j.1464-5491.2003.00890.x; Choi KM, 2013, ENDOCRINOL METAB, V28, P86, DOI 10.3803/EnM.2013.28.2.86; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Chokshi NP, 2013, HEART, V99, P577, DOI 10.1136/heartjnl-2012-302029; Dogan MH, 2012, ACTA CLIN BELG, V67, P328, DOI 10.2143/ACB.67.5.2062685; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Kim HA, 2013, DIABETES RES CLIN PR, V99, P54, DOI 10.1016/j.diabres.2012.10.011; Kim MK, 2010, CLIN ENDOCRINOL, V73, P330, DOI 10.1111/j.1365-2265.2010.03798.x; Ko SH, 2012, DIABETES RES CLIN PR, V97, P151, DOI 10.1016/j.diabres.2012.04.004; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Luke A, 2004, HYPERTENSION, V43, P555, DOI 10.1161/01.HYP.0000118020.44335.20; Miller MD, 2002, J AM GERIATR SOC, V50, P1272, DOI 10.1046/j.1532-5415.2002.50316.x; Preedy VR, 2001, EUR J NEUROL, V8, P677, DOI 10.1046/j.1468-1331.2001.00303.x; Primatesta P, 2001, HYPERTENSION, V37, P187, DOI 10.1161/01.HYP.37.2.187; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Snijder MB, 2004, J HYPERTENS, V22, P2339, DOI 10.1097/00004872-200412000-00016; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stellman Steven D., 1996, Yonsei Medical Journal, V37, P31; Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961	27	72	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86902	10.1371/journal.pone.0086902	http://dx.doi.org/10.1371/journal.pone.0086902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489804	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000079
J	Lee, M; Narayanan, S; McGeer, EG; McGeer, PL				Lee, Moonhee; Narayanan, Sujaatha; McGeer, Edith G.; McGeer, Patrick L.			Aurin Tricarboxylic Acid Protects against Red Blood Cell Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinemia	PLOS ONE			English	Article							C9 DEFICIENCY; COMPLEMENT; MUTATION; DISEASE	Objectives: Paroxysmal nocturnal hemoglobinemia (PNH) is a rare but serious condition characterized by complement-mediated red blood cell (RBC) hemolysis and episodic thrombotic attack. It results from decay accelerating factor (CD55), and protectin (CD59), becoming attached to RBC and other cell surfaces. Absence of these protective proteins leaves such cells vulnerable to self attack at the C3 convertase and membrane attack complex (MAC) stages of complement activation. We have previously reported that aurin tricarboxylic acid (ATA) is an orally effective agent that selectively blocks complement activation at the C3 convertase stage as well as MAC formation at the C9 insertion stage. Design and Methods: We used a CH50 assay method and western blot analysis to investigate the vulnerability to complement attack of PNH RBCs compared with normal RBCs. Zymosan was used as the activator of normal serum and PNH serum. ATA was added to the sera to determine the concentration necessary to protect the RBCs from lysis by the zymosan-activated sera. Results: We found that erythrocytes from PNH patients on long term treatment with eculizumab were twice as vulnerable as normal erythrocytes to lysis induced by complement activated serum. Western blot data showed the presence of both C3 and C5 convertases on the PNH patient erythrocyte membranes. These data indicate persistent vulnerability of PNH erythrocytes to complement attack due to deficiencies in CD55 and CD59. ATA, when added to serum in vitro, protected PNH erythrocytes from complement attack, restoring their resistance to that of normal erythrocytes. Conclusions: We conclude that ATA, by protecting PNH erythrocytes from their decay accelerating factor (CD55) and protectin (CD59) deficiencies, may be an effective oral treatment in this disorder.	[Lee, Moonhee; McGeer, Edith G.; McGeer, Patrick L.] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V5Z 1M9, Canada; [Narayanan, Sujaatha] BC Canc Agcy, Vancouver Gen Hosp, Div Hematol, Leukemia BMT Program BC, Vancouver, BC, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	McGeer, PL (corresponding author), Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V5Z 1M9, Canada.	mcgeerpl@mail.ubc.ca			University of British Columbia	University of British Columbia	This work was supported by the University of British Columbia, with the resources directed to be utilized for medical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG C, 1992, J BIOL CHEM, V267, P25347; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Hill A, 2010, HAEMATOL-HEMATOL J, V95, P567, DOI 10.3324/haematol.2009.007229; HOLGUIN MH, 1989, J CLIN INVEST, V84, P1387, DOI 10.1172/JCI114311; Horiuchi T, 1998, J IMMUNOL, V160, P1509; Kang HJ, 2005, ANN CLIN LAB SCI, V35, P144; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Kira R, 1999, J HUM GENET, V44, P109, DOI 10.1007/s100380050119; Lee M, 2012, NEUROBIOL AGING, V34, P1451; Lee M, 2012, NEUROBIOL AGING, V33, P2237, DOI 10.1016/j.neurobiolaging.2011.12.005; Luzzatto L, 2006, CURR OPIN GENET DEV, V16, P317, DOI 10.1016/j.gde.2006.04.015; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; NICHOLSONWELLER A, 1992, CURR TOP MICROBIOL, V178, P7; Parker CJ, 2012, CURR OPIN HEMATOL, V19, P141, DOI 10.1097/MOH.0b013e328351c348; Parker CJ, 2002, BRIT J HAEMATOL, V117, P3; Risitano AM, 2009, BLOOD, V113, P4094, DOI 10.1182/blood-2008-11-189944; TAKAHASHI M, 1993, J EXP MED, V177, P517, DOI 10.1084/jem.177.2.517	19	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87316	10.1371/journal.pone.0087316	http://dx.doi.org/10.1371/journal.pone.0087316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489894	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000131
J	Manns, R; Schmandke, A; Schmandke, A; Jareonsettasin, P; Cook, G; Schwab, ME; Holt, C; Keynes, R				Manns, Richard; Schmandke, Andre; Schmandke, Antonio; Jareonsettasin, Prem; Cook, Geoffrey; Schwab, Martin E.; Holt, Christine; Keynes, Roger			Protein Synthesis Dependence of Growth Cone Collapse Induced by Different Nogo-A-Domains	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; SEMAPHORIN 3A; AXONAL REGENERATION; NEURITE OUTGROWTH; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS; INHIBITION; RECEPTOR; IDENTIFICATION; EXPRESSION	Background: The protein Nogo-A regulates axon growth in the developing and mature nervous system, and this is carried out by two distinct domains in the protein, Nogo-A-Delta 20 and Nogo-66. The differences in the signalling pathways engaged in axon growth cones by these domains are not well characterized, and have been investigated in this study. Methodology/Principal Findings: We analyzed growth cone collapse induced by the Nogo-A domains Nogo-A-Delta 20 and Nogo-66 using explanted chick dorsal root ganglion neurons growing on laminin/poly-lysine substratum. Collapse induced by purified Nogo-A-Delta 20 peptide is dependent on protein synthesis whereas that induced by Nogo-66 peptide is not. Nogo-A-Delta 20-induced collapse is accompanied by a protein synthesis-dependent rise in RhoA expression in the growth cone, but is unaffected by proteasomal catalytic site inhibition. Conversely Nogo-66-induced collapse is inhibited similar to 50% by proteasomal catalytic site inhibition. Conclusion/Significance: Growth cone collapse induced by the Nogo-A domains Nogo-A-Delta 20 and Nogo-66 is mediated by signalling pathways with distinguishable characteristics concerning their dependence on protein synthesis and proteasomal function.	[Manns, Richard; Jareonsettasin, Prem; Cook, Geoffrey; Holt, Christine; Keynes, Roger] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Schmandke, Andre; Schmandke, Antonio; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Schmandke, Andre; Schmandke, Antonio; Schwab, Martin E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	University of Cambridge; University of Zurich; ETH Zurich	Keynes, R (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	rjk10@cam.ac.uk	Schwab, Martin E/B-6818-2016	Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [08534/Z/08/Z]; Trinity College, Cambridge	Wellcome Trust(Wellcome TrustEuropean Commission); Trinity College, Cambridge	The Wellcome Trust (www.wellcome.ac.uk) project grant no. 08534/Z/08/Z. RM was funded by a graduate studentship from Trinity College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Deng KW, 2010, J BIOL CHEM, V285, P6425, DOI 10.1074/jbc.M109.071548; Dickson HM, 2010, J NEUROSCI, V30, P13319, DOI 10.1523/JNEUROSCI.1324-10.2010; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Dontchev VD, 2002, J NEUROSCI, V22, P6659; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gao Y, 2010, STEM CELLS DEV, V19, P53, DOI 10.1089/scd.2008.0357; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Grunewald E, 2009, MOL CELL NEUROSCI, V42, P363, DOI 10.1016/j.mcn.2009.08.007; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Murthy R, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-30; Nangle MR, 2011, BRIT J PHARMACOL, V162, P1083, DOI 10.1111/j.1476-5381.2010.01108.x; Niederost B, 2002, J NEUROSCI, V22, P10368; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Oertle T, 2003, J NEUROSCI, V23, P5393; Peng XM, 2011, J NEUROCHEM, V119, P1183, DOI 10.1111/j.1471-4159.2011.07520.x; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86820	10.1371/journal.pone.0086820	http://dx.doi.org/10.1371/journal.pone.0086820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489789	Green Published, gold, Green Accepted			2022-12-25	WOS:000330570000071
J	Perez-Hedo, M; Rivera-Perez, C; Noriega, FG				Perez-Hedo, Meritxell; Rivera-Perez, Crisalejandra; Noriega, Fernando G.			Starvation Increases Insulin Sensitivity and Reduces Juvenile Hormone Synthesis in Mosquitoes	PLOS ONE			English	Article							FEMALE AEDES-AEGYPTI; CORPORA-ALLATA; NUTRITIONAL REGULATION; OVARIAN DEVELOPMENT; FARNESOIC ACID; LIFE-SPAN; BIOSYNTHESIS; EXPRESSION; DROSOPHILA; PEPTIDES	Background: The interactions between the insulin signaling pathway (ISP) and juvenile hormone (JH) controlling reproductive trade-offs are well documented in insects. JH and insulin regulate reproductive output in mosquitoes; both hormones are involved in a complex regulatory network, in which they influence each other and in which the mosquito's nutritional status is a crucial determinant of the network's output. Previous studies reported that the insulin-TOR (target of rapamacyn) signaling pathway is involved in the nutritional regulation of JH synthesis in female mosquitoes. The present studies further investigate the regulatory circuitry that controls both JH synthesis and reproductive output in response to nutrient availability. Methods: We used a combination of diet restriction, RNA interference (RNAi) and insulin treatments to modify insulin signaling and study the cross-talk between insulin and JH in response to starvation. JH synthesis was analyzed using a newly developed assay utilizing fluorescent tags. Conclusions: Our results reveal that starvation decreased JH synthesis via a decrease in insulin signaling in the corpora allata (CA). Paradoxically, starvation-induced up regulation of insulin receptor transcripts and therefore "primed" the gland to respond rapidly to increases in insulin levels. During this response to starvation the synthetic potential of the CA remained unaffected, and the gland rapidly and efficiently responded to insulin stimulation by increasing JH synthesis to rates similar to those of CA from non-starved females.	[Perez-Hedo, Meritxell; Rivera-Perez, Crisalejandra; Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Noriega, FG (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	noriegaf@fiu.edu	Rivera-Perez, Crisalejandra/AAM-1269-2021; Perez-Hedo, Meritxell/O-6441-2019	Perez-Hedo, Meritxell/0000-0003-3411-0761; Rivera Perez, Crisalejandra/0000-0002-9746-3225	National Institutes of Health (NIH) [AI 45545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI 45545 to FGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badisco L, 2013, FRONTIERS PHYSL, V4, P1; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; BOGGS CL, 1993, ECOLOGY, V74, P433, DOI 10.2307/1939305; Briegel H, 2001, J MED ENTOMOL, V38, P557, DOI 10.1603/0022-2585-38.4.557; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005; Clifton ME, 2011, J INSECT PHYSIOL, V57, P1274, DOI 10.1016/j.jinsphys.2011.06.002; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hattori A, 2013, J EXP ZOOL PART B, V320B, P295, DOI 10.1002/jez.b.22501; Hernandez-Martinez S, 2007, J INSECT PHYSIOL, V53, P230, DOI 10.1016/j.jinsphys.2006.08.009; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Klowden MJ, 1997, ARCH INSECT BIOCHEM, V35, P491, DOI 10.1002/(SICI)1520-6327(1997)35:4<491::AID-ARCH10>3.3.CO;2-5; Li YP, 2006, J BIOL CHEM, V281, P34048, DOI 10.1074/jbc.M606341200; Li YP, 2004, REGUL PEPTIDES, V118, P175, DOI 10.1016/j.regpep.2003.12.004; Li YP, 2003, INSECT BIOCHEM MOLEC, V33, P1307, DOI 10.1016/j.ibmb.2003.07.003; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Libbrecht R, 2013, P NATL ACAD SCI USA, V110, P11050, DOI 10.1073/pnas.1221781110; Maestro JL, 2009, J BIOL CHEM, V284, P5506, DOI 10.1074/jbc.M807042200; Marquez AG, 2011, GEN COMP ENDOCR, V173, P303, DOI 10.1016/j.ygcen.2011.06.005; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Noriega F.G., 1993, Insect Molecular Biology, V2, P21, DOI 10.1111/j.1365-2583.1993.tb00121.x; Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Osawa N, 2005, EUR J ENTOMOL, V102, P503, DOI 10.14411/eje.2005.072; Perez-Hedo M, 2013, INSECT BIOCHEM MOLEC, V43, P495, DOI 10.1016/j.ibmb.2013.03.008; Puig O, 2006, CELL CYCLE, V5, P503, DOI 10.4161/cc.5.5.2501; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Rivera-Perez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043784; Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; SIDDLE K, 2012, FRONT ENDOCRINOL, V3, P1, DOI DOI 10.3389/FEND0.2012.00034; Suren-Castillo S, 2012, INSECT BIOCHEM MOLEC, V42, P491, DOI 10.1016/j.ibmb.2012.03.006; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776	39	29	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86183	10.1371/journal.pone.0086183	http://dx.doi.org/10.1371/journal.pone.0086183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489697	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000027
J	Kim, S; Lee, HG; Park, SA; Kundu, JK; Keum, YS; Cha, YN; Na, HK; Surh, YJ				Kim, Sanghyun; Lee, Hee-Geum; Park, Sin-Aye; Kundu, Joydeb Kumar; Keum, Young-Sam; Cha, Young-Nam; Na, Hye-Kyung; Surh, Young-Joon			Keap1 Cysteine 288 as a Potential Target for Diallyl Trisulfide-Induced Nrf2 Activation	PLOS ONE			English	Article							OXIDATIVE STRESS; HEME OXYGENASE-1; REACTIVE OXYGEN; NAD(P)H-QUINONE OXIDOREDUCTASE-1; GENE-EXPRESSION; CELL-LINE; INDUCTION; ANTIOXIDANT; CANCER; PROTEIN	Diallyl sulfide, diallyl disulfide, and daillyl trisulfide (DATS) are major volatile components of garlic oil. In this study, we assessed their relative potency in inducing antioxidant enzyme expression. Among the three organosulfur compounds, DATS was found to be most potent in inducing heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase-1 (NQO1) in human gastric epithelial (AGS) cells. Furthermore, DATS administration by gavage increased the expression of HO-1 and NQO1 in C57BL/6 mouse stomach. Treatment with DATS increased the accumulation of nuclear factor-erythroid-2-related factor-2 (Nrf2) in the nucleus of cultured AGS cells and in mouse stomach in vivo. The DATS-induced expression of HO-1 and NQO1 was abrogated in the cells transiently transfected with Nrf2-siRNA or in the embryonic fibroblasts from Nrf2-null mice, indicating that Nrf2 is a key mediator of the cytoprotective effects of DATS. Pretreatment of AGS cells with N-acetylcysteine or dithiothreitol attenuated DATS-induced nuclear localization of Nrf2 and the expression of HO-1 and NQO1. Cysteine-151, -273 and -288 of Kelch-like ECH-associated protein-1 (Keap1), a cytosolic repressor of Nrf2, have been considered to act as a redox sensor and play a role in Nrf2 activation. To determine whether DATS could inactivate Keap1 through thiol modification, we established cell lines constitutively expressing wild type-Keap1 or three different mutant constructs in which cysteine-151, -273, or -288 of Keap1 was replaced with serine by retroviral gene transfer. DATS failed to activate Nrf2, and to induce expression of HO-1 and NQO1 only in Keap1-C288S mutant cells. LC-ESI-MS/MS analysis of recombinant Keap1 treated with DATS revealed that the peptide fragment containing Cys288 gained a molecular mass of 72.1 Da equivalent to the molecular weight of mono-allyl mono-sulfide. Taken together, these findings suggest that DATS may directly interact with the Cys288 residue of Keap1, which partly accounts for its ability to induce Nrf2 activation and upregulate defensive gene expression.	[Kim, Sanghyun; Lee, Hee-Geum; Park, Sin-Aye; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Kundu, Joydeb Kumar] Keimyung Univ, Coll Pharm, Taegu, South Korea; [Keum, Young-Sam] Dongguk Univ, Coll Pharm, Ilsan, South Korea; [Cha, Young-Nam] Inha Univ, Coll Med, Inchon, South Korea; [Na, Hye-Kyung] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Surh, Young-Joon] Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Keimyung University; Dongguk University; Inha University; Sungshin Women's University; Seoul National University (SNU); Seoul National University (SNU)	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea.	surh@plaza.snu.ac.kr	Park, Sin-Aye/E-2303-2019	Park, Sin-Aye/0000-0003-2456-3572; Kim, Sanghyun/0000-0001-9519-1994	Global Core Research Center grant from the National Research Foundation, Republic of Korea	Global Core Research Center grant from the National Research Foundation, Republic of Korea	This work was supported by the Global Core Research Center grant from the National Research Foundation, Republic of Korea. The funders have no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bartsch H, 2005, MUTAT RES-FUND MOL M, V591, P34, DOI 10.1016/j.mrfmmm.2005.04.013; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Cobbs CS, 2003, CANCER RES, V63, P8670; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Correa P, 1996, CANCER EPIDEM BIOMAR, V5, P477; Eggler AL, 2007, CHEM RES TOXICOL, V20, P1878, DOI 10.1021/tx700217c; Fisher CD, 2007, DRUG METAB DISPOS, V35, P995, DOI 10.1124/dmd.106.014340; Fukao T, 2004, BIOFACTORS, V21, P171, DOI 10.1002/biof.552210135; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; Hamajima Nobuyuki, 2002, Int J Clin Oncol, V7, P103; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hosono T, 2008, CARCINOGENESIS, V29, P1400, DOI 10.1093/carcin/bgn124; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kong ANT, 2001, DRUG METAB REV, V33, P255, DOI 10.1081/DMR-120000652; Kundu JK, 2010, PHARM RES-DORDR, V27, P999, DOI 10.1007/s11095-010-0096-8; Lee HH, 2010, ARCH BIOCHEM BIOPHYS, V501, P142, DOI 10.1016/j.abb.2010.06.011; Long DJ, 2000, CANCER RES, V60, P5913; Malik MA, 2011, DNA CELL BIOL, V30, P297, DOI 10.1089/dna.2010.1115; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Munday R, 2003, FREE RADICAL BIO MED, V34, P1200, DOI 10.1016/S0891-5849(03)00144-8; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pedraza-Chaverri J, 2003, EUR J PHARMACOL, V473, P71, DOI 10.1016/S0014-2999(03)01948-4; PROCHASKA HJ, 1987, J BIOL CHEM, V262, P1931; PRUTZ WA, 1993, FREE RADICAL RES COM, V18, P159, DOI 10.3109/10715769309147489; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Stewart WC, 2011, OBESITY, V19, P1731, DOI 10.1038/oby.2011.66; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; WARGOVICH MJ, 1988, CANCER RES, V48, P6872; Was H, 2011, FREE RADICAL BIO MED, V51, P1717, DOI 10.1016/j.freeradbiomed.2011.07.025; WEFERS H, 1984, FEBS LETT, V169, P63, DOI 10.1016/0014-5793(84)80290-2; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	46	55	62	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85984	10.1371/journal.pone.0085984	http://dx.doi.org/10.1371/journal.pone.0085984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489685	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000027
J	Sha, K; Choi, SH; Im, J; Lee, GG; Loeffler, F; Park, JH				Sha, Kai; Choi, Seung-Hoon; Im, Jeongdae; Lee, Gyunghee G.; Loeffler, Frank; Park, Jae H.			Regulation of Ethanol-Related Behavior and Ethanol Metabolism by the Corazonin Neurons and Corazonin Receptor in Drosophila melanogaster	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE ALDH; PROTEIN-COUPLED-RECEPTORS; LIVER ALCOHOL-DEHYDROGENASE; NEUROPEPTIDE CORAZONIN; RAT-LIVER; DISULFIRAM TREATMENT; SIGNALING PATHWAY; GROWTH-HORMONE; BOMBYX-MORI; EXPRESSION	Impaired ethanol metabolism can lead to various alcohol-related health problems. Key enzymes in ethanol metabolism are alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH); however, neuroendocrine pathways that regulate the activities of these enzymes are largely unexplored. Here we identified a neuroendocrine system involving Corazonin (Crz) neuropeptide and its receptor (CrzR) as important physiological regulators of ethanol metabolism in Drosophila. Crz-cell deficient (Crz-CD) flies displayed significantly delayed recovery from ethanol-induced sedation that we refer to as hangover-like phenotype. Newly generated mutant lacking Crz Receptor (CrzR(01)) and CrzR-knockdown flies showed even more severe hangover-like phenotype, which is causally associated with fast accumulation of acetaldehyde in the CrzR(01) mutant following ethanol exposure. Higher levels of acetaldehyde are likely due to 30% reduced ALDH activity in the mutants. Moreover, increased ADH activity was found in the CrzR(01) mutant, but not in the Crz-CD flies. Quantitative RT-PCR revealed transcriptional upregulation of Adh gene in the CrzR(01). Transgenic inhibition of cyclic AMP-dependent protein kinase (PKA) also results in significantly increased ADH activity and Adh mRNA levels, indicating PKA-dependent transcriptional regulation of Adh by CrzR. Furthermore, inhibition of PKA or cAMP response element binding protein (CREB) in CrzR cells leads to comparable hangover-like phenotype to the CrzR(01) mutant. These findings suggest that CrzR-associated signaling pathway is critical for ethanol detoxification via Crz-dependent regulation of ALDH activity and Crz-independent transcriptional regulation of ADH. Our study provides new insights into the neuroendocrine-associated ethanol-related behavior and metabolism.	[Sha, Kai; Choi, Seung-Hoon; Lee, Gyunghee G.; Park, Jae H.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Im, Jeongdae; Loeffler, Frank] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Park, Jae H.] Univ Tennessee, Genome Sci Technol, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Park, JH (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	jhpark@utk.edu	Im, Jeongdae/K-8500-2013	Im, Jeongdae/0000-0002-6871-5366; Park, Jae/0000-0002-4846-2197; Lee, Gyunghee/0000-0003-3108-1870	National Science Foundation (NSF) [IOS-0919797, IBN-0133538]; Fite fellowship from BCMB	National Science Foundation (NSF)(National Science Foundation (NSF)); Fite fellowship from BCMB	This work was supported by National Science Foundation (NSF) grants (IOS-0919797, IBN-0133538) (http://www.nsf.gov/) and a Fite fellowship from BCMB (K. S.) (http://web.bio.utk.edu/bcmb/grad/financial_support/advanced.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; BARBANCHO M, 1987, HEREDITY, V58, P443, DOI 10.1038/hdy.1987.73; Boccia S, 2009, CANCER EPIDEM BIOMAR, V18, P248, DOI 10.1158/1055-9965.EPI-08-0462; Broughton SJ, 1996, J CELL BIOCHEM, V60, P584, DOI 10.1002/(SICI)1097-4644(19960315)60:4<584::AID-JCB14>3.0.CO;2-H; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Chen YC, 2009, CHEM-BIOL INTERACT, V178, P2, DOI 10.1016/j.cbi.2008.10.029; CHICK J, 1992, BRIT J PSYCHIAT, V161, P84, DOI 10.1192/bjp.161.1.84; Choi SH, 2009, THESIS TENNESSEE RES; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; Crabb DW, 2001, ALCOHOL CLIN EXP RES, V25, P945, DOI 10.1097/00000374-200107000-00001; Dannenberg LO, 2005, DNA CELL BIOL, V24, P543, DOI 10.1089/dna.2005.24.543; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Fry JD, 2006, GENET RES, V87, P87, DOI 10.1017/S0016672306008032; GIBSON JB, 1981, OECOLOGIA, V51, P191, DOI 10.1007/BF00540600; HEINSTRA PWH, 1989, BIOCHEM J, V259, P791, DOI 10.1042/bj2590791; HILLBOM ME, 1970, BIOCHEM PHARMACOL, V19, P2097, DOI 10.1016/0006-2952(70)90308-4; ISRAEL Y, 1975, J PHARMACOL EXP THER, V192, P565; Isse T, 2002, PHARMACOGENETICS, V12, P621, DOI 10.1097/00008571-200211000-00006; Jelski W, 2008, CLIN CHIM ACTA, V395, P1, DOI 10.1016/j.cca.2008.05.001; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; LEAL JFM, 1993, INSECT BIOCHEM MOLEC, V23, P543, DOI 10.1016/0965-1748(93)90027-P; LEAL JFM, 1992, INSECT BIOCHEM MOLEC, V22, P885, DOI 10.1016/0965-1748(92)90115-U; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee G, 2008, CELL TISSUE RES, V331, P659, DOI 10.1007/s00441-007-0549-5; Lee GG, 2013, J COMP NEUROL, V521, P3972, DOI 10.1002/cne.23387; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClure KD, 2013, J NEUROSCI, V33, P4044, DOI 10.1523/JNEUROSCI.3413-12.2013; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; MEZEY E, 1979, ENDOCRINOLOGY, V104, P1667, DOI 10.1210/endo-104-6-1667; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; MOXON LN, 1985, COMP BIOCHEM PHYS B, V80, P525, DOI 10.1016/0305-0491(85)90285-8; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; POTTER JJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P548, DOI 10.1016/0003-9861(89)90469-4; Rodan AR, 2002, J NEUROSCI, V22, P9490; Seifert R, 2009, MOL PHARMACOL, V75, P13, DOI 10.1124/mol.108.052944; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Sha K, 2012, GENE, V497, P191, DOI 10.1016/j.gene.2012.01.052; Simon FR, 2002, AM J PHYSIOL-GASTR L, V283, pG646, DOI 10.1152/ajpgi.00438.2001; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Song BJ, 2011, J PROTEOMICS, V74, P2691, DOI 10.1016/j.jprot.2011.05.013; Swift R, 1998, ALCOHOL HEALTH RES W, V22, P54; Tanaka Y, 2002, J INSECT PHYSIOL, V48, P707, DOI 10.1016/S0022-1910(02)00094-X; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; WRIGHT C, 1990, AM J MED, V88, P647, DOI 10.1016/0002-9343(90)90534-K; Yang JW, 2013, J BIOL CHEM, V288, P11662, DOI 10.1074/jbc.M112.441675; Yokoyama M, 2005, ALCOHOL CLIN EXP RES, V29, P1165, DOI 10.1097/01.ALC.0000172457.62535.EE; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; YU M, 1994, GENE, V141, P249, DOI 10.1016/0378-1119(94)90580-0; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141	61	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87062	10.1371/journal.pone.0087062	http://dx.doi.org/10.1371/journal.pone.0087062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489834	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000102
J	Zhao, Y; Yu, YB; Tian, XL; Yang, X; Li, XQ; Jiang, F; Chen, YD; Shi, MW				Zhao, Ying; Yu, Yanbo; Tian, Xiaoli; Yang, Xi; Li, Xueqi; Jiang, Feng; Chen, Yundai; Shi, Maowei			Association Study to Evaluate FoxO1 and FoxO3 Gene in CHD in Han Chinese	PLOS ONE			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTORS; CARDIAC-HYPERTROPHY; FORKHEAD; ATHEROSCLEROSIS; LONGEVITY; DYSFUNCTION; MECHANISMS; EXPRESSION	Background: Coronary heart disease (CHD) is one of the leading causes of mortality and morbidity in China. Genetic factors that predispose individuals to CHD are unclear. In the present study, we aimed to determine whether the variation of FoxOs, a novel genetic factor associated with longevity, was associated with CHD in Han Chinese populations. Methods: 1271 CHD patients and 1287 age-and sex-matched controls from Beijing and Harbin were included. We selected four tagging single nucleotide polymorphisms (SNPs) of FoxO1 (rs2755209, rs2721072, rs4325427 and rs17592371) and two tagging SNPs of FoxO3 (rs768023 and rs1268165). And the genotypes of these SNPs were determined in both CHD patients and non-CHD controls. Results: For population from Beijing, four SNPs of FoxO1 and two SNPs of FoxO3 were found not to be associated with CHD (p>0.05). And this was validated in the other population from Harbin (p>0.05). After combining the two geographically isolated case-control populations, the results showed that the six SNPs did not necessarily predispose to CHD in Han Chinese(p>0.05). In stratified analysis according to gender, the history of smoking, hypertension, diabetes mellitus, hyperlipidemia and the metabolic syndrome, we further explored that neither the variants of FoxO1 nor the variants of FoxO3 might be associated with CHD (p>0.05). Conclusion: The variants of FoxO1 and FoxO3 may not increase the prevalence of CHD in Han Chinese population.	[Zhao, Ying; Shi, Maowei] Jinan Mil Gen Hosp, Dept Geriatr, Jinan, Peoples R China; [Yu, Yanbo] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China; [Tian, Xiaoli; Yang, Xi] Peking Univ, Inst Mol Med, Dept Human Populat Genet, Beijing 100871, Peoples R China; [Li, Xueqi; Jiang, Feng] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 4, Harbin, Peoples R China; [Chen, Yundai] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China	Shandong University; Peking University; Harbin Medical University; Chinese People's Liberation Army General Hospital	Chen, YD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China.	ydchen301@163.com; jnshimw@163.com	chen, yundai/I-4353-2019; yu, yanbo/GZM-8474-2022	chen, yundai/0000-0003-2252-8992; Yang, Xi/0000-0002-1154-2919	Beijing Natural Science Foundation [7092099]; National Natural Science Foundation of China [81200270]; scientific research foundation for outstanding young scientist of Shandong Province [BS2012SW012]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research foundation for outstanding young scientist of Shandong Province	This study was supported by Beijing Natural Science Foundation (7092099), National Natural Science Foundation of China (81200270) and the scientific research foundation for outstanding young scientist of Shandong Province (BS2012SW012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Bachschmid MM, 2013, ANN MED, V45, P17, DOI 10.3109/07853890.2011.645498; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Cai DS, 2009, CELL CYCLE, V8, P2542, DOI 10.4161/cc.8.16.9386; Calixto A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003141; Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; Cuaz-Perolin C, 2008, ARTERIOSCL THROM VAS, V28, P272, DOI 10.1161/ATVBAHA.107.155606; Dabek J, 2008, BIOCHEM GENET, V46, P241, DOI 10.1007/s10528-007-9137-3; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Frieri M, 2012, CURR ALLERGY ASTHM R, V12, P25, DOI 10.1007/s11882-011-0236-1; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Iwata H, 2012, CURR ATHEROSCLER REP, V14, P484, DOI 10.1007/s11883-012-0267-7; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kim M, 2012, DIABETES RES CLIN PR, V98, P132, DOI 10.1016/j.diabres.2012.04.013; Kuo CC, 2007, MOL MED, V13, P561, DOI 10.2119/2007-00021.Kuo; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Lytvyn Olena Ivanivna, 2004, Kardiol Pol, V61, P110; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Maiese K, 2009, ADV EXP MED BIOL, V665, P242; Maiese K, 2009, CLIN SCI, V116, P191, DOI 10.1042/CS20080113; Morris JB, 2005, ENDOCRINOLOGY, V146, P4370, DOI 10.1210/en.2005-0162; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; O'Rourke MF, 2007, VASC MED, V12, P329, DOI 10.1177/1358863x07083392; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Peng SL, 2007, AUTOIMMUNITY, V40, P462, DOI 10.1080/08916930701464913; Qiang L, 2012, J BIOL CHEM, V287, P13944, DOI 10.1074/jbc.M111.332767; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Rossouw JE, 2008, ARCH INTERN MED, V168, P2245, DOI 10.1001/archinte.168.20.2245; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Tian Xiao-Li, 2006, V129, P69; Tilstra JS, 2011, AGING DIS, V2, P449; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wassmann S, 2004, HYPERTENSION, V44, P381, DOI 10.1161/01.HYP.0000142232.29764.a7; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yeagley D, 2001, J BIOL CHEM, V276, P33705, DOI 10.1074/jbc.M101215200	53	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86252	10.1371/journal.pone.0086252	http://dx.doi.org/10.1371/journal.pone.0086252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489705	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000038
J	Roignot, J; Bonacci, T; Ghigo, E; Iovanna, JL; Soubeyran, P				Roignot, Julie; Bonacci, Thomas; Ghigo, Eric; Iovanna, Juan L.; Soubeyran, Philippe			Oligomerization and Phosphorylation Dependent Regulation of ArgBP2 Adaptive Capabilities and Associated Functions	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STIMULATED GLUT4 TRANSLOCATION; CELL-MIGRATION; STRESS FIBERS; PROTEIN; VINEXIN; INTERACTS; ADHESION; FAMILY; DOMAIN	ArgBP2 (Arg-Binding Protein 2/SORBS2) is an adaptor protein involved in cytoskeleton associated signal transduction, thereby regulating cell migration and adhesion. These features are associated with its antitumoral role in pancreatic cancer cells. Tyrosine phosphorylation of ArgBP2, mediated by c-Abl kinase and counterbalanced by PTP-PEST phosphatase, regulates many of its interactions. However, the exact mechanisms of action and of regulation of ArgBP2 remain largely unknown. We found that ArgBP2 has the capacity to form oligomers which are destabilized by tyrosine phosphorylation. We could show that ArgBP2 oligomerization involves the binding of one of its SH3 domains to a specific proline rich cluster. ArgBP2 self-association increases its binding to some of its molecular partners and decreased its affinity for others. Hence, the phosphorylation/oligomerization state of ArgBP2 directly regulates its functions by modulating its adaptive capabilities. Importantly, using a human pancreatic cancer cell model (MiaPaCa-2 cells), we could validate that this property of ArgBP2 is critical for its cytoskeleton associated functions. In conclusions, we describe a new mechanism of regulation of ArgBP2 where tyrosine phosphorylation of the protein interfere with a SH3 mediated self-interaction, thereby controlling its panel of interacting partners and related functions.	[Roignot, Julie; Bonacci, Thomas; Iovanna, Juan L.; Soubeyran, Philippe] Aix Marseille Univ, CNRS, UMR 7258, CRCM,INSERM,UMR 1068, Marseille, France; [Roignot, Julie; Bonacci, Thomas; Iovanna, Juan L.; Soubeyran, Philippe] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Ghigo, Eric] Aix Marseille Univ, CNRS, UMR7278, URMITE IRD198,INSERM,U1095, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Soubeyran, P (corresponding author), Aix Marseille Univ, CNRS, UMR 7258, CRCM,INSERM,UMR 1068, Marseille, France.	philippe.soubeyran@inserm.fr	Iovanna, Juan/M-9805-2017; Soubeyran, Philippe/P-1758-2018; Eric, Ghigo/N-9427-2016	Iovanna, Juan/0000-0003-1822-2237; Soubeyran, Philippe/0000-0002-5876-3217	FRM (Fondation pour la recherche medicale)/Institut Lilly fellowship	FRM (Fondation pour la recherche medicale)/Institut Lilly fellowship	This work was supported by a FRM (Fondation pour la recherche medicale)/Institut Lilly fellowship to J.R., and T. B. was a fellow of La Ligue contre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 1999, J BIOL CHEM, V274, P35933, DOI 10.1074/jbc.274.50.35933; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Backsch C, 2011, CARCINOGENESIS, V32, P1100, DOI 10.1093/carcin/bgr093; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Fernow I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-80; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Kioka N, 2010, EXP CELL RES, V316, P1728, DOI 10.1016/j.yexcr.2010.03.019; Martin M, 2013, EMBO J, V32, P2491, DOI 10.1038/emboj.2013.187; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200; Mitsushima M, 2006, GENES CELLS, V11, P971, DOI 10.1111/j.1365-2443.2006.00995.x; Mitsushima M, 2006, FEBS LETT, V580, P4288, DOI 10.1016/j.febslet.2006.06.072; Mizutani K, 2007, ONCOGENE, V26, P7122, DOI 10.1038/sj.onc.1210512; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roignot J, 2010, CANCER LETT, V288, P116, DOI 10.1016/j.canlet.2009.06.030; Roignot J, 2009, CELL ADHES MIGR, V3, P167, DOI 10.4161/cam.3.2.7576; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Soubeyran P, 2003, BIOCHEM J, V370, P29, DOI 10.1042/BJ20021539; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Tujague M, 2004, J BIOL CHEM, V279, P9255, DOI 10.1074/jbc.M312160200; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1074/jbc.M500097200; Zhang M, 2006, EMBO J, V25, P5284, DOI 10.1038/sj.emboj.7601406	36	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87130	10.1371/journal.pone.0087130	http://dx.doi.org/10.1371/journal.pone.0087130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475245	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300148
J	Safren, N; El Ayadi, A; Chang, L; Terrillion, CE; Gould, TD; Boehning, DF; Monteiro, MJ				Safren, Nathaniel; El Ayadi, Amina; Chang, Lydia; Terrillion, Chantelle E.; Gould, Todd D.; Boehning, Darren F.; Monteiro, Mervyn J.			Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MUTANT HUNTINGTIN; ER STRESS; TRANSGENIC MICE; CAG REPEAT; AUTOPHAGY; PROTEINS; IDENTIFICATION; DEGRADATION; UBIQUITIN	Huntington's Disease (HD) is a neurodegenerative disorder that is caused by abnormal expansion of a polyglutamine tract in huntingtin (htt) protein. The expansion leads to increased htt aggregation and toxicity. Factors that aid in the clearance of mutant huntingtin proteins should relieve the toxicity. We previously demonstrated that overexpression of ubiqulin-1, which facilitates protein clearance through the proteasome and autophagy pathways, reduces huntingtin aggregates and toxicity in mammalian cell and invertebrate models of HD. Here we tested whether overexpression of ubiquilin-1 delays or prevents neurodegeneration in R6/2 mice, a well-established model of HD. We generated transgenic mice overexpressing human ubiquilin-1 driven by the neuron-specific Thy1.2 promoter. Immunoblotting and immunohistochemistry revealed robust and widespread overexpression of ubiquilin-1 in the brains of the transgenic mice. Similar analysis of R6/2 animals revealed that ubiquilin is localized in huntingtin aggregates and that ubiquilin levels decrease progressively to 30% during the end-stage of disease. We crossed our ubiquilin-1 transgenic line with R6/2 mice to assess whether restoration of ubiquilin levels would delay HD symptoms and pathology. In the double transgenic progeny, ubiquilin levels were fully restored, and this correlated with a 20% increase in lifespan and a reduction in htt inclusions in the hippocampus and cortex. Furthermore, immunoblots indicated that endoplasmic reticulum stress response that is elevated in the hippocampus of R6/2 animals was attenuated by ubiquilin-1 overexpression. However, ubiquilin-1 overexpression neither altered the load of htt aggregates in the striatum nor improved motor impairments in the mice.	[Safren, Nathaniel; Terrillion, Chantelle E.; Gould, Todd D.; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Neurosci Grad Program, Baltimore, MD 21201 USA; [Safren, Nathaniel; Chang, Lydia; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Safren, Nathaniel; Chang, Lydia; Gould, Todd D.; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [El Ayadi, Amina; Boehning, Darren F.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Terrillion, Chantelle E.; Gould, Todd D.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Gould, Todd D.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Medical Branch Galveston; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Neurosci Grad Program, Baltimore, MD 21201 USA.	monteiro@umaryland.edu	Boehning, Darren/I-8539-2015	Boehning, Darren/0000-0001-7920-6922; El Ayadi, Amina/0000-0002-3657-0633; Safren, Nathaniel/0000-0003-4866-4837				BATES G, 2002, HUNTINGTONS DIS; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Finkbeiner S., 2011, HUNTINGTONS DIS; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Gong B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041450; Gonzalez-Perez P, 2012, NEUROBIOL DIS, V48, P391, DOI 10.1016/j.nbd.2012.06.018; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Li A, 2007, HUM MOL GENET, V16, P2626, DOI 10.1093/hmg/ddm219; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Monteiro MJ, 1996, EXP CELL RES, V223, P443, DOI 10.1006/excr.1996.0100; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Satoh J, 2013, NEUROPATH APPL NEURO, V39, P817, DOI 10.1111/nan.12036; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; STARR R, 1995, J NEUROCHEM, V64, P1860; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HM, 2007, BIOCHEM BIOPH RES CO, V360, P423, DOI 10.1016/j.bbrc.2007.06.097; Weissman Tamily A, 2011, Cold Spring Harb Protoc, V2011, P763, DOI 10.1101/pdb.top114; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; XIAO JS, 1994, J NEUROSCI, V14, P1820, DOI 10.1523/JNEUROSCI.14-03-01820.1994; Yan J, 2013, NEUROLOGY, V80; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	67	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87513	10.1371/journal.pone.0087513	http://dx.doi.org/10.1371/journal.pone.0087513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475300	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300194
J	Steinsiek, S; Stagge, S; Bettenbrock, K				Steinsiek, Sonja; Stagge, Stefan; Bettenbrock, Katja			Analysis of Escherichia coli Mutants with a Linear Respiratory Chain	PLOS ONE			English	Article							CYX-APPA OPERON; OXYGEN AVAILABILITY; 2-COMPONENT SYSTEM; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; MEDIATING REPRESSION; GROWTH-CONDITIONS; REDOX REGULATION; ACETYL-COENZYME; DNA-BINDING	The respiratory chain of E. coli is branched to allow the cells' flexibility to deal with changing environmental conditions. It consists of the NADH: ubiquinone oxidoreductases NADH dehydrogenase I and II, as well as of three terminal oxidases. They differ with respect to energetic efficiency (proton translocation) and their affinity to the different quinone/quinol species and oxygen. In order to analyze the advantages of the branched electron transport chain over a linear one and to assess how usage of the different terminal oxidases determines growth behavior at varying oxygen concentrations, a set of isogenic mutant strains was created, which lack NADH dehydrogenase I as well as two of the terminal oxidases, resulting in strains with a linear respiratory chain. These strains were analyzed in glucose-limited chemostat experiments with defined oxygen supply, adjusting aerobic, anaerobic and different microaerobic conditions. In contrast to the wild-type strain MG1655, the mutant strains produced acetate even under aerobic conditions. Strain TBE032, lacking NADH dehydrogenase I and expressing cytochrome bd-II as sole terminal oxidase, showed the highest acetate formation rate under aerobic conditions. This supports the idea that cytochrome bd-II terminal oxidase is not able to catalyze the efficient oxidation of the quinol pool at higher oxygen conditions, but is functioning mainly under limiting oxygen conditions. Phosphorylation of ArcA, the regulator of the two-component system ArcBA, besides Fnr the main transcription factor for the response towards different oxygen concentrations, was studied. Its phosphorylation pattern was changed in the mutant strains. Dephosphorylation and therefore inactivation of ArcA started at lower aerobiosis levels than in the wild-type strain. Notably, not only the micro-and aerobic metabolism was affected by the mutations, but also the anaerobic metabolism, where the respiratory chain should not be important.	[Steinsiek, Sonja; Stagge, Stefan; Bettenbrock, Katja] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany	Max Planck Society	Bettenbrock, K (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	bettenbrock@mpi-magdeburg.mpg.de	Bettenbrock, Katja/AAN-5812-2020	Stagge, Stefan/0000-0003-4908-0913	BMBF, research program SysMO (Systems Biology of Microorganisms) within the project SUMO (Systems Understanding of Microbial Oxygen response)	BMBF, research program SysMO (Systems Biology of Microorganisms) within the project SUMO (Systems Understanding of Microbial Oxygen response)	Sonja Steinsiek was supported by the BMBF as part of the research program SysMO (Systems Biology of Microorganisms) within the project SUMO (Systems Understanding of Microbial Oxygen response). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Alexeeva S, 2003, J BACTERIOL, V185, P204, DOI 10.1128/JB.185.1.204-209.2003; Alexeeva S, 2000, J BACTERIOL, V182, P4934, DOI 10.1128/JB.182.17.4934-4940.2000; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; ATLUNG T, 1994, J BACTERIOL, V176, P5414, DOI 10.1128/JB.176.17.5414-5422.1994; AU DCT, 1984, J BACTERIOL, V157, P122, DOI 10.1128/JB.157.1.122-125.1984; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker S, 1997, ARCH MICROBIOL, V168, P290, DOI 10.1007/s002030050501; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Bogachev AV, 1996, J BACTERIOL, V178, P6233, DOI 10.1128/jb.178.21.6233-6237.1996; BONGAERTS J, 1995, MOL MICROBIOL, V16, P521, DOI 10.1111/j.1365-2958.1995.tb02416.x; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brondsted L, 1996, J BACTERIOL, V178, P1556, DOI 10.1128/jb.178.6.1556-1564.1996; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; CALHOUN MW, 1993, J BACTERIOL, V175, P3020, DOI 10.1128/JB.175.10.3020-3025.1993; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; DASSA J, 1991, MOL GEN GENET, V229, P341, DOI 10.1007/BF00267454; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Evans C. G. T., 1970, METHODS MICROBIOLOGY, V2, DOI [10.1016/S0580-9517(08)70227-7, DOI 10.1016/S0580-9517(08)70227-7]; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 2009, CHEM PHYS LETT, V477, P340, DOI 10.1016/j.cplett.2009.07.002; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; IUCHI S, 1989, J BACTERIOL, V171, P868, DOI 10.1128/jb.171.2.868-873.1989; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; IUCHI S, 1992, J BACTERIOL, V174, P5617, DOI 10.1128/JB.174.17.5617-5623.1992; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kihira C, 2012, J BIOTECHNOL, V158, P215, DOI 10.1016/j.jbiotec.2011.06.029; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; LAMBDEN PR, 1976, J GEN MICROBIOL, V97, P145, DOI 10.1099/00221287-97-2-145; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MOSS F, 1952, AUST J EXP BIOL MED, V30, P531, DOI 10.1038/icb.1952.51; NEIJSSEL OM, 1994, MOL MICROBIOL, V13, P179, DOI 10.1111/j.1365-2958.1994.tb00413.x; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; RICE CW, 1978, J BACTERIOL, V134, P115, DOI 10.1128/JB.134.1.115-124.1978; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Sharma P, 2012, FEBS J, V279, P3364, DOI 10.1111/j.1742-4658.2012.08608.x; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Steinsiek S, 2011, J BIOTECHNOL, V154, P35, DOI 10.1016/j.jbiotec.2011.03.015; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Unden G, 2008, ESCHERICHIA COLI SAL; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8	59	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87307	10.1371/journal.pone.0087307	http://dx.doi.org/10.1371/journal.pone.0087307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475268	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300165
J	Untergehrer, G; Jordan, D; Kochs, EF; Ilg, R; Schneider, G				Untergehrer, Gisela; Jordan, Denis; Kochs, Eberhard F.; Ilg, Ruediger; Schneider, Gerhard			Fronto-Parietal Connectivity Is a Non-Static Phenomenon with Characteristic Changes during Unconsciousness	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; ANESTHETIC-INDUCED UNCONSCIOUSNESS; FUNCTIONAL CONNECTIVITY; CONSCIOUSNESS; BRAIN; SYNCHRONIZATION; NETWORKS; TIME; COMMUNICATION; INFORMATION	Background: It has been previously shown that loss of consciousness is associated with a breakdown of dominating frontoparietal feedback connectivity as assessed by electroencephalogram (EEG) recordings. Structure and strength of network connectivity may change over time. Aim of the current study is to investigate cortico-cortical connectivity at different time intervals during consciousness and unconsciousness. For this purpose, EEG symbolic transfer entropy (STEn) was calculated to indicate cortico-cortical information transfer at different transfer times. Methods: The study was performed in 15 male volunteers. 29-channel EEG was recorded during consciousness and propofol-induced unconsciousness. EEG data were analyzed by STEn, which quantifies intensity and directionality of the mutual information flow between two EEG channels. STEn was computed over fronto-parietal channel pair combinations (10 s length, 0.5-45 Hz total bandwidth) to analyze changes of intercortical directional connectivity. Feedback (fronto -> parietal) and feedforward (parieto -> frontal) connectivity was calculated for transfer times from 25 ms to 250 ms in 5 ms steps. Transfer times leading to maximum directed interaction were identified to detect changes of cortical information transfer (directional connectivity) induced by unconsciousness (p < 0.05). Results: The current analyses show that fronto-parietal connectivity is a non-static phenomenon. Maximum detected interaction occurs at decreased transfer times during propofol-induced unconsciousness (feedback interaction: 60 ms to 40 ms, p = 0.002; feedforward interaction: 65 ms to 45 ms, p = 0.001). Strength of maximum feedback interaction decreases during unconsciousness (p = 0.026), while no effect of propofol was observed on feedforward interaction. During both consciousness and unconsciousness, intensity of fronto-parietal interaction fluctuates with increasing transfer times. Conclusion: Non-stationarity of directional connectivity may play a functional role for cortical network communication as it shows characteristic changes during propofol-induced unconsciousness.	[Untergehrer, Gisela; Schneider, Gerhard] Univ Witten Herdecke, Helios Clin Wuppertal, Dept Anesthesiol, Wuppertal, Germany; [Untergehrer, Gisela; Jordan, Denis; Kochs, Eberhard F.; Schneider, Gerhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, D-80290 Munich, Germany; [Ilg, Ruediger] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	Witten Herdecke University; Technical University of Munich; Technical University of Munich	Untergehrer, G (corresponding author), Univ Witten Herdecke, Helios Clin Wuppertal, Dept Anesthesiol, Wuppertal, Germany.	g.untergehrer@gmx.de		Schneider, Gerhard/0000-0002-4903-0118				Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Andrada J, 2012, ANESTH ANALG, V114, P661, DOI 10.1213/ANE.0b013e3182405228; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Chang C, 2010, FILM COMMENT, V46, P81; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Fiset P, 1999, J NEUROSCI, V19, P5506; Gonzalez JR, 2009, 4 EUR C INT FED MED, V22, P1268; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Hutchison RM, 2012, CEREB CORTEX, V22, P1294, DOI 10.1093/cercor/bhr181; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; Jordan D, 2013, ANESTHESIOLOGY, V119, P1031, DOI 10.1097/ALN.0b013e3182a7ca92; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lee H, 2013, ANESTHESIOLOGY, V119, P1347, DOI 10.1097/ALN.0b013e3182a8ec8c; Lee U, 2013, ANESTHESIOLOGY, V118, P1264, DOI 10.1097/ALN.0b013e31829103f5; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Nicolaou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033869; Prado J, 2011, NEUROIMAGE, V54, P541, DOI 10.1016/j.neuroimage.2010.08.022; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Staniek M, 2009, BIOMED TECH, V54, P323, DOI 10.1515/BMT.2009.040; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Tagliazucchi E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00339; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809	36	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87498	10.1371/journal.pone.0087498	http://dx.doi.org/10.1371/journal.pone.0087498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475298	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300192
J	Fujiwara, T; Saitoh, H; Inoue, A; Kobayashi, M; Okitsu, Y; Katsuoka, Y; Fukuhara, N; Onishi, Y; Ishizawa, K; Ichinohasama, R; Harigae, H				Fujiwara, Tohru; Saitoh, Haruka; Inoue, Ai; Kobayashi, Masahiro; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Ichinohasama, Ryo; Harigae, Hideo			3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Erythropoeisis; Gene Transcription; Hemoglobin; Histone Deacetylase; Histone Methylation; DZNep; ETO2; EZH2	COMBINED EPIGENETIC THERAPY; REPRESSIVE COMPLEX 2; HISTONE METHYLATION; MICE LACKING; LEUKEMIA; BINDING; GATA-1; EZH2; SCL; EXPRESSION	Background:S-adenosylmethionine-dependent methyltransferase inhibitor, DZNep, targets the degradation of histone methyltransferase EZH2 that catalyzes H3K27 trimethylation. Results: DZNep induced erythroid-related genes, which may not be directly related to EZH2 inhibition but may be partly associated with reduced protein level of hematopoietic corepressor ETO2. Conclusion: DZNep has the capacity to induce erythroid differentiation. Significance: Our data may be exploited for therapeutic applications for hematological diseases, including anemia. EZH2, a core component of polycomb repressive complex 2 (PRC2), plays a role in transcriptional repression through histone H3 Lys-27 trimethylation and is involved in various biological processes, including hematopoiesis. It is well known that 3-deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase that targets the degradation of EZH2, preferentially induces apoptosis in various hematological malignancies, suggesting that EZH2 may be a new target for epigenetic treatment. Because PRC2 participates in epigenetic silencing of a subset of GATA-1 target genes during erythroid differentiation, inhibition of EZH2 may influence erythropoiesis. To explore this possibility, we evaluated the impact of DZNep on erythropoiesis. DZNep treatment significantly induced erythroid differentiation of K562 cells, as assessed by benzidine staining and quantitative RT-PCR analysis for representative erythroid-related genes, including globins. When we evaluated the effects of DZNep in human primary erythroblasts derived from cord blood CD34-positive cells, the treatment significantly induced erythroid-related genes, as observed in K562 cells, suggesting that DZNep induces erythroid differentiation. Unexpectedly, siRNA-mediated EZH2 knockdown had no significant effect on the expression of erythroid-related genes. Transcriptional profiling of DZNep-treated K562 cells revealed marked up-regulation of SLC4A1 and EPB42, previously reported as representative targets of the transcriptional corepressor ETO2. In addition, DZNep treatment reduced the protein level of ETO2. These data suggest that erythroid differentiation by DZNep may not be directly related to EZH2 inhibition but may be partly associated with reduced protein level of hematopoietic corepressor ETO2. These data provide a better understanding of the mechanism of action of DZNep, which may be exploited for therapeutic applications for hematological diseases, including anemia.	[Fujiwara, Tohru; Saitoh, Haruka; Inoue, Ai; Kobayashi, Masahiro; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808575, Japan; [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Mol Hematol Oncol, Sendai, Miyagi 9808575, Japan; [Ichinohasama, Ryo] Tohoku Univ, Grad Sch, Dept Hematopathol, Sendai, Miyagi 9808575, Japan; [Ishizawa, Kenichi] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Fujiwara, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808575, Japan.	fujiwarato@apple.email.ne.jp	Inoue, Akihisa/E-5271-2015; Fujiwara, Tohru/GOG-9775-2022		Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research [23791067] Funding Source: KAKEN	Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of the Hematology and Rheumatology department of Tohoku University Graduate School of Medicine for helpful comments. We also acknowledge the support of Biomedical Research Core of Tohoku University School of Medicine.	Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Benjamini Y, 2001, ANN STAT, V29, P1165; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Chiang PK, 1998, PHARMACOL THERAPEUT, V77, P115, DOI 10.1016/S0163-7258(97)00089-2; COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Fibach E, 2003, BLOOD, V102, P1276, DOI 10.1182/blood-2002-10-3096; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fujiwara T., 2012, PLOS ONE, V7; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2013, EXP HEMATOL, V41, P303, DOI 10.1016/j.exphem.2012.10.015; Fujiwara T, 2010, P NATL ACAD SCI USA, V107, P20429, DOI 10.1073/pnas.1007804107; Gambari R, 2003, MINERVA BIOTECNOL, V15, P123; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; GLAZER RI, 1986, BIOCHEM PHARMACOL, V35, P4523, DOI 10.1016/0006-2952(86)90774-4; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; He S, 2012, BLOOD, V119, P1274, DOI 10.1182/blood-2011-06-364422; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Kang YA, 2012, MOL CELL BIOL, V32, P226, DOI 10.1128/MCB.06166-11; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Ross J, 2012, MOL CELL BIOL, V32, P3624, DOI 10.1128/MCB.00163-12; Rossetti S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-93; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xie Z., 2011, PLOS ONE, V6; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	44	39	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8121	8134		10.1074/jbc.M114.548651	http://dx.doi.org/10.1074/jbc.M114.548651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492606	Green Published, hybrid			2022-12-25	WOS:000333157500010
J	Ma, LF; Wang, JY; Lin, JF; Pan, QH; Yu, YC; Sun, FY				Ma, Lifang; Wang, Jiayi; Lin, Jiafei; Pan, Qiuhui; Yu, Yongchun; Sun, Fenyong			Cluster of Differentiation 166 (CD166) Regulated by Phosphatidylinositide 3-Kinase (PI3K)/AKT Signaling to Exert Its Anti-apoptotic Role via Yes-associated Protein (YAP) in Liver Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; CREB; Hepatocellular Carcinoma; Membrane Proteins; Signal Transduction	INDEPENDENT PROGNOSTIC MARKER; ORGAN SIZE CONTROL; HIPPO PATHWAY; HEPATOCELLULAR-CARCINOMA; MUTUAL INTERACTION; COLORECTAL-CANCER; BREAST-CANCER; CELLS; EXPRESSION; PHOSPHORYLATION	Background: CD166 is overexpressed and regarded as a valuable prognostic marker in tumors. Results: An autoregulatory feedback between PI3K/AKT and CD166 was revealed, and YAP was identified as a CD166 downstream effecter. Conclusion: CD166 is regulated by PI3K/AKT to exert its anti-apoptotic role via YAP. Significance: The relationship between CD166 and YAP provides new therapeutic insights into liver cancer. Cluster of differentiation 166 (CD166 or Alcam) is a cell surface molecule that can be greatly induced in liver cancer cells after serum deprivation, suggesting its role in influencing cell survival. However, whether and how CD166 acts as an anti-apoptotic regulator needs to be further investigated. Here, we report that gene silencing of CD166 promoted apoptosis via down-regulation of Bcl-2 in liver cancer cells. PI3K/AKT signaling was found to up-regulate CD166 expression independently of transcription. We also revealed that CD166 promoted both AKT expression and activity, thus providing a novel positive regulatory feedback between PI3K/AKT signaling and CD166. Moreover, Yes-associated protein (YAP) was identified as a CD166 downstream effecter, which can partly rescue CD166 knockdown-induced apoptosis and reduced in vivo cancer cell growth. Mechanically, CD166 modulated YAP expression and activity through at least two different ways, transcriptional regulation of YAP through cAMP-response element-binding protein and post-transcriptional control of YAP stability through inhibition to AMOT130. We also showed that CD9 enhanced CD166-mediated regulation of YAP via a mechanism involving facilitating CD166-CD166 homophilic interaction. Tissue microarray analysis revealed that CD166 and YAP were up-regulated and closely correlated in liver cancer samples, demonstrating the importance of their relationship. Taken together, this work summarizes a novel link between CD166 and YAP, explores the interplay among related important signaling pathways, and may lead to more effective therapeutic strategies for liver cancer.	[Ma, Lifang; Wang, Jiayi; Sun, Fenyong] Tongji Univ, Dept Clin Lab Med, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Lin, Jiafei] Shanghai Jiao Tong Univ, Sch Med, Dept Clin Lab Med, Ruijin Hosp, Shanghai 200025, Peoples R China; [Pan, Qiuhui; Yu, Yongchun] Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China	Tongji University; Shanghai Jiao Tong University; Tongji University	Wang, JY (corresponding author), Tongji Univ, Dept Clin Lab Med, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	karajan2@163.com; sunfenyong@126.com		Wang, Jiayi/0000-0003-1688-2864	China National 973 projects [20111812, 20110402]; Natural Science Foundation of China [81301689]; Shanghai Tenth People's Hospital Climbing Training Program; China Central High School basic research-specific grant	China National 973 projects(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Tenth People's Hospital Climbing Training Program; China Central High School basic research-specific grant	This work was supported by China National 973 projects (Grants 20111812 and 20110402), Natural Science Foundation of China Grant 81301689, the Shanghai Tenth People's Hospital Climbing Training Program (to J.W.), and a China Central High School basic research-specific grant (to J.X.).	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Burkhardt M, 2006, J CLIN PATHOL, V59, P403, DOI 10.1136/jcp.2005.028209; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Gilsanz A, 2013, CELL MOL LIFE SCI, V70, P475, DOI 10.1007/s00018-012-1132-0; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Graham TR, 2009, PROSTATE, V69, P168, DOI 10.1002/pros.20870; Huo XY, 2013, ONCOL REP, V29, P840, DOI 10.3892/or.2012.2176; Jezierska A, 2006, MED SCI MONITOR, V12, pBR263; Jiao J, 2012, PLOS ONE, V7; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li LL, 2013, FEBS LETT, V587, P3921, DOI 10.1016/j.febslet.2013.10.042; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lugli A, 2010, BRIT J CANCER, V103, P382, DOI 10.1038/sj.bjc.6605762; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Wang J., 2014, CELL SIGNAL, DOI 10.1016/j.cellsig.2014.01.022; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	38	41	43	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6921	6933		10.1074/jbc.M113.524819	http://dx.doi.org/10.1074/jbc.M113.524819			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24482231	Green Published, hybrid			2022-12-25	WOS:000332389400052
J	Rieucau, G; Boswell, KM; De Robertis, A; Macaulay, GJ; Handegard, NO				Rieucau, Guillaume; Boswell, Kevin M.; De Robertis, Alex; Macaulay, Gavin J.; Handegard, Nils Olav			Experimental Evidence of Threat-Sensitive Collective Avoidance Responses in a Large Wild-Caught Herring School	PLOS ONE			English	Article							JUVENILE ATLANTIC SALMON; PREDATOR-PREY INTERACTIONS; CLUPEA-HARENGUS; INFORMATION-TRANSFER; VISUAL INFORMATION; MULTIBEAM SONAR; ESCAPE BEHAVIOR; MULTIPLE CUES; SHOAL SIZE; FISH	Aggregation is commonly thought to improve animals' security. Within aquatic ecosystems, group-living prey can learn about immediate threats using cues perceived directly from predators, or from collective behaviours, for example, by reacting to the escape behaviours of companions. Combining cues from different modalities may improve the accuracy of prey antipredatory decisions. In this study, we explored the sensory modalities that mediate collective antipredatory responses of herring (Clupea harengus) when in a large school (approximately 60 000 individuals). By conducting a simulated predator encounter experiment in a semi-controlled environment (a sea cage), we tested the hypothesis that the collective responses of herring are threat-sensitive. We investigated whether cues from potential threats obtained visually or from the perception of water displacement, used independently or in an additive way, affected the strength of the collective avoidance reactions. We modified the sensory nature of the simulated threat by exposing the herring to 4 predator models differing in shape and transparency. The collective vertical avoidance response was observed and quantified using active acoustics. The combination of sensory cues elicited the strongest avoidance reactions, suggesting that collective antipredator responses in herring are mediated by the sensory modalities involved during threat detection in an additive fashion. Thus, this study provides evidence for magnitude-graded threat responses in a large school of wild-caught herring which is consistent with the "threat-sensitive hypothesis".	[Rieucau, Guillaume; Macaulay, Gavin J.; Handegard, Nils Olav] Inst Marine Res, N-5024 Bergen, Norway; [Boswell, Kevin M.] Florida Int Univ, North Miami, FL USA; [De Robertis, Alex] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA	Institute of Marine Research - Norway; State University System of Florida; Florida International University; National Oceanic Atmospheric Admin (NOAA) - USA	Rieucau, G (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	guillaume.rieucau@imr.no	Boswell, Kevin M./B-6380-2016; Handegard, Nils Olav/I-3047-2012	Boswell, Kevin M./0000-0002-2037-1541; Handegard, Nils Olav/0000-0002-9708-9042; Macaulay, Gavin/0000-0003-2518-6537; Rieucau, Guillaume/0000-0002-8968-4992	Norwegian Research Council [204229/F20]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was financed by the Norwegian Research Council (grant 204229/F20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Axelsen BE, 2001, CAN J ZOOL, V79, P1586, DOI 10.1139/cjz-79-9-1586; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Brown GE, 2006, CAN J ZOOL, V84, P1, DOI 10.1139/Z05-166; Brown GE, 2003, ETHOLOGY, V109, P739, DOI 10.1046/j.1439-0310.2003.00919.x; BROWN GE, 1995, J FISH BIOL, V47, P387; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Chivers DP, 2001, CAN J ZOOL, V79, P867, DOI 10.1139/cjz-79-5-867; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dionne M, 2002, CAN J ZOOL, V80, P2006, DOI 10.1139/Z02-176; Doksaeter L, 2012, J ACOUST SOC AM, V131, P1632, DOI 10.1121/1.3675944; Doksaeter L, 2009, J ACOUST SOC AM, V125, P554, DOI [10.1121/1.3021301, 10.1121/1.4784426]; Domenici P, 1997, MAR BIOL, V128, P29, DOI 10.1007/s002270050065; DOMENICI P, 1994, J FISH BIOL, V45, P97, DOI 10.1111/j.1095-8649.1994.tb01086.x; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; Ferno A, 1998, SARSIA, V83, P149; Ferrari MCO, 2008, BEHAV ECOL SOCIOBIOL, V63, P113, DOI 10.1007/s00265-008-0641-1; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; Giske J, 1998, REV FISH BIOL FISHER, V8, P57, DOI 10.1023/A:1008864517488; GODIN JGJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P105, DOI 10.1007/BF00295142; GRAY JAB, 1991, J MAR BIOL ASSOC UK, V71, P83, DOI 10.1017/S0025315400037413; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hettyey A, 2012, BIOL J LINN SOC, V106, P820, DOI 10.1111/j.1095-8312.2012.01923.x; Holmin AJ, 2013, ANAL MULTIBEAM SONAR; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ioannou CC, 2008, BEHAV ECOL, V19, P126, DOI 10.1093/beheco/arm109; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Kim JW, 2009, J FISH BIOL, V74, P1280, DOI 10.1111/j.1095-8649.2009.02199.x; Knudsen FR, 1997, J FISH BIOL, V51, P824, DOI 10.1006/jfbi.1997.0486; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Leduc AOHC, 2010, CAN J ZOOL, V88, P398, DOI 10.1139/Z10-016; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima Steven L., 2005, P166; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; MAGURRAN AE, 1985, Z TIERPSYCHOL, V67, P167; MAGURRAN AE, 1987, PROC R SOC SER B-BIO, V229, P439, DOI 10.1098/rspb.1987.0004; MAGURRAN AE, 1986, J FISH BIOL, V29, P159, DOI 10.1111/j.1095-8649.1986.tb05007.x; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Marras S, 2012, ADAPT BEHAV, V20, P44, DOI 10.1177/1059712311426799; METCALFE NB, 1987, ANIM BEHAV, V35, P901, DOI 10.1016/S0003-3472(87)80125-2; MISUND OA, 1993, ICES J MAR SCI, V50, P145, DOI 10.1006/jmsc.1993.1016; Natale GS, 2011, ACTA ZOOL-STOCKHOLM, V92, P46, DOI 10.1111/j.1463-6395.2009.00445.x; Nottestad L, 1999, CAN J ZOOL, V77, P1540, DOI 10.1139/cjz-77-10-1540; Nottestad L, 1996, SARSIA, V80, P277, DOI 10.1080/00364827.1996.10413601; Pecor KW, 2003, ETHOLOGY, V109, P97, DOI 10.1046/j.1439-0310.2003.00834.x; Pitcher T. J., 1983, PREDATORS PREY FISHE, P193; Pitcher TJ, 1996, ICES J MAR SCI, V53, P449, DOI 10.1006/jmsc.1996.0063; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Radakov D. V., 1973, SCH ECOLOGY FISH; SEGHERS BH, 1981, ENVIRON BIOL FISH, V6, P21, DOI 10.1007/BF00001795; Skaret G, 2006, FISH RES, V78, P359, DOI 10.1016/j.fishres.2005.11.007; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Vabo R, 2002, FISH RES, V58, P59, DOI 10.1016/S0165-7836(01)00360-5; Ward AJW, 2010, BEHAV ECOL, V21, P1315, DOI 10.1093/beheco/arq152; WEBB PW, 1982, J COMP PHYSIOL, V147, P371, DOI 10.1007/BF00609671; WEBB PW, 1980, COMP BIOCHEM PHYS A, V65, P231, DOI 10.1016/0300-9629(80)90230-3; Wilson B, 2002, CAN J FISH AQUAT SCI, V59, P542, DOI 10.1139/F02-029; Wilson M, 2011, J EXP BIOL, V214, P22, DOI 10.1242/jeb.043323; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668	63	21	21	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86726	10.1371/journal.pone.0086726	http://dx.doi.org/10.1371/journal.pone.0086726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489778	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000065
J	Sriram, U; Xu, J; Chain, RW; Varghese, L; Chakhtoura, M; Bennett, HL; Zoltick, PW; Gallucci, S				Sriram, Uma; Xu, Jun; Chain, Robert W.; Varghese, Linda; Chakhtoura, Marita; Bennett, Heather L.; Zoltick, Philip W.; Gallucci, Stefania			IL-4 Suppresses the Responses to TLR7 and TLR9 Stimulation and Increases the Permissiveness to Retroviral Infection of Murine Conventional Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CYTOKINE SIGNALING SOCS; SINGLE-STRANDED RNA; I INTERFERON; HIV-1 TRANSMISSION; IMMUNITY; VIRUS; RECOGNITION; EXPRESSION; DISTINCT	Th2-inducing pathological conditions such as parasitic diseases increase susceptibility to viral infections through yet unclear mechanisms. We have previously reported that IL-4, a pivotal Th2 cytokine, suppresses the response of murine bone-marrow- derived conventional dendritic cells (cDCs) and splenic DCs to Type I interferons (IFNs). Here, we analyzed cDC responses to TLR7 and TLR9 ligands, R848 and CpGs, respectively. We found that IL-4 suppressed the gene expression of IFN beta and IFN-responsive genes (IRGs) upon TLR7 and TLR9 stimulation. IL-4 also inhibited IFN-dependent MHC Class I expression and amplification of IFN signaling pathways triggered upon TLR stimulation, as indicated by the suppression of IRF7 and STAT2. Moreover, IL-4 suppressed TLR7-and TLR9-induced cDC production of pro-inflammatory cytokines such as TNF alpha, IL-12p70 and IL-6 by inhibiting IFN-dependent and NFkB-dependent responses. IL-4 similarly suppressed TLR responses in splenic DCs. IL-4 inhibition of IRGs and pro-inflammatory cytokine production upon TLR7 and TLR9 stimulation was STAT6-dependent, since DCs from STAT6-KO mice were resistant to the IL-4 suppression. Analysis of SOCS molecules (SOCS1, 22 and 23) showed that IL-4 induces SOCS1 and SOCS2 in a STAT6 dependent manner and suggest that IL-4 suppression could be mediated by SOCS molecules, in particular SOCS2. IL-4 also decreased the IFN response and increased permissiveness to viral infection of cDCs exposed to a HIV-based lentivirus. Our results indicate that IL-4 modulates and counteracts pro-inflammatory stimulation induced by TLR7 and TLR9 and it may negatively affect responses against viruses and intracellular parasites.	[Sriram, Uma; Xu, Jun; Chain, Robert W.; Varghese, Linda; Chakhtoura, Marita; Gallucci, Stefania] Temple Univ, Dept Microbiol & Immunol, Sch Med, Lab Dendrit Cell Biol, Philadelphia, PA 19122 USA; [Bennett, Heather L.] Childrens Hosp Philadelphia, Dept Pediat, Div Rheumatol, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; [Zoltick, Philip W.] Childrens Hosp Philadelphia, Dept Surg, Childrens Ctr Fetal Res, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia	Sriram, U (corresponding author), Temple Univ, Dept Microbiol & Immunol, Sch Med, Lab Dendrit Cell Biol, Philadelphia, PA 19122 USA.	sriram@temple.edu; gallucci@temple.edu			National Institutes of Health; National Institute of Allergy and Infectious Diseases [RO1-AI076423]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant RO1-AI076423 and the Arthritis Foundation (www.arthritis.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boyer JD, 2002, INT J PARASITOL, V32, P543, DOI 10.1016/S0020-7519(01)00355-1; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Coleman CM, 2013, ADV EXP MED BIOL, V762, P109, DOI 10.1007/978-1-4614-4433-6_4; Coleman CM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-26; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Collman RG, 2003, J LEUKOCYTE BIOL, V74, P631, DOI 10.1189/jlb.0703357; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; DONNELLY RP, 1993, J IMMUNOL, V151, P5603; Elkon KB, 2011, J INTERF CYTOK RES, V31, P803, DOI 10.1089/jir.2011.0045; Endo M, 2008, MOL THER, V16, P131, DOI 10.1038/sj.mt.6300332; Eriksen KW, 2004, J BIOL CHEM, V279, P169, DOI 10.1074/jbc.M310472200; Fischer JE, 1997, J VIROL, V71, P8672, DOI 10.1128/JVI.71.11.8672-8677.1997; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirsch I, 2010, TRENDS IMMUNOL, V31, P391, DOI 10.1016/j.it.2010.07.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; HORISBERGER MA, 1995, AM J RESP CRIT CARE, V152, pS67, DOI 10.1164/ajrccm/152.4_Pt_2.S67; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Labeur MS, 1999, J IMMUNOL, V162, P168; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Levings MK, 1999, J IMMUNOL, V162, P5224; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miyamoto R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3014; Moran TM, 1996, J VIROL, V70, P5230, DOI 10.1128/JVI.70.8.5230-5235.1996; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Secor WE, 2012, CURR OPIN HIV AIDS, V7, P254, DOI 10.1097/COH.0b013e328351b9e3; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Sriram U, 2007, J IMMUNOL, V179, P6446, DOI 10.4049/jimmunol.179.10.6446; Sriram U, 2012, J IMMUNOL, V189, P80, DOI 10.4049/jimmunol.1101686; Swiecki M, 2011, J LEUKOCYTE BIOL, V90, P691, DOI 10.1189/jlb.0311166; Tel J, 2011, J INVEST DERMATOL, V131, P900, DOI 10.1038/jid.2010.410; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Toscano MG, 2010, MOL THER, V18, P1035, DOI 10.1038/mt.2009.293; Yin JM, 2012, HUM VACC IMMUNOTHER, V8, P1555, DOI 10.4161/hv.22142; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhang MC, 2012, J IMMUNOL, V189, P2746, DOI 10.4049/jimmunol.1103129	71	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87668	10.1371/journal.pone.0087668	http://dx.doi.org/10.1371/journal.pone.0087668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489947	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000167
J	Bakkar, MM; Hardaker, L; March, P; Morgan, PB; Maldonado-Codina, C; Dobson, CB				Bakkar, May M.; Hardaker, Luke; March, Peter; Morgan, Philip B.; Maldonado-Codina, Carole; Dobson, Curtis B.			The Cellular Basis for Biocide-Induced Fluorescein Hyperfluorescence in Mammalian Cell Culture	PLOS ONE			English	Article								Clinical examination of the ocular surface is commonly carried out after application of sodium fluorescein in both veterinary and medical practice by assessing the resulting 'staining'. Although localized intensely stained regions of the cornea frequently occur after exposure to 'adverse' clinical stimuli, the cell biology underlying this staining is unknown, including whether intense fluorescein staining indicates the presence of damaged cells. Ocular exposure to certain contact lens multipurpose solutions (MPS) gives rise to intense fluorescein staining referred to as solution induced corneal staining (SICS), and we have made use of this phenomenon with Vero and L929 cell culture models to investigate the fundamental biology of fluorescein interactions with cells. We found that all cells take up fluorescein, however a sub-population internalize much higher levels, giving rise to brightly staining 'hyperfluorescent' cells within the treated cultures, which contain fluorescein throughout the cell cytoplasm and nucleus. The numbers of these hyperfluorescent cells are significantly increased after exposure to MPS associated with SICS. Surprisingly, hyperfluorescent cells did not show higher levels of staining with propidium iodide, a marker of lysed cells. Consistently, treatment with the cytolytic toxin benzalkonium chloride resulted in almost all cells staining with propidium iodide, and the complete abolition of fluorescein hyperfluorescence. Finally we found that internalization of fluorescein and its loss from treated cells both require cellular activity, as both processes were halted after incubation at 4 degrees C. We conclude that fluorescein hyperfluorescence can be replicated in three diverse cell cultures, and is increased by MPS-treatment, as occurs clinically. The process involves the concentration of fluorescein by a sub-population of cells that are active, and does not occur in lysed cells. Our data suggest that corneal staining in the clinic reflects active living cells, and is not directly caused by dead cells being produced in response to adverse clinical stimuli.	[Bakkar, May M.; Morgan, Philip B.; Maldonado-Codina, Carole] Univ Manchester, Eurolens Res, Fac Life Sci, Manchester, Lancs, England; [Bakkar, May M.; Hardaker, Luke; Morgan, Philip B.; Maldonado-Codina, Carole; Dobson, Curtis B.] Univ Manchester, Fac Life Sci, Med Device Biol Grp, Manchester, Lancs, England; [March, Peter] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Dobson, CB (corresponding author), Univ Manchester, Fac Life Sci, Med Device Biol Grp, Manchester, Lancs, England.	curtis.dobson@manchester.ac.uk		Morgan, Philip/0000-0003-0680-8169; Dobson, Curtis/0000-0002-6483-4608	Jordan University of Science and Technology	Jordan University of Science and Technology	This work was funded by Jordan University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandamwar KL, 2012, CONTACT LENS ANTERIO, V35, P81, DOI 10.1016/j.clae.2011.08.008; Barret R, 2005, INVEST OPHTHALMOL VI, V46; Berginc K, 2007, EUR J PHARM BIOPHARM, V66, P281, DOI 10.1016/j.ejpb.2006.10.023; Bright FV, 2012, CORNEA, V31, P1480, DOI 10.1097/ICO.0b013e31824a2083; Carnt N, 2007, CONTACT LENS SPECTRU, V22, P38; CERCEK L, 1978, BIOPHYS J, V23, P395, DOI 10.1016/S0006-3495(78)85458-7; Dumbleton Kathy, 2003, Eye Contact Lens, V29, pS186; FEENSTRA RPG, 1992, OPHTHALMOLOGY, V99, P605; Horsley MB, 2009, CLIN OPHTHALMOL, V3, P291; Jones L, 1997, Cont Lens Anterior Eye, V20, P23, DOI 10.1016/S1367-0484(97)80032-X; Jones L, 2002, OPTOMETRY VISION SCI, V79, P753, DOI 10.1097/00006324-200212000-00007; JOSEPHSON JE, 1988, INVEST OPHTH VIS SCI, V29, P1096; Kuwayama K, 2002, BIOCHEM PHARMACOL, V63, P81, DOI 10.1016/S0006-2952(01)00853-X; McMonnies Charles W, 2007, Cont Lens Anterior Eye, V30, P37, DOI 10.1016/j.clae.2006.12.002; Mokhtarzadeh M, 2011, INVEST OPHTH VIS SCI, V52, P2127, DOI 10.1167/iovs.10-6489; Morgan PB, 2009, CONTACT LENS ANTERIO, V32, P48, DOI 10.1016/j.clae.2008.09.004; Peate WF, 2007, AM FAM PHYSICIAN, V75, P1017; Scarlett A, 2007, EMERG MED J, V24, P733, DOI 10.1136/emj.2006.045658; Tchao Ruy, 2002, CLAO Journal, V28, P151; van der Worp E, 2003, OPTOMETRY VISION SCI, V80, P280, DOI 10.1097/00006324-200304000-00005; Wilson G, 1995, J Am Optom Assoc, V66, P435; Wipperman JL, 2013, AM FAM PHYSICIAN, V87, P114	22	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84427	10.1371/journal.pone.0084427	http://dx.doi.org/10.1371/journal.pone.0084427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489650	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000006
J	Bobrowski, L; Lukaszuk, T; Lindholm, B; Stenvinkel, P; Heimburger, O; Axelsson, J; Barany, P; Carrero, JJ; Qureshi, AR; Luttropp, K; Debowska, M; Nordfors, L; Schalling, M; Waniewski, J				Bobrowski, Leon; Lukaszuk, Tomasz; Lindholm, Bengt; Stenvinkel, Peter; Heimburger, Olof; Axelsson, Jonas; Barany, Peter; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Luttropp, Karin; Debowska, Malgorzata; Nordfors, Louise; Schalling, Martin; Waniewski, Jacek			Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method	PLOS ONE			English	Article							CANCER CLASSIFICATION; CLASSIFIERS; BIOMARKERS	Identification of risk factors in patients with a particular disease can be analyzed in clinical data sets by using feature selection procedures of pattern recognition and data mining methods. The applicability of the relaxed linear separability (RLS) method of feature subset selection was checked for high-dimensional and mixed type (genetic and phenotypic) clinical data of patients with end-stage renal disease. The RLS method allowed for substantial reduction of the dimensionality through omitting redundant features while maintaining the linear separability of data sets of patients with high and low levels of an inflammatory biomarker. The synergy between genetic and phenotypic features in differentiation between these two subgroups was demonstrated.	[Bobrowski, Leon; Debowska, Malgorzata; Waniewski, Jacek] Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Bobrowski, Leon; Lukaszuk, Tomasz] Bialystok Tech Univ, Bialystok, Poland; [Lindholm, Bengt; Stenvinkel, Peter; Heimburger, Olof; Axelsson, Jonas; Barany, Peter; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Luttropp, Karin; Debowska, Malgorzata; Nordfors, Louise; Schalling, Martin] Karolinska Inst, Baxter Novum & Renal Med, Stockholm, Sweden; [Carrero, Juan Jesus; Luttropp, Karin; Nordfors, Louise; Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Bialystok University of Technology; Karolinska Institutet; Karolinska Institutet	Bobrowski, L (corresponding author), Inst Biocybernet & Biomed Engn, Warsaw, Poland.	l.bobrowski@pb.edu.pl	Łukaszuk, Tomasz/T-5454-2018; Bobrowski, Leon/T-9230-2018; Barany, Peter/I-6116-2019; Qureshi, Abdul Rashid Tony/G-1358-2010; Schalling, Martin/F-1518-2015; Debowska, Malgorzata/F-3035-2015; Lindholm, Bengt/P-1334-2017	Łukaszuk, Tomasz/0000-0003-0489-7567; Bobrowski, Leon/0000-0003-4735-2460; Barany, Peter/0000-0001-6501-8293; Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Schalling, Martin/0000-0001-5011-2922; Debowska, Malgorzata/0000-0001-8741-7930; Stenvinkel, Peter/0000-0002-8785-4820; Carrero, Juan Jesus/0000-0003-4763-2024; Lindholm, Bengt/0000-0003-4269-4293; Heimburger, Olof/0000-0003-0901-4145	Polish National Center for Research and Development [N R13 0014 04]; Institute of Biocybernetics and Biomedical Engineering PAS [4.2/St/2012]; Bialystok University of Technology [S/WI/2/2013]; GENECURE [LSHM-CT-2006-037697]; Swedish Research Council [Dnr 521-2012-2721]; Baxter Healthcare Corporation	Polish National Center for Research and Development; Institute of Biocybernetics and Biomedical Engineering PAS; Bialystok University of Technology; GENECURE(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Baxter Healthcare Corporation	This work was supported by Polish National Center for Research and Development [N R13 0014 04]; Institute of Biocybernetics and Biomedical Engineering PAS [4.2/St/2012]; Bialystok University of Technology [S/WI/2/2013]; GENECURE [grant LSHM-CT-2006-037697]; Swedish Research Council (Dnr 521-2012-2721). Baxter Novum is the result of a grant from Baxter Healthcare Corporation to Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2012, NAT REV CARDIOL, V9, P347, DOI 10.1038/nrcardio.2012.37; Bobrowski L, 2001, ST HEAL T, V84, P1309; BOBROWSKI L, 1991, PATTERN RECOGN, V24, P863, DOI 10.1016/0031-3203(91)90005-P; Bobrowski L., 2005, DATA MINING BASED CO; Bobrowski L, 2011, SELECTED WORKS BIOIN; Bobrowski L, 2009, BIOCYBERN BIOMED ENG, V29, P43; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Demsar J, 2006, J MACH LEARN RES, V7, P1; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Ding SF, 2012, ARTIF INTELL REV, V37, P169, DOI 10.1007/s10462-011-9225-y; Duan KB, 2005, IEEE T NANOBIOSCI, V4, P228, DOI 10.1109/TNB.2005.853657; Duda R.O., 2006, PATTERN CLASSIFICATI; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M. A., 2000, P 17 INT C MACH LEAR; Hand D., 2001, ADAP COMP MACH LEARN; Johnson R.A., 1991, APPL MULTIVARIATE ST; KIRA K, 1992, MACHINE LEARNING /, P249; Kononenko I, 1994, MACH LEARN, V94; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Luttropp K, 2009, SEMIN DIALYSIS, V22, P417, DOI 10.1111/j.1525-139X.2009.00592.x; Minsky ML, 1987, PERCEPTRONS EXPANDED; Pecoits R, 2003, KIDNEY INT, V63, pS162, DOI 10.1046/j.1523-1755.63.s84.39.x; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V, 1988, STAT LEARNING THEORY; Witten I, 2000, DATA MINING PRACITCA; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86630	10.1371/journal.pone.0086630	http://dx.doi.org/10.1371/journal.pone.0086630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489753	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000064
J	Iqbal, M; Reddy, KB; Brookes, SM; Essen, SC; Brown, IH; McCauley, JW				Iqbal, Munir; Reddy, Kolli B.; Brookes, Sharon M.; Essen, Steve C.; Brown, Ian H.; McCauley, John W.			Virus Pathotype and Deep Sequencing of the HA Gene of a Low Pathogenicity H7N1 Avian Influenza Virus Causing Mortality in Turkeys	PLOS ONE			English	Article							HEMAGGLUTININ CLEAVAGE SITE; A VIRUS; CHICKENS; EMERGENCE; REPLICATION; ADAPTATION; GENERATION; EVOLUTION; INFECTION; SUBTYPE	Low pathogenicity avian influenza (LPAI) viruses of the H7 subtype generally cause mild disease in poultry. However the evolution of a LPAI virus into highly pathogenic avian influenza (HPAI) virus results in the generation of a virus that can cause severe disease and death. The classification of these two pathotypes is based, in part, on disease signs and death in chickens, as assessed in an intravenous pathogenicity test, but the effect of LPAI viruses in turkeys is less well understood. During an investigation of LPAI virus infection of turkeys, groups of three-week-old birds inoculated with A/chicken/Italy/1279/99 (H7N1) showed severe disease signs and died or were euthanised within seven days of infection. Virus was detected in many internal tissues and organs from culled birds. To examine the possible evolution of the infecting virus to a highly pathogenic form in these turkeys, sequence analysis of the haemagglutinin (HA) gene cleavage site was carried out by analysing multiple cDNA amplicons made from swabs and tissue sample extracts employing Sanger and Next Generation Sequencing. In addition, a RT-PCR assay to detect HPAI virus was developed. There was no evidence of the presence of HPAI virus in either the virus used as inoculum or from swabs taken from infected birds. However, a small proportion (<0.5%) of virus carried in individual tracheal or liver samples did contain a molecular signature typical of a HPAI virus at the HA cleavage site. All the signature sequences were identical and were similar to HPAI viruses collected during the Italian epizootic in 1999/2000. We assume that the detection of HPAI virus in tissue samples following infection with A/chicken/ Italy/1279/99 reflected amplification of a virus present at very low levels within the mixed inoculum but, strikingly, we observed no new HPAI virus signatures in the amplified DNA analysed by deep-sequencing.	[Iqbal, Munir; Reddy, Kolli B.] Pirbright Inst, Avian Viral Dis Programme, Compton Lab, Newbury, Berks, England; [Brookes, Sharon M.; Essen, Steve C.; Brown, Ian H.] Avian Virol Anim Hlth & Vet Labs Agcy Weybridge, Addlestone, Surrey, England; [McCauley, John W.] MRC Natl Inst Med Res, Div Virol, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; MRC National Institute for Medical Research	Iqbal, M (corresponding author), Pirbright Inst, Avian Viral Dis Programme, Compton Lab, Newbury, Berks, England.	Munir.iqbal@pirbright.ac.uk	Brown, Ian H/E-1119-2011; Brookes, Sharon M/C-8016-2011; Brookes, Sharon M/W-2128-2019; Essen, Stephen/E-9721-2011	Brookes, Sharon M/0000-0001-9207-6659; Brookes, Sharon M/0000-0001-9207-6659; Iqbal, Munir/0000-0001-5165-5339	Biotechnology and Biological Sciences Research Council [BBS/B/00093, BB/E010849/1]; Medical Research Council [U117585868]; Department for Environment, Food and Rural Affairs [SE0776, FT5094]; Biotechnology and Biological Sciences Research Council [BB/E010806/1, BBS/E/I/00001025, BBS/E/I/00001759, BBS/E/I/00001422, BB/L004240/1, BBS/E/I/00001708, BB/L026341/1] Funding Source: researchfish; Medical Research Council [MC_U117512723, MC_U117585868] Funding Source: researchfish; BBSRC [BB/E010806/1, BB/L004240/1, BBS/E/I/00001422, BBS/E/I/00001759, BB/E010849/1, BB/L026341/1, BBS/E/I/00001708] Funding Source: UKRI; MRC [MC_U117585868, MC_U117512723] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (award nos. BBS/B/00093 and BB/E010849/1), the Medical Research Council (programme U117585868) and the Department for Environment, Food and Rural Affairs (project SE0776 and FT5094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2008, ZOONOSES PUBLIC HLTH, V55, P16, DOI 10.1111/j.1863-2378.2007.01082.x; ALEXANDER DJ, 1979, RES VET SCI, V26, P17; ALLAN WH, 1977, AVIAN DIS, V21, P359, DOI 10.2307/1589318; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; BRUGH M, 1991, AVIAN DIS, V35, P824, DOI 10.2307/1591616; BRUGH M, 1992, AVIAN DIS, V36, P968, DOI 10.2307/1591557; BRUGH M, 1988, AVIAN DIS, V32, P695, DOI 10.2307/1590987; Brugh M, 1992, RECOVERY MINORITY SU, P166; Cannon RM, 1982, LIVESTOCK DIS SURVEY, Viii, P35; Capua I, 2000, AVIAN PATHOL, V29, P537, DOI 10.1080/03079450020016779; CEC, 2006, OFF J EUR COMMUNIT L, VL10, P16; Dundon WG, 2006, VIRUS RES, V119, P171, DOI 10.1016/j.virusres.2006.01.005; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Halvorson DA, 1992, INFLUENZA TURKEYS US, P33; HORIMOTO T, 1995, VIROLOGY, V206, P755, DOI 10.1016/S0042-6822(95)80004-2; Iqbal M, 2012, VIROLOGY, V433, P282, DOI 10.1016/j.virol.2012.08.001; Iqbal M, 2009, PHILOS T R SOC B, V364, P2739, DOI 10.1098/rstb.2009.0088; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; KAWAOKA Y, 1987, VIROLOGY, V158, P218, DOI 10.1016/0042-6822(87)90256-X; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Lee CW, 2007, AVIAN DIS, V51, P260, DOI 10.1637/7572-033106R.1; LI SQ, 1990, J VIROL, V64, P3297, DOI 10.1128/JVI.64.7.3297-3303.1990; Londt B, 2008, AVIAN PATHOL, V37, P619, DOI 10.1080/03079450802499126; Matrosovich Mikhail N., 2008, V27, P134; McCapes RH, 1986, AVIAN INFLUENZA CALI, P118; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Mutinelli E, 2003, AVIAN DIS, V47, P844, DOI 10.1637/0005-2086-47.s3.844; OIE, 2005, MAN DIAGN TESTS VACC; ORLICH M, 1990, VIROLOGY, V176, P531, DOI 10.1016/0042-6822(90)90023-K; PERDUE ML, 1990, VIRUS RES, V16, P137, DOI 10.1016/0168-1702(90)90018-7; Poss PE, 1987, P 2 INT S AV INFL, P112; ROTT R, 1992, VET MICROBIOL, V33, P303, DOI 10.1016/0378-1135(92)90058-2; ROTT R, 1980, ARCH VIROL, V65, P123, DOI 10.1007/BF01317323; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Swayne DE, 2008, AVIAN DIS, V52, P455, DOI 10.1637/8229-012508-Reg.1; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; SWAYNE DE, 1994, AVIAN PATHOL, V23, P345, DOI 10.1080/03079459408419002; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; Villegras P, 2008, LAB MANUAL ISOLATION, P217; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wood GW, 1996, AVIAN PATHOL, V25, P799, DOI 10.1080/03079459608419182; WOOD GW, 1993, ARCH VIROL, V130, P209, DOI 10.1007/BF01319010; Zanella A, 2001, AVIAN DIS, V45, P257, DOI 10.2307/1593038; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	46	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87076	10.1371/journal.pone.0087076	http://dx.doi.org/10.1371/journal.pone.0087076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489838	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000105
J	Ishizawa, K; Izawa-Ishizawa, Y; Yamano, N; Urushihara, M; Sakurada, T; Imanishi, M; Fujii, S; Nuno, A; Miyamoto, L; Kihira, Y; Ikeda, Y; Kagami, S; Kobori, H; Tsuchiya, K; Tamaki, T				Ishizawa, Keisuke; Izawa-Ishizawa, Yuki; Yamano, Noriko; Urushihara, Maki; Sakurada, Takumi; Imanishi, Masaki; Fujii, Shoko; Nuno, Asami; Miyamoto, Licht; Kihira, Yoshitaka; Ikeda, Yasumasa; Kagami, Shoji; Kobori, Hiroyuki; Tsuchiya, Koichiro; Tamaki, Toshiaki			Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PHOTODEGRADATION PRODUCT; ILLUMINATED NIFEDIPINE; ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; RENAL INJURY; COMPLICATIONS; PATHOGENESIS; RECEPTOR; RATS	Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Recently, we reported that NO-NIF has potential as a novel antioxidant with radical scavenging abilities and has the capacity to treat vascular dysfunction by exerting an endothelial protective effect. In the present study, we extended these findings by evaluating the efficacy of NO-NIF against DN and by clarifying the mechanisms of its antioxidative effect. In a model of type 2 DN (established in KKAy mice), NO-NIF administration reduced albuminuria and proteinuria as well as glomerular expansion without affecting glucose metabolism or systolic blood pressure. NO-NIF also suppressed renal and systemic oxidative stress and decreased the expression of intercellular adhesion molecule (ICAM)-1, a marker of endothelial cell injury, in the glomeruli of the KKAy mice. Similarly, NO-NIF reduced albuminuria, oxidative stress, and ICAM-1 expression in endothelial nitric oxide synthase (eNOS) knockout mice. Moreover, NO-NIF suppressed urinary angiotensinogen (AGT) excretion and intrarenal AGT protein expression in proximal tubular cells in the KKAy mice. On the other hand, hyperglycemia-induced mitochondrial superoxide production was not attenuated by NO-NIF in cultured endothelial cells. These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.	[Ishizawa, Keisuke; Fujii, Shoko; Nuno, Asami; Miyamoto, Licht; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan; [Izawa-Ishizawa, Yuki; Yamano, Noriko; Sakurada, Takumi; Imanishi, Masaki; Kihira, Yoshitaka; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Dept Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan; [Urushihara, Maki; Kagami, Shoji] Univ Tokushima, Grad Sch, Dept Pediat, Inst Hlth Biosci, Tokushima 770, Japan; [Kobori, Hiroyuki] Kagawa Univ, Fac Med, Dept Pharmacol, Kagawa, Japan	Tokushima University; Tokushima University; Tokushima University; Kagawa University	Ishizawa, K (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan.	ishizawa@tokushima-u.ac.jp	Yamano-Adachi, Noriko/AAH-8605-2019; Kobori, Hiroyuki/F-1994-2014	Yamano-Adachi, Noriko/0000-0002-2167-5379; Kobori, Hiroyuki/0000-0001-5128-5059; Ikeda, Yasumasa/0000-0003-4318-7349; /0000-0003-2331-964X; Imanishi, Masaki/0000-0003-1305-5943	Grants for the Regional Innovation Cluster Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072408] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25860063] Funding Source: KAKEN	Grants for the Regional Innovation Cluster Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants for the Regional Innovation Cluster Program (to TT), Grants-in-Aid for Young Scientist B (to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mendoza MGA, 2008, NEPHROLOGY, V13, P218, DOI 10.1111/j.1440-1797.2007.00897.x; Atkins RC, 2010, NAT REV NEPHROL, V6, P134, DOI 10.1038/nrneph.2010.10; BAUER V, 1995, BRIT J PHARMACOL, V115, P871, DOI 10.1111/j.1476-5381.1995.tb15890.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fukuhara Y, 2011, J MED INVESTIG, V58, P118, DOI 10.2152/jmi.58.118; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; Horinouchi Y, 2011, CHEM PHARM BULL, V59, P208, DOI 10.1248/cpb.59.208; Huang H, 2006, J ENDOCRINOL, V189, P643, DOI 10.1677/joe.1.06630; Ikeda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040465; Ishizawa K, 2005, HYPERTENSION, V46, P1046, DOI 10.1161/01.HYP.0000172622.51973.f5; Ishizawa K, 2009, J PHARMACOL SCI, V109, P14, DOI 10.1254/jphs.08R08FM; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Kobori H, 2008, AM J PHYSIOL-RENAL, V294, pF1257, DOI 10.1152/ajprenal.00588.2007; Kobori H, 2013, J INVEST MED, V61, P256, DOI 10.2310/JIM.0b013e31827c28bb; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mason RP, 1996, BIOCHEM PHARMACOL, V51, P653, DOI 10.1016/S0006-2952(95)02238-4; MISIK V, 1991, MOL PHARMACOL, V40, P435; Miyata K, 2008, CLIN EXP PHARMACOL P, V35, P922, DOI 10.1111/j.1440-1681.2008.04938.x; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ogawa Susumu, 2009, Biomark Insights, V4, P97; OHKUBO T, 1992, J PHARMACEUT BIOMED, V10, P67, DOI 10.1016/0731-7085(92)80012-C; Perico N, 2008, NAT REV DRUG DISCOV, V7, P936, DOI 10.1038/nrd2685; Pomytkin IA, 2012, CURR NEUROPHARMACOL, V10, P311, DOI 10.2174/157015912804143559; Rossing P, 2013, NAT REV NEPHROL, V9, P128, DOI 10.1038/nrneph.2013.13; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Sakurada T, 2013, N-S ARCH PHARMACOL, V386, P29, DOI 10.1007/s00210-012-0810-7; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; STASKO A, 1994, FREE RADICAL BIO MED, V17, P545, DOI 10.1016/0891-5849(94)90094-9; Suzaki Y, 2007, INT J BIOL SCI, V3, P40; Usui M, 2000, CIRCULATION, V101, P305, DOI 10.1161/01.CIR.101.3.305; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Yanez C, 2004, BIOORGAN MED CHEM, V12, P2459, DOI 10.1016/j.bmc.2004.01.050; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	37	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86335	10.1371/journal.pone.0086335	http://dx.doi.org/10.1371/journal.pone.0086335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489716	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000046
J	Mahalingaiah, PKS; Singh, KP				Mahalingaiah, Prathap Kumar S.; Singh, Kamaleshwar P.			Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TUMOR-GROWTH; STEM-CELLS; E-CADHERIN; ROS; ACTIVATION; APOPTOSIS; INFLAMMATION; METASTASIS; MECHANISMS	Accumulating evidence suggests that exposures to elevated levels of either endogenous estrogen or environmental estrogenic chemicals are associated with breast cancer development and progression. These natural or synthetic estrogens are known to produce reactive oxygen species (ROS) and increased ROS has been implicated in both cellular apoptosis and carcinogenesis. Though there are several studies on direct involvement of ROS in cellular apoptosis using short-term exposure model, there is no experimental evidence to directly implicate chronic exposure to ROS in increased growth and tumorigenicity of breast cancer cells. Therefore, the objective of this study was to evaluate the effects of chronic oxidative stress on growth, survival and tumorigenic potential of MCF-7 breast cancer cells. MCF-7 cells were exposed to exogenous hydrogen peroxide (H2O2) as a source of ROS at doses of 25 mu M and 250 mM for acute (24 hours) and chronic period (3 months) and their effects on cell growth/survival and tumorigenic potential were evaluated. The results of cell count, MTT and cell cycle analysis showed that while acute exposure inhibits the growth of MCF-7 cells in a dose-dependent manner, the chronic exposure to H2O2-induced ROS leads to increased cell growth and survival of MCF-7 cells. This was further confirmed by gene expression analysis of cell cycle and cell survival related genes. Significant increase in number of soft agar colonies, up-regulation of pro-metastatic genes VEGF, WNT1 and CD44, whereas down-regulation of anti-metastatic gene E-Cadherin in H2O2 treated MCF-7 cells observed in this study further suggests that persistent exposure to oxidative stress increases tumorigenic and metastatic potential of MCF-7 cells. Since many chemotherapeutic drugs are known to induce their cytotoxicity by increasing ROS levels, the results of this study are also highly significant in understanding the mechanism for adaptation to ROS-induced toxicity leading to acquired chemotherapeutic resistance in breast cancer cells.	[Mahalingaiah, Prathap Kumar S.; Singh, Kamaleshwar P.] Texas Tech Univ, Inst Environm & Human Hlth TIEHH, Dept Environm Toxicol, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Singh, KP (corresponding author), Texas Tech Univ, Inst Environm & Human Hlth TIEHH, Dept Environm Toxicol, Lubbock, TX 79409 USA.	kamaleshwar.singh@ttu.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020					Achuthan S, 2011, J BIOL CHEM, V286, P37813, DOI 10.1074/jbc.M110.200675; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2627, DOI 10.1002/cncr.22656; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Cavalieri EL, 2004, ANN NY ACAD SCI, V1028, P247, DOI 10.1196/annals.1322.029; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Deng YT, 2010, MOL CARCINOGEN, V49, P141, DOI 10.1002/mc.20583; Fenton SE, 2012, ANNU REV PHARMACOL, V52, P455, DOI 10.1146/annurev-pharmtox-010611-134659; Ferlini C, 1999, BRIT J CANCER, V79, P257, DOI 10.1038/sj.bjc.6690042; Florea AM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/159619; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Fujita T, 2002, AM J RESP CELL MOL, V27, P542, DOI 10.1165/rcmb.4775; Ganie SA, 2011, EUR REV MED PHARMACO, V15, P906; Geiser T, 2004, AM J PHYSIOL-LUNG C, V287, pL448, DOI 10.1152/ajplung.00177.2003; Goitre L, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/807682; Heirman I, 2006, FREE RADICAL BIO MED, V40, P285, DOI 10.1016/j.freeradbiomed.2005.08.033; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hoshida Y, 2007, HEPATO-GASTROENTEROL, V54, P489; Hwang SL, 2008, J AGR FOOD CHEM, V56, P859, DOI 10.1021/jf072826r; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Jefcoate C R, 2000, J Natl Cancer Inst Monogr, P95; KUNDU N, 1995, CLIN EXP METASTAS, V13, P16, DOI 10.1007/BF00144014; Laden F, 2001, JNCI-J NATL CANCER I, V93, P768, DOI 10.1093/jnci/93.10.768; Lan T, 2013, INT J CLIN EXP PATHO, V6, P1799; Lerebours F, 2002, CRIT REV ONCOL HEMAT, V44, P121, DOI 10.1016/S1040-8428(01)00191-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li YB, 2013, PHARMACOL REP, V65, P700, DOI 10.1016/S1734-1140(13)71048-X; Lin CH, 2013, INT J MOL SCI, V14, P13266, DOI 10.3390/ijms140713266; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073038; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui A, 2000, CANCER LETT, V151, P87, DOI 10.1016/S0304-3835(99)00424-3; Mense SM, 2008, TOXICOL APPL PHARM, V232, P78, DOI 10.1016/j.taap.2008.06.007; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Nickels S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003284; Niederacher D, 1999, ONCOLOGY-BASEL, V56, P59, DOI 10.1159/000011931; Nishikawa M, 2005, J CONTROL RELEASE, V109, P101, DOI 10.1016/j.jconrel.2005.09.017; Oesterreich S, 2003, CANCER RES, V63, P5203; Okada F, 2006, BRIT J CANCER, V94, P854, DOI 10.1038/sj.bjc.6603016; Okoh VO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054206; Owens TW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00225; Patel MM, 2004, J BIOCHEM MOL TOXIC, V18, P37, DOI 10.1002/jbt.20005; Paul S, 2012, NUTR CANCER, V64, P1087, DOI 10.1080/01635581.2012.712735; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Rathore K, 2012, CARCINOGENESIS, V33, P174, DOI 10.1093/carcin/bgr244; Roy D, 2004, CURR GENOMICS, V5, P245, DOI 10.2174/1389202043349471; Roy SS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/654698; Santner SJ, 1997, J CLIN ENDOCR METAB, V82, P200, DOI 10.1210/jc.82.1.200; Saud A, 2011, AFRICAN J BIOTECHNOL, V10, P3872; St-Hilaire S, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-32; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sullivan R, 2008, CURR PHARM DESIGN, V14, P1113, DOI 10.2174/138161208784246225; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yue W, 2013, STEROIDS, V78, P161, DOI 10.1016/j.steroids.2012.11.001; Zhai Yubo, 2012, Drug Discov Today Dis Mech, V9, pe35; Zhao M, 2013, IEEE ENG MED BIO, P6433	70	91	94	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87371	10.1371/journal.pone.0087371	http://dx.doi.org/10.1371/journal.pone.0087371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489904	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000131
J	Raynaud, X; Nunan, N				Raynaud, Xavier; Nunan, Naoise			Spatial Ecology of Bacteria at the Microscale in Soil	PLOS ONE			English	Article							MICROBIAL DIVERSITY; COMMUNITIES; COMPETITION; PATTERNS; SCALE; BIODIVERSITY; RHIZOSPHERE; MAINTENANCE; COEXISTENCE; DYNAMICS	Despite an exceptional number of bacterial cells and species in soils, bacterial diversity seems to have little effect on soil processes, such as respiration or nitrification, that can be affected by interactions between bacterial cells. The aim of this study is to understand how bacterial cells are distributed in soil to better understand the scaling between cell-to-cell interactions and what can be measured in a few milligrams, or more, of soil. Based on the analysis of 744 images of observed bacterial distributions in soil thin sections taken at different depths, we found that the inter-cell distance was, on average 12.46 mu m and that these inter-cell distances were shorter near the soil surface (10.38 mu m) than at depth (>18 mu m), due to changes in cell densities. These images were also used to develop a spatial statistical model, based on Log Gaussian Cox Processes, to analyse the 2D distribution of cells and construct realistic 3D bacterial distributions. Our analyses suggest that despite the very high number of cells and species in soil, bacteria only interact with a few other individuals. For example, at bacterial densities commonly found in bulk soil (10(8) cells g(-1) soil), the number of neighbours a single bacterium has within an interaction distance of ca. 20 mu m is relatively limited (120 cells on average). Making conservative assumptions about the distribution of species, we show that such neighbourhoods contain less than 100 species. This value did not change appreciably as a function of the overall diversity in soil, suggesting that the diversity of soil bacterial communities may be species-saturated. All in all, this work provides precise data on bacterial distributions, a novel way to model them at the micrometer scale as well as some new insights on the degree of interactions between individual bacterial cells in soils.	[Raynaud, Xavier] Univ Paris 06, Sorbonne Univ, Inst Ecol & Environm Sci Paris, Paris, France; [Nunan, Naoise] CNRS, Inst Ecol & Environm Sci Paris, Campus AgroParisTech, Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Raynaud, X (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Ecol & Environm Sci Paris, Paris, France.	xavier.raynaud@upmc.fr	Nunan, Naoise/P-3135-2019; Nunan, Naoise/I-5297-2013; Raynaud, Xavier/C-2381-2009	Nunan, Naoise/0000-0003-3448-7171; Raynaud, Xavier/0000-0002-9065-2867	INSU EC2CO Microbiologie Environnementale; ANR Syscomm Programme MEPSOM	INSU EC2CO Microbiologie Environnementale; ANR Syscomm Programme MEPSOM(French National Research Agency (ANR))	This research was supported by the INSU EC2CO Microbiologie Environnementale and ANR Syscomm Programme MEPSOM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2004, J ANIM ECOL, V73, P128, DOI 10.1046/j.0021-8790.2004.00788.x; Andrey P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000853; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baveye PC, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c2; Bonami A, 2003, J FOURIER ANAL APPL, V9, P215, DOI 10.1007/s00041-003-0012-2; CHARLEY JL, 1975, J ECOL, V63, P945, DOI 10.2307/2258613; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Dechesne A, 2003, SOIL BIOL BIOCHEM, V35, P1537, DOI 10.1016/S0038-0717(03)00243-8; Dechesne A, 2008, FEMS MICROBIOL ECOL, V64, P1, DOI 10.1111/j.1574-6941.2008.00446.x; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Franklin RB, 2008, SPATIAL DISTRIBUTION, P1; Gantner S, 2006, FEMS MICROBIOL ECOL, V56, P188, DOI 10.1111/j.1574-6941.2005.00037.x; Gonod LV, 2003, SOIL BIOL BIOCHEM, V35, P373, DOI 10.1016/S0038-0717(02)00287-0; Goreaud F, 2002, ECOL MODEL, V158, P1, DOI 10.1016/S0304-3800(02)00058-3; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hodge A, 2003, NEW PHYTOL, V157, P303, DOI 10.1046/j.1469-8137.2003.00662.x; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jansen VAA, 1995, OIKOS, V74, P384, DOI 10.2307/3545983; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kinkel LL, 2011, ANNU REV PHYTOPATHOL, V49, P47, DOI 10.1146/annurev-phyto-072910-095232; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Marilley L, 1999, APPL SOIL ECOL, V13, P127, DOI 10.1016/S0929-1393(99)00028-1; Moller J, 1998, SCAND J STAT, V25, P451, DOI 10.1111/1467-9469.00115; Moller J., 2003, STAT INFERENCE SIMUL; Ngom NF, 2011, GEODERMA, V163, P127, DOI 10.1016/j.geoderma.2011.04.013; Nunan N, 2002, MICROBIAL ECOL, V44, P296, DOI 10.1007/s00248-002-2021-0; Nunan N, 2003, FEMS MICROBIOL ECOL, V44, P203, DOI 10.1016/S0168-6496(03)00027-8; Nunan N, 2001, FEMS MICROBIOL ECOL, V37, P67, DOI 10.1111/j.1574-6941.2001.tb00854.x; Nunan Naoise, 2007, P61, DOI 10.1007/978-1-4020-6216-2_3; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Raynaud X, 2008, AM NAT, V171, P44, DOI 10.1086/523951; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2011, APPL ENVIRON MICROB, V77, P2791, DOI 10.1128/AEM.02870-10; Sanguin H, 2006, APPL ENVIRON MICROB, V72, P4302, DOI 10.1128/AEM.02686-05; SCHLATHER M, 2001, R NEWS, V1, P18; Stefanic P, 2009, J BACTERIOL, V191, P1756, DOI 10.1128/JB.01290-08; Stoyan D, 2006, CASE STUDIES SPATIAL, P3; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Van Groenigen JW, 2005, RAPID COMMUN MASS SP, V19, P1289, DOI 10.1002/rcm.1929; VanMarcke E., 1988, RANDOM FIELDS ANAL S, P138; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x	53	176	178	5	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87217	10.1371/journal.pone.0087217	http://dx.doi.org/10.1371/journal.pone.0087217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489873	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000117
J	Whiley, PJ; Parsons, MT; Leary, J; Tucker, K; Warwick, L; Dopita, B; Thorne, H; Lakhani, SR; Goldgar, DE; Brown, MA; Spurdle, AB				Whiley, Phillip J.; Parsons, Michael T.; Leary, Jennifer; Tucker, Kathy; Warwick, Linda; Dopita, Belinda; Thorne, Heather; Lakhani, Sunil R.; Goldgar, David E.; Brown, Melissa A.; Spurdle, Amanda B.			Multifactorial Likelihood Assessment of BRCA1 and BRCA2 Missense Variants Confirms That BRCA1:c.122A > G(p.His41Arg) Is a Pathogenic Mutation	PLOS ONE			English	Article							UNKNOWN CLINICAL-SIGNIFICANCE; UBIQUITIN LIGASE ACTIVITY; FAMILIAL BREAST-CANCER; DNA-SEQUENCE VARIANTS; RING-DOMAIN; CLASSIFICATION; PROTEIN; GENES; MODEL; SUSCEPTIBILITY	Rare exonic, non-truncating variants in known cancer susceptibility genes such as BRCA1 and BRCA2 are problematic for genetic counseling and clinical management of relevant families. This study used multifactorial likelihood analysis and/or bioinformatically-directed mRNA assays to assess pathogenicity of 19 BRCA1 or BRCA2 variants identified following patient referral to clinical genetic services. Two variants were considered to be pathogenic (Class 5). BRCA1: c. 4484G>C(p. Arg1495Thr) was shown to result in aberrant mRNA transcripts predicted to encode truncated proteins. The BRCA1:c. 122A>G(p.His41Arg) RING-domain variant was found from multifactorial likelihood analysis to have a posterior probability of pathogenicity of 0.995, a result consistent with existing protein functional assay data indicating lost BARD1 binding and ubiquitin ligase activity. Of the remaining variants, seven were determined to be not clinically significant (Class 1), nine were likely not pathogenic (Class 2), and one was uncertain (Class 3). These results have implications for genetic counseling and medical management of families carrying these specific variants. They also provide additional multifactorial likelihood variant classifications as reference to evaluate the sensitivity and specificity of bioinformatic prediction tools and/or functional assay data in future studies.	[Whiley, Phillip J.; Parsons, Michael T.; Spurdle, Amanda B.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Whiley, Phillip J.; Brown, Melissa A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Leary, Jennifer] Westmead Hosp, Univ Sydney, Westmead Millennium Inst, Familial Canc Serv,Westmead Inst Canc Res, Sydney, NSW, Australia; [Tucker, Kathy] Prince Wales Hosp, Hereditary Canc Clin, Sydney, NSW, Australia; [Warwick, Linda; Dopita, Belinda] Canberra Hosp, Dept Genet, Canberra, ACT, Australia; [Thorne, Heather] KConFab, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, Pathol Queensland, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Goldgar, David E.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Goldgar, David E.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA	QIMR Berghofer Medical Research Institute; University of Queensland; University of Sydney; Westmead Institute for Medical Research; Australian National University; Canberra Hospital; Peter Maccallum Cancer Center; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Spurdle, AB (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	Amanda.Spurdle@qimrberghofer.edu.au	Brown, Melissa A/F-1451-2010; Spurdle, Amanda B/A-4978-2011; Lakhani, Sunil R/I-1970-2018	Spurdle, Amanda B/0000-0003-1337-7897; Lakhani, Sunil R/0000-0003-4067-2760; Thorne, Heather/0000-0003-3610-2511; Brown, Melissa/0000-0002-2830-9259; Parsons, Michael/0000-0003-3242-8477	NHMRC; National Breast Cancer Foundation; Cancer Australia [628333]; National Health and Medical Research Council (NHMRC) [ID442970, ID1010719]; Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Council of Tasmania; Cancer Council of South Australia; Cancer Foundation of Western Australia; National Institutes of Health (NIH) [CA116167]; NIH Recovery Act supplement [CA116167Z]; NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA116201, U01CA116167] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Cancer Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Tasmania(Cancer Council Tasmania); Cancer Council of South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Recovery Act supplement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Clinical Follow Up Study was funded 2001-2009 by NHMRC (www.nhmrc.gov.au) and currently by the National Breast Cancer Foundation (www.nbcf.org.au) and Cancer Australia (www.canceraustralia.gov.au) # 628333. kConFab is supported by grants from the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. This work was supported in part by project grants from The National Health and Medical Research Council (NHMRC, ID442970 & ID1010719) to Amanda B. Spurdle who is supported by an NHMRC Senior Research Fellowship. David E. Goldgar was supported by National Institutes of Health (NIH) (www.nih.gov) grant CA116167, an NIH Recovery Act supplement (CA116167Z) and an NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JF, 1999, HUM MUTAT, V13, P311, DOI 10.1002/(SICI)1098-1004(1999)13:4<311::AID-HUMU8>3.3.CO;2-G; Bouwman P, 2013, CANC DISCOV; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Domchek SM, 2012, CANC DISCOV; Domchek SM, 2013, CANCER DISCOV, V3, P399, DOI 10.1158/2159-8290.CD-12-0421; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Gaildrat P, 2012, J MED GENET, V49, P609, DOI 10.1136/jmedgenet-2012-100965; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081; Hu YF, 2002, GENE DEV, V16, P1509, DOI 10.1101/gad.995502; Hu YF, 2000, J BIOL CHEM, V275, P40910, DOI 10.1074/jbc.C000607200; Lakhani SR, 2000, CLIN CANCER RES, V6, P782; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Orban TI, 2003, J CLIN PATHOL-MOL PA, V56, P191, DOI 10.1136/mp.56.4.191; Ozcelik H, 1999, HUM MUTAT, V14, P540, DOI 10.1002/(SICI)1098-1004(199912)14:6<540::AID-HUMU13>3.3.CO;2-3; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Raponi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037255; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sarkar M, 2008, MOL BIOSYST, V4, P599, DOI 10.1039/b802481b; Sevcik J, 2012, CELL SIGNAL, V24, P1023, DOI 10.1016/j.cellsig.2011.12.023; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; Spurdle AB, 2010, CURR OPIN GENET DEV, V20, P315, DOI 10.1016/j.gde.2010.03.009; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Sweet K, 2010, BREAST CANCER RES TR, V119, P737, DOI 10.1007/s10549-009-0438-6; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Vallee MP, 2012, HUM MUTAT, V33, P22, DOI 10.1002/humu.21629; Walker LC, 2013, HUM MUTAT, V34, P1424, DOI 10.1002/humu.22388; Walker LC, 2010, HUM MUTAT, V31, pE1484, DOI 10.1002/humu.21267; Whiley P, 2013, CLIN CHEM; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang YP, 2003, HUM MOL GENET, V12, P2121, DOI 10.1093/hmg/ddg222; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	46	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86836	10.1371/journal.pone.0086836	http://dx.doi.org/10.1371/journal.pone.0086836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489791	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000082
J	Cheah, FY; Baltic, S; Temple, SEL; Bhoola, K; Thompson, PJ				Cheah, Faang Y.; Baltic, Svetlana; Temple, Suzanna E. L.; Bhoola, Kanti; Thompson, Philip J.			Novel Kinin B-1 Receptor Splice Variant and 5 ' UTR Regulatory Elements Are Responsible for Cell Specific B-1 Receptor Expression	PLOS ONE			English	Article							BRADYKININ B1 RECEPTOR; HUMAN LUNG FIBROBLASTS; ACTIVATED PROTEIN-KINASE; RAT PAW EDEMA; UP-REGULATION; IN-VIVO; KAPPA-B; GENE-EXPRESSION; INFLAMMATORY CYTOKINES; TRANSLATION EFFICIENCY	The kinin B-1 receptor (B1R) is rapidly upregulated after tissue trauma or inflammation and is involved in cancer and inflammatory diseases such as asthma. However, the role of the: promoter; a postulated alternative promoter; and spliced variants in airway epithelial and other lung cells are poorly understood. We identified, in various lung cell lines and leucocytes, a novel, naturally occurring splice variant (SV) of human B1R gene with a shorter 5'untranslated region. This novel SV is approximate to 35% less stable than the wild-type (WT) transcript in lung adenocarcinoma cells (H2126), but does not influence translation efficiency. Cell-specific differences in splice variant expression were observed post des[Arg10]-kallidin stimulation with delayed upregulation of SV compared to WT suggesting potentially different regulatory responses to inflammation. Although an alternative promoter was not identified in our cell-lines, several cell-specific regulatory elements within the postulated alternative promoter region (negative response element (NRE) -1020 to -766 bp in H2126; positive response element (PRE) -766 to -410 bp in 16HBE; -410 to +1 region acts as a PRE in H2126 and NRE in 16HBE cells) were found. These findings reveal complex regulation of B1R receptor expression in pulmonary cells which may allow future therapeutic manipulation in chronic pulmonary inflammation and cancer.	[Cheah, Faang Y.; Baltic, Svetlana; Temple, Suzanna E. L.; Bhoola, Kanti; Thompson, Philip J.] LIWA, Mol Genet & Inflammat Unit, Perth, WA, Australia; [Cheah, Faang Y.; Baltic, Svetlana; Temple, Suzanna E. L.; Bhoola, Kanti; Thompson, Philip J.] Univ Western Australia, Sch Med & Pharmacol, CAARR, Perth, WA 6009, Australia; [Thompson, Philip J.] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia; [Bhoola, Kanti] Univ Austral Chile, Dept Cellular Pathol, Valdivia, Chile	University of Western Australia; University of Western Australia; Universidad Austral de Chile	Thompson, PJ (corresponding author), LIWA, Mol Genet & Inflammat Unit, Perth, WA, Australia.	philip.thompson@liwa.uwa.edu.au		Baltic, Svetlana/0000-0002-3428-940X	Lung Institute of Western Australia; Cooperative Research Centre for Asthma and Airways	Lung Institute of Western Australia; Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The study was funded by The Lung Institute of Western Australia and The Cooperative Research Centre for Asthma and Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers M, 2000, J CELL BIOCHEM, V78, P278, DOI 10.1002/(SICI)1097-4644(20000801)78:2<278::AID-JCB10>3.0.CO;2-F; Angers M, 2005, BIOCHEM J, V389, P37, DOI 10.1042/BJ20042104; Belichard P, 1999, BRIT J PHARMACOL, V128, P213, DOI 10.1038/sj.bjp.0702769; Bertram C, 2007, INT IMMUNOPHARMACOL, V7, P1862, DOI 10.1016/j.intimp.2007.07.012; Bertram CM, 2007, J LEUKOCYTE BIOL, V81, P1445, DOI 10.1189/jlb.0106055; Bertram CM, 2009, J LEUKOCYTE BIOL, V85, P544, DOI 10.1189/jlb.0508283; BHOOLA KD, 1992, BRIT J RHEUMATOL, V31, P509; Blaukat A, 1999, BIOCHEMISTRY-US, V38, P1300, DOI 10.1021/bi981727r; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Campos MM, 1999, BRIT J PHARMACOL, V127, P1851, DOI 10.1038/sj.bjp.0702715; Campos MM, 1996, BRIT J PHARMACOL, V117, P793, DOI 10.1111/j.1476-5381.1996.tb15262.x; Campos MM, 1998, PEPTIDES, V19, P1269, DOI 10.1016/S0196-9781(98)00087-4; Chai KX, 1996, GENOMICS, V31, P51, DOI 10.1006/geno.1996.0008; Chan DC, 2002, CLIN CANCER RES, V8, P1280; Chee J, 2008, BIOL CHEM, V389, P1225, DOI 10.1515/BC.2008.139; Christiansen SC, 2002, J IMMUNOL, V169, P2054, DOI 10.4049/jimmunol.169.4.2054; Corvelo A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r141; Ellis KM, 2004, N-S ARCH PHARMACOL, V369, P166, DOI 10.1007/s00210-003-0857-6; Faussner A, 1999, IMMUNOPHARMACOLOGY, V45, P13, DOI 10.1016/S0162-3109(99)00052-1; Gera L, 2008, INT IMMUNOPHARMACOL, V8, P289, DOI 10.1016/j.intimp.2007.06.006; Goodyer CG, 2001, J MOL ENDOCRINOL, V27, P357, DOI 10.1677/jme.0.0270357; Gulliver R, 2011, AM J RESP CELL MOL, V45, P542, DOI 10.1165/rcmb.2010-0238OC; Haddad EB, 2000, MOL PHARMACOL, V57, P1123; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jones C, 1999, EUR J PHARMACOL, V374, P423, DOI 10.1016/S0014-2999(99)00315-5; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; KUBO M, 1989, J BACTERIOL, V171, P4080, DOI 10.1128/jb.171.7.4080-4082.1989; Landgraf RG, 2004, INFLAMM RES, V53, P78, DOI 10.1007/s00011-003-1226-0; Landry JR, 2001, GENOMICS, V76, P110, DOI 10.1006/geno.2001.6604; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin JCJ, 2010, PEPTIDES, V31, P1940, DOI 10.1016/j.peptides.2010.07.008; Loewen GM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-145; Marceau F, 1998, PHARMACOL REV, V50, P357; Medeiros R, 2004, CIRC RES, V94, P1375, DOI 10.1161/01.RES.0000128404.65887.08; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Newton R, 2002, EUR J PHARMACOL, V441, P193, DOI 10.1016/S0014-2999(01)01624-7; Ni A, 1998, BBA-GENE STRUCT EXPR, V1442, P177, DOI 10.1016/S0167-4781(98)00163-8; Ni AG, 1998, J BIOL CHEM, V273, P2784, DOI 10.1074/jbc.273.5.2784; Passos GF, 2004, J IMMUNOL, V172, P1839, DOI 10.4049/jimmunol.172.3.1839; Pastor T, 2009, NUCLEIC ACIDS RES, V37, P7258, DOI 10.1093/nar/gkp778; Phagoo SB, 2005, J PHARMACOL EXP THER, V313, P1231, DOI 10.1124/jpet.104.083030; Phagoo SB, 2001, J PHARMACOL EXP THER, V298, P77; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Scohy S, 2000, NUCLEIC ACIDS RES, V28, P3743, DOI 10.1093/nar/28.19.3743; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Wong J, 2011, PATH RES INT 2011; Wotherspoon G, 2000, NEUROSCI LETT, V294, P175, DOI 10.1016/S0304-3940(00)01561-5; Xu Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-13; Yang XG, 2001, J CELL BIOCHEM, V82, P163, DOI 10.1002/jcb.1116; Yang XH, 1998, J BIOL CHEM, V273, P10763, DOI 10.1074/jbc.273.17.10763; Yang XH, 1996, BIOCHEM BIOPH RES CO, V222, P718, DOI 10.1006/bbrc.1996.0810; Zhou XF, 1998, BIOCHEM J, V330, P361, DOI 10.1042/bj3300361	57	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87175	10.1371/journal.pone.0087175	http://dx.doi.org/10.1371/journal.pone.0087175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475248	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300150
J	Pakladok, T; Hosseinzadeh, Z; Almilaji, A; Lebedeva, A; Shumilina, E; Alesutan, I; Lang, F				Pakladok, Tatsiana; Hosseinzadeh, Zohreh; Almilaji, Ahmad; Lebedeva, Aleksandra; Shumilina, Ekaterina; Alesutan, Ioana; Lang, Florian			Up-Regulation of hERG K+ Channels by B-RAF	PLOS ONE			English	Article							LONG-QT SYNDROME; GLUCOSE-TRANSPORTER SGLT1; UBIQUITIN LIGASE NEDD4-2; DOWN-REGULATION; POTASSIUM CHANNELS; CANCER-CELLS; CARDIAC-ARRHYTHMIA; SIGNALING PATHWAYS; DENDRITIC CELLS; EXPRESSION	Human ether-a-go-go related-gene K+ channels (hERG) participate in the regulation of tumor cell proliferation and apoptosis. HERG channel activity is up-regulated by growth factors. Kinases sensitive to growth factor signaling include the serine/threonine protein kinase B-RAF. The present study thus explored whether B-RAF influences hERG channel expression and activity. To this end, hERG channels were expressed in Xenopus oocytes with or without wild-type B-RAF, hERG channel activity was determined utilizing dual-electrode voltage clamp and hERG protein abundance in the cell membrane was analyzed utilizing confocal microscopy as well as chemiluminescence. Moreover, in rhabdomyosarcoma RD cells the effect of B-RAF inhibitor PLX-4720 on hERG-mediated current was quantified by whole-cell patch clamp and hERG cell surface protein abundance by utilizing biotinylation of cell surface proteins as well as flow cytometry. As a result, co-expression of wild-type B-RAF in hERG-expressing Xenopus oocytes significantly increased hERG channel activity and hERG channel protein abundance in the cell membrane. Treatment for 24 hours of B-RAF and hERG-expressing Xenopus oocytes with B-RAF inhibitor PLX-4720 (10 mu M) significantly decreased hERG-mediated current and hERG cell surface expression. Similarly, in rhabdomyosarcoma RD cells, treatment for 24 hours with B-RAF inhibitor PLX-4720 significantly decreased hERG cell membrane protein abundance and hERG-mediated current. In conclusion, B-RAF is a powerful regulator of hERG channel activity and cell surface hERG protein abundance.	[Pakladok, Tatsiana; Hosseinzadeh, Zohreh; Almilaji, Ahmad; Lebedeva, Aleksandra; Shumilina, Ekaterina; Alesutan, Ioana; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Lebedeva, Aleksandra] Russian Acad Med Sci, Inst Expt Med, Dept Immunol, St Petersburg P-22, Russia	Eberhard Karls University of Tubingen; Institute of Experimental Medicine; Russian Academy of Medical Sciences	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Hosseinzadeh, Zohreh/X-8548-2019; Lebedeva, Aleksandra/ABI-2117-2020	Hosseinzadeh, Zohreh/0000-0003-3407-7754; 	Deutsche Forschungsgemeinschaft [GRK 1302/1, SE 1077/3, SFB 773]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (GRK 1302/1, SE 1077/3 and SFB 773)(URL: http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesutan I, 2012, CELL PHYSIOL BIOCHEM, V30, P458, DOI 10.1159/000339039; Almilaji A, 2013, PFLUGERS AR IN PRESS; Almilaji A, 2013, CELL PHYSIOL BIOCHEM, V31, P638, DOI 10.1159/000350083; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Bianchi L, 1998, CANCER RES, V58, P815; Bogatikov E, 2012, CELL PHYSIOL BIOCHEM, V30, P1538, DOI 10.1159/000343341; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; BROER S, 1994, BBA-BIOMEMBRANES, V1192, P95, DOI 10.1016/0005-2736(94)90147-3; Cheng H, 2011, CIRC RES, V109, P1401, DOI 10.1161/CIRCRESAHA.111.255695; Cordes JS, 2005, BRIT J PHARMACOL, V145, P15, DOI 10.1038/sj.bjp.0706140; Cui Z, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461715; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Eisenhardt AE, 2011, INT J CANCER, V129, P2297, DOI 10.1002/ijc.25893; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Fuchs Ota, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P16; Glassmeier G, 2012, PFLUG ARCH EUR J PHY, V463, P365, DOI 10.1007/s00424-011-1045-z; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Henrion U, 2012, CELL PHYSIOL BIOCHEM, V29, P809, DOI 10.1159/000178470; Hosseinzadeh Z, 2013, CELL PHYSIOL BIOCHEM, V31, P673, DOI 10.1159/000350086; Hosseinzadeh Z, 2012, CELL PHYSIOL BIOCHEM, V30, P1473, DOI 10.1159/000343335; Hosseinzadeh Z, 2012, CELL PHYSIOL BIOCHEM, V29, P737, DOI 10.1159/000178560; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; Huang FD, 2001, CIRCULATION, V104, P1071, DOI 10.1161/hc3501.093815; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Kamata T, 2011, AM J CANCER RES, V1, P955; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lamothe SM, 2013, J BIOL CHEM, V288, P15075, DOI 10.1074/jbc.M113.453670; Li GH, 2013, INT J NANOMED, V8, P1293, DOI 10.2147/IJN.S41555; Li HY, 2009, EXP CELL RES, V315, P2256, DOI 10.1016/j.yexcr.2009.04.017; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Masi A, 2005, BRIT J CANCER, V93, P781, DOI 10.1038/sj.bjc.6602775; Mia S, 2012, CELL PHYSIOL BIOCHEM, V30, P1039, DOI 10.1159/000341480; Muslin AJ, 2005, TRENDS CARDIOVAS MED, V15, P225, DOI 10.1016/j.tcm.2005.06.008; Ouadid-Ahidouch H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00220; Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096; Pakladok T, 2012, BIOCHEM BIOPH RES CO, V427, P689, DOI 10.1016/j.bbrc.2012.09.062; Pathare G, 2012, KIDNEY BLOOD PRESS R, V36, P149, DOI 10.1159/000343405; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Pillozzi S, 2010, ADV EXP MED BIOL, V674, P55; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Roering Michael, 2012, Critical Reviews in Oncogenesis, V17, P97; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Schmid E, 2012, CELL PHYSIOL BIOCHEM, V30, P1423, DOI 10.1159/000343330; Sisko JT, 2006, BIOORG MED CHEM LETT, V16, P1146, DOI 10.1016/j.bmcl.2005.11.089; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; Szteyn K, 2012, CELL PHYSIOL BIOCHEM, V30, P1319, DOI 10.1159/000343321; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vincent GM, 1998, ANNU REV MED, V49, P263; Zhang DY, 2008, CELL SIGNAL, V20, P1815, DOI 10.1016/j.cellsig.2008.06.006; Zheng F, 2012, MED ONCOL, V29, P2127, DOI 10.1007/s12032-011-0102-y; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	61	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87457	10.1371/journal.pone.0087457	http://dx.doi.org/10.1371/journal.pone.0087457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475291	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300186
J	Prieto, D; Roman, E; Correia, I; Pla, J				Prieto, Daniel; Roman, Elvira; Correia, Ines; Pla, Jesus			The HOG Pathway Is Critical for the Colonization of the Mouse Gastrointestinal Tract by Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE-STRESS-RESPONSE; GENE-EXPRESSION; CHLAMYDOSPORE FORMATION; VIRULENCE; FUNGI; MORPHOGENESIS; CONSTRUCTION; DIMORPHISM; TRIGGERS	The opportunistic pathogen Candida albicans is a frequent inhabitant of the human gastrointestinal tract where it usually behaves as a harmless commensal. In this particular niche, it needs to adapt to the different micro environments that challenge its survival within the host. In order to determine those factors involved in gut adaptation, we have used a gastrointestinal model of colonization in mouse to trace the behaviour of fungal cells. We have developed a genetic labelling system based on the complementary spectral properties of the fluorescent proteins GFP and a new C. albicans codon-adapted RFP (dTOM2) that allow a precise quantification of the fungal population in the gut via standard in vitro cultures or flow cytometry. This methodology has allowed us to determine the role of the three MAP kinase pathways of C. albicans (mediated by the MAPK Mkc1, Cek1 or Hog1) in mouse gut colonization via competitive assays with MAPK pathway mutants and their isogenic wild type strain. This approach reveals the signalling through HOG pathway as a critical factor influencing the establishment of C. albicans in the mouse gut. Less pronounced effects for mkc1 or cek1 mutants were found, only evident after 2-3 weeks of colonization. We have also seen that hog1 mutants is defective in adhesion to the gut mucosa and sensitive to bile salts. Finally, we have developed a genetic strategy for the in vivo excision (tetracycline-dependent) of any specific gene during the course of colonization in this particular niche, allowing the analysis of its role during gut colonization.	[Prieto, Daniel; Roman, Elvira; Correia, Ines; Pla, Jesus] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain	Complutense University of Madrid	Pla, J (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal S-N, Madrid, Spain.	jesuspla@farm.ucm.es	Pla, Jesús/G-8238-2015; GONZALEZ, ELVIRA ROMAN/U-3576-2019; Román, Elvira/H-8894-2015; Correia, Catarina/AAC-9702-2021; Pla, Jesús/ABG-9609-2020; Prieto, Daniel/P-2038-2017	Pla, Jesús/0000-0003-0897-1963; GONZALEZ, ELVIRA ROMAN/0000-0002-7335-7292; Román, Elvira/0000-0002-7335-7292; Prieto, Daniel/0000-0003-3931-5790; Correia, Ines/0000-0001-9723-8493	 [BIO2012-31839];  [PIM2010EPA-00658];  [P2010_BMD-2414]	; ; 	This work is supported by Grants BIO2012-31839, PIM2010EPA-00658, and P2010_BMD-2414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2009, CLIN MICROBIOL INFEC, V15, P17, DOI 10.1111/j.1469-0691.2008.02690.x; Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Antachopoulos C, 2007, EUR J PEDIATR, V166, P1099, DOI 10.1007/s00431-007-0527-7; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arana DM, 2005, MICROBIOL-SGM, V151, P1033, DOI 10.1099/mic.0.27723-0; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Bendel CM, 2002, PEDIATR RES, V51, P290, DOI 10.1203/00006450-200203000-00005; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; FONZI WA, 1993, GENETICS, V134, P717; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gerami-Nejad M, 2009, YEAST, V26, P399, DOI 10.1002/yea.1674; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gratacap RL, 2013, DIS MODEL MECH, V6, P1260, DOI 10.1242/dmm.012039; Hernday AD, 2010, METHOD ENZYMOL, V470, P737, DOI 10.1016/S0076-6879(10)70031-8; de Dios CH, 2013, FUNGAL GENET BIOL, V50, P21, DOI 10.1016/j.fgb.2012.11.001; Iliev ID, 2013, CURR OPIN MICROBIOL, V16, P366, DOI 10.1016/j.mib.2013.05.004; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Kinneberg KM, 1999, J SURG RES, V87, P245, DOI 10.1006/jsre.1999.5755; Koh AY, 2013, EUKARYOT CELL, V12, P1416, DOI 10.1128/EC.00196-13; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Mansour MK, 2002, CURR OPIN MICROBIOL, V5, P359, DOI 10.1016/S1369-5274(02)00342-9; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Morschhauser J, 1998, MOL GEN GENET, V257, P412, DOI 10.1007/s004380050665; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Navarro-Garcia F, 1998, MICROBIOL-UK, V144, P411, DOI 10.1099/00221287-144-2-411; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; Oh J, 2011, METHODS MOL BIOL, V765, P225, DOI 10.1007/978-1-61779-197-0_14; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Pande K, 2013, NAT GENET, V45, P1088, DOI 10.1038/ng.2710; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Perez JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001510; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Staib P, 2000, ADV EXP MED BIOL, V485, P167; VANDERWAAIJ LA, 1994, CYTOMETRY, V16, P270, DOI 10.1002/cyto.990160312; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184; Wiesner SM, 2001, CLIN DIAGN LAB IMMUN, V8, P192, DOI 10.1128/CDLI.8.1.192-195.2001; Wu W, 2007, MOL MICROBIOL, V64, P1587, DOI 10.1111/j.1365-2958.2007.05759.x; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yin ZK, 2009, PROTEOMICS, V9, P4686, DOI 10.1002/pmic.200800958; Zucchi PC, 2010, MOL MICROBIOL, V76, P733, DOI 10.1111/j.1365-2958.2010.07137.x	70	64	67	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87128	10.1371/journal.pone.0087128	http://dx.doi.org/10.1371/journal.pone.0087128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475243	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000330507300147
J	Nebor, D; Bowers, A; Connes, P; Hardy-Dessources, MD; Knight-Madden, J; Cumming, V; Reid, M; Romana, M				Nebor, Danitza; Bowers, Andre; Connes, Philippe; Hardy-Dessources, Marie-Dominique; Knight-Madden, Jennifer; Cumming, Vanessa; Reid, Marvin; Romana, Marc			Plasma Concentration of Platelet-Derived Microparticles Is Related to Painful Vaso-Occlusive Phenotype Severity in Sickle Cell Anemia	PLOS ONE			English	Article							DISEASE; HEMOLYSIS; HYPERCOAGULABILITY; MICROVESICLES; COAGULATION; ACTIVATION; STATE; RISK	High plasma level of microparticles (MPs) deriving mainly from erythrocytes and platelets has been detected in sickle cell anemia (SCA) patients. Flow cytometry was used to determine the concentration of MPs in two groups of SCA patients exhibiting marked differences in painful vaso-occlusive crisis rates [a non-severe group (n = 17) and a severe group (n = 12)], and in a control group composed of healthy subjects (n = 20). A 3- to 4-fold increase of total MP plasma concentration was detected in SCA patients. Higher platelet-derived MPs concentration was detected in the severe SCA group while erythrocyte-derived MPs concentration was increased in the non-severe SCA patient group only. Our results suggest that plasma concentration of MPs shed by platelets is a biomarker of the vaso-occlusive phenotype-related severity.	[Nebor, Danitza; Connes, Philippe; Hardy-Dessources, Marie-Dominique; Romana, Marc] INSERM, U665, Pointe A Pitre, Guadeloupe, France; [Nebor, Danitza; Connes, Philippe; Hardy-Dessources, Marie-Dominique; Romana, Marc] Univ Antilles Guyane, Pointe a Pitre, France; [Bowers, Andre] Univ W Indies, Dept Basic Med Sci, Physiol Sect, Kingston 7, Jamaica; [Connes, Philippe; Hardy-Dessources, Marie-Dominique; Romana, Marc] Lab Excellence GR Ex, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe] Univ French West Indies, Lab ACTES, St Claude, Guadeloupe, France; [Connes, Philippe; Hardy-Dessources, Marie-Dominique; Knight-Madden, Jennifer; Reid, Marvin; Romana, Marc] CAribbean Network REsearchers Sickle Cell Dis & T, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe] Inst Univ France, Paris, France; [Knight-Madden, Jennifer; Cumming, Vanessa; Reid, Marvin] Univ W Indies, Sickle Cell Unit, Res Inst Trop Med, Kingston 7, Jamaica	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; University West Indies Mona Jamaica; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France; University West Indies Mona Jamaica	Romana, M (corresponding author), INSERM, U665, Pointe A Pitre, Guadeloupe, France.	marc.romana@inserm.fr	Connes, Philippe/J-7835-2019; , Hardy-dessources/K-9189-2017; Romana, Marc/K-6442-2017; Reid, Marvin/J-2884-2014	Connes, Philippe/0000-0002-9232-0268; , Hardy-dessources/0000-0003-0861-3648; Romana, Marc/0000-0002-8715-9836; Reid, Marvin/0000-0003-4005-9384; Philippe, Connes/0000-0001-8449-7998	French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR); French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR)	French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR); French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR)	This study was supported in part by the French Embassy in Jamaica, the Universite des Antilles et de la Guyane and by the Fonds de Cooperation Regionale (FCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataga KI, 2003, AM J MED, V115, P721, DOI 10.1016/j.amjmed.2003.07.011; Camus SM, 2012, BLOOD, V120, P5050, DOI 10.1182/blood-2012-02-413138; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Lamarre Y, CLIN HEMORHEOL MICRO; Lamarre Y, 2013, CLIN HEMORHEOL MICRO; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Nebor D, 2013, HAEMATOLOGICA, V98, P862, DOI 10.3324/haematol.2012.073619; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Sparkenbaugh E, 2013, BRIT J HAEMATOL, V162, P3, DOI 10.1111/bjh.12336; Steinberg MH, 2005, BRIT J HAEMATOL, V129, P465, DOI 10.1111/j.1365-2141.2005.05411.x; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; van Beers EJ, 2009, HAEMATOL-HEMATOL J, V94, P1513, DOI 10.3324/haematol.2009.008938; van Tits LJ, 2009, BIOCHEM BIOPH RES CO, V390, P161, DOI 10.1016/j.bbrc.2009.09.102; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x; Willekens FLA, 2005, BLOOD, V105, P2141, DOI 10.1182/blood-2004-04-1578; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008; Wun T, 1998, BRIT J HAEMATOL, V100, P741, DOI 10.1046/j.1365-2141.1998.00627.x	25	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87243	10.1371/journal.pone.0087243	http://dx.doi.org/10.1371/journal.pone.0087243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475257	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800090
J	Suen, VYM; Brown, MRG; Morck, RK; Silverstone, PH				Suen, Victoria Y. M.; Brown, Matthew R. G.; Morck, Randall K.; Silverstone, Peter H.			Regional Brain Changes Occurring during Disobedience to "Experts" in Financial Decision-Making	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; RISK-TAKING; ACTION SELECTION; HERD BEHAVIOR; MUTUAL FUNDS; NEURAL BASIS; ACTIVATION; REWARD; PERFORMANCE	It is well recognized that individuals follow "Expert'' advice, even when flawed and offers no advantage, and sometimes leads to disadvantages. The neurobiology underlying this is uncertain, and in particular there is an incomplete understanding of which brain regions are most involved when individuals chose to disobey an expert. To study this we examined functional magnetic resonance imaging (fMRI) differences during an investment game where subjects received differentially credible investment advice. Participants (n = 42; 32 males) played an investment game, in which they could Buy or Not Buy a sequence of stocks. The better they did, the more money they made. Participants received either "Expert'' advice or "Peer'' advice. Those receiving Expert advice were told the advice came from a certified financial "Expert''. Those receiving Peer Advice were told the advice was that of the student administering the scans, who deliberately dressed and acted casually. Both streams of advice were predetermined and identical. The advice was scripted to be helpful initially, but progressively worse as the task continued, becoming 100% wrong by the end of the task. Subjects receiving Expert Advice followed the advice significantly longer on average, even though this was progressively worse advice. Thus, following Expert advice had poorer consequences for individuals, but this did not dissuade them from continuing to follow the advice. In contrast, when subjects disobeyed Expert advice they exhibited significant anterior cingulate cortex (ACC) and superior frontal gyrus activation relative to those disobeying Peer advice. These findings may suggest that in subjects who defy authority, or believe they are doing so (in this case by disobeying an "Expert'') there is increased activation of these two brain regions. This may have relevance to several areas of behavior, and the potential role of these two brain regions in regard to disobedience behavior requires further study.	[Suen, Victoria Y. M.; Brown, Matthew R. G.; Silverstone, Peter H.] Univ Alberta, Dept Psychiat, Fac Med & Dent, Edmonton, AB, Canada; [Morck, Randall K.] Univ Alberta, Fac Business, Dept Finance & Stat Anal, Edmonton, AB, Canada	University of Alberta; University of Alberta	Silverstone, PH (corresponding author), Univ Alberta, Dept Psychiat, Fac Med & Dent, Edmonton, AB, Canada.	peter.silverstone@ualberta.ca	Morck, Randall/AAD-9048-2019	Morck, Randall/0000-0001-7412-0222	Alberta Gambling Research Institute, Alberta, Canada; Social Sciences and Humanities Research Council of Canada	Alberta Gambling Research Institute, Alberta, Canada; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was funded in part by the Alberta Gambling Research Institute, Alberta, Canada, and in part by a grant from the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Bausell R. B., 2007, SNAKE OIL SCI; Bergstresser D, 2009, REV FINANC STUD, V22, P4129, DOI 10.1093/rfs/hhp022; Brown MRG, 2012, NEUROIMAGE, V63, P434, DOI 10.1016/j.neuroimage.2012.06.056; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Del Guercio D., 2010, 16312 NBER; Elliott R, 1998, NEUROIMAGE, V8, P17, DOI 10.1006/nimg.1998.0344; Engelmann JB, 2012, SOC COGN AFFECT NEUR, V7, P557, DOI 10.1093/scan/nss050; Engelmann JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004957; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; French KR, 2008, J FINANC, V63, P1537, DOI 10.1111/j.1540-6261.2008.01368.x; Gruber MJ, 1996, J FINANC, V51, P783, DOI 10.2307/2329222; Hargreaves IS, 2012, BRAIN LANG, V120, P73, DOI 10.1016/j.bandl.2011.10.004; Harrison G.W., 1994, EMPIR ECON, P43, DOI DOI 10.1007/BF01175873; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Inderst R, 2012, J EC LIT, V50; JENSEN MC, 1968, J FINANC, V23, P389, DOI 10.2307/2325404; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kim KK, 2011, EPILEPSY BEHAV, V20, P613, DOI 10.1016/j.yebeh.2010.11.010; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Loh RK, 2011, REV FINANC STUD, V24, P593, DOI 10.1093/rfs/hhq094; Luu P., 2004, COGNITIVE NEUROSCIEN; Malkiel B. G., 2003, RANDOM WALK WALL STR; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Meshi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049748; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Paulus MP, 2004, BIOL PSYCHIAT, V55, P1179, DOI 10.1016/j.biopsych.2004.02.023; Paulus MP, 2004, NEUROIMAGE, V21, P733, DOI 10.1016/j.neuroimage.2003.09.060; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rosenbloom MH, 2012, J NEUROPSYCH CLIN N, V24, P266, DOI 10.1176/appi.neuropsych.11060139; SCHARFSTEIN DS, 1990, AM ECON REV, V80, P465; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Singh S., 2008, TRICK TREATMENT ALTE; Sjoberg L, 2009, J BEHAV FINANC, V10, P33, DOI 10.1080/15427560902728712; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; TAYLOR JG, 1979, NATURE, V279, P631, DOI 10.1038/279631a0; TRUEMAN B, 1994, REV FINANC STUD, V7, P97, DOI 10.1093/rfs/7.1.97; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; WILCOX NT, 1993, ECON J, V103, P1397, DOI 10.2307/2234473	50	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87321	10.1371/journal.pone.0087321	http://dx.doi.org/10.1371/journal.pone.0087321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475270	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800094
J	Gui, SY; Gathiaka, S; Li, J; Qu, J; Acevedo, O; Hevel, JM				Gui, Shanying; Gathiaka, Symon; Li, Jun; Qu, Jun; Acevedo, Orlando; Hevel, Joan M.			A Remodeled Protein Arginine Methyltransferase 1 ( PRMT1) Generates Symmetric Dimethylarginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Enzyme Mechanisms; Histone Methylation; Protein Methylation; S-adenosylmethionine (SAM); Site-directed Mutagenesis; Dimethylarginine; Product Specificity; Protein Arginine Methyltransferase	FREE-ENERGY SIMULATIONS; PRODUCT SPECIFICITY; ASYMMETRIC DIMETHYLARGININE; LYSINE METHYLTRANSFERASES; SUBSTRATE-SPECIFICITY; KINETIC MECHANISM; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; METHYLATION; RESIDUES	Background: Asymmetric and symmetric dimethylarginine (ADMA and SDMA) residues are biologically distinct products of protein arginine methyltransferase (PRMT) isoforms. Results: Met-48 in PRMT1 regulates the regiochemistry of dimethylation, and SDMA formation is energetically costly. Conclusion: Steric changes in the PRMT1 active site can reprogram product formation. Significance: SDMA-forming PRMTs may require additional factors to overcome the energetic cost of SDMA. Protein arginine methylation is emerging as a significant post-translational modification involved in various cell processes and human diseases. As the major arginine methylation enzyme, protein arginine methyltransferase 1 (PRMT1) strictly generates monomethylarginine and asymmetric dimethylarginine (ADMA), but not symmetric dimethylarginine (SDMA). The two types of dimethylarginines can lead to distinct biological outputs, as highlighted in the PRMT-dependent epigenetic control of transcription. However, it remains unclear how PRMT1 product specificity is regulated. We discovered that a single amino acid mutation (Met-48 to Phe) in the PRMT1 active site enables PRMT1 to generate both ADMA and SDMA. Due to the limited amount of SDMA formed, we carried out quantum mechanical calculations to determine the free energies of activation of ADMA and SDMA synthesis. Our results indicate that the higher energy barrier of SDMA formation (G(double dagger) = 3.2 kcal/mol as compared with ADMA) may explain the small amount of SDMA generated by M48F-PRMT1. Our study reveals unique energetic challenges for SDMA-forming methyltransferases and highlights the exquisite control of product formation by active site residues in the PRMTs.	[Gui, Shanying; Hevel, Joan M.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Gathiaka, Symon; Acevedo, Orlando] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Amherst, NY 14260 USA	Utah System of Higher Education; Utah State University; Auburn University System; Auburn University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hevel, JM (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84322 USA.	Joanie.Hevel@usu.edu	Gui, Shanying/AAM-8633-2021; Li, Jun/N-3806-2014	Li, Jun/0000-0001-9940-3421; Hevel, Joan/0000-0002-9559-4635	National Science Foundation [0920776]; American Recovery and Reinvestment Act; Auburn University; Alabama Supercomputer Center; National Institutes of Health [U54HD071594, DA027528, AI060260, HD075363, HL103411]; Center for Protein Therapeutics; American Heart Association (AHA) [12SDG9450036]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071594, R21HD075363] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060260, R56AI060260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027528] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Recovery and Reinvestment Act; Auburn University; Alabama Supercomputer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Protein Therapeutics; American Heart Association (AHA)(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Science Foundation Award 0920776 (to J. M. H.); the American Recovery and Reinvestment Act, Auburn University, and the Alabama Supercomputer Center (to O. A.); National Institutes of Health Grants U54HD071594, DA027528, AI060260, HD075363, and HL103411 (to J. Q.); the Center for Protein Therapeutics (to J. Q.); and American Heart Association (AHA) Award 12SDG9450036 (to J. Q.).	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chu YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037674; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; De Gennaro Colonna V., 2009, MED SCI MONIT, V15, pRA91; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gui SY, 2013, BIOCHEMISTRY-US, V52, P199, DOI 10.1021/bi301283t; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Gunaydin H, 2007, J CHEM THEORY COMPUT, V3, P1028, DOI 10.1021/ct050318n; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Levine T. B., 2006, METABOLIC SYNDROME C, P421; Markowski P, 2007, ANAL CHIM ACTA, V605, P205, DOI 10.1016/j.aca.2007.10.033; MATSUOKA Y, 1972, SEIKAGAKU, V44, P364; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Ochterski JW, 1996, J CHEM PHYS, V104, P2598, DOI 10.1063/1.470985; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Paik W. K., 1980, PROTEIN METHYLATION, P8; Parr R. G., 1989, DENSITY FUNCTIONAL T; Qu J, 2007, ANAL CHEM, V79, P3786, DOI 10.1021/ac062184r; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wang H, 2009, J AM SOC MASS SPECTR, V20, P507, DOI 10.1016/j.jasms.2008.11.008; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xu Q, 2009, CHEM-EUR J, V15, P12596, DOI 10.1002/chem.200902297; Yao JZ, 2012, J CHEM INF MODEL, V52, P449, DOI 10.1021/ci200364m; Zhang RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072424; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	43	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9320	9327		10.1074/jbc.M113.535278	http://dx.doi.org/10.1074/jbc.M113.535278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24478314	Green Published, hybrid			2022-12-25	WOS:000333472100048
J	Brown, LM; Rogers, KE; McCammon, JA; Insel, PA				Brown, Loren M.; Rogers, Kathleen E.; McCammon, J. Andrew; Insel, Paul A.			Identification and Validation of Modulators of Exchange Protein Activated by cAMP (Epac) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioluminescence Resonance Energy Transfer (BRET); Cyclic AMP (cAMP); Enzyme Inhibitors; Guanine Nucleotide Exchange Factor (GEF); Molecular Docking; Molecular Pharmacology; Epac1	RESONANCE ENERGY-TRANSFER; ANALOGS; KINASE; RAP1; MECHANISM; BINDING; SIMULATION; DYNAMICS; FAMILY; TOOLS	Background: Epac1 is a guanine nucleotide exchange factor for Rap1 activated by cAMP. Results: We use a BRET-based method to identify modulators of Epac1 activity. Conclusion: Molecules that displace cAMP but do not stabilize the lid of Epac are novel inhibitors. Significance: Understanding how cAMP analogs influence movement of Epac can aid in designing inhibitors for Epac-mediated cAMP signaling. The signaling molecule cAMP primarily mediates its effects by activating PKA and/or exchange protein activated by cAMP (Epac). Epac has been implicated in many responses in cells, but its precise roles have been difficult to define in the absence of Epac inhibitors. Epac, a guanine nucleotide exchange factor for the low molecular weight G protein Rap, is directly activated by cAMP. Using a bioluminescence resonance energy transfer-based assay (CAMYEL) to examine modulators of Epac activity, we took advantage of its intramolecular movement that occurs upon cAMP binding to assess Epac activation. We found that the use of CAMYEL can detect the binding of cAMP analogs to Epac and their modulation of its activity and can distinguish between agonists (cAMP), partial agonists (8-chlorophenylthio-cAMP), and super agonists (8-chlorophenylthio-2-O-Me-cAMP). The CAMYEL assay can also identify competitive and uncompetitive Epac inhibitors, e.g. (R-p)-cAMPS and CE3F4, respectively. To confirm the results with the CAMYEL assay, we used Swiss 3T3 cells and assessed the ability of cyclic nucleotide analogs to modulate the activity of Epac or PKA, determined by Rap1 activity or VASP phosphorylation, respectively. We used computational molecular modeling to analyze the interaction of analogs with Epac1. The results reveal a rapid means to identify modulators (potentially including allosteric inhibitors) of Epac activity that also provides insight into the mechanisms of Epac activation and inhibition.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	McCammon, J. Andrew/AAG-1832-2021	McCammon, J. Andrew/0000-0003-3065-1456	National Institutes of Health [5T32DK007541-27, GM31749]; National Science Foundation [MCB1020765]; Howard Hughes Medical Institute; National Biomedical Computation Resource; Center for Theoretical Biological Physics; National Science Foundation Supercomputer Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM031749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Biomedical Computation Resource; Center for Theoretical Biological Physics; National Science Foundation Supercomputer Centers(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant 5T32DK007541-27 and Grant GM31749 (to J. A. M.). This work was also supported by National Science Foundation Grant MCB1020765 (to J. A. M.), the Howard Hughes Medical Institute, the National Biomedical Computation Resource, the Center for Theoretical Biological Physics, and National Science Foundation Supercomputer Centers.	Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Case DA, 2012, AMBER 12; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Consonni SV, 2012, P NATL ACAD SCI USA, V109, P3814, DOI 10.1073/pnas.1117599109; Courilleau D, 2013, BIOCHEM BIOPH RES CO, V440, P443, DOI 10.1016/j.bbrc.2013.09.107; Courilleau D, 2012, J BIOL CHEM, V287, P44192, DOI 10.1074/jbc.M112.422956; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DeLano W. L., 2013, SMALL MOL DRUG DISCO; DeLano W. L., 2013, LIGPREP VERSION 2 6; DeLano W. L., 2013, PROTEIN PREPARATION; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Henzler AM, 2010, MOL INFORM, V29, P164, DOI 10.1002/minf.200900078; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Matthiesen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024392; McPhee I, 2005, BIOCHEM SOC T, V33, P1330, DOI 10.1042/BST0331330; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Tsalkova T., 2012, PLOS ONE, V7; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	45	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8217	8230		10.1074/jbc.M114.548636	http://dx.doi.org/10.1074/jbc.M114.548636			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497631	Green Published, hybrid			2022-12-25	WOS:000333157500017
J	Suzuki, T; Suzuki, J; Nagata, S				Suzuki, Takayuki; Suzuki, Jun; Nagata, Shigekazu			Functional Swapping between Transmembrane Proteins TMEM16A and TMEM16F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloride Channels; Enzyme Mutation; Phosphatidylserine; Plasma Membrane; Protein Domains	CA2+-ACTIVATED CL-CHANNEL; ACTIVATED CHLORIDE CHANNEL; GNATHODIAPHYSEAL-DYSPLASIA; SCRAMBLASE ACTIVITY; MEMBRANE-PROTEIN; FAMILY-MEMBERS; GREEN TEA; EXPRESSION; CELLS; PHOSPHATIDYLSERINE	Background: TMEM16A and -16F function as a Ca2+-dependent Cl- channel and phospholipid scramblase, respectively. Results: The N- and C-terminal domains of TMEM16A and -16F are exchangeable and are necessary for ER exit and stability. Conclusion: TMEM16A and -16F use a similar mechanism for transporting and stabilizing protein, but their functional domains differ. Significance: Identifying functional domains will lead to better understanding of TMEM16 family. The transmembrane proteins TMEM16A and -16F each carry eight transmembrane regions with cytoplasmic N and C termini. TMEM16A carries out Ca2+-dependent Cl- ion transport, and TMEM16F is responsible for Ca2+-dependent phospholipid scrambling. Here we established assay systems for the Ca2+-dependent Cl- channel activity using 293T cells and for the phospholipid scramblase activity using TMEM16F(-/-) immortalized fetal thymocytes. Chemical cross-linking analysis showed that TMEM16A and -16F form homodimers in both 293T cells and immortalized fetal thymocytes. Successive deletion from the N or C terminus of both proteins and the swapping of regions between TMEM16A and -16F indicated that their cytoplasmic N-terminal (147 amino acids for TMEM16A and 95 for 16F) and C-terminal (88 amino acids for TMEM16A and 68 for 16F) regions were essential for their localization at plasma membranes and protein stability, respectively, and could be exchanged. Analyses of TMEM16A and -16F mutants with point mutations in the pore region (located between the fifth and sixth transmembrane regions) indicated that the pore region is essential for both the Cl- channel activity of TMEM16A and the phospholipid scramblase activity of TMEM16F. Some chemicals such as epigallocatechin-3-gallate and digallic acid inhibited the Cl- channel activity of TMEM16A and the scramblase activity of TMEM16F with an opposite preference. These results indicate that TMEM16A and -16F use a similar mechanism for sorting to plasma membrane and protein stabilization, but their functional domains significantly differ.	[Suzuki, Takayuki; Suzuki, Jun; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture in Japan; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture in Japan.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Das S, 2007, CANCER RES, V67, P1594, DOI 10.1158/0008-5472.CAN-06-2673; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Flores CA, 2009, BRAZ J MED BIOL RES, V42, P993, DOI 10.1590/S0100-879X2009005000028; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Kuba H, 2003, J PHYSIOL-LONDON, V552, P611, DOI 10.1113/jphysiol.2003.041574; Lhermusier T, 2011, J THROMB HAEMOST, V9, P1883, DOI 10.1111/j.1538-7836.2011.04478.x; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murai K, 1998, P NATL ACAD SCI USA, V95, P3461, DOI 10.1073/pnas.95.7.3461; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szteyn K, 2012, CELL PHYSIOL BIOCHEM, V30, P1319, DOI 10.1159/000343321; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	43	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7438	7447		10.1074/jbc.M113.542324	http://dx.doi.org/10.1074/jbc.M113.542324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478309	hybrid, Green Published			2022-12-25	WOS:000332761500015
J	Guo, M; Zhou, Q; Zhou, YZ; Yang, LF; Liu, TX; Yang, JL; Chen, YL; Su, LX; Xu, J; Chen, J; Liu, F; Chen, JP; Dai, WK; Ni, PX; Fang, CX; Yang, RF				Guo, Min; Zhou, Qian; Zhou, Yizhuang; Yang, Linfeng; Liu, Tianxiang; Yang, Jinlong; Chen, Yanling; Su, Longxiang; Xu, Jin; Chen, Jing; Liu, Feng; Chen, Jiapeng; Dai, Wenkui; Ni, Peixiang; Fang, Chengxiang; Yang, Ruifu			Genomic Evolution of 11 Type Strains within Family Planctomycetaceae	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FEATURE FREQUENCY PROFILES; DNA-DNA HYBRIDIZATION; SP-NOV.; GEN. NOV.; SEQUENCE; IDENTIFICATION; PIRELLULA; ALIGNMENT; ORDER	The species in family Planctomycetaceae are ideal groups for investigating the origin of eukaryotes. Their cells are divided by a lipidic intracytoplasmic membrane and they share a number of eukaryote-like molecular characteristics. However, their genomic structures, potential abilities, and evolutionary status are still unknown. In this study, we searched for common protein families and a core genome/pan genome based on 11 sequenced species in family Planctomycetaceae. Then, we constructed phylogenetic tree based on their 832 common protein families. We also annotated the 11 genomes using the Clusters of Orthologous Groups database. Moreover, we predicted and reconstructed their core/pan metabolic pathways using the KEGG (Kyoto Encyclopedia of Genes and Genomes) orthology system. Subsequently, we identified genomic islands (GIs) and structural variations (SVs) among the five complete genomes and we specifically investigated the integration of two Planctomycetaceae plasmids in all 11 genomes. The results indicate that Planctomycetaceae species share diverse genomic variations and unique genomic characteristics, as well as have huge potential for human applications.	[Guo, Min; Fang, Chengxiang; Yang, Ruifu] BGI Shenzhen, Shenzhen Key Lab Environm Microbial Genom & Appli, Shenzhen, Peoples R China; [Guo, Min; Zhou, Yizhuang; Yang, Jinlong; Chen, Jing; Fang, Chengxiang; Yang, Ruifu] BGI Shenzhen, Shenzhen Key Lab Bioenergy, Shenzhen, Peoples R China; [Guo, Min; Zhou, Qian; Zhou, Yizhuang; Yang, Linfeng; Liu, Tianxiang; Yang, Jinlong; Chen, Yanling; Xu, Jin; Chen, Jing; Liu, Feng; Chen, Jiapeng; Dai, Wenkui; Ni, Peixiang; Yang, Ruifu] BGI Shenzhen, Shenzhen, Peoples R China; [Su, Longxiang] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Fang, Chengxiang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Nankai University; Wuhan University; Beijing Institute of Microbiology & Epidemiology	Yang, RF (corresponding author), BGI Shenzhen, Shenzhen Key Lab Environm Microbial Genom & Appli, Shenzhen, Peoples R China.	ruifuyang@gmail.com	Yang, Linfeng/AAZ-8792-2020; xu, jin/O-6912-2019; chen, yanling/GRE-8287-2022; Yang, Ruifu/A-2273-2011; Su, Longxiang/I-6788-2019	xu, jin/0000-0003-2289-4896; Yang, Ruifu/0000-0003-3219-7269; Su, Longxiang/0000-0002-0942-2870; Chen, Jing/0000-0001-9481-9997; Chen, Jiapeng/0000-0002-9145-3018	Shenzhen Key Laboratory of Bioenergy [CXB201005240001A]; Shenzhen Key Laboratory of Environmental Microbial Genomics and Application [CXB201108250097A]; State Key Development Program for Basic Research of China [2009CB522600]; National Natural Science Foundation of China [30930001]	Shenzhen Key Laboratory of Bioenergy; Shenzhen Key Laboratory of Environmental Microbial Genomics and Application; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shenzhen Key Laboratory of Bioenergy (grant CXB201005240001A), Shenzhen Key Laboratory of Environmental Microbial Genomics and Application(grant CXB201108250097A) and by grants from the State Key Development Program for Basic Research of China (2009CB522600), the National Natural Science Foundation of China (Contract 30930001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2011, DNA RES, V18, P423, DOI 10.1093/dnares/dsr029; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bondoso J, 2011, INT J SYST EVOL MICR, V61, P2844, DOI 10.1099/ijs.0.027474-0; Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Chavan A, 2012, BMJ CASE REP; Clum Alicia, 2010, Stand Genomic Sci, V2, P228, DOI 10.4056/sigs.881234; Clum A, 2009, STAND GENOMIC SCI, V1, P308, DOI 10.4056/sigs.51657; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Damste JSS, 2005, FEBS J, V272, P4270, DOI 10.1111/j.1742-4658.2005.04842.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dhillon BK, 2013, NUCLEIC ACIDS RES, V41, pW129, DOI 10.1093/nar/gkt394; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ermolaeva MD, 2001, NUCLEIC ACIDS RES, V29, P1216, DOI 10.1093/nar/29.5.1216; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Gade D, 2005, PROTEOMICS, V5, P3672, DOI 10.1002/pmic.200401200; Gade D, 2004, MICROB ECOL, V47, P243, DOI 10.1007/s00248-003-1016-9; GIOVANNONI SJ, 1987, ARCH MICROBIOL, V147, P276, DOI 10.1007/BF00463488; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guo M, 2012, J BACTERIOL, V194, P3740, DOI 10.1128/JB.00639-12; Henrici AT, 1935, J BACTERIOL, V30, P61, DOI 10.1128/JB.30.1.61-93.1935; Hieu CX, 2008, PROTEOMICS, V8, P1608, DOI 10.1002/pmic.200701017; Jetten MSM, 2008, ENVIRON MICROBIOL, V10, P2903, DOI 10.1111/j.1462-2920.2008.01786.x; Jogler C, 2012, J BACTERIOL, V194, P6419, DOI 10.1128/JB.01325-12; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; KERGER BD, 1988, ARCH MICROBIOL, V149, P255, DOI 10.1007/BF00422014; Kleiner M, 2012, CURR OPIN MICROBIOL, V15, P621, DOI 10.1016/j.mib.2012.09.003; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kulichevskaya IS, 2008, INT J SYST EVOL MICR, V58, P1186, DOI 10.1099/ijs.0.65593-0; Kulichevskaya IS, 2007, INT J SYST EVOL MICR, V57, P2680, DOI 10.1099/ijs.0.65157-0; Kulichevskaya IS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00146; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LaButti K, 2010, STAND GENOMIC SCI, V3, P47, DOI 10.4056/sigs.1052813; LACASSE EC, 1993, ENDOCRINOLOGY, V133, P2760, DOI 10.1210/endo.133.6.8243301; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lango Zsuzsanna, 2005, Acta Microbiologica et Immunologica Hungarica, V52, P73, DOI 10.1556/AMicr.52.2005.1.3; Leary BA, 1998, GENE, V221, P151, DOI 10.1016/S0378-1119(98)00423-5; Lee HW, 2012, INT J SYST EVOL MICR; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Nardi E, 2011, CLIN NEPHROL, V76, P330, DOI 10.5414/CN106676; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; SCHMIDT JM, 1979, CURR MICROBIOL, V3, P187, DOI 10.1007/BF02601865; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	56	13	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86752	10.1371/journal.pone.0086752	http://dx.doi.org/10.1371/journal.pone.0086752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489782	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000068
J	Jacka, FN; Cherbuin, N; Anstey, KJ; Butterworth, P				Jacka, Felice N.; Cherbuin, Nicolas; Anstey, Kaarin J.; Butterworth, Peter			Dietary Patterns and Depressive Symptoms over Time: Examining the Relationships with Socioeconomic Position, Health Behaviours and Cardiovascular Risk	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; OXIDATIVE STRESS; ASSOCIATION; QUALITY; COHORT; WOMEN; LIFE; INEQUALITIES; INFLAMMATION; METAANALYSIS	Introduction: Recent research suggests that diet quality influences depression risk; however, a lack of experimental evidence leaves open the possibility that residual confounding explains the observed relationships. The aim of this study was to document the cross-sectional and longitudinal associations between dietary patterns and symptoms of depression and to undertake a detailed examination of potential explanatory factors, particularly socioeconomic circumstances, in the diet-depression relationship. Methods: Data were drawn from the Personality and Total Health (PATH) Through Life Study, a longitudinal community study following three age cohorts (20+; 40+; 60+ yrs) from south-eastern Australia over three assessment periods (n = 3663). Regression analyses evaluated the cross-sectional and longitudinal relationships between dietary patterns, depressive symptoms, age, detailed measures of socioeconomic circumstances, other health behaviours, and cardiovascular risk factors. Results: The lowest tertile of prudent (healthy) dietary pattern and the highest tertile of western (unhealthy) dietary pattern were associated with an increased likelihood of depressive symptoms. However, these contemporaneous associations were explained by adjustment for detailed measures of socioeconomic circumstances and physical activity. In prospective analyses, lower scores on the healthy dietary pattern and higher scores on the unhealthy dietary pattern independently predicted increased depressive symptoms across time, before and after adjustment for potential confounders and baseline depressive symptoms, but only for those in the oldest cohort. Dietary patterns did not explain the relationship between socioeconomic position and depressive symptoms. Conclusion: The results of this study confirm that the relationship between habitual dietary intake and depressive symptoms is somewhat explained by socioeconomic circumstances and other health behaviours, but suggest that long term exposure to unhealthy dietary habits independently predisposes to depression over the lifecourse.	[Jacka, Felice N.] Deakin Univ, IMPACT Strateg Res Ctr, Div Nutr Psychiat Res, Geelong, Vic 3217, Australia; [Jacka, Felice N.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Cherbuin, Nicolas; Anstey, Kaarin J.; Butterworth, Peter] Australian Natl Univ, Ctr Res Ageing Hlth & Well Being, Canberra, ACT, Australia	Deakin University; University of Melbourne; Australian National University	Jacka, FN (corresponding author), Deakin Univ, IMPACT Strateg Res Ctr, Div Nutr Psychiat Res, Geelong, Vic 3217, Australia.	felice@barwonhealth.org.au	Jacka, Felice N/D-9424-2012; Butterworth, Peter/AFK-2636-2022; Jacka, Felice N/ABE-6322-2020; Anstey, Kaarin/A-3852-2008; Cherbuin, Nicolas/A-8515-2008	Jacka, Felice N/0000-0002-9825-0328; Jacka, Felice N/0000-0002-9825-0328; Anstey, Kaarin/0000-0002-9706-9316; Cherbuin, Nicolas/0000-0001-6481-0748; Butterworth, Peter/0000-0002-1531-3881	NHMRC [973302, 157125, 1002560, 628912]; ARC [120100227];  [179805];  [350833]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); ; 	This study was supported by NHMRC Grant No. 973302, Program Grants No. 179805 and 350833, NHMRC project grant No. 157125. KJA is funded by NHMRC Research Fellowship No. 1002560. NC is funded by an ARC Future Fellowship No. 120100227. FNJ is funded by an NHMRC Postdoctoral Fellowship No. 628912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Ambrosini GL, 2003, PUBLIC HEALTH NUTR, V6, P415, DOI 10.1079/PHN2002434; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2012, INT J EPIDEMIOL, V41, P951, DOI 10.1093/ije/dyr025; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P23, DOI 10.1177/0891988708328216; Berk M, 2012, BRIT J PSYCHIAT, V201, P339, DOI 10.1192/bjp.bp.111.107797; Butterworth P, 2013, J AFFECT DISORDERS, V149, P75, DOI 10.1016/j.jad.2013.01.006; Butterworth P, 2012, AUST NZ J PSYCHIAT, V46, P364, DOI 10.1177/0004867411433215; Butterworth P, 2009, SOC SCI MED, V69, P229, DOI 10.1016/j.socscimed.2009.05.008; Chatzi L, 2011, PUBLIC HEALTH NUTR, V14, P1663, DOI 10.1017/S1368980010003629; Collins CE, 2008, J AM COLL NUTR, V27, P146, DOI 10.1080/07315724.2008.10719686; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Gerecke KM, 2013, BRAIN RES; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Guenther PM, 2007, DEV EVALUATION HLTH; Henderson L, 2002, NATL DIET NUTR SURVE; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jacka FN, 2013, J AM ACAD CHILD PSY, V52, P1038, DOI 10.1016/j.jaac.2013.07.002; Jacka FN, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-149; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jacka FN, 2011, J AFFECT DISORDERS, V129, P332, DOI 10.1016/j.jad.2010.09.004; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kohlboeck G, 2012, ANN NUTR METAB, V60, P247, DOI 10.1159/000337552; Lassale C, 2009, J HUM NUTR DIET, V22, P559, DOI 10.1111/j.1365-277X.2009.00990.x; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Maron David J, 2004, Curr Atheroscler Rep, V6, P73, DOI 10.1007/s11883-004-0119-1; Mila-Villarroel R, 2011, PUBLIC HEALTH NUTR, V14, P2338, DOI 10.1017/S1368980011002606; Mohanty P, 2002, AM J CLIN NUTR, V75, P767, DOI 10.1093/ajcn/75.4.767; Morris LJ, 2011, MENTAL HLTH WELLBEIN; Mulder M, 1998, INT J EPIDEMIOL, V27, P199, DOI 10.1093/ije/27.2.199; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Weng T T, 2011, PUBLIC HLTH NUT, V25, P1; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	43	101	101	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87657	10.1371/journal.pone.0087657	http://dx.doi.org/10.1371/journal.pone.0087657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489946	Green Published, gold			2022-12-25	WOS:000330570000166
J	Nigro, S; Cerasa, A; Zito, G; Perrotta, P; Chiaravalloti, F; Donzuso, G; Fera, F; Bilotta, E; Pantano, P; Quattrone, A				Nigro, Salvatore; Cerasa, Antonio; Zito, Giancarlo; Perrotta, Paolo; Chiaravalloti, Francesco; Donzuso, Giulia; Fera, Franceso; Bilotta, Eleonora; Pantano, Pietro; Quattrone, Aldo		Alzheimer's Dis Neuroimaging	Fully Automated Segmentation of the Pons and Midbrain Using Human T1 MR Brain Images	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CLASSIFICATION; DEFORMATION; NUCLEUS; DISEASE; REGION; PLANE; MODEL	Purpose: This paper describes a novel method to automatically segment the human brainstem into midbrain and pons, called LABS: Landmark-based Automated Brainstem Segmentation. LABS processes high-resolution structural magnetic resonance images (MRIs) according to a revised landmark-based approach integrated with a thresholding method, without manual interaction. Methods: This method was first tested on morphological T1-weighted MRIs of 30 healthy subjects. Its reliability was further confirmed by including neurological patients (with Alzheimer's Disease) from the ADNI repository, in whom the presence of volumetric loss within the brainstem had been previously described. Segmentation accuracies were evaluated against expert-drawn manual delineation. To evaluate the quality of LABS segmentation we used volumetric, spatial overlap and distance-based metrics. Results: The comparison between the quantitative measurements provided by LABS against manual segmentations revealed excellent results in healthy controls when considering either the midbrain (DICE measures higher that 0.9; Volume ratio around 1 and Hausdorff distance around 3) or the pons (DICE measures around 0.93; Volume ratio ranging 1.024-1.05 and Hausdorff distance around 2). Similar performances were detected for AD patients considering segmentation of the pons (DICE measures higher that 0.93; Volume ratio ranging from 0.97-0.98 and Hausdorff distance ranging 1.07-1.33), while LABS performed lower for the midbrain (DICE measures ranging 0.86-0.88; Volume ratio around 0.95 and Hausdorff distance ranging 1.71-2.15). Conclusions: Our study represents the first attempt to validate a new fully automated method for in vivo segmentation of two anatomically complex brainstem subregions. We retain that our method might represent a useful tool for future applications in clinical practice.	[Nigro, Salvatore; Cerasa, Antonio; Perrotta, Paolo; Donzuso, Giulia; Quattrone, Aldo] CNR, Inst Bioimaging & Mol Physiol, Catanzaro, Italy; [Cerasa, Antonio; Quattrone, Aldo] Magna Graecia Univ Catanzaro, Inst Neurol, Catanzaro, Italy; [Zito, Giancarlo] CNR, Lab Electrophysiol Translat Neurosci, Rome, Italy; [Zito, Giancarlo] S Giovanni Calibita Fatebenefratelli Hosp, Dept Clin Neurosci, Rome, Italy; [Chiaravalloti, Francesco; Bilotta, Eleonora; Pantano, Pietro] Univ Calabria, Evolutionary Syst Grp, I-87036 Cosenza, Italy; [Fera, Franceso] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); University of Calabria; Magna Graecia University of Catanzaro	Cerasa, A (corresponding author), CNR, Inst Bioimaging & Mol Physiol, Catanzaro, Italy.	a.cerasa@unicz.it	Donzuso, Giulia/AAY-8502-2020; cerasa, antonio/E-8614-2011; Chiaravalloti, Francesco/B-3974-2017; QUATTRONE, Aldo/A-6734-2016; Nigro, Salvatore/L-7210-2019	Donzuso, Giulia/0000-0003-4925-694X; cerasa, antonio/0000-0002-8022-4770; Chiaravalloti, Francesco/0000-0002-9394-5550; QUATTRONE, Aldo/0000-0003-2001-957X; Nigro, Salvatore/0000-0001-7566-7983; Bilotta, Eleonora/0000-0002-1902-813X; Zito, Giancarlo/0000-0002-6766-5483	Consiglio Nazionale delle Ricerche; ADNI (National Institutes of Health (NIH) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER	Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); ADNI (National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Core funding for this work was supported by the Consiglio Nazionale delle Ricerche "Ageing Project''. Data collection and sharing for the Alzheimer's Disease Neuroimaging Initiative (ADNI) data used in this project was funded by the ADNI (National Institutes of Health (NIH) Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the United States Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the NIH (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 1997, J NEUROL SCI, V152, P210, DOI 10.1016/S0022-510X(97)00166-4; Babalola KO, 2008, LECT NOTES COMPUT SC, V5241, P409, DOI 10.1007/978-3-540-85988-8_49; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; BRUMMER ME, 1991, IEEE T MED IMAGING, V10, P74, DOI 10.1109/42.75613; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Cocosco CA, 2003, MED IMAGE ANAL, V7, P513, DOI 10.1016/S1361-8415(03)00037-9; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Free SL, 2001, NEUROIMAGE, V13, P801, DOI 10.1006/nimg.2001.0748; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2009.00997.x, 10.1111/j.1365-2990.2008.00997.x]; Haralick R.M., 1992, COMPUTER ROBOT VISIO, VI, P28, DOI DOI 10.1109/MRA.2011.941638; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Khan AR, 2008, NEUROIMAGE, V41, P735, DOI 10.1016/j.neuroimage.2008.03.024; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Lambert C, 2013, NEUROIMAGE-CLIN, V2, P684, DOI 10.1016/j.nicl.2013.04.017; LI CL, 1993, IEEE T MED IMAGING, V12, P740, DOI 10.1109/42.251125; Liang LC, 2007, NEUROIMAGE, V34, P1160, DOI 10.1016/j.neuroimage.2006.07.046; Liu YX, 2001, IEEE T MED IMAGING, V20, P175, DOI 10.1109/42.918469; Luft AR, 1999, CEREB CORTEX, V9, P712, DOI 10.1093/cercor/9.7.712; Maes F, 1999, LECT NOTES COMPUT SC, V1679, P348; Marais P, 2000, MED IMAGE ANAL, V4, P283, DOI 10.1016/S1361-8415(00)00020-7; Marais P, 1996, LECT NOTES COMPUT SC, V1131, P411, DOI 10.1007/BFb0046981; Massey LA, 2013, NEUROLOGY, V80, P1856, DOI 10.1212/WNL.0b013e318292a2d2; Oba H, 2005, NEUROLOGY, V64, P2050, DOI 10.1212/01.WNL.0000165960.04422.D0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Patenaude B, 2007, THESIS OXFORD U OXFO; Paviour DC, 2006, BRAIN, V129, P1040, DOI 10.1093/brain/awl021; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Prima S, 2002, IEEE T MED IMAGING, V21, P122, DOI 10.1109/42.993131; Prima S, 2013, PROC SPIE, V8669, DOI 10.1117/12.2007075; Quattrone A, 2008, RADIOLOGY, V246, P214, DOI 10.1148/radiol.2453061703; Rohlfing T, 2004, IEEE T MED IMAGING, V23, P983, DOI 10.1109/TMI.2004.830803; Simic G, 2009, NEUROPATH APPL NEURO, V35, P532, DOI 10.1111/j.1365-2990.2009.01038.x; Sun CM, 1997, IEEE T PATTERN ANAL, V19, P164, DOI 10.1109/34.574800; SWANSON LW, 1995, TRENDS NEUROSCI, V18, P471, DOI 10.1016/0166-2236(95)92766-J; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Xia Y, 2007, IEEE T MED IMAGING, V26, P509, DOI 10.1109/TMI.2006.891481; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	43	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85618	10.1371/journal.pone.0085618	http://dx.doi.org/10.1371/journal.pone.0085618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489664	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000015
J	Wan, PJ; Jia, S; Li, N; Fan, JM; Li, GQ				Wan, Pin-Jun; Jia, Shuang; Li, Na; Fan, Jin-Mei; Li, Guo-Qing			RNA Interference Depletion of the Halloween Gene Disembodied Implies its Potential Application for Management of Planthopper Sogatella furcifera and Laodelphax striatellus	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; STEROID-HORMONE ECDYSONE; NILAPARVATA-LUGENS; ECDYSTEROID BIOSYNTHESIS; DROSOPHILA-MELANOGASTER; DSRNA INGESTION; P450 ENZYMES; CHLORPYRIFOS RESISTANCE; CYTOCHROME-P450 ENZYME; ANOPHELES-GAMBIAE	Sogatella furcifera and Laodelphax striatellus are economically important rice pests in China by acting as vectors of several rice viruses, sucking the phloem sap and blocking the phloem vessels. Ecdysteroid hormone 20-hydroxyecdysone regulates insect development and reproduction. A cytochrome P450 monooxygenase CYP302A1 (22-hydroxylase), encoded by the Halloween gene disembodied (dib), plays a critical role in ecdysteroidogenesis. The objective of this study is to test whether dib genes are potential targets for RNA interference-based management of S. furcifera and L. striatellus. We cloned and characterized Sfdib and Lsdib. The open reading frame regions of dib genes were generated and used for designing and constructing dsRNA fragments. Experiments were conducted using oral delivery of dsdib to investigate the effectiveness of RNAi in S. furcifera and L. striatellus nymphs. Real-time quantitative reverse transcriptase-PCR analysis demonstrated that continuous ingestion of dsdib at the concentration of 0.01, 0.05 and 0.50 mg/ml diminished Sfdib expression levels by 35.9%, 45.1% and 66.2%, and ecdysone receptor (SfEcR) gene mRNA levels by 34.0%, 36.2% and 58.5% respectively in S. furcifera, and decreased Lsdib expression level by 18.8%, 35.8% and 56.7%, and LsEcR mRNA levels by 25.2%, 46.8% and 68.8% respectively in L. striatellus. The reduction in dib and EcR transcript abundance resulted in observable phenotypes. The development of nymphs was impaired and the survival was negatively affected. Our data will enable the development of new insect control strategies and functional analysis of vital genes in S. furcifera and L. striatellus nymphs.	[Wan, Pin-Jun; Jia, Shuang; Li, Na; Fan, Jin-Mei; Li, Guo-Qing] Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, GQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	ligq@njau.edu.cn			National Basic Research Program of China (973 Program) [2010CB126200]; National Natural Sciences Foundation of China [31360442]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (973 Program, No. 2010CB126200) and the National Natural Sciences Foundation of China (31360442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Christiaens O, 2010, INSECT MOL BIOL, V19, P187, DOI 10.1111/j.1365-2583.2009.00957.x; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GRIENEISEN ML, 1993, INSECT BIOCHEM MOLEC, V23, P13, DOI 10.1016/0965-1748(93)90077-6; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; Jia S, 2013, GENE, V531, P168, DOI 10.1016/j.gene.2013.09.034; Jia S, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-19; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KAPPLER C, 1988, J STEROID BIOCHEM, V31, P891, DOI 10.1016/0022-4731(88)90330-5; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; KOBAYASHI M, 1989, PESTIC BIOCHEM PHYS, V34, P9, DOI 10.1016/0048-3575(89)90135-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Lu DH, 2013, PEST MANAG SCI, V69, P1034, DOI 10.1002/ps.3553; Luan JB, 2013, INSECT BIOCHEM MOLEC, V43, P740, DOI 10.1016/j.ibmb.2013.05.012; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Marchal E, 2011, J INSECT PHYSIOL, V57, P1240, DOI 10.1016/j.jinsphys.2011.05.009; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; Nelson David R., 2009, Human Genomics, V4, P59; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Ren XL, 2013, APPL ENVIRON MICROB, V79, P5576, DOI 10.1128/AEM.01519-13; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Sanada-Morimura S, 2011, APPL ENTOMOL ZOOL, V46, P65, DOI 10.1007/s13355-010-0009-7; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Sieglaff DH, 2005, INSECT BIOCHEM MOLEC, V35, P471, DOI 10.1016/j.ibmb.2005.01.011; Singh AD, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6901; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064026; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wan PJ, 2014, INSECT SCI, V21, P147, DOI 10.1111/1744-7917.12034; Wang LH, 2010, PEST MANAG SCI, V66, P1096, DOI 10.1002/ps.1984; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wu WJ, 2012, J INSECT PHYSIOL, V58, P420, DOI 10.1016/j.jinsphys.2012.01.012; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yamazaki Y, 2011, INSECT BIOCHEM MOLEC, V41, P283, DOI 10.1016/j.ibmb.2011.01.005; Yao JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070243; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhang XY, 2013, INSECT SCI, V20, P61, DOI 10.1111/j.1744-7917.2012.01539.x; Zhang YL, 2013, PESTIC BIOCHEM PHYS, V106, P8, DOI 10.1016/j.pestbp.2013.03.002; Zhang YL, 2012, PESTIC BIOCHEM PHYS, V104, P277, DOI 10.1016/j.pestbp.2012.10.002; Zhou LT, 2013, J INSECT PHYSIOL, V59, P1049, DOI 10.1016/j.jinsphys.2013.08.002; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	72	38	39	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86675	10.1371/journal.pone.0086675	http://dx.doi.org/10.1371/journal.pone.0086675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489765	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000071
J	Bray, A; Nieh, J				Bray, Allison; Nieh, James			Non-Consumptive Predator Effects Shape Honey Bee Foraging and Recruitment Dancing	PLOS ONE			English	Article							CRAB-SPIDERS; RISK; POLLINATORS; METAANALYSIS; ECOLOGY; FLOWERS; PLANT; COST; SIZE; FOOD	Predators can reduce bee pollination and plant fitness through successful predation and non-consumptive effects. In honey bees, evidence of predation or a direct attack can decrease recruitment dancing and thereby magnify the effects of individual predation attempts at a colony level. However, actual predation attempts and successes are relatively rare. It was not known if a far more common event, just detection of a predator, could inhibit recruitment. We began by testing honey bees' avoidance of the praying mantis (Tenodera sinensis). Larger predators (later mantis instars, >= 4.5 cm in body length) elicited significantly more avoidance (1.3 fold) than smaller mantis instars. Larger instars also attempted to capture honey bees significantly more often than did smaller instars. Foragers could detect and avoid mantises based upon mantis odor (74% of bees avoided an odor extract) or visual appearance (67% avoided a mantis model). Finally, foragers decreased recruitment dancing by 1.8 fold for a food source with a live adult mantis, even when they were not attacked. This reduction in recruitment dancing, elicited by predator presence alone, expands our understanding of predator non-consumptive effects and of cascading ecosystem effects for plants served by an important generalist pollinator.	[Bray, Allison; Nieh, James] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Bray, A (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA.	alliebray@gmail.com	Nieh, James C/H-8705-2014	Nieh, James C/0000-0001-6237-0726	University of California Academic Senate	University of California Academic Senate(University of California System)	The University of California Academic Senate (http://senate.ucsd.edu/rgc/calls/bridge.htm) provided financial support for these experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; [Anonymous], ANN REPORT BOARD REG; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Bolbroe T, 2000, ANN ZOOL FENN, V37, P169; Brechbuhl R, 2010, BASIC APPL ECOL, V11, P76, DOI 10.1016/j.baae.2009.07.001; BROMLEY S. W., 1948, JOUR NEW YORK ENT SOC, V56, P195; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; CARTAR RV, 1991, ETHOLOGY, V87, P90, DOI 10.1111/j.1439-0310.1991.tb01191.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dornhaus A, 2003, J COMP PHYSIOL A, V189, P47, DOI 10.1007/s00359-002-0374-y; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; EVANS CS, 1993, ANIM BEHAV, V46, P1, DOI 10.1006/anbe.1993.1156; Fagan WF, 2002, ECOL ENTOMOL, V27, P385, DOI 10.1046/j.1365-2311.2002.00425.x; Gardner KE, 2008, ANIM BEHAV, V75, P1291, DOI 10.1016/j.anbehav.2007.09.032; Ginzel MD, 2003, J CHEM ECOL, V29, P533, DOI 10.1023/A:1022894419521; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Goodale E, 2012, ANIM BEHAV, V84, P919, DOI 10.1016/j.anbehav.2012.07.016; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Haynes K.F., 1998, METHODS CHEM ECOLOGY; Heiling AM, 2004, P ROY SOC B-BIOL SCI, V271, pS196, DOI 10.1098/rsbl.2003.0138; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Horridge A, 2003, J INSECT PHYSIOL, V49, P1145, DOI 10.1016/j.jinsphys.2003.08.008; Hurd L.E., 1989, Entomologist, V108, P223; Ings TC, 2009, P ROY SOC B-BIOL SCI, V276, P2031, DOI 10.1098/rspb.2008.1748; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Jones EI, 2010, OIKOS, V119, P835, DOI 10.1111/j.1600-0706.2009.17841.x; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Lichtenberg EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P763, DOI 10.1007/s00265-010-1080-3; LOUDA SM, 1982, OECOLOGIA, V55, P185, DOI 10.1007/BF00384486; McMonigle O., 2008, PRAYING MANTIDS KEEP; MORSE DH, 1979, OECOLOGIA, V39, P309, DOI 10.1007/BF00345442; MORSE DH, 1986, OIKOS, V46, P223, DOI 10.2307/3565470; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Orrock JL, 2008, ECOLOGY, V89, P2426, DOI 10.1890/07-1024.1; Palleroni A, 2005, ANIM COGN, V8, P200, DOI 10.1007/s10071-004-0250-y; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; REITZE M, 1991, OECOLOGIA, V86, P568, DOI 10.1007/BF00318324; Robertson IC, 2005, OIKOS, V109, P577, DOI 10.1111/j.0030-1299.2005.13903.x; Rodriguez-Girones MA, 2012, OIKOS, V121, P1473, DOI 10.1111/j.1600-0706.2011.19473.x; Romero GQ, 2004, ECOLOGY, V85, P446, DOI 10.1890/02-0327; Romero GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020689; Schwarz C.J., 2011, SAMPLING REGRESSION, P57; Seeley T., 1995, WISDOM HIVE; Sen Sarma M, 2002, ZOOLOGY, V105, P215, DOI 10.1078/0944-2006-00064; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Suttle KB, 2003, ECOL LETT, V6, P688, DOI 10.1046/j.1461-0248.2003.00490.x; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Zar J. H., 2009, BIOSTATISTICAL ANAL	57	17	17	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87459	10.1371/journal.pone.0087459	http://dx.doi.org/10.1371/journal.pone.0087459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475292	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300187
J	Bruells, CS; Bergs, I; Rossaint, R; Du, J; Bleilevens, C; Goetzenich, A; Weis, J; Wiggs, MP; Powers, SK; Hein, M				Bruells, Christian S.; Bergs, Ingmar; Rossaint, Rolf; Du, Jun; Bleilevens, Christian; Goetzenich, Andreas; Weis, Joachim; Wiggs, Michael P.; Powers, Scott K.; Hein, Marc			Recovery of Diaphragm Function following Mechanical Ventilation in a Rodent Model	PLOS ONE			English	Article							OXIDATIVE STRESS; DYSFUNCTION; EXPRESSION; CALPAIN; FAILURE; RAT	Background: Mechanical ventilation (MV) induces diaphragmatic muscle fiber atrophy and contractile dysfunction (ventilator induced diaphragmatic dysfunction, VIDD). It is unknown how rapidly diaphragm muscle recovers from VIDD once spontaneous breathing is restored. We hypothesized that following extubation, the return to voluntary breathing would restore diaphragm muscle fiber size and contractile function using an established rodent model. Methods: Following 12 hours of MV, animals were either euthanized or, after full wake up, extubated and returned to voluntary breathing for 12 hours or 24 hours. Acutely euthanized animals served as controls (each n = 8/group). Diaphragmatic contractility, fiber size, protease activation, and biomarkers of oxidative damage in the diaphragm were assessed. Results: 12 hours of MV induced VIDD. Compared to controls diaphragm contractility remained significantly depressed at 12 h after extubation but rebounded at 24 h to near control levels. Diaphragmatic levels of oxidized proteins were significantly elevated after MV (p = 0.002) and normalized at 24 hours after extubation. Conclusions: These findings indicate that diaphragm recovery from VIDD, as indexed by fiber size and contractile properties, returns to near control levels within 24 hours after returning to spontaneous breathing. Besides the down-regulation of proteolytic pathways and oxidative stress at 24 hours after extubation further repairing mechanisms have to be determined.	[Bruells, Christian S.; Bergs, Ingmar; Rossaint, Rolf; Du, Jun; Bleilevens, Christian; Hein, Marc] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Surg Intens & Intermediate Care, Aachen, Germany; [Bruells, Christian S.; Bergs, Ingmar; Rossaint, Rolf; Du, Jun; Bleilevens, Christian; Hein, Marc] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Anesthesiol, Aachen, Germany; [Goetzenich, Andreas] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Cardiothorac & Vasc Surg, Aachen, Germany; [Weis, Joachim] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Inst Neuropathol, Aachen, Germany; [Weis, Joachim] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, JARA Translat Brain Med, Aachen, Germany; [Wiggs, Michael P.; Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; State University System of Florida; University of Florida	Bruells, CS (corresponding author), Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Surg Intens & Intermediate Care, Aachen, Germany.	cbruells@ukaachen.de	Bleilevens, Christian/AAG-8034-2020; Weis, Joachim/G-1984-2014	Bleilevens, Christian/0000-0002-2104-1843; Weis, Joachim/0000-0003-3280-6773	Deutsche Forschungsgemeinschaft [RO 2000/14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work has been funded by the Deutsche Forschungsgemeinschaft (RO 2000/14). CSB was research fellow of the medical faculty of the RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZUETO A, 1992, J APPL PHYSIOL, V72, P529, DOI 10.1152/jappl.1992.72.2.529; Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08; Callahan LA, 2005, AM J RESP CRIT CARE, V172, P861, DOI 10.1164/rccm.200410-1344OC; Cholette J, 2009, CRIT CARE MED, V37, pA434, DOI 10.1097/CCM.0b013e3181b6e760; Criswell DS, 2003, CHEST, V124, P2302, DOI 10.1378/chest.124.6.2302; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; Frutos-Vivar F, 2011, J CRIT CARE, V26, P502, DOI 10.1016/j.jcrc.2010.12.015; Gayan-Ramirez G, 2003, INTENS CARE MED, V29, P825, DOI 10.1007/s00134-003-1688-0; Huang TT, 2011, J THORAC CARDIOV SUR, V142, P1214, DOI 10.1016/j.jtcvs.2011.02.025; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Jaber S, 2008, ANESTHESIOLOGY, V108, P651, DOI 10.1097/ALN.0b013e31816725a6; Jaber S, 2011, CRIT CARE, V15, DOI 10.1186/cc10023; Jiang TX, 1998, AM J RESP CRIT CARE, V157, P736, DOI 10.1164/ajrccm.157.3.9707056; KILARSKI W, 1990, J ANAT, V168, P13; Levine S, 1997, NEW ENGL J MED, V337, P1799, DOI 10.1056/NEJM199712183372503; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; McClung JM, 2007, FASEB J, V21, pA1306; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Quinnell TG, 2006, CHEST, V129, P133, DOI 10.1378/chest.129.1.133; Richard C, 2005, INTENS CARE MED, V31, P1605, DOI 10.1007/s00134-005-2698-x; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Thomas D, 2013, J APPL PHYSIOL, V115, P775, DOI 10.1152/japplphysiol.00302.2012; Van Gammeren D, 2005, CHEST, V127, P2204, DOI 10.1378/chest.127.6.2204; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008	29	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87460	10.1371/journal.pone.0087460	http://dx.doi.org/10.1371/journal.pone.0087460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475293	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300188
J	Grahnert, A; Richter, T; Piehler, D; Eschke, M; Schulze, B; Muller, U; Protschka, M; Kohler, G; Sabat, R; Brombacher, F; Alber, G				Grahnert, Andreas; Richter, Tina; Piehler, Daniel; Eschke, Maria; Schulze, Bianca; Mueller, Uwe; Protschka, Martina; Koehler, Gabriele; Sabat, Robert; Brombacher, Frank; Alber, Gottfried			IL-4 Receptor-Alpha-Dependent Control of Cryptococcus neoformans in the Early Phase of Pulmonary Infection	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY-MYCOSIS; DENDRITIC CELL MATURATION; PROTECTIVE TH1 RESPONSE; NITRIC-OXIDE; INTERLEUKIN-4 RECEPTOR; INTERFERON-GAMMA; ACTIVATED MACROPHAGES; CYTOKINE PRODUCTION; LEISHMANIA-MAJOR; BINDING-PROTEIN	Cryptococcus neoformans is an opportunistic fungal pathogen that causes lung inflammation and meningoencephalitis in immunocompromised people. Previously we showed that mice succumb to intranasal infection by induction of pulmonary interleukin (IL)-4R alpha-dependent type 2 immune responses, whereas IL-12-dependent type 1 responses confer resistance. In the experiments presented here, IL-4R alpha(-/-) mice unexpectedly show decreased fungal control early upon infection with C. neoformans, whereas wild-type mice are able to control fungal growth accompanied by enhanced macrophage and dendritic cell recruitment to the site of infection. Lower pulmonary recruitment of macrophages and dendritic cells in IL-4R alpha(-/-) mice is associated with reduced pulmonary expression of CCL2 and CCL20 chemokines. Moreover, IFN-gamma and nitric oxide production are diminished in IL-4R alpha(-/-) mice compared to wild-type mice. To directly study the potential mechanism(s) responsible for reduced production of IFN-gamma, conventional dendritic cells were stimulated with C. neoformans in the presence of IL-4 which results in increased IL-12 production and reduced IL-10 production. Together, a beneficial role of early IL-4R alpha signaling is demonstrated in pulmonary cryptococcosis, which contrasts with the well-known IL-4R alpha-mediated detrimental effects in the late phase.	[Grahnert, Andreas; Richter, Tina; Piehler, Daniel; Eschke, Maria; Schulze, Bianca; Mueller, Uwe; Protschka, Martina; Alber, Gottfried] Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, D-04109 Leipzig, Germany; [Koehler, Gabriele] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Sabat, Robert] Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol, Berlin, Germany; [Brombacher, Frank] ICGEB, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, IIDMM, ZA-7925 Cape Town, South Africa	Leipzig University; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town	Alber, G (corresponding author), Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, D-04109 Leipzig, Germany.	alber@rz.uni-leipzig.de	Mendez, Fausto R./O-3512-2018	Mendez, Fausto R./0000-0002-5084-1276; Muller, Uwe/0000-0003-1502-9271	Deutsche Forschungsgemeinschaft (German Research Foundation) [AL 371/5-4, SA 1868/2-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation, grant AL 371/5-4 and grant SA 1868/2-1; http://dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre KM, 2000, MED MYCOL, V38, P343, DOI 10.1080/mmy.38.5.343.353; Alexander J, 2008, MICROBES INFECT, V10, P953, DOI 10.1016/j.micinf.2008.07.038; ALSPAUGH JA, 1991, INFECT IMMUN, V59, P2291, DOI 10.1128/IAI.59.7.2291-2296.1991; Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Blackstock R, 2004, AM J RESP CELL MOL, V30, P109, DOI 10.1165/rcmb.2003-0156OC; Brombacher F, 2000, BIOESSAYS, V22, P646, DOI 10.1002/1521-1878(200007)22:7&lt;646::AID-BIES7&gt;3.0.CO;2-9; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; Charlier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001950; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chen GH, 2007, AM J PATHOL, V170, P1028, DOI 10.2353/ajpath.2007.060595; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Flesch IEA, 1997, INT IMMUNOL, V9, P467, DOI 10.1093/intimm/9.4.467; Goldman DL, 2006, J INFECT DIS, V193, P1178, DOI 10.1086/501363; Gunn MD, 1997, J IMMUNOL, V158, P376; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hernandez Y, 2005, J IMMUNOL, V174, P1027, DOI 10.4049/jimmunol.174.2.1027; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hoag KA, 1997, AM J RESP CELL MOL, V17, P733, DOI 10.1165/ajrcmb.17.6.2879; HOAG KA, 1995, AM J RESP CELL MOL, V13, P487, DOI 10.1165/ajrcmb.13.4.7546779; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Huffnagle GB, 1998, J IMMUNOL, V160, P2393; Husain S, 2001, EMERG INFECT DIS, V7, P375; Jain AV, 2009, INFECT IMMUN, V77, P5389, DOI 10.1128/IAI.00809-09; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Kawakami K, 1997, INFECT IMMUN, V65, P1307, DOI 10.1128/IAI.65.4.1307-1312.1997; Kawakami K, 1999, CLIN EXP IMMUNOL, V117, P113; Kawakami K, 1999, CELL IMMUNOL, V197, P55, DOI 10.1006/cimm.1999.1557; LEE SC, 1994, J EXP MED, V180, P365, DOI 10.1084/jem.180.1.365; LOCKSLEY RM, 1991, RES IMMUNOL, V142, P28, DOI 10.1016/0923-2494(91)90007-6; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; Mohrs M, 1999, J IMMUNOL, V162, P7302; Muller U, 2012, MUCOSAL IMMUNOL, V5, P299, DOI 10.1038/mi.2012.9; Muller U, 2008, J INFECT DIS, V198, P1714, DOI 10.1086/593068; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Muller U, 2013, INT IMMUNOL; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; Osterholzer JJ, 2009, J IMMUNOL, V183, P8044, DOI 10.4049/jimmunol.0902823; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Piehler D, 2013, MUCOSAL IMMUNOL, V6, P405, DOI 10.1038/mi.2012.84; Pietrella D, 2005, INFECT IMMUN, V73, P820, DOI 10.1128/IAI.73.2.820-827.2005; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Suzuki Y, 1996, J IMMUNOL, V157, P2564; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Webb DC, 2007, J IMMUNOL, V178, P219, DOI 10.4049/jimmunol.178.1.219; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wozniak KL, 2008, INFECT IMMUN, V76, P4764, DOI 10.1128/IAI.00660-08; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324	59	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87341	10.1371/journal.pone.0087341	http://dx.doi.org/10.1371/journal.pone.0087341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475277	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300172
J	Hamm, JP; Crawford, TJ; Nebl, H; Kean, M; Williams, SCR; Ettinger, U				Hamm, Jeff P.; Crawford, Trevor J.; Nebl, Helmut; Kean, Matthew; Williams, Steven C. R.; Ettinger, Ulrich			Neural Correlates of Illusory Line Motion	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PRIMARY VISUAL-CORTEX; APPARENT MOTION; RESPONSE CONFLICT; HUMAN BRAIN; AREA MT/V5; ATTENTION; ILLUSION; INHIBITION; STIMULUS	Illusory line motion (ILM) refers to a motion illusion in which a flash at one end of a bar prior to the bar's instantaneous presentation or removal results in the percept of motion. While some theories attribute the origin of ILM to attention or early perceptual mechanisms, others have proposed that ILM results from impletion mechanisms that reinterpret the static bar as one in motion. The current functional magnetic resonance imaging study examined participants while they made decisions about the direction of motion in which a bar appeared to be removed. Preceding the instantaneous removal of the bar with a flash at one end resulted in a motion percept away from the flash. If this flash and the bar's removal overlapped in time, it appeared that the bar was removed towards the flash (reverse ILM). Independent of the motion type, brain responses indicated activations in areas associated with motion (MT+), endogenous and exogenous attention (intraparietal sulcus, frontal eye fields, and ventral frontal cortex), and response selection (ACC). ILM was associated with lower percept scores and higher activations in ACC relative to real motion, but no differences in shape-selective areas emerged. This pattern of brain activation is consistent with the attentional gradient model or bottom-up accounts of ILM in preference to impletion.	[Hamm, Jeff P.] Univ Auckland, Sch Psychol, Cognit Neurosci Res Grp, Auckland 1, New Zealand; [Crawford, Trevor J.] Univ Lancaster, Ctr Aging Res, Dept Psychol, Lancaster LA1 4YF, England; [Crawford, Trevor J.] Univ Lancaster, Ctr Human Learning & Dev, Dept Psychol, Lancaster LA1 4YF, England; [Nebl, Helmut] Univ Regensburg, Study Programme Psychol, D-93053 Regensburg, Germany; [Kean, Matthew] Univ Manchester, Manchester, Lancs, England; [Williams, Steven C. R.] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Sci, London, England; [Ettinger, Ulrich] Univ Bonn, Dept Psychol, Bonn, Germany	University of Auckland; Lancaster University; Lancaster University; University of Regensburg; University of Manchester; University of London; King's College London; University of Bonn	Hamm, JP (corresponding author), Univ Auckland, Sch Psychol, Cognit Neurosci Res Grp, Auckland 1, New Zealand.	j.hamm@auckland.ac.nz; t.crawford@lancaster.ac.uk; helmut.nebl@ur.de; ulrich.ettinger@uni-bonn.de	Williams, Steve C/D-6979-2011; Ettinger, Ulrich/D-3731-2014; Crawford, Trevor J/N-4237-2015	Williams, Steve C/0000-0003-4299-1941; Ettinger, Ulrich/0000-0002-0160-0281; Crawford, Trevor J/0000-0001-5928-7307; opoku, anita/0000-0001-7243-8157	DFG [ET 31/2-1]; New Zealand Foundation for Research, Science Technology [LANC0401]	DFG(German Research Foundation (DFG)); New Zealand Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology)	Ulrich Ettinger is supported by DFG grant ET 31/2-1. Matt Kean was partly funded by the New Zealand Foundation for Research, Science & Technology (grant no. LANC0401). No further external funding was received for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baloch AA, 1997, VISION RES, V37, P3037, DOI 10.1016/S0042-6989(97)00103-X; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Cartwright D, 1941, AM J PSYCHOL, V54, P174, DOI 10.2307/1416790; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christie J, 2005, PERCEPT PSYCHOPHYS, V67, P1032, DOI 10.3758/BF03193629; Christie J, 2002, CONSCIOUS COGN, V11, P347, DOI 10.1006/ccog.2001.0539; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COWAN N, 1995, PERCEPT PSYCHOPHYS, V57, P546, DOI 10.3758/BF03213079; Crawford TJ, 2006, EXP BRAIN RES, V173, P498, DOI 10.1007/s00221-006-0392-z; Danziger S, 1999, PERCEPT PSYCHOPHYS, V61, P1024, DOI 10.3758/BF03207610; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Downing PE, 1997, J EXP PSYCHOL HUMAN, V23, P768; FAUBERT J, 1995, VISION RES, V35, P3119, DOI 10.1016/0042-6989(95)00061-4; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Hamm JP, 2002, PERCEPT PSYCHOPHYS, V64, P279, DOI 10.3758/BF03195792; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; HIKOSAKA O, 1991, INVEST OPHTH VIS SCI, V32, P716; HIKOSAKA O, 1993, PERCEPTION, V22, P517, DOI 10.1068/p220517; HIKOSAKA O, 1993, NEUROSCI RES, V18, P11, DOI 10.1016/0168-0102(93)90100-5; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hubbard TL, 2011, ATTEN PERCEPT PSYCHO, V73, P1133, DOI 10.3758/s13414-010-0081-7; Huk AC, 2002, J NEUROSCI, V22, P7195; Indovina I, 2004, MAGN RESON IMAGING, V22, P1477, DOI 10.1016/j.mri.2004.10.016; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kawamoto M, 1997, NEUROSCI LETT, V231, P49, DOI 10.1016/S0304-3940(97)00539-9; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kuriki I, 2008, J VISION, V8, DOI 10.1167/8.10.16; LABERGE D, 1986, PERCEPT PSYCHOPHYS, V40, P188, DOI 10.3758/BF03203016; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; Larsen A, 2006, J COGNITIVE NEUROSCI, V18, P1174, DOI 10.1162/jocn.2006.18.7.1174; Liu TS, 2004, NEUROIMAGE, V21, P1772, DOI 10.1016/j.neuroimage.2003.12.025; Markounikau V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000919; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Merchant H, 2005, EXP BRAIN RES, V161, P532, DOI 10.1007/s00221-004-2100-1; Muckli L, 2005, PLOS BIOL, V3, P1501, DOI 10.1371/journal.pbio.0030265; Muckli L, 2002, J NEUROSCI, V22; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rangan AV, 2005, P NATL ACAD SCI USA, V102, P18793, DOI 10.1073/pnas.0509481102; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Schmidt WC, 1997, PERCEPTION, V26, P857, DOI 10.1068/p260857; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; STEINMAN BA, 1995, VISION RES, V35, P1859, DOI 10.1016/0042-6989(94)00276-R; Sterzer P, 2006, NEUROIMAGE, V32, P1308, DOI 10.1016/j.neuroimage.2006.05.029; Tanabe HC, 2002, J INT SOC LIFE INFOR, V20, P627; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tse P, 1998, HIGH LEVEL MOTION PR; Tse PU, 2006, NEUROIMAGE, V31, P766, DOI 10.1016/j.neuroimage.2005.12.029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; vonGrunau M, 1996, VISION RES, V36, P2447, DOI 10.1016/0042-6989(95)00330-4; vonGrunau M, 1996, VISION RES, V36, P2433, DOI 10.1016/0042-6989(95)00326-6; Wibral M, 2009, CEREB CORTEX, V19, P1567, DOI 10.1093/cercor/bhn192; Wilms M, 2010, NEUROIMAGE, V49, P1171, DOI 10.1016/j.neuroimage.2009.09.063; Wohlschlager AM, 2005, NEUROIMAGE, V26, P73, DOI 10.1016/j.neuroimage.2005.01.021; Yan TY, 2011, J MAGN RESON IMAGING, V33, P441, DOI 10.1002/jmri.22404; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; Zhuo Y, 2003, SCIENCE, V299, P417, DOI 10.1126/science.1077091	74	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87595	10.1371/journal.pone.0087595	http://dx.doi.org/10.1371/journal.pone.0087595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475313	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000330507300206
J	Hawkins, ED; Oliaro, J; Ramsbottom, KM; Ting, SB; Sacirbegovic, F; Harvey, M; Kinwell, T; Ghysdael, J; Johnstone, RW; Humbert, PO; Russell, SM				Hawkins, Edwin D.; Oliaro, Jane; Ramsbottom, Kelly M.; Ting, Stephen B.; Sacirbegovic, Faruk; Harvey, Michael; Kinwell, Tanja; Ghysdael, Jacques; Johnstone, Ricky W.; Humbert, Patrick O.; Russell, Sarah M.			Lethal Giant Larvae 1 Tumour Suppressor Activity Is Not Conserved in Models of Mammalian T and B Cell Leukaemia	PLOS ONE			English	Article							SELF-RENEWAL; PAR COMPLEX; IN-VIVO; DIVISION; POLARITY; EXPRESSION; NOTCH1; HUGL-1; LGL; MUTATIONS	In epithelial and stem cells, lethal giant larvae (Lgl) is a potent tumour suppressor, a regulator of Notch signalling, and a mediator of cell fate via asymmetric cell division. Recent evidence suggests that the function of Lgl is conserved in mammalian haematopoietic stem cells and implies a contribution to haematological malignancies. To date, direct measurement of the effect of Lgl expression on malignancies of the haematopoietic lineage has not been tested. In Lgl1(-/-) mice, we analysed the development of haematopoietic malignancies either alone, or in the presence of common oncogenic lesions. We show that in the absence of Lgl1, production of mature white blood cell lineages and long-term survival of mice are not affected. Additionally, loss of Lgl1 does not alter leukaemia driven by constitutive Notch, c-Myc or Jak2 signalling. These results suggest that the role of Lgl1 in the haematopoietic lineage might be restricted to specific co-operating mutations and a limited number of cellular contexts.	[Hawkins, Edwin D.; Oliaro, Jane; Ramsbottom, Kelly M.; Sacirbegovic, Faruk; Harvey, Michael; Johnstone, Ricky W.; Russell, Sarah M.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Hawkins, Edwin D.; Oliaro, Jane; Ramsbottom, Kelly M.; Sacirbegovic, Faruk; Harvey, Michael; Kinwell, Tanja; Johnstone, Ricky W.; Humbert, Patrick O.; Russell, Sarah M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Ting, Stephen B.] Monash Univ, Australian Ctr Blood Dis, Stem Cell Res Grp, Melbourne, Vic 3004, Australia; [Ting, Stephen B.] Alfred Hlth, Melbourne, Vic, Australia; [Kinwell, Tanja; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Ghysdael, Jacques] Ctr Univ Orsay, Inst Curie, F-91405 Orsay, France; [Ghysdael, Jacques] CNRS, UMR 3306, F-91405 Orsay, France; [Ghysdael, Jacques] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Russell, Sarah M.] Swinburne Univ Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Peter Maccallum Cancer Center; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Swinburne University of Technology	Hawkins, ED (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	e.hawkins@imperial.ac.uk; sarah.russell@petermac.org	Johnstone, Ricky w/H-3748-2014; Humbert, Patrick O/L-4264-2016; Russell, Sarah M/B-9341-2009	Johnstone, Ricky w/0000-0001-7053-9237; Humbert, Patrick O/0000-0002-1366-6691; Russell, Sarah M/0000-0001-5826-9641; Hawkins, Edwin/0000-0002-3686-8261; Oliaro, Jane/0000-0002-2097-6428; Harvey, Michael/0000-0003-1699-5412	Australian National Health and Medical Research Council (NHRMC); Human Frontiers Science Program; Australian Research Council (ARC); Australian Cancer Research Foundation (ACRF)	Australian National Health and Medical Research Council (NHRMC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program(Human Frontier Science Program); Australian Research Council (ARC)(Australian Research Council); Australian Cancer Research Foundation (ACRF)	The work was funded by the Australian National Health and Medical Research Council (NHRMC, project grants and fellowships to EDH, JO, SMR, POH, RWJ, SBT), the Human Frontiers Science Program, the Australian Research Council (ARC, fellowship to SMR) and the Australian Cancer Research Foundation (ACRF, ACRF Cell Biology Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Carron C, 2000, BLOOD, V95, P3891; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Hagn M, 2012, J IMMUNOL, V188, P3886, DOI 10.4049/jimmunol.1103285; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hawkins ED, 2008, ONCOGENE, V27, P7003, DOI 10.1038/onc.2008.350; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2796; Heidel FH, 2013, J EXP MED, V210, P15, DOI 10.1084/jem.20120596; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Korshunov A, 2006, ACTA NEUROPATHOL, V111, P465, DOI 10.1007/s00401-006-0057-9; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Sengupta A, 2011, P NATL ACAD SCI USA, V108, P9957, DOI 10.1073/pnas.1103132108; Sripathy S, 2011, MOL CELL BIOL, V31, P2920, DOI 10.1128/MCB.05431-11; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87376	10.1371/journal.pone.0087376	http://dx.doi.org/10.1371/journal.pone.0087376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475281	Green Published, gold			2022-12-25	WOS:000330507300176
J	Kupcinskas, J; Wex, T; Link, A; Leja, M; Bruzaite, I; Steponaitiene, R; Juzenas, S; Gyvyte, U; Ivanauskas, A; Ancans, G; Petrenkiene, V; Skieceviciene, J; Kupcinskas, L; Malfertheiner, P				Kupcinskas, Juozas; Wex, Thomas; Link, Alexander; Leja, Marcis; Bruzaite, Indre; Steponaitiene, Ruta; Juzenas, Simonas; Gyvyte, Ugne; Ivanauskas, Audrius; Ancans, Guntis; Petrenkiene, Vitalija; Skieceviciene, Jurgita; Kupcinskas, Limas; Malfertheiner, Peter			Gene Polymorphisms of Micrornas in Helicobacter pylori-Induced High Risk Atrophic Gastritis and Gastric Cancer	PLOS ONE			English	Article							ASSOCIATION; ADENOCARCINOMA; EPIDEMIOLOGY; EXPRESSION; INFECTION; VARIANTS; NETWORKS	Background and aims: MicroRNAs (miRNAs) are known for their function as translational regulators of tumor suppressor or oncogenes. Single nucleotide polymorphisms (SNPs) in miRNAs related genes have been shown to affect the regulatory capacity of miRNAs and were linked with gastric cancer (GC) and premalignant gastric conditions. The purpose of this study was to evaluate potential associations between miRNA-related gene polymorphisms (miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608) and the presence of GC or high risk atrophic gastritis (HRAG) in European population. Methods: Gene polymorphisms were analyzed in 995 subjects (controls: n = 351; GC: n = 363; HRAG: n = 281) of European descent. MiR-27a T>C (rs895819), miR-146a G>C (rs2910164), miR-196a-2 C>T (rs11614913), miR-492 G>C (rs2289030) and miR-608 C>G (rs4919510) SNPs were genotyped by RT-PCR. Results: Overall, SNPs of miRNAs were not associated with the presence of GC or HRAG. We observed a tendency for miR-196a-2 CT genotype to be associated with higher risk of GC when compared to CC genotype, however, the difference did not reach the adjusted P-value (odds ratio (OR) - 1.46, 95% confidence interval (CI) 1.03-2.07, P = 0.032). MiR-608 GG genotype was more frequent in GC when compared to controls (OR -2.34, 95% CI 1.08-5.04), but significance remained marginal (P = 0.029). A similar tendency was observed in a recessive model for miR-608, where CC + CG vs GG genotype comparison showed a tendency for increased risk of GC with OR of 2.44 (95% CI 1.14-5.22, P = 0.021). The genotypes and alleles of miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 SNPs had similar distribution between histological subtypes of GC and were not linked with the presence of diffuse or intestinal-type GC. Conclusions: Gene polymorphisms of miR-27a, miR-146a, miR-196a-2, miR-492, miR-492a and miR-608 were not associated with the presence of HRAG, GC or different histological subtypes of GC in European subjects.	[Kupcinskas, Juozas; Bruzaite, Indre; Steponaitiene, Ruta; Juzenas, Simonas; Gyvyte, Ugne; Ivanauskas, Audrius; Skieceviciene, Jurgita; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania; [Kupcinskas, Juozas; Petrenkiene, Vitalija; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania; [Wex, Thomas; Link, Alexander; Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Wex, Thomas] Dept Mol Genet, Med Lab Clin Chem Microbiol & Infect Dis, Magdeburg, Germany; [Leja, Marcis] Latvian State Univ, Fac Med, LV-1063 Riga, Latvia; [Leja, Marcis; Ancans, Guntis] Digest Dis Ctr GASTRO, Riga, Latvia; [Leja, Marcis; Ancans, Guntis] Riga East Univ Hosp, Riga, Latvia	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Otto von Guericke University; University of Latvia; Riga East University Hospital	Kupcinskas, J (corresponding author), Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania.	j_kupcinskas@yahoo.com	Juzenas, Simonas/F-3187-2018; Kupcinskas, Juozas/AAU-6968-2021	Juzenas, Simonas/0000-0001-9293-0691; Link, Alexander/0000-0002-9514-4562; Kulokiene, Ugne/0000-0002-1130-2472	European Social Fund [VP1-3.1-Angstrom MM-07-K-01-156]; BMBF in the frame of ERA-Net PathoGenoMics project [BMBF-0315905D]; European Fund for Regional Development [2010/0302/2DP/2.1.1.1.0/10/APIA/VIAA/158]	European Social Fund(European Social Fund (ESF)); BMBF in the frame of ERA-Net PathoGenoMics project(Federal Ministry of Education & Research (BMBF)); European Fund for Regional Development(European Commission)	This work was supported by the European Social Fund (No. VP1-3.1-angstrom MM-07-K-01-156) and in part by a grant from the BMBF (BMBF-0315905D) in the frame of ERA-Net PathoGenoMics project. The recruitment of patients in Latvia was supported in part from the project of European Fund for Regional Development (No. 2010/0302/2DP/2.1.1.1.0/10/APIA/VIAA/158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DH, 2013, MOL CARCINOGEN, V52, P39, DOI 10.1002/mc.21962; Bornschein J, 2010, DIGEST DIS, V28, P609, DOI 10.1159/000320061; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CORREA P, 1992, CANCER RES, V52, P6735; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Hishida A, 2011, DIGEST DIS SCI, V56, P1131, DOI 10.1007/s10620-010-1376-1; Huang AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035252; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kupcinskas J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-112; Kupcinskas L, 2010, EUR J GASTROEN HEPAT, V22, P1189, DOI 10.1097/MEG.0b013e32833cf3d5; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee HC, 2010, J CANCER RES CLIN, V136, P1073, DOI 10.1007/s00432-009-0754-6; Lin MB, 2012, CLIN CANCER RES, V18, P3982, DOI 10.1158/1078-0432.CCR-11-2951; Link A, 2012, DIGEST DIS, V30, P255, DOI 10.1159/000336919; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ryan BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036306; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Song MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061250; Srivastava K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050966; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; von Frowein J, 2011, HEPATOLOGY, V53, P833, DOI 10.1002/hep.24125; Wang F, 2012, PLOS ONE, V7; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Wang SZ, 2013, MOL CARCINOGEN, V52, P87, DOI [10.1002/mc.22017, 10.1002/mc.21930]; Yang Q, 2012, ONCOGENE; Yoon KA, 2012, J THORAC CARDIOV SUR, V144, P794, DOI 10.1016/j.jtcvs.2012.06.030; Zhang Huan, 2012, Cancer Biology Medicine, V9, P63, DOI 10.3969/j.issn.2095-3941.2012.01.012; Zhou Y, 2012, J CANCER RES CLIN, V138, P939, DOI 10.1007/s00432-012-1164-8; Zhu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079334	38	66	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87467	10.1371/journal.pone.0087467	http://dx.doi.org/10.1371/journal.pone.0087467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475294	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300189
J	Eberlein, C; Rooney, C; Ross, SJ; Farren, M; Weir, HM; Barry, ST				Eberlein, C.; Rooney, C.; Ross, S. J.; Farren, M.; Weir, H. M.; Barry, S. T.			E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin alpha v beta 6 and maintained through TGF beta signalling	ONCOGENE			English	Article						NSCLC; stroma; CAF; integrin; alpha v beta 6; TGF beta	CARCINOMA-ASSOCIATED-FIBROBLASTS; GROWTH-FACTOR-BETA; STROMAL MYOFIBROBLASTS; CANCER; INHIBITION; INVASION; KINASE; INTEGRIN-ALPHA-V-BETA-6; SIGNATURE; RECEPTOR	Fibroblasts in the tumour stroma (cancer-associated fibroblasts) influence tumour progression and response to therapeutics; little is known about the mechanisms through which the tumour cell co-opts a normal fibroblast. To study the activation of fibroblasts by tumour cells, a panel of non-small cell lung cancer (NSCLC) cell lines and normal human dermal fibroblasts were co-cultured. A subset of the NSCLC cells induced an activated cancer-associated fibroblast-like fibroblast phenotype defined by induction of fibroblast alpha-smooth muscle actin expression. Tumour cells that activated fibroblasts were associated with E-Cadherin and EpCAM expression and expression of integrin alpha v beta 6. Co-culture of activating tumour cells with fibroblasts resulted in induction of transcripts associated with tumour cell invasion and growth, TGF beta 1 and TGFBR1, SERPINE-1, BMP6, SPHK1 and MMP9. Fibroblast activation was inhibited by an alpha v beta 6/8 integrin blocking antibody (264RAD) and a small molecule inhibitor of the TGF-beta type I receptor activin-like kinase (ALK5) (SB431542), demonstrating that transactivation of the TGF beta pathway initiates fibroblast activation. Both integrin and ALK5 antagonists inhibited initiation. Only ALK5 was effective when added after 3 days of co-culture. This suggests that although activation is alpha v beta 6-dependent, once fibroblasts are activated alternative TGF beta pathway regulators maintain an activation loop. In co-culture activating cells had reduced sensitivity to selumetinib, AZD8931 and afatinib compared with mono-culture. In contrast, non-activating cells were insensitive to selumetinib and AZD8931 in both mono-culture and co-culture. In conclusion NSCLC cell lines, positive for E-Cadherin, EpCAM and alpha v beta 6 expression, activate normal fibroblasts through alpha v beta 6/TGF beta signalling in vitro, and influence both gene expression and response to therapeutic agents.	[Eberlein, C.; Rooney, C.; Ross, S. J.; Farren, M.; Weir, H. M.; Barry, S. T.] AstraZeneca, Oncol iMED, Macclesfield SK10 4TG, Cheshire, England	AstraZeneca	Barry, ST (corresponding author), AstraZeneca, Oncol iMED, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	Simon.T.Barry@astrazeneca.com						Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Cardone A, 1997, PANMINERVA MED, V39, P174; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Eberlein C, 2013, ONCOGENE, V32, P4406, DOI 10.1038/onc.2012.460; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hickinson DM, 2010, CLIN CANCER RES, V16, P1159, DOI 10.1158/1078-0432.CCR-09-2353; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Lewis MP, 2004, BRIT J CANCER, V90, P822, DOI 10.1038/sj.bjc.6601611; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Marsh D, 2008, CANCER RES, V68, P3295, DOI 10.1158/0008-5472.CAN-08-0174; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Mink SR, 2010, MOL CANCER RES, V8, P809, DOI 10.1158/1541-7786.MCR-09-0460; Minkovsky N, 2008, CURR OPIN INVEST DR, V9, P1336; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Surowiak P, 2006, FOLIA HISTOCHEM CYTO, V44, P111; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Varga J, 2002, ARTHRITIS RHEUM-US, V46, P1703, DOI 10.1002/art.10413; Yazhou C, 2004, TUMOR BIOL, V25, P290, DOI 10.1159/000081394; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zieba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013482	47	31	33	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					704	716		10.1038/onc.2013.600	http://dx.doi.org/10.1038/onc.2013.600			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24488011				2022-12-25	WOS:000348853800004
J	Rivera, J; Sellers, RS; Zeng, WY; van Rooijen, N; Casadevall, A; Goldman, DL				Rivera, Johanna; Sellers, Rani S.; Zeng, Wangyong; van Rooijen, Nico; Casadevall, Arturo; Goldman, David L.			Platelet-activating Factor Contributes to Bacillus anthracis Lethal Toxin-associated Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anthrax Toxin; Bacterial Pathogenesis; Cytokine; Lipids; Macrophages; Platelet-activating Factor	FACTOR ACETYLHYDROLASE ACTIVITY; PERFUSED-RAT-LIVER; FACTOR PAF; IN-VIVO; INHALATIONAL ANTHRAX; PROTECTIVE ANTIGEN; PULMONARY-FUNCTION; EPITHELIAL-CELLS; CLINICAL SEPSIS; ILL PATIENTS	Background: PAF has been implicated as a potent lipid mediator of endotoxin-induced sepsis, but its role in anthrax-associated shock is unknown. Results: Increased serum levels of PAF were present in LeTx-challenged mice. Inhibition of PAF activity prolonged survival ameliorated increased vascular permeability and hepatic necrosis. Conclusion: PAF appears to be a mediator in lethal toxin-associated damage. Significance: PAF antagonists may be helpful as adjunctive therapy for anthrax-associated shock. The lethal toxin (LeTx) of Bacillus anthracis plays a central role in the pathogenesis of anthrax-associated shock. Platelet-activating factor (PAF) is a potent lipid mediator that has been implicated in endotoxin-associated shock. In this study, we examined the contribution of PAF to the manifestations of lethal toxin challenge in WT mice. LeTx challenge resulted in transient increase in serum PAF levels and a concurrent decrease in PAF acetylhydrolase activity. Inhibition of PAF activity using PAF antagonists or toxin challenge of PAF receptor negative mice reversed or ameliorated many of the pathologic features of LeTx-induced damage, including changes in vascular permeability, hepatic necrosis, and cellular apoptosis. In contrast, PAF inhibition had minimal effects on cytokine levels. Findings from these studies support the continued study of PAF antagonists as potential adjunctive agents in the treatment of anthrax-associated shock.	[Rivera, Johanna; Casadevall, Arturo; Goldman, David L.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Sellers, Rani S.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA; [Zeng, Wangyong] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Goldman, David L.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Vrije Universiteit Amsterdam	Goldman, DL (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	david.goldman@einstein.yu.edu	Van Rooijen, Nico/Z-1578-2019		National Institutes of Health [AI33774-11, HL59842-07, AI33142-11, AI52733-02]; Northeastern Biodefense Center [U54-AI057158-Lipkin]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R37AI033142, U54AI057158, R01AI052733, R01AI033774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern Biodefense Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI33774-11, HL59842-07, AI33142-11, and AI52733-02 (to A. C.). This work was also supported by the Northeastern Biodefense Center under Grant U54-AI057158-Lipkin.	ALTIN JG, 1987, BIOCHEM J, V245, P145, DOI 10.1042/bj2450145; BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P909; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Claud EC, 2008, AM J PHYSIOL-GASTR L, V294, pG1191, DOI 10.1152/ajpgi.00318.2007; Claus RA, 2005, CRIT CARE MED, V33, P1416, DOI 10.1097/01.CCM.0000165807.26485.ED; CRISCUOLI M, 1987, BRIT J PHARMACOL, V90, P203, DOI 10.1111/j.1476-5381.1987.tb16841.x; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Del Sorbo L, 2001, EUR J IMMUNOL, V31, P376, DOI 10.1002/1521-4141(200102)31:2<376::AID-IMMU376>3.0.CO;2-5; DeLorme MP, 2002, J PHARMACOL TOXICOL, V47, P1, DOI 10.1016/S1056-8719(02)00191-0; DIEZ FL, 1989, J CLIN INVEST, V83, P1733, DOI 10.1172/JCI114074; DOEBBER TW, 1985, BIOCHEM BIOPH RES CO, V127, P799, DOI 10.1016/S0006-291X(85)80014-0; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Glaab T, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-63; Goldman DL, 2008, CLIN VACCINE IMMUNOL, V15, P970, DOI 10.1128/CVI.00064-08; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Grypioti AD, 2006, LIVER INT, V26, P97, DOI 10.1111/j.1478-3231.2005.01186.x; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hoymann Heinz Gerd, 2007, Journal of Pharmacological and Toxicological Methods, V55, P16, DOI 10.1016/j.vascn.2006.04.006; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Kimura K, 1998, J BIOCHEM-TOKYO, V123, P142; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KUIPER J, 1988, BIOCHEM BIOPH RES CO, V157, P1288, DOI 10.1016/S0006-291X(88)81014-3; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Bachi ALL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/610371; Ma X, 2001, CURR EYE RES, V23, P326, DOI 10.1076/ceyr.23.5.326.5445; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Montrucchio G, 1996, CIRCULATION, V93, P2152, DOI 10.1161/01.CIR.93.12.2152; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Muehlbauer SM, 2010, AM J PATHOL, V177, P735, DOI 10.2353/ajpath.2010.090828; Murohisa G, 2002, LIVER, V22, P394, DOI 10.1034/j.1600-0676.2002.01552.x; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Pandey J, 2004, MICROBES INFECT, V6, P835, DOI 10.1016/j.micinf.2004.04.013; Partrick DA, 1997, SHOCK, V7, P170, DOI 10.1097/00024382-199703000-00003; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Ryan SD, 2008, J LIPID RES, V49, P2250, DOI 10.1194/jlr.M800263-JLR200; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Serizawa A, 1996, HEPATOLOGY, V23, P1656; SILVESTRO L, 1994, SEMIN THROMB HEMOST, V20, P214, DOI 10.1055/s-2007-1001905; SORENSEN J, 1994, INTENS CARE MED, V20, P555, DOI 10.1007/BF01705721; STAFFORINI DM, 1990, J BIOL CHEM, V265, P9682; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; TERASHITA Z, 1985, EUR J PHARMACOL, V109, P257, DOI 10.1016/0014-2999(85)90427-3; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Victorino GP, 2004, J TRAUMA, V56, P379, DOI 10.1097/01.TA.0000042156.89779.6C; Vincent JL, 2000, CRIT CARE MED, V28, P638, DOI 10.1097/00003246-200003000-00006; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Yang JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009190; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	60	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7131	7141		10.1074/jbc.M113.524900	http://dx.doi.org/10.1074/jbc.M113.524900			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24478317	hybrid, Green Published			2022-12-25	WOS:000332389400072
J	Whyteside, AR; Turner, AJ; Lambert, DW				Whyteside, Alison R.; Turner, Anthony J.; Lambert, Daniel W.			Endothelin-Converting Enzyme-1 (ECE-1) Is Post-Transcriptionally Regulated by Alternative Polyadenylation	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; CELL; MICRORNA; GROWTH; CLEAVAGE	Endothelin-converting enzyme-1 (ECE-1) is the enzyme predominantly responsible for producing active endothelin-1 (ET-1), a mitogenic peptide implicated in the aetiology of a number of diseases, including cancer. Elevated levels of ECE-1 have been observed in a range of malignancies, with high expression conferring poor prognosis and aiding the acquisition of androgen independence in prostate cancer. The mechanisms regulating the expression of ECE-1 in cancer cells are poorly understood, hampering the development of novel therapies targeting the endothelin axis. Here we provide evidence that the expression of ECE-1 is markedly inhibited by its 3'UTR, and that alternative polyadenylation (APA) results in the production of ECE-1 transcripts with truncated 3'UTRs which promote elevated protein expression. Abolition of the ECE-1 APA sites reduced protein expression from a reporter vector in prostate cancer cells, suggesting these sites are functional. This is the first study to identify ECE-1 as a target for APA, a regulatory mechanism aberrantly activated in cancer cells, and provides novel information about the mechanisms leading to ECE-1 overexpression in malignant cells.	[Whyteside, Alison R.; Turner, Anthony J.] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, Sch Clin Dent, Sheffield, S Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, CR UK YCR Sheffield Canc Ctr, Sheffield, S Yorkshire, England	University of Leeds; University of Sheffield; University of Sheffield	Turner, AJ (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England.	a.j.turner@leeds.ac.uk; d.w.lambert@sheffield.ac.uk			Yorkshire Cancer Research [L342]	Yorkshire Cancer Research	This study was financially supported by a project grant from Yorkshire Cancer Research (ref L342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bagnato A, 1998, TRENDS ENDOCRIN MET, V9, P378, DOI 10.1016/S1043-2760(98)00094-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATTISTINI B, 1993, PEPTIDES, V14, P385, DOI 10.1016/0196-9781(93)90057-N; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Dawson LA, 2004, BRIT J CANCER, V90, P1577, DOI 10.1038/sj.bjc.6601717; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Knowles Jonathan, 2005, Current Vascular Pharmacology, V3, P309, DOI 10.2174/157016105774329462; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Raoch V, 2011, ARTERIOSCL THROM VAS, V31, P2577, DOI 10.1161/ATVBAHA.111.232025; Rayhman O, 2008, CANCER RES, V68, P9265, DOI 10.1158/0008-5472.CAN-08-2093; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; ROSSI GP, 1995, BIOCHEM BIOPH RES CO, V211, P249, DOI 10.1006/bbrc.1995.1803; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Shao R, 2003, MOL BIOL CELL, V14, P2327, DOI 10.1091/mbc.02-06-0093; Smollich M, 2007, BREAST CANCER RES TR, V106, P361, DOI 10.1007/s10549-007-9516-9; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Valdenaire O, 1999, EUR J BIOCHEM, V264, P341, DOI 10.1046/j.1432-1327.1999.00602.x	21	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e83260	10.1371/journal.pone.0083260	http://dx.doi.org/10.1371/journal.pone.0083260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497914	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000330621900003
J	Cornwell, EW; Mirbod, A; Wu, CL; Kandarian, SC; Jackman, RW				Cornwell, Evangeline W.; Mirbod, Azadeh; Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.			C26 Cancer-Induced Muscle Wasting Is IKK beta-Dependent and NF-kappaB-Independent	PLOS ONE			English	Article							SKELETAL-MUSCLE; MESSENGER-RNA; GENE-TRANSFER; B ACTIVATION; INHIBITION; PATHWAY; EXPRESSION; ATROPHY; BINDING; SUBSET	Existing data suggest that NF-kappaB signaling is a key regulator of cancer-induced skeletal muscle wasting. However, identification of the components of this signaling pathway and of the NF-kappa B transcription factors that regulate wasting is far from complete. In muscles of C26 tumor bearing mice, overexpression of dominant negative (d.n.) IKK beta blocked muscle wasting by 69% and the I kappa B beta-super repressor blocked wasting by 41%. In contrast, overexpression of d.n. IKK alpha or d.n. NIK did not block C26-induced wasting. Surprisingly, overexpression of d.n. p65 or d.n. c-Rel did not significantly affect muscle wasting. Genome-wide mRNA expression arrays showed upregulation of many genes previously implicated in muscle atrophy. To test if these upregulated genes were direct targets of NF-kappa B transcription factors, we compared genome-wide p65 binding to DNA in control and cachectic muscle using ChIP-sequencing. Bioinformatic analysis of ChIP-sequencing data from control and C26 muscles showed very little p65 binding to genes in cachexia and little to suggest that upregulated p65 binding influences the gene expression associated with muscle based cachexia. The p65 ChIP-seq data are consistent with our finding of no significant change in protein binding to an NF-kappa B oligonucleotide in a gel shift assay, no activation of a NF-kappa B-dependent reporter, and no effect of d.n. p65 overexpression in muscles of tumor bearing mice. Taken together, these data support the idea that although inhibition of I kappa B alpha, and particularly IKK beta, blocks cancer-induced wasting, the alternative NF-kappa B signaling pathway is not required. In addition, the downstream NF-kappa B transcription factors, p65 and c-Rel do not appear to regulate the transcriptional changes induced by the C26 tumor. These data are consistent with the growing body of literature showing that there are NF-kappa B-independent substrates of IKK beta and I kappa B alpha that regulate physiological processes.	[Cornwell, Evangeline W.; Mirbod, Azadeh; Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Jackman, RW (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	rjackman@bu.edu			National Institutes of Health (NIH) award [AR060217]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060217] Funding Source: NIH RePORTER	National Institutes of Health (NIH) award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) award AR060217. (http://grants.nih.gov/grants/oer.htm.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1609, DOI 10.1016/j.biocel.2005.03.007; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Baracos VE, 2003, NES NUTR WS, V8, P1, DOI 10.1159/000072744; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Busquets S, 2004, CANCER RES, V64, P6725, DOI 10.1158/0008-5472.CAN-04-0425; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Jackman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051478; Jackman RW, 2009, EXP CELL RES, V315, P3242, DOI 10.1016/j.yexcr.2009.08.020; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Rhoads MG, 2009, EUR J CANC; Rossini K, 2002, BASIC APPL MYOL, V12, P97; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Shadfar S, 2011, NUTR CANCER, V63, P749, DOI 10.1080/01635581.2011.563032; Taylor J, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-11; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Xing YJ, 2013, FUNCT INTEGR GENOMIC, V13, P143, DOI 10.1007/s10142-012-0305-0; Yamaki T, 2012, AM J PHYSIOL-CELL PH, V303, pC135, DOI 10.1152/ajpcell.00111.2012; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	48	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87776	10.1371/journal.pone.0087776	http://dx.doi.org/10.1371/journal.pone.0087776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489962	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000179
J	Hoffman, JI; Krause, ET; Lehmann, K; Kruger, O				Hoffman, Joseph I.; Krause, E. Tobias; Lehmann, Katrin; Krueger, Oliver			MC1R Genotype and Plumage Colouration in the Zebra Finch (Taeniopygia guttata): Population Structure Generates Artefactual Associations	PLOS ONE			English	Article							GENETIC-BASIS; RECEPTOR GENE; POLYMORPHISM; EVOLUTION; ORNAMENTS; BIRDS; LOCI; MICE; WILD	Polymorphisms at the melanocortin-1 receptor (MC1R) gene have been linked to coloration in many vertebrate species. However, the potentially confounding influence of population structure has rarely been controlled for. We explored the role of the MC1R in a model avian system by sequencing the coding region in 162 zebra finches comprising 79 wild type and 83 white individuals from five stocks. Allelic counts differed significantly between the two plumage morphs at multiple segregating sites, but these were mostly synonymous. To provide a control, the birds were genotyped at eight microsatellites and subjected to Bayesian cluster analysis, revealing two distinct groups. We therefore crossed wild type with white individuals and backcrossed the F1s with white birds. No significant associations were detected in the resulting offspring, suggesting that our original findings were a byproduct of genome-wide divergence. Our results are consistent with a previous study that found no association between MC1R polymorphism and plumage coloration in leaf warblers. They also contribute towards a growing body of evidence suggesting that care should be taken to quantify, and where necessary control for, population structure in association studies.	[Hoffman, Joseph I.; Krause, E. Tobias; Lehmann, Katrin; Krueger, Oliver] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Krause, E. Tobias] Wageningen Univ, Behav Ecol Grp, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands	University of Bielefeld; Wageningen University & Research	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	joseph.hoffman@uni-bielefeld.de	Krause, E. Tobias/A-9900-2009; Hoffman, Joseph i/K-7725-2012	Krause, E. Tobias/0000-0002-8327-3711; Hoffman, Joseph i/0000-0001-5895-8949	Deutsche 422 Forschungsgemeinschaft (DFG) through a Heisenberg-Professorship [KR2089/2-1]	Deutsche 422 Forschungsgemeinschaft (DFG) through a Heisenberg-Professorship(German Research Foundation (DFG))	O.K. was funded by the Deutsche 422 Forschungsgemeinschaft (DFG) through a Heisenberg-Professorship (KR2089/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bolund E, 2010, J EVOLUTION BIOL, V23, P586, DOI 10.1111/j.1420-9101.2009.01927.x; Bolund E, 2010, ANIM BEHAV, V79, P947, DOI 10.1016/j.anbehav.2010.01.014; Bradley BJ, 2013, J MAMM EVOL, V20, P263, DOI 10.1007/s10914-012-9212-3; Dawson DA, 2005, MOL ECOL NOTES, V5, P298, DOI 10.1111/j.1471-8286.2005.00907.x; Doucet SM, 2004, P ROY SOC B-BIOL SCI, V271, P1663, DOI 10.1098/rspb.2004.2779; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Dunn PO, 2001, EVOLUTION, V55, P161; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Forstmeier W, 2007, MOL ECOL NOTES, V7, P1026, DOI 10.1111/j.1471-8286.2007.01762.x; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Fowlie MK, 2003, J EVOLUTION BIOL, V16, P577, DOI 10.1046/j.1420-9101.2003.00564.x; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Gangoso L, 2011, J EVOLUTION BIOL, V24, P2055, DOI 10.1111/j.1420-9101.2011.02336.x; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harrison C. J. O., 1963, Bird Study, V10, P219; Immelmann K., 1969, ZEBRAFINK TAENIOPYGI; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Krause ET, 2011, ANIM BEHAV, V81, P1295, DOI 10.1016/j.anbehav.2011.03.021; Leader N, 2006, ANIM BEHAV, V72, P113, DOI 10.1016/j.anbehav.2005.09.013; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Mayr E., 1963, ANIMAL SPECIES EVOLU, P12; Mcgraw KJ, 2004, CONDOR, V106, P686, DOI 10.1650/7418.1; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Naguib M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000901; O'Connor TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065834; Prado-Martinez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-363; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SMYTH JR, 1990, POULTRY BREEDING GEN; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Xu HY, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S109; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054; Zann RA., 1996, ZEBRA FINCH SYNTHESI	46	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86519	10.1371/journal.pone.0086519	http://dx.doi.org/10.1371/journal.pone.0086519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489736	Green Published, gold			2022-12-25	WOS:000330570000044
J	Yamasaki, S; Taguchi, Y; Shimamoto, A; Mukasa, H; Tahara, H; Okamoto, T				Yamasaki, Sachiko; Taguchi, Yuki; Shimamoto, Akira; Mukasa, Hanae; Tahara, Hidetoshi; Okamoto, Tetsuji			Generation of Human Induced Pluripotent Stem (Ips) Cells in Serum- and Feeder-Free Defined Culture and TGF-B1 Regulation of Pluripotency	PLOS ONE			English	Article							SELF-RENEWAL; RECOMBINANT VITRONECTIN; MAINTAINS PLURIPOTENCY; SOMATIC-CELLS; MOUSE; INDUCTION; GROWTH; FIBROBLASTS; EFFICIENT; NANOG	Human Embryonic Stem cells (hESCs) and human induced Pluripotent Stem cells (hiPSCs) are commonly maintained on inactivated mouse embryonic fibroblast as feeder cells in medium supplemented with FBS or proprietary replacements. Use of culture medium containing undefined or unknown components has limited the development of applications for pluripotent cells because of the relative lack of knowledge regarding cell responses to differentiating growth factors. In addition, there is no consensus as to the optimal formulation, or the nature of the cytokine requirements of the cells to promote their self-renewal and inhibit their differentiation. In this study, we successfully generated hiPSCs from human dental pulp cells (DPCs) using Yamanaka's factors (Oct3/4, Sox2, Klf4, and c-Myc) with retroviral vectors in serum-and feeder-free defined culture conditions. These hiPSCs retained the property of self-renewal as evaluated by the expression of self-renewal marker genes and proteins, morphology, cell growth rates, and pluripotency evaluated by differentiation into derivatives of all three primary germ layers in vitro and in vivo. In this study, we found that TGF-beta 1 increased the expression levels of pluripotency markers in a dose-dependent manner. However, increasing doses of TGF-beta 1 suppressed the growth rate of hiPSCs cultured under the defined conditions. Furthermore, over short time periods the hiPSCs cultured in hESF9 or hESF9T exhibited similar morphology, but hiPSCs maintained in hESF9 could not survive beyond 30 passages. This result clearly confirmed that hiPSCs cultured in hESF9 medium absolutely required TGF-beta 1 to maintain pluripotency. This simple serum-free adherent monoculture system will allow us to elucidate the cell responses to growth factors under defined conditions and can eliminate the risk might be brought by undefined pathogens.	[Yamasaki, Sachiko; Taguchi, Yuki; Mukasa, Hanae; Okamoto, Tetsuji] Hiroshima Univ, Dept Mol Oral Med & Maxillofacial Surg, Grad Inst Biomed & Hlth Sci, Hiroshima 730, Japan; [Shimamoto, Akira; Tahara, Hidetoshi] Hiroshima Univ, Dept Cellular & Mol Biol, Grad Inst Biomed & Hlth Sci, Hiroshima 730, Japan	Hiroshima University; Hiroshima University	Okamoto, T (corresponding author), Hiroshima Univ, Dept Mol Oral Med & Maxillofacial Surg, Grad Inst Biomed & Hlth Sci, Hiroshima 730, Japan.	tetsuok@hiroshima-u.ac.jp	Yamasaki, Sachiko/H-2333-2019; Tahara, Hidetoshi/G-7697-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology [22659369, 24890139]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants (no. 22659369 and 24890139) from the Japanese Ministry of Education, Culture, Sports, Science and Technology to TO and SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; MATSUO M, 1982, J GERONTOL, V37, P33, DOI 10.1093/geronj/37.1.33; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MYOKEN Y, 1989, IN VITRO CELL DEV B, V25, P477; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; SATO JD, 1987, J EXP MED, V165, P1761, DOI 10.1084/jem.165.6.1761; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	40	30	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87151	10.1371/journal.pone.0087151	http://dx.doi.org/10.1371/journal.pone.0087151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489856	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000108
J	Lakes-Harlan, R; deVries, T; Stolting, H; Stumpner, A				Lakes-Harlan, Reinhard; deVries, Thomas; Stoelting, Heiko; Stumpner, Andreas			Useless Hearing in Male Emblemasoma auditrix (Diptera, Sarcophagidae) - A Case of Intralocus Sexual Conflict during Evolution of a Complex Sense Organ?	PLOS ONE			English	Article							CICADA OKANAGANA-RIMOSA; ORMIA-OCHRACEA DIPTERA; PARASITOID FLY; ACOUSTIC COMMUNICATION; TYMPANAL HEARING; AUDITORY-SYSTEM; TACHINIDAE; BEHAVIOR; HOST; DIMORPHISM	Sensory modalities typically are important for both sexes, although sex-specific functional adaptations may occur frequently. This is true for hearing as well. Consequently, distinct behavioural functions were identified for the different insect hearing systems. Here we describe a first case, where a trait of an evolutionary novelty and a highly specialized hearing organ is adaptive in only one sex. The main function of hearing of the parasitoid fly Emblemasoma auditrix is to locate the host, males of the cicada species Okanagana rimosa, by their calling song. This task is performed by female flies, which deposit larvae into the host. We show that male E. auditrix possess a hearing sense as well. The morphology of the tympanal organ of male E. auditrix is rather similar to the female ear, which is 8% broader than the male ear. In both sexes the physiological hearing threshold is tuned to 5 kHz. Behavioural tests show that males are able to orient towards the host calling song, although phonotaxis often is incomplete. However, despite extensive observations in the field and substantial knowledge of the biology of E. auditrix, no potentially adaptive function of the male auditory sense has been identified. This unique hearing system might represent an intralocus sexual conflict, as the complex sense organ and the behavioural relevant neuronal network is adaptive for only one sex. The correlated evolution of the sense organ in both sexes might impose substantial constraints on the sensory properties of the ear. Similar constraints, although hidden, might also apply to other sensory systems in which behavioural functions differ between sexes.	[Lakes-Harlan, Reinhard; deVries, Thomas] Univ Giessen, Inst Anim Physiol, AG Integrat Sensory Physiol, D-35390 Giessen, Germany; [Stoelting, Heiko; Stumpner, Andreas] Univ Gottingen, Schwann Schleiden Forschungszentrum, D-37073 Gottingen, Germany	Justus Liebig University Giessen; University of Gottingen	Lakes-Harlan, R (corresponding author), Univ Giessen, Inst Anim Physiol, AG Integrat Sensory Physiol, D-35390 Giessen, Germany.	reinhard.lakes-harlan@physzool.bio.uni-giessen.de		Stumpner, Andreas/0000-0003-3349-4038	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Parts of the study were funded by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen GR, 1999, J INSECT BEHAV, V12, P67, DOI 10.1023/A:1020929231430; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; CARDONE B, 1988, PHYSIOL ENTOMOL, V13, P9, DOI 10.1111/j.1365-3032.1988.tb00903.x; de Vries T, 2005, ZOOLOGY, V108, P239, DOI 10.1016/j.zool.2005.04.004; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Egelhaaf M, 2002, CURR OPIN NEUROBIOL, V12, P699, DOI 10.1016/S0959-4388(02)00390-2; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; FORREST TG, 1994, AM ZOOL, V34, P644; FOWLER H G, 1987, Revista Brasileira de Biologia, V47, P371; Fullard JH, 2007, BIOL LETT-UK, V3, P26, DOI 10.1098/rsbl.2006.0550; FULLARD JH, 1994, J EVOLUTION BIOL, V7, P435, DOI 10.1046/j.1420-9101.1994.7040435.x; FULLARD JH, 1993, TRENDS ECOL EVOL, V8, P248, DOI 10.1016/0169-5347(93)90200-9; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gopfert MC, 1999, J EXP BIOL, V202, P2727; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; Gu JJ, 2012, P NATL ACAD SCI USA, V109, P3868, DOI 10.1073/pnas.1118372109; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; Hustert R, 1999, J COMP NEUROL, V410, P444, DOI 10.1002/(SICI)1096-9861(19990802)410:3<444::AID-CNE7>3.0.CO;2-E; Kohler U, 2001, J COMP PHYSIOL A, V187, P581, DOI 10.1007/s003590100230; Lakes-Harlan R, 2000, ZOOL-ANAL COMPLEX SY, V103, P31; Lakes-Harlan R, 1999, P ROY SOC B-BIOL SCI, V266, P1161, DOI 10.1098/rspb.1999.0758; LAKESHARLAN R, 1991, J EXP BIOL, V158, P307; Lane KA, 2008, J COMP NEUROL, V508, P677, DOI 10.1002/cne.21675; LEDERHOUSE RC, 1976, ANN ENTOMOL SOC AM, V69, P656, DOI 10.1093/aesa/69.4.656; Lehmann GUC, 2010, J COMP PHYSIOL A, V196, P807, DOI 10.1007/s00359-010-0560-2; Parsch J, 2013, NAT REV GENET, V14, P83, DOI 10.1038/nrg3376; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; ROBERT D, 1994, CELL TISSUE RES, V275, P63, DOI 10.1007/BF00305376; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Rust J, 1999, NATURE, V399, P650, DOI 10.1038/21356; Schniederkotter K, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.36; SOPER RS, 1976, CAN ENTOMOL, V108, P61, DOI 10.4039/Ent10861-1; Stolting H, 2004, ZOOLOGY, V107, P243, DOI 10.1016/j.zool.2004.07.003; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; Stumpner A, 1996, J COMP PHYSIOL A, V178, P227; Stumpner A, 2007, J COMP PHYSIOL A, V193, P113, DOI 10.1007/s00359-006-0174-x; Sueur J, 2005, J ACOUST SOC AM, V118, P530, DOI 10.1121/1.1932227; Sueur J, 2008, J EXP BIOL, V211, P2379, DOI 10.1242/jeb.018804; vonHelversen D, 1997, J COMP PHYSIOL A, V180, P373, DOI 10.1007/s003590050056; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P527, DOI 10.1098/rstb.1986.0017; WALKER TJ, 1993, J INSECT BEHAV, V6, P389, DOI 10.1007/BF01048119; Warren B, 2009, CURR BIOL, V19, P485, DOI 10.1016/j.cub.2009.01.059; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542; Yager DD, 2008, BIOL J LINN SOC, V94, P541, DOI 10.1111/j.1095-8312.2008.00996.x; Yager DD, 2012, CURR OPIN NEUROBIOL, V22, P201, DOI 10.1016/j.conb.2011.12.011; YAGER DD, 1990, J ZOOL, V221, P517, DOI 10.1111/j.1469-7998.1990.tb04017.x; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	48	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87211	10.1371/journal.pone.0087211	http://dx.doi.org/10.1371/journal.pone.0087211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489872	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000116
J	Niehus, S; Smith, TK; Azzouz, N; Campos, MA; Dubremetz, JF; Gazzinelli, RT; Schwarz, RT; Debierre-Grockiego, F				Niehus, Sebastian; Smith, Terry K.; Azzouz, Nahid; Campos, Marco A.; Dubremetz, Jean-Francois; Gazzinelli, Ricardo T.; Schwarz, Ralph T.; Debierre-Grockiego, Francoise			Virulent and Avirulent Strains of Toxoplasma gondii Which Differ in Their Glycosylphosphatidylinositol Content Induce Similar Biological Functions in Macrophages	PLOS ONE			English	Article							MOLECULAR-WEIGHT ANTIGEN; SIGNAL-TRANSDUCTION; SURFACE-ANTIGENS; TNF-ALPHA; HOST; PROTEIN; TRYPANOSOMA; ACTIVATION; INFECTION; EFFECTORS	Glycosylphosphatidylinositols (GPIs) from several protozoan parasites are thought to elicit a detrimental stimulation of the host innate immune system aside their main function to anchor surface proteins. Here we analyzed the GPI biosynthesis of an avirulent Toxoplasma gondii type 2 strain (PTG) by metabolic radioactive labeling. We determined the biological function of individual GPI species in the PTG strain in comparison with previously characterized GPI-anchors of a virulent strain (RH). The GPI intermediates of both strains were structurally similar, however the abundance of two of six GPI intermediates was significantly reduced in the PTG strain. The side-by-side comparison of GPI-anchor content revealed that the PTG strain had only similar to 34% of the protein-free GPIs as well as similar to 70% of the GPI-anchored proteins with significantly lower rates of protein N-glycosylation compared to the RH strain. All mature GPIs from both strains induced comparable secretion levels of TNF-alpha and IL-12p40, and initiated TLR4/MyD88-dependent NF-kappa Bp65 activation in macrophages. Taken together, these results demonstrate that PTG and RH strains differ in their GPI biosynthesis and possess significantly different GPI-anchor content, while individual GPI species of both strains induce similar biological functions in macrophages.	[Niehus, Sebastian; Azzouz, Nahid; Schwarz, Ralph T.; Debierre-Grockiego, Francoise] Univ Marburg, Inst Virol, Parasitol Lab, D-35032 Marburg, Germany; [Niehus, Sebastian] UPR 9022 CNRS, Inst Mol & Cellular Biol, Strasbourg, France; [Smith, Terry K.] Univ St Andrews, St Andrews, Fife, Scotland; [Campos, Marco A.; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Res Ctr Rene Rachou, Immunopathol Lab, Belo Horizonte, MG, Brazil; [Dubremetz, Jean-Francois] Univ Montpellier 2, UMR CNRS 5235, Montpellier, France; [Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Massachusetts Med Sch, Div Infect Dis & Immunol, Dept Med, Worcester, MA USA; [Schwarz, Ralph T.] Univ Lille, UMR CNRS 8576, Unit Struct & Funct Glycobiol, Lille, France; [Debierre-Grockiego, Francoise] Univ Tours, UMR Infectiol & Publ Hlth 1282, Tours, France; [Debierre-Grockiego, Francoise] INRA, F-37380 Nouzilly, France	Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of St Andrews; Fundacao Oswaldo Cruz; Universite de Montpellier; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Tours; INRAE	Niehus, S (corresponding author), Univ Marburg, Inst Virol, Parasitol Lab, D-35032 Marburg, Germany.	s.niehus@unistra.fr	Campos, Marco A/C-4000-2013; Debierre-Grockiego, Francoise/AAD-4322-2021; Campos, Marco Antonio/AAU-6229-2021	Campos, Marco A/0000-0003-4683-0176; Campos, Marco Antonio/0000-0003-4683-0176; Gazzinelli, Ricardo/0000-0003-2427-7699	Deutsche Forschungsgemeinschaft; NIH [R01 AI071319]; PROBRAL of Deutscher Akademischer Austausch Dienst/CAPES; Wellcome Trust Senior Research Fellowship [067441]; Wellcome Trust [086658, 093228]; CNPq	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PROBRAL of Deutscher Akademischer Austausch Dienst/CAPES; Wellcome Trust Senior Research Fellowship(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Deutsche Forschungsgemeinschaft (R. T. S.), NIH grant number R01 AI071319 (R. T. G. and R. T. S.) and PROBRAL of Deutscher Akademischer Austausch Dienst/CAPES (R. T. G. and R. T. S.). T. K. S. is supported by a Wellcome Trust Senior Research Fellowship (067441), and Wellcome Trust grants (086658) and (093228). R. T. G. and M. A. C. are research fellows from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Azzouz N, 2005, ANAL BIOCHEM, V343, P152, DOI 10.1016/j.ab.2005.04.030; Azzouz N, 2006, INT J BIOCHEM CELL B, V38, P1914, DOI 10.1016/j.biocel.2006.05.006; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; Boothroyd JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003296; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Debierre-Grockiego F, 2010, J BIOL CHEM, V285, P32744, DOI 10.1074/jbc.M110.137588; Delude RL, 1998, J IMMUNOL, V161, P3001; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; GRIMWOOD BG, 1979, EXP PARASITOL, V48, P282, DOI 10.1016/0014-4894(79)90110-3; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Khan A, 2011, MBIO, V2, DOI 10.1128/mBio.00228-11; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; KHAN IA, 1988, J INFECT DIS, V157, P979, DOI 10.1093/infdis/157.5.979; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; MacRae JI, 2005, GLYCOBIOLOGY, V15, P131, DOI 10.1093/glycob/cwh149; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; MENON AK, 1990, J BIOL CHEM, V265, P9033; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Niehus S, 2012, IMMUNOBIOLOGY, V217, P61, DOI 10.1016/j.imbio.2011.08.001; Pekari K, 2001, J ORG CHEM, V66, P7432, DOI 10.1021/jo015840q; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard AM, 2009, TRENDS PARASITOL, V25, P491, DOI 10.1016/j.pt.2009.07.009; Rachinel N, 2004, J IMMUNOL, V173, P2725, DOI 10.4049/jimmunol.173.4.2725; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Smith TK, 2007, J BIOL CHEM, V282, P32032, DOI 10.1074/jbc.M703784200; STRIEPEN B, 1992, Biochemical Society Transactions, V20, p296S; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; TACHADO SD, 1994, BIOCHEM BIOPH RES CO, V205, P984, DOI 10.1006/bbrc.1994.2763; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; TOMAVO S, 1992, J BIOL CHEM, V267, P11721; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Wichroski MJ, 2003, EUKARYOT CELL, V2, P1132, DOI 10.1128/EC.2.5.1132-1136.2003; YAMASHITA K, 1982, METHOD ENZYMOL, V83, P105; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	60	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85386	10.1371/journal.pone.0085386	http://dx.doi.org/10.1371/journal.pone.0085386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489660	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000013
J	Toju, H; Sato, H; Tanabe, AS				Toju, Hirokazu; Sato, Hirotoshi; Tanabe, Akifumi S.			Diversity and Spatial Structure of Belowground Plant-Fungal Symbiosis in a Mixed Subtropical Forest of Ectomycorrhizal and Arbuscular Mycorrhizal Plants	PLOS ONE			English	Article							COMMUNITY STRUCTURE; RAIN-FOREST; PATTERNS; COMPETITION; CARBON; ESTABLISHMENT; COLONIZATION; VARIABILITY; NUTRITION; PHOSPHATE	Plant-mycorrhizal fungal interactions are ubiquitous in forest ecosystems. While ectomycorrhizal plants and their fungi generally dominate temperate forests, arbuscular mycorrhizal symbiosis is common in the tropics. In subtropical regions, however, ectomycorrhizal and arbuscular mycorrhizal plants co-occur at comparable abundances in single forests, presumably generating complex community structures of root-associated fungi. To reveal root-associated fungal community structure in a mixed forest of ectomycorrhizal and arbuscular mycorrhizal plants, we conducted a massively-parallel pyrosequencing analysis, targeting fungi in the roots of 36 plant species that co-occur in a subtropical forest. In total, 580 fungal operational taxonomic units were detected, of which 132 and 58 were probably ectomycorrhizal and arbuscular mycorrhizal, respectively. As expected, the composition of fungal symbionts differed between fagaceous (ectomycorrhizal) and non-fagaceous (possibly arbuscular mycorrhizal) plants. However, non-fagaceous plants were associated with not only arbuscular mycorrhizal fungi but also several clades of ectomycorrhizal (e. g., Russula) and root-endophytic ascomycete fungi. Many of the ectomycorrhizal and root-endophytic fungi were detected from both fagaceous and non-fagaceous plants in the community. Interestingly, ectomycorrhizal and arbuscular mycorrhizal fungi were concurrently detected from tiny root fragments of non-fagaceous plants. The plant-fungal associations in the forest were spatially structured, and non-fagaceous plant roots hosted ectomycorrhizal fungi more often in the proximity of ectomycorrhizal plant roots. Overall, this study suggests that belowground plant-fungal symbiosis in subtropical forests is complex in that it includes "non-typical'' plant-fungal combinations (e. g., ectomycorrhizal fungi on possibly arbuscular mycorrhizal plants) that do not fall within the conventional classification of mycorrhizal symbioses, and in that associations with multiple functional (or phylogenetic) groups of fungi are ubiquitous among plants. Moreover, ectomycorrhizal fungal symbionts of fagaceous plants may "invade'' the roots of neighboring non-fagaceous plants, potentially influencing the interactions between non-fagaceous plants and their arbuscular-mycorrhizal fungal symbionts at a fine spatial scale.	[Toju, Hirokazu; Sato, Hirotoshi; Tanabe, Akifumi S.] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan; [Toju, Hirokazu; Sato, Hirotoshi] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan	Kyoto University; Kyoto University; Japan Fisheries Research & Education Agency (FRA)	Toju, H (corresponding author), Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan.	toju.hirokazu.4c@kyoto-u.ac.jp	Sato, Hirotoshi/A-2429-2015; Toju, Hirokazu/T-7355-2019; Toju, Hirokazu/S-7307-2017; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government [GS014]	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government	This work was financially supported by the Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government (to H. T.; GS014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander I. J., 2005, P165, DOI 10.1017/CBO9780511541971.008; Bahram M, 2011, FEMS MICROBIOL ECOL, V75, P313, DOI 10.1111/j.1574-6941.2010.01000.x; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Bonneau L, 2013, NEW PHYTOL, V199, P188, DOI 10.1111/nph.12234; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caruso T, 2012, NEW PHYTOL, V194, P891, DOI 10.1111/j.1469-8137.2012.04163.x; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Chen YL, 2000, NEW PHYTOL, V146, P545, DOI 10.1046/j.1469-8137.2000.00663.x; Comas LH, 2009, NEW PHYTOL, V182, P919, DOI 10.1111/j.1469-8137.2009.02799.x; Dickie IA, 2001, NEW PHYTOL, V151, P257, DOI 10.1046/j.1469-8137.2001.00148.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eguchi T, 1984, CONSERVATION REPORTS, V3-26; Enoki T, 2003, ECOL RES, V18, P103, DOI 10.1046/j.1440-1703.2003.00549.x; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; FINLAY RD, 1986, NEW PHYTOL, V103, P157, DOI 10.1111/j.1469-8137.1986.tb00604.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hogberg MN, 2002, NEW PHYTOL, V154, P791, DOI 10.1046/j.1469-8137.2002.00417.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; KAGEYAMA S.A., 2008, MYCORRHIZA STATE ART, P29, DOI DOI 10.1007/978-3-540-78826-3_2; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Mandyam K, 2005, STUD MYCOL, P173; McGuire KL, 2008, MYCORRHIZA, V18, P217, DOI 10.1007/s00572-008-0170-9; McHugh TA, 2006, NEW PHYTOL, V171, P171, DOI 10.1111/j.1469-8137.2006.01735.x; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Murata H, 2013, MYCORRHIZA, V23, P235, DOI 10.1007/s00572-012-0466-7; Nara K, 2006, NEW PHYTOL, V169, P169, DOI 10.1111/j.1469-8137.2005.01545.x; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Nilsson RH, 2011, NEW PHYTOL, V191, P314, DOI 10.1111/j.1469-8137.2011.03755.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Oksanen J., 2017, R PACKAGE VERSION 26; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Sato H, 2008, MOL PHYLOGENET EVOL, V48, P326, DOI 10.1016/j.ympev.2008.01.033; Selosse MA, 2002, NEW PHYTOL, V155, P183, DOI 10.1046/j.1469-8137.2002.00442.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Sokal R. R., 2012, BIOMETRY; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Tanabe AS, 2012, CLAIDENT V0 1 2012 1; Tanabe AS, 2013, ASSAMS V0 1 2013 01; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Toju H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078248; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wu BY, 2012, NEW PHYTOL, V194, P1070, DOI 10.1111/j.1469-8137.2012.04126.x; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066829; Xie XA, 2013, NEW PHYTOL, V198, P836, DOI 10.1111/nph.12188; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao ZW, 2001, MYCORRHIZA, V11, P159, DOI 10.1007/s005720100117	73	55	56	13	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86566	10.1371/journal.pone.0086566	http://dx.doi.org/10.1371/journal.pone.0086566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489745	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000060
J	Yang, TL; Lin, L; Lou, PJ; Chang, TC; Young, TH				Yang, Tsung-Lin; Lin, Lin; Lou, Pei-Jen; Chang, Ta-Chau; Young, Tai-Horng			Detection of Cell Carcinogenic Transformation by a Quadruplex DNA Binding Fluorescent Probe	PLOS ONE			English	Article							BALB/C 3T3-CELL TRANSFORMATION; EXPERIMENTAL PARAMETERS; MOLECULAR-MECHANISMS; PREMALIGNANT LESIONS; CANCER; TELOMERASE; ASSAY; CHEMICALS; RISK; TUMORIGENICITY	Cancer can be easily treated when found early. A probe capable of detecting cell transformation may increase the success rate of early diagnosis of cancer. In this report we have tested the ability of a fluorescent, quadruplex DNA binding probe, 3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC), to detect cell transformation in vitro. BMVC was applied to living cells in several different models of cell transformation, and the fluorescence signals of BMVC were measured. The degrees of cell transformation in these models were characterized by alterations in cellular morphological phenotype and subcellular organization. When BMVC probes were applied, the number of BMVC-positive cells increased in accordance with the degree of transformation. BMVC was capable of significantly detecting formation of foci, increased cellular motility, cell proliferation, cell apoptosis, anchorage-independent growth, and increased invasiveness of transformed cells. These results demonstrate the ability of BMVC probes to detect cell transformation and indicate that BMVC is of promise for use as a probe in early cancer detection.	[Yang, Tsung-Lin; Lou, Pei-Jen] Natl Taiwan Univ, Dept Otolaryngol, Taipei 10764, Taiwan; [Yang, Tsung-Lin; Lou, Pei-Jen] Coll Med, Taipei, Taiwan; [Yang, Tsung-Lin] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Lin, Lin; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan; [Lin, Lin; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Chang, Ta-Chau] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Yang, TL (corresponding author), Natl Taiwan Univ, Dept Otolaryngol, Taipei 10764, Taiwan.	yangtl@ntu.edu.tw; thyoung@ntu.edu.tw	Chang, Ta-Chau/F-7921-2012	Chang, Ta-Chau/0000-0001-5878-8556; YANG, TSUNG-LIN/0000-0001-6521-8631; LOU, PEI-JEN/0000-0002-3383-8593	National Science Council of the Republic of China [98-2218-E-001-002-]; National Taiwan University Hospital [HCH101-18]; National Health Research Institutes (NHRI) [NHRI-EX99-9912EI]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan)	The authors thank National Science Council of the Republic of China (98-2218-E-001-002-), National Taiwan University Hospital (HCH101-18), and National Health Research Institutes (NHRI, NHRI-EX99-9912EI) for their financial support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao L, 2010, TOXICOL IN VITRO, V24, P430, DOI 10.1016/j.tiv.2009.10.006; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; BARRETT JC, 1987, ENVIRON HEALTH PERSP, V76, P65, DOI 10.2307/3430466; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Boukamp Petra, 2005, J Dtsch Dermatol Ges, V3, P493, DOI 10.1111/j.1610-0387.2005.05037.x; Chang C, 2003, FILM COMMENT, V39, P75; Chang CC, 2004, CHEM BIODIVERS, V1, P1377, DOI 10.1002/cbdv.200490100; Chang TC, 2010, METHODS MOL BIOL, V608, P183, DOI 10.1007/978-1-59745-363-9_12; Colacci A, 2011, TOXICOL IN VITRO; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Ebert MPA, 2006, J PROTEOME RES, V5, P19, DOI 10.1021/pr050271e; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Hsiao YC, 2011, BIOMATERIALS, V32, P4424, DOI 10.1016/j.biomaterials.2011.02.057; Hsue SS, 2007, J ORAL PATHOL MED, V36, P25; Hurley LH, 2000, PHARMACOL THERAPEUT, V85, P141, DOI 10.1016/S0163-7258(99)00068-6; Kang CC, 2007, ANALYST, V132, P745, DOI 10.1039/b617733f; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Keshava N, 2000, MUTAT RES-FUND MOL M, V447, P281, DOI 10.1016/S0027-5107(99)00216-X; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; LeBoeuf RA, 1999, IARC SCI PUBL, P409; Liao LJ, 2011, HEAD NECK-J SCI SPEC, V33, P719, DOI 10.1002/hed.21531; Liao LJ, 2009, ANALYST, V134, P708, DOI 10.1039/b814417f; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Luo HM, 2011, FASEB J, V25, P1865, DOI 10.1096/fj.10-174318; Mao L, 1996, CANCER RES, V56, P5600; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; Maruvada P., 2005, BIOTECHNIQUES, V4, P9, DOI DOI 10.2144/05384SU04; Mascolo MG, 2010, TOXICOL IN VITRO, V24, P1292, DOI 10.1016/j.tiv.2010.03.003; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P347, DOI 10.2307/3431405; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P277, DOI 10.2307/3431401; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P311, DOI 10.2307/3431403; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P293, DOI 10.2307/3431402; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P319, DOI 10.2307/3431404; MCCORMICK JJ, 1994, RISK ANAL, V14, P257, DOI 10.1111/j.1539-6924.1994.tb00240.x; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Redpath JL, 2004, CANCER METAST REV, V23, P333, DOI 10.1023/B:CANC.0000031771.56142.9b; Rosin MP, 2000, CLIN CANCER RES, V6, P357; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sagiv Idit, 2009, J Carcinog, V8, P16, DOI 10.4103/1477-3163.58372; Sakai A, 2007, MUTAT RES-GEN TOX EN, V630, P103, DOI 10.1016/j.mrgentox.2007.03.005; SAKAI N, 1994, INT J CANCER, V58, P309, DOI 10.1002/ijc.2910580227; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; SHEU CW, 1992, FOOD CHEM TOXICOL, V30, P307, DOI 10.1016/0278-6915(92)90008-9; Sudbo J, 2001, NEW ENGL J MED, V344, P1270, DOI 10.1056/NEJM200104263441702; Tsuchiya T, 2010, ATLA-ALTERN LAB ANIM, V38, P11, DOI 10.1177/026119291003800111; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; YAMASAKI H, 1985, CANCER RES, V45, P2395; Yang TL, 2008, HEAD NECK-J SCI SPEC, V30, P631, DOI 10.1002/hed.20758; Yang TL, 2011, ORAL ONCOL, V47, P720, DOI 10.1016/j.oraloncology.2011.04.006; Yang TL, 2010, BIOMATERIALS, V31, P288, DOI 10.1016/j.biomaterials.2009.09.052; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0	60	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86143	10.1371/journal.pone.0086143	http://dx.doi.org/10.1371/journal.pone.0086143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489694	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000033
J	Cheema, AK; Suman, S; Kaur, P; Singh, R; Fornace, AJ; Datta, K				Cheema, Amrita K.; Suman, Shubhankar; Kaur, Prabhjit; Singh, Rajbir; Fornace, Albert J., Jr.; Datta, Kamal			Long-Term Differential Changes in Mouse Intestinal Metabolomics after gamma and Heavy Ion Radiation Exposure	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; PROSTAGLANDIN E-2; PYRUVIC-ACID; D-ASPARTATE; CANCER; EXPRESSION; BIOMARKERS; METABOLISM; RECEPTOR; SERUM	Tissue consequences of radiation exposure are dependent on radiation quality and high linear energy transfer (high-LET) radiation, such as heavy ions in space is known to deposit higher energy in tissues and cause greater damage than low-LET gamma radiation. While radiation exposure has been linked to intestinal pathologies, there are very few studies on long-term effects of radiation, fewer involved a therapeutically relevant gamma radiation dose, and none explored persistent tissue metabolomic alterations after heavy ion space radiation exposure. Using a metabolomics approach, we report long-term metabolomic markers of radiation injury and perturbation of signaling pathways linked to metabolic alterations in mice after heavy ion or c radiation exposure. Intestinal tissues (C57BL/6J, female, 6 to 8 wks) were analyzed using ultra performance liquid chromatography coupled with electrospray quadrupole time-of-flight mass spectrometry (UPLC-QToF-MS) two months after 2 Gy gamma radiation and results were compared to an equitoxic Fe-56 (1.6 Gy) radiation dose. The biological relevance of the metabolites was determined using Ingenuity Pathway Analysis, immunoblots, and immunohistochemistry. Metabolic profile analysis showed radiation-type-dependent spatial separation of the groups. Decreased adenine and guanosine and increased inosine and uridine suggested perturbed nucleotide metabolism. While both the radiation types affected amino acid metabolism, the Fe-56 radiation preferentially altered dipeptide metabolism. Furthermore, Fe-56 radiation caused upregulation of 'prostanoid biosynthesis' and 'eicosanoid signaling', which are interlinked events related to cellular inflammation and have implications for nutrient absorption and inflammatory bowel disease during space missions and after radiotherapy. In conclusion, our data showed for the first time that metabolomics can not only be used to distinguish between heavy ion and gamma radiation exposures, but also as a radiation-risk assessment tool for intestinal pathologies through identification of biomarkers persisting long after exposure.	[Cheema, Amrita K.; Suman, Shubhankar; Kaur, Prabhjit; Singh, Rajbir; Fornace, Albert J., Jr.; Datta, Kamal] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Cheema, Amrita K.; Suman, Shubhankar; Kaur, Prabhjit; Singh, Rajbir; Fornace, Albert J., Jr.; Datta, Kamal] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Fornace, Albert J., Jr.] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia	Georgetown University; Georgetown University; King Abdulaziz University	Datta, K (corresponding author), Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA.	kd257@georgetown.edu	Singh, Rajbir/HHN-9064-2022; kaur, prabhjit/HHS-3727-2022; Fornace, Albert/A-7407-2008; Suman, Shubhankar/H-4610-2011	Fornace, Albert/0000-0001-9695-085X; Suman, Shubhankar/0000-0002-9197-0461; Cheema, Amrita/0000-0003-4877-7583	NASA [NNX13AD58G, NNX09AU95G]; National Cancer Institute (NCI) [P30CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by NASA Grant# NNX13AD58G and NNX09AU95G. The authors acknowledge the Histopathology and Tissue Shared Resources for histology services and Proteomics and Metabolomics Shared Resource for metabolomics services, which are in part supported by Award Number P30CA051008 from the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULSEBRO.KA, 1965, BIOCHEM BIOPH RES CO, V18, P165, DOI 10.1016/0006-291X(65)90734-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks AL, 2001, RADIAT RES, V155, P353, DOI 10.1667/0033-7587(2001)155[0353:REOHIP]2.0.CO;2; BURNS GA, 1995, J AUTONOM NERV SYST, V55, P207, DOI 10.1016/0165-1838(95)00043-W; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CASTER WO, 1956, RADIAT RES, V5, P189, DOI 10.2307/3570367; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Costedio MM, 2007, DIS COLON RECTUM, V50, P376, DOI 10.1007/s10350-006-0763-3; Coy SL, 2011, INT J RADIAT BIOL, V87, P802, DOI 10.3109/09553002.2011.556177; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta Francis A, 2003, Gravit Space Biol Bull, V16, P11; CURTIS SB, 1992, ADV SPACE RES-SERIES, V12, P407, DOI 10.1016/0273-1177(92)90137-M; Dassesse T, 2006, EUR UROL, V50, P1021, DOI 10.1016/j.eururo.2006.01.036; Datta K, 2005, P NATL ACAD SCI USA, V102, P10569, DOI 10.1073/pnas.0503975102; Datta K, 2013, PLOS ONE, V8; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Datta K, 2012, INT J RADIAT BIOL, V88, P213, DOI 10.3109/09553002.2012.639434; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Drafta D S, 1981, Endocrinologie, V19, P115; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; EBERHART CE, 1995, GASTROENTEROLOGY, V109, P285, DOI 10.1016/0016-5085(95)90296-1; Farthmann E. H., 1994, Strahlentherapie und Onkologie, V170, P437; Fukunaga Y, 2010, NEUROREPORT, V21, P772, DOI 10.1097/WNR.0b013e32833bfd17; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Ghosh SP, 2013, MOL BIOSYST, V9, P723, DOI 10.1039/c3mb25454b; GILLILAND IC, 1951, BMJ-BRIT MED J, V1, P14, DOI 10.1136/bmj.1.4696.14; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Hamilton SA, 2006, J APPL PHYSIOL, V101, P789, DOI 10.1152/japplphysiol.01078.2005; Hayatsu K, 2009, J PHYS SOC JPN, V78, P149, DOI 10.1143/JPSJS.78SA.149; Hess JR, 2012, NUTR CLIN PRACT, V27, P281, DOI 10.1177/0884533611434933; Hess LM, 2004, CANCER EPIDEM BIOMAR, V13, P861; HOLLAND RE, 1993, BIOCHEM PHARMACOL, V45, P43, DOI 10.1016/0006-2952(93)90375-7; Horio M, 2013, NEUROCHEM INT, V62, P843, DOI 10.1016/j.neuint.2013.02.015; HUBEL KA, 1976, AM J PHYSIOL, V231, P252, DOI 10.1152/ajplegacy.1976.231.1.252; Hunter MH, 2000, AM FAM PHYSICIAN, V62, P1079; Hyland K, 2007, J NUTR, V137, p1568S, DOI 10.1093/jn/137.6.1568S; Johnson CH, 2012, RADIAT RES, V178, P328, DOI 10.1667/RR2950.1; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Johnson Louis Banka, 2004, BMC Surg, V4, P10, DOI 10.1186/1471-2482-4-10; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Laiakis EC, 2012, RADIAT RES, V177, P187, DOI 10.1667/RR2771.1; Lee DY, 2012, RADIAT RES, V178, P551, DOI 10.1667/RR2990.1; Lee MS, 2001, CANCER RES, V61, P3290; Liu HX, 2013, RADIAT PROT DOSIM, V154, P9, DOI 10.1093/rpd/ncs138; Liu T, 2012, P NATL ACAD SCI USA, V109, P12692, DOI 10.1073/pnas.1207816109; MATHEWS CK, 1982, P NATL ACAD SCI-BIOL, V79, P302, DOI 10.1073/pnas.79.2.302; Matsui Y, 2012, CANCER SCI, V103, P700, DOI 10.1111/j.1349-7006.2012.02200.x; MAXWELL WJ, 1990, DIGESTION, V47, P160, DOI 10.1159/000200492; MUNRO AF, 1951, J PHYSIOL-LONDON, V112, P84, DOI 10.1113/jphysiol.1951.sp004510; Nakanishi M, 2011, CANCER PREV RES, V4, P1198, DOI 10.1158/1940-6207.CAPR-11-0188; Obenaus A, 2008, RADIAT RES, V169, P149, DOI 10.1667/RR1135.1; Okunieff P, 2008, CANCER METAST REV, V27, P363, DOI 10.1007/s10555-008-9138-7; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Patterson AD, 2010, MASS SPECTROM REV, V29, P503, DOI 10.1002/mas.20272; Pendyala L, 1997, CLIN CANCER RES, V3, P793; Peng Y, 2009, RADIAT RES, V171, P474, DOI 10.1667/RR1547.1; Peterson JW, 1998, LAB INVEST, V78, P523; Platt BS, 1939, BIOCHEM J, V33, P1525; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; PUGH S, 1994, GUT, V35, P675, DOI 10.1136/gut.35.5.675; Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; ROSEN IB, 1964, CAN MED ASSOC J, V91, P681; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Sandig H, 2007, J LEUKOCYTE BIOL, V81, P372, DOI 10.1189/jlb.0706424; Sheikh Kathryn D, 2011, J Biomol Tech, V22, P1; Sheng HM, 1998, CANCER RES, V58, P362; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Silfen ME, 2003, J CLIN ENDOCR METAB, V88, P4682, DOI 10.1210/jc.2003-030617; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Smith T, 2011, J NEUROCHEM, V118, P187, DOI 10.1111/j.1471-4159.2011.07305.x; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Snyder R D, 1985, Basic Life Sci, V31, P163; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Suman S, 2012, RAD ENV BIOPHYS; Suman S, 2012, INT J RADIAT ONCOL, V84, P500, DOI 10.1016/j.ijrobp.2011.12.033; Tessner TG, 2004, CARCINOGENESIS, V25, P37, DOI 10.1093/carcin/bgg183; Tseng BP, 2013, ANTIOXID REDOX SIGNA; Tucker JD, 2004, RADIAT RES, V161, P648, DOI 10.1667/RR3177; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; vanderHulst RRWJ, 1997, ANN SURG, V225, P112, DOI 10.1097/00000658-199701000-00013; Vistad I, 2009, INT J RADIAT ONCOL, V73, P1141, DOI 10.1016/j.ijrobp.2008.05.064; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]; ZIFRONI A, 1983, GUT, V24, P659, DOI 10.1136/gut.24.7.659	95	44	46	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87079	10.1371/journal.pone.0087079	http://dx.doi.org/10.1371/journal.pone.0087079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475228	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300135
J	Mir, R; Leon, J				Mir, Ricardo; Leon, Jose			Pathogen and Circadian Controlled 1 (PCC1) Protein Is Anchored to the Plasma Membrane and Interacts with Subunit 5 of COP9 Signalosome in Arabidopsis	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; FLOWERING TIME; PLANT DEVELOPMENT; FLORAL INDUCTION; FT PROTEIN; GIBBERELLIN; LIGHT; DEFENSE; LIGASES; THALIANA	The Pathogen and Circadian Controlled 1 (PCC1) gene, previously identified and further characterized as involved in defense to pathogens and stress-induced flowering, codes for an 81-amino acid protein with a cysteine-rich C-terminal domain. This domain is essential for homodimerization and anchoring to the plasma membrane. Transgenic plants with the beta-glucuronidase (GUS) reporter gene under the control of 1.1 kb promoter sequence of PCC1 gene display a dual pattern of expression. At early post-germination, PCC1 is expressed only in the root vasculature and in the stomata guard cells of cotyledons. During the transition from vegetative to reproductive development, PCC1 is strongly expressed in the vascular tissue of petioles and basal part of the leaf, and it further spreads to the whole limb in fully expanded leaves. This developmental pattern of expression together with the late flowering phenotype of long-day grown RNA interference (iPCC1) plants with reduced PCC1 expression pointed to a regulatory role of PCC1 in the photoperiod-dependent flowering pathway. iPCC1 plants are defective in light perception and signaling but are not impaired in the function of the core CO-FT module of the photoperiod-dependent pathway. The regulatory effect exerted by PCC1 on the transition to flowering as well as on other reported phenotypes might be explained by a mechanism involving the interaction with the subunit 5 of the COP9 signalosome (CSN).	[Mir, Ricardo; Leon, Jose] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Leon, J (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	jleon@ibmcp.upv.es	Moreno, Ricardo Mir/AAC-9447-2022; León, José/C-4756-2016	Moreno, Ricardo Mir/0000-0003-1506-4683; León, José/0000-0002-7332-1572	Ministerio de Ciencia e Innovacion of Spain [BIO2008-00839, BIO2011-27526, CSD2007-0057]; FPU program of the Ministerio de Educacion y Ciencia (Spain)	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU program of the Ministerio de Educacion y Ciencia (Spain)(German Research Foundation (DFG))	This work was funded by grants BIO2008-00839, BIO2011-27526 and CSD2007-0057 from Ministerio de Ciencia e Innovacion of Spain to J.L. A fellowship/contract of the FPU program of the Ministerio de Educacion y Ciencia (Spain) funded R.M. work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arc E, 2011, PROTEOMICS, V11, P1606, DOI 10.1002/pmic.201000641; Bastian R, 2010, PLANT SIGNAL BEHAV, V5, P224, DOI 10.4161/psb.5.3.10718; Belda-Palazon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046907; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galvao VC, 2012, DEVELOPMENT, V139, P4072, DOI 10.1242/dev.080879; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kuramata M, 2009, PLANT CELL PHYSIOL, V50, P106, DOI 10.1093/pcp/pcn175; Kwok SF, 1999, J MOL BIOL, V285, P85, DOI 10.1006/jmbi.1998.2315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Liu B, 2011, GENE DEV, V25, P1029, DOI 10.1101/gad.2025011; Lozano-Juste J, 2011, PLANT PHYSIOL, V156, P1410, DOI 10.1104/pp.111.177741; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Mir R, 2013, J EXP BOT, V64, P3385, DOI 10.1093/jxb/ert177; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nezames CD, 2012, PLANT PHYSIOL, V160, P38, DOI 10.1104/pp.112.198879; Nordgard O, 2001, BIOCHIMIE, V83, P969, DOI 10.1016/S0300-9084(01)01329-3; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Sauerbrunn N, 2004, PLANTA, V218, P552, DOI 10.1007/s00425-003-1143-z; Schwechheimer C, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00107; Segarra S, 2010, PLANT CELL ENVIRON, V33, P11, DOI 10.1111/j.1365-3040.2009.02045.x; Seo M, 2009, PLANT MOL BIOL, V69, P463, DOI 10.1007/s11103-008-9429-y; Serino G, 2003, ANNU REV PLANT BIOL, V54, P165, DOI 10.1146/annurev.arplant.54.031902.134847; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Stratmann JW, 2012, PLANT SCI, V185, P50, DOI 10.1016/j.plantsci.2011.10.004; Venancio TM, 2010, BIOINFORMATICS, V26, P149, DOI 10.1093/bioinformatics/btp647; Wang F, 2011, CELL RES, V21, P1286, DOI 10.1038/cr.2011.118; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Weidler G, 2012, PLANT CELL, V24, P2610, DOI 10.1105/tpc.112.098210; Wigge PA, 2011, CURR BIOL, V21, pR374, DOI 10.1016/j.cub.2011.03.038; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006	51	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87216	10.1371/journal.pone.0087216	http://dx.doi.org/10.1371/journal.pone.0087216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475254	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300155
J	Jia, LL; Kang, YM; Wang, FX; Li, HB; Zhang, Y; Yu, XJ; Qi, J; Suo, YP; Tian, ZJ; Zhu, ZM; Zhu, GQ; Qin, DN				Jia, Lin-Lin; Kang, Yu-Ming; Wang, Fu-Xin; Li, Hong-Bao; Zhang, Yan; Yu, Xiao-Jing; Qi, Jie; Suo, Yu-Ping; Tian, Zhen-Jun; Zhu, Zhiming; Zhu, Guo-Qing; Qin, Da-Nian			Exercise Training Attenuates Hypertension and Cardiac Hypertrophy by Modulating Neurotransmitters and Cytokines in Hypothalamic Paraventricular Nucleus	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; FACTOR-KAPPA-B; II-INDUCED HYPERTENSION; INDUCED HEART-FAILURE; OXIDATIVE STRESS; TRACTUS-SOLITARII; AEROBIC EXERCISE; BLOOD-PRESSURE; GABA RELEASE; BRAIN	Aims: Regular exercise as an effective non-pharmacological antihypertensive therapy is beneficial for prevention and control of hypertension, but the central mechanisms are unclear. In this study, we hypothesized that chronic exercise training (ExT) delays the progression of hypertension and attenuates cardiac hypertrophy by up-regulating anti-inflammatory cytokines, reducing pro-inflammatory cytokines (PICs) and restoring the neurotransmitters balance in the hypothalamic paraventricular nucleus (PVN) in young spontaneously hypertensive rats (SHR). In addition, we also investigated the involvement of nuclear factor-kappa B (NF-kappa B) p65 and NAD(P) H oxidase in exercise-induced effects. Methods and results: Moderate-intensity ExT was administrated to young normotensive Wistar-Kyoto (WKY) and SHR rats for 16 weeks. SHR rats had a significant increase in mean arterial pressure and cardiac hypertrophy. SHR rats also had higher levels of glutamate, norepinephrine (NE), phosphorylated IKK beta, NF-kappa B p65 activity, NAD(P) H oxidase subunit gp91(phox), PICs and the monocyte chemokine protein-1 (MCP-1), and lower levels of gamma-aminobutyric acid (GABA) and interleukin-10 (IL-10) in the PVN. These SHR rats also exhibited higher renal sympathetic nerve activity (RSNA), and higher plasma levels of PICs, and lower plasma IL-10. However, ExT ameliorates all these changes in SHR rats. Conclusion: These findings suggest that there are the imbalances between excitatory and inhibitory neurotransmitters and between pro-and anti-inflammatory cytokines in the PVN of SHR rats, which at least partly contributing to sympathoexcitation, hypertension and cardiac hypertrophy; chronic exercise training attenuates hypertension and cardiac hypertrophy by restoring the balances between excitatory and inhibitory neurotransmitters and between pro-and anti-inflammatory cytokines in the PVN; NF-kappa B and oxidative stress in the PVN may be involved in these exercise-induced effects.	[Jia, Lin-Lin; Kang, Yu-Ming; Li, Hong-Bao; Zhang, Yan; Yu, Xiao-Jing; Qi, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Cardiovasc Res Ctr, Xian 710049, Peoples R China; [Qin, Da-Nian] Shantou Univ, Coll Med, Dept Physiol, Shantou, Peoples R China; [Wang, Fu-Xin] Jiamusi Univ, Affiliated Hosp 1, Dept Neurol, Jiamusi, Peoples R China; [Zhu, Zhiming] Third Mil Med Univ, Dept Hypertens & Endocrinol, Ctr Hypertens & Metab Dis, Chongqing Inst Hypertens,Daping Hosp, Chongqing, Peoples R China; [Tian, Zhen-Jun] Shaanxi Normal Univ, Sch Phys Educ, Inst Sports & Exercise Biol, Xian, Peoples R China; [Suo, Yu-Ping] Shanxi Prov Peoples Hosp, Dept Obstet & Gynecol, Taiyuan, Peoples R China; [Zhu, Guo-Qing] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Dept Physiol, Nanjing, Jiangsu, Peoples R China	Xi'an Jiaotong University; Shantou University; Jiamusi University; Army Medical University; Shaanxi Normal University; Shanxi People's Hospital; Nanjing Medical University	Kang, YM (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Cardiovasc Res Ctr, Xian 710049, Peoples R China.	ykang@mail.xjtu.edu.cn; dnqin@stu.edu.cn	Li, Hong-Bao/ACO-9139-2022	Zhu, Guo-Qing/0000-0002-3132-9592; Tian, Zhenjun/0000-0002-8747-6161	National Basic Research Program of China [2012CB517805]; National Natural Science Foundation of China [31271254, 81170248, 81070199, 31171095, 31171141]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program of China (No. 2012CB517805) and National Natural Science Foundation of China (Nos. 31271254, 81170248, 81070199, 31171095, 31171141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Barber M, 2003, BRAIN RES, V964, P128, DOI 10.1016/s0006-8993(02)04091-X; Bertagnolli M, 2008, AM J HYPERTENS, V21, P1188, DOI 10.1038/ajh.2008.270; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Casillas JM, 2007, ANN READAPT MED PHYS, V50, P403, DOI DOI 10.1016/j.annrmp.2007.03.008; Chen QH, 2003, HYPERTENSION, V42, P725, DOI 10.1161/01.HYP.0000085197.20043.44; Cornelissen Veronique A., 2005, Journal of Hypertension, V23, P251; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Ferguson AV, 2000, EXP PHYSIOL, V85, p153S, DOI 10.1111/j.1469-445X.2000.tb00019.x; Goldberg MJ, 2012, J HUM HYPERTENS, V26, P644, DOI 10.1038/jhh.2011.95; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hamer M, 2006, SPORTS MED, V36, P109, DOI 10.2165/00007256-200636020-00002; Hirooka Y, 2008, AUTON NEUROSCI-BASIC, V142, P20, DOI 10.1016/j.autneu.2008.06.001; Kang YM, 2008, CARDIOVASC RES, V79, P671, DOI 10.1093/cvr/cvn119; Kang YM, 2006, CIRC RES, V99, P758, DOI 10.1161/01.RES.0000244092.95152.86; Kang YM, 2011, BASIC RES CARDIOL, V106, P1087, DOI 10.1007/s00395-011-0215-7; Kang YM, 2011, BASIC RES CARDIOL, V106, P473, DOI 10.1007/s00395-011-0155-2; Kang YM, 2009, CARDIOVASC RES, V83, P737, DOI 10.1093/cvr/cvp160; Kang YM, 2009, CARDIOVASC RES, V82, P503, DOI 10.1093/cvr/cvp073; Kishi T, 2001, HYPERTENSION, V38, P896, DOI 10.1161/hyp.38.4.896; Kishi T, 2012, CLIN EXP HYPERTENS, V34, P278, DOI 10.3109/10641963.2012.681084; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Li YF, 2005, METH MOLEC MED, V112, P59; Lin YZ, 2005, BRAIN RES, V1058, P161, DOI 10.1016/j.brainres.2005.07.070; Lindley TE, 2004, CIRC RES, V94, P402, DOI 10.1161/01.RES.0000112964.40701.93; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Mariappan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046568; Michelini LC, 2009, EXP PHYSIOL, V94, P947, DOI 10.1113/expphysiol.2009.047449; Nishihara M, 2012, J HYPERTENS, V30, P97, DOI 10.1097/HJH.0b013e32834e1df4; Pescatello LS, 2004, J HYPERTENS, V22, P1881, DOI 10.1097/00004872-200410000-00009; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Potts JT, 2006, EXP PHYSIOL, V91, P59, DOI 10.1113/expphysiol.2005.032227; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Roque FR, 2013, BRIT J PHARMACOL, V168, P686, DOI 10.1111/j.1476-5381.2012.02224.x; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Tasker JG, 1998, ADV EXP MED BIOL, V449, P117; Wang S, 2006, FASEB J, V20, P1537, DOI 10.1096/fj.05-5547fje; Yu XJ, 2013, CARDIOVASC TOXICOL, V13, P381, DOI 10.1007/s12012-013-9219-x; Zheng H, 2005, AM J PHYSIOL-HEART C, V288, pH2332, DOI 10.1152/ajpheart.00473.2004	41	38	43	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85481	10.1371/journal.pone.0085481	http://dx.doi.org/10.1371/journal.pone.0085481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24482680	gold, Green Submitted, Green Published			2022-12-25	WOS:000330237000038
J	Carr, SK; Chen, JH; Cooper, WN; Constancia, M; Yeo, GSH; Ozanne, SE				Carr, Sarah K.; Chen, Jian-Hua; Cooper, Wendy N.; Constancia, Miguel; Yeo, Giles S. H.; Ozanne, Susan E.			Maternal diet amplifies the hepatic aging trajectory of Cidea in male mice and leads to the development of fatty liver	FASEB JOURNAL			English	Article						developmental programming; maternal low protein; catch-up growth; lipid accumulation; epigenetic	POSTNATAL-GROWTH LEADS; LIFE-SPAN; PRENATAL EXPOSURE; DEFENSE CAPACITY; GENE-EXPRESSION; ADIPOSE-TISSUE; DNA-DAMAGE; EFFECTOR-A; RESTRICTION; PROTEIN	The importance of the early environment on long-term heath and life span is well documented. However, the molecular mechanisms mediating these effects remain poorly understood. Male offspring from a maternal protein restriction model, in which animals are exposed to a low-protein diet while in utero and then are cross-fostered to normally fed dams, demonstrate low birth weight, catch-up growth, and reduced life span (recuperated offspring). In the current study, we used microarray analysis to identify hepatic genes that changed with age. Cell death-inducing DNA fragmentation factor, subunit-like effector A (Cidea), a transcriptional coactivator that has been implicated in lipid accumulation demonstrated one of the largest age-associated increases in expression (200-fold, P<0.001). This increase was exaggerated approximate to 3-fold in recuperated offspring. These demonstrated increased hepatic lipid accumulation, higher levels of transcription factors important in lipid regulation, and greater oxidative stress. In vitro analysis revealed that Cidea expression was regulated by oxidative stress and DNA methylation. These findings suggest that maternal diet modulates the age-associated changes in Cidea expression through several mechanisms. This expression affects hepatic lipid metabolism in these animals and thus provides a mechanism by which maternal diet can contribute to the metabolic health and ultimately the life span of the offspring.Carr, S. K., Chen, J.-H., Cooper, W. N., Constancia, M., Yeo, G. S. H., Ozanne, S. E. Maternal diet amplifies the hepatic ageing trajectory of Cidea in male mice and leads to the development of fatty liver.	[Carr, Sarah K.; Chen, Jian-Hua; Cooper, Wendy N.; Constancia, Miguel; Yeo, Giles S. H.; Ozanne, Susan E.] Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, MRC Metab Dis Unit, Metab Res Labs,Addenbrookes Hosp, Cambridge CB2 OQQ, England; [Constancia, Miguel] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 OQQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Carr, SK (corresponding author), Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, MRC Metab Dis Unit, Metab Res Labs,Addenbrookes Hosp, Level 4,Box 289, Cambridge CB2 OQQ, England.	sb716@cam.ac.uk	Constancia, Miguel/F-6654-2013	Yeo, Giles See How/0000-0001-8823-3615; Ozanne, Susan/0000-0001-8753-5144; Constancia, Miguel/0000-0002-8976-1679	UK Biotechnology and Biological Science Research Council; BBSRC [BB/D01235X/1, BB/E002161/1, BB/D01235X/2] Funding Source: UKRI; MRC [MC_UU_12012/5, MC_UU_12012/1, MC_UU_12012/4, G0600717] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002161/1, BB/D01235X/1, BB/D01235X/2] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish; Medical Research Council [MC_UU_12012/5/B, MC_UU_12012/1, MC_UU_12012/5, G0600717B, G0600717, MC_UU_12012/4] Funding Source: researchfish	UK Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Biotechnology and Biological Science Research Council. S.E.O. is a British Heart Foundation Senior Fellow.	ANDERSON JM, 1972, J CLIN PATHOL, V25, P867, DOI 10.1136/jcp.25.10.867; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200; Chen JH, 2010, CLIN SCI, V119, P373, DOI 10.1042/CS20100230; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291; HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Kelder Bruce, 2007, Comp Hepatol, V6, P4, DOI 10.1186/1476-5926-6-4; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Li D, 2008, NUCLEIC ACIDS RES, V36, P330, DOI 10.1093/nar/gkm1028; Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nathanielsz PW, 2003, J PHYSIOL-LONDON, V548, P333, DOI 10.1113/jphysiol.2003.040527; Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050; Okamoto Y, 2002, HEPATOL RES, V23, P138, DOI 10.1016/S1386-6346(01)00172-3; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Roseboom TJ, 2000, BRIT J HAEMATOL, V111, P112, DOI 10.1046/j.1365-2141.2000.02268.x; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	37	12	12	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2191	2201		10.1096/fj.13-242727	http://dx.doi.org/10.1096/fj.13-242727			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24481968				2022-12-25	WOS:000335336000022
J	Bomtorin, AD; Mackert, A; Rosa, GCC; Moda, LM; Martins, JR; Bitondi, MMG; Hartfelder, K; Simoes, ZLP				Bomtorin, Ana Durvalina; Mackert, Aline; Couto Rosa, Gustavo Conrado; Moda, Livia Maria; Martins, Juliana Ramos; Gentile Bitondi, Marcia Maria; Hartfelder, Klaus; Paulino Simoes, Zila Luz			Juvenile Hormone Biosynthesis Gene Expression in the corpora allata of Honey Bee (Apis mellifera L.) Female Castes	PLOS ONE			English	Article							DIVISION-OF-LABOR; BEHAVIORAL-DEVELOPMENT; METHYL FARNESOATE; HEMOLYMPH TITERS; VITELLOGENIN; WORKER; METHYLTRANSFERASE; LIFE; PRECURSOR; ESTERASE	Juvenile hormone (JH) controls key events in the honey bee life cycle, viz. caste development and age polyethism. We quantified transcript abundance of 24 genes involved in the JH biosynthetic pathway in the corpora allata-corpora cardiaca (CA-CC) complex. The expression of six of these genes showing relatively high transcript abundance was contrasted with CA size, hemolymph JH titer, as well as JH degradation rates and JH esterase (jhe) transcript levels. Gene expression did not match the contrasting JH titers in queen and worker fourth instar larvae, but jhe transcript abundance and JH degradation rates were significantly lower in queen larvae. Consequently, transcriptional control of JHE is of importance in regulating larval JH titers and caste development. In contrast, the same analyses applied to adult worker bees allowed us inferring that the high JH levels in foragers are due to increased JH synthesis. Upon RNAi-mediated silencing of the methyl farnesoate epoxidase gene (mfe) encoding the enzyme that catalyzes methyl farnesoate-to-JH conversion, the JH titer was decreased, thus corroborating that JH titer regulation in adult honey bees depends on this final JH biosynthesis step. The molecular pathway differences underlying JH titer regulation in larval caste development versus adult age polyethism lead us to propose that mfe and jhe genes be assayed when addressing questions on the role(s) of JH in social evolution.	[Bomtorin, Ana Durvalina; Mackert, Aline; Moda, Livia Maria; Martins, Juliana Ramos] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Mackert, Aline] Univ Fed Mato Grosso do Sul, Dept Ciencias Ambiente, Corumba, Brazil; [Couto Rosa, Gustavo Conrado; Gentile Bitondi, Marcia Maria; Paulino Simoes, Zila Luz] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, Brazil; [Hartfelder, Klaus] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo	Simoes, ZLP (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, Brazil.	zlpsimoe@usp.br	Hartfelder, Klaus/L-2300-2019; Martins, Juliana Ramos/AAD-4694-2021; Moda, Livia M/I-6451-2012; Martins, Juliana Ramos/F-6726-2012; Hartfelder, Klaus/A-4293-2009; Bomtorin, Ana/I-8817-2012; Simoes, Zila Luz Paulino/H-7314-2014; Bitondi, Marcia MG/E-8014-2012	Hartfelder, Klaus/0000-0001-7981-8427; Martins, Juliana Ramos/0000-0002-7185-6477; Moda, Livia M/0000-0001-6381-7788; Hartfelder, Klaus/0000-0001-7981-8427; Bomtorin, Ana/0000-0002-3331-7843; Bitondi, Marcia MG/0000-0002-5619-6378; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [05/03926-5, 11/03171-5, 09/05675-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [research grant numbers 05/03926-5, 11/03171-5], which also provided a fellowship [09/05675-0] to ADB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Ament SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002596; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Bitondi MMG, 2006, J APICULT RES, V35, P27; Burtenshaw SM, 2008, PEPTIDES, V29, P242, DOI 10.1016/j.peptides.2007.10.030; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Chandrasekaran S, 2011, P NATL ACAD SCI USA, V108, P18020, DOI 10.1073/pnas.1114093108; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Cusson M, 2006, PROTEINS, V65, P742, DOI 10.1002/prot.21057; de Sousa CS, 2013, GENET MOL BIOL, V36, P292, DOI [10.1590/S1415-47572013000200022, 10.1590/s1415-47572013000200022]; Denlinger D.L., 2012, INSECT ENDOCRINOLOGY, P430, DOI DOI 10.1016/B978-0-12-384749-2.10010-X; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; GOODMAN WG, 1990, INSECT BIOCHEM, V20, P357, DOI 10.1016/0020-1790(90)90055-Y; GRANGER NA, 1979, MOL CELL ENDOCRINOL, V16, P1, DOI 10.1016/0303-7207(79)90002-9; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hartfelder K., 2012, INSECT ENDOCRINOLOGY, P464, DOI [10.1016/B978-0-12-384749-2.10011-1, DOI 10.1016/B978-0-12-384749-2.10011-1]; Hartfelder K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.06; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; HUANG ZY, 1991, J INSECT PHYSIOL, V37, P733, DOI 10.1016/0022-1910(91)90107-B; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; LAUFER H, 1987, INSECT BIOCHEM, V17, P1129, DOI 10.1016/0020-1790(87)90134-X; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Li WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068544; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Mackert A, 2008, COMP BIOCHEM PHYS B, V150, P33, DOI 10.1016/j.cbpb.2008.01.004; Mackert A, 2010, J INSECT PHYSIOL, V56, P1139, DOI 10.1016/j.jinsphys.2010.03.007; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Antonio DSM, 2008, NATURWISSENSCHAFTEN, V95, P953, DOI 10.1007/s00114-008-0413-9; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nijhout H.F., 1994, INSECT HORMONES; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; Ollivier M, 2010, INSECT MOL BIOL, V19, P33, DOI 10.1111/j.1365-2583.2009.00976.x; RACHINSKY A, 1990, J INSECT PHYSIOL, V36, P189, DOI 10.1016/0022-1910(90)90121-U; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; RACHINSKY A, 1991, NATURWISSENSCHAFTEN, V78, P270, DOI 10.1007/BF01134355; Rachinsky A, 2000, INSECT BIOCHEM MOLEC, V30, P729, DOI 10.1016/S0965-1748(00)00044-8; Rachinsky A, 2000, J INSECT PHYSIOL, V46, P41, DOI 10.1016/S0022-1910(99)00100-6; REMBOLD H, 1987, INSECT BIOCHEM, V17, P1003, DOI 10.1016/0020-1790(87)90110-7; ROBINSON GE, 1991, J INSECT PHYSIOL, V37, P929, DOI 10.1016/0022-1910(91)90008-N; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; SHARE MR, 1988, ANAL BIOCHEM, V169, P81, DOI 10.1016/0003-2697(88)90257-6; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Ueda H, 2009, J INSECT PHYSIOL, V55, P798, DOI 10.1016/j.jinsphys.2009.04.013; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston M.L., 1987, P1	59	47	48	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86923	10.1371/journal.pone.0086923	http://dx.doi.org/10.1371/journal.pone.0086923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489805	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000080
J	Cailotto, C; Gomez-Pinilla, PJ; Costes, LM; van der Vliet, J; Di Giovangiulio, M; Nemethova, A; Matteoli, G; Boeckxstaens, GE				Cailotto, Cathy; Gomez-Pinilla, Pedro J.; Costes, Lea M.; van der Vliet, Jan; Di Giovangiulio, Martina; Nemethova, Andrea; Matteoli, Gianluca; Boeckxstaens, Guy E.			Neuro-Anatomical Evidence Indicating Indirect Modulation of Macrophages by Vagal Efferents in the Intestine but Not in the Spleen	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VAGUS NERVE; GASTROINTESTINAL-TRACT; KAPPA-B; STIMULATION; RAT; INNERVATION; ACTIVATION; ANTIBODIES; MOUSE	Background: Electrical stimulation of the vagus nerve suppresses intestinal inflammation and normalizes gut motility in a mouse model of postoperative ileus. The exact anatomical interaction between the vagus nerve and the intestinal immune system remains however a matter of debate. In the present study, we provide additional evidence on the direct and indirect vagal innervation of the spleen and analyzed the anatomical evidence for neuroimmune modulation of macrophages by vagal preganglionic and enteric postganglionic nerve fibers within the intestine. Methods: Dextran conjugates were used to label vagal preganglionic (motor) fibers projecting to the small intestine and spleen. Moreover, identification of the neurochemical phenotype of the vagal efferent fibers and enteric neurons was performed by immunofluorescent labeling. F4/80 antibody was used to label resident macrophages. Results: Our anterograde tracing experiments did not reveal dextran-labeled vagal fibers or terminals in the mesenteric ganglion or spleen. Vagal efferent fibers were confined within the myenteric plexus region of the small intestine and mainly endings around nNOS, VIP and ChAT positive enteric neurons. nNOS, VIP and ChAT positive fibers were found in close proximity of intestinal resident macrophages carrying alpha 7 nicotinic receptors. Of note, VIP receptors were found on resident macrophages located in close proximity of VIP positive nerve fibers. Conclusion: In the present study, we show that the vagus nerve does not directly interact with resident macrophages in the gut or spleen. Instead, the vagus nerve preferentially interacts with nNOS, VIP and ChAT enteric neurons located within the gut muscularis with nerve endings in close proximity of the resident macrophages.	[Cailotto, Cathy; Costes, Lea M.; van der Vliet, Jan] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Gomez-Pinilla, Pedro J.; Di Giovangiulio, Martina; Nemethova, Andrea; Matteoli, Gianluca; Boeckxstaens, Guy E.] Catholic Univ Louvain, Dept Gastroenterol, Univ Hosp Leuven, B-3000 Louvain, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; University Hospital Leuven; Universite Catholique Louvain	Cailotto, C (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.cailotto@amc.uva.nl	Boeckxstaens, Guy/AAP-2502-2020	Matteoli, Gianluca/0000-0002-2902-4976; Di Giovangiulio, Martina/0000-0003-3004-578X	Research Foundation - Flanders (FWO) (Odysseus program); FWO; FWO Ph.D. fellowship; European Union 7th Framework Program; Netherlands Organization for Scientific Research (NWO Vici grant) [918-76 623]; Maag Lever Darm Stichting [W09-30]	Research Foundation - Flanders (FWO) (Odysseus program)(FWO); FWO(FWO); FWO Ph.D. fellowship(FWO); European Union 7th Framework Program(European Commission); Netherlands Organization for Scientific Research (NWO Vici grant)(Netherlands Organization for Scientific Research (NWO)); Maag Lever Darm Stichting	This work was supported by grants from the Research Foundation - Flanders (FWO) (Odysseus program to G.E.B.), by a FWO postdoctoral research fellowship (to G.M. and P.J.G.), and by FWO Ph.D. fellowship (to M.D.G.). This work was partly supported by grant from the European Union 7th Framework Program (to A.N.), by the Netherlands Organization for Scientific Research (NWO Vici grant 918-76 623), and by the Maag Lever Darm Stichting (W09-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Berthoud HR, 1996, MICROSC RES TECHNIQ, V35, P80, DOI 10.1002/(SICI)1097-0029(19960901)35:1<80::AID-JEMT7>3.0.CO;2-W; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Buijs RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003152; Cailotto C, 2012, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Delgado M, 1999, J IMMUNOL, V162, P4685; Delgado M, 1999, J IMMUNOL, V162, P1707; Gautron L, 2013, J COMP NEUROL, V521, P3741, DOI 10.1002/cne.23376; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Herber DL, 2004, J HISTOCHEM CYTOCHEM, V52, P1367, DOI 10.1369/jhc.4A6319.2004; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Lanciego JL, 2000, J NEUROSCI METH, V103, P127, DOI 10.1016/S0165-0270(00)00302-2; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Matteoli G, 2013, DISTINCT VAGAL ANTII; Pena G, 2011, J IMMUNOL, V187, P718, DOI 10.4049/jimmunol.1100013; RAJAKUMAR N, 1992, ANAT EMBRYOL, V185, P25, DOI 10.1007/BF00213598; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; Tsuchida Y, 2011, GUT, V60, P638, DOI 10.1136/gut.2010.227546; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Walter GC, 2009, J NEUROSCI METH, V178, P1, DOI 10.1016/j.jneumeth.2008.11.003; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x	33	78	79	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87785	10.1371/journal.pone.0087785	http://dx.doi.org/10.1371/journal.pone.0087785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489965	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000181
J	Koh, YW; Park, CS; Yoon, DH; Suh, C; Huh, J				Koh, Young Wha; Park, Chan-Sik; Yoon, Dok Hyun; Suh, Cheolwon; Huh, Jooryung			CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; EPSTEIN-BARR-VIRUS; CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; CHI-SQUARE STATISTICS; ADVANCED-STAGE; FACTOR VEGF; INFILTRATING MACROPHAGES; ANTIANGIOGENIC THERAPY	Background: Recent studies have reported the prognostic value of tissue-associated magrophages (TAMs) in classical Hodgkin lymphoma (cHL). In addition, TAMs are implicated in the tumor angiogenesis. In this study, we examined the prognostic relevance of TAMs in relation to vascular endothelial growth factor (VEGF) expression and angiogenesis in uniformly treated cases of cHL. Methods: Diagnostic tissue from 116 patients with ABVD-treated cHL was evaluated retrospectively by immunohistochemical analysis for CD68, CD163 and VEGF expression and for CD31 expression as a measure of microvessel density (MVD). Results: High CD163 expression (>= 35% of cellularity) correlated with VEGF expression (Pearson's Chi-square test, P = 0.008) and MVD (Spearman correlation coefficient 0.310, P<0.001). High CD163 expression was associated with inferior event-free survival (EFS, P = 0.005) and overall survival (OS, P<0.001) in univariate analysis. In multivariate analysis, high CD163 expression was strongly associated with inferior EFS (P = 0.043) and OS (P = 0.008). Patients with high MVD had a lower OS than those with low MVD, but the difference was not significant (P = 0.071, respectively). While high expression of CD68 was also associated with inferior EFS (P = 0.007), it showed no correlation with VEGF or MVD. Conclusions: Our data confirms that CD163 expression provides independent prognostic information in cHL. The correlation of CD163 with VEGF expression and MVD suggests the role of CD163-positive cells in tumor angiogenesis of cHL.	[Koh, Young Wha] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Pathol, Ulsan 680749, South Korea; [Park, Chan-Sik; Huh, Jooryung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Yoon, Dok Hyun; Suh, Cheolwon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Huh, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	jrhuh@amc.seoul.kr			Asan Institute for Life Sciences, Seoul, Korea [2011-090]	Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant (2011-090) from the Asan Institute for Life Sciences, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RH, 2012, LEUKEMIA LYMPHOMA, V53, P718, DOI 10.3109/10428194.2011.623256; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Casulo C, 2013, LEUKEMIA RES, V37, P1178, DOI 10.1016/j.leukres.2013.03.021; Chen JJW, 2003, CLIN CANCER RES, V9, P729; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Doussis-Anagnostopoulou IA, 2002, J PATHOL, V197, P677, DOI 10.1002/path.1151; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Enblad G, 1999, ACTA ONCOL, V38, P425, DOI 10.1080/028418699431942; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gratzinger D, 2007, AM J PATHOL, V170, P1362, DOI 10.2353/ajpath.2007.060901; Greaves P, 2013, J CLIN ONCOL, V31, P256, DOI 10.1200/JCO.2011.39.9881; Guzman-Medrano R, 2012, PATHOL RES PRACT, V208, P672, DOI 10.1016/j.prp.2012.09.001; Habermann TM, 2013, CONNS CURRENT THERAP, P810; HALPERN J, 1982, BIOMETRICS, V38, P1017, DOI 10.2307/2529882; Harris JA, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-12; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Huh J, 1999, AM J HEMATOL, V60, P205, DOI 10.1002/(SICI)1096-8652(199903)60:3<205::AID-AJH7>3.0.CO;2-J; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ishigami SI, 1998, BRIT J CANCER, V78, P1379, DOI 10.1038/bjc.1998.688; Jakovic LR, 2012, ONKOLOGIE, V35, P733, DOI 10.1159/000343664; Jakovic LR, 2011, LEUKEMIA LYMPHOMA, V52, P1913, DOI 10.3109/10428194.2011.580026; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Keegan THM, 2005, J CLIN ONCOL, V23, P7604, DOI 10.1200/JCO.2005.02.6310; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Koh YW, 2012, ANN HEMATOL, V91, P1403, DOI 10.1007/s00277-012-1464-8; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Korkolopoulou P, 2005, LEUKEMIA, V19, P894, DOI 10.1038/sj.leu.2403690; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Leek RD, 2000, J PATHOL, V190, P430, DOI 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6; Mainou-Fowler T, 2006, LEUKEMIA LYMPHOMA, V47, P223, DOI 10.1080/01674820500305838; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Ohri CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021874; Panico L, 2013, LEUKEMIA LYMPHOMA, V54, P2418, DOI 10.3109/10428194.2013.778405; Passam FH, 2009, PATHOL RES PRACT, V205, P11, DOI 10.1016/j.prp.2008.07.007; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Quddus F, 2009, CANCER J, V15, P161, DOI 10.1097/PPO.0b013e3181a1438a; Reiners KS, 2009, J IMMUNOTHER, V32, P508, DOI 10.1097/CJI.0b013e3181a25daf; Ruan J, 2009, ANN ONCOL, V20, P413, DOI 10.1093/annonc/mdn666; Ruan J, 2006, CLIN CANCER RES, V12, P5622, DOI 10.1158/1078-0432.CCR-06-1204; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; Schmidt T, 2010, NATURE, V465, P697, DOI 10.1038/465697a; Shieh YS, 2009, ANN SURG ONCOL, V16, P751, DOI 10.1245/s10434-008-0259-6; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stopeck AT, 2012, BLOOD, V120, P1210, DOI 10.1182/blood-2012-04-423079; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Uchida S, 1998, BRIT J CANCER, V77, P1704, DOI 10.1038/bjc.1998.281; Watkins SK, 2009, EUR J IMMUNOL, V39, P2126, DOI 10.1002/eji.200839010; WEIDNER N, 1993, AM J PATHOL, V143, P401; White ES, 2001, J IMMUNOL, V166, P7549, DOI 10.4049/jimmunol.166.12.7549; Won YW, 2012, ANN HEMATOL, V91, P223, DOI 10.1007/s00277-011-1297-x; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Yahalom Joachim, 2006, J Natl Compr Canc Netw, V4, P233; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yoon DH, 2012, EUR J HAEMATOL, V88, P292, DOI 10.1111/j.1600-0609.2011.01731.x; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8	67	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87066	10.1371/journal.pone.0087066	http://dx.doi.org/10.1371/journal.pone.0087066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489836	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000096
J	Kung, D; Bigler, L; Davis, LR; Gratwicke, B; Griffith, E; Woodhams, DC				Kueng, Denise; Bigler, Laurent; Davis, Leyla R.; Gratwicke, Brian; Griffith, Edgardo; Woodhams, Douglas C.			Stability of Microbiota Facilitated by Host Immune Regulation: Informing Probiotic Strategies to Manage Amphibian Disease	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; ANTIMICROBIAL PEPTIDES; POPULATION DECLINES; CUTANEOUS BACTERIA; GUT MICROBIOTA; SKIN PEPTIDES; T-RFLP; CHYTRIDIOMYCOSIS; ECOLOGY; COMMUNITIES	Microbial communities can augment host immune responses and probiotic therapies are under development to prevent or treat diseases of humans, crops, livestock, and wildlife including an emerging fungal disease of amphibians, chytridiomycosis. However, little is known about the stability of host-associated microbiota, or how the microbiota is structured by innate immune factors including antimicrobial peptides (AMPs) abundant in the skin secretions of many amphibians. Thus, conservation medicine including therapies targeting the skin will benefit from investigations of amphibian microbial ecology that provide a model for vertebrate host-symbiont interactions on mucosal surfaces. Here, we tested whether the cutaneous microbiota of Panamanian rocket frogs, Colostethus panamansis, was resistant to colonization or altered by treatment. Under semi-natural outdoor mesocosm conditions in Panama, we exposed frogs to one of three treatments including: (1) probiotic - the potentially beneficial bacterium Lysinibacillus fusiformis, (2) transplant - skin washes from the chytridiomycosis-resistant glass frog Espadarana prosoblepon, and (3) control - sterile water. Microbial assemblages were analyzed by a culture-independent T-RFLP analysis. We found that skin microbiota of C. panamansis was resistant to colonization and did not differ among treatments, but shifted through time in the mesocosms. We describe regulation of host AMPs that may function to maintain microbial community stability. Colonization resistance was metabolically costly and microbe-treated frogs lost 7-12% of body mass. The discovery of strong colonization resistance of skin microbiota suggests a well-regulated, rather than dynamic, host-symbiont relationship, and suggests that probiotic therapies aiming to enhance host immunity may require an approach that circumvents host mechanisms maintaining equilibrium in microbial communities.	[Kueng, Denise; Davis, Leyla R.; Woodhams, Douglas C.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Bigler, Laurent] Univ Zurich, Inst Organ Chem, Zurich, Switzerland; [Gratwicke, Brian] Smithsonian Inst, Natl Zool Pk, Ctr Species Survival Conservat & Sci, Washington, DC 20008 USA; [Griffith, Edgardo] El Valle Amphibian Conservat Ctr, El Valle, Panama; [Woodhams, Douglas C.] Smithsonian Trop Res Inst, Panama City, Panama	University of Zurich; University of Zurich; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian Tropical Research Institute	Woodhams, DC (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	dwoodhams@gmail.com	Bigler, Laurent/AAP-3799-2020; Woodhams, Douglas/B-1962-2012	Bigler, Laurent/0000-0003-3548-3594; Woodhams, Douglas/0000-0003-4559-1046; Gratwicke, Brian/0000-0002-7332-4060	Swiss National Science Foundation [31-125099]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided through Swiss National Science Foundation grant 31-125099 to D. C. W. and fieldwork was supported by SCNAT (Akademie der Naturwissenschaften Schweiz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Apponyi MA, 2004, PEPTIDES, V25, P1035, DOI 10.1016/j.peptides.2004.03.006; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brook I, 2005, OTOLARYNG HEAD NECK, V133, P139, DOI 10.1016/j.otohns.2005.03.012; CHAN RCY, 1985, INFECT IMMUN, V47, P84, DOI 10.1128/IAI.47.1.84-89.1985; Chinchar VG, 2001, VIROLOGY, V288, P351, DOI 10.1006/viro.2001.1080; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; DALY JW, 1994, TOXICON, V32, P279, DOI 10.1016/0041-0101(94)90081-7; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Flechas SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044832; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hartmann M, 2005, J MICROBIOL METH, V61, P349, DOI 10.1016/j.mimet.2004.12.011; Hartmann M, 2008, FEMS MICROBIOL ECOL, V63, P249, DOI 10.1111/j.1574-6941.2007.00427.x; Hartmann M, 2006, APPL ENVIRON MICROB, V72, P7804, DOI 10.1128/AEM.01464-06; Irianto A, 2002, J FISH DIS, V25, P633, DOI 10.1046/j.1365-2761.2002.00422.x; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kelly CP, 2013, NEW ENGL J MED, V368, P474, DOI 10.1056/NEJMe1214816; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Matutte B, 2000, FEBS LETT, V483, P135, DOI 10.1016/S0014-5793(00)02102-5; MCCLANAH.L, 1969, COMP BIOCHEM PHYSIOL, V28, P381, DOI 10.1016/0010-406X(69)91351-6; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Miele R, 1998, FEBS LETT, V431, P23, DOI 10.1016/S0014-5793(98)00718-2; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Pask JD, 2012, GLOBAL CHANGE BIOL, V18, P1231, DOI 10.1111/j.1365-2486.2011.02622.x; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Reid G, 2011, NAT REV MICROBIOL, V9, P27, DOI 10.1038/nrmicro2473; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rollins-Smith L. A., 2012, ECOIMMUNOLOGY, P92; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Rosenberg E, 2011, BIRTH DEFECTS RES C, V93, P56, DOI 10.1002/bdrc.20196; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schadich Ermin, 2009, Australasian Journal of Ecotoxicology, V15, P17; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Simmaco M, 1997, FEBS LETT, V416, P273, DOI 10.1016/S0014-5793(97)01216-7; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Taylor Sharon K., 2001, P159; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vredenburg V.T., 2011, FUNGAL DIS EMERGING, P342; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Wang J, 2010, TOXICON, V56, P640, DOI 10.1016/j.toxicon.2010.05.011; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Widmer F, 2006, APPL SOIL ECOL, V33, P294, DOI 10.1016/j.apsoil.2005.09.007; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Woodhams DC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-197; Woodhams DC, 2012, DIS AQUAT ORGAN, V98, P11, DOI 10.3354/dao02429; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; Woodhams DC, 2008, ECOHEALTH, V5, P268, DOI 10.1007/s10393-008-0190-0; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	85	50	51	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87101	10.1371/journal.pone.0087101	http://dx.doi.org/10.1371/journal.pone.0087101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489847	Green Published, gold, Green Accepted			2022-12-25	WOS:000330570000103
J	Lohse, K; Grafenhain, M; Behne, T; Rakoczy, H				Lohse, Karoline; Graefenhain, Maria; Behne, Tanya; Rakoczy, Hannes			Young Children Understand the Normative Implications of Future-Directed Speech Acts	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; EPISODIC MEMORY; EVENTS; FORESIGHT; EVOLUTION; YESTERDAY; TOMORROW; REMEMBER; HUMANS; SENSE	Much recent research has shown that the capacity for mental time travel and temporal reasoning emerges during the preschool years. Nothing is known so far, however, about young children's grasp of the normative dimension of future-directed thought and speech. The present study is the first to show that children from age 4 understand the normative outreach of such future-directed speech acts: subjects at time 1 witnessed a speaker make future-directed speech acts about/towards an actor A, either in imperative mode ("A, do X!") or as a prediction ("the actor A will do X"). When at time 2 the actor A performed an action that did not match the content of the speech act at time 1, children identified the speaker as the source of a mistake in the prediction case, and the actor as the source of the mistake in the imperative case and leveled criticism accordingly. These findings add to our knowledge about the emergence and development of temporal cognition in revealing an early sensitivity to the normative aspects of future-orientation.	[Lohse, Karoline; Graefenhain, Maria; Behne, Tanya; Rakoczy, Hannes] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany; [Lohse, Karoline; Graefenhain, Maria; Behne, Tanya; Rakoczy, Hannes] Univ Gottingen, Courant Res Ctr, D-37073 Gottingen, Germany; [Graefenhain, Maria] Univ Leipzig, Dept Child & Adolescent Psychiat Psychotherapy &, D-04109 Leipzig, Germany	University of Gottingen; University of Gottingen; Leipzig University	Lohse, K (corresponding author), Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany.	klohse@uni-goettingen.de		rakoczy, hannes/0000-0003-3296-0551	Volkswagen Foundation; Fritz Thyssen Foundation; German Initiative of Excellence	Volkswagen Foundation(Volkswagen); Fritz Thyssen Foundation; German Initiative of Excellence	This work was supported by a "Dilthey Fellowship" of the Volkswagen Foundation and the Fritz Thyssen Foundation to HR and by the German Initiative of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; ASTINGTON JW, 1990, CHILD LANG, V7, P223; ASTINGTON JW, 1988, J CHILD LANG, V15, P157, DOI 10.1017/S0305000900012101; BISCHOFKOHLER D, 2000, KINDER ZEITREISE THE; BRATMAN M, 1984, PHILOS REV, V93, P375, DOI 10.2307/2184542; Busby J, 2005, COGNITIVE DEV, V20, P362, DOI 10.1016/j.cogdev.2005.05.002; Clayton NS, 2009, NEUROPSYCHOLOGIA, V47, P2330, DOI 10.1016/j.neuropsychologia.2008.10.011; Diessel H, 2001, COGN LINGUIST, V12, P97, DOI 10.1515/cogl.12.2.97; FODOR JA, 1985, MIND, V94, P76; Friedman WJ, 2005, LEARN MOTIV, V36, P145, DOI 10.1016/j.lmot.2005.02.005; Friedman WJ, 2003, ADV CHILD DEV BEHAV, V31, P229; HARNER L, 1975, DEV PSYCHOL, V11, P864, DOI 10.1037/0012-1649.11.6.864; Hayne H, 2011, COGNITIVE DEV, V26, P343, DOI 10.1016/j.cogdev.2011.09.006; Hoerl C., 2011, OXFORD HDB PHILOS TI, P439; Hoerl C, 2008, PHENOMENOL COGN SCI, V7, P485, DOI 10.1007/s11097-008-9089-z; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Lemmon K, 2001, SELF IN TIME: DEVELOPMENTAL PERSPECTIVES, P163; Maas FK, 1998, J CHILD LANG, V25, P203, DOI 10.1017/S0305000997003346; Malcolm N, 1991, J SEARLE HIS CRITICS; McColgan KL, 2008, CHILD DEV, V79, P1477, DOI 10.1111/j.1467-8624.2008.01200.x; McCormack T, 2007, J EXP CHILD PSYCHOL, V98, P168, DOI 10.1016/j.jecp.2007.06.001; McCormack T, 2011, COGNITIVE DEV, V26, P299, DOI 10.1016/j.cogdev.2011.10.001; McCormack T, 2011, DEV REV, V31, P1, DOI 10.1016/j.dr.2011.02.002; Metcalf JL, 2011, COGNITIVE DEV, V26, P371, DOI 10.1016/j.cogdev.2011.09.003; NELSON K, 1993, PSYCHOL SCI, V4, P7, DOI 10.1111/j.1467-9280.1993.tb00548.x; Perner J, 2000, OXFORD HDB MEMORY, P297; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.2307/1131717; Povinelli DJ, 1999, DEV PSYCHOL, V35, P1426, DOI 10.1037/0012-1649.35.6.1426; Putnam H., 1960, DIMENSIONS MIND, P57; Rakoczy H, 2009, COGNITION, V113, P205, DOI 10.1016/j.cognition.2009.07.013; Russell J, 2012, MIND LANG, V27, P29, DOI 10.1111/j.1468-0017.2011.01434.x; Searle John, 1969, SPEECH ACTS, P33; Searle John, 1983, INTENTIONALITY; SELLARS W, 1956, MINN STUD PHILOS SCI, V1, P253; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suddendorf T, 2011, DEVELOPMENTAL SCI, V14, P26, DOI 10.1111/j.1467-7687.2010.00950.x; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; Zelazo PD, 1999, DEV PSYCHOL, V35, P1059, DOI 10.1037/0012-1649.35.4.1059	40	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86958	10.1371/journal.pone.0086958	http://dx.doi.org/10.1371/journal.pone.0086958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489815	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000085
J	Norton, JE; Lytle, AG; Shen, SX; Tzvetkov, EP; Dorfmeier, CL; McGettigan, JP				Norton, James E., Jr.; Lytle, Andrew G.; Shen, Shixue; Tzvetkov, Evgeni P.; Dorfmeier, Corin L.; McGettigan, James P.			ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo	PLOS ONE			English	Article							ANTIGEN LFA-1; TYPE-1; RHABDOVIRUS; INDUCTION; LIVE; LYMPHOCYTES; EXPRESSION; PROTECTION; ADHESION; RECEPTOR	We have previously shown that live-attenuated rabies virus (RABV)-based vaccines infect and directly activate murine and human primary B cells in-vitro, which we propose can be exploited to help develop a single-dose RABV-based vaccine. Here we report on a novel approach to utilize the binding of Intracellular Adhesion Molecule-1 (ICAM-1) to its binding partner, Lymphocyte Function-associated Antigen-1 (LFA-1), on B cells to enhance B cell activation and RABV-specific antibody responses. We used a reverse genetics approach to clone, recover, and characterize a live-attenuated recombinant RABV-based vaccine expressing the murine Icam1 gene (rRABV-mICAM-1). We show that the murine ICAM-1 gene product is incorporated into virus particles, potentially exposing ICAM-1 to extracellular binding partners. While rRABV-mICAM-1 showed 10-100-fold decrease in viral titers on baby hamster kidney cells compared to the parental virus (rRABV), rRABV-mICAM-1 infected and activated primary murine B cells in-vitro more efficiently than rRABV, as indicated by significant upregulation of CD69, CD40, and MHCII on the surface of infected B cells. ICAM-1 expression on the virus surface was responsible for enhanced B cell infection since pre-treating rRABV-mICAM-1 with a neutralizing anti-ICAM-1 antibody reduced B cell infection to levels observed with rRABV alone. Furthermore, 100-fold less rRABV-mICAM-1 was needed to induce antibody titers in immunized mice equivalent to antibody titers observed in rRABV-immunized mice. Of note, only 10 3 focus forming units (ffu)/mouse of rRABV-mICAM-1 was needed to induce significant anti-RABV antibody titers as early as five days post-immunization. As both speed and potency of antibody responses are important in controlling human RABV infection in a post-exposure setting, these data show that expression of Icam1 from the RABV genome, which is then incorporated into the virus particle, is a promising strategy for the development of a single-dose RABV vaccine that requires only a minimum of virus.	[Norton, James E., Jr.; Lytle, Andrew G.; Shen, Shixue; Tzvetkov, Evgeni P.; Dorfmeier, Corin L.; McGettigan, James P.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [McGettigan, James P.] Thomas Jefferson Univ, Jefferson Med Coll, Jefferson Vaccine Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	McGettigan, JP (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	james.mcgettigan@jefferson.edu			NIH/NIAID [R01AI079211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079211] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grant R01AI079211 to JPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaney JE, 2011, J VIROL, V85, P10605, DOI 10.1128/JVI.00558-11; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Cenna J, 2008, VACCINE, V26, P6405, DOI 10.1016/j.vaccine.2008.08.069; Cenna J, 2009, J INFECT DIS, V200, P1251, DOI 10.1086/605949; CONZELMANN KK, 1990, VIROLOGY, V175, P485, DOI 10.1016/0042-6822(90)90433-R; DENNIG D, 1994, CELL IMMUNOL, V156, P414, DOI 10.1006/cimm.1994.1186; Dorfmeier CL, 2013, J VIROL, V87, P9217, DOI 10.1128/JVI.00995-13; Dorfmeier CL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002129; Dorfmeier CL, 2012, J VIROL, V86, P11533, DOI 10.1128/JVI.00615-12; DUBEY C, 1995, J IMMUNOL, V155, P45; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Ertl HCJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000515; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Gaglia JL, 2000, J IMMUNOL, V165, P6091, DOI 10.4049/jimmunol.165.11.6091; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; KURZINGER K, 1981, J IMMUNOL, V127, P596; Lackay SN, 2008, VET CLIN N AM-SMALL, V38, P851, DOI 10.1016/j.cvsm.2008.03.003; Lytle AG, 2013, B CELL INFECT ACTIVA; McGettigan JP, 2010, EXPERT REV VACCINES, V9, P1177, DOI 10.1586/ERV.10.105; McGettigan JP, 2003, J VIROL, V77, P10889, DOI 10.1128/JVI.77.20.10889-10899.2003; McGettigan JP, 2003, J VIROL, V77, P237, DOI 10.1128/JVI.77.1.237-244.2003; Mebatsion T, 1996, P NATL ACAD SCI USA, V93, P11366, DOI 10.1073/pnas.93.21.11366; Mebatsion T, 1997, CELL, V90, P841, DOI 10.1016/S0092-8674(00)80349-9; Moore SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000595; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Rupprecht Charles E., 2010, Morbidity and Mortality Weekly Report, V59, P1; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; Schnell MJ, 2000, P NATL ACAD SCI USA, V97, P3544, DOI 10.1073/pnas.050589197; Shinde S, 1996, J IMMUNOL, V157, P2764; Siler CA, 2002, VIROLOGY, V292, P24, DOI 10.1006/viro.2001.1212; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Strady C, 2009, T ROY SOC TROP MED H, V103, P1159, DOI 10.1016/j.trstmh.2009.03.007; Tardif MR, 2003, J VIROL, V77, P12299, DOI 10.1128/JVI.77.22.12299-12309.2003; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; *WHO, 1997, WHO REC RAB POST TRE; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	41	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87098	10.1371/journal.pone.0087098	http://dx.doi.org/10.1371/journal.pone.0087098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489846	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000102
J	Jacobs, AC; Blanchard, CE; Catherman, SC; Dunman, PM; Murata, Y				Jacobs, Anna C.; Blanchard, Catlyn E.; Catherman, Seana C.; Dunman, Paul M.; Murata, Yoshihiko			An Ribonuclease T2 Family Protein Modulates Acinetobacter baumannii Abiotic Surface Colonization	PLOS ONE			English	Article							ENVIRONMENTAL CONTAMINATION; BIOFILM FORMATION; SURVIVAL; RNASE; CALCOACETICUS; RESISTANCE; OUTBREAK; GROWTH; PILI	Acinetobacter baumannii is an emerging bacterial pathogen of considerable medical concern. The organism's transmission and ability to cause disease has been associated with its propensity to colonize and form biofilms on abiotic surfaces in health care settings. To better understand the genetic determinants that affect biomaterial attachment, we performed a transposon mutagenesis analysis of abiotic surface-colonization using A. baumannii strain 98-37-09. Disruption of an RNase T2 family gene was found to limit the organism's ability to colonize polystyrene, polypropylene, glass, and stainless steel surfaces. DNA microarray analyses revealed that in comparison to wild type and complemented cells, the RNase T2 family mutant exhibited reduced expression of 29 genes, 15 of which are predicted to be associated with bacterial attachment and surface-associated motility. Motility assays confirmed that RNase T2 mutant displays a severe motility defect. Taken together, our results indicate that the RNase T2 family protein identified in this study is a positive regulator of A. baumannii's ability to colonize inanimate surfaces and motility. Moreover, the enzyme may be an effective target for the intervention of biomaterial colonization, and consequently limit the organism's transmission within the hospital setting.	[Jacobs, Anna C.; Blanchard, Catlyn E.; Dunman, Paul M.] Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Catherman, Seana C.; Murata, Yoshihiko] Univ Rochester Sch Med & Dent, Div Infect Dis, Dept Med, Rochester, NY USA	University of Rochester; University of Rochester	Dunman, PM (corresponding author), Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	paul_dunman@urmc.rochester.edu; yoshihiko_murata@urmc.rochester.edu			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NIDCR NIH HHS [T90 DE021985] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Acquati F, 2013, P NATL ACAD SCI USA, V110, P8140, DOI 10.1073/pnas.1222079110; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; Aygun G, 2002, J HOSP INFECT, V52, P259, DOI 10.1053/jhin.2002.1300; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; GETCHELLWHITE SI, 1989, INFECT CONT HOSP EP, V10, P402, DOI 10.1086/646061; Grupper M, 2007, INFECT CONT HOSP EP, V28, P293, DOI 10.1086/512629; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; HIRAI Y, 1991, J HOSP INFECT, V19, P191, DOI 10.1016/0195-6701(91)90223-U; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Jacobs AC, 2012, FEMS IMMUNOL MED MIC, V64, P403, DOI 10.1111/j.1574-695X.2011.00926.x; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Lappann M, 2010, MED MICROBIOL IMMUN, V199, P173, DOI 10.1007/s00430-010-0149-y; Levin AS, 2001, INFECT CONT HOSP EP, V22, P717, DOI 10.1086/501852; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Luhtala N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041111; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; Manian FA, 2013, AM J INFECT CONTROL, V41, P384, DOI 10.1016/j.ajic.2012.04.321; Markogiannakis A, 2008, INFECT CONT HOSP EP, V29, P410, DOI 10.1086/533545; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; MURRAY BE, 1982, ANN INTERN MED, V96, P176, DOI 10.7326/0003-4819-96-2-176; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; MUSA EK, 1990, J HOSP INFECT, V15, P219, DOI 10.1016/0195-6701(90)90029-N; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Schwartz B, 2007, CANCER RES, V67, P5258, DOI 10.1158/0008-5472.CAN-07-0129; Shin JH, 2013, PLOS ONE, V8; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004	35	17	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85729	10.1371/journal.pone.0085729	http://dx.doi.org/10.1371/journal.pone.0085729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489668	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000017
J	Komorita, T; Kajihara, R; Tsutsumi, H; Shibanuma, S; Yamada, T; Montani, S				Komorita, Tomohiro; Kajihara, Rumiko; Tsutsumi, Hiroaki; Shibanuma, Seiichiro; Yamada, Toshiro; Montani, Shigeru			Food Sources for Ruditapes philippinarum in a Coastal Lagoon Determined by Mass Balance and Stable Isotope Approaches	PLOS ONE			English	Article							ENERGY BUDGET; TIDAL-FLAT; CERASTODERMA-EDULE; HICHIRIPPU LAGOON; MYTILUS-EDULIS; SHALLOW LAGOON; ARIAKE SOUND; POPULATION; CARBON; HOKKAIDO	The relationship between the food demand of a clam population (Ruditapes philippinarum (Adams & Reeve 1850)) and the isotopic contributions of potential food sources (phytoplankton, benthic diatoms, and organic matter derived from the sediment surface, seagrass, and seaweeds) to the clam diet were investigated. In particular, we investigated the manner in which dense patches of clams with high secondary productivity are sustained in a coastal lagoon ecosystem (Hichirippu Lagoon) in Hokkaido, Japan. Clam feeding behavior should affect material circulation in this lagoon owing to their high secondary productivity (ca. 130 g C m(-2) yr(-1)). Phytoplankton were initially found to constitute 14-77% of the clam diet, although phytoplankton nitrogen content (1.79-4.48 kmol N) and the food demand of the clam (16.2 kmol N d(-1)) suggest that phytoplankton can constitute only up to 28% of clam dietary demands. However, use of isotopic signatures alone may be misleading. For example, the contribution of microphytobenthos (MPB) were estimated to be 0-68% on the basis of isotopic signatures but was subsequently shown to be 35 +/- 13% (mean +/- S.D.) and 64 +/- 4% (mean +/- S.D.) on the basis of phytoplankton biomass and clam food demand respectively, suggesting that MPB are the primary food source for clams. Thus, in the present study, the abundant MPB in the subtidal area appear to be a key food source for clams, suggesting that these MPB may sustain the high secondary production of the clam.	[Komorita, Tomohiro; Kajihara, Rumiko; Shibanuma, Seiichiro; Montani, Shigeru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Komorita, Tomohiro; Tsutsumi, Hiroaki] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Tsukide, Kumamoto, Japan; [Yamada, Toshiro] Nishimuragumi Co Ltd, Mombetsu, Hokkaido, Japan	Hokkaido University	Komorita, T (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	komorita@pu-kumamoto.ac.jp	Komorita, Tomohiro/J-8817-2019	Komorita, Tomohiro/0000-0002-9469-5602	MEXT [22380102, 15201001]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by MEXT Grants-in-Aid for Scientific Research, Nos. 22380102 (to SM) and 15201001 (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brey T., 2001, POPULATION DYNAMICS; Cahoon LB, 1999, OCEANOGR MAR BIOL, V37, P47; COUCH CA, 1989, ESTUAR COAST SHELF S, V28, P433, DOI 10.1016/0272-7714(89)90090-5; Crisp D, 1984, IBP HDB, V16, P416; Dang C, 2009, MAR ECOL PROG SER, V387, P167, DOI 10.3354/meps08100; DEJONGE VN, 1980, MAR ECOL PROG SER, V2, P345, DOI 10.3354/meps002345; EPPLEY RW, 1968, LIMNOL OCEANOGR, V13, P574, DOI 10.4319/lo.1968.13.4.0574; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; GRIFFITHS RJ, 1981, ESTUAR COAST SHELF S, V13, P477, DOI 10.1016/S0302-3524(81)80053-9; Hicks DW, 2001, MAR ECOL PROG SER, V211, P181, DOI 10.3354/meps211181; HUGHES RN, 1970, J ANIM ECOL, V39, P357, DOI 10.2307/2976; HUMMEL H, 1985, NETH J SEA RES, V19, P84, DOI 10.1016/0077-7579(85)90045-6; Jonge V De, 1992, NETHERLANDS J SEA RE, V22, P445; Kach DJ, 2008, MAR BIOL, V153, P797, DOI 10.1007/s00227-007-0852-4; Kajihara Rumiko, 2010, Plankton & Benthos Research, V5, P90; Kanaya G, 2005, MAR ECOL PROG SER, V299, P67, DOI 10.3354/meps299067; Kanaya G, 2007, MAR ECOL PROG SER, V345, P117, DOI 10.3354/meps07025; Kanaya G, 2013, MAR POLLUT BULL, V71, P179, DOI 10.1016/j.marpolbul.2013.03.018; Kang CK, 1999, MAR ECOL PROG SER, V187, P147, DOI 10.3354/meps187147; Kasai A, 2004, FISHERIES SCI, V70, P11, DOI 10.1111/j.1444-2906.2003.00764.x; Koh CH, 2006, MAR ECOL PROG SER, V312, P85, DOI 10.3354/meps312085; Komorita T, 2012, MAR ECOL PROG SER, V446, P161, DOI 10.3354/meps09459; Komorita T, 2010, J EXP MAR BIOL ECOL, V383, P8, DOI 10.1016/j.jembe.2009.10.018; Komorita Tomohiro, 2009, Plankton & Benthos Research, V4, P31; LANGTON RW, 1977, AQUACULTURE, V12, P283, DOI 10.1016/0044-8486(77)90207-1; Laudien J, 2003, ESTUAR COAST SHELF S, V58, P105, DOI 10.1016/S0272-7714(03)00044-1; Loo LO, 1996, J SEA RES, V35, P199, DOI 10.1016/S1385-1101(96)90747-9; Lorenzen C., 1967, LIMNOL OCEANOGR, V22, P1096; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Montani S, 2003, MAR ECOL PROG SER, V249, P79, DOI 10.3354/meps249079; Nakamura Y, 2001, J EXP MAR BIOL ECOL, V266, P181, DOI 10.1016/S0022-0981(01)00354-9; NAKAOKA M, 1992, MAR ECOL PROG SER, V88, P215, DOI 10.3354/meps088215; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Ponurovsky S, 1992, J SHELLFISH RES, V22, P814; Garcia-March JR, 2008, MAR BIOL, V153, P689, DOI 10.1007/s00227-007-0842-6; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rodland DL, 2006, J EXP MAR BIOL ECOL, V334, P316, DOI 10.1016/j.jembe.2006.02.012; SHAFEE MS, 1992, J EXP MAR BIOL ECOL, V163, P183, DOI 10.1016/0022-0981(92)90048-F; Suga Natsumi, 2011, Plankton & Benthos Research, V6, P115; THOMPSON RJ, 1984, MAR ECOL PROG SER, V16, P249, DOI 10.3354/meps016249; TREVALLION A, 1971, Journal of Experimental Marine Biology and Ecology, V7, P95, DOI 10.1016/0022-0981(71)90006-2; Tsutsumi Hiroaki, 1994, Benthos Research, V46, P1; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Watanabe S, 2009, FISHERIES SCI, V75, P937, DOI 10.1007/s12562-009-0113-1; Yamaguchi Hitomi, 2004, Benthos Research, V59, P67; Yokoyama H, 2005, MAR ECOL PROG SER, V304, P101, DOI 10.3354/meps304101; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115; Yokoyama H, 2009, ESTUAR COAST SHELF S, V82, P243, DOI 10.1016/j.ecss.2009.01.010; Yoshino K, 2012, ESTUAR COAST SHELF S, V109, P138, DOI 10.1016/j.ecss.2012.05.021	50	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86732	10.1371/journal.pone.0086732	http://dx.doi.org/10.1371/journal.pone.0086732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489779	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000077
J	Olson, AD; Meyer, L; Prins, M; Thiebaut, R; Gurdasani, D; Guiguet, M; Chaix, ML; Amornkul, P; Babiker, A; Sandhu, MS; Porter, K				Olson, Ashley D.; Meyer, Laurence; Prins, Maria; Thiebaut, Rodolphe; Gurdasani, Deepti; Guiguet, Marguerite; Chaix, Marie-Laure; Amornkul, Pauli; Babiker, Abdel; Sandhu, Manjinder S.; Porter, Kholoud		C A S C A D E Collaboration EuroCo	An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-LEVEL VIREMIA; CD4(+) T-CELLS; VIRAL LOAD; INFECTION; PROGRESSION; ABSENCE; COUNT; INDIVIDUALS; ACTIVATION	Background: Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elite control (EC) of HIV infection. Although numerous definitions of EC exist, it is not clear which, if any, best identify this rare phenotype. Methods: We assessed a number of EC definitions used in the literature using CASCADE data of 25,692 HIV seroconverters. We estimated proportions maintaining EC of total ART-naive follow-up time, and disease progression, comparing to non-EC. We also examined HIV-RNA and CD4 values and CD4 slope during EC and beyond (while ART naive). Results: Most definitions classify, similar to 1% as ECs with median HIV-RNA 43-903 copies/ml and median CD4>500 cells/mm(3). Beyond EC status, median HIV-RNA levels remained low, although often detectable, and CD4 values high but with strong evidence of decline for all definitions. Median % ART-naive time as EC was >= 92% although overlap between definitions was low. EC definitions with consecutive HIV-RNA measurements <75 copies/ml with follow-up >= six months, or with 90% of measurements <400 copies/ml over >= 10 year follow-up preformed best overall. Individuals thus defined were less likely to progress to endpoint (hazard ratios ranged from 12.5-19.0 for non-ECs compared to ECs). Conclusions: ECs are rare, less likely to progress to clinical disease, but may eventually lose control. We suggest definitions requiring individuals to have consecutive undetectable HIV-RNA measurements for >= six months or otherwise with >90% of measurements <400 copies/ml over >= 10 years be used to define this phenotype.	[Olson, Ashley D.; Babiker, Abdel; Porter, Kholoud] UCL, Med Res Council Clin Trials Unit, London, England; [Meyer, Laurence] Univ Paris 11, INSERM, U1018, Le Kremlin Bicetre, France; [Prins, Maria] Amsterdam Publ Hlth Serv, Amsterdam, Netherlands; [Thiebaut, Rodolphe] Univ Bordeaux Segalen, INSERM, U897, Bordeaux, France; [Gurdasani, Deepti; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Gurdasani, Deepti; Sandhu, Manjinder S.] Univ Cambridge, Cambridge, England; [Guiguet, Marguerite] INSERM, U943, Paris, France; [Guiguet, Marguerite] Univ Paris 06, S943, Paris, France; [Chaix, Marie-Laure] Univ Paris 05, Hop Necker Enfants Malad, EA 3620, Paris, France; [Amornkul, Pauli] Int AIDS Vaccine Initiat, San Francisco, CA USA	Medical Research Council Clinical Trials Unit; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Public Health Service Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Wellcome Trust Sanger Institute; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; International AIDS Vaccine Initiative	Olson, AD (corresponding author), UCL, Med Res Council Clin Trials Unit, London, England.	a.olson@ucl.ac.uk	lutsar, irja/H-3177-2015; rezza, giovanni/D-4393-2016; Perez Hoyos, Santiago/O-1075-2019; DORRUCCI, MARIA/C-6485-2016; Guiguet, Marguerite/L-8480-2018; Muga, Roberto/AAY-8655-2021; DEL AMO VALERO, JULIA/M-7020-2015; Thiebaut, Rodolphe/T-6803-2019	rezza, giovanni/0000-0003-0268-6790; Perez Hoyos, Santiago/0000-0001-9797-4917; DORRUCCI, MARIA/0000-0002-8543-6430; Muga, Roberto/0000-0001-6301-431X; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Thiebaut, Rodolphe/0000-0002-5235-3962; Sabin, Miriam/0000-0002-7758-8338; Gurdasani, Deepti/0000-0001-9996-6929; Porter, Kholoud/0000-0002-9226-6206; GIAQUINTO, CARLO/0000-0001-9365-0413	European Union Seventh Framework Programme under EuroCoord grant [260694]; MRC [MC_U122886352, MC_UU_12023/15, MC_UU_12023/16] Funding Source: UKRI; Medical Research Council [MC_UU_12023/16, MC_U122886352, MC_UU_12023/15] Funding Source: researchfish	European Union Seventh Framework Programme under EuroCoord grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran B, 2011, CURR OPIN HIV AIDS, V6, P181, DOI 10.1097/COH.0b013e328345a328; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Boufassa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018726; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Eriksson EM, 2012, BLOOD, V119, P745, DOI 10.1182/blood-2010-12-324848; Gurdasani D, 2013, AIDS IN PRESS; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Lopez M, 2011, AIDS RES HUM RETROV, V27, P157, DOI 10.1089/aid.2010.0107; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2005, CLIN INFECT DIS, V40, P1350, DOI 10.1086/429318; Mandalia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029844; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Okulicz JF, 2012, J AIDS CLIN RES; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Sajadi MM, 2009, JAIDS-J ACQ IMM DEF, V50, P403, DOI 10.1097/QAI.0b013e3181945f1e; Strathdee SA, 1996, AIDS, V10, P959, DOI 10.1097/00002030-199610090-00005; Thiebaut R, 2005, STAT MED, V24, P65, DOI 10.1002/sim.1923; Thiebaut R, 2011, AIDS, V25, P865, DOI 10.1097/QAD.0b013e328344892e; Walker Bruce D, 2007, Top HIV Med, V15, P134; Wolf F. de, 2012, Clinical Investigation, V2, P255, DOI 10.4155/cli.12.3	33	61	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86719	10.1371/journal.pone.0086719	http://dx.doi.org/10.1371/journal.pone.0086719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489776	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000076
J	Tonosaki, M; Itoh, K; Umekage, M; Kishimoto, T; Yaoi, T; Lemmon, VP; Fushiki, S				Tonosaki, Madoka; Itoh, Kyoko; Umekage, Masafumi; Kishimoto, Tomokazu; Yaoi, Takeshi; Lemmon, Vance P.; Fushiki, Shinji			L1cam Is Crucial for Cell Locomotion and Terminal Translocation of the Soma in Radial Migration during Murine Corticogenesis	PLOS ONE			English	Article							ADHESION MOLECULE L1; NEURONAL MIGRATION; NERVOUS-SYSTEM; BRAIN-DEVELOPMENT; GENE-EXPRESSION; CEREBRAL-CORTEX; KNOCKOUT MICE; AXON GUIDANCE; OUTGROWTH; NEOCORTEX	L1cam (L1) is a cell adhesion molecule associated with a spectrum of human neurological diseases, the most well-known being X-linked hydrocephalus. Although we recently demonstrated that L1 plays an important role in neuronal migration during cortical histogenesis, the mechanisms of delayed migration have still not been clarified. In this study, we found that cell locomotion in the intermediate zone and terminal translocation in the primitive cortical zone (PCZ) were affected by L1-knockdown (L1-KD). Time-lapse analyses revealed that L1-KD neurons produced by in utero electroporation of shRNA targeting L1 (L1-shRNAs) molecules showed decreased locomotion velocity in the intermediate zone, compared with control neurons. Furthermore, L1-KD neurons showed longer and more undulated leading processes during translocation through the primitive cortical zone. The curvature index, a quantitative index for curvilinearity, as well as the length of the leading process, were increased, whereas the somal movement was decreased in L1-KD neurons during terminal translocation in the PCZ. These results suggest that L1 has a role in radial migration of cortical neurons.	[Tonosaki, Madoka; Itoh, Kyoko; Umekage, Masafumi; Kishimoto, Tomokazu; Yaoi, Takeshi; Fushiki, Shinji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto, Japan; [Kishimoto, Tomokazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kyoto, Japan; [Lemmon, Vance P.] Univ Miami, Sch Med, Lois Pope LIFE Ctr, Miami Project Cure Paralysis, Miami, FL USA	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; University of Miami	Itoh, K (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto, Japan.	kxi14@koto.kpu-m.ac.jp	çè, æ/CAJ-4397-2022; Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576	JSPS (KAKENHI) [18390308, 22390214]	JSPS (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS (KAKENHI) Grants-in-Aid for Scientific Research (B) (18390308, 22390214 to KI). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Britto JM, 2011, CEREB CORTEX, V21, P1018, DOI 10.1093/cercor/bhq168; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; FISCHER G, 1986, J NEUROSCI, V6, P605; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Gast D, 2008, ONCOGENE, V27, P1281, DOI 10.1038/sj.onc.1210747; Itoh K, 2005, MOL CELL NEUROSCI, V30, P624, DOI 10.1016/j.mcn.2005.06.012; Itoh K, 2004, J CELL BIOL, V165, P145, DOI 10.1083/jcb.200312107; Kamiguchi H, 1998, ANNU REV NEUROSCI, V21, P97, DOI 10.1146/annurev.neuro.21.1.97; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; Kishimoto T, 2013, J NEUROSCI RES, V91, P42, DOI 10.1002/jnr.23141; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Marchetti G, 2010, EUR J NEUROSCI, V31, P399, DOI 10.1111/j.1460-9568.2009.07072.x; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Miyata T, 2002, J NEUROSCI RES, V69, P861, DOI 10.1002/jnr.10335; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86186	10.1371/journal.pone.0086186	http://dx.doi.org/10.1371/journal.pone.0086186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489698	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000034
J	Velasquez, NA; Opazo, D; Diaz, J; Penna, M				Velasquez, Nelson A.; Opazo, Daniel; Diaz, Javier; Penna, Mario			Divergence of Acoustic Signals in a Widely Distributed Frog: Relevance of Inter-Male Interactions	PLOS ONE			English	Article							PLEURODEMA-THAUL AMPHIBIA; SOUTHERN TEMPERATE FOREST; GEOGRAPHIC-VARIATION; SEXUAL SELECTION; FEMALE PREFERENCES; RECEIVER BIASES; CALL; DISCRIMINATION; EVOLUTION; RESPONSES	Divergence of acoustic signals in a geographic scale results from diverse evolutionary forces acting in parallel and affecting directly inter-male vocal interactions among disjunct populations. Pleurodema thaul is a frog having an extensive latitudinal distribution in Chile along which males' advertisement calls exhibit an important variation. Using the playback paradigm we studied the evoked vocal responses of males of three populations of P. thaul in Chile, from northern, central and southern distribution. In each population, males were stimulated with standard synthetic calls having the acoustic structure of local and foreign populations. Males of both northern and central populations displayed strong vocal responses when were confronted with the synthetic call of their own populations, giving weaker responses to the call of the southern population. The southern population gave stronger responses to calls of the northern population than to the local call. Furthermore, males in all populations were stimulated with synthetic calls for which the dominant frequency, pulse rate and modulation depth were varied parametrically. Individuals from the northern and central populations gave lower responses to a synthetic call devoid of amplitude modulation relative to stimuli containing modulation depths between 30-100%, whereas the southern population responded similarly to all stimuli in this series. Geographic variation in the evoked vocal responses of males of P. thaul underlines the importance of inter-male interactions in driving the divergence of the acoustic traits and contributes evidence for a role of intra-sexual selection in the evolution of the sound communication system of this anuran.	[Velasquez, Nelson A.; Opazo, Daniel; Diaz, Javier; Penna, Mario] Univ Chile, Fac Med, ICBM, Programa Fisiol & Biofis, Santiago 7, Chile; [Opazo, Daniel] Univ Chile, Fac Ciencias, Dept Biol, Lab Neurobiol & Biol Conocer, Santiago, Chile	Universidad de Chile; Universidad de Chile	Velasquez, NA (corresponding author), Univ Chile, Fac Med, ICBM, Programa Fisiol & Biofis, Santiago 7, Chile.	nelson.velasquez@gmail.com	Velasquez, Nelson A./S-7106-2019		CONICYT [AT24080118]; Guillermo Puelma Foundation; FONDECYT [3120208, 1080459]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Guillermo Puelma Foundation; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by a Fellowship for Doctoral thesis CONICYT AT24080118, a Fellowship for Doctoral thesis from the Guillermo Puelma Foundation, postdoctoral FONDECYT grant 3120208, and FONDECYT grant 1080459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anderson M, 1994, SEXUAL SELECTION; [Anonymous], 1953, SOCIAL BEHAV ANIMALS; Bee MA, 1996, BEHAVIOUR, V133, P283, DOI 10.1163/156853996X00152; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; Bosch J, 2002, ETHOL ECOL EVOL, V14, P217; Bosch J, 2000, BEHAV ECOL SOCIOBIOL, V49, P62, DOI 10.1007/s002650000280; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Burley NT, 1998, AM NAT, V152, P792, DOI 10.1086/286209; Byrne PG, 2004, BEHAV ECOL, V15, P872, DOI 10.1093/beheco/arh100; Castellano S, 2000, ETHOLOGY, V106, P1129, DOI 10.1046/j.1439-0310.2000.00639.x; Correa C, 2008, HERPETOL J, V18, P77; Correa Q. Claudio L., 2007, Check List, V3, P267; Coyne JA, 1998, NATURE, V396, P35, DOI 10.1038/23856; Coyne JA, 2004, SPECIATION, V37; Darwin G., 1871, P423; Endler J. A., 1999, GEOGRAPHIC VARIATION; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Funk WC, 2009, J EVOLUTION BIOL, V22, P1839, DOI 10.1111/j.1420-9101.2009.01795.x; Grant BR, 2002, BIOL J LINN SOC, V76, P545, DOI 10.1046/j.1095-8312.2002.00076.x; Hair J. F., 1999, ANALISIS MULTIVARIAN; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Kwiatkowski MA, 2002, EVOLUTION, V56, P2039; Parker G.A., 1982, P173; Parker G.A., 1983, P141; Penna M, 1997, J COMP PHYSIOL A, V180, P313, DOI 10.1007/s003590050051; Penna M, 2008, J COMP PHYSIOL A, V194, P361, DOI 10.1007/s00359-007-0312-0; Penna M, 2011, ETHOLOGY, V117, P1147, DOI 10.1111/j.1439-0310.2011.01973.x; Penna M, 2011, ETHOLOGY, V117, P63, DOI 10.1111/j.1439-0310.2010.01847.x; Podos J, 2007, ANIM BEHAV, V73, P833, DOI 10.1016/j.anbehav.2006.11.001; Podos J, 2010, PHILOS T R SOC B, V365, P1031, DOI 10.1098/rstb.2009.0289; Prohl H, 2007, ETHOLOGY, V113, P825, DOI 10.1111/j.1439-0310.2007.01396.x; Prohl H, 2006, EVOLUTION, V60, P1669; Quinn GP, 2003, EXPT DESIGN DATA ANA; Quispe R, 2009, ETHOLOGY, V115, P465, DOI 10.1111/j.1439-0310.2009.01621.x; RATCLIFFE LM, 1985, ANIM BEHAV, V33, P290, DOI 10.1016/S0003-3472(85)80143-3; Ryan MJ, 2010, CURR ZOOL, V56, P343, DOI 10.1093/czoolo/56.3.343; RYAN MJ, 1990, EVOLUTION, V44, P1869, DOI 10.1111/j.1558-5646.1990.tb05256.x; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Searcy W, 2009, ENCY NEUROSCIENCE, P769; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; van Dongen WFD, 2010, BEHAV ECOL, V21, P1243, DOI 10.1093/beheco/arq145; Velasquez NA, 2013, BIOL J LINN SOC, DOI 10.1111-bij.12113.; Veloso A, 2006, MACROFITAS VERTEBRAD; VICTORIANO P, 1995, COMP BIOCHEM PHYS B, V112, P487, DOI 10.1016/0305-0491(95)00071-2; Villagra CA, 2011, B ENTOMOL RES, V101, P573, DOI 10.1017/S0007485311000174; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Zahavi A, 1999, HANDICAP PRINCIPLE M	59	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87732	10.1371/journal.pone.0087732	http://dx.doi.org/10.1371/journal.pone.0087732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489957	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000148
J	Wang, J; Chen, DJ; Lei, Y; Chang, JW; Hao, BH; Xing, F; Li, S; Xu, Q; Deng, XX; Chen, LL				Wang, Jia; Chen, Dijun; Lei, Yang; Chang, Ji-Wei; Hao, Bao-Hai; Xing, Feng; Li, Sen; Xu, Qiang; Deng, Xiu-Xin; Chen, Ling-Ling			Citrus sinensis Annotation Project (CAP): A Comprehensive Database for Sweet Orange Genome	PLOS ONE			English	Article							GENE ANNOTATION; WEB; INTEGRATION; PLATFORM	Citrus is one of the most important and widely grown fruit crop with global production ranking firstly among all the fruit crops in the world. Sweet orange accounts for more than half of the Citrus production both in fresh fruit and processed juice. We have sequenced the draft genome of a double-haploid sweet orange (C. sinensis cv. Valencia), and constructed the Citrus sinensis annotation project (CAP) to store and visualize the sequenced genomic and transcriptome data. CAP provides GBrowse-based organization of sweet orange genomic data, which integrates ab initio gene prediction, EST, RNA-seq and RNA-paired end tag (RNA-PET) evidence-based gene annotation. Furthermore, we provide a user-friendly web interface to show the predicted protein-protein interactions (PPIs) and metabolic pathways in sweet orange. CAP provides comprehensive information beneficial to the researchers of sweet orange and other woody plants, which is freely available at http://citrus.hzau.edu.cn/.	[Wang, Jia; Chen, Dijun; Lei, Yang; Chang, Ji-Wei; Hao, Bao-Hai; Xing, Feng; Li, Sen; Chen, Ling-Ling] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Bioinformat, Wuhan, Peoples R China; [Wang, Jia] Huazhong Agr Univ, Sch Sci, Wuhan, Peoples R China; [Xu, Qiang; Deng, Xiu-Xin] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Chen, LL (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Bioinformat, Wuhan, Peoples R China.	llchen@mail.hzau.edu.cn	Chen, Dijun/P-3877-2014; Chen, Ling-Ling/AAY-3547-2021	Chen, Dijun/0000-0002-7456-2511; Xiuxin, Deng/0000-0003-4490-4514	National Basic Research Program of China [2012AA10A304]; National Natural Science Foundation of China [31271406, 31222047]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the National Basic Research Program of China (2012AA10A304) and the National Natural Science Foundation of China (31271406 and 31222047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Attwood TK, 2012, DATABASE OXFORD, V2012; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blanco E, 2009, METHODS MOL BIOL, V537, P243, DOI 10.1007/978-1-59745-251-9_12; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Ding YD, 2014, PREDICTION FUN UNPUB; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Stein LD, 2013, BRIEF BIOINFORM, V14, P162, DOI 10.1093/bib/bbt001; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	24	14	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87723	10.1371/journal.pone.0087723	http://dx.doi.org/10.1371/journal.pone.0087723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489955	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000147
J	Eckerdt, F; Perez-Neut, M; Colamonici, OR				Eckerdt, Frank; Perez-Neut, Mathew; Colamonici, Oscar R.			LIN-9 Phosphorylation on Threonine-96 Is Required for Transcriptional Activation of LIN-9 Target Genes and Promotes Cell Cycle Progression	PLOS ONE			English	Article							B-MYB; DEPENDENT KINASES; REPRESSOR COMPLEX; DREAM COMPLEX; G(2)/M GENES; EXPRESSION; DROSOPHILA; CDK3; QUIESCENCE; PROTEINS	Cell cycle transitions are governed by the timely expression of cyclins, the activating subunits of Cyclin-dependent kinases (Cdks), which are responsible for the inactivation of the pocket proteins. Overexpression of cyclins promotes cell proliferation and cancer. Therefore, it is important to understand the mechanisms by which cyclins regulate the expression of cell cycle promoting genes including subsequent cyclins. LIN-9 and the pocket proteins p107 and p130 are members of the DREAM complex that in G0 represses cell cycle genes. Interestingly, little is know about the regulation and function of LIN-9 after phosphorylation of p107, p130 by Cyclin D/Cdk4 disassembles the DREAM complex in early G1. In this report, we demonstrate that cyclin E1/Cdk3 phosphorylates LIN-9 on Thr-96. Mutating Thr-96 to alanine inhibits activation of cyclins A2 and B1 promoters, whereas a phosphomimetic Asp mutant strongly activates their promoters and triggers accelerated entry into G2/M phase in 293T cells. Taken together, our data suggest a novel role for cyclin E1 beyond G1/S and into S/G2 phase, most likely by inducing the expression of subsequent cyclins A2 and B1 through LIN-9.	[Eckerdt, Frank; Perez-Neut, Mathew; Colamonici, Oscar R.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colamonici, OR (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.	ocolamon@uic.edu			National Institutes of Medical Sciences [GM81562]; Public Health Service Grants from National Institutes of Health [RO1GM81562]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081562] Funding Source: NIH RePORTER	National Institutes of Medical Sciences; Public Health Service Grants from National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Medical Sciences Grant GM81562. This work was supported by Public Health Service Grants RO1GM81562 (ORC) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall EL, 2004, GENE DEV, V18, P1667, DOI 10.1101/gad.1206604; Braun K, 1998, ONCOGENE, V17, P2259, DOI 10.1038/sj.onc.1202145; Braun K, 1998, DNA CELL BIOL, V17, P789, DOI 10.1089/dna.1998.17.789; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hengstschlager M, 1999, MUTAT RES-REV MUTAT, V436, P1, DOI 10.1016/S1383-5742(98)00022-2; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hofmann F, 1996, GENE DEV, V10, P851, DOI 10.1101/gad.10.7.851; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Sandoval R, 2006, EXP CELL RES, V312, P2465, DOI 10.1016/j.yexcr.2006.04.002; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Siu KT, 2012, CELL CYCLE, V11, P57, DOI 10.4161/cc.11.1.18775; Song J, 2010, ONCOGENE, V29, P1976, DOI 10.1038/onc.2009.485; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Zariwala M, 1998, ONCOGENE, V17, P2787, DOI 10.1038/sj.onc.1202505; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87620	10.1371/journal.pone.0087620	http://dx.doi.org/10.1371/journal.pone.0087620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475316	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300209
J	Kerr, RR; Grayden, DB; Thomas, DA; Gilson, M; Burkitt, AN				Kerr, Robert R.; Grayden, David B.; Thomas, Doreen A.; Gilson, Matthieu; Burkitt, Anthony N.			Coexistence of Reward and Unsupervised Learning During the Operant Conditioning of Neural Firing Rates	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; NEURONAL NETWORKS; SPIKE; MODEL; MODULATION; REINFORCEMENT; STDP; SENSITIVITY	A fundamental goal of neuroscience is to understand how cognitive processes, such as operant conditioning, are performed by the brain. Typical and well studied examples of operant conditioning, in which the firing rates of individual cortical neurons in monkeys are increased using rewards, provide an opportunity for insight into this. Studies of reward-modulated spike-timing-dependent plasticity (RSTDP), and of other models such as R-max, have reproduced this learning behavior, but they have assumed that no unsupervised learning is present (i.e., no learning occurs without, or independent of, rewards). We show that these models cannot elicit firing rate reinforcement while exhibiting both reward learning and ongoing, stable unsupervised learning. To fix this issue, we propose a new RSTDP model of synaptic plasticity based upon the observed effects that dopamine has on long-term potentiation and depression (LTP and LTD). We show, both analytically and through simulations, that our new model can exhibit unsupervised learning and lead to firing rate reinforcement. This requires that the strengthening of LTP by the reward signal is greater than the strengthening of LTD and that the reinforced neuron exhibits irregular firing. We show the robustness of our findings to spike-timing correlations, to the synaptic weight dependence that is assumed, and to changes in the mean reward. We also consider our model in the differential reinforcement of two nearby neurons. Our model aligns more strongly with experimental studies than previous models and makes testable predictions for future experiments.	[Kerr, Robert R.; Grayden, David B.; Gilson, Matthieu; Burkitt, Anthony N.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia; [Kerr, Robert R.; Grayden, David B.; Gilson, Matthieu; Burkitt, Anthony N.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia; [Kerr, Robert R.; Grayden, David B.; Burkitt, Anthony N.] Univ Melbourne, NICTA, Victoria Res Lab, Melbourne, Vic, Australia; [Grayden, David B.; Burkitt, Anthony N.] Bion Inst, Melbourne, Vic, Australia; [Thomas, Doreen A.] Univ Melbourne, Dept Mech Engn, Melbourne, Vic, Australia; [Gilson, Matthieu] RIKEN Brain Sci Inst, Lab Neural Circuit Theory, Saitama, Japan	University of Melbourne; University of Melbourne; Australian National University; University of Melbourne; Bionics Institute; University of Melbourne; RIKEN	Kerr, RR (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia.	r.kerr@pgrad.unimelb.edu.au	Burkitt, Anthony/N-9077-2013; Grayden, David B/L-5782-2018; Thomas, Doreen/F-4408-2016	Burkitt, Anthony/0000-0001-5672-2772; Grayden, David B/0000-0002-5497-7234; Gilson, Matthieu/0000-0002-6726-7207; Thomas, Doreen/0000-0002-8141-3362	Australian Research Council (ARC) [DP1096699]; Victorian Government; Australian Federal and Victorian State Governments; Australian Research Council through the ICT Centre of Excellence program, National ICT Australia (NICTA)	Australian Research Council (ARC)(Australian Research Council); Victorian Government; Australian Federal and Victorian State Governments; Australian Research Council through the ICT Centre of Excellence program, National ICT Australia (NICTA)(Australian Research Council)	Funding is acknowledged from the Australian Research Council (ARC Discovery Project DP1096699). The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. This work was supported by the Australian Federal and Victorian State Governments and the Australian Research Council through the ICT Centre of Excellence program, National ICT Australia (NICTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOHRNSTE.GW, 1969, J AM STAT ASSOC, V64, P1439, DOI 10.2307/2286081; Burkitt AN, 2001, BIOL CYBERN, V85, P247, DOI 10.1007/s004220100262; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Christodoulou C, 2011, NEURAL COMPUT, V23, P656, DOI 10.1162/NECO_a_00090; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gerstner W, 2002, BIOL CYBERN, V87, P404, DOI 10.1007/s00422-002-0353-y; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gilson M, 2010, BIOL CYBERN, V103, P365, DOI 10.1007/s00422-010-0405-7; Gilson M, 2009, BIOL CYBERN, V101, P427, DOI 10.1007/s00422-009-0346-1; Gilson M, 2009, BIOL CYBERN, V101, P81, DOI [10.1007/S00422-009-0319-4, 10.1007/s00422-009-0319-4]; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; Gutig R, 2003, J NEUROSCI, V23, P3697; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Herzog MH, 2012, VISION RES, V61, P95, DOI 10.1016/j.visres.2011.11.001; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kerr RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002897; Kobayashi S, 2010, J NEUROPHYSIOL, V103, P1843, DOI 10.1152/jn.00173.2009; Kuhn A, 2003, NEURAL COMPUT, V15, P67, DOI 10.1162/089976603321043702; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meffin H, 2006, PHYS REV E, V73, P384; Moreno-Bote R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028101; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nargeot R, 1999, J NEUROPHYSIOL, V81, P1983, DOI 10.1152/jn.1999.81.4.1983; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Salgado H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00417; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shouval HZ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00019; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sugisaki E, 2011, NEUROSCIENCE, V192, P91, DOI 10.1016/j.neuroscience.2011.06.064; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	50	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87123	10.1371/journal.pone.0087123	http://dx.doi.org/10.1371/journal.pone.0087123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475240	Green Published, gold			2022-12-25	WOS:000330507300145
J	Ibuka, Y; Li, M; Vietri, J; Chapman, GB; Galvani, AP				Ibuka, Yoko; Li, Meng; Vietri, Jeffrey; Chapman, Gretchen B.; Galvani, Alison P.			Free-Riding Behavior in Vaccination Decisions: An Experimental Study	PLOS ONE			English	Article							INFLUENZA VACCINATION; PREDICTORS; PRIVATE; PARENTS; HEALTH	Individual decision-making regarding vaccination may be affected by the vaccination choices of others. As vaccination produces externalities reducing transmission of a disease, it can provide an incentive for individuals to be free-riders who benefit from the vaccination of others while avoiding the cost of vaccination. This study examined an individual's decision about vaccination in a group setting for a hypothetical disease that is called "influenza'' using a computerized experimental game. In the game, interactions with others are allowed. We found that higher observed vaccination rate within the group during the previous round of the game decreased the likelihood of an individual's vaccination acceptance, indicating the existence of free-riding behavior. The free-riding behavior was observed regardless of parameter conditions on the characteristics of the influenza and vaccine. We also found that other predictors of vaccination uptake included an individual's own influenza exposure in previous rounds increasing the likelihood of vaccination acceptance, consistent with existing empirical studies. Influenza prevalence among other group members during the previous round did not have a statistically significant effect on vaccination acceptance in the current round once vaccination rate in the previous round was controlled for.	[Ibuka, Yoko] Tohoku Univ, Grad Sch Econ, Sendai, Miyagi 980, Japan; [Li, Meng] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Vietri, Jeffrey] Kantar Hlth, Hlth Econ & Outcomes Res, Princeton, NJ USA; [Chapman, Gretchen B.] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA; [Galvani, Alison P.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Tohoku University; University of Colorado System; University of Colorado Denver; Rutgers State University New Brunswick; Yale University	Ibuka, Y (corresponding author), Tohoku Univ, Grad Sch Econ, Sendai, Miyagi 980, Japan.	ibuka@econ.tohoku.ac.jp	Ibuka, Yoko/AAW-5135-2020	Ibuka, Yoko/0000-0001-5505-8988; Chapman, Gretchen/0000-0002-1146-480X	National Science Foundation [SBE-0624117]; Direct For Social, Behav & Economic Scie [1227306, 1227390] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by the National Science Foundation SBE-0624117 (http://www.nsf.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson R, 2004, ACTA PAEDIATR, V93, P1232, DOI 10.1080/08035250410033970; ANDERSON R M, 1991; Barham T, 2009, J HEALTH ECON, V28, P611, DOI 10.1016/j.jhealeco.2008.12.010; Boulier BL, 2007, BE J ECON ANAL POLI, V7; Brewer NT, 2006, CLIN INFECT DIS, V43, P1379, DOI 10.1086/508466; BRITO DL, 1991, J PUBLIC ECON, V45, P69, DOI 10.1016/0047-2727(91)90048-7; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chapman GB, 2012, PSYCHOL SCI, V23, P1008, DOI 10.1177/0956797612437606; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Connolly T, 2003, ORGAN BEHAV HUM DEC, V91, P186, DOI 10.1016/S0749-5978(03)00057-8; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Francis PJ, 2004, J ECON DYN CONTROL, V28, P2037, DOI 10.1016/j.jedc.2003.08.001; Francis PJ, 1997, J PUBLIC ECON, V63, P383, DOI 10.1016/S0047-2727(96)01586-1; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Geoffard PY, 1997, AM ECON REV, V87, P222; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; HERSHEY JC, 1994, ORGAN BEHAV HUM DEC, V59, P177, DOI 10.1006/obhd.1994.1055; Jaccard James., 2001, INTERACTION EFFECTS, DOI 10.4135/9781412984515; Kagel JH, 1995, HDB EXPT EC; Leyland AH, 2001, MULTILEVEL MODELLING; Li YC, 2004, HEALTH SERV RES, V39, P905, DOI 10.1111/j.1475-6773.2004.00264.x; Meszaros JR, 1996, J CLIN EPIDEMIOL, V49, P697, DOI 10.1016/0895-4356(96)00007-8; Philipson T, 1996, J HUM RESOUR, V31, P611, DOI 10.2307/146268; Serpell L, 2006, VACCINE, V24, P4041, DOI 10.1016/j.vaccine.2006.02.037; Stiglitz J, 2000, EC PUBLIC SECTOR	26	65	65	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87164	10.1371/journal.pone.0087164	http://dx.doi.org/10.1371/journal.pone.0087164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475246	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800088
J	Hernandez-Ortega, A; Quesne, MG; Bui, S; Heuts, DPHM; Steiner, RA; Heyes, DJ; de Visser, SP; Scrutton, NS				Hernandez-Ortega, Aitor; Quesne, Matthew G.; Bui, Soi; Heuts, Dominic P. H. M.; Steiner, Roberto A.; Heyes, Derren J.; de Visser, Sam P.; Scrutton, Nigel S.			Origin of the Proton-transfer Step in the Cofactor-free (1H)-3-Hydroxy-4-oxoquinaldine 2,4-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Isotope Effects; Molecular Dynamics; Site-directed Mutagenesis; DFT Calculations; Quantum Mechanics; Molecular Mechanics	ALPHA/BETA-HYDROLASE-FOLD; GENERAL BASE CATALYSIS; 1H-3-HYDROXY-4-OXOQUINALDINE 2,4-DIOXYGENASE; TRIMETHYLAMINE DEHYDROGENASE; INDEPENDENT DIOXYGENATION; ELECTRON OXIDATION; STRUCTURAL BASIS; RING-CLEAVAGE; ACTIVE-SITE; ENZYMES	Background: The mechanism of cofactor-free dioxygenases has not been clearly elucidated. Results: Mutation of the His/Asp dyad in (1H)-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase strongly affects substrate deprotonation and overall catalysis. Conclusion: Base mechanism is demonstrated where His-251 acts as catalytic base and Asp-126 modulates basicity. Significance: Many dioxygenases activate their substrates via deprotonation, which is an essential step for later reaction with oxygen. Dioxygenases catalyze a diverse range of chemical reactions that involve the incorporation of oxygen into a substrate and typically use a transition metal or organic cofactor for reaction. Bacterial (1H)-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase (HOD) belongs to a class of oxygenases able to catalyze this energetically unfavorable reaction without any cofactor. In the quinaldine metabolic pathway, HOD breaks down its natural N-heteroaromatic substrate using a mechanism that is still incompletely understood. Experimental and computational approaches were combined to study the initial step of the catalytic cycle. We have investigated the role of the active site His-251/Asp-126 dyad, proposed to be involved in substrate hydroxyl group deprotonation, a critical requirement for subsequent oxygen reaction. The pH profiles obtained under steady-state conditions for the H251A and D126A variants show a strong pH effect on their k(cat) and k(cat)/K-m constants, with a decrease in k(cat)/K-m of 5500- and 9-fold at pH 10.5, respectively. Substrate deprotonation studies under transient-state conditions show that this step is not rate-limiting and yield a pK(a) value of approximate to 7.2 for WT HOD. A large solvent isotope effect was found, and the pK(a) value was shifted to approximate to 8.3 in D2O. Crystallographic and computational studies reveal that the mutations have a minor effect on substrate positioning. Computational work shows that both His-251 and Asp-126 are essential for the proton transfer driving force of the initial reaction. This multidisciplinary study offers unambiguous support to the view that substrate deprotonation, driven by the His/Asp dyad, is an essential requirement for its activation.	[Heyes, Derren J.; de Visser, Sam P.; Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Bui, Soi; Steiner, Roberto A.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of Manchester; University of London; King's College London	Steiner, RA (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England.	roberto.steiner@kcl.ac.uk; sam.devisser@manchester.ac.uk; nigel.scrutton@manchester.ac.uk	Steiner, Roberto/AAZ-9582-2021; de Visser, Samuel P/A-6960-2008; Quesne, Matthew/AAI-4136-2020; Quesne, Matthew/I-4938-2015; Scrutton, Nigel/B-7352-2017	Steiner, Roberto/0000-0001-7084-9745; de Visser, Samuel P/0000-0002-2620-8788; Quesne, Matthew/0000-0001-5130-1266; Heyes, Derren/0000-0002-7453-1571; Scrutton, Nigel/0000-0002-4182-3500	United Kingdom Biotechnology and Biological Sciences Research Council [BB/I020411/1, BB/I020543/1]; BBSRC [BB/I020543/1, BB/I020411/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I020411/1, BB/I020543/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grants BB/I020411/1 (to R. A. S.), BB/I020543/1 (to N. S. S. and S. P. dV.), and a studentship (to M. G. Q.).	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Basran J, 2001, J BIOL CHEM, V276, P42887, DOI 10.1074/jbc.M108296200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; Bauer I, 1996, EUR J BIOCHEM, V240, P576, DOI 10.1111/j.1432-1033.1996.0576h.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bugg TDH, 2001, CURR OPIN CHEM BIOL, V5, P550, DOI 10.1016/S1367-5931(00)00236-2; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fetzner S, 2007, NAT CHEM BIOL, V3, P374, DOI 10.1038/nchembio0707-374; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; FIFE TH, 1961, J PHYS CHEM-US, V65, P1079, DOI 10.1021/j100824a525; Fischer F, 1999, J BACTERIOL, V181, P5725, DOI 10.1128/JB.181.18.5725-5733.1999; Fischer F, 2000, FEMS MICROBIOL LETT, V190, P21, DOI 10.1111/j.1574-6968.2000.tb09256.x; Frerichs-Deeken U, 2004, BIOCHEMISTRY-US, V43, P14485, DOI 10.1021/bi048735u; Frerichs-Deeken U, 2005, CURR MICROBIOL, V51, P344, DOI 10.1007/s00284-005-0065-3; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Furukawa K, 2000, CURR OPIN BIOTECH, V11, P244, DOI 10.1016/S0958-1669(00)00091-4; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Imhoff RD, 2003, BIOCHEMISTRY-US, V42, P4094, DOI 10.1021/bi027377x; Johnson K. A., 1992, ENZYMES, P61; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Kumar D, 2011, J AM CHEM SOC, V133, P3869, DOI 10.1021/ja107514f; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Rebollar-Zepeda AM, 2011, J CHEM THEORY COMPUT, V7, P2528, DOI 10.1021/ct2001864; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Prescott AG, 1996, ANNU REV PLANT PHYS, V47, P245, DOI 10.1146/annurev.arplant.47.1.245; Prokop KA, 2011, J AM CHEM SOC, V133, P15874, DOI 10.1021/ja2066237; Quesne MG, 2014, CHEM-EUR J, V20, P435, DOI 10.1002/chem.201303282; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Smith W, 2002, MOL SIMULAT, V28, P385, DOI 10.1080/08927020290018769; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Steiner RA, 2007, ACTA CRYSTALLOGR F, V63, P382, DOI 10.1107/S174430910701353X; Steiner RA, 2010, P NATL ACAD SCI USA, V107, P657, DOI 10.1073/pnas.0909033107; Steinmuller R., 2013, Ernahrungs Umschau Supplements, P1; Stipanuk MH, 2004, NEUROCHEM RES, V29, P105, DOI 10.1023/B:NERE.0000010438.40376.c9; Thierbach S., 2014, CHEM BIOL, V20, P1; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; Vardhaman AK, 2011, CHEM COMMUN, V47, P11044, DOI 10.1039/c1cc13775a; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; Widboom PF, 2007, NATURE, V447, P342, DOI 10.1038/nature05702; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Woo JC, 2008, PROTEIN SCI, V17, P725, DOI 10.1110/ps.073355508; YAGIL G, 1967, TETRAHEDRON, V23, P2855, DOI 10.1016/0040-4020(67)85151-2; Zuegg J, 1999, PROTEIN SCI, V8, P1990, DOI 10.1110/ps.8.10.1990	56	25	26	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8620	8632		10.1074/jbc.M113.543033	http://dx.doi.org/10.1074/jbc.M113.543033			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24482238	Green Published, hybrid			2022-12-25	WOS:000333157500052
J	Shao, W; Espenshade, PJ				Shao, Wei; Espenshade, Peter J.			Sterol Regulatory Element-binding Protein (SREBP) Cleavage Regulates Golgi-to-Endoplasmic Reticulum Recycling of SREBP Cleavage-activating Protein (SCAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Lipids; Lysosomes; Protein Degradation; Transcription Factors; SCAP; SREBP; Recycling	HAMSTER OVARY CELLS; DSC E3 LIGASE; FISSION YEAST; PROTEASOME INHIBITORS; SITE-1 PROTEASE; LIPID-SYNTHESIS; COPII PROTEINS; ER MEMBRANES; FATTY LIVER; CHOLESTEROL	Background: The SREBP-SCAP pathway controls lipid homeostasis. Results: SCAP Golgi-to-ER transport requires cleavage of SREBP precursor, reductions in SREBP cleavage at site-1 lead to SCAP degradation in lysosomes, and SREBP control of SCAP expression is conserved in yeast. Conclusion: Site-1 protease activity and SREBP binding regulate SCAP expression through degradation. Sterol regulatory element-binding protein (SREBP) transcription factors are central regulators of cellular lipogenesis. Release of membrane-bound SREBP requires SREBP cleavage-activating protein (SCAP) to escort SREBP from the endoplasmic reticulum (ER) to the Golgi for cleavage by site-1 and site-2 proteases. SCAP then recycles to the ER for additional rounds of SREBP binding and transport. Mechanisms regulating ER-to-Golgi transport of SCAP-SREBP are understood in molecular detail, but little is known about SCAP recycling. Here, we have demonstrated that SCAP Golgi-to-ER transport requires cleavage of SREBP at site-1. Reductions in SREBP cleavage lead to SCAP degradation in lysosomes, providing additional negative feedback control to the SREBP pathway. Current models suggest that SREBP plays a passive role prior to cleavage. However, we show that SREBP actively prevents premature recycling of SCAP-SREBP until initiation of SREBP cleavage. SREBP regulates SCAP in human cells and yeast, indicating that this is an ancient regulatory mechanism.	[Shao, Wei; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu		Shao, Wei/0000-0002-5966-4376	National Institutes of Health [HL077588]; Pancreatic Cancer Action Network-AACR Innovative Grant [12-60-25-ESPE]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network-AACR Innovative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077588. This work was also supported by Grant 12-60-25-ESPE, the 2012 Pancreatic Cancer Action Network-AACR Innovative Grant in memory of Bonnie L. Tobin.	Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; COPELAND NG, 1979, CELL, V16, P347, DOI 10.1016/0092-8674(79)90011-4; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1533, DOI 10.1172/JCI107331; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hachinski V, 1996, ARCH NEUROL-CHICAGO, V53, P303, DOI 10.1001/archneur.1996.00550040031011; HASAN MT, 1994, SOMAT CELL MOLEC GEN, V20, P183, DOI 10.1007/BF02254759; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SATO R, 1994, J BIOL CHEM, V269, P17267; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Tanida I, 2012, AUTOPHAGY, V8, P88, DOI 10.4161/auto.8.1.18339; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152	55	50	55	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7547	7557		10.1074/jbc.M113.545699	http://dx.doi.org/10.1074/jbc.M113.545699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478315	Green Published, hybrid			2022-12-25	WOS:000332761500025
J	Nguyen, MD; Lee, ST; Ross, AE; Ryals, M; Choudhry, VI; Venton, BJ				Nguyen, Michael D.; Lee, Scott T.; Ross, Ashley E.; Ryals, Matthew; Choudhry, Vishesh I.; Venton, B. Jill			Characterization of Spontaneous, Transient Adenosine Release in the Caudate-Putamen and Prefrontal Cortex	PLOS ONE			English	Article							CARBON-FIBER MICROELECTRODES; INTERSTITIAL FLUID ADENOSINE; EXTRACELLULAR ADENOSINE; NERVOUS-SYSTEM; BRAIN-SLICES; RAT-BRAIN; DOPAMINE; RECEPTORS; INCREASES; NEUROTRANSMISSION	Adenosine is a neuroprotective agent that inhibits neuronal activity and modulates neurotransmission. Previous researchhas shown adenosine gradually accumulates during pathologies such as stroke and regulates neurotransmission on the minute-to-hour time scale. Our lab developed a method using carbon-fiber microelectrodes to directly measure adenosine changes on a sub-second time scale with fast-scan cyclic voltammetry (FSCV). Recently, adenosine release lasting a couple of seconds has been found in murine spinal cord slices. In this study, we characterized spontaneous, transient adenosine release in vivo, in the caudate-putamen and prefrontal cortex of anesthetized rats. The average concentration of adenosine release was 0.17 +/- 0.01 mu M in the caudate and 0.19 +/- 0.01 mu M in the prefrontal cortex, although the range was large, from 0.04 to 3.2 mu M. The average duration of spontaneous adenosine release was 2.9 +/- 0.1 seconds and 2.8 +/- 0.1 seconds in the caudate and prefrontal cortex, respectively. The concentration and number of transients detected do not change over a four hour period, suggesting spontaneous events are not caused by electrode implantation. The frequency of adenosine transients was higher in the prefrontal cortex than the caudate-putamen and was modulated by A(1) receptors. The A(1) antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine, 6 mg/kg i.p.) increased the frequency of spontaneous adenosine release, while the A(1) agonist CPA (N-6-cyclopentyladenosine, 1 mg/kg i.p.) decreased the frequency. These findings are a paradigm shift for understanding the time course of adenosine signaling, demonstrating that there is a rapid mode of adenosine signaling that could cause transient, local neuromodulation.	[Nguyen, Michael D.; Lee, Scott T.; Ross, Ashley E.; Ryals, Matthew; Choudhry, Vishesh I.; Venton, B. Jill] Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA	University of Virginia	Venton, BJ (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA.	bjv2n@virginia.edu	Venton, B. Jill/A-2902-2008	Venton, B. Jill/0000-0002-5096-9309; Ross, Ashley/0000-0003-2456-3636	National Institute of Health [R01NS076875]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076875] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This reasearch was supported by the National Institute of Health (R01NS076875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula KK, 2008, J CHROMATOGR A, V1209, P230, DOI 10.1016/j.chroma.2008.08.086; BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; Cechova S, 2010, NEUROSCIENCE, V171, P1006, DOI 10.1016/j.neuroscience.2010.09.063; Cechova S, 2008, J NEUROCHEM, V105, P1253, DOI 10.1111/j.1471-4159.2008.05223.x; Chang SY, 2012, MAYO CLIN PROC, V87, P760, DOI 10.1016/j.mayocp.2012.05.006; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dryhurst G, 1977, ELECTROCHEMISTRY BIO, P71; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; FASTBOM J, 1987, NEUROSCIENCE, V22, P813, DOI 10.1016/0306-4522(87)92961-7; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Garris PA, 1997, J NEUROCHEM, V68, P152; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Huffman ML, 2008, ELECTROANAL, V20, P2422, DOI 10.1002/elan.200804343; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; Karcz-Kubicha M, 2003, NEUROPSYCHOPHARMACOL, V28, P1281, DOI 10.1038/sj.npp.1300167; Keithley RB, 2009, TRAC-TREND ANAL CHEM, V28, P1127, DOI 10.1016/j.trac.2009.07.002; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Kobayashi T, 1998, BRAIN RES, V787, P211, DOI 10.1016/S0006-8993(97)01481-9; Kovacs Z, 2010, NEUROCHEM RES, V35, P452, DOI 10.1007/s11064-009-0080-z; LASLEY RD, 1995, AM J PHYSIOL-HEART C, V269, pH1460, DOI 10.1152/ajpheart.1995.269.4.H1460; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; MALINOWSKI ER, 1977, ANAL CHEM, V49, P606, DOI 10.1021/ac50012a026; Milton JS, 2003, INTRO PROBABILITY ST; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; NAYEBPOUR M, 1993, CIRCULATION, V88, P2632, DOI 10.1161/01.CIR.88.6.2632; Pajski ML, 2013, PURINERG SIGNAL, V9, P167, DOI 10.1007/s11302-012-9343-2; Pajski ML, 2010, ACS CHEM NEUROSCI, V1, P775, DOI 10.1021/cn100037d; Paxinos G, 2007, RAT BRAIN STEREOTAXI, V6; Peairs MJ, 2011, ANAL METHODS-UK, V3, P2379, DOI 10.1039/c1ay05348e; PHILLIS JW, 1987, J CEREBR BLOOD F MET, V7, P679, DOI 10.1038/jcbfm.1987.122; PIHEL K, 1995, ANAL CHEM, V67, P4514, DOI 10.1021/ac00120a014; Prediger RDS, 2004, EUR J PHARMACOL, V499, P147, DOI 10.1016/j.ejphar.2004.07.106; Ross AE, 2012, ANALYST, V137, P3045, DOI 10.1039/c2an35297d; Sanford AL, 2010, ANAL CHEM, V82, P5205, DOI 10.1021/ac100536s; Sharma R, 2010, ALCOHOL CLIN EXP RES, V34, P813, DOI 10.1111/j.1530-0277.2010.01153.x; SORICELLI A, 1995, STROKE, V26, P1572, DOI 10.1161/01.STR.26.9.1572; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Strand AM, 2008, ANAL CHEM, V80, P3708, DOI 10.1021/ac8001275; Street SE, 2013, J NEUROSCI, V33, P11314, DOI 10.1523/JNEUROSCI.0133-13.2013; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Swamy BEK, 2007, ANAL CHEM, V79, P744, DOI 10.1021/ac061820i; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; Venton BJ, 2003, J NEUROCHEM, V84, P373, DOI 10.1046/j.1471-4159.2003.01527.x; WATT AH, 1985, BRIT J CLIN PHARMACO, V20, P503, DOI 10.1111/j.1365-2125.1985.tb05108.x; Wei Z, 2006, J AM CHEM SOC, V128, P3134, DOI 10.1021/ja053950z; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; WINN HR, 1985, ANN BIOMED ENG, V13, P321, DOI 10.1007/BF02584250; Xu YD, 2010, PHYS CHEM CHEM PHYS, V12, P10027, DOI 10.1039/c0cp00294a; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X	58	51	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87165	10.1371/journal.pone.0087165	http://dx.doi.org/10.1371/journal.pone.0087165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24494035	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000112
J	Bekaert, M; Conant, GC				Bekaert, Michael; Conant, Gavin C.			Gene Duplication and Phenotypic Changes in the Evolution of Mammalian Metabolic Networks	PLOS ONE			English	Article							CALORIE RESTRICTION; ENERGY-METABOLISM; LONGEVITY; LIFE; TEMPERATURE; RECONSTRUCTION; MECHANISMS; RECEPTOR; DATABASE; HISTORY	Metabolic networks attempt to describe the complete suite of biochemical reactions available to an organism. One notable feature of these networks in mammals is the large number of distinct proteins that catalyze the same reaction. While the existence of these isoenzymes has long been known, their evolutionary significance is still unclear. Using a phylogenetically-aware comparative genomics approach, we infer enzyme orthology networks for sixteen mammals as well as for their common ancestors. We find that the pattern of isoenzymes copy-number alterations (CNAs) in these networks is suggestive of natural selection acting on the retention of certain gene duplications. When further analyzing these data with a machine-learning approach, we found that that the pattern of CNAs is also predictive of several important phenotypic traits, including milk composition and geographic range. Integrating tools from network analyses, phylogenetics and comparative genomics both allows the prediction of phenotypes from genetic data and represents a means of unifying distinct biological disciplines.	[Bekaert, Michael] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Conant, Gavin C.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Conant, Gavin C.] Univ Missouri, Inst Informat, Columbia, MO USA	University of Stirling; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Conant, GC (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	conantg@missouri.edu	Conant, Gavin/R-7022-2019	Conant, Gavin/0000-0002-8677-4933; Bekaert, Michael/0000-0002-1206-7654	University of Missouri; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri	University of Missouri; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri	This work was supported by a Research Board grant from the University of Missouri (MB) and the Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri (GCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agutter Paul S, 2004, Theor Biol Med Model, V1, P13, DOI 10.1186/1742-4682-1-13; Basler G, 2011, BIOINFORMATICS, V27, P1397, DOI 10.1093/bioinformatics/btr145; Bekaert M, 2011, MOL BIOL EVOL, V28, P1111, DOI 10.1093/molbev/msq296; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004; Chautard E, 2010, BIOGERONTOLOGY, V11, P463, DOI 10.1007/s10522-010-9268-5; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Ebenhoh O, 2006, IEE P SYST BIOL, V153, P354, DOI 10.1049/ip-syb:20060014; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GREGORY TR, 2011, ANIMAL GENOME SIZE D; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hall M. A., 1998, CORRELATION BASED FE; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Hedges SB, 2009, TIMETREE LIFE, Vxxi; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Langer P, 2008, ZOOLOGY, V111, P148, DOI 10.1016/j.zool.2007.06.007; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Messer M, 2002, TRENDS GLYCOSCI GLYC, V14, P153, DOI 10.4052/tigg.14.153; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Nakamura T, 2003, COMP BIOCHEM PHYS B, V135, P439, DOI 10.1016/S1096-4959(03)00093-9; Oftedal O. T., 1995, HDB MILK COMPOSITION, P749; Oksanen J., 2016, R PACKAG; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Park YW, 2006, HDB MILK NONBOVINE M, Vx; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pigliucci M, 2010, PHILOS T R SOC B, V365, P557, DOI 10.1098/rstb.2009.0241; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; ROUSSEEUW PJ, 1987, WILEY SERIES PROBABI, V14, P329; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Selvarasu S, 2010, MOL BIOSYST, V6, P152, DOI 10.1039/b912865d; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wagner A, 2008, BIOESSAYS, V30, P367, DOI 10.1002/bies.20728; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Witten I. H., 2005, DATA MINING PRACTICA; Wooden KM, 2002, J EXP BIOL, V205, P2099	69	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87115	10.1371/journal.pone.0087115	http://dx.doi.org/10.1371/journal.pone.0087115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489850	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000109
J	Liu, Z; Lebrin, F; Maring, JA; van den Driesche, S; van der Brink, S; van Dinther, M; Thorikay, M; Martin, S; Kobayashi, K; Hawinkels, LJAC; van Meeteren, LA; Pardali, E; Korving, J; Letarte, M; Arthur, HM; Theuer, C; Goumans, MJ; Mummery, C; ten Dijke, P				Liu, Zhen; Lebrin, Franck; Maring, Janita A.; van den Driesche, Sander; van der Brink, Stieneke; van Dinther, Maarten; Thorikay, Midory; Martin, Sabrina; Kobayashi, Kazuki; Hawinkels, Lukas J. A. C.; van Meeteren, Laurens A.; Pardali, Evangelia; Korving, Jeroen; Letarte, Michelle; Arthur, Helen M.; Theuer, Charles; Goumans, Marie-Jose; Mummery, Christine; ten Dijke, Peter			ENDOGLIN Is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; EMBRYONIC STEM-CELLS; BLOOD-VESSEL DEVELOPMENT; BETA RECEPTOR COMPLEX; MOUSE BONE EXPLANTS; TGF-BETA; IN-VITRO; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; KINASE	ENDOGLIN (ENG) is a co-receptor for transforming growth factor-beta (TGF-beta) family members that is highly expressed in endothelial cells and has a critical function in the development of the vascular system. Mutations in Eng are associated with the vascular disease known as hereditary hemorrhagic telangiectasia type l. Using mouse embryonic stem cells we observed that angiogenic factors, including vascular endothelial growth factor (VEGF), induce vasculogenesis in embryoid bodies even when Eng deficient cells or cells depleted of Eng using shRNA are used. However, ENG is required for the stem cell-derived endothelial cells to organize effectively into tubular structures. Consistent with this finding, fetal metatarsals isolated from E17.5 Eng heterozygous mouse embryos showed reduced VEGF-induced vascular network formation. Moreover, shRNA-mediated depletion and pharmacological inhibition of ENG in human umbilical vein cells mitigated VEGF-induced angiogenesis. In summary, we demonstrate that ENG is required for efficient VEGF-induced angiogenesis.	[Liu, Zhen; Maring, Janita A.; van Dinther, Maarten; Thorikay, Midory; Kobayashi, Kazuki; Hawinkels, Lukas J. A. C.; van Meeteren, Laurens A.; Pardali, Evangelia; Goumans, Marie-Jose; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol,Canc Gen Ctr, Leiden, Netherlands; [Lebrin, Franck; van den Driesche, Sander; van der Brink, Stieneke; Korving, Jeroen; Mummery, Christine] Hubrecht Inst, Utrecht, Netherlands; [Mummery, Christine] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Lebrin, Franck; Martin, Sabrina] Coll France, Ctr Interdisciplinary Res Biol CIRB, CNRS, UMR 7241,INSERM,U1050, F-75231 Paris, France; [Letarte, Michelle] Univ Toronto, Hosp Sick Children, Mol Struct & Funct Program, Dept Immunol, Toronto, ON, Canada; [Letarte, Michelle] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada; [Arthur, Helen M.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Theuer, Charles] Tracon Pharmaceut, San Diego, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Newcastle University - UK	Goumans, MJ (corresponding author), Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol,Canc Gen Ctr, Leiden, Netherlands.	M.J.T.H.Goumans@lumc.nl; C.L.Mummery@lumc.nl; p.ten_dijke@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Arthur, Helen/C-7808-2009; van den Driesche, Sander/H-7094-2019; Hawinkels, Lukas/Q-5098-2019; Van Meeteren, Laurens A./AGQ-6139-2022; Goumans, Marie-José/AAG-4994-2021; Goumans, Marie Jose/U-1455-2019; van Meeteren, Laurens/A-9890-2008	Dijke, Peter ten/0000-0002-7234-342X; Hawinkels, Lukas/0000-0002-2274-9325; Goumans, Marie Jose/0000-0001-9344-6746; van Meeteren, Laurens/0000-0001-9885-0668; lebrin, franck/0000-0002-1650-6757; Mummery, Christine/0000-0002-4549-6535; van den Driesche, Sander/0000-0002-8092-6588; van Dinther, Maarten/0000-0002-9451-8884; Arthur, Helen/0000-0001-6522-1363	Dutch Cancer Society [UL2011-5051]; Leducq Foundation; Royal Netherlands Academy of Arts and Sciences; Netherlands Institute for Regenerative Medicine (NIRM); Centre for Biomedical Genetics; British Heart Foundation [RG/12/2/29416] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); Leducq Foundation(Leducq Foundation); Royal Netherlands Academy of Arts and Sciences; Netherlands Institute for Regenerative Medicine (NIRM); Centre for Biomedical Genetics; British Heart Foundation(British Heart Foundation)	This study was supported by grants from Dutch Cancer Society (UL2011-5051), Leducq Foundation, the Royal Netherlands Academy of Arts and Sciences, Netherlands Institute for Regenerative Medicine (NIRM) and Centre for Biomedical Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9312; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Baik J, 2012, EXP HEMATOL, V40, P837, DOI 10.1016/j.exphem.2012.06.007; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Borges L, 2012, BLOOD, V119, P5417, DOI 10.1182/blood-2011-11-391896; Bot PTG, 2009, STROKE, V40, P439, DOI 10.1161/STROKEAHA.108.522284; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cho SK, 2001, BLOOD, V98, P3635, DOI 10.1182/blood.V98.13.3635; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deckers M, 2001, LAB INVEST, V81, P5, DOI 10.1038/labinvest.3780207; Feraud O, 2003, HISTOL HISTOPATHOL, V18, P191, DOI 10.14670/HH-18.191; Feraud O, 2001, LAB INVEST, V81, P1669, DOI 10.1038/labinvest.3780380; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; GOUGOS A, 1988, J IMMUNOL, V141, P1925; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 1999, DEVELOPMENT, V126, P3473; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Korff T, 1999, J CELL SCI, V112, P3249; Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li X, 2009, J THROMB HAEMOST, V7, P53, DOI 10.1111/j.1538-7836.2009.03427.x; Liu Z, 2012, PREGNANCY HYPERTENS, V2, P358, DOI 10.1016/j.preghy.2012.06.003; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Nolan-Stevaux O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050920; Nomura-Kitabayashi A, 2009, DEV BIOL, V335, P66, DOI 10.1016/j.ydbio.2009.08.016; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pardali E, 2011, ONCOGENE, V30, P334, DOI 10.1038/onc.2010.418; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Park S, 2013, J CELL SCI, V126, P1392, DOI 10.1242/jcs.117275; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perlingeiro RCR, 2007, DEVELOPMENT, V134, P3041, DOI 10.1242/dev.002907; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROELEN BAJ, 1994, DEV BIOL, V166, P716, DOI 10.1006/dbio.1994.1350; Sambrook J., 2002, MOL CLONING LAB MANU; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; She XW, 2004, INT J CANCER, V108, P251, DOI 10.1002/ijc.11551; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; SLAGER HG, 1993, J CELL PHYSIOL, V156, P247, DOI 10.1002/jcp.1041560205; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02)00852-0; VANDERPLUIJM G, 1991, J BONE MINER RES, V6, P1203; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; WANG R, 1992, DEVELOPMENT, V114, P303; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Xu B, 2004, J CEREBR BLOOD F MET, V24, P237, DOI 10.1097/01.WCB.0000107730.66603.51	64	123	128	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86273	10.1371/journal.pone.0086273	http://dx.doi.org/10.1371/journal.pone.0086273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489709	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000042
J	Weingartl, HM; Zhang, SZ; Marszal, P; McGreevy, A; Burton, L; Wilson, WC				Weingartl, Hana M.; Zhang, Shunzhen; Marszal, Peter; McGreevy, Alan; Burton, Lynn; Wilson, William C.			Rift Valley Fever Virus Incorporates the 78 kDa Glycoprotein into Virions Matured in Mosquito C6/36 Cells	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; EXPRESSION STRATEGY; DENDRITIC CELLS; M SEGMENT; DC-SIGN; PHLEBOVIRUS; NSM; ALPHAVIRUSES; REPLICATION; INFECTION	Rift Valley fever virus (RVFV), genus Phlebovirus, family Bunyaviridae is a zoonotic arthropod-borne virus able to transition between distant host species, causing potentially severe disease in humans and ruminants. Viral proteins are encoded by three genomic segments, with the medium M segment coding for four proteins: nonstructural NSm protein, two glycoproteins Gn and Gc and large 78 kDa glycoprotein (LGp) of unknown function. Goat anti-RVFV polyclonal antibody and mouse monoclonal antibody, generated against a polypeptide unique to the LGp within the RVFV proteome, detected this protein in gradient purified RVFV ZH501 virions harvested from mosquito C6/36 cells but not in virions harvested from the mammalian Vero E6 cells. The incorporation of LGp into the mosquito cell line - matured virions was confirmed by immune-electron microscopy. The LGp was incorporated into the virions immediately during the first passage in C6/36 cells of Vero E6 derived virus. Our data indicate that LGp is a structural protein in C6/36 mosquito cell generated virions. The protein may aid the transmission from the mosquitoes to the ruminant host, with a possible role in replication of RVFV in the mosquito host. To our knowledge, this is a first report of different protein composition between virions formed in insect C6/36 versus mammalian Vero E6 cells.	[Weingartl, Hana M.; Zhang, Shunzhen; Marszal, Peter; Burton, Lynn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Weingartl, Hana M.; McGreevy, Alan] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Wilson, William C.] USDA, Arthropod Borne Anim Dis Res Unit, Manhattan, KS USA	Canadian Food Inspection Agency; University of Manitoba; United States Department of Agriculture (USDA)	Weingartl, HM (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	hana.weingartl@inspection.gc.ca	Wilson, William/Y-8857-2019	Wilson, William/0000-0002-7877-9224	CFIA; USDA; ARS CRIS [5430-32000-005-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-07-00982];  [CRTI-06-0138RD]	CFIA; USDA(United States Department of Agriculture (USDA)); ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); 	The funding for the project was provided from the CRTI-06-0138RD project, by CFIA, the USDA, ARS CRIS project #5430-32000-005-00D, and through an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-07-00982. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSELAAR TG, 1991, ARCH VIROL, V121, P111, DOI 10.1007/BF01316748; Brennan B, 2011, J VITOL, V85; COLLETT MS, 1985, VIROLOGY, V144, P228, DOI 10.1016/0042-6822(85)90320-4; Crabtree MB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001639; Darpel KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017545; Drolet BS, 2012, J VIROL METHODS, V179, P373, DOI 10.1016/j.jviromet.2011.11.025; Faburay B, 2013, VECTOR-BORNE ZOONOT, V13, P619, DOI 10.1089/vbz.2012.1285; Fernandez JC, 2012, CLIN VACCINE IMMUNOL, V19, P5, DOI 10.1128/CVI.05420-11; Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; He LL, 2010, J VIROL, V84, P5270, DOI 10.1128/JVI.00044-10; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Ikegami T, 2005, J VIROL, V79; KAKACH LT, 1989, VIROLOGY, V170, P505, DOI 10.1016/0042-6822(89)90442-X; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Kumar M, 2011, MOL BIOSYST, V7, P1629, DOI 10.1039/c0mb00259c; Liu L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-82; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Nfon CK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001623; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Rusu M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00254; Shabman RS, 2007, J VIROL, V81, P237, DOI 10.1128/JVI.01590-06; Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; STRUTHERS JK, 1984, VIROLOGY, V134, P118, DOI 10.1016/0042-6822(84)90277-0; SUZICH JA, 1990, J VIROL, V64, P1549, DOI 10.1128/JVI.64.4.1549-1555.1990; Vaughn VM, 2010, VIRUSES-BASEL, V2, P655, DOI 10.3390/v2020655; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06	29	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87385	10.1371/journal.pone.0087385	http://dx.doi.org/10.1371/journal.pone.0087385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489907	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000132
J	Zanotti, S; Kalajzic, I; Aguila, HL; Canalis, E				Zanotti, Stefano; Kalajzic, Ivo; Aguila, Hector Leonardo; Canalis, Ernesto			Sex and Genetic Factors Determine Osteoblastic Differentiation Potential of Murine Bone Marrow Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; GROWTH-FACTOR; MICE; MUSCLE; MOUSE; ACTIVATION; FATE; ARCHITECTURE; OSTEOCLASTS; DIMORPHISM	Sex and genetic factors determine skeletal mass, and we tested whether bone histomorphometric parameters were sexually dimorphic in femurs from 1 to 6 month old C57BL/6 mice. Trabecular bone volume declined more rapidly in female mice than in male littermates because of enhanced bone resorption. Although bone formation was not different between sexes, female mice exhibited a higher number of osteoblasts than male littermates, suggesting that osteoblasts from female mice may have a reduced ability to form bone. To determine the impact of sex on osteoblastogenesis, we investigated the potential for osteoblastic differentiation of bone marrow stromal cells from C57BL/6, Friend leukemia virus-B (FVB), C3H/HeJ and BALB/c mice of both sexes. Bone marrow stromal cells from female FVB, C57BL/6 and C3H/HeJ mice exhibited lower Alpl and Osteocalcin expression and alkaline phosphatase activity, and formed fewer mineralized nodules than cells from male littermates. Proliferative capacity was greater in cells from male than female C57BL/6, but not FVB, mice. Sorting of bone marrow stromal cells from mice expressing an alpha-Smooth muscle actin-green fluorescent protein transgene, revealed a higher yield of mesenchymal stem cells in cultures from male mice than in those from female littermates. Sex had a modest impact on osteoblastic differentiation of mesenchymal stem cells. To determine the influence of sex and genetic factors on osteoblast function, calvarial osteoblasts were harvested from C57BL/6, FVB, C3H/HeJ and BALB/c mice. Alpl expression and activity were lower in osteoblasts from C57BL/6 and C3H/HeJ, but not FVB or BALB/c, female mice than in cells from littermates. Sex had no effect on osteoclastogenesis of bone marrow cultures of C57BL/6 mice, but osteoblasts from female mice exhibited higher Rankl and lower Opg expression than cells from male littermates. In conclusion, osteoblastogenesis is sexually dimorphic and influenced by genetic factors.	[Zanotti, Stefano; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Ctr Hlth, Farmington, CT USA; [Kalajzic, Ivo] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT USA; [Aguila, Hector Leonardo] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA	Saint Francis Hospital & Medical Center; University of Connecticut; University of Connecticut; University of Connecticut	Zanotti, S (corresponding author), St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA.	szanotti@stfranciscare.org			Arthritis Foundation [5371]; National Institute of Diabetes, Digestive and Kidney Diseases [DK045227]; National Institute of Arthritis Musculoskeletal and Skin Diseases [AR021707, AR063049, AR055607]; National Heart, Lung, and Blood Institute, National Institutes of Health [HL100569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063049, R37AR021707, R01AR055607, R01AR021707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	Arthritis Foundation; National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by a Research Fellowship from the Arthritis Foundation (http://www.arthritis.org/), under Award Number 5371 (S.Z.), Grant from the National Institute of Diabetes, Digestive and Kidney Diseases, under Award Number DK045227 (E. C.), Grants from the National Institute of Arthritis Musculoskeletal and Skin Diseases, under Award Number AR021707, AR063049 (E. C.) and AR055607 (I. K.) and Grant from the National Heart, Lung, and Blood Institute, under Award Number HL100569 (H. L. A.), all part of the National Institutes of Health (http://www.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aksu AE, 2008, ANN PLAS SURG, V60, P306, DOI 10.1097/SAP.0b013e3180621ff0; Arnold AP, 2012, ENDOCRINOLOGY, V153, P2551, DOI 10.1210/en.2011-2134; Beamer WG, 2007, J BONE MINER RES, V22, P1187, DOI 10.1359/JBMR.070419; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Cahill L, 2012, ENDOCRINOLOGY, V153, P2541, DOI 10.1210/en.2011-2167; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; Canalis E, 2005, NEW ENGL J MED, V352, P2014, DOI 10.1056/NEJMe058080; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Canalis E, 2010, ENDOCRINOLOGY, V151, P3490, DOI 10.1210/en.2010-0145; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Corsi KA, 2007, J BONE MINER RES, V22, P1592, DOI 10.1359/JBMR.070702; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; HEFLEY T, 1981, AM J PHYSIOL, V240, pC234, DOI 10.1152/ajpcell.1981.240.5.C234; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; KAPLOW LS, 1955, BLOOD, V10, P1023, DOI 10.1182/blood.V10.10.1023.1023; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Seeman E, 2001, J CLIN ENDOCR METAB, V86, P4576, DOI 10.1210/jc.86.10.4576; Sokal R. R, 1981, BIOMETRY; Strube P, 2009, BONE, V45, P1065, DOI 10.1016/j.bone.2009.08.005; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Wang JW, 1998, ENDOCRINOLOGY, V139, P2605, DOI 10.1210/en.139.5.2605; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; YATES AJ, 1991, J BONE MINER RES, V6, P473; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Zanotti S, 2013, J BIOL CHEM, V288, P21547, DOI 10.1074/jbc.M113.489435; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514	48	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86757	10.1371/journal.pone.0086757	http://dx.doi.org/10.1371/journal.pone.0086757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489784	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000078
J	Abada, PB; Howell, SB				Abada, Paolo B.; Howell, Stephen B.			Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; RETINOIC ACID; MESENCHYMAL TRANSITION; MARKER NANOG; IN-VITRO; EXPRESSION; APOPTOSIS; TUMORS; LINE; CHEMORESISTANCE	Although testicular germ cell tumors are generally quite responsive to treatment with cisplatin, a small fraction of them acquire resistance during therapy. Even when cisplatin treatment is successful the patient is often left with a residual teratoma at the site of the primary tumor suggesting that cisplatin may trigger differentiation in some tumors. Using the human embryonal carcinoma cell line NTera2/D1, we confirmed that exposure to the differentiating agent retinoic acid produced a reduction in pluripotency markers NANOG and POU5F1 (Oct3/4) and an acute concentration-dependent increase in resistance to both cisplatin and paclitaxel that reached as high as 18-fold for cisplatin and 61-fold for paclitaxel within four days. A two day exposure to cisplatin also produced a concentration-dependent decrease in the expression of the NANOG and POU5F1 and increased expression of three markers whose levels increase with differentiation including Nestin, SCG10 and Fibronectin. In parallel, exposure to cisplatin induced up to 6.2-fold resistance to itself and 104-fold resistance to paclitaxel. Paclitaxel did not induce differentiation or resistance to either itself or cisplatin. Neither retinoic acid nor cisplatin induced resistance in cervical or prostate cancer cell lines or other germ cell tumor lines in which they failed to alter the expression of NANOG and POU5F1. Forced expression of NANOG prevented the induction of resistance to cisplatin by retinoic acid. We conclude that cisplatin can acutely induce resistance to itself and paclitaxel by triggering a differentiation response in pluripotent germ cell tumor cells.	[Howell, Stephen B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Howell, SB (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	showell@ucsd.edu			Alex's Lemonade Stand Foundation;  [T32 CA121938];  [R01 CA152185]; NATIONAL CANCER INSTITUTE [T32CA121938, P30CA023100, R01CA152185] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by a grant from the Alex's Lemonade Stand Foundation and grants T32 CA121938 and R01 CA152185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; ANDREWS PW, 1988, BIOCHIM BIOPHYS ACTA, V948, P17, DOI 10.1016/0304-419X(88)90003-0; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Chadalavada Rajendrakumar S. V., 2005, Functional & Integrative Genomics, V5, P59, DOI 10.1007/s10142-005-0132-7; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Choi SC, 2012, J CELL PHYSIOL, V227, P3678, DOI 10.1002/jcp.24076; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; di Pietro A, 2005, INT J BIOCHEM CELL B, V37, P2437, DOI 10.1016/j.biocel.2005.06.014; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gagliardi AR, 2008, CANCER CAUSE CONTROL, V19, P615, DOI 10.1007/s10552-008-9126-9; Gutekunst M, 2013, CANCER RES, V73, P1460, DOI 10.1158/0008-5472.CAN-12-2876; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; HOGAN B, 1977, NATURE, V270, P515, DOI 10.1038/270515a0; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Houldsworth J, 2001, CELL TISSUE RES, V303, P371; Izumiya M, 2012, ANTICANCER RES, V32, P3847; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Katoh M, 2002, INT J MOL MED, V10, P683; KELLAND LR, 1992, CANCER RES, V52, P1710; Lee M, 2012, INT J GYNECOL CANCER, V22, P1489, DOI 10.1097/IGJ.0b013e3182738307; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Looijenga LHJ, 2011, INT J ANDROL, V34, pE234, DOI 10.1111/j.1365-2605.2011.01157.x; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Mayer F, 2003, CLIN CANCER RES, V9, P767; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mueller T, 2006, TUMOR BIOL, V27, P71, DOI 10.1159/000092324; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; PERA MF, 1989, DIFFERENTIATION, V42, P10, DOI 10.1111/j.1432-0436.1989.tb00602.x; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Przyborski SA, 2004, STEM CELLS DEV, V13, P400, DOI 10.1089/1547328041797507; Rocha CRR, 2013, MUTAT RES-REV MUTAT, V752, P25, DOI 10.1016/j.mrrev.2012.09.001; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simonatto M, 2007, J CELL PHYSIOL, V213, P642, DOI 10.1002/jcp.21275; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Timmer-Bosscha H, 1998, CANCER CHEMOTH PHARM, V41, P469, DOI 10.1007/s002800050769; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Werner S, 2013, J BIOL CHEM; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781	51	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87444	10.1371/journal.pone.0087444	http://dx.doi.org/10.1371/journal.pone.0087444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475288	Green Published, gold			2022-12-25	WOS:000330507300183
J	Le, TT; Urasaki, Y; Pizzorno, G				Le, Thuc T.; Urasaki, Yasuyo; Pizzorno, Giuseppe			Uridine Prevents Fenofibrate-Induced Fatty Liver	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; MITOCHONDRIAL PROTEIN HYPERACETYLATION; RAMAN SCATTERING MICROSCOPY; LYSINE ACETYLATION; DEPENDENT DEACETYLASE; BETA-OXIDATION; SIR2 HOMOLOG; METABOLISM; ACID; DISEASE	Uridine, a pyrimidine nucleoside, can modulate liver lipid metabolism although its specific acting targets have not been identified. Using mice with fenofibrate-induced fatty liver as a model system, the effects of uridine on liver lipid metabolism are examined. At a daily dosage of 400 mg/kg, fenofibrate treatment causes reduction of liver NAD(+)/NADH ratio, induces hyper-acetylation of peroxisomal bifunctional enzyme (ECHD) and acyl-CoA oxidase 1 (ACOX1), and induces excessive accumulation of long chain fatty acids (LCFA) and very long chain fatty acids (VLCFA). Uridine co-administration at a daily dosage of 400 mg/kg raises NAD(+)/NADH ratio, inhibits fenofibrate-induced hyper-acetylation of ECHD, ACOX1, and reduces accumulation of LCFA and VLCFA. Our data indicates a therapeutic potential for uridine co-administration to prevent fenofibrate-induced fatty liver.	[Le, Thuc T.; Urasaki, Yasuyo; Pizzorno, Giuseppe] Nevada Canc Inst, Las Vegas, NV USA; [Le, Thuc T.; Urasaki, Yasuyo; Pizzorno, Giuseppe] Desert Res Inst, Las Vegas, NV USA	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Le, TT (corresponding author), Nevada Canc Inst, Las Vegas, NV USA.	thuc@uchicago.edu; giuseppe.pizzorno@dri.edu			Nevada INBRE Program of the National Center for Research Resources [P20RR-016464]; American Cancer Society [IRG-08-062-04]; Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	Nevada INBRE Program of the National Center for Research Resources; American Cancer Society(American Cancer Society); Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Nevada INBRE Program of the National Center for Research Resources (P20RR-016464, TTL), the American Cancer Society (IRG-08-062-04, TTL), and the Vons Breast Cancer Research Award (TTL and GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2006, POSTGRAD MED J, V82, P315, DOI 10.1136/pgmj.2005.042200; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; BALFOUR JA, 1990, DRUGS, V40, P260, DOI 10.2165/00003495-199040020-00007; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brunmair B, 2004, J PHARMACOL EXP THER, V311, P109, DOI 10.1124/jpet.104.068312; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Grieco A, 2005, Eur Rev Med Pharmacol Sci, V9, P261; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249; Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; McKeage K, 2011, DRUGS, V71, P1917, DOI 10.2165/11208090-000000000-00000; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; Samburova V, 2013, J AM OIL CHEM SOC, V90, P53, DOI 10.1007/s11746-012-2138-3; Saydoff JA, 2003, BRAIN RES, V994, P44, DOI 10.1016/j.brainres.2003.09.049; Saydoff JA, 2013, J ALZHEIMERS DIS; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Traut TW, 1996, PROG NUCLEIC ACID RE, V53, P1, DOI 10.1016/S0079-6603(08)60142-7; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Urasaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038418; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yamamoto T, 2011, CLIN CHIM ACTA, V412, P1712, DOI 10.1016/j.cca.2011.06.006; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	61	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87179	10.1371/journal.pone.0087179	http://dx.doi.org/10.1371/journal.pone.0087179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475249	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800089
J	Menon, P; Kiernan, MC; Vucic, S				Menon, Parvathi; Kiernan, Matthew C.; Vucic, Steve			Cortical Dysfunction Underlies the Development of the Split-Hand in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THRESHOLD TRACKING TECHNIQUES; HUMAN PERIPHERAL-NERVE; AXONAL EXCITABILITY PROPERTIES; SILENT PERIOD; INTRACORTICAL INHIBITION; GLUTAMATE TRANSPORTER; MOTOR AXONS; MOUSE MODEL; ALS	The split-hand phenomenon, a specific feature of amyotrophic lateral sclerosis (ALS), refers to preferential wasting of abductor pollicis brevis (APB) and first dorsal interosseous (FDI) with relative preservation of abductor digiti minimi (ADM). The pathophysiological mechanisms underlying the split-hand phenomenon remain elusive and resolution of this issue would provide unique insights into ALS pathophysiology. Consequently, the present study dissected out the relative contribution of cortical and peripheral processes in development of the split-hand phenomenon in ALS. Cortical and axonal excitability studies were undertaken on 26 ALS patients, with motor responses recorded over the APB, FDI and ADM muscles. Results were compared to 21 controls. Short interval intracortical inhibition (SICI), a biomarker of cortical excitability, was significantly reduced across the range of intrinsic hand muscles (APB(SICI ALS) 0.3 +/- 2.0%, APB(SICI controls) 16.0 +/- 1.9%, P<0.0001; FDISICI ALS 2.7 +/- 1.7%, FDI (SICI controls) 14.8 +/- 1.9%, P<0.0001; ADM(SICI ALS) 2.6 +/- 1.5%, ADM (SICI) (controls) 9.7 +/- 2.2%, P<0.001), although the reduction was most prominent when recorded over APB/FDI. Changes in SICI were accompanied by a significant increase in motor evoked potential amplitude and reduction of cortical silent period duration, all indicative of cortical hyperexcitability, and these were most prominent from the APB/FDI. At a peripheral level, a significant increase in strength-duration time constant and reduction in depolarising threshold electrotonus were evident in ALS, although these changes did not follow a split-hand distribution. Cortical dysfunction contributed to development of the split-hand in ALS, thereby implying an importance of cortical hyperexcitability in ALS pathogenesis.	[Menon, Parvathi; Vucic, Steve] Univ Sydney, Sydney Med Sch Westmead, Sydney, NSW 2006, Australia; [Kiernan, Matthew C.; Vucic, Steve] Neurosci Res Australia, Sydney, NSW, Australia; [Kiernan, Matthew C.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia	University of Sydney; Neuroscience Research Australia; University of Sydney	Vucic, S (corresponding author), Univ Sydney, Sydney Med Sch Westmead, Sydney, NSW 2006, Australia.	s.vucic@neura.edu.au	Kiernan, Matthew C/E-4460-2011	Kiernan, Matthew/0000-0001-9054-026X; Vucic, Steve/0000-0002-8323-873X	Motor Neuron Disease Research Institute of Australia [MNDRIA]; National Health and Medical Research Council of Australia [510233, 1024915]	Motor Neuron Disease Research Institute of Australia [MNDRIA]; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding support from the Motor Neuron Disease Research Institute of Australia [MNDRIA], National Health and Medical Research Council of Australia (Project)grant numbers 510233 and 1024915] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1999, J PHYSIOL-LONDON, V514, P895, DOI 10.1111/j.1469-7793.1999.895ad.x; Bae JS, 2013, NEUROSCI LETT, V541, P150, DOI 10.1016/j.neulet.2013.03.003; Bae JS, 2009, MUSCLE NERVE, V39, P350, DOI 10.1002/mus.21107; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Bostock H, 1997, J PHYSIOL-LONDON, V498, P277, DOI 10.1113/jphysiol.1997.sp021857; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Bostock Hugh, 1995, P311; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; CANTELLO R, 1992, NEUROLOGY, V42, P1951; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; EISEN A, 1992, MUSCLE NERVE, V15, P219, DOI 10.1002/mus.880150215; Eisen A, 2012, J NEUROL NEUROSUR PS, V83, P399, DOI 10.1136/jnnp-2011-301456; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; FRIEDMAN AP, 1950, J NERV MENT DIS, V111, P1, DOI 10.1097/00005053-195011110-00001; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kanai K, 2006, BRAIN, V129, P953, DOI 10.1093/brain/awl024; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Komissarow L, 2004, CLIN NEUROPHYSIOL, V115, P356, DOI 10.1016/j.clinph.2003.10.003; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Kuwabara S, 2008, MUSCLE NERVE, V37, P426, DOI 10.1002/mus.20949; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Menon P, 2014, MUSCLE NERVE, V49, P836, DOI 10.1002/mus.24072; Menon P, 2013, CLIN NEUROPHYSIOL, V124, P410, DOI 10.1016/j.clinph.2012.07.025; MILLS KR, 1986, ELECTROEN CLIN NEURO, V63, P582, DOI 10.1016/0013-4694(86)90145-8; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; NIHEI K, 1993, ACTA NEUROPATHOL, V86, P55, DOI 10.1007/BF00454899; OBrien M.D, 2004, AID EXAMINATION PERI, P1; PROUT AJ, 1994, MUSCLE NERVE, V17, P217, DOI 10.1002/mus.880170213; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Shibuya K, 2013, J NEUROL NEUROSUR PS, V84, P969, DOI 10.1136/jnnp-2012-304109; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Stetkarova I, 2012, CLIN NEUROP IN PRESS; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; Vucic S, 2006, MUSCLE NERVE, V33, P477, DOI 10.1002/mus.20481; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; Vucic S, 2006, CLIN NEUROPHYSIOL, V117, P1458, DOI 10.1016/j.clinph.2006.04.016; Vucic S, 2013, J NEUROL NEUROSUR PS, V84, P1161, DOI 10.1136/jnnp-2012-304019; Vucic S, 2013, BRAIN, V136, P1361, DOI 10.1093/brain/awt085; Vucic S, 2011, CLIN NEUROPHYSIOL, V122, P1860, DOI 10.1016/j.clinph.2010.12.062; Vucic S, 2010, J NEUROL NEUROSUR PS, V81, P222, DOI 10.1136/jnnp.2009.183079; Weber M, 2000, J NEUROL SCI, V180, P66, DOI 10.1016/S0022-510X(00)00430-5; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Wilbourn AJ, 2000, MUSCLE NERVE, V23, P138, DOI 10.1002/(SICI)1097-4598(200001)23:1<138::AID-MUS22>3.0.CO;2-7; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	52	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87124	10.1371/journal.pone.0087124	http://dx.doi.org/10.1371/journal.pone.0087124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475241	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800086
J	Seijkens, T; Hoeksema, MA; Beckers, L; Smeets, E; Meiler, S; Levels, J; Tjwa, M; de Winther, MPJ; Lutgens, E				Seijkens, Tom; Hoeksema, Marten A.; Beckers, Linda; Smeets, Esther; Meiler, Svenja; Levels, Johannes; Tjwa, Marc; de Winther, Menno P. J.; Lutgens, Esther			Hypercholesterolemia-induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis	FASEB JOURNAL			English	Article						lipoproteins; inflammation	PROLIFERATION; MONOCYTOSIS; DISEASE; ACCUMULATION; MAINTENANCE; INFECTION; SUBSETS; LESSONS; LESIONS; MICE	Modulation of hematopoietic stem and progenitor cells (HSPCs) determines immune cell function. In this study, we investigated how hypercholesterolemia affects HSPC biology and atherosclerosis. Hypercholesterolemia induced loss of HSPC quiescence, characterized by increased proliferation and expression of cyclin B-1, C-1, and D-1, and a decreased expression of Rb, resulting in a 3.6- fold increase in the number of HSPCs in hypercholesterolemic Ldlr(-/-) mice. Competitive bone marrow (BM) transplantations showed that a hypercholesterolemic BM microenvironment activates HSPCs and skews their development toward myeloid lineages. Conversely, hypercholesterolemia-primed HSPCs acquired an enhanced propensity to generate myeloid cells, especially granulocytes and Ly6C(high) monocytes, even in a normocholesterolemic BM microenvironment. In conformity, macrophages differentiated from hypercholesterolemia-primed HSPCs produced 17.0% more TNF-, 21.3% more IL-6, and 10.5% more MCP1 than did their normocholesterolemic counterparts. Hypercholesterolemia-induced priming of HSPCs generated leukocytes that more readily migrated into the artery, which resulted in a 2.1-fold increase in atherosclerotic plaque size. In addition, these plaques had a more advanced phenotype and exhibited a 1.2-fold increase in macrophages and 1.8-fold increase in granulocytes. These results identify hypercholesterolemia-induced activation and priming of HSPCs as a novel pathway in the development of atherosclerosis. Inhibition of this proinflammatory differentiation pathway on the HSPC level has the potential to reduce atherosclerosis.Seijkens, T., Hoeksema, M. A., Beckers, L., Smeets, E., Meiler, S., Levels, J., Tjwa, M., de Winther, M. P. J., Lutgens, E. Hypercholesterolemia-induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis.	[Seijkens, Tom; Hoeksema, Marten A.; Beckers, Linda; Smeets, Esther; Meiler, Svenja; de Winther, Menno P. J.; Lutgens, Esther] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 CZ Amsterdam, Netherlands; [Levels, Johannes] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 CZ Amsterdam, Netherlands; [Tjwa, Marc] Goethe Univ Frankfurt, Inst Transfus Med, Lab Vasc Hematol Angiogenesis, D-60054 Frankfurt, Germany; [Lutgens, Esther] Univ Munich, Inst Cardiovasc Prevent IPEK, Munich, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Goethe University Frankfurt; University of Munich	Lutgens, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 15, NL-1105 CZ Amsterdam, Netherlands.	e.lutgens@amc.uva.nl	Lutgens, Esther/E-2919-2010	Lutgens, Esther/0000-0002-2609-5744; Seijkens, Tom/0000-0001-6370-1267; Hoeksema, Marten/0000-0001-5981-121X; de Winther, Menno/0000-0002-4038-6636	Dutch Heart Foundation; Netherlands Organization for Scientific Research (NOW); Academisch Medisch Centrum (AMC); Humboldt Foundation; Deutsche Forschungsgemeinschaft [DFG809, SFB 1054]; Netherlands CardioVascular Research Initiative [CVON2011-19]	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO)); Academisch Medisch Centrum (AMC); Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands CardioVascular Research Initiative	This study was supported by the Dutch Heart Foundation (Dr. E. Dekker grant to T. S.; Dr. E. Dekker Established Investigator grant to E. L. and M.P.J.D.W.), the Netherlands Organization for Scientific Research (NOW; Vidi grant to E. L.; Vici grant to E. L.), the Academisch Medisch Centrum (AMC; fellowship to E. L. and M.P.J.D.W.), the Humboldt Foundation (Sofja Kovalevskaja grant to E. L.), and the Deutsche Forschungsgemeinschaft (DFG809 and SFB 1054 to E. L.). The authors acknowledge the support from the Netherlands CardioVascular Research Initiative (participants: the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development, and the Royal Netherlands Academy of Sciences) for the GENIUS project Generating the Best Evidence-Based Pharmaceutical Targets for Atherosclerosis (CVON2011-19).	Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; BARLOW CW, 1990, CARDIOVASC DRUG THER, V4, P1389, DOI 10.1007/BF02018267; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Davis R, 2012, CELL CYCLE, V11, P109, DOI 10.4161/cc.11.1.18473; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Dybedal I, 2001, BLOOD, V98, P1782, DOI 10.1182/blood.V98.6.1782; FELDMAN DL, 1991, ARTERIOSCLER THROMB, V11, P985, DOI 10.1161/01.ATV.11.4.985; Feng Y., 2012, PLOS ONE, V11; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; Kanters E, 2004, BLOOD, V103, P934, DOI 10.1182/blood-2003-05-1450; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kiseleva EP, 2003, B EXP BIOL MED+, V135, P475, DOI 10.1023/A:1024923611004; Kolb-Maurer A, 2004, FEMS IMMUNOL MED MIC, V40, P147, DOI 10.1016/S0928-8244(03)00305-5; Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Matsumoto A, 2013, BBA-GEN SUBJECTS, V1830, P2335, DOI 10.1016/j.bbagen.2012.07.004; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Niu HT, 2013, BLOOD, V121, P1986, DOI 10.1182/blood-2012-05-433755; Oduro KA, 2012, BLOOD, V120, P2203, DOI 10.1182/blood-2011-11-391342; OLIVARES R, 1993, AM J EPIDEMIOL, V137, P49, DOI 10.1093/oxfordjournals.aje.a116601; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Soehnlein O, 2013, TRENDS ENDOCRIN MET, V24, P129, DOI 10.1016/j.tem.2012.10.008; Soehnlein O, 2009, J CELL MOL MED, V13, P4293, DOI 10.1111/j.1582-4934.2009.00965.x; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tjwa M, 2009, J CLIN INVEST, V119, P1008, DOI 10.1172/JCI36010; Tolani S, 2013, ATHEROSCLEROSIS, V229, P79, DOI 10.1016/j.atherosclerosis.2013.03.031; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	41	79	82	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2202	2213		10.1096/fj.13-243105	http://dx.doi.org/10.1096/fj.13-243105			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24481967				2022-12-25	WOS:000335336000023
J	Sawada, H; Oeda, T; Umemura, A; Tomita, S; Hayashi, R; Kohsaka, M; Yamamoto, K; Sudoh, S; Sugiyama, H				Sawada, Hideyuki; Oeda, Tomoko; Umemura, Atsushi; Tomita, Satoshi; Hayashi, Ryutaro; Kohsaka, Masayuki; Yamamoto, Kenji; Sudoh, Shinji; Sugiyama, Hiroshi			Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson's Disease: Case-control Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; PSYCHOSIS QUESTIONNAIRE; COGNITIVE IMPAIRMENT; HALLUCINATIONS; DEMENTIA; DIAGNOSIS; ASSOCIATION; MICROGLIA; MORTALITY	Background: Though infections are associated with psychotic symptoms, whether or not subclinical inflammation is associated with hallucinations is not known in Parkinson's disease (PD). Purpose: To investigate the association of illusions/hallucinations and plasma CRP levels in PD patients without symptomatic infections. Methods: PD patients not diagnosed as having infections were assessed for illusions and hallucinations using the Parkinson Psychosis Questionnaire (PPQ). It comprises four-domain questions: PPQ-A for sleep problems, PPQ-B for hallucinations/illusions, PPQ-C for delusions, and PPQ-D for disorientation. Assigning patients with >= 1 points in the PPQ-B score to be cases and others as controls, the association of hallucinations/illusions and clinical features (age, sex, duration of PD, Unified Parkinson's Disease Rating Scale part 3 (UPDRS-3), Mini-Mental State Examination (MMSE) score, sleep disturbance (PPQ-A score) as well as daily doses of L-Dopa, dopamine agonists, amantadine, and selegiline) were analyzed using a case-control design. Results: A total of 111 patients were examined and plasma CRP levels were <0.1-6.0 mg/L. Hallucinations or illusions were detected in 28 (25.2%). There were significant differences in age, UPDRS-3 score, MMSE score, PPQ-A, daily doses of L-Dopa and dopamine agonists and plasma CRP levels between cases and controls. A multivariate logistic regression model revealed that UPDRS-3 scores and plasma CRP levels were significantly associated with hallucinations/illusions with an adjusted odds ratio of 1.96 (95% confidence interval (CI) 1.20-3.20) per 10 points and 1.57 (95% confidence interval 1.13-2.16) per two-fold, respectively. Dividing patients into thirds by CRP levels (<= 0.2, 0.3-0.6, >= 0.7 mg/L), the prevalence of hallucinations/illusions was 13.2%, 21.6%, and 41.7%, in the bottom-, middle-, and top-thirds, respectively (for trend p=0.012). Conclusions: Subclinical elevation of plasma CRP levels was associated with hallucinations or illusions after adjustment for motor disability, suggesting that subclinical elevations of CRP levels might be an independent risk for hallucinations/illusions.	[Sawada, Hideyuki] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan; Natl Utano Hosp, Dept Neurol, Kyoto, Japan		Sawada, H (corresponding author), Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan.	sawada@unh.hosp.go.jp	Umemura, Atsushi/ABC-4716-2021; Yamamoto, Kenji/AAD-8766-2019	Umemura, Atsushi/0000-0001-8557-6014; Yamamoto, Kenji/0000-0003-1240-6369; Sawada, Hideyuki/0000-0002-5909-3366; Tomita, Satoshi/0000-0003-4410-6539	National Hospital Organization; National Hospital Organization, Japan	National Hospital Organization; National Hospital Organization, Japan	This study was supported by the National Hospital Organization. Drs Sawada, Oeda, Umemura, and Kohsaka have received grant support from National Hospital Organization, Japan. Dr Yamamoto has received a grant-in-aid from the Minister of Education, Science and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2003, CIRCULATION, V108, P161, DOI 10.1161/01.CIR.0000080289.72166.CF; Brandstaedter D, 2005, J NEUROL, V252, P1060, DOI 10.1007/s00415-005-0816-x; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Closhen D, 2010, CYTOKINE, V50, P117, DOI 10.1016/j.cyto.2010.02.011; de Maindreville AD, 2005, MOVEMENT DISORD, V20, P212, DOI 10.1002/mds.20263; Factor SA, 2003, NEUROLOGY, V60, P1756, DOI 10.1212/01.WNL.0000068010.82167.CF; Fenelon G, 2000, BRAIN, V123, P733, DOI 10.1093/brain/123.4.733; Fenelon G, 2010, MOVEMENT DISORD, V25, P763, DOI 10.1002/mds.22839; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Forsaa EB, 2010, ARCH NEUROL-CHICAGO, V67, P996, DOI 10.1001/archneurol.2010.166; Friedman JH, 2010, PARKINSONISM RELAT D, V16, P553, DOI 10.1016/j.parkreldis.2010.05.004; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; GOETZ CG, 1993, NEUROLOGY, V43, P2227, DOI 10.1212/WNL.43.11.2227; Goetz CG, 2001, NEUROLOGY, V57, P2078, DOI 10.1212/WNL.57.11.2078; Graham JM, 1997, J NEUROL NEUROSUR PS, V63, P434, DOI 10.1136/jnnp.63.4.434; Hassin-Baer S, 2011, J NEURAL TRANSM, V118, P539, DOI 10.1007/s00702-010-0535-z; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Lee AH, 2012, MOVEMENT DISORD, V27, P858, DOI 10.1002/mds.25003; Leroi I, 2006, J NEUROL SCI, V248, P104, DOI 10.1016/j.jns.2006.05.021; Li YN, 2008, J NEUROSCI RES, V86, P3556, DOI 10.1002/jnr.21810; Lindqvist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047387; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; Pacchetti C, 2005, MOVEMENT DISORD, V20, P1439, DOI 10.1002/mds.20582; Poewe Werner, 2008, Pract Neurol, V8, P238, DOI 10.1136/jnnp.2008.152579; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Ravina B, 2007, MOVEMENT DISORD, V22, P1061, DOI 10.1002/mds.21382; Sawada H, 2011, EUR J NEUROL, V18, P518; Sawada H, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-145; Sawada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003533; Scalzo P, 2011, NEUROIMMUNOMODULAT, V18, P240, DOI 10.1159/000323779; Scalzo P, 2010, NEUROSCI LETT, V468, P56, DOI 10.1016/j.neulet.2009.10.062; Schrag A, 2006, PARKINSONISM RELAT D, V12, P35, DOI 10.1016/j.parkreldis.2005.06.011; Song IU, 2011, NEUROL SCI, V32, P31, DOI 10.1007/s10072-010-0335-0; Song IU, 2009, EUR NEUROL, V62, P99, DOI 10.1159/000222780; Suvisaari J, 2011, PSYCHIAT RES, V189, P305, DOI 10.1016/j.psychres.2011.07.006; Svetel M, 2012, ACTA NEUROL BELG, V112, P33, DOI 10.1007/s13760-012-0027-z; Voon Valerie, 2005, Adv Neurol, V96, P130; Williams DR, 2005, LANCET NEUROL, V4, P605, DOI 10.1016/S1474-4422(05)70146-0; Xu GL, 2009, J NEUROL SCI, V284, P77, DOI 10.1016/j.jns.2009.04.018	42	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85886	10.1371/journal.pone.0085886	http://dx.doi.org/10.1371/journal.pone.0085886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497930	Green Submitted, gold, Green Published			2022-12-25	WOS:000330621900011
J	Lian, PH; Sun, YF; Ji, ZG; Li, HZ; Peng, JX				Lian, Penghu; Sun, Yunfeng; Ji, Zhigang; Li, Hanzhong; Peng, Jiaxi			Moving Away from Exhaustion: How Core Self-Evaluations Influence Academic Burnout	PLOS ONE			English	Article							JOB-SATISFACTION; LIFE SATISFACTION; WORK SUCCESS; MODELS; PERSONALITY; ENGAGEMENT; MOTIVATION; RESOURCES; STUDENTS; COLLEGE	Background: Academic burnout refers to students who have low interest, lack of motivation, and tiredness in studying. Studies concerning how to prevent academic burnout are rare. Objective: The present study aimed to investigate the impact of core self-evaluations on the academic burnout of university students, and mainly focused on the confirmation of the mediator role of life satisfaction. Methods: A total of 470 university students accomplished the core self-evaluation scale, Satisfaction with Life, and academic burnout scale. Results: Both core self-evaluations and life satisfaction were significantly correlated with academic burnout. Structural equation modeling indicated that life satisfaction partially mediated the relationship between core self-evaluations and academic burnout. Conclusions: Core self-evaluations significantly influence academic burnout and are partially mediated by life satisfaction.	[Lian, Penghu; Ji, Zhigang; Li, Hanzhong] Chinese Acad Med Sci, Dept Urol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Lian, Penghu; Ji, Zhigang; Li, Hanzhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yunfeng] Natl Def Univ, Polit Work Acad Dept, Beijing, Peoples R China; [Peng, Jiaxi] Forth Mil Med Univ, Dept Psychol, Xian, Shaanxi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Air Force Military Medical University	Li, HZ (corresponding author), Chinese Acad Med Sci, Dept Urol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	lihanzhong@medmail.com.cn; pengjx880124@sina.com						Anderson James C., 1988, PSYCHOL BULL, V103, P411, DOI [DOI 10.1037/0033-2909.103.3.411, 10.1037/0033-2909.103.3.411]; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Best RG, 2005, J OCCUP HEALTH PSYCH, V10, P441, DOI 10.1037/1076-8998.10.4.441; BIELBY WT, 1977, ANNU REV SOCIOL, V3, P137, DOI 10.1146/annurev.so.03.080177.001033; Bono JE, 2003, ACAD MANAGE J, V46, P554, DOI 10.2307/30040649; Chamorro-Premuzic T, 2008, LEARN INDIVID DIFFER, V18, P258, DOI 10.1016/j.lindif.2007.09.002; CLOGG CC, 1992, J EDUC STAT, V17, P51, DOI 10.3102/10769986017001051; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Erez A, 2001, J APPL PSYCHOL, V86, P1270, DOI 10.1037/0021-9010.86.6.1270; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Haydock Deborah, 2011, Community Pract, V84, P19; Hobfoll SE, 2002, REV GEN PSYCHOL, V6, P307, DOI 10.1037//1089-2680.6.4.307; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JACOBS SR, 2003, J COLL STUDENT DEV, V44, P291, DOI DOI 10.1353/CSD.2003.0028; Judge TA, 1997, RES ORGAN BEHAV, V19, P151; Judge TA, 1998, J APPL PSYCHOL, V83, P17, DOI 10.1037/0021-9010.83.1.17; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2000, J APPL PSYCHOL, V85, P237, DOI 10.1037//0021-9010.85.2.237; Judge TA, 2008, J APPL PSYCHOL, V93, P849, DOI 10.1037/0021-9010.93.4.849; Judge TA, 2009, J APPL PSYCHOL, V94, P742, DOI 10.1037/a0015497; Judge TA, 2009, CURR DIR PSYCHOL SCI, V18, P58, DOI 10.1111/j.1467-8721.2009.01606.x; KAFRY D, 1980, HUM RELAT, V33, P477, DOI 10.1177/001872678003300703; Kline RB, 1998, J PSYCHOEDUC ASSESS, V16, P343, DOI 10.1177/073428299801600407; Kong Y, 2010, CHINESE J CLIN PSYCH, V19, P234; Lee J, 2010, STRESS HEALTH, V26, P404, DOI 10.1002/smi.1312; [连榕 Lian Rong], 2005, [心理学报, Acta Psychologica Sinica], V37, P632; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Ng TWH, 2008, J VOCAT BEHAV, V73, P268, DOI 10.1016/j.jvb.2008.05.004; Piccolo RF, 2005, J ORGAN BEHAV, V26, P965, DOI 10.1002/job.358; Ronen S, 2012, EUR J WORK ORGAN PSY, V21, P828, DOI 10.1080/1359432X.2011.595561; Rosopa PJ, 2009, PERS INDIV DIFFER, V47, P1003, DOI 10.1016/j.paid.2009.07.028; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Scott BA, 2009, J APPL PSYCHOL, V94, P20, DOI 10.1037/a0012951; Slivar B., 2001, HORIZONS PSYCHOL, V10, P21; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stumpp T, 2009, EUR J WORK ORGAN PSY, V18, P148, DOI 10.1080/13594320802281110; Taylor AB, 2008, ORGAN RES METHODS, V11, P241, DOI 10.1177/1094428107300344; Tsaousis I, 2007, PERS INDIV DIFFER, V42, P1441, DOI 10.1016/j.paid.2006.10.025; Visser MRM, 2003, CAN MED ASSOC J, V168, P271; Wanberg CR, 2005, J APPL PSYCHOL, V90, P411, DOI 10.1037/0021-9010.90.3.411; Williams J, 2008, STRUCT EQU MODELING, V15, P23, DOI 10.1080/10705510701758166; Yagil D, 2008, INT J SERV IND MANAG, V19, P575, DOI 10.1108/09564230810903479; Yang HJ, 2005, COMPUT HUM BEHAV, V21, P917, DOI 10.1016/j.chb.2004.03.001; Zhang JX, 2014, SOC INDIC RES, V116, P809, DOI 10.1007/s11205-013-0328-5; Zhang YW, 2007, PERS INDIV DIFFER, V43, P1529, DOI 10.1016/j.paid.2007.04.010	48	29	31	8	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87152	10.1371/journal.pone.0087152	http://dx.doi.org/10.1371/journal.pone.0087152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489857	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000109
J	Alistar, SS; Owens, DK; Brandeau, ML				Alistar, Sabina S.; Owens, Douglas K.; Brandeau, Margaret L.			Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES; METHADONE-MAINTENANCE; AFRICAN WOMEN; INFECTION; UKRAINE; TRANSMISSION; MEN; RISK; SEX	Background: Pre-exposure prophylaxis with oral antiretroviral treatment (oral PrEP) for HIV-uninfected injection drug users (IDUs) is potentially useful in controlling HIV epidemics with a significant injection drug use component. We estimated the effectiveness and cost effectiveness of strategies for using oral PrEP in various combinations with methadone maintenance treatment (MMT) and antiretroviral treatment (ART) in Ukraine, a representative case for mixed HIV epidemics. Methods and Findings: We developed a dynamic compartmental model of the HIV epidemic in a population of non-IDUs, IDUs who inject opiates, and IDUs in MMT, adding an oral PrEP program (tenofovir/emtricitabine, 49% susceptibility reduction) for uninfected IDUs. We analyzed intervention portfolios consisting of oral PrEP (25% or 50% of uninfected IDUs), MMT (25% of IDUs), and ART (80% of all eligible patients). We measured health care costs, quality-adjusted life years (QALYs), HIV prevalence, HIV infections averted, and incremental cost effectiveness. A combination of PrEP for 50% of IDUs and MMT lowered HIV prevalence the most in both IDUs and the general population. ART combined with MMT and PrEP (50% access) averted the most infections (14,267). For a PrEP cost of $950, the most cost-effective strategy was MMT, at $520/QALY gained versus no intervention. The next most cost-effective strategy consisted of MMT and ART, costing $1,000/QALY gained compared to MMT alone. Further adding PrEP (25% access) was also cost effective by World Health Organization standards, at $1,700/QALY gained. PrEP alone became as cost effective as MMT at a cost of $650, and cost saving at $370 or less. Conclusions: Oral PrEP for IDUs can be part of an effective and cost-effective strategy to control HIV in regions where injection drug use is a significant driver of the epidemic. Where budgets are limited, focusing on MMT and ART access should be the priority, unless PrEP has low cost.	[Alistar, Sabina S.; Brandeau, Margaret L.] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Owens, Douglas K.] Vet Affairs Palo Healthcare Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Ctr Hlth Policy, Program Clin Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University	Alistar, SS (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	ssabina@stanford.edu			National Institute on Drug Abuse [R01DA15612]; Department of Veterans Affairs; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Grant Number R01DA15612 from the National Institute on Drug Abuse. Dr. Owens is supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; [Anonymous], 2013, E CAT ARVS; [Anonymous], 2005, SUMM COUNTR PROF HIV; [Anonymous], 2008, GUIDELINES USE ANTIR; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barcal Katerina, 2005, Harm Reduct J, V2, P16, DOI 10.1186/1477-7517-2-16; Booth RE, 2006, AIDS, V20, P2217, DOI 10.1097/QAD.0b013e328010e019; Booth RE, 2006, DRUG ALCOHOL DEPEN, V82, pS49, DOI 10.1016/S0376-8716(06)80009-8; Bruce RD, 2007, INT J DRUG POLICY, V18, P326, DOI 10.1016/j.drugpo.2006.12.011; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Celentano DD, 2008, HIV CENTRAL ASIA TAJ, P557; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Connock M, 2007, METHADONE BUPRENORPH; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Dvoriak S, 2007, 4 IAS C HIV PATH TRE; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gold MR, 1996, COST EFFECTIVENESS H; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; GRONBLADH L, 1989, DRUG ALCOHOL DEPEN, V24, P31, DOI 10.1016/0376-8716(89)90005-7; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; International HIV/AIDS Alliance in Ukraine, 2008, METH SUBST THER STAR; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, UKR NAT REP MON PROG; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, UKR COUNTR SIT FACT; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195; Long EF, 2013, J GEN INT MED; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; MacArthur GJ, BMJ, V345, pe5945; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Health of Ukraine, 2012, UKR HARM AIDS RESP P; Murray C. J., 2002, WORLD HLTH REPORT 20; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Nichols BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059549; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; The World Bank, 2013, GDP PER CAP PPP CURR; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2012, UNAIDS GLOB REP AIDS; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008, EP FACTSH HIV AIDS C; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; WHO, 2013, DAT HIV AIDS RESP AN; WHO, 2003, MAKING CHOICES HLTH; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2009, GLOB PRIC REP MECH; World Health Organization, 2006, ANT THER HIV INF AD; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zaric GS, 2000, MANAGE SCI, V46, P1013, DOI 10.1287/mnsc.46.8.1013.12025	62	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86584	10.1371/journal.pone.0086584	http://dx.doi.org/10.1371/journal.pone.0086584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489747	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000062
J	Ashlock, BM; Ma, Q; Issac, B; Mesri, EA				Ashlock, Brittany M.; Ma, Qi; Issac, Biju; Mesri, Enrique A.			Productively Infected Murine Kaposi's Sarcoma-Like Tumors Define New Animal Models for Studying and Targeting KSHV Oncogenesis and Replication	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; GENE-EXPRESSION; HERPESVIRUS REPLICATION; VASCULAR-PERMEABILITY; ENDOTHELIAL-CELLS; PRECURSOR CELLS; DNA-SEQUENCES; DOUBLE-BLIND; STEM-CELLS; IN-VIVO	Kaposi's sarcoma (KS) is an AIDS-defining cancer caused by the KS-associated herpesvirus (KSHV). KS tumors are composed of KSHV-infected spindle cells of vascular origin with aberrant neovascularization and erythrocyte extravasation. KSHV genes expressed during both latent and lytic replicative cycles play important roles in viral oncogenesis. Animal models able to recapitulate both viral and host biological characteristics of KS are needed to elucidate oncogenic mechanisms, for developing targeted therapies, and to trace cellular components of KS ontogeny. Herein, we describe two new murine models of Kaposi's sarcoma. We found that murine bone marrow-derived cells, whether established in culture or isolated from fresh murine bone marrow, were infectable with rKSHV.219, formed KS-like tumors in immunocompromised mice and produced mature herpesvirus-like virions in vivo. Further, we show in vivo that the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA/Vorinostat) enhanced viral lytic reactivation. We propose that these novel models are ideal for studying both viral and host contributions to KSHV-induced oncogenesis as well as for testing virally-targeted antitumor strategies for the treatment of Kaposi's sarcoma. Furthermore, our isolation of bone marrow-derived cell populations containing a cell type that, when infected with KSHV, renders a tumorigenic KS-like spindle cell, should facilitate systematic identification of KS progenitor cells.	[Ashlock, Brittany M.; Ma, Qi; Mesri, Enrique A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Ashlock, Brittany M.; Ma, Qi; Mesri, Enrique A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Ashlock, Brittany M.; Ma, Qi; Mesri, Enrique A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Viral Oncol Program, Miami, FL 33136 USA; [Issac, Biju] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Div Bioinformat,Biostat & Bioinformat Core, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Mesri, EA (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami Ctr AIDS Res, Miami, FL 33136 USA.	emesri@med.miami.edu		Issac, Biju/0000-0002-7311-678X	National Institutes of Health (NIH) [CA75918, CA136387]; National Cancer Institute/Office of HIV and AIDS Malignancy (NCI/OHAM) from Miami CFAR; Miami CFAR Grant [5P30AI073961]; Florida Biomedical Foundation BankHead Coley Grant [3BB05]; NATIONAL CANCER INSTITUTE [R01CA136387, R01CA075918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute/Office of HIV and AIDS Malignancy (NCI/OHAM) from Miami CFAR; Miami CFAR Grant; Florida Biomedical Foundation BankHead Coley Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants CA75918 and CA136387, by National Cancer Institute/Office of HIV and AIDS Malignancy (NCI/OHAM) supplements from the Miami CFAR grant, and by the Miami CFAR Grant 5P30AI073961, and by a Florida Biomedical Foundation BankHead Coley Grant 3BB05 to EAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austgen K, 2012, J VIROL, V86, P1877, DOI 10.1128/JVI.06600-11; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bhatt S, 2013, J CLIN INVEST, V123, P2616, DOI 10.1172/JCI64503; Bogoslovsky T, 2010, NEUROLOGY, V75, P2059, DOI 10.1212/WNL.0b013e318200d741; Cancian L, 2013, TRENDS CELL BIOL, V23, P421, DOI 10.1016/j.tcb.2013.04.001; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; Casper C, 2004, BLOOD, V103, P1632, DOI 10.1182/blood-2003-05-1721; Casper C, 2008, J INFECT DIS, V198, P23, DOI 10.1086/588820; Cattelan Anna M, 2002, Am J Clin Dermatol, V3, P451, DOI 10.2165/00128071-200203070-00002; Chang H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000606; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Choi YB, 2008, J VIROL, V82, P6501, DOI 10.1128/JVI.02396-07; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Cooley T, 2007, ONCOLOGIST, V12, P114, DOI 10.1634/theoncologist.12-1-114; Cornali E, 1996, AM J PATHOL, V149, P1851; Della Bella S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001520; Dittmer D, 1999, J EXP MED, V190, P1857, DOI 10.1084/jem.190.12.1857; Fonseca AV, 2008, BLOOD CELL MOL DIS, V41, P194, DOI 10.1016/j.bcmd.2008.04.004; Fu DX, 2008, NAT MED, V14, P1118, DOI 10.1038/nm.1864; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Ghosh SK, 2012, BLOOD, V119, P1008, DOI 10.1182/blood-2011-06-362434; GOTTLIEB GJ, 1981, AM J DERMATOPATH, V3, P111, DOI 10.1097/00000372-198100320-00002; Grayson W, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-31; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530; Krishnan HH, 2005, J VIROL, V79, P10952, DOI 10.1128/JVI.79.17.10952-10967.2005; Lee HR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00044; Leung HJ, 2012, ANTIMICROB AGENTS CH, V56, P5794, DOI 10.1128/AAC.01126-12; Liu R, 2010, BLOOD, V115, P887, DOI 10.1182/blood-2009-08-236745; Ma T, 2010, P NATL ACAD SCI USA, V107, P14363, DOI 10.1073/pnas.1001065107; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; Maskew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064392; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Moses AV, 1999, J VIROL, V73, P6892, DOI 10.1128/JVI.73.8.6892-6902.1999; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Nguyen HQ, 2008, AIDS, V22, P937, DOI 10.1097/QAD.0b013e3282ff6275; Orenstein JM, 1997, AIDS, V11, pF35, DOI 10.1097/00002030-199705000-00001; Parsons CH, 2004, BLOOD, V104, P2736, DOI 10.1182/blood-2004-02-0693; Parsons CH, 2006, J CLIN INVEST, V116, P1963, DOI 10.1172/JCI27249; Paul AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024379; Perrine SR, 2007, BLOOD, V109, P2571, DOI 10.1182/blood-2006-01-024703; Picchio GR, 1997, VIROLOGY, V238, P22, DOI 10.1006/viro.1997.8822; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Simonart T, 2000, BRIT J DERMATOL, V143, P557, DOI 10.1111/j.1365-2133.2000.03709.x; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staudt MR, 2004, CANCER RES, V64, P4790, DOI 10.1158/0008-5472.CAN-03-3835; Sternbach George, 1995, Journal of Emergency Medicine, V13, P671, DOI 10.1016/0736-4679(95)00077-N; Sullivan RJ, 2009, BIODRUGS, V23, P69, DOI 10.2165/00063030-200923020-00001; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697; Yakushko Y, 2011, J VIROL, V85, P4612, DOI 10.1128/JVI.02068-10; Yu XZ, 2011, CURR COLORECT CANC R, V7, P253, DOI 10.1007/s11888-011-0106-1; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002	58	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87324	10.1371/journal.pone.0087324	http://dx.doi.org/10.1371/journal.pone.0087324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489895	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000128
J	Cunniff, J; Wilkinson, S; Charles, M; Jones, G; Rees, M; Osborne, CP				Cunniff, Jennifer; Wilkinson, Sarah; Charles, Michael; Jones, Glynis; Rees, Mark; Osborne, Colin P.			Functional Traits Differ between Cereal Crop Progenitors and Other Wild Grasses Gathered in the Neolithic Fertile Crescent	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; NET ASSIMILATION RATE; SEED SIZE; LEAF-AREA; TRADE-OFFS; PLANT SIZE; OHALO-II; DOMESTICATION; ORIGINS; MASS	The reasons why some plant species were selected as crops and others were abandoned during the Neolithic emergence of agriculture are poorly understood. We tested the hypothesis that the traits of Fertile Crescent crop progenitors were advantageous in the fertile, disturbed habitats surrounding early settlements and in cultivated fields. We screened functional traits related to competition and disturbance in a group of grass species that were increasingly exploited by early plant gatherers, and that were later domesticated (crop progenitors); and in a set of grass species for which there is archaeological evidence of gathering, but which were never domesticated (wild species). We hypothesised that crop progenitors would have greater seed mass, growth rate, height and yield than wild species, as these traits are indicative of greater competitive ability, and that crop progenitors would be more resilient to defoliation. Our results show that crop progenitors have larger seed mass than wild species, germinate faster and have greater seedling size. Increased seed size is weakly but positively correlated with a higher growth rate, which is primarily driven by greater biomass assimilation per unit leaf area. Crop progenitors also tend to have a taller stature, greater grain yield and higher resilience to defoliation. Collectively, the data are consistent with the hypothesis that adaptations to competition and disturbance gave crop progenitors a selective advantage in the areas surrounding early human settlements and in cultivated environments, leading to their adoption as crops through processes of unconscious selection.	[Cunniff, Jennifer; Wilkinson, Sarah; Rees, Mark; Osborne, Colin P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Charles, Michael] Univ Oxford, Sch Archaeol, Oxford, England; [Jones, Glynis] Univ Sheffield, Dept Archaeol, Sheffield, S Yorkshire, England	University of Sheffield; University of Oxford; University of Sheffield	Cunniff, J (corresponding author), Rothamsted Res, Dept Agroecol, Harpenden, Herts, England.	jennifer.cunniff@rothamsted.ac.uk		Swarbrick, Jennifer/0000-0003-3669-3665	University of Sheffield; NERC [NE/H022716/1]; ERC [269830-EOA]; Natural Environment Research Council [NE/H022716/1] Funding Source: researchfish	University of Sheffield; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a post graduate scholarship from the University of Sheffield to Jennifer Cunniff; a NERC standard grant (NE/H022716/1) awarded to Colin P Osborne, Glynis Jones and Michael Charles; and an ERC advanced research grant (269830-EOA) awarded to Glynis Jones. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2005, GENET RESOUR CROP EV, V52, P491, DOI 10.1007/s10722-004-7069-x; Anderson E, 1952, MANS ROLE CHANGING F, P763; [Anonymous], 1999, PREHISTORY FOOD APPE; ARMSTRONG DP, 1993, ECOLOGY, V74, P1092, DOI 10.2307/1940479; Asouti E, 2013, CURR ANTHROPOL, V54, P299, DOI 10.1086/670679; Blackman VH, 1919, ANN BOT-LONDON, V33, P353, DOI 10.1093/oxfordjournals.aob.a089727; BLUMLER MA, 1991, CURR ANTHROPOL, V32, P23, DOI 10.1086/203912; Cohen MN, 2009, CURR ANTHROPOL, V50, P591, DOI 10.1086/603548; Colledge S, 1998, ORIGINS AGR CROP DOM, P121; Darwin Charles R, 1875, VARIATION ANIMALS PL, Vsecond; Engelbrecht T.H., 1916, GEOGR Z, V22, P328; Fairbairn A, 2007, VEG HIST ARCHAEOBOT, V16, P467, DOI 10.1007/s00334-006-0069-3; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Fuller DQ, 2010, WORLD ARCHAEOL, V42, P13, DOI 10.1080/00438240903429680; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; HAMMER K, 1984, Kulturpflanze, V32, P11; HARLAN JR, 1965, EUPHYTICA, V14, P173, DOI 10.1007/BF00038984; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Harlan JR, 1992, CROPS MAN; Harms KE, 1997, J TROP ECOL, V13, P617, DOI 10.1017/S0266467400010750; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hawkes J. G., 1969, The domestication and exploitation of plants and animals., P17; Hayden B, 2009, CURR ANTHROPOL, V50, P597, DOI 10.1086/605110; Hendry GAF, 1993, METHODS COMP PLANT E, P9; Hewitt E. J., 1966, Technical Communications. Commonwealth Bureau of Horticulture and Plantation Crops, P547; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; Hunt R, 1997, NEW PHYTOL, V135, P395, DOI 10.1046/j.1469-8137.1997.00671.x; Kidson R, 2000, OECOLOGIA, V125, P11, DOI 10.1007/PL00008882; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Leibniz-Institut Fur Pflanzengenetik und Kulturpflanzenforschung (IPK), 2013, GEN INT IPK GAT; Li Q, 2010, THEOR APPL GENET, V120, P753, DOI 10.1007/s00122-009-1196-x; MARANON T, 1993, FUNCT ECOL, V7, P591, DOI 10.2307/2390136; Metcalf CJE, 2006, FUNCT ECOL, V20, P217, DOI 10.1111/j.1365-2435.2006.01084.x; Nesbitt M., 2002, DAWN FARMING NEAR E, P113; Noy-Meir I, 2002, J APPL ECOL, V39, P259, DOI 10.1046/j.1365-2664.2002.00707.x; POORTER H, 1989, PHYSIOL PLANTARUM, V75, P237, DOI 10.1111/j.1399-3054.1989.tb06175.x; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Poorter L, 2005, OECOLOGIA, V142, P378, DOI 10.1007/s00442-004-1732-y; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Rees M, 2010, AM NAT, V176, pE152, DOI 10.1086/657037; RINDOS D, 1980, CURR ANTHROPOL, V21, P751, DOI 10.1086/202569; Rindos D., 1984, ORIGINS AGR EVOLUTIO; Rose KE, 2009, ECOL LETT, V12, P1379, DOI 10.1111/j.1461-0248.2009.01394.x; Ryser R, 2001, PLANT BIOLOGY, V3, P426; Savard M., 2003, PALEORIENT, V29, P93, DOI [DOI 10.3406/paleo.2003.4756, DOI 10.3406/PALEO.2003.4756]; Savard M, 2006, WORLD ARCHAEOL, V38, P179, DOI 10.1080/00438240600689016; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Shipley B, 2002, FUNCT ECOL, V16, P682, DOI 10.1046/j.1365-2435.2002.00672.x; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Taylor SH, 2010, NEW PHYTOL, V185, P780, DOI 10.1111/j.1469-8137.2009.03102.x; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Thompson K, 2001, SEED SCI RES, V11, P345; Tilman D., 1998, PLANT STRATEGIES DYN; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Turnbull LA, 2008, ECOLOGY, V89, P1352, DOI 10.1890/07-1531.1; Turnbull LA, 2012, ECOLOGY, V93, P1283, DOI 10.1890/11-0261.1; Van Zeist W., 1984, PALAEOHISTORIA, V26, P171; Vesk PA, 2004, FUNCT ECOL, V18, P939, DOI 10.1111/j.0269-8463.2004.00899.x; Vesk PA, 2004, OIKOS, V107, P72, DOI 10.1111/j.0030-1299.2004.13122.x; Vesk PA, 2004, OIKOS, V106, P200, DOI 10.1111/j.0030-1299.2004.13204.x; Vesk PA, 2006, J ECOL, V94, P1027, DOI 10.1111/j.1365-2745.2006.01154.x; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Weiss E, 2004, ECON BOT, V58, pS125, DOI 10.1663/0013-0001(2004)58[S125:SWGASF]2.0.CO;2; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zeder MA, 2009, J ARCHAEOL RES, V17, P1, DOI 10.1007/s10814-008-9025-3	76	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87586	10.1371/journal.pone.0087586	http://dx.doi.org/10.1371/journal.pone.0087586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489941	gold, Green Accepted, Green Published			2022-12-25	WOS:000330510000144
J	Jin, XL; Feng, HK; Zhu, XK; Li, ZH; Song, SN; Song, XY; Yang, GJ; Xu, XG; Guo, WS				Jin, Xiu-liang; Feng, Hai-kuan; Zhu, Xin-kai; Li, Zhen-hai; Song, Sen-nan; Song, Xiao-yu; Yang, Gui-jun; Xu, Xin-gang; Guo, Wen-shan			Assessment of the AquaCrop Model for Use in Simulation of Irrigated Winter Wheat Canopy Cover, Biomass, and Grain Yield in the North China Plain	PLOS ONE			English	Article							WATER-USE EFFICIENCY; FAO CROP MODEL; SUPPLEMENTAL IRRIGATION; PRODUCTIVITY; MANAGEMENT; DEFICIENT; PARAMETERIZATION; OPTIMIZATION; ADAPTATION; STRESS	Improving winter wheat water use efficiency in the North China Plain (NCP), China is essential in light of current irrigation water shortages. In this study, the AquaCrop model was used to calibrate, and validate winter wheat crop performance under various planting dates and irrigation application rates. All experiments were conducted at the Xiaotangshan experimental site in Beijing, China, during seasons of 2008/2009, 2009/2010, 2010/2011 and 2011/2012. This model was first calibrated using data from 2008/2009 and 2009/2010, and subsequently validated using data from 2010/2011 and 2011/2012. The results showed that the simulated canopy cover (CC), biomass yield (BY) and grain yield (GY) were consistent with the measured CC, BY and GY, with corresponding coefficients of determination (R-2) of 0.93, 0.91 and 0.93, respectively. In addition, relationships between BY, GY and transpiration (T), (R-2 = 0.57 and 0.71, respectively) was observed. These results suggest that frequent irrigation with a small amount of water significantly improved BY and GY. Collectively, these results indicate that the AquaCrop model can be used in the evaluation of various winter wheat irrigation strategies. The AquaCrop model predicted winter wheat CC, BY and GY with acceptable accuracy. Therefore, we concluded that AquaCrop is a useful decision-making tool for use in efforts to optimize wheat winter planting dates, and irrigation strategies.	[Jin, Xiu-liang; Zhu, Xin-kai; Song, Sen-nan; Guo, Wen-shan] Yangzhou Univ, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Peoples R China; [Jin, Xiu-liang; Feng, Hai-kuan; Li, Zhen-hai; Song, Sen-nan; Song, Xiao-yu; Yang, Gui-jun; Xu, Xin-gang] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Jin, Xiu-liang; Feng, Hai-kuan; Li, Zhen-hai; Song, Sen-nan; Song, Xiao-yu; Yang, Gui-jun; Xu, Xin-gang] Natl Engn Res Ctr Informat Technol Agr, Beijing, Peoples R China	Yangzhou University; Beijing Academy of Agriculture & Forestry; Beijing Academy of Agriculture & Forestry	Xu, XG (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China.	xxgpaper@126.com; guows@yzu.edu.cn	Jin, Xiuliang/L-2802-2019; Li, Zhenhai/AAU-3396-2020; Song, xiaoyu/AHE-19540-2022	Jin, Xiuliang/0000-0003-2720-6247; Li, Zhenhai/0000-0001-9878-3274; Xu, Xingang/0000-0002-8473-5631; Feng, Haikuan/0000-0003-3312-6200; Yang, Guijun/0000-0002-6425-8321	National Natural Science Foundation of China [41001244, 41271415]; Beijing Nova Program [2011036]; 8th Six Talents Peak Project of Jiangsu Province [2011-NY039]; Key Projects in the National Science & Technology Pillar Program [2012BAH27B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); 8th Six Talents Peak Project of Jiangsu Province; Key Projects in the National Science & Technology Pillar Program	The National Natural Science Foundation of China (Grant No. 41001244, 41271415), Beijing Nova Program (Grant No. 2011036), the 8th Six Talents Peak Project of Jiangsu Province (2011-NY039) and the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (Grant No. 2012BAH27B04). The authors are grateful to Mr. Weiguo Li, Mrs. Zhihong Ma and Hong Chang for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedinpour M, 2012, AGR WATER MANAGE, V110, P55, DOI 10.1016/j.agwat.2012.04.001; Abrha B, 2012, EXP AGR, V48, P252, DOI 10.1017/S0014479711001190; Ali MH, 2008, AGR WATER MANAGE, V95, P1201, DOI 10.1016/j.agwat.2008.06.008; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Anac M. S., 1999, Crop yield response to deficit irrigation., P196; Araya A, 2010, AGR WATER MANAGE, V97, P1838, DOI 10.1016/j.agwat.2010.06.021; Araya A, 2010, FIELD CROP RES, V116, P196, DOI 10.1016/j.fcr.2009.12.010; Behera SK, 2009, AGR WATER MANAGE, V96, P1532, DOI 10.1016/j.agwat.2009.06.016; Blank H., 1975, THESIS COLORADO STAT; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Dawney Z., 1972, J IRR DRAIN DIV-ASCE, V98, P107, DOI [10.1061/JRCEA4.0000853, DOI 10.1061/JRCEA4.0000853]; De Nys E, 2001, P 4 INT REG C ENV WA, P235; DE WIT C. T., 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Trebon, [Czechoslovakia], 14-21 September, 1969, P17; Debaeke P, 2004, EUR J AGRON, V21, P433, DOI 10.1016/j.eja.2004.07.006; deVries F. W. T.Penning, 1989, SIMULATION MONOGRAPH, P82; Doorenbos J., 1979, YIELD RESPONSE WATER; Fang QuanXiao, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P34; FAO, 2009, EVAP REF SURF; Farahani HJ, 2009, AGRON J, V101, P469, DOI 10.2134/agronj2008.0182s; Farre I, 2009, AGR WATER MANAGE, V96, P383, DOI 10.1016/j.agwat.2008.07.002; Garcia-Vila M, 2009, AGRON J, V101, P477, DOI 10.2134/agronj2008.0179s; Garcia-Vila M, 2012, EUR J AGRON, V36, P21, DOI 10.1016/j.eja.2011.08.003; Geerts S, 2009, AGRON J, V101, P499, DOI 10.2134/agronj2008.0137s; Hedge DM, 1987, HORTIC SCI, V62, P507; Heng LK, 2009, AGRON J, V101, P488, DOI 10.2134/agronj2008.0029xs; Hill R. W., 1996, Water Reports, P69; Hsiao TC, 2009, AGRON J, V101, P448, DOI 10.2134/agronj2008.0218s; JENSEN M. E., 1968, Water Deficits and Plant Growth., V2, P1; Kang ShaoZhong, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P1; Kar G, 2006, AGR WATER MANAGE, V79, P280, DOI 10.1016/j.agwat.2005.03.001; Karunaratne AS, 2011, EXP AGR, V47, P509, DOI 10.1017/S0014479711000111; Katerji N, 2013, AGR WATER MANAGE, V130, P14, DOI 10.1016/j.agwat.2013.08.005; KIPKORIR EC, 2002, THESIS KU LEUVEN U B; Legesse A, 2006, THESIS KU LEUVEN U L; Li ZiZhong, 2011, Journal of China Agricultural University, V16, P59; MINHAS BS, 1974, WATER RESOUR RES, V10, P383, DOI 10.1029/WR010i003p00383; Molden D, 2003, COMP ASSESS WAT MAN, V1, P1, DOI 10.1079/9780851996691.0001; Oweis T, 2006, AGR WATER MANAGE, V80, P57, DOI 10.1016/j.agwat.2005.07.004; Raer D, 2010, REFERENCE MANUAL; Raes D., 2000, Irrigation and Drainage Systems, V14, P343, DOI 10.1023/A:1006412031535; Raes D, 2006, AGR WATER MANAGE, V81, P335, DOI 10.1016/j.agwat.2005.04.006; Raes D, 2009, CROP WATER PRODUCTIV; Raes D., 2009, AQUACROP FAO CROP MO; RAO NH, 1988, AGR WATER MANAGE, V15, P165, DOI 10.1016/0378-3774(88)90109-6; RAO NH, 1992, AGR WATER MANAGE, V20, P267, DOI 10.1016/0378-3774(92)90002-E; Salemi H, 2011, AFR J AGR RES, V6, P2204; [杜文勇 Du Wenyong], 2011, [农业机械学报, Transactions of the Chinese Society of Agricultural Machinery], V42, P174; Soddu A, 2013, PROCEDIA ENVIRON SCI, V19, P830, DOI 10.1016/j.proenv.2013.06.092; Steduto P, 2009, AGRON J, V101, P426, DOI 10.2134/agronj2008.0139s; Stewart JI, 1976, PRODUCTION FUNCTIONS, P80; Stricevic R, 2011, AGR WATER MANAGE, V98, P1615, DOI 10.1016/j.agwat.2011.05.011; Todorovic M, 2009, AGRON J, V101, P509, DOI 10.2134/agronj2008.0166s; Vanuytrecht E, 2011, AGR FOREST METEOROL, V151, P1753, DOI 10.1016/j.agrformet.2011.07.011; Wang JP, 2001, IRRIG DRAIN, V2, P76; Wang XX, 2013, AGR WATER MANAGE, V129, P95, DOI 10.1016/j.agwat.2013.07.010; Yuan M, 2013, AGR WATER MANAGE, V122, P28, DOI 10.1016/j.agwat.2013.02.006; Zhang HongCheng, 2000, Jiangsu Agricultural Sciences, P2; Zinyengere N, 2011, AGR FOREST METEOROL, V151, P1792, DOI 10.1016/j.agrformet.2011.07.015; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	59	57	61	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86938	10.1371/journal.pone.0086938	http://dx.doi.org/10.1371/journal.pone.0086938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489808	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000090
J	Koningstein, M; van der Bij, AK; de Kraker, MEA; Monen, JC; Muilwijk, J; de Greeff, SC; Geerlings, SE; Leverstein-van Hall, MA				Koningstein, Maike; van der Bij, Akke K.; de Kraker, Marlieke E. A.; Monen, Jos C.; Muilwijk, Jan; de Greeff, Sabine C.; Geerlings, Suzanne E.; Leverstein-van Hall, Maurine A.		ISIS-AR Study Grp	Recommendations for the Empirical Treatment of Complicated Urinary Tract Infections Using Surveillance Data on Antimicrobial Resistance in the Netherlands	PLOS ONE			English	Article							ESCHERICHIA-COLI; UNITED-STATES; SUSCEPTIBILITY; OUTPATIENTS; WOMEN	Background: Complicated urinary tract infections (c-UTIs) are among the most common nosocomial infections and a substantial part of the antimicrobial agents used in hospitals is for the treatment of c-UTIs. Data from surveillance can be used to guide the empirical treatment choices of clinicians when treating c-UTIs. We therefore used nation-wide surveillance data to evaluate antimicrobial coverage of agents for the treatment of c-UTI in the Netherlands. Methods: We included the first isolate per patient of urine samples of hospitalised patients collected by the Infectious Disease Surveillance Information System for Antibiotic Resistance (ISIS-AR) in 2012, and determined the probability of inadequate coverage for antimicrobial agents based on species distribution and susceptibility. Analyses were repeated for various patient groups and hospital settings. Results: The most prevalent bacteria in 27,922 isolates of 23,357 patients were Escherichia coli (47%), Enterococcus spp. (14%), Proteus mirabilis (8%), and Klebsiella pneumoniae (7%). For all species combined, the probability of inadequate coverage was <5% for amoxicillin or amoxicillin-clavulanic acid combined with gentamicin and the carbapenems. When including gram-negative bacteria only, the probability of inadequate coverage was 4.0%, 2.7%, 2.3% and 1.7%, respectively, for amoxicillin, amoxicillin-clavulanic acid, a second or a third generation cephalosporin in combination with gentamicin, and the carbapenems (0.4%). There were only small variations in results among different patient groups and hospital settings. Conclusions: When excluding Enterococcus spp., considered as less virulent, and the carbapenems, considered as last-resort drugs, empirical treatment for c-UTI with the best chance of adequate coverage are one of the studied beta-lactam-gentamicin combinations. This study demonstrates the applicability of routine surveillance data for up-to-date clinical practice guidelines on empirical antimicrobial therapy, essential in patient care given the evolving bacterial susceptibility.	[Koningstein, Maike; van der Bij, Akke K.; de Kraker, Marlieke E. A.; Monen, Jos C.; Muilwijk, Jan; de Greeff, Sabine C.; Leverstein-van Hall, Maurine A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Bij, Akke K.] Reinier Graaf Grp, Dept Med Microbiol, Delft, Netherlands; [Geerlings, Suzanne E.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Leverstein-van Hall, Maurine A.] Bronovo Hosp, Dept Med Microbiol & Infect Prevent, The Hague, Netherlands	Netherlands National Institute for Public Health & the Environment; Reinier de Graaf Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Haaglanden Medical Center; Bronovo Hospital	van der Bij, AK (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	akke.van.der.bij@rivm.nl		de Kraker, Marlieke/0000-0003-0903-8614	Dutch Ministry of Health	Dutch Ministry of Health	ISIS-AR is supported by the Dutch Ministry of Health. This study was conducted as part of our routine work and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos JI, 2005, CLIN MICROBIOL INFEC, V11, P199, DOI 10.1111/j.1469-0691.2004.01057.x; Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; Edson RS, 1999, MAYO CLIN PROC, V74, P519, DOI 10.4065/74.5.519; European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in europe, 2012, ANN REP EUR ANT RES; Fluit AC, 2000, CLIN INFECT DIS, V30, P454, DOI 10.1086/313710; Fridkin SK, 1999, CLIN CHEST MED, V20, P303, DOI 10.1016/S0272-5231(05)70143-X; Geerlings S E, 2006, Ned Tijdschr Geneeskd, V150, P2370; Gonzalez LS, 1998, AM FAM PHYSICIAN, V58, P1811; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Johnson JR, 2004, J INFECT DIS, V190, P1739, DOI 10.1086/425018; Kahlmeter G, 2003, INT J ANTIMICROB AG, V22, pS49, DOI 10.1016/S0924-8579(03)00229-2; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Masterton R, 2008, CLIN INFECT DIS, V47, pS21, DOI 10.1086/590063; Nicolle LE, 2013, CRIT CARE CLIN, V29, P699, DOI 10.1016/j.ccc.2013.03.014; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; Orenstein R, 1999, AM FAM PHYSICIAN, V59, P1225; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Paterson DL, 2000, CLIN INFECT DIS, V30, P473, DOI 10.1086/313719; Pitout JD., 2009, F1000 MED REP, V1; Stichting Werkgroep Antibiotica Beleid & National Insitute for Public Health and the Environment, 2013, NETHM 2013 CONS ANT; Stichting Werkgroep Antibioticabeleid, 2013, OPT ANT POL NETH SWA; van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE466, DOI 10.1111/j.1469-0691.2012.03996.x; van der Kooi TII, 2010, J HOSP INFECT, V75, P168, DOI 10.1016/j.jhin.2009.11.020; Wagenlehner FME, 2006, EUR UROL, V49, P235, DOI 10.1016/j.eururo.2005.12.017; Zuschneid I, 2010, INFECT CONT HOSP EP, V31, P934, DOI 10.1086/655462	29	30	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86634	10.1371/journal.pone.0086634	http://dx.doi.org/10.1371/journal.pone.0086634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489755	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000066
J	Lu, HY; Lu, QX; Gaddipati, S; Kasetti, RB; Wang, W; Pasparakis, M; Kaplan, HJ; Li, QT				Lu, Huayi; Lu, Qingxian; Gaddipati, Subhash; Kasetti, Ramesh Babu; Wang, Wei; Pasparakis, Manolis; Kaplan, Henry J.; Li, Qiutang			IKK2 Inhibition Attenuates Laser-Induced Choroidal Neovascularization	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; ALPHA-INDUCED APOPTOSIS; NECROSIS-FACTOR-ALPHA; MACULAR DEGENERATION; CANCER-CELLS; TRANSCRIPTIONAL REGULATION; INCREASED EXPRESSION; MOUSE MODEL	Choroidal neovascularization (CNV) is aberrant angiogenesis associated with exudative age-related macular degeneration (AMD), a leading cause of blindness in the elderly. Inflammation has been suggested as a risk factor for AMD. The IKK2/NF-kappa B pathway plays a key role in the inflammatory response through regulation of the transcription of cytokines, chemokines, growth factors and angiogenic factors. We investigated the functional role of IKK2 in development of the laser-induced CNV using either Ikk2 conditional knockout mice or an IKK2 inhibitor. The retinal neuronal tissue and RPE deletion of IKK2 was generated by breeding Ikk2(-/flox) mice with Nestin-Cre mice. Deletion of Ikk2 in the retina caused no obvious defect in retinal development or function, but resulted in a significant reduction in laser-induced CNV. In addition, intravitreal or retrobulbar injection of an IKK2 specific chemical inhibitor, TPCA-1, also showed similar inhibition of CNV. Furthermore, in vitro inhibition of IKK2 in ARPE-19 cells significantly reduced heat shock-induced expression of NFKBIA, IL1B, CCL2, VEGFA, PDGFA, HIF1A, and MMP-2, suggesting that IKK2 may regulate multiple molecular pathways involved in laser-induced CNV. The in vivo laser-induced expression of VEGFA, and HIF1A in RPE and choroidal tissue was also blocked by TPCA-1 treatment. Thus, IKK2/NF-kappa B signaling appears responsible for production of pro-inflammatory and pro-angiogenic factors in laser-induced CNV, suggesting that this intracellular pathway may serve as an important therapeutic target for aberrant angiogenesis in exudative AMD.	[Lu, Huayi; Lu, Qingxian; Gaddipati, Subhash; Kasetti, Ramesh Babu; Wang, Wei; Kaplan, Henry J.; Li, Qiutang] Univ Louisville, Sch Med, Dept Ophthalmol, Louisville, KY 40292 USA; [Lu, Huayi; Lu, Qingxian; Gaddipati, Subhash; Kasetti, Ramesh Babu; Wang, Wei; Kaplan, Henry J.; Li, Qiutang] Univ Louisville, Sch Med, Dept Visual Sci, Louisville, KY 40292 USA; [Lu, Qingxian; Gaddipati, Subhash; Li, Qiutang] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Lu, Huayi] Jilin Univ, Hosp 2, Changchun, Jilin Province, Peoples R China; [Pasparakis, Manolis] Univ Cologne, Inst Genet, Cologne, Germany	University of Louisville; University of Louisville; University of Louisville; Jilin University; University of Cologne	Li, QT (corresponding author), Univ Louisville, Sch Med, Dept Ophthalmol, Louisville, KY 40292 USA.	q.li@louisville.edu	Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019; Kasetti, Ramesh Babu/H-5157-2019	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; KASETTI, RAMESH/0000-0001-7874-3988; Gaddipati, Subhash/0000-0002-5323-5466	National Institutes of Health [EY019891, EY021584]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY021584, R01EY019891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY019891 and EY021584 and Ernest & Elizabeth Althose Special Scholar Award to Qiutang Li from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 2012, OPHTH NOV ANT COMB A; Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Bora PS, 2003, P NATL ACAD SCI USA, V100, P2679, DOI 10.1073/pnas.0438014100; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dinh HKB, 2001, PHYSIOL GENOMICS, V7, P3, DOI 10.1152/physiolgenomics.2001.7.1.3; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Grossniklaus HE, 2005, ARCH OPHTHALMOL-CHIC, V123, P914; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haines JL, 2007, P NATL ACAD SCI USA, V104, P16725, DOI 10.1073/pnas.0708151104; Hu WZ, 2005, RETINA-J RET VIT DIS, V25, P1054, DOI 10.1097/00006982-200512000-00015; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; Levine L, 2003, CANCER RES, V63, P3495; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liu J, 2011, J BIOL CHEM, V286, P20991, DOI 10.1074/jbc.M111.226266; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Neuvians TAP, 2005, J BIOTECHNOL, V117, P163, DOI 10.1016/j.jbiotec.2005.01.011; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Shono T, 1996, MOL CELL BIOL, V16, P4231; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yang P, 2004, INVEST OPHTH VIS SCI, V45, P2438, DOI 10.1167/iovs.03-0805; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yasuda M, 2002, AM J PHYSIOL-CELL PH, V282, pC917, DOI 10.1152/ajpcell.00223.2001; Ye F, 2011, J IMMUNOL, V187, P4178, DOI 10.4049/jimmunol.1101201; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	67	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87530	10.1371/journal.pone.0087530	http://dx.doi.org/10.1371/journal.pone.0087530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489934	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000141
J	Oliveira, GF; Oliveira, TRR; Ikejiri, AT; Andraus, MP; Galvao, TF; Silva, MT; Pereira, MG				Oliveira, Geraldo F.; Oliveira, Teresinha R. R.; Ikejiri, Adauto T.; Andraus, Mariela P.; Galvao, Tais F.; Silva, Marcus T.; Pereira, Mauricio G.			Prevalence of Hypertension and Associated Factors in an Indigenous Community of Central Brazil: A Population-Based Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; METABOLIC SYNDROME; BLOOD-PRESSURE; WHITE	Objective: The aim of the present study was to assess the prevalence of hypertension and cardiovascular risk factors among the native indigenous of Jaguapiru village in Dourados, Mato Grosso do Sul, Brazil. Method: A cross-sectional, population-based study was conducted with adult indigenous aged 18 years or more. The subjects' blood pressure was measured twice, and the mean of the two measurements was calculated. Body weight, height, capillary blood glucose and waist circumference were measured. Pregnant women, individuals using glucocorticoids, and non-indigenous villagers and their offspring were excluded. Multivariate regression analyses were conducted on the socio-demographic and clinical independent variables. Interactions between independent variables were also tested. Results: We included 1,608 native indigenous eligible to the research. The prevalence of hypertension was 29.5% (95% CI: 27-31.5), with no significant difference between the genders. For both men and women, diastolic hypertension was more common than systolic hypertension. The prevalence of hypertension was higher among obese, diabetic, and older participants, as well as those who consumed alcohol, had a lower educational level, or had a family history of hypertension. There was no association between hypertension and tobacco smoking or family income. Conclusion: Hypertension among the indigenous from Jaguapiru village was similar to the prevalence in the Brazilians, but may have a more negative effect in such disadvantaged population. The associated factors we found can help drawing prevention policies.	[Oliveira, Geraldo F.; Oliveira, Teresinha R. R.; Ikejiri, Adauto T.] Fed Univ Grande Dourados, Dept Clin Med, Dourados, Brazil; [Andraus, Mariela P.] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil; [Galvao, Tais F.; Pereira, Mauricio G.] Univ Brasilia, Fac Med, Brasilia, DF, Brazil; [Galvao, Tais F.] Univ Fed Amazonas, Getulio Vargas Univ Hosp, Manaus, Amazonas, Brazil; [Silva, Marcus T.] Univ Fed Amazonas, Fac Med, Manaus, Amazonas, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade de Brasilia; Universidade Federal de Amazonas; Universidade Federal de Amazonas	Pereira, MG (corresponding author), Univ Brasilia, Fac Med, Brasilia, DF, Brazil.	mauriciogpereira@gmail.com	Silva, Marcus Tolentino/J-1791-2014; Oliveira, Geraldo Ferreira/A-5831-2018; Galvao, Tais F/E-4317-2010	Silva, Marcus Tolentino/0000-0002-7186-9075; Galvao, Tais F/0000-0003-2072-4834	Federal University of Grande Dourados	Federal University of Grande Dourados	The financing of transport and rapid test strips (glucose oxidase) was sponsored by the Federal University of Grande Dourados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2004, HLTH CONS SMOK REP S; Australian Institute of Health and Welfare, 2019, NO TERR REM AB INV O; Brazil, 2012, VIG BRAZ 2011 TEL SU; Brazilian Society of Cardiology/Brazilian Society of Hypertension/Brazilian Society of Nephrology, 2010, ARQ BRAS CARDIOL S91, P91; Cardoso A M, 2001, Cad Saude Publica, V17, P345, DOI 10.1590/S0102-311X2001000200009; Coimbra Jr. C. E. A., 2003, EPIDEMIOLOGIA SAUDE; Correa TD, 2006, ARQ MED ABC, V31, P91; Costa E de A, 1990, Bull Pan Am Health Organ, V24, P159; Passos VMD, 2006, EPIDEMIOL SERV SAUDE, V15, P35; de Oliveira GF, 2011, ETHNIC DIS, V21, P301; de Oliveira GF, 2011, REV PANAM SALUD PUBL, V29, P315, DOI 10.1590/S1020-49892011000500003; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Ding JZ, 2004, AM J HYPERTENS, V17, P971, DOI 10.1016/j.amjhyper.2004.05.001; Franklin SS, 2013, WHITE COAT HYPERTENS; Gimeno SGA, 2009, J EPIDEMIOL COMMUN H, V63, P299, DOI 10.1136/jech.2008.077966; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Gressler LA SL, 1988, ASPECTOS HIST POVOAM; Guerrero-Romero F, 2000, J HUM HYPERTENS, V14, P555, DOI 10.1038/sj.jhh.1001067; Hayashi T, 2003, CIRCULATION, V108, P1718, DOI 10.1161/01.CIR.0000087597.59169.8D; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hoy WE, 2010, AUST NZ J PUBL HEAL, V34, P11, DOI 10.1111/j.1753-6405.2010.00467.x; IBGE, 2012, CENS DEM 2010 RES GE; International Diabetes Federation, 2013, GLOB GUID TYP 2 DIAB; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kadonaga Y, 2009, PREV MED, V48, P567, DOI 10.1016/j.ypmed.2009.03.018; Matsuzawa Y, 2005, BEST PRACT RES CL EN, V19, P637, DOI 10.1016/j.beem.2005.07.001; Medina-Lezama J, 2008, REV PANAM SALUD PUBL, V24, P169, DOI 10.1590/S1020-49892008000900003; Murphy N J, 1997, Ethn Health, V2, P267; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Rhoades DA, 2007, J AM GERIATR SOC, V55, P87, DOI 10.1111/j.1532-5415.2006.01018.x; Saad M, 2005, THESIS U FEDERAL MAT; Salvo VLMAd, 2009, REV BRAS EPIDEMIOL, V12, P458; Silva L C, 2001, Rev Panam Salud Publica, V10, P152; Stamler J, 2003, J HUM HYPERTENS, V17, P655, DOI 10.1038/sj.jhh.1001608; Waeber B, 2001, J HYPERTENS, V19, pS9; World Health Organization, 2011, NONCOMMUNICABLE DIS; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86278	10.1371/journal.pone.0086278	http://dx.doi.org/10.1371/journal.pone.0086278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489710	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000043
J	Thelemann, C; Eren, RO; Coutaz, M; Brasseit, J; Bouzourene, H; Rosa, M; Duval, A; Lavanchy, C; Mack, V; Mueller, C; Reith, W; Acha-Orbea, H				Thelemann, Christoph; Eren, Remzi Onur; Coutaz, Manuel; Brasseit, Jennifer; Bouzourene, Hanifa; Rosa, Muriel; Duval, Anais; Lavanchy, Christine; Mack, Vanessa; Mueller, Christoph; Reith, Walter; Acha-Orbea, Hans			Interferon-gamma Induces Expression of MHC Class II on Intestinal Epithelial Cells and Protects Mice from Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HEPATICUS-INDUCED COLITIS; INNATE LYMPHOID-CELLS; CD4+ T-CELLS; HELICOBACTER-HEPATICUS; INTERLEUKIN-10-DEFICIENT MICE; IMMUNODEFICIENT MICE; MESSENGER-RNA; IN-VIVO; ANTIGEN	Immune responses against intestinal microbiota contribute to the pathogenesis of inflammatory bowel diseases (IBD) and involve CD4(+) T cells, which are activated by major histocompatibility complex class II (MHCII) molecules on antigen-presenting cells (APCs). However, it is largely unexplored how inflammation-induced MHCII expression by intestinal epithelial cells (IEC) affects CD4(+) T cell-mediated immunity or tolerance induction in vivo. Here, we investigated how epithelial MHCII expression is induced and how a deficiency in inducible epithelial MHCII expression alters susceptibility to colitis and the outcome of colon-specific immune responses. Colitis was induced in mice that lacked inducible expression of MHCII molecules on all nonhematopoietic cells, or specifically on IECs, by continuous infection with Helicobacter hepaticus and administration of interleukin (IL)-10 receptor-blocking antibodies (anti-IL10R mAb). To assess the role of interferon (IFN)-gamma in inducing epithelial MHCII expression, the T cell adoptive transfer model of colitis was used. Abrogation of MHCII expression by nonhematopoietic cells or IECs induces colitis associated with increased colonic frequencies of innate immune cells and expression of proinflammatory cytokines. CD4(+) T-helper type (Th) 1 cells - but not group 3 innate lymphoid cells (ILCs) or Th17 cells - are elevated, resulting in an unfavourably altered ratio between CD4(+) T cells and forkhead box P3 (FoxP3)(+) regulatory T (Treg) cells. IFN-gamma produced mainly by CD4(+) T cells is required to upregulate MHCII expression by IECs. These results suggest that, in addition to its proinflammatory roles, IFN-gamma exerts a critical anti-inflammatory function in the intestine which protects against colitis by inducing MHCII expression on IECs. This may explain the failure of anti-IFN-gamma treatment to induce remission in IBD patients, despite the association of elevated IFN-gamma and IBD.	[Thelemann, Christoph; Eren, Remzi Onur; Coutaz, Manuel; Rosa, Muriel; Duval, Anais; Lavanchy, Christine; Mack, Vanessa; Acha-Orbea, Hans] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Brasseit, Jennifer; Mueller, Christoph] Univ Bern, Inst Pathol, Bern, Switzerland; [Bouzourene, Hanifa] Unilabs Pathol Suisse Romande, Epalinges, Switzerland; [Reith, Walter] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	University of Lausanne; University of Bern; University of Geneva	Acha-Orbea, H (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	hans.acha-orbea@unil.ch	Eren, Remzi Onur/GNW-6605-2022; Mueller, Christoph/F-2233-2014	Eren, Remzi Onur/0000-0003-2795-0156; Mueller, Christoph/0000-0002-3921-8678	Swiss National Science Fellowship [310030_132492]	Swiss National Science Fellowship	The project was funded by a Swiss National Science Fellowship to HAO No 310030_132492, Website: http://www.snf.ch/E/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND PW, 1986, IMMUNOLOGY, V58, P1; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Buning J, 2006, FASEB J, V20, P359, DOI 10.1096/fj.05-4807fje; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cottone M, 2010, EXPERT OPIN INV DRUG, V19, P1147, DOI 10.1517/13543784.2010.510513; Cruickshank SM, 2004, GUT, V53, P678, DOI 10.1136/gut.2003.029967; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dotan I, 2007, AM J PHYSIOL-GASTR L, V292, pG1630, DOI 10.1152/ajpgi.00294.2006; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2003, CANCER RES, V63, P6042; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Framson PE, 1999, GASTROENTEROLOGY, V116, P1054, DOI 10.1016/S0016-5085(99)70008-9; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; KAISERLIAN D, 1989, EUR J IMMUNOL, V19, P1513, DOI 10.1002/eji.1830190827; Krishnan K, 2011, INFLAMM BOWEL DIS, V17, P410, DOI 10.1002/ibd.21316; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Kullberg MC, 2001, INFECT IMMUN, V69, P4232, DOI 10.1128/IAI.69.7.4232-4241.2001; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lee HO, 2000, GASTROENTEROLOGY, V119, P129, DOI 10.1053/gast.2000.8542; Maggio-Price L, 2012, INFLAMM BOWEL DIS; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; MAYER L, 1987, J EXP MED, V166, P1471, DOI 10.1084/jem.166.5.1471; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morrison PJ, 2013, MUCOSAL IMMUNOL, DOI 10.1038/mi.2013.11; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Nakazawa A, 1999, GASTROENTEROLOGY, V117, P536, DOI 10.1016/S0016-5085(99)70446-4; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; SANDERSON IR, 1993, IMMUNOLOGY, V79, P434; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Verdu EF, 2002, AM J PHYSIOL-GASTR L, V283, pG27, DOI 10.1152/ajpgi.00460.2001; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Ward JM, 1996, LAB ANIM SCI, V46, P15; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Westendorf AM, 2009, GUT, V58, P211, DOI 10.1136/gut.2008.151720; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	49	72	72	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86844	10.1371/journal.pone.0086844	http://dx.doi.org/10.1371/journal.pone.0086844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489792	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000083
J	Tzou, WS; Chu, Y; Lin, TY; Hu, CH; Pai, TW; Liu, HF; Lin, HJ; Cases, I; Rojas, A; Sanchez, M; You, ZY; Hsu, MW				Tzou, Wen-Shyong; Chu, Ying; Lin, Tzung-Yi; Hu, Chin-Hwa; Pai, Tun-Wen; Liu, Hsin-Fu; Lin, Han-Jia; Cases, Ildeofonso; Rojas, Ana; Sanchez, Mayka; You, Zong-Ye; Hsu, Ming-Wei			Molecular Evolution of Multiple-Level Control of Heme Biosynthesis Pathway in Animal Kingdom	PLOS ONE			English	Article							ERYTHROID 5-AMINOLEVULINATE SYNTHASE; UROPORPHYRINOGEN-III SYNTHASE; TISSUE-SPECIFIC EXPRESSION; IRON-RESPONSIVE ELEMENT; PHYLOGENETIC ANALYSIS; REGULATORY MOTIF; PORPHOBILINOGEN DEAMINASE; GENOME BROWSER; ALTERNATIVE PROMOTERS; POSITIVE SELECTION	Adaptation of enzymes in a metabolic pathway can occur not only through changes in amino acid sequences but also through variations in transcriptional activation, mRNA splicing and mRNA translation. The heme biosynthesis pathway, a linear pathway comprised of eight consecutive enzymes in animals, provides researchers with ample information for multiple types of evolutionary analyses performed with respect to the position of each enzyme in the pathway. Through bioinformatics analysis, we found that the protein-coding sequences of all enzymes in this pathway are under strong purifying selection, from cnidarians to mammals. However, loose evolutionary constraints are observed for enzymes in which self-catalysis occurs. Through comparative genomics, we found that in animals, the first intron of the enzyme-encoding genes has been co-opted for transcriptional activation of the genes in this pathway. Organisms sense the cellular content of iron, and through iron-responsive elements in the 59 untranslated regions of mRNAs and the intron-exon boundary regions of pathway genes, translational inhibition and exon choice in enzymes may be enabled, respectively. Pathway product (heme)-mediated negative feedback control can affect the transport of pathway enzymes into the mitochondria as well as the ubiquitin-mediated stability of enzymes. Remarkably, the positions of these controls on pathway activity are not ubiquitous but are biased towards the enzymes in the upstream portion of the pathway. We revealed that multiple-level controls on the activity of the heme biosynthesis pathway depend on the linear depth of the enzymes in the pathway, indicating a new strategy for discovering the molecular constraints that shape the evolution of a metabolic pathway.	[Tzou, Wen-Shyong; Chu, Ying] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan; [Lin, Tzung-Yi; Hu, Chin-Hwa; Liu, Hsin-Fu; Lin, Han-Jia; You, Zong-Ye; Hsu, Ming-Wei] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Pai, Tun-Wen] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Cases, Ildeofonso; Rojas, Ana] Inst Predict & Personalized Med Canc IMPPC, Computat Cell Biol Grp, Barcelona, Spain; [Sanchez, Mayka] Inst Predict & Personalized Med Canc IMPPC, Canc & Iron Grp, Barcelona, Spain	National Taiwan Ocean University; National Taiwan Ocean University; National Taiwan Ocean University; Mackay Memorial Hospital	Tzou, WS (corresponding author), Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan.	wstzou@ntou.edu.tw	Rojas, Ana M/D-5777-2011; Liu, Hsin-Fu/AAR-5960-2020; Cases, Ildefonso/C-2998-2008; Rojas, Ana M./I-2882-2019; Sanchez, Mayka/F-5140-2010; Tzou, Wen-Shyong/H-4517-2014; Hu, Chin-Hwa/D-1178-2009; IBIS, BIOINFORMATICA/O-1882-2015	Rojas, Ana M/0000-0003-0750-9099; Liu, Hsin-Fu/0000-0003-0082-2269; Cases, Ildefonso/0000-0002-8784-5174; Rojas, Ana M./0000-0003-0750-9099; Sanchez, Mayka/0000-0002-6499-5989; Tzou, Wen-Shyong/0000-0002-6726-1390; Hu, Chin-Hwa/0000-0001-9582-2303; Lin, Han-Jia/0000-0002-4929-6573	National Science Council, Taiwan, R.O.C. [NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019 -001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019 -001 -]; Center of Excellence for the Oceans, National Taiwan Ocean University	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University	This work was supported by the National Science Council, Taiwan, R.O.C. (Grant Nos. NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019 -001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019 -001 -) and the Center of Excellence for the Oceans, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizencang G, 2000, GENOMICS, V70, P223, DOI 10.1006/geno.2000.6373; Aizencang GI, 2000, J BIOL CHEM, V275, P2295, DOI 10.1074/jbc.275.4.2295; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; BLOOMER JR, 1981, J INVEST DERMATOL, V77, P102, DOI 10.1111/1523-1747.ep12479280; BRENNER DA, 1980, NEW ENGL J MED, V302, P765, DOI 10.1056/NEJM198004033021401; Campbell PK, 2011, LEUKEMIA RES, V35, P1321, DOI 10.1016/j.leukres.2011.05.004; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; Clotault J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038724; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Dailey HA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011676; Dailey TA, 2005, BIOCHEM J, V386, P381, DOI 10.1042/BJ20040570; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Duncan R, 1999, MOL BIOL EVOL, V16, P383, DOI 10.1093/oxfordjournals.molbev.a026119; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frankenberg N, 1999, J MOL BIOL, V289, P591, DOI 10.1006/jmbi.1999.2808; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Graham PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002185; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Jiang J, 2012, BIOCHEM BIOPH RES CO, V421, P274, DOI 10.1016/j.bbrc.2012.03.151; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; KAYA AH, 1994, GENOMICS, V19, P242, DOI 10.1006/geno.1994.1054; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Ma J, 2012, P NATL ACAD SCI USA, V109, P8417, DOI 10.1073/pnas.1120045109; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; Montanucci L, 2011, MOL BIOL EVOL, V28, P813, DOI 10.1093/molbev/msq259; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakanishi T, 2006, CANCER RES, V66, P5007, DOI 10.1158/0008-5472.CAN-05-4572; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Olson-Manning CF, 2013, MOL BIOL EVOL, V30, P14, DOI 10.1093/molbev/mss204; Philip S, 2012, MOL BIOL EVOL, V29, P3887, DOI 10.1093/molbev/mss194; Phillips JD, 2003, EMBO J, V22, P6225, DOI 10.1093/emboj/cdg606; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOENHAUT DS, 1989, NUCLEIC ACIDS RES, V17, P7013, DOI 10.1093/nar/17.17.7013; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Taketani S, 1999, GENE, V227, P117, DOI 10.1016/S0378-1119(99)00011-6; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan JS, 2006, BLOOD, V107, P2557, DOI 10.1182/blood-2005-07-2957; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yang YH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-206; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang L, 2011, HEME BIOL SECRET LIF; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	84	4	4	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86718	10.1371/journal.pone.0086718	http://dx.doi.org/10.1371/journal.pone.0086718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489775	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000075
J	Shigematsu, H; Iida, K; Nakano, M; Chaudhuri, P; Iida, H; Nagayama, K				Shigematsu, Hideki; Iida, Kazuko; Nakano, Masataka; Chaudhuri, Pratima; Iida, Hidetoshi; Nagayama, Kuniaki			Structural Characterization of the Mechanosensitive Channel Candidate MCA2 from Arabidopsis thaliana	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTEIN; ELECTRON-MICROSCOPY; CA2+ INFLUX; CALCIUM; VISUALIZATION; TOMOGRAPHY; TOUCH	mechanosensitive channel. The plasma membrane protein MCA1 and its paralog MCA2 from Arabidopsis thaliana are involved in mechanical stress-induced Ca2+ influx and are thus considered as candidates for such channels or their regulators. Both MCA1 and MCA2 were functionally expressed in Sf9 cells using a baculovirus system in order to elucidate their molecular natures. Because of the abundance of protein in these cells, MCA2 was chosen for purification. Purified MCA2 in a detergent-solubilized state formed a tetramer, which was confirmed by chemical cross-linking. Single-particle analysis of cryo-electron microscope images was performed to depict the overall shape of the purified protein. The three-dimensional structure of MCA2 was reconstructed at a resolution of 26 angstrom from 5,500 particles and appears to comprise a small transmembrane region and large cytoplasmic region.	[Shigematsu, Hideki; Chaudhuri, Pratima; Iida, Hidetoshi; Nagayama, Kuniaki] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Iida, Kazuko] Tokyo Metropolitan Inst Med Sci, Biomembrane Lab, Setagaya Ku, Tokyo 113, Japan; [Nakano, Masataka; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan; [Nagayama, Kuniaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Nagayama, Kuniaki] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Tokyo Metropolitan Institute of Medical Science; Tokyo Gakugei University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Iida, H (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	iida@u-gakugei.ac.jp; nagayama@nips.ac.jp	Iida, Hidetoshi/AAO-5506-2020; Shigematsu, Hideki/E-1052-2017; Nagayama, Kuniaki/O-2522-2018	Shigematsu, Hideki/0000-0003-3951-8651; Chaudhuri (Chattopadhyay), Pratima/0000-0002-5723-4428	Ministry of Education, Culture, Sports, Science, and Technology of Japan [13GS0016, 21026009, 23120509, 25120708]; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Corporation; Scientific Research on Priority Areas [21370017]; Novartis Foundation (Japan) for the Promotion of Science [KEN20-191]; Frontiers of Membrane Protein Research (a Joint Project between the Institute for Protein Research, Osaka University); Okazaki Institute for Integrative Bioscience	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Corporation; Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Novartis Foundation (Japan) for the Promotion of Science(Novartis); Frontiers of Membrane Protein Research (a Joint Project between the Institute for Protein Research, Osaka University); Okazaki Institute for Integrative Bioscience(National Institutes of Natural Sciences (NINS) - Japan)	This study was partly supported by a Grant-in-Aid for Creative Scientiyc Research (No. 13GS0016 to K. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Corporation to K.N. It was also supported by Grants-in-Aid for Scientific Research (B) (No. 21370017 to H.I.) and for Scientific Research on Priority Areas (Nos. 19045009, 21026009, 23120509 and 25120708 to H.I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Novartis Foundation (Japan) for the Promotion of Science (No. KEN20-191 to H.I.); and a grant for the Frontiers of Membrane Protein Research (a Joint Project between the Institute for Protein Research, Osaka University and Okazaki Institute for Integrative Bioscience) to K. N. and H. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Clemens S, 1998, P NATL ACAD SCI USA, V95, P12043, DOI 10.1073/pnas.95.20.12043; Cleverley RM, 2008, MOL MEMBR BIOL, V25, P625, DOI 10.1080/09687680802448530; Dai W, 2013, NATURE, V502, P707, DOI 10.1038/nature12604; Danev R, 2008, J STRUCT BIOL, V161, P211, DOI 10.1016/j.jsb.2007.10.015; Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; DING JP, 1993, PLANT J, V3, P83, DOI 10.1111/j.1365-313X.1993.tb00013.x; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fukuda Y, 2012, J STRUCT BIOL, V177, P484, DOI 10.1016/j.jsb.2011.11.018; Furuichi T, 2012, PLANT SIGNAL BEHAV, V7, P1022, DOI 10.4161/psb.20783; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Hosogi N, 2011, J STRUCT BIOL, V173, P67, DOI 10.1016/j.jsb.2010.08.004; Hosokawa F, 2005, J ELECTRON MICROSC, V54, P317, DOI 10.1093/jmicro/dfi049; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Jensen GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040336; Jimenez-Preitner M, 2011, CELL METAB, V14, P658, DOI 10.1016/j.cmet.2011.08.008; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kurusu T, 2013, TRENDS PLANT SCI, V18, P227, DOI 10.1016/j.tplants.2012.12.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maksaev G, 2012, P NATL ACAD SCI USA, V109, P19015, DOI 10.1073/pnas.1213931109; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Mio K, 2009, STRUCTURE, V17, P266, DOI 10.1016/j.str.2008.12.007; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006; Nagayama Kuniaki, 2009, Biophys Rev, V1, P37, DOI 10.1007/s12551-008-0006-z; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Nakano M, 2011, PLANT CELL PHYSIOL, V52, P1915, DOI 10.1093/pcp/pcr131; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tada T, 2003, J BIOL CHEM, V278, P9647, DOI 10.1074/jbc.M206993200; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; TREWAVAS A, 1994, PLANT MOL BIOL, V26, P1329, DOI 10.1007/BF00016478; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veley KM, 2012, CURR BIOL, V22, P408, DOI 10.1016/j.cub.2012.01.027; Venturi E, 2011, BIOCHEMISTRY-US, V50, P2623, DOI 10.1021/bi1019447; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Yamaguchi M, 2008, J STRUCT BIOL, V162, P271, DOI 10.1016/j.jsb.2008.01.009; Yamanaka T, 2010, PLANT PHYSIOL, V152, P1284, DOI 10.1104/pp.109.147371	47	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87724	10.1371/journal.pone.0087724	http://dx.doi.org/10.1371/journal.pone.0087724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475319	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300211
J	Yang, CC; Iwasaki, W				Yang, Ching-Chia; Iwasaki, Wataru			MetaMetaDB: A Database and Analytic System for Investigating Microbial Habitability	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; RNA GENE DATABASE; FUNCTIONAL-ANALYSIS; METAGENOMICS; PROJECT	MetaMetaDB (http://mmdb.aori.u-tokyo.ac.jp/) is a database and analytic system for investigating microbial habitability, i.e., how a prokaryotic group can inhabit different environments. The interaction between prokaryotes and the environment is a key issue in microbiology because distinct prokaryotic communities maintain distinct ecosystems. Because 16S ribosomal RNA (rRNA) sequences play pivotal roles in identifying prokaryotic species, a system that comprehensively links diverse environments to 16S rRNA sequences of the inhabitant prokaryotes is necessary for the systematic understanding of the microbial habitability. However, existing databases are biased to culturable prokaryotes and exhibit limitations in the comprehensiveness of the data because most prokaryotes are unculturable. Recently, metagenomic and 16S rRNA amplicon sequencing approaches have generated abundant 16S rRNA sequence data that encompass unculturable prokaryotes across diverse environments; however, these data are usually buried in large databases and are difficult to access. In this study, we developed MetaMetaDB (Meta-Metagenomic DataBase), which comprehensively and compactly covers 16S rRNA sequences retrieved from public datasets. Using MetaMetaDB, users can quickly generate hypotheses regarding the types of environments a prokaryotic group may be adapted to. We anticipate that MetaMetaDB will improve our understanding of the diversity and evolution of prokaryotes.	[Yang, Ching-Chia; Iwasaki, Wataru] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	University of Tokyo	Yang, CC (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	chia@aori.u-tokyo.ac.jp; iwasaki@aori.u-tokyo.ac.jp	Iwasaki, Wataru/O-4917-2014	Iwasaki, Wataru/0000-0002-9169-9245; Yang, Ching-chia/0000-0003-0760-9209	CREST Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science [23710231]	CREST Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the CREST Program from the Japan Science and Technology Agency and Grant-in-Aid for Young Scientists (B) [grant number 23710231] from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferrer M, 2005, CURR OPIN BIOTECH, V16, P588, DOI 10.1016/j.copbio.2005.09.001; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kirchman DL, 2012, Processes in Microbial Ecology, P79; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972	40	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87126	10.1371/journal.pone.0087126	http://dx.doi.org/10.1371/journal.pone.0087126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475242	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300146
J	Yu, CH; Yu, CC				Yu, Chuan-Hang; Yu, Cheng-Chia			Photodynamic Therapy with 5-Aminolevulinic acid (ALA) Impairs Tumor Initiating and Chemo-Resistance Property in Head and Neck Cancer-Derived Cancer Stem Cells	PLOS ONE			English	Article							ORAL VERRUCOUS HYPERPLASIA; METASTASIS; APOPTOSIS; NANOG	Background: Head and neck cancer (HNC) ranks the fourth leading malignancy and cancer death in male population in Taiwan. Despite recent therapeutic advances, the prognosis for HNC patients is still dismal. New strategies are urgently needed to improve the chemosensitization to conventional chemotherapeutic drugs and clinical responses of HNC patients. Studies have demonstrated that topical 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) is being used in the treatment of various human premalignant and malignant lesions with some encouraging clinical outcomes. However, the molecular mechanisms of ALA-PDT in the therapeutic effect in HNC tumorigenesis and whether ALA-PDT as chemosensitizer for HNC treatment remain unclear. Accumulating data support cancer stem cells (CSCs) contributes chemoresistance in HNC. Based on the previous studies, the purpose of the study is to investigate the effect of ALA-PDT on CSCs and chemosensitization property in HNC. Methodology/Principal Finding: CSCs marker ALDH1 activity of HNC cells with ALA-PDT treatment as assessed by the Aldefluor assay flow cytometry analysis. Secondary Sphere-forming self-renewal, stemness markers expression, and invasiveness of HNC-CSCs with ALA-PDT treatment were presented. We observed that the treatment of ALA-PDT significantly down-regulated the ALDH1 activity and CD44 positivity of HNC-CSCs. Moreover, ALA-PDT reduced self-renewal property and stemness signatures expression (Oct4 and Nanog) in sphere-forming HNC-CSCs. ALA-PDT sensitized highly tumorigenic HNC-CSCs to conventional chemotherapies. Lastly, synergistic effect of ALA-PDT and Cisplatin treatment attenuated invasiveness/colongenicity property in HNC-CSCs. Conclusion/Significance: Our results provide insights into the clinical prospect of ALA-PDT as a potential chemo-adjuvant therapy against head and neck cancer through eliminating CSCs property.	[Yu, Chuan-Hang; Yu, Cheng-Chia] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yu, Chuan-Hang; Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Yu, CH (corresponding author), Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.	d94422004@ntu.edu.tw; ccyu@csmu.edu.tw			National Science Council [100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 - MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This study is supported by research grant from National Science Council (100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 - MY3).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HM, 2005, LASER SURG MED, V37, P114, DOI 10.1002/lsm.20214; Chen HM, 2004, ORAL ONCOL, V40, P630, DOI 10.1016/j.oraloncology.2003.12.010; Chen HM, 2011, J ORAL PATHOL MED, V40, P483, DOI 10.1111/j.1600-0714.2010.00973.x; Chen YW, 2010, MOL CANCER THER, V9, P2879, DOI 10.1158/1535-7163.MCT-10-0504; Chen YC, 2010, ORAL ONCOL, V46, P158, DOI 10.1016/j.oraloncology.2009.11.007; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Green B, 2013, BRIT J ORAL MAX SURG, V51, P283, DOI 10.1016/j.bjoms.2012.11.011; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hu FW, 2012, MOL NUTR FOOD RES, V56, P1247, DOI 10.1002/mnfr.201200150; Korkaya H, 2010, NAT CELL BIOL, V12, P419, DOI 10.1038/ncb0510-419; Lisnjak IO, 2005, EXP ONCOL, V27, P333; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Lo WL, 2011, J PATHOL, V223, P482, DOI 10.1002/path.2826; Lou PJ, 2004, BRIT J CANCER, V91, P441, DOI 10.1038/sj.bjc.6601993; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-283; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang TH, 2007, ORAL ONCOL, V43, P358, DOI 10.1016/j.oraloncology.2006.04.007; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Yu CC, 2011, J ONCOL, V2011, DOI 10.1155/2011/609259; Yu CC, 2011, ORAL ONCOL, V47, P202, DOI 10.1016/j.oraloncology.2010.12.001; Yu CH, 2008, ORAL ONCOL, V44, P595, DOI 10.1016/j.oraloncology.2007.08.016; Yu CH, 2013, J ORAL PATHOL MED, V42, P257, DOI 10.1111/jop.12007	30	31	33	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87129	10.1371/journal.pone.0087129	http://dx.doi.org/10.1371/journal.pone.0087129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475244	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800087
J	Sanchez-Perez, T; Medema, RH; Lopez-Rivas, A				Sanchez-Perez, T.; Medema, R. H.; Lopez-Rivas, A.			Delaying mitotic exit downregulates FLIP expression and strongly sensitizes tumor cells to TRAIL	ONCOGENE			English	Article						mitotic exit; TRAIL; FLIP; apoptosis; tumor cells	SPINDLE CHECKPOINT; INDUCED APOPTOSIS; CANCER-CELLS; CYCLIN-B; ANAPHASE; RECEPTOR; PHOSPHORYLATION; DEGRADATION; MITOSIS; ARREST	Many of the current antitumor therapeutic strategies are based on the perturbation of the cell cycle, especially during mitosis. Antimitotic drugs trigger mitotic checkpoint activation, mitotic arrest and eventually cell death. However, mitotic slippage represents a major mechanism of resistance to these treatments. In an attempt to circumvent the process of slippage, targeting mitotic exit has been proposed as a better strategy to kill tumor cells. In this study, we show that treatments that induce mitotic checkpoint activation and mitotic arrest downregulate FLICE-like inhibitory protein (FLIP) levels and sensitize several tumor cell lines to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. Interestingly, we also demonstrate that in absence of mitotic checkpoint activation, mitotic arrest induced either by Cdc20 knockdown or overexpression of nondegradable cyclin B is sufficient to induce both FLIP downregulation and sensitivity to TRAIL. In summary, our data suggest that a combination of antimitotic drugs targeting cyclin B degradation and TRAIL might prevent mitotic slippage and allow tumor cells to reach the threshold for apoptosis induction, thereby facilitating tumor suppression.	[Sanchez-Perez, T.; Lopez-Rivas, A.] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain; [Sanchez-Perez, T.; Medema, R. H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Netherlands Cancer Institute	Lopez-Rivas, A (corresponding author), CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Aven Amer Vespucio S-N, Seville 41092, Spain.	abelardo.lopez@cabimer.es	Lopez-Rivas, Abelardo/E-5115-2015	Lopez-Rivas, Abelardo/0000-0002-9351-9690; Medema, Rene/0000-0002-6754-0381	Ministerio de Ciencia e Innovacion [SAF2009-07163, SAF2012-32824]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/0068, RD12/0036/0026]; European Community through the regional development funding program (FEDER); Junta de Andalucia [P09-CVI-4497]; Ministerio de Economia y Competitividad (MINECO)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); European Community through the regional development funding program (FEDER); Junta de Andalucia(Junta de Andalucia); Ministerio de Economia y Competitividad (MINECO)(Spanish Government)	This work was supported by grants SAF2009-07163 and SAF2012-32824 from Ministerio de Ciencia e Innovacion, Red Tematica de Investigacion Cooperativa en Cancer (RTICC: RD06/0020/0068 and RD12/0036/0026), the European Community through the regional development funding program (FEDER) and Junta de Andalucia (P09-CVI-4497) to AL-R. TS-P was supported by contracts from Ministerio de Economia y Competitividad (MINECO). We are grateful to Aniek Janssen, Monica Alvarez and Martin Vromans for providing helpful advice and discussions. We also thank FJ Fernandez-Farran for excellent technical assistance.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Griffith TS, 1998, J IMMUNOL, V161, P2833; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jordan MA, 1996, CANCER RES, V56, P816; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Matthess Y, 2010, MOL CELL BIOL, V30, P5726, DOI 10.1128/MCB.00731-10; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Piao XH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003558; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Ruiz-Ruiz C, 2002, BIOCHEM J, V365, P825, DOI 10.1042/BJ20020184; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zhang XD, 1999, CANCER RES, V59, P2747	40	5	5	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					661	669		10.1038/onc.2013.601	http://dx.doi.org/10.1038/onc.2013.601			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24488010				2022-12-25	WOS:000348853500013
J	Dhar, SS; Alam, H; Li, N; Wagner, KW; Chung, JY; Ahn, YW; Lee, MG				Dhar, Shilpa S.; Alam, Hunain; Li, Na; Wagner, Klaus W.; Chung, Jimyung; Ahn, Yeo Won; Lee, Min Gyu			Transcriptional Repression of Histone Deacetylase 3 by the Histone Demethylase KDM2A Is Coupled to Tumorigenicity of Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Gene Regulation; Histone Modification; Lung Cancer; Transcription Repressor	HUMAN COLON-CANCER; LYSINE METHYLATION; INK4A-ARF LOCUS; HUMAN GENOME; EXPRESSION; HDAC3; PROGNOSIS; APOPTOSIS; COMPLEX; MAINTENANCE	Background: Overexpression of the epigenetic repressor KDM2A promotes lung tumorigenesis. Results: Transcriptional inhibition of HDAC3 expression by KDM2A releases cell cycle and proinvasive genes from HDAC3-mediated repression and positively regulates cell proliferation and invasiveness. Conclusion: KDM2A-mediated repression of HDAC3 is linked to KDM2A-promoted tumorigenicity. Significance: Our findings provide a novel epigenetic insight into how KDM2A promotes lung tumorigenesis and have implications for therapeutic intervention. Dysregulated expression of histone methyltransferases and demethylases is an emerging epigenetic mechanism underlying cancer development and metastasis. We recently showed that the histone H3 lysine 36 (H3K36) demethylase KDM2A (also called FBXL11 and JHDM1A) is necessary for tumorigenic and metastatic capabilities of KDM2A-overexpressing non-small cell lung cancer (NSCLC) cells. Here, we report that KDM2A transcriptionally represses the histone deacetylase 3 (HDAC3) gene by removing methyl groups from dimethylated H3K36 at the HDAC3 promoter in KDM2A-overexpressing NSCLC cells. KDM2A depletion reduced expression levels of cell cycle-associated genes (e.g. CDK6) and cell invasion-related genes (e.g. NANOS1); these levels were rescued by ectopic expression of KDM2A but not its catalytic mutant. These genes were occupied and down-regulated by HDAC3. HDAC3 knockdown significantly recovered the proliferation and invasiveness of KDM2A-depleted NSCLC cells as well as the levels of CDK6 and NANOS1 expression in these cells. Similar to their previously reported functions in other cell types, CDK6 and NANOS1 were required for the proliferation and invasion, respectively, of KDM2A-overexpressing NSCLC cells. In a mouse xenograft model, HDAC3 depletion substantially restored the tumorigenic ability of KDM2A knockdown cells. These findings reveal a novel cancer-epigenetic pathway in which the antagonistic effect of KDM2A on HDAC3 expression releases cell cycle-associated genes and cell invasion-related genes from HDAC3 repression and indicate the importance of this pathway for tumorigenicity and invasiveness of KDM2A-overexpressing NSCLC cells.	[Dhar, Shilpa S.; Alam, Hunain; Li, Na; Wagner, Klaus W.; Lee, Min Gyu] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wagner, Klaus W.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Chung, Jimyung] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Ahn, Yeo Won] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Lee, Min Gyu] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Emory University; University of Texas System; University of Texas Health Science Center Houston	Lee, MG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mglee@mdanderson.org	Li, Na/AAV-8761-2020; Alam, Hunain/H-2984-2019	Alam, Hunain/0000-0002-6183-3677	National Institutes of Health [CA157919, GM095659]; Cancer Prevention and Research Institute of Texas Grant [RP110183]; Center for Cancer Epigenetics at The University of Texas MD Anderson Cancer Center; Center for Cancer Epigenetics at MD Anderson Cancer Center; Odyssey Program; Estate of C. G. Johnson, Jr. at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA157919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant; Center for Cancer Epigenetics at The University of Texas MD Anderson Cancer Center; Center for Cancer Epigenetics at MD Anderson Cancer Center; Odyssey Program; Estate of C. G. Johnson, Jr. at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA157919 and GM095659 (to M. G. L.). This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP110183 (to M. G. L.), a fund from the Center for Cancer Epigenetics at The University of Texas MD Anderson Cancer Center (to M. G. L.), a scholar fellowship from the Center for Cancer Epigenetics at MD Anderson Cancer Center (to S. S. D.), and a fellowship from the Odyssey Program and the Estate of C. G. Johnson, Jr. at MD Anderson Cancer Center (to H. A.).	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bonnomet A, 2008, ONCOGENE, V27, P3692, DOI 10.1038/sj.onc.1211035; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Braden WA, 2008, ONCOGENE, V27, P7083, DOI 10.1038/onc.2008.319; Chaturvedi CP, 2012, P NATL ACAD SCI USA, V109, P18845, DOI 10.1073/pnas.1213951109; Chen CQ, 2013, MOL CELL BIOCHEM, V383, P137, DOI 10.1007/s11010-013-1762-z; Chopin V, 2004, ONCOGENE, V23, P21, DOI 10.1038/sj.onc.1207020; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2000, GENE DEV, V14, P1048; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Ma HX, 2011, LUNG CANCER, V73, P32, DOI 10.1016/j.lungcan.2010.11.001; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005	48	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7483	7496		10.1074/jbc.M113.521625	http://dx.doi.org/10.1074/jbc.M113.521625			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482232	hybrid, Green Published			2022-12-25	WOS:000332761500019
J	Alstott, J; Bullmore, ET; Plenz, D				Alstott, Jeff; Bullmore, Edward T.; Plenz, Dietmar			powerlaw: A Python Package for Analysis of Heavy-Tailed Distributions	PLOS ONE			English	Article							NEURONAL AVALANCHES	Power laws are theoretically interesting probability distributions that are also frequently used to describe empirical data. In recent years, effective statistical methods for fitting power laws have been developed, but appropriate use of these techniques requires significant programming and statistical insight. In order to greatly decrease the barriers to using good statistical methods for fitting power law distributions, we developed the powerlaw Python package. This software package provides easy commands for basic fitting and statistical analysis of distributions. Notably, it also seeks to support a variety of user needs by being exhaustive in the options available to the user. The source code is publicly available and easily extensible.	[Alstott, Jeff; Plenz, Dietmar] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA; [Alstott, Jeff; Bullmore, Edward T.] Univ Cambridge, Behav & Clin Neurosci Inst, Brain Mapping Unit, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Cambridge	Alstott, J (corresponding author), NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA.	alstottjd@mail.nih.gov	Bullmore, Ed/C-1706-2012	Bullmore, Ed/0000-0002-8955-8283	National Institute of MentalHealth; Wellcome Trust; Medical Research Council (UK); National Institutes of Health-Oxford-Cambridge Scholarship Program; GlaxoSmithKline (GSK); Medical Research Council [G1000183B, G0001354, G0001354B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER	National Institute of MentalHealth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health-Oxford-Cambridge Scholarship Program; GlaxoSmithKline (GSK)(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Program of the National Institute of MentalHealth. The Behavioural and Clinical Neuroscience Institute, University of Cambridge, is supported by the Wellcome Trust and the Medical Research Council (UK). J.A. is supported by the National Institutes of Health-Oxford-Cambridge Scholarship Program. E. B. is employed half-time by the University of Cambridge, UK, and half-time by GlaxoSmithKline (GSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would also like to declare one of the authors, Ed Bullmore, is employed half-time by GlaxoSmithKline (GSK), a commercial funder. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Asmussen S., 2003, APPL PROBABILITY QUE, Vsecond; Beggs JM, 2003, J NEUROSCI, V23, P11167; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Ginsburg A, 2012, PLFIT; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Malevergne Y, 2005, QUANT FINANC, V5, P379, DOI 10.1080/14697680500151343; Malevergne Y, 2009, GIBRATS LAW CITIES U, P7; Michel M, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/51; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, POWER LAWS PARETO DI; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Zipf G. K., 1935, PSYCHOBIOLOGY LANGUA	14	397	402	9	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85777	10.1371/journal.pone.0085777	http://dx.doi.org/10.1371/journal.pone.0085777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489671	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000016
J	Hojo, MK; Yamamoto, A; Akino, T; Tsuji, K; Yamaoka, R				Hojo, Masaru K.; Yamamoto, Ari; Akino, Toshiharu; Tsuji, Kazuki; Yamaoka, Ryohei			Ants Use Partner Specific Odors to Learn to Recognize a Mutualistic Partner	PLOS ONE			English	Article							BUTTERFLY MACULINEA-REBELI; CUTICULAR HYDROCARBONS; SUGAR COMPOSITION; HOST-SPECIFICITY; SOCIAL PARASITE; LYCAENID LARVAE; EVOLUTION; DISCRIMINATION; COOPERATION; SYMBIOSIS	Regulation via interspecific communication is an important for the maintenance of many mutualisms. However, mechanisms underlying the evolution of partner communication are poorly understood for many mutualisms. Here we show, in an ant-lycaenid butterfly mutualism, that attendant ants selectively learn to recognize and interact cooperatively with a partner. Workers of the ant Pristomyrmex punctatus learn to associate cuticular hydrocarbons of mutualistic Narathura japonica caterpillars with food rewards and, as a result, are more likely to tend the caterpillars. However, the workers do not learn to associate the cuticular hydrocarbons of caterpillars of a non-ant-associated lycaenid, Lycaena phlaeas, with artificial food rewards. Chemical analysis revealed cuticular hydrocarbon profiles of the mutualistic caterpillars were complex compared with those of non-ant-associated caterpillars. Our results suggest that partner-recognition based on partner-specific chemical signals and cognitive abilities of workers are important mechanisms underlying the evolution and maintenance of mutualism with ants.	[Hojo, Masaru K.; Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 90301, Japan; [Hojo, Masaru K.; Yamamoto, Ari; Akino, Toshiharu; Yamaoka, Ryohei] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto 606, Japan; [Hojo, Masaru K.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Tsuji, Kazuki] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan	University of the Ryukyus; Kyoto Institute of Technology; Harvard University; Kagoshima University	Hojo, MK (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	m.k.hojo@gmail.com	Tsuji, Kazuki/D-6607-2014; Hojo, Masaru K/O-4909-2014	Tsuji, Kazuki/0000-0002-2027-8582; Hojo, Masaru K/0000-0002-1573-9356	JSPS;  [223146]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This study was supported by a Grant-in-Aid for JSPS Fellows (No. 223146). M. K. H. was supported by JSPS Research Fellowship for young scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, P ROY SOC B-BIOL SCI, V267, P1857, DOI 10.1098/rspb.2000.1221; Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Axen AH, 1996, ANIM BEHAV, V52, P321, DOI 10.1006/anbe.1996.0178; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Bos N, 2012, J INSECT PHYSIOL, V58, P138, DOI 10.1016/j.jinsphys.2011.10.010; Brandstaetter AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021383; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; Chaline N, 2005, CHEM SENSES, V30, P327, DOI 10.1093/chemse/bji027; CUSHMAN JH, 1991, AM NAT, V138, P851, DOI 10.1086/285256; Daniels H, 2005, J CHEM ECOL, V31, P2805, DOI 10.1007/s10886-005-8395-y; FIEDLER K, 1995, OECOLOGIA, V104, P316, DOI 10.1007/BF00328367; Fiedler K, 1996, EXPERIENTIA, V52, P14, DOI 10.1007/BF01922410; FIEDLER K, 1992, OECOLOGIA, V91, P468, DOI 10.1007/BF00650318; Fiedler K, 1991, BONN ZOOL MONOGR, V31, P1; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Gibbs AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P100, DOI 10.1017/CBO9780511711909.007; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Hojo MK, 2008, J COMP PHYSIOL A, V194, P1043, DOI 10.1007/s00359-008-0375-6; Hojo MK, 2009, P ROY SOC B-BIOL SCI, V276, P551, DOI 10.1098/rspb.2008.1064; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Lang C, 2011, ANIM BEHAV, V82, P1245, DOI 10.1016/j.anbehav.2011.08.020; LEIMAR O, 1993, ANIM BEHAV, V46, P1177, DOI 10.1006/anbe.1993.1307; Leimar O, 1997, P ROY SOC B-BIOL SCI, V264, P1209, DOI 10.1098/rspb.1997.0167; Leimar O, 2003, DAHL WS ENV, P203; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; PIERCE NE, 1987, BEHAV ECOL SOCIOBIOL, V21, P237, DOI 10.1007/BF00292505; PIERCE NE, 1981, SCIENCE, V211, P1185, DOI 10.1126/science.211.4487.1185; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; ROBBINS RK, 1991, OIKOS, V62, P363, DOI 10.2307/3545502; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Schlick-Steiner BC, 2004, NATURWISSENSCHAFTEN, V91, P209, DOI 10.1007/s00114-004-0518-8; Schonrogge K, 2004, J CHEM ECOL, V30, P91, DOI 10.1023/B:JOEC.0000013184.18176.a9; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012377; Travassos MA, 2000, ANIM BEHAV, V60, P13, DOI 10.1006/anbe.1999.1364; van Wilgenburg E, 2011, J EVOLUTION BIOL, V24, P1188, DOI 10.1111/j.1420-9101.2011.02248.x; van Wilgenburg E, 2012, BIOL LETTERS, V8, P17, DOI 10.1098/rsbl.2011.0643; Wada A, 2001, CHEM SENSES, V26, P983, DOI 10.1093/chemse/26.8.983; Yao I, 2001, OECOLOGIA, V128, P36, DOI 10.1007/s004420100633	52	25	27	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86054	10.1371/journal.pone.0086054	http://dx.doi.org/10.1371/journal.pone.0086054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489690	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000023
J	Myles, IA; Pincus, NB; Fontecilla, NM; Datta, SK				Myles, Ian A.; Pincus, Nathan B.; Fontecilla, Natalia M.; Datta, Sandip K.			Effects of Parental Omega-3 Fatty Acid Intake on Offspring Microbiome and Immunity	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; GUT MICROBIOTA; T-CELLS; N-3; EXPRESSION; RESOLVIN; DIFFERS; MODEL; VITRO	The "Western diet" is characterized by increased intake of saturated and omega-6 (n-6) fatty acids with a relative reduction in omega-3 (n-3) consumption. These fatty acids can directly and indirectly modulate the gut microbiome, resulting in altered host immunity. Omega-3 fatty acids can also directly modulate immunity through alterations in the phospholipid membranes of immune cells, inhibition of n-6 induced inflammation, down-regulation of inflammatory transcription factors, and by serving as pre-cursors to anti-inflammatory lipid mediators such as resolvins and protectins. We have previously shown that consumption by breeder mice of diets high in saturated and n-6 fatty acids have inflammatory and immune-modulating effects on offspring that are at least partially driven by vertical transmission of altered gut microbiota. To determine if parental diets high in n-3 fatty acids could also affect offspring microbiome and immunity, we fed breeding mice an n-3-rich diet with 40% calories from fat and measured immune outcomes in their offspring. We found offspring from mice fed diets high in n-3 had altered gut microbiomes and modestly enhanced anti-inflammatory IL-10 from both colonic and splenic tissue. Omega-3 pups were protected during peanut oral allergy challenge with small but measurable alterations in peanut-related serologies. However, n-3 pups displayed a tendency toward worsened responses during E. coli sepsis and had significantly worse outcomes during Staphylococcus aureus skin infection. Our results indicate excess parental n-3 fatty acid intake alters microbiome and immune response in offspring.	[Myles, Ian A.; Pincus, Nathan B.; Fontecilla, Natalia M.; Datta, Sandip K.] NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Myles, IA (corresponding author), NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mylesi@niaid.nih.gov	Myles, Ian/AAE-7623-2019	Myles, Ian/0000-0001-9316-3703; Pincus, Nathan/0000-0002-3134-7176; Datta, Sandip/0000-0003-0243-7815	National Institutes of Health; Office of Dietary Supplements; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also the funding was entirely from National Institutes of Health and the Office of Dietary Supplements. There are no current external funding sources for this study.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Calder PC, 2009, INT REV IMMUNOL, V28, P506, DOI 10.3109/08830180903197480; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055468; Halabi-Tawil M, 2009, BRIT J DERMATOL, V160, P645, DOI 10.1111/j.1365-2133.2008.08835.x; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Issazadeh-Navikas S, 2012, MOL MED, V18, P95, DOI 10.2119/molmed.2011.00311; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jones ML, 2013, J LIPID RES, V54, P2247, DOI 10.1194/jlr.M039842; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim T, 2012, INTEGR COMPUT-AID E, V19, P1, DOI 10.3233/ICA-2012-0394; Langerhuus SN, 2012, BRIT J NUTR, V107, P735, DOI 10.1017/S0007114511003503; Lee HM, 2009, J IMMUNOL, V183, P6839, DOI 10.4049/jimmunol.0901856; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; Li JJ, 2013, AM J CLIN NUTR, V97, P173, DOI 10.3945/ajcn.112.041145; Mabrok HB, 2012, CARCINOGENESIS, V33, P203, DOI 10.1093/carcin/bgr256; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Saurer L, 2009, ALLERGY, V64, P505, DOI 10.1111/j.1398-9995.2009.01965.x; Shaikh SR, 2012, MOL ASPECTS MED, V33, P46, DOI 10.1016/j.mam.2011.10.002; Shek LP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/730568; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Teague H, 2013, IMMUNOLOGY, V139, P386, DOI 10.1111/imm.12088; Thang CL, 2013, MOL NUTR FOOD RES; van den Elsen LWJ, 2013, CLIN EXP ALLERGY, V43, P798, DOI 10.1111/cea.12111; van den Elsen LWJ, 2013, BRIT J NUTR, V109, P1821, DOI 10.1017/S0007114512003959; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Wright GP, 2011, EXPERT REV CLIN IMMU, V7, P213, DOI [10.1586/eci.10.96, 10.1586/ECI.10.96]	37	35	37	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87181	10.1371/journal.pone.0087181	http://dx.doi.org/10.1371/journal.pone.0087181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489864	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000114
J	Ooi, JH; Waddell, A; Lin, YD; Albert, I; Rust, LT; Holden, V; Cantorna, MT				Ooi, Jot Hui; Waddell, Amanda; Lin, Yang-Ding; Albert, Istvan; Rust, Laura T.; Holden, Victoria; Cantorna, Margherita T.			Dominant Effects of the Diet on the Microbiome and the Local and Systemic Immune Response in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED TRIAL; GUT MICROBIOTA; MULTIPLE-SCLEROSIS; CROHNS-DISEASE; DOUBLE-BLIND; EPIDEMIOLOGY; MICROFLORA; DISORDERS	Outside the nutrition community the effects of diet on immune-mediated diseases and experimental outcomes have not been appreciated. Investigators that study immune-mediated diseases and/or the microbiome have overlooked the potential of diet to impact disease phenotype. We aimed to determine the effects of diet on the bacterial microbiota and immune-mediated diseases. Three different laboratory diets were fed to wild-type mice for 2 weeks and resulted in three distinct susceptibilities to dextran sodium sulfate (DSS)-induced colitis. Examination of the fecal microbiota demonstrated a diet-mediated effect on the bacteria found there. Broad-spectrum antibiotics disturbed the gut microbiome and partially eliminated the diet-mediated changes in DSS susceptibility. Dietary changes 2 days after DSS treatment were protective and suggested that the diet-mediated effect occurred quickly. There were no diet-mediated effects on DSS susceptibility in germ-free mice. In addition, the diet-mediated effects were evident in a gastrointestinal infection model (Citrobacter rodentium) and in experimental autoimmune encephalomyelitis. Taken together, our study demonstrates a dominant effect of diet on immune-mediated diseases that act rapidly by changing the microbiota. These findings highlight the potential of using dietary manipulation to control the microbiome and prevent/treat immune-mediated disease.	[Ooi, Jot Hui; Waddell, Amanda; Lin, Yang-Ding; Albert, Istvan; Rust, Laura T.; Holden, Victoria; Cantorna, Margherita T.] Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Biochem & Mol Biol, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cantorna, MT (corresponding author), Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Biochem & Mol Biol, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	mxc69@psu.edu	Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X; Holden, Victoria/0000-0003-4584-068X	National Institutes of Health/National Institute of Neurologic and Stroke [NS067563]; National Institutes of Health/National Center for Complementary and Alternative Medicine; Office of Dietary Supplements [AT005378]; National Gnotobiotic Rodent Resource Center, National Institutes of Health [5-P39-DK034987, 5-P40-OD010995]; National Center for Complementary & Integrative Health [R01AT005378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067563] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurologic and Stroke; National Institutes of Health/National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Gnotobiotic Rodent Resource Center, National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by the National Institutes of Health/National Institute of Neurologic and Stroke Grant NS067563 and National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements AT005378 and the National Gnotobiotic Rodent Resource Center, National Institutes of Health grants 5-P39-DK034987 AND 5-P40-OD010995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Chapman-Kiddell CA, 2010, INFLAMM BOWEL DIS, V16, P137, DOI 10.1002/ibd.20968; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Halme L, 2006, WORLD J GASTROENTERO, V12, P3668, DOI 10.3748/wjg.v12.i23.3668; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Hugot JP, 2004, BEST PRACT RES CL GA, V18, P451, DOI 10.1016/j.bpg.2004.01.001; Hunter JO, 2008, INFLAMM BOWEL DIS, V14, pS35, DOI 10.1002/ibd.20547; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; King TS, 1997, ALIMENT PHARM THER, V11, P17, DOI 10.1046/j.1365-2036.1997.90262000.x; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Ooi JH, 2013, J NUTR, V143, P1679, DOI 10.3945/jn.113.180794; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Steinhoff U, 2005, IMMUNOL LETT, V99, P12, DOI 10.1016/j.imlet.2004.12.013; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Varshney J, 2013, J NUTR, V143, P526, DOI 10.3945/jn.112.171355; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	30	32	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86366	10.1371/journal.pone.0086366	http://dx.doi.org/10.1371/journal.pone.0086366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489720	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000035
J	Selfe, J; Alexander, J; Costello, JT; May, K; Garratt, N; Atkins, S; Dillon, S; Hurst, H; Davison, M; Przybyla, D; Coley, A; Bitcon, M; Littler, G; Richards, J				Selfe, James; Alexander, Jill; Costello, Joseph T.; May, Karen; Garratt, Nigel; Atkins, Stephen; Dillon, Stephanie; Hurst, Howard; Davison, Matthew; Przybyla, Daria; Coley, Andrew; Bitcon, Mark; Littler, Greg; Richards, Jim			The Effect of Three Different (-135 degrees C) Whole Body Cryotherapy Exposure Durations on Elite Rugby League Players	PLOS ONE			English	Article							ANTERIOR KNEE; TEMPERATURE; MUSCLE; CRYOSTIMULATION	Background: Whole body cryotherapy (WBC) is the therapeutic application of extreme cold air for a short duration. Minimal evidence is available for determining optimal exposure time. Purpose: To explore whether the length of WBC exposure induces differential changes in inflammatory markers, tissue oxygenation, skin and core temperature, thermal sensation and comfort. Method: This study was a randomised cross over design with participants acting as their own control. Fourteen male professional first team super league rugby players were exposed to 1, 2, and 3 minutes of WBC at -135 degrees C. Testing took place the day after a competitive league fixture, each exposure separated by seven days. Results: No significant changes were found in the inflammatory cytokine interleukin six. Significant reductions (p<0.05) in deoxyhaemoglobin for gastrocnemius and vastus lateralis were found. In vastus lateralis significant reductions (p<0.05) in oxyhaemoglobin and tissue oxygenation index (p<0.05) were demonstrated. Significant reductions (p<0.05) in skin temperature were recorded. No significant changes were recorded in core temperature. Significant reductions (p<0.05) in thermal sensation and comfort were recorded. Conclusion: Three brief exposures to WBC separated by 1 week are not sufficient to induce physiological changes in IL-6 or core temperature. There are however significant changes in tissue oxyhaemoglobin, deoxyhaemoglobin, tissue oxygenation index, skin temperature and thermal sensation. We conclude that a 2 minute WBC exposure was the optimum exposure length at temperatures of -135 degrees C and could be applied as the basis for future studies.	[Selfe, James] Univ Cent Lancashire, Allied Hlth Res Unit, Preston PR1 2HE, Lancs, England; [Alexander, Jill; May, Karen; Littler, Greg; Richards, Jim] Univ Cent Lancashire, AHRu, Preston PR1 2HE, Lancs, England; [Costello, Joseph T.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Garratt, Nigel] Univ Cent Lancashire, SSTO, Preston PR1 2HE, Lancs, England; [Atkins, Stephen; Dillon, Stephanie; Hurst, Howard; Davison, Matthew; Przybyla, Daria] Univ Cent Lancashire, SENS, Preston PR1 2HE, Lancs, England; [Coley, Andrew; Bitcon, Mark] Wigan Warriors Rugby League, Wigan, England	University of Central Lancashire; University of Central Lancashire; Queensland University of Technology (QUT); University of Central Lancashire; University of Central Lancashire	Alexander, J (corresponding author), Univ Cent Lancashire, AHRu, Preston PR1 2HE, Lancs, England.	jalexander3@uclan.ac.uk	Costello, Joseph/AAW-8764-2020; Costello, Joseph/G-6294-2011; Costello, Joseph/J-1374-2012; Richards, Jim/AAI-7331-2020	Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Richards, Jim/0000-0002-4004-3115; Alexander, Jill/0000-0002-6492-1621; Littler, Greg/0000-0002-2575-0874; Selfe, James/0000-0001-9931-4998	University of Central Lancashire	University of Central Lancashire	Jill Alexander was funded to work on the project by a University of Central Lancashire innovation voucher. The use of the mobile Cryochamber, liquid nitrogen and specialist operator were provided free of charge by BOC Linde throughout the testing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, ERG THERM ENV ASS IN; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Austin DJ, 2011, J STRENGTH COND RES, V25, P1898, DOI 10.1519/JSC.0b013e3181e83a5b; Banfi G, 2010, SPORTS MED, V7, P1; Banfi G, 2009, J THERM BIOL, V34, P55, DOI 10.1016/j.jtherbio.2008.10.003; Cholewka A, 2012, SKIN RES TECHNOL, V18, P180, DOI 10.1111/j.1600-0846.2011.00550.x; Costello J, 2012, PLOS ONE, V7, P1; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Costello JT, 2012, J THERM BIOL, V37, P103, DOI 10.1016/j.jtherbio.2011.11.008; Costello JT, 2013, ACSM; Delpy DT, 1997, PHILOS T R SOC B, V352, P649, DOI 10.1098/rstb.1997.0046; Flouris AD, 2008, EUR J APPL PHYSIOL, V104, P491, DOI 10.1007/s00421-008-0798-3; Flouris AD, 2009, J APPL PHYSIOL, V106, P1264, DOI 10.1152/japplphysiol.91426.2008; Fonda B, 2013, SCAND J MED SCI SPOR, V23, pE270, DOI 10.1111/sms.12074; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gregson W, 2011, AM J SPORT MED, V39, P1316, DOI 10.1177/0363546510395497; Hausswirth C, 2011, PLOS ONE, V12, P1; Karki A, 2004, THERMOL INT, V14, P137; Lombardi G, 2013, PLOS ONE, V8, P1; Lubkowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046352; Lubkowska A, 2010, CRYOBIOLOGY, V61, P22, DOI 10.1016/j.cryobiol.2010.03.010; Lubkowska A, 2010, EUR J APPL PHYSIOL, V109, P67, DOI 10.1007/s00421-009-1207-2; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Ring EFJ, 2015, INFRARED IMAGING: A CASEBOOK IN CLINICAL MEDICINE, DOI 10.1088/978-0-7503-1143-4ch1; Savic M, 2013, J THERM BIOL, V38, P186, DOI 10.1016/j.jtherbio.2013.02.004; Selfe J, 2006, ARCH PHYS MED REHAB, V87, P1630, DOI 10.1016/j.apmr.2006.08.346; Selfe J, 2010, KNEE, V17, P319, DOI 10.1016/j.knee.2009.10.005; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; Twist C, 2012, J SPORT SCI, V30, P359, DOI 10.1080/02640414.2011.640707; Wozniak A, 2007, EUR J APPL PHYSIOL, V100, P137, DOI 10.1007/s00421-007-0404-0; Ziemann E, 2012, J ATHL TRAINING, V47, P664, DOI 10.4085/1062-6050-47.6.13	35	51	55	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86420	10.1371/journal.pone.0086420	http://dx.doi.org/10.1371/journal.pone.0086420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489726	Green Accepted, Green Published, gold			2022-12-25	WOS:000330570000039
J	Craig, SM; Reagon, M; Resnick, LE; Caicedo, AL				Craig, Stephanie M.; Reagon, Michael; Resnick, Lauren E.; Caicedo, Ana L.			Allele Distributions at Hybrid Incompatibility Loci Facilitate the Potential for Gene Flow between Cultivated and Weedy Rice in the US	PLOS ONE			English	Article							ORYZA-SATIVA L.; RED RICE; WIDE-COMPATIBILITY; NEUTRAL ALLELES; MALE-STERILITY; POLYMORPHISM; EVOLUTION; SYSTEM	The accumulation of independent mutations over time in two populations often leads to reproductive isolation. Reproductive isolation between diverging populations may be reinforced by barriers that occur either pre- or postzygotically. Hybrid sterility is the most common form of postzygotic isolation in plants. Four postzygotic sterility loci, comprising three hybrid sterility systems (Sa, s5, DPL), have been recently identified in Oryza sativa. These loci explain, in part, the limited hybridization that occurs between the domesticated cultivated rice varieties, O. sativa spp. japonica and O. sativa spp. indica. In the United States, cultivated fields of japonica rice are often invaded by conspecific weeds that have been shown to be of indica origin. Crop-weed hybrids have been identified in crop fields, but at low frequencies. Here we examined the possible role of these hybrid incompatibility loci in the interaction between cultivated and weedy rice. We identified a novel allele at Sa that seemingly prevents loss of fertility in hybrids. Additionally, we found wide-compatibility type alleles at strikingly high frequencies at the Sa and s5 loci in weed groups, and a general lack of incompatible alleles between crops and weeds at the DPL loci. Our results suggest that weedy individuals, particularly those of the SH and BRH groups, should be able to freely hybridize with the local japonica crop, and that prezygotic factors, such as differences in flowering time, have been more important in limiting weed-crop gene flow in the past. As the selective landscape for weedy rice changes due to increased use of herbicide resistant strains of cultivated rice, the genetic barriers that hinder indica-japonica hybridization cannot be counted on to limit the flow of favorable crop genes into weeds.	[Craig, Stephanie M.; Resnick, Lauren E.; Caicedo, Ana L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Reagon, Michael] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Lima, OH 45804 USA	University of Massachusetts System; University of Massachusetts Amherst; University System of Ohio; Ohio State University	Caicedo, AL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	caicedo@bio.umass.edu			U.S. National Science Foundation Plant Genome Research Program [IOS-1032023]	U.S. National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This project was funded by a grant from the U.S. National Science Foundation Plant Genome Research Program (IOS-1032023) to A. L. C., Kenneth M. Olsen and Yulin Jia (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 1032023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bres-Patry C, 2001, THEOR APPL GENET, V102, P118, DOI 10.1007/s001220051626; Burgos NR, 2008, WEED TECHNOL, V22, P200, DOI 10.1614/WT-07-075.1; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Delouche J. C, 2007, 188 FAO; Du HY, 2011, NEW PHYTOL, V191, P275, DOI 10.1111/j.1469-8137.2011.03691.x; Gealy DR, 2005, CROP FERALITY AND VOLUNTEERISM, P323, DOI 10.1201/9781420037999.ch20; Harushima Y, 2002, GENETICS, V160, P313; Kubo T, 2008, GENES GENET SYST, V83, P443, DOI 10.1266/ggs.83.443; Li JQ, 2012, PLANT SYST EVOL, V298, P33, DOI 10.1007/s00606-011-0520-5; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; OKA H. -I., 1957, Journal of Genetics, V55, P397, DOI 10.1007/BF02984059; OKA HI, 1974, GENETICS, V77, P521; Orr HA, 1996, GENETICS, V144, P1331; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Ouyang YD, 2009, CHINESE SCI BULL, V54, P2332, DOI 10.1007/s11434-009-0371-4; Rajguru SN, 2005, WEED SCI, V53, P946; Reagon M, 2011, MOL ECOL, V20, P3743, DOI 10.1111/j.1365-294X.2011.05216.x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Reflinur, 2012, GENES GENOM, V34, P355, DOI 10.1007/s13258-011-0209-8; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rozen S, 2000, Methods Mol Biol, V132, P365; Salassi ME, 2012, POTENTIAL UNCONVENTI, P17; Sha XY, 2007, CROP SCI, V47, P1177, DOI 10.2135/cropsci2006.09.0592; Shi LG, 2009, CHINESE SCI BULL, V54, P3813, DOI 10.1007/s11434-009-0571-y; Shivrain VK, 2010, CROP PROT, V29, P336, DOI 10.1016/j.cropro.2009.10.002; Shivrain VK, 2009, PEST MANAG SCI, V65, P1124, DOI 10.1002/ps.1802; Song Z. P., 2001, International Rice Research Notes, V26, P31; Sun J, 2013, NEW PHYTOL, V197, P290, DOI 10.1111/nph.12012; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Wang GW, 2009, PLANT BREEDING, V128, P451, DOI 10.1111/j.1439-0523.2008.01514.x; Wang Y, 2010, PLANTA, V231, P559, DOI 10.1007/s00425-009-1063-7; Yang CY, 2004, CHINESE SCI BULL, V49, P1718, DOI 10.1360/04wc0197; Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702	40	14	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86647	10.1371/journal.pone.0086647	http://dx.doi.org/10.1371/journal.pone.0086647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489758	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000068
J	Dreze, M; Calkins, AS; Galicza, J; Echelman, DJ; Schnorenberg, MR; Fell, GL; Iwai, S; Fisher, DE; Szuts, D; Iglehart, JD; Lazaro, JB				Dreze, Matija; Calkins, Anne S.; Galicza, Judit; Echelman, Daniel J.; Schnorenberg, Mathew R.; Fell, Gillian L.; Iwai, Shigenori; Fisher, David E.; Szuets, David; Iglehart, J. Dirk; Lazaro, Jean-Bernard			Monitoring Repair of UV-Induced 6-4-Photoproducts with a Purified DDB2 Protein Complex	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-BINDING PROTEIN; XERODERMA-PIGMENTOSUM; DAMAGED DNA; UBIQUITIN LIGASE; IN-VIVO; MOLECULAR-BASIS; RECOGNITION; PHOTOPRODUCTS; XPC	Because cells are constantly subjected to DNA damaging insults, DNA repair pathways are critical for genome integrity [1]. DNA damage recognition protein complexes (DRCs) recognize DNA damage and initiate DNA repair. The DNA-Damage Binding protein 2 (DDB2) complex is a DRC that initiates nucleotide excision repair (NER) of DNA damage caused by ultraviolet light (UV) [2-4]. Using a purified DDB2 DRC, we created a probe ("DDB2 proteo-probe") that hybridizes to nuclei of cells irradiated with UV and not to cells exposed to other genotoxins. The DDB2 proteo-probe recognized UV-irradiated DNA in classical laboratory assays, including cyto-and histo-chemistry, flow cytometry, and slot-blotting. When immobilized, the proteo-probe also bound soluble UV-irradiated DNA in ELISA-like and DNA pull-down assays. In vitro, the DDB2 proteo-probe preferentially bound 6-4-photoproducts [(6-4) PPs] rather than cyclobutane pyrimidine dimers (CPDs). We followed UV-damage repair by cyto-chemistry in cells fixed at different time after UV irradiation, using either the DDB2 proteo-probe or antibodies against CPDs, or (6-4) PPs. The signals obtained with the DDB2 proteo-probe and with the antibody against (6-4) PPs decreased in a nearly identical manner. Since (6-4) PPs are repaired only by nucleotide excision repair (NER), our results strongly suggest the DDB2 proteo-probe hybridizes to DNA containing (6-4) PPs and allows monitoring of their removal during NER. We discuss the general use of purified DRCs as probes, in lieu of antibodies, to recognize and monitor DNA damage and repair.	[Dreze, Matija; Calkins, Anne S.; Echelman, Daniel J.; Schnorenberg, Mathew R.; Iglehart, J. Dirk; Lazaro, Jean-Bernard] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Dreze, Matija; Fell, Gillian L.; Iglehart, J. Dirk] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Galicza, Judit; Szuets, David] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Iwai, Shigenori] Osaka Univ, Div Chem, Grad Sch Engn Sci, Osaka, Japan; [Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Osaka University; Harvard University; Massachusetts General Hospital	Lazaro, JB (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	jean-bernard_lazaro@dfci.harvard.edu	Fisher, David/AAH-2878-2019; Dreze, Matija/AAZ-3293-2020; Szuts, David/N-1149-2016	Schnorenberg, Mathew/0000-0002-2876-573X; /0000-0001-7002-8488; Rajkumar, Anne/0000-0003-0614-0840; Szuts, David/0000-0001-7985-0136	Pallotta Investigator Fund; Susan F. Smith Center for Women's Cancers; Marjorie Powell Allen Memorial Fund; Barbara and Paul Ferry Fund for Cancer Research; Hungarian Academy of Sciences; Breast Cancer Research Foundation of New York; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Pallotta Investigator Fund; Susan F. Smith Center for Women's Cancers; Marjorie Powell Allen Memorial Fund; Barbara and Paul Ferry Fund for Cancer Research; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Breast Cancer Research Foundation of New York; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pallotta Investigator Fund (J.-B.L.), the Susan F. Smith Center for Women's Cancers (J.-B.L. and J.D.I.), the Marjorie Powell Allen Memorial Fund (J.-B.L.), The Barbara and Paul Ferry Fund for Cancer Research (J.D.I.), and a Momentum Grant of the Hungarian Academy of Sciences (D. S.). J.D.I. is supported by The Breast Cancer Research Foundation of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dejmek J, 2009, MOL CANCER RES, V7, P581, DOI 10.1158/1541-7786.MCR-08-0049; Fagbemi AF, 2011, DNA REPAIR, V10, P722, DOI 10.1016/j.dnarep.2011.04.022; Fei J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001183; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Reed SH, 2011, DNA REPAIR, V10, P734, DOI 10.1016/j.dnarep.2011.04.029; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Szuts D, 2008, NUCLEIC ACIDS RES, V36, P6767, DOI 10.1093/nar/gkn651; TAKAO M, 1993, NUCLEIC ACIDS RES, V21, P4111, DOI 10.1093/nar/21.17.4111; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Varga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052472; Vermeulen W, 2011, DNA REPAIR, V10, P760, DOI 10.1016/j.dnarep.2011.04.015	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85896	10.1371/journal.pone.0085896	http://dx.doi.org/10.1371/journal.pone.0085896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489677	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330510000022
J	Richter, LM; Lonnroth, K; Desmond, C; Jackson, R; Jaramillo, E; Weil, D				Richter, Linda M.; Loennroth, Knut; Desmond, Chris; Jackson, Robin; Jaramillo, Ernesto; Weil, Diana			Economic Support to Patients in HIV and TB Grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK-FACTORS; RESISTANT TUBERCULOSIS; HEALTH-CARE; COSTS; ADHERENCE; BURDEN; ACCESS; HOUSEHOLDS; INFECTION	People with TB and/or HIV frequently experience severe economic barriers to health care, including out-of-pocket expenses related to diagnosis and treatment, as well as indirect costs due to loss of income. These barriers can both aggravate economic hardship and prevent or delay diagnosis, treatment and successful outcome, leading to increased transmission, morbidity and mortality. WHO, UNAIDS and the ILO argue that economic support of various kinds is essential to enable vulnerable people to protect themselves from infection, avoid delayed diagnosis and treatment, overcome barriers to adherence, and avert destitution. This paper analyses successful country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria that include economic support in Rounds 7 and 10; 36 and 20 HIV and TB grants in Round 7 and 32 and 26, respectively, in Round 10. Of these, up to 84 percent included direct or indirect economic support for beneficiaries, although the amount constituted a very small proportion of the total grant. In TB grants, the objectives of economic support were generally clearly stated, and focused on mechanisms to improve treatment uptake and adherence, and the case was most clearly made for MDR-TB patients. In HIV grants, the objectives were much broader in scope, including mitigation of adverse economic and social effects of HIV and its treatment on both patients and families. The analysis shows that economic support is on the radar for countries developing Global Fund proposals, and a wide range of economic support activities are in place. In order to move forward in this area, the wealth of country experience that exists needs to be collated, assessed and disseminated. In addition to trials, operational research and programme evaluations, more precise guidance to countries is needed to inform evidence-based decision about activities that are cost-effective, affordable and feasible.	[Richter, Linda M.; Desmond, Chris] Human Sci Res Council, Durban, Kwazulu Natal, South Africa; [Richter, Linda M.; Desmond, Chris] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, Gauteng, South Africa; [Loennroth, Knut; Jaramillo, Ernesto; Weil, Diana] World Hlth Org, HIV AIDS TB Malaria & Neglected Trop Dis HTM, Geneva, Switzerland; [Jackson, Robin] World Food Programme, Rome, Italy	Human Sciences Research Council-South Africa; University of Witwatersrand; World Health Organization	Richter, LM (corresponding author), Human Sci Res Council, Durban, Kwazulu Natal, South Africa.	lrichter@hsrc.ac.za	Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256	Swedish International Development Cooperation Agency (SIDA), through HelpAge International; World Health Organization; Global Fund	Swedish International Development Cooperation Agency (SIDA), through HelpAge International; World Health Organization(World Health Organization); Global Fund	The Swedish International Development Cooperation Agency (SIDA), through HelpAge International, funded Linda Richter's secondment to the Global Fund from June 2010 to July 2012. The World Health Organization and the Global Fund provided support for the interns who worked on the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, UNAIDS EXP BUS CAS E; Beith A, 2009, PERFORMANCE INCENTIV, P237; Bobrova N, 2007, INT J DRUG POLICY, V18, P313, DOI 10.1016/j.drugpo.2007.01.015; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Bridge J, 2012, INT J DRUG POLICY, V23, P279, DOI 10.1016/j.drugpo.2012.01.013; Brigido LFM, 2001, AIDS PATIENT CARE ST, V15, P587, DOI 10.1089/108729101753287685; Buchanan RJ, 1997, AM J PUBLIC HEALTH, V87, P2014, DOI 10.2105/AJPH.87.12.2014; Burstrom B, 2009, INT J HEALTH SERV, V39, P271, DOI 10.2190/HS.39.2.c; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; ILO, 2011, SOC PROT FLOOR FAIR; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; Kielmann K, 2010, AIDS CARE, V22, P21, DOI 10.1080/09540121003721000; Kim MH, 2012, JAIDS-J ACQ IMM DEF, V59, P173, DOI 10.1097/QAI.0b013e3182405f8f; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Louis C, 2007, AIDS CARE, V19, P487, DOI 10.1080/09540120701203246; Lutge E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-154; Lutge EE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007952.pub2; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mauch V, 2013, INT J TUBERC LUNG D, V17, P381, DOI 10.5588/ijtld.12.0368; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Msellati P, 2003, AIDS, V17, pS63, DOI 10.1097/00002030-200317003-00009; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Muko K N, 2004, SAHARA J, V1, P107; Muniyandi M., 2005, Indian Journal of Tuberculosis, V52, P188; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; PETERS DH, 2007, INT J EQUITY HEALTH, V1136, P161; Pichenda K, 2012, INT J TUBERC LUNG D, V16, P828, DOI 10.5588/ijtld.11.0688; Qian DF, 2009, HEALTH POLICY PLANN, V24, P324, DOI 10.1093/heapol/czp016; Riyarto S, 2010, HEALTH POLICY PLANN, V25, P272, DOI 10.1093/heapol/czq004; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2007, SAMJ S AFR MED J, V97, P524; Rouzier VA, 2010, INT J TUBERC LUNG D, V14, P1316; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Subbaro K, 1997, SAFETY NET PROGRAMS; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Ukwaja KN, 2012, INT J TUBERC LUNG D, V16, P733, DOI 10.5588/ijtld.11.0193; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Volmink J, 2000, COCHRANE DB SYST REV, V2; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WHO, 2010, WOR HEALT REP, P1; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	50	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86225	10.1371/journal.pone.0086225	http://dx.doi.org/10.1371/journal.pone.0086225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489702	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000037
J	Buscariollo, DL; Fang, XF; Greenwood, V; Xue, HL; Rivkees, SA; Wendler, CC				Buscariollo, Daniela L.; Fang, Xiefan; Greenwood, Victoria; Xue, Huiling; Rivkees, Scott A.; Wendler, Christopher C.			Embryonic Caffeine Exposure Acts via A1 Adenosine Receptors to Alter Adult Cardiac Function and DNA Methylation in Mice	PLOS ONE			English	Article							METABOLIC SYNDROME; GENE; EXPRESSION; HEART; RISK; HYPERTROPHY; EPIGENOMICS; CONSUMPTION; TRIMESTER; ALCOHOL	Evidence indicates that disruption of normal prenatal development influences an individual's risk of developing obesity and cardiovascular disease as an adult. Thus, understanding how in utero exposure to chemical agents leads to increased susceptibility to adult diseases is a critical health related issue. Our aim was to determine whether adenosine A1 receptors (A1ARs) mediate the long-term effects of in utero caffeine exposure on cardiac function and whether these long-term effects are the result of changes in DNA methylation patterns in adult hearts. Pregnant A1AR knockout mice were treated with caffeine (20 mg/kg) or vehicle (0.09% NaCl) i.p. at embryonic day 8.5. This caffeine treatment results in serum levels equivalent to the consumption of 2-4 cups of coffee in humans. After dams gave birth, offspring were examined at 8-10 weeks of age. A1AR+/+ offspring treated in utero with caffeine were 10% heavier than vehicle controls. Using echocardiography, we observed altered cardiac function and morphology in adult mice exposed to caffeine in utero. Caffeine treatment decreased cardiac output by 11% and increased left ventricular wall thickness by 29% during diastole. Using DNA methylation arrays, we identified altered DNA methylation patterns in A1AR+/+ caffeine treated hearts, including 7719 differentially methylated regions (DMRs) within the genome and an overall decrease in DNA methylation of 26%. Analysis of genes associated with DMRs revealed that many are associated with cardiac hypertrophy. These data demonstrate that A1ARs mediate in utero caffeine effects on cardiac function and growth and that caffeine exposure leads to changes in DNA methylation.	[Buscariollo, Daniela L.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Fang, Xiefan; Rivkees, Scott A.; Wendler, Christopher C.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32610 USA; [Greenwood, Victoria] Univ Connecticut, Storrs, CT USA; [Xue, Huiling] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; State University System of Florida; University of Florida; University of Connecticut; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wendler, CC (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32610 USA.	cwendler@ufl.edu	Fang, Xiefan/G-1186-2015	Fang, Xiefan/0000-0002-7804-7832	NIH [R01 HD058086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from NIH R01 HD058086 (Scott Rivkees and Christopher Wendler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkader TS, 2012, J APPL TOXICOL; Balkau B, 2007, DIABETES METAB, V33, P405, DOI 10.1016/j.diabet.2007.08.001; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288; Browne ML, 2006, EPIDEMIOLOGY, V17, P324, DOI 10.1097/01.ede.0000208476.36988.44; Buscariollo DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028296; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Christian MS, 2001, TERATOLOGY, V64, P51, DOI 10.1002/tera.1047; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; Cnattingius S, 2003, FOOD CHEM TOXICOL, V41, P1202, DOI 10.1016/S0278-6915(03)00103-0; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cooper-Dehoff RM, 2007, CLIN CARDIOL, V30, P593, DOI 10.1002/clc.7; Curtis LH, 2007, DIABETES CARE, V30, P2553, DOI 10.2337/dc07-0460; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Espinoza-Lewis RA, 2012, CURR TOP DEV BIOL, V100, P279, DOI 10.1016/B978-0-12-387786-4.00009-9; Fang XF, 2013, ENVIRON TOXICOL PHAR, V36, P40, DOI 10.1016/j.etap.2013.02.014; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; IMAMURA S, 1992, CIRC RES, V71, P1031, DOI 10.1161/01.RES.71.5.1031; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KOOS BJ, 1994, AM J PHYSIOL, V266, pR215, DOI 10.1152/ajpregu.1994.266.1.R215; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LARROQUE B, 1993, AM J EPIDEMIOL, V137, P941, DOI 10.1093/oxfordjournals.aje.a116764; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Matsuoka R, 1987, Am J Med Genet Suppl, V3, P433; Momoi N, 2008, AM J PHYSIOL-HEART C, V294, pH2248, DOI 10.1152/ajpheart.91469.2007; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Obunai K, 2007, MED CLIN N AM, V91, P1169, DOI 10.1016/j.mcna.2007.06.003; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Palmke N, 2011, METHODS, V53, P175, DOI 10.1016/j.ymeth.2010.07.006; Ping J, 2012, CHEM-BIOL INTERACT, V195, P68, DOI 10.1016/j.cbi.2011.11.001; Qiao Q, 2007, ANN CLIN BIOCHEM, V44, P232, DOI 10.1258/000456307780480963; RIVKEES SA, 1995, DEV BRAIN RES, V89, P202, DOI 10.1016/0165-3806(95)00120-3; Rivkees SA, 2001, MOL GENET METAB, V74, P160, DOI 10.1006/mgme.2001.3217; Rivkees SA, 2012, ARTERIOSCL THROM VAS, V32, P851, DOI 10.1161/ATVBAHA.111.226811; Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf; ROSS CP, 1986, HISTOL HISTOPATHOL, V1, P13; Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7; Simon DK, 2008, CLIN NEUROPHARMACOL, V31, P189, DOI 10.1097/WNF.0b013e31815a3f03; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104; Wendler CC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-57; Wendler CC, 2009, FASEB J, V23, P1272, DOI 10.1096/fj.08-124941; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; Workman C, 2002, GENOME BIOL, V3; Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497; Yeh CH, 2012, DRUG CHEM TOXICOL; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	62	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87547	10.1371/journal.pone.0087547	http://dx.doi.org/10.1371/journal.pone.0087547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475304	Green Published, gold			2022-12-25	WOS:000330507300198
J	Kidia, KK; Mupambireyi, Z; Cluver, L; Ndhlovu, CE; Borok, M; Ferrand, RA				Kidia, Khameer K.; Mupambireyi, Zivai; Cluver, Lucie; Ndhlovu, Chiratidzo E.; Borok, Margaret; Ferrand, Rashida A.			HIV Status Disclosure to Perinatally-Infected Adolescents in Zimbabwe: A Qualitative Study of Adolescent and Healthcare Worker Perspectives	PLOS ONE			English	Article							CHILDREN; DIAGNOSIS; BARRIERS	Introduction & Objectives: Due to the scale up of antiretroviral therapy, increasing numbers of HIV-infected children are living into adolescence. As these children grow and surpass the immediate threat of death, the issue of informing them of their HIV status arises. This study aimed to understand how perinatally-infected adolescents learn about their HIV-status as well as to examine their preferences for the disclosure process. Methods: In-depth interviews were conducted with 31 (14 male, 17 female) perinatally-infected adolescents aged 16-20 at an HIV clinic in Harare, Zimbabwe, and focused on adolescents' experiences of disclosure. In addition, 15 (1 male, 14 female) healthcare workers participated in two focus groups that were centred on healthcare workers' practices surrounding disclosure in the clinic. Purposive sampling was used to recruit participants. A coding frame was developed and major themes were extracted using grounded theory methods. Results: Healthcare workers encouraged caregivers to initiate disclosure in the home environment. However, many adolescents preferred disclosure to take place in the presence of healthcare workers at the clinic because it gave them access to accurate information as well as an environment that made test results seem more credible. Adolescents learned more specific information about living with an HIV-positive status and the meaning of that status from shared experiences among peers at the clinic. Conclusions: HIV-status disclosure to adolescents is distinct from disclosure to younger children and requires tailored, age-appropriate guidelines. Disclosure to this age group in a healthcare setting may help overcome some of the barriers associated with caregivers disclosing in the home environment and make the HIV status seem more credible to an adolescent. The study also highlights the value of peer support among adolescents, which could help reduce the burden of psychosocial care on caregivers and healthcare workers.	[Kidia, Khameer K.; Cluver, Lucie] Univ Oxford, Oxford, England; [Mupambireyi, Zivai] UCL, London, England; [Mupambireyi, Zivai] Ctr Sexual Hlth & HIV AIDS Res, Harare, Zimbabwe; [Cluver, Lucie] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Ndhlovu, Chiratidzo E.; Borok, Margaret] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Ferrand, Rashida A.] London Sch Hyg & Trop Med, London WC1, England; [Ferrand, Rashida A.] Biomed Res & Training Inst, Harare, Zimbabwe	University of Oxford; University of London; University College London; University of Cape Town; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine; Biomedical Research Training Institute	Kidia, KK (corresponding author), Univ Oxford, Oxford, England.	kkidia@gmail.com	; Ndhlovu, Chiratidzo Ellen/N-8763-2013	Cluver, Lucie/0000-0002-0418-835X; Ndhlovu, Chiratidzo Ellen/0000-0001-7863-7974	Godfrey Lienhardt Grant	Godfrey Lienhardt Grant	This study was financed in part by a Godfrey Lienhardt Grant to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrive E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033690; Barbour R., 2007, DOING FOCUS GROUPS; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; De Bacts AJ, 2008, SOC SCI MED, V66, P479, DOI 10.1016/j.socscimed.2007.08.028; Domek GJ, 2010, J TROP PEDIATRICS, V56, P440, DOI 10.1093/tropej/fmq013; Ferguson J, 2013, 7 INT AIDS SOC C; FunckBrentano I, 1995, PSYCHIAT ENFANT, V38, P109; Glaser B, 1978, DISCOV GROUNDED THEO; Greeff M, 2008, QUAL HEALTH RES, V18, P311, DOI 10.1177/1049732307311118; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Instone S L, 2000, J Pediatr Health Care, V14, P235, DOI 10.1067/mph.2000.107338; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Liampputtong P, 2013, QUALITATIVE RES METH; LIPSON M, 1994, J DEV BEHAV PEDIATR, V15, pS61; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mavhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070254; MAYER RE, 1983, J EDUC PSYCHOL, V75, P40, DOI 10.1037/0022-0663.75.1.40; Mellins C.A., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [https://doi.org/10.1177/1359104502007001008, DOI 10.1177/1359104502007001008, 10.1177/1359104502007001008]; Ministry of Health & Child Welfare, 2008, ZIMB NAT GUID HIV TE; Mofenson LM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18650; Muller AD, 2011, AIDS CARE, V23, P129, DOI 10.1080/09540121003758523; Open Society, 2009, BEST PRACT GUID HIV; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Remien RH, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000298104.02356.b3; Riekert KA, 1999, CHILD HEALTH CARE, V28, P201, DOI 10.1207/s15326888chc2803_1; Skhosana Nokuthula L, 2006, Afr J AIDS Res, V5, P17, DOI 10.2989/16085900609490363; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; Strauss A., 1990, BASICS QUALITATIVE R; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; UNAIDS, 2012, GLOB REP WORLD AIDS; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; WHO, 2013, HIV AD GUID HIV TEST; Wiener L, 1998, HIV SOCIAL WORK PRAC, P327; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wiener LS, 2006, J ADOLESCENT HEALTH, V38, P307, DOI 10.1016/j.jadohealth.2005.03.024; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS; Yoshioka MR, 2001, AIDS PATIENT CARE ST, V15, P77, DOI 10.1089/108729101300003672	41	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87322	10.1371/journal.pone.0087322	http://dx.doi.org/10.1371/journal.pone.0087322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475271	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000330507300167
J	Olt, J; Mburu, P; Johnson, SL; Parker, A; Kuhn, S; Bowl, M; Marcotti, W; Brown, SDM				Olt, Jennifer; Mburu, Philomena; Johnson, Stuart L.; Parker, Andy; Kuhn, Stephanie; Bowl, Mike; Marcotti, Walter; Brown, Steve D. M.			The Actin-Binding Proteins Eps8 and Gelsolin Have Complementary Roles in Regulating the Growth and Stability of Mechanosensory Hair Bundles of Mammalian Cochlear Outer Hair Cells	PLOS ONE			English	Article							FAST ADAPTATION; MYOSIN-XVA; STEREOCILIA; WHIRLIN; MOUSE; INNER; ELONGATION; LOCALIZATION; CHANNELS; DEAFNESS	Sound transduction depends upon mechanosensitive channels localized on the hair-like bundles that project from the apical surface of cochlear hair cells. Hair bundles show a stair-case structure composed of rows of stereocilia, and each stereocilium contains a core of tightly-packed and uniformly-polarized actin filaments. The growth and maintenance of the stereociliary actin core are dynamically regulated. Recently, it was shown that the actin-binding protein gelsolin is expressed in the stereocilia of outer hair cells (OHCs) and in its absence they become long and straggly. Gelsolin is part of a whirlin scaffolding protein complex at the stereocilia tip, which has been shown to interact with other actin regulatory molecules such as Eps8. Here we investigated the physiological effects associated with the absence of gelsolin and its possible overlapping role with Eps8. We found that, in contrast to Eps8, gelsolin does not affect mechanoelectrical transduction during immature stages of development. Moreover, OHCs from gelsolin knockout mice were able to mature into fully functional sensory receptors as judged by the normal resting membrane potential and basolateral membrane currents. Mechanoelectrical transducer current in gelsolin-Eps8 double knockout mice showed a profile similar to that observed in the single mutants for Eps8. We propose that gelsolin has a non-overlapping role with Eps8. While Eps8 is mainly involved in the initial growth of stereocilia in both inner hair cells (IHCs) and OHCs, gelsolin is required for the maintenance of mature hair bundles of low-frequency OHCs after the onset of hearing.	[Olt, Jennifer; Johnson, Stuart L.; Kuhn, Stephanie; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Mburu, Philomena; Parker, Andy; Bowl, Mike; Brown, Steve D. M.] MRC, Mammalian Genet Unit, Harwell, Berks, England	University of Sheffield	Marcotti, W (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	marcotti@sheffield.ac.uk; S.Brown@har.mrc.ac.uk		, Stephanie/0000-0001-6633-9478; Bowl, Michael/0000-0001-7971-445X	Wellcome Trust [091895]; MRC; MRC [MC_U142684175] Funding Source: UKRI; Medical Research Council [MC_U142684175] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (091895) to W.M. and by the MRC to S.D.M.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Furness DN, 2013, P NATL ACAD SCI USA, V110, P13898, DOI 10.1073/pnas.1304644110; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Johnson SL, 2012, J NEUROSCI, V32, P10479, DOI 10.1523/JNEUROSCI.0803-12.2012; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Mburu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011627; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Stepanyan R, 2009, J NEUROSCI, V29, P4023, DOI 10.1523/JNEUROSCI.4566-08.2009; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87331	10.1371/journal.pone.0087331	http://dx.doi.org/10.1371/journal.pone.0087331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475274	Green Accepted, gold, Green Published			2022-12-25	WOS:000330507300169
J	Zayner, JP; Sosnick, TR				Zayner, Josiah P.; Sosnick, Tobin R.			Factors That Control the Chemistry of the LOV Domain Photocycle	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; AVENA-SATIVA; CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; STRUCTURAL-CHANGES; BINDING DOMAINS; PHOTOTROPIN 1; MECHANISM	Algae, plants, bacteria and fungi contain Light-Oxygen-Voltage (LOV) domains that function as blue light sensors to control cellular responses to light. All LOV domains contain a bound flavin chromophore that is reduced upon photon absorption and forms a reversible, metastable covalent bond with a nearby cysteine residue. In Avena sativa LOV2 (AsLOV2), the photocycle is accompanied by an allosteric conformational change that activates the attached phototropin kinase in the full-length protein. Both the conformational change and formation of the cysteinyl-flavin adduct are stabilized by the reduction of the N5 atom in the flavin's isoalloxazine ring. In this study, we perform a mutational analysis to investigate the requirements for LOV2 to photocycle. We mutated all the residues that interact with the chromophore isoalloxazine ring to inert functional groups but none could fully inhibit the photocycle except those to the active-site cysteine. However, electronegative side chains in the vicinity of the chromophore accelerate the N5 deprotonation and the return to the dark state. Mutations to the N414 and Q513 residues identify a potential water gate and H2O coordination sites. These residues affect the electronic nature of the chromophore and photocycle time by helping catalyze the N5 reduction leading to the completion of the photocycle. In addition, we demonstrate that dehydration leads to drastically slower photocycle times. Finally, to investigate the requirements of an active-site cysteine for photocycling, we moved the nearby cysteine to alternative locations and found that some variants can still photocycle. We propose a new model of the LOV domain photocycle that involves all of these components.	[Zayner, Josiah P.; Sosnick, Tobin R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sosnick, Tobin R.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Sosnick, TR (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA.	trsosnic@uchicago.edu	Freed, Karl F/J-7764-2018	Freed, Karl F/0000-0001-6240-2599; Zayner, Josiah/0000-0003-3590-3341	US National Institutes of Health [GM088668, 5T32GM007183-34]; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088668, T32GM007183, R01GM055694] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research and training grants from the US National Institutes of Health (GM088668 to T. R. S. and M. Glotzer, 5T32GM007183-34 to B. Glick), and the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust (to T. R. S., M. Glotzer and E. Weiss). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Alexandre MTA, 2008, PHYS CHEM CHEM PHYS, V10, P6693, DOI 10.1039/b810040c; Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Alexandre MTA, 2009, BIOPHYS J, V97, P238, DOI 10.1016/j.bpj.2009.03.047; Chan RH, 2012, J PHYS CHEM B, V116, P10609, DOI 10.1021/jp304934t; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Circolone F, 2012, J MOL BIOL, V417, P362, DOI 10.1016/j.jmb.2012.01.056; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; FREDDOLINO PL, 2013, PHOTOCHEM PHOTOBIOL; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Kennis JTM, 2004, J AM CHEM SOC, V126, P4512, DOI 10.1021/ja031840r; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lanzl K, 2010, PHYS CHEM CHEM PHYS, V12, P6594, DOI 10.1039/b922408d; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Neiss C, 2003, PHOTOCHEM PHOTOBIOL, V77, P101, DOI 10.1562/0031-8655(2003)077<0101:AIQCIO>2.0.CO;2; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Song SH, 2011, BIOCHEMISTRY-US, V50, P2411, DOI 10.1021/bi200198x; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Yamamoto A, 2008, BIOCHEMISTRY-US, V47, P922, DOI 10.1021/bi701851v; Zayner JP, 2013, BIOPHYS J, V105, P1027, DOI 10.1016/j.bpj.2013.07.010; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	37	72	71	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87074	10.1371/journal.pone.0087074	http://dx.doi.org/10.1371/journal.pone.0087074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475227	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300134
J	Tang, WZ; Cui, JG; Shan, BQ; Wang, C; Zhang, WQ				Tang, Wenzhong; Cui, Jingguo; Shan, Baoqing; Wang, Chao; Zhang, Wenqiang			Heavy Metal Accumulation by Periphyton Is Related to Eutrophication in the Hai River Basin, Northern China	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SPATIAL-DISTRIBUTION; SURFACE SEDIMENTS; RISK-ASSESSMENT; WATER-QUALITY; BOHAI BAY; BIOACCUMULATION; POLLUTION; GROWTH; LAKE	The Hai River Basin (HRB) is one of the most polluted river basins in China. The basin suffers from various types of pollutants including heavy metals and nutrients due to a high population density and rapid economic development in this area. We assessed the relationship between heavy metal accumulation by periphyton playing an important role in fluvial food webs and eutrophication in the HRB. The concentrations of the unicellular diatoms (type A), filamentous algae with diatoms (type B), and filamentous algae (type C) varied along the river, with type A dominating upstream, and types B then C increasing in concentration further downstream, and this was consistent with changes in the trophic status of the river. The mean heavy metal concentrations in the type A, B and C organisms were Cr: 18, 18 and 24 mg/kg, respectively, Ni: 9.2, 10 and 12 mg/kg, respectively, Cu: 8.4, 19 and 29 mg/kg, respectively, and Pb: 11, 9.8 and 7.1 mg/kg respectively. The bioconcentration factors showed that the abilities of the organisms to accumulate Cr, Ni and Pb decreased in the order type A, type B, then type C, but their abilities to accumulate Cu increased in that order. The Ni concentration was a good predictor of Cr, Cu and Pb accumulation by all three periphyton types. Our study shows that heavy metal accumulation by periphyton is associated with eutrophication in the rivers in the HRB.	[Tang, Wenzhong; Shan, Baoqing; Wang, Chao; Zhang, Wenqiang] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing, Peoples R China; [Cui, Jingguo] Beijing Sound Environm Engn Co Ltd, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Shan, BQ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 934, Beijing, Peoples R China.	bqshan@rcees.ac.cn	Tang, Wenzhong/AAM-6971-2020	Tang, Wenzhong/0000-0001-8347-8592	National Natural Science Foundation of China [21107126]; One-Three-Fiver Program of Research Center for Eco-Environmental Sciences [YSW2013B02]; National Water Pollution Control Program [2012ZX07203-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One-Three-Fiver Program of Research Center for Eco-Environmental Sciences; National Water Pollution Control Program	This work was supported by the National Natural Science Foundation of China (No. 21107126), the One-Three-Fiver Program of Research Center for Eco-Environmental Sciences (No. YSW2013B02), and the National Water Pollution Control Program (No. 2012ZX07203-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aji K, 2008, HYDROL PROCESS, V22, P63, DOI 10.1002/hyp.6640; Anishchenko OV, 2010, CENT EUR J BIOL, V5, P125, DOI 10.2478/s11535-009-0060-y; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Biggs B.J.F., 2000, STREAM PERIPHYTON MO; Bowes MJ, 2012, SCI TOTAL ENVIRON, V434, P201, DOI 10.1016/j.scitotenv.2011.09.082; Buck S., 2000, NUTR CRITERIA TECHNI; CAIRNS J, 1986, ENVIRON MONIT ASSESS, V6, P207, DOI 10.1007/BF00396790; Chakravarty R, 2012, BIORESOURCE TECHNOL, V108, P176, DOI 10.1016/j.biortech.2011.12.100; China E. P. A, 2002, MONITORING ANAL METH; Cui JG, 2012, J ENVIRON SCI, V24, P1723, DOI 10.1016/S1001-0742(11)60976-5; Dodds WK, 2006, LIMNOL OCEANOGR, V51, P671, DOI 10.4319/lo.2006.51.1_part_2.0671; Doshi H, 2008, CURR MICROBIOL, V56, P246, DOI 10.1007/s00284-007-9070-z; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Gold C, 2002, WATER RES, V36, P3654, DOI 10.1016/S0043-1354(02)00051-9; Hauer F.R., 2011, METHODS STREAM ECOLO; Hill WR, 1996, CAN J FISH AQUAT SCI, V53, P812, DOI 10.1139/cjfas-53-4-812; Hu BQ, 2013, ENVIRON SCI POLLUT R, V20, P4099, DOI 10.1007/s11356-012-1332-z; Huang HJ, 2011, BIORESOURCE TECHNOL, V102, P10346, DOI 10.1016/j.biortech.2011.08.117; Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071176; KELLY MG, 1995, HYDROBIOLOGIA, V302, P179, DOI 10.1007/BF00032108; Kelly MG, 1998, ENVIRON CONSERV, V25, P22, DOI 10.1017/S037689299800006X; Maltais MJ, 1997, CAN J BOT, V75, P1556, DOI 10.1139/b97-868; Moreira-Santos M, 2004, ENVIRON TOXICOL CHEM, V23, P1549, DOI 10.1897/03-389; Morin S, 2008, ENVIRON POLLUT, V151, P532, DOI 10.1016/j.envpol.2007.04.023; NEWMAN MC, 1989, ENVIRON POLLUT, V60, P83, DOI 10.1016/0269-7491(89)90222-4; NIELSEN ES, 1971, PHYSIOL PLANTARUM, V24, P480, DOI 10.1111/j.1399-3054.1971.tb03522.x; Qiu YW, 2011, ECOTOX ENVIRON SAFE, V74, P284, DOI 10.1016/j.ecoenv.2010.10.008; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Sekar R, 2002, FRESHWATER BIOL, V47, P1893, DOI 10.1046/j.1365-2427.2002.00936.x; STERNER RW, 1993, ECOLOGY, V74, P2351, DOI 10.2307/1939587; Suresh G, 2012, ECOTOX ENVIRON SAFE, V84, P117, DOI 10.1016/j.ecoenv.2012.06.027; Tang WZ, 2010, J HAZARD MATER, V176, P945, DOI 10.1016/j.jhazmat.2009.11.131; Vis C, 1998, ENVIRON POLLUT, V101, P13, DOI 10.1016/S0269-7491(98)00042-6; WANG HK, 1984, ENVIRON SCI TECHNOL, V18, P106, DOI 10.1021/es00120a011	34	13	16	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86458	10.1371/journal.pone.0086458	http://dx.doi.org/10.1371/journal.pone.0086458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24482681	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100170
J	Valdes, R; Elferich, J; Shinde, U; Landfear, SM				Valdes, Raquel; Elferich, Johannes; Shinde, Ujwal; Landfear, Scott M.			Identification of the Intracellular Gate for a Member of the Equilibrative Nucleoside Transporter ( ENT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Gating; Nucleoside Nucleotide Transport; Purine; Transporters	NUCLEOBASE TRANSPORTER; LEISHMANIA-DONOVANI; CRYSTAL-STRUCTURE; STRUCTURAL MODEL; LACTOSE PERMEASE; CHEMOTHERAPY; EXPRESSION; SYMPORTER; PROXIMITY; MECHANISM	Background: Equilibrative nucleoside transporters (ENTs) play important roles in biology and disease. Results: The intracellular gate for an ENT, LdNT1.1, has been identified by computational and experimental methods. Conclusion: The intracellular gate consists of the ends of four transmembrane helices. Significance: An important functional component of ENTs has been identified. Equilibrative nucleoside transporters of the SLC29 family play important roles in many physiological and pharmacological processes, including import of drugs for treatment of cancer, AIDS, cardiovascular, and parasitic diseases. However, no crystal structure is available for any member of this family. In previous studies we generated a computational model of the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1) that captured this permease in the outward-closed conformation, and we identified the extracellular gate. In the present study we have modeled the inward-closed conformation of LdNT1.1 using the crystal structure of the Escherichia coli fucose transporter FucP and have identified four transmembrane helices whose ends close to form a predicted intracellular gate. We have tested this prediction by site-directed mutagenesis of relevant helix residues and by cross-linking of introduced cysteine pairs. The results are consistent with the predictions of the computational model and suggest that a similarly constituted gate operates in other members of the equilibrative nucleoside transporter family.	[Valdes, Raquel; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Elferich, Johannes; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu		Landfear, Scott/0000-0002-1643-6664; Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health [AI44138]; National Science Foundation [0746589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138, R01AI023682] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0746589] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44138 (to S. M. L.). This work was also supported by National Science Foundation Grant 0746589 (to U.S.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; Detke S, 2007, EXP CELL RES, V313, P1963, DOI 10.1016/j.yexcr.2007.02.027; DREW ME, 1995, MOL CELL BIOL, V15, P5508; Etchebest C, 2010, METHODS MOL BIOL, V654, P363, DOI 10.1007/978-1-60761-762-4_19; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kavanaugh MP, 1998, P NATL ACAD SCI USA, V95, P12737, DOI 10.1073/pnas.95.22.12737; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LEBOWITZ JH, 1994, METHOD CELL BIOL, V45, P65; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Ortiz D, 2010, MOL MICROBIOL, V78, P108, DOI 10.1111/j.1365-2958.2010.07328.x; Ortiz D, 2009, J BIOL CHEM, V284, P16164, DOI 10.1074/jbc.M109.006718; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; TAYLOR WR, 1994, J BIOTECHNOL, V35, P281, DOI 10.1016/0168-1656(94)90042-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Wu JH, 1997, J MOL BIOL, V270, P285, DOI 10.1006/jmbi.1997.1099; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young J.D., 2003, RED CELL MEMBRANE TR, P321; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4; Zhang XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025822; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	50	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8799	8809		10.1074/jbc.M113.546960	http://dx.doi.org/10.1074/jbc.M113.546960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24497645	hybrid, Green Published			2022-12-25	WOS:000333472100006
J	DeBalsi, KL; Wong, KE; Koves, TR; Slentz, DH; Seiler, SE; Wittmann, AH; Ilkayeva, OR; Stevens, RD; Perry, CGR; Lark, DS; Hui, ST; Szweda, L; Neufer, PD; Muoio, DM				DeBalsi, Karen L.; Wong, Kari E.; Koves, Timothy R.; Slentz, Dorothy H.; Seiler, Sarah E.; Wittmann, April H.; Ilkayeva, Olga R.; Stevens, Robert D.; Perry, Christopher G. R.; Lark, Daniel S.; Hui, Simon T.; Szweda, Luke; Neufer, P. Darrell; Muoio, Deborah M.			Targeted Metabolomics Connects Thioredoxin-interacting Protein (TXNIP) to Mitochondrial Fuel Selection and Regulation of Specific Oxidoreductase Enzymes in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Energy Metabolism; Ketone Body Metabolism; Mitochondrial Metabolism; Redox; Skeletal Muscle Metabolism; Branched Chain Amino Acids; Thioredoxin Interacting Protein	CARNITINE PALMITOYLTRANSFERASE-I; ACID DEHYDROGENASE COMPLEX; CELLULAR REDOX STATE; INSULIN STIMULATION; OXIDATIVE STRESS; CHAIN; DELETION; CYCLE; METABOLISM; RESISTANCE	Background: Thioredoxin-interacting protein (TXNIP) is a redox sensor that opposes glucose uptake and glycolytic metabolism. Results: TXNIP-deficient skeletal muscles lose capacity for ketone and branched chain amino acid oxidation due to deficits in specific mitochondrial dehydrogenases. Conclusion: TXNIP permits muscle use of alternative respiratory fuels during glucose deprivation. Significance: Dysregulation of TXNIP might contribute to aberrant fuel selection in the context of metabolic disease. Thioredoxin-interacting protein (TXNIP) is an -arrestin family member involved in redox sensing and metabolic control. Growing evidence links TXNIP to mitochondrial function, but the molecular nature of this relationship has remained poorly defined. Herein, we employed targeted metabolomics and comprehensive bioenergetic analyses to evaluate oxidative metabolism and respiratory kinetics in mouse models of total body (TKO) and skeletal muscle-specific (TXNIPSKM-/-) Txnip deficiency. Compared with littermate controls, both TKO and TXNIPSKM-/- mice had reduced exercise tolerance in association with muscle-specific impairments in substrate oxidation. Oxidative insufficiencies in TXNIP null muscles were not due to perturbations in mitochondrial mass, the electron transport chain, or emission of reactive oxygen species. Instead, metabolic profiling analyses led to the discovery that TXNIP deficiency causes marked deficits in enzymes required for catabolism of branched chain amino acids, ketones, and lactate, along with more modest reductions in enzymes of -oxidation and the tricarboxylic acid cycle. The decrements in enzyme activity were accompanied by comparable deficits in protein abundance without changes in mRNA expression, implying dysregulation of protein synthesis or stability. Considering that TXNIP expression increases in response to starvation, diabetes, and exercise, these findings point to a novel role for TXNIP in coordinating mitochondrial fuel switching in response to nutrient availability.	[DeBalsi, Karen L.; Wong, Kari E.; Koves, Timothy R.; Slentz, Dorothy H.; Seiler, Sarah E.; Wittmann, April H.; Ilkayeva, Olga R.; Stevens, Robert D.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Durham, NC 27704 USA; [DeBalsi, Karen L.; Seiler, Sarah E.; Muoio, Deborah M.] Duke Univ, Dept Pharmacol, Durham, NC 27704 USA; [DeBalsi, Karen L.; Seiler, Sarah E.; Muoio, Deborah M.] Duke Univ, Dept Canc Biol, Durham, NC 27704 USA; [Perry, Christopher G. R.; Lark, Daniel S.; Neufer, P. Darrell] E Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Perry, Christopher G. R.; Lark, Daniel S.; Neufer, P. Darrell] E Carolina Univ, Dept Physiol, Greenville, NC 27858 USA; [Hui, Simon T.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Szweda, Luke] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Duke University; Duke University; Duke University; Duke University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of California System; University of California Los Angeles; Oklahoma Medical Research Foundation	Muoio, DM (corresponding author), Independence Pk Facil, 4321 Med Pk Dr,Suite 200, Durham, NC 27704 USA.	muoio@duke.edu	Koves, Tim/I-4806-2012; Muoio, Debbie Marie/E-1147-2012	Koves, Tim/0000-0001-8763-5866; Lark, Daniel/0000-0001-8386-8478; Muoio, Deborah/0000-0003-3760-9277	National Institutes of Health Grants from the United States Public Health Service [P01DK058398, R01DK080339]; American Heart Association Mid-Atlantic Affiliate Predoctoral Fellowship [10PRE4140033]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK080339, R01DK073488] Funding Source: NIH RePORTER	National Institutes of Health Grants from the United States Public Health Service; American Heart Association Mid-Atlantic Affiliate Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01DK058398 (to D. M. M.) and R01DK080339 (to S. H.) from the United States Public Health Service and an American Heart Association Mid-Atlantic Affiliate Predoctoral Fellowship 10PRE4140033 (to K. L. D.).	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bunik V, 1999, PROTEIN SCI, V8, P65; Bunik VI, 2003, EUR J BIOCHEM, V270, P1036, DOI 10.1046/j.1432-1033.2003.03470.x; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Elustondo PA, 2013, J BIOL CHEM, V288, P25309, DOI 10.1074/jbc.M113.476648; FUJII H, 1994, BBA-GEN SUBJECTS, V1199, P130, DOI 10.1016/0304-4165(94)90107-4; GRINBLAT L, 1986, BIOCHEM J, V240, P49, DOI 10.1042/bj2400049; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Hale DE, 1997, CLIN CHEM, V43, P273; Holecek M, 2001, PHYSIOL RES, V50, P19; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Jacobs RA, 2013, AM J PHYSIOL-ENDOC M, V304, pE686, DOI 10.1152/ajpendo.00476.2012; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Koeberl DD, 2003, PEDIATR RES, V54, P219, DOI 10.1203/01.PDR.0000074972.36356.89; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kuznetsov AV, 1996, EUR J BIOCHEM, V241, P909, DOI 10.1111/j.1432-1033.1996.00909.x; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Muoio DM, 1999, AM J PHYSIOL-ENDOC M, V276, pE913, DOI 10.1152/ajpendo.1999.276.5.E913; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; SHIMOMURA Y, 1995, J NUTR, V125, pS1762; Soeters MR, 2012, METABOLISM, V61, P966, DOI 10.1016/j.metabol.2011.11.009; Spindel ON, 2012, ANTIOXID REDOX SIGN, V16, P587, DOI 10.1089/ars.2011.4137; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	59	42	42	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8106	8120		10.1074/jbc.M113.511535	http://dx.doi.org/10.1074/jbc.M113.511535			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24482226	hybrid, Green Published			2022-12-25	WOS:000333157500009
J	Wang, CC; Man, GCW; Chu, CY; Borchert, A; Ugun-Klusek, A; Billett, EE; Kuhn, H; Ufer, C				Wang, Chi Chiu; Man, Gene Chi Wai; Chu, Ching Yan; Borchert, Astrid; Ugun-Klusek, Aslihan; Billett, E. Ellen; Kuehn, Hartmut; Ufer, Christoph			Serotonin Receptor 6 Mediates Defective Brain Development in Monoamine Oxidase A-deficient Mouse Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Eicosanoid; Embryo; Oxidase; Receptors; Serotonin; Signaling	PROGRAMMED CELL-DEATH; KNOCK-OUT MICE; TRYPTOPHAN-HYDROXYLASE; BCL-2 EXPRESSION; GENE-EXPRESSION; CEREBRAL-CORTEX; KINASE PATHWAY; MAO-A; APOPTOSIS; ACTIVATION	Background: Monoamine oxidase A (MAO-A) catalyzes the degradation of neurotransmitters such as serotonin. Results: Knockdown of MAO-A expression in embryos induces high serotonin levels and abnormal brain development, which can be rescued by inactivation of serotonin receptor-6 (5-Htr6). Conclusion: 5-Htr6 activation is vital for early development of the embryonic brain. Significance: Serotonin signaling and metabolism are important in early embryos. Monoamine oxidases A and B (MAO-A and MAO-B) are enzymes of the outer mitochondrial membrane that metabolize biogenic amines. In the adult central nervous system, MAOs have important functions for neurotransmitter homeostasis. Expression of MAO isoforms has been detected in the developing embryo. However, suppression of MAO-B does not induce developmental alterations. In contrast, targeted inhibition and knockdown of MAO-A expression (E7.5-E10.5) caused structural abnormalities in the brain. Here we explored the molecular mechanisms underlying defective brain development induced by MAO-A knockdown during in vitro embryogenesis. The developmental alterations were paralleled by diminished apoptotic activity in the affected neuronal structures. Moreover, dysfunctional MAO-A expression led to elevated levels of embryonic serotonin (5-hydroxytryptamine (5-HT)), and we found that knockdown of serotonin receptor-6 (5-Htr6) expression or pharmacologic inhibition of 5-Htr6 activity rescued the MAO-A knockdown phenotype and restored apoptotic activity in the developing brain. Our data suggest that excessive 5-Htr6 activation reduces activation of caspase-3 and -9 of the intrinsic apoptotic pathway and enhances expression of antiapoptotic proteins Bcl-2 and Bcl-XL. Moreover, we found that elevated 5-HT levels in MAO-A knockdown embryos coincided with an enhanced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and a reduction of proliferating cell numbers. In summary, our findings suggest that excessive 5-HT in MAO-A-deficient mouse embryos triggers cellular signaling cascades via 5-Htr6, which suppresses developmental apoptosis in the brain and thus induces developmental retardations.	[Wang, Chi Chiu; Man, Gene Chi Wai; Chu, Ching Yan] Chinese Univ Hong Kong, Sch Biomed Sci, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Borchert, Astrid; Kuehn, Hartmut; Ufer, Christoph] Charite, Inst Biochem, D-10117 Berlin, Germany; [Ugun-Klusek, Aslihan; Billett, E. Ellen] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Nottingham Trent University	Ufer, C (corresponding author), Charite, Inst Biochem, Charitepl 1, D-10117 Berlin, Germany.	christoph.ufer@charite.de	Wang, Ronald/C-6541-2014; Man, Gene Chi-Wai/AAH-4865-2019	Wang, Ronald/0000-0002-3928-7278; Man, Gene Chi-Wai/0000-0002-8608-9688; Billett, Ellen/0000-0001-8245-6519; Ugun Klusek, Aslihan/0000-0002-0199-0275; Borchert, Astrid/0000-0003-3551-5592				Amireault P, 2005, MOL PHARMACOL, V68, P1678, DOI 10.1124/mol.104.010124; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Anderson DG, 2011, J BIOL CHEM, V286, P26978, DOI 10.1074/jbc.M111.249532; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; Basu B, 2008, REPRODUCTION, V135, P657, DOI 10.1530/REP-07-0577; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Billett EE, 2004, NEUROTOXICOLOGY, V25, P139, DOI 10.1016/S0161-813X(03)00094-9; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Bortolato M, 2011, NEUROPSYCHOPHARMACOL, V36, P2674, DOI 10.1038/npp.2011.157; Bou-Flores C, 2000, J NEUROSCI, V20, P4646, DOI 10.1523/JNEUROSCI.20-12-04646.2000; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Bras H, 2008, EUR J NEUROSCI, V28, P1097, DOI 10.1111/j.1460-9568.2008.06407.x; Brown P, 2006, J COMP NEUROL, V498, P415, DOI 10.1002/cne.21034; Burke WJ, 1999, BRAIN RES, V816, P633, DOI 10.1016/S0006-8993(98)01211-6; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chen K, 2005, J BIOL CHEM, V280, P11552, DOI 10.1074/jbc.M410033200; Chen K, 2004, NEUROTOXICOLOGY, V25, P31, DOI 10.1016/S0161-813X(03)00113-X; Cheng AW, 2010, J NEUROSCI, V30, P10752, DOI 10.1523/JNEUROSCI.2037-10.2010; Chiou SH, 2006, BRIT J PHARMACOL, V148, P587, DOI 10.1038/sj.bjp.0706766; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Desire L, 2000, J NEUROCHEM, V75, P151, DOI 10.1046/j.1471-4159.2000.0750151.x; Edmondson DE, 2009, BIOCHEMISTRY-US, V48, P4220, DOI 10.1021/bi900413g; Fidalgo S, 2013, BIOGERONTOLOGY, V14, P21, DOI 10.1007/s10522-012-9406-3; Fitzgerald JC, 2007, J NEUROCHEM, V103, P2189, DOI 10.1111/j.1471-4159.2007.04921.x; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Inaba-Hasegawa K, 2012, J NEURAL TRANSM, V119, P405, DOI 10.1007/s00702-011-0730-6; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jaworski J, 2003, J NEUROSCI, V23, P4519; Marazziti D, 2013, CURR MED CHEM, V20, P371; Nakamura K, 2007, MOL NEUROBIOL, V35, P45, DOI 10.1007/BF02700623; Naoi M, 2009, J NEURAL TRANSM, V116, P1371, DOI 10.1007/s00702-009-0309-7; Nicotra A, 2004, NEUROTOXICOLOGY, V25, P155, DOI 10.1016/S0161-813X(03)00095-0; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Persico AM, 2003, NEUROREPORT, V14, P341, DOI 10.1097/01.wnr.0000058244.21747.83; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Saito M, 2014, BRAIN DEV-JPN, V36, P64, DOI 10.1016/j.braindev.2013.01.004; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Shih JC, 1999, BRAIN RES, V835, P104, DOI 10.1016/S0006-8993(99)01478-X; Stankovski L, 2007, J NEUROSCI, V27, P1315, DOI 10.1523/JNEUROSCI.4395-06.2007; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Ufer C, 2010, ANTIOXID REDOX SIGN, V13, P833, DOI 10.1089/ars.2009.3044; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; VANMAELEFABRY G, 1990, TOXICOL IN VITRO, V4, P149, DOI 10.1016/0887-2333(90)90037-T; Vitalis T, 2007, EUR J NEUROSCI, V26, P331, DOI 10.1111/j.1460-9568.2007.05661.x; Walther DJ, 1999, MOL BRAIN RES, V68, P55, DOI 10.1016/S0169-328X(99)00046-7; Wang CC, 2013, CELL MOL LIFE SCI, V70, P599, DOI 10.1007/s00018-012-1065-7; Wang CC, 2011, J BIOL CHEM, V286, P28322, DOI 10.1074/jbc.M111.241422; Wang ZQ, 2011, J NEURAL TRANSM, V118, P997, DOI 10.1007/s00702-011-0655-0; Watts SW, 2001, J CARDIOVASC PHARM, V38, P539, DOI 10.1097/00005344-200110000-00006; Weiss KM, 2000, THEOR POPUL BIOL, V57, P187, DOI 10.1006/tpbi.2000.1460; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yi H, 2006, J NEURAL TRANSM, V113, P21, DOI 10.1007/s00702-005-0299-z; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	62	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8252	8263		10.1074/jbc.M113.522094	http://dx.doi.org/10.1074/jbc.M113.522094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497636	hybrid, Green Published			2022-12-25	WOS:000333157500020
J	Taniguchi, R; Fukushima, H; Osawa, K; Maruyama, T; Yasuda, H; Weih, F; Doi, T; Maki, K; Jimi, E				Taniguchi, Rei; Fukushima, Hidefumi; Osawa, Kenji; Maruyama, Toshimasa; Yasuda, Hisataka; Weih, Falk; Doi, Takahiro; Maki, Kenshi; Jimi, Eijiro			RelB-induced Expression of Cot, an MAP3K Family Member, Rescues RANKL-induced Osteoclastogenesis in Alymphoplasia Mice by Promoting NF-kappa B2 Processing by IKK alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; NF-kappaB; Osteoclast; Phosphorylation; Signal Transduction	NF-KAPPA-B; PROTEIN-KINASE; DIFFERENTIATION; PHOSPHORYLATION; ACTIVATION; AKT2; P100; INDUCTION; REGULATOR; RECEPTOR	Background: The alternative NF-B pathway plays important roles in osteoclastogenesis through an unknown mechanism. Results: RelB-induced Cot expression rescues RANKL-induced osteoclastogenesis in cells isolated from aly/aly mice, which lack active NIK. Conclusion: The overexpression of RelB rescues RANKL-induced osteoclastogenesis by Cot/IKK-induced NF-B2 processing in aly/aly cells. Significance: The Akt/Cot/IKK pathway that is induced by RelB contributes to RANKL-induced osteoclastogenesis by activating the alternative NF-B pathway. The alternative nuclear factor-B (NF-B) pathway, mainly the RelB-p52 heterodimer, plays important roles in bone metabolism through an unknown mechanism. We have previously reported that alymphoplasia (aly/aly) mice, which lack active NF-B-inducing kinase (NIK), show mild osteopetrosis due to the inhibition of osteoclastogenesis. p100 retains RelB in the cytoplasm and inhibits RANKL-induced osteoclastogenesis in aly/aly cells. Furthermore, the overexpression of RelB in aly/aly cells rescues RANKL-induced osteoclastogenesis by inducing p100 processing. In contrast, the overexpression of p65 in aly/aly cells has no effect. However, the overexpression of RelB fails to rescue RANKL-induced osteoclastogenesis in the presence of p100GRR, which cannot be processed to p52, suggesting that p100 processing is a key step in RelB-rescued, RANKL-induced osteoclastogenesis in aly/aly cells. In this study, Cot (cancer Osaka thyroid), an MAP3K, was up-regulated by RelB overexpression. Analysis of the Cot promoter demonstrated that p65 and RelB bound to the distal NF-B-binding site and that RelB but not p65 bound to the proximal NF-B-binding site in the Cot promoter. The knocking down of Cot expression significantly reduced the RANKL-induced osteoclastogenesis induced by RelB overexpression. The phosphorylation of IKK at threonine 23 and its kinase activity were indispensable for the processing of p100 and osteoclastogenesis by RelB-induced Cot. Finally, constitutively activated Akt enhanced osteoclastogenesis by RelB-induced Cot, and a dominant-negative form of Akt significantly inhibited it. Taken together, these results indicate that the overexpression of RelB restores RANKL-induced osteoclastogenesis by activation of Akt/Cot/IKK-induced p100 processing.	[Taniguchi, Rei; Fukushima, Hidefumi; Osawa, Kenji; Maruyama, Toshimasa; Jimi, Eijiro] Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Taniguchi, Rei; Maki, Kenshi] Kyushu Dent Univ, Dept Hlth Improvement, Div Dev Stomatognath Funct Sci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan; [Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, Res Grp Immunol, D-07745 Jena, Germany; [Doi, Takahiro] RIKEN BioResource Ctr, Technol & Dev Team BioSignal Program, Subteam BioSignal Integrat, Tsukuba, Ibaraki 3050074, Japan; [Jimi, Eijiro] Kyushu Dent Univ, Oral Biol Res Ctr, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan	Kyushu Dental University; Kyushu Dental University; Oriental Yeast Co., Ltd.; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); RIKEN; Kyushu Dental University	Jimi, E (corresponding author), Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	ejimi@kyu-dent.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390424, 23593039, 24890214]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 23390424 (to E. J.), 23593039 (to M. K.), and 24890214 (to K. O.).	Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Heusch M, 1999, ONCOGENE, V18, P6201, DOI 10.1038/sj.onc.1203022; Hirata K, 2010, BIOL PHARM BULL, V33, P133, DOI 10.1248/bpb.33.133; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 1999, J IMMUNOL, V163, P434; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kuroda Y, 2012, MOL CELL BIOL, V32, P2954, DOI 10.1128/MCB.05611-11; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Macpherson AJ, 2003, IMMUNOGENETICS, V54, P693, DOI 10.1007/s00251-002-0517-x; Maruyama T, 2010, J BONE MINER RES, V25, P1058, DOI 10.1359/jbmr.091032; Matsuo K, 2012, CELL ADHES MIGR, V6, P148, DOI 10.4161/cam.20888; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ozes ON, 1999, NATURE, V401, P82; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Soysa NS, 2010, J BONE MINER RES, V25, P809, DOI 10.1359/jbmr.091030; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tanaka S, 2013, WORLD J ORTHOP, V4, P1, DOI 10.5312/wjo.v4.i1.1; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	45	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7349	7361		10.1074/jbc.M113.538314	http://dx.doi.org/10.1074/jbc.M113.538314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24488495	Green Published, hybrid			2022-12-25	WOS:000332761500008
J	Cibiel, A; Quang, NN; Gombert, K; Theze, B; Garofalakis, A; Duconge, F				Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic			From Ugly Duckling to Swan: Unexpected Identification from Cell-SELEX of an Anti-Annexin A2 Aptamer Targeting Tumors	PLOS ONE			English	Article							SYSTEMATIC EVOLUTION; EXPONENTIAL ENRICHMENT; LIVE CELLS; RNA; LIGANDS; BINDING; PROTEIN; TOMOGRAPHY; POLYMERASE; SELECTION	Background: Cell-SELEX is now widely used for the selection of aptamers against cell surface biomarkers. However, despite negative selection steps using mock cells, this method sometimes results in aptamers against undesirable targets that are expressed both on mock and targeted cells. Studying these junk aptamers might be useful for further applications than those originally envisaged. Methodology/Principal Findings: Cell-SELEX was performed to identify aptamers against CHO-K1 cells expressing human Endothelin type B receptor (ETBR). CHO-K1 cells were used for negative selection of aptamers. Several aptamers were identified but no one could discriminate between both cell lines. We decided to study one of these aptamers, named ACE4, and we identified that it binds to the Annexin A2, a protein overexpressed in many cancers. Radioactive binding assays and flow cytometry demonstrated that the aptamer was able to bind several cancer cell lines from different origins, particularly the MCF-7 cells. Fluorescence microscopy revealed it could be completely internalized in cells in 2 hours. Finally, the tumor targeting of the aptamer was evaluated in vivo in nude mice xenograft with MCF-7 cells using fluorescence diffuse optical tomography (fDOT) imaging. Three hours after intravenous injection, the aptamer demonstrated a significantly higher uptake in the tumor compared to a scramble sequence. Conclusions/Significance: Although aptamers could be selected during cell-SELEX against other targets than those initially intended, they represent a potential source of ligands for basic research, diagnoses and therapy. Here, studying such aptamers, we identify one with high affinity for Annexin A2 that could be a promising tool for biomedical application.	[Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic] SHFJ, Intitut Imagerie Biomed I2BM, Commissariat Energie Atom & Energies Alternat CEA, DSV, Orsay, France; [Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic] Univ Paris 11, INSERM, U1023, Lab Imagerie Mol Expt, F-91405 Orsay, France; [Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic] Univ Paris 11, Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Duconge, F (corresponding author), SHFJ, Intitut Imagerie Biomed I2BM, Commissariat Energie Atom & Energies Alternat CEA, DSV, Orsay, France.	frederic.duconge@cea.fr	Duconge, Frederic/C-6729-2012; Quang, Nam Nguyen/E-8234-2013; Garofalakis, Anikitos/AAU-7459-2020	Duconge, Frederic/0000-0002-8595-0050; Quang, Nam Nguyen/0000-0001-9321-155X; 	Agence Nationale pour la Recherche; FMT-XCT European program [201792]; European Molecular Imaging Laboratory (EMIL) network [EU] [LSH-2004-503569]; CEA-irtelis	Agence Nationale pour la Recherche(French National Research Agency (ANR)); FMT-XCT European program; European Molecular Imaging Laboratory (EMIL) network [EU]; CEA-irtelis	This work was supported by grants from the "Agence Nationale pour la Recherche" [projects ANR-RNTS TomoFluo3D, ANR-PNANO nanorings and under the frame of Euro- NanoMed (project META)]; the FMT-XCT European program [Grant agreement no. 201792] and the European Molecular Imaging Laboratory (EMIL) network [EU contract LSH-2004-503569]. AC was supported by a PhD fellowship [CEA-irtelis]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard B, 2011, DNA CELL BIOL, V30, P727, DOI 10.1089/dna.2011.1239; Aquino-Jarquin G, 2011, INT J MOL SCI, V12, P9155, DOI 10.3390/ijms12129155; Aukrust I, 2007, J MOL BIOL, V368, P1367, DOI 10.1016/j.jmb.2007.02.094; Berezovski MV, 2008, J AM CHEM SOC; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cibiel A, 2011, PHARMACEUTICALS-BASE, V4, P1216, DOI 10.3390/ph4091216; Cibiel A, 2012, BIOCHIMIE, V94, P1595, DOI 10.1016/j.biochi.2012.02.025; Da Pieve C, 2009, NUCL MED BIOL, V36, P703, DOI 10.1016/j.nucmedbio.2009.04.004; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Dassah M, 2009, GEN PHYSIOL BIOPHYS, V28, pF20; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Dua P, 2011, METHODS, V54, P215, DOI 10.1016/j.ymeth.2011.02.002; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Garofalakis A, 2010, OPT LETT, V35, P3024, DOI 10.1364/OL.35.003024; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Grimshaw MJ, 2004, CANCER RES, V64, P2461, DOI 10.1158/0008-5472.CAN-03-1069; Gu F, 2008, P NATL ACAD SCI US; Hansske F, 1979, Methods Enzymol, V59, P172; Herve L, 2007, APPL OPTICS, V46, P4896, DOI 10.1364/AO.46.004896; Hicke BJ, 2006, J NUCL MED, V47, P668; Hwang DW, 2010, J NUCL MED, V51, P98, DOI 10.2967/jnumed.109.069880; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kesavan K, 2010, J BIOL CHEM, V285, P4366, DOI 10.1074/jbc.M109.066092; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Li N., 2009, J PROTEOME RES; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Meyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071798; Ohuchi S, 2012, BIORESEARCH OPEN ACC, V1, P265, DOI 10.1089/biores.2012.0253; Ohuchi Shoji P, 2005, Nucleic Acids Symp Ser (Oxf), P351; Ohuchi SP, 2006, BIOCHIMIE; Palchetti I, 2012, ANAL BIOANAL CHEM, V402, P3103, DOI 10.1007/s00216-012-5769-1; Parekh P, 2010, ANAL CHEM, V82, P8642, DOI 10.1021/ac101801j; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Pestourie C, 2005, BIOCHIMIE, V87, P921, DOI 10.1016/j.biochi.2005.04.013; Pestourie C, 2006, OLIGONUCLEOTIDES, V16, P323, DOI 10.1089/oli.2006.16.323; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Sousa R, 2000, METHOD ENZYMOL, V317, P65; Sun W, 2011, CURR PHARM DESIGN, V17, P80, DOI 10.2174/138161211795049769; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Tavitian B, 2009, EUR J NUCL MED MOL I, V36, P1475, DOI 10.1007/s00259-009-1192-z; Thiel WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043836; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ulrich H, 2009, DIS SPECIFIC BIOMARK; Wang CL, 2003, J BIOTECHNOL, V102, P15, DOI 10.1016/S0168-1656(02)00360-7; Wang RE, 2011, CURR MED CHEM, V18, P4175; Zhou J, 2008, MOL THER; Zueva E, 2011, INT J CANCER, V128, P797, DOI 10.1002/ijc.25401	53	29	30	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87002	10.1371/journal.pone.0087002	http://dx.doi.org/10.1371/journal.pone.0087002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489826	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000091
J	Range, F; Viranyi, Z				Range, Friederike; Viranyi, Zsofia			Wolves Are Better Imitators of Conspecifics than Dogs	PLOS ONE			English	Article							HUMAN POINTING GESTURES; FREE-RANGING DOGS; CANIS-FAMILIARIS; GENETIC-EVIDENCE; DOMESTIC DOGS; EVOLUTION; BEHAVIOR; LUPUS; WOLF; DISCRIMINATION	Domestication is thought to have influenced the cognitive abilities of dogs underlying their communication with humans, but little is known about its effect on their interactions with conspecifics. Since domestication hypotheses offer limited predictions in regard to wolf-wolf compared to dog-dog interactions, we extend the cooperative breeding hypothesis suggesting that the dependency of wolves on close cooperation with conspecifics, including breeding but also territory defense and hunting, has created selection pressures on motivational and cognitive processes enhancing their propensity to pay close attention to conspecifics' actions. During domestication, dogs' dependency on conspecifics has been relaxed, leading to reduced motivational and cognitive abilities to interact with conspecifics. Here we show that 6-month-old wolves outperform same aged dogs in a two-action-imitation task following a conspecific demonstration. While the wolves readily opened the apparatus after a demonstration, the dogs failed to solve the problem. This difference could not be explained by differential motivation, better physical insight of wolves, differential developmental pathways of wolves and dogs or a higher dependency of dogs from humans. Our results are best explained by the hypothesis that higher cooperativeness may come together with a higher propensity to pay close attention to detailed actions of others and offer an alternative perspective to domestication by emphasizing the cooperativeness of wolves as a potential source of dog-human cooperation.	[Range, Friederike; Viranyi, Zsofia] Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Range, Friederike; Viranyi, Zsofia] Wolf Sci Ctr, Ernstbrunn, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Range, F (corresponding author), Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.	friederike.range@vetmeduni.ac.at		Range, Friederike/0000-0003-3127-5536	Austrian Science Fund (FWF) [P21244-B17]; ERC [311870]; WWTF [CS11-026]; Austrian Science Fund (FWF) [P 21244] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); WWTF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was financially supported by Austrian Science Fund (FWF) project P21244-B17. Writing was supported by ERC Starting Grant CanCoop (311870) to the first and by the WWTF project CS11-026 to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardalan A, 2011, ECOL EVOL, V1, P373, DOI 10.1002/ece3.35; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bonanni R, 2010, ANIM BEHAV, V79, P957, DOI 10.1016/j.anbehav.2010.01.016; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2010, ANIM COGN, V13, P1, DOI 10.1007/s10071-009-0263-7; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Feddersen-Petersen D.U., 2004, HUNDEPSYCHOLOGIE; Fiset S., 2013, Open Journal of Animal Sciences, V3, P1; Fiset S, 2013, J COMP PSYCHOL, V127, P115, DOI 10.1037/a0030595; FRANK H, 1985, J COMP PSYCHOL, V99, P266, DOI 10.1037/0735-7036.99.3.266; FRANK H, 1982, APPL ANIM ETHOL, V8, P507, DOI 10.1016/0304-3762(82)90215-2; FRANK H, 1989, B PSYCHONOMIC SOC, V27, P455; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; FRANK H, 1980, Z TIERPSYCHOL, V53, P389; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Hare B, 2005, TRENDS COGN SCI, V9, P464, DOI 10.1016/j.tics.2005.08.010; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Heyes C, 2009, PHILOS T R SOC B, V364, P2293, DOI 10.1098/rstb.2009.0049; Heyes CM, 2013, SIGNALLING COMMITMEN; Hopkins WD, 2002, ANIM COGN, V5, P27, DOI 10.1007/s10071-001-0121-8; Hrdy S.B., 2005, ATTACHMENT BONDING N, P9, DOI DOI 10.1016/J.GLOENVCHA.2013.12.001; Huber L, 2013, LEARN MOTIV, V44, P258, DOI 10.1016/j.lmot.2013.04.005; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Mech L. David, 2003, P1; Mech L. David, 1970, WOLF ECOLOGY BEHAV E; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Pal SK, 2005, APPL ANIM BEHAV SCI, V90, P31, DOI 10.1016/j.applanim.2004.08.002; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Paukner A, 2009, SCIENCE, V325, P880, DOI 10.1126/science.1176269; Pongracz P, 2004, J COMP PSYCHOL, V118, P375, DOI 10.1037/0735-7036.118.4.375; Range F, 2007, ANIM BEHAV, V73, P1033, DOI 10.1016/j.anbehav.2006.07.015; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Range F, 2012, ANIM COGN, V15, P597, DOI 10.1007/s10071-012-0488-8; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Scott JP., 1965, GENETICS SOCIAL BEHA; Slabbert JM, 1997, APPL ANIM BEHAV SCI, V53, P309, DOI 10.1016/S0168-1591(96)01163-X; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Topal J, 1997, ANTHROZOOS, V10, P214, DOI 10.2752/089279397787000987; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Valentini F, 2012, VISUAL PERCEPTION DO; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Viranyi Zs, 2008, LEARNING ANIMALS; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y	55	57	57	1	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86559	10.1371/journal.pone.0086559	http://dx.doi.org/10.1371/journal.pone.0086559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489744	gold, Green Submitted, Green Published			2022-12-25	WOS:000330570000048
J	Mackenzie, CL; Ormondroyd, GA; Curling, SF; Ball, RJ; Whiteley, NM; Malham, SK				Mackenzie, Clara L.; Ormondroyd, Graham A.; Curling, Simon F.; Ball, Richard J.; Whiteley, Nia M.; Malham, Shelagh K.			Ocean Warming, More than Acidification, Reduces Shell Strength in a Commercial Shellfish Species during Food Limitation	PLOS ONE			English	Article							MYTILUS-EDULIS; SEAWATER ACIDIFICATION; CARBONIC-ACID; BLUE MUSSEL; HIGH CO2; TEMPERATURE; GROWTH; CALCIFICATION; DISSOCIATION; ADAPTATION	Ocean surface pH levels are predicted to fall by 0.3-0.4 pH units by the end of the century and are likely to coincide with an increase in sea surface temperature of 2-4 degrees C. The combined effect of ocean acidification and warming on the functional properties of bivalve shells is largely unknown and of growing concern as the shell provides protection from mechanical and environmental challenges. We examined the effects of near-future pH (ambient pH -0.4 pH units) and warming (ambient temperature +4 degrees C) on the shells of the commercially important bivalve, Mytilus edulis when fed for a limited period (4-6 h day(-1)). After six months exposure, warming, but not acidification, significantly reduced shell strength determined as reductions in the maximum load endured by the shells. However, acidification resulted in a reduction in shell flex before failure. Reductions in shell strength with warming could not be explained by alterations in morphology, or shell composition but were accompanied by reductions in shell surface area, and by a fall in whole-body condition index. It appears that warming has an indirect effect on shell strength by re-allocating energy from shell formation to support temperature-related increases in maintenance costs, especially as food supply was limited and the mussels were probably relying on internal energy reserves. The maintenance of shell strength despite seawater acidification suggests that biomineralisation processes are unaffected by the associated changes in CaCO3 saturation levels. We conclude that under near-future climate change conditions, ocean warming will pose a greater risk to shell integrity in M. edulis than ocean acidification when food availability is limited.	[Mackenzie, Clara L.; Malham, Shelagh K.] Bangor Univ, Coll Nat Sci, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Ormondroyd, Graham A.; Curling, Simon F.] Bangor Univ, Biocomposites Ctr, Bangor, Gwynedd, Wales; [Ball, Richard J.] Univ Bath, Dept Architecture & Civil Engn, Bath, Somerset, England; [Whiteley, Nia M.] Bangor Univ, Coll Nat Sci, Sch Biol Sci, Bangor, Gwynedd, Wales	Bangor University; Bangor University; University of Bath; Bangor University	Whiteley, NM (corresponding author), Bangor Univ, Coll Nat Sci, Sch Biol Sci, Bangor, Gwynedd, Wales.	n.m.whiteley@bangor.ac.uk	Malham, Shelagh K/O-9054-2014	Mackenzie, Clara/0000-0002-5797-6106; Curling, Simon/0000-0002-3486-0311; Ball, Richard/0000-0002-7413-3944	Shellfish Productivity in the Irish Sea, working towards a sustainable future (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme; EPSRC [EP/K025597/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K025597/1] Funding Source: researchfish	Shellfish Productivity in the Irish Sea, working towards a sustainable future (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funded by the project entitled: Shellfish Productivity in the Irish Sea, working towards a sustainable future (SUSFISH). SUSFISH is part-funded by the European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme 2007-2013. INTERREG 4A is managed in Ireland by the Southern and Eastern Regional Assembly on behalf of the Irish Government, the Welsh Government and the European Commission. http:// www.irelandwales.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMADAVILLELA PC, 1982, J EXP MAR BIOL ECOL, V59, P275, DOI 10.1016/0022-0981(82)90121-6; BAYNE BL, 1970, HELGOLAND WISS MEER, V20, P526, DOI 10.1007/BF01609927; Beesley A, 2008, CLIM RES, V37, P215, DOI 10.3354/cr00765; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Branch TA, 2013, TRENDS ECOL EVOL, V28, P178, DOI 10.1016/j.tree.2012.10.001; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carter JG, 1980, SKELETAL GROWTH AQUA, P69; Clausen I, 1996, MAR ECOL PROG SER, V141, P37, DOI 10.3354/meps141037; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dumousseaud C, 2011, PRACTICAL GUIDE UK O; Dunphy BJ, 2001, MAR FRESHWATER RES, V52, P781, DOI 10.1071/MF99189; ELNER RW, 1978, OECOLOGIA, V36, P333, DOI 10.1007/BF00348059; *FAO, 2008, STAT WORLD FISH AQ S; Findlay HS, 2011, MAR BIOL RES, V7, P565, DOI 10.1080/17451000.2010.547200; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Hiebenthal C, 2012, AQUAT BIOL, V14, P289, DOI 10.3354/ab00405; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Holt T., 1998, BIOGENIC REEFS; Huning A, 2013, MAR BIOL, V160, P1845, DOI 10.1007/s00227-012-1930-9; Kontoyannis CG, 2000, ANALYST, V125, P251, DOI 10.1039/a908609i; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Leonard GH, 1999, ECOLOGY, V80, P1; Lewis E., 1998, PROGRAM DEV CO2 SYST; Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679; LUCAS A, 1985, AQUACULTURE, V44, P187, DOI 10.1016/0044-8486(85)90243-1; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Matoo OB, 2013, COMP BIOCHEM PHYS A, V164, P545, DOI 10.1016/j.cbpa.2012.12.025; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nagarajan R, 2006, J EXP MAR BIOL ECOL, V339, P241, DOI 10.1016/j.jembe.2006.08.001; Nicholls RJ, 2007, CLIMATIC CHANGE 2007, P315, DOI 10.2134/jeq2008.0015br; Olson IC, 2012, J AM CHEM SOC, V134, P7351, DOI 10.1021/ja210808s; PALMER AR, 1983, MAR BIOL, V75, P287, DOI 10.1007/BF00406014; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SEED R, 1968, J MAR BIOL ASSOC UK, V48, P561, DOI 10.1017/S0025315400019159; Shumway S. E., 2012, WORLD AQUACULT, V34, P15, DOI DOI 10.1097/TA.0b013e318270160d; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Vermeij G.J., 1993, NATURAL HIST SHELLS; Wang RZ, 2011, ANNU REV MATER RES, V41, P41, DOI 10.1146/annurev-matsci-062910-095806; Welladsen HM, 2010, MOLLUSCAN RES, V30, P125; Wheeler A.P., 1992, P179; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zuschin M, 2001, PALAIOS, V16, P161, DOI 10.2307/3515527	58	79	79	4	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86764	10.1371/journal.pone.0086764	http://dx.doi.org/10.1371/journal.pone.0086764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489785	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000079
J	Murakami, A; Takahashi, F; Nurwidya, F; Kobayashi, I; Minakata, K; Hashimoto, M; Nara, T; Kato, M; Tajima, K; Shimada, N; Iwakami, S; Moriyama, M; Moriyama, H; Koizumi, F; Takahashi, K				Murakami, Akiko; Takahashi, Fumiyuki; Nurwidya, Fariz; Kobayashi, Isao; Minakata, Kunihiko; Hashimoto, Muneaki; Nara, Takeshi; Kato, Motoyasu; Tajima, Ken; Shimada, Naoko; Iwakami, Shin-ichiro; Moriyama, Mariko; Moriyama, Hiroyuki; Koizumi, Fumiaki; Takahashi, Kazuhisa			Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor	PLOS ONE			English	Article							FACTOR-I RECEPTOR; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; PHASE-II; MET AMPLIFICATION; MUTANT; SENSITIVITY; COMBINATION; MECHANISMS; MUTATIONS	Accumulating evidence indicates that a small population of cancer stem cells (CSCs) is involved in intrinsic resistance to cancer treatment. The hypoxic microenvironment is an important stem cell niche that promotes the persistence of CSCs in tumors. Our aim here was to elucidate the role of hypoxia and CSCs in the resistance to gefitinib in non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation. NSCLC cell lines, PC9 and HCC827, which express the EGFR exon 19 deletion mutations, were exposed to high concentration of gefitinib under normoxic or hypoxic conditions. Seven days after gefitinib exposure, a small fraction of viable cells were detected, and these were referred to as "gefitinib-resistant persisters'' (GRPs). CD133, Oct4, Sox2, Nanog, CXCR4, and ALDH1A1-all genes involved in stemness- were highly expressed in GRPs in PC9 and HCC827 cells, and PC9 GRPs exhibited a high potential for tumorigenicity in vivo. The expression of insulin-like growth factor 1 (IGF1) was also upregulated and IGF1 receptor (IGF1R) was activated on GRPs. Importantly, hypoxic exposure significantly increased sphere formation, reflecting the self-renewal capability, and the population of CD133- and Oct4-positive GRPs. Additionally, hypoxia upregulated IGF1 expression through hypoxia-inducible factor 1 alpha (HIF1 alpha), and markedly promoted the activation of IGF1R on GRPs. Knockdown of IGF1 expression significantly reduced phosphorylated IGF1R-expressing GRPs under hypoxic conditions. Finally, inhibition of HIF1 alpha or IGF1R by specific inhibitors significantly decreased the population of CD133- and Oct4-positive GRPs, which were increased by hypoxia in PC9 and HCC827 cells. Collectively, these findings suggest that hypoxia increased the population of lung CSCs resistant to gefitinib in EGFR mutation-positive NSCLC by activating IGF1R. Targeting the IGF1R pathway may be a promising strategy for overcoming gefitinib resistance in EGFR mutation-positive NSCLC induced by lung CSCs and microenvironment factors such as tumor hypoxia.	[Murakami, Akiko; Takahashi, Fumiyuki; Nurwidya, Fariz; Kobayashi, Isao; Minakata, Kunihiko; Kato, Motoyasu; Tajima, Ken; Shimada, Naoko; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan; [Murakami, Akiko; Takahashi, Fumiyuki; Nurwidya, Fariz; Kobayashi, Isao; Minakata, Kunihiko; Kato, Motoyasu; Tajima, Ken; Shimada, Naoko; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Ages, Tokyo, Japan; [Hashimoto, Muneaki; Nara, Takeshi] Juntendo Univ, Grad Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Iwakami, Shin-ichiro] Juntendo Univ, Shizuoka Hosp, Shizuoka, Japan; [Moriyama, Mariko; Moriyama, Hiroyuki] Kinki Univ, Sch Med, Pharmaceut Res & Technol Inst, Osaka 589, Japan; [Koizumi, Fumiaki] Natl Canc Ctr, Shien Lab, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Kindai University (Kinki University); National Cancer Center - Japan	Takahashi, F (corresponding author), Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan.	fumiyuki@dol.hi-ho.ne.jp	Nurwidya, Fariz/E-4375-2015; Nurwidya, Fariz/AAS-1206-2020; Hashimoto, Muneaki/L-6386-2018	Nurwidya, Fariz/0000-0002-8379-9510; Nurwidya, Fariz/0000-0002-8379-9510; Hashimoto, Muneaki/0000-0001-7215-7558	Ministry of Education, Culture, Sports, Science and Technology of Japan [23591906]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aids for Scientific Research No. 23591906 (Fumiyuki Takahashi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DW, 2008, CLIN CANCER RES, V14, P4079, DOI 10.1158/1078-0432.CCR-07-5030; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Costa DB, 2007, LUNG CANCER, V58, P95, DOI 10.1016/j.lungcan.2007.05.017; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Espinoza I, 2013, ONCOTARGETS THER, V6, P1249, DOI 10.2147/OTT.S36162; Habben K, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7584; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jameson MJ, 2011, MOL CANCER THER, V10, P2124, DOI 10.1158/1535-7163.MCT-11-0294; Jassem J, 2010, J CLIN ONCOL S, V28; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung MJ, 2013, ONCOGENE, V32, P209, DOI 10.1038/onc.2012.37; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Lin Q, 2010, CANCER BIOL THER, V9, P949, DOI 10.4161/cbt.9.12.12347; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minakata K, 2012, CANCER SCI, V103, P1946, DOI 10.1111/j.1349-7006.2012.02408.x; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110	36	94	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86459	10.1371/journal.pone.0086459	http://dx.doi.org/10.1371/journal.pone.0086459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489728	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000051
J	Zimmer, A; Durand, C; Loira, N; Durrens, P; Sherman, DJ; Marullo, P				Zimmer, Adrien; Durand, Cecile; Loira, Nicolas; Durrens, Pascal; Sherman, David James; Marullo, Philippe			QTL Dissection of Lag Phase in Wine Fermentation Reveals a New Translocation Responsible for Saccharomyces cerevisiae Adaptation to Sulfite	PLOS ONE			English	Article							CHROMOSOMAL TRANSLOCATION; NUCLEOTIDE RESOLUTION; ADAPTIVE EVOLUTION; RESISTANCE GENE; YEAST; REARRANGEMENTS; TRAIT; SSU1; DUPLICATION; POPULATIONS	Quantitative genetics and QTL mapping are efficient strategies for deciphering the genetic polymorphisms that explain the phenotypic differences of individuals within the same species. Since a decade, this approach has been applied to eukaryotic microbes such as Saccharomyces cerevisiae in order to find natural genetic variations conferring adaptation of individuals to their environment. In this work, a QTL responsible for lag phase duration in the alcoholic fermentation of grape juice was dissected by reciprocal hemizygosity analysis. After invalidating the effect of some candidate genes, a chromosomal translocation affecting the lag phase was brought to light using de novo assembly of parental genomes. This newly described translocation (XV-t-XVI) involves the promoter region of ADH1 and the gene SSU1 and confers an increased expression of the sulfite pump during the first hours of alcoholic fermentation. This translocation constitutes another adaptation route of wine yeast to sulfites in addition to the translocation VIII-t-XVI previously described. A population survey of both translocation forms in a panel of domesticated yeast strains suggests that the translocation XV-t-XVI has been empirically selected by human activity.	[Zimmer, Adrien; Durand, Cecile; Marullo, Philippe] LAFFORT, Bordeaux, France; [Zimmer, Adrien; Durand, Cecile; Marullo, Philippe] Univ Bordeaux, ISVV, EA OEnol 4577, Villenave Dornon, France; [Loira, Nicolas] Univ Chile, Ctr Genome Regulat FONDAP 15090007, Santiago, Chile; [Durrens, Pascal; Sherman, David James] Univ Bordeaux, CNRS, UMR 5800, INRIA Project Team Magnome, Talence, France	UDICE-French Research Universities; Universite de Bordeaux; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Marullo, P (corresponding author), LAFFORT, Bordeaux, France.	philippe.marullo@u-bordeaux2.fr		Marullo, Philippe/0000-0002-3594-5173; Sherman, David James/0000-0002-2316-1005	Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]; Investissements d'avenir, Convention attributive d'aide [ANR-10-EQPX-16-01]; Conseil Regional d'Aquitaine (SAGESSE)	Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER(European Commission); Investissements d'avenir, Convention attributive d'aide(French National Research Agency (ANR)); Conseil Regional d'Aquitaine (SAGESSE)	Genome sequencing presented in the present publication were performed at the Genomic and Transcriptomic Facility of Bordeaux (grants from the Conseil Regional d'Aquitaine no20030304002FA and 20040305003FA and from the European Union, FEDER no2003227 and from Investissements d'avenir, Convention attributive d'aide NoANR-10-EQPX-16-01). NL received a grant from Conseil Regional d'Aquitaine (SAGESSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Albertin W, PLOS ONE IN PRESS; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; [Anonymous], 2010, R LANG ENV STAT COMP; Araya CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-88; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; BIDENNE C, 1992, CURR GENET, V22, P1, DOI 10.1007/BF00351734; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; CASALONE E, 1992, CURR GENET, V22, P435, DOI 10.1007/BF00326407; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chuma I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002147; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Divol B, 2012, APPL MICROBIOL BIOT, V95, P601, DOI 10.1007/s00253-012-4186-x; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Egli CM, 1998, J APPL MICROBIOL, V85, P779, DOI 10.1046/j.1365-2672.1998.00521.x; Ehrenreich IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002570; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Engle EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002763; Favier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049082; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Galeote V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017872; Galeote V, 2010, MICROBIOL-SGM, V156, P3754, DOI 10.1099/mic.0.041673-0; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goto-Yamamoto N, 1998, J FERMENT BIOENG, V86, P427, DOI 10.1016/S0922-338X(98)80146-3; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Henick-Kling T, 1998, J APPL MICROBIOL, V84, P865, DOI 10.1046/j.1365-2672.1998.00423.x; HINZE H, 1986, ARCH MICROBIOL, V145, P27, DOI 10.1007/BF00413023; Infante JJ, 2003, GENETICS, V165, P1745; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Katou T, 2009, J BIOSCI BIOENG, V107, P383, DOI 10.1016/j.jbiosc.2008.12.014; King T, 2006, GENETICS, V172, P2071, DOI 10.1534/genetics.105.053892; Koszul R, 2006, GENETICS, V172, P2211, DOI 10.1534/genetics.105.048058; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liti G, 2005, ANNU REV MICROBIOL, V59, P135, DOI 10.1146/annurev.micro.59.030804.121400; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2007, FEMS YEAST RES, V7, P1295, DOI 10.1111/j.1567-1364.2007.00281.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Nardi T, 2010, MICROBIOL-SGM, V156, P1686, DOI 10.1099/mic.0.036723-0; NESS F, 1995, GENETICS, V140, P945; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; P Ribereau-Gayon, 2000, HDB ENOLOGY; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Park H, 2008, J MICROBIOL, V46, P542, DOI 10.1007/s12275-008-0053-y; PATE JB, 1962, ANAL CHEM, V34, P1660, DOI 10.1021/ac60192a001; Pennaneach V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006389; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Romano GH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.1; Rossi B, 2010, GENETICS, V186, P775, DOI 10.1534/genetics.110.120683; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Shibata Y, 2009, NUCLEIC ACIDS RES, V37, P6454, DOI 10.1093/nar/gkp650; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; STRATFORD M, 1987, J GEN MICROBIOL, V133, P2173; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THORNTON RJ, 1982, EUR J APPL MICROBIOL, V14, P159, DOI 10.1007/BF00497893; Tosato V, 2009, CHROMOSOMA, V118, P179, DOI 10.1007/s00412-008-0187-z; Umezu K, 2002, GENETICS, V160, P97; WELCH JW, 1983, MOL CELL BIOL, V3, P1353, DOI 10.1128/MCB.3.8.1353; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; XU X, 1994, CURR GENET, V25, P488, DOI 10.1007/BF00351667; Yang YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003693; Yu X, 2004, GENETICS, V166, P741, DOI 10.1534/genetics.166.2.741; Yuasa N, 2005, BIOSCI BIOTECH BIOCH, V69, P1584, DOI 10.1271/bbb.69.1584; Yuasa N, 2004, J BIOSCI BIOENG, V98, P394, DOI 10.1016/S1389-1723(04)00303-2; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	83	71	71	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86298	10.1371/journal.pone.0086298	http://dx.doi.org/10.1371/journal.pone.0086298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489712	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000045
J	Nejepinska, J; Malik, R; Wagner, S; Svoboda, P				Nejepinska, Jana; Malik, Radek; Wagner, Susan; Svoboda, Petr			Reporters Transiently Transfected into Mammalian Cells Are Highly Sensitive to Translational Repression Induced by dsRNA Expression	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INITIATION FACTOR-II; PROTEIN-KINASE PKR; GENE-EXPRESSION; MOUSE OOCYTES; MESSENGER-RNAS; HAIRPIN RNA; PHOSPHORYLATION; TRANSCRIPTION; INTERFERENCE	In mammals, double-stranded RNA (dsRNA) can mediate sequence-specific RNA interference, activate sequence-independent interferon response, or undergo RNA editing by adenosine deaminases. We showed that long hairpin dsRNA expression had negligible effects on mammalian somatic cells-expressed dsRNA was slightly edited, poorly processed into siRNAs, and it did not activate the interferon response. At the same time, we noticed reduced reporter expression in transient co-transfections, which was presumably induced by expressed dsRNA. Since transient co-transfections are frequently used for studying gene function, we systematically explored the role of expressed dsRNA in this silencing phenomenon. We demonstrate that dsRNA expressed from transiently transfected plasmids strongly inhibits the expression of co-transfected reporter plasmids but not the expression of endogenous genes or reporters stably integrated in the genome. The inhibition is concentration-dependent, it is found in different cell types, and it is independent of transfection method and dsRNA sequence. The inhibition occurs at the level of translation and involves protein kinase R, which binds the expressed dsRNA. Thus, dsRNA expression represents a hidden danger in transient transfection experiments and must be taken into account during interpretation of experimental results.	[Nejepinska, Jana; Malik, Radek; Svoboda, Petr] ASCR, Inst Mol Genet, Vvi, Prague, Czech Republic; [Wagner, Susan] ASCR, Inst Microbiol, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Svoboda, P (corresponding author), ASCR, Inst Mol Genet, Vvi, Prague, Czech Republic.	svobodap@img.cas.cz	Wagner, Susan/K-8240-2014; Wagner, Susan/ABA-1307-2021; Svoboda, Petr/G-3890-2012; Urbanova, Jana/G-2748-2014; Malik, Radek/G-3578-2014	Svoboda, Petr/0000-0002-4370-3705; Urbanova, Jana/0000-0001-9778-6289; Malik, Radek/0000-0002-6783-1146; Wagner, Susan/0000-0002-7492-7541	Czech Science Foundation [GACR 204/09/0085, AV0Z50520514, RVO 68378050, GACR P305/12/G034]; EMBO Young Investigator Program [1488/2006]	Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	The main support was provided by the Czech Science Foundation grant (GACR 204/09/0085), institutional support AV0Z50520514 and RVO 68378050 to P.S., J.N., and R.M.; the EMBO Young Investigator Program (Installation grant 1488/2006) to P.S.; all authors are members of the Centrum of Excellence supported by the Czech Science Foundation (GACR P305/12/G034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; DeCerbo J, 2005, CURR OPIN CELL BIOL, V17, P302, DOI 10.1016/j.ceb.2005.04.008; Flemr M, 2013, CELL, V155, P807, DOI 10.1016/j.cell.2013.10.001; Gantier MP, 2007, J INTERF CYTOK RES, V27, P789, DOI 10.1089/jir.2006.0152; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Gommans WM, 2008, BIOCHEM BIOPH RES CO, V377, P170, DOI 10.1016/j.bbrc.2008.09.109; Gong CG, 2013, NAT STRUCT MOL BIOL, V20, P1214, DOI 10.1038/nsmb.2664; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Kaname T, 2001, GENE, V266, P147, DOI 10.1016/S0378-1119(01)00375-4; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; Nejepinska J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043283; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Rubin CM, 2002, NUCLEIC ACIDS RES, V30, P3253, DOI 10.1093/nar/gkf419; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sambrook J, 2006, COLD SPRING HARB PRO, V2006, P4455, DOI DOI 10.1101/PDB.PR0T4455; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Stein P, 2003, DEV BIOL, V256, P187, DOI 10.1016/S0012-1606(02)00122-7; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Svoboda P, 2001, BIOCHEM BIOPH RES CO, V287, P1099, DOI 10.1006/bbrc.2001.5707; Svoboda P, 2006, CELL MOL LIFE SCI, V63, P901, DOI 10.1007/s00018-005-5558-5; Svoboda P, 2004, NUCLEIC ACIDS RES, V32, P3601, DOI 10.1093/nar/gkh697; Terenzi F, 1999, NUCLEIC ACIDS RES, V27, P4369, DOI 10.1093/nar/27.22.4369; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang Y, 2009, J MOL BIOL, V393, P777, DOI 10.1016/j.jmb.2009.08.070; Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87517	10.1371/journal.pone.0087517	http://dx.doi.org/10.1371/journal.pone.0087517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475301	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300195
J	Tkalec, M; Stefanic, PP; Cvjetko, P; Sikic, S; Pavlica, M; Balen, B				Tkalec, Mirta; Stefanic, Petra Peharec; Cvjetko, Petra; Sikic, Sandra; Pavlica, Mirjana; Balen, Biljana			The Effects of Cadmium-Zinc Interactions on Biochemical Responses in Tobacco Seedlings and Adult Plants	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; DNA-DAMAGE; SUBCELLULAR-DISTRIBUTION; SUPEROXIDE-DISMUTASE; PRIMARY LEAVES; ASCORBIC-ACID; TOXICITY; GROWTH; PROTEIN	The objective of the present study was to investigate the effects of cadmium-zinc (Cd-Zn) interactions on their uptake, oxidative damage of cell macromolecules (lipids, proteins, DNA) and activities of antioxidative enzymes in tobacco seedlings as well as roots and leaves of adult plants. Seedlings and plants were exposed to Cd (10 mu M and 15 mu M) and Zn (25 mu M and 50 mu M) as well as their combinations (10 mu M or 15 mu M Cd with either 25 mu M or 50 mu M Zn). Measurement of metal accumulation exhibited that Zn had mostly positive effect on Cd uptake in roots and seedlings, while Cd had antagonistic effect on Zn uptake in leaves and roots. According to examined oxidative stress parameters, in seedlings and roots individual Cd treatments induced oxidative damage, which was less prominent in combined treatments, indicating that the presence of Zn alleviates oxidative stress. However, DNA damage found in seedlings, and lower glutathione reductase (GR) and superoxide dismutase (SOD) activity recorded in both seedlings and roots, after individual Zn treatments, indicate that Zn accumulation could impose toxic effects. In leaves, oxidative stress was found after exposure to Cd either alone or in combination with Zn, thus implying that in this tissue Zn did not have alleviating effects. In conclusion, results obtained in different tobacco tissues suggest tissue-dependent Cd-Zn interactions, which resulted in activation of different mechanisms involved in the protection against metal stress.	[Tkalec, Mirta] Univ Zagreb, Fac Sci, Dept Bot, Zagreb 41000, Croatia; [Stefanic, Petra Peharec; Cvjetko, Petra; Pavlica, Mirjana; Balen, Biljana] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia; [Sikic, Sandra] Inst Publ Hlth Dr Andrija Stampar, Dept Ecol, Zagreb, Croatia	University of Zagreb; University of Zagreb	Balen, B (corresponding author), Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia.	bbalen@zg.biol.pmf.hr	Stefanic, Petra peharec/AAC-8128-2019	Stefanic, Petra peharec/0000-0003-4889-6910; Tkalec, Mirta/0000-0003-4733-828X	Ministry of Science, Education and Sports of the Republic of Croatia [119-1191196-1200]; University of Zagreb	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); University of Zagreb	The financial support of this work was provided by The Ministry of Science, Education and Sports of the Republic of Croatia (119-1191196-1200) as well as by the University of Zagreb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; [Anonymous], 2009, 11885 EN ISO; [Anonymous], 2002, 13657 EN; Aravind P, 2003, PLANT PHYSIOL BIOCH, V41, P391, DOI 10.1016/S0981-9428(03)00035-4; Aravind P, 2009, J TRACE ELEM MED BIO, V23, P50, DOI 10.1016/j.jtemb.2008.10.002; Aravind Parameswaran, 2005, Braz. J. Plant Physiol., V17, P3, DOI 10.1590/S1677-04202005000100002; Arora A, 2002, CURR SCI INDIA, V82, P1227; Balen B, 2011, ECOTOXICOLOGY, V20, P815, DOI 10.1007/s10646-011-0633-1; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Bueno P, 2002, PLANT GROWTH REGUL, V36, P161, DOI 10.1023/A:1015044705137; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Cao YY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/576189; Cherif J, 2011, J ENVIRON SCI, V23, P837, DOI 10.1016/S1001-0742(10)60415-9; Cuypers A, 2001, PLANT PHYSIOL BIOCH, V39, P657, DOI 10.1016/S0981-9428(01)01276-1; Cvjetko P, 2010, ARH HIG RADA TOKSIKO, V61, P287, DOI 10.2478/10004-1254-61-2010-2059; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Dixit V, 2001, J EXP BOT, V52, P1101, DOI 10.1093/jexbot/52.358.1101; DUDKA S, 1994, WATER AIR SOIL POLL, V76, P333, DOI 10.1007/BF00482710; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gallego SM, 1996, PLANT SCI, V121, P151, DOI 10.1016/S0168-9452(96)04528-1; Gichner T, 1999, ENVIRON MOL MUTAGEN, V33, P279, DOI 10.1002/(SICI)1098-2280(1999)33:4<279::AID-EM4>3.0.CO;2-K; Gichner T, 2004, MUTAT RES-GEN TOX EN, V559, P49, DOI 10.1016/j.mrgentox.2003.12.008; Gichner T, 2008, ENVIRON EXP BOT, V62, P113, DOI 10.1016/j.envexpbot.2007.07.013; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; GREGER M, 1995, ENVIRON EXP BOT, V35, P215, DOI 10.1016/0098-8472(94)00047-9; Hassan MJ, 2005, J PLANT NUTR SOIL SC, V168, P255, DOI 10.1002/jpln.200420403; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Lefevre I, 2009, PLANT GROWTH REGUL, V59, P1, DOI 10.1007/s10725-009-9382-z; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin CW, 2005, PLANT PHYSIOL BIOCH, V43, P963, DOI 10.1016/j.plaphy.2005.10.001; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; Lloret F, 2004, GLOBAL CHANGE BIOL, V10, P248, DOI 10.1111/j.1365-2486.2004.00725.x; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORAGHAN JT, 1993, PLANT SOIL, V150, P61, DOI 10.1007/BF00779176; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nan ZR, 2002, SCI TOTAL ENVIRON, V285, P187, DOI 10.1016/S0048-9697(01)00919-6; Okamoto OK, 1996, J PHYCOL, V32, P74, DOI 10.1111/j.0022-3646.1996.00074.x; Pandey N, 2012, RUSS J PLANT PHYSL+, V59, P198, DOI 10.1134/S1021443712010141; Parlak KU, 2012, ECOTOX ENVIRON SAFE, V85, P52, DOI 10.1016/j.ecoenv.2012.08.023; Peraza MA, 1998, ENVIRON HEALTH PERSP, V106, P203, DOI 10.2307/3433921; Perronnet K, 2003, PLANT SOIL, V249, P19, DOI 10.1023/A:1022560711597; Ramos I, 2002, PLANT SCI, V162, P761, DOI 10.1016/S0168-9452(02)00017-1; Romero-Puertas MC, 2002, PLANT CELL ENVIRON, V25, P677, DOI 10.1046/j.1365-3040.2002.00850.x; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Shah K, 1998, J PLANT PHYSIOL, V152, P448, DOI 10.1016/S0176-1617(98)80262-9; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Shan ShiHua, 2012, Journal of Agricultural Science (Toronto), V4, P142; Sharma P., 2012, J BOT, DOI DOI 10.1155/2012/650206; Sharma P., 2012, J BOT LE, V2012, P217037, DOI [DOI 10.1155/2012/217037, 10.1155/2012/217037]; Siedlecka A, 2002, PHYSIOLOGY AND BIOCHEMISTRY OF METAL TOXICITY AND TOLERANCE IN PLANTS, P303; Stefanic PP, 2012, ARH HIG RADA TOKSIKO, V63, P321, DOI 10.2478/10004-1254-63-2012-2173; Tkalec M, 2008, ACTA PHYSIOL PLANT, V30, P881, DOI 10.1007/s11738-008-0194-y; Tran TA, 2013, TURK J BOT, V37, P698, DOI 10.3906/bot-1209-8; Ullrich SM, 1999, APPL GEOCHEM, V14, P187, DOI 10.1016/S0883-2927(98)00042-0; Unyayar S, 2006, MUTAGENESIS, V21, P77, DOI 10.1093/mutage/gel001; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Valverde M, 2001, MUTAGENESIS, V16, P265, DOI 10.1093/mutage/16.3.265; Wang C, 2009, CHEMOSPHERE, V76, P938, DOI 10.1016/j.chemosphere.2009.04.038; Wang JA, 2010, J ENVIRON SCI-CHINA, V22, P1916, DOI 10.1016/S1001-0742(09)60339-9; Weckx JEJ, 1996, PHYSIOL PLANTARUM, V96, P506, DOI 10.1111/j.1399-3054.1996.tb00465.x; Wilde KL, 2006, ARCH ENVIRON CON TOX, V51, P174, DOI 10.1007/s00244-004-0256-0; Wu FB, 2005, CHEMOSPHERE, V60, P1437, DOI 10.1016/j.chemosphere.2005.01.071; Wu FB, 2002, J PLANT NUTR, V25, P2745, DOI 10.1081/PLN-120015536; Wu FB, 2003, COMMUN SOIL SCI PLAN, V34, P2003, DOI 10.1081/CSS-120023233; Yang XE, 2004, J PLANT NUTR, V27, P1963, DOI [10.1081/LPLA-200030082, 10.1081/PLN-200030082]; Zrobek-Sokolnik A, 2009, ACTA PHYSIOL PLANT, V31, P43, DOI 10.1007/s11738-008-0197-8	72	94	109	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87582	10.1371/journal.pone.0087582	http://dx.doi.org/10.1371/journal.pone.0087582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475312	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300205
J	Kuhlmann, AS; Steckbeck, JD; Sturgeon, TJ; Craigo, JK; Montelaro, RC				Kuhlmann, Anne-Sophie; Steckbeck, Jonathan D.; Sturgeon, Timothy J.; Craigo, Jodi K.; Montelaro, Ronald C.			Unique Functional Properties of Conserved Arginine Residues in the Lentivirus Lytic Peptide Domains of the C-terminal Tail of HIV-1 gp41	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; Lentivirus; Membrane Proteins; Site-directed Mutagenesis; Viral Replication; C-terminal Tail; Envelope; Arginines	TYPE-1 ENVELOPE GLYCOPROTEIN; CYTOPLASMIC DOMAIN; POINT MUTATIONS; INTRACYTOPLASMIC TAIL; LLP DOMAINS; SIDE-CHAINS; TRANSMEMBRANE; FUSION; PROTEIN; SEQUENCE	Background: The C-terminal tail of the HIV-1 envelope preferentially incorporates arginine over lysine despite the similar physicochemical properties of these two residues. Results: Conservative arginine to lysine substitutions impair HIV-1 Env functions and virus replication. Conclusion: Arginine conservation provides unique functions that cannot be provided by lysines. Significance: These observations conclusively demonstrate unique functional properties for the conserved arginine residues in mediating Env functional properties. A previous study from our laboratory reported a preferential conservation of arginine relative to lysine in the C-terminal tail (CTT) of HIV-1 envelope (Env). Despite substantial overall sequence variation in the CTT, specific arginines are highly conserved in the lentivirus lytic peptide (LLP) motifs and are scarcely substituted by lysines, in contrast to gp120 and the ectodomain of gp41. However, to date, no explanation has been provided to explain the selective incorporation and conservation of arginines over lysines in these motifs. Herein, we address the functions in virus replication of the most conserved arginines by performing conservative mutations of arginine to lysine in the LLP1 and LLP2 motifs. The presence of lysine in place of arginine in the LLP1 motif resulted in significant impairment of Env expression and consequently virus replication kinetics, Env fusogenicity, and incorporation. By contrast, lysine exchanges in LLP2 only affected the level of Env incorporation and fusogenicity. Our findings demonstrate that the conservative lysine substitutions significantly affect Env functional properties indicating a unique functional role for the highly conserved arginines in the LLP motifs. These results provide for the first time a functional explanation to the preferred incorporation of arginine, relative to lysine, in the CTT of HIV-1 Env. We propose that these arginines may provide unique functions for Env interaction with viral or cellular cofactors that then influence overall Env functional properties.	[Kuhlmann, Anne-Sophie; Steckbeck, Jonathan D.; Sturgeon, Timothy J.; Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15261 USA; [Kuhlmann, Anne-Sophie; Steckbeck, Jonathan D.; Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Montelaro, RC (corresponding author), 3501 Fifth Ave,9014 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.	rmont@pitt.edu			National Institutes of Health from the NIAID [5R01 AI087533]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087533] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 AI087533 (to R. C. M.) from the NIAID.	Barnes M. R., 2007, BIOINFORMATICS GENET, P249; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Boscia AL, 2013, BIOPHYS J, V105, P657, DOI 10.1016/j.bpj.2013.06.042; Chen SSL, 2001, J VIROL, V75, P9925, DOI 10.1128/JVI.75.20.9925-9938.2001; Cheng DC, 2010, BIOCHEM BIOPH RES CO, V391, P1780, DOI 10.1016/j.bbrc.2009.12.155; COPLEY RR, 1994, J MOL BIOL, V242, P321; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-123; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunyat F, 2012, J BIOMOL SCREEN, V17, P727, DOI 10.1177/1087057112439890; da Silva ES, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-54; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Denner J, 2011, HUM VACCINES, V7, P4, DOI 10.4161/hv.7.0.14555; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; HAFFAR OK, 1988, J CELL BIOL, V107, P1677, DOI 10.1083/jcb.107.5.1677; HAFFAR OK, 1991, VIROLOGY, V180, P439, DOI 10.1016/0042-6822(91)90054-F; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; Kliger Y, 1997, BIOCHEMISTRY-US, V36, P5157, DOI 10.1021/bi962935r; Lee SF, 2000, J BIOL CHEM, V275, P15809, DOI 10.1074/jbc.M000601200; Lee SF, 2002, J BIOL CHEM, V277, P15363, DOI 10.1074/jbc.M201479200; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Long YF, 2011, PROTEIN CELL, V2, P369, DOI 10.1007/s13238-011-1051-0; Martinez JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018375; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; MILLER MA, 1993, VIROLOGY, V196, P89, DOI 10.1006/viro.1993.1457; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moreno MR, 2006, BBA-BIOMEMBRANES, V1758, P111, DOI 10.1016/j.bbamem.2006.01.007; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murakami T., 2012, MOL BIOL INT, V2012; Newman JT, 2007, VIROLOGY, V367, P102, DOI 10.1016/j.virol.2007.05.027; Paintsil E, 2007, ANTIMICROB AGENTS CH, V51, P3870, DOI 10.1128/AAC.00692-07; Paintsil Elijah, 2009, AIDS Res Ther, V6, P5, DOI 10.1186/1742-6405-6-5; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Sakai N, 2006, SOFT MATTER, V2, P636, DOI 10.1039/b606955j; Schramm CA, 2012, STRUCTURE, V20, P924, DOI 10.1016/j.str.2012.03.016; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; TENCZA SB, 1995, J VIROL, V69, P5199, DOI 10.1128/JVI.69.8.5199-5202.1995; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Vzorov AN, 2011, AIDS RES HUM RETROV, V27, P1213, DOI [10.1089/aid.2010.0321, 10.1089/AID.2010.0321]; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wu Z, 2013, J PHYS CHEM B, V117, P12145, DOI 10.1021/jp4068729; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; YANG CL, 1995, P NATL ACAD SCI USA, V92, P9871, DOI 10.1073/pnas.92.21.9871; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhu Y, 2007, CHEM BIOL DRUG DES, V70, P311, DOI 10.1111/j.1747-0285.2007.00564.x	58	7	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7630	7640		10.1074/jbc.M113.529339	http://dx.doi.org/10.1074/jbc.M113.529339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497632	Green Published, hybrid			2022-12-25	WOS:000332761500032
J	Callari, M; Lembo, A; Bianchini, G; Musella, V; Cappelletti, V; Gianni, L; Daidone, MG; Provero, P				Callari, Maurizio; Lembo, Antonio; Bianchini, Giampaolo; Musella, Valeria; Cappelletti, Vera; Gianni, Luca; Daidone, Maria Grazia; Provero, Paolo			Accurate Data Processing Improves the Reliability of Affymetrix Gene Expression Profiles from FFPE Samples	PLOS ONE			English	Article							BREAST-CANCER; RNA; CLASSIFICATION; CHEMOTHERAPY; SET	Formalin fixed paraffin-embedded (FFPE) tumor specimens are the conventionally archived material in clinical practice, representing an invaluable tissue source for biomarkers development, validation and routine implementation. For many prospective clinical trials, this material has been collected allowing for a prospective-retrospective study design which represents a successful strategy to define clinical utility for candidate markers. Gene expression data can be obtained even from FFPE specimens with the broadly used Affymetrix HG-U133 Plus 2.0 microarray platform. Nevertheless, important major discrepancies remain in expression data obtained from FFPE compared to fresh-frozen samples, prompting the need for appropriate data processing which could help to obtain more consistent results in downstream analyses. In a publicly available dataset of matched frozen and FFPE expression data, the performances of different normalization methods and specifically designed Chip Description Files (CDFs) were compared. The use of an alternative CDFs together with fRMA normalization significantly improved frozen-FFPE sample correlations, frozen-FFPE probeset correlations and agreement of differential analysis between different tumor subtypes. The relevance of our optimized data processing was assessed and validated using two independent datasets. In this study we demonstrated that an appropriate data processing can significantly improve the reliability of gene expression data derived from FFPE tissues using the standard Affymetrix platform. Tools for the implementation of our data processing algorithm are made publicly available at http://www.biocut.unito.it/cdf-ffpe/.	[Callari, Maurizio; Musella, Valeria; Cappelletti, Vera; Daidone, Maria Grazia] Fondaz IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Lembo, Antonio; Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Life Sci, Turin, Italy; [Bianchini, Giampaolo; Gianni, Luca] Univ Milan, Osped San Raffaele, Dept Med Oncol, I-20127 Milan, Italy; [Provero, Paolo] Univ Milan, Osped San Raffaele, Ctr Translat Genom & Bioinformat, I-20127 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Turin; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Daidone, MG (corresponding author), Fondaz IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	MariaGrazia.Daidone@istitutotumori.mi.it; paolo.provero@unito.it	Callari, Maurizio/AAF-7089-2019; Daidone, Maria Grazia/E-9232-2017; Provero, Paolo/AAC-1930-2019; Musella, Valeria/H-4458-2016; Cappelletti, Vera/B-9310-2017	Callari, Maurizio/0000-0001-5239-0918; Daidone, Maria Grazia/0000-0002-4786-1321; Musella, Valeria/0000-0001-9517-2670; Cappelletti, Vera/0000-0002-9709-0676; Bianchini, Giampaolo/0000-0002-6790-6267; GIANNI, LUCA/0000-0002-2372-9625	Italian Association for Cancer Research (AIRC) [IG4915, IG 10611, IG 9408]; Ministero della Salute (Progetto Oncologico di Medicina Molecolare: \ Tumori Femminili)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute (Progetto Oncologico di Medicina Molecolare: \ Tumori Femminili)	This work was supported by: the Italian Association for Cancer Research (AIRC) [IG4915 to LG], [IG 10611 to MGD] and [IG 9408 to PP] and the Ministero della Salute (Progetto Oncologico di Medicina Molecolare: vertical bar Tumori Femminili). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bianchini G, 2011, J CLIN ONCOL; Bianchini G, 2013, J CLIN ONCOL, V31; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Frei E, 2013, J CLIN PATHOL, V66, P956, DOI 10.1136/jclinpath-2013-201619; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gianni L, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-S6-7; Gianni L, 2009, J CLIN ONCOL, V27, P2474, DOI 10.1200/JCO.2008.19.2567; Pardo PG, 2011, J CLIN ONCOL, V29; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lembo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031129; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-369; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Millenaar FF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-137; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Waldron L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-124; Williams PM, 2010, J MOL DIAGN, V12, P680, DOI 10.2353/jmoldx.2010.090164	32	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86511	10.1371/journal.pone.0086511	http://dx.doi.org/10.1371/journal.pone.0086511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489733	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000043
J	Chung, SD; Liu, SP; Li, HC; Lin, HC				Chung, Shiu-Dong; Liu, Shih-Ping; Li, Hsien-Chang; Lin, Herng-Ching			Health Care Service Utilization among Patients with Bladder Pain Syndrome/Interstitial Cystitis in a Single Payer Healthcare System	PLOS ONE			English	Article							INTERSTITIAL CYSTITIS; POPULATION; PREVALENCE; WOMEN; SYMPTOMS	Background: This study aims to investigate the differences in the utilization of healthcare services between patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and patients without using a population-based database in Taiwan. Methods: This study comprised of 350 patients with BPS/IC and 1,750 age-matched controls. Healthcare resource utilization was evaluated in the one-year follow-up period as follows: number of outpatient visits and inpatient days, and the mean costs of outpatient and inpatient treatment. A multivariate regression analysis was used to evaluate the relationship between BPS/IC and total costs of health care services. Results: For urological services, patients with BPS/IC had a significantly higher number of outpatient visits (2.5 vs. 0.2, p < 0.001) as well as significantly higher outpatient costs ($US166 vs. $US6.8, p < 0.001) than the controls. For non-urologic services, patients with BPS/IC had a significantly high number of outpatient visits (35.0 vs. 21.3, p < 0.001) as well as significantly higher outpatient cots ($US912 vs. $US675, p < 0.001) as compared to the controls. Overall, patients with BPS/IC had 174% more outpatient visits and 150% higher total costs than the controls. Multiple-regression-analyses also showed that the patients with BPS/IC had significantly higher total costs for all healthcare services than the controls. Conclusions: This study found that patients with BPS/IC have a significantly higher number of healthcare related visits, and have significantly higher healthcare related costs than age-matched controls. The high level of healthcare services utilization accrued with BPS/IC was not necessarily exclusive for BPS/IC, but may have also been associated with medical co-morbidities.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Li, Hsien-Chang; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Clemens JQ, 2008, UROLOGY, V71, P776, DOI 10.1016/j.urology.2007.11.154; CLEMENS JQ, 2006, J UROLOGY S, V175, P94; Driscoll A, 2001, J UROLOGY, V166, P2118, DOI 10.1016/S0022-5347(05)65517-6; Forrest John B, 2002, Rev Urol, V4 Suppl 1, pS44; Keller JJ, NEUROUROL U IN PRESS; Leppilahti M, 2002, J UROLOGY, V168, P139, DOI 10.1016/S0022-5347(05)64847-1; Metts JF, 2001, AM FAM PHYSICIAN, V64, P1199; Michael YL, 2000, J UROLOGY, V164, P423, DOI 10.1016/S0022-5347(05)67376-4; Parsons CL, 2002, UROLOGY, V60, P573, DOI 10.1016/S0090-4295(02)01829-0; Payne CK, 2007, J UROLOGY, V177, P2042, DOI 10.1016/j.juro.2007.01.124; Rosenberg MT, 2005, J UROLOGY, V174, P2231, DOI 10.1097/01.ju.0000181203.82693.95; Wu EQ, 2006, PHARMACOECONOMICS, V24, P55, DOI 10.2165/00019053-200624010-00005	12	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87522	10.1371/journal.pone.0087522	http://dx.doi.org/10.1371/journal.pone.0087522			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489932	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000157
J	Friedlander, AM; Obura, D; Aumeeruddy, R; Ballesteros, E; Church, J; Cebrian, E; Sala, E				Friedlander, Alan M.; Obura, David; Aumeeruddy, Riaz; Ballesteros, Enric; Church, Julie; Cebrian, Emma; Sala, Enric			Coexistence of Low Coral Cover and High Fish Biomass at Farquhar Atoll, Seychelles	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF FISHES; RESILIENCE; IMPACTS; COMMUNITIES; ISLANDS; ECOLOGY; SIZE	We report a reef ecosystem where corals may have lost their role as major reef engineering species but fish biomass and assemblage structure is comparable to unfished reefs elsewhere around the world. This scenario is based on an extensive assessment of the coral reefs of Farquhar Atoll, the most southern of the Seychelles Islands. Coral cover and overall benthic community condition at Farquhar was poor, likely due to a combination of limited habitat, localized upwelling, past coral bleaching, and cyclones. Farquhar Atoll harbors a relatively intact reef fish assemblage with very large biomass (3.2 t ha(-1)) reflecting natural ecological processes that are not influenced by fishing or other local anthropogenic factors. The most striking feature of the reef fish assemblage is the dominance by large groupers, snappers, and jacks with large (>1 m) potato cod (Epinephelus tukula) and marbled grouper (E. polyphekadion), commonly observed at many locations. Napoleon wrasse (Cheilinus undulatus) and bumphead parrotfish (Bolbometopon muricatum) are listed as endangered and vulnerable, respectively, but were frequently encountered at Farquhar. The high abundance and large sizes of parrotfishes at Farquhar also appears to regulate macroalgal abundance and enhance the dominance of crustose corallines, which are a necessary condition for maintenance of healthy reef communities. Overall fish biomass and biomass of large predators at Farquhar are substantially higher than other areas within the Seychelles, and are some of the highest recorded in the Indian Ocean. Remote islands like Farquhar Atoll with low human populations and limited fishing pressure offer ideal opportunities for understanding whether reefs can be resilient from global threats if local threats are minimized.	[Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Obura, David] Coastal Res & Dev Indian Ocean CORDIO, Mombasa, Kenya; [Aumeeruddy, Riaz] Isl Conservat Soc, Mahe, Seychelles; [Ballesteros, Enric; Cebrian, Emma; Sala, Enric] Ctr Estudis Avancats Blanes, Blanes, Spain; [Church, Julie] UniquEco Designs Ltd, Nairobi, Kenya; [Sala, Enric] Natl Geog Soc, Washington, DC USA	University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); National Geographic Society	Friedlander, AM (corresponding author), Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu	Cebrian, Emma/J-9640-2012	Cebrian, Emma/0000-0001-7588-0135	National Geographic Society; National Research Council of Spain	National Geographic Society(National Geographic Society); National Research Council of Spain	Funding for this work was provided by the National Geographic Society and the National Research Council of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Braithwaite C.J.R., 1971, S ZOOL SOC LOND, V28, P39; Clarke K., 2001, PRIMER V5 USER MANUA; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Froese R., 2012, FISHBASE; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham Nicholas A.J., 2013, P253; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2011, SCIENCE, V334, P1494, DOI 10.1126/science.334.6062.1494-b; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Jennings S, 2002, CORAL REEFS INDIAN O, P383; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kobayashi D. R., 2011, NOAATMNMFSPIFSC26; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Ludwig J. A., 1988, STAT ECOLOGY; MAPSTONE BD, 1998, GREAT BARRIER REEF M, V47; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2011, FRONT ECOL ENVIRON, V9, P94, DOI 10.1890/11.WB.002; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Nageon de Lestang J, 1999, CASE STUDIES MANAGEM, P285; Naim Odile, 2000, P353; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Novozhilov AV, 1992, ATOLL RES B, V366, P1; Obura D, 2009, RESILIENCE ASSESSMEN; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Payet R, 2006, AMBIO, V35, P182, DOI 10.1579/0044-7447(2006)35[182:CCITSI]2.0.CO;2; PLUMMER PS, 1995, J AFR EARTH SCI, V20, P91, DOI 10.1016/0899-5362(95)00035-R; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Randall J. E, 1967, STUD TROP OCEANOGR U, V5, P665; Robinson J, 2008, B MAR SCI, V83, P415; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; STODDART D R, 1970, Atoll Research Bulletin, V136, P7; Zar JH, 1999, BIOSTATISTICAL ANAL	55	9	9	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87359	10.1371/journal.pone.0087359	http://dx.doi.org/10.1371/journal.pone.0087359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489903	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000137
J	Kim, DW; Lee, SA; Kim, H; Won, YS; Kim, BJ				Kim, Dong-Won; Lee, Seoung-Ae; Kim, Hong; Won, You-Sub; Kim, Bum-Joon			Naturally Occurring Mutations in the Nonstructural Region 5B of Hepatitis C Virus (HCV) from Treatment-Naive Korean Patients Chronically Infected with HCV Genotype 1b	PLOS ONE			English	Article							ALPHA-2A PLUS RIBAVIRIN; T-CELL RESPONSE; NS5B POLYMERASE; HEPATOCELLULAR-CARCINOMA; GENETIC-VARIATION; INTERFERON-ALPHA; VIRAL LOAD; COMBINATION; ASSOCIATION; THERAPY	The nonstructural 5B (NS5B) protein of the hepatitis C virus (HCV) with RNA-dependent RNA polymerase (RdRp) activity plays a pivotal role in viral replication. Therefore, monitoring of its naturally occurring mutations is very important for the development of antiviral therapies and vaccines. In the present study, mutations in the partial NS5B gene (492 bp) from 166 quasispecies of 15 genotype-1b (GT) treatment-naive Korean chronic patients were determined and mutation patterns and frequencies mainly focusing on the T cell epitope regions were evaluated. The mutation frequency within the CD8+ T cell epitopes was significantly higher than those outside the CD8+ T cell epitopes. Of note, the mutation frequency within predicted CD4+ T cell epitopes, a particular mutational hotspot in Korean patients was significantly higher than it was in patients from other areas, suggesting distinctive CD4+ T cell-mediated immune pressure against HCV infection in the Korean population. The mutation frequency in the NS5B region was positively correlated with patients with carrier-stage rather than progressive liver disease (chronic hepatitis, liver cirrhosis and hepatocellular carcinoma). Furthermore, the mutation frequency in four codons (Q309, A333, V338 and Q355) known to be related to the sustained virological response (SVR) and end-of treatment response (ETR) was also significantly higher in Korean patients than in patients from other areas. In conclusion, a high degree of mutation frequency in the HCV GT-1b NS5B region, particularly in the predicted CD4+ T cell epitopes, was found in Korean patients, suggesting the presence of distinctive CD4+ T cell pressure in the Korean population. This provides a likely explanation of why relatively high levels of SVR after a combined therapy of pegylated interferon (PEG-IFN) and ribavirin (RBV) in Korean chronic patients with GT-1b infections are observed.	[Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Seoul, South Korea; Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022; Kim, Bum Joon/J-2739-2012	Kim, Bum Joon/0000-0003-0085-6709; Kim, Hong/0000-0003-1383-6803	National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2013-005810]	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013-005810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Ali L, 2010, J GEN VIROL, V91, P1931, DOI 10.1099/vir.0.018119-0; Blackard JT, 2010, J CLIN MICROBIOL, V48, P4256, DOI 10.1128/JCM.01613-10; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; BRUGUERA M, 1974, GUT, V15, P799, DOI 10.1136/gut.15.10.799; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chang KM, 2001, HEPATOLOGY, V33, P267, DOI 10.1053/jhep.2001.21162; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Cheney IW, 2002, VIROLOGY, V297, P298, DOI 10.1006/viro.2002.1461; Chung HY, 2010, KOREAN J LAB MED, V30, P1, DOI 10.3343/kjlm.2010.30.1.1; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; DILELIO A, 1989, RADIOLOGY, V172, P389, DOI 10.1148/radiology.172.2.2526349; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hamano K, 2005, J GASTROEN HEPATOL, V20, P1401, DOI 10.1111/j.1440-1746.2005.04024.x; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Heo NY, 2013, CLIN MOL HEPATOL, V19, P60, DOI 10.3350/cmh.2013.19.1.60; Jaspe RC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-214; Kim DW, 2012, PLOS ONE, V7; Kobayashi K, 2005, CLIN EXP IMMUNOL, V141, P81, DOI 10.1111/j.1365-2249.2005.02018.x; Kuzushita N, 1998, HEPATOLOGY, V27, P240, DOI 10.1002/hep.510270136; Liu L, 2010, J VIROL, V84, P5067, DOI 10.1128/JVI.02265-09; Liu Z, 2009, HEPATOLOGY, V50, P25, DOI 10.1002/hep.22987; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Ludmerer SW, 2005, ANTIMICROB AGENTS CH, V49, P2059, DOI 10.1128/AAC.49.5.2059-2069.2005; Lyoo K, 2011, J CLIN VIROL, V52, P363, DOI 10.1016/j.jcv.2011.08.006; Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2; Minton EJ, 1998, J INFECT DIS, V178, P39, DOI 10.1086/514258; Missiha S, 2007, AM J GASTROENTEROL, V102, P2181, DOI 10.1111/j.1572-0241.2007.01431.x; Mo HM, 2005, ANTIMICROB AGENTS CH, V49, P4305, DOI 10.1128/AAC.49.10.4305-4314.2005; Nakatani SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010150; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Neumann-Haefelin C, 2011, HEPATOLOGY, V54, P1157, DOI 10.1002/hep.24541; Neumann-Haefelin C, 2010, HEPATOLOGY, V51, P54, DOI 10.1002/hep.23275; Oh DJ, 2012, ANN LAB MED, V32, P210, DOI 10.3343/alm.2012.32.3.210; Pawlotsky JM, 2002, HEPATOLOGY, V36, pS65, DOI 10.1053/jhep.2002.36815; Plaza Z, 2011, J ANTIMICROB CHEMOTH, V66, P2838, DOI 10.1093/jac/dkr385; Puoti Claudio, 2004, Rom J Gastroenterol, V13, P329; Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sinn DH, 2013, WORLD J GASTROENTERO, V19, P2256, DOI 10.3748/wjg.v19.i14.2256; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thio CL, 2001, J INFECT DIS, V184, P16, DOI 10.1086/321005; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Uzicanin S, 2012, J MED VIROL, V84, P1571, DOI 10.1002/jmv.23361; van Asten L, 2004, J INFECT DIS, V189, P292, DOI 10.1086/380821; Watanabe K, 2005, J MED VIROL, V75, P504, DOI 10.1002/jmv.20301; Yan KK, 2008, WORLD J GASTROENTERO, V14, P3416, DOI 10.3748/wjg.14.3416; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	58	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87773	10.1371/journal.pone.0087773	http://dx.doi.org/10.1371/journal.pone.0087773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489961	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000178
J	Li, W; Teng, GJ; Tong, HF; Jiao, YM; Zhang, T; Chen, H; Wu, H				Li, Wei; Teng, Guangju; Tong, Hongfei; Jiao, Yanmei; Zhang, Tong; Chen, Hui; Wu, Hao			Study on Risk Factors for Severe Hand, Foot and Mouth Disease in China	PLOS ONE			English	Article							BRAIN-STEM ENCEPHALITIS; ENTEROVIRUS 71; CEREBROSPINAL-FLUID; INFECTIONS; CHILDREN; CYTOKINES; FEATURES; THERAPY; TAIWAN	Background: Epidemics of HFMD are elevated every year globally, especially in mainland China. The disease now presents as an increasing threat to public health worldwide. Methods: Five hundred and seventy-one EV71-infected HFMD patients in Beijing You'an Hospital were grouped by disease severity: Mild (no severe complication) (n = 221), and Severe group (complicated with brainstem encephalitis (BE), and/or pulmonary edema (PE) (n = 350)). Clinical and laboratory findings and levels of 7 serum cytokines were analyzed. Results: Univariate analysis showed that (RR)> 26/min (p < 0.001), age, 4 yo (p = 0.001), GLU > 8.3 mmol/L (p = 0.008), CL < 98 mmol/L (p = 0.026), and WBC > 1.2x10(9)/L (p = 0.040) were associated with severe cases. Results of multivariate analysis indicated five independent risk factors (RR > 26/min (p < 0.001), Age, 4 yo (p < 0.001), GLU > 8.3 mmol/L (p = 0.011), LYM > 40% (p = 0.010), and ALT > 40 U/L (p = 0.045)). In addition to single-factor analysis, we further analyzed the use of different combinations of risk factors. "GLU > 8.3 and CL < 98 and RR > 26'' (confidence ration (CR) = 100%) is the top indicator, followed by "ALT > 40 and LYM > 40% and RR > 26 and Age, 4 yo'' (CR = 92.9%). Serum levels of IL-2, IL-4, IL-10, IFN gamma, GM-CSF, and TNF alpha were higher in severe cases than in mild cases. A new evaluation scoring system by scoring each risk factor 1 and independent risk factor 2 was developed for early identification of severe HFMD cases. Conclusions: Five independent risk factors, along with indicative combinations of risk factors, for severe cases were identified, and a scoring system was created to facilitate the use of indicators for early medical intervention.	[Li, Wei; Jiao, Yanmei; Zhang, Tong; Wu, Hao] Capital Med Univ, Ctr Infect Dis, Beijing Youan Hosp, Beijing, Peoples R China; [Teng, Guangju] 302 Mil Hosp China, Dept Noninfect Liver Disorders, Beijing, Peoples R China; [Tong, Hongfei] Wenzhou Med Coll, Affiliated Hosp 2, Dept Gen Surg, Wenzhou, Zhejiang, Peoples R China; [Chen, Hui] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Capital Medical University; Fifth Medical Center of Chinese PLA General Hospital; Wenzhou Medical University; Capital Medical University	Chen, H (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	exjhww8@163.com; wuhao90000@gmail.com	Li, Wei/I-8060-2014; Zhang, Tong/HGC-1090-2022	Li, Wei/0000-0002-9991-7892; Chen, Hui/0000-0002-0048-0193	National Natural Science Foundation of China [81371332, 81161120423/H19]; Twelve-five Project for Control and Prevention of Major Infectious Diseases [2012ZX10001-006/003]; Beijing Key Laboratory [BZ0089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelve-five Project for Control and Prevention of Major Infectious Diseases; Beijing Key Laboratory	This work was supported by National Natural Science Foundation of China [81371332], National Natural Science Foundation of China [81161120423/H19], Twelve-five Project for Control and Prevention of Major Infectious Diseases [2012ZX10001-006/003], Beijing Key Laboratory [BZ0089]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1994, IMMUNOL REV, V139, P5, DOI 10.1111/j.1600-065X.1994.tb00854.x; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Griffiths MJ, 2012, J INFECT DIS, V206, P881, DOI 10.1093/infdis/jis446; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Mao G, 2008, CHIN J INFECT DIS, V26, P3; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yu L, 2011, CHIN PEDIAT EMERG ME, V18, P2; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067430; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	22	39	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87603	10.1371/journal.pone.0087603	http://dx.doi.org/10.1371/journal.pone.0087603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489943	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000163
J	Maxim, L; van der Sluijs, JP				Maxim, Laura; van der Sluijs, Jeroen P.			Qualichem In Vivo: A Tool for Assessing the Quality of In Vivo Studies and Its Application for Bisphenol A	PLOS ONE			English	Article							DEVELOPMENTAL NEUROTOXICITY; UNCERTAINTY; IMPACT	In regulatory toxicology, quality assessment of in vivo studies is a critical step for assessing chemical risks. It is crucial for preserving public health studies that are considered suitable for regulating chemicals are robust. Current procedures for conducting quality assessments in safety agencies are not structured, clear or consistent. This leaves room for criticism about lack of transparency, subjective influence and the potential for insufficient protection provided by resulting safety standards. We propose a tool called "Qualichem in vivo'' that is designed to systematically and transparently assess the quality of in vivo studies used in chemical health risk assessment. We demonstrate its use here with 12 experts, using two controversial studies on Bisphenol A (BPA) that played an important role in BPA regulation in Europe. The results obtained with Qualichem contradict the quality assessments conducted by expert committees in safety agencies for both of these studies. Furthermore, they show that reliance on standardized guidelines to ensure scientific quality is only partially justified. Qualichem allows experts with different disciplinary backgrounds and professional experiences to express their individual and sometimes divergent views-an improvement over the current way of dealing with minority opinions. It provides a transparent framework for expressing an aggregated, multi-expert level of confidence in a study, and allows a simple graphical representation of how well the study integrates the best available scientific knowledge. Qualichem can be used to compare assessments of the same study by different health agencies, increasing transparency and trust in the work of expert committees. In addition, it may be used in systematic evaluation of in vivo studies submitted by industry in the dossiers that are required for compliance with the REACH Regulation. Qualichem provides a balanced, common framework for assessing the quality of studies that may or may not be following standardized guidelines.	[Maxim, Laura] CNRS, UPS 3088, Inst Commun Sci, Paris, France; [van der Sluijs, Jeroen P.] Univ Utrecht, Copernicus Inst, Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); Utrecht University	Maxim, L (corresponding author), CNRS, UPS 3088, Inst Commun Sci, Paris, France.	laura.maxim@iscc.cnrs.fr	van der Sluijs, Jeroen P/B-6302-2008; Maxim, Laura/F-4605-2019	van der Sluijs, Jeroen P/0000-0002-1346-5953; Maxim, Laura/0000-0001-9641-6649	French Ministry of Ecology	French Ministry of Ecology	This work has been funded by the French Ministry of Ecology in the framework of the PNRPE 2010 programme (URL: http://www.pnrpe.fr/), as part of the project "Toolkit for uncertainty and knowledge quality analysis of endocrine disruptors' risk assessments: the case study of Bisphenol A'' (DICO-Risk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000151; ANSES (Agence Nationale de Securite Sanitaire Alimentation Environnement Travail), 2013, PERT END EV RISQ BIS, V1; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Beronius A, 2010, REPROD TOXICOL, V29, P132, DOI 10.1016/j.reprotox.2009.11.007; Brozek JL, 2011, ALLERGY, V66, P588, DOI 10.1111/j.1398-9995.2010.02530.x; Chateauraynaud F, 2011, DOSE TOUJOURS POISON; Craye M., 2005, INT J RISK ASSESSMEN, V5, P216, DOI DOI 10.1504/IJRAM.2005.007169; de Jong A, 2012, ENVIRON SCI POLICY, V16, P114, DOI 10.1016/j.envsci.2011.11.012; ECB, 2003, EUR UN RISK ASS REP, p[179, 214]; ECHA, 2011, GUID INF REQ CHEM SA; EFSA, 2010, EFSA J, V8, P116; EFSA, 2010, EFSA J, V8, P67; European Food Safety Authority, 2006, EFSA J, V2006, P1, DOI [DOI 10.2903/J.EFSA.2006.69R, DOI 10.2903/J.EFSA.2006.365]; Funtowicz S. O., 1990, UNCERTAINTY QUALITY; Hartung T, 2009, ALTEX-ALTERN TIEREXP, V26, P75; Hillier S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-23; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klimisch HJ, 1997, REGUL TOXICOL PHARM, V25, P1, DOI 10.1006/rtph.1996.1076; Kloprogge P, 2011, ENVIRON MODELL SOFTW, V26, P289, DOI 10.1016/j.envsoft.2009.06.009; Knol AB, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-19; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Makris SL, 2009, ENVIRON HEALTH PERSP, V117, P17, DOI 10.1289/ehp.11447; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Maxim L, 2013, SCI PRECAUTIONARY PR, P401; Maxim L, 2011, ENVIRON SCI POLICY, V14, P482, DOI 10.1016/j.envsci.2011.01.003; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173; Noelle-Neumann E, 1986, SPIRAL SILENCE; OECD, 2000, OECD SER PRINC GOOD, V5; OECD, 2007, OECD GUID TEST CHEM; OECD, 2001, OECD GUID TEST CHEM; Organisation for Economic Co-operation and Development, 1998, OECD SER PRINC GOOD, V1; Ruden C, 2001, REGUL TOXICOL PHARM, V34, P3, DOI 10.1006/rtph.2001.1482; SCF, 2002, OP SCI COMM FOOD BIS, P7; Schneider K, 2009, TOXICOL LETT, V189, P138, DOI 10.1016/j.toxlet.2009.05.013; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Stump DG, 2009, DIETARY DEV NEUROTOX, V1; Stump DG, 2010, TOXICOL SCI, V115, P167, DOI 10.1093/toxsci/kfq025; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; Tyl RW, 2006, 80057 CAS BPA RTI IN; [United States Environmental Protection Agency Pesticides and Toxic Substances Office of Prevention], 1998, HLTH EFF TEST GUID; *US EPA, 1998, HLTH EFF TEST GUID O; van der Sluijs JP, 2007, ENVIRON MODELL SOFTW, V22, P590, DOI 10.1016/j.envsoft.2005.12.020; van der Sluijs JP, 2005, RISK ANAL, V25, P481, DOI 10.1111/j.1539-6924.2005.00604.x; Van der Sluijs JP, 2005, ENVIRON MONIT ASSESS, V105, P229, DOI 10.1007/s10661-005-3697-7; van der Sluijs JP, 2002, FUTURES, V34, P133, DOI 10.1016/S0016-3287(01)00051-9; Van Gijlswijk R, 2004, UNCERTAINTY ASSESSME; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; vom Saal FS, 2010, TOXICOL SCI, V115, P612, DOI 10.1093/toxsci/kfq048; Wandall B, 2007, ARCH TOXICOL, V81, P605, DOI 10.1007/s00204-007-0194-5	50	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87738	10.1371/journal.pone.0087738	http://dx.doi.org/10.1371/journal.pone.0087738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489958	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000175
J	Szalowska, E; van der Burg, B; Man, HY; Hendriksen, PJM; Peijnenburg, AACM				Szalowska, Ewa; van der Burg, Bart; Man, Hai-Yen; Hendriksen, Peter J. M.; Peijnenburg, Ad A. C. M.			Model Steatogenic Compounds (Amiodarone, Valproic Acid, and Tetracycline) Alter Lipid Metabolism by Different Mechanisms in Mouse Liver Slices	PLOS ONE			English	Article							GENE-EXPRESSION; RAT-LIVER; HEPATIC STEATOSIS; INDUCED CHOLESTASIS; OXIDATIVE STRESS; FATTY-ACIDS; DRUG; HEPATOCYTES; INDUCTION; MICE	Although drug induced steatosis represents a mild type of hepatotoxicity it can progress into more severe non-alcoholic steatohepatitis. Current models used for safety assessment in drug development and chemical risk assessment do not accurately predict steatosis in humans. Therefore, new models need to be developed to screen compounds for steatogenic properties. We have studied the usefulness of mouse precision-cut liver slices (PCLS) as an alternative to animal testing to gain more insight into the mechanisms involved in the steatogenesis. To this end, PCLS were incubated 24 h with the model steatogenic compounds: amiodarone (AMI), valproic acid (VA), and tetracycline (TET). Transcriptome analysis using DNA microarrays was used to identify genes and processes affected by these compounds. AMI and VA upregulated lipid metabolism, whereas processes associated with extracellular matrix remodelling and inflammation were downregulated. TET downregulated mitochondrial functions, lipid metabolism, and fibrosis. Furthermore, on the basis of the transcriptomics data it was hypothesized that all three compounds affect peroxisome proliferator activated-receptor (PPAR) signaling. Application of PPAR reporter assays classified AMI and VA as PPAR gamma and triple PPAR alpha/(beta/delta)/gamma agonist, respectively, whereas TET had no effect on any of the PPARs. Some of the differentially expressed genes were considered as potential candidate biomarkers to identify PPAR agonists (i.e. AMI and VA) or compounds impairing mitochondrial functions (i.e. TET). Finally, comparison of our findings with publicly available transcriptomics data showed that a number of processes altered in the mouse PCLS was also affected in mouse livers and human primary hepatocytes exposed to known PPAR agonists. Thus mouse PCLS are a valuable model to identify early mechanisms of action of compounds altering lipid metabolism.	[Szalowska, Ewa; Hendriksen, Peter J. M.; Peijnenburg, Ad A. C. M.] Univ Wageningen & Res Ctr, Cluster Bioassays & Toxicol, RIKILT Inst Food Safety, Wageningen, Netherlands; [van der Burg, Bart; Man, Hai-Yen] BDS BioDetect Syst, Amsterdam, Netherlands	Wageningen University & Research	Szalowska, E (corresponding author), Univ Wageningen & Res Ctr, Cluster Bioassays & Toxicol, RIKILT Inst Food Safety, Wageningen, Netherlands.	ewa.szalowska@wur.nl		Hendriksen, Peter/0000-0002-0951-3270	Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research; Netherlands Toxicogenomics Centre [05060510]	Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Toxicogenomics Centre	This work was supported by the Netherlands Genomics Initiative, the Netherlands Organisation for Scientific Research, and the Netherlands Toxicogenomics Centre (grant number 05060510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNATHY CO, 1992, P SOC EXP BIOL MED, V199, P54; Amacher DE, 2011, EXPERT OPIN DRUG MET, V7, P949, DOI 10.1517/17425255.2011.577740; Amacher DE, 1997, FUND APPL TOXICOL, V40, P256, DOI 10.1006/faat.1997.2389; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Antherieu S, 2013, HEPATOLOGY, V57, P1518, DOI 10.1002/hep.26160; Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; BURK RF, 1980, J CLIN INVEST, V65, P1024, DOI 10.1172/JCI109754; Cherkaoui-Malki M, 2012, CURR DRUG METAB, V13, P1412, DOI 10.2174/138920012803762765; Dandel M, 2010, TRANSPL IMMUNOL, V23, P93, DOI 10.1016/j.trim.2010.04.007; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; de Longueville F, 2003, TOXICOL SCI, V75, P378, DOI 10.1093/toxsci/kfg196; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durand J L, 1979, Adv Intern Med, V24, P97; Ernst MC, 2010, PHARMACOL RES, V62, P408, DOI 10.1016/j.phrs.2010.07.004; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513; FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1377; Fujimura H, 2009, J APPL TOXICOL, V29, P356, DOI 10.1002/jat.1420; Furuno T, 2001, BIOCHEM PHARMACOL, V62, P1037, DOI 10.1016/S0006-2952(01)00745-6; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gijsbers L, 2013, J AGR FOOD CHEM, V61, P3419, DOI 10.1021/jf304790a; Gijsbers L, 2011, ANAL BIOCHEM, V414, P77, DOI 10.1016/j.ab.2011.02.032; Grieco A, 2005, Eur Rev Med Pharmacol Sci, V9, P261; Hirode M, 2008, TOXICOL APPL PHARM, V229, P290, DOI 10.1016/j.taap.2008.01.036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illsinger S, 2011, CLIN TRANSPLANT, V25, P584, DOI 10.1111/j.1399-0012.2010.01301.x; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Larrain S, 2012, CLIN LIVER DIS, V16, P525, DOI 10.1016/j.cld.2012.05.009; Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4; McCarthy TC, 2004, J PHARMACOL EXP THER, V311, P864, DOI 10.1124/jpet.104.072785; Nakajima Y, 2004, DRUG METAB DISPOS, V32, P1383, DOI 10.1124/dmd.104.000661; Pessayre D, 1999, CELL BIOL TOXICOL, V15, P367, DOI 10.1023/A:1007649815992; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Qu Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-211; Rogue A, 2012, DRUG METAB DISPOS, V40, P151, DOI 10.1124/dmd.111.042028; Rogue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018816; Shen C, 2009, TOXICOL APPL PHARM, V238, P178, DOI 10.1016/j.taap.2009.05.014; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; SKORIN C, 1992, BIOCHEM J, V281, P561, DOI 10.1042/bj2810561; Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005; Spaniol M, 2001, J HEPATOL, V35, P628, DOI 10.1016/S0168-8278(01)00189-1; Staels B, 2013, HEPATOLOGY; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Tamura Kotaro, 2006, Journal of Toxicological Sciences, V31, P471, DOI 10.2131/jts.31.471; TIMBRELL JA, 1980, J PHARMACOL EXP THER, V213, P364; van der Toorn M, 2007, FEBS J, V274, P3003, DOI 10.1111/j.1742-4658.2007.05827.x; Vassallo P, 2007, JAMA-J AM MED ASSOC, V298, P1312, DOI 10.1001/jama.298.11.1312; Videla LA, 2012, PPAR RES, V2012, DOI 10.1155/2012/107434; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Yin HQ, 2006, TOXICOL SCI, V94, P206, DOI 10.1093/toxsci/kfl078; Yu HY, 2009, TOXICOLOGY, V261, P112, DOI 10.1016/j.tox.2009.04.058	55	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86795	10.1371/journal.pone.0086795	http://dx.doi.org/10.1371/journal.pone.0086795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489787	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000070
J	Hu, JY; Wang, GH; Liu, XT; Zhou, LN; Jiang, ML; Yang, L				Hu, Jinyue; Wang, Guihua; Liu, Xueting; Zhou, Lina; Jiang, Manli; Yang, Li			A20 Is Critical for the Induction of Pam3CSK4-Tolerance in Monocytic THP-1 Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; ENDOTOXIN-TOLERANCE; CROSS-TOLERANCE; IRAK-M; NEGATIVE REGULATOR; ENZYME A20; EXPERIMENTAL COLITIS; COMPLEX-FORMATION; UP-REGULATION	A20 functions to terminate Toll-like receptor (TLR)-induced immune response, and play important roles in the induction of lipopolysacchride (LPS)-tolerance. However, the molecular mechanism for Pam3CSK4-tolerance is uncertain. Here we report that TLR1/2 ligand Pam3CSK4 induced tolerance in monocytic THP-1 cells. The pre-treatment of THP-1 cells with Pam3CSK4 down-regulated the induction of pro-inflammatory cytokines induced by Pam3CSK4 re-stimulation. Pam3CSK4 pre-treatment also down-regulated the signaling transduction of JNK, p38 and NF-kappa B induced by Pam3CSK4 re-stimulation. The activation of TLR1/2 induced a rapid and robust up-regulation of A20, suggesting that A20 may contribute to the induction of Pam3CSK4-tolerance. This hypothesis was proved by the observation that the over-expression of A20 by gene transfer down-regulated Pam3CSK4-induced inflammatory responses, and the down-regulation of A20 by RNA interference inhibited the induction of tolerance. Moreover, LPS induced a significant up-regulation of A20, which contributed to the induction of cross-tolerance between LPS and Pam3CSK4. A20 was also induced by the treatment of THP-1 cells with TNF-alpha and IL-1 beta. The pre-treatment with TNF-alpha and IL-1 beta partly down-regulated Pam3CSK4-induced activation of MAPKs. Furthermore, pharmacologic inhibition of GSK3 signaling down-regulated Pam3CSK4-induced A20 expression, up-regulated Pam3CSK4-induced inflammatory responses, and partly reversed Pam3CSK4 pre-treatment-induced tolerance, suggesting that GSK3 is involved in TLR1/2-induced tolerance by up-regulation of A20 expression. Taken together, these results indicated that A20 is a critical regulator for TLR1/2-induced pro-inflammatory responses.	[Hu, Jinyue; Liu, Xueting; Jiang, Manli] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Wang, Guihua] Changsha Cent Hosp, Ctr Canc, Changsha, Hunan, Peoples R China; [Zhou, Lina] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan, Hubei, Peoples R China; [Yang, Li] Changsha Cent Hosp, TB Res Ctr, Changsha, Hunan, Peoples R China	Wuhan University	Hu, JY (corresponding author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.	jinyueh@yahoo.com; YL7618@126.com			National Science and Technology Major Project [2013ZX10005004]	National Science and Technology Major Project	This work was supported by National Science and Technology Major Project (2013ZX10005004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Dou W, 2013, BRIT J NUTR, V110, P599, DOI 10.1017/S0007114512005594; Fernandez ED, 2002, CRIT CARE MED, V30, P165; Gon Y, 2004, AM J RESP CELL MOL, V31, P330, DOI 10.1165/rcmb.2003-0438OC; Gui J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046515; Hofmann SR, 2012, CLIN IMMUNOL, V145, P69, DOI 10.1016/j.clim.2012.07.012; Hu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078832; Huang X, 2006, J IMMUNOL, V177, P548, DOI 10.4049/jimmunol.177.1.548; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Joh EH, 2011, BRIT J PHARMACOL, V162, P1731, DOI 10.1111/j.1476-5381.2010.01195.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lemaire LCJM, 1998, J CLIN IMMUNOL, V18, P414, DOI 10.1023/A:1023282706945; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu ZJ, 2008, J SURG RES, V150, P34, DOI 10.1016/j.jss.2007.12.759; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Rehani K, 2009, J IMMUNOL, V182, P547, DOI 10.4049/jimmunol.182.1.547; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen E, 2008, J CELL BIOCHEM, V104, P329, DOI 10.1002/jcb.21629; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; Yokota SI, 2008, FASEB J, V22, P74, DOI 10.1096/fj.07-8976com; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694	50	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87528	10.1371/journal.pone.0087528	http://dx.doi.org/10.1371/journal.pone.0087528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489933	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000140
J	Keshavarz-Motamed, Z; Garcia, J; Gaillard, E; Capoulade, R; Le Ven, F; Cloutier, G; Kadem, L; Pibarot, P				Keshavarz-Motamed, Zahra; Garcia, Julio; Gaillard, Emmanuel; Capoulade, Romain; Le Ven, Florent; Cloutier, Guy; Kadem, Lyes; Pibarot, Philippe			Non-Invasive Determination of Left Ventricular Workload in Patients with Aortic Stenosis Using Magnetic Resonance Imaging and Doppler Echocardiography	PLOS ONE			English	Article							PARADOXICAL LOW-FLOW; VALVULOARTERIAL IMPEDANCE; EJECTION FRACTION; VALVE STENOSIS; PRESSURE; GRADIENT; QUANTIFICATION; HEART; LOAD; AFTERLOAD	Early detection and accurate estimation of aortic stenosis (AS) severity are the most important predictors of successful long-term outcomes in patients. Current clinical parameters used for evaluation of the AS severity have several limitations including flow dependency. Estimation of AS severity is specifically challenging in patients with low-flow and low transvalvular pressure gradient conditions. A proper diagnosis in these patients needs a comprehensive evaluation of the left ventricle (LV) hemodynamic loads. This study has two objectives: (1) developing a lumped-parameter model to describe the ventricular-valvular-arterial interaction and to estimate the LV stroke work (SW); (2) introducing and validating a new index, the normalized stroke work (N-SW), to assess the global hemodynamic load imposed on the LV. N-SW represents the global hemodynamic load that the LV faces for each unit volume of blood ejected. The model uses a limited number of parameters which all can be measured non-invasively using current clinical imaging modalities. The model was first validated by comparing its calculated flow waveforms with the ones measured using Cardiovascular Magnetic Resonance (CMR) in 49 patients and 8 controls. A very good correlation and concordance were found throughout the cycle (median root mean square: 12.21 mL/s) and between the peak values (r = 0.98; SEE = 0.001, p < 0.001). The model was then used to determine SW using the parameters measured with transthoracic Doppler-echocardiography (TTE) and CMR. N-SW showed very good correlations with a previously-validated index of global hemodynamic load, the valvular arterial impedance (Z(VA)), using data from both imaging modalities (TTE: r = 0.82, SEE = 0.01, p < 0.001; CMR: r = 0.74, SEE = 0.01, p < 0.001). Furthermore, unlike, N-SW was almost independent from variations in the flow rate. This study suggests that considering N-SW may provide incremental diagnostic and prognostic information, beyond what standard indices of stenosis severity and provide, particularly in patients with low LV outflow.	[Keshavarz-Motamed, Zahra; Cloutier, Guy] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Keshavarz-Motamed, Zahra; Gaillard, Emmanuel; Kadem, Lyes] Concordia Univ, Lab Cardiovasc Fluid Dynam Mech & Ind Engn, Montreal, PQ, Canada; [Garcia, Julio] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Garcia, Julio; Capoulade, Romain; Le Ven, Florent; Pibarot, Philippe] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	Universite de Montreal; Concordia University - Canada; Northwestern University; Laval University; Quebec Heart & Lung Institute; Universite de Montreal; Universite de Montreal	Keshavarz-Motamed, Z (corresponding author), Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.	zahra.keshavarz@crchum.qc.ca	Garcia, Julio/F-6305-2014; Flores, Julio Garcia/AAI-3938-2020; Pibarot, Philippe/ABD-5300-2021; Capoulade, Romain/A-3966-2019; Garcia, Julio/AAF-7659-2020	Garcia, Julio/0000-0001-9528-8155; Flores, Julio Garcia/0000-0001-9528-8155; Capoulade, Romain/0000-0002-7233-7409; Le Ven, Florent/0000-0003-0555-1816	Fonds de la Recherche du Quebec postdoctoral Grant (FQRNT)	Fonds de la Recherche du Quebec postdoctoral Grant (FQRNT)	Dr. Pibarot is the director of the Canada Research Chair in Valvular Heart Diseases, Canadian Institutes of Health Research, Ottawa, Ontario, Canada. Dr. Keshavarz-Motamed was supported by a Fonds de la Recherche du Quebec postdoctoral Grant (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermejo J, 2003, J AM COLL CARDIOL, V41, P142, DOI 10.1016/S0735-1097(02)02627-X; Bonow RO, 2008, CIRCULATION, V2008, p[118, e523], DOI DOI 10.1161/CIRCULATI0NAHA.108.190748; Braunwald E., 2001, VALVULAR HEART DIS, P1643; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Caruthers SD, 2003, CIRCULATION, V108, P2236, DOI 10.1161/01.CIR.0000095268.47282.A1; Cawley PJ, 2009, CIRCULATION, V119, P468, DOI 10.1161/CIRCULATIONAHA.107.742486; Chan KL, 2003, J AM COLL CARDIOL, V42, P593, DOI 10.1016/S0735-1097(03)00786-1; Dumesnil JG, 2010, EUR HEART J, V31, P281, DOI 10.1093/eurheartj/ehp361; Garcia D, 2005, J BIOMECH, V38, P1303, DOI 10.1016/j.jbiomech.2004.06.018; Garcia D, 2006, WILEY ENCY BIOMEDICA, P1; Garcia J, 2013, EUR HEART J CARDIOVA, P1; Garcia J, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-23; Garcia J, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-25; Hachicha Z, 2007, CIRCULATION, V115, P2856, DOI 10.1161/CIRCULATIONAHA.106.668681; Hachicha Z, 2009, J AM COLL CARDIOL, V54, P1003, DOI 10.1016/j.jacc.2009.04.079; Hung J, 2009, JASE, V22, P1; Keshavarz-Motamed Z, 2011, J BIOMECH, V44, P2817, DOI 10.1016/j.jbiomech.2011.08.001; Lancellotti P, 2011, EUR J ECHOCARDIOGR, V12, P354, DOI 10.1093/ejechocard/jer044; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Omran H, 2003, LANCET, V361, P1241, DOI 10.1016/S0140-6736(03)12978-9; Page A, 2010, J AM COLL CARDIOL, V55, P1867, DOI 10.1016/j.jacc.2009.11.083; Pibarot P, 2012, J AM COLL CARDIOL, V60, P1845, DOI 10.1016/j.jacc.2012.06.051; Pibarot P, 2012, J AM COLL CARDIOL, V60, P169, DOI 10.1016/j.jacc.2011.11.078; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rieck AE, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-43; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; Stergiopulos N, 1999, AM J PHYSIOL-HEART C, V276, pH424, DOI 10.1152/ajpheart.1999.276.2.H424; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; Yap SC, 2007, J CARDIOVASC MAGN R, V9, P899, DOI 10.1080/10976640701693717	31	23	23	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86793	10.1371/journal.pone.0086793	http://dx.doi.org/10.1371/journal.pone.0086793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489786	Green Published, gold			2022-12-25	WOS:000330510000080
J	Liu, GZ; Li, XL; Jin, SX; Liu, XY; Zhu, LF; Nie, YC; Zhang, XL				Liu, Guanze; Li, Xuelin; Jin, Shuangxia; Liu, Xuyan; Zhu, Longfu; Nie, Yichun; Zhang, Xianlong			Overexpression of Rice NAC Gene SNAC1 Improves Drought and Salt Tolerance by Enhancing Root Development and Reducing Transpiration Rate in Transgenic Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM-L; TRANSCRIPTION FACTOR; STRESS TOLERANCE; GRAIN-YIELD; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; PLANTS; IDENTIFICATION; EXPRESSION; RESISTANCE	The SNAC1 gene belongs to the stress-related NAC superfamily of transcription factors. It was identified from rice and overexpressed in cotton cultivar YZ1 by Agrobacterium tumefaciens-mediated transformation. SNAC1-overexpressing cotton plants showed more vigorous growth, especially in terms of root development, than the wild-type plants in the presence of 250 mM NaCl under hydroponic growth conditions. The content of proline was enhanced but the MDA content was decreased in the transgenic cotton seedlings under drought and salt treatments compared to the wild-type. Furthermore, SNAC1-overexpressing cotton plants also displayed significantly improved tolerance to both drought and salt stresses in the greenhouse. The performances of the SNAC1-overexpressing lines under drought and salt stress were significantly better than those of the wild-type in terms of the boll number. During the drought and salt treatments, the transpiration rate of transgenic plants significantly decreased in comparison to the wild-type, but the photosynthesis rate maintained the same at the flowering stage in the transgenic plants. These results suggested that overexpression of SNAC1 improve more tolerance to drought and salt in cotton through enhanced root development and reduced transpiration rates.	[Liu, Guanze; Jin, Shuangxia; Liu, Xuyan; Zhu, Longfu; Nie, Yichun; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Liu, Guanze] Yunnan Agr Univ, Coll Tobacco Sci, Kunming, Yunnan, Peoples R China; [Li, Xuelin] Henan Univ Sci & Technol, Coll Agr, Luoyang, Henan, Peoples R China	Huazhong Agricultural University; Yunnan Agricultural University; Henan University of Science & Technology	Zhang, XL (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	xlzhang@mail.hzau.edu.cn		Zhang, Xianlong/0000-0002-7703-524X; Jin, Shuangxia/0000-0002-1495-9154	National High-Tech Program of China [2013AA102601-4]; Ministry of Agriculture of China [2013ZX08005-004]	National High-Tech Program of China(National High Technology Research and Development Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National High-Tech Program of China (2013AA102601-4) and the project from Ministry of Agriculture of China (2013ZX08005-004). The funders had no role in study design, data cellection and analysis, decision to publish or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Han QQ, 2012, MOL BIOL REP, V39, P1713, DOI 10.1007/s11033-011-0911-2; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jin S, 2006, BIOL PLANTARUM, V50, P519, DOI 10.1007/s10535-006-0082-5; Jin SX, 2005, PLANT CELL TISS ORG, V81, P229, DOI 10.1007/s11240-004-5209-9; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Liu GZ, 2012, PLANT CELL TISS ORG, V110, P261, DOI 10.1007/s11240-012-0148-3; Lv S, 2007, MOL BREEDING, V20, P233, DOI 10.1007/s11032-007-9086-x; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Meng CM, 2009, PLANT SCI, V176, P352, DOI 10.1016/j.plantsci.2008.12.003; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Peng H, 2009, PLANT PHYSIOL BIOCH, V47, P1037, DOI 10.1016/j.plaphy.2009.09.002; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; STEWART JMD, 1977, PLANTA, V137, P113, DOI 10.1007/BF00387547; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yan JQ, 2004, PLANT CELL PHYSIOL, V45, P1007, DOI 10.1093/pcp/pch115; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Yokotani N, 2009, PLANTA, V229, P1065, DOI 10.1007/s00425-009-0895-5; You J, 2013, J EXP BOT, V64, P569, DOI 10.1093/jxb/ers349; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	33	144	174	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86895	10.1371/journal.pone.0086895	http://dx.doi.org/10.1371/journal.pone.0086895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489802	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000087
J	Sansone, A; Hassenklover, T; Syed, AS; Korsching, SI; Manzini, I				Sansone, Alfredo; Hassenkloever, Thomas; Syed, Adnan S.; Korsching, Sigrun I.; Manzini, Ivan			Phospholipase C and Diacylglycerol Mediate Olfactory Responses to Amino Acids in the Main Olfactory Epithelium of an Amphibian	PLOS ONE			English	Article							XENOPUS-LAEVIS TADPOLES; RECEPTOR POTENTIAL CHANNEL; SIGNAL-TRANSDUCTION; ODORANT RECEPTOR; VOMERONASAL NEURONS; SENSORY NEURONS; SYSTEM; TRPC2; ORGAN; ORGANIZATION	The semi-aquatic lifestyle of amphibians represents a unique opportunity to study the molecular driving forces involved in the transition of aquatic to terrestrial olfaction in vertebrates. Most amphibians have anatomically segregated main and vomeronasal olfactory systems, but at the cellular and molecular level the segregation differs from that found in mammals. We have recently shown that amino acid responses in the main olfactory epithelium (MOE) of larval Xenopus laevis segregate into a lateral and a medial processing stream, and that the former is part of a vomeronasal type 2 receptor expression zone in the MOE. We hypothesized that the lateral amino acid responses might be mediated via a vomeronasal-like transduction machinery. Here we report that amino acid-responsive receptor neurons in the lateral MOE employ a phospholipase C (PLC) and diacylglycerol-mediated transduction cascade that is independent of Ca2+ store depletion. Furthermore, we found that putative transient receptor potential (TRP) channel blockers inhibit most amino acid-evoked responses in the lateral MOE, suggesting that ion channels belonging to the TRP family may be involved in the signaling pathway. Our data show, for the first time, a widespread PLC-and diacylglycerol-dependent transduction cascade in the MOE of a vertebrate already possessing a vomeronasal organ.	[Sansone, Alfredo; Hassenkloever, Thomas; Manzini, Ivan] Univ Gottingen, Inst Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany; [Syed, Adnan S.; Korsching, Sigrun I.] Univ Cologne, Inst Genet, Cologne, Germany; [Hassenkloever, Thomas; Manzini, Ivan] Univ Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37073 Gottingen, Germany	University of Gottingen; University of Cologne; University of Gottingen	Manzini, I (corresponding author), Univ Gottingen, Inst Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany.	imanzin@gwdg.de	Manzini, Ivan/V-4545-2019; Manzini, Ivan/F-8927-2015	Manzini, Ivan/0000-0002-3575-9637; Manzini, Ivan/0000-0002-3575-9637; Sansone, Alfredo/0000-0002-1197-7322; Hassenklover, Thomas/0000-0002-9895-1263	DFG; Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	DFG(German Research Foundation (DFG)); Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was supported by DFG Schwerpunktprogramm 1392 (I. M. and S. I. K.; URL: http://cms.uni-konstanz.de/spp/) and Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (I. M.; URL: http://www.cmpb.uni-goettingen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brann JH, 2002, J NEUROCHEM, V83, P1452, DOI 10.1046/j.1471-4159.2002.01266.x; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Delay RJ, 2002, CHEM SENSES, V27, P673, DOI 10.1093/chemse/27.8.673; DeMaria S, 2013, J NEUROSCI, V33, P15235, DOI 10.1523/JNEUROSCI.2339-13.2013; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gliem S, 2013, CELL MOL LIFE SCI, V70, P1965, DOI 10.1007/s00018-012-1226-8; Gonzalez A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00130; Hagino-Yamagishi K, 2004, J COMP NEUROL, V472, P246, DOI 10.1002/cne.20073; Hamdani EH, 2007, PROG NEUROBIOL, V82, P80, DOI 10.1016/j.pneurobio.2007.02.007; Hansen A, 1998, J COMP NEUROL, V398, P273, DOI 10.1002/(SICI)1096-9861(19980824)398:2<273::AID-CNE8>3.0.CO;2-Y; Hansen A, 2003, J NEUROSCI, V23, P9328; Hassenklover T, 2008, GLIA, V56, P1614, DOI 10.1002/glia.20714; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Inamura K, 1997, NEUROSCI LETT, V233, P129, DOI 10.1016/S0304-3940(97)00655-1; Junek S, 2009, BIOPHYS J, V96, P3801, DOI 10.1016/j.bpj.2008.12.3962; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; LO YH, 1994, CHEM SENSES, V19, P371, DOI 10.1093/chemse/19.5.371; LO YH, 1993, BIOCHEMISTRY-US, V32, P12358, DOI 10.1021/bi00097a012; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luu P, 2004, J NEUROSCI, V24, P10128, DOI 10.1523/JNEUROSCI.3117-04.2004; Ma L, 1998, J NEUROPHYSIOL, V79, P1183, DOI 10.1152/jn.1998.79.3.1183; Manzini I, 2004, J GEN PHYSIOL, V123, P99, DOI 10.1085/jgp.200308970; Manzini I, 2003, J PHYSIOL-LONDON, V551, P115, DOI 10.1113/jphysiol.2003.043059; Manzini I, 2003, J PHYSIOL-LONDON, V546, P375, DOI 10.1113/jphysiol.2002.033175; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiss JO, 1997, J NEUROBIOL, V32, P213, DOI 10.1002/(SICI)1097-4695(199702)32:2<213::AID-NEU6>3.0.CO;2-B; Sato K, 2001, CHEM SENSES, V26, P1145, DOI 10.1093/chemse/26.9.1145; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Spehr M, 2002, J NEUROSCI, V22, P8429; Syed AS, 2013, P NATL ACAD SCI USA, V110, P7714, DOI 10.1073/pnas.1302088110; Taniguchi K, 2011, J VET MED SCI, V73, P139, DOI 10.1292/jvms.10-0316; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Zhang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1253, DOI 10.1152/ajpcell.00271.2009; Zufall F, 2005, PFLUG ARCH EUR J PHY, V451, P61, DOI 10.1007/s00424-005-1432-4	36	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87721	10.1371/journal.pone.0087721	http://dx.doi.org/10.1371/journal.pone.0087721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489954	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000146
J	Tebben, J; Guest, JR; Sin, TM; Steinberg, PD; Harder, T				Tebben, Jan; Guest, James R.; Sin, Tsai M.; Steinberg, Peter D.; Harder, Tilmann			Corals Like It Waxed: Paraffin-Based Antifouling Technology Enhances Coral Spat Survival	PLOS ONE			English	Article							EARLY POSTSETTLEMENT MORTALITY; PHASE-SHIFTS; SCLERACTINIAN CORALS; MASS-CULTURE; RECRUITMENT; SETTLEMENT; ALGAE; REEFS; GROWTH; COMPETITION	The early post-settlement stage is the most sensitive during the life history of reef building corals. However, few studies have examined the factors that influence coral mortality during this period. Here, the impact of fouling on the survival of newly settled coral spat of Acropora millepora was investigated by manipulating the extent of fouling cover on settlement tiles using non-toxic, wax antifouling coatings. Survival of spat on coated tiles was double that on control tiles. Moreover, there was a significant negative correlation between percentage cover of fouling and spat survival across all tiles types, suggesting that fouling in direct proximity to settled corals has detrimental effects on early post-settlement survival. While previous studies have shown that increased fouling negatively affects coral larval settlement and health of juvenile and adult corals, to the best of our knowledge, this is the first study to show a direct relationship between fouling and early post-settlement survival for a broadcast spawning scleractinian coral. The negative effects of fouling on this sensitive life history stage may become more pronounced in the future as coastal eutrophication increases. Our results further suggest that targeted seeding of coral spat on artificial surfaces in combination with fouling control could prove useful to improve the efficiency of sexual reproduction-based coral propagation for reef rehabilitation.	[Tebben, Jan; Guest, James R.; Steinberg, Peter D.; Harder, Tilmann] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Guest, James R.; Steinberg, Peter D.] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Singapore 639798, Singapore; [Sin, Tsai M.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Tebben, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	jan.tebben@unsw.edu.au	Harder, Tilmann/B-6861-2008; Tebben, Jan/ABD-2247-2020; Guest, James/D-5179-2011	Harder, Tilmann/0000-0003-3173-6806; Tebben, Jan/0000-0002-2780-2236; Guest, James/0000-0002-9714-9009; Steinberg, Peter/0000-0002-1781-0726	Centre for Marine Bio-Innovation (Sydney); Advanced Environmental Biotechnology Centre (Singapore); Singapore National Parks Board	Centre for Marine Bio-Innovation (Sydney); Advanced Environmental Biotechnology Centre (Singapore); Singapore National Parks Board	The project work was partly funded by the Centre for Marine Bio-Innovation (Sydney), the Advanced Environmental Biotechnology Centre (Singapore) and a research grant from the Singapore National Parks Board awarded to JR Guest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida E, 2007, PROG ORG COAT, V59, P2, DOI 10.1016/j.porgcoat.2007.01.017; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; BAK RPM, 1984, OECOLOGIA, V63, P194, DOI 10.1007/BF00379877; Baria MVB, 2010, J EXP MAR BIOL ECOL, V394, P149, DOI 10.1016/j.jembe.2010.08.003; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; CHORNESKY EA, 1983, BIOL BULL, V165, P569, DOI 10.2307/1541466; Christiansen NA, 2009, CORAL REEFS, V28, P47, DOI 10.1007/s00338-008-0429-9; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; DALBY JE, 1992, MAR ECOL PROG SER, V80, P221, DOI 10.3354/meps080221; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Den Hartog JC, 1977, P 3 INT COR REEF S B, V1; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Edwards AJ, 2010, REEF REHABILITATION; Epstein N, 2001, RESTOR ECOL, V9, P432, DOI 10.1046/j.1526-100X.2001.94012.x; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Guest J., 2010, REEF REHABILITATION; Guest JR, 2005, CORAL REEFS, V24, P112, DOI 10.1007/s00338-004-0433-7; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Hatta M., 2004, MANUAL RESTORATION R, P14; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Heyward AJ, 2002, MAR ECOL PROG SER, V230, P113, DOI 10.3354/meps230113; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hoipkemeier-Wilson L, 2004, BIOFOULING, V20, P53, DOI 10.1080/08927010410001662689; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kavanagh CJ, 2003, BIOFOULING, V19, P381, DOI 10.1080/08927010310001623296; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Lee E, 2013, STAT METHODS SURVIVA; Linares C, 2012, MAR ECOL PROG SER, V452, P81, DOI 10.3354/meps09586; Maida M, 2001, MAR ECOL-P S Z N I, V22, P397, DOI 10.1046/j.1439-0485.2001.01709.x; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Nozawa Y, 2006, MAR BIOL, V149, P1047, DOI 10.1007/s00227-006-0285-5; Nugues MM, 2006, CORAL REEFS, V25, P585, DOI 10.1007/s00338-006-0147-0; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Omori M, 2005, CORAL REEFS, V24, P563, DOI 10.1007/s00338-005-0030-4; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Shafir S, 2009, J EXP MAR BIOL ECOL, V368, P124, DOI 10.1016/j.jembe.2008.08.017; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SMITH SR, 1992, AM ZOOL, V32, P663; Steele MA, 2002, ECOLOGY, V83, P1076, DOI 10.1890/0012-9658(2002)083[1076:EPPOTR]2.0.CO;2; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Truby K, 2000, BIOFOULING, V15, P141, DOI 10.1080/08927010009386305; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Wilson J, 2005, CORAL REEFS, V24, P418, DOI 10.1007/s00338-005-0033-1; Zar J. H., 1996, BIOSTATISTICAL ANAL	63	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87545	10.1371/journal.pone.0087545	http://dx.doi.org/10.1371/journal.pone.0087545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489936	Green Published, gold			2022-12-25	WOS:000330510000143
J	Wolfe, JD; Johnson, MD; Ralph, CJ				Wolfe, Jared D.; Johnson, Matthew D.; Ralph, C. John			Do Birds Select Habitat or Food Resources? Nearctic-Neotropic Migrants in Northeastern Costa Rica	PLOS ONE			English	Article							FOREST; AVAILABILITY; EVOLUTION; MIGRATION; PATTERNS; WARBLERS; COLOR	Nearctic-neotropic migrant birds need to replenish energy reserves during stopover periods to successfully complete their semiannual movements. In this study we used linear models to examine the habitat use of 11 migrant species in northeastern Costa Rica to better understand the influence of food and structural resources on the presence of birds during stopover periods. Our models indicated that frugivorous migrants primarily used food abundance, while insectivorous migrants chiefly used vegetation structure as cues for habitat use during stopover. In addition to habitat use models, we documented fruiting plant phenology and found a general relationship between migrant arrival and the timing of ripe fruit availability. Our results suggest that insectivorous migrants probably rely on structural features when using habitat because it may be inherently difficult to assess cryptic-arthropod availability during a short period of time in a novel habitat, such as stopover periods.	[Wolfe, Jared D.] Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Wolfe, Jared D.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Wolfe, Jared D.; Johnson, Matthew D.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Ralph, C. John] US Forest Serv, Redwood Sci Lab, USDA, Arcata, CA USA; [Ralph, C. John] Klamath Bird Observ, Ashland, OR USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; California State University System; California State Polytechnic University, Humboldt; United States Department of Agriculture (USDA); United States Forest Service	Wolfe, JD (corresponding author), Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA.	jwolfe5@lsu.edu		Wolfe, Jared/0000-0001-5575-086X	United States Department of Agriculture Forest Service's Redwood Sciences Laboratory; Klamath Bird Observatory; United States Fish and Wildlife Service Richard J. Guadagno Memorial Scholarship; Stanley Harris Scholarship	United States Department of Agriculture Forest Service's Redwood Sciences Laboratory; Klamath Bird Observatory; United States Fish and Wildlife Service Richard J. Guadagno Memorial Scholarship; Stanley Harris Scholarship	This project was funded in part by United States Department of Agriculture Forest Service's Redwood Sciences Laboratory, Klamath Bird Observatory, United States Fish and Wildlife Service Richard J. Guadagno Memorial Scholarship and the Stanley Harris Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BLAKE JG, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P257; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Burnham K. P., 1998, MODEL SELECTION INFE; Butler RW, 2000, AUK, V117, P518, DOI 10.1642/0004-8038(2000)117[0518:SSFSNA]2.0.CO;2; Chernetsov N, 2006, J ORNITHOL, V147, P185, DOI 10.1007/s10336-006-0064-6; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Holdridge LR, 1987, ECOLOGIA BASADA ZONA; Janzen DH, 1983, COSTA RICAN NATURAL; Johnson MD, 2000, J FIELD ORNITHOL, V71, P88, DOI 10.1648/0273-8570-71.1.88; Johnson MD, 2001, J ANIM ECOL, V70, P546, DOI 10.1046/j.1365-2656.2001.00522.x; Johnson MD, 2000, ENTOMOL NEWS, V111, P270; LEFEBVRE G, 1992, WILSON BULL, V104, P400; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; LOISELLE BA, 1994, CONDOR, V96, P368, DOI 10.2307/1369321; Martin T.E., 1985, Journal of Tropical Ecology, V1, P157; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; McGrath LJ, 2009, J ANIM ECOL, V78, P22, DOI 10.1111/j.1365-2656.2008.01464.x; Morton E.S., 1980, P437; Ogden LJE, 2013, AUK, V130, P98, DOI 10.1525/auk.2012.11229; Parrish JD, 2000, STUD AVIAN BIOL-SER, P53; Parrish JD, 1997, CONDOR, V99, P681, DOI 10.2307/1370480; Poulin B, 1996, AUK, V113, P277, DOI 10.2307/4088894; POWELL GVN, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P287; R Development Core Team, 2010, R LANG ENV STAT COMP; Sapir N, 2004, NATURWISSENSCHAFTEN, V91, P544, DOI 10.1007/s00114-004-0564-2; SCHOENER TW, 1980, ANN ENTOMOL SOC AM, V73, P106, DOI 10.1093/aesa/73.1.106; Seewagen CL, 2010, ACTA OECOL, V36, P484, DOI 10.1016/j.actao.2010.06.005; Sherry Thomas W., 2005, P414; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; SLUD PAUL, 1964, BULL AMER MUS NATUR HIST, V128, P1; Tietz JR, 2007, CONDOR, V109, P795, DOI 10.1650/0010-5422(2007)109[795:SEAHSO]2.0.CO;2; Willis E.O., 1980, P205; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; Wolfe Jared D., 2009, Journal of Caribbean Ornithology, V22, P37; Wolfe JD, 2009, AUK, V126, P809, DOI 10.1525/auk.2009.08018	41	23	27	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86221	10.1371/journal.pone.0086221	http://dx.doi.org/10.1371/journal.pone.0086221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489701	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000036
J	Yang, R; Guo, L; Wang, P; Huang, L; Tang, Y; Wang, WH; Chen, K; Ye, JC; Lu, CY; Wu, YF; Shen, HY				Yang, Rui; Guo, Lan; Wang, Peng; Huang, Lin; Tang, Yong; Wang, Wenhao; Chen, Keng; Ye, Jichao; Lu, Ciyong; Wu, Yanfeng; Shen, Huiyong			Epidemiology of Spinal Cord Injuries and Risk Factors for Complete Injuries in Guangdong, China: A Retrospective Study	PLOS ONE			English	Article							OUTCOMES; REHABILITATION; CANADA; MULTICENTER; MEDICINE; PROFILE	Background: Spinal cord injuries are highly disabling and deadly injuries. Currently, few studies focus on non-traumatic spinal cord injuries, and there is little information regarding the risk factors for complete injuries. This study aims to describe the demographics and the injury characteristics for both traumatic and non-traumatic spinal cord injuries and to explore the risk factors for complete spinal cord injuries. Methods: A retrospective study was performed by reviewing the medical records of 3,832 patients with spinal cord injuries who were first admitted to the sampled hospitals in Guangdong, China. The demographics and injury characteristics of the patients were described and compared between the different groups using the chi-square test. Logistic regression was conducted to analyze the risk factors for complete spinal cord injuries. Results: The proportion of patients increased from 7.0% to 14.0% from 2003 to 2011. The male-to-female ratio was 3.0: 1. The major cause of spinal cord injuries was traffic accidents (21.7%). Many of the injured were workers (36.2%), peasants (22.8%), and unemployed people (13.9%); these occupations accounted for 72.9% of the total sample. A multivariate logistic regression model revealed that the OR (95% CI) for male gender compared to female gender was 1.25 (1.07-1.89), the OR (95% CI) for having a spinal fracture was 1.56 (1.35-2.60), the OR (95% CI) for having a thoracic injury was 1.23 (1.10-2.00), and the OR (95% CI) for having complications was 2.47 (1.96-3.13). Conclusion: The proportion of males was higher than the proportion of females. Workers, peasants and the unemployed comprised the high-risk occupational categories. Male gender, having a spinal fracture, having a thoracic injury, and having complications were the major risk factors for a complete injury. We recommend that preventive measures should focus on high-risk populations, such as young males.	[Yang, Rui; Wang, Peng; Huang, Lin; Tang, Yong; Wang, Wenhao; Chen, Keng; Ye, Jichao; Shen, Huiyong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Yanfeng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Biotherapy Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Lan; Lu, Ciyong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wu, YF (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Biotherapy Ctr, Guangzhou 510275, Guangdong, Peoples R China.	wuyanfengcn@126.com; shenh.y.@163.com		Chen, Keng/0000-0002-1198-8005	Department of Health of Guangdong Province, People's Republic of China [C2010021]	Department of Health of Guangdong Province, People's Republic of China	This study was supported by Department of Health of Guangdong Province, People's Republic of China (C2010021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Albert T, 2005, SPINAL CORD, V43, P357, DOI 10.1038/sj.sc.3101717; Behrman AL, 2012, DEV MED CHILD NEUROL, V54, P1078, DOI 10.1111/j.1469-8749.2012.04440.x; Brotherton SS, 2007, SPINAL CORD, V45, P37, DOI 10.1038/sj.sc.3101909; Chien LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039264; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Chun-xia H, 2007, CHINESE J REHABILITA, V13, P1011; Couris CM, 2010, SPINAL CORD, V48, P39, DOI 10.1038/sc.2009.77; Dahlberg A, 2005, SPINAL CORD, V43, P47, DOI 10.1038/sj.sc.3101616; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Erdogan MO, 2013, ULUS TRAVMA ACIL CER, V19, P49, DOI 10.5505/tjtes.2013.74501; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; Galvin J, 2013, SPINE PHILA PA 1976; Gittler MS, 2002, ARCH PHYS MED REHAB, V83, pS65, DOI 10.1053/apmr.2002.32160; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Karacan I, 2000, SPINAL CORD, V38, P697, DOI 10.1038/sj.sc.3101064; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Kirshblum SC, 2007, ARCH PHYS MED REHAB, V88, pS62, DOI 10.1016/j.apmr.2006.12.003; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; New PW, 2011, SPINAL CORD, V49, P397, DOI 10.1038/sc.2010.77; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; Pagliacci MC, 2007, SPINAL CORD, V45, P404, DOI 10.1038/sj.sc.3101991; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; RICHARDS JS, 1991, J PEDIATR PSYCHOL, V16, P595; Scivoletto G, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-42; Shin JC, 2013, ANN REHABIL MED-ARM, V37, P50, DOI 10.5535/arm.2013.37.1.50	31	31	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84733	10.1371/journal.pone.0084733	http://dx.doi.org/10.1371/journal.pone.0084733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489652	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000008
J	Miller, BA; Hoffman, NE; Merali, S; Zhang, XQ; Wang, JF; Rajan, S; Shanmughapriya, S; Gao, E; Barrero, CA; Mallilankaraman, K; Song, JL; Gu, TD; Hirschler-Laszkiewicz, I; Koch, WJ; Feldman, AM; Madesh, M; Cheung, JY				Miller, Barbara A.; Hoffman, Nicholas E.; Merali, Salim; Zhang, Xue-Qian; Wang, JuFang; Rajan, Sudarsan; Shanmughapriya, Santhanam; Gao, Erhe; Barrero, Carlos A.; Mallilankaraman, Karthik; Song, Jianliang; Gu, Tongda; Hirschler-Laszkiewicz, Iwona; Koch, Walter J.; Feldman, Arthur M.; Madesh, Muniswamy; Cheung, Joseph Y.			TRPM2 Channels Protect against Cardiac Ischemia-Reperfusion Injury ROLE OF MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Cardiovascular Disease; Electrophysiology; Mitochondria; TRP Channels; Cardiac Ischemia; Global Proteomics Analysis; Mitochondrial Bioenergetics	MYOCYTE CONTRACTILITY; ESSENTIAL COMPONENT; CALCIUM UNIPORTER; CA2+ UPTAKE; ADP-RIBOSE; PHOSPHOLEMMAN; DEFICIENT; APOPTOSIS; MICU1; OVEREXPRESSION	Background: TRPM2 channels are present in the heart, but their function is unknown. Results: Genetic ablation of TRPM2 results in cardiac mitochondrial dysfunction, enhanced ROS production, and exacerbated cardiac ischemic injury. Conclusion: TRPM2 channels preserve cardiac mitochondrial bioenergetics and protect cardiac myocytes from ischemic injury. Significance: TRPM2 is a rational target for treatment of ischemic heart disease. Cardiac TRPM2 channels were activated by intracellular adenosine diphosphate-ribose and blocked by flufenamic acid. In adult cardiac myocytes the ratio of G(Ca) to G(Na) of TRPM2 channels was 0.56 +/- 0.02. To explore the cellular mechanisms by which TRPM2 channels protect against cardiac ischemia/reperfusion (I/R) injury, we analyzed proteomes from WT and TRPM2 KO hearts subjected to I/R. The canonical pathways that exhibited the largest difference between WT-I/R and KO-I/R hearts were mitochondrial dysfunction and the tricarboxylic acid cycle. Complexes I, III, and IV were down-regulated, whereas complexes II and V were up-regulated in KO-I/R compared with WT-I/R hearts. Western blots confirmed reduced expression of the Complex I subunit and other mitochondria-associated proteins in KO-I/R hearts. Bioenergetic analyses revealed that KO myocytes had a lower mitochondrial membrane potential, mitochondrial Ca2+ uptake, ATP levels, and O-2 consumption but higher mitochondrial superoxide levels. Additionally, mitochondrial Ca2+ uniporter (MCU) currents were lower in KO myocytes, indicating reduced mitochondrial Ca2+ uptake was likely due to both lower (m) and MCU activity. Similar to isolated myocytes, O-2 consumption and ATP levels were also reduced in KO hearts. Under a simulated I/R model, aberrant mitochondrial bioenergetics was exacerbated in KO myocytes. Reactive oxygen species levels were also significantly higher in KO-I/R compared with WT-I/R heart slices, consistent with mitochondrial dysfunction in KO-I/R hearts. We conclude that TRPM2 channels protect the heart from I/R injury by ameliorating mitochondrial dysfunction and reducing reactive oxygen species levels.	[Hoffman, Nicholas E.; Zhang, Xue-Qian; Wang, JuFang; Rajan, Sudarsan; Shanmughapriya, Santhanam; Gao, Erhe; Mallilankaraman, Karthik; Song, Jianliang; Gu, Tongda; Koch, Walter J.; Feldman, Arthur M.; Madesh, Muniswamy; Cheung, Joseph Y.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA; [Cheung, Joseph Y.] Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19140 USA; [Hoffman, Nicholas E.; Merali, Salim; Rajan, Sudarsan; Shanmughapriya, Santhanam; Barrero, Carlos A.; Mallilankaraman, Karthik; Madesh, Muniswamy] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Hirschler-Laszkiewicz, Iwona] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheung, JY (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, 3500 N Broad St,MERB 960, Philadelphia, PA 19140 USA.	joseph.cheung@tuhs.temple.edu	; Shanmughapriya, Santhanam/P-2828-2017	Barrero, Carlos/0000-0001-5779-6642; Shanmughapriya, Santhanam/0000-0003-1041-8198; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050	National Institutes of Health [RO1-DK46778, R21-CA165068, RO1-HL56205, RO1-HL61690, RO1-HL85503, PO1-HL-75443, PO1-HL-91799, PO1-HL91799, 2, RO1-HL86699, RO1-HL58672, RO1-HL74854]; NATIONAL CANCER INSTITUTE [R21CA165068] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058672, P01HL075443, P01HL091799, R01HL056205, R01HL061690, R01HL074854, R01HL086699, R01HL085503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK46778 (to B. A. M.), R21-CA165068 (to S. M.), RO1-HL56205, RO1-HL61690, RO1-HL85503, PO1-HL-75443, and PO1-HL-91799 (to W. J. K.), PO1-HL91799 (Project 2; to A. M. F.), RO1-HL86699 (to M. M.), and RO1-HL58672 and RO1-HL74854 (to J. Y. C.).	Abriel H, 2012, BIOCHEM PHARMACOL, V84, P873, DOI 10.1016/j.bcp.2012.06.021; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Barrero CA, 2013, AM J RESP CRIT CARE, V188, P673, DOI 10.1164/rccm.201302-0342OC; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; CHEUNG JY, 1982, AM J PHYSIOL, V243, pC184, DOI 10.1152/ajpcell.1982.243.3.C184; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hiroi T, 2013, CARDIOVASC RES, V97, P271, DOI 10.1093/cvr/cvs332; Hoffman NE, 2013, CELL REP, V5, P1576, DOI 10.1016/j.celrep.2013.11.026; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li X, 2011, AM J PHYSIOL-HEART C, V301, pH1932, DOI 10.1152/ajpheart.00755.2010; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Miller B. A., 2012, METHODS PHARM TOXICO, P89; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Simard Christophe, 2012, Br J Pharmacol, V165, P2354, DOI 10.1111/j.1476-5381.2011.01715.x; Song JL, 2008, AM J PHYSIOL-HEART C, V295, pH1615, DOI 10.1152/ajpheart.00287.2008; Song JL, 2012, AM J PHYSIOL-HEART C, V302, pH770, DOI 10.1152/ajpheart.00733.2011; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tucker AL, 2006, AM J PHYSIOL-HEART C, V291, pH2199, DOI 10.1152/ajpheart.01181.2005; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; Wang JF, 2010, AM J PHYSIOL-HEART C, V298, pH807, DOI 10.1152/ajpheart.00877.2009; Wang JF, 2009, AM J PHYSIOL-HEART C, V297, pH590, DOI 10.1152/ajpheart.00190.2009; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang ZY, 2012, AM J PHYSIOL-ENDOC M, V302, pE807, DOI 10.1152/ajpendo.00239.2011; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	58	62	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7615	7629		10.1074/jbc.M113.533851	http://dx.doi.org/10.1074/jbc.M113.533851			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492610	Green Published, hybrid			2022-12-25	WOS:000332761500031
J	Ming, M; Obata, F; Kuranaga, E; Miura, M				Ming, Ming; Obata, Fumiaki; Kuranaga, Erina; Miura, Masayuki			Persephone/Spatzle Pathogen Sensors Mediate the Activation of Toll Receptor Signaling in Response to Endogenous Danger Signals in Apoptosis-deficient Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Drosophila; Innate Immunity; Necrosis (Necrotic Death); Serine Protease; Stress Response; Toll Receptors; Damage-associated Molecular Patterns	DEVELOPMENTAL CELL-DEATH; INNATE IMMUNE-RESPONSE; CASPASE DRONC; FUNCTIONAL-ANALYSIS; FUNGAL; PROTEIN; DORSAL; PHOSPHORYLATION; INFLAMMATION; RECOGNITION	Background: Apoptosis deficiency causes necrotic cell death that activates the innate immune response in mammals. Results: Apoptosis-deficient Drosophila exhibited constitutive Toll pathway activation mediated by serine protease Persephone. Conclusion: Apoptosis-deficient Drosophila produces damage-associated molecular patterns (DAMPs) leading to canonical Toll signaling through a Persephone-mediated proteolytic cascade that cleaves the Toll ligand Spatzle. Significance: DAMP-mediated Toll-like receptor signaling is conserved in invertebrates. Apoptosis is an evolutionarily conserved mechanism that removes damaged or unwanted cells, effectively maintaining cellular homeostasis. It has long been suggested that a deficiency in this type of naturally occurring cell death could potentially lead to necrosis, resulting in the release of endogenous immunogenic molecules such as damage-associated molecular patterns (DAMPs) and a noninfectious inflammatory response. However, the details about how danger signals from apoptosis-deficient cells are detected and translated to an immune response are largely unknown. In this study, we found that Drosophila mutants deficient for Dronc, the key initiator caspase required for apoptosis, produced the active form of the endogenous Toll ligand Spatzle (Spz). We speculated that, as a system for sensing potential DAMPs in the hemolymph, the dronc mutants constitutively activate a proteolytic cascade that leads to Spz proteolytic processing. We demonstrated that Toll signaling activation required the action of Persephone, a CLIP domain serine protease that usually reacts to microbial proteolytic activities. Our findings show that the Persephone proteolytic cascade plays a crucial role in mediating DAMP-induced systemic responses in apoptosis-deficient Drosophila mutants.	[Ming, Ming; Obata, Fumiaki; Miura, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, Tokyo 1130033, Japan; [Obata, Fumiaki; Miura, Masayuki] Japan Sci & Technol Agcy, Basic Res Program, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Kuranaga, Erina] RIKEN, Ctr Dev Biol, Lab Histogenet Dynam, Kobe, Hyogo 6500047, Japan	University of Tokyo; Japan Science & Technology Agency (JST); RIKEN	Miura, M (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miura@mol.f.u-tokyo.ac.jp	Kuranaga, Erina/AAE-4309-2019	Kuranaga, Erina/0000-0001-6300-2087; Obata, Fumiaki/0000-0002-8641-5818	Japanese Ministry of Education, Science, Sports, Culture, and Technology; Uehara Memorial Foundation	Japanese Ministry of Education, Science, Sports, Culture, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants from the Japanese Ministry of Education, Science, Sports, Culture, and Technology (to M. M. and E. K.) and the Uehara Memorial Foundation (E.K.).	Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; An S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031920; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Cho YS, 2010, CURR BIOL, V20, P1133, DOI 10.1016/j.cub.2010.04.056; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Patterson RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061773; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Qiu P, 1998, DEVELOPMENT, V125, P1909; Ramsden S, 2008, AGING CELL, V7, P225, DOI 10.1111/j.1474-9726.2008.00370.x; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Seong CS, 2006, CELL IMMUNOL, V240, P5, DOI 10.1016/j.cellimm.2006.05.007; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tsuzuki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00210; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wu SC, 2012, CELL HOST MICROBE, V11, P410, DOI 10.1016/j.chom.2012.03.004; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yang CS, 2010, EMBO J, V29, P3196, DOI 10.1038/emboj.2010.191; Zerofsky M, 2005, AGING CELL, V4, P103, DOI 10.1111/j.1474-9728.2005.00147.x; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	57	49	50	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7558	7568		10.1074/jbc.M113.543884	http://dx.doi.org/10.1074/jbc.M113.543884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492611	hybrid, Green Published			2022-12-25	WOS:000332761500026
J	Seror, J; Amand, G; Guibourdenche, J; Ceccaldi, PF; Luton, D				Seror, Jeremy; Amand, Gaelle; Guibourdenche, Jean; Ceccaldi, Pierre-Francois; Luton, Dominique			Anti-TPO Antibodies Diffusion through the Placental Barrier during Pregnancy	PLOS ONE			English	Article							THYROID-DISEASE; ANTIPHOSPHOLIPID SYNDROME; HYPOTHYROIDISM; AUTOANTIBODIES; ABNORMALITIES; DYSFUNCTION; MANAGEMENT	Background: Hashimoto's thyroiditis is the principal aetiology of hypothyroidism with presence of anti-thyroperoxidase antibodies (anti-TPO). The association between anti-TPO and foeto-placental complications has been observed in previous studies. To go further in the understanding, the current study compares the level of anti-TPO in maternal blood and in the cord blood of her fetus at the moment of childbirth to demonstrate the passage of anti-TPO through the placenta barrier. Methods and Findings: This study was realised in a maternity ward located in the Northern district of Paris, France from 2006 to 2007. Women with normal pregnancy were included in a first study and only women with no abnormal thyroid dosage at baseline and tested positive with anti-TPO were prospectively enrolled. Maternal blood samples were collected in the third trimester and at the arrival to the ward when patients came to deliver. After delivery, cord blood sample was collected. Pearson's correlation coefficient was computed. 5941 patients delivered in the ward during the study, 33 pregnant women were included. We found a correlation between the anti-TPO levels in maternal and in the cord blood of their fetus with a correlation coefficient of 0.98 and a p-value<0.001. Conclusions: This is the first demonstration of the free passage through the placental barrier of anti-TPO from the mother to the fetus at the moment of childbirth. These findings can be extrapolated all along pregnancy and open the door to a direct action of the anti-TPO on fetus and to a possible action on the fetal thyroid.	[Seror, Jeremy; Amand, Gaelle; Ceccaldi, Pierre-Francois; Luton, Dominique] Univ Paris 07, Paris, France; [Seror, Jeremy; Amand, Gaelle; Ceccaldi, Pierre-Francois; Luton, Dominique] Beaujon Bichat Hosp, AP HP, Dept Gynecol & Obstet, Clichy, France; [Guibourdenche, Jean] Cochin Hosp, AP HP, Dept Hormonal & Metab Biol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Seror, J (corresponding author), Univ Paris 07, Paris, France.	jeremy.seror@bjn.aphp.fr	Ceccaldi, Pierre-Francois/B-7966-2008	Ceccaldi, Pierre-Francois/0000-0003-4716-9199	Development and Clinical Research Department Ile de France of Assistance Publique - Hopitaux de Paris [CRC 04-106]	Development and Clinical Research Department Ile de France of Assistance Publique - Hopitaux de Paris	The project was funded by Development and Clinical Research Department Ile de France (CRC 04-106) of Assistance Publique - Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarian M, 2004, MISES JOUR GYNECOLOG, VXXVIII; Azlin MIN, 2010, J OBSTET GYNAECOL, V30, P675, DOI 10.3109/01443615.2010.503908; BLANK M, 1991, P NATL ACAD SCI USA, V88, P3069, DOI 10.1073/pnas.88.8.3069; Brown R S, 1996, Endocr Pract, V2, P53; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Elahi S., 2005, Pakistan Journal of Medical Sciences, V21, P325; Ghafoor Farkhanda, 2006, J Coll Physicians Surg Pak, V16, P468; Girling JC., 2006, CURRENT OBSTET GYNAE, V16, P47; GLINOER D, 1991, J CLIN ENDOCR METAB, V73, P421, DOI 10.1210/jcem-73-2-421; GOODWIN TM, 1992, AM J OBSTET GYNECOL, V167, P648, DOI 10.1016/S0002-9378(11)91565-8; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Harborne LR, 2005, AUST NZ J OBSTET GYN, V45, P239, DOI 10.1111/j.1479-828X.2005.00365.x; Kuppens SMI, 2011, CLIN ENDOCRINOL, V75, P382, DOI 10.1111/j.1365-2265.2011.04083.x; Lazarus JH, 2000, CLIN ENDOCRINOL, V53, P265, DOI 10.1046/j.1365-2265.2000.01087.x; Lee YL, 2009, FERTIL STERIL, V91, P2104, DOI 10.1016/j.fertnstert.2008.07.1704; LEJEUNE B, 1993, BRIT J OBSTET GYNAEC, V100, P669, DOI 10.1111/j.1471-0528.1993.tb14236.x; Luton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014707; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Montoro MN, 1997, CLIN OBSTET GYNECOL, V40, P65, DOI 10.1097/00003081-199703000-00008; Nguyen PH, 2004, EMEDICINE WORLD MED; Oken E, 2009, J CLIN ENDOCR METAB, V94, P497, DOI 10.1210/jc.2008-0936; Poppe K, 2003, HUM REPROD UPDATE, V9, P149, DOI 10.1093/humupd/dmg012; Schlienger J, 2001, THYROIDE CONCEPTS PR, P503; Seror J, 2005, 6 JNGOF C PAR FRANC; Smyth PPA, 2005, THYROID, V15, P474, DOI 10.1089/thy.2005.15.474; THORPEBEESTON JG, 1991, NEW ENGL J MED, V324, P532, DOI 10.1056/NEJM199102213240805; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VULSMA T, 1989, NEW ENGL J MED, V321, P13, DOI 10.1056/NEJM198907063210103; Williams GR, 2008, J NEUROENDOCRINOL, V20, P784, DOI 10.1111/j.1365-2826.2008.01733.x; Ziporen L, 1997, RHEUM DIS CLIN N AM, V23, P99, DOI 10.1016/S0889-857X(05)70317-3	32	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e84647	10.1371/journal.pone.0084647	http://dx.doi.org/10.1371/journal.pone.0084647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497920	Green Published, Green Submitted, gold			2022-12-25	WOS:000330621900007
J	Gueriau, P; Mocuta, C; Dutheil, DB; Cohen, SX; Thiaudiere, D; Charbonnier, S; Clement, G; Bertrand, L				Gueriau, Pierre; Mocuta, Cristian; Dutheil, Didier B.; Cohen, Serge X.; Thiaudiere, Dominique; Charbonnier, Sylvain; Clement, Gael; Bertrand, Loic		OT1 Consortium	Trace Elemental Imaging of Rare Earth Elements Discriminates Tissues at Microscale in Flat Fossils	PLOS ONE			English	Article							SYNCHROTRON; MOROCCO; PRESERVATION; BIOAPATITES; SYSTEMATICS; SEDIMENTS; TAPHONOMY; CALCIUM	The interpretation of flattened fossils remains a major challenge due to compression of their complex anatomies during fossilization, making critical anatomical features invisible or hardly discernible. Key features are often hidden under greatly preserved decay prone tissues, or an unpreparable sedimentary matrix. A method offering access to such anatomical features is of paramount interest to resolve taxonomic affinities and to study fossils after a least possible invasive preparation. Unfortunately, the widely-used X-ray micro-computed tomography, for visualizing hidden or internal structures of a broad range of fossils, is generally inapplicable to flattened specimens, due to the very high differential absorbance in distinct directions. Here we show that synchrotron X-ray fluorescence spectral raster-scanning coupled to spectral decomposition or a much faster Kullback-Leibler divergence based statistical analysis provides microscale visualization of tissues. We imaged exceptionally well-preserved fossils from the Late Cretaceous without needing any prior delicate preparation. The contrasting elemental distributions greatly improved the discrimination of skeletal elements material from both the sedimentary matrix and fossilized soft tissues. Aside content in alkaline earth elements and phosphorus, a critical parameter for tissue discrimination is the distinct amounts of rare earth elements. Local quantification of rare earths may open new avenues for fossil description but also in paleoenvironmental and taphonomical studies.	[Gueriau, Pierre; Charbonnier, Sylvain; Clement, Gael] UPMC, MNHN, UMR CNRS 7207, CR2P, Paris, France; [Gueriau, Pierre; Cohen, Serge X.; Bertrand, Loic] MCC, USR CNRS 3461, IPANEMA, Gif Sur Yvette, France; [Mocuta, Cristian; Thiaudiere, Dominique; Bertrand, Loic] Synchrotron SOLEIL, Gif Sur Yvette, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; SOLEIL Synchrotron	Gueriau, P (corresponding author), UPMC, MNHN, UMR CNRS 7207, CR2P, Paris, France.	gueriau@mnhn.fr; loic.bertrand@synchrotron-soleil.fr	BERTRAND, Loic E/D-3556-2013; /ABG-2074-2021; BERTRAND, Loïc/ABA-5354-2020; Gueriau, Pierre/X-6682-2019; MOCUTA, Cristian/AAZ-9342-2020; Charbonnier, Sylvain/AAU-9571-2020	BERTRAND, Loic E/0000-0001-6622-9113; Gueriau, Pierre/0000-0002-7529-3456; Dutheil, Didier/0000-0002-4856-0918; JALIL, Nour-Eddine/0000-0002-7617-7625	French ANR under the TERRES project [ANR-2010-BLAN-607-03]; CNRS/MNHN/UPMC [UMR 7207 CR2P]; ATM biodiversite actuelle et fossile (MNHN); Cadi Ayyad University, Marrakesh, Morocco	French ANR under the TERRES project(French National Research Agency (ANR)); CNRS/MNHN/UPMC; ATM biodiversite actuelle et fossile (MNHN); Cadi Ayyad University, Marrakesh, Morocco	This work was supported by the French ANR (http://www.agence-nationale-recherche.fr/) under the TERRES project (ANR-2010-BLAN-607-03 grant). The field campaign was supported by the UMR 7207 CR2P (CNRS/MNHN/UPMC), the ATM biodiversite actuelle et fossile (MNHN), and the Cadi Ayyad University, Marrakesh, Morocco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler Z.S., 1980, SOC EC PALEONTOL MIN, V29, P19; Ardanova LI, 2010, INORG CHEM, V49, P10687, DOI 10.1021/ic1015127; ARRHENIUS G, 1957, NATURE, V180, P85, DOI 10.1038/180085a0; Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; Bernard S, 2009, REV PALAEOBOT PALYNO, V156, P248, DOI 10.1016/j.revpalbo.2008.09.002; Bernat M., 1975, CAH ORSTROM SR GEOL, V7, P65; Bertrand L, 2012, PHYS REP, V519, P51, DOI 10.1016/j.physrep.2012.03.003; BRIGGS DEG, 1981, LETHAIA, V14, P157, DOI 10.1111/j.1502-3931.1981.tb01918.x; Cai YP, 2012, PALAEOGEOGR PALAEOCL, V326, P109, DOI 10.1016/j.palaeo.2012.02.009; Dutheil DB, 1999, J VERTEBR PALEONTOL, V19, P243, DOI 10.1080/02724634.1999.10011138; DUTHEIL DB, 1999, MESOZOIC FISHES, V2, P553; Edwards N, 2012, APPL PHYS A, P1; Edwards NP, 2011, P ROY SOC B-BIOL SCI, V278, P3209, DOI 10.1098/rspb.2011.0135; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Filleul A, 2004, J VERTEBR PALEONTOL, V24, P290, DOI 10.1671/3004; Filleul A, 2001, J VERTEBR PALEONTOL, V21, P774, DOI 10.1671/0272-4634(2001)021[0774:SOAFAF]2.0.CO;2; Friel JJ, 2006, MICROSC MICROANAL, V12, P2, DOI 10.1017/S1431927606060211; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Garassino Alessandro, 2006, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V147, P3; Get'man EI, 2008, RUSS J INORG CHEM+, V53, P1342, DOI 10.1134/S0036023608080329; Herwartz D, 2013, GEOCHIM COSMOCHIM AC, V103, P161, DOI 10.1016/j.gca.2012.10.038; Houssaye A, 2011, J VERTEBR PALEONTOL, V31, P2, DOI 10.1080/02724634.2011.539650; Kocsis L, 2010, GEOCHIM COSMOCHIM AC, V74, P6077, DOI 10.1016/j.gca.2010.08.007; Koenig AE, 2009, GEOLOGY, V37, P511, DOI 10.1130/G25551A.1; MARTILL DM, 1992, PALAEONTOLOGY, V35, P869; Matton O, 2012, PALAEOGEOGR PALAEOCL, V361, P73, DOI 10.1016/j.palaeo.2012.08.004; Orr PJ, 2009, PALAEOGEOGR PALAEOCL, V277, P1, DOI 10.1016/j.palaeo.2009.02.009; Orr PJ, 1998, SCIENCE, V281, P1173, DOI 10.1126/science.281.5380.1173; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Seilacher A., 1970, MONATSHEFTE, V1970, P34; Smith SY, 2009, P NATL ACAD SCI USA, V106, P12013, DOI 10.1073/pnas.0901468106; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Trueman CN, 2013, PALAEONTOLOGY, V56, P475, DOI 10.1111/pala.12041; Trueman CN, 2011, PALAEOGEOGR PALAEOCL, V310, P124, DOI 10.1016/j.palaeo.2011.01.002; Tutken T, 2011, GEOCHIM COSMOCHIM AC, V75, P5951, DOI 10.1016/j.gca.2011.07.024; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748	37	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86946	10.1371/journal.pone.0086946	http://dx.doi.org/10.1371/journal.pone.0086946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489809	gold, Green Published			2022-12-25	WOS:000330570000082
J	Martins-Green, M; Adhami, N; Frankos, M; Valdez, M; Goodwin, B; Lyubovitsky, J; Dhall, S; Garcia, M; Egiebor, I; Martinez, B; Green, HW; Havel, C; Yu, L; Liles, S; Matt, G; Destaillats, H; Sleiman, M; Gundel, LA; Benowitz, N; Jacob, P; Hovell, M; Winickoff, JP; Curras-Collazo, M				Martins-Green, Manuela; Adhami, Neema; Frankos, Michael; Valdez, Mathew; Goodwin, Benjamin; Lyubovitsky, Julia; Dhall, Sandeep; Garcia, Monika; Egiebor, Ivie; Martinez, Bethanne; Green, Harry W.; Havel, Christopher; Yu, Lisa; Liles, Sandy; Matt, Georg; Destaillats, Hugo; Sleiman, Mohammed; Gundel, Laura A.; Benowitz, Neal; Jacob, Peyton, III; Hovell, Melbourne; Winickoff, Jonathan P.; Curras-Collazo, Margarita			Cigarette Smoke Toxins Deposited on Surfaces: Implications for Human Health	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; THIRDHAND-SMOKE; METABOLIC SYNDROME; 2ND-HAND SMOKE; US POPULATION; NITROUS-ACID; EXPOSURE; AIR; NONSMOKERS	Cigarette smoking remains a significant health threat for smokers and nonsmokers alike. Secondhand smoke (SHS) is intrinsically more toxic than directly inhaled smoke. Recently, a new threat has been discovered - Thirdhand smoke (THS) the accumulation of SHS on surfaces that ages with time, becoming progressively more toxic. THS is a potential health threat to children, spouses of smokers and workers in environments where smoking is or has been allowed. The goal of this study is to investigate the effects of THS on liver, lung, skin healing, and behavior, using an animal model exposed to THS under conditions that mimic exposure of humans. THS-exposed mice show alterations in multiple organ systems and excrete levels of NNAL (a tobacco-specific carcinogen biomarker) similar to those found in children exposed to SHS (and consequently to THS). In liver, THS leads to increased lipid levels and non-alcoholic fatty liver disease, a precursor to cirrhosis and cancer and a potential contributor to cardiovascular disease. In lung, THS stimulates excess collagen production and high levels of inflammatory cytokines, suggesting propensity for fibrosis with implications for inflammation-induced diseases such as chronic obstructive pulmonary disease and asthma. In wounded skin, healing in THS-exposed mice has many characteristics of the poor healing of surgical incisions observed in human smokers. Lastly, behavioral tests show that THS-exposed mice become hyperactive. The latter data, combined with emerging associated behavioral problems in children exposed to SHS/THS, suggest that, with prolonged exposure, they may be at significant risk for developing more severe neurological disorders. These results provide a basis for studies on the toxic effects of THS in humans and inform potential regulatory policies to prevent involuntary exposure to THS.	[Martins-Green, Manuela; Adhami, Neema; Frankos, Michael; Valdez, Mathew; Goodwin, Benjamin; Dhall, Sandeep; Garcia, Monika; Egiebor, Ivie; Martinez, Bethanne; Curras-Collazo, Margarita] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Lyubovitsky, Julia] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Green, Harry W.] Univ Calif Riverside, Grad Div, Riverside, CA 92521 USA; [Havel, Christopher; Yu, Lisa; Benowitz, Neal; Jacob, Peyton, III] Univ Calif San Francisco, Div Clin Pharmacol, San Francisco, CA 94143 USA; [Liles, Sandy; Hovell, Melbourne] San Diego State Univ, Ctr Behav Epidemiol & Community Hlth, Sch Publ Hlth, San Diego, CA 92182 USA; [Matt, Georg] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Destaillats, Hugo; Sleiman, Mohammed; Gundel, Laura A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Indoor Environm Grp, Berkeley, CA 94720 USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, MGH Ctr Child & Adolescent Hlth Res & Policy, Boston, MA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California San Francisco; California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Harvard Medical School	Martins-Green, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	manuela.martins@ucr.edu	Destaillats, Hugo/B-7936-2013	Matt, Georg/0000-0001-5604-4609; Sleiman, Mohamad/0000-0002-2273-1053	Tobacco Research Disease Related Program (TRDRP) [19XT-0166]; American Physiological Society; University of California Institute for Mexico; United States/Consejo Nacional de Ciencia y Tecnologia; California Consortium on Third Hand Smoke, TRDRP [20PT-0184]; National Institutes of Health [S10 RR026437, P30 DA012393]; Maternal & Child Health Bureau [R4O MC 00185]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026437, P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012393] Funding Source: NIH RePORTER	Tobacco Research Disease Related Program (TRDRP); American Physiological Society; University of California Institute for Mexico; United States/Consejo Nacional de Ciencia y Tecnologia; California Consortium on Third Hand Smoke, TRDRP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maternal & Child Health Bureau(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by Tobacco Research Disease Related Program (TRDRP) grant #19XT-0166 to MM-G, a Porter Fellowship from the American Physiological Society to MV and a The University of California Institute for Mexico and the United States/Consejo Nacional de Ciencia y Tecnologia grant to MC-C. The Analytical Chemistry work done at the University of California, San Francisco, was supported by the California Consortium on Third Hand Smoke, TRDRP 20PT-0184, and the National Institutes of Health, grants #S10 RR026437 and #P30 DA012393. Child NNAL assays were supported by a grant from Maternal & Child Health Bureau #R4O MC 00185 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, HLTH CONS INV EXP TO; Anthony HM, 1985, REVS ENV HLTH, V8, P25; Asotra K, 2009, P INT S CANC CHEM TR, P3; Azambuja E, 2005, PULM PHARMACOL THER, V18, P363, DOI 10.1016/j.pupt.2005.01.007; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Burton A, 2011, ENVIRON HEALTH PERSP, V119, pA71; Chaouachi K, 2009, INT J ENV RES PUB HE, V6, P798, DOI 10.3390/ijerph6020798; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; de Zeeuw P, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.12; Demarin V, 2010, ACTA CLIN CROAT, V49, P429; Drehmer JE, 2012, AM J PREV MED, V43, P533, DOI 10.1016/j.amepre.2012.07.020; EPA, 2004, ICR19960 EPA ETS; Fmlayson-Pitts BJ, 2000, CHEM UPPER LOWER ATM, P847; FOLCH J, 1957, J BIOL CHEM, V226, P497; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Hang B, 2013, MUTAGENESIS IN PRESS, DOI [10.1093/mutage/get013, DOI 10.1093/MUTAGE/GET013)]; Herrmann M, 2008, CURR OPIN PEDIATR, V20, P184, DOI 10.1097/MOP.0b013e3282f56165; Hovell MF, 2009, NICOTINE TOB RES, V11, P1383, DOI 10.1093/ntr/ntp148; Jacob P, 2008, ANAL CHEM, V80, P8115, DOI 10.1021/ac8009005; Kabir Z, 2011, PEDIATRICS, V128, P263, DOI 10.1542/peds.2011-0023; Kisfali P, 2010, CURR MED CHEM, V17, P3533, DOI 10.2174/092986710792927822; Kupiainen H, 2012, PULM MED, V2012, DOI 10.1155/2012/725024; Lee K, 2002, ENVIRON HEALTH PERSP, V110, P145, DOI 10.1289/ehp.02110145; Levy DE, 2011, PEDIATRICS, V128, P650, DOI 10.1542/peds.2011-1067; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Matsuki Hideaki, 2008, Journal of UOEH, V30, P235; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; Matt GE, 2013, TOB CONTROL, V0, P1, DOI [10.1136/tobaccocontrol-2012-05082, DOI 10.1136/T0BACC0C0NTR0L-2012-050824]; Matt GE, 2008, NICOTINE TOB RES, V10, P1467, DOI 10.1080/14622200802279898; Matt GE, 2011, ENVIRON HEALTH PERSP, V119, P1218, DOI 10.1289/ehp.1103500; Matt GE, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037382; National Institutes of Heath, 1994, SMOK TOB CONTR MPOON, V7; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Ott W, 2008, J EXPO SCI ENV EPID, V18, P312, DOI 10.1038/sj.jes.7500601; Pirkle JL, 2006, ENVIRON HEALTH PERSP, V114, P853, DOI 10.1289/ehp.8850; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Prignot JJ, 2011, INT J ENV RES PUB HE, V8, P648, DOI 10.3390/ijerph8030648; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; Schick SF, 2013, TOP CONTROL IN PRESS, DOI [10.1136/tobaccocontrol-2012-050915, DOI 10.1136/T0BACC0C0NTR0L-2012-050915)]; Singer BC, 2003, ATMOS ENVIRON, V37, P5551, DOI 10.1016/j.atmosenv.2003.07.015; Sleiman M, 2010, ATMOS ENVIRON, V44, P4191, DOI 10.1016/j.atmosenv.2010.07.023; Sleiman M, 2010, P NATL ACAD SCI USA, V107, P6576, DOI 10.1073/pnas.0912820107; Sorensen LT, 2010, ADV WOUND CARE, V1, P83, DOI 10.1089/awc.2009.0134; Stanford SC, 2007, J PSYCHOPHARMACOL, V21, P134, DOI 10.1177/0269881107073199; U.S. Food and Drug Administration, 2012, GUID REG COMPL HARMF; Venn A, 2007, CIRCULATION, V115, P990, DOI 10.1161/CIRCULATIONAHA.106.648469; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; Winickoff JP, 2009, PEDIATRICS, V123, pE74, DOI 10.1542/peds.2008-2184; Yolton K, 2003, ENVIRON HEALTH PERSP, V113, P98; Yolton K, 2009, NEUROTOXICOL TERATOL, V31, P356, DOI 10.1016/j.ntt.2009.07.004; Yuan HW, 2009, J HEPATOL, V51, P535, DOI 10.1016/j.jhep.2009.03.026	51	90	95	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86391	10.1371/journal.pone.0086391	http://dx.doi.org/10.1371/journal.pone.0086391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489722	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000037
J	Ni, YL; Kuan, AS; Chen, TY				Ni, Yu-Li; Kuan, Ai-Seon; Chen, Tsung-Yu			Activation and Inhibition of TMEM16A Calcium-Activated Chloride Channels	PLOS ONE			English	Article							CL-CHANNEL; CONDUCTANCE; COMPONENTS; MECHANISM; AFFINITY; CA2+	Calcium-activated chloride channels (CaCC) encoded by family members of transmembrane proteins of unknown function 16 (TMEM16) have recently been intensely studied for functional properties as well as their physiological roles as chloride channels in various tissues. One technical hurdle in studying these channels is the well-known channel rundown that frequently impairs the precision of electrophysiological measurements for the channels. Using experimental protocols that employ fast-solution exchange, we circumvented the problem of channel rundown by normalizing the Ca2+-induced current to the maximally-activated current obtained within a time period in which the channel rundown was negligible. We characterized the activation of the TMEM16A-encoded CaCC (also called ANO1) by Ca2+, Sr2+, and Ba2+, and discovered that Mg2+ competes with Ca2+ in binding to the divalent-cation binding site without activating the channel. We also studied the permeability of the ANO1 pore for various anions and found that the anion occupancy in the pore-as revealed by the permeability ratios of these anions-appeared to be inversely correlated with the apparent affinity of the ANO1 inhibition by niflumic acid (NFA). On the other hand, the NFA inhibition was neither affected by the degree of the channel activation nor influenced by the types of divalent cations used for the channel activation. These results suggest that the NFA inhibition of ANO1 is likely mediated by altering the pore function but not through changing the channel gating. Our study provides a precise characterization of ANO1 and documents factors that can affect divalent cation activation and NFA inhibition of ANO1.	[Ni, Yu-Li; Kuan, Ai-Seon; Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, TY (corresponding author), Univ Calif Davis, Dept Neurol, Ctr Neurosci, Davis, CA 95616 USA.	tycchen@ucdavis.edu		Ni, Yu Li/0000-0003-1600-9854	National Institutes of Health, USA [R01GM065447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065447] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research grant from National Institutes of Health, USA (R01GM065447) to TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomaviciene A, 2013, J PHYSIOL-LONDON, V591, P3487, DOI 10.1113/jphysiol.2013.251660; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen YF, 2011, J MEMBRANE BIOL, V240, P121, DOI 10.1007/s00232-011-9350-1; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, SCIENCE, V322, P534, DOI 10.1126/science.1165668; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kunzelmann K, 2013, PFLUGERS ARCH; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Lee TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055930; Machaca K, 2002, CURR TOP MEMBR, V53, P3; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Qu ZQ, 2001, J BIOL CHEM, V276, P18423, DOI 10.1074/jbc.M101264200; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Richman DP, 2012, NEUROMOL MED, V14, P328, DOI 10.1007/s12017-012-8190-1; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2012, EXP PHYSIOL, V97, P177, DOI 10.1113/expphysiol.2011.058198; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607; Zhang XD, 2009, J GEN PHYSIOL, V133, P43, DOI 10.1085/jgp.200810004; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	43	43	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86734	10.1371/journal.pone.0086734	http://dx.doi.org/10.1371/journal.pone.0086734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489780	Green Published, gold			2022-12-25	WOS:000330570000066
J	Palomba, ML; Piersanti, K; Ziegler, CGK; Decker, H; Cotari, JW; Bantilan, K; Rijo, I; Gardner, JR; Heaney, M; Bemis, D; Balderas, R; Malek, SN; Seymour, E; Zelenetz, AD; van den Brink, MRM; Altan-Bonnet, G				Palomba, M. Lia; Piersanti, Kelly; Ziegler, Carly G. K.; Decker, Hugo; Cotari, Jesse W.; Bantilan, Kurt; Rijo, Ivelise; Gardner, Jeff R.; Heaney, Mark; Bemis, Debra; Balderas, Robert; Malek, Sami N.; Seymour, Erlene; Zelenetz, Andrew D.; van den Brink, Marcel R. M.; Altan-Bonnet, Gregoire			Multidimensional Single-Cell Analysis of BCR Signaling Reveals Proximal Activation Defect As a Hallmark of Chronic Lymphocytic Leukemia B Cells	PLOS ONE			English	Article							TYROSINE KINASE; CD38 EXPRESSION; LYMPHOMA; RECEPTOR; APOPTOSIS; SURVIVAL; SYK; TRANSDUCTION; VARIABILITY; INHIBITION	Purpose: Chronic Lymphocytic Leukemia (CLL) is defined by a perturbed B-cell receptor-mediated signaling machinery. We aimed to model differential signaling behavior between B cells from CLL and healthy individuals to pinpoint modes of dysregulation. Experimental Design: We developed an experimental methodology combining immunophenotyping, multiplexed phosphospecific flow cytometry, and multifactorial statistical modeling. Utilizing patterns of signaling network covariance, we modeled BCR signaling in 67 CLL patients using Partial Least Squares Regression (PLSR). Results from multidimensional modeling were validated using an independent test cohort of 38 patients. Results: We identified a dynamic and variable imbalance between proximal (pSYK, pBTK) and distal (pPLC gamma 2, pBLNK, ppERK) phosphoresponses. PLSR identified the relationship between upstream tyrosine kinase SYK and its target, PLC gamma 2, as maximally predictive and sufficient to distinguish CLL from healthy samples, pointing to this juncture in the signaling pathway as a hallmark of CLL B cells. Specific BCR pathway signaling signatures that correlate with the disease and its degree of aggressiveness were identified. Heterogeneity in the PLSR response variable within the B cell population is both a characteristic mark of healthy samples and predictive of disease aggressiveness. Conclusion: Single-cell multidimensional analysis of BCR signaling permitted focused analysis of the variability and heterogeneity of signaling behavior from patient-to-patient, and from cell-to-cell. Disruption of the pSYK/pPLC gamma 2 relationship is uncovered as a robust hallmark of CLL B cell signaling behavior. Together, these observations implicate novel elements of the BCR signal transduction as potential therapeutic targets.	[Palomba, M. Lia; Piersanti, Kelly; Bantilan, Kurt; Rijo, Ivelise; Gardner, Jeff R.; Heaney, Mark; Zelenetz, Andrew D.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Div Hematol, New York, NY 10021 USA; [Palomba, M. Lia; Piersanti, Kelly; Ziegler, Carly G. K.; Decker, Hugo; Cotari, Jesse W.; Bemis, Debra; Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Ctr Canc Syst Biol, New York, NY 10021 USA; [Ziegler, Carly G. K.; Decker, Hugo; Cotari, Jesse W.; Bemis, Debra; Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Program Computat Biol, New York, NY 10021 USA; [Balderas, Robert] BD Biosci, San Diego, CA USA; [Malek, Sami N.; Seymour, Erlene] Univ Michigan Hlth Syst, Div Hematol Oncol, Ann Arbor, MI USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan	van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Div Hematol, 1275 York Ave, New York, NY 10021 USA.	m-van-den-brink@ski.mskcc.org; altanbog@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022; Seymour, Erlene Kuizon/AFP-2481-2022	Altan-Bonnet, Gregoire/0000-0002-7283-3162; Cotari, Jesse/0000-0002-6026-8469; Seymour, Erlene/0000-0003-0242-4352; Ziegler, Carly/0000-0002-8279-7150	NIH [U54 CA148967, K08 CA118260, R01-HL069929, R01-CA107096, NIH R01- AI080455, AI083408]; Lymphoma Foundation; Laskin Charitable Foundation; DOD-USAMRAA award [W81XWH-09-1-0294]; RERF-NIAID; MSKCC Experimental Therapeutics Center; Alex's Lemonade Stand; MSKCC Geoffrey Beene Cancer Research Center; Peter Solomon Fund; NSF [0848030]; NATIONAL CANCER INSTITUTE [R01CA107096, U54CA148967, K08CA118260] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621, R01AI080455, R56AI083408, R01AI083408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Foundation; Laskin Charitable Foundation; DOD-USAMRAA award; RERF-NIAID; MSKCC Experimental Therapeutics Center; Alex's Lemonade Stand; MSKCC Geoffrey Beene Cancer Research Center; Peter Solomon Fund; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH U54 CA148967 (MLP, KP, CZ, DB, JWC, MvdB, GA-B) Lymphoma Foundation (MLP) NIH K08 CA118260 (MLP) The Laskin Charitable Foundation (MLP) NIH R01-HL069929 (MvdB) NIH R01-CA107096 (MvdB) NIH R01- AI080455 (MvdB) DOD-USAMRAA award W81XWH-09-1-0294 (MvdB) RERF-NIAID (MvdB) MSKCC Experimental Therapeutics Center (MvdB) Lymphoma Foundation (MvdB) Alex's Lemonade Stand (MvdB) MSKCC Geoffrey Beene Cancer Research Center (MvdB) Peter Solomon Fund (MvdB) NSF 0848030 (JWC, GA-B) NIH AI083408 (CZ, GA-B) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Agnelli L, 2012, BLOOD, V120, P1274, DOI 10.1182/blood-2012-01-405555; Amrein PC, 2011, CLIN CANCER RES, V17, P2977, DOI 10.1158/1078-0432.CCR-10-2879; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Behbehani GK, 2012, CYTOM PART A, V81A, P552, DOI 10.1002/cyto.a.22075; Blix ES, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-478; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Cotari JW, 2013, CURR OPIN BIOTECH, V24, P760, DOI 10.1016/j.copbio.2013.05.002; Cotari JW, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003240; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dighiero G, 2000, NEW ENGL J MED, V343, P1799, DOI 10.1056/NEJM200012143432410; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Grzybowska-Izydorczyk O, 2010, EUR J CANCER, V46, P800, DOI 10.1016/j.ejca.2009.11.023; Hoellenriegel J, 2011, BLOOD; Ibrahim S, 2001, BLOOD, V98, P181, DOI 10.1182/blood.V98.1.181; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; JP Sharman JI, 2007, ASCO M; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; Palazzo AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024592; Ralfkiaer U, 2011, BLOOD, V118, P5891, DOI 10.1182/blood-2011-06-358382; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Ringshausen I, 2002, BLOOD, V100, P3741, DOI 10.1182/blood-2002-02-0539; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schliep S, 2004, EXP HEMATOL, V32, P556, DOI 10.1016/j.exphem.2004.03.006; Song Z, CLIN CANC RES, V16, P587; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Zupo S, 1996, BLOOD, V88, P1365, DOI 10.1182/blood.V88.4.1365.bloodjournal8841365	45	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e79987	10.1371/journal.pone.0079987	http://dx.doi.org/10.1371/journal.pone.0079987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489640	gold, Green Submitted, Green Published			2022-12-25	WOS:000330570000003
J	Sasabe, J; Suzuki, M; Miyoshi, Y; Tojo, Y; Okamura, C; Ito, S; Konno, R; Mita, M; Hamase, K; Aiso, S				Sasabe, Jumpei; Suzuki, Masataka; Miyoshi, Yurika; Tojo, Yosuke; Okamura, Chieko; Ito, Sonomi; Konno, Ryuichi; Mita, Masashi; Hamase, Kenji; Aiso, Sadakazu			Ischemic Acute Kidney Injury Perturbs Homeostasis of Serine Enantiomers in the Body Fluid in Mice: Early Detection of Renal Dysfunction Using the Ratio of Serine Enantiomers	PLOS ONE			English	Article							AMINO-ACID OXIDASE; D-ASPARTATE RECEPTOR; PERFORMANCE LIQUID-CHROMATOGRAPHY; FUNCTIONAL NMDA RECEPTORS; INDUCED NEPHROTOXICITY; ATYPICAL PROPERTIES; HUMAN-PLASMA; RACEMASE; SERUM; EXPRESSION	The imbalance of blood and urine amino acids in renal failure has been studied mostly without chiral separation. Although a few reports have shown the presence of D-serine, an enantiomer of L-serine, in the serum of patients with severe renal failure, it has remained uncertain how serine enantiomers are deranged in the development of renal failure. In the present study, we have monitored serine enantiomers using a two-dimensional HPLC system in the serum and urine of mice after renal ischemia-reperfusion injury (IRI), known as a mouse model of acute kidney injury. In the serum, the level of D-serine gradually increased after renal IRI in parallel with that of creatinine, whereas the L-serine level decreased sharply in the early phase after IRI. The increase of D-serine was suppressed in part by genetic inactivation of a D-serine-degrading enzyme, D-amino acid oxidase (DAO), but not by disruption of its synthetic enzyme, serine racemase, in mice. Renal DAO activity was detected exclusively in proximal tubules, and IRI reduced the number of DAO-positive tubules. On the other hand, in the urine, D-serine was excreted at a rate nearly triple that of L-serine in mice with sham operations, indicating that little D-serine was reabsorbed while most L-serine was reabsorbed in physiological conditions. IRI significantly reduced the ratio of urinary D-/L-serine from 2.82+/-0.18 to 1.10+/-0.26 in the early phase and kept the ratio lower than 0.5 thereafter. The urinary D-/L-serine ratio can detect renal ischemia earlier than kidney injury molecule-1 (KIM-1) or neutrophil gelatinase-associated lipocalin (NGAL) in the urine, and more sensitively than creatinine, cystatin C, or the ratio of D-/L-serine in the serum. Our findings provide a novel understanding of the imbalance of amino acids in renal failure and offer a potential new biomarker for an early detection of acute kidney injury.	[Sasabe, Jumpei; Suzuki, Masataka; Ito, Sonomi; Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan; [Miyoshi, Yurika; Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 812, Japan; [Tojo, Yosuke; Okamura, Chieko; Mita, Masashi] Shiseido Co Ltd, Innovat Sci Res & Dev Ctr, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Konno, Ryuichi] Int Univ Hlth & Welf, Dept Pharmacol Sci, Ohtawara, Tochigi, Japan	Keio University; Kyushu University; Shiseido Company, Limited; International University of Health & Welfare	Sasabe, J (corresponding author), Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Shinanomachi, Tokyo, Japan.	sasabe@a8.keio.jp; aiso@a3.keio.jp	Suzuki, Masataka/HHC-1883-2022	Suzuki, Masataka/0000-0001-5352-8595	Grants-in-Aid for Scientific Research [25293007] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anderson M, 2011, AM J PHYSIOL-CELL PH, V300, pC22, DOI 10.1152/ajpcell.00268.2010; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; BRUCKNER H, 1993, J CHROMATOGR-BIOMED, V614, P7, DOI 10.1016/0378-4347(93)80218-S; Deng AH, 2009, AM J PHYSIOL-RENAL, V296, pF976, DOI 10.1152/ajprenal.90391.2008; FUKUSHIMA T, 1995, BIOL PHARM BULL, V18, P1130; FURST P, 1989, J AM COLL NUTR, V8, P310; GANOTE CE, 1974, AM J PATHOL, V77, P269; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; Grant SL, 2006, J CHROMATOGR B, V844, P278, DOI 10.1016/j.jchromb.2006.07.022; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; KALTENBACH JP, 1982, EXP MOL PATHOL, V37, P225, DOI 10.1016/0014-4800(82)90038-7; Kawasaka K, 1998, CLIN NEPHROL, V49, P214; Kottgen M, 2011, AM J PHYSIOL-CELL PH, V300, pC9, DOI 10.1152/ajpcell.00453.2010; Krug AW, 2007, AM J PHYSIOL-RENAL, V293, pF382, DOI 10.1152/ajprenal.00441.2006; Leung JC, 2002, AM J PHYSIOL-REG I, V283, pR964, DOI 10.1152/ajpregu.00629.2001; Maekawa M, 2005, CHEM RES TOXICOL, V18, P1678, DOI 10.1021/tx0500326; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Miyoshi Y, 2012, AMINO ACIDS, V43, P1919, DOI 10.1007/s00726-012-1398-4; Miyoshi Y, 2011, J CHROMATOGR B, V879, P3184, DOI 10.1016/j.jchromb.2010.08.024; Miyoshi Y, 2009, J CHROMATOGR B, V877, P2506, DOI 10.1016/j.jchromb.2009.06.028; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NAGATA Y, 1987, CLIN SCI, V73, P105, DOI 10.1042/cs0730105; Obermuller N, 2013, INT UROL NE IN PRESS; Pundir M, 2013, J SURG RES, V183, P668, DOI 10.1016/j.jss.2013.01.040; Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109; Silbernagl S, 1999, AM J PHYSIOL-RENAL, V276, pF857, DOI 10.1152/ajprenal.1999.276.6.F857; Sproul A, 2011, AM J PHYSIOL-RENAL, V301, pF44, DOI 10.1152/ajprenal.00666.2010; TIZIANELLO A, 1989, CONTRIB NEPHROL, V75, P185; WATANABE T, 1978, ANAL BIOCHEM, V86, P310, DOI 10.1016/0003-2697(78)90347-0; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Xia MH, 2004, MOL BRAIN RES, V125, P96, DOI 10.1016/j.molbrainres.2004.03.007; Yang CC, 2008, AM J PHYSIOL-RENAL, V294, pF1433, DOI 10.1152/ajprenal.00481.2007; Zhang HZ, 2012, AMINO ACIDS, V42, P337, DOI 10.1007/s00726-010-0811-0	35	43	49	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86504	10.1371/journal.pone.0086504	http://dx.doi.org/10.1371/journal.pone.0086504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489731	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000041
J	Fu, RG; Zhang, T; Wang, L; Du, Y; Jia, LN; Hou, JJ; Yao, GL; Liu, XD; Zhang, L; Chen, L; Gui, BS; Xue, RL				Fu, Rong-Guo; Zhang, Tao; Wang, Li; Du, Yan; Jia, Li-Ning; Hou, Jing-Jing; Yao, Gang-Lian; Liu, Xiao-Dan; Zhang, Lei; Chen, Ling; Gui, Bao-Song; Xue, Rong-Liang			Inhibition of the K+ Channel K(Ca)3.1 Reduces TGF-beta 1-Induced Premature Senescence, Myofibroblast Phenotype Transition and Proliferation of Mesangial Cells	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; SMALL-CONDUCTANCE; RENAL FIBROSIS; EXPRESSION; MARKER; KCA3.1; MODULATION; BLOCKADE; KINASE; ACTIN	Objective: K(Ca)3.1 channel participates in many important cellular functions. This study planned to investigate the potential involvement of K(Ca)3.1 channel in premature senescence, myofibroblast phenotype transition and proliferation of mesangial cells. Methods & Materials: Rat mesangial cells were cultured together with TGF-beta 1 (2 ng/ml) and TGF-beta 1 (2 ng/ml) + TRAM-34 (16 nM) separately for specified times from 0 min to 60 min. The cells without treatment served as controls. The location of K(Ca)3.1 channels in mesangial cells was determined with Confocal laser microscope, the cell cycle of mesangial cells was assessed with flow cytometry, the protein and mRNA expression of K(Ca)3.1, alpha-smooth muscle actin (alpha-SMA) and fibroblast-specific protein-1 (FSP-1) were detected with Western blot and RT-PCR. One-way analysis of variance (ANOVA) and Student-Newman-Keuls-q test (SNK-q) were used to do statistical analysis. Statistical significance was considered at P<0.05. Results: K(ca)3.1 channels were located in the cell membranes and/or in the cytoplasm of mesangial cells. The percentage of cells in G(0)-G(1) phase and the expression of K(ca)3.1, alpha-SMA and FSP-1 were elevated under the induction of TGF-beta 1 when compared to the control and decreased under the induction of TGF-beta 1+TRAM-34 when compared to the TGF-beta 1 induced (P<0.05 or P<0.01). Conclusion: Targeted disruption of K(Ca)3.1 inhibits TGF-beta 1-induced premature aging, myofibroblast-like phenotype transdifferentiation and proliferation of mesangial cells.	[Fu, Rong-Guo; Wang, Li; Du, Yan; Jia, Li-Ning; Yao, Gang-Lian; Gui, Bao-Song] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Nephrol, Xian, Shaanxi Provinc, Peoples R China; [Zhang, Tao; Hou, Jing-Jing] Xi An Jiao Tong Univ, Sch Med, Xian, Shaanxi Provinc, Peoples R China; [Liu, Xiao-Dan] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Cadres Ward, Xian, Shaanxi Provinc, Peoples R China; [Zhang, Lei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Med Lab, Xian, Shaanxi Provinc, Peoples R China; [Chen, Ling] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian, Shaanxi Provinc, Peoples R China; [Xue, Rong-Liang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesia, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Gui, BS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Nephrol, Xian, Shaanxi Provinc, Peoples R China.	guibsdoctor@sina.com; xuerl2h@126.com			National Natural Science Foundation of China [81100530, 81070590, 30901926]; Scientific and Technological Project of Shaanxi Province [2011K14-09-02, 2012K16-08-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Shaanxi Province	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81100530, 81070590, 30901926) (http://www.nsfc.gov.cn), and Scientific and Technological Project of Shaanxi Province (Nos. 2011K14-09-02, 2012K16-08-04) (http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K. -I., 2010, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/175381; Bariety J, 2003, NEPHROL DIAL TRANSPL, V18, P1777, DOI 10.1093/ndt/gfg231; Bedi Surmeet, 2008, Transplant Rev (Orlando), V22, P1, DOI 10.1016/j.trre.2007.09.004; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Catacuzzeno Luigi, 2012, J Signal Transduct, V2012, P421564, DOI 10.1155/2012/421564; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Dorado F, 2008, NEPHROL DIAL TRANSPL, V23, P3403, DOI 10.1093/ndt/gfn333; Fu RG, 2013, RENAL FAILURE, V35, P1142, DOI 10.3109/0886022X.2013.817279; Garneau L, 2009, J BIOL CHEM, V284, P389, DOI 10.1074/jbc.M805700200; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Huang C, 2013, NEPHROL DIAL TRANSPL; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jiao SM, 2012, MOL CELL BIOCHEM, V365, P9, DOI 10.1007/s11010-011-1197-3; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Kaneko Y, 2003, PATHOL INT, V53, P507, DOI 10.1046/j.1440-1827.2003.01507.x; Kimura Kuniko, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P160; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Lee DH, 2012, AM J PHYSIOL-RENAL, V302, pF183, DOI 10.1152/ajprenal.00407.2011; Li JH, 2010, NEPHROLOGY, V15, P507, DOI 10.1111/j.1440-1797.2010.01319.x; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; Ma R, 2005, PHYSIOLOGY, V20, P102, DOI 10.1152/physiol.00050.2004; Nishitani Y, 2005, KIDNEY INT, V68, P1078, DOI 10.1111/j.1523-1755.2005.00500.x; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Stephenson LA, 1998, KIDNEY INT, V54, P1175, DOI 10.1046/j.1523-1755.1998.00101.x; STERZEL RB, 1993, KIDNEY INT, V43, pS26; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Vandorpe DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008732; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yoshimura H, 2009, EXP MOL PATHOL, V87, P70, DOI 10.1016/j.yexmp.2009.02.002	46	10	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87410	10.1371/journal.pone.0087410	http://dx.doi.org/10.1371/journal.pone.0087410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489911	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000133
J	Jankowski, K; Schindler, DE; Horner-Devine, MC				Jankowski, KathiJo; Schindler, Daniel E.; Horner-Devine, M. Claire			Resource Availability and Spatial Heterogeneity Control Bacterial Community Response to Nutrient Enrichment in Lakes	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; MICROBIAL DIVERSITY; FRESH-WATER; BACTERIOPLANKTON COMMUNITY; PRODUCTIVITY; EUTROPHICATION; ABUNDANCE; PATTERNS; BIODIVERSITY; VARIABILITY	The diversity and composition of ecological communities often co-vary with ecosystem productivity. However, the relative importance of productivity, or resource abundance, versus the spatial distribution of resources in shaping those ecological patterns is not well understood, particularly for the bacterial communities that underlie most important ecosystem functions. Increasing ecosystem productivity in lakes has been shown to influence the composition and ecology of bacterial communities, but existing work has only evaluated the effect of increasing resource supply and not heterogeneity in how those resources are distributed. We quantified how bacterial communities varied with the trophic status of lakes and whether community responses differed in surface and deep habitats in response to heterogeneity in nutrient resources. Using ARISA fingerprinting, we found that bacterial communities were more abundant, richer, and more distinct among habitats as lake trophic state and vertical heterogeneity in nutrients increased, and that spatial resource variation produced habitat specific responses of bacteria in response to increased productivity. Furthermore, changes in communities in high nutrient lakes were not produced by turnover in community composition but from additional taxa augmenting core bacterial communities found in lower productivity lakes. These data suggests that bacterial community responses to nutrient enrichment in lakes vary spatially and are likely influenced disproportionately by rare taxa.	[Jankowski, KathiJo; Schindler, Daniel E.; Horner-Devine, M. Claire] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Jankowski, K (corresponding author), Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA.	kathijo@u.washington.edu		Jankowski, Kathi Jo/0000-0002-3292-4182; Horner-Devine, Claire/0000-0002-0783-3406	University of Washington Keeler Professorship; Seattle ARCS Foundation; EPA STAR Fellowship	University of Washington Keeler Professorship; Seattle ARCS Foundation; EPA STAR Fellowship(United States Environmental Protection Agency)	University of Washington Keeler Professorship to Daniel Schindler, Seattle ARCS Foundation and EPA STAR Fellowship to KathiJo Jankowski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Barnett A, 2007, ECOLOGY, V88, P1675, DOI 10.1890/06-1056.1; Bell T, 2010, BIOL LETTERS, V6, P639, DOI 10.1098/rsbl.2010.0027; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; De Wever A, 2005, APPL ENVIRON MICROB, V71, P5029, DOI 10.1128/AEM.71.9.5029-5037.2005; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Dorigo U, 2006, FEMS MICROBIOL ECOL, V58, P109, DOI 10.1111/j.1574-6941.2006.00139.x; Eaton A. D., 2005, STANDARD METHODS EXA; Eilts JA, 2011, AM NAT, V177, P574, DOI 10.1086/659633; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Garcia SL, 2013, ENV MICROBIOL REP, V5, P549, DOI 10.1111/1758-2229.12044; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Horner-Devine MC, 2003, ECOL LETT, V6, P613; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jankowski K, 2012, LIMNOL OCEANOGR, V57, P671, DOI 10.4319/lo.2012.57.3.0671; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kent AD, 2004, MICROB ECOL, V48, P550, DOI 10.1007/s00248-004-0244-y; Kolmonen E, 2011, AQUAT MICROB ECOL, V62, P241, DOI 10.3354/ame01461; Korhonen JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022041; Kovacs A, 2010, RES MICROBIOL, V161, P192, DOI 10.1016/j.resmic.2010.01.006; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; Madigan MT, 2010, BROCK BIOL MICROORGA; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; PACE ML, 1994, MICROBIAL ECOL, V28, P181, DOI 10.1007/BF00166807; R Core Team, 2012, R LANG ENV STAT COMP; Reich PB, 2012, J ECOL, V100, P539, DOI 10.1111/j.1365-2745.2011.01922.x; Reid W.V., 2005, MILLENNIUM ECOSYSTEM, DOI [10.1196/annals.1439.003, DOI 10.1196/ANNALS.1439.003]; Ribalet F, 2010, P NATL ACAD SCI USA, V107, P16571, DOI 10.1073/pnas.1005638107; ROZENZWEIG ML, 1995, SPECIES DIVERSITY SP; Schindler DE, 2003, IMPORTANCE SPECIES P; Shade A., 2010, MICROB ECOL, V59, P546, DOI [10.1007/s00248-009-9589-6, DOI 10.1007/s00248-009-9589-6]; Shade A, 2008, ENVIRON MICROBIOL, V10, P1057, DOI 10.1111/j.1462-2920.2007.01527.x; Shurin JB, 2010, ECOL LETT, V13, P453, DOI 10.1111/j.1461-0248.2009.01438.x; Smith VH, 2007, FEMS MICROBIOL ECOL, V62, P181, DOI 10.1111/j.1574-6941.2007.00381.x; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stevens MHH, 2002, ECOL LETT, V5, P420, DOI 10.1046/j.1461-0248.2002.00333.x; Tilman D., 1982, Monographs in Population Biology, pi; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	60	27	31	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86991	10.1371/journal.pone.0086991	http://dx.doi.org/10.1371/journal.pone.0086991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489823	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000098
J	Liang, Z; Diepstra, A; Xu, CH; van Imhoff, G; Plattel, W; Van Den Berg, A; Visser, L				Liang, Zheng; Diepstra, Arjan; Xu, Chuanhui; van Imhoff, Gustaaf; Plattel, Wouter; Van Den Berg, Anke; Visser, Lydia			Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma	PLOS ONE			English	Article							FACTOR-I RECEPTOR; FACTOR TYPE-1 RECEPTOR; PROSTATE-CANCER CELLS; HUMAN BREAST-CANCER; INSULIN-LIKE-GROWTH-FACTOR-1 RECEPTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASES; IGF-I; EXPRESSION; SURVIVAL	The interaction between the tumor cells in classical Hodgkin lymphoma (cHL) and the microenvironment includes aberrant activity of receptor tyrosine kinases. In this study we evaluated the expression, functionality and prognostic significance of Insulin-like growth factor-1 receptor (IGF-1R) in cHL. IGF-1R was overexpressed in 55% (44/80) of cHL patients. Phosphorylated IGF-1R was detectable in a minority of the IGF-1R positive tumor cells. The overall survival (OS, 98%) and 5-year progression-free survival (PFS, 93%) was significantly higher in IGF-1R positive cHL patients compared to IGF-1R negative patients (OS 83%, p = .029 and PFS 77%, p = .047, respectively). Three cHL cell lines showed expression of IGF-1R, with strong staining especially in the mitotic cells and expression of IGF-1. IGF-1 treatment had a prominent effect on the cell growth of L428 and L1236 cells and resulted in an increased phosphorylation of IGF1R, Akt and ERK. Inhibition of IGF-1R with cyclolignan picropodophyllin (PPP) decreased cell growth and induced a G2/M cell cycle arrest in all three cell lines. Moreover, a decrease in pCcd2 and an increase in CyclinB1 levels were observed which is consistent with the G2/M cell cycle arrest. In conclusion, IGF-1R expression in HRS cells predicts a favorable outcome, despite the oncogenic effect of IGF-1R in cHL cell lines.	[Liang, Zheng; Diepstra, Arjan; Plattel, Wouter; Van Den Berg, Anke; Visser, Lydia] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Liang, Zheng; Diepstra, Arjan; van Imhoff, Gustaaf; Plattel, Wouter; Van Den Berg, Anke; Visser, Lydia] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Liang, Zheng] Tianjin Med Univ, Canc Inst & Hosp, Canc Cell Biol Lab, Tianjin, Peoples R China; [Liang, Zheng] Tianjin Med Univ, Gen Hosp, Dept Otolaryngol, Tianjin, Peoples R China; [Xu, Chuanhui] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; Tianjin Medical University; Tianjin Medical University; Peking University; University of Groningen	Visser, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	l.visser@umcg.nl	van den Berg, Anke/H-1718-2011; Plattel, Wouter J/A-4135-2012	van den Berg, Anke/0000-0002-8894-2638; Liang, Zheng/0000-0003-4532-4888; Xu, Chuanhui/0000-0002-3222-7168; Diepstra, Arjan/0000-0001-9239-1050	Abel Tasman Talent fellowship (UMCG); Dutch Cancer Society (KWF) fellowship	Abel Tasman Talent fellowship (UMCG); Dutch Cancer Society (KWF) fellowship	Zheng Liang is supported by an Abel Tasman Talent fellowship (UMCG). Wouter Plattel and Arjan Diepstra are both supported by a Dutch Cancer Society (KWF) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen J, 2005, CLIN CANCER RES, V11, P206; Allison AS, 2007, HUM PATHOL, V38, P1590, DOI 10.1016/j.humpath.2007.03.013; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Baserga R, 2000, GROWTH HORM IGF RES, V10, pS43, DOI 10.1016/S1096-6374(00)90021-2; Buettner M, 2005, HEMATOL ONCOL, V23, P127, DOI 10.1002/hon.764; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dutton A, 2005, J PATHOL, V205, P498, DOI 10.1002/path.1725; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; FLORKE RR, 1990, EUR J BIOCHEM, V191, P473, DOI 10.1111/j.1432-1033.1990.tb19146.x; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Garcia JF, 2003, BLOOD, V101, P681, DOI 10.1182/blood-2002-04-1128; Gilam A, 2013, BREAST CANCER RES TR, V138, P753, DOI 10.1007/s10549-013-2502-5; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; JOHNSON EW, 1992, J IMMUNOL, V148, P63; Kikuchi R, 2012, ANN SURG ONCOL, V19, pS412, DOI 10.1245/s10434-011-1878-x; Kornprat P, 2006, J CLIN PATHOL, V59, P202, DOI 10.1136/jcp.2005.028480; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2002, ADV CANCER RES, V84, P277, DOI 10.1016/S0065-230X(02)84009-X; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; Lara PC, 2011, ORAL ONCOL, V47, P615, DOI 10.1016/j.oraloncology.2011.05.005; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; LeRoith D, 1995, ANN NY ACAD SCI, V766, P402, DOI 10.1111/j.1749-6632.1995.tb26689.x; Liu YC, 2002, J BIOMED SCI, V9, P665, DOI 10.1159/000067282; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; PAPA V, 1993, CANCER RES, V53, P3736; Pinheiro GS, 2007, SAO PAULO MED J, V125, P77, DOI 10.1590/S1516-31802007000200003; Reiss K, 2001, ONCOGENE, V20, P490, DOI 10.1038/sj.onc.1204112; Renne C, 2005, BLOOD, V105, P4051, DOI 10.1182/blood-2004-10-4008; Renne C, 2007, INT J CANCER, V120, P2504, DOI 10.1002/ijc.22511; Schnarr B, 2000, INT J CANCER, V89, P506, DOI 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F; Scott DW, 2013, J CLIN ONCOL, V31, P692, DOI 10.1200/JCO.2012.43.4589; SEELY BL, 1995, J BIOL CHEM, V270, P19151, DOI 10.1074/jbc.270.32.19151; Stromberg T, 2006, BLOOD, V107, P669, DOI 10.1182/blood-2005-01-0306; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Vishwamitra D, 2011, HAEMATOL-HEMATOL J, V96, P871, DOI 10.3324/haematol.2010.031567; Xu CH, 2012, HAEMATOL-HEMATOL J, V97, P572, DOI 10.3324/haematol.2011.056101; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Zumkeller W, 2002, LEUKEMIA LYMPHOMA, V43, P487, DOI 10.1080/10428190290011958	44	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87474	10.1371/journal.pone.0087474	http://dx.doi.org/10.1371/journal.pone.0087474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489919	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000136
J	McMinn, A; Muller, MN; Martin, A; Ryan, KG				McMinn, Andrew; Mueller, Marius N.; Martin, Andrew; Ryan, Ken G.			The Response of Antarctic Sea Ice Algae to Changes in pH and CO2	PLOS ONE			English	Article							INORGANIC CARBON ACQUISITION; GLOBAL CLIMATE-CHANGE; OCEAN ACIDIFICATION; PHYTOPLANKTON; GROWTH; DIATOM; PHOTOSYNTHESIS; SENSITIVITY; PERFORMANCE; ORGANISMS	Ocean acidification substantially alters ocean carbon chemistry and hence pH but the effects on sea ice formation and the CO2 concentration in the enclosed brine channels are unknown. Microbial communities inhabiting sea ice ecosystems currently contribute 10-50% of the annual primary production of polar seas, supporting overwintering zooplankton species, especially Antarctic krill, and seeding spring phytoplankton blooms. Ocean acidification is occurring in all surface waters but the strongest effects will be experienced in polar ecosystems with significant effects on all trophic levels. Brine algae collected from McMurdo Sound (Antarctica) sea ice was incubated in situ under various carbonate chemistry conditions. The carbon chemistry was manipulated with acid, bicarbonate and bases to produce a pCO(2) and pH range from 238 to 6066 mu atm and 7.19 to 8.66, respectively. Elevated pCO(2) positively affected the growth rate of the brine algal community, dominated by the unique ice dinoflagellate, Polarella glacialis. Growth rates were significantly reduced when pH dropped below 7.6. However, when the pH was held constant and the pCO(2) increased, growth rates of the brine algae increased by more than 20% and showed no decline at pCO(2) values more than five times current ambient levels. We suggest that projected increases in seawater pCO(2), associated with OA, will not adversely impact brine algal communities.	[McMinn, Andrew; Mueller, Marius N.; Martin, Andrew] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Martin, Andrew; Ryan, Ken G.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of Tasmania; Victoria University Wellington	McMinn, A (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Andrew.mcminn@utas.edu.au	Müller, Marius Nils/N-9338-2014; McMinn, Andrew/A-9910-2008	Müller, Marius Nils/0000-0003-4765-3933; McMinn, Andrew/0000-0002-2133-3854; Martin, Andrew/0000-0001-8260-5529; Ryan, Ken/0000-0001-7075-0112	Australian Antarctic Division [AAS 4008]; Australian Research Council (ARC) [DP1093801]	Australian Antarctic Division; Australian Research Council (ARC)(Australian Research Council)	Financial support for this project came from the Australian Antarctic Division (AAS 4008) and the Australian Research Council (ARC) Discovery Project DP1093801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Bach LT, 2012, BIOGEOSCIENCES, V9, P3449, DOI 10.5194/bg-9-3449-2012; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Berge T, 2010, MAR ECOL PROG SER, V416, P79, DOI 10.3354/meps08780; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Boyd PW, 2013, NAT CLIM CHANGE, V3, P530, DOI 10.1038/nclimate1881; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Chen SW, 2011, HYDROBIOLOGIA, V675, P105, DOI 10.1007/s10750-011-0807-0; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; de Kluijver A, 2013, BIOGEOSCIENCES, V10, P1425, DOI 10.5194/bg-10-1425-2013; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Evans CA, 1987, HDB MEASUREMENT CHLO; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; GYURE RA, 1987, APPL ENVIRON MICROB, V53, P2069, DOI 10.1128/AEM.53.9.2069-2076.1987; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; KOTTMEIER ST, 1987, MAR ECOL PROG SER, V36, P287, DOI 10.3354/meps036287; Krembs C, 2000, J EXP MAR BIOL ECOL, V243, P55, DOI 10.1016/S0022-0981(99)00111-2; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055562; Matson PG, 2011, ANTARCT SCI, V23, P607, DOI 10.1017/S0954102011000551; McMinn A, 2005, J PHYCOL, V41, P732, DOI 10.1111/j.1529-8817.2005.00095.x; McMinn A, 1999, POLAR BIOL, V21, P220, DOI 10.1007/s003000050356; Mitchell C, 1996, POLAR BIOL, V16, P95; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Ralph PJ, 2005, J PHYCOL, V41, P763, DOI 10.1111/j.1529-8817.2005.00106.x; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2004, J OCEANOGR, V60, P719, DOI 10.1007/s10872-004-5764-z; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rost B, 2006, PLANT CELL ENVIRON, V29, P810, DOI 10.1111/j.1365-3040.2005.01450.x; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Ryan KG, 2012, J PHYCOL, V48, P74, DOI 10.1111/j.1529-8817.2011.01104.x; Schnack-Schiel SB, 2001, POLAR BIOL, V24, P724, DOI 10.1007/s003000100273; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Suffrian K, 2011, NEW PHYTOL, V190, P595, DOI 10.1111/j.1469-8137.2010.03633.x; The Royal Society, 2005, 1205 ROYAL SOC; Thomas DN, 2004, SEA ICE INTRO ITS PH; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P1485, DOI 10.4319/lo.2000.45.7.1485; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Trimborn S, 2013, LIMNOL OCEANOGR, V58, P997, DOI 10.4319/lo.2013.58.3.0997; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002	48	48	49	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86984	10.1371/journal.pone.0086984	http://dx.doi.org/10.1371/journal.pone.0086984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489821	gold, Green Accepted, Green Published			2022-12-25	WOS:000330510000097
J	Vagedes, J; Bialkowski, A; Wiechers, C; Poets, CF; Dietz, K				Vagedes, Jan; Bialkowski, Anja; Wiechers, Cornelia; Poets, Christian F.; Dietz, Klaus			A Conversion Formula for Comparing Pulse Oximeter Desaturation Rates Obtained with Different Averaging Times	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; TUCSON CHILDRENS ASSESSMENT; POSITIVE AIRWAY PRESSURE; OXYGEN-SATURATION; PRETERM INFANTS; BREATHING PATTERNS; HEART-RATE; CARE-UNIT; ACCURACY; ARTIFACT	Objective: The number of desaturations determined in recordings of pulse oximeter saturation (SpO(2)) primarily depends on the time over which values are averaged. As the averaging time in pulse oximeters is not standardized, it varies considerably between centers. To make SpO(2) data comparable, it is thus desirable to have a formula that allows conversion between desaturation rates obtained using different averaging times for various desaturation levels and minimal durations. Methods: Oxygen saturation was measured for 170 hours in 12 preterm infants with a mean number of 65 desaturations <90% per hour of arbitrary duration by using a pulse oximeter in a 2-4 s averaging mode. Using 7 different averaging times between 3 and 16 seconds, the raw red-to-infrared data were reprocessed to determine the number of desaturations (D). The whole procedure was carried out for 7 different minimal desaturation durations (>= 1, >= 5, >= 10, >= 15, >= 20, >= 25, >= 30 s) below SpO(2) threshold values of 80%, 85% or 90% to finally reach a conversion formula. The formula was validated by splitting the infants into two groups of six children each and using one group each as a training set and the other one as a test set. Results: Based on the linear relationship found between the logarithm of the desaturation rate and the logarithm of the averaging time, the conversion formula is: D-2 = D-1 (T-2/T-1)(c), where D-2 is the desaturation rate for the desired averaging time T-2, and D-1 is the desaturation rate for the original averaging time T-1, with the exponent c depending on the desaturation threshold and the minimal desaturation duration. The median error when applying this formula was 2.6%. Conclusion: This formula enables the conversion of desaturation rates between different averaging times for various desaturation thresholds and minimal desaturation durations.	[Vagedes, Jan; Bialkowski, Anja; Wiechers, Cornelia; Poets, Christian F.] Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany; [Vagedes, Jan] Filderklin, ARCIM Inst, Res Dept, Filderstadt, Germany; [Dietz, Klaus] Univ Tubingen, Dept Med Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Poets, CF (corresponding author), Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany.	Christian-F.Poets@med.uni-tuebingen.de	Wiechers, Cornelia/AAU-9008-2021; Dietz, Klaus/R-9268-2016	Wiechers, Cornelia/0000-0002-6850-6249; Dietz, Klaus/0000-0001-8503-9737				Accardo JA, 2010, SLEEP, V33, P1333, DOI 10.1093/sleep/33.10.1333; Adler JN, 1998, ACAD EMERG MED, V5, P965, DOI 10.1111/j.1553-2712.1998.tb02772.x; Ahmed SJM, 2010, PEDIATRICS, V125, pE115, DOI 10.1542/peds.2008-1749; AMAR D, 1989, J CLIN MONITOR, V5, P135, DOI 10.1007/BF01617888; Barker SJ, 2002, ANESTH ANALG, V95, P967, DOI 10.1213/01.ANE.0000029029.03601.08; Brockmann PE, 2011, ARCH DIS CHILD-FETAL, V96, pF335, DOI 10.1136/adc.2010.196758; Craig S, 2009, J SLEEP RES, V18, P329, DOI 10.1111/j.1365-2869.2008.00726.x; Davila DG, 2003, SLEEP, V26, P91; Davila DG, 2002, CHEST, V122, P1654, DOI 10.1378/chest.122.5.1654; Farre R, 1998, SLEEP, V21, P386, DOI 10.1093/sleep/21.4.386; Goodwin JL, 2010, J PEDIATR-US, V157, P57, DOI 10.1016/j.jpeds.2010.01.033; Goodwin JL, 2001, SLEEP, V24, P937, DOI 10.1093/sleep/24.8.937; HAY WW, 1989, PEDIATRICS, V83, P717; Heimann K, 2010, NEONATOLOGY, V97, P311, DOI 10.1159/000255163; Hensey CC, 2013, ARCH DIS CHILD FETAL; Korcarz CE, 2010, SLEEP, V33, P1081, DOI 10.1093/sleep/33.8.1081; LANGTON JA, 1990, BRIT J ANAESTH, V65, P564, DOI 10.1093/bja/65.4.564; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; McBride GB, 2005, HAM2005062 NIWA; Ortega Rafael, 2011, N Engl J Med, V364, pe33, DOI 10.1056/NEJMvcm0904262; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Petterson MT, 2007, ANESTH ANALG, V105, pS78, DOI 10.1213/01.ane.0000278134.47777.a5; POETS CF, 1993, PEDIATR RES, V34, P144, DOI 10.1203/00006450-199308000-00007; POETS CF, 1991, J DEV PHYSIOL, V15, P341; POETS CF, 1993, PEDIATRICS, V92, P686; POETS CF, 1994, PEDIATRICS, V93, P737; POETS CF, 1991, EARLY HUM DEV, V26, P1, DOI 10.1016/0378-3782(91)90038-5; POETS CF, 1991, ARCH DIS CHILD, V66, P574, DOI 10.1136/adc.66.5.574; Poets CF, 1997, EUR J PEDIATR, V156, P808, DOI 10.1007/s004310050719; Quan SF, 2011, SLEEP, V34, P303, DOI 10.1093/sleep/34.3.303; Rheineck-Leyssius AT, 1999, J CLIN ANESTH, V11, P196, DOI 10.1016/S0952-8180(98)00133-0; Rheineck-Leyssius AT, 1998, J CLIN MONITOR COMP, V14, P151, DOI 10.1023/A:1007431305610; Rheineck-Leyssius RT, 1999, J CLIN ANESTH, V11, P192, DOI 10.1016/S0952-8180(99)00034-3; Robertson FA, 2004, ANESTH ANALG, V98, P617, DOI 10.1213/01.ANE.0000101601.43781.15; Salyer John W, 2003, Respir Care, V48, P386; SEVERINGHAUS JW, 1990, ANESTHESIOLOGY, V73, P532, DOI 10.1097/00000542-199009000-00025; Singh JKSB, 2008, J PAEDIATR CHILD H, V44, P273, DOI 10.1111/j.1440-1754.2007.01250.x; Urschitz MS, 2003, CHEST, V123, P96, DOI 10.1378/chest.123.1.96; Vagedes J, 2012, ARCH DIS CHILD FETAL; Villanueva R, 1999, J CLIN ANESTH, V11, P317, DOI 10.1016/S0952-8180(99)00054-9	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87280	10.1371/journal.pone.0087280	http://dx.doi.org/10.1371/journal.pone.0087280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489887	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000123
J	Amorim, F; Carvalho, SB; Honrado, J; Rebelo, H				Amorim, Francisco; Carvalho, Silvia B.; Honrado, Joao; Rebelo, Hugo			Designing Optimized Multi-Species Monitoring Networks to Detect Range Shifts Driven by Climate Change: A Case Study with Bats in the North of Portugal	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; POTENTIAL IMPACTS; FORAGING HABITATS; DISTRIBUTIONS; CHIROPTERA; IDENTIFICATION; SUITABILITY; PREDICTIONS; PHENOLOGY; RESPONSES	Here we develop a framework to design multi-species monitoring networks using species distribution models and conservation planning tools to optimize the location of monitoring stations to detect potential range shifts driven by climate change. For this study, we focused on seven bat species in Northern Portugal (Western Europe). Maximum entropy modelling was used to predict the likely occurrence of those species under present and future climatic conditions. By comparing present and future predicted distributions, we identified areas where each species is likely to gain, lose or maintain suitable climatic space. We then used a decision support tool (the Marxan software) to design three optimized monitoring networks considering: a) changes in species likely occurrence, b) species conservation status, and c) level of volunteer commitment. For present climatic conditions, species distribution models revealed that areas suitable for most species occur in the north-eastern part of the region. However, areas predicted to become climatically suitable in the future shifted towards west. The three simulated monitoring networks, adaptable for an unpredictable volunteer commitment, included 28, 54 and 110 sampling locations respectively, distributed across the study area and covering the potential full range of conditions where species range shifts may occur. Our results show that our framework outperforms the traditional approach that only considers current species ranges, in allocating monitoring stations distributed across different categories of predicted shifts in species distributions. This study presents a straightforward framework to design monitoring schemes aimed specifically at testing hypotheses about where and when species ranges may shift with climatic changes, while also ensuring surveillance of general population trends.	[Amorim, Francisco; Carvalho, Silvia B.; Honrado, Joao; Rebelo, Hugo] Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO InBIO, Vairao, Portugal; [Honrado, Joao] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal; [Rebelo, Hugo] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Universidade do Porto; Universidade do Porto; University of Bristol	Amorim, F (corresponding author), Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO InBIO, Vairao, Portugal.	famorim@cibio.up.pt	Rebelo, Hugo/C-9005-2009; Carvalho, Silvia/AAE-9566-2020; Carvalho, Silvia B/J-3343-2013; Amorim, Francisco/L-7376-2013; Honrado, Joao/L-8365-2013	Rebelo, Hugo/0000-0002-7118-4068; Carvalho, Silvia/0000-0003-4368-4708; Carvalho, Silvia B/0000-0003-4368-4708; Amorim, Francisco/0000-0002-7731-9242; Honrado, Joao/0000-0001-8443-4276	Fundacao para a Ciencia e Tecnologia [PTDC/AGR-AAM/104819/2008, SFRH/BPD/65418/2009, SFRH/BPD/74423/2010]; QREN/ON2 in the context of project "SIMBioN-Biodiversity Information and Monitoring System for Northern Portugal" [ON2:3-2-14-1-1192]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); QREN/ON2 in the context of project "SIMBioN-Biodiversity Information and Monitoring System for Northern Portugal"	This research was funded by Fundacao para a Ciencia e Tecnologia through FEDER/COMPETE, under project "EcoSensing" (PTDC/AGR-AAM/104819/2008), and by QREN/ON2 in the context of project "SIMBioN-Biodiversity Information and Monitoring System for Northern Portugal" (ON2:3-2-14-1-1192). Hugo Rebelo and Silvia B. Carvalho were funded by Fundacao para a Ciencia e Tecnologia (grants SFRH/BPD/65418/2009 and SFRH/BPD/74423/2010 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; [Anonymous], 2013, 2013 18 ADV COMM M; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Atlas Equipa, 2008, ATL AV NID PORT 1999; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ball IR, 2000, MARXAN V1 8 2 MARINE, V67; Barbet-Massin M, 2010, ECOGRAPHY, V33, P878, DOI 10.1111/j.1600-0587.2010.06181.x; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Battersby J., 2010, GUIDELINES SURVEILLA; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Braunisch V, 2008, ECOL MODEL, V214, P153, DOI 10.1016/j.ecolmodel.2008.02.001; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Conroy MJ, 2011, BIOL CONSERV, V144, P1204, DOI 10.1016/j.biocon.2010.10.019; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Franklin, 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Franklin J, 2011, AM J BOT, V98, P559, DOI 10.3732/ajb.1000292; Game ET, 2008, MARXAN USER MANUAL M; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kunz TH, 2003, BAT ECOLOGY, P3; KUNZ TH, 1975, J MAMMAL, V56, P907, DOI 10.2307/1379662; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; LaVal RK, 2004, J MAMMAL, V85, P237, DOI 10.1644/BWG-016; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; Lundy M, 2010, J BIOGEOGR, V37, P2232, DOI 10.1111/j.1365-2699.2010.02384.x; Macdonald DW, 2007, KEY TOPICS CONSERVAT; Manley PN, 2004, ECOL APPL, V14, P296, DOI 10.1890/02-5249; McComb B, 2010, MONITORING ANIMAL POPULATIONS AND THEIR HABITATS: A PRACTITIONERS GUIDE, P1, DOI 10.1201/9781420070583; McDonald-Madden E, 2011, TRENDS ECOL EVOL, V26, P108, DOI 10.1016/j.tree.2010.12.005; McDonald-Madden E, 2010, TRENDS ECOL EVOL, V25, P547, DOI 10.1016/j.tree.2010.07.002; Metzger MJ, 2013, ECOL INDIC, V33, P26, DOI 10.1016/j.ecolind.2012.11.009; Mitchell-Jones T, 2007, PROTECTING MANAGING; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; O'Shea TJ, 2003, USGSBRDITR20030003; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rainho A, 2011, CHAVE IDENTIFICACAO, P16; Rainho A, 2007, ACTA CHIROPTEROL, V9, P171, DOI 10.3161/1733-5329(2007)9[171:SFHOBI]2.0.CO;2; Rainho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019227; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Roche N, 2011, ANIM CONSERV, V14, P642, DOI 10.1111/j.1469-1795.2011.00470.x; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Sachanowicz K, 2006, ACTA CHIROPTEROL, V8, P543, DOI 10.3161/1733-5329(2006)8[543:FREOPK]2.0.CO;2; Santos F. D., 2002, CLIMATE CHANGE PORTU; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Suarez-Seoane S, 2008, ECOL MODEL, V219, P17, DOI 10.1016/j.ecolmodel.2008.07.035; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Verburg PH, 2008, ANN REGIONAL SCI, V42, P57, DOI 10.1007/s00168-007-0136-4; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; WALSH A., 2001, FINAL REPORT 2001 BA; Walsh AL, 1996, J APPL ECOL, V33, P519, DOI 10.2307/2404981; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Walters CL, 2012, J APPL ECOL, V49, P1064, DOI 10.1111/j.1365-2664.2012.02182.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WEBB PI, 1995, J ZOOL, V235, P269; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	83	30	30	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87291	10.1371/journal.pone.0087291	http://dx.doi.org/10.1371/journal.pone.0087291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475265	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300163
J	Kruta, I; Landman, NH; Cochran, JK				Kruta, Isabelle; Landman, Neil H.; Cochran, J. Kirk			A New Approach for the Determination of Ammonite and Nautilid Habitats	PLOS ONE			English	Article							WESTERN INTERIOR SEAWAY; NORTH-AMERICA; ISOTOPE FRACTIONATION; STABLE-ISOTOPES; NEW-CALEDONIA; OXYGEN; CARBON; DELTA-C-13; PALEOTEMPERATURES; RECONSTRUCTION	Externally shelled cephalopods were important elements in open marine habitats throughout Earth history. Paleotemperatures calculated on the basis of the oxygen isotope composition of their shells can provide insights into ancient marine systems as well as the ecology of this important group of organisms. In some sedimentary deposits, however, the aragonitic shell of the ammonite or nautilid is poorly or not preserved at all, while the calcitic structures belonging to the jaws are present. This study tests for the first time if the calcitic jaw structures in fossil cephalopods can be used as a proxy for paleotemperature. We first analyzed the calcitic structures on the jaws of Recent Nautilus and compared the calculated temperatures of precipitation with those from the aragonitic shell in the same individuals. Our results indicate that the jaws of Recent Nautilus are secreted in isotopic equilibrium, and the calculated temperatures approximately match those of the shell. We then extended our study to ammonites from the Upper Cretaceous (Campanian) Pierre Shale of the U. S. Western Interior and the age-equivalent Mooreville Chalk of the Gulf Coastal Plain. In the Pierre Shale, jaws occur in situ inside the body chambers of well-preserved Baculites while in the Mooreville Chalk, the jaw elements appear as isolated occurrences in the sediment and the aragonitic shell material is not preserved. For the Pierre Shale specimens, the calculated temperatures of well-preserved jaw material match those of well-preserved shell material in the same individual. Analyses of the jaw elements in the Mooreville Chalk permit a comparison of the paleotemperatures between the two sites, and show that the Western Interior is warmer than the Gulf Coast at that time. In summary, our data indicate that the calcitic jaw elements of cephalopods can provide a reliable geochemical archive of the habitat of fossil forms.	[Kruta, Isabelle; Landman, Neil H.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Kruta, Isabelle] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Cochran, J. Kirk] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	American Museum of Natural History (AMNH); Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kruta, I (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	ikruta@amnh.org			AMNH Lerner Gray Postgraduate doctoral fellowship; N.D. Newell Fund (AMNH)	AMNH Lerner Gray Postgraduate doctoral fellowship; N.D. Newell Fund (AMNH)	IK was funded by AMNH Lerner Gray Postgraduate doctoral fellowship. Funding for isotopic analyses was provided by the N.D. Newell Fund (AMNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMON WD, 1992, VELIGER, V35, P52; Auclair AC, 2004, CHEM GEOL, V207, P91, DOI 10.1016/j.chemgeo.2004.02.006; BOWEN R, 1963, EXPERIENTIA, V19, P268, DOI 10.1007/BF02151377; Cochran JK, 2010, AM J SCI, V310, P69, DOI 10.2475/02.2010.01; Cochran JK, 2003, PALAEOGEOGR PALAEOCL, V191, P45, DOI 10.1016/S0031-0182(02)00642-9; COCHRAN JK, 1981, PALEOBIOLOGY, V7, P469, DOI 10.1017/S0094837300025525; CROCKER KC, 1985, GEOCHIM COSMOCHIM AC, V49, P2527, DOI 10.1016/0016-7037(85)90120-6; Dennis KJ, 2013, EARTH PLANET SC LETT, V362, P51, DOI 10.1016/j.epsl.2012.11.036; Dunstan AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016312; Fatherree JW, 1998, PALAIOS, V13, P376, DOI 10.2307/3515325; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; He S, 2005, PALAEOGEOGR PALAEOCL, V217, P67, DOI 10.1016/j.palaeo.2004.11.016; HOUSE MR, 1993, AMMONOIDEA ENV ECOLO, V47, P13; Kruta I, 2009, LETHAIA, V42, P312, DOI 10.1111/j.1502-3931.2009.00154.x; Landman NH, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P257, DOI 10.1007/978-1-4020-6806-5_13; Landman NH, 2012, GEOLOGY, V40, P507, DOI 10.1130/G32782.1; LANDMAN NH, 1983, PALEOBIOLOGY, V9, P269, DOI 10.1017/S0094837300007685; LANDMAN NH, 1994, PALEOBIOLOGY, V20, P40, DOI 10.1017/S009483730001112X; Lecuyer C., 2006, eEarth, V1, P1; LOWENSTAM HA, 1984, PALEOBIOLOGY, V10, P268, DOI 10.1017/S0094837300008198; Lukeneder A, 2010, EARTH PLANET SC LETT, V296, P103, DOI 10.1016/j.epsl.2010.04.053; Moriya K, 2003, GEOLOGY, V31, P167, DOI 10.1130/0091-7613(2003)031<0167:DHOLCA>2.0.CO;2; ONEIL JR, 1969, J CHEM PHYS, V51, P5547, DOI 10.1063/1.1671982; Price GD, 1997, PALAEOGEOGR PALAEOCL, V129, P315, DOI 10.1016/S0031-0182(96)00058-2; Schlogl J, 2011, PALAEOGEOGR PALAEOCL, V308, P330, DOI 10.1016/j.palaeo.2011.05.037; Seuss B, 2012, PALAEOGEOGR PALAEOCL, V319, P1, DOI 10.1016/j.palaeo.2011.12.008; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; TAYLOR BE, 1983, PALAEOGEOGR PALAEOCL, V41, P1, DOI 10.1016/0031-0182(83)90072-X; TOURTELOT HA, 1969, GEOL SOC AM BULL, V80, P1903, DOI 10.1130/0016-7606(1969)80[1903:DOOACI]2.0.CO;2; Wierzbowski H, 2007, PALAEOGEOGR PALAEOCL, V254, P523, DOI 10.1016/j.palaeo.2007.07.010; Wierzbowski H, 2011, PALAEOGEOGR PALAEOCL, V299, P250, DOI 10.1016/j.palaeo.2010.11.006; Zakharov YD, 2006, GEOSCI J, V10, P331, DOI 10.1007/BF02910374; [No title captured]	34	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87479	10.1371/journal.pone.0087479	http://dx.doi.org/10.1371/journal.pone.0087479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475295	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300190
J	Kwasniewska, J; Mikolajczyk, A				Kwasniewska, Jolanta; Mikolajczyk, Agnieszka			Influence of the Presence of B Chromosomes on DNA Damage in Crepis capillaris	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; ETHYL METHANESULFONATE; A-CHROMOSOME; COMET ASSAY; MUTATION; PLANT; METHYLATION; BREAKAGE; MUTAGENS; DEPENDS	The sensitivity of different plant species to mutagenic agents is related to the DNA content and organization of the chromatin, which have been described in ABCW and bodyguard hypotheses, respectively. Plant species that have B chromosomes are good models for the study of these hypotheses. This study presents an analysis of the correlation between the occurrence of B chromosomes and the DNA damage that is induced by the chemical mutagen, maleic hydrazide (MH), in Crepis capillaris plants using comet assay. The presence of B chromosomes has a detectable impact on the level of DNA damage. The level of DNA damage after MH treatment was correlated with the number of B chromosomes and it was observed that it increased significantly in plants with 3B chromosomes. We did not find evidence of the protective role from chemical mutagens of the constitutive heterochromatin for euchromatin in relation to DNA damage. The DNA damage involving the 25S rDNA sequences was analyzed using the comet-FISH technique. Fragmentation within or near the 25S rDNA involved the loci on the A and B chromosomes. The presence of B chromosomes in C. capillaris cells had an influence on the level of DNA damage that involves the 25S rDNA region.	[Kwasniewska, Jolanta; Mikolajczyk, Agnieszka] Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Kwasniewska, J (corresponding author), Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland.	jolanta.kwasniewska@us.edu.pl	Mikolajczyk, Agnieszka/I-4854-2014; Kwasniewska, Jolanta/ABF-1547-2020	Kwasniewska, Jolanta/0000-0002-8965-8727	National Science Centre, Poland [3178/B/P01/2011/40]	National Science Centre, Poland(National Science Centre, Poland)	National Science Centre, Poland an agreement 3178/B/P01/2011/40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON S, 1973, NATURE, V245, P460, DOI 10.1038/245460a0; Banaei-Moghaddam AM, 2013, PLANT CELL, V25, P2536, DOI 10.1105/tpc.113.111856; Bandyopadhyay A, 2011, ECOTOX ENVIRON SAFE, V74, P860, DOI 10.1016/j.ecoenv.2010.12.002; Camacho JPM, 2004, CYTOGENET GENOME RES, V106, P147, DOI 10.1159/000080118; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; DELGADO M, 1995, CHROMOSOME RES, V3, P487, DOI 10.1007/BF00713963; Delgado M, 2004, CYTOGENET GENOME RES, V106, P320, DOI 10.1159/000079306; Evans G.M., 1972, CHROMOSOMES TODAY, V3, P24; Gichner T, 2003, MUTAT RES-GEN TOX EN, V535, P187, DOI 10.1016/S1383-5718(02)00320-0; Gichner T, 1998, MUTAT RES-FUND MOL M, V401, P143, DOI 10.1016/S0027-5107(98)00003-7; Gichner T, 2008, ENVIRON EXP BOT, V62, P113, DOI 10.1016/j.envexpbot.2007.07.013; Goklap FD, 2002, B SERISI, V3, P141; Grant WF, 1998, MUTAT RES-REV MUTAT, V410, P291, DOI 10.1016/S1383-5742(98)00004-0; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Houben A, 2013, PLANT GENOME DIVERSI, V2, P149, DOI DOI 10.1007/978-3-7091-1160-4_10; HSU TC, 1975, GENETICS, V79, P137; Jones RN, 2008, ANN BOT-LONDON, V101, P767, DOI 10.1093/aob/mcm167; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Juchimiuk J, 2006, FOLIA HISTOCHEM CYTO, V44, P127; Kasamatsu T, 1996, MUTAT RES-GENET TOX, V369, P1, DOI 10.1016/S0165-1218(96)90041-5; Kwasniewska J, 2012, ENVIRON MOL MUTAGEN, V53, P369, DOI 10.1002/em.21699; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; Luchniak P, 2002, FOLIA HISTOCHEM CYTO, V40, P325; MALUSZYNSKA J, 1989, HEREDITY, V62, P59, DOI 10.1038/hdy.1989.8; Maluszynska J, 2003, FOLIA HISTOCHEM CYTO, V41, P101; Maluszynska J., 1990, B CHROMOSOMES CREPIS; Minkevich I G, 2007, Bioorg Khim, V33, P474; Plewa MJ, 1983, MAIZE GEN COOP NEWSL, V57, P147; Rapp A, 2000, J PHOTOCH PHOTOBIO B, V56, P109, DOI 10.1016/S1011-1344(00)00052-X; SCHALET AP, 1978, MUTAT RES, V49, P313, DOI 10.1016/0027-5107(78)90104-5; Shaposhnikov S, 2009, MUTAGENESIS, V24, P383, DOI 10.1093/mutage/gep021; Shu Q.Y., 2009, INDUCED MUTATIONS GE; UNDERBRI.AG, 1968, RADIAT BOT, V8, P205, DOI 10.1016/S0033-7560(68)80019-5; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Vosa C.G., 1973, NOBEL S CHROMOSOME I, P156; Weber DF, 2007, MAYDICA, V52, P109	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87337	10.1371/journal.pone.0087337	http://dx.doi.org/10.1371/journal.pone.0087337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475276	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300171
J	Jangani, M; Poolman, TM; Matthews, L; Yang, N; Farrow, SN; Berry, A; Hanley, N; Williamson, AJK; Whetton, AD; Donn, R; Ray, DW				Jangani, Maryam; Poolman, Toryn M.; Matthews, Laura; Yang, Nan; Farrow, Stuart N.; Berry, Andrew; Hanley, Neil; Williamson, Andrew J. K.; Whetton, Anthony D.; Donn, Rachelle; Ray, David W.			The Methyltransferase WBSCR22/Merm1 Enhances Glucocorticoid Receptor Function and Is Regulated in Lung Inflammation and Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucocorticoid Receptor; Glucocorticoids; Histone Methylation; Inflammation; Interferon; Lung; Tumor Necrosis Factor (TNF); Ubiquitination	TRANSCRIPTION FACTORS; HISTONE H3; IN-VIVO; CHROMATIN ACCESSIBILITY; LYSINE 9; GENE; METHYLATION; BINDING; PROMOTER; EXPRESSION	Background: Glucocorticoid (GC) action in inflammation is important but poorly understood. Results: Merm1 regulates glucocorticoid receptor (GR) recruitment to the genome and mediates subsequent histone modification. Proinflammatory cytokine induction of GC resistance is accompanied by Merm1 degradation; restoration of Merm1 expression rescues GC action. Conclusion: Merm1 is a novel GR co-modulator. Significance: Merm1 mediates inflammation regulation of GC action. Glucocorticoids (GC) regulate cell fate and immune function. We identified the metastasis-promoting methyltransferase, metastasis-related methyltransferase 1 (WBSCR22/Merm1) as a novel glucocorticoid receptor (GR) regulator relevant to human disease. Merm1 binds the GR co-activator GRIP1 but not GR. Loss of Merm1 impaired both GR transactivation and transrepression by reducing GR recruitment to its binding sites. This was accompanied by loss of GR-dependent H3K4Me3 at a well characterized promoter. Inflammation promotes GC resistance, in part through the actions of TNF and IFN. These cytokines suppressed Merm1 protein expression by driving ubiquitination of two conserved lysine residues. Restoration of Merm1 expression rescued GR transactivation. Cytokine suppression of Merm1 and of GR function was also seen in human lung explants. In addition, striking loss of Merm1 protein was observed in both inflammatory and neoplastic human lung pathologies. In conclusion, Merm1 is a novel regulator of chromatin structure affecting GR recruitment and function, contributing to loss of GC sensitivity in inflammation, with suppressed expression in pulmonary disease.	[Jangani, Maryam; Poolman, Toryn M.; Matthews, Laura; Yang, Nan; Farrow, Stuart N.; Berry, Andrew; Hanley, Neil; Ray, David W.] Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester M13 9PT, Lancs, England; [Jangani, Maryam; Donn, Rachelle] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Williamson, Andrew J. K.; Whetton, Anthony D.] Univ Manchester, Stem Cell & Leukaemia Prote Lab, Fac Inst Canc Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Donn, R (corresponding author), Univ Manchester, Musckuloskeletal Res Grp, Manchester M13 9PT, Lancs, England.	rachelle.donn@manchester.ac.uk; david.w.ray@manchester.ac.uk		Ray, David/0000-0002-4739-6773; Poolman, Toryn/0000-0002-7427-6603; Yang, Nan/0000-0002-1610-5240; Donn, Rachelle/0000-0001-6976-9828; WHETTON, ANTHONY D/0000-0002-1098-3878; Hanley, Neil/0000-0003-3234-4038	Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester Strategic Fund; EPSRC [EP/I037253/1] Funding Source: UKRI; MRC [MR/L010240/1, MR/L00254X/1, MR/K015885/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I037253/1] Funding Source: researchfish; Medical Research Council [MR/L00254X/1, MR/L010240/1, MR/K015885/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester Strategic Fund; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge Peter March and Roger Meadows (University of Manchester Bioimaging) for technical assistance. BioImaging Facility microscopes used in this study were purchased with grants from Biotechnology and Biological Sciences Research Council, Wellcome Trust, and the University of Manchester Strategic Fund.	ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Astrand C, 2009, EXP CELL RES, V315, P2604, DOI 10.1016/j.yexcr.2009.05.012; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barr FD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006766; Berry A, 2010, FASEB J, V24, P1700, DOI 10.1096/fj.09-139998; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Chavez S, 1997, P NATL ACAD SCI USA, V94, P2885, DOI 10.1073/pnas.94.7.2885; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Cutolo M, 2008, ANN RHEUM DIS, V67, P905, DOI 10.1136/ard.2008.088955; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Doll A, 2001, CYTOGENET CELL GENET, V95, P20, DOI 10.1159/000057012; Dong S, 2007, MOL ENDOCRINOL, V21, P1617, DOI 10.1210/me.2006-0550; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Elsby LA, 2009, ARTHRITIS RHEUM-US, V60, P2220, DOI 10.1002/art.24659; Elsby LM, 2006, EMBO REP, V7, P898, DOI 10.1038/sj.embor.7400767; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Figaro S, 2012, MOL CELL BIOL, V32, P2254, DOI 10.1128/MCB.06623-11; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Nakazawa Y, 2011, CANCER RES, V71, P1146, DOI 10.1158/0008-5472.CAN-10-2695; Ounap K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075686; Paszek P, 2010, CURR OPIN GENET DEV, V20, P670, DOI 10.1016/j.gde.2010.08.004; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; RENKAWITZ R, 1984, CELL, V37, P503, DOI 10.1016/0092-8674(84)90380-5; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Sommer P, 2007, ONCOGENE, V26, P7111, DOI 10.1038/sj.onc.1210524; Sommer P, 2008, CURR OPIN INVEST DR, V9, P1070; Sommer P, 2010, ENDOCR-RELAT CANCER, V17, P203, DOI 10.1677/ERC-09-0241; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; TRUSS M, 1992, J STEROID BIOCHEM, V43, P365, DOI 10.1016/0960-0760(92)90071-P; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Wu SC, 2009, MOL ENDOCRINOL, V23, P1323, DOI 10.1210/me.2009-0131; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562	55	22	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8931	8946		10.1074/jbc.M113.540906	http://dx.doi.org/10.1074/jbc.M113.540906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24488492	Green Published, hybrid			2022-12-25	WOS:000333472100017
J	Park, D; Jagtap, S; Nair, SK				Park, David; Jagtap, Sujit; Nair, Satish K.			Structure of a PL17 Family Alginate Lyase Demonstrates Functional Similarities among Exotype Depolymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Algae; Biofuel; Carbohydrate Processing; Enzyme Catalysis; Protein Structure; Alginate Lyase	CRYSTAL-STRUCTURE; OLIGOALGINATE LYASE; CLASSIFICATION; DEGRADATION; MECHANISM; CHECKING; CLONING	Background: Exotype polysaccharide lyases can cleave glycosidic bonds to catabolize complex carbohydrates into simple monosaccharides. Results: The first characterization of a family 17 polysaccharide lyase (PL17) provides insights into the mechanism of alginate depolymerization. Conclusion: The structure of a PL17 enzyme illustrates unexpected similarities to other polysaccharide lyases despite a lack of sequence conservation. Significance: These studies demonstrate an unexpected evolutionary relationship among the polysaccharide lyases. Brown macroalgae represent an ideal source for complex polysaccharides that can be utilized as precursors for cellulosic biofuels. The lack of recalcitrant lignin components in macroalgae polysaccharide reserves provides a facile route for depolymerization of constituent polysaccharides into simple monosaccharides. The most abundant sugars in macroalgae are alginate, mannitol, and glucan, and although several classes of enzymes that can catabolize the latter two have been characterized, studies of alginate-depolymerizing enzymes have lagged. Here, we present several crystal structures of Alg17c from marine bacterium Saccharophagus degradans along with structure-function characterization of active site residues that are suggested to be involved in the exolytic mechanism of alginate depolymerization. This represents the first structural and biochemical characterization of a family 17 polysaccharide lyase enzyme. Despite the lack of appreciable sequence conservation, the structure and -elimination mechanism for glycolytic bond cleavage by Alg17c are similar to those observed for family 15 polysaccharide lyases and other lyases. This work illuminates the evolutionary relationships among enzymes within this unexplored class of polysaccharide lyases and reinforces the notion of a structure-based hierarchy in the classification of these enzymes.	[Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Jagtap, Sujit] Univ Illinois, Dept Chem Engn, Urbana, IL 61801 USA; [Park, David; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Park, David; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 427 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.	snair@illinois.edu	Jagtap, Sujit/D-9092-2011; Nair, Satish/AAY-2510-2021	Jagtap, Sujit/0000-0001-9402-2259; 				Blanch HW, 2012, CURR OPIN BIOTECH, V23, P390, DOI 10.1016/j.copbio.2011.10.002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong W, 2012, PROTEIN CELL, V3, P950, DOI 10.1007/s13238-012-2056-z; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu G., 2013, ADV BIOCH ENG BIOTEC, DOI 10.1007/10_2013_245; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim HT, 2012, APPL MICROBIOL BIOT, V93, P2233, DOI 10.1007/s00253-012-3882-x; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kraiwattanapong J, 1997, BIOSCI BIOTECH BIOCH, V61, P1853, DOI 10.1271/bbb.61.1853; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee SJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00092; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Markou G, 2012, APPL MICROBIOL BIOT, V96, P631, DOI 10.1007/s00253-012-4398-0; Martin MA, 2010, NEW BIOTECHNOL, V27, P596, DOI 10.1016/j.nbt.2010.06.010; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Park HH, 2012, MAR BIOTECHNOL, V14, P189, DOI 10.1007/s10126-011-9402-7; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rye CS, 2006, CHEMBIOCHEM, V7, P631, DOI 10.1002/cbic.200500428; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289	33	62	71	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8645	8655		10.1074/jbc.M113.531111	http://dx.doi.org/10.1074/jbc.M113.531111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24478312	Green Published, hybrid			2022-12-25	WOS:000333157500054
J	Brzozowska, I; Zielenkiewicz, U				Brzozowska, Iwona; Zielenkiewicz, Urszula			The ClpXP Protease Is Responsible for the Degradation of the Epsilon Antidote to the Zeta Toxin of the Streptococcal pSM19035 Plasmid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent Protease; Microbiology; Protease; Protein Degradation; Streptococcus pyogenes	BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ANTITOXIN SYSTEM; CRYSTAL-STRUCTURE; LON PROTEASE; TRANSLATION; RESISTANCE; SEQUENCE; COMPLEX; GROWTH	Background: Epsilon is an antitoxin of the E/ toxin-antitoxin (TA) system family, which is widespread in pathogenic bacteria. Results:In vitro and in vivo degradation of the Epsilon protein is shown. Conclusion: ClpXP protease is responsible for the degradation of the Epsilon antitoxin. Significance: The first demonstration of in vitro degradation of the antitoxin from Gram-positive bacteria. Most bacterial genomes contain different types of toxin-antitoxin (TA) systems. The -E- proteinaceous type II TA cassette from the streptococcal pSM19035 plasmid is a member of the E/ family, which is commonly found in multiresistance plasmids and chromosomes of various human pathogens. Regulation of type II TA systems relies on the proteolysis of antitoxin proteins. Under normal conditions, the Epsilon antidote neutralizes the Zeta toxin through the formation of a tight complex. In this study, we show, using both in vivo and in vitro analyses, that the ClpXP protease is responsible for Epsilon antitoxin degradation. Using in vivo studies, we examined the stability of the plasmids with active or inactive -E- TA cassettes in B. subtilis mutants that were defective for different proteases. Using in vitro assays, the degradation of purified His(6)-Epsilon by the His(6)-Lon(Bs), ClpP(Bs), and ClpX(Bs) proteases from B. subtilis was analyzed. Additionally, we showed that purified Zeta toxin protects the Epsilon protein from rapid ClpXP-catalyzed degradation.	[Brzozowska, Iwona; Zielenkiewicz, Urszula] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zielenkiewicz, U (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Ul Pawinskiego 5A, PL-02106 Warsaw, Poland.	ulazet@ibb.waw.pl		Zielenkiewicz, Urszula/0000-0003-0615-7546				Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bakun M, 2009, PROTEOM CLIN APPL, V3, P932, DOI 10.1002/prca.200800111; BEHNKE D, 1979, PLASMID, V2, P605, DOI 10.1016/0147-619X(79)90058-1; BRANTL S, 1990, NUCLEIC ACIDS RES, V18, P4783, DOI 10.1093/nar/18.16.4783; BRON S, 1990, MOL BIOL METHODS BAC, P75; Brzozowska I, 2013, PLASMID, V70, P33, DOI 10.1016/j.plasmid.2013.01.007; Brzozowska I, 2012, PLASMID, V68, P51, DOI 10.1016/j.plasmid.2012.01.010; BURDETT V, 1982, J BACTERIOL, V149, P995, DOI 10.1128/JB.149.3.995-1004.1982; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Diago-Navarro E, 2013, PLASMID, V70, P78, DOI 10.1016/j.plasmid.2013.01.010; Dmowski M, 2006, J BACTERIOL, V188, P4362, DOI 10.1128/JB.01922-05; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; FRIEDMAN BM, 1983, MOL GEN GENET, V190, P481, DOI 10.1007/BF00331080; Gerth U, 1996, GENE, V181, P77, DOI 10.1016/S0378-1119(96)00467-2; Gerth U, 2004, J BACTERIOL, V186, P179, DOI 10.1128/JB.186.1.179-191.2004; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hansen S., 2012, PLOS ONE, V7; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Koga M, 2011, GENETICS, V187, P123, DOI 10.1534/genetics.110.121798; Kubik S, 2012, NUCLEIC ACIDS RES, V40, P1148, DOI 10.1093/nar/gkr813; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; Liu JJ, 1999, MOL MICROBIOL, V33, P415, DOI 10.1046/j.1365-2958.1999.01489.x; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; MSADEK T, 1994, P NATL ACAD SCI USA, V91, P5788, DOI 10.1073/pnas.91.13.5788; Msadek T, 1998, MOL MICROBIOL, V27, P899, DOI 10.1046/j.1365-2958.1998.00735.x; Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pachulec E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009962; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; ROBERTS RC, 1994, J MOL BIOL, V237, P35, DOI 10.1006/jmbi.1994.1207; ROTTLANDER E, 1970, MOL GEN GENET, V108, P47, DOI 10.1007/BF00343184; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; Smith ASG, 1998, J BACTERIOL, V180, P5458, DOI 10.1128/JB.180.20.5458-5462.1998; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005; Zielenkiewicz U, 2009, J BACTERIOL, V191, P3677, DOI 10.1128/JB.01763-08	61	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7514	7523		10.1074/jbc.M113.519488	http://dx.doi.org/10.1074/jbc.M113.519488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492616	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000332761500022
J	Chandrasekaran, P; Moore, V; Buckley, M; Spurrier, J; Kehrl, JH; Venkatesan, S				Chandrasekaran, Prabha; Moore, Victoria; Buckley, Monica; Spurrier, Joshua; Kehrl, John H.; Venkatesan, Sundararajan			HIV-1 Nef Down-Modulates C-C and C-X-C Chemokine Receptors via Ubiquitin and Ubiquitin-Independent Mechanism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; REGULATES MHC-I; TYPE-1 NEF; ENDOCYTIC PATHWAY; WW DOMAINS; MEMBRANE TRAFFICKING; ARRESTIN-2 INTERACTS; PERIPHERAL-TISSUES	Human and Simian Immunodeficiency virus (HIV-1, HIV-2, and SIV) encode an accessory protein, Nef, which is a pathogenesis and virulence factor. Nef is a multivalent adapter that dysregulates the trafficking of many immune cell receptors, including chemokine receptors (CKRs). Physiological endocytic itinerary of agonist occupied CXCR4 involves ubiquitinylation of the phosphorylated receptor at three critical lysine residues and dynamin-dependent trafficking through the ESCRT pathway into lysosomes for degradation. Likewise, Nef induced CXCR4 degradation was critically dependent on the three lysines in the C-terminal -SSLKILSKGK-motif. Nef directly recruits the HECT domain E3 ligases AIP4 or NEDD4 to CXCR4 in the resting state. This mechanism was confirmed by ternary interactions of Nef, CXCR4 and AIP4 or NEDD4; by reversal of Nef effect by expression of catalytically inactive AIP4-C830A mutant; and siRNA knockdown of AIP4, NEDD4 or some ESCRT-0 adapters. However, ubiquitinylation dependent lysosomal degradation was not the only mechanism by which Nef downregulated CKRs. Agonist and Nef mediated CXCR2 (and CXCR1) degradation was ubiquitinylation independent. Nef also profoundly downregulated the naturally truncated CXCR4 associated with WHIM syndrome and engineered variants of CXCR4 that resist CXCL12 induced internalization via an ubiquitinylation independent mechanism.	[Chandrasekaran, Prabha; Moore, Victoria; Buckley, Monica; Spurrier, Joshua; Venkatesan, Sundararajan] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Kehrl, John H.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Venkatesan, S (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sv1s@nih.gov	Kehrl, John/AAE-6292-2019	Spurrier, Joshua/0000-0002-6267-7231; Kehrl, John/0000-0002-6526-159X	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the Intramural Research Program of National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Arora VK, 2002, MICROBES INFECT, V4, P189, DOI 10.1016/S1286-4579(01)01527-1; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Baugher PJ, 2008, J BIOL CHEM, V283, P30868, DOI 10.1074/jbc.M804054200; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Casartelli N, 2003, J VIROL, V77, P11536, DOI 10.1128/JVI.77.21.11536-11545.2003; Chandrasekaran P, 2012, J BIOL CHEM, V287, P41481, DOI 10.1074/jbc.M112.361782; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen N, 2006, EUR J IMMUNOL, V36, P278, DOI 10.1002/eji.200535487; Chrobak P, 2010, J IMMUNOL, V185, P3948, DOI 10.4049/jimmunol.1001064; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; David Y, 2011, J BIOL CHEM, V286, P44104, DOI 10.1074/jbc.M111.234559; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Drakesmith H, 2005, P NATL ACAD SCI USA, V102, P11017, DOI 10.1073/pnas.0504823102; El-Far M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054295; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kawai T, 2005, EXP HEMATOL, V33, P460, DOI 10.1016/j.exphem.2005.01.001; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kuo LS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-47; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lama J, 2000, J VIROL, V74, P9396, DOI 10.1128/JVI.74.20.9396-9402.2000; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2009, METHOD ENZYMOL, V460, P413, DOI 10.1016/S0076-6879(09)05221-5; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Michel N, 2006, MOL BIOL CELL, V17, P3578, DOI 10.1091/mbc.E06-02-0117; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rose JJ, 2008, J BIOMED SCI, V15, P441, DOI 10.1007/s11373-008-9239-x; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shinya E, 2004, VIROLOGY, V326, P79, DOI 10.1016/j.virol.2004.06.004; Signoret N, 1998, J CELL SCI, V111, P2819; SKOWRONSKI J, 1993, EMBO J, V12, P703, DOI 10.1002/j.1460-2075.1993.tb05704.x; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2000, J VIROL, V74, P5691, DOI 10.1128/JVI.74.12.5691-5701.2000; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Vigerust DJ, 2005, J LEUKOCYTE BIOL, V77, P522, DOI 10.1189/jlb.0804454; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yamada T, 2003, J VIROL, V77, P1589, DOI 10.1128/JVI.77.2.1589-1594.2003; Yi L, 2010, J BIOL CHEM, V285, P30884, DOI 10.1074/jbc.M110.135947	104	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86998	10.1371/journal.pone.0086998	http://dx.doi.org/10.1371/journal.pone.0086998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489825	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000090
J	Schirer, Y; Malishkevich, A; Ophir, Y; Lewis, J; Giladi, E; Gozes, I				Schirer, Yulie; Malishkevich, Anna; Ophir, Yotam; Lewis, Jada; Giladi, Eliezer; Gozes, Illana			Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEUROFIBRILLARY TANGLES; SPLICING FACTORS; UP-REGULATION; GENE; BRAIN; EXPRESSION; INTERACTS; ISOFORMS; LOCALIZATION	Tauopathy, a major pathology in Alzheimer's disease, is also found in similar to 50% of frontotemporal dementias (FTDs). Tau transcript, a product of a single gene, undergoes alternative splicing to yield 6 protein species, each with either 3 or 4 microtubule binding repeat domains (tau 3R or 4R, associated with dynamic and stable microtubules, respectively). While the healthy human brain shows a 1/1 ratio of tau 3R/4R, this ratio may be dramatically changed in the FTD brain. We have previously discovered that activity-dependent neuroprotective protein (ADNP) is essential for brain formation in the mouse, with ADNP+/- mice exhibiting tauopathy, age-driven neurodegeneration and behavioral deficits. Here, in transgenic mice overexpressing a mutated tau 4R species, in the cerebral cortex but not in the cerebellum, we showed significantly increased ADNP expression (similar to 3-fold transcripts) in the cerebral cortex of young transgenic mice (similar to disease onset), but not in the cerebellum, as compared to control littermates. The transgene-age-related increased ADNP expression paralleled augmented dynamic tau 3R transcript level compared to control littermates. Blocking mutated tau 4R transgene expression resulted in normalization of ADNP and tau 3R expression. ADNP was previously shown to be a member of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex. Here, Brahma (Brm), a component of the SWI/SNF complex regulating alternative splicing, showed a similar developmental expression pattern to ADNP. Immunoprecipitations further suggested Brm-ADNP interaction coupled to ADNP - polypyrimidine tract-binding protein (PTB)-associated splicing factor (PSF)-binding, with PSF being a direct regulator of tau transcript splicing. It should be noted that although we have shown a correlation between levels of ADNP and tau isoform expression three months of age, we are not presenting evidence of a direct link between the two. Future research into ADNP/tau relations is warranted.	[Schirer, Yulie; Malishkevich, Anna; Ophir, Yotam; Giladi, Eliezer; Gozes, Illana] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem,Lily & Avraham Gil, Adams Super Ctr Brain Studies,Elton Lab Neuroendo, IL-69978 Tel Aviv, Israel; [Schirer, Yulie; Malishkevich, Anna; Ophir, Yotam; Giladi, Eliezer; Gozes, Illana] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Lewis, Jada] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; State University System of Florida; University of Florida	Gozes, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem,Lily & Avraham Gil, Adams Super Ctr Brain Studies,Elton Lab Neuroendo, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il			AMN Foundation; Montreal Circle of Friend; Joe and Grace Alter; Barbara and Don Seal; Oberfeld family; Adams family; Allon Therapeutics Inc.	AMN Foundation; Montreal Circle of Friend; Joe and Grace Alter; Barbara and Don Seal; Oberfeld family; Adams family; Allon Therapeutics Inc.	Support was provided by the AMN Foundation, Montreal Circle of Friend, Joe and Grace Alter, Barbara and Don Seal, the Oberfeld family and the Adams family and Allon Therapeutics Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboonq MS, 2012, J MOL NEUROSCI, V46, P33, DOI 10.1007/s12031-011-9562-y; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Antunes-Martins A, 2007, LEARN MEMORY, V14, P693, DOI 10.1101/lm.640307; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Borozdin Wiktor, 2007, Hum Mutat, V28, P830, DOI 10.1002/humu.9502; Braitch M, 2010, NEUROIMMUNOMODULAT, V17, P120, DOI 10.1159/000258695; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cohen-Armon M, 2006, CHEM BIODIVERS, V3, P535, DOI 10.1002/cbdv.200690057; Cosgrave AS, 2009, J MOL NEUROSCI, V39, P9, DOI 10.1007/s12031-008-9169-0; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Dresner E, 2011, EUR NEUROPSYCHOPHARM, V21, P355, DOI 10.1016/j.euroneuro.2010.06.004; Fernandez-Montesinos R, 2010, J MOL NEUROSCI, V41, P114, DOI 10.1007/s12031-009-9300-x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; de Barreda EG, 2010, FEBS LETT, V584, P2265, DOI 10.1016/j.febslet.2010.03.032; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gozes I, 2010, CURR ALZHEIMER RES, V7, P685, DOI 10.2174/156720510793611628; Gozes I, 2013, J ALZHEIMER IN PRESS; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Gozes I, 2008, J MOL NEUROSCI, V36, P115, DOI 10.1007/s12031-008-9105-3; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Ito T, 2008, BIOCHEM J, V411, P201, DOI 10.1042/BJ20071075; Jouroukhin Y, 2013, NEUROBIOL DIS; Kalbfuss B, 2001, J BIOL CHEM, V276, P42986, DOI 10.1074/jbc.M105113200; Ke YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035678; Lee BC, 1996, BLOOD, V87, P2283, DOI 10.1182/blood.V87.6.2283.bloodjournal8762283; Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013; Mandel S, 2008, J MOL NEUROSCI, V35, P127, DOI 10.1007/s12031-007-9013-y; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Monroy-Ramirez HC, 2013, J ALZHEIMERS DIS, V36, P503, DOI 10.3233/JAD-122401; Mosch K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015894; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051458; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Quraishe S, 2013, MOL PSYCHIATR, V18, P834, DOI 10.1038/mp.2013.32; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Ray P, 2011, J MOL NEUROSCI, V45, P453, DOI 10.1007/s12031-011-9634-z; Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shav-Tal Y, 2000, EXP HEMATOL, V28, P1029, DOI 10.1016/S0301-472X(00)00510-5; Shiryaev N, 2011, CURR PHARM DES; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tsukahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058749; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Yang MH, 2012, J PROTEOMICS, V75, P3617, DOI 10.1016/j.jprot.2012.04.017; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200	55	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87383	10.1371/journal.pone.0087383	http://dx.doi.org/10.1371/journal.pone.0087383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489906	Green Published, Green Submitted, gold			2022-12-25	WOS:000330570000139
J	Li, HY; Bu, Q; Chen, B; Shao, X; Hu, ZT; Deng, PC; Lv, L; Deng, Y; Zhu, RM; Li, Y; Zhang, BL; Hou, J; Du, CM; Zhao, Q; Fu, DQ; Zhao, YL; Cen, XB				Li, Hongyu; Bu, Qian; Chen, Bo; Shao, Xue; Hu, Zhengtao; Deng, Pengchi; Lv, Lei; Deng, Yi; Zhu, Ruiming; Li, Yan; Zhang, Baolai; Hou, Jing; Du, Changman; Zhao, Qian; Fu, Dengqi; Zhao, Yinglan; Cen, Xiaobo			Mechanisms of Metabonomic for a Gateway Drug: Nicotine Priming Enhances Behavioral Response to Cocaine with Modification in Energy Metabolism and Neurotransmitter Level	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; INDUCED DOPAMINE OVERFLOW; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; EXCITATORY INPUTS; BLOOD-GLUCOSE; LONG-TERM; EXPOSURE; BRAIN; REWARD	Nicotine, one of the most commonly used drugs, has become a major concern because tobacco serves as a gateway drug and is linked to illicit drug abuse, such as cocaine and marijuana. However, previous studies mainly focused on certain genes or neurotransmitters which have already been known to participate in drug addiction, lacking endogenous metabolic profiling in a global view. To further explore the mechanism by which nicotine modifies the response to cocaine, we developed two conditioned place preference (CPP) models in mice. In threshold dose model, mice were pretreated with nicotine, followed by cocaine treatment at the dose of 2 mg/kg, a threshold dose of cocaine to induce CPP in mice. In high-dose model, mice were only treated with 20 mg/kg cocaine, which induced a significant CPP. H-1 nuclear magnetic resonance based on metabonomics was used to investigate metabolic profiles of the nucleus accumbens (NAc) and striatum. We found that nicotine pretreatment dramatically increased CPP induced by 2 mg/kg cocaine, which was similar to 20 mg/kg cocaine-induced CPP. Interestingly, metabolic profiles showed considerable overlap between these two models. These overlapped metabolites mainly included neurotransmitters as well as the molecules participating in energy homeostasis and cellular metabolism. Our results show that the reinforcing effect of nicotine on behavioral response to cocaine may attribute to the modification of some specific metabolites in NAc and striatum, thus creating a favorable metabolic environment for enhancing conditioned rewarding effect of cocaine. Our findings provide an insight into the effect of cigarette smoking on cocaine dependence and the underlying mechanism.	[Li, Hongyu; Bu, Qian; Chen, Bo; Shao, Xue; Hu, Zhengtao; Lv, Lei; Deng, Yi; Zhu, Ruiming; Li, Yan; Zhang, Baolai; Hou, Jing; Du, Changman; Zhao, Qian; Fu, Dengqi; Zhao, Yinglan; Cen, Xiaobo] Sichuan Univ, Natl Chengdu Ctr Safety Evaluat Drugs, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Deng, Pengchi] Sichuan Univ, Analyt & Testing Ctr, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Cen, XB (corresponding author), Sichuan Univ, Natl Chengdu Ctr Safety Evaluat Drugs, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	xbcenalan@vip.sina.com			National Natural Sciences Foundation of China 483 [81271467, 30970938]; National Innovative Drug Development [2012ZX09302-004]	National Natural Sciences Foundation of China 483; National Innovative Drug Development	This work was supported by the Project of the National Natural Sciences Foundation of China 483 (81271467 and 30970938), and National Innovative Drug Development (2012ZX09302-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnwell S, 1984, INHIBITION UPTAKE AM, P101; Bechtholt AJ, 2002, PSYCHOPHARMACOLOGY, V162, P178, DOI 10.1007/s00213-002-1079-1; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BUCCAFUSCO JJ, 1995, PSYCHOPHARMACOLOGY, V120, P256, DOI 10.1007/BF02311172; CAMPFIELD LA, 1986, BRAIN RES BULL, V17, P427, DOI 10.1016/0361-9230(86)90250-9; Canis M, 2009, NEUROSCI RES, V64, P429, DOI 10.1016/j.neures.2009.04.017; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Collins SL, 2004, NEUROPHARMACOLOGY, V46, P349, DOI 10.1016/j.neuropharm.2003.09.024; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Debora E, 2011, LIPIDS HLTH DIS, V16, P18; Duarte I, 2013, MOL PHARM; Gao M, 2010, J NEUROSCI, V30, P13814, DOI 10.1523/JNEUROSCI.1943-10.2010; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hu ZT, 2012, BEHAV BRAIN RES, V231, P11, DOI 10.1016/j.bbr.2012.02.026; Itzhak Y, 1998, NEUROREPORT, V9, P2485, DOI 10.1097/00001756-199808030-00011; Ivanov A, 2011, FRONTIERS NEUROENERG, V3; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Jutkiewicz EM, 2008, PSYCHOPHARMACOLOGY, V200, P93, DOI 10.1007/s00213-008-1159-y; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; KANDEL D, 1975, SCIENCE, V190, P912, DOI 10.1126/science.1188374; Kelley BM, 1999, J ADDICT DIS, V18, P27, DOI 10.1300/J069v18n03_04; Kelley BM, 2004, INT J DEV NEUROSCI, V22, P339, DOI 10.1016/j.ijdevneu.2004.04.002; Khan AR, 2011, INT J RADIAT BIOL, V87, P91, DOI 10.3109/09553002.2010.518211; Lan MJ, 2009, MOL PSYCHIATR, V14, P269, DOI 10.1038/sj.mp.4002130; Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P731, DOI 10.1016/j.ntt.2004.06.010; LEVIN L, 1983, EUR J CANCER CLIN ON, V19, P711, DOI 10.1016/0277-5379(83)90002-0; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Li Y, 2012, NEUROSCIENCE, V218, P196, DOI 10.1016/j.neuroscience.2012.05.019; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Macallan DC, 1998, CLIN SCI, V94, P321, DOI 10.1042/cs0940321; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mao DY, 2011, J NEUROSCI, V31, P6710, DOI 10.1523/JNEUROSCI.5671-10.2011; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McFarland K, 2003, J NEUROSCI, V23, P3531; McMillen BA, 2005, EUR J PHARMACOL, V509, P161, DOI 10.1016/j.ejphar.2005.01.002; O'DONNELL J A, 1979, National Institute on Drug Abuse Research Monograph, P30; Patkar AA, 2009, PSYCHOPHARMACOLOGY, V206, P479, DOI 10.1007/s00213-009-1625-1; Pears MR, 2005, J BIOL CHEM, V280, P42508, DOI 10.1074/jbc.M507380200; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; RITTER RC, 1981, SCIENCE, V213, P451, DOI 10.1126/science.6264602; Rothman RB, 2006, TRENDS PHARMACOL SCI, V27, P612, DOI 10.1016/j.tips.2006.10.006; Salas R, 2008, NEUROSCI LETT, V440, P32, DOI 10.1016/j.neulet.2008.05.038; Salek RM, 2008, NEUROCHEM RES, V33, P292, DOI 10.1007/s11064-007-9542-3; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sun LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060598; Sziraki I, 1999, ANN NY ACAD SCI, V877, P800, DOI 10.1111/j.1749-6632.1999.tb09326.x; Tian WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033435; TORABI MR, 1993, J SCHOOL HEALTH, V63, P302, DOI 10.1111/j.1746-1561.1993.tb06150.x; Uys JD, 2008, CNS NEUROL DISORD-DR, V7, P482, DOI 10.2174/187152708786927868; Willuhn I, 2012, P NATL ACAD SCI USA, V109, P20703, DOI 10.1073/pnas.1213460109; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Yao JK, 2005, MOL NEUROBIOL, V31, P193, DOI 10.1385/MN:31:1-3:193; Zernig G, 1997, EUR J PHARMACOL, V337, P1, DOI 10.1016/S0014-2999(97)01184-9; Zhang XR, 2009, NEUROCHEM INT, V54, P481, DOI 10.1016/j.neuint.2009.02.004	59	26	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87040	10.1371/journal.pone.0087040	http://dx.doi.org/10.1371/journal.pone.0087040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489831	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000100
J	Kurka, H; Ehrenreich, A; Ludwig, W; Monot, M; Rupnik, M; Barbut, F; Indra, A; Dupuy, B; Liebl, W				Kurka, Hedwig; Ehrenreich, Armin; Ludwig, Wolfgang; Monot, Marc; Rupnik, Maja; Barbut, Frederic; Indra, Alexander; Dupuy, Bruno; Liebl, Wolfgang			Sequence Similarity of Clostridium difficile Strains by Analysis of Conserved Genes and Genome Content Is Reflected by Their Ribotype Affiliation	PLOS ONE			English	Article							IDENTIFICATION; EVOLUTION; MARKERS; DNA	PCR-ribotyping is a broadly used method for the classification of isolates of Clostridium difficile, an emerging intestinal pathogen, causing infections with increased disease severity and incidence in several European and North American countries. We have now carried out clustering analysis with selected genes of numerous C. difficile strains as well as gene content comparisons of their genomes in order to broaden our view of the relatedness of strains assigned to different ribotypes. We analyzed the genomic content of 48 C. difficile strains representing 21 different ribotypes. The calculation of distance matrix-based dendrograms using the neighbor joining method for 14 conserved genes (standard phylogenetic marker genes) from the genomes of the C. difficile strains demonstrated that the genes from strains with the same ribotype generally clustered together. Further, certain ribotypes always clustered together and formed ribotype groups, i.e. ribotypes 078, 033 and 126, as well as ribotypes 002 and 017, indicating their relatedness. Comparisons of the gene contents of the genomes of ribotypes that clustered according to the conserved gene analysis revealed that the number of common genes of the ribotypes belonging to each of these three ribotype groups were very similar for the 078/033/126 group (at most 69 specific genes between the different strains with the same ribotype) but less similar for the 002/017 group (86 genes difference). It appears that the ribotype is indicative not only of a specific pattern of the amplified 16S-23S rRNA intergenic spacer but also reflects specific differences in the nucleotide sequences of the conserved genes studied here. It can be anticipated that the sequence deviations of more genes of C. difficile strains are correlated with their PCR-ribotype. In conclusion, the results of this study corroborate and extend the concept of clonal C. difficile lineages, which correlate with ribotypes affiliation.	[Kurka, Hedwig; Ehrenreich, Armin; Ludwig, Wolfgang; Liebl, Wolfgang] Tech Univ Munich, Dept Microbiol, Freising Weihenstephan, Germany; [Monot, Marc; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Rupnik, Maja] Inst Publ Hlth Maribor, Ljubljana, Slovenia; [Rupnik, Maja] Univ Maribor, Fac Med, Ljubljana, Slovenia; [Rupnik, Maja] Ctr Excellence Cipkebip, Ljubljana, Slovenia; [Barbut, Frederic] Fac Med Pierre & Marie Curie, Natl Reference Lab Clostridium Difficile, Paris, France; [Barbut, Frederic] Hop St Antoine, AP HP, F-75571 Paris, France; [Indra, Alexander] AGES Austrian Agcy Hlth & Food Safety, Inst Med Microbiol & Hyg, Vienna, Austria	Technical University of Munich; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Maribor; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Liebl, W (corresponding author), Tech Univ Munich, Dept Microbiol, Freising Weihenstephan, Germany.	wliebl@wzw.tum.de	Barbut, frederic/AAF-4952-2021; Liebl, Wolfgang/D-3766-2014; Monot, Marc/F-3058-2015	Liebl, Wolfgang/0000-0002-8421-2478; Monot, Marc/0000-0003-0738-7335; Ehrenreich, Armin/0000-0001-9580-3620	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support of this work (collaborative project CDIFFGEN - Pathogenomics of increased Clostridium difficile virulence) within the framework ERA-NET PathoGenoMics 2 by the German Federal Ministry of Education and Research (BMBF) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barbut F, 2012, CLIN INFECT DIS, V55, P1669, DOI 10.1093/cid/cis790; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Cheknis AK, 2009, ANAEROBE, V15, P230, DOI 10.1016/j.anaerobe.2009.09.001; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Gorbach SL, 1999, NEW ENGL J MED, V341, P1690, DOI 10.1056/NEJM199911253412211; He M, 2012, NAT GENET; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Indra A, 2010, J MED MICROBIOL, V59, P1317, DOI 10.1099/jmm.0.020792-0; Janezic S, 2010, SPRINGER PROTOCOLS M; Knetsch CW, 2013, EUROSURVEILLANCE, V18, P57; Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003; Knetsch CW, 2011, MICROBIOL-SGM, V157, P3113, DOI 10.1099/mic.0.051953-0; Kuijper EJ, 2009, METHODS MOL BIOL, V551, P159, DOI 10.1007/978-1-60327-999-4_13; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W, 2010, MOLECULAR PHYLOGENY OF MICROORGANISMS, P65; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86535	10.1371/journal.pone.0086535	http://dx.doi.org/10.1371/journal.pone.0086535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24482682	Green Published, gold			2022-12-25	WOS:000330288000108
J	Esteve, PO; Terragni, J; Deepti, K; Chin, HG; Dai, N; Espejo, A; Correa, IR; Bedford, MT; Pradhan, S				Esteve, Pierre-Olivier; Terragni, Jolyon; Deepti, Kanneganti; Chin, Hang Gyeong; Dai, Nan; Espejo, Alexsandra; Correa, Ivan R., Jr.; Bedford, Mark T.; Pradhan, Sriharsa			Methyllysine Reader Plant Homeodomain ( PHD) Finger Protein 20-like 1 ( PHF20L1) Antagonizes DNA ( Cytosine-5) Methyltransferase 1 ( DNMT1) Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Methylation; DNA Methyltransferase; Protein Degradation; Protein Methylation; MBT Domain; PHF20L1; SET7; UNC1215	RIBOSOMAL-RNA GENES; LYSINE METHYLATION; MAMMALIAN-CELLS; HISTONE H3; DE-NOVO; MAINTENANCE; STABILITY; DOMAIN; UBIQUITINATION; ESTABLISHMENT	Background: SET7 monomethylates DNMT1, promoting its proteasomal degradation, yet methylated DNMT1 still remains throughout the cell cycle. Results: The methyllysine reader PHF20L1 stabilizes methylated DNMT1. Disruption of PHF20L1 induces DNMT1 degradation and genome hypomethylation. Conclusion: PHF20L1, an epigenetic reader, cooperates with writer and eraser to regulate epigenetic inheritance. Significance: PHF20L1 can be targeted as a means of regulating DNMT1 activity and DNA methylation in cells. Inheritance of DNA cytosine methylation pattern during successive cell division is mediated by maintenance DNA (cytosine-5) methyltransferase 1 (DNMT1). Lysine 142 of DNMT1 is methylated by the SET domain containing lysine methyltransferase 7 (SET7), leading to its degradation by proteasome. Here we show that PHD finger protein 20-like 1 (PHF20L1) regulates DNMT1 turnover in mammalian cells. Malignant brain tumor (MBT) domain of PHF20L1 binds to monomethylated lysine 142 on DNMT1 (DNMT1K142me1) and colocalizes at the perinucleolar space in a SET7-dependent manner. PHF20L1 knockdown by siRNA resulted in decreased amounts of DNMT1 on chromatin. Ubiquitination of DNMT1K142me1 was abolished by overexpression of PHF20L1, suggesting that its binding may block proteasomal degradation of DNMT1K142me1. Conversely, siRNA-mediated knockdown of PHF20L1 or incubation of a small molecule MBT domain binding inhibitor in cultured cells accelerated the proteasomal degradation of DNMT1. These results demonstrate that the MBT domain of PHF20L1 reads and controls enzyme levels of methylated DNMT1 in cells, thus representing a novel antagonist of DNMT1 degradation.	[Esteve, Pierre-Olivier; Terragni, Jolyon; Deepti, Kanneganti; Chin, Hang Gyeong; Dai, Nan; Correa, Ivan R., Jr.; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Espejo, Alexsandra; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	New England Biolabs; University of Texas System; UTMD Anderson Cancer Center	Pradhan, S (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	pradhan@neb.com	Kalra, D/H-6661-2019; Dai, Nan/I-5950-2013	Kalra, D/0000-0001-5254-4067; Espejo, Alexsandra/0000-0002-8841-7219; Correa, Ivan/0000-0002-3169-6878	New England Biolabs, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023206] Funding Source: NIH RePORTER	New England Biolabs, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Richard J. Roberts, Dr. William Jack, James V. Ellard, Dr. Donald G. Comb, and New England Biolabs, Inc., for research support.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BESTOR TH, 1985, P NATL ACAD SCI USA, V82, P2674, DOI 10.1073/pnas.82.9.2674; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chen T, 2006, CURR TOP MICROBIOL, V301, P179; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Cui GF, 2012, NAT STRUCT MOL BIOL, V19, P916, DOI 10.1038/nsmb.2353; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fortschegger K, 2011, EPIGENETICS-US, V6, P4, DOI 10.4161/epi.6.1.13297; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Guan D, 2013, ONCOGENE, V32, P3819, DOI 10.1038/onc.2012.406; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI LH, 1970, CANCER RES, V30, P2760; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	43	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8277	8287		10.1074/jbc.M113.525279	http://dx.doi.org/10.1074/jbc.M113.525279			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492612	Green Published, hybrid			2022-12-25	WOS:000333157500022
J	Kobe, MJ; Neau, DB; Mitchell, CE; Bartlett, SG; Newcomer, ME				Kobe, Matthew J.; Neau, David B.; Mitchell, Caitlin E.; Bartlett, Sue G.; Newcomer, Marcia E.			The Structure of Human 15-Lipoxygenase-2 with a Substrate Mimic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Eicosanoid-specific Enzymes; Fatty Acid Oxidation; Lipoxygenase Pathway; Protein Structure	INDUCED ATHEROSCLEROSIS; LIPOXYGENASE; MACROPHAGES; DOMAIN; 15S-LIPOXYGENASE; OXYGENATION; EXPRESSION; MEDIATORS; NANODISCS; SUGGESTS	Background: 15-Lipoxygenase-2 is linked to atherosclerotic plaque formation; the homologous enzyme 5-lipoxygenase initiates the synthesis of proinflammatory leukotrienes. Results: We determined the crystal structure of 15-LOX-2 in the presence of a substrate mimic. Conclusion: 15-Lipoxygenase-2 and 5-lipoxgenase display active site variations that confer distinct product specificities. Significance: These differences can be exploited for the design of isoform-specific anti-inflammatories. Atherosclerosis is associated with chronic inflammation occurring over decades. The enzyme 15-lipoxygenase-2 (15-LOX-2) is highly expressed in large atherosclerotic plaques, and its activity has been linked to the progression of macrophages to the lipid-laden foam cells present in atherosclerotic plaques. We report here the crystal structure of human 15-LOX-2 in complex with an inhibitor that appears to bind as a substrate mimic. 15-LOX-2 contains a long loop, composed of hydrophobic amino acids, which projects from the amino-terminal membrane-binding domain. The loop is flanked by two Ca2+-binding sites that confer Ca2+-dependent membrane binding. A comparison of the human 15-LOX-2 and 5-LOX structures reveals similarities at the active sites, as well striking differences that can be exploited for design of isoform-selective inhibitors.	[Kobe, Matthew J.; Mitchell, Caitlin E.; Bartlett, Sue G.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Argonne National Laboratory	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu			Louisiana Governors' Biotechnology Initiative; Beam Line 24-ID-E of Northeastern Collaborative Access Team's at the Advanced Photon Source; NIGMS at the National Institutes of Health. Use of the Advanced Photon Source; U.S. DOE [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	Louisiana Governors' Biotechnology Initiative; Beam Line 24-ID-E of Northeastern Collaborative Access Team's at the Advanced Photon Source; NIGMS at the National Institutes of Health. Use of the Advanced Photon Source; U.S. DOE(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alan Brash for helpful discussions throughout the course of this work. X-ray data were collected at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative, and at Beam Line 24-ID-E of Northeastern Collaborative Access Team's at the Advanced Photon Source, supported by award P41 GM103403 from the NIGMS at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.	Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Bocan TMA, 1998, ATHEROSCLEROSIS, V136, P203, DOI 10.1016/S0021-9150(97)00204-9; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Cleland W W, 1979, Methods Enzymol, V63, P103; Coffa G, 2004, P NATL ACAD SCI US; Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Hutchins PM, 2012, J LIPID RES, V53, P1588, DOI 10.1194/jlr.M026799; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Magnusson LU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043142; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Wuest SJA, 2012, ATHEROSCLEROSIS, V225, P121, DOI 10.1016/j.atherosclerosis.2012.07.022; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	35	74	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8562	8569		10.1074/jbc.M113.543777	http://dx.doi.org/10.1074/jbc.M113.543777			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497644	Green Published, hybrid			2022-12-25	WOS:000333157500046
J	Perrett, RM; Voliotis, M; Armstrong, SP; Fowkes, RC; Pope, GR; Tsaneva-Atanasova, K; McArdle, CA				Perrett, Rebecca M.; Voliotis, Margaritis; Armstrong, Stephen P.; Fowkes, Robert C.; Pope, George R.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Pulsatile Hormonal Signaling to Extracellular Signal-regulated Kinase EXPLORING SYSTEM SENSITIVITY TO GONADOTROPIN-RELEASING HORMONE PULSE FREQUENCY AND WIDTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; ERK; MAP Kinases (MAPKs); Mathematical Modeling; Receptors; GnRH	ACTIVATED PROTEIN-KINASE; DIFFERENTIAL REGULATION; SPATIOTEMPORAL REGULATION; ELECTRICAL-ACTIVITY; SUBUNIT GENES; RECEPTOR; GNRH; PITUITARY; DURATION; CALCIUM	Background: Cellular decoding of stimulus dynamics is poorly understood. Results: GnRH pulses activate ERK, and response kinetics determine sensitivity to different pulse features. Conclusion: The system is sensitive to pulse frequency but robust to width; this distinction develops through the cascade and is dictated by response kinetics. Significance: We describe mathematical and biochemical design features for pulsatile hormonal signaling. Gonadotropin-releasing hormone (GnRH) is secreted in brief pulses that stimulate synthesis and secretion of pituitary gonadotropin hormones and thereby mediate control of reproduction. It acts via G-protein-coupled receptors to stimulate effectors, including ERK. Information could be encoded in GnRH pulse frequency, width, amplitude, or other features of pulse shape, but the relative importance of these features is unknown. Here we examine this using automated fluorescence microscopy and mathematical modeling, focusing on ERK signaling. The simplest scenario is one in which the system is linear, and response dynamics are relatively fast (compared with the signal dynamics). In this case integrated system output (ERK activation or ERK-driven transcription) will be roughly proportional to integrated input, but we find that this is not the case. Notably, we find that relatively slow response kinetics lead to ERK activity beyond the GnRH pulse, and this reduces sensitivity to pulse width. More generally, we show that the slowing of response kinetics through the signaling cascade creates a system that is robust to pulse width. We, therefore, show how various levels of response kinetics synergize to dictate system sensitivity to different features of pulsatile hormone input. We reveal the mathematical and biochemical basis of a dynamic GnRH signaling system that is robust to changes in pulse amplitude and width but is sensitive to changes in receptor occupancy and frequency, precisely the features that are tightly regulated and exploited to exert physiological control in vivo.	[Perrett, Rebecca M.; Armstrong, Stephen P.; Pope, George R.; McArdle, Craig A.] Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Voliotis, Margaritis] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Fowkes, Robert C.] Univ London Royal Vet Coll, Endocrine Signaling Grp, London NW1 0TU, England; [Tsaneva-Atanasova, Krasimira] Univ Exeter, Coll Engn Math & Phys Sci, Dept Math, Exeter EX4 4QF, Devon, England	University of Bristol; University of Bristol; University of London; University of London Royal Veterinary College; University of Exeter	McArdle, CA (corresponding author), Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Fowkes, Robert/HHT-0664-2022; Fowkes, Robert/AAI-4756-2020; McArdle, Craig/AAQ-5660-2021	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Fowkes, Robert/0000-0002-2222-2056; McArdle, Craig/0000-0003-4836-5351; Voliotis, Margaritis/0000-0001-6488-7198	Medical Research Council [G0901763]; Biochemical and Biophysical Science Research Council [BB/J014699/1]; Medical Research Council Biomedical Informatics Fellowship [MR/K021826/1]; BBSRC [BB/J014699/1] Funding Source: UKRI; MRC [G0901763, MR/K021826/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014699/1] Funding Source: researchfish; Medical Research Council [MR/K021826/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biochemical and Biophysical Science Research Council; Medical Research Council Biomedical Informatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grant G0901763 and Biochemical and Biophysical Science Research Council Grant BB/J014699/1.; Recipient of a Medical Research Council Biomedical Informatics Fellowship (MR/K021826/1).	Armstrong SP, 2011, MOL CELL ENDOCRINOL, V331, P194, DOI 10.1016/j.mce.2010.07.008; Armstrong SP, 2010, J BIOL CHEM, V285, P24360, DOI 10.1074/jbc.M110.115964; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; BARRELL GK, 1992, BIOL REPROD, V46, P1130, DOI 10.1095/biolreprod46.6.1130; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; CARDENAS H, 1993, P NATL ACAD SCI USA, V90, P9630, DOI 10.1073/pnas.90.20.9630; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040077; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; CLAYTON RN, 1981, ENDOCR REV, V2, P186, DOI 10.1210/edrv-2-2-186; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Durham PL, 2000, MOL ENDOCRINOL, V14, P1570, DOI 10.1210/me.14.10.1570; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Haisenleder DJ, 1998, ENDOCRINOLOGY, V139, P3104, DOI 10.1210/en.139.7.3104; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marshall J C, 1993, Trans Am Clin Climatol Assoc, V104, P31; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; MOENTER SM, 1992, ENDOCRINOLOGY, V130, P503, DOI 10.1210/en.130.1.503; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; OBYRNE KT, 1993, NEUROENDOCRINOLOGY, V57, P588, DOI 10.1159/000126411; Padmanabhan V, 2003, ENDOCRINOLOGY, V144, P1380, DOI 10.1210/en.2002-220973; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; SAVOYMOORE RT, 1980, SCIENCE, V209, P942, DOI 10.1126/science.6250218; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Tsaneva-Atanasova K, 2012, J R SOC INTERFACE, V9, P170, DOI 10.1098/rsif.2011.0215; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; WILLIAMS CL, 1990, P NATL ACAD SCI USA, V87, P8580, DOI 10.1073/pnas.87.21.8580	42	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7873	7883		10.1074/jbc.M113.532473	http://dx.doi.org/10.1074/jbc.M113.532473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482225	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000332761500052
J	Cai, ZGG; Wang, RM				Cai, Zhenguang G.; Wang, Ruiming			Numerical Magnitude Affects Temporal Memories but Not Time Encoding	PLOS ONE			English	Article							INTERNAL CLOCK; SPEEDING-UP; HUMANS; SPACE; DURATION; PERCEPTION; THINK	Previous research has suggested that the perception of time is influenced by concurrent magnitude information (e. g., numerical magnitude in digits, spatial distance), but the locus of the effect is unclear, with some findings suggesting that concurrent magnitudes such as space affect temporal memories and others suggesting that numerical magnitudes in digits affect the clock speed during time encoding. The current paper reports 6 experiments in which participants perceived a stimulus duration and then reproduced it. We showed that though a digit of a large magnitude (e. g., 9), relative to a digit of a small magnitude (e. g., 2), led to a longer reproduced duration when the digits were presented during the perception of the stimulus duration, such a magnitude effect disappeared when the digits were presented during the reproduction of the stimulus duration. These findings disconfirm the account that large numerical magnitudes accelerate the speed of an internal clock during time encoding, as such an account incorrectly predicts that a large numerical magnitude should lead to a shorter reproduced duration when presented during reproduction. Instead, the findings suggest that numerical magnitudes, like other magnitudes such as space, affect temporal memories when numerical magnitudes and temporal durations are concurrently held in memory. Under this account, concurrent numerical magnitudes have the chance to influence the memory of the perceived duration when they are presented during perception but not when they are presented at the reproduction stage.	[Cai, Zhenguang G.] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Wang, Ruiming] S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China	University of Plymouth; South China Normal University	Cai, ZGG (corresponding author), Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England.	zhenguangcai@gmal.com	Cai, Zhenguang G/B-3765-2016	Cai, Zhenguang G/0000-0002-4097-6038	National Excellent Doctoral Dissertation of P. R. China [201204]; Ministry of Education of P. R. China [13JJD190006]	National Excellent Doctoral Dissertation of P. R. China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Ministry of Education of P. R. China(Ministry of Education, China)	The research was supported by the National Excellent Doctoral Dissertation of P. R. China (201204) and a humanities and social science research base project from the Ministry of Education of P. R. China (13JJD190006), both to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bausenhart KM, 2014, ACTA PSYCHO IN PRESS; Block RA, 2008, PSYCHOLOGY OF TIME, P367, DOI 10.1016/B978-0-08046-977-5.00012-0; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cai ZGG, 2013, PSYCHON B REV, V20, P973, DOI 10.3758/s13423-013-0414-3; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chang AYC, 2011, PSYCHOL SCI, V22, P1567, DOI 10.1177/0956797611418837; DELONG AJ, 1981, SCIENCE, V213, P681, DOI 10.1126/science.7256273; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Grondin S, 2005, J EXP PSYCHOL HUMAN, V31, P869, DOI 10.1037/0096-1523.31.5.869; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gu BM, 2011, LECT NOTES ARTIF INT, V6789, P67, DOI 10.1007/978-3-642-21478-3_6; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Jones LA, 2004, Q J EXP PSYCHOL-B, V57, P55, DOI 10.1080/02724990344000088; Lejeune H, 2009, EUR J COGN PSYCHOL, V21, P941, DOI 10.1080/09541440802453006; MARICQ AV, 1983, PSYCHOPHARMACOLOGY, V79, P10, DOI 10.1007/BF00433008; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; MECK WH, 1987, BEHAV NEUROSCI, V101, P465, DOI 10.1037/0735-7044.101.4.465; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; Merritt DJ, 2010, COGNITION, V117, P191, DOI 10.1016/j.cognition.2010.08.011; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Ortega L, 2008, BEHAV PROCESS, V78, P380, DOI 10.1016/j.beproc.2008.02.004; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wearden JH, 2007, Q J EXP PSYCHOL, V60, P1616, DOI 10.1080/17470210601121916; Wearden JH, 1999, BEHAV PROCESS, V45, P3, DOI 10.1016/S0376-6357(99)00006-6; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wearden JH, 1999, BEHAV PROCESS, V46, P63, DOI 10.1016/S0376-6357(99)00004-2; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	34	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e83159	10.1371/journal.pone.0083159	http://dx.doi.org/10.1371/journal.pone.0083159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489646	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000330570000006
J	Chen, M; Ma, YL; Su, YZ; Yang, L; Zhang, RZ; Yang, CJ; Chen, HC; Yan, WY; Shi, YH; Dong, LJ; Chen, L; Jia, MH; Lu, L				Chen, Min; Ma, Yanling; Su, Yingzhen; Yang, Li; Zhang, Renzhong; Yang, Chaojun; Chen, Huichao; Yan, Wenyun; Shi, Yuhua; Dong, Lijuan; Chen, Ling; Jia, Manhong; Lu, Lin			HIV-1 Genetic Characteristics and Transmitted Drug Resistance among Men Who Have Sex with Men in Kunming, China	PLOS ONE			English	Article							CIRCULATING RECOMBINANT; TYPE-1; YUNNAN; PREVALENCE; EPIDEMIC; SUBTYPES; TRANSMISSION; POPULATION; CHALLENGES; DIVERSITY	Background: Yunnan has been severely affected by HIV/AIDS in China. Recently, the reported prevalence of HIV-1 among men who have sex with men (MSM) in Yunnan was high in China. To monitor dynamic HIV-1 epidemic among Yunnan MSM, HIV-1 genetic characteristics and transmitted drug resistance (TDR) were investigated. Methods: Blood samples from 131 newly HIV-1 diagnosed MSM were continuously collected at fixed sites from January 2010 to December 2012 in Kunming City, Yunnan Province. Partial gag, pol and env genes were sequenced. Phylogenetic, evolutionary and genotypic drug resistance analyses were performed. Results: Multiple genotypes were identified among MSM in Kunming, including CRF01_AE (64.9%), CRF07_BC (25.2%), unique recombinant forms (URFs, 5.3%), subtype B (3.1%) and CRF08_BC (1.5%). CRF01_AE and CRF07_BC were the predominant strains. The mean of genetic distance within CRF01_AE were larger than that within CRF07_BC. The estimated introducing time of CRF01_AE in Yunnan MSM (1996.9) is earlier than that of CRF07_BC (2002.8). In this study, subtype B was first identified in Yunnan MSM. CRF08_BC seems to be the distinctive strain in Yunnan MSM, which was seldom found among MSM outside Yunnan. The proportion of URFs increased, which further contributed to genetic diversity among MSM. Strikingly, genetic relatedness was found among these strains with MSM isolates from multiple provinces, which suggested that a nationwide transmission network may exist. TDR-associated mutations were identified in 4.6% individuals. The multivariate analysis revealed that non-native MSM and divorced/widowed MSM were independently associated with a higher TDR rate. Conclusion: This work revealed diverse HIV-1 genetics, national transmission networks and a baseline level of TDR in MSM. These findings enhance our understanding of the distribution and evolution of HIV-1 in MSM, and are valuable for developing HIV prevention strategies for MSM.	[Chen, Min; Ma, Yanling; Su, Yingzhen; Yang, Li; Zhang, Renzhong; Yang, Chaojun; Chen, Huichao; Yan, Wenyun; Shi, Yuhua; Dong, Lijuan; Chen, Ling; Jia, Manhong; Lu, Lin] Yunnan Ctr Dis Control & Prevent, Ctr AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China; [Lu, Lin] Kunming Med Univ, Coll Publ Hlth, Kunming, Yunnan, Peoples R China	Kunming Medical University	Jia, MH (corresponding author), Yunnan Ctr Dis Control & Prevent, Ctr AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China.	jiamanhong@hotmail.com; lulin@yncdc.cn	MA, YAN/HHN-2912-2022		Major Project of China's "Twelfth Five-Year Plan" for Science and Technology Development [2011ZX10004-903, 2012ZX10001006]	Major Project of China's "Twelfth Five-Year Plan" for Science and Technology Development	This work was supported by the Major Project of China's "Twelfth Five-Year Plan" for Science and Technology Development (2011ZX10004-903) and (2012ZX10001006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Chen Min, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P75; CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; China Ministry of Health UNAIDS WHO, 2012, CHIN J AIDS STD, V18, P1; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Han XX, 2013, JAIDS-J ACQ IMM DEF, V64, P16, DOI 10.1097/QAI.0b013e3182932210; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Li L, 2012, AIDS RES HUM RETROVI; Li L, 2012, AIDS RES HUM RETROV, V28, P947, DOI [10.1089/aid.2011.0379, 10.1089/AID.2011.0379]; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li Z, 2010, J KUNMING MED U, V10, P127; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Yan-ling, 2008, Zhonghua Yufang Yixue Zazhi, V42, P892; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meng ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052373; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Weber J, 2010, AIDS, V24, pS27, DOI 10.1097/01.aids.0000390705.73759.2c; Wu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054322; Xu JJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-3; Yang ChaoJun, 2011, Modern Preventive Medicine, V38, P686; Yang J, 2013, ARCH VIROL, V158, P839, DOI 10.1007/s00705-012-1557-7; YAO J, 2002, CHIN J STD AIDS PREV, V8, P131; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422; Yun K, 2011, SEX TRANSM INFECT, V87, P563, DOI 10.1136/sextrans-2011-050079; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]; Zhao Guang-lu, 2012, Zhonghua Yi Xue Za Zhi, V92, P1165	42	23	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87033	10.1371/journal.pone.0087033	http://dx.doi.org/10.1371/journal.pone.0087033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489829	gold, Green Submitted, Green Published			2022-12-25	WOS:000330570000093
J	Zografou, K; Kati, V; Grill, A; Wilson, RJ; Tzirkalli, E; Pamperis, LN; Halley, JM				Zografou, Konstantina; Kati, Vassiliki; Grill, Andrea; Wilson, Robert J.; Tzirkalli, Elli; Pamperis, Lazaros N.; Halley, John M.			Signals of Climate Change in Butterfly Communities in a Mediterranean Protected Area	PLOS ONE			English	Article							SPECIES RICHNESS; MULTIVARIATE ANALYSES; ECOLOGICAL STRUCTURE; DADIA RESERVE; CONSERVATION; HABITAT; DIVERSITY; BIODIVERSITY; LANDSCAPE; RANGE	The European protected-area network will cease to be efficient for biodiversity conservation, particularly in the Mediterranean region, if species are driven out of protected areas by climate warming. Yet, no empirical evidence of how climate change influences ecological communities in Mediterranean nature reserves really exists. Here, we examine long-term (1998-2011/2012) and short-term (2011-2012) changes in the butterfly fauna of Dadia National Park (Greece) by revisiting 21 and 18 transects in 2011 and 2012 respectively, that were initially surveyed in 1998. We evaluate the temperature trend for the study area for a 22-year-period (1990-2012) in which all three butterfly surveys are included. We also assess changes in community composition and species richness in butterfly communities using information on (a) species' elevational distributions in Greece and (b) Community Temperature Index (calculated from the average temperature of species' geographical ranges in Europe, weighted by species' abundance per transect and year). Despite the protected status of Dadia NP and the subsequent stability of land use regimes, we found a marked change in butterfly community composition over a 13 year period, concomitant with an increase of annual average temperature of 0.95 degrees C. Our analysis gave no evidence of significant year-to-year (2011-2012) variability in butterfly community composition, suggesting that the community composition change we recorded is likely the consequence of long-term environmental change, such as climate warming. We observe an increased abundance of low-elevation species whereas species mainly occurring at higher elevations in the region declined. The Community Temperature Index was found to increase in all habitats except agricultural areas. If equivalent changes occur in other protected areas and taxonomic groups across Mediterranean Europe, new conservation options and approaches for increasing species' resilience may have to be devised.	[Zografou, Konstantina; Tzirkalli, Elli; Halley, John M.] Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece; [Kati, Vassiliki] Univ Patras, Dept Environm & Nat Resources Management, Seferi, Agrinio, Greece; [Grill, Andrea] Univ Vienna, Dept Trop Ecol & Anim Biodivers, Vienna, Austria; [Grill, Andrea] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Wilson, Robert J.] Univ Exeter Cornwall Campus, Ctr Ecol & Conservat, Penryn, England	University of Ioannina; University of Patras; University of Vienna; Salzburg University; University of Exeter	Zografou, K (corresponding author), Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece.	ntinazografou@yahoo.co.uk	Kati, Vassiliki I/AAB-9418-2020; Zografou, Konstantina/J-4609-2015; Halley, John M/AAP-3004-2020; Wilson, Robert J/I-8726-2014	Kati, Vassiliki I/0000-0003-3357-4556; Zografou, Konstantina/0000-0003-4305-0238; Wilson, Robert J/0000-0003-4477-7068; Tzirkalli, Elli/0000-0002-7839-2150	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II Investing in knowledge society through the European Social Fund; Austrian Science Fund (FWF) [V 169] Funding Source: researchfish	European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II Investing in knowledge society through the European Social Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamakopoulos T, 1995, SPECIFIC ENV STUDY D; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Argyropoulou MD, 2005, BELG J ZOOL, V135, P127; Asher J, 2001, MILLENNIUM ATLAS BUT; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Dapporto L, 2013, BIOL CONSERV, V157, P229, DOI 10.1016/j.biocon.2012.09.016; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Filz KJ, 2013, EUR J ENTOMOL, V110, P633, DOI 10.14411/eje.2013.086; Gatzogiannis S, 1999, GUIDLINES PREPARATIO; Gerard F, 2010, PROG PHYS GEOG, V34, P183, DOI 10.1177/0309133309360141; Gonzalez-Estebanez FJ, 2011, AGR ECOSYST ENVIRON, V144, P262, DOI 10.1016/j.agee.2011.09.002; Grill A, 2003, BIOL CONSERV, V114, P427, DOI 10.1016/S0006-3207(03)00070-3; Halley JM, 2011, CLIMATIC CHANGE, V109, P549, DOI 10.1007/s10584-011-0053-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; IPCC, 2007, 3 ASS REP INT PAN CL; K?llander, 2010, DADIA LEFKIMI SOUFLI; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Kati V, 2004, BIOL CONSERV, V115, P33, DOI 10.1016/S0006-3207(03)00091-0; Kati V, 2007, AMPHIBIA-REPTILIA, V28, P517, DOI 10.1163/156853807782152471; Kati Vassiliki, 2000, Naturalistes Belges, V81, P269; Kati V, 2010, BIODIVERS CONSERV, V19, P1585, DOI 10.1007/s10531-010-9788-y; Kati VI, 2006, DIVERS DISTRIB, V12, P620, DOI 10.1111/j.1366-9516.2006.00288.x; Korakis G, 2006, FLORA MEDITERRANEA, V16, P11; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Maris F, 2010, DADIA LEFKIMI SOUFLI, P41; Matter SF, 2011, INSECT SCI, V18, P385, DOI 10.1111/j.1744-7917.2011.01407.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Merrill RM, 2008, J ANIM ECOL, V77, P145, DOI 10.1111/j.1365-2656.2007.01303.x; Morecroft MD, 2012, J APPL ECOL, V49, P546, DOI 10.1111/j.1365-2664.2012.02147.x; New TR, 1997, J INSECT CONSERV, V1, P5, DOI 10.1023/A:1018433406701; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Pamperis LN, 2009, BUTTERFLIES GREECE; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Pinheiro J, 2003, NLME LINEAR NONLINEA; Robinson N, 2012, ENTOMOL EXP APPL, V145, P50, DOI 10.1111/j.1570-7458.2012.01308.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schindler S, 2010, INTEGRATED STUDY LAN; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Schweiger O, 2014, ZOOKEYS, P65, DOI 10.3897/zookeys.367.6185; Settele J, 2008, CLIMATIC RISK ATLAS; Stefanescu C, 2004, J BIOGEOGR, V31, P905, DOI 10.1111/j.1365-2699.2004.01088.x; Stefanescu C, 2013, ECOGRAPHY, V36, P474, DOI 10.1111/j.1600-0587.2012.07738.x; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Stefanescu C, 2011, J INSECT CONSERV, V15, P83, DOI 10.1007/s10841-010-9325-z; Stefanescu C, 2009, INSECT CONSERV DIVER, V2, P261, DOI 10.1111/j.1752-4598.2009.00063.x; Suggitt AJ, 2012, BIOL LETTERS, V8, P590, DOI 10.1098/rsbl.2012.0112; Ulrich W, 2005, BIODIVERS CONSERV, V14, P1977, DOI 10.1007/s10531-004-2526-6; van Swaay C., 2010, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2010-1.RLTS; Van Swaay CAM, 2012, VS2012019 VLIND; van Swaay C, 2011, BIOL CONSERV, V144, P470, DOI 10.1016/j.biocon.2010.09.034; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	67	39	40	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87245	10.1371/journal.pone.0087245	http://dx.doi.org/10.1371/journal.pone.0087245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489880	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000125
J	Nagasawa, Y; Iio, K; Fukuda, S; Date, Y; Iwatani, H; Yamamoto, R; Horii, A; Inohara, H; Imai, E; Nakanishi, T; Ohno, H; Rakugi, H; Isaka, Y				Nagasawa, Yasuyuki; Iio, Kenichiro; Fukuda, Shinji; Date, Yasuhiro; Iwatani, Hirotsugu; Yamamoto, Ryohei; Horii, Arata; Inohara, Hidenori; Imai, Enyu; Nakanishi, Takeshi; Ohno, Hiroshi; Rakugi, Hiromi; Isaka, Yoshitaka			Periodontal Disease Bacteria Specific to Tonsil in IgA Nephropathy Patients Predicts the Remission by the Treatment	PLOS ONE			English	Article							HAEMOPHILUS-PARAINFLUENZAE ANTIGEN; CANDIDATE GENE APPROACH; STEROID PULSE THERAPY; SYSTEMIC INFLAMMATION; OXFORD CLASSIFICATION; RHEUMATOID-ARTHRITIS; HELICOBACTER-PYLORI; CLINICAL REMISSION; RENAL-DISEASE; ASSOCIATION	Background: Immunoglobulin (Ig) A nephropathy (IgAN) is the most common form of primary glomerulonephritis in the world. Some bacteria were reported to be the candidate of the antigen or the pathogenesis of IgAN, but systematic analysis of bacterial flora in tonsil with IgAN has not been reported. Moreover, these bacteria specific to IgAN might be candidate for the indicator which can predict the remission of IgAN treated by the combination of tonsillectomy and steroid pulse. Methods and Findings: We made a comprehensive analysis of tonsil flora in 68 IgAN patients and 28 control patients using Denaturing gradient gel electrophoresis methods. We also analyzed the relationship between several bacteria specific to the IgAN and the prognosis of the IgAN. Treponema sp. were identified in 24% IgAN patients, while in 7% control patients (P = 0.062). Haemophilus segnis were detected in 53% IgAN patients, while in 25% control patients (P = 0.012). Campylobacter rectus were identified in 49% IgAN patients, while in 14% control patients (P = 0.002). Multiple Cox proportional-hazards model revealed that Treponema sp. or Campylobactor rectus are significant for the remission of proteinuria (Hazard ratio 2.35, p = 0.019). There was significant difference in remission rates between IgAN patients with Treponema sp. and those without the bacterium (p = 0.046), and in remission rates between IgAN patients with Campylobacter rectus and those without the bacterium (p = 0.037) by Kaplan-Meier analysis. Those bacteria are well known to be related with the periodontal disease. Periodontal bacteria has known to cause immune reaction and many diseases, and also might cause IgA nephropathy. Conclusion: This insight into IgAN might be useful for diagnosis of the IgAN patients and the decision of treatment of IgAN.	[Nagasawa, Yasuyuki; Iio, Kenichiro; Iwatani, Hirotsugu; Yamamoto, Ryohei; Imai, Enyu; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Nagasawa, Yasuyuki; Nakanishi, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Kidney & Dialysis, Nishinomiya, Hyogo 6638501, Japan; [Fukuda, Shinji; Date, Yasuhiro; Ohno, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Fukuda, Shinji; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan; [Date, Yasuhiro] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Horii, Arata; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otolaryngol, Suita, Osaka, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Osaka University; Hyogo College of Medicine; RIKEN; Yokohama City University; Waseda University; Osaka University; Keio University	Nagasawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan.	nagasawa@kid.med.osaka-u.ac.jp	Ohno, Hiroshi/L-7899-2014; DATE, Yasuhiro/V-3630-2018; YAMAMOTO, Ryohei/AAU-3059-2021	Ohno, Hiroshi/0000-0001-8776-9661; DATE, Yasuhiro/0000-0001-9645-4370; YAMAMOTO, Ryohei/0000-0003-2610-9824; Rakugi, Hiromi/0000-0001-6508-4338; Horii, Arata/0000-0002-6036-0492; Fukuda, Shinji/0000-0001-5161-9880	Research Conference of IgA nephropathy [21790809, 22590891]; Osaka kidney bank [OK-3]	Research Conference of IgA nephropathy; Osaka kidney bank	This study was supported by grant-in-aid for Young Scientists B (21790809), grant-in-aid for Scientific Research C (22590891), grant from Research Conference of IgA nephropathy, and grant from Osaka kidney bank (OK-3, 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali J, 2011, AUTOIMMUN REV, V10, P426, DOI 10.1016/j.autrev.2010.04.005; Appel GB, 2006, KIDNEY INT, V69, P1939, DOI 10.1038/sj.ki.5000434; Arbes SJ, 1999, J DENT RES, V78, P1777, DOI 10.1177/00220345990780120301; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Craig RG, 2007, NEPHROL DIAL TRANSPL, V22, P312, DOI 10.1093/ndt/gfl604; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Goto T, 2008, CLIN IMMUNOL, V126, P260, DOI 10.1016/j.clim.2007.11.003; Holmes LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060352; Hotta O, 2001, AM J KIDNEY DIS, V38, P736, DOI 10.1053/ajkd.2001.27690; Iio K, 2010, BIOCHEM BIOPH RES CO, V393, P565, DOI 10.1016/j.bbrc.2010.01.120; Iwama H, 1998, AM J KIDNEY DIS, V32, P785, DOI 10.1016/S0272-6386(98)70134-9; Iwatani H, 2012, BIOCHEM BIOPH RES CO, V428, P339, DOI 10.1016/j.bbrc.2012.10.049; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Khalaf H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045192; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040495; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Kobayashi N, 2008, J PERIODONTAL RES, V43, P156, DOI 10.1111/j.1600-0765.2007.01005.x; Kodama S, 2001, CLIN EXP IMMUNOL, V123, P301, DOI 10.1046/j.1365-2249.2001.01431.x; Komatsu H, 2008, CLIN J AM SOC NEPHRO, V3, P1301, DOI 10.2215/CJN.00310108; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Kshirsagar AV, 2005, AM J KIDNEY DIS, V45, P650, DOI 10.1053/j.ajkd.2004.12.009; Kusano K, 2007, HUM PATHOL, V38, P1788, DOI 10.1016/j.humpath.2007.04.012; Lau SKP, 2004, J CLIN MICROBIOL, V42, P877, DOI 10.1128/JCM.42.2.877-880.2004; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Mai TV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010559; March AKD, 1997, CLIN IMMUNOL IMMUNOP, V84, P158, DOI 10.1006/clin.1997.4389; Miyazaki M, 2007, CONTRIB NEPHROL, V157, P94, DOI 10.1159/000102310; Muyzer G, 1998, MOL MICROBIAL ECOLOG, V344; Nagasawa Y, 2012, HYPERTENS RES, V35, P261, DOI 10.1038/hr.2011.205; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Nakajima T, 2009, ODONTOLOGY, V97, P84, DOI 10.1007/s10266-009-0104-9; Nakano K, 2011, ORAL DIS, V17, P370, DOI 10.1111/j.1601-0825.2010.01759.x; Novak J, 2012, SEMIN IMMUNOPATHOL, V34, P365, DOI 10.1007/s00281-012-0306-z; Ogura Y, 2000, AM J KIDNEY DIS, V36, P47, DOI 10.1053/ajkd.2000.8264; Okuda K, 2003, J PERIODONTOL, V74, P123, DOI 10.1902/jop.2003.74.1.123; Pettersson E, 1997, J INTERN MED, V242, P349, DOI 10.1046/j.1365-2796.1997.00194.x; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shinzawa M, 2012, CLIN EXP NEPHROL, V16, P250, DOI 10.1007/s10157-011-0553-7; Siqueira JF, 2004, ORAL MICROBIOL IMMUN, V19, P336, DOI 10.1111/j.1399-302x.2004.00156.x; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Thompson Stuart A, 2002, Ann Periodontol, V7, P43, DOI 10.1902/annals.2002.7.1.43; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Xie YS, 2004, KIDNEY INT, V65, P1135, DOI 10.1111/j.1523-1755.2004.00486.x; Xie YS, 2003, KIDNEY INT, V63, P1861, DOI 10.1046/j.1523-1755.2003.00935.x; Xu F, ATHEROSCLEROSIS, V218, P536; Yamamoto C, 2002, NEPHRON, V90, P320, DOI 10.1159/000049068; Yamamoto R, 2012, NEPHROL DIAL TRANSPL, V27, P1020, DOI 10.1093/ndt/gfr369; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Yamamoto R, 2009, NEPHROL DIAL TRANSPL, V24, P3686, DOI 10.1093/ndt/gfp210; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zhou XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061208; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018788	67	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e81636	10.1371/journal.pone.0081636	http://dx.doi.org/10.1371/journal.pone.0081636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489644	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000003
J	Cacan, E; Ali, MW; Boyd, NH; Hooks, SB; Greer, SF				Cacan, Ercan; Ali, Mourad W.; Boyd, Nathaniel H.; Hooks, Shelley B.; Greer, Susanna F.			Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; CPG-BINDING PROTEIN; HUMAN BREAST-CANCER; DNA METHYLATION; PREDICT PROGNOSIS; CELL-GROWTH; REGULATOR; TARGET; GENE; METHYLTRANSFERASE	RGS10 is an important regulator of cell survival and chemoresistance in ovarian cancer. We recently showed that RGS10 transcript expression is suppressed during acquired chemoresistance in ovarian cancer. The suppression of RGS10 is due to DNA hypermethylation and histone deacetylation, two important mechanisms that contribute to silencing of tumor suppressor genes during cancer progression. Here, we fully investigate the molecular mechanisms of epigenetic silencing of RGS10 expression in chemoresistant A2780-AD ovarian cancer cells. We identify two important epigenetic regulators, HDAC1 and DNMT1, that exhibit aberrant association with RGS10 promoters in chemoresistant ovarian cancer cells. Knockdown of HDAC1 or DNMT1 expression, and pharmacological inhibition of DNMT or HDAC enzymatic activity, significantly increases RGS10 expression and cisplatin-mediated cell death. Finally, DNMT1 knock down also decreases HDAC1 binding to the RGS10 promoter in chemoresistant cells, suggesting HDAC1 recruitment to RGS10 promoters requires DNMT1 activity. Our results suggest that HDAC1 and DNMT1 contribute to the suppression of RGS10 during acquired chemoresistance and support inhibition of HDAC1 and DNMT1 as an adjuvant therapeutic approach to overcome ovarian cancer chemoresistance.	[Cacan, Ercan; Boyd, Nathaniel H.; Greer, Susanna F.] Georgia State Univ, Dept Biol, Div Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Ali, Mourad W.; Hooks, Shelley B.] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; Georgia State University; University System of Georgia; University of Georgia	Greer, SF (corresponding author), Georgia State Univ, Dept Biol, Div Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	sgreer@gsu.edu	Cacan, Ercan/AAC-1204-2019; Cacan, Ercan/I-7279-2019	Cacan, Ercan/0000-0002-3487-9493; Ali, Mourad Wagdy/0000-0003-3263-9055; Hooks, Shelley/0000-0003-4702-0490	American Cancer Society [RSG-09-067-01-LB]; NATIONAL CANCER INSTITUTE [R15CA151006] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by grant # RSG-09-067-01-LB from the American Cancer Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060185; ANDREWS PA, 1985, CANCER RES, V45, P6250; Arts J, 2007, BRIT J CANCER, V97, P1344, DOI 10.1038/sj.bjc.6604025; Ballestar E, 2002, CARCINOGENESIS, V23, P1103, DOI 10.1093/carcin/23.7.1103; Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bodle CR, 2013, FUTURE MED CHEM, V5, P995, DOI 10.4155/fmc.13.91; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Cai Y., 2013, ONCOGENE; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Carafa V, 2011, RECENT PAT ANTI-CANC, V6, P131, DOI 10.2174/157489211793980088; Carrieri A, 2013, CURR TOP MED CHEM, V13, P1069, DOI 10.2174/15680266113139990028; Dear RF, 2010, ASIA-PAC J CLIN ONCO, V6, P66, DOI 10.1111/j.1743-7563.2009.01263.x; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Espino PS, 2005, J CELL BIOCHEM, V94, P1088, DOI 10.1002/jcb.20387; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Falchook GS, 2013, INVEST NEW DRUGS; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Garcia-Bernal D, 2011, J IMMUNOL, V187, P1264, DOI 10.4049/jimmunol.1002960; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Giacinti L, 2008, CLIN TER, V159, P347; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Gu YF, 2013, ONCOL LETT, V5, P452, DOI 10.3892/ol.2012.1057; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herzog TJ, 2011, GYNECOL ONCOL, V120, P454, DOI 10.1016/j.ygyno.2010.11.008; Hooks SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-289; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Hurst JH, 2009, PHARMACOLOGY, V83, P333, DOI 10.1159/000217582; Ito K, 2000, METH MOLEC MED, V44, P309, DOI 10.1385/1-59259-072-1:309; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jones P.L., 2001, METH MOL B, V181, P297, DOI 10.1385/1-59259-211-2:297; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Lee JK, 2012, J NEUROCHEM, V122, P333, DOI 10.1111/j.1471-4159.2012.07780.x; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Liu B, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-7; LOUIE KG, 1985, CANCER RES, V45, P2110; Lu JB, 2008, EUR J PHARMACOL, V601, P66, DOI 10.1016/j.ejphar.2008.10.044; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Meng CF, 2011, MOL MED REP, V4, P1273, DOI 10.3892/mmr.2011.557; Meng FL, 2013, INT J ONCOL, V43, P495, DOI 10.3892/ijo.2013.1960; MODEST EJ, 1974, CANCER CHEMOTH REP 1, V58, P35; Muller BM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-215; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rivero G, 2013, PSYCHOPHARMACOLOGY, V226, P177, DOI 10.1007/s00213-012-2888-5; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100; Terasawa K, 2004, CLIN CANCER RES, V10, P2000, DOI 10.1158/1078-0432.CCR-0932-03; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang C, 2011, J NAT PROD, V74, P2031, DOI 10.1021/np200324x; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xie Y, 2013, BIOCHEM PHARMACOL, V85, P1454, DOI 10.1016/j.bcp.2013.03.001; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	79	63	64	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87455	10.1371/journal.pone.0087455	http://dx.doi.org/10.1371/journal.pone.0087455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475290	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300185
J	Shan, C; Mei, ZL; Duan, JL; Chen, HY; Feng, HF; Cai, WM				Shan, Chi; Mei, Zhiling; Duan, Jianli; Chen, Haiying; Feng, Huafeng; Cai, Weiming			OsGA2ox5, a Gibberellin Metabolism Enzyme, Is Involved in Plant Growth, the Root Gravity Response and Salt Stress	PLOS ONE			English	Article							RICE ORYZA-SATIVA; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; CYTOCHROME-P450 MONOOXYGENASE; FUNCTIONAL EXPRESSION; GREEN-REVOLUTION; GENE; BIOSYNTHESIS; MUTANT; OVEREXPRESSION	Gibberellin (GA) 2-oxidases play an important role in the GA catabolic pathway through 2 beta-hydroxylation. There are two classes of GA2oxs, i.e., a larger class of C-19-GA2oxs and a smaller class of C-20-GA2oxs. In this study, the gene encoding a GA 2-oxidase of rice, Oryza sativa GA 2-oxidase 5 (OsGA2ox5), was cloned and characterized. BLASTP analysis showed that OsGA2ox5 belongs to the C-20-GA2oxs subfamily, a subfamily of GA2oxs acting on C-20-GAs (GA(12), GA(53)). Subcellular localization of OsGA2ox5-YFP in transiently transformed onion epidermal cells revealed the presence of this protein in both of the nucleus and cytoplasm. Real-time PCR analysis, along with GUS staining, revealed that OsGA2ox5 is expressed in the roots, culms, leaves, sheaths and panicles of rice. Rice plants overexpressing OsGA2ox5 exhibited dominant dwarf and GA-deficient phenotypes, with shorter stems and later development of reproductive organs than the wild type. The dwarfism phenotype was partially rescued by the application of exogenous GA(3) at a concentration of 10 mu M. Ectopic expression of OsGA2ox5 cDNA in Arabidopsis resulted in a similar phenotype. Real-time PCR assays revealed that both GA synthesis-related genes and GA signaling genes were expressed at higher levels in transgenic rice plants than in wild-type rice; OsGA3ox1, which encodes a key enzyme in the last step of the bioactive GAs synthesis pathway, was highly expressed in transgenic rice. The roots of OsGA2ox5-ox plants exhibited increased starch granule accumulation and gravity responses, revealing a role for GA in root starch granule development and gravity responses. Furthermore, rice and Arabidopsis plants overexpressing OsGA2ox5 were more resistant to high-salinity stress than wild-type plants. These results suggest that OsGA2ox5 plays important roles in GAs homeostasis, development, gravity responses and stress tolerance in rice.	[Shan, Chi; Mei, Zhiling; Duan, Jianli; Chen, Haiying; Cai, Weiming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Feng, Huafeng] E China Univ Sci & Technol, Sch Chem & Mol Engn, Shanghai Key Lab Funct Mat Chem, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; East China University of Science & Technology	Cai, WM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	wmcai@sibs.ac.cn	Duan, Jianli/GOP-3297-2022	Duan, Jianli/0000-0001-7347-4774	National Basic Research Program of China [2011CB710902]; National Natural Science Foundation of China [31070237]; National Scientific Program [2012AA101103-04]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA04020202-15]; China Manned Space Flight Technology Project	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific Program; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China Manned Space Flight Technology Project	This work was supported by the National Basic Research Program of China (2011CB710902), National Natural Science Foundation of China (31070237), the National Scientific Program (2012AA101103-04), Strategic Priority Research Program of the Chinese Academy of Sciences (XDA04020202-15) and the China Manned Space Flight Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSCH MB, 1990, PLANTA, V181, P358, DOI 10.1007/BF00195888; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Harberd NP, 1998, BIOESSAYS, V20, P1001, DOI 10.1002/(SICI)1521-1878(199812)20:12&lt;1001::AID-BIES6&gt;3.0.CO;2-O; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; King RW, 2003, ANNU REV PLANT BIOL, V54, P307, DOI 10.1146/annurev.arplant.54.031902.135029; Lange T, 1998, PLANTA, V204, P409, DOI 10.1007/s004250050274; Lee DJ, 2005, PLANT PHYSIOL, V138, P243, DOI 10.1104/pp.104.056499; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Rebers M, 1999, PLANT J, V17, P241, DOI 10.1046/j.1365-313X.1999.00366.x; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Scott A, 1999, BIOTECHNIQUES, V26, P1125, DOI 10.2144/99266st04; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Suo HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045568; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yamaguchi S, 2000, PLANT CELL PHYSIOL, V41, P251, DOI 10.1093/pcp/41.3.251; Zang AP, 2010, J EXP BOT, V61, P777, DOI 10.1093/jxb/erp341; Zhang YY, 2008, CELL RES, V18, P412, DOI 10.1038/cr.2008.28; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	47	64	76	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87110	10.1371/journal.pone.0087110	http://dx.doi.org/10.1371/journal.pone.0087110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475234	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300141
J	Miao, H; Gale, NW; Guo, H; Qian, J; Petty, A; Kaspar, J; Murphy, AJ; Valenzuela, DM; Yancopoulos, G; Hambardzumyan, D; Lathia, JD; Rich, JN; Lee, J; Wang, B				Miao, H.; Gale, N. W.; Guo, H.; Qian, J.; Petty, A.; Kaspar, J.; Murphy, A. J.; Valenzuela, D. M.; Yancopoulos, G.; Hambardzumyan, D.; Lathia, J. D.; Rich, J. N.; Lee, J.; Wang, B.			EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties	ONCOGENE			English	Article						EphA2; Akt; stem cells; glioma; invasion; ephrin-A	INTEGRATED GENOMIC ANALYSIS; HUMAN BRAIN; GLIOBLASTOMA; RECEPTOR; ACTIVATION; EXPRESSION; EPHRINA1; TUMORS; LIGAND; ROLES	Diffuse infiltrative invasion is a major cause for the dismal prognosis of glioblastoma multiforme (GBM), but the underlying mechanisms remain incompletely understood. Using human glioma stem cells (GSCs) that recapitulate the invasive propensity of primary GBM, we find that EphA2 critically regulates GBM invasion in vivo. EphA2 was expressed in all seven GSC lines examined, and overexpression of EphA2 enhanced intracranial invasion. The effects required Akt-mediated phosphorylation of EphA2 on serine 897. In vitro the Akt-EphA2 signaling axis is maintained in the absence of ephrin-A ligands and is disrupted upon ligand stimulation. To test whether ephrin-As in tumor microenvironment can regulate GSC invasion, the newly established Efna1;Efna3;Efna4 triple knockout mice (TKO) were used in an ex vivo brain slice invasion assay. We observed significantly increased GSC invasion through the brain slices of TKO mice relative to wild-type (WT) littermates. Mechanistically EphA2 knockdown suppressed stem cell properties of GSCs, causing diminished self-renewal, reduced stem marker expression and decreased tumorigenicity. In a subset of GSCs, the reduced stem cell properties were associated with lower Sox2 expression. Overexpression of EphA2 promoted stem cell properties in a kinase-independent manner and increased Sox2 expression. Disruption of Akt-EphA2 cross-talk attenuated stem cell marker expression and neurosphere formation while having minimal effects on tumorigenesis. Taken together, the results show that EphA2 endows invasiveness of GSCs in vivo in cooperation with Akt and regulates glioma stem cell properties.	[Miao, H.; Guo, H.; Qian, J.; Petty, A.; Kaspar, J.; Wang, B.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Rammelkamp Ctr Res, Cleveland, OH 44109 USA; [Miao, H.; Guo, H.; Qian, J.; Petty, A.; Kaspar, J.; Wang, B.] Case Western Reserve Univ, Sch Med, Dept Pharmacol & Oncol, Cleveland, OH 44109 USA; [Gale, N. W.; Murphy, A. J.; Valenzuela, D. M.; Yancopoulos, G.] Regeneron Pharmaceut Inc, VelociGene Div, Tarrytown, NY 10591 USA; [Hambardzumyan, D.; Lathia, J. D.; Rich, J. N.; Lee, J.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Hambardzumyan, D.; Lathia, J. D.; Rich, J. N.; Lee, J.; Wang, B.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Regeneron; Cleveland Clinic Foundation; Case Western Reserve University	Wang, B (corresponding author), Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Rammelkamp Ctr Res, R421,2500 MetroHlth Dr, Cleveland, OH 44109 USA.	bxw14@case.edu	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Murphy, Andrew/0000-0003-4152-4081	National Institute of Health [CA152371, CA155676]; FAMRI Foundation [072216_CIA]; Maria Foundation; Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [T32CA059366, R01CA155676, P30CA043703, R01CA152371] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI Foundation; Maria Foundation; Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institute of Health CA152371 (HM and BW), CA155676 (BW) and by awards to BW from FAMRI Foundation (072216_CIA) and Prayers From Maria Foundation. This research was also supported by the Case Comprehensive Cancer Center (P30 CA43703).	Annovazzi L, 2011, CANCER GENOM PROTEOM, V8, P139; [Anonymous], 1997, Cell, V90, P403; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chakravarti Arnab, 2008, P173; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garcia JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-454; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miao H, 2009, INT J BIOCHEM CELL B, V41, P762, DOI 10.1016/j.biocel.2008.07.019; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wegner M, 2011, GENE DEV, V25, P2423, DOI 10.1101/gad.181487.111; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244	55	101	106	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					558	567		10.1038/onc.2013.590	http://dx.doi.org/10.1038/onc.2013.590			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24488013	Green Accepted			2022-12-25	WOS:000348853500003
J	Bansal, S; Leu, AN; Gonzalez, FJ; Guengerich, FP; Chowdhury, AR; Anandatheerthavarada, HK; Avadhani, NG				Bansal, Seema; Leu, Adrian N.; Gonzalez, Frank J.; Guengerich, F. Peter; Chowdhury, Anindya Roy; Anandatheerthavarada, Hindupur K.; Avadhani, Narayan G.			Mitochondrial Targeting of Cytochrome P450 (CYP) 1B1 and Its Role in Polycyclic Aromatic Hydrocarbon- induced Mitochondrial Dysfunction*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carcinogenesis; Cytochrome P450; DNA Damage; Membrane Proteins; Mitochondria; Mitochondrial DNA	KNOCKOUT MOUSE LINES; PROTEIN-KINASE-A; ENDOPLASMIC-RETICULUM; BETA-NAPHTHOFLAVONE; DRUG-METABOLISM; MEDIATED PHOSPHORYLATION; CATALYTIC-PROPERTIES; CHIMERIC SIGNALS; OXIDATIVE STRESS; P4501B1 VARIANTS	Background: Cytochrome P450 (CYP) 1B1 activates diverse polycyclic aromatic hydrocarbons (PAH) to reactive species. Results: Processing by a cytosolic Ser protease activates a mitochondrial (mt) targeting signal of CYP1B1. Conclusion: Mitochondrial CYP1B1 plays a role in PAH-induced mtDNA damage and mitochondrial dysfunction. Significance: PAH-induced mitochondrial dysfunction may be important in tissue injury and inflammation. We report that polycyclic aromatic hydrocarbon (PAH)-inducible CYP1B1 is targeted to mitochondria by sequence-specific cleavage at the N terminus by a cytosolic Ser protease (polyserase 1) to activate the cryptic internal signal. Site-directed mutagenesis, COS-7 cell transfection, and in vitro import studies in isolated mitochondria showed that a positively charged domain at residues 41-48 of human CYP1B1 is part of the mitochondrial (mt) import signal. Ala scanning mutations showed that the Ser protease cleavage site resides between residues 37 and 41 of human CYP1B1. Benzo[a]pyrene (BaP) treatment induced oxidative stress, mitochondrial respiratory defects, and mtDNA damage that was attenuated by a CYP1B1-specific inhibitor, 2,3,4,5-tetramethoxystilbene. In support, the mitochondrial CYP1B1 supported by mitochondrial ferredoxin (adrenodoxin) and ferredoxin reductase showed high aryl hydrocarbon hydroxylase activity. Administration of benzo[a]pyrene or 2,3,7,8-tetrachlorodibenzodioxin induced similar mitochondrial functional abnormalities and oxidative stress in the lungs of wild-type mice and Cyp1a1/1a2-null mice, but the effects were markedly blunted in Cyp1b1-null mice. These results confirm a role for CYP1B1 in inducing PAH-mediated mitochondrial dysfunction. The role of mitochondrial CYP1B1 was assessed using A549 lung epithelial cells stably expressing shRNA against NADPH-cytochrome P450 oxidoreductase or mitochondrial adrenodoxin. Our results not only show conservation of the endoprotease cleavage mechanism for mitochondrial import of family 1 CYPs but also reveal a direct role for mitochondrial CYP1B1 in PAH-mediated oxidative and chemical damage to mitochondria.	[Bansal, Seema; Leu, Adrian N.; Chowdhury, Anindya Roy; Anandatheerthavarada, Hindupur K.; Avadhani, Narayan G.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bansal, Seema; Leu, Adrian N.; Chowdhury, Anindya Roy; Anandatheerthavarada, Hindupur K.; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu			National Institutes of Health [R01 GM34883, R37 CA090426]; Harret Ellison Woodward Trust; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harret Ellison Woodward Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM34883 (to N. G. A.) and Grant R37 CA090426 (to F. P. G.). This work was also supported by the Harret Ellison Woodward Trust (to N. G. A).	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 2009, J BIOL CHEM, V284, P17352, DOI 10.1074/jbc.M109.007492; Anandatheerthavarada HK, 1999, J BIOL CHEM, V274, P6617, DOI 10.1074/jbc.274.10.6617; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Badawi AF, 2001, METABOLISM, V50, P1001, DOI 10.1053/meta.2001.25592; Bagiyeva S, 2007, MOL VIS, V13, P1458; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; Bhagwat SV, 1999, TOXICOL APPL PHARM, V156, P231, DOI 10.1006/taap.1999.8646; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; CONNEY AH, 1982, CANCER RES, V42, P4875; Dasari VR, 2006, J BIOL CHEM, V281, P30834, DOI 10.1074/jbc.M510725200; Dong HB, 2009, MOL PHARMACOL, V75, P555, DOI 10.1124/mol.108.051888; Dragin N, 2007, BIOCHEM BIOPH RES CO, V359, P635, DOI 10.1016/j.bbrc.2007.05.202; Dutheil F, 2008, BIOCHIMIE, V90, P426, DOI 10.1016/j.biochi.2007.10.007; Edwards RJ, 1998, BIOCHEM PHARMACOL, V56, P377, DOI 10.1016/S0006-2952(98)00033-1; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; GONZALEZ FJ, 1986, COLD SPRING HARB SYM, V51, P879, DOI 10.1101/SQB.1986.051.01.101; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045; Hakkola J, 1997, CARCINOGENESIS, V18, P391, DOI 10.1093/carcin/18.2.391; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; JERINA DM, 1983, DRUG METAB DISPOS, V11, P1; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liang HCL, 1996, P NATL ACAD SCI USA, V93, P1671, DOI 10.1073/pnas.93.4.1671; MCKAY JA, 1995, FEBS LETT, V374, P270, DOI 10.1016/0014-5793(95)01126-Y; McKay Judith A., 1996, Biochemical Society Transactions, V24, p327S; Miller KP, 2001, DRUG METAB REV, V33, P1, DOI 10.1081/DMR-100000138; MURRAY GI, 1995, J PATHOL, V177, P147, DOI 10.1002/path.1711770208; Murray GI, 1997, CANCER RES, V57, P3026; Nebert DW, 2013, MOL PHARMACOL, V84, P304, DOI 10.1124/mol.113.086637; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NEBERT DW, 1968, J BIOL CHEM, V243, P6242; NEBERT DW, 1987, BIOCHEM SOC T, V15, P586, DOI 10.1042/bst0150586; OMURA T, 1964, J BIOL CHEM, V239, P2379; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; RAZA H, 1988, J BIOL CHEM, V263, P9533; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Sangar MC, 2010, MOL GENET METAB, V99, P90, DOI 10.1016/j.ymgme.2009.08.009; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; SCHWEIKL H, 1993, PHARMACOGENETICS, V3, P239, DOI 10.1097/00008571-199310000-00003; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Shi ZQ, 2010, INT J CANCER, V127, P2334, DOI 10.1002/ijc.25222; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Shimada T, 2001, XENOBIOTICA, V31, P163, DOI 10.1080/00498250110043490; Shimada T, 1996, CANCER RES, V56, P2979; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Tang YM, 1999, DRUG METAB DISPOS, V27, P274; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yaks F. M., 1997, P NATL ACAD SCI USA, V94, P514	66	56	60	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9936	9951		10.1074/jbc.M113.525659	http://dx.doi.org/10.1074/jbc.M113.525659			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24497629	Green Published, hybrid			2022-12-25	WOS:000333807000043
J	Ramakrishnan, NA; Drescher, MJ; Morley, BJ; Kelley, PM; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Morley, Barbara J.; Kelley, Philip M.; Drescher, Dennis G.			Calcium Regulates Molecular Interactions of Otoferlin with Soluble NSF Attachment Protein Receptor ( SNARE) Proteins Required for Hair Cell Exocytosis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Exocytosis; Hair Cell; Isothermal Titration Calorimetry; Mass Spectrometry (MS); Phosphoinositides; Snare; Surface Plasmon Resonance (SPR); C2 Domains; Otoferlin	AUTOSOMAL RECESSIVE DEAFNESS; MEMBRANE-FUSION; RIBBON SYNAPSE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; AUDITORY NEUROPATHY; CA2+ BINDING; C2 DOMAIN; DEPENDENT EXOCYTOSIS; PRESYNAPTIC CALCIUM; ENCODING OTOFERLIN	Background: Otoferlin deficiency impairs hair cell exocytosis and causes deafness. Results: Otoferlin binds Ca2+, regulating phosphatidylinositol 4,5-bisphosphate, t-SNARE, and intramolecular C2 interactions; otoferlin directly interacts with SNAP-25 and syntaxin-1B. Conclusion: Low Ca2+ promotes interactions among otoferlin C2C, C2D, C2E, and C2F; high Ca2+ drives t-SNARE and lipid interactions. Significance: Otoferlin may mediate novel modes of Ca2+-driven membrane fusion in hair cells. Mutations in otoferlin, a C2 domain-containing ferlin family protein, cause non-syndromic hearing loss in humans (DFNB9 deafness). Furthermore, transmitter secretion of cochlear inner hair cells is compromised in mice lacking otoferlin. In the present study, we show that the C2F domain of otoferlin directly binds calcium (K-D = 267 m) with diminished binding in a pachanga (D1767G) C2F mouse mutation. Calcium was found to differentially regulate binding of otoferlin C2 domains to target SNARE (t-SNARE) proteins and phospholipids. C2D-F domains interact with the syntaxin-1 t-SNARE motif with maximum binding within the range of 20-50 m Ca2+. At 20 m Ca2+, the dissociation rate was substantially lower, indicating increased binding (K-D = approximate to 10(-9)) compared with 0 m Ca2+ (K-D = approximate to 10(-8)), suggesting a calcium-mediated stabilization of the C2 domaint-SNARE complex. C2A and C2B interactions with t-SNAREs were insensitive to calcium. The C2F domain directly binds the t-SNARE SNAP-25 maximally at 100 m and with reduction at 0 m Ca2+, a pattern repeated for C2F domain interactions with phosphatidylinositol 4,5-bisphosphate. In contrast, C2F did not bind the vesicle SNARE protein synaptobrevin-1 (VAMP-1). Moreover, an antibody targeting otoferlin immunoprecipitated syntaxin-1 and SNAP-25 but not synaptobrevin-1. As opposed to an increase in binding with increased calcium, interactions between otoferlin C2F domain and intramolecular C2 domains occurred in the absence of calcium, consistent with intra-C2 domain interactions forming a closed tertiary structure at low calcium that opens as calcium increases. These results suggest a direct role for otoferlin in exocytosis and modulation of calcium-dependent membrane fusion.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Lab Biootol, Dept Otolaryngol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Morley, Barbara J.; Kelley, Philip M.] Boys Town Natl Res Hosp, Omaha, NE 68131 USA	Wayne State University; Wayne State University; Boys Town National Research Hospital	Drescher, DG (corresponding author), Wayne State Univ, Sch Med, Lab Biootol, 259 Lande Med Res Bldg,540 East Canfield Ave, Detroit, MI 48201 USA.	ddresche@med.wayne.edu	Morley, Barbara/AAB-7980-2019		National Institutes of Health [R01 DC000156, R01 DC004076, R01 DC006907]; Hearing Health Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000156, R01DC004076, P30DC005188, R01DC006907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearing Health Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC000156 (to D. G. D.), R01 DC004076 (to M.J.D.), and R01 DC006907 (to B.J.M.). This work was also supported by the Hearing Health Foundation (to N.A.R.) and the Deafness Research Foundation (to N.A.R. and P.M.K.).	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Choi BY, 2009, CLIN GENET, V75, P237, DOI 10.1111/j.1399-0004.2008.01128.x; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Dulon D, 2009, J NEUROSCI, V29, P10474, DOI 10.1523/JNEUROSCI.1009-09.2009; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Heidrych P, 2008, HUM MOL GENET, V17, P3814, DOI 10.1093/hmg/ddn279; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Helfmann S, 2011, J MOL BIOL, V406, P479, DOI 10.1016/j.jmb.2010.12.031; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Kaneko Y, 2011, J MOL HISTOL, V42, P483, DOI 10.1007/s10735-011-9346-2; Kelley P. M., 2006, ABSTR SOC NEUROSCI, V32, P4; Kuo WW, 2011, BIOCHEMISTRY-US, V50, P2633, DOI 10.1021/bi200049c; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Longo-Guess C, 2007, HEARING RES, V234, P21, DOI 10.1016/j.heares.2007.09.005; Marlin S, 2010, BIOCHEM BIOPH RES CO, V394, P737, DOI 10.1016/j.bbrc.2010.03.062; Migliosi V, 2002, J MED GENET, V39, P502, DOI 10.1136/jmg.39.7.502; Mirghomizadeh F, 2002, NEUROBIOL DIS, V10, P157, DOI 10.1006/nbdi.2002.0488; Mishima T., 2011, JAP NEUR RES ABSTR S, pP2; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nouvian R, 2011, NAT NEUROSCI, V14, P411, DOI 10.1038/nn.2774; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Radhakrishnan A, 2009, J BIOL CHEM, V284, P25749, DOI 10.1074/jbc.M109.042499; Ramakrishnan NA, 2006, NEUROSCIENCE, V139, P1417, DOI 10.1016/j.neuroscience.2006.01.064; Ramakrishnan N. A., 2009, ASS RES OT ABSTR, V32, P16; Ramakrishnan N. A., 2010, ASS RES OT ABSTR, V33, P31; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Ramakrishnan NA, 2012, MOL CELL NEUROSCI, V50, P58, DOI 10.1016/j.mcn.2012.03.009; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; Rodriguez-Ballesteros M, 2008, HUM MUTAT, V29, P823, DOI 10.1002/humu.20708; Rouillon I, 2006, INT J PEDIATR OTORHI, V70, P689, DOI 10.1016/j.ijporl.2005.09.006; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schug N, 2006, EUR J NEUROSCI, V24, P3372, DOI 10.1111/j.1460-9568.2006.05225.x; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tekin M, 2005, AM J MED GENET A, V138A, P6, DOI 10.1002/ajmg.a.30907; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wang Z, 2010, J BIOL CHEM, V285, P30759, DOI 10.1074/jbc.M110.137745; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8; Xu L., 2011, PLOS ONE, V6; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zak M, 2012, CELL PHYSIOL BIOCHEM, V29, P941, DOI 10.1159/000188338	69	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8750	8766		10.1074/jbc.M113.480533	http://dx.doi.org/10.1074/jbc.M113.480533			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24478316	hybrid, Green Published			2022-12-25	WOS:000333472100003
J	Bowd, C; Weinreb, RN; Balasubramanian, M; Lee, I; Jang, GJ; Yousefi, S; Zangwill, LM; Medeiros, FA; Girkin, CA; Liebmann, JM; Goldbaum, MH				Bowd, Christopher; Weinreb, Robert N.; Balasubramanian, Madhusudhanan; Lee, Intae; Jang, Giljin; Yousefi, Siamak; Zangwill, Linda M.; Medeiros, Felipe A.; Girkin, Christopher A.; Liebmann, Jeffrey M.; Goldbaum, Michael H.			Glaucomatous Patterns in Frequency Doubling Technology (FDT) Perimetry Data Identified by Unsupervised Machine Learning Classifiers	PLOS ONE			English	Article							STANDARD AUTOMATED PERIMETRY; RELEVANCE VECTOR MACHINE; VISUAL-FIELD DEFECTS; INDEPENDENT COMPONENT ANALYSIS; ARTIFICIAL NEURAL-NETWORK; FUNCTIONAL MEASUREMENTS; DIAGNOSTIC-ACCURACY; OPTIC DISC; MIXTURE; EYES	Purpose: The variational Bayesian independent component analysis-mixture model (VIM), an unsupervised machine-learning classifier, was used to automatically separate Matrix Frequency Doubling Technology (FDT) perimetry data into clusters of healthy and glaucomatous eyes, and to identify axes representing statistically independent patterns of defect in the glaucoma clusters. Methods: FDT measurements were obtained from 1,190 eyes with normal FDT results and 786 eyes with abnormal FDT results from the UCSD-based Diagnostic Innovations in Glaucoma Study (DIGS) and African Descent and Glaucoma Evaluation Study (ADAGES). For all eyes, VIM input was 52 threshold test points from the 24-2 test pattern, plus age. Results: FDT mean deviation was -1.00 dB (S.D. = 2.80 dB) and -5.57 dB (S.D. = 5.09 dB) in FDT-normal eyes and FDT-abnormal eyes, respectively (p<0.001). VIM identified meaningful clusters of FDT data and positioned a set of statistically independent axes through the mean of each cluster. The optimal VIM model separated the FDT fields into 3 clusters. Cluster N contained primarily normal fields (1109/1190, specificity 93.1%) and clusters G(1) and G(2) combined, contained primarily abnormal fields (651/786, sensitivity 82.8%). For clusters G(1) and G(2) the optimal number of axes were 2 and 5, respectively. Patterns automatically generated along axes within the glaucoma clusters were similar to those known to be indicative of glaucoma. Fields located farther from the normal mean on each glaucoma axis showed increasing field defect severity. Conclusions: VIM successfully separated FDT fields from healthy and glaucoma eyes without a priori information about class membership, and identified familiar glaucomatous patterns of loss.	[Bowd, Christopher; Weinreb, Robert N.; Balasubramanian, Madhusudhanan; Lee, Intae; Jang, Giljin; Yousefi, Siamak; Zangwill, Linda M.; Medeiros, Felipe A.; Goldbaum, Michael H.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Jang, Giljin] Ulsan Natl Inst Sci & Technol, Sch Elect & Comp Engn, Ulsan, South Korea; [Girkin, Christopher A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Liebmann, Jeffrey M.] NYU, Dept Ophthalmol, Sch Med, New York, NY 10016 USA; [Liebmann, Jeffrey M.] New York Eye & Ear Infirm, New York, NY 10003 USA	University of California System; University of California San Diego; Ulsan National Institute of Science & Technology (UNIST); University of Alabama System; University of Alabama Birmingham; New York University; New York Eye & Ear Infirmary of Mount Sinai	Bowd, C (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	cbowd@ucsd.edu	Goldbaum, Michael/AAG-4258-2020	Goldbaum, Michael/0000-0002-7721-2736; Bowd, Christopher/0000-0001-9330-9987; Girkin, Chris/0000-0002-9676-4499; Girkin, Christopher/0000-0002-5781-7682	NIH [EY022039, EY020518, EY011008, EY014267, EY019869, EY021818]; Research to Prevent Blindness; Eyesight Foundation of Alabama; Corinne Graber Research Fund of the New York Glaucoma Research Institute; Alcon Laboratories; Allergan; Pfizer; NATIONAL EYE INSTITUTE [R00EY020518, R01EY019869, P30EY022589, R01EY022039, U10EY014267, R01EY011008, R01EY021818, K99EY020518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eyesight Foundation of Alabama; Corinne Graber Research Fund of the New York Glaucoma Research Institute; Alcon Laboratories(Novartis); Allergan(AbbVieAllergan); Pfizer(Pfizer); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH EY022039, EY020518, NIH EY011008, NIH EY014267, NIH EY019869, NIH EY021818, and an unrestricted grant from Research to Prevent Blindness, Eyesight Foundation of Alabama, Corinne Graber Research Fund of the New York Glaucoma Research Institute. The authors also would like to acknowledge funding from Alcon Laboratories, Allergan, and Pfizer in the form of glaucoma medications at no cost to study participants to which they are prescribed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaly M F, 1971, Trans Am Ophthalmol Soc, V69, P147; Bengtsson B, 2005, INVEST OPHTH VIS SCI, V46, P3730, DOI 10.1167/iovs.05-0175; Bizios D, 2007, J GLAUCOMA, V16, P20, DOI 10.1097/IJG.0b013e31802b34e4; Bowd C, 2005, INVEST OPHTH VIS SCI, V46, P1322, DOI 10.1167/iovs.04-1122; Bowd C, 2002, INVEST OPHTH VIS SCI, V43, P3444; Bowd C, 2006, ACTA OPHTHALMOL SCAN, V84, P569; Bowd C, 2008, INVEST OPHTH VIS SCI, V49, P945, DOI 10.1167/iovs.07-1083; Bowd C, 2012, INVEST OPHTH VIS SCI, V53, P2382, DOI 10.1167/iovs.11-7951; Brigatti L, 1996, AM J OPHTHALMOL, V121, P511, DOI 10.1016/S0002-9394(14)75425-X; Burgansky-Eliash Z, 2005, INVEST OPHTH VIS SCI, V46, P4147, DOI 10.1167/iovs.05-0366; Chan K, 2003, J MACH LEARN RES, V3, P99, DOI 10.1162/153244303768966120; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Choudrey RA, 2003, NEURAL COMPUT, V15, P213, DOI 10.1162/089976603321043766; De Moraes CGV, 2012, ARCH OPHTHALMOL-CHIC, V130, P833, DOI 10.1001/archophthalmol.2012.786; DRANCE SM, 1972, BRIT J OPHTHALMOL, V56, P186, DOI 10.1136/bjo.56.3.186; DRANCE SM, 1969, INVEST OPHTH VISUAL, V8, P84; Goldbaum MH, 2005, INVEST OPHTH VIS SCI, V46, P3676, DOI 10.1167/iovs.04-1167; GOLDBAUM MH, 1994, INVEST OPHTH VIS SCI, V35, P3362; Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162; Goldbaum MH, 2012, INVEST OPHTH VIS SCI, V53, P6557, DOI 10.1167/iovs.11-8363; Goldbaum Michael H, 2009, Trans Am Ophthalmol Soc, V107, P136; Goldbaum Michael Henry, 2005, Trans Am Ophthalmol Soc, V103, P270; Grewal DS, 2008, EUR J OPHTHALMOL, V18, P915, DOI 10.1177/112067210801800610; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; Hothorn T, 2003, ARTIF INTELL MED, V27, P65, DOI 10.1016/S0933-3657(02)00085-4; Keltner JL, 2003, ARCH OPHTHALMOL-CHIC, V121, P643, DOI 10.1001/archopht.121.5.643; Kiviluoto K, 1998, ICONIP'98: THE FIFTH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING JOINTLY WITH JNNS'98: THE 1998 ANNUAL CONFERENCE OF THE JAPANESE NEURAL NETWORK SOCIETY - PROCEEDINGS, VOLS 1-3, P895; Lee TW, 2000, IEEE T PATTERN ANAL, V22, P1078, DOI 10.1109/34.879789; Lietman T, 1999, J GLAUCOMA, V8, P77; Maddess T, 2011, INVEST OPHTH VIS SCI, V52, P3759, DOI 10.1167/iovs.11-7405; MAKEIG S, 1996, ADV NEUR IN, V88, P145; McKay D, 1995, NETWORK COMPUTATION, P469; Racette L, 2008, INVEST OPHTH VIS SCI, V49, P954, DOI 10.1167/iovs.07-0493; Racette L, 2010, J GLAUCOMA, V19, P167, DOI 10.1097/IJG.0b013e3181a98b85; Sample PA, 2004, INVEST OPHTH VIS SCI, V45, P2596, DOI 10.1167/iovs.03-0343; Sample PA, 2000, INVEST OPHTH VIS SCI, V41, P1783; Skillicorn D, 2006, EMERGENT INFORM TECH, P331; SPENCELEY SE, 1994, OPHTHAL PHYSL OPT, V14, P239, DOI 10.1111/j.1475-1313.1994.tb00004.x; Swanson WH, 2011, INVEST OPHTH VIS SCI, V52, P764, DOI 10.1167/iovs.10-6158; Townsend KA, 2008, BRIT J OPHTHALMOL, V92, P814, DOI 10.1136/bjo.2007.133074; Turpin A, 2002, INVEST OPHTH VIS SCI, V43, P709; Turpin A, 2002, INVEST OPHTH VIS SCI, V43, P322; Uchida H, 1996, INVEST OPHTH VIS SCI, V37, P2393; Wall M, 2009, INVEST OPHTH VIS SCI, V50, P974, DOI 10.1167/iovs.08-1789; Wroblewski D, 2009, GRAEF ARCH CLIN EXP, V247, P1517, DOI 10.1007/s00417-009-1121-7; Zangwill LM, 2004, INVEST OPHTH VIS SCI, V45, P3144, DOI 10.1167/iovs.04-0202	46	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85941	10.1371/journal.pone.0085941	http://dx.doi.org/10.1371/journal.pone.0085941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497932	Green Published, gold			2022-12-25	WOS:000330617100011
J	Nunna, S; Reinhardt, R; Ragozin, S; Jeltsch, A				Nunna, Suneetha; Reinhardt, Richard; Ragozin, Sergey; Jeltsch, Albert			Targeted Methylation of the Epithelial Cell Adhesion Molecule (EpCAM) Promoter to Silence Its Expression in Ovarian Cancer Cells	PLOS ONE			English	Article							DNA METHYLATION; EP-CAM; ZINC FINGERS; TRANSCRIPTION FACTORS; EPIGENETIC MARKS; BREAST-CANCER; OVEREXPRESSION; CATUMAXOMAB; SELECTION; ANTIGEN	The Epithelial Cell Adhesion Molecule (EpCAM) is overexpressed in many cancers including ovarian cancer and EpCAM overexpression correlates with decreased survival of patients. It was the aim of this study to achieve a targeted methylation of the EpCAM promoter and silence EpCAM gene expression using an engineered zinc finger protein that specifically binds the EpCAM promoter fused to the catalytic domain of the Dnmt3a DNA methyltransferase. We show that transient transfection of this construct increased the methylation of the EpCAM promoter in SKOV3 cells from 4-8% in untreated cells to 30%. Up to 48% methylation was observed in stable cell lines which express the chimeric methyltransferase. Control experiments confirmed that the methylation was dependent on the fusion of the Zinc finger and the methyltransferase domains and specific for the target region. The stable cell lines with methylated EpCAM promoter showed a 60-80% reduction of EpCAM expression as determined at mRNA and protein level and exhibited a significantly reduced cell proliferation. Our data indicate that targeted methylation of the EpCAM promoter could be an approach in the therapy of EpCAM overexpressing cancers.	[Nunna, Suneetha; Ragozin, Sergey; Jeltsch, Albert] Univ Stuttgart, Inst Biochem, D-70174 Stuttgart, Germany; [Reinhardt, Richard] Max Planck Genomzentrum Koln, Cologne, Germany	University of Stuttgart; Max Planck Society	Jeltsch, A (corresponding author), Univ Stuttgart, Inst Biochem, D-70174 Stuttgart, Germany.	albert.jeltsch@ibc.uni-stuttgart.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290; Reinhardt, Richard/0000-0001-9376-2132	Sander Foundation; DAAD (Deutscher Akademischer Austauschdienst)	Sander Foundation; DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	This work has been supported by the Sander Foundation and the DAAD (Deutscher Akademischer Austauschdienst). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Barnholtz-Sloan JS, 2003, AM J OBSTET GYNECOL, V189, P1120, DOI 10.1067/S0002-9378(03)00579-9; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bokemeyer C, 2010, EXPERT OPIN BIOL TH, V10, P1259, DOI 10.1517/14712598.2010.504706; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Frampton JE, 2012, DRUGS, V72, P1399, DOI 10.2165/11209040-000000000-00000; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gommans WM, 2007, MOL CARCINOGEN, V46, P391, DOI 10.1002/mc.20289; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; JAMIESON AC, 1994, BIOCHEMISTRY-US, V33, P5689, DOI 10.1021/bi00185a004; Jeltsch A, 2007, APPL MICROBIOL BIOT, V75, P1233, DOI 10.1007/s00253-007-0966-0; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jurkowska RZ, 2010, METHODS MOL BIOL, V649, P149, DOI 10.1007/978-1-60761-753-2_9; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mostert B, 2009, CANCER TREAT REV, V35, P463, DOI 10.1016/j.ctrv.2009.03.004; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Oberneder R, 2006, EUR J CANCER, V42, P2530, DOI 10.1016/j.ejca.2006.05.029; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Rescigno P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852839; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Schwartzberg LS, 2001, CRIT REV ONCOL HEMAT, V40, P17, DOI 10.1016/S1040-8428(01)00131-7; Seimetz D, 2010, CANCER TREAT REV, V36, P458, DOI 10.1016/j.ctrv.2010.03.001; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Spizzo G, 2007, CANCER LETT, V246, P253, DOI 10.1016/j.canlet.2006.03.002; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Spizzo G, 2011, J CLIN PATHOL, V64, P415, DOI 10.1136/jcp.2011.090274; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Thiery JP, 1996, J CELL BIOCHEM, V61, P489; van der Gun BTF, 2013, BRIT J CANCER, V108, P881, DOI 10.1038/bjc.2013.45; van der Gun BTF, 2011, BRIT J CANCER, V105, P312, DOI 10.1038/bjc.2011.231; van der Gun BTF, 2008, INT J CANCER, V123, P484, DOI 10.1002/ijc.23476; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wimberger P, 2009, ANTICANCER RES, V29, P1787; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; WU H, 1995, P NATL ACAD SCI USA, V92, P344, DOI 10.1073/pnas.92.2.344; Xiang W, 2003, J CANCER RES CLIN, V129, P341, DOI 10.1007/s00432-003-0438-6; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Zhang Yingying, 2009, V507, P177, DOI 10.1007/978-1-59745-522-0_14	66	49	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87703	10.1371/journal.pone.0087703	http://dx.doi.org/10.1371/journal.pone.0087703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489952	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000172
J	Cremene, M; Dumitrescu, D; Cremene, L				Cremene, Marcel; Dumitrescu, D.; Cremene, Ligia			A Strategic Interaction Model of Punishment Favoring Contagion of Honest Behavior	PLOS ONE			English	Article							EVOLUTIONARY; CORRUPTION; EMERGENCE; TRAGEDY	The punishment effect on social behavior is analyzed within the strategic interaction framework of Cellular Automata and computational Evolutionary Game Theory. A new game, called Social Honesty (SH), is proposed. The SH game is analyzed in spatial configurations. Probabilistic punishment is used as a dishonesty deterrence mechanism. In order to capture the intrinsic uncertainty of social environments, payoffs are described as random variables. New dynamics, with a new relation between punishment probability and punishment severity, are revealed. Punishment probability proves to be more important than punishment severity in guiding convergence towards honesty as predominant behavior. This result is confirmed by empirical evidence and reported experiments. Critical values and transition intervals for punishment probability and severity are identified and analyzed. Clusters of honest or dishonest players emerge spontaneously from the very first rounds of interaction and are determinant for the future dynamics and outcomes.	[Cremene, Marcel; Cremene, Ligia] Tech Univ Cluj Napoca, Cluj Napoca, Romania; [Dumitrescu, D.] Univ Babes Bolyai, R-3400 Cluj Napoca, Romania	Technical University of Cluj Napoca; Babes Bolyai University from Cluj	Cremene, M (corresponding author), Tech Univ Cluj Napoca, Cluj Napoca, Romania.	cremene.marcel@gmail.com	Cremene, Marcel/AAO-9204-2021; Cremene, Ligia/AAG-3198-2021; Cremene, Marcel/AAG-3193-2021	Cremene, Ligia/0000-0003-1262-2221; Cremene, Marcel/0000-0003-2276-8662	 [TE 252];  [33/2010]	; 	This work was supported by the national grant TE 252, contract no. 33/2010, founded by CNCS-UEFISCDI of Romania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A, 2010, GAME OF LIFE CELLULAR AUTOMATA, P1, DOI 10.1007/978-1-84996-217-9; Aidt TS, 2009, OXFORD REV ECON POL, V25, P271, DOI 10.1093/oxrep/grp012; Akerlof George, 2009, ANIMAL SPIRITS HUMAN; Ariely D., 2012, HONEST TRUTH DISHONE; Axelrod R., 2006, EVOLUTION COOPERATIO; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Becker GS, 1974, ESSAYS EC CRIME PUNI; Binmore K., 2006, PAPERS EC EVOLUTION; Binmore K, 1998, GAME THEORY SOCIAL C; Bonabeau E, 2004, HARVARD BUS REV, V82, P135; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fukuyama F, 2000, GREAT DISRUPTION HUM; GARDNER M, 1970, SCI AM, V223, P120, DOI 10.1038/scientificamerican1070-120; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gladwell M., 2006, TIPPING POINT LITTLE; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Hofbauer J., 1998, EVOLUTIONARY GAMES P; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Nagin DS, 2001, CRIMINOLOGY, V39, P865, DOI 10.1111/j.1745-9125.2001.tb00943.x; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2012, J THEOR BIOL, V299, P1, DOI 10.1016/j.jtbi.2012.01.014; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Olson M., 1965, LOGIC COLLECTIVE ACT; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Rotberg RI, 2009, CORRUPTION, GLOBAL SECURITY, AND WORLD ORDER, P1; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Schuster HG, 2009, ANN REV NONLINEAR DY, V2; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; von Hirsch A, 1999, CRIMINAL DETERRENCE; vonNeumann J, 1951, CEREBRAL MECH BEHAV, P2070; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Watson JB, 1913, PSYCHOL REV, V20, P158, DOI 10.1037/h0074428	41	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87471	10.1371/journal.pone.0087471	http://dx.doi.org/10.1371/journal.pone.0087471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489917	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000134
J	Eves-van den Akker, S; Lilley, CJ; Ault, JR; Ashcroft, AE; Jones, JT; Urwin, PE				Eves-van den Akker, Sebastian; Lilley, Catherine J.; Ault, James R.; Ashcroft, Alison E.; Jones, John T.; Urwin, Peter E.			The Feeding Tube of Cyst Nematodes: Characterisation of Protein Exclusion	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; GREEN-FLUORESCENT PROTEIN; ION MOBILITY MEASUREMENTS; MASS-SPECTROMETRY; GLOMERULAR-FILTRATION; HETERODERA-SCHACHTII; ARABIDOPSIS-THALIANA; SIZE-SELECTIVITY; AGGREGATION; CELLS	Plant parasitic nematodes comprise several groups; the most economically damaging of these are the sedentary endoparasites. Sedentary endoparasitic nematodes are obligate biotrophs and modify host root tissue, using a suite of effector proteins, to create a feeding site that is their sole source of nutrition. They feed by withdrawing host cell assimilate from the feeding site though a structure known as the feeding tube. The function, composition and molecular characteristics of feeding tubes are poorly characterised. It is hypothesised that the feeding tube facilitates uptake of host cell assimilate by acting as a molecular sieve. Several studies, using molecular mass as the sole indicator of protein size, have given contradictory results about the exclusion limits of the cyst nematode feeding tube. In this study we propose a method to predict protein size, based on protein database coordinates in silico. We tested the validity of these predictions using travelling wave ion mobility spectrometry - mass spectrometry, where predictions and measured values were within approximately 6%. We used the predictions, coupled with mass spectrometry, analytical ultracentrifugation and protein electrophoresis, to resolve previous conflicts and define the exclusion characteristics of the cyst nematode feeding tube. Heterogeneity was tested in the liquid, solid and gas phase to provide a comprehensive evaluation of three proteins of particular interest to feeding tube size exclusion, GFP, mRFP and Dual PI. The data and procedures described here could be applied to the design of plant expressed defence compounds intended for uptake into cyst nematodes. We also highlight the need to assess protein heterogeneity when creating novel fusion proteins.	[Eves-van den Akker, Sebastian; Lilley, Catherine J.; Urwin, Peter E.] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Eves-van den Akker, Sebastian; Jones, John T.] James Hutton Inst, Dundee, Scotland; [Ault, James R.; Ashcroft, Alison E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds; James Hutton Institute; University of Leeds	Urwin, PE (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	P.E.Urwin@leeds.ac.uk	Ault, James R/O-8904-2019	Ault, James R/0000-0002-5131-438X; Urwin, Peter Edward/0000-0003-0398-2372; Jones, John/0000-0003-2074-0551; Eves-van den Akker, Sebastian/0000-0002-8833-9679	UK Biotechnology and Biological Sciences Research Council (BBSRC); James Hutton Institute; University of Leeds [SRIF4]; Scottish Government; BBSRC [BB/D009944/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [959589, BB/D009944/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); James Hutton Institute; University of Leeds; Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SEvdA was supported by a Ph.D. studentship jointly funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and The James Hutton Institute. The Synapt HDMS mass spectrometer was purchased with funds from the University of Leeds (SRIF4). The James Hutton Institute receives funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCKENHOFF A, 1994, PARASITOLOGY, V109, P249, DOI 10.1017/S003118200007637X; Carpenter JF, 1999, METHOD ENZYMOL, V309, P236; Cellmer T, 2007, TRENDS BIOTECHNOL, V25, P254, DOI 10.1016/j.tibtech.2007.03.011; Clemmer DE, 1997, J MASS SPECTROM, V32, P577; Edwards A, 1999, AM J PHYSIOL-RENAL, V276, pF892, DOI 10.1152/ajprenal.1999.276.6.F892; FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Goverse A, 1998, PHYSIOL MOL PLANT P, V52, P275, DOI 10.1006/pmpp.1998.0154; GUASCH A, 1993, J CLIN INVEST, V92, P2274, DOI 10.1172/JCI116831; Hogan CJ, 2011, J PHYS CHEM B, V115, P3614, DOI 10.1021/jp109172k; Hopper JTS, 2009, J AM SOC MASS SPECTR, V20, P1851, DOI 10.1016/j.jasms.2009.06.010; HUSSEY RS, 1991, PROTOPLASMA, V162, P99, DOI 10.1007/BF02562553; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Mack E, 1925, J AM CHEM SOC, V47, P2468, DOI 10.1021/ja01687a007; McCarter J, 2010, J NEMATOL, V42, P256; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Raso SW, 2005, PROTEIN SCI, V14, P2246, DOI 10.1110/ps.051489405; RAZAK AR, 1976, NEMATOLOGICA, V22, P182; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; RUMPENHORST HJ, 1984, NEMATOLOGICA, V30, P77, DOI 10.1163/187529284X00473; Rutschow HL, 2011, PLANT PHYSIOL, V155, P1817, DOI 10.1104/pp.110.168187; Shelimov KB, 1997, J AM CHEM SOC, V119, P2240, DOI 10.1021/ja9619059; Shvartsburg AA, 1998, J CHEM PHYS, V108, P2416, DOI 10.1063/1.475625; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; Shvartsburg AA, 2007, J PHYS CHEM A, V111, P2002, DOI 10.1021/jp066953m; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Sobczak M, 1999, NEMATOLOGY, V1, P363, DOI 10.1163/156854199508351; Tencer J, 1998, KIDNEY INT, V53, P709, DOI 10.1046/j.1523-1755.1998.00797.x; TERRY BR, 1987, PLANTA, V171, P145, DOI 10.1007/BF00391090; Treuheit MJ, 2002, PHARM RES-DORDR, V19, P511, DOI 10.1023/A:1015108115452; Trudgill DL, 1997, PLANT PATHOL, V46, P26, DOI 10.1046/j.1365-3059.1997.d01-201.x; Urwin PE, 1997, MOL PLANT MICROBE IN, V10, P394, DOI 10.1094/MPMI.1997.10.3.394; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; Valentine SJ, 1997, J PHYS CHEM B, V101, P3891, DOI 10.1021/jp970217o; Valentine TA, 2007, PLANT BIOTECHNOL J, V5, P827, DOI 10.1111/j.1467-7652.2007.00289.x; van Duijn E, 2009, J AM CHEM SOC, V131, P1452, DOI 10.1021/ja8055134; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; WYSS U, 1992, NETH J PLANT PATHOL, V98, P165, DOI 10.1007/BF01974483; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	43	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87289	10.1371/journal.pone.0087289	http://dx.doi.org/10.1371/journal.pone.0087289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489891	Green Published, gold			2022-12-25	WOS:000330510000125
J	Glebes, TY; Sandoval, NR; Reeder, PJ; Schilling, KD; Zhang, M; Gill, RT				Glebes, Tirzah Y.; Sandoval, Nicholas R.; Reeder, Philippa J.; Schilling, Katherine D.; Zhang, Min; Gill, Ryan T.			Genome-Wide Mapping of Furfural Tolerance Genes in Escherichia coli	PLOS ONE			English	Article							ETHANOL-PRODUCTION; LIPOPOLYSACCHARIDE BIOSYNTHESIS; SCALE IDENTIFICATION; OUTER-MEMBRANE; PLASMID DNA; OVEREXPRESSION; GROWTH; EXPRESSION; EVOLUTION; STRAINS	Advances in genomics have improved the ability to map complex genotype-to-phenotype relationships, like those required for engineering chemical tolerance. Here, we have applied the multiSCale Analysis of Library Enrichments (SCALEs; Lynch et al. (2007) Nat. Method.) approach to map, in parallel, the effect of increased dosage for >10(5) different fragments of the Escherichia coli genome onto furfural tolerance (furfural is a key toxin of lignocellulosic hydrolysate). Only 268 of >4,000 E. coli genes (similar to 6%) were enriched after growth selections in the presence of furfural. Several of the enriched genes were cloned and tested individually for their effect on furfural tolerance. Overexpression of thyA, lpcA, or groESL individually increased growth in the presence of furfural. Overexpression of lpcA, but not groESL or thyA, resulted in increased furfural reduction rate, a previously identified mechanism underlying furfural tolerance. We additionally show that plasmid-based expression of functional LpcA or GroESL is required to confer furfural tolerance. This study identifies new furfural tolerant genes, which can be applied in future strain design efforts focused on the production of fuels and chemicals from lignocellulosic hydrolysate.	[Glebes, Tirzah Y.; Sandoval, Nicholas R.; Reeder, Philippa J.; Schilling, Katherine D.; Gill, Ryan T.] Univ Colorado, Boulder, CO 80309 USA; [Zhang, Min] Natl Bioenergy Ctr, Natl Renewable Energy Lab, Golden, CO USA	University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Gill, RT (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	rtg@colorado.edu	Sandoval, Nicholas R./Y-5605-2019	Sandoval, Nicholas R./0000-0002-1743-3975	Department of Energy [ZCO-7-77431-001]; National Science Foundation [CBET 1067730]; National Science Foundation	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Department of Energy through subcontract no. ZCO-7-77431-001 to the National Renewable Energy Laboratory. This work was also supported by the National Science Foundation award number CBET 1067730. With the exception of study conception and roles consistent with authorship by MZ, the funding agencies had no role in the study design, data collection and analysis, or decision to publish. TYG and NRS were supported as National Science Foundation Graduate Research Fellowship Program recipients.	Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bonomo J, 2008, METAB ENG, V10, P109, DOI 10.1016/j.ymben.2007.10.002; Boyle NR, 2012, CURR OPIN BIOTECH, V23, P666, DOI 10.1016/j.copbio.2012.01.012; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Cho RJ, 1998, P NATL ACAD SCI USA, V95, P3752, DOI 10.1073/pnas.95.7.3752; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FRALICK JA, 1994, J BACTERIOL, V176, P6404, DOI 10.1128/jb.176.20.6404-6406.1994; Gall S, 2008, METAB ENG, V10, P382, DOI 10.1016/j.ymben.2008.08.003; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; Gill RT, 1998, BIOTECHNOL BIOENG, V59, P248, DOI 10.1002/(SICI)1097-0290(19980720)59:2<248::AID-BIT12>3.0.CO;2-A; Gutierrez T, 2006, J BIOTECHNOL, V121, P154, DOI 10.1016/j.jbiotec.2005.07.003; Gutierrez T, 2002, APPL BIOCHEM BIOTECH, V98, P327, DOI 10.1385/ABAB:98-100:1-9:327; HADI SM, 1989, MUTAT RES, V225, P101, DOI 10.1016/0165-7992(89)90125-5; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; KHAN QA, 1995, CANCER LETT, V89, P95, DOI 10.1016/0304-3835(95)90163-9; KHAN QA, 1993, BIOCHEM MOL BIOL INT, V29, P1153; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Martinez A, 2000, BIOTECHNOL PROGR, V16, P637, DOI 10.1021/bp0000508; Miller EN, 2010, BIOTECHNOL LETT, V32, P661, DOI 10.1007/s10529-010-0209-9; Miller EN, 2009, APPL ENVIRON MICROB, V75, P4315, DOI 10.1128/AEM.00567-09; Miller EN, 2009, APPL ENVIRON MICROB, V75, P6132, DOI 10.1128/AEM.01187-09; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nicolaou SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr817; NIKAIDO H, 1976, BIOCHIM BIOPHYS ACTA, V433, P118, DOI 10.1016/0005-2736(76)90182-6; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Sandoval NR, 2012, P NATL ACAD SCI US; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Shahabuddin Rahman A, 1991, FOOD CHEM TOXICOL, V29, P719; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Singh A, 2010, APPL ENVIRON MICROB, V76, P5463, DOI 10.1128/AEM.00583-10; Singh A, 2009, METAB ENG, V11, P347, DOI 10.1016/j.ymben.2009.07.002; Skerker JM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.30; Spindler EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055052; Struble JM, 2009, PLOS ONE, V4, pA6, DOI 10.1371/journal.pone.0006576; Taylor PL, 2008, J BIOL CHEM, V283, P2835, DOI 10.1074/jbc.M706163200; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JQ, 2012, BIOTECHNOL BIOENG, V109, P3133, DOI 10.1002/bit.24574; Wang X, 2011, APPL ENVIRON MICROB, V77, P5132, DOI 10.1128/AEM.05008-11; Wang X, 2013, P NATL ACAD SCI USA, V110, P4021, DOI 10.1073/pnas.1217958110; Wang X, 2012, APPL ENVIRON MICROB, V78, P2452, DOI 10.1128/AEM.07783-11; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Warnecke TE, 2008, METAB ENG, V10, P154, DOI 10.1016/j.ymben.2008.04.004; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Woodruff LBA, 2013, METAB ENG, V15, P124, DOI 10.1016/j.ymben.2012.10.007; Woodruff LBA, 2011, CURR OPIN BIOTECH, V22, P576, DOI 10.1016/j.copbio.2011.04.019; Woodruff LB, 2013, METAB ENG; YAMAMORI T, 1980, J BACTERIOL, V142, P843, DOI 10.1128/JB.142.3.843-851.1980; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yomano LP, 1998, J IND MICROBIOL BIOT, V20, P132, DOI 10.1038/sj.jim.2900496; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Zheng HB, 2013, APPL ENVIRON MICROB, V79, P3202, DOI 10.1128/AEM.00149-13; Zheng HB, 2012, APPL ENVIRON MICROB, V78, P4346, DOI 10.1128/AEM.00356-12; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18; Zingaro KA, 2013, METAB ENG, V15, P196, DOI 10.1016/j.ymben.2012.07.009; Zingaro KA, 2012, MBIO, V3, DOI 10.1128/mBio.00308-12	69	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87540	10.1371/journal.pone.0087540	http://dx.doi.org/10.1371/journal.pone.0087540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489935	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000142
J	Chattopadhyay, S; Kessler, SP; Colucci, JA; Yamashita, M; deS Senanayake, P; Sen, GC				Chattopadhyay, Saurabh; Kessler, Sean P.; Colucci, Juliana Almada; Yamashita, Michifumi; deS Senanayake, Preenie; Sen, Ganes C.			Tissue-Specific Expression of Transgenic Secreted ACE in Vasculature Can Restore Normal Kidney Functions, but Not Blood Pressure, of Ace-/- Mice	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; CLEAVAGE-SECRETION; DISTAL ECTODOMAIN; PHOSPHORYLATION; FERTILITY; SYSTEM	Angiotensin-converting enzyme (ACE) regulates normal blood pressure and fluid homeostasis through its action in the renin-angiotensin-system (RAS). Ace-/- mice are smaller in size, have low blood pressure and defective kidney structure and functions. All of these defects are cured by transgenic expression of somatic ACE (sACE) in vascular endothelial cells of Ace-/- mice. sACE is expressed on the surface of vascular endothelial cells and undergoes a natural cleavage secretion process to generate a soluble form in the body fluids. Both the tissue-bound and the soluble forms of ACE are enzymatically active, and generate the vasoactive octapeptide Angiotensin II (Ang II) with equal efficiency. To assess the relative physiological roles of the secreted and the cell-bound forms of ACE, we expressed, in the vascular endothelial cells of Ace-/- mice, the ectodomain of sACE, which corresponded to only the secreted form of ACE. Our results demonstrated that the secreted form of ACE could normalize kidney functions and RAS integrity, growth and development of Ace-/- mice, but not their blood pressure. This study clearly demonstrates that the secreted form of ACE cannot replace the tissue-bound ACE for maintaining normal blood pressure; a suitable balance between the tissue-bound and the soluble forms of ACE is essential for maintaining all physiological functions of ACE.	[Chattopadhyay, Saurabh; Kessler, Sean P.; Colucci, Juliana Almada; Yamashita, Michifumi; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA; [deS Senanayake, Preenie] Cleveland Clin, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sen, GC (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA.	seng@ccf.org	Colucci, Juliana/B-4513-2012; YAMASHITA, Michifumi/AFT-3479-2022; Chattopadhyay, Saurabh/I-4091-2019	Colucci, Juliana/0000-0003-3078-0514; Chattopadhyay, Saurabh/0000-0002-2930-1523; Yamashita, Michifumi/0000-0001-6221-8900	National Institutes of Health [HL-48258]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health grant HL-48258. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudrie V, 2007, AM J PHYSIOL-REG I, V292, pR904, DOI 10.1152/ajpregu.00488.2006; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Chattopadhyay S, 2005, J BIOL CHEM, V280, P33847, DOI 10.1074/jbc.M501718200; Chattopadhyay S, 2008, BIOCHEMISTRY-US, V47, P8335, DOI 10.1021/bi800702a; Cole J, 2000, J Renin Angiotensin Aldosterone Syst, V1, P137, DOI 10.3317/jraas.2000.016; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; Esther CR, 1996, LAB INVEST, V74, P953; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Guimaraes PB, 2011, HYPERTENSION, V57, P965, DOI 10.1161/HYPERTENSIONAHA.110.167171; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; Hsueh WA, 2011, J CLIN HYPERTENS, V13, P224, DOI 10.1111/j.1751-7176.2011.00449.x; Inoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078736; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kessler SP, 2007, FASEB J, V21, P156, DOI 10.1096/fj.06-6678com; Kessler SP, 2000, J BIOL CHEM, V275, P26259, DOI 10.1074/jbc.M004006200; Kessler SP, 2003, J BIOL CHEM, V278, P21105, DOI 10.1074/jbc.M3023472000; Kessler SP, 2002, J BIOL CHEM, V277, P4271, DOI 10.1074/jbc.M109474200; Kessler SP, 2005, J AM SOC NEPHROL; Kohlstedt K, 2006, MOL PHARMACOL, V69, P19, DOI 10.1124/mol.105.016733; Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Kohlstedt K, 2002, CIRC RES, V91, P749, DOI 10.1161/01.RES.0000038114.17939.C8; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Miyazaki M, 2006, J PHARMACOL SCI, V100, P391, DOI 10.1254/jphs.CPJ06008X; Navar LG, 1996, PHYSIOL REV, V76, P425, DOI 10.1152/physrev.1996.76.2.425; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Persu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059537; Ramaraj P, 1998, J CLIN INVEST, V102, P371, DOI 10.1172/JCI3545; Riordan JF, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-225; Sadhukhan R, 1998, P NATL ACAD SCI USA, V95, P138, DOI 10.1073/pnas.95.1.138; Safer R. L., 1981, BIOCH REGULATION BLO, P123; Santhamma KR, 2000, J BIOL CHEM, V275, P23253, DOI 10.1074/jbc.M000593200; Santhamma KR, 2004, J BIOL CHEM, V279, P40227, DOI 10.1074/jbc.M407176200; Senanayake PD, 1998, PEPTIDES, V19, P1685, DOI 10.1016/S0196-9781(98)00123-5; Siragy HM, 2003, ENDOCRINOLOGY, V144, P2229, DOI 10.1210/en.2003-0010; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Sturrock ED, 2012, HDB PROTEOLYTIC ENZY; Varagic J, 2013, AM J HYPERTENS; WEI L, 1991, J BIOL CHEM, V266, P5540	44	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87484	10.1371/journal.pone.0087484	http://dx.doi.org/10.1371/journal.pone.0087484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475296	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300191
J	Wan, GH; Wu, CL; Chen, YF; Huang, SH; Wang, YL; Chen, CW				Wan, Gwo-Hwa; Wu, Chieh-Liang; Chen, Yi-Fang; Huang, Sheng-Hsiu; Wang, Yu-Ling; Chen, Chun-Wan			Particle Size Concentration Distribution and Influences on Exhaled Breath Particles in Mechanically Ventilated Patients	PLOS ONE			English	Article								Humans produce exhaled breath particles (EBPs) during various breath activities, such as normal breathing, coughing, talking, and sneezing. Airborne transmission risk exists when EBPs have attached pathogens. Until recently, few investigations had evaluated the size and concentration distributions of EBPs from mechanically ventilated patients with different ventilation mode settings. This study thus broke new ground by not only evaluating the size concentration distributions of EBPs in mechanically ventilated patients, but also investigating the relationship between EBP level and positive expiratory end airway pressure (PEEP), tidal volume, and pneumonia. This investigation recruited mechanically ventilated patients, with and without pneumonia, aged 20 years old and above, from the respiratory intensive care unit of a medical center. Concentration distributions of EBPs from mechanically ventilated patients were analyzed with an optical particle analyzer. This study finds that EBP concentrations from mechanically ventilated patients during normal breathing were in the range 0.47-2,554.04 particles/breath (0.001-4.644 particles/mL). EBP concentrations did not differ significantly between the volume control and pressure control modes of the ventilation settings in the mechanically ventilated patients. The patient EBPs were sized below 5 mu m, and 80% of them ranged from 0.3 to 1.0 mu m. The EBPs concentrations in patients with high PEEP (> 5 cmH(2)O) clearly exceeded those in patients with low PEEP (<= 5 cmH(2)O). Additionally, a significant negative association existed between pneumonia duration and EBPs concentration. However, tidal volume was not related to EBPs concentration.	[Wan, Gwo-Hwa] Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan; [Wu, Chieh-Liang] Taichung Vet Gen Hosp, Dept Internal Med, Chiayi Branch, Chiayi, Taiwan; [Chen, Yi-Fang] Chung Shan Med Univ Hosp, Dept Resp Therapy, Taichung, Taiwan; [Huang, Sheng-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Wang, Yu-Ling] Taichung Vet Gen Hosp, Dept Resp Therapy, Taichung, Taiwan; [Chen, Chun-Wan] Council Labor Affairs, Inst Occupat Safety & Hlth, New Taipei City, Taiwan	Chang Gung University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; National Taiwan University; Taichung Veterans General Hospital	Wan, GH (corresponding author), Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan.	ghwan@mail.cgu.edu.tw		HUANG, SHENG-HSIU/0000-0003-1372-0480	Institute of Occupational Safety and Health of Taiwan [GMRPD1A0051, GMRPD1B0051]	Institute of Occupational Safety and Health of Taiwan	This study was supported by grants GMRPD1A0051 and GMRPD1B0051 from the Institute of Occupational Safety and Health of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Cheng CK, 2010, EDUC COMPET GLOB WOR, P1; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Edward DA, 2006, INHALING CATIONIC AE; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1080/15298668791385868; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Holmgren H, 2013, RESP PHYSIOL NEUROBI, V185, P228, DOI 10.1016/j.resp.2012.10.010; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Schwarz K, 2010, J AEROSOL MED PULM D, V23, P371, DOI 10.1089/jamp.2009.0809; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610	18	19	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87088	10.1371/journal.pone.0087088	http://dx.doi.org/10.1371/journal.pone.0087088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475230	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300137
J	Fujimaki, S; Hidaka, R; Asashima, M; Takemasa, T; Kuwabara, T				Fujimaki, Shin; Hidaka, Ryo; Asashima, Makoto; Takemasa, Tohru; Kuwabara, Tomoko			Wnt Protein-mediated Satellite Cell Conversion in Adult and Aged Mice Following Voluntary Wheel Running	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Exercise; Fibrosis; Sarcopenia; Wnt Signaling; Adult Stem Cells; Satellite Cells	RAT SKELETAL-MUSCLE; PHYSIOLOGICAL STIMULI; MUSCULAR-DYSTROPHY; BETA-CATENIN; STEM-CELLS; ACTIVATION; EXERCISE; ADAPTATIONS; OVERLOAD; FIBROSIS	Background: Satellite cells are activated in response to muscle injury or mechanical stimuli. Results: Running-induced up-regulation of Wnt/-catenin signaling activates Myf5 and MyoD transcription. Conclusion: Voluntary wheel running induces satellite cell activation by direct regulation of Wnt/-catenin signaling. Significance: Focusing on Wnt signaling may help to understand the function and intrinsic ability of satellite cells in adult myogenesis. Muscle represents an abundant, accessible, and replenishable source of adult stem cells. Skeletal muscle-derived stem cells, called satellite cells, play essential roles in regeneration after muscle injury in adult skeletal muscle. Although the molecular mechanism of muscle regeneration process after an injury has been extensively investigated, the regulation of satellite cells under steady state during the adult stage, including the reaction to exercise stimuli, is relatively unknown. Here, we show that voluntary wheel running exercise, which is a low stress exercise, converts satellite cells to the activated state due to accelerated Wnt signaling. Our analysis showed that up-regulated canonical Wnt/-catenin signaling directly modulated chromatin structures of both MyoD and Myf5 genes, resulting in increases in the mRNA expression of Myf5 and MyoD and the number of proliferative Pax7(+)Myf5(+) and Pax7(+) MyoD(+) cells in skeletal muscle. The effect of Wnt signaling on the activation of satellite cells, rather than Wnt-mediated fibrosis, was observed in both adult and aged mice. The association of -catenin, T-cell factor, and lymphoid enhancer transcription factors of multiple T-cell factor/lymphoid enhancer factor regulatory elements, conserved in mouse, rat, and human species, with the promoters of both the Myf5 and MyoD genes drives the de novo myogenesis in satellite cells even in aged muscle. These results indicate that exercise-stimulated extracellular Wnts play a critical role in the regulation of satellite cells in adult and aged skeletal muscle.	[Fujimaki, Shin; Hidaka, Ryo; Asashima, Makoto; Kuwabara, Tomoko] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3050046, Japan; [Fujimaki, Shin; Takemasa, Tohru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Kuwabara, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Cent 4,1-1-4 Higashi, Tsukuba, Ibaraki 3058562, Japan.	t.warashina@aist.go.jp	Asashima, Makoto/O-8389-2018; Kuwabara, Tomoko/M-1639-2018	Asashima, Makoto/0000-0002-0012-026X; Kuwabara, Tomoko/0000-0002-7668-0896	National Institute of Advanced Industrial Science and Technology; Takeda Science Foundation; Mitsubishi Foundation	National Institute of Advanced Industrial Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	Supported by the National Institute of Advanced Industrial Science and Technology.; Supported in part by a grant-in-aid for scientific research on innovative areas, The Takeda Science Foundation, and The Mitsubishi Foundation. To whom correspondence should be addressed: Research Center for Stem Cell Engineering, National Institute of Advanced Industrial Science and Technology, Central 4, 1-1-4 Higashi, Tsukuba Science City, Ibaraki 305-8562, Japan. Tel.: 81-29-861-2529; Fax: 81-29-861-2897; E-mail: t.warashina@aist.go.jp.	Allen DL, 2010, AM J PHYSIOL-REG I, V298, pR198, DOI 10.1152/ajpregu.00325.2009; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262; Aschenbach WG, 2006, AM J PHYSIOL-ENDOC M, V291, pE152, DOI 10.1152/ajpendo.00180.2005; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chapman MD, 2006, J IMMUNOL METHODS, V310, P62, DOI 10.1016/j.jim.2005.12.004; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; EIKELBOOM R, 1988, PHYSIOL BEHAV, V43, P625, DOI 10.1016/0031-9384(88)90217-X; Fujimaki S, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/420164; Hamada K, 2004, FASEB J, V18, P264, DOI 10.1096/fj.03-1286fje; Ikeda S, 2006, ACTA PHYSIOL, V188, P217, DOI 10.1111/j.1748-1716.2006.01623.x; Ishido M, 2006, ACTA PHYSIOL, V187, P407, DOI 10.1111/j.1748-1716.2006.01577.x; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuwabara T, 2011, EMBO MOL MED, V3, P742, DOI 10.1002/emmm.201100177; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; LAMBERT MI, 1990, J APPL PHYSIOL, V68, P400, DOI 10.1152/jappl.1990.68.1.400; Liao P, 2010, AM J PHYSIOL-REG I, V298, pR599, DOI 10.1152/ajpregu.00480.2009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Machida M, 2010, J PHYSIOL PHARMACOL, V61, P559; Marotta M, 2009, PHYSIOL GENOMICS, V37, P119, DOI 10.1152/physiolgenomics.90370.2008; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Rafael-Fortney JA, 2011, CIRCULATION, V124, P582, DOI 10.1161/CIRCULATIONAHA.111.031716; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Schultz RL, 2013, PHYSIOL RES, V62, P361, DOI 10.33549/physiolres.932330; Scime A, 2010, MECH AGEING DEV, V131, P9, DOI 10.1016/j.mad.2009.11.001; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Smith HK, 2012, ACTA PHYSIOL, V204, P393, DOI 10.1111/j.1748-1716.2011.02350.x; Smith HK, 2001, J APPL PHYSIOL, V90, P1407, DOI 10.1152/jappl.2001.90.4.1407; Swallow JG, 1999, J EXP BIOL, V202, P2513; Swallow JG, 2001, J COMP PHYSIOL B, V171, P651, DOI 10.1007/s003600100216; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Trensz F, 2010, AM J PHYSIOL-CELL PH, V299, pC939, DOI 10.1152/ajpcell.00253.2010; Tsivitse S, 2010, INT J BIOL SCI, V6, P268; UMNOVA MM, 1991, INT J SPORTS MED, V12, P501, DOI 10.1055/s-2007-1024723; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Yablonka-Reuveni Z., 2008, J ANIM SCI, V86, P207	53	45	56	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7399	7412		10.1074/jbc.M113.539247	http://dx.doi.org/10.1074/jbc.M113.539247			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482229	Green Published, hybrid			2022-12-25	WOS:000332761500012
J	Maehara, T; Fujimoto, Z; Ichinose, H; Michikawa, M; Harazono, K; Kaneko, S				Maehara, Tomoko; Fujimoto, Zui; Ichinose, Hitomi; Michikawa, Mari; Harazono, Koichi; Kaneko, Satoshi			Crystal Structure and Characterization of the Glycoside Hydrolase Family 62 alpha-L-Arabinofuranosidase from Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Kinetics; Enzyme Mechanisms; Enzyme Mutation; Enzyme Structure; -l-Arabinofuranosidase; Streptomyces coelicolor; Glycoside Hydrolase Family 62; Substrate Specificity	CARBOHYDRATE-BINDING MODULE; GEOBACILLUS-STEAROTHERMOPHILUS; SUBSTRATE SPECIFICITIES; PURIFICATION; XYLANASE; REVEALS; MECHANISM; SEQUENCE; EXO-1,5-ALPHA-L-ARABINOFURANOSIDASE; ARABINOFURANOHYDROLASE	Background: Glycoside hydrolase family 62 -l-arabinofuranosidases specifically release l-arabinose from arabinoxylan. Results: The crystal structure of glycoside hydrolase family 62 -l-arabinofuranosidase from Streptomyces coelicolor was determined. Conclusion: l-Arabinose and xylohexaose complexed structures revealed the mechanism of substrate specificity of this enzyme. Significance: Efficient catalysis by glycoside hydrolase family 62 -l-arabinofuranosidase requires its binding to terminal xylose sugars at the substrate-binding cleft. -l-Arabinofuranosidase, which belongs to the glycoside hydrolase family 62 (GH62), hydrolyzes arabinoxylan but not arabinan or arabinogalactan. The crystal structures of several -l-arabinofuranosidases have been determined, although the structures, catalytic mechanisms, and substrate specificities of GH62 enzymes remain unclear. To evaluate the substrate specificity of a GH62 enzyme, we determined the crystal structure of -l-arabinofuranosidase, which comprises a carbohydrate-binding module family 13 domain at its N terminus and a catalytic domain at its C terminus, from Streptomyces coelicolor. The catalytic domain was a five-bladed -propeller consisting of five radially oriented anti-parallel -sheets. Sugar complex structures with l-arabinose, xylotriose, and xylohexaose revealed five subsites in the catalytic cleft and an l-arabinose-binding pocket at the bottom of the cleft. The entire structure of this GH62 family enzyme was very similar to that of glycoside hydrolase 43 family enzymes, and the catalytically important acidic residues found in family 43 enzymes were conserved in GH62. Mutagenesis studies revealed that Asp(202) and Glu(361) were catalytic residues, and Trp(270), Tyr(461), and Asn(462) were involved in the substrate-binding site for discriminating the substrate structures. In particular, hydrogen bonding between Asn(462) and xylose at the nonreducing end subsite +2 was important for the higher activity of substituted arabinofuranosyl residues than that for terminal arabinofuranoses.	[Maehara, Tomoko; Ichinose, Hitomi; Michikawa, Mari; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Fujimoto, Zui] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Harazono, Koichi] Nagase ChemteX Corp, Enzyme Div, Bio Chem Dept, Fukuchiyama, Kyoto 6200853, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan	Kaneko, S (corresponding author), Natl Food Res Inst, Food Biotechnol Div, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	sakaneko@affrc.go.jp		Fujimoto, Zui/0000-0002-3551-6854	Japan Society for the Promotion of Science KAKENHI Grant [25450140]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 25450140.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; BELDMAN G, 1997, ADV MACROMOL CARB R, V1, P1; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; Carvalheiro F, 2008, J SCI IND RES INDIA, V67, P849; Chavas LMG, 2012, J SYNCHROTRON RADIAT, V19, P450, DOI 10.1107/S0909049512009727; Chiba S, 2012, BIOSCI BIOTECH BIOCH, V76, P215, DOI 10.1271/bbb.110713; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto Z, 2004, J BIOL CHEM, V279, P9606, DOI 10.1074/jbc.M312293200; Fujimoto Z, 2008, ACTA CRYSTALLOGR F, V64, P1007, DOI 10.1107/S1744309108029692; Fujimoto Z, 2010, J BIOL CHEM, V285, P34134, DOI 10.1074/jbc.M110.164251; Hatanaka T, 2008, PROTEIN EXPRES PURIF, V62, P244, DOI 10.1016/j.pep.2008.09.001; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Ichinose H, 2010, PLANT BIOTECHNOL-NAR, V27, P259, DOI 10.5511/plantbiotechnology.27.259; Ito S, 2004, J BIOTECHNOL, V110, P137, DOI 10.1016/j.jbiotec.2004.01.014; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P695, DOI 10.1271/bbb.62.695; KANEKO S, 1993, BIOSCI BIOTECH BIOCH, V57, P1161, DOI 10.1271/bbb.57.1161; KANEKO S, 1994, APPL ENVIRON MICROB, V60, P3425, DOI 10.1128/AEM.60.9.3425-3428.1994; KANEKO S, 1995, BIOSCI BIOTECH BIOCH, V59, P2132, DOI 10.1271/bbb.59.2132; Kaneko S, 1998, APPL ENVIRON MICROB, V64, P4021; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P2205, DOI 10.1271/bbb.62.2205; Kaneko S, 1998, J FERMENT BIOENG, V85, P518, DOI 10.1016/S0922-338X(98)80073-1; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; KORMELINK FJM, 1993, CARBOHYD RES, V249, P345, DOI 10.1016/0008-6215(93)84099-R; KUSAKABE I, 1975, J AGR CHEM SOC JPN, V49, P295, DOI 10.1271/nogeikagaku1924.49.295; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Miyanaga A, 2006, BIOCHEM J, V399, P503, DOI 10.1042/BJ20060567; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pauly M, 2013, PLANTA, V238, P627, DOI 10.1007/s00425-013-1921-1; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Saha BC, 2000, BIOTECHNOL ADV, V18, P403, DOI 10.1016/S0734-9750(00)00044-6; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P137, DOI 10.1007/s00253-010-2988-2; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Siguier B, 2014, J BIOL CHEM, V289, P5261, DOI 10.1074/jbc.M113.528133; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; Vincent P, 1997, BIOCHEM J, V322, P845, DOI 10.1042/bj3220845; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078; YOSHIDA S, 1990, AGR BIOL CHEM TOKYO, V54, P449, DOI 10.1080/00021369.1990.10869948	61	32	32	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7962	7972		10.1074/jbc.M113.540542	http://dx.doi.org/10.1074/jbc.M113.540542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482228	hybrid, Green Published			2022-12-25	WOS:000332761500060
J	Melo, RDC; Longhini, AL; Bigarella, CL; Baratti, MO; Traina, F; Favaro, P; Campos, PD; Saad, STO				Carvalho Melo, Rita de Cassia; Longhini, Ana Leda; Bigarella, Carolina Louzao; Baratti, Mariana Ozello; Traina, Fabiola; Favaro, Patricia; Campos, Paula de Melo; Olalla Saad, Sara Teresinha			CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; CELL-MIGRATION; VASCULAR ENDOTHELIUM; BETA-ARRESTIN; CD34(+) CELLS; PROTEIN; SDF-1; CROSSTALK; SURVIVAL; BINDS	Recently, a novel CXCL12-binding receptor, has been identified. This CXCL12-binding receptor commonly known as CXCR7 (CXC chemokine receptor 7), has lately, based on a novel nomenclature, has received the name ACKR3 (atypical chemokine receptor 3). In this study, we aimed to investigate the expression of CXCR7 in leukemic cells, as well as its participation in CXCL12 response. Interesting, we clearly demonstrated that CXCR7 is highly expressed in acute lymphoid leukemic cells compared with myeloid or normal hematopoietic cells and that CXCR7 contributed to T-acute lymphoid leukemic cell migration induced by CXCL12. Moreover, we showed that the cellular location of CXCR7 varied among T-lymphoid cells and this finding may be related to their migration capacity. Finally, we hypothesized that CXCR7 potentiates CXCR4 response and may contribute to the maintenance of leukemia by initiating cell recruitment to bone marrow niches that were once occupied by normal hematopoietic stem cells.	[Carvalho Melo, Rita de Cassia; Longhini, Ana Leda; Bigarella, Carolina Louzao; Baratti, Mariana Ozello; Traina, Fabiola; Favaro, Patricia; Campos, Paula de Melo; Olalla Saad, Sara Teresinha] Univ Estadual Campinas, Ctr Hematol & Hemoterapia, Sao Paulo, Brazil; [Favaro, Patricia] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	Melo, RDC (corresponding author), Univ Estadual Campinas, Ctr Hematol & Hemoterapia, Sao Paulo, Brazil.	ritacmelo@hotmail.com	Traina, Fabiola/L-3809-2014; Traina, Fabiola/U-1451-2019; De Melo Campos, Paula/HIK-1076-2022; CTC USP, CEPID 13 18/J-8951-2014	Traina, Fabiola/0000-0003-4258-289X; Traina, Fabiola/0000-0003-4258-289X; CTC USP, CEPID 13 18/0000-0002-7123-9524	Aperfeicoamento Pessoal de Nivel Superior (CAPES); CNPq; FAPESP; INCT-Sangue	Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT-Sangue	This study was funded by grants from Aperfeicoamento Pessoal de Nivel Superior (CAPES). The authors also thank CNPq, FAPESP, and INCT-Sangue for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; Bigarella CL, 2009, BBA-MOL CELL RES, V1793, P806, DOI 10.1016/j.bbamcr.2009.02.010; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Broustas CG, 2012, J BIOL CHEM, V287, P41324, DOI 10.1074/jbc.M112.402784; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Butler JT, 2009, J NEUROSCI RES, V87, P626, DOI 10.1002/jnr.21882; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Faaij CMJM, 2010, PEDIATR BLOOD CANCER, V55, P344, DOI 10.1002/pbc.22500; Favaro P, 2013, J LEUKOCYTE BIOL, V94, P503, DOI 10.1189/jlb.0113057; Grymula K, 2010, INT J CANCER, V127, P2554, DOI 10.1002/ijc.25245; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Kucia M, 2004, J MOL HISTOL, V35, P233; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li T, 2011, J PATHOL, V223, P519, DOI 10.1002/path.2829; Lodowski DT, 2009, CURR OPIN HIV AIDS, V4, P88, DOI 10.1097/COH.0b013e3283223d8d; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Mahabaleshwar H, 2008, CELL ADHES MIGR, V2, P69, DOI 10.4161/cam.2.2.6027; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Monnier J, 2012, EUR J CANCER, V48, P138, DOI 10.1016/j.ejca.2011.06.044; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Ottoson NC, 2001, J IMMUNOL, V167, P1857, DOI 10.4049/jimmunol.167.4.1857; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Shimizu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020680; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Traina F, 2003, FEBS LETT, V535, P17, DOI 10.1016/S0014-5793(02)03845-0; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Werner L, 2011, J LEUKOCYTE BIOL, V90, P583, DOI 10.1189/jlb.0111101; Yao X, 2011, J INT MED RES, V39, P1253, DOI 10.1177/147323001103900413; Yoshida D, 2009, J NEUROENDOCRINOL, V21, P481, DOI 10.1111/j.1365-2826.2009.01867.x; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73	52	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85926	10.1371/journal.pone.0085926	http://dx.doi.org/10.1371/journal.pone.0085926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497931	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900012
J	Attri, P; Baik, KY; Venkatesu, P; Kim, IT; Choi, EH				Attri, Pankaj; Baik, Ku Youn; Venkatesu, Pannuru; Kim, In Tae; Choi, Eun Ha			Influence of Hydroxyl Group Position and Temperature on Thermophysical Properties of Tetraalkylammonium Hydroxide Ionic Liquids with Alcohols	PLOS ONE			English	Article							EXCESS MOLAR VOLUMES; BINARY-MIXTURES; PHYSICAL-PROPERTIES; THERMODYNAMIC PROPERTIES; STRUCTURAL-CHARACTERIZATION; MOLECULAR-INTERACTIONS; CHAIN-LENGTH; DENSITIES; SOLVENTS; WATER	In this work, we have explored the thermophysical properties of tetraalkylammonium hydroxide ionic liquids (ILs) such as tetrapropylammonium hydroxide (TPAH) and tetrabutylammonium hydroxide (TBAH) with isomers of butanol (1-butanol, 2-butanol and 2-methyl-2-propanol) within the temperature range 293.15-313.15 K, with interval of 5 K and over the varied concentration range of ILs. The molecular interactions between ILs and butanol isomers are essential for understanding the function of ILs in related measures and excess functions are sensitive probe for the molecular interactions. Therefore, we calculated the excess molar volume (V-E) and the deviation in isentropic compressibility (Delta kappa(s)) using the experimental values such as densities (rho) and ultrasonic sound velocities (u) that are measured over the whole compositions range at five different temperatures (293.15, 298.15, 303.15, 308.15 and 313.15 K) and atmospheric pressure. These excess functions were adequately correlated by using the Redlich-Kister polynomial equation. It was observed that for all studied systems, the V-E and Delta kappa(s) values are negative for the whole composition range at 293.15 K. And, the excess function follows the sequence: 2-butanol>1-butanol>2-methyl-2-propanol, which reveals that (primary or secondary or tertiary) position of hydroxyl group influence the magnitude of interactions with ILs. The negative values of excess functions are contributions from the ion-dipole interaction, hydrogen bonding and packing efficiency between the ILs and butanol isomers. Hence, the position of hydroxyl group plays an important role in the interactions with ILs. The hydrogen bonding features between ILs and alcohols were analysed using molecular modelling program by using HyperChem 7.	[Attri, Pankaj; Baik, Ku Youn; Choi, Eun Ha] Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea; [Venkatesu, Pannuru] Univ Delhi, Dept Chem, Delhi 110007, India; [Kim, In Tae] Kwangwoon Univ, Dept Chem, Seoul, South Korea	Kwangwoon University; University of Delhi; Kwangwoon University	Attri, P (corresponding author), Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea.	chem.pankaj@gmail.com; ehchoi@kw.ac.kr	Attri, Pankaj/ABE-7522-2020; Choi, Eun Ha/AFN-9488-2022	Attri, Pankaj/0000-0002-5036-7877; Choi, Eun Ha/0000-0001-5385-1878	SRC program of National Research Foundation of Korea (NRF); Korean Government (MEST) [20100029418]; Kwangwoon University	SRC program of National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Kwangwoon University	We gratefully acknowledge SRC program of National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (No. 20100029418) and in part by Kwangwoon University 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abareshi M, 2009, J MOL LIQ, V149, P66, DOI 10.1016/j.molliq.2009.08.004; Alvarez VH, 2011, J CHEM THERMODYN, V43, P997, DOI 10.1016/j.jct.2011.01.014; Annat G, 2012, J PHYS CHEM B, V116, P8251, DOI 10.1021/jp3012602; Anouti M, 2010, J CHEM ENG DATA, V55, P5719, DOI 10.1021/je100671v; Arce A, 2006, J SOLUTION CHEM, V35, P63, DOI 10.1007/s10953-006-8939-y; Attri P., 2013, PLOS ONE, V88, DOI [DOI 10.1371/J0URNAL.P0NE.0068970, 10.1371/journal.pone.0068970.]; Attri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075096; Attri P, 2012, ORG BIOMOL CHEM, V10, P7475, DOI 10.1039/c2ob26001h; Attri P, 2011, J PHYS CHEM B, V115, P10086, DOI 10.1021/jp2059084; Attri P, 2011, PHYS CHEM CHEM PHYS, V13, P2788, DOI 10.1039/c0cp01291b; Attri P, 2010, J PHYS CHEM B, V114, P13415, DOI 10.1021/jp108003x; Attri P, 2010, J PHYS CHEM B, V114, P6126, DOI 10.1021/jp101209j; Capelo SB, 2012, J PHYS CHEM B, V116, P11302, DOI 10.1021/jp3066822; Bravo-Sanchez MG, 2010, J CHEM ENG DATA, V55, P2310, DOI 10.1021/je900722m; Chen T, 2010, J PHYS CHEM B, V114, P5790, DOI 10.1021/jp911372j; Chiappe C, 2011, J PHYS CHEM B, V115, P9653, DOI 10.1021/jp2045788; Couadou E, 2013, J PHYS CHEM B, V117, P1389, DOI 10.1021/jp308139r; Davis JH, 2004, CHEM LETT, V33, P1072, DOI 10.1246/cl.2004.1072; de Cominges BE, 2002, J THERM ANAL CALORIM, V70, P217, DOI 10.1023/A:1020626205538; Deetlefs M, 2006, PHYS CHEM CHEM PHYS, V8, P642, DOI 10.1039/b513453f; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3898, DOI 10.1021/ja00299a023; Domanska U, 2012, J CHEM THERMODYN, V48, P101, DOI 10.1016/j.jct.2011.12.003; Dominguez M, 2000, J CHEM THERMODYN, V32, P1551; Fox ET, 2013, J PHYS CHEM C, V117, P78, DOI 10.1021/jp3089403; Gnanakumari P, 2007, FLUID PHASE EQUILIBR, V252, P137, DOI 10.1016/j.fluid.2006.12.012; Gomez E, 2012, J CHEM THERMODYN, V45, P9, DOI 10.1016/j.jct.2011.08.028; Gonzalez B, 2008, J CHEM ENG DATA, V53, P881, DOI 10.1021/je700700f; Gonzalez EJ, 2007, J CHEM ENG DATA, V52, P1641, DOI 10.1021/je700029q; Gonzalez EJ, 2013, J CHEM ENG DATA, V58, P1440, DOI 10.1021/je300384g; Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u; Hou MY, 2013, J MOL LIQ, V178, P149, DOI 10.1016/j.molliq.2012.11.030; Huq F, 2002, J MOL MODEL, V8, P81, DOI 10.1007/s00894-002-0073-1; Janikowski J, 2013, CHEMPLUSCHEM, V78, P486, DOI 10.1002/cplu.201300068; Jiang HC, 2012, J CHEM THERMODYN, V47, P203, DOI 10.1016/j.jct.2011.10.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kavitha T, 2012, J PHYS CHEM B, V116, P4561, DOI 10.1021/jp3015386; Lachwa J, 2006, J CHEM ENG DATA, V51, P2215, DOI 10.1021/je060307z; Lehmann J, 2010, J CHEM ENG DATA, V55, P4068, DOI 10.1021/je1002237; Liu ZP, 2006, PHYS CHEM CHEM PHYS, V8, P1096, DOI 10.1039/b515905a; Marsh KN, 2004, FLUID PHASE EQUILIBR, V219, P93, DOI 10.1016/j.fluid.2004.02.003; Mokhtarani B, 2009, J CHEM THERMODYN, V41, P1432, DOI 10.1016/j.jct.2009.06.023; Nain AK, 2007, J SOLUTION CHEM, V36, P497, DOI 10.1007/s10953-007-9122-9; Noda A, 2003, J PHYS CHEM B, V107, P4024, DOI 10.1021/jp022347p; Pereiro AB, 2007, J CHEM THERMODYN, V39, P1168, DOI 10.1016/j.jct.2006.12.005; Pop E, 1997, INT J QUANTUM CHEM, V65, P1057, DOI 10.1002/(SICI)1097-461X(1997)65:6<1057::AID-QUA4>3.0.CO;2-U; Qian W, 2012, J CHEM THERMODYN, V49, P87, DOI 10.1016/j.jct.2012.01.013; Reddy PM, 2011, J PHYS CHEM B, V115, P4752, DOI 10.1021/jp201826v; Riddick J.A., 1986, TECHNIQUES CHEM, V4; Rilo E, 2010, FLUID PHASE EQUILIBR, V296, P53, DOI 10.1016/j.fluid.2010.03.039; Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313; Seddon KR, 1997, J CHEM TECHNOL BIOT, V68, P351, DOI 10.1002/(SICI)1097-4660(199704)68:4<351::AID-JCTB613>3.0.CO;2-4; Vercher E, 2007, J CHEM ENG DATA, V52, P1468, DOI 10.1021/je7001804; Weng WL, 1999, J CHEM ENG DATA, V44, P788, DOI 10.1021/je980283z; Wilkes JS, 2004, J MOL CATAL A-CHEM, V214, P11, DOI 10.1016/j.molcata.2003.11.029; Zhang SJ, 2006, J PHYS CHEM REF DATA, V35, P1475, DOI 10.1063/1.2204959; Zhu AL, 2011, J CHEM THERMODYN, V43, P796, DOI 10.1016/j.jct.2010.12.027	56	33	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86530	10.1371/journal.pone.0086530	http://dx.doi.org/10.1371/journal.pone.0086530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489741	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000046
J	Chen, DF; Zuo, D; Luan, C; Liu, M; Na, ML; Ran, L; Sun, YY; Persson, A; Englund, E; Salford, LG; Renstrom, E; Fan, XL; Zhang, EM				Chen, Dongfeng; Zuo, Duo; Luan, Cheng; Liu, Min; Na, Manli; Ran, Liang; Sun, Yingyu; Persson, Annette; Englund, Elisabet; Salford, Leif G.; Renstrom, Erik; Fan, Xiaolong; Zhang, Enming			Glioma Cell Proliferation Controlled by ERK Activity-Dependent Surface Expression of PDGFRA	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NEURAL STEM-CELLS; CLATHRIN-MEDIATED ENDOCYTOSIS; INTEGRATED GENOMIC ANALYSIS; ALPHA-RECEPTOR EXPRESSION; GROWTH-FACTOR RECEPTOR; MALIGNANT GLIOMAS; GLIAL PROGENITORS; TUMOR-SUPPRESSOR; BRAIN-TUMORS	Increased PDGFRA signaling is an essential pathogenic factor in many subtypes of gliomas. In this context the cell surface expression of PDGFRA is an important determinant of ligand sensing in the glioma microenvironment. However, the regulation of spatial distribution of PDGFRA in glioma cells remains poorly characterized. Here, we report that cell surface PDGFRA expression in gliomas is negatively regulated by an ERK-dependent mechanism, resulting in reduced proliferation of glioma cells. Glioma tumor tissues and their corresponding cell lines were isolated from 14 patients and analyzed by single-cell imaging and flow cytometry. In both cell lines and their corresponding tumor samples, glioma cell proliferation correlated with the extent of surface expression of PDGFRA. High levels of surface PDGFRA also correlated to high tubulin expression in glioma tumor tissue in vivo. In glioma cell lines, surface PDGFRA declined following treatment with inhibitors of tubulin, actin and dynamin. Screening of a panel of small molecule compounds identified the MEK inhibitor U0126 as a potent inhibitor of surface PDGFRA expression. Importantly, U0126 inhibited surface expression in a reversible, dose-and time-dependent manner, without affecting general PDGFRA expression. Treatment with U0126 resulted in reduced co-localization between PDGFRA and intracellular trafficking molecules e. g. clathrin, RAB11 and early endosomal antigen-1, in parallel with enhanced co-localization between PDGFRA and the Golgi cisternae maker, Giantin, suggesting a deviation of PDGFRA from the endosomal trafficking and recycling compartment, to the Golgi network. Furthermore, U0126 treatment in glioma cells induced an initial inhibition of ERK1/2 phosphorylation, followed by up-regulated ERK1/2 phosphorylation concomitant with diminished surface expression of PDGFRA. Finally, down-regulation of surface PDGFRA expression by U0126 is concordant with reduced glioma cell proliferation. These findings suggest that manipulation of spatial expression of PDGFRA can potentially be used to combat gliomas.	[Chen, Dongfeng; Liu, Min; Na, Manli; Salford, Leif G.] Lund Univ, Dept Neurosurg, Rausing Lab, Lund, Sweden; [Zuo, Duo; Ran, Liang; Sun, Yingyu; Fan, Xiaolong] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Beijing 100875, Peoples R China; [Persson, Annette; Englund, Elisabet] Lund Univ, Dept Pathol, Lund, Sweden; [Luan, Cheng; Renstrom, Erik; Zhang, Enming] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University; Beijing Normal University; Lund University; Lund University	Fan, XL (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Beijing 100875, Peoples R China.	xfan@bnu.edu.cn; enming.zhang@med.lu.se	Na, Manli/AAM-9864-2020; Zhang, Enming/B-9438-2013	Zhang, Enming/0000-0002-0401-4608; Luan, Cheng/0000-0003-4466-0687; Na, Manli/0000-0002-7306-8941; Englund, Elisabet/0000-0002-2708-2443	National Natural Science Foundation of China [81072080]; Ministry of Science and Technology of China [2012DFA30470]; Hans and Marit Rausing Charitable Foundation; Swedish Research Council [12234]; EU; collaborative SRC grant; Swedish Strategic Research EXODIAB	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hans and Marit Rausing Charitable Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); collaborative SRC grant; Swedish Strategic Research EXODIAB	This study was supported by National Natural Science Foundation of China (grant 81072080), international collaborative program of the Ministry of Science and Technology of China (grant 2012DFA30470), and the Hans and Marit Rausing Charitable Foundation. The study was also supported by grants to E.R. from the Swedish Research Council (project 12234), clinical research grants (ALF). EZ's position receives funding from the EU Integrated project BetaBat and a collaborative SRC grant, as well as the Swedish Strategic Research EXODIAB. This work was done using imaging equipment financed by the Knut and Alice Wallenberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chen DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061556; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chojnacki A, 2011, J NEUROSCI, V31, P9503, DOI 10.1523/JNEUROSCI.1531-11.2011; Clarke ID, 2003, ONCOGENE, V22, P722, DOI 10.1038/sj.onc.1206160; Colello D, 2012, J BIOL CHEM, V287, P2520, DOI 10.1074/jbc.M111.254128; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fukazawa H, 2000, CANCER RES, V60, P2104; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Lokker NA, 2002, CANCER RES, V62, P3729; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mariani L, 2006, J CLIN ONCOL, V24, P4758, DOI 10.1200/JCO.2006.05.9238; Martinho O, 2009, BRIT J CANCER, V101, P973, DOI 10.1038/sj.bjc.6605225; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Neel NF, 2012, MOL CELL BIOL, V32, P1374, DOI 10.1128/MCB.06291-11; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Rand V, 2005, P NATL ACAD SCI USA, V102, P14344, DOI 10.1073/pnas.0507200102; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Uhrbom L, 1998, CANCER RES, V58, P5275; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe K, 2010, CLIN CANCER RES, V16, P1170, DOI 10.1158/1078-0432.CCR-09-2482; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Yip-Schneider MT, 2009, J PHARMACOL EXP THER, V329, P1063, DOI 10.1124/jpet.108.147306; Zhang J, 2013, NAT GENET; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	66	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87281	10.1371/journal.pone.0087281	http://dx.doi.org/10.1371/journal.pone.0087281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489888	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000129
J	Leimgruber, KL; Ward, AF; Widness, J; Norton, MI; Olson, KR; Gray, K; Santos, LR				Leimgruber, Kristin L.; Ward, Adrian F.; Widness, Jane; Norton, Michael I.; Olson, Kristina R.; Gray, Kurt; Santos, Laurie R.			Give What You Get: Capuchin Monkeys (Cebus apella) and 4-Year-Old Children Pay Forward Positive and Negative Outcomes to Conspecifics	PLOS ONE			English	Article							EXPERIMENTER-GIVEN CUES; INDIRECT RECIPROCITY; UPSTREAM RECIPROCITY; PROSOCIAL BEHAVIOR; PUBLIC-GOODS; EVOLUTION; COOPERATION; REPUTATION; GRATITUDE; ALTRUISM	The breadth of human generosity is unparalleled in the natural world, and much research has explored the mechanisms underlying and motivating human prosocial behavior. Recent work has focused on the spread of prosocial behavior within groups through paying-it-forward, a case of human prosociality in which a recipient of generosity pays a good deed forward to a third individual, rather than back to the original source of generosity. While research shows that human adults do indeed pay forward generosity, little is known about the origins of this behavior. Here, we show that both capuchin monkeys (Cebus apella) and 4-year-old children pay forward positive and negative outcomes in an identical testing paradigm. These results suggest that a cognitively simple mechanism present early in phylogeny and ontogeny leads to paying forward positive, as well as negative, outcomes.	[Leimgruber, Kristin L.; Widness, Jane; Olson, Kristina R.; Santos, Laurie R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Ward, Adrian F.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Norton, Michael I.] Harvard Univ, Harvard Business Sch, Boston, MA 02115 USA; [Gray, Kurt] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Yale University; Harvard University; Harvard University; University System of Maryland; University of Maryland College Park	Leimgruber, KL (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	Kleimgruber@gmail.com	Ward, Adrian F/M-7961-2018	Ward, Adrian F/0000-0001-8318-7963; Gray, Kurt/0000-0001-5816-2676; Widness, Jane/0000-0002-9284-2066	Templeton Positive Neuroscience Award; National Science Foundation Research Experiences for Undergraduates Program [SMA-1004797]	Templeton Positive Neuroscience Award; National Science Foundation Research Experiences for Undergraduates Program(National Science Foundation (NSF))	This research was supported in part by funding from The Templeton Positive Neuroscience Award and the National Science Foundation Research Experiences for Undergraduates Program (SMA-1004797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred KG, 1997, ORGAN BEHAV HUM DEC, V70, P175, DOI 10.1006/obhd.1997.2705; ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; ANDERSON JR, 1989, PRIMATES, V30, P581, DOI 10.1007/BF02380884; Andreoni J, 2004, J PUBLIC ECON, V88, P1605, DOI 10.1016/S0047-2727(03)00040-9; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Barnes JL, 2008, BIOL LETTERS, V4, P638, DOI 10.1098/rsbl.2008.0410; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Barta Z, 2011, P ROY SOC B-BIOL SCI, V278, P843, DOI 10.1098/rspb.2010.1634; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Batson C.D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; BenZeev A, 1996, J THEOR SOC BEHAV, V26, P81, DOI 10.1111/j.1468-5914.1996.tb00287.x; Beran MJ, 2009, J EXP PSYCHOL-ANIM B, V35, P371, DOI 10.1037/a0014626; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Buhrmester D., 1992, J EARLY ADOLESCENCE, V12, P61, DOI [10.1177/0272431692012001004, DOI 10.1177/0272431692012001004]; CUNNINGHAM MR, 1980, J PERS SOC PSYCHOL, V38, P181, DOI 10.1037/0022-3514.38.2.181; Dana J, 2007, ECON THEOR, V33, P67, DOI 10.1007/s00199-006-0153-z; Dawkins MS, 2000, AM ZOOL, V40, P883, DOI 10.1668/0003-1569(2000)040[0883:AMAAE]2.0.CO;2; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; de Waal FBM, 2010, PHILOS T R SOC B, V365, P2711, DOI 10.1098/rstb.2010.0119; Dufwenberg M, 2000, EXPT TEST DIRECT IND; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Emerson RW, 1841, COMPENSATION ESSAYS; Emmons RA, 2000, J SOC CLIN PSYCHOL, V19, P56, DOI 10.1521/jscp.2000.19.1.56; Epley N, 2006, J PERS SOC PSYCHOL, V91, P872, DOI 10.1037/0022-3514.91.5.872; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FLAVELL JH, 1995, MONOGR SOC RES CHILD, V60, pR5; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Franklin B, 1784, COMMUNICATION; Gallup GG, 1998, BEHAV PROCESS, V42, P239, DOI 10.1016/S0376-6357(97)00079-X; Grant A, 2012, PSYCHOL SCI, V23, P1033, DOI 10.1177/0956797612439424; Gray K, 2012, J EXP PSYCHOL GEN, V142, P1; Greiner B, 2005, J ECON PSYCHOL, V26, P711, DOI 10.1016/j.joep.2004.04.003; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Gustison ML, 2012, STRESS, V15, P608, DOI 10.3109/10253890.2012.668589; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Hare B, 2003, ANIM BEHAV, V65, P131, DOI 10.1006/anbe.2002.2017; Hattori Y, 2010, ANIM COGN, V13, P87, DOI 10.1007/s10071-009-0248-6; Henrich J, 2003, DAHL WS ENV, P445; ISEN AM, 1972, J PERS SOC PSYCHOL, V21, P384, DOI 10.1037/h0032317; Itakura S, 1996, CAH PSYCHOL COGN, V15, P103; Iwagami A, 2010, J THEOR BIOL, V265, P297, DOI 10.1016/j.jtbi.2010.05.010; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; JOHNSONLAIRD PN, 1992, COGNITION EMOTION, V6, P201, DOI 10.1080/02699939208411069; Judge PG, 2012, AM J PRIMATOL, V74, P199, DOI 10.1002/ajp.21987; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lotze K, 2012, HUFFINGT POST; MacDonald K, 2010, PEPTIDE BINDS SYSTEM, DOI DOI 10.3109/10673220903523615.ACCESSED; Marcus-Newhall A, 2000, J PERS SOC PSYCHOL, V78, P670, DOI 10.1037/0022-3514.78.4.670; McAdams D.P., 2004, PSYCHOL GRATITUDE, P81, DOI DOI 10.1093/ACPROF:OSO/9780195150100.003.0005; Mohtashemi M, 2003, J THEOR BIOL, V223, P523, DOI 10.1016/S0022-5193(03)00143-7; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ortony A., 2005, WHO NEEDS EMOTIONS B, P173, DOI DOI 10.1093/ACPROF:OSO/9780195166194.003.0007; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Paukner A, 2006, ANIM COGN, V9, P110, DOI 10.1007/s10071-005-0007-2; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Perner J, 1991, UNDERSTANDING REPRES; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Piazza J, 2008, EVOL HUM BEHAV, V29, P172, DOI 10.1016/j.evolhumbehav.2007.12.002; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Stanca L, 2009, J ECON PSYCHOL, V30, P190, DOI 10.1016/j.joep.2008.07.010; Takimoto A, 2010, ANIM COGN, V13, P249, DOI 10.1007/s10071-009-0262-8; Trivers R, 1971, Q REV BIOL, DOI DOI 10.2307/2822435.ACCESSED; Tsang JA, 2006, COGNITION EMOTION, V20, P138, DOI 10.1080/02699930500172341; Tsang Jo-Ann, 2007, J POSITIVE PSYCH, V2, P157, DOI DOI 10.1080/17439760701229019; van Doorn GS, 2012, EVOLUTION, V66, P651, DOI 10.1111/j.1558-5646.2011.01479.x; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.0.CO;2-0; Weiner B., 1986, HDB MOTIVATION COGNI, P281; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Whiten A, 1997, MACHIAVELLIAN INTELL, P403; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	82	42	44	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87035	10.1371/journal.pone.0087035	http://dx.doi.org/10.1371/journal.pone.0087035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489830	gold, Green Published			2022-12-25	WOS:000330570000094
J	Verstraeten, R; Van Royen, K; Ochoa-Aviles, A; Penafiel, D; Holdsworth, M; Donoso, S; Maes, L; Kolsteren, P				Verstraeten, Roosmarijn; Van Royen, Kathleen; Ochoa-Aviles, Angelica; Penafiel, Daniela; Holdsworth, Michelle; Donoso, Silvana; Maes, Lea; Kolsteren, Patrick			A Conceptual Framework for Healthy Eating Behavior in Ecuadorian Adolescents: A Qualitative Study	PLOS ONE			English	Article							BALANCE-RELATED BEHAVIORS; ENVIRONMENTAL-INFLUENCES; RISK-FACTORS; FOCUS GROUPS; OBESITY; CHILDREN; DISEASE; DIETARY; INCOME; OVERWEIGHT	Objective: The objective of this study was to identify factors influencing eating behavior of Ecuadorian adolescents - from the perspective of parents, school staff and adolescents - to develop a conceptual framework for adolescents' eating behavior. Study design: Twenty focus groups (N = 144 participants) were conducted separately with adolescents aged 11-15 y (n (focus groups) = 12, N (participants) = 80), parents (n = 4, N = 32) and school staff (n = 4, N = 32) in rural and urban Ecuador. A semi-structured questioning route was developed based on the 'Attitude, Social influences and Self-efficacy' model and the socio-ecological model to assess the relevance of behavioral and environmental factors in low-and middle-income countries. Two researchers independently analyzed verbatim transcripts for emerging themes, using deductive thematic content analysis. Data were analyzed using NVivo 8. Results: All groups recognized the importance of eating healthily and key individual factors in Ecuadorian adolescents' food choices were: financial autonomy, food safety perceptions, lack of self-control, habit strength, taste preferences and perceived peer norms. Environmental factors included the poor nutritional quality of food and its easy access at school. In their home and family environment, time and convenience completed the picture as barriers to eating healthily. Participants acknowledged the impact of the changing socio-cultural environment on adolescents' eating patterns. Availability of healthy food at home and financial constraints differed between settings and socio-economic groups. Conclusion: Our findings endorse the importance of investigating behavioral and environmental factors that influence and mediate healthy dietary behavior prior to intervention development. Several culture-specific factors emerged that were incorporated into a conceptual framework for developing health promotion interventions in Ecuador.	[Verstraeten, Roosmarijn; Kolsteren, Patrick] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Verstraeten, Roosmarijn; Van Royen, Kathleen; Ochoa-Aviles, Angelica; Penafiel, Daniela; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium; [Ochoa-Aviles, Angelica; Donoso, Silvana] Univ Cuenca, Food Nutr & Hlth Program, Cuenca, Ecuador; [Penafiel, Daniela] Escuela Super Politecn Litoral, Rural Res Ctr, Guayaquil, Ecuador; [Holdsworth, Michelle] Univ Sheffield, Publ Hlth Sect, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Maes, Lea] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Institute of Tropical Medicine (ITM); Ghent University; Universidad de Cuenca; Escuela Superior Politecnica del Litoral; University of Sheffield; Ghent University	Verstraeten, R (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	roosmarijn.verstraeten@ugent.be	Maes, Lea/D-6014-2013; holdsworth, michelle/AAH-5400-2020; Van Royen, Kathleen/E-9669-2018	holdsworth, michelle/0000-0001-6028-885X; Van Royen, Kathleen/0000-0001-8182-7971; Penafiel, Daniela/0000-0001-6593-8217; Ochoa-Aviles, Angelica/0000-0001-7926-3644	Flemish Inter-University Collaboration (VLIR-IUC)	Flemish Inter-University Collaboration (VLIR-IUC)	This qualitative research study was part of a programme funded by a Flemish Inter-University Collaboration (VLIR-IUC, http://www.vliruos.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abraham C, 2011, HEALTH EDUC RES, V26, P624, DOI 10.1093/her/cyr018; Baillie K, 2008, OBES REV, V9, P146, DOI 10.1111/j.1467-789X.2007.00457.x; Bisogni CA, 2012, J NUTR EDUC BEHAV, V44, P282, DOI 10.1016/j.jneb.2011.11.009; Brug J, 2008, P NUTR SOC, V67, P307, DOI 10.1017/S0029665108008616; Burg J, 2006, J NUTR EDUC BEHAV, V38, P73, DOI 10.1016/j.jneb.2005.11.027; Cerin E, 2009, J NUTR EDUC BEHAV, V41, P309, DOI 10.1016/j.jneb.2009.03.129; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; Ebrahim Shahul, 2007, Prev Chronic Dis, V4, pA32; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Goldstein J, 2005, PREV MED, V41, P800, DOI 10.1016/j.ypmed.2005.06.001; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Haerens L, 2009, HEALTH EDUC RES, V24, P381, DOI 10.1093/her/cyn033; Kennedy C, 2001, NURS RES, V50, P184, DOI 10.1097/00006199-200105000-00010; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Krolner R, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-112; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Kubik MY, 2005, J ADOLESCENT HEALTH, V36, P494, DOI 10.1016/j.jadohealth.2004.05.010; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Lachat C, 2009, AM J CLIN NUTR, V90, P1648, DOI 10.3945/ajcn.2009.28371; LAU RR, 1990, J HEALTH SOC BEHAV, V31, P240, DOI 10.2307/2136890; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Must A, 1996, AM J CLIN NUTR, V63, P445, DOI 10.1093/ajcn/63.3.445; Nago ES, 2012, J NUTR EDUC BEHAV, V44, P548, DOI 10.1016/j.jneb.2011.06.006; Neumark-Sztainer D, 1999, J AM DIET ASSOC, V99, P929, DOI 10.1016/S0002-8223(99)00222-9; Ochoa-Aviles A, 2012, PEDIATR OBES, V7, P274, DOI 10.1111/j.2047-6310.2012.00061.x; Pettinger C, 2006, PUBLIC HEALTH NUTR, V9, P1020, DOI 10.1017/PHN2006945; POPKIN BM, 1995, OBES RES, V3, pS145, DOI 10.1002/j.1550-8528.1995.tb00457.x; Power TG, 2010, J SCHOOL HEALTH, V80, P13, DOI 10.1111/j.1746-1561.2009.00461.x; Rasmussen M, 2006, DETERMINANTS FRUIT 1; Sandvik C, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-57; Smith LT, 2004, PREV CHRONIC DIS, V1, P1; Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Townsend N, 2013, PUBLIC HEALTH NUTR, V16, P1101, DOI 10.1017/S1368980011002655; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Virdis A, 2009, CURR PHARM DESIGN, V15, P1063, DOI 10.2174/138161209787846900; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; World Health Organization, 2002, WHO TECH REP SER, P916	43	44	45	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87183	10.1371/journal.pone.0087183	http://dx.doi.org/10.1371/journal.pone.0087183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489865	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330570000115
J	Wan, YW; Mach, CM; Allen, GI; Anderson, ML; Liu, ZD				Wan, Ying-Wooi; Mach, Claire M.; Allen, Genevera I.; Anderson, Matthew L.; Liu, Zhandong			On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles	PLOS ONE			English	Article								Dysregulated microRNA (miRNA) expression is a well-established feature of human cancer. However, the role of specific miRNAs in determining cancer outcomes remains unclear. Using Level 3 expression data from the Cancer Genome Atlas (TCGA), we identified 61 miRNAs that are associated with overall survival in 469 ovarian cancers profiled by microarray (p<0.01). We also identified 12 miRNAs that are associated with survival when miRNAs were profiled in the same specimens using Next Generation Sequencing (miRNA-Seq) (p<0.01). Surprisingly, only 1 miRNA transcript is associated with ovarian cancer survival in both datasets. Our analyses indicate that this discrepancy is due to the fact that miRNA levels reported by the two platforms correlate poorly, even after correcting for potential issues inherent to signal detection algorithms. Corrections for false discovery and microRNA abundance had minimal impact on this discrepancy. Further investigation is warranted.	[Wan, Ying-Wooi; Allen, Genevera I.; Liu, Zhandong] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wan, Ying-Wooi; Mach, Claire M.; Anderson, Matthew L.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Mach, Claire M.] Univ Houston, Coll Pharm, Houston, TX 77030 USA; [Wan, Ying-Wooi; Anderson, Matthew L.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Anderson, Matthew L.; Liu, Zhandong] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Liu, Zhandong] Baylor Coll Med, Computat & Integrat Biomed Res CIBR Ctr, Houston, TX 77030 USA; [Allen, Genevera I.; Liu, Zhandong] Texas Childrens Hosp, Neurol Res Inst, Houston, TX 77030 USA; [Allen, Genevera I.] Rice Univ, Dept Stat & Elect & Comp Engn, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University	Anderson, ML (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	matthew@bcm.edu; Zhandonl@bcm.edu	Anderson, Matthew/C-4755-2019	Anderson, Matthew/0000-0002-2081-4672; Liu, Zhandong/0000-0002-7608-0831	Collaborative Advances in Biomedical Computing Seed Funding Program at the Ken Kennedy Institute for Information Technology at Rice University; John and Ann Doerr Fund for Computational Biomedicine; Center for Computational and Integrative Biomedical Research Seed Funding Program at Baylor College of Medicine; NSF [DMS-1209017, DMS-1263932]; Houston Bioinformatics Endowment	Collaborative Advances in Biomedical Computing Seed Funding Program at the Ken Kennedy Institute for Information Technology at Rice University; John and Ann Doerr Fund for Computational Biomedicine; Center for Computational and Integrative Biomedical Research Seed Funding Program at Baylor College of Medicine; NSF(National Science Foundation (NSF)); Houston Bioinformatics Endowment	This work is supported in part through the Collaborative Advances in Biomedical Computing Seed Funding Program at the Ken Kennedy Institute for Information Technology at Rice University supported by the John and Ann Doerr Fund for Computational Biomedicine and through the Center for Computational and Integrative Biomedical Research Seed Funding Program at Baylor College of Medicine. GA is also partially supported by NSF DMS-1209017. ZD is supported by the Houston Bioinformatics Endowment and NSF DMS-1263932. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Wu CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni082; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yauk CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-330; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	18	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87782	10.1371/journal.pone.0087782	http://dx.doi.org/10.1371/journal.pone.0087782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489963	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000180
J	Chollet, MB; Aldridge, K; Pangborn, N; Weinberg, SM; DeLeon, VB				Chollet, Madeleine B.; Aldridge, Kristina; Pangborn, Nicole; Weinberg, Seth M.; DeLeon, Valerie B.			Landmarking the Brain for Geometric Morphometric Analysis: An Error Study	PLOS ONE			English	Article							SHAPE; PATTERNS; AUTISM; MRI	Neuroanatomic phenotypes are often assessed using volumetric analysis. Although powerful and versatile, this approach is limited in that it is unable to quantify changes in shape, to describe how regions are interrelated, or to determine whether changes in size are global or local. Statistical shape analysis using coordinate data from biologically relevant landmarks is the preferred method for testing these aspects of phenotype. To date, approximately fifty landmarks have been used to study brain shape. Of the studies that have used landmark-based statistical shape analysis of the brain, most have not published protocols for landmark identification or the results of reliability studies on these landmarks. The primary aims of this study were two-fold: (1) to collaboratively develop detailed data collection protocols for a set of brain landmarks, and (2) to complete an intra-and inter-observer validation study of the set of landmarks. Detailed protocols were developed for 29 cortical and subcortical landmarks using a sample of 10 boys aged 12 years old. Average intra-observer error for the final set of landmarks was 1.9 mm with a range of 0.72 mm-5.6 mm. Average inter-observer error was 1.1 mm with a range of 0.40 mm-3.4 mm. This study successfully establishes landmark protocols with a minimal level of error that can be used by other researchers in the assessment of neuroanatomic phenotypes.	[Chollet, Madeleine B.; Pangborn, Nicole; DeLeon, Valerie B.] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA; [Aldridge, Kristina] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA; [Weinberg, Seth M.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA	Johns Hopkins University; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chollet, MB (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA.	mchollet@wustl.edu		Aldridge, Kristina/0000-0003-3924-761X; Weinberg, Seth/0000-0001-9467-4556	National Institutes of Dental and Craniofacial Research [F31 DE021302-01, 5 R01 DE014399-05]; Johns Hopkins University Libraries; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE021302] Funding Source: NIH RePORTER	National Institutes of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Johns Hopkins University Libraries(Johns Hopkins University); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants F31 DE021302-01 and 5 R01 DE014399-05 from the National Institutes of Dental and Craniofacial Research. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1996, BRAIN BEHAV EVOLUT, V47, P225, DOI 10.1159/000113243; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Aldridge K, 2005, ANAT REC PART A, V285A, P690, DOI 10.1002/ar.a.20201; Aldridge K, 2005, J ANAT, V206, P373, DOI 10.1111/j.1469-7580.2005.00397.x; Aldridge K, 2002, J ANAT, V201, P31, DOI 10.1046/j.1469-7580.2002.00074.x; Aldridge K, 2004, ORG HUMAN BRAIN DEV; Aldridge K, 2011, J HUM EVOL, V60, P94, DOI 10.1016/j.jhevol.2010.09.007; ANDREASEN NC, 1994, P NATL ACAD SCI USA, V91, P93, DOI 10.1073/pnas.91.1.93; ANDREASEN NC, 1992, J NEUROPSYCH CLIN N, V4, P125; ANDREASEN NC, 1993, J NEUROPSYCH CLIN N, V5, P121; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Cachia A, 2003, IEEE T MED IMAGING, V22, P754, DOI 10.1109/TMI.2003.814781; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Caviness VS, 1999, BRAIN DEV-JPN, V21, P289; Ceyhan E, 2012, CURR ALZHEIMER RES, V9, P972, DOI 10.2174/156720512803251138; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; DEACON TW, 1990, AM ZOOL, V30, P629; DeQuardo JR, 1996, PSYCHIAT RES-NEUROIM, V67, P81; DeQuardo JR, 1999, BIOL PSYCHIAT, V45, P1321, DOI 10.1016/S0006-3223(98)00181-4; Dryden I., 1998, STAT ANAL SHAPE; Free SL, 2001, NEUROIMAGE, V13, P801, DOI 10.1006/nimg.2001.0748; GERHART J, 1997, CELL EMBRYOS EVOLUTI; Gharaibeh WS, 2000, BIOL PSYCHIAT, V48, P398, DOI 10.1016/S0006-3223(00)00916-1; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; HARVEY PH, 1990, SCIENCE, V249, P140, DOI 10.1126/science.2196673; Im K, 2010, CEREB CORTEX, V20, P602, DOI 10.1093/cercor/bhp127; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Joseph J, 2014, HUM BRAIN MAPP, V35, P659, DOI 10.1002/hbm.22209; Joshi SH, 2013, NEUROIMAGE, V64, P547, DOI 10.1016/j.neuroimage.2012.09.024; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Lohmann G, 2000, MED IMAGE ANAL, V4, P179, DOI 10.1016/S1361-8415(00)00024-4; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Magnotta VA, 2002, COMPUT MED IMAG GRAP, V26, P251, DOI 10.1016/S0895-6111(02)00011-3; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Maudgil DD, 1998, J ANAT, V193, P559, DOI 10.1046/j.1469-7580.1998.19340559.x; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mullick R, 1998, ANN M SOC COMP APPL; Mullick R, 1999, BIOM IM S VIS FUT BI; Nordahl CW, 2007, J NEUROSCI, V27, P11725, DOI 10.1523/JNEUROSCI.0777-07.2007; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Pantazis D, 2010, NEUROIMAGE, V49, P2479, DOI 10.1016/j.neuroimage.2009.09.027; Pierson R, 2011, NEUROIMAGE, V54, P328, DOI 10.1016/j.neuroimage.2010.06.047; Purves D, 1996, INDIVIDUAL DEV LIFES, P162; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Richtsmeier J. T., 2001, INTER DISC; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Shattuck DW, 2009, J NEUROSCI METH, V178, P385, DOI 10.1016/j.jneumeth.2008.12.025; Sherwood CC, 2009, ENCY NEUROSCIENCE, P1334; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Valeri CJ, 1998, AM J PHYS ANTHROPOL, V107, P113, DOI 10.1002/(SICI)1096-8644(199809)107:1<113::AID-AJPA9>3.3.CO;2-U; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Weinberg SM, 2009, J ANAT, V214, P926, DOI 10.1111/j.1469-7580.2009.01084.x; Zhong JD, 2010, NEUROIMAGE, V52, P131, DOI 10.1016/j.neuroimage.2010.03.085	57	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86005	10.1371/journal.pone.0086005	http://dx.doi.org/10.1371/journal.pone.0086005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489689	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000330510000030
J	Faghih, RT; Dahleh, MA; Adler, GK; Klerman, EB; Brown, EN				Faghih, Rose T.; Dahleh, Munther A.; Adler, Gail K.; Klerman, Elizabeth B.; Brown, Emery N.			Deconvolution of Serum Cortisol Levels by Using Compressed Sensing	PLOS ONE			English	Article							MODEL; FOCUSS	The pulsatile release of cortisol from the adrenal glands is controlled by a hierarchical system that involves corticotropin releasing hormone (CRH) from the hypothalamus, adrenocorticotropin hormone (ACTH) from the pituitary, and cortisol from the adrenal glands. Determining the number, timing, and amplitude of the cortisol secretory events and recovering the infusion and clearance rates from serial measurements of serum cortisol levels is a challenging problem. Despite many years of work on this problem, a complete satisfactory solution has been elusive. We formulate this question as a non-convex optimization problem, and solve it using a coordinate descent algorithm that has a principled combination of (i) compressed sensing for recovering the amplitude and timing of the secretory events, and (ii) generalized cross validation for choosing the regularization parameter. Using only the observed serum cortisol levels, we model cortisol secretion from the adrenal glands using a second-order linear differential equation with pulsatile inputs that represent cortisol pulses released in response to pulses of ACTH. Using our algorithm and the assumption that the number of pulses is between 15 to 22 pulses over 24 hours, we successfully deconvolve both simulated datasets and actual 24-hr serum cortisol datasets sampled every 10 minutes from 10 healthy women. Assuming a one-minute resolution for the secretory events, we obtain physiologically plausible timings and amplitudes of each cortisol secretory event with R 2 above 0.92. Identification of the amplitude and timing of pulsatile hormone release allows (i) quantifying of normal and abnormal secretion patterns towards the goal of understanding pathological neuroendocrine states, and (ii) potentially designing optimal approaches for treating hormonal disorders.	[Faghih, Rose T.; Dahleh, Munther A.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Faghih, Rose T.; Dahleh, Munther A.] MIT, Lab Informat & Decis Syst, Cambridge, MA 02139 USA; [Faghih, Rose T.; Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Adler, Gail K.; Klerman, Elizabeth B.; Brown, Emery N.] Harvard Univ, Sch Med, Boston, MA USA; [Adler, Gail K.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Klerman, Elizabeth B.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)	Faghih, RT (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	rfaghih@mit.edu			NSF Graduate Fellowship; NSF [0836720]; NIH [P01-AG09975, K24-HL105664, RC2-HL101340, R01-HL-11408, HFP01603, DP1 OD003646, K24 HL103845, R01AR43130, M01RR20635, K01AG00661, R01GM 53559]; National Space Biomedical Research Institute through NASA [HFP02802, NCC 9-58]; NASA [NCC9-58]; NSBRI;  [EFRI-0735956]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101340, K24HL105664, R01HL114088, K24HL103845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975, K01AG000661] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	NSF Graduate Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute through NASA; NASA(National Aeronautics & Space Administration (NASA)); NSBRI; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RTF's work was supported in part by the NSF Graduate Fellowship. For this work ENB is supported in part by NIH DP1 OD003646 and NSF 0836720. MAD is supported in part by EFRI-0735956 while EBK is supported in part by NIH P01-AG09975, K24-HL105664, RC2-HL101340, R01-HL-11408, and HFP01603 and HFP02802 from the National Space Biomedical Research Institute through NASA NCC 9-58. Finally, GKA is supported in part by NIH K24 HL103845. Clinical studies were performed on the Brigham and Women's Hospital General Clinical Research Center. Grants supporting the original data collection include NIH R01AR43130 (GKA), M01RR20635 (BWH GCRC), K01AG00661 (EBK), R01GM 53559 (ENB), and NASA NCC9-58 with the NSBRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attouch H, 2010, MATH OPER RES, V35, P438, DOI 10.1287/moor.1100.0449; Boufounos P, 2007, 2007 IEEE/SP 14TH WORKSHOP ON STATISTICAL SIGNAL PROCESSING, VOLS 1 AND 2, P299, DOI 10.1109/SSP.2007.4301267; Brown EN, 2001, AM J PHYSIOL-ENDOC M, V280, pE450, DOI 10.1152/ajpendo.2001.280.3.E450; Conrad M, 2009, J BIOL PHYS, V35, P149, DOI 10.1007/s10867-009-9134-3; Faghih RT, 2011, IEEE ENG MED BIO, P716, DOI 10.1109/IEMBS.2011.6090162; Faghih RT, 2010, THESIS MIT; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Gorodnitsky IF, 1997, IEEE T SIGNAL PROCES, V45, P600, DOI 10.1109/78.558475; HANSEN PC, 2000, ADV COMPUTATIONAL BI, V4, P119; He Z, 2012, 12025470 ARXIV; Johnson TD, 2003, BIOMETRICS, V59, P650, DOI 10.1111/1541-0420.00075; Keenan DM, 2005, J THEOR BIOL, V236, P242, DOI 10.1016/j.jtbi.2005.03.008; Kettyle William M., 1998, ENDOCRINE PATHOPHYSI; Klerman EB, 2001, J CLIN ENDOCR METAB, V86, P1034, DOI 10.1210/jc.86.3.1034; Murray J., 2005, THESIS U CALIFORNIA; ROELFSEMA F, 1993, J CLIN ENDOCR METAB, V77, P234, DOI 10.1210/jc.77.1.234; Sarabdjitsingh RA, 2012, PHYSIOL BEHAV, V106, P73, DOI 10.1016/j.physbeh.2011.09.017; VELDHUIS JD, 1989, AM J PHYSIOL, V257, pE5, DOI 10.1152/ajpendo.1989.257.1.E6; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Vidal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039001; Vinther F, 2011, J MATH BIOL, V63, P663, DOI 10.1007/s00285-010-0384-2; Vis DJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE146, DOI 10.1152/ajpendo.00048.2009; Zdunek R, 2008, IEEE T SIGNAL PROCES, V56, P4752, DOI 10.1109/TSP.2008.928160	23	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85204	10.1371/journal.pone.0085204	http://dx.doi.org/10.1371/journal.pone.0085204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489656	gold, Green Published, Green Submitted			2022-12-25	WOS:000330510000011
J	Jay, M; Bradley, S; McDearmid, JR				Jay, Michael; Bradley, Sophie; McDearmid, Jonathan Robert			Effects of Nitric Oxide on Neuromuscular Properties of Developing Zebrafish Embryos	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; SYNTHASE-IMMUNOREACTIVE NEURONS; GROWTH CONE FILOPODIA; WHITE MUSCLE-FIBERS; ACETYLCHOLINE-RECEPTOR; SPINAL-CORD; SKELETAL-MUSCLE; TIME-COURSE; RETINOTECTAL PROJECTION; LOCOMOTOR NETWORK	Nitric oxide is a bioactive signalling molecule that is known to affect a wide range of neurodevelopmental processes. However, its functional relevance to neuromuscular development is not fully understood. Here we have examined developmental roles of nitric oxide during formation and maturation of neuromuscular contacts in zebrafish. Using histochemical approaches we show that elevating nitric oxide levels reduces the number of neuromuscular synapses within the axial swimming muscles whilst inhibition of nitric oxide biosynthesis has the opposite effect. We further show that nitric oxide signalling does not change synapse density, suggesting that the observed effects are a consequence of previously reported changes in motor axon branch formation. Moreover, we have used in vivo patch clamp electrophysiology to examine the effects of nitric oxide on physiological maturation of zebrafish neuromuscular junctions. We show that developmental exposure to nitric oxide affects the kinetics of spontaneous miniature end plate currents and impacts the neuromuscular drive for locomotion. Taken together, our findings implicate nitrergic signalling in the regulation of zebrafish neuromuscular development and locomotor maturation.	[Jay, Michael; Bradley, Sophie; McDearmid, Jonathan Robert] Univ Leicester, Dept Biol, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Leicester	McDearmid, JR (corresponding author), Univ Leicester, Dept Biol, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	jrm33@le.ac.uk		Bradley, Sophie/0000-0001-5505-3765	BBSRC [BBE015352, BBF01516X]; BBSRC [BB/E015352/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E015352/1, 1068275] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a BBSRC studentship to MJ, a BBSRC studentship to SB, and in part by BBSRC grants BBE015352 and BBF01516X to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausborn J, 2012, P NATL ACAD SCI USA, V109, pE3631, DOI 10.1073/pnas.1216256110; Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Bradley S, 2010, J NEUROSCI, V30, P16818, DOI 10.1523/JNEUROSCI.4456-10.2010; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; Bruning G, 1996, NEUROSCI LETT, V202, P189, DOI 10.1016/0304-3940(95)12239-7; Buckingham SD, 2004, J EXP BIOL, V207, P841, DOI 10.1242/jeb.00839; Bukcharaeva EA, 1999, J PHYSIOL-LONDON, V517, P879, DOI 10.1111/j.1469-7793.1999.0879s.x; Buss RR, 2002, J NEUROPHYSIOL, V87, P1244, DOI 10.1152/jn.00659.2001; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Campello-Costa P, 2000, J NEUROBIOL, V44, P371, DOI 10.1002/1097-4695(20000915)44:4<371::AID-NEU1>3.0.CO;2-X; Chung YH, 2004, NEUROSCI LETT, V360, P1, DOI 10.1016/j.neulet.2004.01.002; Cogen J, 2000, J NEUROBIOL, V45, P120, DOI 10.1002/1097-4695(20001105)45:2<120::AID-NEU6>3.0.CO;2-6; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; DELCASTILLO J, 1978, J CELL BIOL, V78, P782, DOI 10.1083/jcb.78.3.782; Drapeau P, 2001, J NEUROPHYSIOL, V86, P2951, DOI 10.1152/jn.2001.86.6.2951; Ernst AF, 2000, J NEUROSCI, V20, P1458; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FORSTERMANN U, 1986, CIRC RES, V58, P531, DOI 10.1161/01.RES.58.4.531; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Gibbs SM, 2001, J NEUROSCI, V21, P7705, DOI 10.1523/JNEUROSCI.21-19-07705.2001; Godfrey EW, 2007, DEV BIOL, V307, P195, DOI 10.1016/j.ydbio.2007.04.021; Godfrey EW, 2003, J NEUROCYTOL, V32, P591, DOI 10.1023/B:NEUR.0000020612.87729.98; Gotti S, 2005, MICROSC RES TECHNIQ, V68, P13, DOI 10.1002/jemt.20219; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Hindley S, 1997, J NEUROSCI RES, V47, P427; Holmqvist B, 2004, J EXP BIOL, V207, P923, DOI 10.1242/jeb.00845; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; Iwase K, 1998, MOL BRAIN RES, V53, P1, DOI 10.1016/S0169-328X(97)00139-3; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Jones MG, 2000, NETW COMPUT, V11, P16; Judas M, 1999, MICROSC RES TECHNIQ, V45, P401, DOI 10.1002/(SICI)1097-0029(19990615)45:6<401::AID-JEMT7>3.0.CO;2-Q; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KULLBERG RW, 1980, DEV BIOL, V75, P255, DOI 10.1016/0012-1606(80)90161-X; Kyriakatos A, 2009, J NEUROSCI, V29, P13283, DOI 10.1523/JNEUROSCI.3069-09.2009; LIU DWC, 1992, J NEUROSCI, V12, P1859; Luna VM, 2006, J GEN PHYSIOL, V128, P89, DOI 10.1085/jgp.200609501; Luna VM, 2004, J NEUROPHYSIOL, V92, P2003, DOI 10.1152/jn.00454.2004; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; McLean DL, 2004, J NEUROSCI, V24, P9561, DOI 10.1523/JNEUROSCI.1817-04.2004; Menelaou E, 2012, J NEUROSCI, V32, P10925, DOI 10.1523/JNEUROSCI.1809-12.2012; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Mongeon R, 2011, J GEN PHYSIOL, V138, P353, DOI 10.1085/jgp.201110649; NARANJO D, 1993, SCIENCE, V260, P1811, DOI 10.1126/science.8511590; Nguyen PV, 1999, J NEUROPHYSIOL, V81, P2852, DOI 10.1152/jn.1999.81.6.2852; Oermann E, 1999, ANAT EMBRYOL, V200, P27, DOI 10.1007/s004290050256; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Poon KL, 2003, GENE EXPR PATTERNS, V3, P463, DOI 10.1016/S1567-133X(03)00063-2; Ribera J, 1998, J NEUROSCI RES, V51, P90, DOI 10.1002/(SICI)1097-4547(19980101)51:1<90::AID-JNR10>3.0.CO;2-C; ROSKAMS AJ, 1994, NEURON, V13, P289; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Samigullin D, 2003, PHYSIOL RES, V52, P475; Schwarte RC, 2004, DEV BIOL, V273, P276, DOI 10.1016/j.ydbio.2004.06.003; Sylvain NJ, 2011, NEUROTOXICOL TERATOL, V33, P313, DOI 10.1016/j.ntt.2010.12.001; Terada H, 2001, DEV BRAIN RES, V128, P121, DOI 10.1016/S0165-3806(01)00162-6; Terada H, 1996, J CHEM NEUROANAT, V10, P273, DOI 10.1016/0891-0618(96)00141-X; Tojima T, 2009, J NEUROSCI, V29, P7886, DOI 10.1523/JNEUROSCI.0087-09.2009; Tornieri K, 2007, DEV NEUROBIOL, V67, P1932, DOI 10.1002/dneu.20572; Tricoire L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00082; Trimm KR, 2004, EUR J NEUROSCI, V19, P809, DOI 10.1111/j.0953-816X.2004.03182.x; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; Van Wagenen S, 2001, J NEUROBIOL, V46, P206, DOI 10.1002/1097-4695(20010215)46:3<206::AID-NEU1003>3.3.CO;2-J; VANRAAMSDONK W, 1978, ANAT EMBRYOL, V153, P137; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; Welshhans K, 2005, EUR J NEUROSCI, V22, P3006, DOI 10.1111/j.1460-9568.2005.04490.x; Welshhans K, 2007, EUR J NEUROSCI, V26, P1537, DOI 10.1111/j.1460-9568.2007.05768.x; Wen H, 2005, J NEUROSCI, V25, P8104, DOI 10.1523/JNEUROSCI.2611-05.2005; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wu HH, 2000, DEV BRAIN RES, V120, P105, DOI 10.1016/S0165-3806(99)00145-5; Wu J, 2001, PAIN, V94, P47, DOI 10.1016/S0304-3959(01)00340-2; Yamada RX, 2006, NEUROREPORT, V17, P661, DOI 10.1097/00001756-200604240-00021; Yamazaki M, 2006, NEUROSCI LETT, V393, P222, DOI 10.1016/j.neulet.2005.09.068; Zhang YT, 2002, BRAIN RES BULL, V58, P385, DOI 10.1016/S0361-9230(02)00808-0	80	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86930	10.1371/journal.pone.0086930	http://dx.doi.org/10.1371/journal.pone.0086930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489806	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000089
J	Manzoor, U; Kim, DK; Islam, M; Bhatti, AS				Manzoor, Umair; Kim, Do K.; Islam, Mohammad; Bhatti, Arshad S.			Removal of Micrometer Size Morphological Defects and Enhancement of Ultraviolet Emission by Thermal Treatment of Ga-Doped ZnO Nanostructures	PLOS ONE			English	Article							ZINC-OXIDE; THIN-FILMS; TEMPERATURE; PHOTOLUMINESCENCE; SUBLIMATION; MECHANISMS; SUBSTRATE; GROWTH	Mixed morphologies of Ga-doped Zinc Oxide (ZnO) nanostructures are synthesized by vapor transport method. Systematic scanning electron microscope (SEM) studies of different morphologies, after periodic heat treatments, gives direct evidence of sublimation. SEM micrographs give direct evidence that morphological defects of nanostructures can be removed by annealing. Ultra Violet (UV) and visible emission depends strongly on the annealing temperatures and luminescent efficiency of UV emission is enhanced significantly with each subsequent heat treatment. X-Ray diffraction (XRD) results suggest that crystal quality improved by annealing and phase separation may occur at high temperatures.	[Manzoor, Umair] King Saud Univ, Alamoudi Water Chair, Riyadh, Saudi Arabia; [Manzoor, Umair; Bhatti, Arshad S.] COMSATS Inst Informat Technol, Ctr Micro & Nano Devices, Dept Phys, Islamabad, Pakistan; [Kim, Do K.] Korea Adv Inst Sci & Technol KAIST, Dept Mat Sci & Engn, Taejon, South Korea; [Islam, Mohammad] King Saud Univ, Coll Engn, Riyadh, Saudi Arabia	King Saud University; COMSATS University Islamabad (CUI); Korea Advanced Institute of Science & Technology (KAIST); King Saud University	Manzoor, U (corresponding author), King Saud Univ, Alamoudi Water Chair, Riyadh, Saudi Arabia.	umanzoor@comsats.edu.pk	Bhatti, Arshad S/D-5104-2011; Islam, Mohammad/K-8385-2013; Kim, Do Kyung/C-2039-2011; manzoor, Umair/K-1178-2014	Islam, Mohammad/0000-0003-0117-6422; Kim, Do Kyung/0000-0001-9092-9427; 	Higher Education Commission (HEC) Pakistan; King Saud University [RGP-VPP-283]	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan); King Saud University(King Saud University)	Authors would like to thank Higher Education Commission (HEC) Pakistan for the financial support through "National Research Program for Universities". The authors would also like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project no. RGP-VPP-283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2012, SENSORS-BASEL, V12, P13842, DOI 10.3390/s121013842; Assuncao V, 2003, THIN SOLID FILMS, V442, P102, DOI 10.1016/S0040-6090(03)00955-6; Chen Z, 2005, SCRIPTA MATER, V52, P63, DOI 10.1016/j.scriptamat.2004.08.024; Cheong KY, 2002, THIN SOLID FILMS, V410, P142, DOI 10.1016/S0040-6090(02)00286-9; Fang ZB, 2005, APPL SURF SCI, V241, P303, DOI 10.1016/j.apsusc.2004.07.056; Fortunato E, 2003, THIN SOLID FILMS, V442, P121, DOI 10.1016/S0040-6090(03)00958-1; Goncalves AD, 2006, J SOLID STATE CHEM, V179, P1330, DOI 10.1016/j.jssc.2006.01.046; GOPEL W, 1979, J VAC SCI TECHNOL, V16, P1229, DOI 10.1116/1.570197; Greene LE, 2006, INORG CHEM, V45, P7535, DOI 10.1021/ic0601900; GRUNZE M, 1981, J CRYST GROWTH, V52, P241, DOI 10.1016/0022-0248(81)90199-8; Gu F, 2003, CHEM PHYS LETT, V372, P451, DOI 10.1016/S0009-2614(03)00440-8; IWANAGA H, 1979, J CRYST GROWTH, V47, P703, DOI 10.1016/0022-0248(79)90015-0; Janotti A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165202; Ko HJ, 2002, J APPL PHYS, V92, P4354, DOI 10.1063/1.1509103; KOHL D, 1974, SURF SCI, V41, P403, DOI 10.1016/0039-6028(74)90057-0; Kolmakov A, 2004, ANNU REV MATER RES, V34, P151, DOI 10.1146/annurev.matsci.34.040203.112141; Lannoo M., 1983, POINT DEFECTS SEMICO, V2; Law M, 2004, ANNU REV MATER RES, V34, P83, DOI 10.1146/annurev.matsci.34.040203.112300; Lim J, 2004, MAT SCI ENG B-SOLID, V107, P301, DOI 10.1016/j.mseb.2003.12.006; Lin BX, 2001, APPL PHYS LETT, V79, P943, DOI 10.1063/1.1394173; Manzoor U, 2006, SCRIPTA MATER, V54, P807, DOI 10.1016/j.scriptamat.2005.11.012; Mtangi W, 2012, J APPL PHYS, V111; Oh SJ, 2008, PHYSICA E, V41, P31, DOI 10.1016/j.physe.2008.05.019; Peterson RB, 2004, LANGMUIR, V20, P5114, DOI 10.1021/la049683c; Roberts N, 1998, PHYS REV B, V57, P5734, DOI 10.1103/PhysRevB.57.5734; Simon H, 2013, CRYST GROWTH DES, V13, P572, DOI 10.1021/cg301640v; Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349; Wang RP, 1996, CHEM MATER, V8, P433, DOI 10.1021/cm950372k; Zhang YT, 2004, SEMICOND SCI TECH, V19, P755, DOI 10.1088/0268-1242/19/6/017	29	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86418	10.1371/journal.pone.0086418	http://dx.doi.org/10.1371/journal.pone.0086418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489725	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000050
J	Gelir, E; Budak, MT; Ardic, S				Gelir, Ethem; Budak, Murat Timur; Ardic, Sadik			The Relationship between CPAP Usage and Corneal Thickness	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; REM-SLEEP; HEALTHY-SUBJECTS; HYPOXIA; DENSITY; WEAR	The purpose of this study was to determine whether there is a correlation between CPAP usage and corneal thickness in patients with sleep disordered breathing. Full-night polysomnography (PSG) recordings were collected. Ten patients had undergone PSG recordings with continuous positive airway pressure (CPAP), and seven patients had undergone PSG recordings without CPAP. We measured corneal thickness by ultrasonic pachymeter before sleep and ten minutes after waking. We also measured visual acuity with a routine ophthalmologic eye chart before and after sleep. We asked patients to fill out a post-sleep questionnaire to get their subjective opinions. In the without-CPAP group, corneal thickness increased significantly during sleep in both eyes (left, p = 0.0025; right, p<0.0001). In the with-CPAP group, corneal thickness did not increase significantly (p>0.05 for both left and right cornea). There was no significant difference in visual acuity tests (p>0.05 for both left and right eye) between the two groups. According to our results, there is a significant increase in corneal thickness in the without-CPAP group. Our data show that a low percentage of Rapid Eye Movement (REM) sleep may cause an increase in corneal thickness, which can indicate poor corneal oxygenation. In fact, many sleep-disordered breathing (SDB) patients have low REM. Since a contact lens may cause low corneal oxygenation, SDB patients with contact lenses should be monitored carefully for their corneal thickness.	[Gelir, Ethem; Budak, Murat Timur] Hacettepe Univ, Sch Med, Dept Physiol, Ankara, Turkey; [Ardic, Sadik] SGK Ankara Educ Hosp, Sleep Lab, Dept Pulm Med, Ankara, Turkey	Hacettepe University; Ankara Training & Research Hospital	Gelir, E (corresponding author), Hacettepe Univ, Sch Med, Dept Physiol, Ankara, Turkey.	egelir@hacettepe.edu.tr						Aloia M S, 2001, Sleep Breath, V5, P13, DOI 10.1007/s11325-001-0013-9; ANTONIOLI M, 1981, SLEEP, V4, P221, DOI 10.1093/sleep/4.2.221; BONNET M, 1993, SLEEP, V16, P748; Bornstein SK., 1982, SLEEPING WAKING DISO, P183; Buchanan P, 2011, PRINCIPLES PRACTICE, V5th, P1233; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; du Toit R, 2003, CORNEA, V22, P205, DOI 10.1097/00003226-200304000-00004; Faulkner W, 1997, CORNEA FUNDAMENTALS, P279; Feige B, 2002, NEUROPSYCHOPHARMACOL, V26, P246, DOI 10.1016/S0893-133X(01)00314-1; Feng PF, 2001, SLEEP, V24, P645, DOI 10.1093/sleep/24.6.645; Ferini-Strambi L, 2003, BRAIN RES BULL, V61, P87, DOI 10.1016/S0361-9230(03)00068-6; Ferini-Strambi L, 2013, INT J PSYCHOPHYSIOL; FISHER C, 1965, ARCH GEN PSYCHIAT, V12, P29; HAJAK G, 1994, SLEEP, V17, P11, DOI 10.1093/sleep/17.1.11; HEDBYS BO, 1966, EXP EYE RES, V5, P221, DOI 10.1016/S0014-4835(66)80010-6; Heller H, 1988, CLIN PHYSL SLEEP, P145; HOHAGEN F, 1993, NEUROPSYCHOPHARMACOL, V9, P225, DOI 10.1038/npp.1993.58; HOLDEN BA, 1985, INVEST OPHTH VIS SCI, V26, P1489; Horner RL, 1998, SLEEP, V21, P847; Jalbert I, 2009, EYE, V23, P1282, DOI 10.1038/eye.2008.307; JOHNSON MH, 1985, AM J OPTOM PHYS OPT, V62, P768; Karacan I, 1965, THESIS NEW YORK U BR; KING D, 1981, PSYCHIAT RES, V5, P267, DOI 10.1016/0165-1781(81)90073-1; Kleitman N., 1963, SLEEP WAKEFULNESS; KLYCE SD, 1981, J PHYSIOL-LONDON, V321, P49, DOI 10.1113/jphysiol.1981.sp013971; Kohlhaas M, 2006, ARCH OPHTHALMOL-CHIC, V124, P471, DOI 10.1001/archopht.124.4.471; Kryger MH, 2011, PRINCIPLES PRACTICE, P431, DOI [DOI 10.1016/B978-1-4160-6645-3.00037-2, DOI 10.1016/13978-1-4160-6645-3.00037-2]; Maurice DM, 1998, EXP EYE RES, V66, P139, DOI 10.1006/exer.1997.0444; Moezzi AM, 2011, EYE CONTACT LENS, V37, P61, DOI 10.1097/ICL.0b013e31820e0bc3; Moghimi S, 2013, SLEEP MED, V14, P53, DOI 10.1016/j.sleep.2012.07.004; PESSAH MA, 1972, SCIENCE, V178, P773, DOI 10.1126/science.178.4062.773; POLSE KA, 1970, ARCH OPHTHALMOL-CHIC, V84, P505; Rechtschaffen A., 1968, MANUAL STANDARDIZED; SALZ JJ, 1983, OPHTHALMIC SURG LAS, V14, P750; Tai LY, 2013, CORNEA, V32, P766, DOI 10.1097/ICO.0b013e318269938d; Wellman A, 2011, PRINCIPLES PRACTICE, P1140	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87274	10.1371/journal.pone.0087274	http://dx.doi.org/10.1371/journal.pone.0087274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475261	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800092
J	MacIntyre, DA; Lee, YS; Migale, R; Herbert, BR; Waddington, SN; Peebles, D; Hagberg, H; Johnson, MR; Bennett, PR				MacIntyre, David A.; Lee, Yun S.; Migale, Roberta; Herbert, Bronwen R.; Waddington, Simon N.; Peebles, Donald; Hagberg, Henrik; Johnson, Mark R.; Bennett, Phillip R.			Activator protein 1 is a key terminal mediator of inflammation-induced preterm labor in mice	FASEB JOURNAL			English	Article						NFkB; infection; myometrium; progesterone	NF-KAPPA-B; HUMAN MYOMETRIAL CELLS; HUMAN OXYTOCIN RECEPTOR; HUMAN UTERINE MYOCYTES; PROGESTERONE-RECEPTOR; MECHANICAL STRETCH; GENE-EXPRESSION; TRANSCRIPTION FACTOR; HUMAN PARTURITION; AIRWAY INFLAMMATION	Activation of uterine inflammatory pathways leads to preterm labor (PTL), associated with high rates of neonatal mortality and morbidity. The transcription factors nuclear factor B (NFB) and activator protein 1 (AP-1) regulate key proinflammatory and procontractile genes involved in normal labor and PTL. Here we show that NFB activation normally occurs in the mouse myometrium at gestation day E18, prior to labor, whereas AP-1 and JNK activation occurs at labor onset. Where labor was induced using the progesterone receptor antagonist RU486, NFkB and AP-1/JNK activation both occurred at the time of labor (20 h compared to 60 h in DMSO-treated controls). Using an LPS (Escherichia coli: serotype O111)-induced PTL model that selectively activates AP-1 but not NFkB, we show that myometrial AP-1 activation drives production of cytokines (Il-6, Il-8, and Il-1), metalloproteinases (Mmp3 and Mmp10), and procontractile proteins (Cox-2 and Cx43) resulting in PTL after 7 h. Protein levels of CX43 and IL-1, and IL-1 cleavage, were increased following LPS-induced activation of AP-1. Inhibition of JNK by SP600125 (30 mg/kg) delayed PTL by 6 h (7.5 vs. 13.5 h P<0.05). Our data reveal that NFB activation is not a functional requirement for infection/inflammation-induced preterm labor and that AP-1 activation is sufficient to drive inflammatory pathways that cause PTL.MacIntyre, D. A., Lee, Y. S., Migale, R., Herbert, B. R., Waddington, S. N., Peebles, D., Hagberg, H., Johnson, M. R., Bennett, P. R. Activator protein 1 is a key terminal mediator of inflammation-induced preterm labor in mice.	[MacIntyre, David A.; Lee, Yun S.; Migale, Roberta; Herbert, Bronwen R.; Johnson, Mark R.; Bennett, Phillip R.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Imperial Coll Parturit Res Grp, London W12 0NN, England; [Waddington, Simon N.] UCL, Gene Transfer Technol Grp, London, England; [Peebles, Donald] UCL, Inst Womens Hlth, Ctr Perinatal Brain Protect & Repair, London, England; [Waddington, Simon N.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Hagberg, Henrik] Univ Gothenburg, Perinatal Ctr, Dept Clin Sci, Gothenburg, Sweden; [Hagberg, Henrik] Kings Coll London, Ctr Developing Brain, London WC2R 2LS, England; [Johnson, Mark R.] Chelsea & Westminster Hosp, London, England	Imperial College London; University of London; University College London; University of London; University College London; University of Witwatersrand; University of Gothenburg; University of London; King's College London; Imperial College London	MacIntyre, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Imperial Coll Parturit Res Grp, Hammersmith Campus, London W12 0NN, England.	d.macintyre@imperial.ac.uk	MacIntyre, David A/D-9267-2012; Waddington, Simon/G-3778-2011; Migale, Roberta/I-3834-2019	Waddington, Simon/0000-0003-4970-4730; Migale, Roberta/0000-0001-8424-1060; MacIntyre, David/0000-0002-4186-5567; Bennett, Phillip/0000-0002-6253-4919; Hagberg, Henrik/0000-0003-3962-1448	Wellcome Trust [DSRR_P24225]; Arthur Haffenden Fund	Wellcome Trust(Wellcome TrustEuropean Commission); Arthur Haffenden Fund	This work was supported by the Wellcome Trust, grant DSRR_P24225, and the Arthur Haffenden Fund.	Agrawal V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063990; Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Allport VC, 2000, MOL HUM REPROD, V6, P561, DOI 10.1093/molehr/6.6.561; AURON PE, 1987, J IMMUNOL, V138, P1447; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bisits AM, 2005, PLOS COMPUT BIOL, V1, P132, DOI 10.1371/journal.pcbi.0010019; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Dudley DJ, 1996, BIOL REPROD, V55, P992, DOI 10.1095/biolreprod55.5.992; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; Geimonen E, 1996, J BIOL CHEM, V271, P23667, DOI 10.1074/jbc.271.39.23667; Geimonen E, 1998, J CLIN ENDOCR METAB, V83, P1177, DOI 10.1210/jc.83.4.1177; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hutchinson JL, 2014, FASEB J, V28, P94, DOI 10.1096/fj.13-237040; Imada K, 2002, BIOL PHARM BULL, V25, P1223, DOI 10.1248/bpb.25.1223; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Keelan JA, 1999, AM J OBSTET GYNECOL, V181, P1530, DOI 10.1016/S0002-9378(99)70400-X; Khanjani S, 2011, J CELL MOL MED, V15, P809, DOI 10.1111/j.1582-4934.2010.01069.x; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Lee Y, 2012, J CELL MOL MED, V16, P2487, DOI 10.1111/j.1582-4934.2012.01567.x; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034707; LIMJUCO G, 1986, P NATL ACAD SCI USA, V83, P3972, DOI 10.1073/pnas.83.11.3972; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Loudon JAZ, 2004, MOL HUM REPROD, V10, P895, DOI 10.1093/molehr/gah112; MacIntyre D. A., 2007, FETAL MATERNAL MED R, V18, P333; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mitchell JA, 2005, ENDOCRINOLOGY, V146, P2048, DOI 10.1210/en.2004-1066; Mohan AR, 2007, ENDOCRINOLOGY, V148, P1850, DOI 10.1210/en.2006-1289; Nath P, 2005, EUR J PHARMACOL, V506, P273, DOI 10.1016/j.ejphar.2004.11.040; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Pieber D, 2001, EUR J PHARMACOL, V427, P7, DOI 10.1016/S0014-2999(01)01189-X; PIERSANTI M, 1995, ENDOCRINOLOGY, V136, P3571, DOI 10.1210/en.136.8.3571; Pirianov G, 2009, ENDOCRINOLOGY, V150, P699, DOI 10.1210/en.2008-1178; Ramirez-Alcantara V, 2009, AM J PHYSIOL-GASTR L, V297, pG990, DOI 10.1152/ajpgi.00219.2009; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Slater DM, 1999, MOL HUM REPROD, V5, P880, DOI 10.1093/molehr/5.9.880; Soloff MS, 2004, ENDOCRINOLOGY, V145, P1248, DOI 10.1210/en.2003-1310; Sooranna SR, 2004, MOL HUM REPROD, V10, P109, DOI 10.1093/molehr/gah021; Terzidou V, 2005, J CLIN ENDOCR METAB, V90, P237, DOI 10.1210/jc.2004-0277; Terzidou V, 2006, J CLIN ENDOCR METAB, V91, P2317, DOI 10.1210/jc.2005-2649; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wewers MD, 1999, J IMMUNOL, V162, P4858; Williams AS, 2007, J PHARMACOL EXP THER, V322, P351, DOI 10.1124/jpet.107.121624; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	52	80	82	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2358	2368		10.1096/fj.13-247783	http://dx.doi.org/10.1096/fj.13-247783			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24497579				2022-12-25	WOS:000335336000036
J	Jiang, MX; He, JH; Kucera, H; Gaikwad, NW; Zhang, B; Xu, MS; O'Doherty, RM; Selcer, KW; Xie, W				Jiang, Mengxi; He, Jinhan; Kucera, Heidi; Gaikwad, Nilesh W.; Zhang, Bin; Xu, Meishu; O'Doherty, Robert M.; Selcer, Kyle W.; Xie, Wen			Hepatic Overexpression of Steroid Sulfatase Ameliorates Mouse Models of Obesity and Type 2 Diabetes through Sex-specific Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Energy Metabolism; Estrogen; Obesity; Steroid Hormone; Transgenic Mice	DEFICIT HYPERACTIVITY DISORDER; X-LINKED ICHTHYOSIS; POSTMENOPAUSAL WOMEN; INSULIN SENSITIVITY; METABOLIC SYNDROME; ESTRONE SULFATE; OB/OB MICE; RECEPTOR; RESISTANCE; PATHWAY	Background: Steroid sulfatase (STS)-mediated desulfation regulates the chemical and functional homeostasis of estrogens. Results: Overexpression of STS in the liver improved metabolic functions in mouse models of obesity and type 2 diabetes through sex-specific mechanisms. Conclusion: STS-mediated estrogen reactivation is beneficial in energy and glucose metabolism. Significance: Liver-specific activation of estrogen signaling may represent a novel approach to manage metabolic syndrome. The steroid sulfatase (STS)-mediated desulfation is a critical metabolic mechanism that regulates the chemical and functional homeostasis of endogenous and exogenous molecules. In this report, we first showed that the liver expression of Sts was induced in both the high fat diet (HFD) and ob/ob models of obesity and type 2 diabetes and during the fed to fasting transition. In defining the functional relevance of STS induction in metabolic disease, we showed that overexpression of STS in the liver of transgenic mice alleviated HFD and ob/ob models of obesity and type 2 diabetes, including reduced body weight, improved insulin sensitivity, and decreased hepatic steatosis and inflammation. Interestingly, STS exerted its metabolic benefit through sex-specific mechanisms. In female mice, STS may have increased hepatic estrogen activity by converting biologically inactive estrogen sulfates to active estrogens and consequently improved the metabolic functions, whereas ovariectomy abolished this protective effect. In contrast, the metabolic benefit of STS in males may have been accounted for by the male-specific decrease of inflammation in white adipose tissue and skeletal muscle as well as a pattern of skeletal muscle gene expression that favors energy expenditure. The metabolic benefit in male STS transgenic mice was retained after castration. Treatment with the STS substrate estrone sulfate also improved metabolic functions in both the HFD and ob/ob models. Our results have uncovered a novel function of STS in energy metabolism and type 2 diabetes. Liver-specific STS induction or estrogen/estrogen sulfate delivery may represent a novel approach to manage metabolic syndrome.	[Jiang, Mengxi; He, Jinhan; Zhang, Bin; Xu, Meishu; Xie, Wen] Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Jiang, Mengxi; He, Jinhan; Zhang, Bin; Xu, Meishu; Xie, Wen] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Kucera, Heidi; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Kucera, Heidi; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [O'Doherty, Robert M.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15261 USA; [Selcer, Kyle W.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA; [Xie, Wen] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.	wex6@pitt.edu	Selcer, Kyle/J-8365-2015; Xie, Wen/M-1768-2016	Selcer, Kyle/0000-0002-9054-2457; Jiang, Mengxi/0000-0003-4446-984X	National Institutes of Health [DK083952, HD073070, DK058855, DK072162]; University of Pittsburgh Metabolic Diseases Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083952, R01DK058855, R01DK072162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Metabolic Diseases Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083952 and HD073070 (to W. X.) and DK058855 and DK072162 (to R. O. D.). This work was also supported in part by the University of Pittsburgh Metabolic Diseases Research Center.	Al-Dosari MS, 2006, MOL PHARMACEUT, V3, P322, DOI 10.1021/mp0500824; Aoki K, 2003, J STEROID BIOCHEM, V85, P469, DOI 10.1016/S0960-0760(03)00219-X; Billeci AMR, 2008, CURR VASC PHARMACOL, V6, P112, DOI 10.2174/157016108783955338; Borthwick EB, 2001, HORM METAB RES, V33, P721, DOI 10.1055/s-2001-19136; Brookes KJ, 2008, AM J MED GENET B, V147B, P1531, DOI 10.1002/ajmg.b.30873; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Friday KE, 2001, J CLIN ENDOCR METAB, V86, P48, DOI 10.1210/jc.86.1.48; Gaikwad NW, 2013, ANAL CHEM, V85, P4951, DOI 10.1021/ac400016e; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Gao J, 2012, DIABETES, V61, P1543, DOI 10.2337/db11-1152; Gao J, 2009, J BIOL CHEM, V284, P25984, DOI 10.1074/jbc.M109.016808; HAWKINS RA, 1974, J ENDOCRINOL, V60, P3, DOI 10.1677/joe.0.0600003; Hazan Carole, 2005, Dermatol Online J, V11, P12; He JH, 2013, DIABETES, V62, P1876, DOI 10.2337/db12-1039; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kent L, 2008, J MED GENET, V45, P519, DOI 10.1136/jmg.2008.057729; LEITER EH, 1994, J CLIN INVEST, V93, P2007, DOI 10.1172/JCI117194; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Maltais R, 2011, STEROIDS, V76, P929, DOI 10.1016/j.steroids.2011.03.010; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Saini SPS, 2004, MOL PHARMACOL, V65, P292, DOI 10.1124/mol.65.2.292; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SHAPIRO LJ, 1978, LANCET, V1, P70; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Stanway SJ, 2006, CLIN CANCER RES, V12, P1585, DOI 10.1158/1078-0432.CCR-05-1996; Tiano JP, 2012, NAT REV ENDOCRINOL, V8, P342, DOI 10.1038/nrendo.2011.242; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	40	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8086	8097		10.1074/jbc.M113.535914	http://dx.doi.org/10.1074/jbc.M113.535914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497646	Green Published, hybrid			2022-12-25	WOS:000333157500007
J	Mackness, BC; Tran, MT; McClain, SP; Matthews, CR; Zitzewitz, JA				Mackness, Brian C.; Tran, Meme T.; McClain, Shannan P.; Matthews, C. Robert; Zitzewitz, Jill A.			Folding of the RNA Recognition Motif (RRM) Domains of the Amyotrophic Lateral Sclerosis (ALS)-linked Protein TDP-43 Reveals an Intermediate State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Circular Dichroism (CD); Fluorescence; Neurodegenerative Diseases; Protein Folding; Protein Misfolding; Protein-Nucleic Acid Interaction; RNA-binding Protein; Thermodynamics; Frontotemporal Lobar Degeneration (FTLD)	FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; C-TERMINAL FRAGMENTS; INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE; EXCHANGE MASS-SPECTROMETRY; NUCLEIC-ACID BINDING; HEXANUCLEOTIDE REPEAT; TRYPTOPHAN SYNTHASE; SECONDARY STRUCTURE; TARDBP MUTATIONS	Background: TDP-43 aggregates and mutations are observed in patients with ALS and FTLD. Results: The equilibrium unfolding of the RRM domains reveals a highly populated intermediate in RRM2. Conclusion: The stability of RRM2 may result from a large hydrophobic cluster, and the intermediate state may be essential for accessing the nuclear export sequence. Significance: Accessing the RRM2 intermediate state can potentially propagate disease pathogenesis. Pathological alteration of TDP-43 (TAR DNA-binding protein-43), a protein involved in various RNA-mediated processes, is a hallmark feature of the neurodegenerative diseases amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Fragments of TDP-43, composed of the second RNA recognition motif (RRM2) and the disordered C terminus, have been observed in cytoplasmic inclusions in sporadic amyotrophic lateral sclerosis cases, suggesting that conformational changes involving RRM2 together with the disordered C terminus play a role in aggregation and toxicity. The biophysical data collected by CD and fluorescence spectroscopies reveal a three-state equilibrium unfolding model for RRM2, with a partially folded intermediate state that is not observed in RRM1. Strikingly, a portion of RRM2 beginning at position 208, which mimics a cleavage site observed in patient tissues, increases the population of this intermediate state. Mutually stabilizing interactions between the domains in the tethered RRM1 and RRM2 construct reduce the population of the intermediate state and enhance DNA/RNA binding. Despite the high sequence homology of the two domains, a network of large hydrophobic residues in RRM2 provides a possible explanation for the increased stability of RRM2 compared with RRM1. The cluster analysis suggests that the intermediate state may play a functional role by enhancing access to the nuclear export signal contained within its sequence. The intermediate state may also serve as a molecular hazard linking productive folding and function with pathological misfolding and aggregation that may contribute to disease.	[Mackness, Brian C.; Tran, Meme T.; McClain, Shannan P.; Matthews, C. Robert; Zitzewitz, Jill A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zitzewitz, JA (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA.	jill.zitzewitz@umassmed.edu		Mackness, Brian/0000-0002-3587-5603	National Institutes of Health [GM54836]; ALS Therapy Alliance, Inc.; ALS Association; University of Massachusetts Medical School Faculty Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Therapy Alliance, Inc.; ALS Association; University of Massachusetts Medical School Faculty Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54836 (to C. R. M.). This work was also supported by the ALS Therapy Alliance, Inc. (to J. A. Z.), the ALS Association (to J. A. Z.), and a University of Massachusetts Medical School Faculty Scholar Award (to J. A. Z.).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BEROVA N, 2000, CIRCULAR DICHROISM P, P601; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Budini M, 2012, BRAIN RES, V1462, P139, DOI 10.1016/j.brainres.2012.02.031; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Chang CK, 2013, FEBS LETT, V587, P575, DOI 10.1016/j.febslet.2013.01.038; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FINN BE, 1992, PROTEIN ENG PRACTICA, P167; Furukawa Y, 2011, BBA-MOL BASIS DIS, V1812, P1577, DOI 10.1016/j.bbadis.2011.09.005; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gu Z, 2007, J MOL BIOL, V374, P528, DOI 10.1016/j.jmb.2007.09.024; Gu ZY, 2007, J MOL BIOL, V368, P582, DOI 10.1016/j.jmb.2007.02.027; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ihara R, 2013, HUM MOL GENET, V22, P4474, DOI 10.1093/hmg/ddt296; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Janssens J, 2013, HUM MOL GENET, V22, pR77, DOI 10.1093/hmg/ddt349; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kurihara Y, 1997, GENE, V186, P21, DOI 10.1016/S0378-1119(96)00673-7; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Liu XH, 2013, BBA-MOL BASIS DIS, V1832, P375, DOI 10.1016/j.bbadis.2012.11.012; LU JR, 1995, J MOL BIOL, V247, P739, DOI 10.1016/S0022-2836(05)80152-4; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pace C N, 1986, Methods Enzymol, V131, P266; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Rayaprolu S, 2013, PARKINSONISM RELAT D, V19, P312, DOI 10.1016/j.parkreldis.2012.11.003; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Schellman JA, 1997, BIOPHYS J, V73, P2960, DOI 10.1016/S0006-3495(97)78324-3; Shodai A, 2013, J BIOL CHEM, V288, P14886, DOI 10.1074/jbc.M113.451849; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Takagi  S., 2013, PLOS ONE, V8; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005; Xu ZS, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-27; Yang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015383; Youmans KL, 2012, EXP NEUROL, V237, P90, DOI 10.1016/j.expneurol.2012.05.018; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	78	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8264	8276		10.1074/jbc.M113.542779	http://dx.doi.org/10.1074/jbc.M113.542779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497641	hybrid, Green Published			2022-12-25	WOS:000333157500021
J	Feuermann, Y; Kang, K; Shamay, A; Robinson, GW; Hennighausen, L				Feuermann, Yonatan; Kang, Keunsoo; Shamay, Avi; Robinson, Gertraud W.; Hennighausen, Lothar			MiR-21 Is under Control of STAT5 but Is Dispensable for Mammary Development and Lactation	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE; MICRORNA-21; EXPRESSION; DIFFERENTIATION; TARGETS; EPITHELIUM; SURVIVAL; TOPHAT; PDCD4	Development of mammary alveolar epithelium during pregnancy is controlled by prolactin, through the transcription factors STAT5A/B that activate specific sets of target genes. Here we asked whether some of STAT5's functions are mediated by microRNAs. The miR-21 promoter sequence contains a bona-fide STAT5 binding site and miR-21 levels increased in HC11 mammary cells upon prolactin treatment. In vivo miR-21 was abundantly expressed in mammary epithelium at day 6 of pregnancy. Analysis of mice lacking miR-21 revealed that their mammary tissue developed normally during pregnancy and dams were able to nurse their pups. Our study demonstrated that although expression of miR-21 is under prolactin control through the transcription factors STAT5A/B its presence is dispensable for mammary development and lactation.	[Feuermann, Yonatan; Kang, Keunsoo; Robinson, Gertraud W.; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA; [Shamay, Avi] Minist Agr, Volcani Ctr, Dept Anim Sci, Bet Dagan, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Feuermann, Y (corresponding author), NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA.	feuermanny@mail.nih.gov		Feuermann, Yonatan/0000-0002-6561-6397; Hennighausen, Lothar/0000-0001-8319-9841	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000, ZICDK071001] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the intramural programs of The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Feuermann Y, 2012, GENESIS; Friedland DR, 2009, OTOL NEUROTOL, V30, P998, DOI 10.1097/MAO.0b013e3181b4e91f; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Iliopoulos D, 2011, EUR J IMMUNOL, V41, P1754, DOI 10.1002/eji.201040646; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Li G, 2009, BLOOD; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Ohno M, 2009, MOL CANCER RES, V7, P2022, DOI 10.1158/1541-7786.MCR-09-0319; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shen XH, 2009, MOL REPROD DEV, V76, P854, DOI 10.1002/mrd.21048; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109; Yoshinaga H, 1999, PATHOL INT, V49, P1067, DOI 10.1046/j.1440-1827.1999.00995.x; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	35	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85123	10.1371/journal.pone.0085123	http://dx.doi.org/10.1371/journal.pone.0085123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497923	Green Published, gold, Green Submitted			2022-12-25	WOS:000330617100006
J	de Boer, MJ; Steinhagen, HE; Versteegen, GJ; Struys, MMRF; Sanderman, R				de Boer, Maaike J.; Steinhagen, Hannemike E.; Versteegen, Gerbrig J.; Struys, Michel M. R. F.; Sanderman, Robbert			Mindfulness, Acceptance and Catastrophizing in Chronic Pain	PLOS ONE			English	Article							EXPERIENTIAL AVOIDANCE; MOVEMENT (RE)INJURY; COMMITMENT THERAPY; SCALE; DISABILITY; VALIDATION; MODEL; FEAR	Objectives: Catastrophizing is often the primary target of the cognitive-behavioral treatment of chronic pain. Recent literature on acceptance and commitment therapy (ACT) suggests an important role in the pain experience for the concepts mindfulness and acceptance. The aim of this study is to examine the influence of mindfulness and general psychological acceptance on pain-related catastrophizing in patients with chronic pain. Methods: A cross-sectional survey was conducted, including 87 chronic pain patients from an academic outpatient pain center. Results: The results show that general psychological acceptance (measured with the AAQ-II) is a strong predictor of pain-related catastrophizing, independent of gender, age and pain intensity. Mindfulness (measured with the MAAS) did not predict levels of pain-related catastrophizing. Discussion: Acceptance of psychological experiences outside of pain itself is related to catastrophizing. Thus, acceptance seems to play a role in the pain experience and should be part of the treatment of chronic pain. The focus of the ACT treatment of chronic pain does not necessarily have to be on acceptance of pain per se, but may be aimed at acceptance of unwanted experiences in general. Mindfulness in the sense of "acting with awareness" is however not related to catastrophizing. Based on our research findings in comparisons with those of other authors, we recommend a broader conceptualization of mindfulness and the use of a multifaceted questionnaire for mindfulness instead of the unidimensional MAAS.	[de Boer, Maaike J.; Steinhagen, Hannemike E.; Versteegen, Gerbrig J.; Struys, Michel M. R. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Pain Ctr, Groningen, Netherlands; [Sanderman, Robbert] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, Groningen, Netherlands	University of Groningen; University of Groningen	de Boer, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Pain Ctr, Groningen, Netherlands.	m.j.de.boer@umcg.nl	de Boer, M.J./H-8014-2014	Struys, Michel/0000-0003-0421-536X				Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Bishop SR, 2002, PSYCHOSOM MED, V64, P71, DOI 10.1097/00006842-200201000-00010; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Carlson LE, 2005, J PSYCHOSOM RES, V58, P29, DOI 10.1016/j.jpsychores.2004.04.366; Chiros C, 2011, J BEHAV MED, V34, P307, DOI 10.1007/s10865-011-9313-0; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Hayes S.C., 2004, MINDFULNESS ACCEPTAN; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC, 1999, ACCEPTANCE COMMITMEN; Jacobs N., 2008, GEDRAGSTHERAPIE, V41, P349; McCracken LM, 2007, PAIN, V131, P63, DOI 10.1016/j.pain.2006.12.013; McCracken LM, 2010, EUR J PAIN, V14, P170, DOI 10.1016/j.ejpain.2009.03.004; McCracken LM, 2009, J PSYCHOPATHOL BEHAV, V31, P75, DOI 10.1007/s10862-008-9099-8; McCracken LM, 1998, PAIN, V74, P21, DOI 10.1016/S0304-3959(97)00146-2; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Schroevers M., 2008, GEDRAGSTHERAPIE, V41, P225; Schutze R, 2010, PAIN, V148, P120, DOI 10.1016/j.pain.2009.10.030; Severeijns R, 2001, CLIN J PAIN, V17, P165, DOI 10.1097/00002508-200106000-00009; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; van Damme S, 2000, GEDRAGSTHERAPIE, V33, P209; Viane I, 2003, PAIN, V106, P65, DOI 10.1016/S0304-3959(03)00291-4; Vlaeyen JWS, 1995, J OCCUP REHABIL, V5, P235, DOI 10.1007/BF02109988; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Wetherell JL, 2011, PAIN, V152, P2098, DOI 10.1016/j.pain.2011.05.016	29	38	38	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87445	10.1371/journal.pone.0087445	http://dx.doi.org/10.1371/journal.pone.0087445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489915	Green Published, gold, Green Submitted			2022-12-25	WOS:000330570000146
J	Rocklin, D; Levrel, H; Drogou, M; Herfaut, J; Veron, G				Rocklin, Delphine; Levrel, Harold; Drogou, Mickael; Herfaut, Johanna; Veron, Gerard			Combining Telephone Surveys and Fishing Catches Self-Report: The French Sea Bass Recreational Fishery Assessment	PLOS ONE			English	Article							LONG-TERM CHANGES; NONRESPONSE BIAS; STOCK ASSESSMENT; RELEASE SCIENCE; HARVEST; MANAGEMENT; MORTALITY; IMPACT; CONSERVATION; KNOWLEDGE	Fisheries statistics are known to be underestimated, since they are mainly based on information about commercial fisheries. However, various types of fishing activities exist and evaluating them is necessary for implementing effective management plans. This paper assesses the characteristics and catches of the French European sea bass recreational fishery along the Atlantic coasts, through the combination of large-scale telephone surveys and fishing diaries study. Our results demonstrated that half of the total catches (mainly small fish) were released at sea and that the mean length of a kept sea bass was 46.6 cm. We highlighted different patterns of fishing methods and type of gear used. Catches from boats were greater than from the shore, both in abundance and biomass, considering mean values per fishing trip as well as CPUE. Spearfishers caught the highest biomass of sea bass per fishing trip, but the fishing rod with lure was the most effective type of gear in terms of CPUE. Longlines had the highest CPUE value in abundance but not in biomass: they caught numerous but small sea bass. Handlines were less effective, catching few sea bass in both abundance and biomass. We estimated that the annual total recreational sea bass catches was 3,173 tonnes of which 2,345 tonnes were kept. Since the annual commercial catches landings were evaluated at 5,160 tonnes, recreational landings represent 30% of the total fishing catches on the Atlantic coasts of France. Using fishers' self-reports was a valuable way to obtain new information on data-poor fisheries. Our results underline the importance of evaluating recreational fishing as a part of the total amount of fisheries catches. More studies are critically needed to assess overall fish resources caught in order to develop effective fishery management tools.	[Rocklin, Delphine] Univ Brest, Observ Sci Univers, Inst Univ Europeen Mer, UMR Amenagement Usages Ressources & Espaces Marin, Brest, France; [Levrel, Harold; Herfaut, Johanna] IFREMER, UMR Amenagement Usages Ressources & Espaces Marin, Unite Econ Maritime, Plouzane, France; [Drogou, Mickael; Veron, Gerard] IFREMER, Dept Ressources Biol & Environm, Unite Sci & Tech Halieut, Plouzane, France	Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Ifremer; Ifremer	Rocklin, D (corresponding author), Univ Brest, Observ Sci Univers, Inst Univ Europeen Mer, UMR Amenagement Usages Ressources & Espaces Marin, Brest, France.	delphine.rocklin@gmail.com	Rocklin, Delphine/G-6359-2012	Rocklin, Delphine/0000-0003-4442-0704; Veron, Gerard/0000-0003-0865-9371; Levrel, Harold/0000-0002-4611-3639	European Union; French "Direction des Peches Maritimes et de l'Aquaculture"; IFREMER	European Union(European Commission); French "Direction des Peches Maritimes et de l'Aquaculture"; IFREMER	This study was carried out thanks to Data Collection Framework fundings of the European Union, the French "Direction des Peches Maritimes et de l'Aquaculture" and IFREMER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts TWPM, 2008, GLOBAL CHALLENGE REC, P39; Aas Oystein, 2008, GLOBAL CHALLENGES RE; Alos J, 2008, ICES J MAR SCI, V65, P899, DOI 10.1093/icesjms/fsn067; Alos J, 2009, FISH RES, V97, P270, DOI 10.1016/j.fishres.2009.03.003; Andrews R, 2012, CHANGES SAMPLING EST; Arlinghaus R, 2008, GLOBAL CHALLENGES RE, P25; Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Bartholomew A, 2005, REV FISH BIOL FISHER, V15, P129, DOI 10.1007/s11160-005-2175-1; Bertignac M., 1987, EXPLOITATION BAR DIC; Bray K, 2000, AUSIUU20066 FAO; Cardona-Pons F, 2010, FISH RES, V106, P575, DOI 10.1016/j.fishres.2010.09.026; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Chuenpagdee R., 2006, FISHERIES CTR RES RE, V14, P112; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Colman Jonathan E., 2008, P111, DOI 10.1002/9780470697597.ch6; Cooke SJ, 2007, FISHERIES MANAG ECOL, V14, P73, DOI 10.1111/j.1365-2400.2007.00527.x; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; DEVILLE JC, 1993, J AM STAT ASSOC, V88, P1013, DOI 10.2307/2290793; Donaldson MR, 2008, FISH FISH, V9, P79, DOI 10.1111/j.1467-2979.2007.00265.x; Dorow M, 2011, AM FISH S S, V75, P319; Douglas J, 2010, FISH RES, V106, P18, DOI 10.1016/j.fishres.2010.06.006; Dowling CE, 2010, HYDROBIOLOGIA, V641, P145, DOI 10.1007/s10750-009-0073-6; Drogou M, 2011, SYNTHESE INFORM DISP; EU, 2004, FISH EUR MED GUAR SU; Euston ET, 2006, AM FISH S S, V51, P295; FAO, 2020, STAT WORLD FISH AQ, DOI 10.4060/ca9229-n; Ferter K, 2013, ICES J MAR SCI, V70, P1319, DOI 10.1093/icesjms/fst104; Fisher MR, 1996, T AM FISH SOC, V125, P118, DOI 10.1577/1548-8659(1996)125&lt;0118:ETEONB&gt;2.3.CO;2; Fraidenburg M.E., 1982, N AM J FISH MANAGE, V2, P351; Frijlink K, 2010, SOCIOECONOMIC ASSESS; Gale MK, 2011, FISH FISH, P1; Gerdeaux D, 2009, FISH RES, V96, P6, DOI 10.1016/j.fishres.2008.09.016; Gomez S, 2006, COAST MANAGE, V34, P217, DOI 10.1080/08920750500531389; Greiner R, 2010, FISHERIES MANAG ECOL, V17, P336, DOI 10.1111/j.1365-2400.2009.00727.x; Griffiths SP, 2013, REV FISH BIOL FISHER, V23, P395, DOI 10.1007/s11160-012-9299-x; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Gutowsky LFG, 2011, FISH RES, V109, P379, DOI 10.1016/j.fishres.2011.02.022; Hall KC, 2009, J FISH BIOL, V75, P2737, DOI 10.1111/j.1095-8649.2009.02474.x; Hartill BW, 2011, N AM J FISH MANAGE, V31, P1197, DOI 10.1080/02755947.2011.646454; Henry GW, 2003, NATL RECREATIONAL IN; Herfaut J, 2013, OCEAN COAST MANAGE, V78, P121, DOI 10.1016/j.ocecoaman.2013.02.026; ICES, 2011, CM2011ACOM23 ICES PG; ICES, 2010, 2010ACOM21 ICES CM; ICES, 2010, 2010ACOM34 ICES PGRF; Ihde TF, 2011, FISH RES, V108, P268, DOI 10.1016/j.fishres.2010.12.016; Johnston FD, 2011, FISH RES, V110, P189, DOI 10.1016/j.fishres.2011.04.006; Kearney R., 2002, RECREATIONAL FISHERI, P17, DOI [10.1002/9780470995402.ch2, DOI 10.1002/9780470995402.CH2]; Klefoth T, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011072; Landsman SJ, 2011, FISH RES, V110, P377, DOI 10.1016/j.fishres.2011.05.005; Le Floc'h P, 2008, AQUAT LIVING RESOUR, V21, P307, DOI 10.1051/alr:2008047; Le Guennec J, 2002, INS METH ACT JOURN M; Levrel H, 2010, ECOL ECON, V69, P1580, DOI 10.1016/j.ecolecon.2010.03.001; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lyle J.M., 2002, RECREATIONAL FISHERI, P207; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; NMFS, 2012, MAR RECR FISH STAT S; NOAA, 2011, MAR RECR INF PROGR I; Normandeau Associates, 2007, ASS SPRING 2005 HUDS; NRC, 1999, SUST MAR FISH; NRC (National Research Council), 2006, REV RECR FISH SURV M, DOI 10.17226/11616; ONEIL MJ, 1979, PUBLIC OPIN QUART, V43, P218, DOI 10.1086/268513; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pawson MG, 2007, ICES J MAR SCI, V64, P332, DOI 10.1093/icesjms/fsl035; Pickett G., 1994, SEA BASS BIOL EXPLOI; Pitcher T.J., 2002, RECREATIONAL FISHERI, P53; Pitcher T.J., 2002, RECREATIONAL FISHERI, P1; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; Pollock Kenneth H., 1997, North American Journal of Fisheries Management, V17, P11, DOI 10.1577/1548-8675(1997)017&lt;0011:CREFRA&gt;2.3.CO;2; R Development Core Team, 2011, R LANG ENV STAT COMP; Rangel MO, 2007, FISHERIES MANAG ECOL, V14, P343, DOI 10.1111/j.1365-2400.2007.00560.x; Reid DD, 2008, RECREATIONAL FISHERI, P13; Rocklin D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023820; Rudd MA, 2002, RECREATIONAL FISHERI, P34, DOI DOI 10.1002/9780470995402.CH3; Salz RJ, 2011, NONRESPONSE BIAS STU; Sautory O, 1993, MACRO CALMAR REDRESS; Singh R, 2009, J ENVIRON ECON MANAG, V58, P72, DOI 10.1016/j.jeem.2008.08.005; Steinmetz F, 2008, AQUAT LIVING RESOUR, V21, P317, DOI 10.1051/alr:2008048; Strehlow HV, 2012, ICES J MAR SCI, V69, P1769, DOI 10.1093/icesjms/fss152; Thomson CJ, 1991, EFFECTS AVIDITY BIAS, V12, P356; Unal V, 2010, MEDITERR MAR SCI, V11, P315, DOI 10.12681/mms.79; Veiga P, 2010, J FISH BIOL, V76, P2216, DOI 10.1111/j.1095-8649.2010.02665.x; Wallmo K, 2008, N AM J FISH MANAGE, V28, P1459, DOI 10.1577/M07-062.1; Wilberg MJ, 2009, FISH RES, V99, P239, DOI 10.1016/j.fishres.2009.06.008; Zeller D, 2008, FISH RES, V91, P88, DOI 10.1016/j.fishres.2007.11.010; Zeller D, 2007, HIST CATCH RECONSTRU	85	35	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87271	10.1371/journal.pone.0087271	http://dx.doi.org/10.1371/journal.pone.0087271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489885	Green Published, gold			2022-12-25	WOS:000330570000127
J	Shive, HR; West, RR; Embree, LJ; Golden, CD; Hickstein, DD				Shive, Heather R.; West, Robert R.; Embree, Lisa J.; Golden, Champa D.; Hickstein, Dennis D.			brca2 and tp53 Collaborate in Tumorigenesis in Zebrafish	PLOS ONE			English	Article							BREAST-CANCER; GENETIC-HETEROGENEITY; MUTATOR PHENOTYPE; OVARIAN-CANCER; TUMOR TYPES; MUTATIONS; P53	Germline mutations in the tumor suppressor genes BRCA2 and TP53 significantly influence human cancer risk, and cancers from humans who inherit one mutant allele for BRCA2 or TP53 often display loss of the wildtype allele. In addition, BRCA2-associated cancers often exhibit mutations in TP53. To determine the relationship between germline heterozygous mutation (haploinsufficiency) and somatic loss of heterozygosity (LOH) for BRCA2 and TP53 in carcinogenesis, we analyzed zebrafish with heritable mutations in these two genes. Tumor-bearing zebrafish were examined by histology, and normal and neoplastic tissues were collected by laser-capture microdissection for LOH analyses. Zebrafish on a heterozygous tp53(M214K) background had a high incidence of malignant tumors. The brca2(Q658X) mutation status determined both the incidence of LOH and the malignant tumor phenotype. LOH for tp53 occurred in the majority of malignant tumors from brca2 wildtype and heterozygous mutant zebrafish, and most of these were malignant peripheral nerve sheath tumors. Malignant tumors in zebrafish with heterozygous mutations in both brca2 and tp53 frequently displayed LOH for both genes. In contrast, LOH for tp53 was uncommon in malignant tumors from brca2 homozygotes, and these tumors were primarily undifferentiated sarcomas. Thus, carcinogenesis in zebrafish with combined mutations in tp53 and brca2 typically requires biallelic mutation or loss of at least one of these genes, and the specific combination of inherited mutations influences the development of LOH and the tumor phenotype. These results provide insight into cancer development associated with heritable BRCA2 and TP53 mutations.	[Shive, Heather R.; West, Robert R.; Embree, Lisa J.; Golden, Champa D.; Hickstein, Dennis D.] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shive, HR (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	shiveh@mail.nih.gov		West, Robert/0000-0002-2079-0922	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010549] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Birkbak NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080023; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Dworkin AM, 2009, FAM CANCER, V8, P339, DOI 10.1007/s10689-009-9240-1; Feitsma H, 2008, CANCER RES, V68, P5059, DOI 10.1158/0008-5472.CAN-08-0019; Greenblatt MS, 2001, CANCER RES, V61, P4092; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Norquist BM, 2010, CANCER-AM CANCER SOC, V116, P5261, DOI 10.1002/cncr.25439; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rowley M, 2011, GASTROENTEROLOGY, V140, P1303, DOI 10.1053/j.gastro.2010.12.039; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Schmitt MW, 2012, ANN NY ACAD SCI, V1267, P110, DOI 10.1111/j.1749-6632.2012.06590.x; Shive HR, 2010, P NATL ACAD SCI USA, V107, P19350, DOI 10.1073/pnas.1011630107; Tutt ANJ, 2002, EMBO REP, V3, P255, DOI 10.1093/embo-reports/kvf037; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	27	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87177	10.1371/journal.pone.0087177	http://dx.doi.org/10.1371/journal.pone.0087177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489863	Green Published, gold			2022-12-25	WOS:000330570000113
J	Tavano, A; Pesarin, A; Murino, V; Cristani, M				Tavano, Alessandro; Pesarin, Anna; Murino, Vittorio; Cristani, Marco			Automatic Conversational Scene Analysis in Children with Asperger Syndrome/High-Functioning Autism and Typically Developing Peers	PLOS ONE			English	Article							RESONANCE; SPEECH; INFANTS; MIND	Individuals with Asperger syndrome/High Functioning Autism fail to spontaneously attribute mental states to the self and others, a life-long phenotypic characteristic known as mindblindness. We hypothesized that mindblindness would affect the dynamics of conversational interaction. Using generative models, in particular Gaussian mixture models and observed influence models, conversations were coded as interacting Markov processes, operating on novel speech/silence patterns, termed Steady Conversational Periods (SCPs). SCPs assume that whenever an agent's process changes state (e. g., from silence to speech), it causes a general transition of the entire conversational process, forcing inter-actant synchronization. SCPs fed into observed influence models, which captured the conversational dynamics of children and adolescents with Asperger syndrome/High Functioning Autism, and age-matched typically developing participants. Analyzing the parameters of the models by means of discriminative classifiers, the dialogs of patients were successfully distinguished from those of control participants. We conclude that meaning-free speech/silence sequences, reflecting inter-actant synchronization, at least partially encode typical and atypical conversational dynamics. This suggests a direct influence of theory of mind abilities onto basic speech initiative behavior.	[Tavano, Alessandro] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [Tavano, Alessandro] Sci Inst E Medea, San Vito Al Tagliamento, Pordenone, Italy; [Pesarin, Anna; Cristani, Marco] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy; [Murino, Vittorio; Cristani, Marco] Italian Inst Technol, Genoa, Italy	Leipzig University; IRCCS Eugenio Medea; University of Verona; Istituto Italiano di Tecnologia - IIT	Cristani, M (corresponding author), Univ Verona, Dept Comp Sci, I-37100 Verona, Italy.	marco.cristani@univr.it		Murino, Vittorio/0000-0002-8645-2328; Tavano, Alessandro/0000-0002-2096-5542	Italian Ministry of Health, "E. Medea" Research Institute [3:06]; University of Leipzig by a DFG (German Research Foundation)	Italian Ministry of Health, "E. Medea" Research Institute; University of Leipzig by a DFG (German Research Foundation)	The study was funded by the Italian Ministry of Health (www.salute.gov.it) as part of a two-year project on "Neurorehabilitation of prosodic and pragmatic skills in individuals with High-functioning Autism, Specific Language Impairment and Williams syndrome", Principal Investigator Alessandro Tavano, RC-2007/8, 3:06, "E. Medea" Research Institute. Alessandro Tavano was also supported at the University of Leipzig by a DFG (German Research Foundation) Reinhart-Koselleck Project grant, awarded to Professor E. Schroger. Psychologist Elisa Cravello was employed within the project for data analysis purposes and participated to the present study acting as the adult conversational partner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P679, DOI 10.1111/1469-7610.00056; Aitchison J, 2008, ARTICULATE MAMMAL IN; [Anonymous], 19 INT C PATT REC IC; Asavathiratham C., 2000, THESIS MIT; Austin J. L., 1946, P ARISTOTELIAN SOC, V20, P148, DOI DOI 10.1093/019283021X.001.0001; Basu S., 2001, 539 MIT MEDIALAB; Bilmes JA, 1997, ICSITR97021; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Cristani M, 2011, PATTERN RECOGN, V44, P1785, DOI 10.1016/j.patcog.2011.01.013; Duda R.O., 2006, PATTERN CLASSIFICATI; Duin R, 2004, PRTOOLS VERS 4 1 MAT; Fisher JW, 2004, IEEE T MULTIMEDIA, V6, P406, DOI 10.1109/TMM.2004.827503; Frith CD, 2008, PHILOS T R SOC B, V363, P3875, DOI 10.1098/rstb.2008.0156; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Frith U., 2003, AUTISM EXPLAINING EN; Goldinger SD, 2004, BEHAV BRAIN SCI, V27, P199, DOI 10.1017/S0140525X04320054; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; GRICE PAUL, 1989, STUDIES WAY WORDS, P24; Heilmann J, 2013, AM J SPEECH-LANG PAT, V22, P463, DOI 10.1044/1058-0360(2012/11-0035); Hird K, 2002, BRAIN LANG, V80, P536, DOI 10.1006/brln.2001.2613; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jaakkola TS, 1999, ADV NEUR IN, V11, P487; Korkman M, 2011, NEPSY 2 DEV NEUROPSY; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lewis A., 2004, BRIT J LEARN DISABIL, V32, P191, DOI DOI 10.1111/J.1468-3156.2004.00313.X; Lord C., 2005, AUTISM DIAGNOSTIC OB; Manning C.D., 1999, FDN STAT NATURAL LAN; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); Miller G, 2005, SCIENCE, V308, P945, DOI 10.1126/science.308.5724.945; Miller VH, 2008, BIOL CYBERN, V99, P459, DOI 10.1007/s00422-008-0253-x; NARENDRA P, 1977, IEEE T COMPUT, V26, P917, DOI 10.1109/TC.1977.1674939; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perina A., 2009, ADV NEURAL INFORM PR, P1428; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Schiller NO, 2004, BEHAV BRAIN SCI, V27, P208, DOI 10.1017/S0140525X0441005X; Schopler E, 1980, J AUTISM DEV DISORD, V10, P91103; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Smith N., 2001, NIPS, P1197; Solomon M, 2004, J AUTISM DEV DISORD, V34, P649, DOI 10.1007/s10803-004-5286-y; Stambak M, 1980, PROVE RITMO; Talwar V, 2007, DEV PSYCHOL, V43, P804, DOI 10.1037/0012-1649.43.3.804; Tavano A, 2013, MEC PROTOCOLLO MONTR; Tsuda K, 2002, NEURAL COMPUT, V14, P2397, DOI 10.1162/08997660260293274; Uchiyama HT, 2012, CORTEX, V48, P563, DOI 10.1016/j.cortex.2011.01.004; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WARNER RM, 1983, J APPL PHYSIOL, V54, P1324, DOI 10.1152/jappl.1983.54.5.1324; Wechsler D., 1986, WECHSLER INTELLIGENC; Williams DM, 2012, DEV PSYCHOPATHOL, V24, P225, DOI 10.1017/S0954579411000794; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Zion-Golumbic E, 2012, TRENDS COGN SCI, V16, P363, DOI 10.1016/j.tics.2012.05.004	60	1	1	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85819	10.1371/journal.pone.0085819	http://dx.doi.org/10.1371/journal.pone.0085819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489674	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000018
J	Biere, L; Donal, E; Terrien, G; Kervio, G; Willoteaux, S; Furber, A; Prunier, F				Biere, Loic; Donal, Erwan; Terrien, Gwenola; Kervio, Gaelle; Willoteaux, Serge; Furber, Alain; Prunier, Fabrice			Longitudinal Strain Is a Marker of Microvascular Obstruction and Infarct Size in Patients with Acute ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							SPECKLE TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; WALL-MOTION SCORE; 2-DIMENSIONAL STRAIN; CLINICAL-IMPLICATIONS; EJECTION FRACTION; QUANTIFICATION; REPERFUSION; VALIDATION; ANGIOPLASTY	Objectives: We assessed the value of speckle tracking imaging performed early after a first ST-segment elevation myocardial infarction (STEMI) in order to predict infarct size and functional recovery at 3-month follow-up. Methods: 44 patients with STEMI who underwent revascularization within 12 h of symptom onset were prospectively enrolled. Echocardiography was performed 3.9 +/- 1.2 days after myocardial reperfusion, assessing circumferential (CGS), radial (RGS), and longitudinal global (GLS) strains. Late gadolinium-enhanced cardiac magnetic imaging (CMR), for assessing cardiac function, infarct size, and microvascular obstruction (MVO), was conducted 5.6 +/- 2.5 days and 99.4 +/- 4.6 days after myocardial reperfusion. Results: GLS was evaluable in 97% of the patients, while CGS and RGS could be assessed in 85%. Infarct size significantly correlated with GLS (R = 0.601, p < 0.001), RGS (R = -0.405, p = 0.010), CGS (R = 0.526, p = 0.001), ejection fraction (R = -0.699, p < 0.001), wall motion score index (WMSI) (R = 0.539, p = 0.001), and left atrial volume (R = 0.510, p < 0.001). Baseline ejection fraction and GLS were independent predictors of 3-month infarct size. MVO mass significantly correlated with GLS (R = 0.376, p = 0.010), WMSI (R = 0.387, p = 0.011), and ejection fraction (R = -0.389, p = 0.011). In multivariate analysis, GLS was the only independent predictor of MVO mass (p = 0.015). Longitudinal strain >-6.0% within the infarcted area exhibited 96% specificity and 61% sensitivity for predicting the persistence of akinesia (>= 3 segments) at 3-month follow-up. Conclusions: Speckle-tracking strain imaging performed early after a STEMI is easy-to-use as a marker for persistent akinetic territories at 3 months. In addition, GLS correlated significantly with MVO and final infarct size, both parameters being relevant post-MI prognostic factors, usually obtained via CMR.	[Biere, Loic; Terrien, Gwenola; Willoteaux, Serge; Furber, Alain; Prunier, Fabrice] LUNAM Univ, Angers, France; [Biere, Loic; Terrien, Gwenola; Furber, Alain; Prunier, Fabrice] Univ Angers, CHU Angers, Lab Cardioprotect Remodelage & Thrombose, UPRES,EA3860,Serv Cardiol, Angers, France; [Donal, Erwan; Kervio, Gaelle] CHU Rennes, Serv Cardiol, Rennes, France; [Donal, Erwan; Kervio, Gaelle] CHU Rennes, CIC IT 804, Rennes, France; [Donal, Erwan; Kervio, Gaelle] INSERM, U1099, Lab Traitement Signal & Image, Rennes, France; [Willoteaux, Serge] Univ Angers, CHU Angers, Lab Cardioprotect Remodelage & Thrombose, UPRES,EA3860,Serv Radiol, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Prunier, F (corresponding author), LUNAM Univ, Angers, France.	FaPrunier@chu-angers.fr	Prunier, Fabrice/A-5210-2011; donal, erwan/ABC-9736-2020					Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Antoni ML, 2010, EUR HEART J, V31, P1640, DOI 10.1093/eurheartj/ehq105; Bergerot C, 2010, EUR HEART J, V31, P1060; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chan J, 2006, J AM COLL CARDIOL, V48, P2026, DOI 10.1016/j.jacc.2006.07.050; Cimino S, 2013, EUR HEART J-CARD IMG, V14, P805, DOI 10.1093/ehjci/jes295; Gerber B L, 2000, Top Magn Reson Imaging, V11, P372, DOI 10.1097/00002142-200012000-00006; Gerber BL, 2000, CIRCULATION, V101, P2734, DOI 10.1161/01.CIR.101.23.2734; Gerber BL, 2002, CIRCULATION, V106, P1083, DOI 10.1161/01.CIR.0000027818.15792.1E; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; Grabka M, 2013, CORONARY ARTERY DIS, V24, P127, DOI 10.1097/MCA.0b013e32835b6798; Hanekom L, 2005, CIRCULATION, V112, P3892, DOI 10.1161/CIRCULATIONAHA.104.489310; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Ingul CB, 2005, J AM SOC ECHOCARDIOG, V18, P411, DOI 10.1016/j.echo.2005.01.032; KAN G, 1986, BRIT HEART J, V56, P422; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Mollema SA, 2009, HEART, V95, P1732, DOI 10.1136/hrt.2008.161836; Mollema SA, 2010, CIRC-CARDIOVASC IMAG, V3, P15, DOI 10.1161/CIRCIMAGING.108.802785; Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042; Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340; Ortiz-Perez JT, 2008, JACC-CARDIOVASC IMAG, V1, P282, DOI 10.1016/j.jcmg.2008.01.014; Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Reant P, 2008, J AM COLL CARDIOL, V51, P149, DOI 10.1016/j.jacc.2007.07.088; Reant P, 2012, J AM SOC ECHOCARDIOG, V25, P68, DOI 10.1016/j.echo.2011.10.009; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Sjoli B, 2009, JACC-CARDIOVASC IMAG, V2, P24, DOI 10.1016/j.jcmg.2008.10.007; Solomon SD, 2005, CIRCULATION, V111, P3411, DOI 10.1161/CIRCULATIONAHA.104.508093; SUTTON JM, 1994, CIRCULATION, V89, P1126, DOI 10.1161/01.CIR.89.3.1126; Torrent-Guasp F, 2005, EUR J CARDIO-THORAC, V27, P191, DOI 10.1016/j.ejcts.2004.11.026; Vartdal T, 2007, J AM COLL CARDIOL, V49, P1715, DOI 10.1016/j.jacc.2006.12.047; Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X; Wu KC, 1999, CURR OPIN CARDIOL, V14, P480, DOI 10.1097/00001573-199911000-00005; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Zhang Y, 2005, J AM COLL CARDIOL, V46, P864, DOI 10.1016/j.jacc.2005.05.054	41	26	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86959	10.1371/journal.pone.0086959	http://dx.doi.org/10.1371/journal.pone.0086959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489816	Green Published, gold			2022-12-25	WOS:000330510000094
J	Bokenkamp, R; van Brempt, R; van Munsteren, JC; van den Wijngaert, I; de Hoogt, R; Finos, L; Goeman, J; Gittenberger-de Groot, AC; Poelmann, RE; Blom, NA; DeRuiter, MC				Bokenkamp, Regina; van Brempt, Ronald; van Munsteren, Jacoba Cornelia; van den Wijngaert, Ilse; de Hoogt, Ronald; Finos, Livio; Goeman, Jelle; Gittenberger-de Groot, Adriana Cornelia; Poelmann, Robert Eugen; Blom, Nicolaas Andreas; DeRuiter, Marcus Cornelis			Dlx1 and Rgs5 in the Ductus Arteriosus: Vessel-Specific Genes Identified by Transcriptional Profiling of Laser-Capture Microdissected Endothelial and Smooth Muscle Cells	PLOS ONE			English	Article							HOMEOBOX GENES; EXPRESSION; PROTEIN; DIFFERENTIATION; MUTATIONS; PATHWAY; SYSTEM; TISSUE; ARTERY	Closure of the ductus arteriosus (DA) is a crucial step in the transition from fetal to postnatal life. Patent DA is one of the most common cardiovascular anomalies in children with significant clinical consequences especially in premature infants. We aimed to identify genes that specify the DA in the fetus and differentiate it from the aorta. Comparative microarray analysis of laser-captured microdissected endothelial (ECs) and vascular smooth muscle cells (SMCs) from the DA and aorta of fetal rats (embryonic day 18 and 21) identified vessel-specific transcriptional profiles. We found a strong age-dependency of gene expression. Among the genes that were upregulated in the DA the regulator of the G-protein coupled receptor 5 (Rgs5) and the transcription factor distal-less homeobox 1 (Dlx1) exhibited the highest and most significant level of differential expression. The aorta showed a significant preferential expression of the Purkinje cell protein 4 (Pcp4) gene. The results of the microarray analysis were validated by real-time quantitative PCR and immunohistochemistry. Our study confirms vessel-specific transcriptional profiles in ECs and SMCs of rat DA and aorta. Rgs5 and Dlx1 represent novel molecular targets for the regulation of DA maturation and closure.	[Bokenkamp, Regina; Blom, Nicolaas Andreas] Leiden Univ, Med Ctr, Dept Pediat Cardiol, Leiden, Netherlands; [Bokenkamp, Regina; van Brempt, Ronald] Leiden Univ, Dept Intens Care, Med Ctr, Leiden, Netherlands; [van Brempt, Ronald; van den Wijngaert, Ilse; de Hoogt, Ronald] Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium; [van Munsteren, Jacoba Cornelia; Gittenberger-de Groot, Adriana Cornelia; Poelmann, Robert Eugen; DeRuiter, Marcus Cornelis] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Finos, Livio] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Goeman, Jelle] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Gittenberger-de Groot, Adriana Cornelia] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johnson & Johnson; Janssen Pharmaceuticals; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bokenkamp, R (corresponding author), Leiden Univ, Med Ctr, Dept Pediat Cardiol, Leiden, Netherlands.	r.bokenkamp@lumc.nl	Finos, Livio/AAQ-6411-2020; Goeman, Jelle/AAT-1300-2020	Finos, Livio/0000-0003-3181-8078; Goeman, Jelle/0000-0003-4283-0259	Madeleine Schickedanz-KinderKrebs-Stiftung	Madeleine Schickedanz-KinderKrebs-Stiftung	This work was supported by the Madeleine Schickedanz-KinderKrebs-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bergwerff M, 1996, ANAT EMBRYOL, V194, P545; Bergwerff M, 2000, VIRCHOWS ARCH, V436, P12, DOI 10.1007/PL00008193; Bergwerff M, 1998, CIRC RES, V82, P221; Bhandari V, 2009, PEDIATRICS, V123, P669, DOI 10.1542/peds.2008-1117; Bokenkamp R, 2009, NEONATOLOGY, V98; Bokenkamp R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023975; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Chiba S, 2003, P NATL ACAD SCI USA, V100, P15577, DOI 10.1073/pnas.2536757100; Coceani F, 2011, J PHYSIOL SCI, V61, P443, DOI 10.1007/s12576-011-0161-z; Costa M, 2006, PHYSIOL GENOMICS, V25, P250, DOI 10.1152/physiolgenomics.00231.2005; Dagle JM, 2009, PEDIATRICS, V123, P1116, DOI 10.1542/peds.2008-0313; DERUITER MC, 1989, ANAT EMBRYOL, V179, P319; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fowlie PW, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000174.pub2; Fox J., 2011, R COMPANION APPL REG, Vsecond, P1; GITTENBERGERDEGROOT AC, 1980, J PEDIATR-US, V96, P88, DOI 10.1016/S0022-3476(80)80337-4; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Harashima S, 2011, J NEUROSCI RES, V89, P1519, DOI 10.1002/jnr.22688; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hong ZG, 2006, CIRCULATION, V114, P1372, DOI 10.1161/CIRCULATIONAHA.106.641126; Huber A, 2005, OBSTET GYNECOL, V105, P91, DOI 10.1097/01.AOG.0000146636.61611.e3; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jin MH, 2011, J PHYSIOL SCI, V61, P167, DOI 10.1007/s12576-011-0133-3; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Lee SY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-113; LEWIS AB, 1978, J PEDIATR-US, V93, P481, DOI 10.1016/S0022-3476(78)81171-8; Momma K, 2003, PEDIATR RES, V53, P479, DOI 10.1203/01.PDR.0000049516.70216.2E; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Moser M, 2003, LAB INVEST, V83, P571, DOI 10.1097/01.LAB.0000064703.92382.50; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Paulsen SJ, 2011, METHODS MOL BIOL, V789, P127, DOI 10.1007/978-1-61779-310-3_7; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Slomp J, 1997, DIFFERENTIATION, V61, P305, DOI 10.1046/j.1432-0436.1997.6150305.x; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003, DOI 10.1161/01.ATV.17.5.1003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Starkova J, 2011, HAEMATOL-HEMATOL J, V96, P820, DOI 10.3324/haematol.2010.031179; Waleh N, 2004, CIRCULATION, V110, P2326, DOI 10.1161/01.CIR.0000145159.16637.5D; Waleh N, 2010, PEDIATR RES, V68, P292, DOI 10.1203/00006450-201011001-00571; Wang X, 2008, J MOL CELL CARDIOL, V44, P539, DOI 10.1016/j.yjmcc.2007.11.019; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; ZHANG HL, 2011, CHINESE J HYDRODYNAM, V26, P1; Zhao F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022908	45	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86892	10.1371/journal.pone.0086892	http://dx.doi.org/10.1371/journal.pone.0086892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489801	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000086
J	de Oliveira, IT; Dias, JG; Padmadas, SS				de Oliveira, Isabel Tiago; Dias, Jose G.; Padmadas, Sabu S.			Dominance of Sterilization and Alternative Choices of Contraception in India: An Appraisal of the Socioeconomic Impact	PLOS ONE			English	Article							SON PREFERENCE; MARRIED-WOMEN; FAMILY; EMERGENCY	Background: The recent decline in fertility in India has been unprecedented especially in southern India, where fertility is almost exclusively controlled by means of permanent contraceptive methods, mainly female sterilization, which constitutes about two-thirds of overall contraceptive use. Many Indian women undergo sterilization at relatively young ages as a consequence of early marriage and childbearing in short birth intervals. This research aims to investigate the socioeconomic factors determining the choices for alternative contraceptive choices against the dominant preference for sterilization among married women in India. Methods: Data for this study are drawn from the 2005-06 National Family Health Surveys focusing on a sample of married women who reported having used a method of contraception in the five years preceding the survey. A multilevel multinomial logit regression is used to estimate the impact of socioeconomic factors on contraceptive choices, differentiating temporary modern or traditional methods versus sterilization. Findings: Religious affiliation, women's education and occupation had overarching influence on method choices amongst recent users. Muslim women were at higher odds of choosing a traditional or modern temporary method than sterilization. Higher level of women's education increased the odds of modern temporary method choices but the education effect on traditional method choices was only marginally significant. Recent users belonging to wealthier households had higher odds of choosing modern methods over sterilization. Exposure to family planning messages through radio had a positive effect on modern and traditional method choices. Community variations in method choices were highly significant. Conclusion: The persistent dominance of sterilization in the Indian family planning programme is largely determined by socioeconomic conditions. Reproductive health programmes should address the socioeconomic barriers and consider multiple cost-effective strategies such as mass media to promote awareness of modern temporary methods.	[de Oliveira, Isabel Tiago; Dias, Jose G.] Inst Univ Lisboa ISCTE IUL, CIES IUL, Lisbon, Portugal; [Padmadas, Sabu S.] Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England; [Padmadas, Sabu S.] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England	Instituto Universitario de Lisboa; University of Southampton; University of Southampton	de Oliveira, IT (corresponding author), Inst Univ Lisboa ISCTE IUL, CIES IUL, Lisbon, Portugal.	Isabel.Oliveira@iscte.pt	Dias, José G./N-6217-2015; Oliveira, Isabel/AAE-4688-2022	Oliveira, Isabel/0000-0002-9350-4130; Padmadas, Sabu/0000-0002-6538-9374; Dias, Jose G./0000-0003-4732-7230	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/CS-DEM/108033/2008]; Fundação para a Ciência e a Tecnologia [PTDC/CS-DEM/108033/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This research was supported by the Fundacao para a Ciencia e Tecnologia (Portugal), Grant PTDC/CS-DEM/108033/2008. URL: http://www.fct.pt/index.phtml.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold F, 1998, POP STUD-J DEMOG, V52, P301, DOI 10.1080/0032472031000150486; BARU R, 2010, EC POLITIC WKLY, V65, P49; BASU AM, 1985, ECON POLIT WEEKLY, V20, P422; Berg E, 2010, INDIAS POOR RELY MAI; Bose A, 1993, INDIA ASIAN POPULATI; Chacko E, 2001, HEALTH PLACE, V7, P197, DOI 10.1016/S1353-8292(01)00009-0; Clark S, 2000, DEMOGRAPHY, V37, P95, DOI 10.2307/2648099; GWATKIN DR, 1979, POPUL DEV REV, V5, P29, DOI 10.2307/1972317; Harkavy O., 2007, GLOBAL FAMILY PLANNI, P301; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Iyer S, 2002, J SCI STUD RELIG, V41, P711, DOI 10.1111/1468-5906.00156; Jayaraman A, 2009, INT PERSPECT SEX R H, V35, P29, DOI 10.1363/ifpp.35.029.09; Jejeebhoy S., 1995, WOMENS ED AUTONOMY R; Koenig MA, 2000, STUD FAMILY PLANN, V31, P1, DOI 10.1111/j.1728-4465.2000.00001.x; Kumar M, 2011, J SEX MED, V8, P376, DOI 10.1111/j.1743-6109.2010.02047.x; Leon Federico R., 2011, OPEN FAMILY STUDIES, V4, P1; McNay K, 2003, POP STUD-J DEMOG, V57, P21, DOI 10.1080/0032472032000061703; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; Moursund A, 2003, POP STUD-J DEMOG, V57, P285, DOI 10.1080/0032472032000137817; Padmadas SS, 2004, INT FAM PLAN PERSPEC, V30, P12, DOI 10.1363/3001204; Pande R., 2006, SON PREFERENCE DAUGH; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; RAY P, 1973, ECONOMETRICA, V41, P987, DOI 10.2307/1913820; Saavala M, 1999, STUD FAMILY PLANN, V30, P288, DOI 10.1111/j.1728-4465.1999.t01-1-.x; Santhya KG, 2003, CHANGING FAMILY PLAN; Singh A, 2012, INT PERSPECT SEX R H, V38, P187, DOI 10.1363/3818712; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Srinivasan K., 1995, REGULATING REPROD IN; SRINIVASAN K., 1998, DEMOGRAPHY INDIA, V27, P1; Srinivasan K, 2006, LECT 5 C CHANDRASEKH; Stephenson R, 2008, STUD FAMILY PLANN, V39, P177, DOI 10.1111/j.1728-4465.2008.165.x; Visaria L, 1999, INT FAM PLAN PERSPEC, V25, pS44, DOI 10.2307/2991871; Zavier F, 2000, INT FAM PLAN PERSPEC, V26, P29, DOI 10.2307/2648287	34	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86654	10.1371/journal.pone.0086654	http://dx.doi.org/10.1371/journal.pone.0086654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489759	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000330510000069
J	Fernandez-Del-Olmo, M; Rio-Rodriguez, D; Iglesias-Soler, E; Acero, RM				Fernandez-Del-Olmo, Miguel; Rio-Rodriguez, Dan; Iglesias-Soler, Eliseo; Acero, Rafael M.			Startle Auditory Stimuli Enhance the Performance of Fast Dynamic Contractions	PLOS ONE			English	Article							SIMPLE REACTION-TIME; RESPONSE FORCE; ELECTROMECHANICAL DELAY; VOLUNTARY MOVEMENT; INTENSITY; FATIGUE; HUMANS; REFLEX; MUSCLE; FACILITATION	Fast reaction times and the ability to develop a high rate of force development (RFD) are crucial for sports performance. However, little is known regarding the relationship between these parameters. The aim of this study was to investigate the effects of auditory stimuli of different intensities on the performance of a concentric bench-press exercise. Concentric bench-presses were performed by thirteen trained subjects in response to three different conditions: a visual stimulus (VS); a visual stimulus accompanied by a non-startle auditory stimulus (AS); and a visual stimulus accompanied by a startle auditory stimulus (SS). Peak RFD, peak velocity, onset movement, movement duration and electromyography from pectoralis and tricep muscles were recorded. The SS condition induced an increase in the RFD and peak velocity and a reduction in the movement onset and duration, in comparison with the VS and AS condition. The onset activation of the pectoralis and tricep muscles was shorter for the SS than for the VS and AS conditions. These findings point out to specific enhancement effects of loud auditory stimulation on the rate of force development. This is of relevance since startle stimuli could be used to explore neural adaptations to resistance training.	[Fernandez-Del-Olmo, Miguel; Rio-Rodriguez, Dan; Iglesias-Soler, Eliseo; Acero, Rafael M.] Univ A Coruna, INEF Galicia, Learning & Human Movement Control Grp, La Coruna, Spain	Universidade da Coruna	Fernandez-Del-Olmo, M (corresponding author), Univ A Coruna, INEF Galicia, Learning & Human Movement Control Grp, La Coruna, Spain.	mafo@udc.es	Iglesias-Soler, Eliseo/G-5144-2010; MARTÍN-ACERO, RAFAEL/AAB-9221-2021; Rio-Rodriguez, Dan/C-6775-2014	Iglesias-Soler, Eliseo/0000-0002-1212-4188; MARTÍN-ACERO, RAFAEL/0000-0002-7117-8055; Rio-Rodriguez, Dan/0000-0002-1790-9013; Fernandez del Olmo, Miguel/0000-0001-5325-503X	Xunta de Galicia [CN2012/1702]	Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by Xunta de Galicia (CN2012/1702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; ANGEL A, 1973, Q J EXP PSYCHOL, V25, P193, DOI 10.1080/14640747308400338; Anzak A, 2011, EXP BRAIN RES, V208, P237, DOI 10.1007/s00221-010-2474-1; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2007, EXP BRAIN RES, V176, P199, DOI 10.1007/s00221-006-0610-8; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Davis M., 1984, P287; Frere J, 2011, INT J SPORTS MED, V32, P28, DOI 10.1055/s-0030-1267199; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; GRUNER JA, 1989, J NEUROSCI METH, V27, P13, DOI 10.1016/0165-0270(89)90049-6; Harwood B, 2012, J APPL PHYSIOL, V113, P1821, DOI 10.1152/japplphysiol.00879.2012; IKAI M, 1961, J APPL PHYSIOL, V16, P157, DOI 10.1152/jappl.1961.16.1.157; JASKOWSKI P, 1995, ACTA NEUROBIOL EXP, V55, P57; KOHFELD DL, 1969, J EXP PSYCHOL, V82, P88, DOI 10.1037/h0028033; LEE WA, 1990, EXP BRAIN RES, V82, P304; LIEGEOISCHAUVEL C, 1989, BRAIN, V112, P375, DOI 10.1093/brain/112.2.375; Miller J, 1999, J EXP PSYCHOL HUMAN, V25, P1454, DOI 10.1037/0096-1523.25.5.1454; Newton RU, 1997, EUR J APPL PHYSIOL O, V75, P333, DOI 10.1007/s004210050169; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; ROSSIGNOL S, 1976, ELECTROEN CLIN NEURO, V41, P83, DOI 10.1016/0013-4694(76)90217-0; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Stahl J, 2005, ACTA PSYCHOL, V120, P1, DOI 10.1016/j.actpsy.2005.02.003; Ulrich R, 1998, J EXP PSYCHOL HUMAN, V24, P915, DOI 10.1037/0096-1523.24.3.915; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; VANDIEEN JH, 1991, EUR J APPL PHYSIOL O, V63, P216, DOI 10.1007/BF00233851; VencesBrito AM, 2011, J ELECTROMYOGR KINES, V21, P1023, DOI 10.1016/j.jelekin.2011.09.007; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zhou S, 1996, EUR J APPL PHYSIOL, V72, P410, DOI 10.1007/BF00242269	31	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87805	10.1371/journal.pone.0087805	http://dx.doi.org/10.1371/journal.pone.0087805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489967	Green Submitted, gold, Green Published			2022-12-25	WOS:000330510000150
J	Ruggles, DR; Freyman, RL; Oxenham, AJ				Ruggles, Dorea R.; Freyman, Richard L.; Oxenham, Andrew J.			Influence of Musical Training on Understanding Voiced and Whispered Speech in Noise	PLOS ONE			English	Article							TEMPORAL FINE-STRUCTURE; HEARING-IMPAIRED LISTENERS; HUMAN BRAIN-STEM; IN-NOISE; RECEPTION THRESHOLDS; PITCH DISCRIMINATION; FLUCTUATING MASKERS; INTERFERING SPEECH; BACKGROUND-NOISE; MUSICIANS	This study tested the hypothesis that the previously reported advantage of musicians over non-musicians in understanding speech in noise arises from more efficient or robust coding of periodic voiced speech, particularly in fluctuating backgrounds. Speech intelligibility was measured in listeners with extensive musical training, and in those with very little musical training or experience, using normal (voiced) or whispered (unvoiced) grammatically correct nonsense sentences in noise that was spectrally shaped to match the long-term spectrum of the speech, and was either continuous or gated with a 16-Hz square wave. Performance was also measured in clinical speech-in-noise tests and in pitch discrimination. Musicians exhibited enhanced pitch discrimination, as expected. However, no systematic or statistically significant advantage for musicians over non-musicians was found in understanding either voiced or whispered sentences in either continuous or gated noise. Musicians also showed no statistically significant advantage in the clinical speech-in-noise tests. Overall, the results provide no evidence for a significant difference between young adult musicians and non-musicians in their ability to understand speech in noise.	[Ruggles, Dorea R.; Oxenham, Andrew J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Freyman, Richard L.] Univ Massachusetts, Dept Commun Disorders, Amherst, MA 01003 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Amherst	Ruggles, DR (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	druggles@umn.edu		Oxenham, Andrew/0000-0002-9365-1157	National Institutes of Health (NIH) [R01 DC005216, R01 DC001625]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001625, R01DC005216] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) R01 DC005216 and NIH R01 DC001625 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein JGW, 2011, J ACOUST SOC AM, V130, P473, DOI 10.1121/1.3589440; Bernstein JGW, 2009, J ACOUST SOC AM, V125, P3358, DOI 10.1121/1.3110132; Bidelman GM, 2011, EUR J NEUROSCI, V33, P530, DOI 10.1111/j.1460-9568.2010.07527.x; Binns C, 2007, J ACOUST SOC AM, V122, P1765, DOI 10.1121/1.2751394; Carcagno S, 2011, JARO-J ASSOC RES OTO, V12, P89, DOI 10.1007/s10162-010-0236-1; Corrigall KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00222; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; Freyman RL, 2012, J ACOUST SOC AM, V132, P2514, DOI 10.1121/1.4747614; Helfer KS, 1997, J SPEECH LANG HEAR R, V40, P432, DOI 10.1044/jslhr.4002.432; Hopkins K, 2010, J ACOUST SOC AM, V127, P1595, DOI 10.1121/1.3293003; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Levitin DJ, 2012, NEURON, V73, P633, DOI 10.1016/j.neuron.2012.01.017; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Miller SE, 2010, J ACOUST SOC AM, V128, P435, DOI 10.1121/1.3397384; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nelson PB, 2004, J ACOUST SOC AM, V115, P2286, DOI 10.1121/1.1703538; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oxenham AJ, 2003, J ACOUST SOC AM, V114, P1543, DOI 10.1121/1.1598197; Oxenham AJ, 2009, J ACOUST SOC AM, V125, P457, DOI 10.1121/1.3021299; Parbery-Clark A, 2011, NEUROPSYCHOLOGIA, V49, P3338, DOI 10.1016/j.neuropsychologia.2011.08.007; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Peters RW, 1998, J ACOUST SOC AM, V103, P577, DOI 10.1121/1.421128; Qin MK, 2003, J ACOUST SOC AM, V114, P446, DOI 10.1121/1.1579009; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Skoe E, 2012, J NEUROSCI, V32, P11507, DOI 10.1523/JNEUROSCI.1949-12.2012; Soli SD, 2008, INT J AUDIOL, V47, P356, DOI 10.1080/14992020801895136; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Strelcyk O, 2009, J ACOUST SOC AM, V125, P3328, DOI 10.1121/1.3097469; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Wechsler D, 2011, WECHSLER ABBREVIATED; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816	38	97	99	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86980	10.1371/journal.pone.0086980	http://dx.doi.org/10.1371/journal.pone.0086980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489819	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000095
J	Wright, EP; Prasad, KAG; Padula, MP; Coorssen, JR				Wright, Elise P.; Prasad, Kali A. G.; Padula, Matthew P.; Coorssen, Jens R.			Deep Imaging: How Much of the Proteome Does Current Top-Down Technology Already Resolve?	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; IMMOBILIZED PH GRADIENTS; RESOLUTION; PROTEINS; DATABASE; TOOLS	Effective proteome analyses are based on interplay between resolution and detection. It had been claimed that resolution was the main factor limiting the use of two-dimensional gel electrophoresis. Improved protein detection now indicates that this is unlikely to be the case. Using a highly refined protocol, the rat brain proteome was extracted, resolved, and detected. In order to overcome the stain saturation threshold, high abundance protein species were excised from the gel following standard imaging. Gels were then imaged again using longer exposure times, enabling detection of lower abundance, less intensely stained protein species. This resulted in a significant enhancement in the detection of resolved proteins, and a slightly modified digestion protocol enabled effective identification by standard mass spectrometric methods. The data indicate that the resolution required for comprehensive proteome analyses is already available, can assess multiple samples in parallel, and preserve critical information concerning post-translational modifications. Further optimization of staining and detection methods promises additional improvements to this economical, widely accessible and effective top-down approach to proteome analysis.	[Wright, Elise P.; Prasad, Kali A. G.; Coorssen, Jens R.] Univ Western Sydney, Campbelltown, NSW, Australia; [Wright, Elise P.; Prasad, Kali A. G.; Coorssen, Jens R.] Univ Western Sydney, Sch Med, UWS Mol Med Res Grp, Campbelltown, NSW, Australia; [Padula, Matthew P.] Univ Technol Sydney, Fac Sci, Prote Core Facil, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of Technology Sydney	Coorssen, JR (corresponding author), Univ Western Sydney, Campbelltown, NSW, Australia.	j.coorssen@uws.edu.au	Padula, Matthew P/R-6150-2016	Padula, Matthew P/0000-0002-8283-0643	UWS School of Medicine; Bellberry Ltd.	UWS School of Medicine; Bellberry Ltd.	This study was funded by the UWS School of Medicine and Bellberry Ltd. An anonymous private foundation provided a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Berggren KN, 2002, PROTEOMICS, V2, P486, DOI 10.1002/1615-9861(200205)2:5<486::AID-PROT486>3.0.CO;2-X; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Butt RH, 2007, MOL CELL PROTEOMICS, V6, P1574, DOI 10.1074/mcp.M700083-MCP200; Butt RH, 2006, J PROTEOME RES, V5, P3161, DOI 10.1021/pr060282n; Butt RH, 2006, J PROTEOME RES, V5, P437, DOI 10.1021/pr0503634; Butt RH, 2005, J PROTEOME RES, V4, P982, DOI 10.1021/pr050054d; Fountoulakis M, 2003, ANAL BIOCHEM, V313, P267, DOI 10.1016/S0003-2697(02)00617-6; Gauci V. J., 2010, J CHEM BIOL, V4, P3; Gauci VJ, 2013, J PROTEOMICS, V90, P96, DOI 10.1016/j.jprot.2013.01.027; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gorg A, 1999, ELECTROPHORESIS, V20, P712; Harris LR, 2007, J PROTEOME RES, V6, P1418, DOI 10.1021/pr0700246; Herbert B.R., 1997, PROTEOME RES NEW FRO, P13; Herbert BR, 1998, ELECTROPHORESIS, V19, P845, DOI 10.1002/elps.1150190540; Hoving S, 2000, ELECTROPHORESIS, V21, P2617, DOI 10.1002/1522-2683(20000701)21:13<2617::AID-ELPS2617>3.0.CO;2-C; Jungblut P, 1996, ELECTROPHORESIS, V17, P839, DOI 10.1002/elps.1150170505; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Levanen B, 2009, 2 DIMENSIONAL ELECTR, P112; Ly L, 2011, PROTEOMICS, V11, P513, DOI 10.1002/pmic.201000394; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RAYMOND S, 1964, ANN NY ACAD SCI, V121, P350, DOI 10.1111/j.1749-6632.1964.tb14208.x; Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904; Schluter H, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-11; Shaw J, 2003, PROTEOMICS, V3, P1181, DOI 10.1002/pmic.200300439; Smejkal GB, 2004, ELECTROPHORESIS, V25, P2511, DOI 10.1002/elps.200406005; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wu CC, 2002, CURR OPIN MOL THER, V4, P242	33	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86058	10.1371/journal.pone.0086058	http://dx.doi.org/10.1371/journal.pone.0086058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489691	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000031
J	Yuan, T; Zheng, XQ; Hu, X; Zhou, W; Wang, W				Yuan, Tao; Zheng, Xinqi; Hu, Xuan; Zhou, Wei; Wang, Wei			A Method for the Evaluation of Image Quality According to the Recognition Effectiveness of Objects in the Optical Remote Sensing Image Using Machine Learning Algorithm	PLOS ONE			English	Article							VEHICLE DETECTION; RESOLUTION SATELLITE; CLASSIFICATION; FRAMEWORK	Objective and effective image quality assessment (IQA) is directly related to the application of optical remote sensing images (ORSI). In this study, a new IQA method of standardizing the target object recognition rate (ORR) is presented to reflect quality. First, several quality degradation treatments with high-resolution ORSIs are implemented to model the ORSIs obtained in different imaging conditions; then, a machine learning algorithm is adopted for recognition experiments on a chosen target object to obtain ORRs; finally, a comparison with commonly used IQA indicators was performed to reveal their applicability and limitations. The results showed that the ORR of the original ORSI was calculated to be up to 81.95%, whereas the ORR ratios of the quality-degraded images to the original images were 65.52%, 64.58%, 71.21%, and 73.11%. The results show that these data can more accurately reflect the advantages and disadvantages of different images in object identification and information extraction when compared with conventional digital image assessment indexes. By recognizing the difference in image quality from the application effect perspective, using a machine learning algorithm to extract regional gray scale features of typical objects in the image for analysis, and quantitatively assessing quality of ORSI according to the difference, this method provides a new approach for objective ORSI assessment.	[Yuan, Tao; Zheng, Xinqi; Hu, Xuan; Zhou, Wei; Wang, Wei] China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China; [Yuan, Tao; Zheng, Xinqi; Hu, Xuan; Zhou, Wei] Minist Land & Resources, Key Lab Land Regulat, Beijing, Peoples R China	China University of Geosciences; Ministry of Natural Resources of the People's Republic of China	Yuan, T (corresponding author), China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China.	yuantaobj@qq.com			Fundamental Research Funds for the Central Universities [2652011299]; National Natural Science Foundation of China [41240008, 41301118]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (2652011299) and the National Natural Science Foundation of China (41240008, 41301118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnec M, 2008, SIGNAL PROCESS-IMAGE, V23, P239, DOI 10.1016/j.image.2008.02.003; Chen Y, 2009, IMAGE VISION COMPUT, V27, P1421, DOI 10.1016/j.imavis.2007.12.002; Eikvil L, 2009, ISPRS J PHOTOGRAMM, V64, P65, DOI 10.1016/j.isprsjprs.2008.09.005; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Guo QH, 2012, PHOTOGRAMM ENG REM S, V78, P595, DOI 10.14358/PERS.78.6.595; Holt AC, 2009, PHOTOGRAMM ENG REM S, V75, P871, DOI 10.14358/PERS.75.7.871; Jin XY, 2007, IMAGE VISION COMPUT, V25, P1422, DOI 10.1016/j.imavis.2006.12.011; Leitloff J, 2010, IEEE T GEOSCI REMOTE, V48, P2795, DOI 10.1109/TGRS.2010.2043109; Niu XT, 2006, ISPRS J PHOTOGRAMM, V61, P170, DOI 10.1016/j.isprsjprs.2006.08.004; Seghir ZA, 2011, SIGNAL PROCESS-IMAGE, V26, P534, DOI 10.1016/j.image.2011.06.003; Sharma G, 2006, INT J REMOTE SENS, V27, P779, DOI 10.1080/01431160500238901; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Wang Z, 2002, INT CONF ACOUST SPEE, P3313; Zhang J, 2011, SIGNAL PROCESS-IMAGE, V26, P13, DOI 10.1016/j.image.2010.11.003	14	13	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86528	10.1371/journal.pone.0086528	http://dx.doi.org/10.1371/journal.pone.0086528			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489739	Green Published, Green Submitted, gold			2022-12-25	WOS:000330510000057
J	Zhu, C; Wang, JX; Cheng, T; Li, QT; Shen, H; Qin, H; Cheng, MQ; Zhang, XL				Zhu, Chen; Wang, Jiaxing; Cheng, Tao; Li, Qingtian; Shen, Hao; Qin, Hui; Cheng, Mengqi; Zhang, Xianlong			The Potential Role of Increasing the Release of Mouse beta-Defensin-14 in the Treatment of Osteomyelitis in Mice: A Primary Study	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANT STAPHYLOCOCCUS; GENE-EXPRESSION; BACTERICIDAL ACTIVITY; RHEUMATOID-ARTHRITIS; SIGNAL-TRANSDUCTION; BIOFILM FORMATION; JOINT INFECTIONS; INNATE IMMUNITY; SYNOVIAL-FLUID; IN-VITRO	Mammalian beta-defensins are small cationic peptides that have been implicated in mediating innate immune defenses against microbial infection. Mouse beta-defensin-14 (MBD-14), based on structural and functional similarities, appears to be an ortholog of human beta-defensin-3 (HBD-3). Previous studies identified signaling pathway p38 mitogen-activated protein kinase (MAPK) that contributed to the expression of MBD-14 in mouse osteoblasts upon contacted with methicillin-resistance Staphylococcus aureus (MRSA) supernatant, which provided a theoretical basis as a promising therapeutic target in the treatment of intramedullary infection with MRSA in vivo. In this study, the medullary cavities of tibiae were contaminated with MRSA 10(3) colony forming units and different doses of p38 MAPK agonists anisomycin were followed as group III or IV in 30 mice. Fifteen animals that received phosphate-buffered saline served as group II and 15 mice were not contaminated with MRSA and received phosphate-buffered saline served as controls (group I). Follow-up was 7 days. In day 1, day 4 and day 7 postoperatively, infection was evaluated by blood routine, microbiological and histological analyses after sacrifice. All animals of group II developed microbiological and histological signs of infection. Histological signs of infection, white blood counts and cultures of group III and IV showed significantly reduced bacterial growth compared to cultures of group II. Simultaneously, different doses of anisomycin significantly induced the expression of osteoblast-associated genes, including alkaline phosphatase, osteocalcin and collagen type I. In addition, the expression of HBD-3 in human interfacial membranes around infected periprosthetic joint by staphylococcus contaminated was evaluated, and the expression pattern changed with significant induction of HBD-3 in infected periprosthetic joint compared with aseptic loosening under inflammatory conditions. Our primary study indicated that the potential antibacterial role of increased MBD-14 in the osteomyelitis mouse model.	[Zhu, Chen; Wang, Jiaxing; Cheng, Tao; Shen, Hao; Qin, Hui; Cheng, Mengqi; Zhang, Xianlong] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Shanghai Peoples Hosp 6, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Chen] Anhui Med Univ, Anhui Prov Hosp, Dept Orthopaed Surg, Hefei, Peoples R China; [Li, Qingtian] Shanghai Jiao Tong Univ, Dept Med Microbiol & Parasitol, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Anhui Medical University; Shanghai Jiao Tong University	Zhang, XL (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Shanghai Peoples Hosp 6, Sch Med, Shanghai 200030, Peoples R China.	zxl40@vip.sina.com	zhang, xian/GYA-0290-2022		Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao Tong University [YG2011MS30]; Shanghai Municipal health Bureau Science Fund for Young Scholars [2010QJ036A]; Opening Project of State Key Laboratory of High Performance Ceramics and Superfine Microstructure [SKL201206SIC]; National Natural Science Foundation of China [81171688, 81271962]	Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao Tong University; Shanghai Municipal health Bureau Science Fund for Young Scholars; Opening Project of State Key Laboratory of High Performance Ceramics and Superfine Microstructure; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao Tong University (Grant no. YG2011MS30), the Shanghai Municipal health Bureau Science Fund for Young Scholars (Grant no. 2010QJ036A), the Opening Project of State Key Laboratory of High Performance Ceramics and Superfine Microstructure (Grant no. SKL201206SIC), the National Natural Science Foundation of China (Grant no. 81171688) and the National Natural Science Foundation of China (Grant no. 81271962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2011, J INVEST DERMATOL, V131, P443, DOI 10.1038/jid.2010.289; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Baumbauer KM, 2006, BEHAV BRAIN RES, V173, P299, DOI 10.1016/j.bbr.2006.06.041; Bernardi RE, 2007, BEHAV NEUROSCI, V121, P156, DOI 10.1037/0735-7044.121.1.156; Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; Cunningham R, 1996, J MED MICROBIOL, V44, P157, DOI 10.1099/00222615-44-3-157; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; Hein-Kristensen L, 2010, SCAND J IMMUNOL, V72, P302, DOI 10.1111/j.1365-3083.2010.02431.x; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; Klees RF, 2005, MOL BIOL CELL, V16, P881, DOI 10.1091/mbc.e04-08-0695; KOCHI SK, 1993, EXP CELL RES, V208, P296, DOI 10.1006/excr.1993.1249; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lambrecht FY, 2008, J RADIOANAL NUCL CH, V277, P555, DOI 10.1007/s10967-007-7135-x; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Li JY, 2012, ACTA PHARMACOL SIN, V33, P935, DOI 10.1038/aps.2012.46; Liberatore M, 2009, J NUCL MED, V50, P823, DOI 10.2967/jnumed.108.055533; Lippross S, 2012, INJURY, V43, P137, DOI 10.1016/j.injury.2011.03.044; LittlewoodEvans AJ, 1997, INFECT IMMUN, V65, P3438, DOI 10.1128/IAI.65.8.3438-3443.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; Ma GF, 2006, ARTHRITIS RHEUM, V54, P2928, DOI 10.1002/art.22064; Maisetta G, 2006, ANTIMICROB AGENTS CH, V50, P806, DOI 10.1128/AAC.50.2.806-809.2006; Menzies BE, 2006, INFECT IMMUN, V74, P6847, DOI 10.1128/IAI.00389-06; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/fmb.11.117, 10.2217/FMB.11.117]; Nihonyanagi S, 2012, INFLAMMATION, V35, P927, DOI 10.1007/s10753-011-9395-4; Pan XY, 2012, J SURG RES, V176, P484, DOI 10.1016/j.jss.2011.09.047; Paulsen F, 2002, J PATHOL, V198, P369, DOI 10.1002/path.1224; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; Ren W, 2004, SCAND J RHEUMATOL, V33, P349, DOI 10.1080/03009740410005944; Roehrl J, 2008, J BIOL CHEM, V283, P5414, DOI 10.1074/jbc.M709103200; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415; Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084; Varoga D, 2009, HISTOCHEM CELL BIOL, V131, P207, DOI 10.1007/s00418-008-0522-8; WALAKOVITS LA, 1992, ARTHRITIS RHEUM, V35, P35, DOI 10.1002/art.1780350106; Warnke PH, 2006, BONE, V38, P400, DOI 10.1016/j.bone.2005.09.003; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Xing FY, 2008, J IMMUNOTHER, V31, P858, DOI 10.1097/CJI.0b013e3181869873; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; YOSHIDA K, 1992, INT ARCH ALLERGY IMM, V98, P286, DOI 10.1159/000236200; Yu TC, 2004, ACTA BIOCH BIOPH SIN, V36, P741, DOI 10.1093/abbs/36.11.741; Zhu C, 2013, INFLAMMATION, V36, P983, DOI 10.1007/s10753-013-9630-2; Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048; Zhu C, 2013, INT J MOL MED, V31, P1484, DOI 10.3892/ijmm.2013.1346	56	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86874	10.1371/journal.pone.0086874	http://dx.doi.org/10.1371/journal.pone.0086874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489798	Green Submitted, Green Published, gold			2022-12-25	WOS:000330510000085
J	Fernandez, J; Wilson, RA				Fernandez, Jessie; Wilson, Richard A.			Characterizing Roles for the Glutathione Reductase, Thioredoxin Reductase and Thioredoxin Peroxidase-Encoding Genes of Magnaporthe oryzae during Rice Blast Disease	PLOS ONE			English	Article							PLANT INFECTION; SACCHAROMYCES-CEREVISIAE; TRIGGERED IMMUNITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; NADPH OXIDASES; CELL-DEATH; FUNGUS; METABOLISM; INVASION	Understanding how pathogenic fungi adapt to host plant cells is of major concern to securing global food production. The hemibiotrophic rice blast fungus Magnaporthe oryzae, cause of the most serious disease of cultivated rice, colonizes leaf cells asymptomatically as a biotroph for 4-5 days in susceptible rice cultivars before entering its destructive necrotrophic phase. During the biotrophic growth stage, M. oryzae remains undetected in the plant while acquiring nutrients and growing cell-to-cell. Which fungal processes facilitate in planta growth and development are still being elucidated. Here, we used gene functional analysis to show how components of the NADPH-requiring glutathione and thioredoxin antioxidation systems of M. oryzae contribute to disease. Loss of glutathione reductase, thioredoxin reductase and thioredoxin peroxidase-encoding genes resulted in strains severely attenuated in their ability to grow in rice cells and that failed to produce spreading necrotic lesions on the leaf surface. Glutathione reductase, but not thioredoxin reductase or thioredoxin peroxidase, was shown to be required for neutralizing plant generated reactive oxygen species (ROS). The thioredoxin proteins, but not glutathione reductase, were shown to contribute to cell-wall integrity. Furthermore, glutathione and thioredoxin gene expression, under axenic growth conditions, was dependent on both the presence of glucose and the M. oryzae sugar/NADPH sensor Tps1, thereby suggesting how glucose availability, NADPH production and antioxidation might be connected. Taken together, this work identifies components of the fungal glutathione and thioredoxin antioxidation systems as determinants of rice blast disease that act to facilitate biotrophic colonization of host cells by M. oryzae.	[Fernandez, Jessie; Wilson, Richard A.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Wilson, RA (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	rwilson10@unl.edu	Fernandez, Jessie/AAR-3477-2021	Fernandez, Jessie/0000-0002-0897-2707	National Science Foundation [IOS-1145347]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (IOS-1145347). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Donofrio NM, 2014, NEW PHYTOL, V201, P367, DOI 10.1111/nph.12623; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fernandez J, 2012, MOL PLANT MICROBE IN, V25, P1286, DOI 10.1094/MPMI-12-11-0326; Fernandez J., 2011, Mycology - An International Journal on Fungal Biology, V2, P46, DOI 10.1080/21501203.2011.563431; Fernandez J, 2014, PROTOPLASMA, V251, P37, DOI 10.1007/s00709-013-0541-8; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Gassmann W, 2012, MOL PLANT MICROBE IN, V25, P862, DOI 10.1094/MPMI-01-12-0024-IA; Giraldo MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2996; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huang K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001335; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kupferschmidt K, 2012, SCIENCE, V337, P636, DOI 10.1126/science.337.6095.636; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Skamnioti P, 2007, MOL PLANT MICROBE IN, V20, P568, DOI 10.1094/MPMI-20-5-0568; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15	51	43	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87300	10.1371/journal.pone.0087300	http://dx.doi.org/10.1371/journal.pone.0087300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24955977	Green Published, gold			2022-12-25	WOS:000330339800093
J	Liu, YR; Fang, JX; Joo, KI; Wong, MK; Wang, P				Liu, Yarong; Fang, Jinxu; Joo, Kye-Il; Wong, Michael K.; Wang, Pin			Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor	PLOS ONE			English	Article							SMALL INTERFERING RNA; BREAST-CANCER; PACLITAXEL; DOXORUBICIN; DELIVERY; NANOPARTICLES; COMBINATIONS; AGENTS	Multidrug resistance (MDR) is a significant challenge to effective cancer chemotherapy treatment. However, the development of a drug delivery system that allows for the sustained release of combined drugs with improved vesicle stability could overcome MDR in cancer cells. To achieve this, we have demonstrated codelivery of doxorubicin (Dox) and paclitaxel (PTX) via a crosslinked multilamellar vesicle (cMLV). This combinatorial delivery system achieves enhanced drug accumulation and retention, in turn resulting in improved cytotoxicity against tumor cells, including drug-resistant cells. Moreover, this delivery approach significantly overcomes MDR by reducing the expression of P-glycoprotein (P-gp) in cancer cells, thus improving antitumor activity in vivo. Thus, by enhancing drug delivery to tumors and lowering the apoptotic threshold of individual drugs, this combinatorial delivery system represents a potentially promising multimodal therapeutic strategy to overcome MDR in cancer therapy.	[Liu, Yarong; Fang, Jinxu; Joo, Kye-Il; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Wong, Michael K.] Univ So Calif, Keck Sch Med, Div Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Wang, Pin] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wang, P (corresponding author), Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.	pinwang@usc.edu	Liu, Yarong/B-4952-2015; zhang, guoshi/GSD-3017-2022	Joo, Kye Il/0000-0001-8834-5561	National Institutes of Health [R01AI068978, R01CA170820, P01CA132681]; Joint Center for Translational Medicine; National Cancer Institute [P30CA014089]; Ming Hsieh Institute for Research on Engineering Medicine for Cancer; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA170820, P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center for Translational Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ming Hsieh Institute for Research on Engineering Medicine for Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants (R01AI068978, R01CA170820 and P01CA132681), a translational acceleration grant from the Joint Center for Translational Medicine, the National Cancer Institute (P30CA014089), and a grant from the Ming Hsieh Institute for Research on Engineering Medicine for Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; Calabro F, 2009, CANCER-AM CANCER SOC, V115, P2652, DOI 10.1002/cncr.24313; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Dean-Colomb W, 2008, SEMIN ONCOL, V35, pS31, DOI 10.1053/j.seminoncol.2008.02.008; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gao HL, 2014, CURR PHARM BIOTECHNO, V15, P210, DOI 10.2174/1389201015666140617092552; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Grasselli G, 2001, J CLIN ONCOL, V19, P2222, DOI 10.1200/JCO.2001.19.8.2222; Gustafson DL, 2005, CANCER LETT, V220, P161, DOI 10.1016/j.canlet.2004.09.007; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; Joo KI, 2013, BIOMATERIALS, V34, P3098, DOI 10.1016/j.biomaterials.2013.01.039; Kataja V, 2008, ANN ONCOL, V19, P11, DOI 10.1093/annonc/mdn072; Lee BD, 2003, ONCOL RES, V14, P49, DOI 10.3727/000000003108748603; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P230; Liu YR, 2014, NANO LIFE, V4, DOI 10.1142/S1793984414410074; Liu YR, 2014, MOL PHARMACEUT, V11, P1651, DOI 10.1021/mp5000373; Liu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/378380; Mamounas EP, 2001, SEMIN ONCOL, V28, P24, DOI 10.1053/sonc.2001.26432; Rahman AM, 2007, INT J NANOMED, V2, P567; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Schondorf T, 2002, ANTICANCER RES, V22, P2199; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Teicher BA, 2009, BIOCHEM PHARMACOL, V77, P1665, DOI 10.1016/j.bcp.2009.01.006; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Wang H, 2011, BIOMATERIALS, V32, P8281, DOI 10.1016/j.biomaterials.2011.07.032; Xu D, 2005, MOL THER, V11, P523, DOI 10.1016/j.ymthe.2004.12.019; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e	37	32	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110611	10.1371/journal.pone.0110611	http://dx.doi.org/10.1371/journal.pone.0110611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	24489844	gold, Green Submitted, Green Published			2022-12-25	WOS:000345204100095
J	Wei, XW; Ma, XW; Lu, R; Bai, G; Zhang, JW; Deng, RF; Gu, N; Feng, N; Guo, XH				Wei, Xiaowei; Ma, Xiaowei; Lu, Ran; Bai, Ge; Zhang, Jianwei; Deng, Ruifen; Gu, Nan; Feng, Nan; Guo, Xiaohui			Genetic Variants in PCSK1 Gene Are Associated with the Risk of Coronary Artery Disease in Type 2 Diabetes in a Chinese Han Population: A Case Control Study	PLOS ONE			English	Article							INSULIN SENSITIVITY; HEART-DISEASE; OBESITY; PROINSULIN; MELLITUS	Background: Insulin and glucagon-like peptide 1 (GLP-1), converted by proprotein convertase 1 (PC1/3) from proinsulin and proglucagon, are associated with type 2 diabetes (T2DM) and coronary artery disease (CAD). The aim of this study is to investigate the association of PCSK1 gene, which encodes PC1/3, with the risk of CAD in Chinese patients with T2DM. Methods: We selected and genotyped 5 haplotype-tagging single nucleotide polymorphisms (SNPs) at PCSK1 gene (across 39873bp locus) in a case-control study of Chinese Han population involving 425 diabetic patients (62.1% male, mean age 63.2 years) with CAD as positive cases and 258 diabetic patients (44.2% male, mean age 62.0 years) without CAD as controls. Results: The allele frequencies at rs3811951 were significantly different between cases and controls (30.7% vs. 37.2%), with the allele G associated with decreased risk for CAD (OR = 0.75, 95% CI = 0.59-0.94, p = 0.013). In recessive inheritance mode, the carriers of GG had a lower risk (OR = 0.50, 95% CI = 0.31-0.82, p = 0.005), even after adjusted for gender, age, BMI and smoking (OR = 0.43, 95% CI = 0.24-0.77, p = 0.004). The carriers of the minor allele A at rs156019 had a higher risk (OR = 1.66, 95% CI = 1.10-2.50, p = 0.016 after adjustment) in dominant inheritance mode. The SNP rs6234 was also significantly associated with CAD risk in women, with the carriers of the minor allele G at rs6234 associated with a reduced CAD risk in recessive inheritance mode (OR = 0.42, 95% CI = 0.18-0.95, p = 0.036 after adjustment). Conclusions: Our results found that common genetic variants in PCSK1 were associated with CAD in Chinese patients with T2DM.	[Wei, Xiaowei; Ma, Xiaowei; Lu, Ran; Bai, Ge; Zhang, Jianwei; Deng, Ruifen; Gu, Nan; Feng, Nan; Guo, Xiaohui] Peking Univ, Dept Endocrinol, Hosp 1, Beijing 100871, Peoples R China	Peking University	Ma, XW (corresponding author), Peking Univ, Dept Endocrinol, Hosp 1, Beijing 100871, Peoples R China.	mxiaowei@yahoo.com	Blanco, Juan A./A-4554-2009; lu, ran/HHC-8613-2022; FENG, NAN/HGD-3255-2022	Blanco, Juan A./0000-0002-6524-4335; Wei, Xiaohua (Adam)/0000-0003-2711-5636; Gu, Nan/0000-0001-9852-0060	National 973 project in China [2006CB503903, 2006CB503908]	National 973 project in China(National Basic Research Program of China)	The study was granted by National 973 project (2006CB503903, 2006CB503908) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostis P, 2011, DIABETES OBES METAB, V13, P302, DOI 10.1111/j.1463-1326.2010.01345.x; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Gjesing AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023907; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-4; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kaplan M, 2012, PHARMACOL THERAPEUT, V136, P175, DOI 10.1016/j.pharmthera.2012.08.002; Mbikay M, 2011, MOL GENET METAB, V104, P682, DOI 10.1016/j.ymgme.2011.09.027; Qi Q, 2010, PLOS ONE, V5; Schneider Hans, 2003, Clin Biochem Rev, V24, P77; Sirois F, 2012, J COMMUN GENET, V3, P319, DOI 10.1007/s12687-012-0081-5; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349; Zethelius B, 2005, DIABETOLOGIA, V48, P862, DOI 10.1007/s00125-005-1711-9; Zethelius B, 2002, CIRCULATION, V105, P2153, DOI 10.1161/01.CIR.0000015855.04844.E7	19	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87168	10.1371/journal.pone.0087168	http://dx.doi.org/10.1371/journal.pone.0087168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489861	gold, Green Submitted, Green Published			2022-12-25	WOS:000330510000113
J	Xu, YH; Shen, ST; Sun, LZ; Yang, HW; Jin, B; Cao, XH				Xu, Yuhong; Shen, Shutong; Sun, Lizhou; Yang, Haiwei; Jin, Bai; Cao, Xiaohui			Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CARDIOMETABOLIC RISK; GLUCOSE REGULATION; CHINESE WOMEN; FOLLOW-UP; MELLITUS; HYPERGLYCEMIA; HISTORY; ASSOCIATION; INTOLERANCE; PREGNANCY	Background: A number of studies have been conducted to investigate the risk of metabolic syndrome (MS) after gestational diabetes mellitus (GDM), but the results are contradictory. Accordingly, we performed a systematic review and meta-analysis to assess the association between these two conditions. The aim was to better understand the risks of MS with prior gestational diabetes. Methods: Pubmed, ISI Web of Science, and Cochrane databases from September 1, 1979 to July 11, 2013 were searched to identify relevant studies. 17 studies containing 5832 women and 1149 MS events were included. We calculated the odds ratio (OR) with 95% confidence interval (CI) in analysis for each study using a random-effect or fixed-effect model. We also determined heterogeneity among these 17 articles and their publication bias. Results: Women with a history of gestational diabetes had a significantly higher risk of MS than those who had a normal pregnancy (OR, 3.96; 95% CI, 2.99 to 5.26), but had significant heterogeneity (I-2 = 52.6%). The effect remained robust (OR, 4.54; 95% CI, 3.78-5.46) in the subgroup of Caucasians, but no association (OR, 1.28; 95% CI, 0.64-2.56) was found in Asians. Heterogeneity was reduced (body mass index (BMI) matched group I-2 = 14.2%, BMI higher in the GDM group I-2 = 13.2%) in the subgroup of BMI. In addition, mothers with higher BMI in the GDM group had higher risk of MS than those in the BMI matched group (BMI higher in GDM group OR, 5.39; 95% CI, 4.47-6.50, BMI matched group OR, 2.53; 95% CI, 1.88-3.41). Conclusions: This meta-analysis demonstrated increased risk of MS after gestational diabetes. Therefore, attention should be given to preventing or delaying the onset of MS in GDM mothers, particularly in Caucasian and obese mothers.	[Xu, Yuhong; Sun, Lizhou; Jin, Bai; Cao, Xiaohui] Nanjing Med Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Shen, Shutong] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China; [Yang, Haiwei] Nanjing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Sun, LZ (corresponding author), Nanjing Med Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	Lizhou_sun121@hotmail.com	Kreth, Jens/AAU-7833-2021	Kreth, Jens/0000-0002-8599-8310	Natural Science Foundation of China [81270710]; Jiangsu provincial Science and Technology Projects [XK201112]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022601, R01DE021726] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu provincial Science and Technology Projects; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Natural Science Foundation of China (grant number 81270710), Jiangsu provincial Science and Technology Projects (XK201112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci B, 2011, GYNECOL ENDOCRINOL, V27, P361, DOI 10.3109/09513590.2010.492885; Akinci B, 2011, DIABETES RES CLIN PR, V91, P26, DOI 10.1016/j.diabres.2010.09.028; Akinci B, 2010, FERTIL STERIL, V93, P1248, DOI 10.1016/j.fertnstert.2008.12.007; Albareda M, 2005, METABOLISM, V54, P1115, DOI 10.1016/j.metabol.2005.03.017; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Balkau B, 2007, DIABETES METAB, V33, P405, DOI 10.1016/j.diabet.2007.08.001; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bo S, 2004, J ENDOCRINOL INVEST, V27, P629, DOI 10.1007/BF03347494; Bo Simona, 2006, Metabolic Syndrome and Related Disorders, V4, P113, DOI 10.1089/met.2006.4.113; Chatzi L, 2009, DIABETES METAB, V35, P490, DOI 10.1016/j.diabet.2009.07.003; Costacou Tina, 2008, Prev Cardiol, V11, P106; Di Cianni G, 2007, DIABETES-METAB RES, V23, P135, DOI 10.1002/dmrr.661; Edalat B, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-8; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Heitritter SM, 2005, J CLIN ENDOCR METAB, V90, P3983, DOI 10.1210/jc.2004-2494; Huopio H, 2013, EUR J ENDOCRINOL, V169, P291, DOI 10.1530/EJE-13-0286; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim C, 2006, AM J PUBLIC HEALTH, V96, P1643, DOI 10.2105/AJPH.2005.065722; Kousta E, 2006, DIABETOLOGIA, V49, P36, DOI 10.1007/s00125-005-0058-6; Krishnaveni GV, 2007, DIABETES RES CLIN PR, V78, P398, DOI 10.1016/j.diabres.2007.06.002; Kriska A, 2013, PEDIATRICS, V131, pE850, DOI 10.1542/peds.2012-0620; Lauenborg J, 2005, J CLIN ENDOCR METAB, V90, P4004, DOI 10.1210/jc.2004-1713; Madarasz E, 2009, DIABETES RES CLIN PR, V85, P197, DOI 10.1016/j.diabres.2009.05.001; Malcolm J, 2012, DIABETES-METAB RES, V28, P307, DOI 10.1002/dmrr.2275; Mao HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045882; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Niu Jian-min, 2013, Zhonghua Fu Chan Ke Za Zhi, V48, P92; Pereira MA, 2009, INT J ENV RES PUB HE, V6, P2568, DOI 10.3390/ijerph6102568; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Retnakaran R, 2010, J CLIN ENDOCR METAB, V95, P670, DOI 10.1210/jc.2009-1990; Schneider S, 2012, J PERINAT MED, V40, P511, DOI 10.1515/jpm-2012-0015; Shek NW, 2013, ARCH GYNECOL OBSTET; Takata Hiroshi, 2013, Nihon Rinsho, V71, P266; Tam WH, 2007, DIABETES-METAB RES, V23, P485, DOI 10.1002/dmrr.741; Tam WH, 2012, GYNECOL OBSTET INVES, V73, P168, DOI 10.1159/000329339; Verma A, 2002, J CLIN ENDOCR METAB, V87, P3227, DOI 10.1210/jc.87.7.3227; Vrachnis N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/458610; Wender-Ozegowska Ewa, 2007, Pol Arch Med Wewn, V117, P457; Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598	43	115	120	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87863	10.1371/journal.pone.0087863	http://dx.doi.org/10.1371/journal.pone.0087863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24489768	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900188
J	Liu, Y; Wang, J; Liu, DB; Li, ZG; Zhang, GS; Tao, Y; Xie, J; Pan, JF; Chen, F				Liu, Yi; Wang, Jing; Liu, Dongbi; Li, Zhiguo; Zhang, Guoshi; Tao, Yong; Xie, Juan; Pan, Junfeng; Chen, Fang			Straw Mulching Reduces the Harmful Effects of Extreme Hydrological and Temperature Conditions in Citrus Orchards	PLOS ONE			English	Article							WATER-USE EFFICIENCY; ZEA-MAYS L.; SOIL-TEMPERATURE; LOESS PLATEAU; MANAGEMENT-PRACTICES; GRASS COVER; YIELD; RUNOFF; MOISTURE; MAIZE	Extreme weather conditions with negative impacts can strongly affect agricultural production. In the Danjiangkou reservoir area, citrus yields were greatly influenced by cold weather conditions and drought stress in 2011. Soil straw mulching (SM) practices have a major effect on soil water and thermal regimes. A two-year field experiment was conducted to evaluate whether the SM practices can help achieve favorable citrus fruit yields. Results showed that the annual total runoff was significantly (P<0.05) reduced with SM as compared to the control (CK). Correspondingly, mean soil water storage in the top 100 cm of the soil profile was increased in the SM as compared to the CK treatment. However, this result was significant only in the dry season (Jan to Mar), and not in the wet season (Jul to Sep) for both years. Interestingly, the SM treatment did not significantly increase citrus fruit yield in 2010 but did so in 2011, when the citrus crop was completely destroyed (zero fruit yield) in the CK treatment plot due to extremely low temperatures during the citrus overwintering stage. The mulch probably acted as an insulator, resulting in smaller fluctuations in soil temperature in the SM than in the CK treatment. The results suggested that the small effects on soil water and temperature changes created by surface mulch had limited impact on citrus fruit yield in a normal year (e. g., in 2010). However, SM practices can positively impact citrus fruit yield in extreme weather conditions.	[Liu, Yi; Wang, Jing; Li, Zhiguo; Zhang, Guoshi; Tao, Yong; Xie, Juan; Pan, Junfeng; Chen, Fang] Chinese Acad Sci China, Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China; [Liu, Dongbi] Hubei Acad Agr Sci, Inst Plant Protect & Soil Fertilizer, Wuhan, Peoples R China; [Zhang, Guoshi; Chen, Fang] IPNI, China Program, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Hubei Academy of Agricultural Sciences	Chen, F (corresponding author), Chinese Acad Sci China, Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China.	fchenipni@126.com	Liu, Yarong/B-4952-2015; zhang, guoshi/GSD-3017-2022	Joo, Kye Il/0000-0001-8834-5561	National Key Technology RD Program [2012BAD15B01]; NSFC [31100386]; Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences [Y152741s04]; International Plant Nutrition Institute [IPNI-HB-33]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA170820, P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Key Technology RD Program(National Key Technology R&D Program); NSFC(National Natural Science Foundation of China (NSFC)); Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences; International Plant Nutrition Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by the National Key Technology R&D Program (2012BAD15B01), the NSFC (31100386), the Open Funding Project (Y152741s04) of the Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences and the Cooperated Program with the International Plant Nutrition Institute (IPNI-HB-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekalu KO, 2007, BIORESOURCE TECHNOL, V98, P912, DOI 10.1016/j.biortech.2006.02.044; Balwinder-Singh, 2011, FIELD CROP RES, V121, P209, DOI 10.1016/j.fcr.2010.12.005; Bao S., 2000, SOIL AGROCHEMICAL AN; Carrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050755; Chen SY, 2007, ANN APPL BIOL, V150, P261, DOI 10.1111/j.1744-7348.2007.00144.x; Doring TF, 2005, FIELD CROP RES, V94, P238, DOI 10.1016/j.fcr.2005.01.006; Edwards L, 2000, AGR ECOSYST ENVIRON, V81, P217, DOI 10.1016/S0167-8809(00)00162-6; Fang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047369; Farkas C, 2009, BIOLOGIA, V64, P624, DOI 10.2478/s11756-009-0079-6; Ghosh PK, 2006, FIELD CROP RES, V99, P76, DOI 10.1016/j.fcr.2006.03.004; Gutierrez J, 1996, J ARID ENVIRON, V34, P287, DOI 10.1006/jare.1996.0110; Huang YL, 2005, AGR WATER MANAGE, V72, P209, DOI 10.1016/j.agwat.2004.09.012; Kar G, 2007, AGR WATER MANAGE, V94, P109, DOI 10.1016/j.agwat.2007.08.004; LAL R, 1976, GEODERMA, V16, P377, DOI 10.1016/0016-7061(76)90002-1; Li R, 2012, SOIL RES, V50, P105, DOI 10.1071/SR11331; Li XH, 2011, PEDOSPHERE, V21, P238, DOI 10.1016/S1002-0160(11)60123-9; Liu WZ, 2011, CLEAN-SOIL AIR WATER, V39, P109, DOI 10.1002/clen.200900212; Liu Y, 2012, AGR WATER MANAGE, V110, P34, DOI 10.1016/j.agwat.2012.03.011; Liu Y, 2010, AGR FOREST METEOROL, V150, P606, DOI 10.1016/j.agrformet.2010.02.003; Liu Y, 2010, AGR WATER MANAGE, V97, P769, DOI 10.1016/j.agwat.2010.01.010; Lou YL, 2011, CATENA, V86, P117, DOI 10.1016/j.catena.2011.03.006; National Soil Survey Office, 1992, SOIL SURV TECHN CHIN; Novak MD, 2000, AGR FOREST METEOROL, V102, P155, DOI 10.1016/S0168-1923(00)00097-6; Olasantan FO, 1999, SOIL TILL RES, V50, P215, DOI 10.1016/S0167-1987(98)00192-5; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Ramakrishna A, 2006, FIELD CROP RES, V95, P115, DOI 10.1016/j.fcr.2005.01.030; Sarkar S, 2007, SOIL TILL RES, V93, P94, DOI 10.1016/j.still.2006.03.015; She DL, 2009, PESQUI AGROPECU BRAS, V44, P189, DOI 10.1590/S0100-204X2009000200011; Silvente S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038554; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; Wakindiki IIC, 2011, AFR J AGR RES, V6, P725; Wang YJ, 2011, AGR WATER MANAGE, V101, P88, DOI 10.1016/j.agwat.2011.09.006; Zhang QF, 2009, J AM WATER RESOUR AS, V45, P1238, DOI 10.1111/j.1752-1688.2009.00357.x; Zhang SL, 2009, SOIL TILL RES, V102, P78, DOI 10.1016/j.still.2008.07.019; Zhao H, 2012, PLASTIC FILM MULCH H	35	32	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87094	10.1371/journal.pone.0087094	http://dx.doi.org/10.1371/journal.pone.0087094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489844	Green Published, gold, Green Submitted			2022-12-25	WOS:000330510000107
J	Liu, DG; Wang, LJ; Zhai, H; Song, XJ; He, SZ; Liu, QC				Liu, Degao; Wang, Lianjun; Zhai, Hong; Song, Xuejin; He, Shaozhen; Liu, Qingchang			A Novel alpha/beta-Hydrolase Gene IbMas Enhances Salt Tolerance in Transgenic Sweetpotato	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; PROLINE ACCUMULATION; PLANT-REGENERATION; PHOSPHOLIPASE-D; SOYBEAN PLANTS; DROUGHT; MECHANISMS; CLONING; OVEREXPRESSION; PROTEINS	Salt stress is one of the major environmental stresses in agriculture worldwide and affects crop productivity and quality. The development of crops with elevated levels of salt tolerance is therefore highly desirable. In the present study, a novel maspardin gene, named IbMas, was isolated from salt-tolerant sweetpotato (Ipomoea batatas (L.) Lam.) line ND98. IbMas contains maspardin domain and belongs to alpha/beta-hydrolase superfamily. Expression of IbMas was up-regulated in sweetpotato under salt stress and ABA treatment. The IbMas-overexpressing sweetpotato (cv. Shangshu 19) plants exhibited significantly higher salt tolerance compared with the wild-type. Proline content was significantly increased, whereas malonaldehyde content was significantly decreased in the transgenic plants. The activities of superoxide dismutase (SOD) and photosynthesis were significantly enhanced in the transgenic plants. H2O2 was also found to be significantly less accumulated in the transgenic plants than in the wild-type. Overexpression of IbMas up-regulated the salt stress responsive genes, including pyrroline-5-carboxylate synthase, pyrroline-5-carboxylate reductase, SOD, psbA and phosphoribulokinase genes, under salt stress. These findings suggest that overexpression of IbMas enhances salt tolerance of the transgenic sweetpotato plants by regulating osmotic balance, protecting membrane integrity and photosynthesis and increasing reactive oxygen species scavenging capacity.	[Liu, Degao; Wang, Lianjun; Zhai, Hong; Song, Xuejin; He, Shaozhen; Liu, Qingchang] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100094, Peoples R China	China Agricultural University	Liu, QC (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100094, Peoples R China.	liuqc@cau.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455; Li, Zhineng/0000-0002-6255-5947	National Natural Science Foundation of China [31371680, 31271777]; China Agriculture Research System [CARS-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (31371680, 31271777) and China Agriculture Research System (CARS-11, Sweetpotato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia, 1997, J PHOTOCH PHOTOBIO B, V38, P253, DOI 10.1016/S1011-1344(96)07470-2; ALIA, 1991, BIOCHEM BIOPH RES CO, V181, P1238, DOI 10.1016/0006-291X(91)92071-Q; Alia, 2001, AMINO ACIDS, V21, P195; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; Chen HC, 2010, INTEGR SER INFORM SY, V21, P167, DOI 10.1007/978-1-4419-1278-7_12; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; de Ronde JA, 2000, PLANT GROWTH REGUL, V32, P13, DOI 10.1023/A:1006338911617; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deng XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069881; Dhir SK, 1998, PLANT CELL REP, V17, P665, DOI 10.1007/s002990050462; Fernandez-Falcon M, 2006, SCI HORTIC-AMSTERDAM, V107, P373, DOI 10.1016/j.scienta.2005.08.009; Gao S, 2011, PLANT CELL TISS ORG, V107, P205, DOI 10.1007/s11240-011-9971-1; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hanna MC, 2009, NEUROGENETICS, V10, P217, DOI 10.1007/s10048-009-0172-6; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; He SZ, 2009, PLANT CELL TISS ORG, V96, P69, DOI 10.1007/s11240-008-9461-2; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Huang P, 2013, PLANT SCI, V203, P98, DOI 10.1016/j.plantsci.2012.12.019; Jiang T, 2013, SCI HORTIC-AMSTERDAM, V158, P22, DOI 10.1016/j.scienta.2013.04.027; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Koca H, 2006, BIOL PLANTARUM, V50, P745, DOI 10.1007/s10535-006-0121-2; Lenfant N, 2013, CHEM-BIOL INTERACT, V203, P266, DOI 10.1016/j.cbi.2012.09.003; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Liu DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093935; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; Liu QC, 2001, IN VITRO CELL DEV-PL, V37, P564; Liu QC, 2011, PLANT OMICS, V4, P295; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mishra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063064; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Peng XJ, 2013, PLANT CELL TISS ORG, V113, P245, DOI 10.1007/s11240-012-0264-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Sun YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059924; Swapna T. S., 2002, Indian Journal of Experimental Biology, V40, P1056; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tan CM, 2013, INT J MOL SCI, V14, P20204, DOI 10.3390/ijms141020204; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang LJ, 2013, J INTEGR AGR, V12, P27, DOI 10.1016/S2095-3119(13)60202-6; Wang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058952; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069810, 10.1371/journal.pone.0079289]; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang L, 2013, PLANT CELL TISS ORG, V113, P407, DOI 10.1007/s11240-012-0280-0; Zang N, 2009, SCI HORTIC-AMSTERDAM, V122, P649, DOI 10.1016/j.scienta.2009.06.023; Zeitlmann L, 2001, J BIOL CHEM, V276, P9123, DOI 10.1074/jbc.M009270200; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	58	58	68	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115128	10.1371/journal.pone.0115128	http://dx.doi.org/10.1371/journal.pone.0115128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	24489818	Green Submitted, Green Published, gold			2022-12-25	WOS:000346375400074
J	Liu, DF; Sui, SZ; Ma, J; Li, ZN; Guo, YL; Luo, DP; Yang, JF; Li, MY				Liu, Daofeng; Sui, Shunzhao; Ma, Jing; Li, Zhineng; Guo, Yulong; Luo, Dengpan; Yang, Jianfeng; Li, Mingyang			Transcriptomic Analysis of Flower Development in Wintersweet (Chimonanthus praecox)	PLOS ONE			English	Article							FLORAL SCENT PRODUCTION; LINALOOL SYNTHASE GENE; RNA-SEQ DATA; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL EXPRESSION; CLARKIA-BREWERI; SALICYLIC-ACID; SENESCENCE; IDENTIFICATION; HORMONE	Wintersweet (Chimonanthus praecox) is familiar as a garden plant and woody ornamental flower. On account of its unique flowering time and strong fragrance, it has a high ornamental and economic value. Despite a long history of human cultivation, our understanding of wintersweet genetics and molecular biology remains scant, reflecting a lack of basic genomic and transcriptomic data. In this study, we assembled three cDNA libraries, from three successive stages in flower development, designated as the flower bud with displayed petal, open flower and senescing flower stages. Using the Illumina RNA-Seq method, we obtained 21,412,928, 26,950,404, 24,912,954 qualified Illumina reads, respectively, for the three successive stages. The pooled reads from all three libraries were then assembled into 106,995 transcripts, 51,793 of which were annotated in the NCBI non-redundant protein database. Of these annotated sequences, 32,649 and 21,893 transcripts were assigned to gene ontology categories and clusters of orthologous groups, respectively. We could map 15,587 transcripts onto 312 pathways using the Kyoto Encyclopedia of Genes and Genomes pathway database. Based on these transcriptomic data, we obtained a large number of candidate genes that were differentially expressed at the open flower and senescing flower stages. An analysis of differentially expressed genes involved in plant hormone signal transduction pathways indicated that although flower opening and senescence may be independent of the ethylene signaling pathway in wintersweet, salicylic acid may be involved in the regulation of flower senescence. We also succeeded in isolating key genes of floral scent biosynthesis and proposed a biosynthetic pathway for monoterpenes and sesquiterpenes in wintersweet flowers, based on the annotated sequences. This comprehensive transcriptomic analysis presents fundamental information on the genes and pathways which are involved in flower development in wintersweet. And our data provided a useful database for further research of wintersweet and other Calycanthaceae family plants.	[Liu, Daofeng; Sui, Shunzhao; Ma, Jing; Li, Zhineng; Guo, Yulong; Luo, Dengpan; Yang, Jianfeng; Li, Mingyang] Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mt Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China	Southwest University - China	Li, MY (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mt Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China.	limy@swu.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455; Li, Zhineng/0000-0002-6255-5947	National Natural Science Foundation of China [31070622]; Fundamental Research Funds for the Central Universities [XDJK2013A004]; postdoctoral research foundation of Chongqing [Xm201345]; "111" Project [B12006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); postdoctoral research foundation of Chongqing; "111" Project(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China (Grant nos. 31070622), the Fundamental Research Funds for the Central Universities (XDJK2013A004), the postdoctoral research foundation of Chongqing (Xm201345) and the "111" Project (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Ramirez A, 2009, PLANT PHYSIOL, V150, P1335, DOI 10.1104/pp.109.139352; Arora A, 2004, J PLANT BIOCHEM BIOT, V13, P123, DOI 10.1007/BF03263206; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma Hiroshi, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P197; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Benjamini Y, 2001, ANN STAT, V29, P1165; Boatright J, 2004, PLANT PHYSIOL, V135, P1993, DOI 10.1104/pp.104.045468; Boyle P, 2009, PLANT CELL, V21, P3700, DOI 10.1105/tpc.109.069971; Breeze E, 2004, PLANT BIOTECHNOL J, V2, P155, DOI 10.1111/j.1467-7652.2004.00059.x; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Davies B, 2006, ADV BOT RES, V44, P279, DOI 10.1016/S0065-2296(06)44007-6; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Deng CH, 2004, Z NATURFORSCH C, V59, P636; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; Dudareva N, 1998, PLANT PHYSIOL, V116, P599, DOI 10.1104/pp.116.2.599; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Dudareva N, 1996, PLANT PHYSIOL, V111, P815; Eason JR, 2002, FUNCT PLANT BIOL, V29, P1055, DOI 10.1071/PP01174; Fahnrich A, 2011, MOL PLANT, V4, P965, DOI 10.1093/mp/ssr021; Feng JQ, 2007, J BEIJING FORESTR S1, P4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Harada T, 2010, J EXP BOT, V61, P2345, DOI 10.1093/jxb/erq064; Hunter DA, 2002, PLANT SCI, V163, P13, DOI 10.1016/S0168-9452(02)00068-7; Iordachescu M, 2005, J EXP BOT, V56, P2011, DOI 10.1093/jxb/eri199; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; JONES ML, 1995, PLANT MOL BIOL, V28, P505, DOI 10.1007/BF00020397; Kitajima M, 2006, TETRAHEDRON LETT, V47, P3199, DOI 10.1016/j.tetlet.2006.03.047; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2008, PLANT PHYSIOL, V147, P1017, DOI 10.1104/pp.108.115824; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y., 2000, GUIHAIA, V20, P295; Lin CF, 2008, PLANT PHYSIOL, V146, P940, DOI 10.1104/pp.107.109553; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2012, HORTSCIENCE, V47, P1472, DOI 10.21273/HORTSCI.47.10.1472; Ma L, 2012, AGR SCI TECHN, V13, P88; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin DM, 2004, PHYTOCHEMISTRY, V65, P1223, DOI 10.1016/j.phytochem.2004.03.018; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Phillips MA, 2003, ARCH BIOCHEM BIOPHYS, V411, P267, DOI 10.1016/S0003-9861(02)00746-4; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pichersky E, 2007, TRENDS BIOTECHNOL, V25, P105, DOI 10.1016/j.tibtech.2007.01.002; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Shahri W, 2011, BOT REV, V77, P152, DOI 10.1007/s12229-011-9063-2; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Sheng AiWu, 1999, Journal of Beijing Forestry University, V21, P48; Spiller M, 2010, THEOR APPL GENET, V120, P1461, DOI 10.1007/s00122-010-1268-y; Sui SZ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/134596; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; VALPUESTA V, 1995, PLANT MOL BIOL, V28, P575, DOI 10.1007/BF00020403; van Doorn WG, 2003, PLANT MOL BIOL, V53, P845, DOI 10.1023/B:PLAN.0000023670.61059.1d; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wagstaff C, 2002, J EXP BOT, V53, P233, DOI 10.1093/jexbot/53.367.233; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xiang L, 2010, PLANT PHYSIOL BIOCH, V48, P845, DOI 10.1016/j.plaphy.2010.08.015; ZHANG RH, 1998, WAX SHRUBS WORLD CAL; Zhao KG, 2007, HORTSCIENCE, V42, P1144, DOI 10.21273/HORTSCI.42.5.1144; [赵莹 ZHAO Ying], 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P622	69	58	68	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86976	10.1371/journal.pone.0086976	http://dx.doi.org/10.1371/journal.pone.0086976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489818	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000087
J	Zhu, L; Xu, YF; Ferretti, JJ; Kreth, J				Zhu, Lin; Xu, Yifan; Ferretti, Joseph J.; Kreth, Jens			Probing Oral Microbial Functionality - Expression of spxB in Plaque Samples	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; GENE-EXPRESSION; VIRULENCE; BACTERIA; GORDONII; SANGUINIS; SURFACES; GENOME	The Human Oral Microbiome Database (HOMD) provides an extensive collection of genome sequences from oral bacteria. The sequence information is a static snapshot of the microbial potential of the so far sequenced species. A major challenge is to connect the microbial potential encoded in the metagenome to an actual function in the in vivo oral biofilm. In the present study we took a reductionist approach and identified a considerably conserved metabolic gene, spxB to be encoded by a majority of oral streptococci using the HOMD metagenome information. spxB encodes the pyruvate oxidase responsible for the production of growth inhibiting amounts of hydrogen peroxide (H2O2) and has previously been shown as important in the interspecies competition in the oral biofilm. Here we demonstrate a strong correlation of H2O2 production and the presence of the spxB gene in dental plaque. Using Real-Time RT PCR we show that spxB is expressed in freshly isolated human plaque samples from several donors and that the expression is relative constant when followed over time in one individual. This is the first demonstration of an oral community encoded gene expressed in vivo suggesting a functional role of spxB in oral biofilm physiology. This also demonstrates a possible strategy to connect the microbial potential of the metagenome to its functionality in future studies by identifying similar highly conserved genes in the oral microbial community.	[Zhu, Lin] Univ Oklahoma, Hlth Sci Ctr, Coll Dent, Dept Periodont, Oklahoma City, OK 73190 USA; [Xu, Yifan; Ferretti, Joseph J.; Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Xu, Yifan] China Med Univ, Hosp 1, Dept Surg Oncol, Shenyang, Peoples R China; [Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Coll Dent, Dept Oral Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; China Medical University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kreth, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	JKreth@ouhsc.edu	Kreth, Jens/AAU-7833-2021	Kreth, Jens/0000-0002-8599-8310	National Institutes of Health - National Institute of Dental and Craniofacial Research [DE022601]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022601, R01DE021726] Funding Source: NIH RePORTER	National Institutes of Health - National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health - National Institute of Dental and Craniofacial Research grant (DE022601) to J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Carlsson J, 1987, Oral Microbiol Immunol, V2, P15, DOI 10.1111/j.1399-302X.1987.tb00264.x; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; HERZBERG MC, 1990, INFECT IMMUN, V58, P515, DOI 10.1128/IAI.58.2.515-522.1990; Itzek A, 2011, J BACTERIOL, V193, P6912, DOI 10.1128/JB.05791-11; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Kilic AO, 1999, PLASMID, V42, P67, DOI 10.1006/plas.1999.1408; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Maron PA, 2007, MICROB ECOL, V53, P486, DOI 10.1007/s00248-006-9196-8; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Qi FX, 2001, APPL ENVIRON MICROB, V67, P15, DOI 10.1128/AEM.67.1.15-21.2001; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; RYAN CS, 1995, ARCH ORAL BIOL, V40, P753, DOI 10.1016/0003-9969(95)00029-O; Saito M, 2007, MICROBIOL IMMUNOL, V51, P889, DOI 10.1111/j.1348-0421.2007.tb03971.x; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shelburne CE, 2002, J MICROBIOL METH, V49, P147, DOI 10.1016/S0167-7012(01)00362-1; Shelburne SA, 2004, CURR OPIN MICROBIOL, V7, P283, DOI 10.1016/j.mib.2004.04.013; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; SUNDQVIST G, 1988, ORAL MICROBIOL IMMUN, V3, P103, DOI 10.1111/j.1399-302X.1988.tb00093.x; Virtaneva K, 2003, INFECT IMMUN, V71, P2199, DOI 10.1128/IAI.71.4.2199-2207.2003; Walters S, 2009, J DENT RES, V88, P34, DOI 10.1177/0022034508328381; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yoshida Y, 2005, MOL MICROBIOL, V58, P244, DOI 10.1111/j.1365-2958.2005.04820.x; Zaura E, 2012, Adv Dent Res, V24, P81, DOI 10.1177/0022034512449466; Zhang YS, 2009, MICROBIOL-SGM, V155, P165, DOI 10.1099/mic.0.023168-0; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	38	115	120	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86685	10.1371/journal.pone.0086685	http://dx.doi.org/10.1371/journal.pone.0086685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489768	gold, Green Published, Green Submitted			2022-12-25	WOS:000330570000060
J	Wei, XH; Blanco, JA				Wei, Xiaohua; Blanco, Juan A.			Significant Increase in Ecosystem C Can Be Achieved with Sustainable Forest Management in Subtropical Plantation Forests	PLOS ONE			English	Article							CHINESE-FIR PLANTATIONS; CARBON SEQUESTRATION; CUNNINGHAMIA-LANCEOLATA; NITROGEN DEPOSITION; BIOMASS PRODUCTION; SIMULATION-MODEL; PHOEBE-BOURNEI; DOUGLAS-FIR; PRODUCTIVITY; IMPACTS	Subtropical planted forests are rapidly expanding. They are traditionally managed for intensive, short-term goals that often lead to long-term yield decline and reduced carbon sequestration capacity. Here we show how it is possible to increase and sustain carbon stored in subtropical forest plantations if management is switched towards more sustainable forestry. We first conducted a literature review to explore possible management factors that contribute to the potentials in ecosystem C in tropical and subtropical plantations. We found that broadleaves plantations have significantly higher ecosystem C than conifer plantations. In addition, ecosystem C increases with plantation age, and reaches a peak with intermediate stand densities of 1500-2500 trees ha(-1). We then used the FORECAST model to simulate the regional implications of switching from traditional to sustainable management regimes, using Chinese fir (Cunninghamia lanceolata) plantations in subtropical China as a study case. We randomly simulated 200 traditional short-rotation pure stands and 200 sustainably-managed mixed Chinese fir - Phoebe bournei plantations, for 120 years. Our results showed that mixed, sustainably-managed plantations have on average 67.5% more ecosystem C than traditional pure conifer plantations. If all pure plantations were gradually transformed into mixed plantations during the next 10 years, carbon stocks could rise in 2050 by 260.22 TgC in east-central China. Assuming similar differences for temperate and boreal plantations, if sustainable forestry practices were applied to all new forest plantation types in China, stored carbon could increase by 1,482.80 TgC in 2050. Such an increase would be equivalent to a yearly sequestration rate of 40.08 TgC yr(-1), offsetting 1.9% of China's annual emissions in 2010. More importantly, this C increase can be sustained in the long term through the maintenance of higher amounts of soil organic carbon and the production of timber products with longer life spans.	[Wei, Xiaohua] Univ British Columbia, Dept Earth & Environm Sci, Kelowna, BC, Canada; [Blanco, Juan A.] Univ Publ Navarra, Dept Ciencias Medio Nat, Navarra, Spain	University of British Columbia; Universidad Publica de Navarra	Blanco, JA (corresponding author), Univ Publ Navarra, Dept Ciencias Medio Nat, Navarra, Spain.	juan.blanco@unavarra.es	Blanco, Juan A./A-4554-2009; lu, ran/HHC-8613-2022; FENG, NAN/HGD-3255-2022	Blanco, Juan A./0000-0002-6524-4335; Wei, Xiaohua (Adam)/0000-0003-2711-5636; Gu, Nan/0000-0001-9852-0060	Forest Carbon Counting Method Project of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon [XDA05060101]; BC-China Innovation and Commercialization Strategic Development Program [ICSD-2007-Wei-Kimmins]	Forest Carbon Counting Method Project of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon; BC-China Innovation and Commercialization Strategic Development Program	Funding for this research was provided by: 1) Forest Carbon Counting Method Project (XDA05060101) of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon; and 2) BC-China Innovation and Commercialization Strategic Development Program (ICSD-2007-Wei-Kimmins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso MM, 2006, CAN J FOREST RES, V36, P1484, DOI 10.1139/X06-042; Bauhus J, 2000, CAN J FOREST RES, V30, P1886, DOI 10.1139/cjfr-30-12-1886; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bi J, 2007, CAN J FOREST RES, V37, P1615, DOI 10.1139/X07-018; Blanco JA, 2010, J TROP FOR SCI, V22, P139; Blanco JA, 2005, FOREST ECOL MANAG, V213, P209, DOI 10.1016/j.foreco.2005.03.042; Blanco JA, 2007, CAN J FOREST RES, V37, P1808, DOI 10.1139/X07-041; Blanco JA, 2012, SCI TOTAL ENVIRON, V437, P91, DOI 10.1016/j.scitotenv.2012.07.082; Blanco JA, 2012, CAN J FOREST RES, V42, P437, DOI [10.1139/X2012-004, 10.1139/x2012-004]; Cannell MGR, 2003, BIOMASS BIOENERG, V24, P97, DOI 10.1016/S0961-9534(02)00103-4; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; [陈淑容 CHEN Shu-rong], 2010, [福建林学院学报, Journal of Fujian College of Forestry], V30, P157; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; CHEN XY, 2009, JIANGXI FOREST SCI T, V1, P14, DOI DOI 10.3724/SP.J.1227.00001; Cheng Y, 2003, THESIS FUJIAN AGR FO; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Ding Y. X., 1995, Pedosphere, V5, P57; Ding YX, 1999, FOREST STUD CHINA, V1, P34; Du Juan, 2010, Journal of Zhejiang Forestry Science and Technology, V30, P37; Du Juan, 2009, Journal of Zhejiang Forestry Science and Technology, V29, P9; Duan W, 2008, SICHUAN ENV, V27, P57; Eriksson E, 2007, CAN J FOREST RES, V37, P671, DOI 10.1139/X06-257; Erskine PD, 2006, FOREST ECOL MANAG, V233, P205, DOI 10.1016/j.foreco.2006.05.013; Evans J., 2001, 2 FAO FOR RES DEV SE; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; Fan X, 2001, FOR RES, V14, P11; FAO, 2012, STAT WORLDS FOR 2012; FAO, 2006, 38 FAO; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Guan BT, 2012, FOREST ECOL MANAG, V267, P50, DOI 10.1016/j.foreco.2011.11.028; Guan DB, 2012, NAT CLIM CHANGE, V2, P672, DOI [10.1038/NCLIMATE1560, 10.1038/nclimate1560]; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; [郭玉硕 GUO Yushuo], 2007, [福建林学院学报, Journal of Fujian College of Forestry], V27, P199; Hu JingNan, 2010, Journal of Anhui Agricultural University, V37, P541; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jie C, 2011, P 2011 19 INT C GEOI, DOI [10.1109/GeoInformatics.2011.5981581, DOI 10.1109/GE0INF0RMATICS.2011.5981581]; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; KELTY MJ, 1992, FOR SCI, V40, P125; Kimmins J.P., 2010, FORECASTING FOREST F; Kimmins JP, 2008, FOREST ECOL MANAG, V256, P1646, DOI [10.1016/j.foreco.2008.02.057, 10.1016/j.foreco.2008.03.011]; Kimmins JP, 1999, ECOL MODEL, V122, P195, DOI 10.1016/S0304-3800(99)00138-6; Kirilenko AP, 2007, P NATL ACAD SCI USA, V104, P19697, DOI 10.1073/pnas.0701424104; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Li MH, 1999, NEW FOREST, V18, P131, DOI 10.1023/A:1006558900234; Liao CZ, 2012, GLOBAL ECOL BIOGEOGR, V21, P318, DOI 10.1111/j.1466-8238.2011.00690.x; Liao H, 1989, J FUJIAN COLL FOREST, V9, P80; Liao L., 2000, ACTA PHYTOECCOL SIN, V24, P27; Lin Kai-min, 2010, Journal of Plant Resources and Environment, V19, P34; [林开敏 LIN KaiMin], 2006, [生态学报, Acta Ecologica Sinica], V26, P2732; Lin KM, 2001, SCI SILVAE SINICAE, V37, P94, DOI DOI 10.11707/J.1001-7488.2001S117; Lin T, 2011, JIANGXI FORESTRY SCI, V3, P16; Lippke B, 2011, CARBON MANAG, V2, P303, DOI 10.4155/CMT.11.24; Liu F, 1991, J NANJING FOR U, P7; Liu P, 2012, FORESTS, V3, P417, DOI 10.3390/f3020417; Liu Q, 2009, J JIANXI FORESTRY SC, V1, P31; Lo YH, 2012, FOREST ECOSYSTEMS MO, P339; Lu M, 2006, THESIS FUJIAN AGR FO; Lu Zhao-hua, 2002, Journal of Forestry Research (Harbin), V13, P319, DOI 10.1007/BF02860099; Ma MingDong, 2008, Scientia Silvae Sinicae, V44, P34; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Masera OR, 2003, ECOL MODEL, V164, P177, DOI 10.1016/S0304-3800(02)00419-2; McKinley DC, 2011, ECOL APPL, V21, P1902, DOI 10.1890/10-0697.1; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nabuurs GJ, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P541; Niu XZ, 2006, FOREST ECOL MANAG, V223, P415, DOI 10.1016/j.foreco.2005.12.044; Pan WC, 1983, J CENTRAL S FORESTRY, V3, P1; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Peng L, 2008, J FUJIAN FORESTRY SC, V35, P10; Peng L, 2008, J FUJIAN FOR SIC TEC, V35, P15; Peng LongFu, 2003, Journal of Fujian College of Forestry, V23, P128; Perez-Garcia J, 2005, WOOD FIBER SCI, V37, P140; Pretzsch H, 2013, EUR J FOREST RES, V132, P263, DOI 10.1007/s10342-012-0673-y; Primicia I, 2013, EUR J FOREST RES, V132, P121, DOI 10.1007/s10342-012-0662-1; Qi G, 2011, THESIS CHINESE ACAD; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ren CH, 1990, J FUJIAN COLL FOREST, V10, P67; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Seely B, 2002, FOREST ECOL MANAG, V169, P123, DOI 10.1016/S0378-1127(02)00303-1; Seely B, 2010, ECOL INDIC, V10, P999, DOI 10.1016/j.ecolind.2010.02.008; Shao L, 1992, RES SITE DEGRADATION, P87; State Forestry Administration People's Republic of China, 2009, APFSOS2WP200911 FAO; Tian DL, 2011, FORESTRY, V84, P411, DOI 10.1093/forestry/cpr029; Tian DL, 1994, STUDIES FOREST ECOSY, P136; Tian DL, 1989, J CENT S FOR U, V9, P38; Tian DL, 1989, J CENTRAL S FOR COLL, V9, P45; Tummer B, 2006, DATATHEIF 3 V1 6; [吴载璋 Tun Zaizhang], 2004, [福建林学院学报, Journal of Fujian College of Forestry], V24, P371; van Minnen Jelle G, 2008, Carbon Balance Manag, V3, P3, DOI 10.1186/1750-0680-3-3; Wang WF, 2013, FOREST ECOL MANAG, V300, P21, DOI 10.1016/j.foreco.2012.06.044; Wei XH, 2012, SCI TOTAL ENVIRON, V416, P351, DOI 10.1016/j.scitotenv.2011.11.087; Wu W. M., 2009, CHINA FOR SCI TECHNO, V23, P75; Wu ZaiZhang, 2005, Journal of Fujian College of Forestry, V25, P142; Wu ZL, 1984, CHINESE FIR CHINA FO; [项文化 Xiang Wenhua], 2003, [生态学报, Acta Ecologica Sinica], V23, P695; Xiao W, 1999, FOR RES, V3, P253; Yan W, 2003, FOR RES, V16, P82; Yang YuSheng, 2000, Journal of Nanjing Forestry University, V24, P25; Yang YuSheng, 1999, Scientia Silvae Sinicae, V35, P32; Yu X., 1997, SILVICULTURE CHINESE; Yu XT, 1999, CHINESE FORESTS, P1; Zhang G, 2009, ANHUI AGR SCI B, V15, P131; Zhang XQ, 2004, FOREST ECOL MANAG, V202, P131, DOI 10.1016/j.foreco.2004.07.032; ZHONG AL, 1993, FOREST ECOL MANAG, V62, P245, DOI 10.1016/0378-1127(93)90053-P; Zhou H, 1999, J FUJIAN COLL FOR, V2, P165; Zhou X, 1991, J NANJING FOR U, V3, P47; Zhou X. F, 1994, LONG TERM RES CHINAS	110	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89688	10.1371/journal.pone.0089688	http://dx.doi.org/10.1371/journal.pone.0089688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24489861	Green Published, Green Submitted, gold			2022-12-25	WOS:000331880700073
J	Li, X; Zhang, Y; Xia, M; Gulbins, E; Boini, KM; Li, PL				Li, Xiang; Zhang, Yang; Xia, Min; Gulbins, Erich; Boini, Krishna M.; Li, Pin-Lan			Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; NALP3 INFLAMMASOME; SIGNALING PATHWAY; OXIDATIVE STRESS; CHOLESTEROL; CELLS; ATHEROSCLEROSIS; CONTRIBUTE; CRYSTALS	Although Nlrp3 inflammasome activation in macrophages has been shown to be critical for the development of atherosclerosis upon atherogenic stimuli, it remains unknown whether activated Nlrp3 inflammasomes by other non-atherogenic stimuli induce alterations in macrophages that may contribute in the concert with other factors to atherogenesis. Thus, the present study tested the hypothesis that activation of Nlrp3 inflammasomes by ATP, which is a classical non-lipid danger stimulus, enhances the migration of macrophage and increases lipids deposition in macrophages accelerating foam cell formation. We first demonstrated that extracellular ATP (2.5 mM) markedly increased the formation and activation of Nlrp3 inflammasomes in bone marrow macrophages (BMMs) from wild type (Asc(+/+)) mice resulting in activation of caspase-1 and IL-1 beta production. In these Asc(+/+) macrophages, such stimulation of inflammasomes by non-lipid ATP was similar to those induced by atherogenic stimuli such as cholesterol crystals or 7-ketocholesterol. Both non-lipid and lipid forms of stimuli induced formation and activation of Nlrp3 inflammasomes, which were prevented by Asc gene deletion. Interestingly, Asc(+/+) BMMs had dramatic lipids accumulation after stimulation with ATP. Further, we demonstrated that large amount of cholesterol was accumulated in lysosomes of Asc(+/+) BMMs when inflammasomes were activated by ATP. Such intracellular and lysosomal lipids deposition was not observed in Asc(-/-) BMMs and also prevented by caspase-1 inhibitor WEHD. In addition, in vitro and in vivo experiments revealed that migration of Asc(+/+) BMMs increased due to stimulation of Nlrp3 inflammasomes, which was markedly attenuated in Asc(-/-) BMMs. Together, these results suggest that activation of Nlrp3 inflammasomes remarkably increases the susceptibility of macrophages to lipid deposition and their migration ability. Such novel action of inflammasomes may facilitate entry or retention of macrophages into the arterial wall, where they form foam cells and ultimately induce atherosclerosis.	[Li, Xiang; Zhang, Yang; Xia, Min; Boini, Krishna M.; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Gulbins, Erich] Univ Duisburg Essen, Med Sch Essen, Dept Mol Biol, Essen, Germany	Virginia Commonwealth University; University of Duisburg Essen	Li, PL (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	pli@vcu.edu	Xia, Min/C-2084-2012; Gulbins, Erich/L-6989-2014; Han, Zhong Chao/D-7157-2016	Gulbins, Erich/0000-0002-3117-1342; Han, Zhong Chao/0000-0002-2687-7682	National Institutes of Health [HL-57244, HL-075316, HL-091464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057244, R01HL075316, R01HL091464, R01HL057244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (HL-57244, HL-075316, and HL-091464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; CHABRAOUI F, 1993, J IMMUNOL METHODS, V165, P225, DOI 10.1016/0022-1759(93)90348-B; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; HALEY NJ, 1977, LAB INVEST, V37, P287; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Herijgers N, 2000, ARTERIOSCL THROM VAS, V20, P1961, DOI 10.1161/01.ATV.20.8.1961; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Jerome WG, 1998, J LIPID RES, V39, P1362; Johnston TP, 2006, EUR J PHARMACOL, V536, P232, DOI 10.1016/j.ejphar.2006.03.019; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rodriguez G, 2009, INVEST CLIN, V50, P109; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111; Wei YM, 2013, J PHARMACOL EXP THER, V345, P170, DOI 10.1124/jpet.112.201442; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yancey PG, 1998, J LIPID RES, V39, P1349; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang Y, 2011, NAT MED, V17, P341, DOI 10.1038/nm.2296; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	39	142	149	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87552	10.1371/journal.pone.0087552	http://dx.doi.org/10.1371/journal.pone.0087552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475307	Green Published, gold			2022-12-25	WOS:000330507300200
J	Kawaza, K; Machen, HE; Brown, J; Mwanza, Z; Iniguez, S; Gest, A; Smith, EO; Oden, M; Richards-Kortum, RR; Molyneux, E				Kawaza, Kondwani; Machen, Heather E.; Brown, Jocelyn; Mwanza, Zondiwe; Iniguez, Suzanne; Gest, Al; Smith, E. O'Brian; Oden, Maria; Richards-Kortum, Rebecca R.; Molyneux, Elizabeth			Efficacy of a Low-Cost Bubble CPAP System in Treatment of Respiratory Distress in a Neonatal Ward in Malawi	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; PRETERM INFANTS; BIRTH; SUPPORT; CARE; INTUBATION	Background: Respiratory failure is a leading cause of neonatal mortality in the developing world. Bubble continuous positive airway pressure (bCPAP) is a safe, effective intervention for infants with respiratory distress and is widely used in developed countries. Because of its high cost, bCPAP is not widely utilized in low-resource settings. We evaluated the performance of a new bCPAP system to treat severe respiratory distress in a low resource setting, comparing it to nasal oxygen therapy, the current standard of care. Methods: We conducted a non-randomized convenience sample study to test the efficacy of a low-cost bCPAP system treating newborns with severe respiratory distress in the neonatal ward of Queen Elizabeth Central Hospital, in Blantyre, Malawi. Neonates weighing >1,000 g and presenting with severe respiratory distress who fulfilled inclusion criteria received nasal bCPAP if a device was available; if not, they received standard care. Clinical assessments were made during treatment and outcomes compared for the two groups. Findings: 87 neonates (62 bCPAP, 25 controls) were recruited. Survival rate for neonates receiving bCPAP was 71.0% (44/62) compared with 44.0% (11/25) for controls. 65.5% (19/29) of very low birth weight neonates receiving bCPAP survived to discharge compared to 15.4% (1/13) of controls. 64.6% (31/48) of neonates with respiratory distress syndrome (RDS) receiving bCPAP survived to discharge, compared to 23.5% (4/17) of controls. 61.5% (16/26) of neonates with sepsis receiving bCPAP survived to discharge, while none of the seven neonates with sepsis in the control group survived. Interpretation: Use of a low-cost bCPAP system to treat neonatal respiratory distress resulted in 27% absolute improvement in survival. The beneficial effect was greater for neonates with very low birth weight, RDS, or sepsis. Implementing appropriate bCPAP devices could reduce neonatal mortality in developing countries.	[Kawaza, Kondwani; Mwanza, Zondiwe; Molyneux, Elizabeth] Queen Elizabeth Cent Hosp, Dept Pediat, Coll Med, Blantyre, Malawi; [Machen, Heather E.; Smith, E. O'Brian] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Brown, Jocelyn; Oden, Maria; Richards-Kortum, Rebecca R.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Iniguez, Suzanne] Texas Childrens Hosp, Dept Resp Care, Houston, TX 77030 USA	University of Malawi; Baylor College of Medicine; Rice University; Baylor College of Medicine	Richards-Kortum, RR (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467	United States Agency for International Development (USAID); Government of Norway; Bill & Melinda Gates Foundation; Grand Challenges Canada; World Bank; African Network for Drugs and Diagnostics Innovation (ANDI); USAID [AID-OAA-A-13-00014]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Government of Norway; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Grand Challenges Canada(CGIAR); World Bank(The World Bank India); African Network for Drugs and Diagnostics Innovation (ANDI); USAID(United States Agency for International Development (USAID))	This work was made possible through the generous support of the Saving Lives at Birth partners: the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the World Bank. It was prepared by William Marsh Rice University and does not necessarily reflect the views of the Saving Lives at Birth Partners. Funding was also provided by the African Network for Drugs and Diagnostics Innovation (ANDI). 1. USAID Cooperative Agreement Award No. AID-OAA-A-13-00014, www.usaid.gov 2. African Network for Drugs and Diagnostics Innovation (ANDI), www.andi-africa.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Blencowe H, 2009, J TROP PEDIATRICS, V55, P244, DOI 10.1093/tropej/fmn116; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Buckmaster AG, 2007, PEDIATRICS, V120, P509, DOI 10.1542/peds.2007-0775; Clair CS, 2008, AM J PERINAT, V25, P473, DOI 10.1055/s-0028-1085066; Courtney SE, 2001, PEDIATRICS, V107, P304, DOI 10.1542/peds.107.2.304; De Klerk AM, 2001, J PAEDIATR CHILD H, V37, P161, DOI 10.1046/j.1440-1754.2001.00624.x; DiBlasi RM, 2009, RESP CARE, V54, P1209; Duke T, 2005, ARCH DIS CHILD-FETAL, V90, P211, DOI 10.1136/adc.2003.048108; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gittermann MK, 1997, EUR J PEDIATR, V156, P384, DOI 10.1007/s004310050620; Gnanaratnem J, 2000, CURR OPIN PEDIATR, V12, P227, DOI 10.1097/00008480-200006000-00009; Kamath BD, 2011, PEDIATRICS, V127, P1139, DOI 10.1542/peds.2010-3212; Koti J, 2010, INDIAN PEDIATR, V47, P139, DOI 10.1007/s13312-010-0021-6; Koyamaibole L, 2006, J TROP PEDIATRICS, V52, P249, DOI 10.1093/tropej/fmi109; Lawn JE, 2009, BJOG-INT J OBSTET GY, V116, P49, DOI 10.1111/j.1471-0528.2009.02328.x; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Malik K., 2013, HUMAN DEV REPORT 201; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Nowadzky T, 2009, PEDIATRICS, V123, P1534, DOI 10.1542/peds.2008-1279; Pieper CH, 2003, J TROP PEDIATRICS, V49, P148, DOI 10.1093/tropej/49.3.148; Rehan V K, 2001, J Perinatol, V21, P521, DOI 10.1038/sj.jp.7210587; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Sweet D, 2007, J PERINAT MED, V35, P175, DOI 10.1515/JPM.2007.048; Tagare A, 2010, J TROP PEDIATRICS, V56, P191, DOI 10.1093/tropej/fmp092; Urs PS, 2009, INDIAN PEDIATR, V46, P409; Van den Heuvel M, 2011, ANN TROP PAEDIATR, V31, P59, DOI 10.1179/1465328110Y.0000000001; Wilson PT, 2012, J PEDIAT; Zupan J, 2006, NEONATAL PERINATAL M, Viv	29	93	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86327	10.1371/journal.pone.0086327	http://dx.doi.org/10.1371/journal.pone.0086327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	27895847	Green Published, gold			2022-12-25	WOS:000330570000033
J	Wang, YP; Nie, JX; Yap, PT; Li, G; Shi, F; Geng, XJ; Guo, L; Shen, DG				Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Geng, Xiujuan; Guo, Lei; Shen, Dinggang		Alzheimers Dis Neuroimaging Initia	Knowledge-Guided Robust MRI Brain Extraction for Diverse Large-Scale Neuroimaging Studies on Humans and Non-Human Primates	PLOS ONE			English	Article							SKULL STRIPPING PROBLEM; ALZHEIMERS-DISEASE; AUTOMATIC SEGMENTATION; GRAY-MATTER; IMAGES; CLASSIFICATION; REGISTRATION; ALGORITHM; VOLUMES; CORTEX	Accurate and robust brain extraction is a critical step in most neuroimaging analysis pipelines. In particular, for the large-scale multi-site neuroimaging studies involving a significant number of subjects with diverse age and diagnostic groups, accurate and robust extraction of the brain automatically and consistently is highly desirable. In this paper, we introduce population-specific probability maps to guide the brain extraction of diverse subject groups, including both healthy and diseased adult human populations, both developing and aging human populations, as well as non-human primates. Specifically, the proposed method combines an atlas-based approach, for coarse skull-stripping, with a deformable-surface-based approach that is guided by local intensity information and population-specific prior information learned from a set of real brain images for more localized refinement. Comprehensive quantitative evaluations were performed on the diverse large-scale populations of ADNI dataset with over 800 subjects (55 similar to 90 years of age, multi-site, various diagnosis groups), OASIS dataset with over 400 subjects (18 similar to 96 years of age, wide age range, various diagnosis groups), and NIH pediatrics dataset with 150 subjects (5 similar to 18 years of age, multi-site, wide age range as a complementary age group to the adult dataset). The results demonstrate that our method consistently yields the best overall results across almost the entire human life span, with only a single set of parameters. To demonstrate its capability to work on non-human primates, the proposed method is further evaluated using a rhesus macaque dataset with 20 subjects. Quantitative comparisons with popularly used state-of-the-art methods, including BET, Two-pass BET, BET-B, BSE, HWA, ROBEX and AFNI, demonstrate that the proposed method performs favorably with superior performance on all testing datasets, indicating its robustness and effectiveness.	[Wang, Yaping; Guo, Lei] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi Provinc, Peoples R China; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Geng, Xiujuan] NIDA, Neuroimaging Res Branch, Baltimore, MD USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Northwestern Polytechnical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; Li, Gang/D-3324-2013; Geng, Xiujuan/AAR-4306-2020	Shen, Dinggang/0000-0002-7934-5698; Li, Gang/0000-0001-9585-1382; Geng, Xiujuan/0000-0003-4953-0208	NIH [EB008374, EB006733, EB009634, AG041721, MH100217, AG042599]; National Natural Science Foundation of China [61273362, 61333017]; National Research Foundation grant of Korea [2012-005741]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB006733, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217, P50MH071616, R01MH056584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021910, K01AG030514, P50AG005681, R01AG041721, P01AG003991, P30AG010129, R01AG042599, U01AG024904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation grant of Korea(National Research Foundation of Korea); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants EB008374, EB006733, EB009634, AG041721, MH100217, AG042599, National Natural Science Foundation of China (No. 61273362, No. 61333017), and National Research Foundation grant of Korea (No. 2012-005741). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. ADNI data collection and sharing for this project was supported by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904), P30 AG010129, K01 AG030514, the Dana Foundation. OASIS data collection and sharing for this project was supported by P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MS, 1998, IEEE T MED IMAGING, V17, P98, DOI 10.1109/42.668699; BOMANS M, 1990, IEEE T MED IMAGING, V9, P177, DOI 10.1109/42.56342; BRUMMER ME, 1993, IEEE T MED IMAGING, V12, P153, DOI 10.1109/42.232244; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Chiverton J, 2007, COMPUT BIOL MED, V37, P342, DOI 10.1016/j.compbiomed.2006.04.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fennema-Notestine C, 2006, HUM BRAIN MAPP, V27, P99, DOI 10.1002/hbm.20161; Germond L, 2000, ARTIF INTELL MED, V20, P77, DOI 10.1016/S0933-3657(00)00054-3; Hahn HK, 2000, LECT NOTES COMPUT SC, V1935, P134; HOHNE KH, 1992, J COMPUT ASSIST TOMO, V16, P285, DOI 10.1097/00004728-199203000-00019; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huh S, 2002, COMPUT BIOL MED, V32, P311, DOI 10.1016/S0010-4825(02)00023-9; Iglesias JE, 2011, IEEE T MED IMAGING; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lee C, 1998, COMPUT BIOL MED, V28, P309, DOI 10.1016/S0010-4825(98)00013-4; Lemieux L, 1999, MAGN RESON MED, V42, P127, DOI 10.1002/(SICI)1522-2594(199907)42:1<127::AID-MRM17>3.0.CO;2-O; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Miura N, 2002, J COMPUT ASSIST TOMO, V26, P927, DOI 10.1097/00004728-200211000-00012; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rehm K, 2004, NEUROIMAGE, V22, P1262, DOI 10.1016/j.neuroimage.2004.03.011; Rex DE, 2004, NEUROIMAGE, V23, P625, DOI 10.1016/j.neuroimage.2004.06.019; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Sadananthan SA, 2010, NEUROIMAGE, V49, P225, DOI 10.1016/j.neuroimage.2009.08.050; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shan ZY, 2002, NEUROIMAGE, V17, P1587, DOI 10.1006/nimg.2002.1287; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Shattuck DW, 2009, NEUROIMAGE, V45, P431, DOI 10.1016/j.neuroimage.2008.10.066; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Vercauteren T., 2007, LNCS, V10, P319, DOI DOI 10.1016/J.NEUR0IMAGE.2008.10.040; Wang Y, 2012, GROUPWISE SEGMENTATI, P185; Wang YP, 2013, I S BIOMED IMAGING, P1364; Wang YP, 2011, LECT NOTES COMPUT SC, V6893, P635, DOI 10.1007/978-3-642-23626-6_78; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuang AH, 2006, NEUROIMAGE, V32, P79, DOI 10.1016/j.neuroimage.2006.03.019	49	298	308	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e77810	10.1371/journal.pone.0077810	http://dx.doi.org/10.1371/journal.pone.0077810			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489639	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000002
J	Wu, FQ; Price, BW; Haider, W; Seufferheld, G; Nelson, R; Hanzawa, Y				Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Nelson, Randall; Hanzawa, Yoshie			Functional and Evolutionary Characterization of the CONSTANS Gene Family in Short-Day Photoperiodic Flowering in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; TIME GENE; LOCUS-T; ARABIDOPSIS; EXPRESSION; MATURITY; ORTHOLOG; SEQUENCE; NEOFUNCTIONALIZATION; DUPLICATION	CONSTANS (CO) plays a central role in photoperiodic flowering control of plants. However, much remains unknown about the function of the CO gene family in soybean and the molecular mechanisms underlying short-day photoperiodic flowering of soybean. We identified 26 CO homologs (GmCOLs) in the soybean genome, many of them previously unreported. Phylogenic analysis classified GmCOLs into three clades conserved among flowering plants. Two homeologous pairs in Clade I, GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b, showed the highest sequence similarity to Arabidopsis CO. The mRNA abundance of GmCOL1a and GmCOL1b exhibited a strong diurnal rhythm under flowering-inductive short days and peaked at dawn, which coincided with the rise of GmFT5a expression. In contrast, the mRNA abundance of GmCOL2a and GmCOL2b was extremely low. Our transgenic study demonstrated that GmCOL1a, GmCOL1b, GmCOL2a and GmCOL2b fully complemented the late flowering effect of the co-1 mutant in Arabidopsis. Together, these results indicate that GmCOL1a and GmCOL1b are potential inducers of flowering in soybean. Our data also indicate rapid regulatory divergence between GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b but conservation of their protein function. Dynamic evolution of GmCOL regulatory mechanisms may underlie the evolution of photoperiodic signaling in soybean.	[Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Hanzawa, Yoshie] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Nelson, Randall] Univ Illinois, Dept Crop Sci, USDA Agr Res Serv, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Hanzawa, Y (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	yhanzawa@illinois.edu	Haider, Waseem/AAD-6214-2019	Haider, Waseem/0000-0001-9200-6714; Hanzawa, Yoshie/0000-0003-4704-8872	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [USDA-NIFA2011-00078]; ARS [ARS-0424505] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project is supported by the Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (USDA-NIFA2011-00078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Almada R, 2009, PLANT CELL REP, V28, P1193, DOI 10.1007/s00299-009-0720-4; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Borthwick HA, 1939, BOT GAZ, V101, P341, DOI 10.1086/334874; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gonzalez-Schain ND, 2008, BIOL PLANTARUM, V52, P251, DOI 10.1007/s10535-008-0054-z; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Gu XF, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001649; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; He YH, 2012, TRENDS PLANT SCI, V17, P556, DOI 10.1016/j.tplants.2012.05.001; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Herrmann D, 2010, THEOR APPL GENET, V121, P865, DOI 10.1007/s00122-010-1356-z; Hsu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045448; Imamura S, 1967, PHYSL FLOWERING PHAR; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kikuchi R, 2012, J EXP BOT, V63, P773, DOI 10.1093/jxb/err299; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Liu JY, 2001, PLANT PHYSIOL, V125, P1821, DOI 10.1104/pp.125.4.1821; Liu L, 2011, RUSS J PLANT PHYSL+, V58, P330, DOI 10.1134/S1021443711020105; Ma JinHua, 2009, Plant Physiology Communications, V46, P17; Martin J, 2004, PLANT MOL BIOL, V56, P159, DOI 10.1007/s11103-004-2647-z; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Molnar SJ, 2003, GENOME, V46, P1024, DOI [10.1139/g03-079, 10.1139/G03-079]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu F, 2014, HDB PLANT CROP PHYSL, P129; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang QingZhe, 2010, Acta Agronomica Sinica, V36, P539; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	59	97	105	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85754	10.1371/journal.pone.0085754	http://dx.doi.org/10.1371/journal.pone.0085754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24489881	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500105
J	Zhou, JH; Wang, YF; Wang, Y; Yin, X; He, YF; Chen, LL; Wang, WW; Liu, T; Di, W				Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen			FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BREAST-CANCER; REPAIR; RESISTANCE; CELLS; CONTRIBUTES; EXPRESSION	Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in ovarian cancers with chemoresistance to cisplatin. Our results indicate that FOXM1 is upregulated in chemoresistant ovarian cancer samples, and defends ovarian cancer cells against cytotoxicity of cisplatin. FOXM1 facilitates DNA repair through regulating direct transcriptional target EXO1 to protect ovarian cancer cells from cisplatin-mediated apoptosis. Attenuating FOXM1 and EXO1 expression by small interfering RNA, augments the chemotherapy efficacy against ovarian cancer. Our findings indicate that targeting FOXM1 and its target gene EXO1 could improve cisplatin effect in ovarian cancer, confirming their role in modulating cisplatin sensitivity.	[Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Focus Construct Subject Shanghai Educ Dept, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Shanghai Hlth Bur Key Disciplines & Specialties F, Shanghai, Peoples R China; [Zhou, Jinhua] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Di, W (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	diwen163@163.com	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	National Natural Science Foundation of China [81272882, 81302275, 81072137]; Shanghai Committee of Science and Technology [12411950200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	In accomplish of this manuscript, the authors have received the support of the National Natural Science Foundation of China (Grant No. 81272882, 81302275, 81072137) and Shanghai Committee of Science and Technology (Grant No. 12411950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chang IY, 2005, BIOCHEM BIOPH RES CO, V327, P225, DOI 10.1016/j.bbrc.2004.12.008; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Eccleston J, 2011, J IMMUNOL, V186, P2336, DOI 10.4049/jimmunol.1003104; Furuta T, 2002, CANCER RES, V62, P4899; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhao R, 2014, MOL CANCER RES, V12, P370, DOI 10.1158/1541-7786.MCR-13-0281; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Ziebarth AJ, 2013, CLIN CANCER RES, V19, P170, DOI 10.1158/1078-0432.CCR-12-1045	40	158	163	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96989	10.1371/journal.pone.0096989	http://dx.doi.org/10.1371/journal.pone.0096989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24454741	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200045
J	Zhou, J; Xiao, KF; Wei, BY; Wang, Z; Tian, Y; Tian, YX; Song, QS				Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng			Bioaccumulation of Cry1Ab Protein from an Herbivore Reduces Anti-Oxidant Enzyme Activities in Two Spider Species	PLOS ONE			English	Article							BT RICE; SUPEROXIDE-DISMUTASE; BROWN PLANTHOPPER; FIELD-EVALUATION; TRANSGENIC RICE; GENES; RESISTANCE; DIVERSITY; LINES	Cry proteins are expressed in rice lines for lepidopteran pest control. These proteins can be transferred from transgenic rice plants to non-target arthropods, including planthoppers and then to a predatory spider. Movement of Cry proteins through food webs may reduce fitness of non-target arthropods, although recent publications indicated no serious changes in nontarget populations. Nonetheless, Cry protein intoxication influences gene expression in Cry-sensitive insects. We posed the hypothesis that Cry protein intoxication influences enzyme activities in spiders acting in tri-trophic food webs. Here we report on the outcomes of experiments designed to test our hypothesis with two spider species. We demonstrated that the movement of CryAb protein from Drosophila culture medium into fruit flies maintained on the CryAb containing medium and from the flies to the spiders Ummeliata insecticeps and Pardosa pseudoannulata. We also show that the activities of three key metabolic enzymes, acetylcholine esterase (AchE), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) were significantly influenced in the spiders after feeding on Cry1Ab-containing fruit flies. We infer from these data that Cry proteins originating in transgenic crops impacts non-target arthropods at the physiological and biochemical levels, which may be one mechanism of Cry protein-related reductions in fitness of non-target beneficial predators.	[Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Hunan Agricultural University; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	wangzhispider@hotmail.com; SongQ@missouri.edu	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	Natural Science Foundation of P. R. China [31071943, 31272339]; Scientific Research Fund of Hunan Provincial Education Department [10A054]	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was in part supported by the Natural Science Foundation of P. R. China (No. 31071943). The additional part of the funding of the study has come from Natural Science Foundation of P. R. China (No. 31272339) and Scientific Research Fund of Hunan Provincial Education Department(No. 10A054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir K, 2004, MOL BREEDING, V13, P301, DOI 10.1023/B:MOLB.0000034078.54872.25; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Chen H, 2008, J ECON ENTOMOL, V101, P182, DOI 10.1603/0022-0493(2008)101[182:EOTBTR]2.0.CO;2; Chen Mao, 2003, Acta Phytophylacica Sinica, V30, P365; Chen Mao, 2003, Journal of Zhejiang University (Agriculture and Life Sciences), V29, P29; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; GORUN V, 1978, ANAL BIOCHEM, V86, P324, DOI 10.1016/0003-2697(78)90350-0; Hoefler CD, 2006, J ECON ENTOMOL, V99, P432, DOI 10.1603/0022-0493-99.2.432; Jones AK, 2010, ADV EXP MED BIOL, V683, P25; Li FF, 2007, ENVIRON ENTOMOL, V36, P646, DOI 10.1603/0046-225X(2007)36[646:AAADIB]2.0.CO;2; Liu Li-Jun, 2010, Acta Arachnologica Sinica, V19, P47; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; Missirlis F, 2003, PROCEEDINGS OF THE MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH, EUROPEAN SECTION, P147; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oppert B, 2012, PLOS ONE, V4; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Riaz N, 2006, S AFR J BOT, V72, P217, DOI 10.1016/j.sajb.2005.07.005; Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sogawa K, 2003, CHINESE J RICE SCI, V17, P47; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Ye RJ, 2009, PEST MANAG SCI, V65, P1015, DOI 10.1002/ps.1788; Zaidi MA, 2009, MOL BIOTECHNOL, V43, P232, DOI 10.1007/s12033-009-9201-9	28	158	163	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84724	10.1371/journal.pone.0084724	http://dx.doi.org/10.1371/journal.pone.0084724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454741	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500016
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
